Prevalence Estimate Name,Publication Date,Grade of Estimate Scope,Country,Alpha3 Code,State/Province,City,Sampling Start Date,Sampling End Date,Sample Frame (groups of interest),Sample Frame (age),Denominator Value,Serum positive prevalence,"Serum pos prevalence, 95pct CI Lower","Serum pos prevalence, 95pct CI Upper",Sampling Method,Test Manufacturer,Test Type,Isotype(s) Reported,Sensitivity,Specificity,Overall Risk of Bias (JBI),Source Type,First Author Full Name,Lead Institution,URL,Date Created,Last modified time,Data Quality Status
210331_Bulawayo_UniversityofEdinburgh_Primary,31-Mar-21,Regional,Zimbabwe,ZWE,Bulawayo,,09-Jun-20,22-Jun-20,Health care workers and caregivers,Multiple groups,635,8.90%,6.90%,11.50%,Self-referral,Wuhan UNscience Biotechnology Co. Ltd,LFIA,"IgG,IgM",98.51%,88.21%,High,Journal Article (Peer-Reviewed),Simbarashe Rusakaniko,University of Edinburgh,https://dx.doi.org/10.1371/journal.pntd.0009254,16/04/2021,16/07/2022,Verified
211023_Harare_BiomedicalResearchandTrainingInstituteHarare_February2021_Overall,23-Oct-21,Local,Zimbabwe,ZWE,Harare,Harare,10-Feb-21,17-Apr-21,Household and community samples,Multiple groups,1530,53.00%,49.60%,56.40%,Simplified probability,NA,Other,Not reported,99.20%,98.65%,Moderate,Journal Article (Peer-Reviewed),Arun Fryatt,Biomedical Research and Training Institute,https://dx.doi.org/10.1016/j.eclinm.2021.101172,09/11/2021,16/07/2022,Verified
211023_Harare_BiomedicalResearchandTrainingInstituteHarare_November2020_Overall,23-Oct-21,Local,Zimbabwe,ZWE,Harare,Harare,20-Nov-20,20-Dec-20,Household and community samples,Multiple groups,620,19.00%,15.10%,23.50%,Simplified probability,NA,Other,Not reported,99.20%,98.65%,Moderate,Journal Article (Peer-Reviewed),Arun Fryatt,Biomedical Research and Training Institute,https://dx.doi.org/10.1016/j.eclinm.2021.101172,09/11/2021,16/07/2022,Verified
210309_Zambia_ZambiaMinistryofHealth_overall,09-Mar-21,National,Zambia,ZMB,"Kabwe, Livingstone, Lusaka, Nakonde, Ndola, Solwezi",,04-Jul-20,27-Jul-20,Household and community samples,Multiple groups,2704,2.10%,1.10%,3.10%,Stratified probability,EUROIMMUN,ELISA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Lloyd B Mulenga,Zambia Ministry of Health,https://www.thelancet.com/journals/langlo/article/PIIS2214-109X(21)00053-X/fulltext,13/03/2021,16/07/2022,Verified
210330_Zambia_ZambiaMinistryofHealth_HCW,30-Mar-21,National,Zambia,ZMB,"Kabwe, Livingstone, Lusaka, Nakonde, Ndola, Solwezi, Pooled",,02-Jul-20,31-Jul-20,Health care workers and caregivers,Multiple groups,575,2.20%,0.50%,3.90%,Stratified non-probability,EUROIMMUN,ELISA,IgG,90.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Sombo Fwoloshi,Zambia Ministry of Health,https://dx.doi.org/10.1093/cid/ciab273,02/05/2021,16/07/2022,Unverified
210506_Zambia_CentreForInfectiousDiseaseResearchInZambia_Lusaka2_Infants,06-May-21,Local,Zambia,ZMB,Lusaka Province,Lusaka,15-Aug-20,15-Dec-20,Household and community samples,Children and Youth (0-17 years),150,6.00%,,,Convenience,NA,ELISA,IgG,,,High,Preprint,Natasha Makabilo Laban,Centre for Infectious Disease Research in Zambia,https://wellcomeopenresearch.org/articles/6-97/v1,19/05/2021,16/07/2022,Verified
210506_Zambia_CentreForInfectiousDiseaseResearchInZambia_Kalulushi1_HCW,06-May-21,Local,Zambia,ZMB,Copperbelt Province ,Kalulushi,01-Aug-20,30-Aug-20,Health care workers and caregivers,Adults (18-64 years),237,8.00%,,,Convenience,NA,ELISA,IgG,,,High,Preprint,Natasha Makabilo Laban,Centre for Infectious Disease Research in Zambia,https://wellcomeopenresearch.org/articles/6-97/v1,19/05/2021,16/07/2022,Verified
210801_Zambia_USCDC_Outpatient_Primary_Adj,01-Aug-21,National,Zambia,ZMB,"Kabwe, Livingstone, Lusaka, Nakonde, Ndola, Solwezi",NR,02-Jul-20,31-Jul-20,Residual sera,Multiple groups,1657,8.20%,5.10%,11.40%,Convenience,EUROIMMUN,ELISA,IgG,65.70%,100.00%,High,Journal Article (Peer-Reviewed),Jonas Z Hines,US Centers for Disease Control and Prevention,https://wwwnc.cdc.gov/eid/article/27/8/21-0502_article,27/07/2021,16/07/2022,Verified
220316_Zambia_Zambart_Primary,16-Mar-22,Local,Zambia,ZMB,Zambian Central Province,NR,15-Oct-20,15-Mar-21,Household and community samples,Multiple groups,2977,13.50%,,,Simplified probability,Abbott Laboratories,CLIA,IgG,99.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Kwame Shanaube,Zambart,https://dx.doi.org/10.1016/j.ijid.2022.03.021,03/04/2022,16/07/2022,Verified
211216_Aden_HadhramoutUniversity_Primary,16-Dec-21,Local,Yemen,YEM,Adan Governorate,Aden,15-Nov-20,15-Dec-20,Household and community samples,Multiple groups,2001,27.40%,25.60%,29.30%,Stratified probability,"Healgen,Beijing Wantai Biological",Multiple Types,"IgG,IgM",,,Moderate,Journal Article (Peer-Reviewed),Abdulla Bin-Ghouth,"World Health Organization Country Office, Yemen",https://dx.doi.org/10.1016/j.ijid.2021.12.330,18/01/2022,16/07/2022,Verified
201118_HoChiMinhCity_OxfordUniversityClinicalResearchUnit_overall,18-Nov-20,Local,Viet Nam,VNM,Đông Nam Bộ,Ho Chi Minh City,23-Aug-20,30-Aug-20,Health care workers and caregivers,Adults (18-64 years),408,0.00%,,,Convenience,Roche Diagnostics,CLIA,Total Antibody,97.20%,99.80%,High,Journal Article (Peer-Reviewed),Nguyen Van Vinh Chau,Oxford University Clinical Research Unit,https://dx.doi.org/10.1016/j.jinf.2020.11.018,23/01/2021,16/07/2022,Verified
210302_Vietnam_UniversitatsklinikumTubingen_HCW_ELISA_TotalAb,02-Mar-21,Local,Viet Nam,VNM,Red River Delta,Hanoi,01-Mar-20,08-Jan-21,Health care workers and caregivers,Adults (18-64 years),1065,0.56%,,,Unclear,Beijing Wantai Biological,ELISA,Total Antibody,,,High,Journal Article (Peer-Reviewed),Le Huu Song,Universitätsklinikum Tübingen,https://dx.doi.org/10.1016/j.lanwpc.2021.100113,10/04/2021,16/07/2022,Verified
210302_Vietnam_UniversitatsklinikumTubingen_patients_ELISA_TotalAb,02-Mar-21,Local,Viet Nam,VNM,Red River Delta,Hanoi,01-Mar-20,08-Jan-21,Patients seeking care for non-COVID-19 reasons,Multiple groups,288,0.00%,,,Unclear,Beijing Wantai Biological,ELISA,Total Antibody,,,High,Journal Article (Peer-Reviewed),Le Huu Song,Universitätsklinikum Tübingen,https://dx.doi.org/10.1016/j.lanwpc.2021.100113,10/04/2021,16/07/2022,Verified
210610_Vietnam_TheUniversityOfSydney_GenPop1_overall,11-Jun-21,National,Viet Nam,VNM,"Hanoi Capital, Quang Nam Province, Da Nang Province","Hoi sub-commune in Ha Loi commune, Me Linh district, Hanoi Capital,  Giao Ai sub-commune in Dien Hong commune, Dien Ban, Quang Nam Province, Luu Minh sub-commune in Ha Lam Town, Quang Nam, Le Son Nam sub-commune in Hoa Tien commune, Da Nang ",04-Sep-20,23-Nov-20,Household and community samples,Multiple groups,3034,0.40%,,,Unclear,Roche Diagnostics,CLIA,IgG,96.80%,99.80%,Moderate,Journal Article (Peer-Reviewed),Tasnim Hasan,The University of Sydney,http://dx.doi.org/10.3390/ijerph18126353,21/06/2021,16/07/2022,Verified
210610_Vietnam_TheUniversityOfSydney_HCW2_overall,11-Jun-21,Local,Viet Nam,VNM,Da Nang,,24-Nov-20,30-Nov-20,Health care workers and caregivers,Adults (18-64 years),148,0.00%,,,Convenience,Roche Diagnostics,CLIA,IgG,96.80%,99.80%,High,Journal Article (Peer-Reviewed),Tasnim Hasan,The University of Sydney,http://dx.doi.org/10.3390/ijerph18126353,21/06/2021,16/07/2022,Verified
210302_Vietnam_UniversitatsklinikumTubingen_patients_RDT,02-Mar-21,Local,Viet Nam,VNM,Red River Delta,Hanoi,01-Mar-20,08-Jan-21,Patients seeking care for non-COVID-19 reasons,Multiple groups,288,0.00%,,,Unclear,Beijing Wantai Biological,LFIA,Total Antibody,,,High,Journal Article (Peer-Reviewed),Le Huu Song,Universitätsklinikum Tübingen,https://dx.doi.org/10.1016/j.lanwpc.2021.100113,30/06/2021,16/07/2022,Verified
210610_Vietnam_TheUniversityOfSydney_GenPop1_Male,11-Jun-21,National,Viet Nam,VNM,"Hanoi Capital, Quang Nam Province, Da Nang Province","Hoi sub-commune in Ha Loi commune, Me Linh district, Hanoi Capital,  Giao Ai sub-commune in Dien Hong commune, Dien Ban, Quang Nam Province, Luu Minh sub-commune in Ha Lam Town, Quang Nam, Le Son Nam sub-commune in Hoa Tien commune, Da Nang ",04-Sep-20,23-Nov-20,Household and community samples,Multiple groups,1624,0.37%,,,Unclear,Roche Diagnostics,CLIA,IgG,96.80%,99.80%,Moderate,Journal Article (Peer-Reviewed),Tasnim Hasan,The University of Sydney,http://dx.doi.org/10.3390/ijerph18126353,29/09/2021,16/07/2022,Verified
210610_Vietnam_TheUniversityOfSydney_GenPop1_Female,11-Jun-21,National,Viet Nam,VNM,"Hanoi Capital, Quang Nam Province, Da Nang Province","Hoi sub-commune in Ha Loi commune, Me Linh district, Hanoi Capital,  Giao Ai sub-commune in Dien Hong commune, Dien Ban, Quang Nam Province, Luu Minh sub-commune in Ha Lam Town, Quang Nam, Le Son Nam sub-commune in Hoa Tien commune, Da Nang ",04-Sep-20,23-Nov-20,Household and community samples,Multiple groups,1410,0.50%,,,Unclear,Roche Diagnostics,CLIA,IgG,96.80%,99.80%,Moderate,Journal Article (Peer-Reviewed),Tasnim Hasan,The University of Sydney,http://dx.doi.org/10.3390/ijerph18126353,29/09/2021,16/07/2022,Verified
210927_Hanoi_NationalCenterforGlobalHealthandMedicine_primary,27-Sep-21,Local,Viet Nam,VNM,,Hanoi,01-Jun-20,31-Jul-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,1243,0.20%,,,Unclear,Abbott Laboratories,CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Shoko Matsumoto,National Center for Global Health and Medicine,https://dx.doi.org/10.1007/s10461-021-03464-w,12/10/2021,16/07/2022,Unverified
220126_HoChiMinhCity_PasteurInstituteOfHoChiMinhCity_PopAdj_Overall,26-Jan-22,Local,Viet Nam,VNM,,Ho Chi Minh City,27-Aug-20,07-Nov-20,Blood donors,Adults (18-64 years),885,0.20%,0.05%,0.81%,Sequential,NA,Neutralization,IgG,,100.00%,Moderate,Journal Article (Peer-Reviewed),Hanh Hong Ho Nguyen,Pasteur Institute of Ho Chi Minh City,https://dx.doi.org/10.4269/ajtmh.21-0259,01/02/2022,16/07/2022,Unverified
211211_Vietnam_UniversityofSydney_BacMaSubCommune,11-Dec-21,Local,Viet Nam,VNM,Quang Ninh,,01-Jan-21,28-Feb-21,Household and community samples,Multiple groups,897,0.10%,,,Convenience,Roche Diagnostics,Not reported,Not reported,96.80%,99.80%,Moderate,Journal Article (Peer-Reviewed),Tasnim Hasan,University of Sydney,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8665841/,29/06/2022,16/07/2022,Unverified
211211_Vietnam_UniversityofSydney_TienSubCommune,11-Dec-21,Local,Viet Nam,VNM,Hai Duong,,01-Jan-21,28-Feb-21,Household and community samples,Multiple groups,1172,0.40%,,,Convenience,Roche Diagnostics,Not reported,Not reported,96.80%,99.80%,Moderate,Journal Article (Peer-Reviewed),Tasnim Hasan,University of Sydney,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8665841/,29/06/2022,16/07/2022,Unverified
220620_Vietnam_UnitedStatesCDC,20-Jun-22,National,Viet Nam,VNM,Red River Delta,Hanoi,01-Feb-21,28-Feb-21,Health care workers and caregivers,Multiple groups,617,0.16%,,,Convenience,Roche Diagnostics,ELISA,IgG,,,Unclear,Journal Article (Peer-Reviewed),Dien Vu,U.S. Centers for Disease Control and Prevention,https://dx.doi.org/10.1093/cid/ciac493,29/06/2022,16/07/2022,Unverified
211211_Vietnam_UniversityofSydney_HCWs,11-Dec-21,Local,Viet Nam,VNM,Quang Ninh,,01-Jan-21,28-Feb-21,Health care workers and caregivers,Adults (18-64 years),15,6.70%,,,Convenience,Roche Diagnostics,Not reported,Not reported,96.80%,99.80%,High,Journal Article (Peer-Reviewed),Tasnim Hasan,University of Sydney,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8665841/,29/06/2022,16/07/2022,Unverified
211211_Vietnam_UniversityofSydney_LogisticandSecurity,11-Dec-21,Local,Viet Nam,VNM,Quang Ninh,,01-Jan-21,28-Feb-21,Health care workers and caregivers,Adults (18-64 years),11,0.00%,,,Convenience,Roche Diagnostics,Not reported,Not reported,96.80%,99.80%,High,Journal Article (Peer-Reviewed),Tasnim Hasan,University of Sydney,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8665841/,29/06/2022,16/07/2022,Unverified
211211_Vietnam_UniversityofSydney_SpecimenCollectors,11-Dec-21,Local,Viet Nam,VNM,Quang Ninh,,01-Jan-21,28-Feb-21,Health care workers and caregivers,Adults (18-64 years),24,0.00%,,,Convenience,Roche Diagnostics,Not reported,Not reported,96.80%,99.80%,High,Journal Article (Peer-Reviewed),Tasnim Hasan,University of Sydney,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8665841/,29/06/2022,16/07/2022,Unverified
210731_Caracas_UniversidadCentraldeVenezuela,31-Jul-21,Local,Venezuela (Bolivarian Republic of),VEN,,Caracas,01-Feb-21,06-Feb-21,Health care workers and caregivers,Multiple groups,86,31.40%,,,Simplified probability,NA,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Franklin Claro,Universidad Central de Venezuela,https://dx.doi.org/10.1016/j.ijid.2021.07.070,10/08/2021,16/07/2022,Verified
210301_Uzbekistan_ResearchInstituteofVirology,01-Mar-21,National,Uzbekistan,UZB,,,27-Aug-20,11-Sep-20,Residual sera,Multiple groups,86879,23.10%,23.00%,23.20%,Convenience,Beijing Wantai Biological,LFIA,"IgG,IgM",,,Unclear,Journal Article (Peer-Reviewed),R A Rakhimov ,Research Institute of Virology,https://ejmcm.com/article_9453.html,17/05/2021,16/07/2022,Unverified
200424_Brevard_OMNI_GeneralPopulation,24-Apr-20,Local,United States of America,USA,Florida,,17-Apr-20,24-Apr-20,Household and community samples,Multiple groups,1000,1.00%,,,Self-referral,NA,LFIA,"IgM,IgG",100.00%,100.00%,High,News and Media,Alessandro Sassoon,OMNI Healthcare,https://www.floridatoday.com/story/news/2020/04/24/omni-covid-19-immunity-testing-data-brevard-county-florida-antibody/3022571001/,02/05/2020,16/07/2022,Verified
200422_Idaho_CrushTheCurveIdaho_Patients,22-Apr-20,Regional,United States of America,USA,Idaho,,,22-Apr-20,Residual sera,Multiple groups,1946,1.75%,,,Convenience,NA,Not reported,IgG,100.00%,99.60%,High,News and Media,Ryan Morrison,Crush The Curve Idaho,https://idahonews.com/news/coronavirus/crushthecurveidaho-finds-small-population-with-antibodies-we-are-far-from-herd-immunity,02/05/2020,16/07/2022,Verified
200423_BatonRouge_BatonRougeGeneralHospital_GenPop,28-Apr-20,Local,United States of America,USA,Louisiana,Baton Rouge,,21-Apr-20,Household and community samples,Multiple groups,432,4.40%,,,Unclear,NA,Not reported,Not reported,,98.60%,Unclear,News and Media,Blake Paterson,Baton Rouge General Hospital,https://www.theadvocate.com/baton_rouge/news/coronavirus/article_b499efa0-8983-11ea-a3f1-af936ecb1d2c.html,03/05/2020,16/07/2022,Verified
200508_Seattle_UniversityofWashington_Adults,08-May-20,Local,United States of America,USA,Washington,Seattle,01-Mar-20,31-Mar-20,Residual sera,Adults (18-64 years),221,0.40%,,,Convenience,NA,Not reported,Not reported,,,High,Institutional Report,Anne Schuchat,University of Washington,https://www.cdc.gov/mmwr/volumes/69/wr/pdfs/mm6918e2-H.pdf,03/05/2020,16/07/2022,Verified
200503_SaltLakeCity_UniversityofUtah_HCW,03-May-20,Local,United States of America,USA,Utah,Salt Lake City,13-Apr-20,19-Apr-20,Health care workers and caregivers,Adults (18-64 years),270,5.90%,,,Convenience,EUROIMMUN,ELISA,IgG,95.40%,98.30%,High,Journal Article (Peer-Reviewed),Troy Madsen,University of Utah,https://www.ajemjournal.com/article/S0735-6757(20)30306-5/fulltext,14/05/2020,16/07/2022,Verified
200506_Atlanta_GeorgiaStateUniversity_GeneralPop_IgG,06-May-20,Local,United States of America,USA,Georgia,Atlanta,17-Apr-20,27-Apr-20,Household and community samples,Multiple groups,127,2.36%,,,Convenience,NA,ELISA,IgG,,,High,Preprint,Jun Zou,Georgia State University,https://www.medrxiv.org/content/10.1101/2020.05.01.20087478v1,14/05/2020,16/07/2022,Verified
200515_Winona_WinonaHealth_GeneralPopulation,15-May-20,Local,United States of America,USA,Minnesota,Winona,10-May-20,15-May-20,Household and community samples,Multiple groups,1000,7.00%,,,Self-referral,NA,Not reported,IgG,,,High,News and Media,Mal Meyer,Winona Health,https://www.google.com/url?rct=j&sa=t&url=https://www.news8000.com/new-covid-19-antibody-testing-in-winona-gives-health-officials-a-better-picture-of-the-spread/&ct=ga&cd=CAEYDyoTMTE4NjM1MjEyMTUyMjIzNTE5ODIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNE5fpVM7tRmIsEhSRedRkru-TpZOA,18/05/2020,16/07/2022,Verified
200513_Indiana_IndianaUniversity_Wave1GenPop_PopAdj,24-Jul-20,Regional,United States of America,USA,Indiana,,25-Apr-20,29-Apr-20,Household and community samples,Multiple groups,3518,1.09%,0.80%,1.50%,Stratified probability,NA,CLIA,IgG,100.00%,99.60%,Moderate,Institutional Report,Nir Menachemi,Indiana University Fairbanks School of Public Health,https://www.cdc.gov/mmwr/volumes/69/wr/mm6929e1.htm?s_cid=mm6929e1_w,19/05/2020,16/07/2022,Verified
200523_SouthCarolina_MUSCHealthLancaster_HCW,23-May-20,Local,United States of America,USA,South Carolina,Lancaster,16-Mar-20,20-May-20,Health care workers and caregivers,Adults (18-64 years),230,2.17%,,,Unclear,NA,Not reported,Not reported,,,High,News and Media,Lisa Geraci ,MUSC Health-Lancaster,https://www.google.com/url?rct=j&sa=t&url=https://www.thelancasternews.com/content/antibody-tests-show-just-2-exposure-rate-covid-19&ct=ga&cd=CAEYFSoSNjI0MTExNTA1MzQ0Mjc2MzA2Mho5MGRlYTk4OTk0ZTkxODU5OmNvbTplbjpVUw&usg=AFQjCNEYxEO1T-WE8tAinlY5KZVTRufQSA,26/05/2020,16/07/2022,Verified
200520_Iowa_IowaDepartmentofPublicHealth_IowaStateGeneralPopulation,20-May-20,Regional,United States of America,USA,Iowa,,01-Apr-20,20-May-20,Household and community samples,Adults (18-64 years),18160,10.00%,,,Self-referral,NA,Not reported,IgG,,,High,News and Media,Jeff Montgomery,Iowa Department of Public Health,https://www.google.com/url?rct=j&sa=t&url=https://www.telegraphherald.com/coronavirus/article_b5f56348-317d-5f49-abee-0e7cff653cbb.html&ct=ga&cd=CAAYBDIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNG6tWk8Wg2dbYV27AKz5iI4DLM97Q,30/05/2020,16/07/2022,Verified
200617_NewYork_StateUniversityofNewYork_GeneralPopTestPopAdj,17-Jun-20,Regional,United States of America,USA,New York,,19-Apr-20,28-Apr-20,Household and community samples,Multiple groups,15101,14.00%,13.30%,14.70%,Convenience,NA,CLIA,IgG,87.90%,99.75%,Moderate,Journal Article (Peer-Reviewed),Eli Rosenberg,New York State Department of Health,https://dx.doi.org/10.1016/j.annepidem.2020.06.004,30/05/2020,16/07/2022,Verified
200510_US_StanfordUniversity_MajorLeagueBaseballEmployees,10-May-20,National,United States of America,USA,,,08-Apr-20,21-Apr-20,Non-essential workers and unemployed persons,Adults (18-64 years),5603,0.70%,0.28%,1.15%,Convenience,NA,Not reported,Not reported,,,Unclear,News and Media,Susan Slusser,Stanford University,https://www.sfchronicle.com/athletics/article/MLB-antibody-study-7-percent-exposed-to-15260314.php,02/06/2020,16/07/2022,Verified
200601_LongHillTownship_SummitMedicalCenter_FirstResponders,01-Jun-20,Local,United States of America,USA,New Jersey,Long Hill Township,01-May-20,14-May-20,Essential non-healthcare workers,Adults (18-64 years),70,4.29%,,,Convenience,NA,Not reported,Not reported,,,High,News and Media,Alex Parker Magyar,Summit Medical Center,https://www.google.com/url?rct=j&sa=t&url=https://www.newjerseyhills.com/echoes-sentinel/news/few-among-long-hill-first-responders-test-positive-for-covid-19-antibodies/article_007ac367-b3b2-5375-b471-f0a817998f62.html&ct=ga&cd=CAAYFDIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNHWg839bXiyzOxO1Y7-QOECGMRCMw,03/06/2020,16/07/2022,Verified
200602_NewYork_IcahnSchoolofMedicineatMountSinai_HealthCareWorkers,03-Jun-20,Local,United States of America,USA,New York,New York City,24-Mar-20,04-Apr-20,Health care workers and caregivers,Multiple groups,285,32.63%,,,Self-referral,NA,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Mayce Mansour,Icahn School of Medicine at Mount Sinai,https://link.springer.com/article/10.1007/s11606-020-05926-8,04/06/2020,16/07/2022,Verified
200602_HumboldtCounty_HumboldtCountyDepartmentofHealthandHumanServices_GenPop,02-Jun-20,Local,United States of America,USA,California,,,26-May-20,Household and community samples,Multiple groups,1000,1.00%,,,Unclear,NA,Not reported,Not reported,,,High,News and Media,Shomik Mukherjee ,Humboldt County Department of Health and Human Services,https://www.google.com/url?rct=j&sa=t&url=https://www.times-standard.com/1-of-early-humboldt-county-coronavirus-tests-show-antibodies&ct=ga&cd=CAAYDjIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNFdl7jBbUfA1cB9ZXhwgAM8IvQmrA,07/06/2020,16/07/2022,Verified
200612_Guam_USNavy,12-Jun-20,Local,United States of America,USA,Guam,,20-Apr-20,24-Apr-20,Essential non-healthcare workers,Adults (18-64 years),382,59.70%,,,Convenience,NA,ELISA,"IgG,IgM,IgA",96.00%,99.30%,High,Journal Article (Peer-Reviewed),Daniel Payne,US Navy,https://www.cdc.gov/mmwr/volumes/69/wr/mm6923e4.htm,12/06/2020,16/07/2022,Verified
200612_NewJersey_MonmouthMedicalCentre_HealthCareWorkersUnadj,12-Jun-20,Local,United States of America,USA,New Jersey,Long Branch,14-May-20,19-May-20,Health care workers and caregivers,Adults (18-64 years),121,0.83%,,,Convenience,SD Biosensor,LFIA,IgG,96.20%,96.60%,High,Journal Article (Peer-Reviewed),Mohsin Mughal ,Monmouth Medical Centre,https://www.cambridge.org/core/journals/infection-control-and-hospital-epidemiology/article/prevalence-of-sarscov2-igg-antibodies-in-intensive-care-unit-icu-healthcare-personnel-hcp-and-its-implications-a-singlecenter-prospective-pilot-study/296957BF678E512283D4A3770467FFB7,13/06/2020,16/07/2022,Verified
200614_SteamboatSprings_RouttCountyBoardofHealth_GenPop,14-Jun-20,Local,United States of America,USA,Colorado,Steamboat Springs,,10-Jun-20,Household and community samples,Multiple groups,649,2.60%,,,Self-referral,NA,Not reported,Not reported,,,High,News and Media,Kari Harden ,Routt County Board of Health,https://www.google.com/url?rct=j&sa=t&url=https://www.steamboatpilot.com/news/one-new-positive-covid-19-case-in-routt-county-antibody-testing-ramping-up/&ct=ga&cd=CAEYBSoTNzg3MTAwMjkzNzU0ODU4ODgzODIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNGVI81Ue1Rqm7AhmKKlvb0xWvQDKQ,15/06/2020,16/07/2022,Verified
200617_Indiana_IndianaUniversity_Wave2GenPop,17-Jun-20,Regional,United States of America,USA,Indiana,,03-Jun-20,08-Jun-20,Household and community samples,Multiple groups,3600,1.50%,,,Stratified probability,NA,Not reported,Not reported,,,Moderate,News and Media,Shari Rudavsky,Indiana University Fairbanks School of Public Health,https://www.google.com/url?rct=j&sa=t&url=https://www.indystar.com/story/news/health/2020/06/17/indiana-coronavirus-fairbanks-study-indicates-spread-has-slowed/3208509001/&ct=ga&cd=CAAYETIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNH4O6wDIVkk1hAyMEzD78OGtB7YoQ,23/06/2020,16/07/2022,Verified
200622_TruckeeMeadows_TruckeeMeadowsFireProtectionDistrict_FirstResponders,22-Jun-20,Local,United States of America,USA,Nevada,,01-May-20,31-May-20,Essential non-healthcare workers,Adults (18-64 years),132,14.00%,,,Convenience,NA,Not reported,Not reported,,,High,News and Media,Anh Gray,Truckee Meadows Fire Protection District,https://www.kunr.org/post/prevalence-covid-19-antibodies-washoe-co-expected-be-low#stream/0,24/06/2020,16/07/2022,Verified
200504_SouthCarolina_MedicalUniversitySouthCarolina_HealthcareWorkers_FirstResponders,04-May-20,Local,United States of America,USA,South Carolina,Charleston,27-Apr-20,02-May-20,Multiple populations,Adults (18-64 years),920,2.00%,,,Unclear,NA,Not reported,Not reported,,,High,News and Media,Nick Reagan,Medical University South Carolina,https://www.live5news.com/2020/05/04/results-show-tested-musc-staff-have-covid-antibodies/,27/06/2020,16/07/2022,Verified
200523_CoralSprings_CoralSpringsCityGovernment_CityEmployees,22-May-20,Local,United States of America,USA,Florida,Coral Springs,17-May-20,22-May-20,Essential non-healthcare workers,Multiple groups,700,0.00%,,,Self-referral,Cellex Inc.,Not reported,Not reported,,,Unclear,News and Media,Jenny Staletovich,Coral Springs City Government,https://www.google.com/url?rct=j&sa=t&url=https://www.wlrn.org/post/south-florida-cities-begin-testing-employees-covid-19-antibodies&ct=ga&cd=CAAYDjIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNHc4oWG79OOMovZOpWOY8qd-gm3kw,27/06/2020,16/07/2022,Verified
200520_LosAngeles_UniSouthernCalifornia_GenPop,20-May-20,Local,United States of America,USA,California,,08-May-20,12-May-20,Household and community samples,Multiple groups,1014,2.10%,,,Self-referral,NA,Not reported,Not reported,,,Unclear,News and Media,CBS Los Angeles,University of Southern California,https://www.google.com/url?rct=j&sa=t&url=https://losangeles.cbslocal.com/2020/05/20/la-county-still-far-away-from-herd-immunity-new-antibody-numbers-show/&ct=ga&cd=CAAYCDIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNGRZYAUZKxAbfGM7Yh_03xi5M8tDg,27/06/2020,16/07/2022,Verified
200520_Madison_UWHealth_UniWisconsinHealthClinic,20-May-20,Local,United States of America,USA,Wisconsin,Madison,13-May-20,20-May-20,Household and community samples,Multiple groups,5303,1.50%,,,Self-referral,NA,Not reported,Not reported,,,Unclear,News and Media,Michelle Alfini,UW Health,https://www.google.com/url?rct=j&sa=t&url=https://wkow.com/2020/05/20/antibody-tests-for-coronavirus-so-far-trend-overwhelmingly-negative/&ct=ga&cd=CAAYATIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNHstyT58meN6_pst9Z3Iu6amuxEQQ,27/06/2020,16/07/2022,Verified
200520_Madison_UWHealth_UnityPointClinic,20-May-20,Local,United States of America,USA,Wisconsin,Madison,13-May-20,20-May-20,Household and community samples,Multiple groups,433,0.30%,,,Self-referral,NA,Not reported,Not reported,,,Unclear,News and Media,Michelle Alfini,UW Health,https://www.google.com/url?rct=j&sa=t&url=https://wkow.com/2020/05/20/antibody-tests-for-coronavirus-so-far-trend-overwhelmingly-negative/&ct=ga&cd=CAAYATIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNHstyT58meN6_pst9Z3Iu6amuxEQQ,27/06/2020,16/07/2022,Verified
200624_BaskingRidge_FellowshipVillage_Residents2_Overall,24-Jun-20,Local,United States of America,USA,New Jersey,Basking Ridge,15-Apr-20,06-May-20,Assisted living and long-term care facilities,Seniors (65+ years),371,34.77%,,,Convenience,NA,Not reported,"IgG,IgM",,,Unclear,News and Media,Tim Regan,Fellowship Village,https://www.google.com/url?rct=j&sa=t&url=https://seniorhousingnews.com/2020/06/24/fellowship-village-benefits-from-covid-19-antibody-tests-juniper-plans-pilot/&ct=ga&cd=CAEYAyoTMTA4MjA1OTc5ODY3MTIyMzk1NTIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNFY2y-eZOXQXVuQzcKPUzRHkiG26g,29/06/2020,16/07/2022,Verified
201103_NewYorkCity_MountSinai_RoutineCare_1 _Overall,03-Nov-20,Local,United States of America,USA,New York,New York City,02-Feb-20,05-Jul-20,Residual sera,Multiple groups,6590,11.10%,,,Sequential,NA,ELISA,IgG,95.00%,100.00%,High,Journal Article (Peer-Reviewed),Daniel Stadlbauer,Icahn School of Medicine at Mount Sinai,http://dx.doi.org/10.1038/s41586-020-2912-6,29/06/2020,16/07/2022,Verified
200529_NorthCarolina_Psalms/SolidRockMedicineGroup_GenPop,29-May-20,Local,United States of America,USA,North Carolina,,29-May-20,29-May-20,Household and community samples,Multiple groups,329,1.52%,,,Self-referral,NA,Not reported,Not reported,,,Unclear,News and Media,Steve Ohnesorge,Psalms/Solid Rock Medicine Group,https://www.google.com/url?rct=j&sa=t&url=https://www.wbtv.com/2020/05/29/antibody-testing-continues-burke-county/&ct=ga&cd=CAAYGTIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNEvSO7bk5TLI9MT5-BeF8ILKdseXA,04/07/2020,16/07/2022,Verified
200529_CoachellaValley_Desert Healthcare District_GenPop,29-May-20,Local,United States of America,USA,California,,,28-May-20,Household and community samples,Multiple groups,896,6.00%,,,Self-referral,Phamatech,LFIA,"IgG,IgM",,,Unclear,News and Media,Nicole Hayden,Desert Healthcare District,https://www.google.com/url?rct=j&sa=t&url=https://www.desertsun.com/story/news/health/2020/05/29/coachella-valley-far-covid-19-herd-immunity-preliminary-antibody-tests-show/5280021002/&ct=ga&cd=CAAYKzIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNFQxOqwjTX2Kz2_mnj1RV7Upa8rEg,04/07/2020,16/07/2022,Verified
200528_Michigan_MichiganDepartmentofCorrections_ParnallCFa,28-May-20,Local,United States of America,USA,Michigan,,14-May-20,22-May-20,Persons who are incarcerated,Multiple groups,1248,92.00%,,,Convenience,NA,Not reported,Not reported,,,Unclear,News and Media,Angie Jackson,Michigan Department of Corrections ,https://www.google.com/url?rct=j&sa=t&url=https://www.petoskeynews.com/news/state-region/almost-everyone-at-one-michigan-prison-tests-positive-for-covid-19-antibodies/article_423c1ef0-a018-5b50-b746-c93fcb82f71f.html&ct=ga&cd=CAAYEDIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNGW46yu1TPu2kCI0JVHs2BTsuSgjw,06/07/2020,16/07/2022,Verified
200528_Michigan_MichiganDepartmentofCorrections_MacombCF,28-May-20,Local,United States of America,USA,Michigan,Lenox Township,14-May-20,22-May-20,Persons who are incarcerated,Multiple groups,1201,65.60%,,,Convenience,NA,Not reported,Not reported,,,Unclear,News and Media,Angie Jackson,Michigan Department of Corrections ,https://www.google.com/url?rct=j&sa=t&url=https://www.petoskeynews.com/news/state-region/almost-everyone-at-one-michigan-prison-tests-positive-for-covid-19-antibodies/article_423c1ef0-a018-5b50-b746-c93fcb82f71f.html&ct=ga&cd=CAAYEDIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNGW46yu1TPu2kCI0JVHs2BTsuSgjw,06/07/2020,16/07/2022,Verified
200528_Michigan_MichiganDepartmentofCorrections_DetroitRC,28-May-20,Local,United States of America,USA,Michigan,Detroit,14-May-20,22-May-20,Persons who are incarcerated,Multiple groups,57,35.00%,,,Convenience,NA,Not reported,Not reported,,,Unclear,News and Media,Angie Jackson,Michigan Department of Corrections ,https://www.google.com/url?rct=j&sa=t&url=https://www.petoskeynews.com/news/state-region/almost-everyone-at-one-michigan-prison-tests-positive-for-covid-19-antibodies/article_423c1ef0-a018-5b50-b746-c93fcb82f71f.html&ct=ga&cd=CAAYEDIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNGW46yu1TPu2kCI0JVHs2BTsuSgjw,06/07/2020,16/07/2022,Verified
200528_Michigan_MichiganDepartmentofCorrections_GRobertCottonCF,28-May-20,Local,United States of America,USA,Michigan,,14-May-20,22-May-20,Persons who are incarcerated,Multiple groups,867,12.22%,,,Convenience,NA,Not reported,Not reported,,,Unclear,News and Media,Angie Jackson,Michigan Department of Corrections ,https://www.google.com/url?rct=j&sa=t&url=https://www.petoskeynews.com/news/state-region/almost-everyone-at-one-michigan-prison-tests-positive-for-covid-19-antibodies/article_423c1ef0-a018-5b50-b746-c93fcb82f71f.html&ct=ga&cd=CAAYEDIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNGW46yu1TPu2kCI0JVHs2BTsuSgjw,06/07/2020,16/07/2022,Verified
200729_Philadelphia_UniversityofPennsylvania_TotalSampleTestAdj,29-Jul-20,Local,United States of America,USA,Pennsylvania,Philadelphia,04-Apr-20,03-Jun-20,Pregnant or parturient women,Adults (18-64 years),1293,5.20%,,,Sequential,NA,ELISA,"IgG,IgM",100.00%,98.90%,Moderate,Journal Article (Peer-Reviewed),Dustin Flannery,University of Pennsylvania,https://immunology.sciencemag.org/content/5/49/eabd5709,13/07/2020,16/07/2022,Verified
200529_Washington_CDC_KnownContacts,29-May-20,Regional,United States of America,USA,Washington,,20-Jan-20,03-Feb-20,Contacts of COVID patients,Multiple groups,32,0.00%,,,Convenience,NA,ELISA,Not reported,96.00%,99.00%,High,Journal Article (Peer-Reviewed),Victoria Chu,US Centers for Disease Control and Prevention,https://wwwnc.cdc.gov/eid/article/26/8/20-1423_article,16/07/2020,16/07/2022,Verified
200507_Boise_UniversityofWashington_GenPop,07-May-20,Local,United States of America,USA,Idaho,Boise,20-Apr-20,26-Apr-20,Household and community samples,Multiple groups,4856,1.79%,,,Self-referral,Abbott Laboratories,CLIA,IgG,100.00%,100.00%,High,Journal Article (Peer-Reviewed),Andrew Bryan,University of Washington School of Medicine,https://jcm.asm.org/content/early/2020/05/07/JCM.00941-20,19/07/2020,16/07/2022,Verified
200509_NewYork_ColumbiaUniversityIrvingMedicalCenter_HCW,09-Jun-20,Local,United States of America,USA,New York,New York City,01-Mar-20,21-Apr-20,Health care workers and caregivers,Adults (18-64 years),91,12.10%,,,Convenience,Zhejiang Orient Gene Biotech,LFIA,"IgG,IgM",93.10%,99.20%,High,Journal Article (Peer-Reviewed),Miguel Morcuende,Columbia University Irving Medical Center,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7302070/,19/07/2020,16/07/2022,Verified
200717_Chittenden_UniversityVermont_GenPop,17-Jul-20,Local,United States of America,USA,Vermont,,,30-Jun-20,Household and community samples,Multiple groups,455,2.20%,,,Convenience,NA,Not reported,Not reported,,,High,News and Media,Cat Viglienzoni,University of Vermont,https://www.google.com/url?rct=j&sa=t&url=https://www.wcax.com/2020/07/17/early-results-of-uvm-research-tracking-covids-spread-in-vermont/&ct=ga&cd=CAAYCzIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNEblNmlKeakOFmkRkZMbbLnjhptxw,01/08/2020,16/07/2022,Verified
200708_WashoeCounty_WashoeCountyHealthDistrict_GenPop,08-Jul-20,Local,United States of America,USA,Nevada,,09-Jun-20,10-Jun-20,Household and community samples,Adults (18-64 years),234,2.30%,,,Stratified probability,NA,Not reported,Not reported,,99.60%,High,News and Media,Mary Hynes,Washoe County Health District,https://www.google.com/url?rct=j&sa=t&url=https://www.reviewjournal.com/local/local-nevada/nevada-covid-19-infection-rate-5-times-higher-antibody-tests-show-2070094/&ct=ga&cd=CAAYBzIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNGG4t16ng9mGv7ghgkKQP4Qm3hotw,01/08/2020,16/07/2022,Verified
200715_WashintonDC_DCPublicHealth_GenPop,15-Jul-20,Local,United States of America,USA,Washington D.C,Washington DC,15-Jun-20,15-Jul-20,Household and community samples,Multiple groups,13706,5.90%,,,Self-referral,DiaSorin,CLIA,Not reported,,,High,News and Media,Julie Zauzmer,Washington DC Public Health,https://www.google.com/url?rct=j&sa=t&url=https://www.washingtonpost.com/dc-md-va/2020/07/15/dc-health-lab-has-tested-13706-blood-samples-only-809-people-carried-coronavirus-antibodies/&ct=ga&cd=CAAYKTIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNFVGZ6aDeXqXAEUfikIfjfhDgkSVw,02/08/2020,16/07/2022,Verified
200721_Idaho_UniversityofWashington_TotalPopTestAdj,21-Jul-20,Local,United States of America,USA,Idaho,,04-May-20,19-May-20,Household and community samples,Multiple groups,917,23.10%,19.80%,26.50%,Self-referral,Abbott Laboratories,CLIA,IgG,92.90%,99.60%,Moderate,Preprint,Colleen McLaughlin, University of Washington,https://www.medrxiv.org/content/10.1101/2020.07.19.20157198v1,03/08/2020,16/07/2022,Verified
200513_Indiana_IndianaUniversity_Wave1_NonRandom_PopAdj,24-Jul-20,Local,United States of America,USA,Indiana,Indianapolis,02-May-20,03-May-20,Household and community samples,Multiple groups,898,5.80%,,,Convenience,NA,CLIA,IgG,100.00%,99.60%,High,Institutional Report,Nir Menachemi,Indiana University Fairbanks School of Public Health,https://www.cdc.gov/mmwr/volumes/69/wr/mm6929e1.htm?s_cid=mm6929e1_w,04/08/2020,16/07/2022,Verified
201028_Connecticut_YaleSchoolOfMedicine_GenPop1_Overall_PopAdj,28-Oct-20,Regional,United States of America,USA,Connecticut,,04-Jun-20,23-Jun-20,Household and community samples,Multiple groups,567,4.00%,2.00%,6.00%,Simplified probability,Ortho Clinical Diagnostics Inc.,CLIA,IgG,90.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Shiwani Mahajan,Yale School of Medicine,http://dx.doi.org/10.1016/j.amjmed.2020.09.024,24/09/2020,16/07/2022,Verified
200804_Miami_DaVitaClinicalResearch_HemodialysisPatients_Overall,04-Aug-20,Local,United States of America,USA,Florida,Miami,23-Apr-20,30-Apr-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,677,5.60%,4.00%,7.60%,Convenience,Diazyme Laboratories Inc,CLIA,"IgG,IgM",57.10%,85.00%,High,Preprint,Dena Cohen,DaVita Clinical Research,https://doi.org/10.1101/2020.08.03.20163642,24/09/2020,16/07/2022,Verified
200729_RiversideCounty_RiversideUniversityHealthSystem_GenPop,27-Jul-20,Local,United States of America,USA,California,,06-Jul-20,20-Jul-20,Household and community samples,Multiple groups,1726,5.90%,,,Simplified probability,NA,Not reported,Not reported,,,Unclear,News and Media,ABC7 com staff,Riverside University Health System,https://abc7.com/health/riverside-county-may-have-100000-covid-19-cases-study-says/6337677/,26/09/2020,16/07/2022,Verified
200721_NewYork_ShermanAbramsLaboratory_Overall,21-Jul-20,Local,United States of America,USA,New York,New York,15-May-20,15-Jun-20,Residual sera,Multiple groups,28523,44.00%,,,Convenience,DiaSorin,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Josh Reifer,Sherman Abrams Laboratory ,https://dx.doi.org/10.1016/j.diagmicrobio.2020.115128,26/09/2020,16/07/2022,Verified
200904_USA_CDC_HCWs_Overall,04-Sep-20,National,United States of America,USA,"New York, Massachusetts, Tennessee, Colorado, California, Washington, Minnesota, Maryland, Oregon, North Carolina, Utah, Ohio","Bronx, Springfield, Nashville, Aurora, Boston, Los Angeles, Seattle, Minneapolis, Baltimore, Portland, Winston-Salem, Murray, Columbus",03-Apr-20,19-Jun-20,Health care workers and caregivers,Adults (18-64 years),3248,5.97%,,,Convenience,NA,ELISA,Total Antibody,96.00%,99.00%,Moderate,Journal Article (Peer-Reviewed),Wesley Self,CDC COVID-19 Response Team,https://www.cdc.gov/mmwr/volumes/69/wr/mm6935e2.htm,28/09/2020,16/07/2022,Verified
200723_JeffersonCounty_UniversityofLouisville_genpop,23-Jul-20,Local,United States of America,USA,Kentucky,,10-Jun-20,19-Jun-20,Household and community samples,Multiple groups,2237,4.00%,,,Self-referral,NA,Not reported,Not reported,,,High,News and Media,Spectrum News Staff, University of Louisville,https://spectrumnews1.com/ky/louisville/news/2020/07/23/uofl-coimmunity-project-phase-2-results,30/09/2020,16/07/2022,Verified
200724_DeKalbFulton_CDCCOVID-19ResponseTeam_Overall_PopAdj,24-Jul-20,Local,United States of America,USA,Georgia,,28-Apr-20,03-May-20,Household and community samples,Multiple groups,696,2.50%,1.40%,4.50%,Stratified probability,Ortho Clinical Diagnostics Inc.,CLIA,"IgG,IgA,IgM",93.20%,99.00%,Moderate,Journal Article (Peer-Reviewed),Holly Biggs,CDC COVID-19 Response Team,https://dx.doi.org/10.15585/mmwr.mm6929e2,02/10/2020,16/07/2022,Verified
200803_Indiana_IndianaUniversity_healthcareworkers,03-Aug-20,Regional,United States of America,USA,Indiana,Indianapolis,29-Apr-20,08-May-20,Health care workers and caregivers,Adults (18-64 years),734,1.63%,,,Convenience,Abbott Laboratories,CLIA,IgG,100.00%,99.60%,High,Journal Article (Peer-Reviewed),Benton Hunter, Indiana University,https://dx.doi.org/10.1017/ice.2020.390,04/10/2020,16/07/2022,Verified
200730_Louisiana_OschnerClinicFoundation_Overall_PopWeighted,30-Jul-20,Local,United States of America,USA,Louisiana,,09-May-20,15-May-20,Household and community samples,Adults (18-64 years),2640,6.90%,6.80%,6.90%,Stratified probability,Abbott Laboratories,CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Amy K Feehan,Oschner Clinic Foundation,https://dx.doi.org/10.3201/eid2611.203029,05/10/2020,16/07/2022,Verified
200814_NewYorkCity_MemorialSloanKetteringCancerCenter_CancerPatients,14-Aug-20,Local,United States of America,USA,New York,New York City,07-May-20,25-Jun-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,952,5.46%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Preprint,Sean McBride,Memorial Sloan Kettering Cancer Center,https://www.medrxiv.org/content/10.1101/2020.08.11.20172551v1,09/10/2020,16/07/2022,Verified
200806_Florida_UniversityofMiamiMillerSchoolofMedicine_FirstResponders_UnAdj,06-Aug-20,Local,United States of America,USA,Florida,,16-Apr-20,17-Apr-20,Essential non-healthcare workers,Multiple groups,203,8.90%,,,Convenience,"BioMedomics, Inc.",LFIA,"IgG,IgM",88.66%,90.63%,High,Journal Article (Peer-Reviewed),Alberto J Caban Martinez,University of Miami,http://dx.doi.org/10.1136/oemed-2020-106676,10/10/2020,16/07/2022,Verified
200811_NewYork_StFrancisHospital_Overall,11-Aug-20,Local,United States of America,USA,New York,New York City,01-Mar-20,30-Apr-20,Health care workers and caregivers,Adults (18-64 years),1699,9.80%,,,Convenience,"EUROIMMUN,Abbott Laboratories",Not reported,IgG,,,High,Journal Article (Peer-Reviewed),Allen Jeremias,St Francis Hospital,http://dx.doi.org/10.1001/jamainternmed.2020.4214,10/10/2020,16/07/2022,Verified
200814_Oregon_OregonHealthAuthority_Overall_UnAdj,14-Aug-20,Regional,United States of America,USA,Oregon,,11-May-20,15-Jun-20,Residual sera,Multiple groups,897,1.00%,0.20%,1.80%,Stratified probability,Abbott Laboratories,CLIA,IgG,96.80%,99.10%,High,Journal Article (Peer-Reviewed),Melissa Sutton,Oregon Health Authority,https://www.cdc.gov/mmwr/volumes/69/wr/mm6932a4.htm,10/10/2020,16/07/2022,Verified
200818_Cambridge_CambridgeHealthAllianceOverall,18-Aug-20,Local,United States of America,USA,Massachusetts,Cambridge,13-Apr-20,24-May-20,Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),24,16.70%,,,Convenience,"DiaSorin,EUROIMMUN,Abbott Laboratories",Not reported,"IgG,IgA,IgM",,,High,Journal Article (Peer-Reviewed),Robert Stavert,Cambridge Health Alliance,http://dx.doi.org/10.1016/j.jaad.2020.08.049,15/10/2020,16/07/2022,Verified
200818_SanFrancisco_UniversityofCaliforniaSanFrancisco,21-Aug-20,Local,United States of America,USA,California,San Francisco,25-Apr-20,28-Apr-20,Household and community samples,Multiple groups,3861,3.40%,2.90%,4.10%,Self-referral,Abbott Laboratories,CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Gabriel Chamie,"University of California, San Francisco",http://dx.doi.org/10.1093/cid/ciaa1234,17/10/2020,16/07/2022,Verified
200818_Oregon_EarleA.ChilesResearchInstitute_Overall,18-Aug-20,Regional,United States of America,USA,Oregon,"Portland, Oregon City, Medford, Seaside, Hood River, Newberg, Milwaukie",08-Apr-20,22-May-20,Health care workers and caregivers,Multiple groups,10019,2.53%,,,Convenience,NA,ELISA,IgG,80.00%,100.00%,High,Preprint,Rom Leidner,Chiles Research Institute,https://www.medrxiv.org/content/10.1101/2020.08.16.20176107v1,18/10/2020,16/07/2022,Verified
200826_NewYorkCity_JacobiMedicalCenter_HealthCareWorkers,26-Aug-20,Local,United States of America,USA,New York,New York City,28-Apr-20,04-May-20,Health care workers and caregivers,Multiple groups,1700,19.20%,,,Convenience,Abbott Laboratories,CLIA,IgG,100.00%,99.60%,High,Journal Article (Peer-Reviewed),Elana Sydney,Jacobi Medical Center,http://dx.doi.org/10.1017/ice.2020.437,21/10/2020,16/07/2022,Verified
200828_LosAngeles_VeteransAffairsHealthcareSystem_Residents,28-Aug-20,Local,United States of America,USA,California,Los Angeles,05-Jun-20,12-Jun-20,Assisted living and long-term care facilities,Multiple groups,150,17.30%,,,Convenience,DiaSorin,CLIA,IgG,92.00%,98.00%,High,Journal Article (Peer-Reviewed),Amy V Dora,Veterans Affairs Healthcare System,http://dx.doi.org/10.1093/cid/ciaa1286,21/10/2020,16/07/2022,Verified
200909_Chelsea_MassachusettsGeneralHospital_Overall_TestAdj,09-Sep-20,Local,United States of America,USA,Massachusetts,Chelsea,14-Apr-20,15-Apr-20,Household and community samples,Adults (18-64 years),200,32.80%,27.20%,38.80%,Convenience,"BioMedomics, Inc.",LFIA,"IgM,IgG",90.00%,99.00%,Moderate,Journal Article (Peer-Reviewed),Vivek Naranbhai,Massachusetts General Hospital,http://dx.doi.org/10.1093/infdis/jiaa579,21/10/2020,16/07/2022,Verified
200821_NewYorkCityHealthSystem_AlbertEinsteinCollegeofMedicine,21-Aug-20,Local,United States of America,USA,New York,New York City,04-Apr-20,20-Apr-20,Health care workers and caregivers,Adults (18-64 years),98,15.30%,,,Convenience,"Epitope Diagnostics, Inc.",ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Ariel D Stock,Albert Einstein College of Medicine,https://dx.doi.org/10.3389/fmed.2020.00471,24/10/2020,16/07/2022,Verified
200920_NewYorkState_DonaldAndBarbaraZuckerSchoolOfMedicine_Patients_Overall,20-Sep-20,Regional,United States of America,USA,New York,,27-May-20,24-Jul-20,Pregnant or parturient women,Adults (18-64 years),1671,16.10%,,,Convenience,Roche Diagnostics,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Lylach Haizler Cohen,Donald and Barbara Zucker School of Medicine,https://dx.doi.org/10.1016/j.ajog.2020.09.022,30/10/2020,16/07/2022,Verified
200911_NewYorkCity_WeillCornellMedicine_IgGorIgM,11-Sep-20,Local,United States of America,USA,New York,New York City,17-Apr-20,07-May-20,Health care workers and caregivers,Adults (18-64 years),2274,35.40%,,,Convenience,ET Healthcare,Other,"IgG,IgM",,98.80%,Moderate,Journal Article (Peer-Reviewed),Sabrina Racine Brzostek,Weill Cornell Medicine,http://dx.doi.org/10.1093/ajcp/aqaa142,02/11/2020,16/07/2022,Verified
201023_BatonRouge_LouisianaStateUniversity_Total_popadj,23-Oct-20,Local,United States of America,USA,Louisiana,Baton Rouge,15-Jul-20,31-Jul-20,Household and community samples,Multiple groups,2138,3.60%,2.80%,4.40%,Stratified probability,Abbott Laboratories,CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Amy K Feehan,Louisiana State University,https://dx.doi.org/10.3201/eid2701.203808,04/11/2020,16/07/2022,Verified
200917_SanFrancisco_UniversityofCalifornia_BloodDonors,17-Sep-20,Local,United States of America,USA,California,San Francisco,01-Mar-20,31-Mar-20,Blood donors,Multiple groups,1000,0.10%,0.00%,0.56%,Sequential,"Abbott Laboratories,Ortho Clinical Diagnostics Inc.,NA",Multiple Types,IgG,,,Moderate,Journal Article (Peer-Reviewed),Dianna Ng,"University of California, San Francisco",https://dx.doi.org/10.1038/s41467-020-18468-8,06/11/2020,16/07/2022,Verified
200917_SanFrancisco_UniversityofCalifornia_Patients,17-Sep-20,Local,United States of America,USA,California,San Francisco,17-Mar-20,13-Apr-20,Residual sera,Multiple groups,387,0.26%,0.00%,0.76%,Convenience,Abbott Laboratories,CLIA,IgG,99.00%,99.80%,High,Journal Article (Peer-Reviewed),Dianna Ng,"University of California, San Francisco",https://dx.doi.org/10.1038/s41467-020-18468-8,06/11/2020,16/07/2022,Verified
200925_UnitedStates_StanfordUniversity_OverallPopAdj,25-Sep-20,National,United States of America,USA,,,01-Jul-20,31-Jul-20,Residual sera,Multiple groups,28503,9.30%,8.80%,9.90%,Stratified probability,Siemens,CLIA,Total Antibody,100.00%,99.80%,Moderate,Journal Article (Peer-Reviewed),Shuchi Anand,Stanford University,https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)32009-2/fulltext,22/11/2020,16/07/2022,Verified
200923_AnnArbor_VeteransAffairsAnnArborHealthcareSystem,23-Sep-20,Local,United States of America,USA,Michigan,,08-Jun-20,08-Jul-20,Health care workers and caregivers,Multiple groups,1476,4.90%,3.80%,6.10%,Self-referral,Abbott Laboratories,CLIA,IgG,100.00%,99.00%,Moderate,Journal Article (Peer-Reviewed),Derek Dimcheff,Veterans Affairs Ann Arbor Healthcare System,https://dx.doi.org/10.1017/ice.2020.1220,23/11/2020,16/07/2022,Verified
200918_Arizona_VincereCancerCenter_Total,18-Sep-20,Regional,United States of America,USA,Arizona,"Phoenix, Tempe, Glendale, Surprise, Peoria, Chandler",24-Apr-20,21-May-20,Essential non-healthcare workers,Multiple groups,3326,1.50%,,,Convenience,RayBiotech,LFIA,IgG,90.40%,98.30%,Moderate,Journal Article (Peer-Reviewed),Vershalee Shukla,Vincere Cancer Center,https://dx.doi.org/10.1097/JOM.0000000000002027,23/11/2020,16/07/2022,Verified
200917_Nashville_VanderbiltUniversityMedicalCenter_60DaysOverall,17-Sep-20,Local,United States of America,USA,Tennessee,Nashville,02-Jun-20,27-Jun-20,Health care workers and caregivers,Multiple groups,230,3.48%,,,Convenience,NA,ELISA,Total Antibody,96.00%,99.00%,High,Journal Article (Peer-Reviewed),Manish Patel,Vanderbilt University Medical Center,http://dx.doi.org/10.1001/jama.2020.18796,24/11/2020,16/07/2022,Verified
200921_Detroit_Region2SouthHealthcareCoalition_Overall,21-Sep-20,Local,United States of America,USA,Michigan,Detroit,18-May-20,13-Jun-20,Health care workers and caregivers,Adults (18-64 years),16397,6.90%,6.50%,7.30%,Convenience,Ortho Clinical Diagnostics Inc.,Not reported,IgG,90.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Lara Akinbami,Region 2 South Healthcare Coalition,https://dx.doi.org/10.3201/eid2612.203764,04/12/2020,16/07/2022,Verified
200929_NorthCarolina_UniversityofNorthCarolinaChapelHill_ScreenNC2_Overall,29-Sep-20,Regional,United States of America,USA,North Carolina,,03-Mar-20,04-Jun-20,Residual sera,Adults (18-64 years),1449,0.70%,,,Convenience,Abbott Laboratories,CLIA,IgG,100.00%,98.90%,Moderate,Journal Article (Peer-Reviewed),Amir Barzin,University of North Carolina Chapel Hill,http://dx.doi.org/10.1128/mBio.02426-20,07/12/2020,16/07/2022,Verified
200929_NorthCarolina_UniversityofNorthCarolinaChapelHill_ScreenNC_OverallAdj,29-Sep-20,Regional,United States of America,USA,North Carolina,,28-Apr-20,19-Jun-20,Residual sera,Adults (18-64 years),2973,0.00%,0.00%,0.90%,Convenience,Abbott Laboratories,CLIA,IgG,100.00%,98.90%,Moderate,Journal Article (Peer-Reviewed),Amir Barzin,University of North Carolina Chapel Hill,http://dx.doi.org/10.1128/mBio.02426-20,07/12/2020,16/07/2022,Verified
200816_SaltLakeCityMilwaukee_CentersforDiseaseControl_householdcontacts,16-Aug-20,Local,United States of America,USA,"Utah, Wisconsin","Salt Lake City, Milwaukee",22-Mar-20,25-Apr-20,Contacts of COVID patients,Multiple groups,178,25.80%,,,Convenience,NA,ELISA,Not reported,,,High,Journal Article (Peer-Reviewed),Nathaniel M Lewis,Centers for Disease Control ,https://dx.doi.org/10.1093/cid/ciaa1166,16/12/2020,16/07/2022,Verified
201116_Tennessee_VanderbiltUniversity_HCW_Overall,16-Nov-20,Regional,United States of America,USA,Tennessee,,15-May-20,15-Jun-20,Health care workers and caregivers,Adults (18-64 years),11787,0.98%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Preprint,Peter Rebeiro,Vanderbilt University,https://www.medrxiv.org/content/10.1101/2020.11.12.20230912v1,16/12/2020,16/07/2022,Verified
201105_Michigan_OaklandUniversity_testadj,05-Nov-20,Local,United States of America,USA,Michigan,"Dearborn, Farmington Hills, Grosse Pointe, Royal Oak, Taylor, Trenton, Troy, Wayne, Canton",13-Apr-20,28-May-20,Health care workers and caregivers,Multiple groups,20614,8.10%,6.80%,8.90%,Convenience,EUROIMMUN,ELISA,IgG,98.14%,99.35%,Moderate,Journal Article (Peer-Reviewed),Matthew D Sims,Oakland University,https://dx.doi.org/10.1093/cid/ciaa1684,17/12/2020,16/07/2022,Verified
201030_Indianapolis_IndianaUniversity_Overall,30-Oct-20,Local,United States of America,USA,Indiana,Indianapolis ,01-May-20,30-Jun-20,Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),31,3.20%,,,Convenience,"Abnova,NA",ELISA,"IgM,IgG",94.40%,98.50%,High,Journal Article (Peer-Reviewed),Corina Nailescu,Indiana University ,https://dx.doi.org/10.3389/fped.2020.601327,17/12/2020,16/07/2022,Verified
201201_NewHeaven_Yale_SchoolofMedicine_newborns,12-Dec-20,Local,United States of America,USA,Connecticut,New Haven,19-Feb-20,26-May-20,Residual sera,Children and Youth (0-17 years),3048,5.90%,,,Sequential,NA,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Feimei  Liu,Yale School of Medicine,https://dx.doi.org/10.1097/INF.0000000000002918,18/12/2020,16/07/2022,Verified
201021_NewYork_Serimmune_Overall,21-Oct-20,Local,United States of America,USA,New York,New York City,01-Mar-20,07-Jul-20,Blood donors,Multiple groups,1559,4.36%,,,Sequential,Serimmune,Other,IgG,91.00%,99.30%,High,Preprint,Kathy Kamath,Serimmune,https://www.medrxiv.org/content/10.1101/2020.10.19.20215368v1,18/12/2020,16/07/2022,Verified
201107_Lubbock_TexasTechUniversity_Overall,07-Nov-20,Local,United States of America,USA,Texas,Lubbock,12-May-20,13-May-20,Essential non-healthcare workers,Multiple groups,683,0.70%,,,Convenience,Abbott Laboratories,CLIA,IgG,100.00%,99.90%,High,Journal Article (Peer-Reviewed),Kenneth Iwuji,Texas Tech University,https://dx.doi.org/10.1177/2150132720971390,18/12/2020,16/07/2022,Verified
201013_PimaCounty_UniversityofArizona_Overall,13-Oct-20,Local,United States of America,USA,Arizona,,30-Apr-20,07-May-20,Household and community samples,Multiple groups,5882,1.24%,,,Self-referral,NA,ELISA,"IgG,IgM",97.60%,100.00%,High,Journal Article (Peer-Reviewed),Tyler Ripperger,University of Arizona,http://dx.doi.org/10.1016/j.immuni.2020.10.004,18/12/2020,16/07/2022,Verified
201015_NewYorkCity_NYCHealth+Hospitals/Lincoln_Overall,15-Oct-20,Local,United States of America,USA,New York,New York City,01-Mar-20,01-May-20,Health care workers and caregivers,Adults (18-64 years),500,27.00%,,,Convenience,Abbott Laboratories,CLIA,IgG,100.00%,99.60%,Moderate,Journal Article (Peer-Reviewed),Usha Venugopal,NYC Health + Hospitals/Lincoln,http://dx.doi.org/10.1016/j.ijid.2020.10.036,19/12/2020,16/07/2022,Verified
201030_Cleveland_CaseWesternReserveUniversity_Overall,30-Oct-20,Local,United States of America,USA,Ohio,Cleveland,20-Apr-20,19-May-20,Essential non-healthcare workers,Adults (18-64 years),296,5.40%,3.10%,8.60%,Convenience,"Epitope Diagnostics, Inc.",ELISA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Yasir Tarabichi,Case Western Reserve University,https://dx.doi.org/10.1080/10903127.2020.1831668,21/12/2020,16/07/2022,Verified
201026_UpstateNewYork_BassettMedicalCenter_Overall,26-Oct-20,Local,United States of America,USA,New York,Upstate New York,04-May-20,29-May-20,Health care workers and caregivers,Multiple groups,764,2.00%,,,Unclear,Abbott Laboratories,CLIA,IgG,100.00%,99.60%,High,Journal Article (Peer-Reviewed),Wendy M Brunner,Bassett Medical Center,https://dx.doi.org/10.1017/ice.2020.1296,28/12/2020,16/07/2022,Verified
201027_Indiana_Harvard_Overall_testadj,27-Nov-20,Local,United States of America,USA,Indiana,St. John Township,15-Jul-20,20-Jul-20,Essential non-healthcare workers,Multiple groups,753,1.70%,0.27%,3.30%,Self-referral,NA,Not reported,IgG,100.00%,99.00%,Moderate,Preprint,Lilah Lopez,Harvard Medical School,https://www.medrxiv.org/content/10.1101/2020.10.23.20218651v1,05/01/2021,16/07/2022,Verified
201119_LosAngeles_CedarsSinaiMedicalCenter_Overall,19-Nov-20,Local,United States of America,USA,California,Los Angeles,11-May-20,28-Jun-20,Health care workers and caregivers,Adults (18-64 years),6201,3.50%,,,Self-referral,Abbott Laboratories,CLIA,IgG,96.90%,99.90%,Moderate,Journal Article (Peer-Reviewed),Magali Rivas,Cedars-Sinai Medical Center,https://dx.doi.org/10.1172/JCI145157,05/01/2021,16/07/2022,Verified
201120_Rochester_MayoClinic_HighRiskCohort_1_Overall,20-Nov-20,Local,United States of America,USA,Minnesota,Rochester,25-May-20,09-Jul-20,Health care workers and caregivers,Adults (18-64 years),320,0.63%,,,Unclear,"EUROIMMUN,Ortho Clinical Diagnostics Inc.,Roche Diagnostics",Multiple Types,IgG,,,High,Journal Article (Peer-Reviewed),Vishal Shah,Mayo Clinic,https://dx.doi.org/10.1017/ice.2020.1341,05/01/2021,16/07/2022,Verified
201120_Rochester_MayoClinic_LowRiskCohort_2_Overall,20-Nov-20,Local,United States of America,USA,Minnesota,Rochester,25-May-20,09-Jul-20,Health care workers and caregivers,Adults (18-64 years),248,0.00%,,,Unclear,"EUROIMMUN,Ortho Clinical Diagnostics Inc.,Roche Diagnostics",Multiple Types,IgG,,,High,Journal Article (Peer-Reviewed),Vishal Shah,Mayo Clinic,https://dx.doi.org/10.1017/ice.2020.1341,05/01/2021,16/07/2022,Verified
200810_USA_Illinois_PhysicianPractice_Overall,06-Aug-20,Local,United States of America,USA,Illinois,Chicago,22-Apr-20,26-May-20,Residual sera,Multiple groups,113,15.90%,,,Convenience,CLUNGENE,LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Gerald Osher,BioSolutions Services LLC,https://lymphosign.com/doi/full/10.14785/lymphosign-2020-0007,06/01/2021,16/07/2022,Verified
201027_Illinois_CDC_Contacts,27-Oct-20,Regional,United States of America,USA,Illinois,,03-Mar-20,06-Mar-20,Contacts of COVID patients,Adults (18-64 years),59,0.00%,,,Convenience,NA,ELISA,"IgG,IgM,IgA",96.00%,99.00%,High,Journal Article (Peer-Reviewed),Tristan McPherson,US Centers for Disease Control and Prevention,https://dx.doi.org/10.1177/0033354920966064,07/01/2021,16/07/2022,Verified
201013_Pittsburgh_UniversityPittsburgh_PedImmunocompPatients_Overall,13-Oct-20,Local,United States of America,USA,Pennsylvania,Pittsburgh,15-Mar-20,04-Jul-20,Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),485,1.00%,0.30%,2.40%,Convenience,"EUROIMMUN,Beckman Coulter,Siemens",ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Megan Freeman,University of Pittsburgh School of Medicine,http://dx.doi.org/10.1093/jpids/piaa123,07/01/2021,16/07/2022,Verified
201201_LosAngeles_UniversityofSouthernCalifornia_UniversityStudents_Overall,01-Dec-20,Local,United States of America,USA,California,Los Angeles,29-Apr-20,08-May-20,Students and Daycares,Adults (18-64 years),790,4.00%,3.00%,5.10%,Convenience,EUROIMMUN,ELISA,IgG,90.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Kimberly Tilley,University of Southern California,http://dx.doi.org/10.1016/j.jadohealth.2020.09.001,07/01/2021,16/07/2022,Verified
201103_NewYorkCity_MountSinai_UrgentCare_2_Overall,03-Nov-20,Local,United States of America,USA,New York,New York City,02-Feb-20,05-Jul-20,Residual sera,Multiple groups,4101,26.00%,,,Sequential,NA,ELISA,IgG,95.00%,100.00%,High,Journal Article (Peer-Reviewed),Daniel Stadlbauer,Icahn School of Medicine at Mount Sinai,http://dx.doi.org/10.1038/s41586-020-2912-6,08/01/2021,16/07/2022,Verified
200624_BaskingRidge_FellowshipVillage_Staff1_Overall,24-Jun-20,Local,United States of America,USA,New Jersey,Basking Ridge,15-Apr-20,06-May-20,Assisted living and long-term care facilities,Adults (18-64 years),305,23.60%,,,Convenience,NA,Not reported,"IgG,IgM",,,Unclear,News and Media,Tim Regan,Fellowship Village,https://www.google.com/url?rct=j&sa=t&url=https://seniorhousingnews.com/2020/06/24/fellowship-village-benefits-from-covid-19-antibody-tests-juniper-plans-pilot/&ct=ga&cd=CAEYAyoTMTA4MjA1OTc5ODY3MTIyMzk1NTIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNFY2y-eZOXQXVuQzcKPUzRHkiG26g,09/01/2021,16/07/2022,Verified
201015_BronxNY_AlbertEinsteinCollegeofMedicine_KidneyTransplantlPatients,15-Oct-20,Local,United States of America,USA,New York,New York City,03-May-20,29-Jul-20,Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),912,16.66%,,,Convenience,Abbott Laboratories,CLIA,IgG,100.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Yorg Azzi,Albert Einstein College of Medicine,http://dx.doi.org/10.1016/j.kint.2020.10.004,13/01/2021,16/07/2022,Verified
201120_LosAngeles_TheLundquistInstitute_genpop,25-Nov-20,Local,United States of America,USA,California,,21-Apr-20,22-May-20,Multiple populations,Multiple groups,244,20.90%,,,Unclear,Hangzhou Testsea Biotechnology Co. Ltd,LFIA,"IgG,IgM",96.00%,100.00%,High,Journal Article (Peer-Reviewed),Khadije Ahmad,The Lundquist Institute ,https://dx.doi.org/10.1007/s10096-020-04111-3,19/01/2021,16/07/2022,Verified
201130_USA_AmericanRedCross_BloodDonors,30-Nov-20,National,United States of America,USA,"Massachusetts, California, Connecticut, Iowa, Michigan, Oregon, Rhode Island, Washington, Wisconsin",,13-Dec-19,17-Jan-20,Blood donors,Multiple groups,7389,1.40%,,,Sequential,NA,ELISA,Total Antibody,96.00%,99.30%,Moderate,Journal Article (Peer-Reviewed),Sridhar V Basavaraju,American Red Cross,https://dx.doi.org/10.1093/cid/ciaa1785,20/01/2021,16/07/2022,Verified
201123_OrangeCounty_StJudeMedicalCenter_Overall,23-Nov-20,Local,United States of America,USA,California,Fullerton,15-Jul-20,27-Jul-20,Residual sera,Multiple groups,865,9.40%,8.00%,12.00%,Sequential,Abbott Laboratories,CLIA,IgG,100.00%,100.00%,High,Journal Article (Peer-Reviewed),Jason Yamaki,St. Jude Medical Center,https://dx.doi.org/10.1007/s40615-020-00918-0,21/01/2021,16/07/2022,Verified
201121_LosAngeles_UniversityofCaliforniaLosAngeles_HCW,21-Nov-20,Local,United States of America,USA,California,,08-Apr-20,31-Aug-20,Health care workers and caregivers,Multiple groups,1108,3.90%,,,Unclear,NA,ELISA,IgG,,,Moderate,Preprint,Megan Halbrook,University of California Los Angeles,https://www.medrxiv.org/content/10.1101/2020.11.18.20234211v1,21/01/2021,16/07/2022,Verified
201121_LosAngeles_UniversityofCaliforniaLosAngeles_FirstResponders,21-Nov-20,Local,United States of America,USA,California,,19-May-20,31-Aug-20,Essential non-healthcare workers,Multiple groups,679,8.10%,,,Unclear,NA,ELISA,IgG,,,Moderate,Preprint,Megan Halbrook,University of California Los Angeles,https://www.medrxiv.org/content/10.1101/2020.11.18.20234211v1,21/01/2021,16/07/2022,Verified
201127_DistrictofColumbia_DCHealth_Overall,27-Nov-20,Regional,United States of America,USA,Washington D.C,Washington,28-May-20,15-Jul-20,Essential non-healthcare workers,Adults (18-64 years),310,3.55%,,,Self-referral,DiaSorin,CLIA,IgG,97.00%,,High,Preprint,Jacqueline Reuben,District of Columbia Department of Health (DC Health),https://www.medrxiv.org/content/10.1101/2020.11.25.20225490v1,21/01/2021,16/07/2022,Verified
201130_SanFrancisco_StanfordUniversity_Overall,30-Nov-20,Local,United States of America,USA,California,San Francisco,20-Apr-20,08-Jun-20,Health care workers and caregivers,Adults (18-64 years),12418,0.90%,0.70%,1.10%,Self-referral,NA,ELISA,IgG,,99.75%,High,Journal Article (Peer-Reviewed),Catherine Hogan,Stanford University,https://dx.doi.org/10.3201/eid2701.203892,22/01/2021,16/07/2022,Verified
200622_Brooklyn_ColumbiaUniversityMedicalCenter_Overall,22-Jun-20,Local,United States of America,USA,New York,New York City,01-Feb-20,30-Apr-20,Health care workers and caregivers,Adults (18-64 years),50,46.00%,,,Convenience,Abbott Laboratories,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),Jordan Jeong,Columbia University Medical Center,https://dx.doi.org/10.1016/j.annemergmed.2020.06.038,22/01/2021,16/07/2022,Verified
201210_Atlanta_CDC_Lab_OverallPopTestAdj,10-Dec-20,Local,United States of America,USA,Georgia,Atlanta,27-Apr-20,01-May-20,Residual sera,Multiple groups,1343,4.94%,3.34%,6.64%,Convenience,NA,ELISA,Total Antibody,96.00%,99.30%,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,Centers for Disease Control and Prevention,https://dx.doi.org/10.1093/cid/ciaa1804,22/01/2021,16/07/2022,Verified
201215_SanDiego_SharpHealthCare_Overall,15-Dec-20,Local,United States of America,USA,California,San Diego,20-May-20,08-Jun-20,Health care workers and caregivers,Multiple groups,1770,2.20%,,,Convenience,Roche Diagnostics,CLIA,Total Antibody,100.00%,99.80%,High,Journal Article (Peer-Reviewed),Norihiro Yogo,Sharp Healthcare,https://dx.doi.org/10.1017/ice.2020.1370,23/01/2021,16/07/2022,Verified
210101_Seattle_SeattleChildren'sResearchInstitute_FollowUp_Overall,01-Jan-21,Local,United States of America,USA,Washington ,Seattle,06-Jul-20,07-Aug-20,Health care workers and caregivers,Adults (18-64 years),481,1.00%,,,Convenience,Abbott Laboratories,CLIA,IgG,100.00%,,High,Journal Article (Peer-Reviewed),Yekaterina Tokareva,Seattle Childrens Research Institute,https://dx.doi.org/10.1542/hpeds.2020-003517,23/01/2021,16/07/2022,Verified
201119_USA_QuestDiagnostics_Overall,19-Nov-20,National,United States of America,USA,,,21-Apr-20,10-Jul-20,Household and community samples,Multiple groups,2402282,11.81%,,,Sequential,"Abbott Laboratories,Ortho Clinical Diagnostics Inc.,EUROIMMUN",Multiple Types,IgG,,,High,Journal Article (Peer-Reviewed),Harvey W Kaufman,Quest Diagnostics,http://dx.doi.org/10.1089/pop.2020.0256,23/01/2021,16/07/2022,Verified
201214_VirginaUSA_VirginiaCommonwealthUniversity_Overall,14-Dec-20,Local,United States of America,USA,Virginia,Richmond,27-Jul-20,02-Oct-20,Health care workers and caregivers,Multiple groups,1962,1.37%,,,Convenience,Abbott Laboratories,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),Emily Godbout,Virginia Commonwealth University,https://dx.doi.org/10.1017/ice.2020.1374,23/01/2021,16/07/2022,Verified
201207_Massachusetts_MassachusettsGeneralHospital_Cohabitants,07-Dec-20,Local,United States of America,USA,Massachusetts,Boston,29-May-20,23-Jul-20,Multiple populations,Multiple groups,143,6.30%,,,Sequential,NA,ELISA,IgG,99.70%,100.00%,High,Journal Article (Peer-Reviewed),E Klawiter,Massachusetts General Hospital,https://journals.sagepub.com/doi/10.1177/1352458520974938#_i1,27/01/2021,16/07/2022,Verified
201207_Massachusetts_MassachusettsGeneralHospital_MS,07-Dec-20,Local,United States of America,USA,Massachusetts,Boston,29-May-20,23-Jul-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,227,3.50%,,,Sequential,NA,ELISA,IgG,99.70%,100.00%,High,Journal Article (Peer-Reviewed),E Klawiter,Massachusetts General Hospital,https://journals.sagepub.com/doi/10.1177/1352458520974938#_i1,27/01/2021,16/07/2022,Verified
201203_AraphoeCounty_UniversityofColorado,03-Dec-20,Local,United States of America,USA,Colorado,,15-Jul-20,15-Aug-20,Essential non-healthcare workers,Adults (18-64 years),264,4.00%,,,Convenience,Exsera BioLabs,ELISA,IgG,85.00%,98.60%,High,Journal Article (Peer-Reviewed),Katherine Sabourin,University of Colorado,https://pubmed.ncbi.nlm.nih.gov/33298759/,28/01/2021,16/07/2022,Verified
200901_NewYorkCity_NorthwellHealthCOVID-19ResearchConsortium,06-Aug-20,Local,United States of America,USA,New York,New York City,20-Apr-20,23-Jun-20,Health care workers and caregivers,Multiple groups,40329,13.70%,,,Convenience,"EUROIMMUN,AnshLabs ,Abbott Laboratories,Ortho Clinical Diagnostics Inc.,DiaSorin,Roche Diagnostics",Multiple Types,"IgG,Total Antibody",,,High,Journal Article (Peer-Reviewed),Joseph Moscola,Northwell Health COVID-19 Research Consortium,https://pubmed.ncbi.nlm.nih.gov/32780804/,28/01/2021,16/07/2022,Verified
201230_SanDiego_ScrippsClinic_Overall,30-Dec-20,Local,United States of America,USA,California,San Diego,14-Apr-20,28-Jul-20,Health care workers and caregivers,Adults (18-64 years),11993,0.94%,,,Convenience,"Diazyme Laboratories Inc,Abbott Laboratories",CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Laura Nicholson,Scripps Clinic,https://dx.doi.org/10.1016/j.ajic.2020.12.017,29/01/2021,16/07/2022,Verified
201222_Wisconsin_UniversityofWisconsin_WaveI_overall_popadj,22-Dec-20,Regional,United States of America,USA,Wisconsin,,01-Jul-20,31-Aug-20,Household and community samples,Multiple groups,996,1.60%,0.60%,2.50%,Stratified probability,Abbott Laboratories,CLIA,IgG,,99.60%,Moderate,Preprint,Kristen Maleck,University of Wisconsin,https://doi.org/10.1101/2020.12.18.20248479,03/02/2021,16/07/2022,Verified
201222_Wisconsin_UniversityofWisconsin_WaveII_overall_popadj,22-Dec-20,Regional,United States of America,USA,Wisconsin,,18-Oct-20,14-Dec-20,Household and community samples,Multiple groups,994,6.80%,4.30%,9.40%,Stratified probability,Abbott Laboratories,CLIA,IgG,,99.60%,Moderate,Preprint,Kristen Maleck,University of Wisconsin,https://doi.org/10.1101/2020.12.18.20248479,03/02/2021,16/07/2022,Verified
210105_USA_MayoClinic_overall,05-Jan-21,Local,United States of America,USA,Minnesota,Rochester,16-May-20,17-May-20,Essential non-healthcare workers,Adults (18-64 years),255,1.20%,,,Convenience,NA,ELISA,IgG,88.10%,99.60%,High,Journal Article (Peer-Reviewed),Sarayna S McGuire,Mayo Clinic,https://dx.doi.org/10.1017/S1049023X2000151X,03/02/2021,16/07/2022,Unverified
201209_SantaClara_StanfordHealthCare,09-Dec-20,Local,United States of America,USA,California,San Francisco Bay Area,20-Apr-20,20-May-20,Health care workers and caregivers,Adults (18-64 years),10449,1.30%,,,Convenience,NA,CLIA,IgG,87.00%,99.75%,High,Journal Article (Peer-Reviewed),Joelle Rosser,Stanford Health Care,https://dx.doi.org/10.1017/ice.2020.1358,04/02/2021,16/07/2022,Verified
201223_NewYork_MemorialSloanKetteringCancerCenter,23-Dec-20,Local,United States of America,USA,New York,New York City,05-May-20,10-Sep-20,Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),257,7.80%,,,Sequential,Abbott Laboratories,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),Lauren Jimenez Kurlander,Memorial Sloan Kettering Cancer Center,https://dx.doi.org/10.1002/pbc.28857,04/02/2021,16/07/2022,Verified
210119_NewJersey_CooperUniversityHospital_overall,19-Jan-21,Local,United States of America,USA,New Jersey ,,10-Jun-20,31-Aug-20,Health care workers and caregivers,Adults (18-64 years),172,5.20%,2.40%,9.70%,Convenience,"EUROIMMUN,Roche Diagnostics",CLIA,Total Antibody,,,High,Journal Article (Peer-Reviewed),Snehal Gandhi,Cooper University Hospital,https://dx.doi.org/10.1007/s11606-020-06462-1,04/02/2021,16/07/2022,Unverified
201106_Utah_UniversityofUtah_immunosupressed_primary,06-Nov-20,Local,United States of America,USA,Utah,Salt Lake City ,18-Apr-20,21-May-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,39,2.60%,,,Unclear,NA,Not reported,IgG,,,High,Preprint,Quinn Pritchett,University of Utah,https://acrabstracts.org/abstract/assessing-cytokine-profiles-and-covid-serology-in-patients-on-immunosuppression-to-guide-care-recommendations/,04/02/2021,16/07/2022,Verified
210111_Michigan_ UniversityofMichigan_overall,11-Jan-21,Local,United States of America,USA,Michigan,,17-Aug-20,04-Sep-20,Health care workers and caregivers,Adults (18-64 years),1385,1.88%,,,Convenience,"Siemens,Eagle Bioscience",CLIA,Total Antibody,,,Moderate,Journal Article (Peer-Reviewed),Jeffrey Fletcher,Metro Health University of Michigan Health,http://dx.doi.org/10.1017/ice.2020.1438,04/02/2021,16/07/2022,Unverified
201031_NewJersey_RutgersRobertWoodJohnsonMedicalSchool,31-Oct-20,Local,United States of America,USA,New Jersey,"New Brunswick, Somerville",28-Apr-20,30-Jun-20,Health care workers and caregivers,Adults (18-64 years),3907,9.60%,,,Convenience,Abbott Laboratories,Not reported,IgG,96.90%,99.60%,Moderate,Journal Article (Peer-Reviewed),Emily Barrett,Rutgers Robert Wood Johnson Medical School,https://dx.doi.org/10.1093/ofid/ofaa534,05/02/2021,16/07/2022,Verified
210115_Massachusetts_HarvardUniversity_Overall,15-Jan-21,Regional,United States of America,USA,Massachusetts,,16-Jun-20,24-Aug-20,Household and community samples,Multiple groups,1872,3.15%,,,Convenience,EUROIMMUN,ELISA,IgG,,,Moderate,Preprint,Aishani Aatresh,Harvard University,https://www.medrxiv.org/content/10.1101/2021.01.14.21249824v1,11/02/2021,16/07/2022,Verified
201216_Seattle_WashingtonUniversity_fishermen_unadjusted copy,21-Oct-20,Local,United States of America,USA,Washington,Seattle,01-May-20,31-May-20,Essential non-healthcare workers,Adults (18-64 years),120,2.50%,,,Convenience,"Abbott Laboratories,NA",Multiple Types,"IgG,Neutralizing ",,,High,Journal Article (Peer-Reviewed),Amin Addetia,University of Washington,https://jcm.asm.org/content/58/11/e02107-20,17/02/2021,16/07/2022,Verified
210129_Philadelphia_UniversityofPennsylvania_overallmother_unadj,29-Jan-21,Local,United States of America,USA,Pennsylvania,Philadelphia,09-Apr-20,08-Aug-20,Pregnant or parturient women,Adults (18-64 years),1471,6.00%,,,Convenience,NA,ELISA,"IgM,IgG",,,High,Journal Article (Peer-Reviewed),Dustin D Flannery,University of Pennsylvania,https://dx.doi.org/10.1001/jamapediatrics.2021.0038,20/02/2021,16/07/2022,Verified
210117_Maryland_UniversityofMaryland_overall_adj,17-Jan-21,Local,United States of America,USA,Maryland,Baltimore,03-Jun-20,24-Jul-20,Health care workers and caregivers,Adults (18-64 years),8399,3.52%,3.01%,3.98%,Convenience,"Ortho Clinical Diagnostics Inc.,NA",Multiple Types,"IgG,IgM,IgA",,,Moderate,Journal Article (Peer-Reviewed),Kristin E Mullins,University of Maryland,http://dx.doi.org/10.1016/j.clinbiochem.2021.01.004,22/02/2021,16/07/2022,Verified
210201_Minnesota_UniversityofMinnesota_HCW_Primary,01-Feb-21,Regional,United States of America,USA,Minnesota,,13-Apr-20,21-May-20,Health care workers and caregivers,Multiple groups,1282,2.96%,2.04%,3.89%,Convenience,NA,ELISA,Total Antibody,86.10%,100.00%,High,Journal Article (Peer-Reviewed),Stefani Thomas,University of Minnesota,https://dx.doi.org/10.1016/j.clinbiochem.2021.01.010,25/02/2021,16/07/2022,Verified
210201_Minnesota_UniversityofMinnesota_OutPatients_Primary ,01-Feb-21,Regional,United States of America,USA,Minnesota,,13-Apr-20,21-May-20,Residual sera,Multiple groups,2379,4.46%,3.63%,5.28%,Convenience,NA,ELISA,Total Antibody,86.10%,100.00%,High,Journal Article (Peer-Reviewed),Stefani Thomas,University of Minnesota,https://dx.doi.org/10.1016/j.clinbiochem.2021.01.010,25/02/2021,16/07/2022,Verified
201026_UpstateNewYork_BassettMedicalCenter_Overall copy,26-Oct-20,Local,United States of America,USA,New York,Upstate New York,04-May-20,29-May-20,Health care workers and caregivers,Adults (18-64 years),762,4.50%,,,Unclear,Ortho Clinical Diagnostics Inc.,CLIA,IgG,100.00%,99.60%,High,Journal Article (Peer-Reviewed),Wendy M Brunner,Bassett Medical Center,https://dx.doi.org/10.1017/ice.2020.1296,27/02/2021,16/07/2022,Verified
210201_Washington_ChildrensNationalHospital_Overall_TestAdj,01-Feb-21,Local,United States of America,USA,"Washington, D.C, Maryland, Virginia, West Virginia",Washington D.C,07-Jul-20,29-Oct-20,Residual sera,Children and Youth (0-17 years),385,9.46%,6.68%,13.00%,Convenience,DiaSorin,CLIA,IgG,97.60%,99.30%,High,Journal Article (Peer-Reviewed),Burak Bahar,Children's National Hospital,https://www.medrxiv.org/content/10.1101/2021.01.30.21250830v1.full-text,04/03/2021,16/07/2022,Verified
210125_NewYork_CDC+NewYorkCity_Total,25-Jan-21,Local,United States of America,USA,New York,New York City,18-May-20,02-Jul-20,Essential non-healthcare workers,Multiple groups,22647,22.50%,21.90%,23.00%,Convenience,Ortho Clinical Diagnostics Inc.,CLIA,IgG,90.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Samira Sami,CDC and New York City Department of Health and Mental Hygiene,https://dx.doi.org/10.3201/eid2703.204340,05/03/2021,16/07/2022,Unverified
201214_Maricopa_MaricopaCountyDepartmentOfPublicHealth_overall,14-Dec-20,Local,United States of America,USA,Arizona,,11-Sep-20,21-Sep-20,Household and community samples,Multiple groups,260,10.70%,,,Stratified probability,NA,Not reported,Not reported,,,Unclear,News and Media,Fountain Hills Times,Maricopa County Department of Public Health,https://www.fhtimes.com/news/local_news/maricopa-county-covid-19-serosurvey-results-reported/article_6be4ab0a-3983-11eb-ab22-a3b73c8957c7.html,06/03/2021,16/07/2022,Verified
201203_Florida_FloridaDepartmentOfHealth_primary,03-Dec-20,Regional,United States of America,USA,Florida,,01-May-20,30-Nov-20,Household and community samples,Multiple groups,630838,11.03%,,,Self-referral,NA,Not reported,"IgG,Total Antibody",,,Unclear,News and Media,Frank Jolley,Florida Department of Health,https://www.dailycommercial.com/story/news/2020/12/03/area-residents-covid-antibody-below-state-average/6475413002/,07/03/2021,16/07/2022,Verified
201005_Wisconsin_UW-Madison_overall,05-Oct-20,Regional,United States of America,USA,Wisconsin,,15-Jul-20,15-Aug-20,Household and community samples,Multiple groups,1056,1.60%,,,Stratified probability,NA,Not reported,Not reported,,,Unclear,News and Media,Madeline Heim,UW-Madison,https://www.postcrescent.com/story/news/2020/10/05/wisconsin-covid-19-less-than-2-of-state-population-have-antibodies/3457334001/,07/03/2021,16/07/2022,Verified
200830_VenturaCounty_OxnardFireDepartment_overall,30-Aug-20,Local,United States of America,USA,California,,22-Jun-20,06-Jul-20,Household and community samples,Multiple groups,6794,1.30%,,,Self-referral,"Abbott Laboratories,Bio-rad",Not reported,Not reported,,,High,News and Media,Jeremy Childs,Oxnard Fire Department,https://www.vcstar.com/story/news/2020/08/30/covid-19-data-coronavirus-antibodies-ventura-county/3436858001/,07/03/2021,16/07/2022,Verified
200824_Louiseville_UniversityOfLouiseville_HCW_July,24-Aug-20,Local,United States of America,USA,Kentucky,Louiseville,01-Jul-20,31-Jul-20,Health care workers and caregivers,Adults (18-64 years),1100,2.20%,,,Convenience,NA,Not reported,Not reported,,,Unclear,News and Media,Betty Coffman,University of Louiseville ,http://www.uoflnews.com/post/uofltoday/new-co-immunity-project-data-show-covid-19-infection-among-health-care-workers-may-be-lower-than-the-general-population/,08/03/2021,16/07/2022,Verified
201124_JeffersonCounty_UniversityofLouiseville_ProbabilitySampling,24-Nov-20,Local,United States of America,USA,Kentucky,,09-Nov-20,16-Nov-20,Household and community samples,Multiple groups,1091,2.00%,,,Stratified probability,NA,Not reported,Not reported,,,Unclear,News and Media,Betty Coffman,University of Louiseville ,https://www.uoflnews.com/post/uofltoday/co-immunity-project-shows-covid-19-infection-rate-in-jefferson-county-increased-tenfold-since-september/,08/03/2021,16/07/2022,Verified
201124_JeffersonCounty_UniversityofLouiseville_SelfReferal_overall,24-Nov-20,Local,United States of America,USA,Kentucky,,09-Nov-20,16-Nov-20,Household and community samples,Multiple groups,1709,3.30%,,,Self-referral,NA,Not reported,Not reported,,,Unclear,News and Media,Betty Coffman,University of Louiseville ,https://www.uoflnews.com/post/uofltoday/co-immunity-project-shows-covid-19-infection-rate-in-jefferson-county-increased-tenfold-since-september/,08/03/2021,16/07/2022,Verified
200824_Louiseville_UniversityOfLouiseville_HCW_AprilMay,24-Aug-20,Local,United States of America,USA,Kentucky,Louiseville,01-Apr-20,31-May-20,Health care workers and caregivers,Adults (18-64 years),1372,1.00%,,,Convenience,NA,Not reported,Not reported,,,Unclear,News and Media,Betty Coffman,University of Louiseville ,http://www.uoflnews.com/post/uofltoday/new-co-immunity-project-data-show-covid-19-infection-among-health-care-workers-may-be-lower-than-the-general-population/,09/03/2021,16/07/2022,Verified
210123_Norfolk_NavalMedicalCenterPortsmouth_Overall,23-Jan-21,Local,United States of America,USA,Virginia,Norfolk,28-Apr-20,12-May-20,Essential non-healthcare workers,Adults (18-64 years),432,3.01%,1.61%,5.09%,Convenience,LakePharma Inc.,Other,IgG,98.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Tahaniyat Lalani,Naval Medical Center Portsmouth,https://dx.doi.org/10.1093/ofid/ofaa654,13/03/2021,16/07/2022,Verified
201028_Connecticut_YaleSchoolOfMedicine_Black2Overall_PopAdj,28-Oct-20,Regional,United States of America,USA,Connecticut,,23-Jun-20,22-Jul-20,Household and community samples,Multiple groups,148,6.40%,0.90%,11.90%,Simplified probability,Ortho Clinical Diagnostics Inc.,CLIA,IgG,90.00%,100.00%,High,Journal Article (Peer-Reviewed),Shiwani Mahajan,Yale School of Medicine,http://dx.doi.org/10.1016/j.amjmed.2020.09.024,13/03/2021,16/07/2022,Verified
201028_Connecticut_YaleSchoolOfMedicine_Hispanic3_Overall_PopAdj,28-Oct-20,Regional,United States of America,USA,Connecticut,,23-Jun-20,22-Jul-20,Household and community samples,Multiple groups,171,19.90%,13.20%,26.60%,Simplified probability,Ortho Clinical Diagnostics Inc.,CLIA,IgG,90.00%,100.00%,High,Journal Article (Peer-Reviewed),Shiwani Mahajan,Yale School of Medicine,http://dx.doi.org/10.1016/j.amjmed.2020.09.024,13/03/2021,16/07/2022,Verified
210122_USA_YourCareChoice_GenPop,22-Jan-21,National,United States of America,USA,,,24-Apr-20,13-May-20,Household and community samples,Multiple groups,407,21.62%,,,Stratified probability,NA,Not reported,Not reported,,,High,Journal Article (Peer-Reviewed),Robert Morlock,YourCareChoice,https://dx.doi.org/10.1371/journal.pone.0245586,13/03/2021,16/07/2022,Verified
210203_StLouis_WashingtonUniversitySchoolofMedicine_Children_overall_adj,03-Feb-21,Local,United States of America,USA,Missouri,St Louis,14-Apr-20,08-May-20,Residual sera,Children and Youth (0-17 years),555,1.71%,0.04%,3.38%,Sequential,NA,ELISA,IgG,98.20%,98.70%,High,Journal Article (Peer-Reviewed),Brittany Smith,Washington University School of Medicine,https://dx.doi.org/10.1128/mSphere.01207-20,13/03/2021,16/07/2022,Verified
210203_StLouis_WashingtonUniversitySchoolofMedicine_Adults_overall_adj,03-Feb-21,Local,United States of America,USA,Missouri,St Louis,27-Apr-20,12-May-20,Residual sera,Multiple groups,503,3.11%,0.92%,5.32%,Sequential,NA,ELISA,IgG,98.20%,98.70%,High,Journal Article (Peer-Reviewed),Brittany Smith,Washington University School of Medicine,https://dx.doi.org/10.1128/mSphere.01207-20,13/03/2021,16/07/2022,Verified
210212_Arizona_KingmanRegionalMedicalCenter_Overall,12-Feb-21,Local,United States of America,USA,Arizona,Kingman,28-Sep-20,09-Oct-20,Household and community samples,Adults (18-64 years),566,8.00%,,,Self-referral,Ortho Clinical Diagnostics Inc.,LFIA,IgG,87.50%,100.00%,High,Journal Article (Peer-Reviewed),Anthony Santarelli,Kingman Regional Medical Center,https://dx.doi.org/10.1515/jom-2020-0287,14/03/2021,16/07/2022,Verified
210120_NorthDakota_NorthDakotaStateUniversity_PharmacyPersonnel,20-Jan-21,Regional,United States of America,USA,North Dakota,"Fargo, Grand Forks",01-Jul-20,31-Jul-20,Health care workers and caregivers,Adults (18-64 years),247,14.60%,10.40%,19.60%,Convenience,BioSys Laboratories,LFIA,"IgG,IgM",93.50%,100.00%,High,Journal Article (Peer-Reviewed),Amanda Johnson,North Dakota State University,https://www.japha.org/article/S1544-3191(21)00025-X/abstract,14/03/2021,16/07/2022,Verified
210225_Denver_UniversityofColorado_NewOnsetDiabetes,25-Feb-21,Local,United States of America,USA,Colorado,Denver,03-Jan-20,16-Oct-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,129,0.80%,0.10%,4.20%,Sequential,NA,CLIA,Total Antibody,100.00%,99.90%,High,Journal Article (Peer-Reviewed),Xiaofan Jia,University of Colorado,https://dx.doi.org/10.1089/dia.2020.0609,14/03/2021,16/07/2022,Verified
210225_Denver_UniversityofColorado_EstablishedDiabetes,25-Feb-21,Local,United States of America,USA,Colorado,Denver,03-Jan-20,16-Oct-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,94,4.30%,1.70%,10.40%,Sequential,NA,CLIA,Total Antibody,100.00%,99.90%,High,Journal Article (Peer-Reviewed),Xiaofan Jia,University of Colorado,https://dx.doi.org/10.1089/dia.2020.0609,14/03/2021,16/07/2022,Verified
210225_Denver_UniversityofColorado_GenPopChildren,25-Feb-21,Local,United States of America,USA,Colorado,Denver,08-Jul-20,23-Oct-20,Household and community samples,Children and Youth (0-17 years),562,2.80%,1.80%,4.60%,Convenience,NA,CLIA,Total Antibody,100.00%,99.90%,High,Journal Article (Peer-Reviewed),Xiaofan Jia,University of Colorado,https://dx.doi.org/10.1089/dia.2020.0609,14/03/2021,16/07/2022,Verified
210225_Denver_UniversityofColorado_GenPopAdults,25-Feb-21,Local,United States of America,USA,Colorado,Denver,08-Jul-20,23-Oct-20,Household and community samples,Adults (18-64 years),102,3.90%,1.50%,9.70%,Convenience,NA,CLIA,Total Antibody,100.00%,99.90%,High,Journal Article (Peer-Reviewed),Xiaofan Jia,University of Colorado,https://dx.doi.org/10.1089/dia.2020.0609,14/03/2021,16/07/2022,Verified
210202_ParrisIsland_IcahnSchoolofMedicineatMountSinai,02-Feb-21,Local,United States of America,USA,North Carolina,Parris Island,11-May-20,07-Sep-20,Essential non-healthcare workers,Adults (18-64 years),3196,9.00%,,,Convenience,NA,ELISA,IgG,96.08%,97.14%,Moderate,Journal Article (Peer-Reviewed),Andrew Letizia,Icahn School of Medicine at Mount Sinai,http://dx.doi.org/10.3201/eid2704.204732,17/03/2021,16/07/2022,Verified
210226_CentreCounty_PennsylvaniaStateUniversity_Students,26-Feb-21,Local,United States of America,USA,Pennsylvania,,26-Oct-20,23-Nov-20,Students and Daycares,Adults (18-64 years),625,31.20%,,,Convenience,NA,ELISA,IgG,93.30%,99.00%,Moderate,Preprint,Callum Arnold,Pennsylvania State University,https://www.medrxiv.org/content/10.1101/2021.02.17.21251942v3,17/03/2021,16/07/2022,Verified
210226_CentreCounty_PennsylvaniaStateUniversity_Community,26-Feb-21,Local,United States of America,USA,Pennsylvania,,07-Aug-20,20-Dec-20,Household and community samples,Adults (18-64 years),345,8.20%,,,Convenience,NA,ELISA,IgG,93.30%,99.00%,High,Preprint,Callum Arnold,Pennsylvania State University,https://www.medrxiv.org/content/10.1101/2021.02.17.21251942v3,17/03/2021,16/07/2022,Verified
210204_UnitedStates_DaVitaClinicalResearch_Overall,04-Feb-21,National,United States of America,USA,,,27-May-20,01-Jul-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,12932,5.78%,5.40%,6.20%,Simplified probability,Diazyme Laboratories Inc,CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Adam Walker,DaVita Clinical Research,https://dx.doi.org/10.1016/j.xkme.2021.01.002,18/03/2021,16/07/2022,Verified
210201_NewYorkCity_ColumbiaUniversity,01-Feb-21,Local,United States of America,USA,"New York
",New York City,24-Jun-20,16-Jul-20,Pregnant or parturient women,Adults (18-64 years),47,40.40%,,,Sequential,NA,ELISA,"IgG,IgM",92.00%,,High,Journal Article (Peer-Reviewed),Caitlin Baptiste,Columbia University,http://dx.doi.org/10.1016/j.ajog.2020.12.944,18/03/2021,16/07/2022,Verified
210208_Virginia_UniversityOfVirginia_Overall_PopAdj,08-Feb-21,Regional,United States of America,USA,Virginia,,01-Jun-20,14-Aug-20,Residual sera,Multiple groups,4675,2.40%,1.80%,3.10%,Convenience,Abbott Laboratories,CLIA,IgG,92.70%,99.90%,Moderate,Journal Article (Peer-Reviewed),Elizabeth T Rogawski McQuade,University of Virginia ,https://dx.doi.org/10.1001/jamanetworkopen.2020.35234,18/03/2021,16/07/2022,Verified
210130_USA_UniversityofArizona_primary,30-Jan-21,Local,United States of America,USA,,Detroit and New York City,17-May-20,02-Jul-20,Health care workers and caregivers,Multiple groups,40938,16.20%,15.90%,16.60%,Self-referral,Ortho Clinical Diagnostics Inc.,ELISA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Lara J Akinbami,University of Arizona ,https://dx.doi.org/10.1093/cid/ciab080,19/03/2021,16/07/2022,Verified
210129_Atlanta_EmoryUniversityHospital_primary,29-Jan-21,Local,United States of America,USA,Georgia,Atlanta,19-Apr-20,26-Jun-20,Health care workers and caregivers,Adults (18-64 years),10275,3.80%,3.40%,4.30%,Self-referral,NA,ELISA,IgG,97.50%,98.00%,Moderate,Journal Article (Peer-Reviewed),Julia M Baker,Emory University Hospital,https://dx.doi.org/10.7326/M20-7145,19/03/2021,16/07/2022,Verified
210218_WashingtonDC_GovernmentOfTheDistrictOfColumbia_overall,18-Feb-21,Local,United States of America,USA,,Washington DC,27-Jul-20,21-Aug-20,Household and community samples,Multiple groups,671,7.60%,5.70%,9.90%,Convenience,DiaSorin,CLIA,IgG,97.00%,,High,Preprint,Adrienne Sherman,Government of the District of Columbia,10.1101/2021.02.15.21251764,19/03/2021,16/07/2022,Verified
210129_NewYork_NorthwellHealth,29-Jan-21,Regional,United States of America,USA,New York,,27-May-20,23-Aug-20,Pregnant or parturient women,Adults (18-64 years),2930,15.30%,,,Sequential,NA,Not reported,Not reported,,,Unclear,Journal Article (Peer-Reviewed),Lylach Haizler Cohen,Northwell Health,http://dx.doi.org/10.1016/j.ajog.2020.12.631,20/03/2021,16/07/2022,Verified
201124_USA_CDC_July/August1_Alaska,24-Nov-20,Regional,United States of America,USA,Alaska,,06-Aug-20,11-Aug-20,Residual sera,Multiple groups,242,0.30%,0.00%,1.12%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,High,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_August2_Alaska,24-Nov-20,Regional,United States of America,USA,Alaska,,12-Aug-20,26-Aug-20,Residual sera,Multiple groups,704,1.30%,0.50%,2.33%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_August/September3_Alaska,24-Nov-20,Regional,United States of America,USA,Alaska,,26-Aug-20,09-Sep-20,Residual sera,Multiple groups,610,1.00%,0.24%,2.17%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_September4_Alaska,24-Nov-20,Regional,United States of America,USA,Alaska,,09-Sep-20,18-Sep-20,Residual sera,Multiple groups,681,0.40%,0.11%,0.82%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_August/September3_Alabama,24-Nov-20,Regional,United States of America,USA,Alabama,,26-Aug-20,08-Sep-20,Residual sera,Multiple groups,955,9.90%,7.19%,12.79%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_August/September3_Arkansas,24-Nov-20,Regional,United States of America,USA,Arkansas,,24-Aug-20,08-Sep-20,Residual sera,Multiple groups,992,4.90%,3.50%,6.41%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_August/September3_Arizona,24-Nov-20,Regional,United States of America,USA,Arizona,,26-Aug-20,09-Sep-20,Residual sera,Multiple groups,1030,4.90%,3.05%,7.11%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_August/September3_California,24-Nov-20,Regional,United States of America,USA,California,,28-Aug-20,09-Sep-20,Residual sera,Multiple groups,983,6.00%,4.20%,7.82%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_August/September3_Connecticut,24-Nov-20,Regional,United States of America,USA,Connecticut,,26-Aug-20,04-Sep-20,Residual sera,Multiple groups,983,4.30%,2.90%,5.69%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_August/September3_Colorado,24-Nov-20,Regional,United States of America,USA,Colorado,,24-Aug-20,04-Sep-20,Residual sera,Multiple groups,1025,3.60%,2.31%,5.09%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_August/September3_WashingtonD.C,24-Nov-20,Regional,United States of America,USA,Washington D.C,,27-Aug-20,10-Sep-20,Residual sera,Multiple groups,643,5.00%,2.83%,7.55%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_August/September3_Florida,24-Nov-20,Regional,United States of America,USA,Florida,,27-Aug-20,09-Sep-20,Residual sera,Multiple groups,981,5.70%,3.93%,7.49%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_August/September3_Iowa,24-Nov-20,Regional,United States of America,USA,Iowa,,25-Aug-20,10-Sep-20,Residual sera,Multiple groups,1006,8.40%,6.15%,10.74%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_August/September3_Delaware,24-Nov-20,Regional,United States of America,USA,Delaware,,26-Aug-20,10-Sep-20,Residual sera,Multiple groups,914,4.50%,2.42%,7.12%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_August/September3_Georgia,24-Nov-20,Regional,United States of America,USA,Georgia,,25-Aug-20,10-Sep-20,Residual sera,Multiple groups,1020,8.70%,6.69%,11.14%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_August/September3_Idaho,24-Nov-20,Regional,United States of America,USA,Idaho,,26-Aug-20,10-Sep-20,Residual sera,Multiple groups,790,5.70%,2.90%,9.70%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_August/September3_Maine,24-Nov-20,Regional,United States of America,USA, Maine,,26-Aug-20,10-Sep-20,Residual sera,Multiple groups,759,1.50%,0.44%,3.22%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_August/September3_Kansas,24-Nov-20,Regional,United States of America,USA,Kansas,,24-Aug-20,03-Sep-20,Residual sera,Multiple groups,1025,2.90%,1.57%,4.31%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_August/September3_Massachusetts,24-Nov-20,Regional,United States of America,USA, Massachusetts,,27-Aug-20,05-Sep-20,Residual sera,Multiple groups,981,3.60%,2.36%,5.08%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_August/September3_Indiana,24-Nov-20,Regional,United States of America,USA,Indiana,,26-Aug-20,09-Sep-20,Residual sera,Multiple groups,984,2.40%,1.36%,3.52%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_August/September3_Maryland,24-Nov-20,Regional,United States of America,USA, Maryland,,26-Aug-20,08-Sep-20,Residual sera,Multiple groups,980,7.90%,5.72%,10.35%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_August/September3_Minnesota,24-Nov-20,Regional,United States of America,USA, Minnesota,,26-Aug-20,08-Sep-20,Residual sera,Multiple groups,974,9.20%,6.71%,11.95%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_August/September3_Michigan,24-Nov-20,Regional,United States of America,USA, Michigan,,26-Aug-20,03-Sep-20,Residual sera,Multiple groups,976,3.40%,2.16%,4.95%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_August/September3_Illinois,24-Nov-20,Regional,United States of America,USA,Illinois,,26-Aug-20,03-Sep-20,Residual sera,Multiple groups,979,5.60%,3.90%,7.67%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_August/September3_Missouri,24-Nov-20,Regional,United States of America,USA, Missouri,,24-Aug-20,10-Sep-20,Residual sera,Multiple groups,1024,2.90%,1.74%,4.17%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_August/September3_Louisiana,24-Nov-20,Regional,United States of America,USA, Louisiana,,26-Aug-20,08-Sep-20,Residual sera,Multiple groups,1001,8.60%,6.65%,11.30%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_August/September3_Kentucky,24-Nov-20,Regional,United States of America,USA, Kentucky,,26-Aug-20,08-Sep-20,Residual sera,Multiple groups,983,3.10%,1.91%,4.33%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_August/September3_Mississippi,24-Nov-20,Regional,United States of America,USA, Mississippi,,26-Aug-20,10-Sep-20,Residual sera,Multiple groups,987,8.40%,4.89%,12.73%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_August/September3_NewHampshire,24-Nov-20,Regional,United States of America,USA, New Hampshire,,26-Aug-20,03-Sep-20,Residual sera,Multiple groups,1147,1.60%,0.73%,2.84%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_August/September3_Ohio,24-Nov-20,Regional,United States of America,USA, Ohio,,27-Aug-20,10-Sep-20,Residual sera,Multiple groups,983,5.00%,3.17%,7.14%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_August/September3_Nebraska,24-Nov-20,Regional,United States of America,USA, Nebraska,,24-Aug-20,10-Sep-20,Residual sera,Multiple groups,938,6.30%,4.47%,8.27%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_August/September3_Virginia,24-Nov-20,Regional,United States of America,USA, Virginia,,26-Aug-20,08-Sep-20,Residual sera,Multiple groups,1007,3.50%,1.97%,5.26%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_August/September3_NewMexico,24-Nov-20,Regional,United States of America,USA, New Mexico,,25-Aug-20,08-Sep-20,Residual sera,Multiple groups,985,3.70%,2.28%,5.55%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_August/September3_Vermont,24-Nov-20,Regional,United States of America,USA, Vermont,,26-Aug-20,10-Sep-20,Residual sera,Multiple groups,485,0.40%,0.00%,0.94%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,High,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_August/September3_Oregon,24-Nov-20,Regional,United States of America,USA, Oregon,,26-Aug-20,10-Sep-20,Residual sera,Multiple groups,968,1.90%,0.92%,2.94%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_August/September3_PuertoRico,24-Nov-20,Regional,United States of America,USA,Puerto Rico,,24-Aug-20,03-Sep-20,Residual sera,Multiple groups,980,2.50%,1.36%,3.76%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_August/September3_NewJersey,24-Nov-20,Regional,United States of America,USA, New Jersey,,26-Aug-20,07-Sep-20,Residual sera,Multiple groups,944,12.80%,10.49%,15.35%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_August/September3_SouthDakota,24-Nov-20,Regional,United States of America,USA, South Dakota,,26-Aug-20,10-Sep-20,Residual sera,Multiple groups,97,0.70%,0.00%,2.47%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,High,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_August/September3_NewYork,24-Nov-20,Regional,United States of America,USA, New York,,26-Aug-20,10-Sep-20,Residual sera,Multiple groups,1043,19.50%,16.88%,22.38%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_August/September3_Montana,24-Nov-20,Regional,United States of America,USA, Montana,,24-Aug-20,09-Sep-20,Residual sera,Multiple groups,518,0.90%,0.23%,1.82%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,High,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_August/September3_Nevada,24-Nov-20,Regional,United States of America,USA, Nevada,,27-Aug-20,29-Aug-20,Residual sera,Multiple groups,980,6.50%,4.63%,8.58%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_August/September3_NorthCarolina,24-Nov-20,Regional,United States of America,USA, North Carolina,,26-Aug-20,09-Sep-20,Residual sera,Multiple groups,982,3.80%,2.33%,5.26%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_August/September3_Tennessee,24-Nov-20,Regional,United States of America,USA, Tennessee,,25-Aug-20,08-Sep-20,Residual sera,Multiple groups,950,5.40%,3.62%,7.31%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_August/September3_SouthCarolina,24-Nov-20,Regional,United States of America,USA, South Carolina,,26-Aug-20,10-Sep-20,Residual sera,Multiple groups,927,7.20%,5.12%,9.57%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_August/September3_RhodeIsland,24-Nov-20,Regional,United States of America,USA, Rhode Island,,27-Aug-20,10-Sep-20,Residual sera,Multiple groups,786,3.10%,1.73%,4.64%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_August/September3_Oklahoma,24-Nov-20,Regional,United States of America,USA, Oklahoma,,24-Aug-20,01-Sep-20,Residual sera,Multiple groups,979,5.40%,3.83%,7.29%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_August/September3_Utah,24-Nov-20,Regional,United States of America,USA, Utah,,24-Aug-20,08-Sep-20,Residual sera,Multiple groups,1104,4.90%,2.82%,7.67%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_August/September3_NorthDakota,24-Nov-20,Regional,United States of America,USA, North Dakota,,26-Aug-20,09-Sep-20,Residual sera,Multiple groups,109,0.20%,0.00%,0.99%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,High,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_August/September3_Texas,24-Nov-20,Regional,United States of America,USA, Texas,,25-Aug-20,02-Sep-20,Residual sera,Multiple groups,979,5.80%,4.04%,7.92%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_August/September3_Pennsylvania,24-Nov-20,Regional,United States of America,USA, Pennsylvania,,26-Aug-20,09-Sep-20,Residual sera,Multiple groups,845,9.50%,6.58%,13.56%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_August/September3_Washington,24-Nov-20,Regional,United States of America,USA,Washington,,25-Aug-20,10-Sep-20,Residual sera,Multiple groups,820,4.50%,2.63%,6.94%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_August/September3_Wisconsin,24-Nov-20,Regional,United States of America,USA, Wisconsin,,25-Aug-20,10-Sep-20,Residual sera,Multiple groups,976,2.60%,1.48%,3.95%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_August/September3_WestVirginia,24-Nov-20,Regional,United States of America,USA, West Virginia,,26-Aug-20,10-Sep-20,Residual sera,Multiple groups,1128,1.50%,0.78%,2.38%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_August2_Minnesota,24-Nov-20,Regional,United States of America,USA, Minnesota,,11-Aug-20,27-Aug-20,Residual sera,Multiple groups,978,4.50%,3.05%,5.87%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_August2_WestVirginia,24-Nov-20,Regional,United States of America,USA, West Virginia,,13-Aug-20,27-Aug-20,Residual sera,Multiple groups,637,2.20%,0.52%,4.90%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_August2_Wisconsin,24-Nov-20,Regional,United States of America,USA, Wisconsin,,12-Aug-20,27-Aug-20,Residual sera,Multiple groups,838,3.30%,2.03%,4.72%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_August2_Washington,24-Nov-20,Regional,United States of America,USA,Washington,,12-Aug-20,27-Aug-20,Residual sera,Multiple groups,1238,3.00%,1.79%,4.47%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_August2_Arizona,24-Nov-20,Regional,United States of America,USA,Arizona,,12-Aug-20,26-Aug-20,Residual sera,Multiple groups,1304,4.70%,2.70%,7.61%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_August2_Pennsylvania,24-Nov-20,Regional,United States of America,USA, Pennsylvania,,10-Aug-20,26-Aug-20,Residual sera,Multiple groups,887,10.10%,7.53%,13.74%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_August2_California,24-Nov-20,Regional,United States of America,USA,California,,13-Aug-20,19-Aug-20,Residual sera,Multiple groups,980,4.30%,2.85%,6.06%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_August2_Missouri,24-Nov-20,Regional,United States of America,USA, Missouri,,12-Aug-20,21-Aug-20,Residual sera,Multiple groups,1021,3.50%,2.23%,5.06%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_August2_Iowa,24-Nov-20,Regional,United States of America,USA,Iowa,,12-Aug-20,27-Aug-20,Residual sera,Multiple groups,980,9.40%,7.12%,11.63%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_August2_Georgia,24-Nov-20,Regional,United States of America,USA,Georgia,,13-Aug-20,26-Aug-20,Residual sera,Multiple groups,1031,7.40%,5.52%,9.51%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_August2_NewYork,24-Nov-20,Regional,United States of America,USA, New York,,10-Aug-20,26-Aug-20,Residual sera,Multiple groups,1122,20.60%,18.04%,23.14%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_August2_NewJersey,24-Nov-20,Regional,United States of America,USA, New Jersey,,10-Aug-20,26-Aug-20,Residual sera,Multiple groups,1127,12.20%,10.15%,14.53%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_August2_Nevada,24-Nov-20,Regional,United States of America,USA, Nevada,,12-Aug-20,26-Aug-20,Residual sera,Multiple groups,972,7.90%,6.13%,9.83%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_August2_Indiana,24-Nov-20,Regional,United States of America,USA,Indiana,,12-Aug-20,26-Aug-20,Residual sera,Multiple groups,906,3.10%,1.53%,4.76%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_August2_Ohio,24-Nov-20,Regional,United States of America,USA, Ohio,,12-Aug-20,27-Aug-20,Residual sera,Multiple groups,985,2.10%,1.06%,3.29%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_August2_Idaho,24-Nov-20,Regional,United States of America,USA,Idaho,,12-Aug-20,26-Aug-20,Residual sera,Multiple groups,651,4.60%,1.67%,9.05%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_August2_NorthDakota,24-Nov-20,Regional,United States of America,USA, North Dakota,,12-Aug-20,26-Aug-20,Residual sera,Multiple groups,135,0.60%,0.00%,1.45%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,High,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_August2_Florida,24-Nov-20,Regional,United States of America,USA,Florida,,14-Aug-20,14-Aug-20,Residual sera,Multiple groups,978,4.50%,3.15%,6.06%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_August2_Alabama,24-Nov-20,Regional,United States of America,USA,Alabama,,12-Aug-20,26-Aug-20,Residual sera,Multiple groups,974,7.60%,5.33%,9.76%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_August2_Vermont,24-Nov-20,Regional,United States of America,USA, Vermont,,13-Aug-20,27-Aug-20,Residual sera,Multiple groups,382,0.30%,0.00%,0.81%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,High,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_August2_SouthCarolina,24-Nov-20,Regional,United States of America,USA, South Carolina,,12-Aug-20,27-Aug-20,Residual sera,Multiple groups,1063,6.00%,4.37%,7.95%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_August2_Virginia,24-Nov-20,Regional,United States of America,USA, Virginia,,10-Aug-20,26-Aug-20,Residual sera,Multiple groups,1243,4.70%,2.51%,7.22%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_August2_PuertoRico,24-Nov-20,Regional,United States of America,USA,Puerto Rico,,10-Aug-20,17-Aug-20,Residual sera,Multiple groups,986,2.20%,1.18%,3.26%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_August2_Massachusetts,24-Nov-20,Regional,United States of America,USA, Massachusetts,,12-Aug-20,27-Aug-20,Residual sera,Multiple groups,980,3.70%,2.27%,5.21%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_August2_RhodeIsland,24-Nov-20,Regional,United States of America,USA, Rhode Island,,12-Aug-20,27-Aug-20,Residual sera,Multiple groups,570,3.60%,1.69%,5.89%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,High,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_August2_Delaware,24-Nov-20,Regional,United States of America,USA,Delaware,,12-Aug-20,27-Aug-20,Residual sera,Multiple groups,1004,8.50%,5.79%,11.25%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_August2_Texas,24-Nov-20,Regional,United States of America,USA, Texas,,12-Aug-20,24-Aug-20,Residual sera,Multiple groups,1001,6.50%,4.69%,8.47%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_August2_Michigan,24-Nov-20,Regional,United States of America,USA, Michigan,,12-Aug-20,25-Aug-20,Residual sera,Multiple groups,983,4.20%,2.88%,5.76%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_August2_Oregon,24-Nov-20,Regional,United States of America,USA, Oregon,,10-Aug-20,27-Aug-20,Residual sera,Multiple groups,1086,2.40%,1.41%,3.60%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_August2_Kansas,24-Nov-20,Regional,United States of America,USA,Kansas,,11-Aug-20,25-Aug-20,Residual sera,Multiple groups,1016,3.70%,2.02%,5.47%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_August2_Maine,24-Nov-20,Regional,United States of America,USA, Maine,,12-Aug-20,27-Aug-20,Residual sera,Multiple groups,609,0.60%,0.00%,1.44%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_August2_Montana,24-Nov-20,Regional,United States of America,USA, Montana,,12-Aug-20,24-Aug-20,Residual sera,Multiple groups,383,1.30%,0.38%,2.49%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,High,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_August2_Maryland,24-Nov-20,Regional,United States of America,USA, Maryland,,10-Aug-20,26-Aug-20,Residual sera,Multiple groups,1174,7.00%,4.92%,9.33%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_August2_Tennessee,24-Nov-20,Regional,United States of America,USA, Tennessee,,12-Aug-20,26-Aug-20,Residual sera,Multiple groups,1029,6.70%,5.11%,8.57%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_August2_NorthCarolina,24-Nov-20,Regional,United States of America,USA, North Carolina,,11-Aug-20,27-Aug-20,Residual sera,Multiple groups,982,3.80%,2.33%,5.29%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_August2_Kentucky,24-Nov-20,Regional,United States of America,USA, Kentucky,,12-Aug-20,26-Aug-20,Residual sera,Multiple groups,1126,3.10%,2.05%,4.49%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_August2_NewMexico,24-Nov-20,Regional,United States of America,USA, New Mexico,,10-Aug-20,27-Aug-20,Residual sera,Multiple groups,976,2.50%,1.47%,3.79%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_August2_Mississippi,24-Nov-20,Regional,United States of America,USA, Mississippi,,12-Aug-20,27-Aug-20,Residual sera,Multiple groups,968,10.00%,6.69%,14.71%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_August2_Oklahoma,24-Nov-20,Regional,United States of America,USA, Oklahoma,,10-Aug-20,18-Aug-20,Residual sera,Multiple groups,979,4.00%,2.72%,5.51%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_August2_Utah,24-Nov-20,Regional,United States of America,USA, Utah,,15-Aug-20,25-Aug-20,Residual sera,Multiple groups,871,5.50%,2.94%,8.71%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_August2_Colorado,24-Nov-20,Regional,United States of America,USA,Colorado,,10-Aug-20,25-Aug-20,Residual sera,Multiple groups,1019,3.30%,1.83%,4.80%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_August2_NewHampshire,24-Nov-20,Regional,United States of America,USA, New Hampshire,,13-Aug-20,25-Aug-20,Residual sera,Multiple groups,1125,0.80%,0.30%,1.22%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_August2_Washington D.C,24-Nov-20,Regional,United States of America,USA,Washington D.C,,13-Aug-20,27-Aug-20,Residual sera,Multiple groups,781,6.80%,4.59%,9.21%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_August2_Louisiana,24-Nov-20,Regional,United States of America,USA, Louisiana,,12-Aug-20,25-Aug-20,Residual sera,Multiple groups,989,11.80%,9.27%,14.81%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_August2_SouthDakota,24-Nov-20,Regional,United States of America,USA, South Dakota,,12-Aug-20,26-Aug-20,Residual sera,Multiple groups,83,0.00%,0.00%,4.35%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,High,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_August2_Wyoming,24-Nov-20,Regional,United States of America,USA, Wyoming,,13-Aug-20,24-Aug-20,Residual sera,Multiple groups,86,0.80%,0.00%,3.11%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,High,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_August2_Illinois,24-Nov-20,Regional,United States of America,USA,Illinois,,12-Aug-20,27-Aug-20,Residual sera,Multiple groups,985,4.90%,3.40%,6.65%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_August2_Connecticut,24-Nov-20,Regional,United States of America,USA,Connecticut,,11-Aug-20,24-Aug-20,Residual sera,Multiple groups,983,2.40%,1.45%,3.52%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_August2_Arkansas,24-Nov-20,Regional,United States of America,USA,Arkansas,,11-Aug-20,25-Aug-20,Residual sera,Multiple groups,998,3.00%,1.76%,4.35%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_August2_Nebraska,24-Nov-20,Regional,United States of America,USA, Nebraska,,11-Aug-20,25-Aug-20,Residual sera,Multiple groups,990,7.90%,5.51%,10.61%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_July/August1_Pennsylvania,24-Nov-20,Regional,United States of America,USA, Pennsylvania,,31-Jul-20,11-Aug-20,Residual sera,Multiple groups,575,10.20%,5.71%,17.21%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,High,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_July/August1_SouthCarolina,24-Nov-20,Regional,United States of America,USA, South Carolina,,30-Jul-20,13-Aug-20,Residual sera,Multiple groups,840,8.10%,5.79%,10.69%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_July/August1_NewJersey,24-Nov-20,Regional,United States of America,USA, New Jersey,,31-Jul-20,11-Aug-20,Residual sera,Multiple groups,871,14.80%,12.23%,17.57%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_July/August1_Texas,24-Nov-20,Regional,United States of America,USA, Texas,,29-Jul-20,05-Aug-20,Residual sera,Multiple groups,986,5.90%,4.04%,7.95%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_July/August1_NewYork,24-Nov-20,Regional,United States of America,USA, New York,,31-Jul-20,11-Aug-20,Residual sera,Multiple groups,846,23.30%,20.07%,26.32%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_July/August1_Montana,24-Nov-20,Regional,United States of America,USA, Montana,,29-Jul-20,10-Aug-20,Residual sera,Multiple groups,199,0.50%,0.00%,1.67%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,High,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_July/August1_PuertoRico,24-Nov-20,Regional,United States of America,USA,Puerto Rico,,27-Jul-20,07-Aug-20,Residual sera,Multiple groups,984,1.10%,0.43%,1.80%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_July/August1_Washington D.C,24-Nov-20,Regional,United States of America,USA,Washington D.C,,30-Jul-20,13-Aug-20,Residual sera,Multiple groups,717,3.90%,2.18%,5.76%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_July/August1_Vermont,24-Nov-20,Regional,United States of America,USA, Vermont,,30-Jul-20,11-Aug-20,Residual sera,Multiple groups,346,0.50%,0.00%,1.84%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,High,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_July/August1_Maine,24-Nov-20,Regional,United States of America,USA, Maine,,30-Jul-20,11-Aug-20,Residual sera,Multiple groups,598,0.50%,0.00%,1.16%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,High,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_July/August1_NewHampshire,24-Nov-20,Regional,United States of America,USA, New Hampshire,,30-Jul-20,11-Aug-20,Residual sera,Multiple groups,809,0.80%,0.22%,1.48%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_July/August1_Nevada,24-Nov-20,Regional,United States of America,USA, Nevada,,30-Jul-20,02-Aug-20,Residual sera,Multiple groups,979,5.10%,3.63%,6.66%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_July/August1_NorthCarolina,24-Nov-20,Regional,United States of America,USA, North Carolina,,29-Jul-20,10-Aug-20,Residual sera,Multiple groups,928,2.50%,1.31%,3.72%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_July/August1_Idaho,24-Nov-20,Regional,United States of America,USA,Idaho,,04-Aug-20,11-Aug-20,Residual sera,Multiple groups,246,4.50%,1.80%,7.99%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,High,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_July/August1_Colorado,24-Nov-20,Regional,United States of America,USA,Colorado,,30-Jul-20,07-Aug-20,Residual sera,Multiple groups,1001,2.40%,0.89%,4.53%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_July/August1_Florida,24-Nov-20,Regional,United States of America,USA,Florida,,31-Jul-20,03-Aug-20,Residual sera,Multiple groups,980,4.30%,2.77%,5.86%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_July/August1_Nebraska,24-Nov-20,Regional,United States of America,USA, Nebraska,,28-Jul-20,13-Aug-20,Residual sera,Multiple groups,954,7.40%,5.25%,9.75%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_July/August1_Kentucky,24-Nov-20,Regional,United States of America,USA, Kentucky,,30-Jul-20,13-Aug-20,Residual sera,Multiple groups,975,2.40%,1.32%,3.62%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_July/August1_WestVirginia,24-Nov-20,Regional,United States of America,USA, West Virginia,,30-Jul-20,13-Aug-20,Residual sera,Multiple groups,317,1.20%,0.23%,2.50%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,High,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_July/August1_Alabama,24-Nov-20,Regional,United States of America,USA,Alabama,,29-Jul-20,13-Aug-20,Residual sera,Multiple groups,938,5.80%,4.16%,7.71%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_July/August1_Mississippi,24-Nov-20,Regional,United States of America,USA, Mississippi,,30-Jul-20,13-Aug-20,Residual sera,Multiple groups,769,7.10%,3.75%,11.09%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_July/August1_Louisiana,24-Nov-20,Regional,United States of America,USA, Louisiana,,28-Jul-20,13-Aug-20,Residual sera,Multiple groups,1002,9.60%,6.88%,12.29%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_July/August1_Kansas,24-Nov-20,Regional,United States of America,USA,Kansas,,29-Jul-20,08-Aug-20,Residual sera,Multiple groups,962,1.60%,0.70%,2.80%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_July/August1_Massachusetts,24-Nov-20,Regional,United States of America,USA, Massachusetts,,30-Jul-20,10-Aug-20,Residual sera,Multiple groups,978,4.20%,2.89%,5.81%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_July/August1_Indiana,24-Nov-20,Regional,United States of America,USA,Indiana,,31-Jul-20,11-Aug-20,Residual sera,Multiple groups,579,2.20%,1.10%,3.63%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,High,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_July/August1_Oklahoma,24-Nov-20,Regional,United States of America,USA, Oklahoma,,28-Jul-20,04-Aug-20,Residual sera,Multiple groups,979,1.60%,0.85%,2.49%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_July/August1_Wisconsin,24-Nov-20,Regional,United States of America,USA, Wisconsin,,30-Jul-20,13-Aug-20,Residual sera,Multiple groups,814,1.80%,0.76%,3.18%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_July/August1_Delaware,24-Nov-20,Regional,United States of America,USA,Delaware,,29-Jul-20,13-Aug-20,Residual sera,Multiple groups,804,5.70%,3.55%,8.22%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_July/August1_Iowa,24-Nov-20,Regional,United States of America,USA,Iowa,,29-Jul-20,13-Aug-20,Residual sera,Multiple groups,811,8.60%,5.98%,11.34%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_July/August1_Maryland,24-Nov-20,Regional,United States of America,USA, Maryland,,31-Jul-20,11-Aug-20,Residual sera,Multiple groups,783,9.70%,7.26%,12.87%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_July/August1_Connecticut,24-Nov-20,Regional,United States of America,USA,Connecticut,,30-Jul-20,03-Aug-20,Residual sera,Multiple groups,994,3.40%,2.04%,4.72%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_July/August1_Michigan,24-Nov-20,Regional,United States of America,USA, Michigan,,30-Jul-20,11-Aug-20,Residual sera,Multiple groups,982,3.40%,2.16%,4.84%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_July/August1_NewMexico,24-Nov-20,Regional,United States of America,USA, New Mexico,,29-Jul-20,13-Aug-20,Residual sera,Multiple groups,964,2.00%,1.09%,3.02%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_July/August1_Arizona,24-Nov-20,Regional,United States of America,USA,Arizona,,31-Jul-20,11-Aug-20,Residual sera,Multiple groups,591,8.20%,4.11%,13.59%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,High,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_July/August1_Missouri,24-Nov-20,Regional,United States of America,USA, Missouri,,28-Jul-20,10-Aug-20,Residual sera,Multiple groups,979,2.50%,1.44%,3.61%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_July/August1_Tennessee,24-Nov-20,Regional,United States of America,USA, Tennessee,,30-Jul-20,11-Aug-20,Residual sera,Multiple groups,1003,6.30%,4.41%,8.25%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_July/August1_Washington,24-Nov-20,Regional,United States of America,USA,Washington,,29-Jul-20,11-Aug-20,Residual sera,Multiple groups,684,2.10%,0.81%,3.70%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_July/August1_Virginia,24-Nov-20,Regional,United States of America,USA, Virginia,,31-Jul-20,11-Aug-20,Residual sera,Multiple groups,730,4.10%,1.80%,6.93%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_July/August1_Georgia,24-Nov-20,Regional,United States of America,USA,Georgia,,02-Aug-20,11-Aug-20,Residual sera,Multiple groups,985,6.80%,4.83%,8.81%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_July/August1_RhodeIsland,24-Nov-20,Regional,United States of America,USA, Rhode Island,,30-Jul-20,11-Aug-20,Residual sera,Multiple groups,684,3.00%,1.23%,5.51%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_July/August1_Illinois,24-Nov-20,Regional,United States of America,USA,Illinois,,29-Jul-20,10-Aug-20,Residual sera,Multiple groups,1004,3.90%,2.52%,5.21%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_July/August1_NorthDakota,24-Nov-20,Regional,United States of America,USA, North Dakota,,29-Jul-20,12-Aug-20,Residual sera,Multiple groups,121,7.30%,1.30%,14.28%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,High,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_July/August1_Arkansas,24-Nov-20,Regional,United States of America,USA,Arkansas,,29-Jul-20,13-Aug-20,Residual sera,Multiple groups,937,4.10%,2.74%,5.63%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_July/August1_Utah,24-Nov-20,Regional,United States of America,USA, Utah,,30-Jul-20,11-Aug-20,Residual sera,Multiple groups,880,3.20%,1.70%,5.03%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_July/August1_Ohio,24-Nov-20,Regional,United States of America,USA, Ohio,,29-Jul-20,11-Aug-20,Residual sera,Multiple groups,786,2.30%,1.11%,3.61%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_July/August1_California,24-Nov-20,Regional,United States of America,USA,California,,30-Jul-20,05-Aug-20,Residual sera,Multiple groups,980,5.70%,4.05%,7.77%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_July/August1_Minnesota,24-Nov-20,Regional,United States of America,USA, Minnesota,,29-Jul-20,13-Aug-20,Residual sera,Multiple groups,879,3.50%,2.06%,5.01%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_July/August1_Oregon,24-Nov-20,Regional,United States of America,USA, Oregon,,05-Aug-20,11-Aug-20,Residual sera,Multiple groups,658,2.30%,1.03%,3.84%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_September4_Connecticut,24-Nov-20,Regional,United States of America,USA,Connecticut,,09-Sep-20,14-Sep-20,Residual sera,Multiple groups,982,3.10%,2.06%,4.37%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_September4_Wisconsin,24-Nov-20,Regional,United States of America,USA, Wisconsin,,09-Sep-20,24-Sep-20,Residual sera,Multiple groups,976,3.80%,2.20%,5.73%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_September4_NorthCarolina,24-Nov-20,Regional,United States of America,USA, North Carolina,,09-Sep-20,17-Sep-20,Residual sera,Multiple groups,925,6.80%,4.83%,8.87%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_September4_NewHampshire,24-Nov-20,Regional,United States of America,USA, New Hampshire,,09-Sep-20,17-Sep-20,Residual sera,Multiple groups,1034,0.70%,0.26%,1.32%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_September4_Ohio,24-Nov-20,Regional,United States of America,USA, Ohio,,10-Sep-20,22-Sep-20,Residual sera,Multiple groups,978,2.80%,1.69%,4.16%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_September4_PuertoRico,24-Nov-20,Regional,United States of America,USA,Puerto Rico,,08-Sep-20,15-Sep-20,Residual sera,Multiple groups,970,3.00%,1.78%,4.27%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_September4_NorthDakota,24-Nov-20,Regional,United States of America,USA, North Dakota,,09-Sep-20,24-Sep-20,Residual sera,Multiple groups,113,1.20%,0.00%,3.40%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,High,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_September4_Michigan,24-Nov-20,Regional,United States of America,USA, Michigan,,08-Sep-20,22-Sep-20,Residual sera,Multiple groups,980,3.70%,2.54%,4.93%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_September4_Minnesota,24-Nov-20,Regional,United States of America,USA, Minnesota,,09-Sep-20,23-Sep-20,Residual sera,Multiple groups,1033,8.00%,4.74%,11.43%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_September4_SouthCarolina,24-Nov-20,Regional,United States of America,USA, South Carolina,,09-Sep-20,18-Sep-20,Residual sera,Multiple groups,975,7.80%,5.58%,10.19%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_September4_Florida,24-Nov-20,Regional,United States of America,USA,Florida,,11-Sep-20,11-Sep-20,Residual sera,Multiple groups,979,8.50%,6.55%,10.68%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_September4_Washington D.C,24-Nov-20,Regional,United States of America,USA,Washington D.C,,08-Sep-20,24-Sep-20,Residual sera,Multiple groups,976,6.50%,4.47%,8.29%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_September4_WestVirginia,24-Nov-20,Regional,United States of America,USA, West Virginia,,09-Sep-20,22-Sep-20,Residual sera,Multiple groups,968,1.30%,0.51%,2.18%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_September4_NewMexico,24-Nov-20,Regional,United States of America,USA, New Mexico,,08-Sep-20,24-Sep-20,Residual sera,Multiple groups,1014,2.40%,1.19%,3.65%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_September4_Arkansas,24-Nov-20,Regional,United States of America,USA,Arkansas,,09-Sep-20,18-Sep-20,Residual sera,Multiple groups,990,6.30%,4.60%,8.03%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_September4_Nevada,24-Nov-20,Regional,United States of America,USA, Nevada,,09-Sep-20,12-Sep-20,Residual sera,Multiple groups,979,7.80%,5.90%,9.99%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_September4_NewYork,24-Nov-20,Regional,United States of America,USA, New York,,11-Sep-20,24-Sep-20,Residual sera,Multiple groups,1168,17.00%,14.72%,19.23%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_September4_Maryland,24-Nov-20,Regional,United States of America,USA, Maryland,,10-Sep-20,23-Sep-20,Residual sera,Multiple groups,1242,10.20%,7.91%,12.68%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_September4_Colorado,24-Nov-20,Regional,United States of America,USA,Colorado,,09-Sep-20,18-Sep-20,Residual sera,Multiple groups,1032,3.30%,1.90%,4.92%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_September4_Oregon,24-Nov-20,Regional,United States of America,USA, Oregon,,08-Sep-20,22-Sep-20,Residual sera,Multiple groups,971,2.60%,1.51%,4.06%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_September4_Oklahoma,24-Nov-20,Regional,United States of America,USA, Oklahoma,,09-Sep-20,18-Sep-20,Residual sera,Multiple groups,980,5.00%,3.44%,6.54%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_September4_Montana,24-Nov-20,Regional,United States of America,USA, Montana,,09-Sep-20,23-Sep-20,Residual sera,Multiple groups,508,2.20%,0.67%,4.38%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,High,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_September4_Kansas,24-Nov-20,Regional,United States of America,USA,Kansas,,09-Sep-20,19-Sep-20,Residual sera,Multiple groups,1007,3.50%,2.31%,4.84%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_September4_Alabama,24-Nov-20,Regional,United States of America,USA,Alabama,,09-Sep-20,18-Sep-20,Residual sera,Multiple groups,905,8.70%,6.19%,11.31%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_September4_Maine,24-Nov-20,Regional,United States of America,USA, Maine,,08-Sep-20,24-Sep-20,Residual sera,Multiple groups,987,0.50%,0.09%,0.87%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_September4_Georgia,24-Nov-20,Regional,United States of America,USA,Georgia,,09-Sep-20,18-Sep-20,Residual sera,Multiple groups,1100,13.00%,10.51%,15.79%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_September4_Massachusetts,24-Nov-20,Regional,United States of America,USA, Massachusetts,,09-Sep-20,15-Sep-20,Residual sera,Multiple groups,988,3.70%,2.23%,5.16%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_September4_Wyoming,24-Nov-20,Regional,United States of America,USA, Wyoming,,09-Sep-20,24-Sep-20,Residual sera,Multiple groups,111,1.50%,0.00%,3.97%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,High,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_September4_Vermont,24-Nov-20,Regional,United States of America,USA, Vermont,,09-Sep-20,24-Sep-20,Residual sera,Multiple groups,497,1.70%,0.27%,4.15%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,High,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_September4_Illinois,24-Nov-20,Regional,United States of America,USA,Illinois,,08-Sep-20,17-Sep-20,Residual sera,Multiple groups,992,4.50%,3.10%,6.07%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_September4_Nebraska,24-Nov-20,Regional,United States of America,USA, Nebraska,,09-Sep-20,18-Sep-20,Residual sera,Multiple groups,976,6.70%,4.80%,8.88%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_September4_Arizona,24-Nov-20,Regional,United States of America,USA,Arizona,,09-Sep-20,23-Sep-20,Residual sera,Multiple groups,1208,5.40%,3.08%,8.52%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_September4_Texas,24-Nov-20,Regional,United States of America,USA, Texas,,09-Sep-20,24-Sep-20,Residual sera,Multiple groups,988,8.20%,6.16%,10.47%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_September4_Louisiana,24-Nov-20,Regional,United States of America,USA, Louisiana,,09-Sep-20,19-Sep-20,Residual sera,Multiple groups,952,12.50%,10.02%,15.61%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_September4_SouthDakota,24-Nov-20,Regional,United States of America,USA, South Dakota,,09-Sep-20,23-Sep-20,Residual sera,Multiple groups,99,1.80%,0.00%,4.82%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,High,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_September4_Tennessee,24-Nov-20,Regional,United States of America,USA, Tennessee,,08-Sep-20,16-Sep-20,Residual sera,Multiple groups,1028,6.70%,4.96%,8.57%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_September4_Hawaii,24-Nov-20,Regional,United States of America,USA,Hawaii,,08-Sep-20,22-Sep-20,Residual sera,Multiple groups,516,0.80%,0.00%,2.18%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,High,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_September4_Indiana,24-Nov-20,Regional,United States of America,USA,Indiana,,09-Sep-20,23-Sep-20,Residual sera,Multiple groups,1155,4.00%,1.44%,8.79%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_September4_Utah,24-Nov-20,Regional,United States of America,USA, Utah,,09-Sep-20,18-Sep-20,Residual sera,Multiple groups,1022,5.10%,3.29%,7.90%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_September4_RhodeIsland,24-Nov-20,Regional,United States of America,USA, Rhode Island,,09-Sep-20,24-Sep-20,Residual sera,Multiple groups,795,2.70%,1.15%,4.91%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_September4_Mississippi,24-Nov-20,Regional,United States of America,USA, Mississippi,,09-Sep-20,22-Sep-20,Residual sera,Multiple groups,980,7.90%,5.35%,10.87%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_September4_California,24-Nov-20,Regional,United States of America,USA,California,,10-Sep-20,16-Sep-20,Residual sera,Multiple groups,979,4.90%,3.17%,6.85%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_September4_Virginia,24-Nov-20,Regional,United States of America,USA, Virginia,,10-Sep-20,23-Sep-20,Residual sera,Multiple groups,1111,3.20%,1.81%,5.13%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_September4_Iowa,24-Nov-20,Regional,United States of America,USA,Iowa,,09-Sep-20,24-Sep-20,Residual sera,Multiple groups,977,7.60%,5.56%,10.02%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_September4_Idaho,24-Nov-20,Regional,United States of America,USA,Idaho,,08-Sep-20,18-Sep-20,Residual sera,Multiple groups,732,5.20%,2.74%,8.46%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_September4_Kentucky,24-Nov-20,Regional,United States of America,USA, Kentucky,,09-Sep-20,18-Sep-20,Residual sera,Multiple groups,980,3.60%,2.33%,5.21%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_September4_Delaware,24-Nov-20,Regional,United States of America,USA,Delaware,,09-Sep-20,24-Sep-20,Residual sera,Multiple groups,980,7.50%,4.89%,10.50%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_September4_Missouri,24-Nov-20,Regional,United States of America,USA, Missouri,,08-Sep-20,24-Sep-20,Residual sera,Multiple groups,1031,3.50%,2.15%,5.01%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_September4_NewJersey,24-Nov-20,Regional,United States of America,USA, New Jersey,,09-Sep-20,23-Sep-20,Residual sera,Multiple groups,1050,15.10%,12.65%,17.63%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_September4_Pennsylvania,24-Nov-20,Regional,United States of America,USA, Pennsylvania,,09-Sep-20,23-Sep-20,Residual sera,Multiple groups,1341,11.10%,8.85%,13.71%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
201124_USA_CDC_September4_Washington,24-Nov-20,Regional,United States of America,USA,Washington,,09-Sep-20,22-Sep-20,Residual sera,Multiple groups,968,2.50%,1.29%,3.83%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,20/03/2021,16/07/2022,Verified
210305_Chicago_NorthwesternUniversity_overall,05-Mar-21,Local,United States of America,USA,Illinois,Chicago,24-Jun-20,23-Nov-20,Household and community samples,Multiple groups,1667,18.70%,,,Stratified non-probability,NA,ELISA,IgG,,,Moderate,Preprint,Brian Mustanski,Northwestern University,https://www.medrxiv.org/content/10.1101/2021.03.02.21252767v1,22/03/2021,16/07/2022,Verified
210120_LosAngelesCounty_CedarsSinaiMedicalCenter_overall_adj,12-Feb-21,Local,United States of America,USA,,,11-May-20,11-May-20,Health care workers and caregivers,Multiple groups,6062,4.10%,3.10%,5.70%,Convenience,Abbott Laboratories,CLIA,IgG,88.30%,,Moderate,Journal Article (Peer-Reviewed),Joseph Ebinger,Cedars-Sinai Medical Center,https://dx.doi.org/10.1136/bmjopen-2020-043584,22/03/2021,16/07/2022,Verified
210316_UnitedStates_ClinicalReferenceLaboratoryInc_OverallGenPop,16-Mar-21,National,United States of America,USA,,,01-Sep-20,30-Sep-20,Household and community samples,Multiple groups,61910,6.60%,,,Sequential,Roche Diagnostics,CLIA,Total Antibody,99.50%,99.80%,Moderate,Journal Article (Peer-Reviewed),Robert Stout,Clinical Reference Laboratory Inc,https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2777502?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=031621,22/03/2021,16/07/2022,Verified
210205_UnitedStates_BrownUniversity,05-Feb-21,National,United States of America,USA,Multiple states,,,01-Aug-20,Assisted living and long-term care facilities,Seniors (65+ years),272,43.00%,,,Convenience,NA,Not reported,"IgG,IgM,Total Antibody",,,High,Journal Article (Peer-Reviewed),Elizabeth White,Brown University,http://dx.doi.org/10.1111/jgs.17061,22/03/2021,16/07/2022,Verified
210201_Indianapolis_IndianaUniversity_HCW_primary,01-Feb-21,Local,United States of America,USA,Indiana,Indianapolis,01-Apr-20,24-Jun-20,Health care workers and caregivers,Adults (18-64 years),34,35.00%,,,Convenience,"Abnova,NA",ELISA,"IgG,IgM",94.40%,98.50%,High,Journal Article (Peer-Reviewed),Jorge J Canas ,Indiana University,https://dx.doi.org/10.1016/j.kint.2020.11.014,24/03/2021,16/07/2022,Verified
210201_Indianapolis_IndianaUniversity_HDpatients_primary,01-Feb-21,Local,United States of America,USA,Indiana,Indianapolis,01-Apr-20,24-Jun-20,Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),14,36.00%,,,Convenience,"Abnova,NA",ELISA,"IgG,IgM",94.40%,98.50%,High,Journal Article (Peer-Reviewed),Jorge J Canas ,Indiana University,https://dx.doi.org/10.1016/j.kint.2020.11.014,24/03/2021,16/07/2022,Verified
210221_Iowa_UniversityofIowa,21-Feb-21,Local,United States of America,USA,Iowa,,01-May-20,22-Sep-20,Pregnant or parturient women,Adults (18-64 years),1000,5.80%,,,Sequential,"DiaSorin,Roche Diagnostics,EUROIMMUN",Multiple Types,IgG,,,Moderate,Journal Article (Peer-Reviewed),Haley Steffen,University of Iowa,https://dx.doi.org/10.1055/s-0041-1723938,27/03/2021,16/07/2022,Verified
120301_RhodeIsland_CDC,01-Mar-21,Regional,United States of America,USA,Rhode Island,,17-Jul-20,28-Aug-20,Health care workers and caregivers,Multiple groups,9863,4.60%,4.20%,5.00%,Convenience,Ortho Clinical Diagnostics Inc.,Not reported,IgG,90.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Lara Akinbami,Centers for Disease Control,https://dx.doi.org/10.3201/eid2703.204508,27/03/2021,16/07/2022,Verified
210208_Chicago_NorthwesternUniversity_overall,08-Feb-21,Local,United States of America,USA,Illinois,Chicago,24-Jun-20,11-Nov-20,Household and community samples,Multiple groups,3365,17.80%,,,Self-referral,NA,ELISA,IgG,,,High,Preprint,Thomas McDade,Northwestern University,https://www.medrxiv.org/content/10.1101/2021.02.04.21251170v1,27/03/2021,16/07/2022,Verified
210215_USA_SpaceX_overall,15-Feb-21,Local,United States of America,USA,Multiple,Multiple,01-Apr-20,10-Jun-20,Non-essential workers and unemployed persons,Adults (18-64 years),4300,2.80%,,,Convenience,NA,ELISA,IgG,99.50%,,Unclear,Journal Article (Peer-Reviewed),Yannic Bartsch,"Ragon Institute of MGH, MIT and Harvard",https://dx.doi.org/10.1038/s41467-021-21336-8,27/03/2021,16/07/2022,Verified
210226_Washington_CentersforDiseaseControlandPrevention_Overall,26-Feb-21,Regional,United States of America,USA,Washington,,23-Mar-20,14-Aug-20,Residual sera,Multiple groups,7544,2.00%,,,Stratified probability,NA,ELISA,Total Antibody,96.00%,99.30%,Moderate,Journal Article (Peer-Reviewed),Travis Lim,Centers for Disease and Control ,https://dx.doi.org/10.1093/cid/ciab185,27/03/2021,16/07/2022,Verified
210226_Florida_CentersforDiseaseControlandPrevention_Overall,26-Feb-21,Regional,United States of America,USA,Florida,,23-Mar-20,14-Aug-20,Residual sera,Multiple groups,7787,4.80%,,,Stratified probability,NA,ELISA,Total Antibody,96.00%,99.30%,Moderate,Journal Article (Peer-Reviewed),Travis Lim,Centers for Disease and Control ,https://dx.doi.org/10.1093/cid/ciab185,27/03/2021,16/07/2022,Verified
210226_NewYork_CentersforDiseaseControlandPrevention_Overall,26-Feb-21,Local,United States of America,USA,New York,New York City,23-Mar-20,14-Aug-20,Residual sera,Multiple groups,7746,17.20%,,,Stratified probability,NA,ELISA,Total Antibody,96.00%,99.30%,Moderate,Journal Article (Peer-Reviewed),Travis Lim,Centers for Disease and Control ,https://dx.doi.org/10.1093/cid/ciab185,27/03/2021,16/07/2022,Verified
210226_Pennsylvania_CentersforDiseaseControlandPrevention_Overall,26-Feb-21,Local,United States of America,USA,Pennsylvania,Philadelphia,23-Mar-20,14-Aug-20,Residual sera,Multiple groups,8657,4.30%,,,Stratified probability,NA,ELISA,Total Antibody,96.00%,99.30%,Moderate,Journal Article (Peer-Reviewed),Travis Lim,Centers for Disease and Control ,https://dx.doi.org/10.1093/cid/ciab185,27/03/2021,16/07/2022,Verified
210226_Missouri_CentersforDiseaseControlandPrevention_Overall,26-Feb-21,Regional,United States of America,USA,Missouri,,23-Mar-20,14-Aug-20,Residual sera,Multiple groups,9356,2.50%,,,Stratified probability,NA,ELISA,Total Antibody,96.00%,99.30%,Moderate,Journal Article (Peer-Reviewed),Travis Lim,Centers for Disease and Control ,https://dx.doi.org/10.1093/cid/ciab185,27/03/2021,16/07/2022,Verified
210226_Utah_CentersforDiseaseControlandPrevention_Overall,26-Feb-21,Regional,United States of America,USA,Utah,,23-Mar-20,14-Aug-20,Residual sera,Multiple groups,8769,2.70%,,,Stratified probability,NA,ELISA,Total Antibody,96.00%,99.30%,Moderate,Journal Article (Peer-Reviewed),Travis Lim,Centers for Disease and Control ,https://dx.doi.org/10.1093/cid/ciab185,27/03/2021,16/07/2022,Verified
210226_California_CentersforDiseaseControlandPrevention_Overall,26-Feb-21,Local,United States of America,USA,California,,23-Mar-20,14-Aug-20,Residual sera,Multiple groups,4980,1.90%,,,Stratified probability,NA,ELISA,Total Antibody,96.00%,99.30%,Moderate,Journal Article (Peer-Reviewed),Travis Lim,Centers for Disease and Control ,https://dx.doi.org/10.1093/cid/ciab185,27/03/2021,16/07/2022,Verified
210226_Connecticut_CentersforDiseaseControlandPrevention_Overall,26-Feb-21,Regional,United States of America,USA,Connecticut,,23-Mar-20,14-Aug-20,Residual sera,Multiple groups,8929,5.70%,,,Stratified probability,NA,ELISA,Total Antibody,96.00%,99.30%,Moderate,Journal Article (Peer-Reviewed),Travis Lim,Centers for Disease and Control ,https://dx.doi.org/10.1093/cid/ciab185,27/03/2021,16/07/2022,Verified
210226_Minnesota_CentersforDiseaseControlandPrevention_Overall,26-Feb-21,Regional,United States of America,USA,Minnesota,"Minneapolis, St. Paul, St. Cloud",23-Mar-20,14-Aug-20,Residual sera,Multiple groups,7944,4.90%,,,Stratified probability,NA,ELISA,Total Antibody,96.00%,99.30%,Moderate,Journal Article (Peer-Reviewed),Travis Lim,Centers for Disease and Control ,https://dx.doi.org/10.1093/cid/ciab185,27/03/2021,16/07/2022,Verified
210226_Louisiana_CentersforDiseaseControlandPrevention_Overall,26-Feb-21,Regional,United States of America,USA,Louisiana,,23-Mar-20,14-Aug-20,Residual sera,Multiple groups,2849,7.70%,,,Stratified probability,NA,ELISA,Total Antibody,96.00%,99.30%,Moderate,Journal Article (Peer-Reviewed),Travis Lim,Centers for Disease and Control ,https://dx.doi.org/10.1093/cid/ciab185,27/03/2021,16/07/2022,Verified
210204_OrangeCounty_UniversityofCaliforniaIrvine_Overall_PopTestAdj,04-Feb-21,Local,United States of America,USA,California,,10-Jul-20,16-Aug-20,Household and community samples,Multiple groups,2979,11.30%,8.10%,13.20%,Stratified probability,NA,IFA,"IgG,IgM",94.00%,100.00%,Low,Journal Article (Peer-Reviewed),Tim Bruckner,University of California Irvine,https://dx.doi.org/10.1038/s41598-021-82662-x,28/03/2021,16/07/2022,Verified
210222_SantaClaraCounty_UniversityofStanford_GenPop_PopTestAdj,22-Feb-21,Local,United States of America,USA,California,,03-Apr-20,04-Apr-20,Household and community samples,Multiple groups,3328,2.76%,1.32%,4.22%,Stratified non-probability,Premier Biotech,LFIA,"IgG,IgM",85.56%,99.53%,High,Journal Article (Peer-Reviewed),Eran Bendavid,Stanford University School of Medicine,https://dx.doi.org/10.1093/ije/dyab010,28/03/2021,16/07/2022,Verified
210117_OrangeCounty_HoagMemorialHospitalPresbyterian_HCW,17-Jan-21,Local,United States of America,USA,California,,15-Jul-20,15-Aug-20,Health care workers and caregivers,Adults (18-64 years),2754,2.76%,2.18%,3.44%,Convenience,Ortho Clinical Diagnostics Inc.,Not reported,IgG,93.60%,100.00%,High,Journal Article (Peer-Reviewed),Michael Brant Zawadzki,Hoag Memorial Hospital Presbyterian,https://dx.doi.org/10.1093/ofid/ofab015,28/03/2021,16/07/2022,Verified
210117_OrangeCounty_HoagMemorialHospitalPresbyterian_First_responders,17-Jan-21,Local,United States of America,USA,California,,15-Jul-20,15-Aug-20,Essential non-healthcare workers,Adults (18-64 years),92,4.35%,1.20%,10.76%,Convenience,Ortho Clinical Diagnostics Inc.,Not reported,IgG,93.60%,100.00%,High,Journal Article (Peer-Reviewed),Michael Brant Zawadzki,Hoag Memorial Hospital Presbyterian,https://dx.doi.org/10.1093/ofid/ofab015,28/03/2021,16/07/2022,Verified
210309_Massachusetts_UniversityofMassachusetts-Amherst_Undergrad_Primary,09-Mar-21,Local,United States of America,USA,Massachusetts ,Amherst,15-Jul-20,15-Aug-20,Multiple populations,Multiple groups,779,5.30%,3.10%,7.50%,Stratified probability,NA,ELISA,IgG,,,High,Preprint,Teah Snyder,University of Massachusetts-Amherst,https://www.medrxiv.org/content/10.1101/2021.03.05.21249174v2.full.pdf,30/03/2021,16/07/2022,Verified
210309_Massachusetts_UniversityofMassachusetts-Amherst_LocalPop_Primary,09-Mar-21,Local,United States of America,USA,Massachusetts ,Amherst,15-Jul-20,15-Aug-20,Non-essential workers and unemployed persons,Multiple groups,292,4.00%,1.60%,6.50%,Simplified probability,NA,ELISA,IgG,,,High,Preprint,Teah Snyder,University of Massachusetts-Amherst,https://www.medrxiv.org/content/10.1101/2021.03.05.21249174v2.full.pdf,30/03/2021,16/07/2022,Verified
210312_Cincinnati_UniversityOfCincinnati_overall,12-Mar-21,Local,United States of America,USA,Ohio,Greater Cincinnati Metropolitan Area,13-Aug-20,08-Dec-20,Blood donors,Multiple groups,9550,8.40%,,,Simplified probability,NA,ELISA,IgG,,,Moderate,Preprint,Greg Davis,University of Cincinnati,10.1101/2021.03.11.21253263,31/03/2021,16/07/2022,Verified
210218_RhodeIsland_BrownUniversity_overall_adj,18-Feb-21,Regional,United States of America,USA,Rhode Island,,05-May-20,22-May-20,Household and community samples,Multiple groups,1032,2.90%,1.00%,6.20%,Stratified probability,Abbott Laboratories,CLIA,IgG,88.40%,99.60%,Low,Journal Article (Peer-Reviewed),Philip A Chan,Brown University,https://dx.doi.org/10.2105/AJPH.2020.306115,02/04/2021,16/07/2022,Verified
210321_NewYork_WeillCornellMedicine_Pediatrics,22-Mar-21,Local,United States of America,USA,New York ,New York City ,09-Apr-20,31-Aug-20,Residual sera,Children and Youth (0-17 years),1194,16.50%,14.40%,18.70%,Sequential,ET Healthcare,Other,IgG,,,High,Journal Article (Peer-Reviewed),He Yang,NewYork–Presbyterian Hospital/Weill Cornell Medical Center,https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2777743,03/04/2021,16/07/2022,Verified
210321_NewYork_WeillCornellMedicine_Adults,22-Mar-21,Local,United States of America,USA,New York ,New York City ,09-Apr-20,31-Aug-20,Residual sera,Multiple groups,30232,18.60%,18.20%,19.10%,Sequential,ET Healthcare,Other,IgG,,,High,Journal Article (Peer-Reviewed),He Yang,NewYork–Presbyterian Hospital/Weill Cornell Medical Center,https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2777743,04/04/2021,16/07/2022,Verified
210116_Philadelphia_UniversityofPennsylvania_Overall,16-Jan-21,Local,United States of America,USA,Pennsylvania,Philadelphia,21-May-20,08-Oct-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,124,1.60%,,,Sequential,NA,ELISA,"IgG,IgM",,,High,Preprint,Lova Sun,University of Pennsylvania,https://dx.doi.org/10.1101/2021.01.15.21249810,05/04/2021,16/07/2022,Verified
200901_Seattle_FredHutchinsonCancerResearchCenter_Overall,01-Sep-20,Local,United States of America,USA,Washington,Seattle,03-Mar-20,24-Apr-20,Residual sera,Children and Youth (0-17 years),1076,0.93%,,,Convenience,"Abbott Laboratories,NA",Multiple Types,IgG,,,High,Journal Article (Peer-Reviewed),Adam S Dingens,Fred Hutchinson Cancer Research Center,https://www.nature.com/articles/s41467-020-18178-1,08/04/2021,16/07/2022,Verified
2010330_Bolinas_UniversityofCalifornia_Abbott+ELISA,30-Oct-20,Local,United States of America,USA,California,Bolinas,20-Apr-20,24-Apr-20,Household and community samples,Multiple groups,1880,0.05%,,,Self-referral,"Abbott Laboratories,NA",Multiple Types,IgG,,,Moderate,Journal Article (Peer-Reviewed),Ayesha Appa,University of California San Francisco,http://dx.doi.org/10.1093/ofid/ofaa531,08/04/2021,16/07/2022,Verified
210224_USA_NationalInstitutesofHealth_primary,24-Feb-21,National,United States of America,USA,,,01-Jan-20,26-Aug-20,Residual sera,Multiple groups,3257478,11.60%,,,Convenience,NA,Not reported,"IgG,IgA,IgM",,,Moderate,Journal Article (Peer-Reviewed),Raymond Harvey,National Institutes of Health,https://dx.doi.org/10.1001/jamainternmed.2021.0366,09/04/2021,16/07/2022,Verified
210312_Atlanta_EmoryUniversitySchoolOfMedicine_Overall,12-Mar-21,Local,United States of America,USA,Georgia,Atlanta,15-Apr-20,15-Aug-20,Health care workers and caregivers,Adults (18-64 years),642,4.00%,,,Convenience,NA,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Claudia Morris,Emory University School of Medicine,https://dx.doi.org/10.1016/j.ijid.2021.03.017,09/04/2021,16/07/2022,Verified
210302_NewYork_RenaissanceStonyBrookSchoolofMedicine,02-Mar-21,Local,United States of America,USA,New York,,02-Apr-20,18-Apr-20,Health care workers and caregivers,Adults (18-64 years),474,16.90%,13.60%,20.60%,Convenience,ChemBio Diagnostics Inc.,Not reported,"IgG,IgM",84.30%,88.90%,High,Journal Article (Peer-Reviewed),Lilian Talbot,Renaissance Stony Brook School of Medicine,https://dx.doi.org/10.1186/s13741-021-00177-5,16/04/2021,16/07/2022,Verified
210311_USA_IgenomixUSAandCanada_Overall,11-Mar-21,National,United States of America,USA,"Utah, Massachuetts",Boston,18-Jun-20,30-Jul-20,Multiple populations,Adults (18-64 years),337,1.48%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Russel Foulk,Igenomix USA and Canada,https://dx.doi.org/10.1016/j.ajog.2021.03.008,17/04/2021,16/07/2022,Verified
210317_Boston_HarvardMedicalSchool_Primary,17-Mar-21,Local,United States of America,USA,Massachusetts,Boston,16-Jun-20,30-Jun-20,Health care workers and caregivers,Adults (18-64 years),433,11.30%,,,Self-referral,NA,ELISA,"IgG,IgM",80.00%,99.50%,Moderate,Journal Article (Peer-Reviewed),Lou Ann Bruno-Murtha,Harvard Medical School ,https://dx.doi.org/10.1080/20477724.2021.1901041,17/04/2021,16/07/2022,Verified
201217_UnitedStates_UniversityofIowa,17-Dec-20,National,United States of America,USA,,,13-May-20,08-Jul-20,Health care workers and caregivers,Multiple groups,1606,1.74%,,,Stratified non-probability,"Abbott Laboratories,EUROIMMUN",Multiple Types,IgG,,,Moderate,Journal Article (Peer-Reviewed),Nicholas M Mohr,University of Iowa,http://dx.doi.org/10.1016/j.annemergmed.2020.12.007,18/04/2021,16/07/2022,Verified
201125_Washington_GeorgeWashingtonUniversity_hcw,01-Feb-21,Local,United States of America,USA,District of Columbia,Washington ,26-May-20,14-Jun-20,Health care workers and caregivers,Adults (18-64 years),138,5.07%,,,Convenience,"Biolidics Ltd,NA",Multiple Types,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Eric Murakami,George Washington University,https://pubmed.ncbi.nlm.nih.gov/33340874/,19/04/2021,16/07/2022,Verified
210111_Burlington_UniversityOfVermont_overall,11-Jan-21,Local,United States of America,USA,Vermont,Burlington,25-Jun-20,28-Jun-20,Household and community samples,Multiple groups,454,2.20%,0.80%,3.60%,Stratified probability,NA,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Eline M van den Broek Altenburg,University of Vermont,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7800904/,22/04/2021,16/07/2022,Verified
210305_Mississippi_CDCCOVID-19ResponseTeam_Overall,05-Mar-21,Regional,United States of America,USA,Mississippi,,17-May-20,19-Sep-20,Residual sera,Children and Youth (0-17 years),1603,10.90%,9.40%,12.40%,Sequential,"Ortho Clinical Diagnostics Inc.,NA",Multiple Types,Total Antibody,,,Moderate,Journal Article (Peer-Reviewed),Charlotte Hobbs,CDC COVID-19 Response Team,https://dx.doi.org/10.15585/mmwr.mm7009a4,22/04/2021,16/07/2022,Unverified
210312_NorthCarolina_WakeForestBaptistHealth,12-Mar-21,Regional,United States of America,USA,North Carolina,,16-Apr-20,20-Dec-20,Household and community samples,Adults (18-64 years),17688,32.60%,28.40%,35.00%,Stratified non-probability,"Syntron Bioresearch Inc. ,Innovita Biological Technology Co. Ltd",LFIA,"IgM,IgG",,,Moderate,Preprint,John Williamson,Wake Forest Baptist Health,https://www.medrxiv.org/content/10.1101/2021.03.11.21253226v1,22/04/2021,16/07/2022,Verified
210303_MontereyCounty_UniversityofCaliforniaBerkeley_Overall,03-Mar-21,Local,United States of America,USA,California,,16-Jul-20,30-Nov-20,Essential non-healthcare workers,Adults (18-64 years),1058,19.00%,,,Self-referral,NA,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Joseph Lewnard,"University of California, Berkeley",https://dx.doi.org/10.3201/eid2705.204949,23/04/2021,16/07/2022,Verified
210305_Illinois-Wisconsin_AdvocateAuroraHealth,05-Mar-21,Regional,United States of America,USA,"Illinois, Wisconsin (Midwest)",,08-Jun-20,10-Jul-20,Health care workers and caregivers,Multiple groups,16233,3.80%,,,Convenience,Abbott Laboratories,CLIA,IgG,98.70%,99.20%,Moderate,Journal Article (Peer-Reviewed),Veronica Fitzpatrick,Advocate Aurora Health,https://dx.doi.org/10.1177/0033354921999168,30/04/2021,16/07/2022,Unverified
210310_UnitedStatesofAmerica_EmoryUniversity,10-Mar-21,Regional,United States of America,USA,"Georgia, Maryland, Illinois","Atlanta, Baltimore, Chicago",19-Apr-20,30-Aug-20,Health care workers and caregivers,Adults (18-64 years),24749,4.40%,4.10%,4.60%,Convenience,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,EUROIMMUN",Multiple Types,IgG,,,Moderate,Journal Article (Peer-Reviewed),Jesse Jacob,Emory University,https://dx.doi.org/10.1001/jamanetworkopen.2021.1283,30/04/2021,16/07/2022,Unverified
210225_Florida_FloridaDepartmentOfHealth_overall,12-Apr-21,Regional,United States of America,USA,Florida,,06-May-20,03-Jun-20,Health care workers and caregivers,Multiple groups,5776,4.10%,2.60%,8.20%,Convenience,Cellex Inc.,LFIA,"IgG,IgM",93.80%,96.00%,Moderate,Journal Article (Peer-Reviewed),James Matthias,Florida Department of Health,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8040388/,02/05/2021,16/07/2022,Verified
210405_California_StanfordUniversitySchoolofMedicine_overall,06-May-21,Local,United States of America,USA,California,,15-Jun-20,15-Aug-20,Essential non-healthcare workers,Adults (18-64 years),983,2.54%,1.65%,3.73%,Convenience,"Abbott Laboratories,EUROIMMUN,NA",Multiple Types,IgG,,,Moderate,Journal Article (Peer-Reviewed),Jennifer Newberry,Stanford University,http://dx.doi.org/10.1080/10903127.2021.1912227,03/05/2021,16/07/2022,Verified
211231_Denver_DenverPublicHealth,20-Dec-20,Local,United States of America,USA,Colorado,Denver,02-Jun-20,28-Jul-20,Persons experiencing homelessness,Adults (18-64 years),334,16.72%,,,Convenience,NA,Not reported,Not reported,,,Unclear,Journal Article (Peer-Reviewed),David McCormick,Denver Public Health,http://dx.doi.org/10.1093/ofid/ofaa515.1909,03/05/2021,16/07/2022,Verified
201204_SantaClara_O’ConnorHospital_Overall,04-Dec-20,Local,United States of America,USA,California,San Jose,06-May-20,06-May-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,24,0.00%,,,Convenience,Diazyme Laboratories Inc,CLIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Brian D McBeth,O'Connor Hospital,https://dx.doi.org/10.1177/1757177420976814,04/05/2021,16/07/2022,Unverified
200501_SanMiguelCounty_UnitedBiomedical_overall,01-May-20,Local,United States of America,USA,Colorado,,26-Mar-20,15-Apr-20,Household and community samples,Multiple groups,5283,0.53%,,,Entire sample,NA,Not reported,IgG,,,Moderate,Institutional Report,San Miguel County,United Biomedical Group,https://www.sanmiguelcountyco.gov/DocumentCenter/View/5717/San-Miguel-County-IgG-Antibody-Test-Statistics-and-Demographics-PDF,05/05/2021,16/07/2022,Verified
201231_WestVirginia_WestVirginiaUniversityMedicine_HCW,31-Dec-20,Local,United States of America,USA,West Virginia,Morgantown,26-May-20,05-Jun-20,Health care workers and caregivers,Adults (18-64 years),1042,0.86%,,,Simplified probability,NA,Not reported,IgG,,,Moderate,Journal Article (Peer-Reviewed),Joy J Juskowich,West Virginia University Medicine,http://dx.doi.org/10.1093/ofid/ofaa439.694,05/05/2021,16/07/2022,Verified
201231_SanDiego_UniversityofCaliforniaSanDiegoHealth_HCW,31-Dec-20,Local,United States of America,USA,California,San Diego,22-Apr-20,02-Jun-20,Health care workers and caregivers,Adults (18-64 years),5589,1.02%,,,Convenience,NA,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),Lucy E Horton,University of California San Diego Health,http://dx.doi.org/10.1093/ofid/ofaa439.630,05/05/2021,16/07/2022,Verified
200831_KingCounty_UniversityOfWashington_overall,31-Aug-20,Local,United States of America,USA,Washington,,08-Aug-20,29-Aug-20,Household and community samples,Multiple groups,1364,3.90%,2.40%,6.00%,Stratified probability,"Bio-rad,EUROIMMUN",ELISA,"IgG,IgM,IgA",82.94%,100.00%,Moderate,Institutional Report,Karen Cowgill,University of Washington,https://www.kingcounty.gov/depts/health/covid-19/data/~/media/depts/health/communicable-diseases/documents/C19/serosurvey-report-covid19.ashx https://kingcounty.gov/depts/health/covid-19/seroprevalence.aspx https://www.kingcounty.gov/depts/health/covid-19/seroprevalence-study.aspx page 9: http://www.co.cowlitz.wa.us/DocumentCenter/View/20793/8122020-Cowlitz-County-COVID-update-to-Board-of-County-Commissioners,05/05/2021,16/07/2022,Verified
201231_LosAngeles_UniversityofCaliforniaLosAngeles,31-Dec-20,Local,United States of America,USA,California,Los Angeles,01-Jun-20,15-Jun-20,Assisted living and long-term care facilities,Adults (18-64 years),121,1.65%,,,Convenience,DiaSorin,Not reported,IgG,,,High,Presentation or Conference,Debika Bhattacharya,University of California Los Angeles,https://academic.oup.com/ofid/article/7/Supplement_1/S165/6058251,06/05/2021,16/07/2022,Unverified
201231_Charleston_MedicalUniversityofSouthCarolina,31-Dec-20,Local,United States of America,USA,South Carolina ,Charleston,14-Apr-20,06-May-20,Health care workers and caregivers,Adults (18-64 years),439,1.37%,,,Convenience,RayBiotech,LFIA,IgG,76.00%,95.00%,High,Presentation or Conference,Eric G Meissner,Medical University of South Carolina,http://dx.doi.org/10.1093/ofid/ofaa439.653,08/05/2021,16/07/2022,Unverified
210312_UnitedStatesOlympicandParalympicTrainingfacilities_MassachusettsGeneralHospital,12-Mar-21,National,United States of America,USA,Colorado,Colorado Springs,01-Jul-20,31-Jul-20,Non-essential workers and unemployed persons,Adults (18-64 years),301,3.65%,,,Convenience,NA,Not reported,Not reported,,,Unclear,Journal Article (Peer-Reviewed),Ankit B Shah,Massachusetts General Hospital,https://dx.doi.org/10.1177/19417381211002761,09/05/2021,16/07/2022,Unverified
210309_HarrisCounty_HarrisCountyPublicHealth_genpop,09-Mar-21,Local,United States of America,USA,Texas,,15-Nov-20,15-Dec-20,Household and community samples,Multiple groups,646,16.00%,,,Simplified probability,NA,Not reported,Not reported,,,Unclear,News and Media,Harris County Public Health,Harris County Public Health,https://publichealth.harriscountytx.gov/Portals/27/Documents/HCPH%20Antibody%20Results%20NR.pdf?ver=ZkoB5qeX0P1G--8gfGH8fg%3d%3d,10/05/2021,16/07/2022,Verified
201225_Seattle_UniversityofWashington_GenPop_ELISA+Neutralizaion,25-Dec-20,Local,United States of America,USA,Washington,Seattle,26-Mar-20,15-Apr-20,Household and community samples,Multiple groups,100,4.00%,,,Simplified probability,"NA,Abbott Laboratories",Multiple Types,"IgG,Neutralizing ",,,High,Journal Article (Peer-Reviewed),Jennifer Rathe,University of Washington,http://dx.doi.org/10.1093/infdis/jiaa797,17/05/2021,16/07/2022,Verified
210427_NewYorkCity_AlbertEinsteinCollegeofMedicine,27-Apr-21,Local,United States of America,USA,New York state,New York City,01-Jun-20,01-Aug-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,232,13.36%,,,Convenience,NA,Not reported,Not reported,,,High,Journal Article (Peer-Reviewed),Snehal R Patel,Albert Einstein College of Medicine,https://onlinelibrary.wiley.com/doi/10.1111/ctr.14329,17/05/2021,16/07/2022,Unverified
210315_NewYork_DiaSorinInc_overall_unadj,15-Mar-21,Regional,United States of America,USA,New York,,01-Sep-20,30-Sep-20,Residual sera,Multiple groups,1491,24.40%,,,Sequential,"Siemens,DiaSorin",CLIA,"IgG,Total Antibody",,,High,Journal Article (Peer-Reviewed),Fabrizio Bonelli,Dia Sorin Inc,http://dx.doi.org/10.1515/cclm-2021-0023,18/05/2021,16/07/2022,Verified
210315_NewMexico_DiaSorinInc_overall_unadj,15-Mar-21,Regional,United States of America,USA,New Mexico,,01-Sep-20,30-Sep-20,Residual sera,Multiple groups,1931,1.97%,,,Sequential,"DiaSorin,Beckman Coulter",CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Fabrizio Bonelli,Dia Sorin Inc,http://dx.doi.org/10.1515/cclm-2021-0023,18/05/2021,16/07/2022,Verified
210104_Louisville_UniversityOfLouisville,04-Jan-21,Regional,United States of America,USA,Kentucky,Louisville,10-Dec-20,14-Dec-20,Household and community samples,Multiple groups,700,11.16%,,,Simplified probability,NA,Not reported,Not reported,,,Unclear,News and Media,Betty Coffman,University of Louisville,https://www.uoflnews.com/post/uofltoday/covid-19-rates-continue-to-increase-with-highest-rates-among-18-34-year-olds/,18/05/2021,16/07/2022,Unverified
210401_Colorado_AnschutzMedicalCampus_primary,01-Apr-21,Local,United States of America,USA,Colorado,Aurora,01-Jul-20,31-Aug-20,Essential non-healthcare workers,Adults (18-64 years),264,4.20%,,,Convenience,NA,Other,IgG,,,High,Journal Article (Peer-Reviewed),Jonathan S Schultz,Anschutz Medical Campus,https://dx.doi.org/10.1128/JCM.00290-21,18/05/2021,16/07/2022,Verified
210429_SanFrancisco_UniversityOfCaliforniaSanFrancisco_HIV1_TestAdj,29-Apr-21,Local,United States of America,USA,California,San Francisco,01-Aug-20,31-Oct-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,955,3.70%,2.40%,5.00%,Sequential,ET Healthcare,Other,IgG,89.00%,100.00%,High,Journal Article (Peer-Reviewed),Matthew A Spinelli,University of California San Francisco,https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(21)00072-2/fulltext,18/05/2021,16/07/2022,Unverified
210315_SanFranciscoBayArea_StanfordUniversity_overall_unadj,15-Mar-21,Local,United States of America,USA,California,,03-Aug-20,15-Aug-20,Residual sera,Multiple groups,1080,10.65%,,,Convenience,"Abbott Laboratories,EUROIMMUN",Multiple Types,IgG,,,High,Journal Article (Peer-Reviewed),Hannah Wang,Stanford University ,https://dx.doi.org/10.1093/clinchem/hvab045,19/05/2021,16/07/2022,Verified
210519_Rochester_MayoClinic_primary,05-Apr-21,Local,United States of America,USA,Minesota,Rochester,15-May-20,15-Jun-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,1339,1.90%,,,Convenience,"EUROIMMUN,Ortho Clinical Diagnostics Inc.,Roche Diagnostics",ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Elizabeth B Habermann,Mayo Clinic,https://dx.doi.org/10.1017/ice.2021.38,19/05/2021,16/07/2022,Verified
210422_Orlando_JohnsHopkinsUniversity,22-Apr-21,Local,United States of America,USA,Florida,Orlando,11-Jun-20,19-Oct-20,Non-essential workers and unemployed persons,Adults (18-64 years),3648,0.90%,,,Convenience,"Siemens,Abbott Laboratories,Ortho Clinical Diagnostics Inc.,Roche Diagnostics",Multiple Types,"IgG,IgM",,,Moderate,Journal Article (Peer-Reviewed),Christina Mack,Johns Hopkins University School of Medicine,https://dx.doi.org/10.1001/jamainternmed.2021.2114,19/05/2021,16/07/2022,Verified
210413_NewOrleans_OchsnerClinicFoundation_HospitalStaff,13-Apr-21,Local,United States of America,USA,Louisiana,New Orleans,22-Apr-20,01-May-20,Health care workers and caregivers,Adults (18-64 years),13343,8.00%,7.50%,8.50%,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Tung Vu,Ochsner Clinic Foundation,https://journals.sagepub.com/doi/10.1177/00031348211011090,20/05/2021,16/07/2022,Unverified
210413_NewOrleans_OchsnerClinicFoundation_Surgeons,13-Apr-21,Local,United States of America,USA,Louisiana,New Orleans,01-Mar-20,22-Apr-20,Health care workers and caregivers,Adults (18-64 years),105,1.90%,0.20%,6.70%,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Tung Vu,Ochsner Clinic Foundation,https://journals.sagepub.com/doi/10.1177/00031348211011090,20/05/2021,16/07/2022,Unverified
210419_Milwakee_UniversityOfWisconsin,19-Apr-21,Local,United States of America,USA,Wisconsin,Milwaukee,15-Jun-20,03-Jul-20,Health care workers and caregivers,Adults (18-64 years),43,7.00%,2.00%,20.00%,Convenience,Abbott Laboratories,CLIA,IgG,,99.20%,High,Journal Article (Peer-Reviewed),Renuka Jain,University of Wisconsin,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8060043/,20/05/2021,16/07/2022,Verified
210309_Texas_UTSouthwesternMedicalCenter_Tarrant_overall_unadj,09-Mar-21,Local,United States of America,USA,,,15-Aug-20,15-Feb-21,Household and community samples,Multiple groups,5697,8.50%,,,Self-referral,NA,Not reported,Not reported,,,High,Institutional Report,UT Southwestern Medical Center,UT Southwestern Medical Center ,https://s3-us-west-2.amazonaws.com/utsw-patientcare-web-production/documents/DFWCPS_Update_03.09.21_FINAL.pdf,20/05/2021,16/07/2022,Verified
210309_Texas_UTSouthwesternMedicalCenter_Employees_overall_unadj,09-Mar-21,Local,United States of America,USA,,,15-Aug-20,15-Feb-21,Essential non-healthcare workers,Multiple groups,4098,5.20%,,,Self-referral,NA,Not reported,Not reported,,,High,Institutional Report,UT Southwestern Medical Center,UT Southwestern Medical Center ,https://s3-us-west-2.amazonaws.com/utsw-patientcare-web-production/documents/DFWCPS_Update_03.09.21_FINAL.pdf,20/05/2021,16/07/2022,Verified
210309_Texas_UTSouthwesternMedicalCenter_Dallas_overall_unadj,09-Mar-21,Local,United States of America,USA,,,15-Aug-20,15-Feb-21,Household and community samples,Multiple groups,11580,7.20%,,,Self-referral,NA,Not reported,Not reported,,,High,Institutional Report,UT Southwestern Medical Center,UT Southwestern Medical Center ,https://s3-us-west-2.amazonaws.com/utsw-patientcare-web-production/documents/DFWCPS_Update_03.09.21_FINAL.pdf,20/05/2021,16/07/2022,Verified
201202_Utah_UniversityofUtah_Phase1BWashington_TestAdj,02-Dec-20,Local,United States of America,USA,Utah,NR,01-May-20,01-Jul-20,Household and community samples,Multiple groups,1594,0.51%,0.00%,1.59%,Simplified probability,NA,Not reported,Not reported,83.00%,99.60%,Moderate,Institutional Report,University of Utah,University of Utah,https://issuu.com/ecclesschool/docs/utah_hero_report_11.24.20_gardner_at_front,20/05/2021,16/07/2022,Unverified
201202_Utah_UniversityofUtah_Phase1BCache_TestAdj,02-Dec-20,Local,United States of America,USA,Utah,NR,01-May-20,01-Jul-20,Household and community samples,Multiple groups,1622,2.31%,0.68%,5.71%,Simplified probability,NA,Not reported,Not reported,83.00%,99.60%,Moderate,Institutional Report,University of Utah,University of Utah,https://issuu.com/ecclesschool/docs/utah_hero_report_11.24.20_gardner_at_front,20/05/2021,16/07/2022,Unverified
201202_Utah_UniversityofUtah_Phase1BWeber_TestAdj,02-Dec-20,Local,United States of America,USA,Utah,NR,01-May-20,01-Jul-20,Household and community samples,Multiple groups,1211,1.39%,0.27%,3.66%,Simplified probability,NA,Not reported,Not reported,83.00%,99.60%,Moderate,Institutional Report,University of Utah,University of Utah,https://issuu.com/ecclesschool/docs/utah_hero_report_11.24.20_gardner_at_front,20/05/2021,16/07/2022,Unverified
201202_Utah_UniversityofUtah_Phase2Prelim_TestAdj,02-Dec-20,Local,United States of America,USA,Utah,NR,07-Jul-20,15-Aug-20,Household and community samples,Multiple groups,1622,2.81%,1.00%,6.36%,Simplified probability,NA,Not reported,Not reported,83.00%,99.60%,Moderate,Institutional Report,University of Utah,University of Utah,https://issuu.com/ecclesschool/docs/utah_hero_report_11.24.20_gardner_at_front,20/05/2021,16/07/2022,Unverified
210429_Phoenix_VincereCancerCenter_October_IgG_Unadj,29-Apr-21,Regional,United States of America,USA,Arizona,Phoenix Metropolitan Area,10-Oct-20,16-Oct-20,Household and community samples,Multiple groups,1635,8.74%,,,Self-referral,Assure Tech. (Hangzhou) Co. Ltd,LFIA,IgG,100.00%,98.80%,High,Journal Article (Peer-Reviewed),Christine Lau,"Vincere Cancer Center,",https://dx.doi.org/10.1007/s10900-021-00991-4,21/05/2021,16/07/2022,Verified
210429_Phoenix_VincereCancerCenter_November_IgG_Unadj,29-Apr-21,Regional,United States of America,USA,Arizona,Phoenix Metropolitan Area,07-Nov-20,13-Nov-20,Household and community samples,Multiple groups,2037,16.65%,,,Self-referral,Assure Tech. (Hangzhou) Co. Ltd,LFIA,IgG,100.00%,98.80%,High,Journal Article (Peer-Reviewed),Christine Lau,"Vincere Cancer Center,",https://dx.doi.org/10.1007/s10900-021-00991-4,21/05/2021,16/07/2022,Verified
210429_Phoenix_VincereCancerCenter_December_IgG_Unadj,29-Apr-21,Regional,United States of America,USA,Arizona,Phoenix Metropolitan Area,05-Dec-20,11-Dec-20,Household and community samples,Multiple groups,3038,16.50%,,,Self-referral,Assure Tech. (Hangzhou) Co. Ltd,LFIA,IgG,100.00%,98.80%,High,Journal Article (Peer-Reviewed),Christine Lau,"Vincere Cancer Center,",https://dx.doi.org/10.1007/s10900-021-00991-4,21/05/2021,16/07/2022,Verified
210112_PlacerCounty_StanfordUniversity,12-Jan-21,Local,United States of America,USA,California,,01-Nov-20,30-Nov-20,Household and community samples,Multiple groups,810,2.34%,,,Simplified probability,NA,LFIA,Not reported,,,High,Institutional Report,Julie Parsonnet,Stanford University,https://www.placer.ca.gov/DocumentCenter/View/49523/2021-011221-PowerPoint-Item-02A,21/05/2021,16/07/2022,Verified
210415_KentCounty_UniversityofMichigan_S1,15-Apr-21,Local,United States of America,USA,Michigan,NR,17-Aug-20,04-Sep-20,Health care workers and caregivers,Adults (18-64 years),1385,1.90%,1.20%,2.60%,Convenience,"Siemens,BioMérieux",Multiple Types,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Jeffrey Fletcher,University of Michigan,https://dx.doi.org/10.1017/ice.2021.167,21/05/2021,16/07/2022,Verified
210415_KentCounty_UniversityofMichigan_S2,15-Apr-21,Local,United States of America,USA,Michigan,NR,02-Dec-20,23-Dec-20,Health care workers and caregivers,Adults (18-64 years),1445,13.70%,11.90%,15.50%,Convenience,"Siemens,BioMérieux",Multiple Types,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Jeffrey Fletcher,University of Michigan,https://dx.doi.org/10.1017/ice.2021.167,21/05/2021,16/07/2022,Verified
210409_NewYorkCity_NYCdepthealth_overall,09-Apr-21,Local,United States of America,USA,New York,New York,13-May-20,21-Jul-20,Household and community samples,Multiple groups,45367,23.60%,23.20%,24.00%,Convenience,DiaSorin,CLIA,IgG,97.60%,99.30%,Moderate,Journal Article (Peer-Reviewed),Preeti Pathela,New York City Department of Health and Mental Hygiene,https://academic.oup.com/jid/advance-article/doi/10.1093/infdis/jiab200/6219118,22/05/2021,16/07/2022,Verified
210412_NewYork_CityUniversityofNewYork_Primary,12-Apr-21,Regional,United States of America,USA,New York ,"New York City
Bronx
Brooklyn
Long Island
Manhatten
Metro North
Queens
Staten Island",08-Mar-20,01-Jan-21,Household and community samples,Multiple groups,693205,21.60%,21.50%,21.70%,Sequential,NA,Not reported,IgG,,,High,Preprint,Madhura S Rane,City University of New York,https://www.medrxiv.org/content/10.1101/2021.04.06.21255009v3,22/05/2021,16/07/2022,Verified
210317_NewYorkCity_IcahnSchoolOfMedicine,17-Mar-21,Local,United States of America,USA,New York,Mount Sinai,26-May-20,15-Jul-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,383,10.44%,,,Convenience,NA,Not reported,Not reported,,,High,Preprint,Serre Yu Wong,Icahn School Of Medicine,https://www.medrxiv.org/content/10.1101/2021.03.15.21253615v1,23/05/2021,16/07/2022,Verified
210428_NewYorkCity_NewYorkBloodCenter_Ortho+Neut,28-Apr-21,Local,United States of America,USA,New York,New York City,15-Jun-20,15-Jul-20,Blood donors,Multiple groups,1000,9.00%,,,Sequential,"Ortho Clinical Diagnostics Inc.,NA",Multiple Types,"Total Antibody,Neutralizing ",,,Moderate,Journal Article (Peer-Reviewed),Daniel Jin,New York Blood Centre,https://dx.doi.org/10.1371/journal.pone.0250319,23/05/2021,16/07/2022,Verified
210415_ParrisIsland_IchanSchoolofMedicine,15-Apr-21,Local,United States of America,USA,South Carolina,Port Royal,11-May-20,02-Nov-20,Essential non-healthcare workers,Adults (18-64 years),3076,7.30%,,,Convenience,NA,ELISA,IgG,,100.00%,High,Journal Article (Peer-Reviewed),Andrew G Letizia,Icahn School of Medicine at Mount Sinai,https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(21)00158-2/fulltext,23/05/2021,16/07/2022,Verified
210422_Illinois+Wisconsin_AdvocateAuroraHealth_Overall,22-Apr-21,Regional,United States of America,USA,"Illinois, Wisconsin",,08-Jun-20,10-Jul-20,Health care workers and caregivers,Multiple groups,14921,3.59%,,,Convenience,Abbott Laboratories,CLIA,IgG,98.70%,99.20%,Moderate,Journal Article (Peer-Reviewed),Fitzpatrick Veronica,Advocate Aurora Health,https://dx.doi.org/10.1016/j.annepidem.2021.04.005,25/05/2021,16/07/2022,Verified
210501_UnitedStates_MayoClinic,26-Mar-21,Regional,United States of America,USA,"Minnesota, Wisconsin, Florida, Arizona, Iowa",Rochester,15-Jun-20,08-Aug-20,Health care workers and caregivers,Multiple groups,29606,0.60%,0.52%,0.69%,Convenience,"EUROIMMUN,Ortho Clinical Diagnostics Inc.,Roche Diagnostics",Multiple Types,IgG,,,High,Journal Article (Peer-Reviewed),Rickey Carter,The Mayo Clinic,https://dx.doi.org/10.1016/j.mayocp.2021.03.015,25/05/2021,16/07/2022,Verified
210420_NewYorkCity_BronxCareHealthSystem,20-Apr-21,Local,United States of America,USA,New York State,New York City,18-May-20,26-Jun-20,Health care workers and caregivers,Multiple groups,2749,30.20%,29.00%,32.00%,Convenience,Roche Diagnostics,Not reported,Not reported,97.10%,100.00%,High,Journal Article (Peer-Reviewed), Murli U Purswani,BronxCare Health System,https://dx.doi.org/10.12788/jhm.3627,26/05/2021,16/07/2022,Unverified
201205_Maryland_MarylandDepartmentOfHealth_overall,15-Dec-20,Regional,United States of America,USA,Maryland,,24-May-20,30-Jun-20,Residual sera,Multiple groups,500,10.00%,,,Sequential,Hangzhou Biotest Biotech Co. Ltd,LFIA,"IgG,IgM",95.00%,100.00%,High,Journal Article (Peer-Reviewed),Keri N Althoff,The Maryland Department of Health,https://dx.doi.org/10.1093/ofid/ofaa611,27/05/2021,16/07/2022,Unverified
210506_Boston_BostonMedicalCenter_Overall,06-May-21,Local,United States of America,USA,Massachusetts,Boston,13-Jul-20,26-Jul-20,Health care workers and caregivers,Multiple groups,1743,5.45%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Yachana Kataria,Boston Medical Center,https://dx.doi.org/10.1038/s41598-021-89107-5,27/05/2021,16/07/2022,Verified
210427_Connecticut_HartfordHealthcare_overall,27-Apr-21,Regional,United States of America,USA,Connecticut,Hartford,11-May-20,16-Aug-20,Health care workers and caregivers,Multiple groups,6863,6.30%,5.70%,6.90%,Convenience,Abbott Laboratories,CLIA,IgG,100.00%,99.60%,Moderate,Journal Article (Peer-Reviewed),Pavlos Papasavas,Hartford Healthcare,https://dx.doi.org/10.1016/j.jhin.2021.04.021,27/05/2021,16/07/2022,Verified
210508_NorthCarolina_FirstHealthoftheCarolinas_Overall,08-May-21,Regional,United States of America,USA,North Carolina,,10-Jun-20,17-Jul-20,Health care workers and caregivers,Multiple groups,2076,3.00%,1.90%,3.30%,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),GS Arnoczy,FirstHealth of the Carolinas,https://dx.doi.org/10.1016/j.ajic.2021.04.086,28/05/2021,16/07/2022,Unverified
210413_Texas_UniversityOfTexasSouthwesternMedicalCenter_Dallas1,13-Apr-21,Local,United States of America,USA,Texas,Dallas,01-Mar-20,31-Mar-21,Residual sera,Multiple groups,2533,38.90%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Madhusudhanan Narasimhan ,University of Texas Southwestern Medical Center,https://dx.doi.org/10.3390/vaccines9040376,30/05/2021,16/07/2022,Unverified
210413_Texas_UniversityOfTexasSouthwesternMedicalCenter_DallasFortWorth2,13-Apr-21,Local,United States of America,USA,Texas,Dallas-Fort Worth,01-Jun-20,28-Feb-21,Residual sera,Multiple groups,21101,7.10%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Madhusudhanan Narasimhan ,University of Texas Southwestern Medical Center,https://dx.doi.org/10.3390/vaccines9040376,30/05/2021,16/07/2022,Unverified
210430_Baltimore_JohnsHopkinsUniversity_Overall,30-Apr-21,Local,United States of America,USA,Maryland,Baltimore,16-Mar-20,31-May-20,Residual sera,Multiple groups,3255,3.50%,2.90%,4.20%,Sequential,"Hangzhou Biotest Biotech Co. Ltd,EUROIMMUN",Multiple Types,"IgG,IgM",84.00%,100.00%,High,Journal Article (Peer-Reviewed),Oliver Laeyendecker,Johns Hopkins University ,https://dx.doi.org/10.1016/j.ajem.2021.04.081,01/06/2021,16/07/2022,Verified
210519_UnitedStates_QuestDiagnostics,19-May-21,National,United States of America,USA,,,15-Aug-20,15-Nov-20,Non-essential workers and unemployed persons,Adults (18-64 years),18148,5.00%,,,Convenience,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories",CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Yonghong Li,Quest Diagnostics,https://dx.doi.org/10.1001/jamanetworkopen.2021.11634,03/06/2021,16/07/2022,Verified
210430_UnitedStates_MedicalUniversityofSouthCarolina,30-Apr-21,Regional,United States of America,USA,"South Carolina, North Carolina, Georgia",,15-May-20,15-Jul-20,Blood donors,Multiple groups,60835,2.60%,,,Sequential,"GenScript,NA",Multiple Types,"IgG,Neutralizing ,IgM,IgA",,,Moderate,Journal Article (Peer-Reviewed),Connor Dwyer,Medical University of South Carolina,https://dx.doi.org/10.1016/j.isci.2021.102489,03/06/2021,16/07/2022,Verified
210316_MetropolitanDetroit_HenryFordHealthSystem,16-Mar-21,Local,United States of America,USA,Michigan,Detroit,17-Jun-20,24-Jul-20,Health care workers and caregivers,Adults (18-64 years),374,2.41%,1.27%,4.51%,Simplified probability,Beckman Coulter,Not reported,IgG,,,Moderate,Journal Article (Peer-Reviewed),Christine C Johnson,Henry Ford Health System,https://dx.doi.org/10.1016/j.jcv.2021.104794,04/06/2021,16/07/2022,Unverified
210525_UnitedStates_RutgersUniversity_Primary,25-May-21,National,United States of America,USA,,,07-May-20,31-Jul-20,Household and community samples,Multiple groups,124,36.30%,,,Convenience,NA,Not reported,Not reported,,,High,Journal Article (Peer-Reviewed),Richard Martino,Rutgers University,https://dx.doi.org/10.1177/00333549211018190,05/06/2021,16/07/2022,Verified
210601_Providence_BrownUniversity,01-Jun-21,Local,United States of America,USA,Rhode Island,Providence,08-Jun-20,23-Jun-20,Health care workers and caregivers,Adults (18-64 years),101,2.90%,,,Convenience,Abbott Laboratories,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),Matthew Murphy,Brown University,http://rimed.org/rimedicaljournal/2021/06/2021-06-20-contribution-murphy.pdf,05/06/2021,16/07/2022,Verified
210504_Texas_UniversityofTexasSouthwestern,04-May-21,Local,United States of America,USA,Texas,Dallas,01-Jun-20,31-Aug-20,Health care workers and caregivers,Adults (18-64 years),549,3.28%,,,Self-referral,Abbott Laboratories,Not reported,IgG,,,High,Presentation or Conference,Gilberto Salazar,University of Texas Southwestern,http://dx.doi.org/10.1111/acem.14249,05/06/2021,16/07/2022,Verified
210524_LosAngelesCounty_LosAngelesCountyDepartmentofPublicHealth_Staff2,24-May-21,Regional,United States of America,USA,California,,18-Aug-20,24-Sep-20,Health care workers and caregivers,Multiple groups,856,40.00%,,,Convenience,"Abbott Laboratories,DiaSorin",CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Jason Malenfant,Los Angeles County Department of Public Health,https://dx.doi.org/10.1093/infdis/jiab281,07/06/2021,16/07/2022,Unverified
210524_LosAngelesCounty_LosAngelesCountyDepartmentofPublicHealth_Residents1,24-May-21,Regional,United States of America,USA,California,,18-Aug-20,24-Sep-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,1806,25.00%,,,Convenience,"Abbott Laboratories,DiaSorin",CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Jason Malenfant,Los Angeles County Department of Public Health,https://dx.doi.org/10.1093/infdis/jiab281,07/06/2021,16/07/2022,Unverified
210504_DallasTexas_UniversityofTexasSouthwestern,04-May-21,Local,United States of America,USA,,Dallas,01-Oct-20,15-Nov-20,Health care workers and caregivers,Adults (18-64 years),37,0.00%,,,Convenience,Abbott Laboratories,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),Lauren Diercks,University of Texas Southwestern,http://dx.doi.org/10.1111/acem.14249 ,07/06/2021,16/07/2022,Unverified
210503_USA_HIV_ClinicalReferenceLaboratory,03-May-21,National,United States of America,USA,,,01-Jan-20,31-Mar-21,Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),1191,12.80%,,,Convenience,Roche Diagnostics,Not reported,Total Antibody,99.50%,99.80%,Moderate,Preprint,Robert Stout,Clinical Reference Laboratory ,10.1101/2021.04.29.21256302,07/06/2021,16/07/2022,Verified
210429_Indianapolis_IndianaUniversity_overall,29-Apr-21,Local,United States of America,USA,Indiana,Indianapolis,18-May-20,22-May-20,Health care workers and caregivers,Adults (18-64 years),44,27.27%,,,Convenience,Abnova,ELISA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Timothy Crisci,Indiana Univeristy,https://dx.doi.org/10.3389/fped.2021.633082,07/06/2021,16/07/2022,Verified
210527_NewYorkCity_NewYorkUniversityGrossmanSchoolofMedicine_primary,27-May-21,Local,United States of America,USA,New York,New York City,29-Apr-20,09-Feb-21,Patients seeking care for non-COVID-19 reasons,Multiple groups,329,16.00%,,,Convenience,"NA,Abbott Laboratories",CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Amit Saxena,New York University Grossman School of Medicine,https://dx.doi.org/10.1016/S2665-9913(21)00114-4,07/06/2021,16/07/2022,Unverified
210603_UnitedStates_EmoryUniversity,03-Jun-21,National,United States of America,USA,NR,NR,09-Aug-20,08-Dec-20,Household and community samples,Multiple groups,1454,4.68%,,,Simplified probability,NA,Not reported,Not reported,,,Unclear,Presentation or Conference,Aaron Siegler,Emory University ,https://www.croiconference.org/abstract/us-population-based-survey-of-vaccine-willingness-and-sars-cov-2-antibody-prevalence/,07/06/2021,16/07/2022,Verified
210508_SouthDakota_SouthDakotaStateUniversity_Phase3,08-Jun-21,Regional,United States of America,USA,"South Dakota, Minnesota",,16-Oct-20,22-Dec-20,Health care workers and caregivers,Adults (18-64 years),235,14.80%,,,Convenience,Roche Diagnostics,Other,"IgG,IgM,IgA",,,High,Preprint,Jordan Neises,South Dakota State University,https://www.medrxiv.org/content/10.1101/2021.06.07.21258375v1,17/06/2021,16/07/2022,Unverified
210409_OrangeCounty_UniversityofCaliforniaIrvine_Primary,09-Apr-21,Local,United States of America,USA,California,Orange County ,14-Apr-20,13-May-20,Health care workers and caregivers,Adults (18-64 years),143,10.50%,,,Convenience,Superbio Biomedical Company ,Other,"IgM,IgG",100.00%,83.80%,High,Journal Article (Peer-Reviewed),Theodore W. Heyming,University of California Irvine,https://dx.doi.org/10.5811/westjem.2021.1.50058,20/06/2021,16/07/2022,Verified
210611_SanFrancisco_UniversityofCaliforniaSanFrancisco_mostadj,11-Jun-21,Local,United States of America,USA,California,San Francisco,28-Mar-20,26-Jun-20,Residual sera,Multiple groups,4735,4.20%,2.10%,6.30%,Stratified non-probability,NA,Multiple Types,IgG,93.70%,99.60%,Moderate,Journal Article (Peer-Reviewed),Isobel Routledge,University of California San Francisco,https://dx.doi.org/10.1038/s41467-021-23651-6,21/06/2021,16/07/2022,Verified
210602_USA_MontantaStateUniversity_Primary,02-Jun-21,Local,United States of America,USA,Montana,Bozeman,15-Apr-20,15-Nov-20,Blood donors,Adults (18-64 years),168,19.00%,,,Self-referral,NA,Neutralization,IgG,,,Moderate,Journal Article (Peer-Reviewed),Jodi Hedges,Montana State University,http://dx.doi.org/10.3390/vaccines9060587,21/06/2021,16/07/2022,Unverified
210610_USA_BostonHeartDiagnostics,10-Jun-21,National,United States of America,USA,,,06-Apr-20,01-Dec-20,Residual sera,Multiple groups,81624,5.21%,,,Unclear,Diazyme Laboratories Inc,CLIA,IgG,98.40%,97.40%,High,Journal Article (Peer-Reviewed),Ernst J. Schaefer,Boston Heart Diagnostics,http://dx.doi.org/10.1371/journal.pone.0252818,22/06/2021,16/07/2022,Unverified
210604_NewYorkCity_NewYorkCityDepartmentOfHealthAndMentalHygiene_Overall,04-Jun-21,Local,United States of America,USA,New York State,New York City,01-Jun-20,09-Oct-20,Household and community samples,Multiple groups,1074,24.30%,20.70%,28.30%,Stratified probability,DiaSorin,CLIA,IgG,97.60%,99.30%,Moderate,Journal Article (Peer-Reviewed),Jannae Parrott,New York City Department of Health and Mental Hygiene,https://dx.doi.org/10.1093/infdis/jiab296,22/06/2021,16/07/2022,Verified
210615_USA_JohnsHopkinsUniversity,15-Jun-21,National,United States of America,USA,,,02-Jan-20,18-Mar-20,Household and community samples,Multiple groups,24079,0.04%,,,Sequential,"Abbott Laboratories,EUROIMMUN",Multiple Types,IgG,90.70%,100.00%,High,Journal Article (Peer-Reviewed),Keri Althoff ,Johns Hopkins University,https://dx.doi.org/10.1093/cid/ciab519,22/06/2021,16/07/2022,Verified
210606_Pennsylvania_UniversityOfPittsburgh_Fall1_overall,06-Jun-21,Regional,United States of America,USA,Pennsylvania,,21-Sep-20,04-Nov-20,Multiple general populations,Multiple groups,199,2.01%,1.00%,5.00%,Convenience,NA,Multiple Types,"IgG,Neutralizing ",,,High,Journal Article (Peer-Reviewed),Lingqing Xu,University of Pittsburgh,http://dx.doi.org/10.3390/pathogens10060710,29/06/2021,16/07/2022,Verified
210606_Pennsylvania_UniversityOfPittsburgh_Feb2,06-Jun-21,Local,United States of America,USA,Pennsylvania,Pittsburgh,01-Feb-21,05-Feb-21,Residual sera,Multiple groups,194,16.49%,12.00%,22.00%,Sequential,NA,Multiple Types,"IgG,Neutralizing ",,,High,Journal Article (Peer-Reviewed),Lingqing Xu,University of Pittsburgh,http://dx.doi.org/10.3390/pathogens10060710,29/06/2021,16/07/2022,Verified
210621_Jacksonville_MayoClinic,21-Jun-21,Local,United States of America,USA,Florida,Jacksonville,06-May-20,01-Jul-20,Health care workers and caregivers,Adults (18-64 years),292,2.70%,1.20%,5.30%,Convenience,"Epitope Diagnostics, Inc.",ELISA,IgG,100.00%,100.00%,High,Journal Article (Peer-Reviewed),Martin L.De Ruyter,Mayo Clinic,https://dx.doi.org/10.1093/bjs/znab109,30/06/2021,16/07/2022,Unverified
210615_Nashville_VanderbiltUniversityMedicalCenter_FollowUp2_Overall,15-Jun-21,Local,United States of America,USA,Tennessee,Nashville,27-Jan-21,27-Jan-21,Essential non-healthcare workers,Adults (18-64 years),34,14.71%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Sophie E. Katz,Vanderbilt University Medical Center,https://dx.doi.org/10.1016/j.jpeds.2021.06.015,01/07/2021,16/07/2022,Verified
210414_Holyoke_CityofHolyoke_Overall_PopAdj,23-Jun-21,Local,United States of America,USA,Massachusetts,Holyoke,05-Nov-20,31-Jan-21,Household and community samples,Multiple groups,328,13.90%,7.80%,21.80%,Simplified probability,NA,Not reported,"IgM,IgG",,,Moderate,Institutional Report,City of Holyoke,City of Holyoke,https://www.holyoke.org/documents/city-of-holyoke-serosurvey-report/,05/07/2021,16/07/2022,Verified
210602_UnitedStates_TranslationalPulmonaryAndImmunologyResearchCenter_Overall,02-Jun-21,National,United States of America,USA,,,01-Feb-20,20-Apr-20,Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),172,4.00%,,,Convenience,"InBios International, Inc.",ELISA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Nathan Marsteller,Translational Pulmonary and Immunology Research Center,http://dx.doi.org/10.3390/antib10020022,06/07/2021,16/07/2022,Verified
210618_LosAngeles_UniversityCaliforniaLosAngeles,18-Jun-21,Local,United States of America,USA,California,Los Angeles,,10-Aug-20,Residual sera,Multiple groups,3075,8.81%,,,Convenience,DiaSorin,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Douglas Murad,University of California Los Angeles,http://dx.doi.org/10.1128/JCM.00431-21,07/07/2021,16/07/2022,Verified
210707_Monrovia_OakCrestInstituteOfScience_Overall,07-Jul-21,Local,United States of America,USA,California,Monrovia,27-Mar-20,26-May-20,Non-essential workers and unemployed persons,Adults (18-64 years),33,6.10%,,,Convenience,NA,ELISA,"IgG,IgM,IgA",,,High,Journal Article (Peer-Reviewed),Manjula Gunawardana,Oak Crest Institute of Science,https://dx.doi.org/10.1128/mSphere.00542-21,13/07/2021,16/07/2022,Verified
210702_USA_DaVitaClinicalResearch,02-Jul-21,National,United States of America,USA,"California, Connecticut, Minnesota, Nevada, New York, Ohio, Texas, Virginia, and Wisconsin",,01-Jul-20,31-Jul-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,2337,9.50%,,,Convenience,Diazyme Laboratories Inc,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Dena Cohen,DaVita Clinical Research,https://dx.doi.org/10.1681/ASN.2021030387,13/07/2021,16/07/2022,Verified
210703_Atlanta_CentersForDiseaseControlAndPrevention,03-Jul-21,Local,United States of America,USA,Georgia,Atlanta,31-Aug-20,23-Nov-20,Residual sera,Multiple groups,592,17.90%,,,Convenience,NA,ELISA,"IgG,IgM,IgA",,,High,Journal Article (Peer-Reviewed),Talya Shragai,United States Centers for Disease Control and Prevention,https://dx.doi.org/10.1093/infdis/jiab349,14/07/2021,16/07/2022,Verified
210702_Ohio_UniversityHospitalsClevelandMedicalCenter_Overall,02-Jul-21,Regional,United States of America,USA,Northeastern Ohio,,22-May-20,15-Sep-20,Essential non-healthcare workers,Multiple groups,3080,2.40%,,,Convenience,Abbott Laboratories,CLIA,IgG,100.00%,99.60%,Moderate,Preprint,Xiaochun Zhang,University Hospitals Cleveland Medical Center,https://www.medrxiv.org/content/10.1101/2021.06.27.21259432v1.full-text,16/07/2021,16/07/2022,Unverified
210616_LomaLinda_LomaLindaUniversityChildren'sHospital_Overall,16-Jun-21,Local,United States of America,USA,California,Loma Linda,15-Mar-20,15-Mar-21,Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),146,6.16%,,,Sequential,NA,Not reported,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Matthew J. Bock,Loma Linda University Children's Hospital ,https://dx.doi.org/10.1016/j.healun.2021.06.009,18/07/2021,16/07/2022,Verified
210710_USA_EmoryUniversity_overall_PopAdj_TestAdj,10-Jul-21,National,United States of America,USA,,,09-Aug-20,08-Dec-20,Household and community samples,Multiple groups,4654,4.71%,3.30%,6.11%,Stratified probability,Bio-rad,ELISA,Total Antibody,98.00%,99.30%,Low,Journal Article (Peer-Reviewed),Patrick Sullivan,Emory University,https://dx.doi.org/10.1093/cid/ciab626,19/07/2021,16/07/2022,Verified
210707_UnitedStates_NationalInstitutesOfHealth_Overall,07-Jul-21,National,United States of America,USA,,,01-Apr-20,04-Aug-20,Household and community samples,Multiple groups,8058,4.60%,2.60%,6.50%,Stratified non-probability,NA,ELISA,"IgG,IgM",,,Low,Journal Article (Peer-Reviewed),Heather Kalish,National Institutes of Health,http://dx.doi.org/10.1126/scitranslmed.abh3826,19/07/2021,16/07/2022,Verified
210712_UnitedStates_StanfordUniversity_Overall,12-Jul-21,National,United States of America,USA,,,01-Jan-21,31-Jan-21,Patients seeking care for non-COVID-19 reasons,Multiple groups,21464,18.70%,18.10%,19.20%,Convenience,Siemens,CLIA,"IgG,IgM",100.00%,99.80%,Moderate,Journal Article (Peer-Reviewed),Shuchi Anand,Stanford University,https://dx.doi.org/10.1001/jamanetworkopen.2021.16572,21/07/2021,16/07/2022,Unverified
210710_Athens_UniversityofGeorgia_PopTestAdj,10-Jul-21,Local,United States of America,USA,Georgia,Athens,22-Jan-21,22-Mar-21,Students and Daycares,Adults (18-64 years),432,41.00%,31.40%,50.70%,Convenience,NA,ELISA,IgA,88.89%,88.89%,Moderate,Preprint,Mark Ebell,University of Georgia,https://www.medrxiv.org/content/10.1101/2021.07.08.21260201v1,21/07/2021,16/07/2022,Unverified
210719_Arkansas_UniversityOfArkansasForMedicalSciences_1_Overall,19-Jul-21,Regional,United States of America,USA,Arkansas,"Little Rock, Springdale, Pine Bluff",15-Aug-20,05-Sep-20,Residual sera,Multiple groups,1301,2.60%,1.70%,3.50%,Convenience,"Beckman Coulter,NA",Multiple Types,IgG,,,Moderate,Preprint,Joshua Kennedy,University of Arkansas for Medical Sciences,https://www.medrxiv.org/content/10.1101/2021.07.15.21260213v1,26/07/2021,16/07/2022,Verified
210719_Arkansas_UniversityOfArkansasForMedicalSciences_2_Overall,19-Jul-21,Regional,United States of America,USA,Arkansas,"Little Rock, Springdale, Pine Bluff, Fort Smith",12-Sep-20,24-Oct-20,Residual sera,Multiple groups,2098,4.10%,3.10%,5.10%,Convenience,"Beckman Coulter,NA",Multiple Types,IgG,,,Moderate,Preprint,Joshua Kennedy,University of Arkansas for Medical Sciences,https://www.medrxiv.org/content/10.1101/2021.07.15.21260213v1,26/07/2021,16/07/2022,Verified
210719_Arkansas_UniversityOfArkansasForMedicalSciences_3_Overall,19-Jul-21,Regional,United States of America,USA,Arkansas,"Little Rock, Springdale, Pine Bluff, Fort Smith",07-Nov-20,19-Dec-20,Residual sera,Multiple groups,2405,7.40%,6.00%,8.70%,Convenience,"Beckman Coulter,NA",Multiple Types,IgG,,,Moderate,Preprint,Joshua Kennedy,University of Arkansas for Medical Sciences,https://www.medrxiv.org/content/10.1101/2021.07.15.21260213v1,26/07/2021,16/07/2022,Verified
210720_LongIsland_StonyBrookUniversity_Totaladj,20-Jul-21,Local,United States of America,USA,New York,Long Island,25-Mar-20,18-Sep-20,Household and community samples,Multiple groups,1042,21.30%,19.50%,23.20%,Convenience,Abbott Laboratories,CLIA,IgG,93.40%,100.00%,High,Journal Article (Peer-Reviewed),Olga Morozova,Stony Brook University,https://dx.doi.org/10.1371/journal.pone.0254713,28/07/2021,16/07/2022,Verified
210527_NewYorkCity_HospitalForSpecialSurgery_overall,27-May-21,Local,United States of America,USA,New York,New York City,06-May-20,05-Jun-20,Health care workers and caregivers,Adults (18-64 years),143,9.79%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Ellen Soffin,Hospital for Special Surgery,http://dx.doi.org/10.1097/JOM.0000000000002182,01/08/2021,16/07/2022,Verified
210721_FortCollins_ColoradoStateUniversity,21-Jul-21,Local,United States of America,USA,Colorado,Fort Collins,13-Jul-20,02-Sep-20,Essential non-healthcare workers,Adults (18-64 years),508,0.40%,0.10%,1.40%,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Tracy Nelson,Colorado State University,https://dx.doi.org/10.1001/jamanetworkopen.2021.16543,02/08/2021,16/07/2022,Unverified
210715_USA_GeorgeWashingtonUniversity_Overall,14-Jul-21,Regional,United States of America,USA,"California, Connecticut, Michigan, New Jersey, New York",,14-May-20,30-May-20,Household and community samples,Multiple groups,6665,30.00%,,,Convenience,"Epitope Diagnostics, Inc.",ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Jonathan Silverberg,George Washington University,https://dx.doi.org/10.1016/j.jaip.2021.06.046,03/08/2021,16/07/2022,Verified
210728_NewYorkCity_WeillCornellMedicine_overall,28-Jul-21,Local,United States of America,USA,New York ,New York City,28-May-20,12-Dec-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,72,31.94%,,,Sequential,NA,Not reported,IgG,,,High,Preprint,Michelle Lubetzky,Weill Cornell Medicine,https://www.medrxiv.org/content/10.1101/2021.07.25.21261066v1.full-text,04/08/2021,16/07/2022,Verified
210804_StLouis_WashingtonUniversitySchoolOfMedicine_Jul_Children,04-Aug-21,Local,United States of America,USA,Missouri,St Louis,22-Jul-20,16-Aug-20,Residual sera,Children and Youth (0-17 years),546,5.22%,2.76%,7.68%,Convenience,NA,ELISA,IgG,98.20%,98.70%,High,Journal Article (Peer-Reviewed),Brittany K. Smith,Washington University School of Medicine,https://dx.doi.org/10.1128/mSphere.00450-21,10/08/2021,16/07/2022,Verified
210804_StLouis_WashingtonUniversitySchoolOfMedicine_Jul_Adults,04-Aug-21,Local,United States of America,USA,Missouri,St Louis,25-Jul-20,31-Jul-20,Residual sera,Multiple groups,506,4.52%,2.07%,6.93%,Convenience,NA,ELISA,IgG,98.20%,98.70%,High,Journal Article (Peer-Reviewed),Brittany K. Smith,Washington University School of Medicine,https://dx.doi.org/10.1128/mSphere.00450-21,10/08/2021,16/07/2022,Verified
210708_Philadelphia_UniversityofPennsylvania,08-Jul-21,Local,United States of America,USA,Pennsylvania,Philadelphia,13-Apr-20,20-May-20,Health care workers and caregivers,Adults (18-64 years),2043,2.00%,,,Convenience,NA,ELISA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Sigrid Gouma,University of Pennsylvania,http://dx.doi.org/10.1172/jci.insight.150449,15/08/2021,16/07/2022,Unverified
210801_Phoenix_DignityHealthResearchInstitute,01-Aug-21,Local,United States of America,USA,Arizona,Phoenix,15-Jun-20,15-Aug-20,Health care workers and caregivers,Adults (18-64 years),1358,21.40%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Presentation or Conference,B. Tiffany,Dignity Health Research Institute,http://dx.doi.org/10.1016/j.annemergmed.2021.07.033,15/08/2021,22/07/2022,Unverified
210811_UnitedStates_NationalInstitutesOfHealth_Primary,11-Aug-21,National,United States of America,USA,,,15-Apr-20,15-Oct-20,Residual sera,Multiple groups,2542,7.87%,6.88%,8.98%,Convenience,NA,ELISA,"IgG,IgM",100.00%,100.00%,High,Preprint,Tran B Ngo,National Institutes of Health,https://www.medrxiv.org/content/10.1101/2021.08.10.21261849v1,16/08/2021,16/07/2022,Verified
210730_USA_AmericanRedCross_overall,30-Jul-21,National,United States of America,USA,,,15-Jun-20,30-Nov-20,Blood donors,Multiple groups,1531221,4.22%,,,Sequential,Ortho Clinical Diagnostics Inc.,CLIA,Total Antibody,100.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Roger Dodd,American Red Cross,https://dx.doi.org/10.1016/j.tmrv.2021.07.001,17/08/2021,16/07/2022,Verified
210727_California_EmoryUniversity_primary,27-Jul-21,Regional,United States of America,USA,California,,15-Aug-20,15-Dec-20,Household and community samples,Multiple groups,983,4.50%,2.80%,7.40%,Simplified probability,Bio-rad,ELISA,"IgG,IgM,IgA",92.20%,99.60%,Moderate,Journal Article (Peer-Reviewed),Katherine Lamba,Emory University,https://dx.doi.org/10.1093/ofid/ofab379,17/08/2021,16/07/2022,Verified
210806_Columbus_OhioStateUniversityCollegeofMedicine,06-Aug-21,Local,United States of America,USA,Ohio,Columbus,18-Sep-20,25-Sep-20,Health care workers and caregivers,Adults (18-64 years),126,21.43%,,,Convenience,"Epitope Diagnostics, Inc.",ELISA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Miranda Kiefer,Ohio State University College of Medicine,https://dx.doi.org/10.1111/aji.13490,17/08/2021,16/07/2022,Unverified
210809_Chicago_NorthwesternUniversity,09-Aug-21,Local,United States of America,USA,Illinois,"Chicago
",09-Nov-20,08-Jan-21,Health care workers and caregivers,Adults (18-64 years),4947,8.35%,,,Convenience,Abbott Laboratories,CLIA,IgG,100.00%,99.60%,Moderate,Journal Article (Peer-Reviewed),John Wilkins,Northwestern University,https://dx.doi.org/10.1017/ice.2021.367,17/08/2021,16/07/2022,Unverified
210807_Texas_UniversityofTexasinst,07-Aug-21,Regional,United States of America,USA,Texas,NR,01-Oct-20,04-Jul-21,Multiple populations,Multiple groups,14899,35.30%,33.70%,36.90%,Convenience,Roche Diagnostics,CLIA,Not reported,99.50%,99.82%,High,Preprint,Stacia Desantis,University of Texas,https://www.medrxiv.org/content/10.1101/2021.08.05.21261610v1.full-text,17/08/2021,16/07/2022,Verified
210804_StLouis_WashingtonUniversitySchoolOfMedicine_Jul_Primary,04-Aug-21,Local,United States of America,USA,Missouri,St Louis,22-Jul-20,16-Aug-20,Residual sera,Multiple groups,1052,5.89%,,,Convenience,NA,ELISA,IgG,98.20%,98.70%,High,Journal Article (Peer-Reviewed),Brittany K. Smith,Washington University School of Medicine,https://dx.doi.org/10.1128/mSphere.00450-21,18/08/2021,16/07/2022,Verified
210813_NewJersey_RutgersUniversity,13-Aug-21,Local,United States of America,USA,New Jersey,"Newark, New Brunswick, Piscataway",24-Mar-20,22-Sep-20,Health care workers and caregivers,Adults (18-64 years),831,9.99%,,,Convenience,NA,ELISA,"IgG,IgA,IgM",94.30%,99.70%,High,Journal Article (Peer-Reviewed),Daniel Horton,Rutgers University,https://dx.doi.org/10.1093/infdis/jiab411,25/08/2021,16/07/2022,Verified
201105_Detroit_OaklandUniversity_TestAdjustment,05-Nov-20,Local,United States of America,USA,Michigan,Detroit,13-Apr-20,28-May-20,Health care workers and caregivers,Adults (18-64 years),20614,8.07%,6.83%,8.86%,Convenience,EUROIMMUN,ELISA,IgG,98.14%,99.35%,Moderate,Journal Article (Peer-Reviewed),Matthew Sims,Oakland University,http://dx.doi.org/10.1093/cid/ciaa1684,25/08/2021,16/07/2022,Verified
210818_Mongomery_WestVirginiaUniversity,18-Aug-21,Local,United States of America,USA,West Virginia,Montgomery,10-Sep-20,10-Sep-20,Hospital visitors,Multiple groups,150,10.00%,,,Convenience,Tecan,ELISA,IgG,,,High,Preprint,Alexander Horspool,West Virginia University,https://dx.doi.org/10.1101/2021.08.16.21262128,29/08/2021,16/07/2022,Unverified
210729_NorthernVirginia_InovaHeartandVascularInstitute_HCWOctoberNovember3_Primary,29-Jul-21,Regional,United States of America,USA,Virginia,,15-Apr-20,15-Nov-20,Health care workers and caregivers,Adults (18-64 years),1323,4.80%,,,Convenience,Ortho Clinical Diagnostics Inc.,CLIA,"IgG,IgM",,,Moderate,Journal Article (Peer-Reviewed),Abdulla Damluji,Inova Heart and Vascular Institute,https://dx.doi.org/10.1016/j.lana.2021.100030,30/08/2021,16/07/2022,Unverified
210729_NorthernVirginia_InovaHeartandVascularInstitute_Community4_Primary,29-Jul-21,Regional,United States of America,USA,Virginia,,01-Jun-20,14-Aug-20,Household and community samples,Multiple groups,949,4.53%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Abdulla Damluji,Inova Heart and Vascular Institute,https://dx.doi.org/10.1016/j.lana.2021.100030,30/08/2021,16/07/2022,Unverified
210820_Maryland_UniversityofMaryland,20-Aug-21,Local,United States of America,USA,"Maryland
",,01-Jun-20,31-Aug-20,Health care workers and caregivers,Adults (18-64 years),778,2.60%,,,Self-referral,NA,Not reported,Not reported,,,High,Journal Article (Peer-Reviewed),Lyndsay O'Hara,University of Maryland,https://dx.doi.org/10.1017/ice.2021.373,30/08/2021,16/07/2022,Unverified
210825_RhodeIsland_LindsleyFKimballResearchInstitute_CLIA_OverallAdj,25-Aug-21,Regional,United States of America,USA,Rhode Island,,27-Apr-20,11-May-20,Blood donors,Multiple groups,1996,0.60%,0.20%,1.10%,Sequential,Ortho Clinical Diagnostics Inc.,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Daniel Nesbitt,Lindsley F Kimball Research Institute,https://dx.doi.org/10.1186/s12879-021-06438-4,30/08/2021,16/07/2022,Verified
210819_NewYork_ColumbiaUniversityIrvingMedicalCenter_Overall,19-Aug-21,Local,United States of America,USA,New York,,03-Jan-21,21-Jan-21,Household and community samples,Multiple groups,474,67.90%,,,Simplified probability,NA,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Alan Werzberger,Columbia University Irving Medical Center,https://dx.doi.org/10.1016/j.ajic.2021.08.015,30/08/2021,16/07/2022,Verified
210825_OrangeCounty_UniversityofCaliforniaIrvine,25-Aug-21,Local,United States of America,USA,California,NR,05-Oct-20,23-Oct-20,Essential non-healthcare workers,Adults (18-64 years),923,5.40%,,,Convenience,Abbott Laboratories,CLIA,IgG,99.60%,100.00%,Moderate,Journal Article (Peer-Reviewed),Veronica Vieira,University of California Irvine,https://dx.doi.org/10.1136/oemed-2021-107461,31/08/2021,16/07/2022,Unverified
210429_Houston_HoustonHealthDepartment_MultipleTest_Primary,29-Apr-21,Local,United States of America,USA,Texas,Houston,01-Sep-20,19-Sep-20,Household and community samples,Multiple groups,685,11.53%,,,Stratified probability,"Bio-rad,NA",ELISA,"IgG,IgM,IgA",,,Low,Journal Article (Peer-Reviewed),Elaine Symanski,Houston Health Department,https://academic.oup.com/jid/advance-article/doi/10.1093/infdis/jiab203/6258999,03/09/2021,16/07/2022,Verified
210901_Utah_UniversityofUtah_genpop_popadj_testadj,01-Sep-21,Regional,United States of America,USA,Utah,,04-May-20,30-Jun-20,Household and community samples,Multiple groups,8108,0.80%,0.10%,1.60%,Stratified probability,Abbott Laboratories,CLIA,IgG,86.40%,99.60%,Moderate,Journal Article (Peer-Reviewed),Matthew Samore,University of Utah,https://wwwnc.cdc.gov/eid/article/27/11/20-4435_article,07/09/2021,16/07/2022,Verified
210830_Conneticut_YaleUniversity,30-Aug-21,Regional,United States of America,USA,Connecticut,,15-Apr-21,15-Jun-20,Essential non-healthcare workers,Adults (18-64 years),988,10.40%,,,Convenience,NA,ELISA,IgG,99.50%,99.80%,High,Journal Article (Peer-Reviewed),Joseph Zell,Yale University,https://dx.doi.org/10.1371/journal.pone.0251114,09/09/2021,16/07/2022,Unverified
210901_Kentucky_UniversityofKentucky_Primary,01-Sep-21,Local,United States of America,USA,Kentucky,Lexington,22-Jun-20,26-Jun-20,Health care workers and caregivers,Adults (18-64 years),322,1.55%,0.65%,3.71%,Convenience,Abbott Laboratories,CLIA,IgG,100.00%,99.60%,High,Journal Article (Peer-Reviewed),Derek Forster,University of Kentucky,https://dx.doi.org/10.1016/j.ajic.2021.04.005,10/09/2021,16/07/2022,Unverified
210529_NewYorkCity_RenalResearchInstitute_Primary,29-May-21,Local,United States of America,USA,New York,New York City,10-Jun-20,13-Jul-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,429,30.30%,,,Convenience,Diazyme Laboratories Inc,CLIA,IgG,100.00%,98.00%,Unclear,Presentation or Conference,Ohnmar Thwin,Renal Research Institute,http://dx.doi.org/10.1093/ndt/gfab100.002,14/09/2021,16/07/2022,Unverified
210812_NorthCarolina_UniversityOfNorthCarolina,12-Aug-21,Regional,United States of America,USA,North Carolina,,15-Apr-20,15-Oct-20,Household and community samples,Multiple groups,103,28.00%,,,Convenience,"BioMedomics, Inc.,NA",Multiple Types,"IgM,IgG",,,High,Journal Article (Peer-Reviewed),Carla Cerami,University of North Carolina ,http://dx.doi.org/10.1093/cid/ciab701,15/09/2021,16/07/2022,Verified
210818_NewYork_SunRiverHealth,18-Aug-21,Regional,United States of America,USA,New York,,15-Jul-20,15-Sep-20,Health care workers and caregivers,Multiple groups,325,15.40%,,,Convenience,Roche Diagnostics,CLIA,Not reported,,,High,Journal Article (Peer-Reviewed),Anne Kauffman Nolon,Sun River Health,http://dx.doi.org/10.1097/JOM.0000000000002357,21/09/2021,16/07/2022,Unverified
210914_Louisville_UniversityofLouisville_July2020,14-Sep-21,Local,United States of America,USA,Kentucky,Louisville,06-Jul-20,20-Jul-20,Health care workers and caregivers,Adults (18-64 years),915,2.30%,,,Convenience,NA,ELISA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Krystal Hamorsky, University of Louisville,https://dx.doi.org/10.1038/s41598-021-97423-z,21/09/2021,16/07/2022,Unverified
210915_Monterey_UniversityofCalifornia_Primary,15-Sep-21,Regional,United States of America,USA,California,,16-Jul-20,30-Nov-20,Essential non-healthcare workers,Adults (18-64 years),1058,19.00%,,,Convenience,NA,ELISA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Ana M. Mora,"Universityof California,Berkeley",https://dx.doi.org/10.1001/jamanetworkopen.2021.24116,21/09/2021,16/07/2022,Unverified
210729_SouthernUSA_WalterReedArmyInstituteOfResearch_Timepoint3,29-Jul-21,Local,United States of America,USA,Southern United States,NR,18-Nov-20,03-Jan-21,Essential non-healthcare workers,Adults (18-64 years),1211,9.50%,7.90%,11.20%,Convenience,Ortho Clinical Diagnostics Inc.,CLIA,Total Antibody,,,High,Journal Article (Peer-Reviewed),Shilpa Hakre,Walter Reed Army Institute of Research,https://dx.doi.org/10.1093/ofid/ofab407,24/09/2021,16/07/2022,Unverified
210731_Wisconsin_CentersforDiseaseControlandPrevention_1September,31-Jul-21,Regional,United States of America,USA,Wisconsin,,01-Sep-20,04-Sep-20,Students and Daycares,Adults (18-64 years),517,4.06%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Hannah Segaloff,Centers for Disease Control and Prevention,https://dx.doi.org/10.1093/ofid/ofab405,29/09/2021,16/07/2022,Unverified
210731_Wisconsin_CentersforDiseaseControlandPrevention_2November,31-Jul-21,Regional,United States of America,USA,Wisconsin,,09-Nov-20,13-Nov-20,Students and Daycares,Adults (18-64 years),413,18.64%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Hannah Segaloff,Centers for Disease Control and Prevention,https://dx.doi.org/10.1093/ofid/ofab405,29/09/2021,16/07/2022,Unverified
210913_UnitedStates_AirForceResearchLaboratory,13-Sep-21,Local,United States of America,USA,Ohio,,23-Jul-20,23-Oct-20,Household and community samples,Multiple groups,582,3.09%,,,Convenience,NA,Multiple Types,"IgM,IgG,IgA",,,High,Journal Article (Peer-Reviewed),Amy Breedon,"Air Force Research Laboratory, Wright-Patterson Air Force Base",https://dx.doi.org/10.3389/fmed.2021.749732,05/10/2021,16/07/2022,Verified
210924_Michigan_UniversityOfMichigan_BeforeDec14_Overall,24-Sep-21,Local,United States of America,USA,Michigan,,27-Apr-20,13-Dec-20,Household and community samples,Multiple groups,8026,9.20%,,,Unclear,NA,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),Zhangchen Zhao,University of Michigan,http://dx.doi.org/10.3390/jcm10194341,07/10/2021,16/07/2022,Verified
210924_Michigan_UniversityOfMichigan_AfterDec14_Overall,24-Sep-21,Local,United States of America,USA,Michigan,,14-Dec-20,03-May-21,Household and community samples,Multiple groups,2024,36.20%,,,Unclear,NA,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),Zhangchen Zhao,University of Michigan,http://dx.doi.org/10.3390/jcm10194341,07/10/2021,16/07/2022,Verified
211001_UnitedStates_OchsnerHealth,01-Oct-21,Local,United States of America,USA,Louisiana,New Orleans,01-Mar-20,01-May-20,Multiple populations,Adults (18-64 years),13343,7.99%,7.53%,8.45%,Convenience,Abbott Laboratories,CLIA,IgG,100.00%,99.63%,High,Journal Article (Peer-Reviewed),Edmond Kabagambe,Ochsner Health,https://dx.doi.org/10.1016/j.amjms.2021.09.006,12/10/2021,16/07/2022,Unverified
211002_UnitedStates_CohenChildrensMedicalCenter,02-Oct-21,Local,United States of America,USA,New York,New York City,01-May-20,30-Nov-20,Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),262,13.00%,,,Convenience,"Abbott Laboratories,DiaSorin,EUROIMMUN,Roche Diagnostics",Multiple Types,IgG,,,High,Journal Article (Peer-Reviewed),Heather Walters ,"Cohen Children’s Medical Center,",https://dx.doi.org/10.1093/rheumatology/keab730,12/10/2021,16/07/2022,Unverified
211002_NewYork_NorthShoreUniversityHospital_Delivery,02-Oct-21,Local,United States of America,USA,New York,,15-Oct-20,15-Nov-20,Pregnant or parturient women,Adults (18-64 years),149,14.10%,,,Sequential,Roche Diagnostics,CLIA,IgG,,,High,Preprint,Cara Staszewski,North Shore University Hospital,https://dx.doi.org/10.1016/j.ajog.2021.09.037,14/10/2021,16/07/2022,Verified
211001_NewYorkCity_NorthShoreUniversityHospital_Overall,01-Oct-21,Local,United States of America,USA,New York,New York City,01-Mar-20,31-Aug-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,812,2.33%,,,Convenience,,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),Janice Wang,North Shore University Hospital,http://dx.doi.org/10.1016/j.chest.2021.07.1326,19/10/2021,28/10/2021,Unverified
211011_NewYork_ChildrensHospitalAtMontefiore,11-Oct-21,Local,United States of America,USA,New York,New York,15-Apr-20,15-Dec-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,108,11.10%,,,Convenience,Eurofins-Viracor ,ELISA,"IgG,IgM",,100.00%,High,Journal Article (Peer-Reviewed),Neha Bansal,Childrens Hospital at Montefiore,https://dx.doi.org/10.1111/petr.14156,19/10/2021,16/07/2022,Unverified
211012_Colorado_UniversityofColorado_Followup_TestAdjusted,12-Oct-21,Regional,United States of America,USA,Colorado,,15-May-20,15-Mar-21,Essential non-healthcare workers,Adults (18-64 years),783,20.00%,,,Convenience,"Abbott Laboratories,EUROIMMUN",Multiple Types,"IgG,IgA",,,Moderate,Journal Article (Peer-Reviewed),Brian Montague,University of Colorado,https://dx.doi.org/10.1093/infdis/jiab524,19/10/2021,16/07/2022,Unverified
210917_Lakewood_JointBaseLewisMcChord_Overall,17-Sep-21,Local,United States of America,USA,Washington,Lakewood,15-Jun-20,15-Sep-20,Essential non-healthcare workers,Adults (18-64 years),264,0.40%,,,Unclear,Roche Diagnostics,CLIA,Not reported,,,High,Journal Article (Peer-Reviewed),Alex Koo,Joint Base Lewis McChord,https://pubmed.ncbi.nlm.nih.gov/34529807/,19/10/2021,16/07/2022,Unverified
211009_UnitedStates_AmericanRedCross_Overall_S1,09-Oct-21,National,United States of America,USA,,,07-Dec-20,25-Jun-21,Blood donors,Multiple groups,1567446,60.07%,,,Convenience,Ortho Clinical Diagnostics Inc.,CLIA,Total Antibody,,,Moderate,Journal Article (Peer-Reviewed),Roger Dodd,American Red Cross,https://dx.doi.org/10.1093/infdis/jiab514,19/10/2021,16/07/2022,Verified
211001_Charleston_WestVirginiaUniversity_HCW,01-Oct-21,Local,United States of America,USA,West Virginia,Charleston,15-Sep-20,15-Dec-20,Health care workers and caregivers,Adults (18-64 years),458,10.00%,,,Unclear,NA,Not reported,IgG,,,Unclear,Presentation or Conference,Syed Mahmood,West Virginia University,https://www.sciencedirect.com/science/article/pii/S0012369221020201,20/10/2021,16/07/2022,Unverified
211001_Charleston_WestVirginiaUniversity_CEW,01-Oct-21,Local,United States of America,USA,West Virginia,Charleston,15-Sep-20,15-Dec-20,Essential non-healthcare workers,Adults (18-64 years),623,5.80%,,,Unclear,NA,Not reported,IgG,,,Unclear,Presentation or Conference,Syed Mahmood,West Virginia University,https://www.sciencedirect.com/science/article/pii/S0012369221020201,20/10/2021,16/07/2022,Unverified
210801_SouthBronx_MountSinai_primary,01-Aug-21,Local,United States of America,USA,New York,New York City,01-May-20,31-May-20,Health care workers and caregivers,Adults (18-64 years),501,28.40%,,,Convenience,NA,ELISA,IgG,95.00%,100.00%,High,Journal Article (Peer-Reviewed),Juan Manuel Carreno,Icahn School of Medicine at Mount Sinai,https://www.cell.com/iscience/fulltext/S2589-0042(21)00905-6?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS2589004221009056%3Fshowall%3Dtrue,22/10/2021,16/07/2022,Unverified
211018_WRNMMC_UniformedServicesUniversity,18-Oct-21,Local,United States of America,USA,Maryland,Bethesda,01-Feb-21,15-Aug-21,Health care workers and caregivers,Adults (18-64 years),17,23.53%,,,Convenience,NA,ELISA,IgG,94.00%,100.00%,High,Preprint,Eric Laing,Uniformed Services University,https://www.medrxiv.org/content/10.1101/2021.10.16.21265087v1,26/10/2021,16/07/2022,Unverified
211021_OrangeCounty_Children’sHospitalofOrangeCounty_Overall,21-Oct-21,Local,United States of America,USA,California,NA,14-May-20,13-Jul-20,Health care workers and caregivers,Adults (18-64 years),282,0.30%,,,Convenience,"Superbio Biomedical Company ,Abbott Laboratories",Multiple Types,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Theodore Heyming,Children’s Hospital of Orange County,https://dx.doi.org/10.3390/idr13040082,02/11/2021,16/07/2022,Unverified
211026_NewYorkCity_MountSinaiHealthSystem_Phase2_Overall_Spike,26-Oct-21,Local,United States of America,USA,New York,New York,15-Aug-20,15-Sep-20,Health care workers and caregivers,Adults (18-64 years),176,38.64%,,,Convenience,NA,ELISA,IgG,94.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Vidya Menon,Mount Sinai Health System,https://dx.doi.org/10.1136/bmjopen-2021-051045,04/11/2021,16/07/2022,Unverified
201027_Vermont_UniversityOfVermont_Student_Primary,27-Oct-21,Local,United States of America,USA,Vermont,,02-Dec-20,19-Dec-20,Students and Daycares,Children and Youth (0-17 years),196,4.90%,2.00%,9.30%,Convenience,NA,ELISA,IgG,95.00%,99.00%,High,Journal Article (Peer-Reviewed),Sean S M Bullis,University of Vermont,https://dx.doi.org/10.1136/bmjpo-2021-001259,08/11/2021,16/07/2022,Unverified
201027_Vermont_UniversityOfVermont_Staff_Primary,27-Oct-21,Local,United States of America,USA,Vermont,,02-Dec-20,19-Dec-20,Students and Daycares,Adults (18-64 years),336,4.60%,2.50%,7.70%,Convenience,NA,ELISA,IgG,95.00%,99.00%,High,Journal Article (Peer-Reviewed),Sean S M Bullis,University of Vermont,https://dx.doi.org/10.1136/bmjpo-2021-001259,08/11/2021,16/07/2022,Unverified
211103_NewYorkCity_NewYorkCityHealthandHospitals_Overall,03-Nov-21,Local,United States of America,USA,New York ,New York ,30-Apr-20,30-Jun-20,Health care workers and caregivers,Multiple groups,727,29.44%,,,Convenience,NA,Not reported,Not reported,,,High,Journal Article (Peer-Reviewed),Alexander Bryan,New York City Health and hospitals,https://dx.doi.org/10.1136/bmjopen-2021-053158,08/11/2021,16/07/2022,Unverified
211030_Massachusetts_UniversityofMassachusetts,30-Oct-21,Regional,United States of America,USA,Massachusetts,,15-Nov-19,15-Dec-20,Perinatal,Children and Youth (0-17 years),72117,1.75%,,,Convenience,NA,ELISA,IgG,,,Unclear,Preprint,Kevin Ma,University of Massachusetts,https://www.medrxiv.org/content/10.1101/2021.10.29.21265678v1.full-text,09/11/2021,16/07/2022,Unverified
211104_Bronx_MontefioreMedicalCenter,04-Nov-21,Local,United States of America,USA,New York,New York,03-May-21,05-May-21,Patients seeking care for non-COVID-19 reasons,Multiple groups,1164,17.10%,,,Unclear,NA,Not reported,IgG,,,Unclear,Presentation or Conference,Yorg Azzi,Montefiore Medical Center,http://dx.doi.org/10.1681/asn.2020030362,10/11/2021,16/07/2022,Unverified
210605_Bronx_MontefioreMedicalCenter,05-Jun-21,Local,United States of America,USA,New York,New York,03-May-20,30-Nov-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,1042,15.74%,,,Unclear,NA,Not reported,IgG,,,Unclear,Presentation or Conference,Yorg Azzi,Montefiore Medical Center,https://atcmeetingabstracts.com/abstract/prevalence-and-dynamics-of-sars-cov-2-igg-in-kidney-transplant-recipients/,11/11/2021,16/07/2022,Unverified
210604_NewYorkCity_LiveOnNY,04-Jun-21,Local,United States of America,USA,New York,New York City,16-Mar-20,02-Dec-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,208,3.37%,,,Unclear,NA,Not reported,Not reported,,,Unclear,Presentation or Conference,Amy Friedman,LiveOnNY,https://atcmeetingabstracts.com/abstract/covid-studies-in-208-patients-with-consent-for-donation/,11/11/2021,16/07/2022,Unverified
211108_Virginia_InovaHealthSystem,08-Nov-21,Regional,United States of America,USA,Virginia,,31-Jul-20,13-Oct-20,Multiple general populations,Children and Youth (0-17 years),1038,8.50%,6.90%,10.30%,Convenience,Ortho Clinical Diagnostics Inc.,CLIA,Total Antibody,,,Moderate,Journal Article (Peer-Reviewed),Rebecca Levorson,Inova Health System,https://dx.doi.org/10.1371/journal.pone.0259823,15/11/2021,16/07/2022,Verified
211109_Denver_CentersforDiseaseControlandPrevention_CommunitySurvey_Overall,09-Nov-21,Regional,United States of America,USA,Colorado,Denver,22-Jul-20,08-Aug-20,Household and community samples,Multiple groups,381,8.00%,3.90%,15.70%,Stratified probability,Ortho Clinical Diagnostics Inc.,CLIA,Total Antibody,93.20%,99.00%,Moderate,Journal Article (Peer-Reviewed),Kiersten Kugeler,Centers for Disease Control and Prevention,https://dx.doi.org/10.1177/00333549211055137,16/11/2021,16/07/2022,Verified
210908_SanFrancisco_UniversityofCalifornia_overall,08-Sep-21,Local,United States of America,USA,California,San Francisco,15-Jun-20,02-Jul-20,Essential non-healthcare workers,Adults (18-64 years),1231,0.24%,0.05%,0.71%,Convenience,"Abbott Laboratories,DiaSorin",CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Megan Grant,University of California,https://dx.doi.org/10.1097/JOM.0000000000002383,17/11/2021,16/07/2022,Unverified
211021_EssexCounty_RutgersUniversity_Overall,08-Nov-21,Local,United States of America,USA,New Jersey,,15-Sep-20,22-Dec-20,Household and community samples,Multiple groups,924,8.98%,,,Convenience,NA,ELISA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Henry Raymond,Rutgers University,https://dx.doi.org/10.1007/s40615-021-01175-5,17/11/2021,16/07/2022,Verified
211104_OrangeCounty_UniversityofCaliforniaIrvine_2_HCW_May_Multiplex,04-Nov-21,Local,United States of America,USA,California,Inrvine,01-May-20,31-May-20,Health care workers and caregivers,Adults (18-64 years),1060,4.00%,,,Convenience,NA,ELISA,IgG,,,Unclear,Journal Article (Peer-Reviewed),Rafael Assis,University of California Irvine,https://dx.doi.org/10.1038/s41541-021-00396-3,18/11/2021,16/07/2022,Unverified
211104_OrangeCounty_UniversityofCaliforniaIrvine_1_SantaAna_Multiplex,04-Nov-21,Local,United States of America,USA,California,Santa Ana,01-Dec-20,30-Dec-20,Household and community samples,Multiple groups,3347,26.00%,,,Stratified probability,NA,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Rafael Assis,University of California Irvine,https://dx.doi.org/10.1038/s41541-021-00396-3,18/11/2021,16/07/2022,Unverified
211104_OrangeCounty_UniversityofCaliforniaIrvine_3_HCW_December_Multiplex,04-Nov-21,Local,United States of America,USA,California,Irvine,01-Dec-20,30-Dec-20,Health care workers and caregivers,Adults (18-64 years),313,11.00%,,,Convenience,NA,ELISA,IgG,,,Unclear,Journal Article (Peer-Reviewed),Rafael Assis,University of California Irvine,https://dx.doi.org/10.1038/s41541-021-00396-3,18/11/2021,16/07/2022,Unverified
211109_Denver_CentersforDiseaseControlandPrevention_ClinicalResidualSera_Overall,09-Nov-21,Regional,United States of America,USA,Colorado,,22-Jul-20,08-Aug-20,Residual sera,Multiple groups,1598,6.80%,5.00%,9.20%,Convenience,Ortho Clinical Diagnostics Inc.,CLIA,Total Antibody,93.20%,99.00%,Moderate,Journal Article (Peer-Reviewed),Kiersten Kugeler,Centers for Disease Control and Prevention,https://dx.doi.org/10.1177/00333549211055137,19/11/2021,16/07/2022,Verified
200515_Boston_BostonPublicHealthCommission,18-May-20,Local,United States of America,USA,Massachusetts,Boston,,15-May-20,Household and community samples,,750,9.90%,,,Unclear,NA,LFIA,,,,High,News and Media,City of Boston,Boston Public Health Commission ,https://www.boston.gov/news/results-released-antibody-and-covid-19-testing-boston-residents,23/11/2021,16/07/2022,Unverified
210430_StLouis_WashingtonUniversityinStLouis_Overall,30-Apr-21,Local,United States of America,USA,Missouri,St. Louis,29-Aug-20,19-Sep-20,Residual sera,Multiple groups,393,3.60%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Kwaku Tawiah,Washington University in St. Louis,https://doi.org/10.1093/jalm/jfab021,30/11/2021,16/07/2022,Verified
211110_PalmBeachCounty_FloridaDepartmentofHealth_overall,10-Nov-21,Local,United States of America,USA,Florida,"Lantana, West Palm Beach, Delray Beach, Belle Glade",29-Jun-20,05-Aug-20,Pregnant or parturient women,Adults (18-64 years),618,26.40%,,,Convenience,Abbott Laboratories,CLIA,IgG,100.00%,99.60%,Moderate,Journal Article (Peer-Reviewed),Charles Gonik,Wayne State University School of Medicine,https://dx.doi.org/10.1055/s-0041-1739353,01/12/2021,16/07/2022,Unverified
211122_OrangeCounty_UniversityofCalifornia_Primary,22-Nov-21,Local,United States of America,USA,California,,01-May-20,30-Jun-20,Health care workers and caregivers,Adults (18-64 years),654,13.30%,,,Convenience,"NA,Diazyme Laboratories Inc,Beckman Coulter,Abbott Laboratories",Multiple Types,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Shruti Gohil,University of California,https://dx.doi.org/10.1186/s13756-021-01031-5,01/12/2021,16/07/2022,Unverified
211121_NewYorkCity_ IcahnSchoolofMedicine,21-Nov-21,Local,United States of America,USA,New York,New York City,20-Apr-20,22-Sep-20,Pregnant or parturient women,Adults (18-64 years),708,16.40%,13.70%,19.30%,Convenience,NA,ELISA,IgG,95.00%,100.00%,High,Journal Article (Peer-Reviewed),Nina Molenaar, Icahn School of Medicine,https://dx.doi.org/10.1111/ppe.12812,02/12/2021,16/07/2022,Verified
211202_Philadelphia_UniversityofPennsylvania_Overall,02-Dec-21,Local,United States of America,USA,Pennsylvania,Philadelphia,20-Apr-20,04-Nov-20,Health care workers and caregivers,Multiple groups,1740,5.30%,,,Convenience,Beijing Wantai Biological,ELISA,"IgM,IgG",100.00%,98.90%,Moderate,Journal Article (Peer-Reviewed),Brian T Fisher,University of Pennsylvania,https://dx.doi.org/10.1017/ice.2021.487,06/12/2021,16/07/2022,Unverified
210501_Ithaca_CornellUniversity_Primary_AntiRBD,01-May-21,Local,United States of America,USA,New York,Ithaca,01-Jun-20,15-Jun-20,Household and community samples,Multiple groups,332,5.10%,,,Unclear,NA,Not reported,"IgG,IgM,IgA",,,High,Journal Article (Peer-Reviewed),Cassandra Guarino,Cornell University,https://www.jimmunol.org/content/206/1_Supplement/114.11?ct=&utm_source=TrendMD&utm_medium=cpc&utm_campaign=J_Immunol_TrendMD_1,08/12/2021,16/07/2022,Unverified
211128_SanFrancisco_UniversityofCalifornia_Round3,28-Nov-21,Regional,United States of America,USA,California,,15-Feb-21,15-Apr-21,Household and community samples,Multiple groups,4641,31.30%,,,Convenience,"Ortho Clinical Diagnostics Inc.,NA",Multiple Types,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Marcus Wong,University of California,https://www.medrxiv.org/content/10.1101/2021.11.25.21266786v1.full-text,09/12/2021,16/07/2022,Verified
211207_MayoClinicRochester_MayoClinic,07-Dec-21,Local,United States of America,USA,Minnesota,Rochester,01-Nov-19,31-Dec-20,Residual sera,Multiple groups,556,3.24%,,,Convenience,Roche Diagnostics,CLIA,Total Antibody,,,High,Journal Article (Peer-Reviewed),Cristina Sanchez,Mayo Clinic,http://dx.doi.org/10.1212/WNL.0000000000012931,13/12/2021,16/07/2022,Verified
211207_Philadelphia_ThomasJeffersonUniversity,07-Dec-21,Local,United States of America,USA,Pennsylvania,Philadelphia,01-Apr-20,28-Feb-21,Pregnant or parturient women,Adults (18-64 years),76,20.00%,,,Convenience,Meso Scale Discovery,Not reported,"IgG,IgM",,,High,Preprint,Rupsa Boelig,Thomas Jefferson University,https://www.medrxiv.org/content/10.1101/2021.12.06.21267328v1.full-text,15/12/2021,16/07/2022,Unverified
211205_CaliforniaBayArea_UniversityofCalifornia_Round3_primary,05-Dec-21,Regional,United States of America,USA,California,,11-Feb-21,20-Mar-21,Household and community samples,Multiple groups,4608,27.56%,22.84%,33.55%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,NA",Multiple Types,"Total Antibody,IgG",,,Moderate,Preprint,Cameron Adams,"University of California, Berkeley",https://www.medrxiv.org/content/10.1101/2021.12.02.21266871v1.full-text,16/12/2021,16/07/2022,Verified
211210_California_SutterHealth_Overall,10-Dec-21,Regional,United States of America,USA,California,,01-Oct-20,31-Dec-20,Pregnant or parturient women,Adults (18-64 years),4500,8.10%,,,Convenience,Siemens,CLIA,Total Antibody,100.00%,99.80%,Moderate,Journal Article (Peer-Reviewed),Alice Pressman,Sutter Health,https://dx.doi.org/10.1177/17455065211063300,03/01/2022,16/07/2022,Verified
220101_Philadelphia_ChildrensHospitalofPhiladelphia,01-Jan-22,Local,United States of America,USA,Pennsylvania,Philadelphia,15-Apr-20,15-Dec-20,Pregnant or parturient women,Adults (18-64 years),6192,9.17%,,,Convenience,NA,ELISA,"IgG,IgM",,,Moderate,Presentation or Conference,Jourdan Triebwasser,Children’s Hospital of Philadelphia,https://dx.doi.org/10.1016/j.ajog.2021.11.092,10/01/2022,16/07/2022,Unverified
211102_Seattle_UniversityOfWashington_Baseline,02-Nov-21,Local,United States of America,USA,Washington,Seattle,20-Jul-20,28-Feb-21,Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),125,4.00%,,,Convenience,NA,Not reported,IgG,,,High,Presentation or Conference,Georgene Hergenroeder,University of Washington,https://dx.doi.org/10.1016/S1569-1993%2821%2901450-8,10/01/2022,16/07/2022,Unverified
211006_UnitedStates_UniversityofMinnesota_PostexposureProphylaxis,06-Oct-21,National,United States of America,USA,,,17-Mar-20,20-May-20,Multiple populations,Multiple groups,266,11.00%,,,Convenience,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Sarah Lofgren,University of Minnesota,https://academic.oup.com/ofid/article/8/11/ofab506/6382457?login=true,11/01/2022,16/07/2022,Unverified
211006_UnitedStates_UniversityofMinnesota_EarlyTreatment,06-Oct-21,National,United States of America,USA,,,17-Mar-20,20-May-20,Multiple populations,Multiple groups,123,29.00%,,,Convenience,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Sarah Lofgren,University of Minnesota,https://academic.oup.com/ofid/article/8/11/ofab506/6382457?login=true,11/01/2022,16/07/2022,Unverified
211006_UnitedStates_UniversityofMinnesota_Pre-exposureProphylaxis,06-Oct-21,National,United States of America,USA,,,06-Apr-20,13-Jul-20,Multiple populations,Multiple groups,542,4.00%,,,Convenience,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Sarah Lofgren,University of Minnesota,https://academic.oup.com/ofid/article/8/11/ofab506/6382457?login=true,11/01/2022,16/07/2022,Unverified
211227_Chicago_NorthwesternUniversity,27-Dec-21,Local,United States of America,USA,Illinois,Chicago,26-May-20,10-Jul-20,Health care workers and caregivers,Adults (18-64 years),4180,4.31%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Charlesnika Evans,Northwestern University Feinberg School of Medicine,https://dx.doi.org/10.1017/ice.2021.523,12/01/2022,16/07/2022,Unverified
122221_MaricopaCounty_ArizonaStateUniversity_popadj,22-Dec-21,Local,United States of America,USA,Arizona,,12-Sep-20,01-Oct-20,Household and community samples,Multiple groups,260,14.00%,7.20%,24.00%,Stratified probability,Roche Diagnostics,CLIA,Total Antibody,99.80%,99.50%,Moderate,Journal Article (Peer-Reviewed),Megan Jehn,Arizona State University,https://dx.doi.org/10.2105/AJPH.2021.306568,13/01/2022,16/07/2022,Verified
220110_NewYork_F.Hoffmann-LaRocheLtd_Overall,10-Jan-22,Local,United States of America,USA,New York,New York,06-Jan-21,21-Jul-21,Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),212,10.80%,,,Convenience,Roche Diagnostics,CLIA,Total Antibody,81.00%,,High,Preprint,Ilya Kister,F. Hoffmann-La Roche Ltd,https://www.medrxiv.org/content/10.1101/2022.01.10.22268752v1.full-text,18/01/2022,16/07/2022,Unverified
220120_LosAngelesCounty_UniversityOfSouthernCalifornia_Overall,20-Jan-22,Local,United States of America,USA,California,,09-Apr-21,25-Apr-21,Household and community samples,Multiple groups,1335,66.90%,64.40%,69.40%,Stratified probability,Luminex Corporation,Luminex,Not reported,,,Moderate,Journal Article (Peer-Reviewed),Neeraj Sood,University of Southern California,https://dx.doi.org/10.1001/jamanetworkopen.2021.44258,24/01/2022,16/07/2022,Verified
220119_JohnsHopkinsHospital_JohnsHopkinsUniversity_2021_Overall_All,19-Jan-22,Local,United States of America,USA,Maryland,Baltimore,11-Jan-21,10-Mar-21,Residual sera,Multiple groups,2824,23.83%,22.20%,25.40%,Convenience,"EUROIMMUN,Hangzhou Biotest Biotech Co Ltd",Multiple Types,"IgG,IgM",84.40%,100.00%,Moderate,Journal Article (Peer-Reviewed),Evan Beck,Johns Hopkins University,https://dx.doi.org/10.1128/jcm.02390-21,24/01/2022,16/07/2022,Unverified
220118_Denver_UniversityofColoradoDenver_Overall,18-Jan-22,Local,United States of America,USA,Colorado,Denver,02-Jun-20,28-Jul-20,Persons experiencing homelessness,Multiple groups,271,15.50%,,,Convenience,"Gold Standard Diagnostic,Beckman Coulter",Not reported,IgG,,,Unclear,Journal Article (Peer-Reviewed),Sarah Rowan,University of Colorado Denver,https://dx.doi.org/10.1093/cid/ciac039,25/01/2022,16/07/2022,Unverified
220121_Ohio_OhioStateUniversity_Primary,21-Jan-22,Regional,United States of America,USA,Ohio,,09-Jul-20,28-Jul-20,Household and community samples,Multiple groups,667,1.30%,0.20%,2.70%,Stratified probability,"Abbott Laboratories,DiaSorin,Epitope Diagnostics, Inc.",Other,"IgG,IgM",,,Moderate,Journal Article (Peer-Reviewed),Abigail Norris Turner,Ohio State University,https://dx.doi.org/10.1016/j.annepidem.2021.11.009,26/01/2022,16/07/2022,Unverified
220117_Maryland_JohnsHopkinsUniversitySchoolofMedicine_Residents,17-Jan-22,Local,United States of America,USA,Maryland,,01-Oct-20,16-Feb-21,Assisted living and long-term care facilities,Multiple groups,124,57.00%,,,Convenience,Salimetrics,ELISA,IgG,98.80%,100.00%,High,Journal Article (Peer-Reviewed),Morgan Katz,Johns Hopkins University School of Medicine ,https://dx.doi.org/10.1111/jgs.17660,26/01/2022,16/07/2022,Unverified
220117_Maryland_JohnsHopkinsUniversitySchoolofMedicine_Staff,17-Jan-22,Local,United States of America,USA,"Maryland
",,01-Oct-20,16-Feb-21,Health care workers and caregivers,Multiple groups,28,79.00%,,,Convenience,Salimetrics,ELISA,IgG,98.80%,100.00%,High,Journal Article (Peer-Reviewed),Morgan Katz,Johns Hopkins University School of Medicine ,https://dx.doi.org/10.1111/jgs.17660,26/01/2022,16/07/2022,Unverified
220125_UniversityofMissouri_UniversityofMissouri_Random,25-Jan-22,Local,United States of America,USA,Missouri,Columbia,15-Sep-20,15-Dec-20,Students and Daycares,Adults (18-64 years),833,14.89%,,,Stratified probability,NA,Not reported,Not reported,,,Moderate,Preprint,Tyler Myroniuk,University of Missouri,https://www.medrxiv.org/content/10.1101/2022.01.24.22269758v1.full-text,02/02/2022,16/07/2022,Unverified
220125_UniversityofMissouri_UniversityofMissouri_SelfReferral,25-Jan-22,Local,United States of America,USA,Missouri,Columbia,12-Oct-20,15-Dec-20,Students and Daycares,Adults (18-64 years),69,17.39%,,,Self-referral,NA,Not reported,Not reported,,,High,Preprint,Tyler Myroniuk,University of Missouri,https://www.medrxiv.org/content/10.1101/2022.01.24.22269758v1.full-text,02/02/2022,16/07/2022,Unverified
220124_LosAngeles_UniversityofSouthernCalifornia_PopAdj,24-Jan-22,Local,United States of America,USA,California,Los Angeles,20-Oct-20,28-Oct-20,Essential non-healthcare workers,Adults (18-64 years),686,9.30%,7.00%,11.70%,Convenience,Abbott Laboratories,Not reported,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Karen Mulligan,University of Southern California,https://dx.doi.org/10.1136/oemed-2021-107805,03/02/2022,16/07/2022,Unverified
220126_HillsboroughCounty_MoffittCancerCenter_Overall,26-Jan-22,Local,United States of America,USA,Florida,,15-Oct-20,15-Mar-21,Household and community samples,Multiple groups,867,19.50%,16.90%,22.30%,Stratified probability,NA,ELISA,IgG,96.80%,94.10%,Moderate,Journal Article (Peer-Reviewed),Anna Giuliano,Moffitt Cancer Center,https://dx.doi.org/10.3201/eid2803.211495,03/02/2022,16/07/2022,Unverified
220202_LakeCounty_UniversityofTexasMedicalBranch_Overall,02-Feb-22,Local,United States of America,USA,Illinois,,15-Nov-20,15-Jan-21,Household and community samples,Multiple groups,1008,4.50%,,,Convenience,Abbott Laboratories,CLIA,IgG,100.00%,99.60%,High,Journal Article (Peer-Reviewed),Ryan Kilpatrick,University of Texas Medical Branch,https://dx.doi.org/10.1007/s40121-022-00593-0,08/02/2022,16/07/2022,Verified
220117_ Milwaukee_AdvocateAuroraHealth_Overall,17-Jan-22,Local,United States of America,USA,Wisconsin,Milwaukee,15-Jun-20,15-Jul-20,Health care workers and caregivers,Adults (18-64 years),75,1.33%,0.00%,3.90%,Convenience,Abbott Laboratories,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),Dennis Baumgardner,Advocate Aurora Health,https://dx.doi.org/10.17294/2330-0698.1846,10/02/2022,16/07/2022,Unverified
220203_USA_JohnsHopkinsUniversity_noCOVID_Spike,03-Feb-22,National,United States of America,USA,,,24-Sep-21,05-Nov-21,Household and community samples,Adults (18-64 years),246,10.57%,,,Convenience,Roche Diagnostics,Not reported,Not reported,,,High,Journal Article (Peer-Reviewed),Jennifer Alejo,Johns Hopkins University,https://dx.doi.org/10.1001/jama.2022.1393,10/02/2022,16/07/2022,Unverified
220119_GeorgeWashingtonUniversityHospital_UniversityofNorthCarolina,19-Jan-22,Local,United States of America,USA,,Washington DC,15-Jun-20,15-Mar-21,Health care workers and caregivers,Adults (18-64 years),237,12.66%,,,Convenience,NA,Not reported,Not reported,,,High,Journal Article (Peer-Reviewed),Tara Narowski,University of North Carolina,https://dx.doi.org/10.1016/j.celrep.2022.110336,10/02/2022,16/07/2022,Unverified
220207_Indiana_IndianaUniversitySchoolofPublicHealth-Bloomington_Baseline,07-Feb-22,Local,United States of America,USA,Indiana,Bloomington,14-Sep-20,30-Sep-20,Students and Daycares,Adults (18-64 years),1076,4.55%,,,Simplified probability,BGI Genomics,LFIA,"IgG,IgM",64.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Sina Kianersi,Indiana University School of Public Health-Bloomington,https://dx.doi.org/10.1111/add.15835,18/02/2022,16/07/2022,Unverified
220207_Indiana_IndianaUniversitySchoolofPublicHealth-Bloomington_Cohort,07-Feb-22,Local,United States of America,USA,Indiana,Bloomington,28-Sep-20,23-Nov-20,Household and community samples,Adults (18-64 years),808,5.20%,,,Simplified probability,BGI Genomics,LFIA,"IgG,IgM",64.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Sina Kianersi,Indiana University School of Public Health-Bloomington,https://dx.doi.org/10.1111/add.15835,18/02/2022,16/07/2022,Unverified
220202_SanFrancisco_UniversityofCalifornia_6months_Overall,02-Feb-22,Local,United States of America,USA,California,San Francisco,01-Mar-21,31-Mar-21,Health care workers and caregivers,Adults (18-64 years),134,2.20%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Ralph Wang,University of California,https://dx.doi.org/10.1016/j.ajem.2022.01.055,22/02/2022,16/07/2022,Unverified
220130_USA_CentersforDiseaseControlandPrevention_NV_May2021,30-Jan-22,Regional,United States of America,USA,Nevada,,01-May-21,31-May-21,Residual sera,Children and Youth (0-17 years),237,30.40%,20.60%,36.90%,Convenience,Roche Diagnostics,CLIA,"IgA,IgG,IgM",,,High,Journal Article (Peer-Reviewed),Alexia Couture,Centers for Disease Control and Prevention,https://doi.org/10.1093/ofid/ofac044,24/02/2022,16/07/2022,Unverified
220130_USA_CentersforDiseaseControlandPrevention_NJ_May2021,30-Jan-22,Regional,United States of America,USA,New Jersey,,01-May-21,31-May-21,Residual sera,Children and Youth (0-17 years),393,44.00%,38.40%,50.20%,Convenience,Roche Diagnostics,CLIA,"IgA,IgG,IgM",,,High,Journal Article (Peer-Reviewed),Alexia Couture,Centers for Disease Control and Prevention,https://doi.org/10.1093/ofid/ofac044,24/02/2022,16/07/2022,Unverified
220130_USA_CentersforDiseaseControlandPrevention_NC_May2021,30-Jan-22,Regional,United States of America,USA,North Carolina,,01-May-21,31-May-21,Residual sera,Children and Youth (0-17 years),648,26.30%,20.80%,32.30%,Convenience,Roche Diagnostics,CLIA,"IgA,IgG,IgM",,,Moderate,Journal Article (Peer-Reviewed),Alexia Couture,Centers for Disease Control and Prevention,https://doi.org/10.1093/ofid/ofac044,24/02/2022,16/07/2022,Unverified
220130_USA_CentersforDiseaseControlandPrevention_CA_May2021,30-Jan-22,Regional,United States of America,USA,California,,01-May-21,31-May-21,Residual sera,Children and Youth (0-17 years),651,43.70%,38.80%,50.90%,Convenience,Roche Diagnostics,CLIA,"IgA,IgG,IgM",,,Moderate,Journal Article (Peer-Reviewed),Alexia Couture,Centers for Disease Control and Prevention,https://doi.org/10.1093/ofid/ofac044,24/02/2022,16/07/2022,Unverified
220130_USA_CentersforDiseaseControlandPrevention_OH_May2021,30-Jan-22,Regional,United States of America,USA,Ohio,,01-May-21,31-May-21,Residual sera,Children and Youth (0-17 years),627,37.00%,29.40%,41.70%,Convenience,Roche Diagnostics,CLIA,"IgA,IgG,IgM",,,Moderate,Journal Article (Peer-Reviewed),Alexia Couture,Centers for Disease Control and Prevention,https://doi.org/10.1093/ofid/ofac044,24/02/2022,16/07/2022,Unverified
220130_USA_CentersforDiseaseControlandPrevention_SC_May2021,30-Jan-22,Regional,United States of America,USA,South Carolina,,01-May-21,31-May-21,Residual sera,Children and Youth (0-17 years),618,34.80%,29.50%,40.90%,Convenience,Roche Diagnostics,CLIA,"IgA,IgG,IgM",,,Moderate,Journal Article (Peer-Reviewed),Alexia Couture,Centers for Disease Control and Prevention,https://doi.org/10.1093/ofid/ofac044,24/02/2022,16/07/2022,Unverified
220130_USA_CentersforDiseaseControlandPrevention_IL_May2021,30-Jan-22,Regional,United States of America,USA,Illinois,,01-May-21,31-May-21,Residual sera,Children and Youth (0-17 years),942,41.50%,35.30%,46.90%,Convenience,Roche Diagnostics,CLIA,"IgA,IgG,IgM",,,Moderate,Journal Article (Peer-Reviewed),Alexia Couture,Centers for Disease Control and Prevention,https://doi.org/10.1093/ofid/ofac044,24/02/2022,16/07/2022,Unverified
220130_USA_CentersforDiseaseControlandPrevention_TN_May2021,30-Jan-22,Regional,United States of America,USA,Tennessee,,01-May-21,31-May-21,Residual sera,Children and Youth (0-17 years),192,36.50%,27.50%,46.30%,Convenience,Roche Diagnostics,CLIA,"IgA,IgG,IgM",,,High,Journal Article (Peer-Reviewed),Alexia Couture,Centers for Disease Control and Prevention,https://doi.org/10.1093/ofid/ofac044,24/02/2022,16/07/2022,Unverified
220210_SpaceX_LondonSchoolOfHygiene&TropicalMedicine_TestAdj,10-Feb-22,Local,United States of America,USA,"California, Florida, Texas, and Washington State.",,29-Mar-20,23-Aug-20,Non-essential workers and unemployed persons,Multiple groups,4411,8.20%,7.30%,9.10%,Convenience,NA,ELISA,IgG,82.40%,99.60%,High,Journal Article (Peer-Reviewed),Emilie Finch,London School of Hygiene & Tropical Medicine,https://dx.doi.org/10.1371/journal.pbio.3001531,24/02/2022,16/07/2022,Unverified
220214_Atlanta_EmoryUniversity_Follow-up_Overall,14-Feb-22,Local,United States of America,USA,Georgia,Atlanta,06-May-20,12-Jun-20,Health care workers and caregivers,Adults (18-64 years),304,8.60%,,,Convenience,NA,ELISA,IgG,86.70%,99.30%,High,Journal Article (Peer-Reviewed),Jessica Howard-Anderson,Emory University,https://dx.doi.org/10.1017/ice.2021.518,24/02/2022,16/07/2022,Unverified
220207_USA_CentersforDiseaseControlandPrevention_202116_Overall_Anti-S,07-Feb-22,National,United States of America,USA,,,01-Jun-21,30-Jun-21,Blood donors,Multiple groups,133000,87.30%,87.00%,87.60%,Convenience,Ortho Clinical Diagnostics Inc.,CLIA,Total Antibody,,,Moderate,Journal Article (Peer-Reviewed),Zheng Li,Centers for Disease Control and Prevention,https://dx.doi.org/10.1093/cid/ciac105,25/02/2022,16/07/2022,Verified
220201_ParkRidge_AdvocateLutheranGeneralHospital_Dec2020_Overall,01-Feb-22,Local,United States of America,USA,Illinois,Park Ridge,01-Dec-20,31-Dec-20,Health care workers and caregivers,Multiple groups,458,8.50%,,,Convenience,Abbott Laboratories,CLIA,IgG,98.70%,99.20%,High,Journal Article (Peer-Reviewed),Eli Ehrenpreis,Advocate Lutheran General Hospital,https://dx.doi.org/10.3390/healthcare10020285,07/03/2022,16/07/2022,Unverified
220121_NewYork_UniversityOfOxford,21-Jan-22,Local,United States of America,USA,,New York,26-May-20,24-Sep-21,Patients seeking care for non-COVID-19 reasons,Multiple groups,235,8.94%,,,Convenience,"Roche Diagnostics,Siemens",Not reported,Total Antibody,,,High,Presentation or Conference,S Y Wong,University of Oxford,https://dx.doi.org/10.1093/ecco-jcc/jjab232.469,08/03/2022,16/07/2022,Unverified
220214_Bethesda_UniformedServicesUniversityoftheHealthSciences,14-Feb-22,Local,United States of America,USA,Maryland,Betheseda,25-Aug-20,31-Dec-20,Health care workers and caregivers,Multiple groups,263,4.18%,,,Convenience,NA,Other,IgG,94.00%,100.00%,High,Journal Article (Peer-Reviewed),Emilie Goguet,Uniformed Services University of the Health Sciences,https://dx.doi.org/10.1093/ofid/ofac030,08/03/2022,16/07/2022,Unverified
220219_USA_LombardiComprehensiveCancerCenter_Patients,19-Feb-22,Regional,United States of America,USA,New Jersey,"Washington DC, Hackensack",15-Apr-20,15-Jul-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,733,3.10%,2.00%,4.70%,Convenience,"NA,Roche Diagnostics",Multiple Types,Total Antibody,,,Moderate,Journal Article (Peer-Reviewed),Catherine Lai,Lombardi Comprehensive Cancer Center,https://dx.doi.org/10.1155/2022/8798306,09/03/2022,16/07/2022,Unverified
220219_USA_LombardiComprehensiveCancerCenter_HCW,19-Feb-22,Regional,United States of America,USA,New Jersey,"Washington DC, Hackensack",15-Apr-20,15-Jul-20,Health care workers and caregivers,Multiple groups,1220,3.70%,2.70%,4.90%,Convenience,"NA,Roche Diagnostics",Multiple Types,Total Antibody,,,Moderate,Journal Article (Peer-Reviewed),Catherine Lai,Lombardi Comprehensive Cancer Center,https://dx.doi.org/10.1155/2022/8798306,09/03/2022,16/07/2022,Unverified
220301_OrangeCounty_ChildrensHospitalofOrangeCounty,01-Mar-22,Local,United States of America,USA,California,Orange,04-Apr-20,13-Jul-20,Health care workers and caregivers,Adults (18-64 years),362,15.20%,,,Convenience,Superbio Biomedical Company ,Other,"IgG,IgM",,,High,Preprint,Natasha Li,Children’s Hospital of Orange County,10.21203/rs.3.rs-1363530/v1,09/03/2022,16/07/2022,Unverified
210914_AlfredIduPontHospitalforChildren_AlfredIduPontHospitalforChildren,14-Sep-21,Local,United States of America,USA,Delaware,Wilmington,15-Jun-20,15-Dec-20,Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),81,6.17%,,,Convenience,NA,Not reported,IgG,,,High,Presentation or Conference,Domenic Filingeri,Alfred I. duPont Hospital for Children,https://www.karger.com/Article/Pdf/519117,09/03/2022,16/07/2022,Unverified
211031_Texas_UniversityOfTexas_PopTestAdj_AntiS_Overall,31-Oct-21,Regional,United States of America,USA,Texas,,,04-Oct-21,Household and community samples,Multiple groups,88091,75.50%,,,Convenience,Roche Diagnostics,CLIA,Total Antibody,,,High,Institutional Report,The University of Texas Health Science Center at Houston,University of Texas Health Science Center at Houston,https://sph.uth.edu/projects/texascares/docs/TexasCARES%20-%20October%20Report.pdf,14/03/2022,16/07/2022,Verified
012722_NewYorkCity_SUNYDownstateHealthSciencesUniversity,27-Jan-22,Local,United States of America,USA,New York,New York City,15-May-20,31-Aug-20,Health care workers and caregivers,Adults (18-64 years),64,42.00%,,,Convenience,"NA,Abbott Laboratories",Multiple Types,"IgG,Not reported",,,High,Journal Article (Peer-Reviewed),Stacey Frisch,SUNY Downstate Health Sciences University,https://dx.doi.org/10.2196/29539,15/03/2022,16/07/2022,Unverified
210609_Pennsylvania_UPMCChildrensHospitalofPittsburgh_RedPhase_Primary,09-Jun-21,Regional,United States of America,USA,Pennsylvania,,27-Apr-20,19-May-20,Residual sera,Children and Youth (0-17 years),1142,0.53%,0.19%,1.14%,Sequential,"EUROIMMUN,Beckman Coulter,Siemens",CLIA,IgG,,99.99%,Moderate,Journal Article (Peer-Reviewed),Glenn J. Rapsinski,UPMC Children’s Hospital of Pittsburgh,https://dx.doi.org/10.1016/j.jcvp.2021.100026,15/03/2022,16/07/2022,Verified
210609_Pennsylvania_UPMCChildrensHospitalofPittsburgh_YellowPhase_Primary,09-Jun-21,Regional,United States of America,USA,Pennsylvania,,22-Jun-20,03-Jul-20,Residual sera,Children and Youth (0-17 years),1196,0.92%,0.46%,1.64%,Sequential,"EUROIMMUN,Beckman Coulter,Siemens",CLIA,IgG,,99.99%,Moderate,Journal Article (Peer-Reviewed),Glenn J. Rapsinski,UPMC Children’s Hospital of Pittsburgh,https://dx.doi.org/10.1016/j.jcvp.2021.100026,15/03/2022,16/07/2022,Verified
220221_NewYork_DonaldAndBarbaraZuckerSchoolOfMedicineAtHofstra/Northwell_Overall,21-Feb-22,Regional,United States of America,USA,New York,,01-May-20,31-Aug-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,147,12.20%,,,Convenience,NA,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),Joseph L.Simonson,Donald and Barbara Zucker School of Medicine at Hofstra/Northwell,https://dx.doi.org/10.1016/j.jcf.2022.02.012,15/03/2022,16/07/2022,Unverified
211201_Louisiana_TulaneUniversity_Primary,01-Dec-21,Local,United States of America,USA,Louisiana,New Orleans,18-Mar-20,15-May-20,Residual sera,Children and Youth (0-17 years),812,6.80%,,,Sequential,"NA,Zalgen Labs",ELISA,Not reported,,,High,Journal Article (Peer-Reviewed),Monika Dietrich,Tulane University,https://dx.doi.org/10.1016/j.jcvp.2021.100047,16/03/2022,16/07/2022,Verified
220310_USA_UniversityOfSouthCarolinaArnold SchoolOfPublicHealth_OverallAdj,10-Mar-22,Regional,United States of America,USA,South Carolina,,01-Feb-21,04-Mar-21,Household and community samples,Multiple groups,1803,16.40%,14.40%,18.50%,Stratified probability,"Healgen,Assure Tech. (Hangzhou) Co. Ltd",Multiple Types,"IgG,IgM",,,Moderate,Journal Article (Peer-Reviewed),Melissa S. Nolan,University of South Carolina Arnold School of Public Health,https://dx.doi.org/10.1177/00333549221081128,18/03/2022,16/07/2022,Verified
220316_Arkansas_UniversityofArkansasforMedicalSciences_Wave1_Overall,16-Mar-22,Regional,United States of America,USA,Arkansas,"Little Rock, Springdale, Fort Smith, Pine Bluf",02-Apr-20,06-May-20,Residual sera,Children and Youth (0-17 years),316,8.60%,4.90%,11.60%,Convenience,NA,ELISA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Karl Boehme, University of Arkansas for Medical Sciences,https://dx.doi.org/10.1093/jpids/piac010,21/03/2022,16/07/2022,Unverified
220316_Arkansas_UniversityofArkansasforMedicalSciences_Wave2_Overall,16-Mar-22,Regional,United States of America,USA,Arkansas,"Little Rock, Springdale, Fort Smith, Pine Bluf",06-Jun-20,10-Aug-20,Residual sera,Children and Youth (0-17 years),299,9.50%,5.80%,13.20%,Convenience,NA,ELISA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Karl Boehme, University of Arkansas for Medical Sciences,https://dx.doi.org/10.1093/jpids/piac010,21/03/2022,16/07/2022,Unverified
220316_Arkansas_UniversityofArkansasforMedicalSciences_Wave3_Overall,16-Mar-22,Regional,United States of America,USA,Arkansas,"Little Rock, Springdale, Fort Smith, Pine Bluf",08-Sep-20,17-Oct-20,Residual sera,Children and Youth (0-17 years),583,17.30%,13.60%,21.00%,Convenience,NA,ELISA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Karl Boehme, University of Arkansas for Medical Sciences,https://dx.doi.org/10.1093/jpids/piac010,21/03/2022,16/07/2022,Unverified
220316_Arkansas_UniversityofArkansasforMedicalSciences_Wave4_Overall,16-Mar-22,Regional,United States of America,USA,Arkansas,"Little Rock, Springdale, Fort Smith, Pine Bluf",07-Nov-20,17-Dec-20,Residual sera,Children and Youth (0-17 years),570,13.10%,10.00%,16.20%,Convenience,NA,ELISA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Karl Boehme, University of Arkansas for Medical Sciences,https://dx.doi.org/10.1093/jpids/piac010,21/03/2022,16/07/2022,Unverified
220316_Arkansas_UniversityofArkansasforMedicalSciences_Wave5_Overall,16-Mar-22,Regional,United States of America,USA,Arkansas,"Little Rock, Springdale, Fort Smith, Pine Bluf",05-Apr-21,28-Apr-21,Residual sera,Children and Youth (0-17 years),589,23.40%,19.40%,27.40%,Convenience,NA,ELISA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Karl Boehme, University of Arkansas for Medical Sciences,https://dx.doi.org/10.1093/jpids/piac010,21/03/2022,16/07/2022,Unverified
211001_Phoenix_DignityHealthResearchInstituteArizona_Draw4_Overall,01-Oct-21,Local,United States of America,USA,Arizona,Phoenix,01-Apr-21,30-Apr-21,Health care workers and caregivers,Adults (18-64 years),1358,20.80%,18.60%,23.00%,Convenience,Abbott Laboratories,CLIA,IgG,,,Unclear,Journal Article (Peer-Reviewed),Brian Tiffany,Dignity Health Research Institute Arizona,https://dx.doi.org/10.1016/j.annemergmed.2021.09.221,22/03/2022,16/07/2022,Unverified
211204_Annapolis_InfectiousDiseaseClinicalResearchProgram_Baseline_DBS,04-Dec-21,Local,United States of America,USA,Maryland,Annapolis,15-Aug-20,15-Oct-20,Students and Daycares,Adults (18-64 years),97,17.53%,,,Unclear,NA,Not reported,IgG,,,High,Presentation or Conference,Eugene Millar,Infectious Disease Clinical Research Program,https://dx.doi.org/10.1093/ofid/ofab466.1534,22/03/2022,16/07/2022,Unverified
211204_Annapolis_InfectiousDiseaseClinicalResearchProgram_Followup1_DBS,04-Dec-21,Local,United States of America,USA,Maryland,Annapolis,01-Dec-20,31-Dec-20,Students and Daycares,Adults (18-64 years),61,26.23%,,,Unclear,NA,Not reported,IgG,,,High,Presentation or Conference,Eugene Millar,Infectious Disease Clinical Research Program,https://dx.doi.org/10.1093/ofid/ofab466.1534,22/03/2022,16/07/2022,Unverified
211204_Annapolis_InfectiousDiseaseClinicalResearchProgram_Followup2_DBS,04-Dec-21,Local,United States of America,USA,Maryland,Annapolis,01-May-21,31-May-21,Students and Daycares,Adults (18-64 years),63,100.00%,,,Unclear,NA,Not reported,IgG,,,High,Presentation or Conference,Eugene Millar,Infectious Disease Clinical Research Program,https://dx.doi.org/10.1093/ofid/ofab466.1534,22/03/2022,16/07/2022,Unverified
211204_Holyoke_MassachusettsGeneralHospital_Primary,04-Dec-21,Local,United States of America,USA,Massachusetts,Holyoke,04-Nov-20,31-Dec-20,Household and community samples,Multiple groups,328,13.90%,7.80%,21.80%,Simplified probability,NA,Not reported,"IgG,IgM",,,Moderate,Presentation or Conference,Wilfredo Matias,Massachusetts General Hospital,https://dx.doi.org/10.1093/ofid/ofab466.597,22/03/2022,16/07/2022,Unverified
211204_LA_UCLAMedicalCenter_Primary,04-Dec-21,Local,United States of America,USA,California,,15-Sep-20,15-Dec-20,Health care workers and caregivers,Multiple groups,1273,4.70%,,,Convenience,Abbott Laboratories,Not reported,IgG,,,High,Presentation or Conference,Evelyn A Flores,UCLA Medical Center,https://dx.doi.org/10.1093/ofid/ofab466.588,22/03/2022,16/07/2022,Unverified
211204_Seattle_UniversityOfWashington_Primary,04-Dec-21,Local,United States of America,USA,"Washington
","Seattle
",09-Sep-20,07-May-21,Pregnant or parturient women,Adults (18-64 years),1304,4.80%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Presentation or Conference,Sylvia LaCourse,University of Washington,https://dx.doi.org/10.1093/ofid/ofab466.688,22/03/2022,16/07/2022,Verified
220303_Charleston_MedicalUniversityOfSouthCarolina_Period1,08-Mar-22,Local,United States of America,USA,South Carolina,Charleston,17-Apr-20,07-Jun-20,Health care workers and caregivers,Adults (18-64 years),427,0.70%,,,Convenience,RayBiotech,LFIA,IgG,,,High,Preprint,Lauren Card,Medical University of South Carolina,https://dx.doi.org/10.1016/j.amjms.2022.01.025,22/03/2022,16/07/2022,Unverified
211204_Atlanta_EmoryUniversitySchoolofMedicine_Overall,04-Dec-21,Local,United States of America,USA,Georgia,Atlanta,15-Jan-21,15-Mar-21,Blood donors,Multiple groups,2406,17.00%,,,Convenience,NA,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),Daniel Graciaa,Emory University,https://dx.doi.org/10.1093/ofid/ofab466.572,22/03/2022,16/07/2022,Unverified
220312_California_StanfordUniversity,12-Mar-22,Regional,United States of America,USA,California,,15-May-20,15-Sep-20,Health care workers and caregivers,Adults (18-64 years),2435,3.74%,,,Convenience,"Abbott Laboratories,EUROIMMUN,NA",Not reported,"IgG,Neutralizing ",,,High,Journal Article (Peer-Reviewed),Sarah Doernberg,Stanford University,https://dx.doi.org/10.1093/cid/ciac210,25/03/2022,16/07/2022,Unverified
220323_UnitedStatesofAmerica_NationalInstitutesofHealth_Children_Spike,23-Mar-22,National,United States of America,USA,"California, Arizona, Texas, Louisiana, Kansas, Minnesota, Illinois, Michigan, Tennessee, Georgia, Florida, Maryland, New Jersey",,21-Dec-20,21-Mar-21,Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),22,90.90%,,,Convenience,NA,ELISA,"IgG,IgM,IgA",,,High,Preprint,Eliza Gordon-Lipkin,National Institutes of Health,10.1101/2022.03.21.22272358,31/03/2022,16/07/2022,Unverified
220323_UnitedStatesofAmerica_NationalInstitutesofHealth_HouseholdMembers_Spike,23-Mar-22,National,United States of America,USA,"California, Arizona, Texas, Louisiana, Kansas, Minnesota, Illinois, Michigan, Tennessee, Georgia, Florida, Maryland, New Jersey",,21-Dec-20,21-Mar-21,Contacts of COVID patients,Adults (18-64 years),61,68.90%,,,Convenience,NA,ELISA,"IgG,IgM,IgA",,,High,Preprint,Eliza Gordon-Lipkin,National Institutes of Health,10.1101/2022.03.21.22272358,31/03/2022,16/07/2022,Unverified
220316_Minnesota_University of Minnesota,16-Mar-22,Regional,United States of America,USA,Minnesota,,08-Dec-20,24-Mar-21,Non-essential workers and unemployed persons,Multiple groups,706,7.93%,,,Convenience,Quansys Biosciences,ELISA,IgG,97.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Madhura Vachon,University of Minnesota,https://dx.doi.org/10.3390/ijerph19063501,02/04/2022,16/07/2022,Unverified
220320_Baltimore_JohnsHopkinsUniversity_FollowUp_Overall,20-Mar-22,Local,United States of America,USA,Maryland,Baltimore,01-Dec-20,31-Dec-20,Health care workers and caregivers,Adults (18-64 years),174,12.07%,,,Convenience,EUROIMMUN,ELISA,IgG,97.00%,98.00%,High,Journal Article (Peer-Reviewed),Anna Russell,Johns Hopkins University,https://www.mdpi.com/2227-9032/10/3/576/htm,04/04/2022,16/07/2022,Unverified
220320_Baltimore_JohnsHopkinsUniversity_Baseline_Overall,20-Mar-22,Local,United States of America,USA,Maryland,Baltimore,01-Jul-20,31-Jul-20,Health care workers and caregivers,Adults (18-64 years),191,5.76%,,,Convenience,EUROIMMUN,ELISA,IgG,97.00%,98.00%,High,Journal Article (Peer-Reviewed),Anna Russell,Johns Hopkins University,https://www.mdpi.com/2227-9032/10/3/576/htm,04/04/2022,16/07/2022,Unverified
220401_NewYork_LincolnMedicalCenter_May_HCWs,01-Apr-22,Local,United States of America,USA,New York,,01-May-20,30-May-20,Health care workers and caregivers,Adults (18-64 years),42,14.30%,,,Entire sample,NA,Not reported,Not reported,,,High,Presentation or Conference,Susan Kim,Lincoln Medical Center,https://dx.doi.org/10.1053/j.ajkd.2021.02.156,05/04/2022,16/07/2022,Unverified
220401_NewYork_LincolnMedicalCenter_June_patients,01-Apr-22,Local,United States of America,USA,New York,,01-Jun-20,30-Jun-20,Residual sera,Multiple groups,32,18.80%,,,Sequential,NA,Not reported,Not reported,,,High,Presentation or Conference,Susan Kim,Lincoln Medical Center,https://dx.doi.org/10.1053/j.ajkd.2021.02.156,05/04/2022,16/07/2022,Unverified
220325_Detroit_HenryFordHospital_Overall,25-Mar-22,Local,United States of America,USA,Michigan,Detroit,15-Sep-20,15-May-21,Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),504,10.30%,,,Convenience,Beckman Coulter,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),Smitha Gudipati,Henry Ford Hospital,https://dx.doi.org/10.1177/09564624221076629,05/04/2022,16/07/2022,Unverified
220330_NewYorkCity_MountSinaiHealthSystem,30-Mar-22,Local,United States of America,USA,New York,New York City ,15-Apr-20,15-Aug-21,Health care workers and caregivers,Adults (18-64 years),400,37.50%,,,Convenience,NA,ELISA,IgG,,,High,Preprint,John Kubale,Mount Sinai Health System,https://www.medrxiv.org/content/10.1101/2022.03.28.22273068v1.full-text,05/04/2022,16/07/2022,Unverified
220331_Wisconsin_CDC_UniversityB_1September_AntiS,31-Mar-22,Local,United States of America,USA,Wisconsin,,01-Sep-20,11-Sep-20,Students and Daycares,Adults (18-64 years),36,19.44%,,,Convenience,Abbott Laboratories,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),Christine Lee,CDC COVID‑19 Response Team,https://doi.org/10.1186/s12879-022-07314-5,05/04/2022,16/07/2022,Unverified
220331_Wisconsin_CDC_UniversityB_2November_AntiS,31-Mar-22,Local,United States of America,USA,Wisconsin,,09-Nov-20,14-Nov-20,Students and Daycares,Adults (18-64 years),36,36.11%,,,Convenience,Abbott Laboratories,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),Christine Lee,CDC COVID‑19 Response Team,https://doi.org/10.1186/s12879-022-07314-5,05/04/2022,16/07/2022,Unverified
220228_Georgia_EmoryUniversity_MixedImmunity,28-Feb-22,Regional,United States of America,USA,Georgia,,11-Feb-21,07-May-21,Health care workers and caregivers,Adults (18-64 years),203,71.92%,,,Convenience,EUROIMMUN,ELISA,IgG,90.00%,100.00%,High,Journal Article (Peer-Reviewed),William Dube,Emory University,https://dx.doi.org/10.1016/j.jamda.2022.02.014,07/04/2022,16/07/2022,Unverified
220318_Texas_TheUniversityOfTexasSystem_Round1_Overall,18-Mar-22,Regional,United States of America,USA,Texas,,01-Oct-20,30-Nov-20,Household and community samples,Children and Youth (0-17 years),218,34.40%,,,Convenience,Roche Diagnostics,CLIA,Total Antibody,97.00%,,Moderate,Journal Article (Peer-Reviewed),Sarah Messiah,The University of Texas System,https://doi-org.proxy3.library.mcgill.ca/10.1542/peds.2021-055505,07/04/2022,16/07/2022,Unverified
220318_Texas_TheUniversityOfTexasSystem_Round2_Overall,18-Mar-22,Regional,United States of America,USA,Texas,,01-Jan-21,28-Feb-21,Household and community samples,Children and Youth (0-17 years),218,40.80%,,,Convenience,Roche Diagnostics,CLIA,Total Antibody,97.00%,,Moderate,Journal Article (Peer-Reviewed),Sarah Messiah,The University of Texas System,https://doi-org.proxy3.library.mcgill.ca/10.1542/peds.2021-055505,07/04/2022,16/07/2022,Unverified
220318_Texas_TheUniversityOfTexasSystem_Round3_Overall,18-Mar-22,Regional,United States of America,USA,Texas,,01-Apr-21,31-May-21,Household and community samples,Children and Youth (0-17 years),218,44.90%,,,Convenience,Roche Diagnostics,CLIA,Total Antibody,97.00%,,Moderate,Journal Article (Peer-Reviewed),Sarah Messiah,The University of Texas System,https://doi-org.proxy3.library.mcgill.ca/10.1542/peds.2021-055505,07/04/2022,16/07/2022,Unverified
220225_NewYork_NewYorkUniversityLongIslandSchoolofMedicine_Overall,25-Feb-22,Local,United States of America,USA,New York,Long Island,01-Feb-20,25-Aug-20,Residual sera,Multiple groups,343,25.70%,,,Convenience,Abbott Laboratories,CLIA,IgG,100.00%,99.90%,High,Journal Article (Peer-Reviewed),Minesh Khatri,New York University Long Island School of Medicine,https://dx.doi.org/10.34067/KID.0006292020,11/04/2022,16/07/2022,Verified
210624_StLouis_WashingtonUniversitySchoolofMedicine_Patients,24-Jun-21,Local,United States of America,USA,Missouri,St. Louis,01-Sep-20,30-Sep-20,Residual sera,Multiple groups,226,8.40%,,,Convenience,Abbott Laboratories,CLIA,IgG,90.00%,99.00%,High,Journal Article (Peer-Reviewed),Sumanth Gandra,Washington University School of Medicine,https://dx.doi.org/10.34067/KID.0001282021,15/04/2022,16/07/2022,Unverified
210624_StLouis_WashingtonUniversitySchoolofMedicine_HCW,24-Jun-21,Local,United States of America,USA,Missouri,St. Louis,01-Sep-20,30-Sep-20,Health care workers and caregivers,Adults (18-64 years),39,0.00%,,,Convenience,Abbott Laboratories,CLIA,IgG,90.00%,99.00%,High,Journal Article (Peer-Reviewed),Sumanth Gandra,Washington University School of Medicine,https://dx.doi.org/10.34067/KID.0001282021,15/04/2022,16/07/2022,Unverified
220412_Boston_DanaFarberCancerInstitute_1_MayJul2020_TestAdj,12-Apr-22,Local,United States of America,USA,Massachusetts,Boston,15-May-20,15-Jul-20,Health care workers and caregivers,Adults (18-64 years),519,9.20%,6.70%,12.00%,Convenience,NA,ELISA,"IgG,IgM,IgA",,,High,Journal Article (Peer-Reviewed),Jeffrey Meyerhardt,Dana-Farber Cancer Institute,https://dx.doi.org/10.1371/journal.pone.0266791,23/04/2022,16/07/2022,Unverified
220412_Boston_DanaFarberCancerInstitute_2_SepOct2020_TestAdj,12-Apr-22,Local,United States of America,USA,Massachusetts,Boston,15-Sep-20,15-Oct-20,Health care workers and caregivers,Adults (18-64 years),479,8.50%,6.00%,11.00%,Convenience,NA,ELISA,"IgG,IgM,IgA",,,High,Journal Article (Peer-Reviewed),Jeffrey Meyerhardt,Dana-Farber Cancer Institute,https://dx.doi.org/10.1371/journal.pone.0266791,23/04/2022,16/07/2022,Unverified
220408_Tennessee_AccessBiologicals,08-Apr-22,Local,United States of America,USA,Tennessee,,22-Dec-20,25-Feb-21,Health care workers and caregivers,Adults (18-64 years),15,13.33%,,,Convenience,"DiaSorin,Progenika Biopharma, Derio, Bizkaia, Spain",ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Francisco Belda,Access Biologicals,https://dx.doi.org/10.1016/j.vaccine.2022.04.006,28/04/2022,16/07/2022,Unverified
220413_Atlanta_EmoryUniversity_Overall,13-Apr-22,Regional,United States of America,USA,Atlanta,,11-May-20,20-Jul-20,Health care workers and caregivers,Adults (18-64 years),1412,6.40%,5.30%,7.80%,Convenience,Abbott Laboratories,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),Daniel Graciaa,Emory University,https://dx.doi.org/10.1016/j.amjms.2022.04.009,02/05/2022,16/07/2022,Unverified
220427_Arkansas_UniversityOfArkansasForMedicalSciences_OverallTestAdj,27-Apr-22,Regional,United States of America,USA,Arkansas,,01-May-20,31-Dec-20,Household and community samples,Multiple groups,1565,7.10%,5.80%,8.70%,Simplified probability,Beckman Coulter,CLIA,IgG,93.80%,100.00%,Moderate,Journal Article (Peer-Reviewed),Victor M. Cardenas,University of Arkansas for Medical Sciences,https://dx.doi.org/10.1371/journal.pone.0267322,02/05/2022,16/07/2022,Verified
220425_ChapelHill_UniversityofNorthCarolinaatChapelHill_Baseline_Overall,25-Apr-22,Local,United States of America,USA,North Carolina,Chapel Hill,15-Jul-20,15-Dec-20,Multiple populations,Adults (18-64 years),910,6.24%,4.29%,8.19%,Convenience,NA,ELISA,IgG,98.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Audrey Pettifor,University of North Carolina at Chapel Hill,https://dx.doi.org/10.1371/journal.pone.0267353,03/05/2022,16/07/2022,Unverified
220425_ChapelHill_UniversityofNorthCarolinaatChapelHill_1month_Overall,25-Apr-22,Local,United States of America,USA,North Carolina,Chapel Hill,15-Jul-20,15-Dec-20,Multiple populations,Adults (18-64 years),751,9.21%,6.74%,11.68%,Convenience,NA,ELISA,IgG,98.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Audrey Pettifor,University of North Carolina at Chapel Hill,https://dx.doi.org/10.1371/journal.pone.0267353,03/05/2022,16/07/2022,Unverified
220425_ChapelHill_UniversityofNorthCarolinaatChapelHill_3months_Overall,25-Apr-22,Local,United States of America,USA,North Carolina,Chapel Hill,15-Jul-20,15-Dec-20,Multiple populations,Adults (18-64 years),751,10.07%,7.41%,12.72%,Convenience,NA,ELISA,IgG,98.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Audrey Pettifor,University of North Carolina at Chapel Hill,https://dx.doi.org/10.1371/journal.pone.0267353,03/05/2022,16/07/2022,Unverified
220429_UnitedStatesofAmerica_CDC_Overall,26-Apr-22,National,United States of America,USA,,,01-Feb-22,28-Feb-22,Household and community samples,Multiple groups,45810,57.70%,57.10%,58.30%,Convenience,Roche Diagnostics,CLIA,Not reported,,,Unclear,Institutional Report,Kristie Clarke,Centers for Disease Control and Prevention (CDC),http://dx.doi.org/10.15585/mmwr.mm7117e3,03/05/2022,16/07/2022,Verified
220421_NYC_UniversityofPennsylvania,21-Apr-22,Local,United States of America,USA,New York,New York City,15-Apr-20,15-Dec-20,Pregnant or parturient women,Adults (18-64 years),967,20.00%,,,Convenience,NA,ELISA,IgG,95.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Teresa Janevic,University of Pennsylvania,https://dx.doi.org/10.1016/j.ajogmf.2022.100649,04/05/2022,16/07/2022,Verified
220427_SanDiegoCounty&Tijuana_UCSD,27-Apr-22,Regional,United States of America,USA,California,,,10-Sep-21,Multiple populations,Multiple groups,571,30.10%,,,Convenience,"Genalyte (San Diego, CA)",Other,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Samantha Yeager,University of California San Diego,https://dx.doi.org/10.1186/s12889-022-13273-y,05/05/2022,16/07/2022,Unverified
220425_Minneapolis_UniversityOfMinnesota_Sample2,25-Apr-22,Local,United States of America,USA,Minnesota,Minneapolis,18-Dec-20,15-Feb-21,Health care workers and caregivers,Multiple groups,423,17.73%,,,Convenience,Quansys Biosciences,ELISA,IgG,97.00%,100.00%,High,Journal Article (Peer-Reviewed),Talia D. Wiggen,University Of Minnesota,https://dx.doi.org/10.1371/journal.pone.0266410,05/05/2022,16/07/2022,Unverified
220504_SanFrancisco_UniversityofCaliforniaSanFrancisco_Vitros,04-May-22,Local,United States of America,USA,California,San Francisco,04-Feb-21,17-Feb-21,Residual sera,Multiple groups,915,28.42%,,,Stratified non-probability,Ortho Clinical Diagnostics Inc.,CLIA,Total Antibody,83.80%,100.00%,High,Journal Article (Peer-Reviewed),Isobel Routledge,University of California San Francisco,https://doi.org/10.1038/s41467-022-30051-x,11/05/2022,16/07/2022,Verified
220504_US_CDC_Overall,04-May-22,National,United States of America,USA,"All 50 U.S. states, the District of Columbia, and Puerto Rico",,15-Sep-21,15-Feb-22,Residual sera,Children and Youth (0-17 years),71490,52.01%,,,Stratified non-probability,Roche Diagnostics,CLIA,Total Antibody,,,High,Preprint,Kristie Clarke,US Center for Disease Control,https://dx.doi.org/10.2139/ssrn.4092074,11/05/2022,16/07/2022,Verified
211018_Georgia_EmoryUniversity_PopAdj,18-Oct-21,Regional,United States of America,USA,Georgia,,15-Aug-20,15-Dec-20,Household and community samples,Adults (18-64 years),1370,8.60%,6.30%,11.80%,Convenience,Bio-rad,ELISA,"IgA,IgM,IgG",99.30%,98.00%,Moderate,Journal Article (Peer-Reviewed),Allison Chamberlain,Emory University,https://dx.doi.org/10.1093/infdis/jiab522,11/05/2022,16/07/2022,Verified
220506_NewYorkState_NathanSKlineInstituteforPsychiatricResearch,06-May-22,Regional,United States of America,USA,New York,,08-Mar-20,01-Jul-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,1958,29.21%,,,Convenience,Abbott Laboratories,Not reported,IgG,10.00%,99.60%,High,Journal Article (Peer-Reviewed),Katlyn Nemani,Nathan S. Kline Institute for Psychiatric Research,https://dx.doi.org/10.1001/jamanetworkopen.2022.10743,20/05/2022,16/07/2022,Unverified
220518_NewYorkCityDepartmentOfHealthAndMentalHygiene_PrimaryAdj,18-May-22,Local,United States of America,USA,New York State,New York City,15-Sep-20,15-Mar-21,Household and community samples,Multiple groups,2096,23.50%,20.10%,27.40%,Stratified probability,"DiaSorin,NA",Multiple Types,IgG,,,High,Journal Article (Peer-Reviewed),Jannae Parrott,New York City Department of Health and Mental Hygiene,https://dx.doi.org/10.1017/S0950268822000875,30/05/2022,16/07/2022,Unverified
220521_PennsylvaniaStateUniversity_UniversityPark,21-May-22,Local,United States of America,USA,Pennsylvania,University Park,07-Aug-20,02-Oct-20,Students and Daycares,Multiple groups,1313,3.20%,,,Convenience,NA,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Callum Arnold,Pennsylvania State University,https://dx.doi.org/10.1038/s41598-022-12499-5,31/05/2022,16/07/2022,Unverified
220516_LittleRock_UniversityOfArkansasForMedicalSciences,16-May-22,Local,United States of America,USA,Arkansas,Little Rock,25-Oct-20,15-Apr-21,Health care workers and caregivers,Multiple groups,54,26.00%,,,Convenience,NA,ELISA,"IgG,IgM",100.00%,94.60%,High,Journal Article (Peer-Reviewed),Hannah Wilkins,University of Arkansas for Medical Sciences,https://dx.doi.org/10.1002/emp2.12743,03/06/2022,16/07/2022,Unverified
220519_NorthCarolina_UniversityOfNorthCarolina_1AprJun_TestPopAdj,19-May-22,Regional,United States of America,USA,North Carolina,,19-Apr-20,20-Jun-20,Residual sera,Multiple groups,3963,2.90%,1.80%,4.50%,Sequential,NA,ELISA,Total Antibody,89.70%,99.30%,Moderate,Journal Article (Peer-Reviewed),Cesar Lopez,University of North Carolina,https://dx.doi.org/10.1128/msphere.00841-21,07/06/2022,16/07/2022,Unverified
220519_NorthCarolina_UniversityOfNorthCarolina_2JunAug_TestPopAdj,19-May-22,Regional,United States of America,USA,North Carolina,,21-Jun-20,22-Aug-20,Residual sera,Multiple groups,3851,10.20%,8.50%,12.20%,Sequential,NA,ELISA,Total Antibody,89.70%,99.30%,Moderate,Journal Article (Peer-Reviewed),Cesar Lopez,University of North Carolina,https://dx.doi.org/10.1128/msphere.00841-21,08/06/2022,16/07/2022,Unverified
220519_NorthCarolina_UniversityOfNorthCarolina_3AugOct_TestPopAdj,19-May-22,Regional,United States of America,USA,North Carolina,,23-Aug-20,24-Oct-20,Residual sera,Multiple groups,2510,9.10%,7.20%,11.20%,Sequential,NA,ELISA,Total Antibody,89.70%,99.30%,Moderate,Journal Article (Peer-Reviewed),Cesar Lopez,University of North Carolina,https://dx.doi.org/10.1128/msphere.00841-21,08/06/2022,16/07/2022,Unverified
220519_NorthCarolina_UniversityOfNorthCarolina_4OctDec_TestPopAdj,19-May-22,Regional,United States of America,USA,North Carolina,,25-Oct-20,26-Dec-20,Residual sera,Multiple groups,2147,12.80%,10.60%,15.20%,Sequential,NA,ELISA,Total Antibody,89.70%,99.30%,Moderate,Journal Article (Peer-Reviewed),Cesar Lopez,University of North Carolina,https://dx.doi.org/10.1128/msphere.00841-21,08/06/2022,16/07/2022,Unverified
220527_US_CityUniversityOfNewYork_Period1_Overall_TestAdj,27-May-22,National,United States of America,USA,All 50 US states; the District of Columbia; Puerto Rico; Guam.,,15-May-20,15-Sep-20,Household and community samples,Multiple groups,4232,2.20%,1.70%,2.80%,Convenience,Bio-rad,ELISA,"IgG,IgM,IgA",91.70%,98.80%,High,Journal Article (Peer-Reviewed),Denis Nash,City University of New York,https://dx.doi.org/10.1093/cid/ciac423,08/06/2022,29/07/2022,Unverified
220527_US_CityUniversityOfNewYork_Period2_Overall_UnAdj,27-May-22,National,United States of America,USA,All 50 US states; the District of Columbia; Puerto Rico; Guam.,,15-Nov-20,15-Jan-21,Household and community samples,Multiple groups,3883,7.37%,,,Convenience,Bio-rad,ELISA,"IgG,IgM,IgA",91.70%,98.80%,High,Journal Article (Peer-Reviewed),Denis Nash,City University of New York,https://dx.doi.org/10.1093/cid/ciac423,09/06/2022,29/07/2022,Unverified
220530_UnitedStates_NYUGrossmanSchoolofMedicine_Overall,30-May-22,National,United States of America,USA,,,23-Sep-21,05-Nov-21,Household and community samples,Adults (18-64 years),546,60.10%,,,Unclear,NA,Not reported,Not reported,,,High,Preprint,Jennifer Alejo,NYU Grossman School of Medicine,10.1101/2022.05.27.22275630,10/06/2022,16/07/2022,Unverified
211210_Athens_UniversityofGeorgia_Primary,10-Dec-21,Local,United States of America,USA,Georgia,Atlanta,20-Jan-21,22-Mar-21,Household and community samples,Adults (18-64 years),432,41.00%,31.40%,50.70%,Self-referral,NA,ELISA,IgA,77.78%,100.00%,Moderate,Journal Article (Peer-Reviewed),Mark Ebell,University of Georgia,https://dx.doi.org/10.3122/jabfm.2022.03.210348,10/06/2022,16/07/2022,Unverified
220315_USA_UniversityOfMiami_Primary,15-Mar-22,National,United States of America,USA,,,15-Oct-20,15-Sep-21,Blood donors,Adults (18-64 years),73,51.00%,,,Convenience,NA,Not reported,IgG,,,High,Presentation or Conference,Cherenack E.M.,University of Miami ,https://www.iasusa.org/tam/march-2022/,15/06/2022,16/07/2022,Unverified
220601_Philadelphia_ChildrensHospitalofPhiladelphia_OverallCrude,01-Jun-22,Local,United States of America,USA,,Philadelphia,13-Apr-20,31-Dec-20,Pregnant or parturient women,Adults (18-64 years),5991,9.38%,,,Convenience,NA,ELISA,"IgG,IgM",100.00%,98.90%,Moderate,Journal Article (Peer-Reviewed),Heather Burris,Children's Hospital of Philadelphia,https://dx.doi.org/10.1097/AOG.0000000000004791,19/06/2022,16/07/2022,Unverified
220421_Massachusetts_MassachusettsGeneralHospital_Overall,21-Apr-22,Local,United States of America,USA,Massachusetts,Boston,17-Dec-20,27-Jan-21,Health care workers and caregivers,Adults (18-64 years),103,2.90%,,,Convenience,Roche Diagnostics,CLIA,"IgG,IgM,IgA",90.00%,99.00%,High,Journal Article (Peer-Reviewed),Brian Yun,Massachusetts General Hospital,https://dx.doi.org/10.1016/j.jen.2022.04.003,20/06/2022,16/07/2022,Unverified
220615_NewJersey_RutgersNewJerseyMedicalSchool_Residents,15-Jun-22,Regional,United States of America,USA,New Jersey,,20-Oct-20,04-Mar-21,Assisted living and long-term care facilities,Seniors (65+ years),337,61.70%,,,Stratified non-probability,Bio-rad,ELISA,Total Antibody,98.00%,99.30%,High,Journal Article (Peer-Reviewed),Stephen Friedman,Rutgers New Jersey Medical School,https://dx.doi.org/10.1007/s10900-022-01104-5,23/06/2022,16/07/2022,Unverified
220615_NewJersey_RutgersNewJerseyMedicalSchool_Staff,15-Jun-22,Regional,United States of America,USA,New Jersey,,20-Oct-20,04-Mar-21,Assisted living and long-term care facilities,Multiple groups,667,46.30%,,,Stratified non-probability,Bio-rad,ELISA,Total Antibody,98.00%,99.30%,High,Journal Article (Peer-Reviewed),Stephen Friedman,Rutgers New Jersey Medical School,https://dx.doi.org/10.1007/s10900-022-01104-5,23/06/2022,16/07/2022,Unverified
220602_NewYork_UniversityofNewYork_Phase1_Overall,02-Jun-22,Local,United States of America,USA,New York ,New York ,01-Mar-20,04-Mar-21,Residual sera,Multiple groups,699792,21.88%,,,Sequential,Abbott Laboratories,Not reported,IgG,100.00%,99.90%,Moderate,Journal Article (Peer-Reviewed),Madhura S. Rane,University of New York,https://dx.doi.org/10.1016/j.annepidem.2022.05.006,23/06/2022,16/07/2022,Unverified
220602_NewYork_UniversityofNewYork_Phase2_Overall,02-Jun-22,Local,United States of America,USA,New York ,New York ,05-Mar-21,20-Jul-21,Residual sera,Multiple groups,9367,34.67%,,,Sequential,"Abbott Laboratories,Roche Diagnostics",Not reported,IgG,,,High,Journal Article (Peer-Reviewed),Madhura S. Rane,University of New York,https://dx.doi.org/10.1016/j.annepidem.2022.05.006,23/06/2022,16/07/2022,Unverified
220613_USA_CentersforDiseaseControlandPrevention_202012_Overall,13-Jun-22,National,United States of America,USA,,,01-Dec-20,31-Dec-20,Blood donors,Multiple groups,135026,11.90%,11.50%,12.20%,Convenience,Ortho Clinical Diagnostics Inc.,CLIA,Total Antibody,100.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Jefferson Jones,Vitalant Research Institute,https://jamanetwork.com/journals/jama/fullarticle/2793517,25/06/2022,16/07/2022,Unverified
220613_USA_CentersforDiseaseControlandPrevention_202108_Overall,13-Jun-22,National,United States of America,USA,,,01-Aug-21,31-Aug-21,Blood donors,Multiple groups,137583,89.60%,89.30%,89.90%,Convenience,Ortho Clinical Diagnostics Inc.,CLIA,Total Antibody,100.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Jefferson Jones,Vitalant Research Institute,https://jamanetwork.com/journals/jama/fullarticle/2793517,25/06/2022,16/07/2022,Unverified
220613_USA_CentersforDiseaseControlandPrevention_202112_Overall,13-Jun-22,National,United States of America,USA,,,01-Dec-21,31-Dec-21,Blood donors,Multiple groups,136156,94.70%,94.50%,94.90%,Convenience,Ortho Clinical Diagnostics Inc.,CLIA,Total Antibody,100.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Jefferson Jones,Vitalant Research Institute,https://jamanetwork.com/journals/jama/fullarticle/2793517,25/06/2022,16/07/2022,Unverified
220613_USA_CentersforDiseaseControlandPrevention_202008_Overall,13-Jun-22,National,United States of America,USA,,,01-Aug-20,31-Aug-20,Blood donors,Multiple groups,123200,4.80%,4.60%,5.10%,Convenience,Ortho Clinical Diagnostics Inc.,CLIA,Total Antibody,100.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Jefferson Jones,Vitalant Research Institute,https://jamanetwork.com/journals/jama/fullarticle/2793517,25/06/2022,16/07/2022,Unverified
220613_USA_CentersforDiseaseControlandPrevention_202104_Overall,13-Jun-22,National,United States of America,USA,,,01-Apr-21,30-Apr-21,Blood donors,Multiple groups,134510,71.40%,71.10%,71.80%,Convenience,Ortho Clinical Diagnostics Inc.,CLIA,Total Antibody,100.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Jefferson Jones,Vitalant Research Institute,https://jamanetwork.com/journals/jama/fullarticle/2793517,25/06/2022,16/07/2022,Unverified
220613_USA_CentersforDiseaseControlandPrevention_202106_Overall,13-Jun-22,National,United States of America,USA,,,01-Jun-21,30-Jun-21,Blood donors,Multiple groups,134788,87.40%,87.10%,87.70%,Convenience,Ortho Clinical Diagnostics Inc.,CLIA,Total Antibody,100.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Jefferson Jones,Vitalant Research Institute,https://jamanetwork.com/journals/jama/fullarticle/2793517,25/06/2022,16/07/2022,Unverified
220613_USA_CentersforDiseaseControlandPrevention_202110_Overall,13-Jun-22,National,United States of America,USA,,,01-Oct-21,31-Oct-21,Blood donors,Multiple groups,140121,92.90%,92.70%,93.10%,Convenience,Ortho Clinical Diagnostics Inc.,CLIA,Total Antibody,100.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Jefferson Jones,Vitalant Research Institute,https://jamanetwork.com/journals/jama/fullarticle/2793517,25/06/2022,16/07/2022,Unverified
220613_USA_CentersforDiseaseControlandPrevention_202105_Overall,13-Jun-22,National,United States of America,USA,,,01-May-21,31-May-21,Blood donors,Multiple groups,134949,83.30%,82.90%,83.70%,Convenience,Ortho Clinical Diagnostics Inc.,CLIA,Total Antibody,100.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Jefferson Jones,Vitalant Research Institute,https://jamanetwork.com/journals/jama/fullarticle/2793517,25/06/2022,16/07/2022,Unverified
220613_USA_CentersforDiseaseControlandPrevention_202102_Overall,13-Jun-22,National,United States of America,USA,,,01-Feb-21,28-Feb-21,Blood donors,Multiple groups,133288,33.50%,33.10%,33.90%,Convenience,Ortho Clinical Diagnostics Inc.,CLIA,Total Antibody,100.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Jefferson Jones,Vitalant Research Institute,https://jamanetwork.com/journals/jama/fullarticle/2793517,25/06/2022,16/07/2022,Unverified
220613_USA_CentersforDiseaseControlandPrevention_202007_Overall,13-Jun-22,National,United States of America,USA,,,01-Jul-20,31-Jul-20,Blood donors,Multiple groups,116513,3.70%,3.40%,4.00%,Convenience,Ortho Clinical Diagnostics Inc.,CLIA,Total Antibody,100.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Jefferson Jones,Vitalant Research Institute,https://jamanetwork.com/journals/jama/fullarticle/2793517,25/06/2022,16/07/2022,Unverified
220613_USA_CentersforDiseaseControlandPrevention_202107_Overall,13-Jun-22,National,United States of America,USA,,,01-Jul-21,31-Jul-21,Blood donors,Multiple groups,140224,88.80%,88.50%,89.10%,Convenience,Ortho Clinical Diagnostics Inc.,CLIA,Total Antibody,100.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Jefferson Jones,Vitalant Research Institute,https://jamanetwork.com/journals/jama/fullarticle/2793517,25/06/2022,16/07/2022,Unverified
220613_USA_CentersforDiseaseControlandPrevention_202103_Overall,13-Jun-22,National,United States of America,USA,,,01-Mar-21,31-Mar-21,Blood donors,Multiple groups,134557,49.20%,48.70%,49.60%,Convenience,Ortho Clinical Diagnostics Inc.,CLIA,Total Antibody,100.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Jefferson Jones,Vitalant Research Institute,https://jamanetwork.com/journals/jama/fullarticle/2793517,25/06/2022,16/07/2022,Unverified
220613_USA_CentersforDiseaseControlandPrevention_202101_Overall,13-Jun-22,National,United States of America,USA,,,01-Jan-21,31-Jan-21,Blood donors,Multiple groups,134632,20.50%,20.20%,20.90%,Convenience,Ortho Clinical Diagnostics Inc.,CLIA,Total Antibody,100.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Jefferson Jones,Vitalant Research Institute,https://jamanetwork.com/journals/jama/fullarticle/2793517,25/06/2022,16/07/2022,Unverified
220613_USA_CentersforDiseaseControlandPrevention_202010_Overall,13-Jun-22,National,United States of America,USA,,,01-Oct-20,31-Oct-20,Blood donors,Multiple groups,131731,5.90%,5.70%,6.20%,Convenience,Ortho Clinical Diagnostics Inc.,CLIA,Total Antibody,100.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Jefferson Jones,Vitalant Research Institute,https://jamanetwork.com/journals/jama/fullarticle/2793517,25/06/2022,16/07/2022,Unverified
220613_USA_CentersforDiseaseControlandPrevention_202111_Overall,13-Jun-22,National,United States of America,USA,,,01-Nov-21,30-Nov-21,Blood donors,Multiple groups,135135,93.90%,93.80%,94.10%,Convenience,Ortho Clinical Diagnostics Inc.,CLIA,Total Antibody,100.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Jefferson Jones,Vitalant Research Institute,https://jamanetwork.com/journals/jama/fullarticle/2793517,25/06/2022,16/07/2022,Unverified
220613_USA_CentersforDiseaseControlandPrevention_202109_Overall,13-Jun-22,National,United States of America,USA,,,01-Sep-21,30-Sep-21,Blood donors,Multiple groups,140567,91.80%,91.50%,92.00%,Convenience,Ortho Clinical Diagnostics Inc.,CLIA,Total Antibody,100.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Jefferson Jones,Vitalant Research Institute,https://jamanetwork.com/journals/jama/fullarticle/2793517,25/06/2022,16/07/2022,Unverified
220613_USA_CentersforDiseaseControlandPrevention_202011_Overall,13-Jun-22,National,United States of America,USA,,,01-Nov-20,30-Nov-20,Blood donors,Multiple groups,134061,8.20%,7.90%,8.50%,Convenience,Ortho Clinical Diagnostics Inc.,CLIA,Total Antibody,100.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Jefferson Jones,Vitalant Research Institute,https://jamanetwork.com/journals/jama/fullarticle/2793517,25/06/2022,16/07/2022,Unverified
220613_USA_CentersforDiseaseControlandPrevention_202009_Overall,13-Jun-22,National,United States of America,USA,,,01-Sep-20,30-Sep-20,Blood donors,Multiple groups,131052,5.00%,4.80%,5.30%,Convenience,Ortho Clinical Diagnostics Inc.,CLIA,Total Antibody,100.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Jefferson Jones,Vitalant Research Institute,https://jamanetwork.com/journals/jama/fullarticle/2793517,25/06/2022,16/07/2022,Unverified
220620_USA_JohnsHopkinsUniversitySchoolOfMedicine_AbbottIgG,20-Jun-22,National,United States of America,USA,"NY, WI, FL, CA","New York, Milwaukee, Miami, Los Angeles",15-Apr-19,15-Jan-20,Residual sera,Multiple groups,1954,0.70%,,,Convenience,Abbott Laboratories,Not reported,IgG,,99.28%,High,Journal Article (Peer-Reviewed),David J Daghfal,Johns Hopkins University School of Medicine,https://dx.doi.org/10.1093/jalm/jfac060,28/06/2022,16/07/2022,Unverified
210803_NewYorkCity_NewYorkUniversity_Overall_UnAdj,03-Aug-21,Regional,United States of America,USA,New York,New York City,29-Apr-20,09-Feb-21,Patients seeking care for non-COVID-19 reasons,Multiple groups,329,16.00%,,,Convenience,Abbott Laboratories,CLIA,IgG,100.00%,99.60%,High,Journal Article (Peer-Reviewed),Amit Saxena,New York University,https://dx.doi.org/10.1136/lupus-2021-lupus21century.73,07/07/2022,29/07/2022,Unverified
220627_WashingtonDC_MedStarGeorgetownUniversityHospital,27-Jun-22,Local,United States of America,USA,,Washington D.C.,15-Mar-20,30-Jun-21,Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),157,12.10%,,,Sequential,DiaSorin,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Saikat Paul,Medstar Georgetown University Hospital,https://dx.doi.org/10.1097/MPG.0000000000003548,07/07/2022,29/07/2022,Unverified
220316_BaltimoreCity_NationalInstitutesofHealth_Period1_Overall,16-Mar-22,Local,United States of America,USA,"Maryland
","Baltimore City
",16-Mar-20,30-Apr-20,Residual sera,Multiple groups,1536,1.70%,1.10%,2.50%,Convenience,"EUROIMMUN,Hangzhou Biotest Biotech Co Ltd,Bio-rad",Multiple Types,"IgG,IgM,Total Antibody",,,High,Journal Article (Peer-Reviewed),Evan Beck,National Institutes of Health,https://dx.doi.org/10.1128/jcm.02390-21,13/07/2022,21/07/2022,Verified
220316_BaltimoreCity_NationalInstitutesofHealth_Period2_Overall,16-Mar-22,Local,United States of America,USA,Maryland,"Baltimore City
",11-Jan-21,10-Mar-21,Residual sera,Multiple groups,2824,15.70%,,,Convenience,"EUROIMMUN,Hangzhou Biotest Biotech Co Ltd,Bio-rad",Multiple Types,"IgG,IgM,Total Antibody",,,High,Journal Article (Peer-Reviewed),Evan Beck,National Institutes of Health,https://dx.doi.org/10.1128/jcm.02390-21,13/07/2022,21/07/2022,Verified
220614_NorthernCalifornia_StanfordUniversity_Incarcerated,14-Jun-22,Local,United States of America,USA,California,,08-Jul-20,30-Apr-21,Persons who are incarcerated,Multiple groups,690,12.75%,10.00%,15.00%,Stratified non-probability,Hangzhou Biotest Biotech Co. Ltd,LFIA,"IgG,IgM",92.10%,100.00%,High,Journal Article (Peer-Reviewed),Yiran Liu,Stanford University,https://dx.doi.org/10.3389/fpubh.2022.854343,14/07/2022,17/07/2022,Unverified
220706_Boston_BostonUniversity,06-Jul-22,Local,United States of America,USA,Massachusetts,Boston,01-Jul-20,30-Sep-21,Health care workers and caregivers,Adults (18-64 years),527,16.50%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Maura Dodge,Boston University School of Medicine,https://dx.doi.org/10.1093/jalm/jfac056,15/07/2022,16/07/2022,Unverified
220614_NorthernCalifornia_StanfordUniversity_Staff,14-Jun-22,Local,United States of America,USA,California,,08-Jul-20,30-Apr-21,Essential non-healthcare workers,Adults (18-64 years),292,8.22%,6.00%,12.00%,Convenience,Hangzhou Biotest Biotech Co. Ltd,LFIA,"IgG,IgM",92.10%,100.00%,High,Journal Article (Peer-Reviewed),Yiran Liu,Stanford University,https://dx.doi.org/10.3389/fpubh.2022.854343,16/07/2022,17/07/2022,Unverified
220513_California_CaliforniaDepartmentofPublicHealth_Adults_Overall,13-May-22,Regional,United States of America,USA,California,,20-Apr-21,15-Jun-21,Household and community samples,Multiple groups,7483,67.00%,63.00%,71.00%,Stratified probability,Enable Biosciences,Other,Total Antibody,100.00%,100.00%,Low,Journal Article (Peer-Reviewed),Megha Mehrotra,California Department of Public Health,https://dx.doi.org/10.1093/ofid/ofac246,25/07/2022,29/07/2022,Unverified
220513_California_CaliforniaDepartmentofPublicHealth_Children_Overall,13-May-22,Regional,United States of America,USA,California,,20-Apr-21,15-Jun-21,Household and community samples,Children and Youth (0-17 years),1375,41.00%,35.00%,47.00%,Stratified probability,Enable Biosciences,Other,Total Antibody,100.00%,100.00%,Low,Journal Article (Peer-Reviewed),Megha Mehrotra,California Department of Public Health,https://dx.doi.org/10.1093/ofid/ofac246,25/07/2022,29/07/2022,Unverified
220718_Chicago_NorthwesternUniversity_AntiRBDandNAbs,18-Jul-22,Local,United States of America,USA,Illinois,Chicago,24-Jun-20,11-Nov-20,Household and community samples,Multiple groups,4463,6.41%,,,Stratified probability,"Kantaro Biosciences LLC,Meso Scale Diagnostics",Multiple Types,"IgG,Neutralizing ",,,Moderate,Journal Article (Peer-Reviewed),Amelia Sancilio,Northwestern University,https://dx.doi.org/10.1038/s41598-022-15791-6,26/07/2022,29/07/2022,Unverified
220718_NorthCarolina_EastCarolinaUniversity_overall,18-Jul-22,Local,United States of America,USA,"North Carolina
",,26-Aug-20,31-Mar-21,Students and Daycares,Adults (18-64 years),695,9.78%,,,Convenience,Abbott Laboratories,CLIA,IgG,99.00%,100.00%,,Preprint,C. Suzanne Lea,East Carolina Univeristy,10.1101/2022.07.15.22277688,27/07/2022,29/07/2022,Unverified
220804_UnitedStatesofAmerica_GeorgeWashingtonUniversity,04-Aug-22,National,United States of America,USA,,,13-May-20,06-Jul-20,Household and community samples,Multiple groups,6665,34.70%,,,Convenience,"Epitope Diagnostics, Inc.",ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Jonathan Silverberg,George Washington University,https://dx.doi.org/10.1371/journal.pone.0271310,09/08/2022,09/08/2022,Unverified
220601_Colorado_UniversityOfColoradoDenver_Primary,01-Jun-22,Regional,United States of America,USA,Colorado,,15-Aug-20,15-Dec-20,Blood donors,Children and Youth (0-17 years),4172,31.10%,,,Unclear,NA,Not reported,Not reported,,,High,Presentation or Conference,CRISTY GENO RASMUSSEN,University of Colorado Denver,https://dx.doi.org/10.2337/db22-34-OR,16/08/2022,16/08/2022,Unverified
220704_Zanzibar_StateUniversityofZanzibar,04-Jul-22,Regional,United Republic of Tanzania,TZA,Zanzibar Region,,28-Jul-21,20-Oct-21,Household and community samples,Multiple groups,2051,56.90%,,,Convenience,EUROIMMUN,ELISA,IgG,90.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Salum Seif Salum,State University of Zanzibar,https://dx.doi.org/10.1016/j.ijregi.2022.06.007,20/07/2022,20/07/2022,Unverified
200520_England_RutherfordHealth_HCW_IgG,20-May-20,Local,United Kingdom of Great Britain and Northern Ireland,GBR,England,"Reading, Newport, Liverpool, Bedlington",14-Apr-20,24-Apr-20,Health care workers and caregivers,Adults (18-64 years),161,1.24%,,,Convenience,"Sugentech, Inc.",LFIA,IgG,,,High,Preprint,Karol Sikora,Rutherford Health,https://www.medrxiv.org/content/10.1101/2020.05.16.20099408v1.full.pdf+html,21/05/2020,16/07/2022,Verified
200617_Gibraltar_GibraltarGovernment_HCW,17-Jun-20,Regional,United Kingdom of Great Britain and Northern Ireland,GBR,Gibraltar,,03-Jun-20,17-Jun-20,Health care workers and caregivers,Adults (18-64 years),1247,1.40%,,,Convenience,NA,Not reported,IgG,,,Unclear,News and Media,Priya Gulraj,Gibraltar Government ,https://www.google.com/url?rct=j&sa=t&url=https://www.chronicle.gi/after-in-house-gha-screening-programme-govt-rethinks-its-plans-for-anti-body-tests/&ct=ga&cd=CAAYBjIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNHWZarBh_XNDZ6O6KvR5YUdioFyGg,23/06/2020,16/07/2022,Verified
200821_England_PHE_SeroepiUnitPaedsSurvey_Under20_TestAdj_FebMarch,21-Aug-20,National,United Kingdom of Great Britain and Northern Ireland,GBR,England,,01-Feb-20,31-Mar-20,Residual sera,Children and Youth (0-17 years),443,0.80%,0.00%,2.50%,Stratified probability,Abbott Laboratories,ELISA,IgG,95.70%,99.10%,Moderate,Institutional Report,Public Health England,Public Health England,https://www.gov.uk/government/publications/national-covid-19-surveillance-reports,18/07/2020,16/07/2022,Verified
200821_England_PHE_WhatsTheStory_TestAdj_FebMarch,21-Aug-20,National,United Kingdom of Great Britain and Northern Ireland,GBR,England,,01-Feb-20,31-Mar-20,Household and community samples,Children and Youth (0-17 years),106,0.50%,0.00%,3.60%,Stratified probability,Abbott Laboratories,ELISA,IgG,95.70%,99.10%,Moderate,Institutional Report,Public Health England,Public Health England,https://www.gov.uk/government/publications/national-covid-19-surveillance-reports,18/07/2020,16/07/2022,Verified
200717_England_PHE_BloodDonor_GenPop_London_TestPopAdj_Week13,28-Aug-20,Regional,United Kingdom of Great Britain and Northern Ireland,GBR,England,London,26-Mar-20,27-Mar-20,Blood donors,Adults (18-64 years),757,2.60%,1.10%,4.40%,Stratified probability,EUROIMMUN,ELISA,IgG,82.50%,99.10%,Moderate,Institutional Report,Public Health England,Public Health England,https://www.gov.uk/government/publications/national-covid-19-surveillance-reports,18/07/2020,16/07/2022,Verified
200709_England_PHE_BloodDonor_GenPop_Overall_TestPopAdj_Week23to27,09-Jul-20,National,United Kingdom of Great Britain and Northern Ireland,GBR,England,,01-Jun-20,28-Jun-20,Blood donors,Multiple groups,10318,7.20%,6.60%,7.80%,Stratified probability,EUROIMMUN,ELISA,IgG,82.50%,99.10%,Moderate,Institutional Report,Public Health England,Public Health England,https://www.gov.uk/government/publications/national-covid-19-surveillance-reports,18/07/2020,16/07/2022,Verified
200709_England_PHE_BloodDonor_GenPop_Overall_TestPopAdj_Week19to22,09-Jul-20,National,United Kingdom of Great Britain and Northern Ireland,GBR,England,,04-May-20,31-May-20,Blood donors,Adults (18-64 years),7686,8.30%,7.50%,9.20%,Stratified probability,EUROIMMUN,ELISA,IgG,82.50%,99.10%,Moderate,Institutional Report,Public Health England,Public Health England,https://www.gov.uk/government/publications/national-covid-19-surveillance-reports,18/07/2020,16/07/2022,Verified
200709_England_PHE_BloodDonor_GenPop_London_TestPopAdj_Week15to16,28-Aug-20,Regional,United Kingdom of Great Britain and Northern Ireland,GBR,England,London,09-Apr-20,13-Apr-20,Blood donors,Adults (18-64 years),1085,11.10%,8.90%,13.60%,Stratified probability,EUROIMMUN,ELISA,IgG,82.50%,99.10%,Moderate,Institutional Report,Public Health England,Public Health England,https://www.gov.uk/government/publications/national-covid-19-surveillance-reports,19/07/2020,16/07/2022,Verified
200807_England_PHE_RCGP_GenPop_TestPopAdj_Overall_euroimmun,07-Aug-20,National,United Kingdom of Great Britain and Northern Ireland,GBR,England,,16-Mar-20,30-Jun-20,Residual sera,Seniors (65+ years),6000,3.90%,,,Stratified probability,EUROIMMUN,ELISA,IgG,,,Moderate,Institutional Report,Public Health England,Public Health England,https://www.gov.uk/government/publications/national-covid-19-surveillance-reports,19/07/2020,16/07/2022,Verified
200617_England_PHE_BloodDonor_GenPop_Midlands_TestPopAdj_Week14,28-Aug-20,Regional,United Kingdom of Great Britain and Northern Ireland,GBR,England,,02-Apr-20,03-Apr-20,Blood donors,Adults (18-64 years),916,2.40%,1.00%,4.00%,Stratified probability,EUROIMMUN,ELISA,IgG,82.50%,99.10%,Moderate,Institutional Report,Public Health England,Public Health England,https://www.gov.uk/government/publications/national-covid-19-surveillance-reports,19/07/2020,16/07/2022,Verified
200617_England_PHE_BloodDonor_GenPop_Midlands_TestPopAdj_Week17_Mid,28-Aug-20,Regional,United Kingdom of Great Britain and Northern Ireland,GBR,England,,23-Apr-20,24-Apr-20,Blood donors,Adults (18-64 years),1043,7.30%,5.40%,9.40%,Stratified probability,EUROIMMUN,ELISA,IgG,82.50%,99.10%,Moderate,Institutional Report,Public Health England,Public Health England,https://www.gov.uk/government/publications/national-covid-19-surveillance-reports,19/07/2020,16/07/2022,Verified
200603_England_PHE_BloodDonor_GenPop_Southwest_TestPopAdj_Week17_South,28-Aug-20,Regional,United Kingdom of Great Britain and Northern Ireland,GBR,England,,24-Apr-20,26-Apr-20,Blood donors,Adults (18-64 years),865,5.00%,3.20%,7.00%,Stratified probability,EUROIMMUN,ELISA,IgG,82.50%,99.10%,Moderate,Institutional Report,Public Health England,Public Health England,https://www.gov.uk/government/publications/national-covid-19-surveillance-reports,19/07/2020,16/07/2022,Verified
200527_England_PHE_BloodDonor_GenPop_Northeast_TestPopAdj_Week16,28-Aug-20,Regional,United Kingdom of Great Britain and Northern Ireland,GBR,England,,14-Apr-20,16-Apr-20,Blood donors,Adults (18-64 years),1017,4.60%,3.00%,6.40%,Stratified probability,EUROIMMUN,ELISA,IgG,79.00%,99.00%,Moderate,Institutional Report,Public Health England,Public Health England,https://www.gov.uk/government/publications/national-covid-19-surveillance-reports,19/07/2020,16/07/2022,Verified
200527_England_PHE_BloodDonor_GenPop_Northwest_TestPopAdj_Week16to17,28-Aug-20,Regional,United Kingdom of Great Britain and Northern Ireland,GBR,England,,15-Apr-20,20-Apr-20,Blood donors,Adults (18-64 years),936,6.20%,4.40%,8.40%,Stratified probability,EUROIMMUN,ELISA,IgG,79.00%,99.00%,Moderate,Institutional Report,Public Health England,Public Health England,https://www.gov.uk/government/publications/national-covid-19-surveillance-reports,19/07/2020,16/07/2022,Verified
200821_England_PHE_SeroepiUnitPaedsSurvey_Under20_TestAdj_May,11-Sep-20,National,United Kingdom of Great Britain and Northern Ireland,GBR,England,,01-May-20,31-May-20,Residual sera,Children and Youth (0-17 years),1061,7.30%,5.60%,9.20%,Stratified probability,Abbott Laboratories,ELISA,IgG,95.70%,99.10%,Moderate,Institutional Report,Public Health England,Public Health England,https://www.gov.uk/government/publications/national-covid-19-surveillance-reports,19/07/2020,16/07/2022,Verified
200821_England_PHE_WhatsTheStory_TestAdj_April,21-Aug-20,National,United Kingdom of Great Britain and Northern Ireland,GBR,England,,01-Apr-20,30-Apr-20,Household and community samples,Children and Youth (0-17 years),201,3.80%,1.20%,7.50%,Stratified probability,Abbott Laboratories,ELISA,IgG,95.70%,99.10%,Moderate,Institutional Report,Public Health England,Public Health England,https://www.gov.uk/government/publications/national-covid-19-surveillance-reports,19/07/2020,16/07/2022,Verified
200821_England_PHE_SeroepiUnitPaedsSurvey_Under20_TestAdj_April,21-Aug-20,National,United Kingdom of Great Britain and Northern Ireland,GBR,England,,01-Apr-20,30-Apr-20,Residual sera,Children and Youth (0-17 years),647,6.10%,4.10%,8.40%,Stratified probability,Abbott Laboratories,ELISA,IgG,95.70%,99.10%,Moderate,Institutional Report,Public Health England,Public Health England,https://www.gov.uk/government/publications/national-covid-19-surveillance-reports,19/07/2020,16/07/2022,Verified
200707_NorthWestEngland_SalfordRoyalNHSFoundationTrust_HCW,07-Jul-20,Local,United Kingdom of Great Britain and Northern Ireland,GBR,England,,04-May-20,06-May-20,Health care workers and caregivers,Adults (18-64 years),281,6.00%,,,Convenience,Snibe Co. Ltd (Shenzhen New Industries Biomedical Engineering Co. Ltd),CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Dimitrios Poulikakos,Salford Royal NHS Foundation Trust,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7338856/,20/07/2020,16/07/2022,Verified
200709_London_UniversityCollegeLondonHospitals_HCW,09-Jul-20,Local,United Kingdom of Great Britain and Northern Ireland,GBR,England,London,26-Mar-20,08-Apr-20,Health care workers and caregivers,Adults (18-64 years),181,45.30%,,,Convenience,NA,Multiple Types,"IgG,IgA,IgM",,,High,Journal Article (Peer-Reviewed),Catherine Houlihan,University College London Hospitals,https://dx.doi.org/10.1016/S0140-6736(20)31484-7,30/07/2020,16/07/2022,Verified
201004_SEEngland_King’sCollegeLondon,14-Oct-20,Regional,United Kingdom of Great Britain and Northern Ireland,GBR,South East England,,27-Apr-20,02-Jun-20,Household and community samples,Multiple groups,431,12.00%,9.10%,15.20%,Convenience,NA,ELISA,"IgG,IgM",90.00%,100.00%,High,Journal Article (Peer-Reviewed),Philippa M Wells,King’s College London,http://dx.doi.org/10.1016/j.jinf.2020.10.011,28/09/2020,16/07/2022,Verified
200725_UK_TheQueenElizabethHospital_HealthCareWorkers_UnAdj,25-Jul-20,Local,United Kingdom of Great Britain and Northern Ireland,GBR,England,King's Lynn,01-Jun-20,07-Jun-20,Health care workers and caregivers,Adults (18-64 years),70,21.40%,,,Unclear,NA,Other,IgG,,,High,Journal Article (Peer-Reviewed),D M Favara,The Queen Elizabeth Hospital,https://dx.doi.org/10.1016/j.clon.2020.07.015,29/09/2020,16/07/2022,Verified
200808_UK_PortlandHospitalforWomenandChildren_HCW,08-Aug-20,Local,United Kingdom of Great Britain and Northern Ireland,GBR,England,London,15-May-20,28-May-20,Health care workers and caregivers,Adults (18-64 years),190,22.00%,,,Convenience,Abbott Laboratories,ELISA,IgG,96.90%,99.90%,High,Journal Article (Peer-Reviewed),Asma Khalil,St George’s University of London,http://dx.doi.org/10.1093/cid/ciaa893,03/10/2020,16/07/2022,Verified
200810_London_UniversityCollegeLondon_Total,10-Aug-20,Local,United Kingdom of Great Britain and Northern Ireland,GBR,England,London,11-May-20,05-Jun-20,Health care workers and caregivers,Multiple groups,200,14.50%,9.90%,20.10%,Unclear,Abbott Laboratories,CLIA,IgG,100.00%,99.60%,High,Journal Article (Peer-Reviewed),S Bampoe,University College London,https://associationofanaesthetists-publications.onlinelibrary.wiley.com/doi/full/10.1111/anae.15229,04/10/2020,16/07/2022,Verified
200729_London_WhittingtonHealthNHSTrust_Overall,04-Aug-20,Local,United Kingdom of Great Britain and Northern Ireland,GBR,England,London,15-May-20,05-Jun-20,Health care workers and caregivers,Multiple groups,2004,31.60%,,,Convenience,Roche Diagnostics,CLIA,"IgG,IgM",,99.80%,High,Journal Article (Peer-Reviewed),Joseph Grant,Whittington Health NHS Trust,https://dx.doi.org/10.1017/ice.2020.402,05/10/2020,16/07/2022,Verified
200922_Gateshead_NHSFoundationTrust_Overall,22-Sep-20,Local,United Kingdom of Great Britain and Northern Ireland,GBR,England,Gateshead,28-May-20,08-Jun-20,Health care workers and caregivers,Adults (18-64 years),2521,19.40%,,,Convenience,Roche Diagnostics,CLIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Salman Razvi,Gateshead Health NHS Foundation Trust,https://dx.doi.org/10.7861/clinmed.2020-0566,14/10/2020,16/07/2022,Verified
200807_England_PHE_BloodDonor_GenPop_Overall_TestPopAdj_Week27to31,07-Aug-20,National,United Kingdom of Great Britain and Northern Ireland,GBR,England,,29-Jun-20,28-Jul-20,Blood donors,Multiple groups,9388,5.90%,5.30%,6.50%,Stratified probability,EUROIMMUN,ELISA,IgG,83.00%,99.30%,Moderate,Institutional Report,Public Health England,Public Health England,https://www.gov.uk/government/publications/national-covid-19-surveillance-reports,19/10/2020,16/07/2022,Verified
200930_Scotland_PublicHealthScotland_2BloodDonors_Overall_TestAdj,30-Sep-20,National,United Kingdom of Great Britain and Northern Ireland,GBR,Scotland,,29-Jun-20,09-Aug-20,Blood donors,Multiple groups,3220,3.10%,2.50%,3.80%,Sequential,NA,Not reported,Not reported,87.50%,98.60%,Moderate,Institutional Report,Public Health Scotland,Public Health Scotland,https://beta.isdscotland.org/find-publications-and-data/population-health/covid-19/enhanced-surveillance-of-covid-19-in-scotland/30-september-2020/,25/10/2020,16/07/2022,Verified
200724_UK_ChelseaandWestminsterHospital_HCW,24-Jul-20,Local,United Kingdom of Great Britain and Northern Ireland,GBR,England,London,08-Apr-20,12-Jun-20,Health care workers and caregivers,Multiple groups,504,10.60%,7.60%,13.60%,Convenience,"CTK Biotech, Inc.,NA,Abbott Laboratories",Multiple Types,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Scott Pallett,Chelsea and Westminster Hospital NHS Trust,https://dx.doi.org/10.1016/S2213-2600(20)30315-5,28/10/2020,16/07/2022,Verified
200911_Birmingham_UniversityHospitalsBirminghamNHSFoundationTrust_Overall,11-Sep-20,Local,United Kingdom of Great Britain and Northern Ireland,GBR,England,Birmingham,24-Apr-20,25-Apr-20,Health care workers and caregivers,Adults (18-64 years),516,24.40%,,,Self-referral,NA,ELISA,"IgA,IgG,IgM",100.00%,97.80%,High,Journal Article (Peer-Reviewed),Adrian Shields,University Hospitals Birmingham NHS Foundation Trust,http://dx.doi.org/10.1136/thoraxjnl-2020-215414,03/11/2020,16/07/2022,Verified
200920_EasternUK_CambridgeUniversityHospitalsNHSFoundationTrust_Day1Luminex,20-Sep-20,Regional,United Kingdom of Great Britain and Northern Ireland,GBR,East of England,,15-Jun-20,15-Jun-20,Health care workers and caregivers,Adults (18-64 years),434,18.40%,,,Convenience,NA,ELISA,IgG,84.00%,100.00%,High,Preprint,David Favara,Cambridge University Hospitals NHS Foundation Trust,https://www.medrxiv.org/content/10.1101/2020.09.18.20197590v1,14/01/2021,16/07/2022,Verified
201113_London_ImperialCollegeLondon_KidneyTransplantPatients,13-Nov-20,Local,United Kingdom of Great Britain and Northern Ireland,GBR,Greater London,London,01-Jun-20,03-Jul-20,Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),855,10.40%,8.50%,12.60%,Sequential,"Abbott Laboratories,Fortress Diagnostics",Multiple Types,"IgG,Total Antibody",,,High,Journal Article (Peer-Reviewed),Michelle Willicombe,Imperial College London,https://dx.doi.org/10.1097/TP.0000000000003526,16/01/2021,16/07/2022,Verified
201012_UnitedKingdom_RoyalBelfastHospitalForSickChildren,10-Nov-20,National,United Kingdom of Great Britain and Northern Ireland,GBR,"Ireland, Wales, Scotland, England","Belfast, Cardiff, Glasgow, London, Manchester",16-Apr-20,03-Jul-20,Family of essential workers,Children and Youth (0-17 years),992,6.90%,5.40%,8.60%,Convenience,"Abbott Laboratories,DiaSorin,Roche Diagnostics",Not reported,"IgG,Total Antibody",,,High,Journal Article (Peer-Reviewed),Thomas Waterfield,Royal Belfast Hospital for Sick Children,https://dx.doi.org/10.1136/archdischild-2020-320558,17/01/2021,16/07/2022,Verified
201022_Oxford_UniversityOfOxford_unadj,22-Oct-20,Local,United Kingdom of Great Britain and Northern Ireland,GBR,,Oxford,14-Apr-20,15-Jun-20,Pregnant or parturient women,Adults (18-64 years),1000,5.30%,4.00%,6.90%,Sequential,NA,ELISA,IgG,99.10%,99.00%,Moderate,Journal Article (Peer-Reviewed),Sheila F Lumley,University of Oxford,https://dx.doi.org/10.2807/1560-7917.ES.2020.25.41.2001721,21/01/2021,16/07/2022,Verified
201027_England_ImperialCollegeLondon_SamplingPeriod2_TotalAdj,27-Oct-20,National,United Kingdom of Great Britain and Northern Ireland,GBR,,,31-Jul-20,13-Aug-20,Household and community samples,Multiple groups,105829,4.83%,4.67%,5.00%,Simplified probability,Fortress Diagnostics,LFIA,IgG,84.40%,98.60%,Moderate,Preprint,Helen Ward,Imperial College London,https://www.medrxiv.org/content/10.1101/2020.10.26.20219725v1.full.pdf,21/01/2021,16/07/2022,Verified
201027_England_ImperialCollegeLondon_SamplingPeriod3_TotalAdj,27-Oct-20,National,United Kingdom of Great Britain and Northern Ireland,GBR,,,15-Sep-20,28-Sep-20,Household and community samples,Multiple groups,159367,4.38%,4.25%,4.51%,Simplified probability,Fortress Diagnostics,LFIA,IgG,84.40%,98.60%,Moderate,Preprint,Helen Ward,Imperial College London,https://www.medrxiv.org/content/10.1101/2020.10.26.20219725v1.full.pdf,21/01/2021,16/07/2022,Verified
201117_UK_ImmunisationAndCountermeasuresDivision_ChildrenOfHCW,17-Nov-20,National,United Kingdom of Great Britain and Northern Ireland,GBR,,"Belfast, Cardiff, Glasgow, London, Manchester",01-May-20,31-May-20,Contacts of COVID patients,Children and Youth (0-17 years),44,36.20%,9.00%,63.40%,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Shamez Ladhani,Immunisation and Countermeasures Division,https://dx.doi.org/10.1093/cid/ciaa1737,22/01/2021,16/07/2022,Verified
200904_England_PHE_BloodDonors_Overall_TestPopAdj_Week31to35,11-Sep-20,National,United Kingdom of Great Britain and Northern Ireland,GBR,England,,27-Jul-20,30-Aug-20,Blood donors,Multiple groups,8764,5.30%,4.80%,5.80%,Stratified probability,EUROIMMUN,ELISA,IgG,83.00%,99.30%,Moderate,Institutional Report,Public Health England,Public Health England,https://www.gov.uk/government/publications/national-covid-19-surveillance-reports,23/01/2021,16/07/2022,Verified
201103_London_PHE_LTCStaff,03-Nov-20,Local,United Kingdom of Great Britain and Northern Ireland,GBR,Greater London,London,03-Jun-20,30-Jun-20,Health care workers and caregivers,Multiple groups,327,47.10%,,,Convenience,Abbott Laboratories,Not reported,IgG,93.90%,100.00%,High,Journal Article (Peer-Reviewed),Thomas Rowland,Public Health England,https://dx.doi.org/10.1016/j.jinf.2020.10.035,23/01/2021,16/07/2022,Verified
201223_Oxford_OxfordUniversityHospitals_HCW_Spike,23-Dec-20,Local,United Kingdom of Great Britain and Northern Ireland,GBR,,,23-Apr-20,30-Nov-20,Health care workers and caregivers,Multiple groups,12541,10.08%,,,Convenience,NA,ELISA,IgG,99.10%,99.00%,Moderate,Journal Article (Peer-Reviewed),Sheila Lumley,Oxford University Hospitals,https://dx.doi.org/10.1056/NEJMoa2034545,23/01/2021,16/07/2022,Verified
201119_UK_QueensUniversityBelfast_adj,19-Nov-20,National,United Kingdom of Great Britain and Northern Ireland,GBR,,"Belfast, Cardiff, Glasgow, London, Manchester",26-Jun-20,15-Aug-20,Family of essential workers,Children and Youth (0-17 years),849,7.66%,6.05%,9.64%,Convenience,"Roche Diagnostics,DiaSorin",Multiple Types,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Cathal Roarty,Queens University Belfast,https://dx.doi.org/10.1016/S1473-3099(20)30884-7,23/01/2021,16/07/2022,Verified
200911_England_PHE_WhatsTheStory_Summary_5_May_August,11-Sep-20,National,United Kingdom of Great Britain and Northern Ireland,GBR,England,,01-May-20,05-Aug-20,Household and community samples,Children and Youth (0-17 years),568,5.20%,3.20%,7.80%,Stratified probability,Abbott Laboratories,CLIA,IgG,95.70%,99.10%,Moderate,Institutional Report,Public Health England,Public Health England,https://www.gov.uk/government/publications/national-covid-19-surveillance-reports,23/01/2021,16/07/2022,Verified
201002_England_PHE_BloodDonors_Summary_Final,02-Oct-20,National,United Kingdom of Great Britain and Northern Ireland,GBR,England,,24-Aug-20,18-Sep-20,Blood donors,Multiple groups,8230,6.10%,5.40%,6.80%,Stratified probability,EUROIMMUN,ELISA,IgG,83.00%,99.30%,Moderate,Institutional Report,Public Health England,Public Health England,https://www.gov.uk/government/publications/national-covid-19-surveillance-reports,23/01/2021,16/07/2022,Verified
201002_England_PHE_RCGP_Collection_Summary_Final_week25to33_abbott,02-Oct-20,National,United Kingdom of Great Britain and Northern Ireland,GBR,England,,15-Jun-20,16-Aug-20,Residual sera,Seniors (65+ years),4315,6.50%,5.50%,7.60%,Stratified probability,Abbott Laboratories,CLIA,IgG,95.70%,99.10%,Moderate,Institutional Report,Public Health England,Public Health England,https://www.gov.uk/government/publications/national-covid-19-surveillance-reports,23/01/2021,16/07/2022,Verified
201002_England_PHE_SeroepiUnitPaedsSurvey_6_Final_week25to33_Abbott,02-Oct-20,National,United Kingdom of Great Britain and Northern Ireland,GBR,England,,15-Jun-20,16-Aug-20,Residual sera,Multiple groups,1212,5.20%,3.90%,7.00%,Stratified probability,Abbott Laboratories,CLIA,IgG,95.70%,99.10%,Low,Institutional Report,Public Health England,Public Health England,https://www.gov.uk/government/publications/national-covid-19-surveillance-reports,23/01/2021,16/07/2022,Verified
200826_London_ImperialCollegeLondon_LTC,26-Aug-20,Local,United Kingdom of Great Britain and Northern Ireland,GBR,Greater London,London,01-Jun-20,30-Jun-20,Assisted living and long-term care facilities,Seniors (65+ years),241,71.80%,66.00%,77.00%,Convenience,Abbott Laboratories,Not reported,IgG,93.90%,100.00%,High,Journal Article (Peer-Reviewed),Neil Graham,Imperial College London,https://www.journalofinfection.com/article/S0163-4453(20)30574-0/fulltext,23/01/2021,16/07/2022,Verified
201109_UK_WatfordGeneralHospital_ACU,09-Nov-20,Local,United Kingdom of Great Britain and Northern Ireland,GBR,NR,Watford,27-Mar-20,08-Jun-20,Residual sera,Multiple groups,443,1.58%,,,Sequential,NA,Not reported,Not reported,,,High,Journal Article (Peer-Reviewed),Muhammad Arif,Watford General Hospital,https://dx.doi.org/10.7759/cureus.11398,23/01/2021,16/07/2022,Verified
201215_Leicester_UniversityHospitalsofLeicesterNHSTrust,15-Dec-20,Local,United Kingdom of Great Britain and Northern Ireland,GBR,England,Leicester ,29-May-20,03-Aug-20,Health care workers and caregivers,Adults (18-64 years),200,12.00%,,,Convenience,Abbott Laboratories,Not reported,IgG,92.70%,100.00%,High,Journal Article (Peer-Reviewed),John Black,University Hospitals of Leicester NHS Trust,https://dx.doi.org/10.1111/tri.13791,27/01/2021,16/07/2022,Verified
201130_Bristol_NorthBristolNHSTrust_hcw,30-Nov-20,Local,United Kingdom of Great Britain and Northern Ireland,GBR,England,"Bristol, South Gloucestershire, North Somerset",15-Jan-20,15-Jun-20,Health care workers and caregivers,Multiple groups,6858,9.30%,,,Self-referral,"Abbott Laboratories,Roche Diagnostics",CLIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Christopher Jones,North Bristol NHS Trust,https://www.journalofinfection.com/article/S0163-4453(20)30755-6/fulltext,31/01/2021,16/07/2022,Verified
201222_Newcastle_Newcastle-upon-TyneHospitalsNHSTrust,22-Dec-20,Local,United Kingdom of Great Britain and Northern Ireland,GBR,England ,Newcastle-Upon-Tyne,29-May-20,06-Jul-20,Health care workers and caregivers,Adults (18-64 years),11103,8.40%,,,Convenience,Roche Diagnostics,Not reported,IgG,,,High,Preprint,Aidan Hanrath,Newcastle-upon-Tyne Hospitals NHS Trust,https://www.medrxiv.org/content/10.1101/2020.12.22.20242362v1,02/02/2021,16/07/2022,Verified
201211_London_RichmondPharmacologyLtd,11-Dec-20,Local,United Kingdom of Great Britain and Northern Ireland,GBR,England,London,19-Mar-20,02-Dec-20,Multiple populations,Multiple groups,6061,6.40%,,,Unclear,NA,Other,IgG,,,High,Preprint,Jorg Taubel,Richmond Pharmacology Ltd,https://www.medrxiv.org/content/10.1101/2020.12.08.20245894v2,04/02/2021,16/07/2022,Verified
201022_Scotland_UniversityOfOxford_overall,22-Oct-20,Regional,United Kingdom of Great Britain and Northern Ireland,GBR,Scotland,,17-Mar-20,18-May-20,Blood donors,Adults (18-64 years),3500,3.17%,,,Simplified probability,NA,Neutralization,Neutralizing ,94.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Craig P Thompson,University of Oxford,https://dx.doi.org/10.2807/1560-7917.ES.2020.25.42.2000685,06/02/2021,16/07/2022,Verified
210111_UK_PublicHealthEngland_Round1_overall,20-Jan-21,National,United Kingdom of Great Britain and Northern Ireland,GBR,England,,01-Jun-20,15-Jun-20,Multiple populations,Multiple groups,2198,13.60%,12.40%,15.10%,Simplified probability,Abbott Laboratories,CLIA,IgG,,,Moderate,Preprint, Shamez Ladhani,Public Health England,https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3764198,11/02/2021,16/07/2022,Verified
210111_UK_PublicHealthEngland_Round2_overall ,20-Jan-21,National,United Kingdom of Great Britain and Northern Ireland,GBR,England,,07-Jul-20,21-Jul-20,Household and community samples,Multiple groups,1431,12.10%,10.50%,13.90%,Simplified probability,Abbott Laboratories,CLIA,IgG,,,Moderate,Preprint, Shamez Ladhani,Public Health England,https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3764198,11/02/2021,16/07/2022,Verified
210111_UK_PublicHealthEngland_Round3_overall,20-Jan-21,National,United Kingdom of Great Britain and Northern Ireland,GBR,England,,17-Nov-20,30-Nov-20,Household and community samples,Multiple groups,1216,10.40%,8.80%,12.30%,Simplified probability,Abbott Laboratories,CLIA,IgG,,,Moderate,Preprint, Shamez Ladhani,Public Health England,https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3764198,11/02/2021,16/07/2022,Verified
201104_Cambridge_CambridgeUniversityHospitalsNHSFoundationTrust_HCW&HospitalStaff,04-Nov-20,Local,United Kingdom of Great Britain and Northern Ireland,GBR,England,Cambridge,10-Jun-20,07-Aug-20,Health care workers and caregivers,Multiple groups,5698,7.20%,,,Convenience,Siemens,CLIA,Total Antibody,98.10%,99.90%,Moderate,Preprint,Daniel Cooper,Cambridge University Hospitals NHS Foundation Trust,https://doi.org/10.1101/2020.11.03.20220699,13/02/2021,16/07/2022,Verified
201116_Leicester_UniversityofLeicester_HCW,16-Nov-20,Local,United Kingdom of Great Britain and Northern Ireland,GBR,East Midlands,Leicester,29-May-20,13-Jul-20,Health care workers and caregivers,Adults (18-64 years),10662,10.77%,,,Convenience,Abbott Laboratories,Not reported,IgG,93.50%,100.00%,Moderate,Journal Article (Peer-Reviewed),Christopher Martin,University of Leicester,https://dx.doi.org/10.1093/pubmed/fdaa199,13/02/2021,16/07/2022,Verified
210203_England_TheUniversityofNottingham_HCW_primary,03-Feb-21,Local,United Kingdom of Great Britain and Northern Ireland,GBR,East Midlands,,24-Apr-20,10-Jul-20,Health care workers and caregivers,Adults (18-64 years),633,18.00%,,,Convenience,NA,ELISA,"IgG,IgA,IgM",,,High,Preprint,Simon Craxford,The University of Nottingham,https://www.medrxiv.org/content/10.1101/2021.02.01.21250950v1,17/02/2021,16/07/2022,Unverified
210203_England_TheUniversityofNottingham_HHC_primary,03-Feb-21,Local,United Kingdom of Great Britain and Northern Ireland,GBR,England,,01-Sep-20,30-Sep-20,Health care workers and caregivers,Adults (18-64 years),178,7.30%,,,Convenience,NA,ELISA,"IgG,IgA,IgM",,,High,Preprint,Simon Craxford,The University of Nottingham,https://www.medrxiv.org/content/10.1101/2021.02.01.21250950v1,17/02/2021,16/07/2022,Unverified
201021_London_BartsHealthNHSTrust_primary,21-Oct-20,Local,United Kingdom of Great Britain and Northern Ireland,GBR,,London,01-May-20,04-Jun-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,1253,18.00%,,,Convenience,Roche Diagnostics,CLIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Kieran McCafferty,Barts Health NHS Trust ,http://dx.doi.org/10.1111/hdi.12883,24/02/2021,16/07/2022,Verified
210101_London_LewishamGreenwichNHSTrust_HCW_Overall,01-Jan-21,Local,United Kingdom of Great Britain and Northern Ireland,GBR,England,"Lewisham, Greenwich ",27-May-20,24-Jun-20,Health care workers and caregivers,Adults (18-64 years),6212,26.00%,,,Convenience,Abbott Laboratories,CLIA,IgG,99.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Mehool Patel,Lewisham and greenwich NHS Trust ,https://dx.doi.org/10.7861/clinmed.2020-0619,01/03/2021,16/07/2022,Verified
200626_UK_OfficeforNationalStatistics_May_June2020_England_Genpop,25-Jun-20,Regional,United Kingdom of Great Britain and Northern Ireland,GBR,England,,08-May-20,04-Jun-20,Household and community samples,Multiple groups,1575,6.30%,4.50%,8.70%,Stratified probability,NA,ELISA,IgG,99.00%,99.10%,Moderate,Institutional Report,Office for National Statistics,Office of National Statistics,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020,12/03/2021,16/07/2022,Verified
200726_UK_OfficeforNationalStatistics_June_July2020_England_Genpop,31-Jul-20,Regional,United Kingdom of Great Britain and Northern Ireland,GBR,England,,05-Jun-20,02-Jul-20,Household and community samples,Multiple groups,2392,4.18%,,,Stratified probability,NA,ELISA,IgG,99.00%,99.10%,Moderate,Institutional Report,Office for National Statistics,Office of National Statistics,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020,12/03/2021,16/07/2022,Verified
200826_UK_OfficeforNationalStatistics_July_020_England_genpop,28-Aug-20,Regional,United Kingdom of Great Britain and Northern Ireland,GBR,England,,03-Jul-20,30-Jul-20,Household and community samples,Multiple groups,3236,6.50%,5.20%,8.10%,Stratified probability,NA,ELISA,IgG,99.00%,99.10%,Moderate,Institutional Report,Office for National Statistics,Office of National Statistics,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020,12/03/2021,16/07/2022,Verified
200826_UK_OfficeforNationalStatistics_July_August2020_England_genpop,28-Aug-20,Regional,United Kingdom of Great Britain and Northern Ireland,GBR,England,,31-Jul-20,27-Aug-20,Household and community samples,Multiple groups,6189,5.60%,4.70%,6.50%,Stratified probability,NA,ELISA,IgG,99.00%,99.10%,Moderate,Institutional Report,Office for National Statistics,Office of National Statistics,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020,12/03/2021,16/07/2022,Verified
200926_UK_OfficeforNationalStatistics_August_Sept2020_England_genpop,25-Sep-20,Regional,United Kingdom of Great Britain and Northern Ireland,GBR,England,,28-Aug-20,24-Sep-20,Household and community samples,Multiple groups,8742,5.80%,5.10%,6.50%,Stratified probability,NA,ELISA,IgG,99.00%,99.10%,Moderate,Institutional Report,Office for National Statistics,Office of National Statistics,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020,12/03/2021,16/07/2022,Verified
201026_UK_OfficeforNationalStatistics_Sept_Oct2020_England_Genpop,23-Oct-20,Regional,United Kingdom of Great Britain and Northern Ireland,GBR,England,,25-Sep-20,22-Oct-20,Household and community samples,Multiple groups,15687,6.90%,6.40%,7.50%,Stratified probability,NA,ELISA,IgG,99.00%,99.10%,Moderate,Institutional Report,Office for National Statistics,Office of National Statistics,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020,12/03/2021,16/07/2022,Verified
201126_UK_OfficeforNationalStatistics_Oct_Nov2020_England_genpop,26-Nov-20,Regional,United Kingdom of Great Britain and Northern Ireland,GBR,England,,23-Oct-20,19-Nov-20,Household and community samples,Multiple groups,15834,8.70%,8.10%,9.40%,Stratified probability,NA,ELISA,IgG,99.00%,99.10%,Moderate,Institutional Report,Office for National Statistics,Office of National Statistics,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020,12/03/2021,16/07/2022,Verified
201226_UK_OfficeforNationalStatistics_Nov_Dec2020_England_genpop,24-Dec-20,Regional,United Kingdom of Great Britain and Northern Ireland,GBR,England,,20-Nov-20,17-Dec-20,Household and community samples,Multiple groups,21684,10.10%,9.60%,10.60%,Stratified probability,NA,ELISA,IgG,99.00%,99.10%,Moderate,Institutional Report,Office for National Statistics,Office of National Statistics,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020,12/03/2021,16/07/2022,Verified
210126_UK_OfficeforNationalStatistics_Dec_Jan20_21_England_Genpop,29-Jan-21,Regional,United Kingdom of Great Britain and Northern Ireland,GBR,England,,18-Dec-20,14-Jan-21,Household and community samples,Multiple groups,24150,15.30%,14.70%,15.90%,Stratified probability,NA,ELISA,IgG,99.00%,99.10%,Moderate,Institutional Report,Office for National Statistics,Office of National Statistics,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020,12/03/2021,16/07/2022,Verified
200926_UK_OfficeforNationalStatistics_August_Sept2020_Wales_Genpop,25-Sep-20,Regional,United Kingdom of Great Britain and Northern Ireland,GBR,Wales,,28-Aug-20,24-Sep-20,Household and community samples,Multiple groups,236,4.70%,2.00%,9.20%,Stratified probability,NA,ELISA,IgG,99.00%,99.10%,Moderate,Institutional Report,Office for National Statistics,Office of National Statistics,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020,12/03/2021,16/07/2022,Verified
201026_UK_OfficeforNationalStatistics_Sept_Oct2020_NorthernIreland_genpop,23-Oct-20,Regional,United Kingdom of Great Britain and Northern Ireland,GBR,Northern Ireland,,25-Sep-20,22-Oct-20,Household and community samples,Multiple groups,249,2.80%,1.20%,5.50%,Stratified probability,NA,ELISA,IgG,99.00%,99.10%,High,Institutional Report,Office for National Statistics,Office of National Statistics,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020,12/03/2021,16/07/2022,Verified
201026_UK_OfficeforNationalStatistics_Sept_Oct2020_Scotland_Genpop,23-Oct-20,Regional,United Kingdom of Great Britain and Northern Ireland,GBR,"Scotland
",,25-Sep-20,22-Oct-20,Household and community samples,Multiple groups,383,6.80%,4.30%,10.20%,Stratified probability,NA,ELISA,IgG,99.00%,99.10%,High,Institutional Report,Office for National Statistics,Office of National Statistics,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020,12/03/2021,16/07/2022,Verified
201026_UK_OfficeforNationalStatistics_Sept_Oct2020_Wales_Genpop,23-Oct-20,Regional,United Kingdom of Great Britain and Northern Ireland,GBR,Wales,,25-Sep-20,22-Oct-20,Household and community samples,Multiple groups,473,4.70%,2.90%,7.30%,Stratified probability,NA,ELISA,IgG,99.00%,99.10%,Moderate,Institutional Report,Office for National Statistics,Office of National Statistics,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020,12/03/2021,16/07/2022,Verified
201126_UK_OfficeforNationalStatistics_Oct_Nov2020 _Scotland_Genpop,26-Nov-20,Regional,United Kingdom of Great Britain and Northern Ireland,GBR,"Scotland
",,23-Oct-20,19-Nov-20,Household and community samples,Multiple groups,397,7.80%,5.00%,11.70%,Stratified probability,NA,ELISA,IgG,99.00%,99.10%,High,Institutional Report,Office for National Statistics,Office of National Statistics,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020,12/03/2021,16/07/2022,Verified
201126_UK_OfficeforNationalStatistics_Oct_Nov2020_NorthernIreland_Genpop,26-Nov-20,Regional,United Kingdom of Great Britain and Northern Ireland,GBR,Northern Ireland,,23-Oct-20,19-Nov-20,Household and community samples,Multiple groups,333,3.50%,1.60%,6.40%,Stratified probability,NA,ELISA,IgG,99.00%,99.10%,High,Institutional Report,Office for National Statistics,Office of National Statistics,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020,12/03/2021,16/07/2022,Verified
201126_UK_OfficeforNationalStatistics_Oct_Nov2020_Wales_genpop,26-Nov-20,Regional,United Kingdom of Great Britain and Northern Ireland,GBR,Wales,,23-Oct-20,19-Nov-20,Household and community samples,Multiple groups,497,6.10%,4.00%,9.00%,Stratified probability,NA,ELISA,IgG,99.00%,99.10%,Moderate,Institutional Report,Office for National Statistics,Office of National Statistics,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020,12/03/2021,16/07/2022,Verified
201226_UK_OfficeforNationalStatistics_Nov_Dec2020_NortherIreland_genpop,24-Dec-20,Regional,United Kingdom of Great Britain and Northern Ireland,GBR,Northern Ireland,,20-Nov-20,17-Dec-20,Household and community samples,Multiple groups,248,3.70%,1.70%,7.10%,Stratified probability,NA,ELISA,IgG,99.00%,99.10%,High,Institutional Report,Office for National Statistics,Office of National Statistics,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020,12/03/2021,16/07/2022,Verified
201226_UK_OfficeforNationalStatistics_Nov_Dec2020_Scotland_genpop,24-Dec-20,Regional,United Kingdom of Great Britain and Northern Ireland,GBR,Scotland,,20-Nov-20,17-Dec-20,Household and community samples,Multiple groups,1034,5.90%,4.40%,7.60%,Stratified probability,NA,ELISA,IgG,99.00%,99.10%,Moderate,Institutional Report,Office for National Statistics,Office of National Statistics,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020,12/03/2021,16/07/2022,Verified
201226_UK_OfficeforNationalStatistics_Nov_Dec2020_Wales_genpop,24-Dec-20,Regional,United Kingdom of Great Britain and Northern Ireland,GBR,Wales,,20-Nov-20,17-Dec-20,Household and community samples,Multiple groups,631,7.20%,5.10%,9.90%,Stratified probability,NA,ELISA,IgG,99.00%,99.10%,Moderate,Institutional Report,Office for National Statistics,Office of National Statistics,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020,12/03/2021,16/07/2022,Verified
210126_UK_OfficeforNationalStatistics_Dec_Jan20_21_NortherIreland_genpop,29-Jan-21,Regional,United Kingdom of Great Britain and Northern Ireland,GBR,Northern Ireland,,18-Dec-20,14-Jan-21,Household and community samples,Multiple groups,313,12.00%,7.80%,17.40%,Stratified probability,NA,ELISA,IgG,99.00%,99.10%,High,Institutional Report,Office for National Statistics,Office of National Statistics,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020,12/03/2021,16/07/2022,Verified
210126_UK_OfficeforNationalStatistics_Dec_Jan20_21_Scotland_genpop,29-Jan-21,Regional,United Kingdom of Great Britain and Northern Ireland,GBR,"Scotland
",,18-Dec-20,14-Jan-21,Household and community samples,Multiple groups,1832,10.70%,9.10%,12.40%,Stratified probability,NA,ELISA,IgG,99.00%,99.10%,Moderate,Institutional Report,Office for National Statistics,Office of National Statistics,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020,12/03/2021,16/07/2022,Verified
210126_UK_OfficeforNationalStatistics_Dec_Jan20_21_Wales_genpop,29-Jan-21,Regional,United Kingdom of Great Britain and Northern Ireland,GBR,Wales,,18-Dec-20,14-Jan-21,Household and community samples,Multiple groups,732,11.50%,8.60%,14.90%,Stratified probability,NA,ELISA,IgG,99.00%,99.10%,Moderate,Institutional Report,Office for National Statistics,Office of National Statistics,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020,12/03/2021,16/07/2022,Verified
210107_London_UniversityCollegeLondon_June_PaediatricHCW,27-Jan-21,Local,United Kingdom of Great Britain and Northern Ireland,GBR,England,London,01-Jun-20,30-Jun-20,Health care workers and caregivers,Adults (18-64 years),1134,16.93%,14.86%,19.22%,Convenience,"Epitope Diagnostics, Inc.,Meso Scale Discovery",ELISA,IgG,,,High,Journal Article (Peer-Reviewed),D Goldblatt,University College London,http://dx.doi.org/10.1016/j.jhin.2020.12.019,13/03/2021,16/07/2022,Verified
210107_London_UniversityCollegeLondon_May_PaediatricHCW,27-Jan-21,Local,United Kingdom of Great Britain and Northern Ireland,GBR,England,London,01-May-20,31-May-20,Health care workers and caregivers,Adults (18-64 years),1754,15.34%,13.73%,17.10%,Convenience,"Epitope Diagnostics, Inc.,Meso Scale Discovery",ELISA,IgG,,,High,Journal Article (Peer-Reviewed),D Goldblatt,University College London,http://dx.doi.org/10.1016/j.jhin.2020.12.019,13/03/2021,16/07/2022,Unverified
210219_England_PHE_UniversityStudents_Overall,19-Feb-21,Regional,United Kingdom of Great Britain and Northern Ireland,GBR,England,,02-Dec-20,11-Dec-20,Students and Daycares,Adults (18-64 years),2905,17.80%,16.50%,19.30%,Convenience,"Abbott Laboratories,NA",CLIA,IgG,,,Moderate,Preprint,Amoolya Vusirikala,Public Health England,https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3787684,15/03/2021,16/07/2022,Verified
210127_UK_UniversityCollegeLondon_overall,27-Jan-21,Regional,United Kingdom of Great Britain and Northern Ireland,GBR,England,"Nottingham, London",23-Mar-20,10-Jul-20,Health care workers and caregivers,Adults (18-64 years),1364,19.94%,,,Convenience,"EUROIMMUN,Roche Diagnostics,NA",ELISA,IgG,,,High,Preprint,Ana Valdes,University College London,https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3754805,17/03/2021,16/07/2022,Verified
210115_UK_UKBiobank_Overall,15-Jan-21,National,United Kingdom of Great Britain and Northern Ireland,GBR,"England, Scotland, Wales",,27-May-20,04-Dec-20,Household and community samples,Multiple groups,18893,8.99%,,,Convenience,NA,Not reported,Not reported,,,Unclear,Institutional Report,UK Biobank,UK Biobank,https://www.ukbiobank.ac.uk/media/x0nd5sul/ukb_serologystudy_report_revised_6months_jan21.pdf,19/03/2021,16/07/2022,Unverified
210301_London_King’sCollegeHospital_primary,01-Mar-21,Local,United Kingdom of Great Britain and Northern Ireland,GBR,,London,22-Apr-20,24-Apr-20,Health care workers and caregivers,Adults (18-64 years),625,21.00%,,,Convenience,NA,ELISA,Total Antibody,,,High,Journal Article (Peer-Reviewed),Kat El Bouzidi,King’s College Hospital,https://dx.doi.org/10.1097/CCM.0000000000004878,19/03/2021,16/07/2022,Verified
210127_London_King'sCollegeLondon_September_PostgradStudents&Staff,27-Jan-21,Local,United Kingdom of Great Britain and Northern Ireland,GBR,,London,01-Sep-20,30-Sep-20,Essential non-healthcare workers,Adults (18-64 years),1675,5.40%,,,Convenience,SureScreen Diagnostics,LFIA,"IgG,IgM",,,High,Preprint,Daniel Leightley,King's College London,https://doi.org/10.1101/2021.01.26.21249744,21/03/2021,16/07/2022,Verified
210225_England_ImperialCollegeLondon_Round4_overall_adj,25-Feb-21,National,United Kingdom of Great Britain and Northern Ireland,GBR,England,,27-Oct-20,10-Nov-20,Household and community samples,Multiple groups,161537,5.56%,5.43%,5.71%,Stratified probability,Fortress Diagnostics,LFIA,IgG,84.40%,98.60%,Moderate,Institutional Report,Helen Ward,Imperial College London ,https://www.medrxiv.org/content/10.1101/2021.02.26.21252512v1,24/03/2021,16/07/2022,Verified
210119_Lacashire_PublicHealthEngland_overall,19-Jan-21,Local,United Kingdom of Great Britain and Northern Ireland,GBR,England,Lacashire,03-Jun-20,04-Jun-20,Essential non-healthcare workers,Adults (18-64 years),195,9.20%,,,Convenience,Roche Diagnostics,CLIA,Total Antibody,,,High,Journal Article (Peer-Reviewed),Ranya Mulchandani,Public Health England,http://dx.doi.org/10.1016/j.jcv.2021.104739,25/03/2021,16/07/2022,Verified
210202_UK_SalfordRoyalNHS_primary,02-Feb-21,Local,United Kingdom of Great Britain and Northern Ireland,GBR,,,15-Mar-20,30-Oct-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,237,5.10%,,,Convenience,"Snibe Co. Ltd (Shenzhen New Industries Biomedical Engineering Co. Ltd),Siemens",CLIA,IgG,,,High,Preprint,Olivia Wickens,Salford Royal NHS ,https://www.researchsquare.com/article/rs-154513/v1,26/03/2021,16/07/2022,Verified
210212_Oxford_UniversityofOxford,12-Feb-21,Local,United Kingdom of Great Britain and Northern Ireland,GBR,,Oxford,15-Apr-20,15-Jun-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,404,3.00%,,,Sequential,Abbott Laboratories,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),Colleen GC McGregor,University of Oxford,https://dx.doi.org/10.1136/gutjnl-2021-324116,27/03/2021,16/07/2022,Verified
210303_London_NorthMiddlesexUniversityHospitalNHSTrust_Overall,03-Mar-21,Local,United Kingdom of Great Britain and Northern Ireland,GBR,England,London,04-Jun-20,03-Jul-20,Health care workers and caregivers,Adults (18-64 years),3285,35.70%,,,Convenience,NA,Not reported,Not reported,,,High,Journal Article (Peer-Reviewed),Emily Martin,North Middlesex University Hospital NHS Trust,https://dx.doi.org/10.1016/j.jinf.2021.02.027,31/03/2021,16/07/2022,Verified
210211_UnitedKingdom_ImperialCollegeNHSTrust_GlomerularDiseasePatients,11-Feb-21,Local,United Kingdom of Great Britain and Northern Ireland,GBR,,London,19-May-20,21-Jul-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,493,7.70%,,,Sequential,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Tabitha Turner Stokes,Imperial College Healthcare NHS Trust,https://dx.doi.org/10.1016/j.ekir.2021.02.006,02/04/2021,16/07/2022,Verified
201105_London_ImperialCollegeLondon,05-Nov-20,Local,United Kingdom of Great Britain and Northern Ireland,GBR,England,London,01-Jun-20,27-Jul-20,Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),161,11.20%,,,Convenience,NA,Other,Total Antibody,94.80%,,High,Journal Article (Peer-Reviewed),Simone Claudiani,Imperial College London,http://dx.doi.org/10.1182/blood-2020-142454,04/04/2021,16/07/2022,Verified
210322_TheUnitedKingdom_RoyalDevonAndExeterNHSFoundationTrust_Overall,22-Mar-21,National,United Kingdom of Great Britain and Northern Ireland,GBR,,,22-Sep-20,23-Dec-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,6935,4.30%,3.80%,4.80%,Sequential,Roche Diagnostics,CLIA,Not reported,,,Moderate,Journal Article (Peer-Reviewed),Nicholas Kennedy,Royal Devon and Exeter NHS Foundation Trust,https://dx.doi.org/10.1136/gutjnl-2021-324388,09/04/2021,16/07/2022,Verified
210212_London_RoyalFreeHospital,12-Feb-21,Local,United Kingdom of Great Britain and Northern Ireland,GBR,,London,26-Mar-20,24-Jun-20,Health care workers and caregivers,Adults (18-64 years),43,18.60%,,,Unclear,NA,Not reported,Not reported,,,High,Journal Article (Peer-Reviewed),Natarajan Angamuthu,Royal Free Hospital,https://dx.doi.org/10.1016/j.surge.2021.01.007,10/04/2021,16/07/2022,Verified
210401_London_PublicHealthEngland_Overall,01-Apr-21,Local,United Kingdom of Great Britain and Northern Ireland,GBR,,London,30-Mar-20,21-Jul-20,Health care workers and caregivers,Multiple groups,1069,29.00%,26.00%,32.00%,Unclear,Roche Diagnostics,CLIA,"IgG,IgM,IgA",,,Unclear,Journal Article (Peer-Reviewed),Madhumita Shrotri,Public Health England,https://dx.doi.org/10.3201/eid2704.204554,11/04/2021,16/07/2022,Verified
210302_London_UniversityCollegeLondon_HCW_Overall,02-Mar-21,Local,United Kingdom of Great Britain and Northern Ireland,GBR,England,London,23-Mar-20,17-Aug-20,Health care workers and caregivers,Adults (18-64 years),729,21.50%,,,Convenience,"EUROIMMUN,Roche Diagnostics",Multiple Types,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Charlotte Manisty,University College London,https://dx.doi.org/10.1016/j.ebiom.2021.103259,12/04/2021,16/07/2022,Unverified
210226_WestMidlands_BirminghamCommunityHealthcareTrust_Baseline,26-Feb-21,Local,United Kingdom of Great Britain and Northern Ireland,GBR,,,01-Jun-20,30-Jun-20,Health care workers and caregivers,Adults (18-64 years),1507,16.30%,,,Convenience,The Binding Site,ELISA,"IgG,IgM,IgA",98.60%,98.30%,Moderate,Preprint,Adrian Shields,Birmingham Community Healthcare Trust,10.1101/2021.02.24.21252368,15/04/2021,16/07/2022,Verified
210316_Sussex_UniversityofSussex_RocheBSUH,16-Mar-21,Local,United Kingdom of Great Britain and Northern Ireland,GBR,England,Brighton and Sussex,19-May-20,29-Sep-20,Health care workers and caregivers,Adults (18-64 years),14473,12.99%,,,Convenience,Roche Diagnostics,CLIA,"IgG,IgM",99.50%,99.80%,High,Journal Article (Peer-Reviewed),Alyss Robinson,University of Sussex,https://dx.doi.org/10.7861/clinmed.2020.1007,16/04/2021,16/07/2022,Verified
210316_Sussex_UniversityofSussex_AbbottWSHT,16-Mar-21,Local,United Kingdom of Great Britain and Northern Ireland,GBR,England,West Sussex,19-May-20,20-Oct-20,Health care workers and caregivers,Adults (18-64 years),12388,7.89%,,,Convenience,Abbott Laboratories,CLIA,IgG,100.00%,99.60%,High,Journal Article (Peer-Reviewed),Alyss Robinson,University of Sussex,https://dx.doi.org/10.7861/clinmed.2020.1007,16/04/2021,16/07/2022,Verified
210417_Leicestershire_UniversityofLeicester_Diasorin+Siemens,17-Mar-21,Local,United Kingdom of Great Britain and Northern Ireland,GBR,England,NR,01-Oct-19,31-Mar-20,Residual sera,Multiple groups,428,0.00%,,,Simplified probability,"DiaSorin,Siemens",Multiple Types,"IgG,IgM",,,Moderate,Journal Article (Peer-Reviewed),Paul William Bird,University of Leicester,https://dx.doi.org/10.1016/j.jinf.2021.03.007,16/04/2021,16/07/2022,Unverified
210323_Surrey_RoyalHollowayUniversityofLondon,23-Mar-21,Local,United Kingdom of Great Britain and Northern Ireland,GBR,England,Chertsey,15-Oct-20,15-Nov-20,Health care workers and caregivers,Adults (18-64 years),3119,19.65%,,,Convenience,Abbott Laboratories,CLIA,IgG,82.50%,95.00%,High,Journal Article (Peer-Reviewed),Gie Ken Dror,Royal Holloway University of London,https://dx.doi.org/10.7861/clinmed.2020-1096,17/04/2021,16/07/2022,Verified
210212_London_UniversityofOxford_Overall,12-Feb-21,Local,United Kingdom of Great Britain and Northern Ireland,GBR,,London,15-Apr-20,15-Jun-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,236,8.47%,,,Sequential,Abbott Laboratories,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),Colleen GC McGregor,University of Oxford,https://dx.doi.org/10.1136/gutjnl-2021-324116,19/04/2021,16/07/2022,Verified
201113_London_ImperialCollegeLondon_KidneyTransplantPatients copy,13-Nov-20,Local,United Kingdom of Great Britain and Northern Ireland,GBR,Greater London,London,01-Jun-20,03-Jul-20,Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),855,8.10%,6.40%,10.10%,Sequential,Abbott Laboratories,CLIA,IgG,68.40%,100.00%,High,Journal Article (Peer-Reviewed),Michelle Willicombe,Imperial College London,https://dx.doi.org/10.1097/TP.0000000000003526,21/04/2021,16/07/2022,Verified
210316_Lancashire_LancashireTeachingHospitalsNHSTrust_OverallHCW,16-Mar-21,Local,United Kingdom of Great Britain and Northern Ireland,GBR,England,"Chorley, Preston, South Ribble",29-May-20,04-Jul-20,Health care workers and caregivers,Adults (18-64 years),4474,17.40%,,,Convenience,Roche Diagnostics,CLIA,Total Antibody,92.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Robert Shorten ,Lancashire Teaching Hospitals NHS Foundation Trust,https://dx.doi.org/10.1136/bmjopen-2020-045384,21/04/2021,16/07/2022,Verified
200930_Scotland_PublicHealthScotland_1ResidualSera_Overall_UnAdj,30-Sep-20,National,United Kingdom of Great Britain and Northern Ireland,GBR,Scotland,,20-Apr-20,09-Aug-20,Residual sera,Multiple groups,9802,4.89%,,,Stratified non-probability,NA,Not reported,Not reported,87.50%,98.60%,Moderate,Institutional Report,Public Health Scotland,Public Health Scotland,https://beta.isdscotland.org/find-publications-and-data/population-health/covid-19/enhanced-surveillance-of-covid-19-in-scotland/30-september-2020/,22/04/2021,16/07/2022,Verified
210322_England_PublicHealthEnglandColindale_Overall,22-Mar-21,Local,United Kingdom of Great Britain and Northern Ireland,GBR,England,"London, Wythenshawe, Porton",23-Mar-20,18-Nov-20,Multiple populations,Adults (18-64 years),2246,11.80%,,,Convenience,"EUROIMMUN,Abbott Laboratories,Roche Diagnostics,NA",Multiple Types,"IgG,IgM",,,Moderate,Journal Article (Peer-Reviewed),Robert Harris,Public Health England Colindale ,https://dx.doi.org/10.1016/j.jinf.2021.03.015,13/05/2021,16/07/2022,Unverified
201221_London_PublicHealthEngland_overall_unadj,21-Dec-20,Local,United Kingdom of Great Britain and Northern Ireland,GBR,,London,05-May-20,05-May-20,Multiple populations,Adults (18-64 years),193,13.00%,,,Convenience,NA,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Hannah Taylor,Public Health England,https://dx.doi.org/10.1016/j.lanepe.2020.100015,17/05/2021,16/07/2022,Verified
210423_Blackpool_NHSFoundationTrust_primaryAbbott,23-Apr-21,Local,United Kingdom of Great Britain and Northern Ireland,GBR,,Blackpool,01-Aug-20,31-Aug-20,Residual sera,Multiple groups,225,5.30%,,,Convenience,Abbott Laboratories,ELISA,IgG,100.00%,,High,Journal Article (Peer-Reviewed),Jane Oakey,NHS Foundation Trust ,https://dx.doi.org/10.1177/00045632211015711,20/05/2021,16/07/2022,Verified
210421_London_DMGDental-MaterialGesellschaftmbH_overall_unadj,21-Apr-21,Local,United Kingdom of Great Britain and Northern Ireland,GBR,England,London,01-May-20,31-May-20,Health care workers and caregivers,Adults (18-64 years),14,21.43%,,,Convenience,SureScreen Diagnostics,LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Linda Greenwall,DMG Dental-Material Gesellschaft mbH,https://dx.doi.org/10.1038/s41415-021-2849-7,20/05/2021,16/07/2022,Verified
210408_London_St.Thomas’NHSFoundationTrust_Primary,08-Apr-21,Local,United Kingdom of Great Britain and Northern Ireland,GBR,,London,01-Jul-20,31-Jul-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,681,18.65%,,,Convenience,DiaSorin,Not reported,IgG,97.40%,,High,Journal Article (Peer-Reviewed),Caroline Dudreuilh,St. Thomas’ NHS Foundation Trust,https://dx.doi.org/10.1016/j.ekir.2021.03.900,22/05/2021,16/07/2022,Verified
210409_England_PublicHealthEngland,09-Apr-21,National,United Kingdom of Great Britain and Northern Ireland,GBR,,,18-Jun-20,31-Dec-20,Health care workers and caregivers,Multiple groups,25661,29.43%,,,Convenience,NA,Not reported,Not reported,,,Unclear,Journal Article (Peer-Reviewed),Victoria Jane Hall,Public Health England,https://dx.doi.org/10.1016/S0140-6736(21)00675-9,22/05/2021,16/07/2022,Verified
210316_UK_OfficeForNationalStatistics_England_overall,30-Mar-21,Regional,United Kingdom of Great Britain and Northern Ireland,GBR,England,,04-Feb-21,03-Mar-21,Household and community samples,Multiple groups,34623,34.60%,34.00%,35.30%,Stratified probability,NA,ELISA,IgG,99.00%,99.10%,Moderate,Institutional Report,Office for National Statistics,Office For National Statistics,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/datasets/coronaviruscovid19antibodydatafortheuk/2021,23/05/2021,16/07/2022,Verified
210316_UK_OfficeForNationalStatistics_NorthernIreland_overall,30-Mar-21,Regional,United Kingdom of Great Britain and Northern Ireland,GBR,Northern Ireland,,04-Feb-21,03-Mar-21,Household and community samples,Multiple groups,632,31.20%,27.30%,35.20%,Stratified probability,NA,ELISA,IgG,99.00%,99.10%,Moderate,Institutional Report,Office for National Statistics,Office For National Statistics,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/datasets/coronaviruscovid19antibodydatafortheuk/2021,23/05/2021,16/07/2022,Verified
210316_UK_OfficeForNationalStatistics_Scotland_overall,30-Mar-21,Regional,United Kingdom of Great Britain and Northern Ireland,GBR,"Scotland
",,04-Feb-21,03-Mar-21,Household and community samples,Multiple groups,2737,22.30%,20.60%,24.10%,Stratified probability,NA,ELISA,IgG,99.00%,99.10%,Moderate,Institutional Report,Office for National Statistics,Office For National Statistics,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/datasets/coronaviruscovid19antibodydatafortheuk/2021,23/05/2021,16/07/2022,Verified
210316_UK_OfficeForNationalStatistics_Wales_overall,30-Mar-21,Regional,United Kingdom of Great Britain and Northern Ireland,GBR,Wales,,04-Feb-21,03-Mar-21,Household and community samples,Multiple groups,1224,30.50%,27.50%,33.60%,Stratified probability,NA,ELISA,IgG,99.00%,99.10%,Moderate,Institutional Report,Office for National Statistics,Office For National Statistics,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/datasets/coronaviruscovid19antibodydatafortheuk/2021,23/05/2021,16/07/2022,Verified
201226_Scotland_UniversityofGlasgow_overall_unaj,26-Dec-20,Local,United Kingdom of Great Britain and Northern Ireland,GBR,Scotland,Greater Glasgow area,16-Mar-20,24-May-20,Residual sera,Multiple groups,6635,7.81%,7.17%,8.48%,Simplified probability,NA,ELISA,IgG,95.31%,97.20%,Moderate,Journal Article (Peer-Reviewed),Ellen C Hughes,University of Glasgow,http://dx.doi.org/10.1093/infdis/jiaa788,23/05/2021,16/07/2022,Verified
210324_London_ImperialCollegeLondon_Overall,24-Mar-21,Local,United Kingdom of Great Britain and Northern Ireland,GBR,England,London,24-Feb-20,01-Jan-21,Patients seeking care for non-COVID-19 reasons,Multiple groups,301,42.86%,,,Unclear,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Candice L Clarke,Imperial College London,https://dx.doi.org/10.1016/j.kint.2021.03.009,23/05/2021,16/07/2022,Verified
210426_England_CambridgeUniversityHospitalsNHS,24-Apr-21,Regional,United Kingdom of Great Britain and Northern Ireland,GBR,England,,15-Jun-20,15-Jul-20,Health care workers and caregivers,Adults (18-64 years),434,7.80%,,,Convenience,Abbexa,LFIA,"IgG,IgM",98.50%,97.94%,Moderate,Journal Article (Peer-Reviewed),DM Favara,Cambridge University Hospitals NHS Foundation Trust,https://dx.doi.org/10.1016/j.clon.2021.04.005,27/05/2021,16/07/2022,Unverified
210522_UK_UniversityCollegeLondon_overall,22-May-21,National,United Kingdom of Great Britain and Northern Ireland,GBR,England and Wales,,01-Feb-21,03-May-21,Household and community samples,Multiple groups,10330,8.20%,,,Convenience,Roche Diagnostics,CLIA,Total Antibody,,,Moderate,Preprint,Robert W Aldridge,University College London,https://www.medrxiv.org/content/10.1101/2021.05.10.21256912v2,27/05/2021,16/07/2022,Verified
210428_Europe_SorbonneUniversité_6London,28-Apr-21,Regional,United Kingdom of Great Britain and Northern Ireland,GBR,London,London,07-Jun-20,08-Dec-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,239,14.60%,,,Convenience,"Abbott Laboratories,Siemens,DiaSorin,Beckman Coulter,Roche Diagnostics",Not reported,"IgG,IgM,IgA",,,High,Journal Article (Peer-Reviewed),David Saadoun,Sorbonne Université,https://dx.doi.org/10.1016/S2665-9913(21)00112-0,31/05/2021,16/07/2022,Verified
210427_EastLondon_QueenMaryUniversityofLondon,27-Apr-21,Local,United Kingdom of Great Britain and Northern Ireland,GBR,,London,15-Jun-20,15-Aug-20,Health care workers and caregivers,Multiple groups,2001,25.30%,,,Convenience,Abbott Laboratories,Not reported,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Naheed Choudhry,Queen Mary University of London,https://dx.doi.org/10.3389/fmed.2021.642723,01/06/2021,16/07/2022,Unverified
210510_UK_PublicHealthEngland_Primary_RocheS,10-May-21,National,United Kingdom of Great Britain and Northern Ireland,GBR,,,22-Feb-21,21-Mar-21,Blood donors,Multiple groups,7720,46.40%,45.40%,47.50%,Convenience,Roche Diagnostics,CLIA,Not reported,97.00%,99.80%,Moderate,Journal Article (Peer-Reviewed),Heather J Whitaker,Public Health England,http://dx.doi.org/10.1016/j.jinf.2021.04.037,05/06/2021,16/07/2022,Verified
201212_Europe_UniversityOfGlasgow_UK1,12-Dec-20,National,United Kingdom of Great Britain and Northern Ireland,GBR,,,15-Apr-20,30-Jun-20,Health care workers and caregivers,Adults (18-64 years),311,6.75%,4.46%,10.10%,Convenience,Abbott Laboratories,CLIA,IgG,100.00%,99.60%,High,Journal Article (Peer-Reviewed),Scott M Nelson,University of Glasgow,https://dx.doi.org/10.1093/hropen/hoaa056,07/06/2021,16/07/2022,Verified
210602_UK_dental_UniversityBirmingham_Follow-up,02-Jun-21,Regional,United Kingdom of Great Britain and Northern Ireland,GBR,West midlands,,01-Jan-21,31-Jan-21,Health care workers and caregivers,Adults (18-64 years),944,51.40%,,,Convenience,NA,ELISA,"IgG,IgA,IgM",98.60%,98.30%,High,Journal Article (Peer-Reviewed),A M Shields,University of Birmingham,https://dx.doi.org/10.1177/00220345211020270,07/06/2021,16/07/2022,Unverified
210502_England_ImperialCollegeLondon_TestPopAdj,02-May-21,National,United Kingdom of Great Britain and Northern Ireland,GBR,England,,20-Jun-20,28-Sep-20,Household and community samples,Multiple groups,365104,4.94%,4.85%,5.03%,Stratified probability,Fortress Diagnostics,LFIA,IgG,84.40%,98.60%,Low,Journal Article (Peer-Reviewed),Helen Ward,Imperial College London,https://dx.doi.org/10.1016/j.lanepe.2021.100098,08/06/2021,16/07/2022,Unverified
210225_England_ImperialCollegeLondon_Round5_overall_Primary,25-Feb-21,National,United Kingdom of Great Britain and Northern Ireland,GBR,England,,25-Jan-21,08-Feb-21,Household and community samples,Multiple groups,155172,13.90%,13.70%,14.10%,Stratified probability,Fortress Diagnostics,LFIA,IgG,84.40%,98.60%,Low,Institutional Report,Helen Ward,Imperial College London ,https://www.medrxiv.org/content/10.1101/2021.02.26.21252512v1,18/06/2021,16/07/2022,Verified
210607_EastScotland_UniversityofDundee_HCW1,07-Jun-21,Regional,United Kingdom of Great Britain and Northern Ireland,GBR,Scotland,Dundee,28-May-20,02-Sep-20,Health care workers and caregivers,Adults (18-64 years),2063,14.50%,,,Convenience,Siemens,CLIA,"IgG,IgM,IgA",95.00%,,Moderate,Journal Article (Peer-Reviewed),Hani Abo-Leyah,University of Dundee,http://dx.doi.org/10.1183/23120541.00080-2021,21/06/2021,16/07/2022,Verified
210607_EastScotland_UniversityofDundee_Control2,07-Jun-21,Regional,United Kingdom of Great Britain and Northern Ireland,GBR,Scotland,Dundee,28-May-20,02-Sep-20,Residual sera,Multiple groups,231,4.80%,,,Sequential,Siemens,CLIA,"IgG,IgM,IgA",95.00%,,High,Journal Article (Peer-Reviewed),Hani Abo-Leyah,University of Dundee,http://dx.doi.org/10.1183/23120541.00080-2021,21/06/2021,16/07/2022,Verified
210525_London_PublicHealthEngland_Week18_Euroimmun_Primary ,25-May-21,Local,United Kingdom of Great Britain and Northern Ireland,GBR,England,London,01-May-20,03-May-20,Blood donors,Multiple groups,974,14.90%,12.10%,18.00%,Convenience,EUROIMMUN,ELISA,IgG,82.50%,99.10%,Moderate,Journal Article (Peer-Reviewed),Gayatri Amirthalingam,Public Health England,https://dx.doi.org/10.3201/eid2707.203167,01/07/2021,16/07/2022,Verified
210626_Leicester_UniversityOfLeicester,26-Jun-21,Local,United Kingdom of Great Britain and Northern Ireland,GBR,England,Leicester,16-Mar-20,03-Jun-20,Household and community samples,Multiple groups,1779,11.35%,,,Simplified probability,DiaSorin,CLIA,IgG,97.00%,98.90%,Low,Journal Article (Peer-Reviewed),Paul William Bird,University of Leicester,https://dx.doi.org/10.1002/jmv.27162,07/07/2021,16/07/2022,Verified
210713_England_DepartmentofHealthandSocialCare,13-Jul-21,Regional,United Kingdom of Great Britain and Northern Ireland,GBR,England,NR,26-May-20,31-Aug-20,Health care workers and caregivers,Adults (18-64 years),1146310,16.30%,16.20%,16.40%,Convenience,NA,Multiple Types,"IgM,IgG,Total Antibody",,,Moderate,Journal Article (Peer-Reviewed),Cordelia Coltart,Department of Health and Social Care,https://dx.doi.org/10.1136/bmjopen-2021-049703,21/07/2021,16/07/2022,Unverified
210316_England_PublicHealthEngland_Round1_Students_Primary,01-Jun-21,Regional,United Kingdom of Great Britain and Northern Ireland,GBR,England,,01-Jun-20,19-Jun-20,Students and Daycares,Children and Youth (0-17 years),816,11.20%,7.90%,15.10%,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Shamez Ladhani,Public Health England,https://dx.doi.org/10.1016/S2352-4642(21)00061-4,22/07/2021,16/07/2022,Verified
210316_England_PublicHealthEngland_Round1_Staff_Primary,01-Jun-21,Regional,United Kingdom of Great Britain and Northern Ireland,GBR,England,,01-Jun-20,19-Jun-20,Essential non-healthcare workers,Adults (18-64 years),1379,15.10%,11.90%,18.90%,Convenience,Abbott Laboratories,CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Shamez Ladhani,Public Health England,https://dx.doi.org/10.1016/S2352-4642(21)00061-4,22/07/2021,16/07/2022,Verified
210622_London_LondonSchoolOfHygieneAndTropicalMedicine_HCWs,22-Jun-21,Local,United Kingdom of Great Britain and Northern Ireland,GBR,England,London,04-May-20,30-Jun-20,Health care workers and caregivers,Adults (18-64 years),615,40.70%,,,Convenience,"Zhuhai Livzon Diagnostics Inc,CTK Biotech, Inc.,Zhejiang Orient Gene Biotech,VivaChek Biotech (Hangzhou) Co. Ltd",LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Admire Murongazvombo,London School Of Hygiene And Tropical Medicine,http://dx.doi.org/10.1016/j.infpip.2021.100157,28/07/2021,16/07/2022,Verified
210601_England_UniversityCollegeLondon_residents_primary,01-Jun-21,Regional,United Kingdom of Great Britain and Northern Ireland,GBR,England,,01-Oct-20,01-Feb-21,Assisted living and long-term care facilities,Seniors (65+ years),682,33.00%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Maria Krutikov,University College London,https://www.thelancet.com/journals/lanhl/article/PIIS2666-7568(21)00093-3/fulltext,28/07/2021,16/07/2022,Verified
210601_England_UniversityCollegeLondon_staff_primary,01-Jun-21,Regional,United Kingdom of Great Britain and Northern Ireland,GBR,England,,01-Oct-20,01-Feb-21,Health care workers and caregivers,Adults (18-64 years),1429,29.00%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Maria Krutikov,University College London,https://www.thelancet.com/journals/lanhl/article/PIIS2666-7568(21)00093-3/fulltext,28/07/2021,16/07/2022,Verified
210706_London_LondonSchoolofHygiene&TropicalMedicine,06-Jul-21,Local,United Kingdom of Great Britain and Northern Ireland,GBR,England,London,19-Oct-20,07-Dec-20,Household and community samples,Multiple groups,1242,64.30%,61.60%,67.00%,Simplified probability,NA,CLIA,IgG,96.20%,97.40%,Moderate,Journal Article (Peer-Reviewed),Katherine Gaskell,London School of Hygiene & Tropical Medicine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8291041/,04/08/2021,16/07/2022,Verified
201214_UnitedKingdom_UniversityOfSouthamptonSchoolOfMedicine,14-Dec-20,National,United Kingdom of Great Britain and Northern Ireland,GBR,,,13-May-20,15-May-20,Health care workers and caregivers,Adults (18-64 years),135,13.00%,,,Convenience,DiaSorin,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Kordo Saeed,University of Southampton School of Medicine,https://dx.doi.org/10.1177/1757177420976798,04/08/2021,16/07/2022,Unverified
210808_Birmingham_UniversityHospitalsBirmingham_primary,02-Aug-21,Local,United Kingdom of Great Britain and Northern Ireland,GBR,,Birmingham,15-Mar-20,15-Jul-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,990,25.90%,,,Convenience,NA,ELISA,"IgA,IgG,IgM",,,High,Journal Article (Peer-Reviewed),Gemma D. Banham,University Hospitals Birmingham,https://dx.doi.org/10.1681/ASN.2021020188,17/08/2021,16/07/2022,Verified
210819_England_UniversityofBirmingham_Overall,19-Aug-21,National,United Kingdom of Great Britain and Northern Ireland,GBR,England,,11-Dec-20,18-Dec-20,Assisted living and long-term care facilities,Adults (18-64 years),124,24.00%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Gokhan Tut,University of Birmingham,https://dx.doi.org/10.1016/S2666-7568(21)00168-9,31/08/2021,16/07/2022,Unverified
210811_England_OfficeForNationalStatistics_Round6_StaffPrimary,11-Aug-21,National,United Kingdom of Great Britain and Northern Ireland,GBR,England,,14-Jun-21,06-Jul-21,Essential non-healthcare workers,Adults (18-64 years),832,25.16%,19.73%,31.22%,Stratified probability,Roche Diagnostics,CLIA,Not reported,97.20%,99.80%,Moderate,Institutional Report,Office for National Statistics,Office for National Statistics,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/covid19schoolsinfectionsurveyengland/round6june2021,01/09/2021,16/07/2022,Unverified
210811_England_OfficeForNationalStatistics_Round6_StaffSecondary,11-Aug-21,National,United Kingdom of Great Britain and Northern Ireland,GBR,England,,14-Jun-21,06-Jul-21,Essential non-healthcare workers,Adults (18-64 years),1574,23.36%,20.66%,26.22%,Stratified probability,Roche Diagnostics,CLIA,Not reported,97.20%,99.80%,Moderate,Institutional Report,Office for National Statistics,Office for National Statistics,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/covid19schoolsinfectionsurveyengland/round6june2021,01/09/2021,16/07/2022,Unverified
210825_London_NHSFoundationTrust_Overall,25-Aug-21,Local,United Kingdom of Great Britain and Northern Ireland,GBR,,London,01-Aug-20,16-Oct-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,1621,9.25%,,,Sequential,NA,Not reported,Not reported,,,Unclear,Presentation or Conference,Venkateshwaran Sivaraj,Guy's and St Thomas' NHS Foundation Trust,https://onlinelibrary.wiley.com/doi/epdf/10.1111/hiv.13131,08/09/2021,16/07/2022,Unverified
210221_UnitedKingdom_RoyalDevonAndExeterNHSFoundationTrust,02-Sep-21,National,United Kingdom of Great Britain and Northern Ireland,GBR,,,29-Jan-20,30-Sep-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,13509,3.10%,,,Sequential,Roche Diagnostics,CLIA,"IgG,IgM,IgA",99.50%,99.80%,Moderate,Journal Article (Peer-Reviewed),Neil Chanchlani,Royal Devon And Exeter NHS Foundation Trust,https://dx.doi.org/10.1093/ecco-jcc/jjab153,08/09/2021,16/07/2022,Unverified
210910_SouthWales_PublicHealthWales,10-Sep-21,Regional,United Kingdom of Great Britain and Northern Ireland,GBR,Wales,,02-Jun-20,07-Jul-20,Health care workers and caregivers,Adults (18-64 years),276,38.80%,,,Convenience,"EUROIMMUN,Roche Diagnostics",Multiple Types,"IgG,IgA,IgM",,,High,Journal Article (Peer-Reviewed),Favian Narrainen,Public Health Wales Microbiology,https://dx.doi.org/10.7861/clinmed.2021-0225,23/09/2021,16/07/2022,Unverified
210920_Dublin_UniversityCollegeDublin_overall,20-Sep-21,Local,United Kingdom of Great Britain and Northern Ireland,GBR,Ireland,Dublin,04-May-20,15-May-20,Pregnant or parturient women,Adults (18-64 years),598,1.67%,0.80%,3.10%,Convenience,"Abbott Laboratories,Roche Diagnostics",Multiple Types,IgG,,,High,Journal Article (Peer-Reviewed),Kate Glennon,University College Dublin,https://dx.doi.org/10.1371/journal.pone.0253090,27/09/2021,16/07/2022,Verified
210929_England_PublicHealthEngland_Overall,29-Sep-21,National,United Kingdom of Great Britain and Northern Ireland,GBR,England,,01-Jun-20,23-Jul-20,Students and Daycares,Multiple groups,2179,14.00%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Georgina Ireland,Public Health England,https://dx.doi.org/10.1016/j.eclinm.2021.101150,12/10/2021,16/07/2022,Unverified
210106_UnitedKingdom_OxfordUniversity,06-Jan-21,National,United Kingdom of Great Britain and Northern Ireland,GBR,,,23-Apr-20,20-Oct-20,Health care workers and caregivers,Multiple groups,3217,16.00%,,,Convenience,Abbott Laboratories,ELISA,IgG,,,Unclear,Journal Article (Peer-Reviewed),Sheila F Lumley,Oxford University,https://academic.oup.com/cid/article/73/3/e699/6064824,14/10/2021,16/07/2022,Unverified
201223_Scotland_PublicHealthScotland_1ResidualSera_Overall_PopAdj_TestAdj,23-Dec-20,National,United Kingdom of Great Britain and Northern Ireland,GBR,Scotland,,26-Oct-20,29-Nov-20,Residual sera,Multiple groups,3638,6.82%,5.74%,7.74%,Stratified probability,NA,CLIA,Not reported,87.50%,98.60%,Moderate,Institutional Report,Public Health Scotland,Public Health Scotland,https://publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-23-december-2020/,24/10/2021,16/07/2022,Verified
201223_Scotland_PublicHealthScotland_2BloodDonors_Overall_PopAdj_TestAdj,23-Dec-20,National,United Kingdom of Great Britain and Northern Ireland,GBR,Scotland,,26-Oct-20,29-Nov-20,Blood donors,Multiple groups,2499,6.26%,4.55%,8.89%,Sequential,EUROIMMUN,ELISA,IgG,84.00%,100.00%,Moderate,Institutional Report,Public Health Scotland,Public Health Scotland,https://publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-23-december-2020/,24/10/2021,16/07/2022,Verified
210512_Scotland_PublicHealthScotland_2BloodDonors_Overall_PopAdj_TestAdj,12-May-21,National,United Kingdom of Great Britain and Northern Ireland,GBR,Scotland,,15-Mar-21,18-Apr-21,Blood donors,Multiple groups,2493,46.60%,44.00%,48.90%,Sequential,EUROIMMUN,ELISA,IgG,84.00%,100.00%,Moderate,Institutional Report,Public Health Scotland,Public Health Scotland,https://publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-12-may-2021/,26/10/2021,16/07/2022,Verified
210512_Scotland_PublicHealthScotland_3PregnantWomen_overall_adj,12-May-21,National,United Kingdom of Great Britain and Northern Ireland,GBR,Scotland,,15-Mar-21,18-Apr-21,Pregnant or parturient women,Adults (18-64 years),3326,12.50%,11.20%,13.80%,Sequential,Roche Diagnostics,CLIA,Total Antibody,92.30%,100.00%,Moderate,Institutional Report,Public Health Scotland,Public Health Scotland,https://publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-12-may-2021/,26/10/2021,16/07/2022,Verified
210512_Scotland_PublicHealthScotland_1ResidualSera_Overall_PopAdj_TestAdj,12-May-21,National,United Kingdom of Great Britain and Northern Ireland,GBR,Scotland,,12-Apr-21,18-Apr-21,Residual sera,Multiple groups,708,43.80%,40.20%,47.40%,Stratified probability,DiaSorin,CLIA,Not reported,97.30%,99.60%,Moderate,Institutional Report,Public Health Scotland,Public Health Scotland,https://publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-12-may-2021/,26/10/2021,16/07/2022,Verified
210407_Scotland_PublicHealthScotland_2BloodDonors_overall_adj,07-Apr-21,National,United Kingdom of Great Britain and Northern Ireland,GBR,Scotland,,08-Feb-21,14-Mar-21,Blood donors,Multiple groups,2492,25.20%,22.50%,27.90%,Sequential,EUROIMMUN,ELISA,IgG,84.00%,100.00%,Moderate,Institutional Report,Public Health Scotland,Public Health Scotland,https://publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-7-april-2021/,26/10/2021,16/07/2022,Verified
210407_Scotland_PublicHealthScotland_3PregnantWomen_overall_adj,07-Apr-21,National,United Kingdom of Great Britain and Northern Ireland,GBR,Scotland,,08-Feb-21,14-Mar-21,Pregnant or parturient women,Adults (18-64 years),3355,9.60%,8.50%,10.70%,Sequential,Roche Diagnostics,CLIA,Total Antibody,92.30%,100.00%,Moderate,Institutional Report,Public Health Scotland,Public Health Scotland,https://publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-7-april-2021/,26/10/2021,16/07/2022,Verified
210407_Scotland_PublicHealthScotland_1ResidualSera_overall_adj,07-Apr-21,National,United Kingdom of Great Britain and Northern Ireland,GBR,Scotland,,08-Feb-21,14-Mar-21,Residual sera,Multiple groups,3436,23.70%,22.10%,25.50%,Stratified probability,NA,CLIA,Not reported,87.50%,98.60%,Moderate,Institutional Report,Public Health Scotland,Public Health Scotland,https://publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-7-april-2021/,26/10/2021,16/07/2022,Verified
210303_Scotland_PublicHealthScotland_2BloodDonors_overall_adj,03-Mar-21,National,United Kingdom of Great Britain and Northern Ireland,GBR,Scotland,,04-Jan-21,07-Feb-21,Blood donors,Multiple groups,2497,15.20%,13.40%,17.60%,Sequential,EUROIMMUN,ELISA,IgG,84.00%,100.00%,Moderate,Institutional Report,Public Health Scotland,Public Health Scotland,https://publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-3-march-2021/,26/10/2021,16/07/2022,Verified
210303_Scotland_PublicHealthScotland_1ResidualSera_overall_adj,03-Mar-21,National,United Kingdom of Great Britain and Northern Ireland,GBR,Scotland,,04-Jan-21,07-Feb-21,Residual sera,Multiple groups,3606,12.50%,11.20%,13.80%,Stratified probability,NA,CLIA,Not reported,87.50%,98.60%,Moderate,Institutional Report,Public Health Scotland,Public Health Scotland,https://publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-3-march-2021/,26/10/2021,16/07/2022,Verified
210127_Scotland_PublicHealthScotland_1ResidualSera_overall_adj,27-Jan-21,National,United Kingdom of Great Britain and Northern Ireland,GBR,Scotland,,30-Nov-20,03-Jan-21,Residual sera,Multiple groups,3485,9.60%,8.40%,10.80%,Stratified probability,NA,CLIA,Not reported,87.50%,98.60%,Moderate,Institutional Report,Public Health Scotland,Public Health Scotland,https://publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-27-january-2021/,26/10/2021,16/07/2022,Verified
210127_Scotland_PublicHealthScotland_2BloodDonors_overall_adj,27-Jan-21,National,United Kingdom of Great Britain and Northern Ireland,GBR,Scotland,,30-Nov-20,03-Jan-21,Blood donors,Multiple groups,2499,5.90%,4.40%,7.10%,Sequential,EUROIMMUN,ELISA,IgG,84.00%,100.00%,Moderate,Institutional Report,Public Health Scotland,Public Health Scotland,https://publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-27-january-2021/,26/10/2021,16/07/2022,Verified
210825_Scotland_PublicHealthScotland_1ResidualSera_overall_adj,25-Aug-21,National,United Kingdom of Great Britain and Northern Ireland,GBR,Scotland,,28-Jun-21,01-Aug-21,Residual sera,Multiple groups,3427,72.90%,71.40%,74.40%,Stratified probability,DiaSorin,CLIA,Not reported,97.30%,99.60%,Moderate,Institutional Report,Public Health Scotland,Public Health Scotland,https://www.publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-25-august-2021/,26/10/2021,16/07/2022,Verified
210825_Scotland_PublicHealthScotland_2BloodDonors_overall_adj,25-Aug-21,National,United Kingdom of Great Britain and Northern Ireland,GBR,Scotland,,28-Jun-21,01-Aug-21,Blood donors,Multiple groups,2493,99.50%,98.40%,100.00%,Sequential,EUROIMMUN,ELISA,IgG,84.00%,100.00%,Moderate,Institutional Report,Public Health Scotland,Public Health Scotland,https://www.publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-25-august-2021/,26/10/2021,16/07/2022,Verified
210825_Scotland_PublicHealthScotland_3PregnantWomen_overall_adj,25-Aug-21,National,United Kingdom of Great Britain and Northern Ireland,GBR,Scotland,,28-Jun-21,01-Aug-21,Pregnant or parturient women,Adults (18-64 years),2990,13.80%,12.40%,15.20%,Sequential,Roche Diagnostics,CLIA,Total Antibody,92.30%,100.00%,Moderate,Institutional Report,Public Health Scotland,Public Health Scotland,https://www.publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-25-august-2021/,26/10/2021,16/07/2022,Verified
210616_Scotland_PublicHealthScotland_1ResidualSera_Overall_PopAdj_TestAdj,16-Jun-21,National,United Kingdom of Great Britain and Northern Ireland,GBR,Scotland,,19-Apr-21,23-May-21,Residual sera,Multiple groups,3589,48.61%,46.96%,50.30%,Stratified probability,DiaSorin,CLIA,Not reported,97.30%,99.60%,Moderate,Institutional Report,Public Health Scotland,Public Health Scotland,https://publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-16-june-2021/,26/10/2021,16/07/2022,Verified
210616_Scotland_PublicHealthScotland_2BloodDonors_Overall_PopAdj_TestAdj,16-Jun-21,National,United Kingdom of Great Britain and Northern Ireland,GBR,Scotland,,19-Apr-21,23-May-21,Blood donors,Multiple groups,2494,66.32%,63.80%,68.40%,Sequential,EUROIMMUN,ELISA,IgG,84.00%,100.00%,Moderate,Institutional Report,Public Health Scotland,Public Health Scotland,https://publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-16-june-2021/,26/10/2021,16/07/2022,Verified
210616_Scotland_PublicHealthScotland_3PregnantWomen_Overall_PopAdj_TestAdj,16-Jun-21,National,United Kingdom of Great Britain and Northern Ireland,GBR,Scotland,,19-Apr-21,23-May-21,Pregnant or parturient women,Adults (18-64 years),3333,10.84%,9.69%,12.00%,Sequential,Roche Diagnostics,CLIA,Total Antibody,92.30%,100.00%,Moderate,Institutional Report,Public Health Scotland,Public Health Scotland,https://publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-16-june-2021/,26/10/2021,16/07/2022,Verified
211020_Avon_UniversityOfBristol_G1_Overall,20-Oct-21,Local,United Kingdom of Great Britain and Northern Ireland,GBR,,,08-Apr-21,28-Jun-21,Household and community samples,Adults (18-64 years),1686,42.05%,,,Convenience,Roche Diagnostics,CLIA,Total Antibody,98.80%,99.98%,Moderate,Journal Article (Peer-Reviewed),Daniel Major-Smith,University of Bristol,https://wellcomeopenresearch.org/articles/6-283,26/10/2021,16/07/2022,Verified
211020_Avon_UniversityOfBristol_G0_Overall,20-Oct-21,Local,United Kingdom of Great Britain and Northern Ireland,GBR,,,08-Apr-21,28-Jun-21,Household and community samples,Adults (18-64 years),2555,96.40%,,,Convenience,Roche Diagnostics,CLIA,Total Antibody,98.80%,99.98%,Moderate,Journal Article (Peer-Reviewed),Daniel Major-Smith,University of Bristol,https://wellcomeopenresearch.org/articles/6-283,26/10/2021,16/07/2022,Verified
210303_Scotland_PublicHealthScotland_3PregnantWomen_Overall_PopAdj_TestAdj,03-Mar-21,National,United Kingdom of Great Britain and Northern Ireland,GBR,Scotland,,04-Jan-21,07-Feb-21,Pregnant or parturient women,Adults (18-64 years),3478,7.50%,6.60%,8.50%,Sequential,Roche Diagnostics,CLIA,Total Antibody,92.30%,100.00%,Moderate,Institutional Report,Public Health Scotland,Public Health Scotland,https://publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-3-march-2021/,29/10/2021,16/07/2022,Verified
210127_Scotland_PublicHealthScotland_3PregnantWomen_Overall_PopAdj_TestAdj,27-Jan-21,National,United Kingdom of Great Britain and Northern Ireland,GBR,Scotland,,30-Nov-20,03-Jan-21,Pregnant or parturient women,Adults (18-64 years),3052,5.80%,5.00%,6.80%,Sequential,Roche Diagnostics,CLIA,Total Antibody,92.30%,100.00%,Moderate,Institutional Report,Public Health Scotland,Public Health Scotland,https://publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-27-january-2021/,29/10/2021,16/07/2022,Verified
211025_Ynysmaerdy _CardiffUniversity,25-Oct-21,Local,United Kingdom of Great Britain and Northern Ireland,GBR,South Wales, Ynysmaerdy,15-Jun-20,15-Oct-20,Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),5,0.00%,,,Entire sample,NA,Not reported,Not reported,,,High,Journal Article (Peer-Reviewed),David Barron,Cardiff University,https://dx.doi.org/10.1186/s12887-021-02831-9,02/11/2021,16/07/2022,Verified
210721_Scotland_PublicHealthScotland_1ResidualSera_overall_adj,21-Jul-21,National,United Kingdom of Great Britain and Northern Ireland,GBR,Scotland,,24-May-21,27-Jun-21,Residual sera,Multiple groups,3554,61.40%,59.70%,62.90%,Stratified probability,DiaSorin,CLIA,Not reported,97.30%,99.60%,Moderate,Institutional Report,Public Health Scotland,Public Health Scotland,https://publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-21-july-2021/,03/11/2021,16/07/2022,Verified
210721_Scotland_PublicHealthScotland_2BloodDonors_overall_adj,21-Jul-21,National,United Kingdom of Great Britain and Northern Ireland,GBR,Scotland,,24-May-21,27-Jun-21,Blood donors,Multiple groups,2494,81.80%,79.80%,84.00%,Sequential,EUROIMMUN,ELISA,IgG,84.00%,100.00%,Moderate,Institutional Report,Public Health Scotland,Public Health Scotland,https://publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-21-july-2021/,03/11/2021,16/07/2022,Verified
210721_Scotland_PublicHealthScotland_3PregnantWomen_overall_adj,21-Jul-21,National,United Kingdom of Great Britain and Northern Ireland,GBR,Scotland,,24-May-21,27-Jun-21,Pregnant or parturient women,Adults (18-64 years),3052,12.10%,10.80%,13.50%,Sequential,Roche Diagnostics,CLIA,Total Antibody,92.30%,100.00%,Moderate,Institutional Report,Public Health Scotland,Public Health Scotland,https://publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-21-july-2021/,03/11/2021,16/07/2022,Verified
210811_England_OfficeForNationalStatistics_Round6_StudentsPrimary3_PopAdj_TestAdj,11-Aug-21,National,United Kingdom of Great Britain and Northern Ireland,GBR,England,,14-Jun-21,06-Jul-21,Students and Daycares,Children and Youth (0-17 years),3798,11.25%,8.93%,13.90%,Stratified probability,NA,Other,IgG,80.00%,99.00%,Moderate,Institutional Report,Office for National Statistics,Office for National Statistics,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/covid19schoolsinfectionsurveyengland/round6june2021,10/11/2021,16/07/2022,Unverified
210811_England_OfficeForNationalStatistics_Round6_StudentsSecondary4_TestAdj_PopAdj,11-Aug-21,National,United Kingdom of Great Britain and Northern Ireland,GBR,England,,14-Jun-21,06-Jul-21,Students and Daycares,Children and Youth (0-17 years),6927,12.95%,11.62%,14.37%,Stratified probability,NA,Other,IgG,80.00%,99.00%,Moderate,Institutional Report,Office for National Statistics,Office for National Statistics,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/covid19schoolsinfectionsurveyengland/round6june2021,10/11/2021,16/07/2022,Unverified
210804_Cambridge_RoyalPapworthHospitalNHSTrust_HCW,04-Aug-21,Local,United Kingdom of Great Britain and Northern Ireland,GBR,England,Cambridge,20-Apr-20,10-Jun-20,Health care workers and caregivers,Adults (18-64 years),498,14.00%,,,Convenience,NA,Other,IgG,97.00%,100.00%,High,Journal Article (Peer-Reviewed),Helen Baxendale,Cambridge University Hospitals NHS Foundation Trust,https://dx.doi.org/10.2478/jccm-2021-0018,10/11/2021,16/07/2022,Unverified
210930_UnitedKingdom_QueensUniversityBelfast_Round2_overall,30-Sep-21,National,United Kingdom of Great Britain and Northern Ireland,GBR,"England, Northern Ireland, Wales, Scotland","London, Belfast, Cardiff, Glasgow, Manchester",16-Jun-20,30-Jun-20,Family of essential workers,Children and Youth (0-17 years),849,7.66%,6.05%,9.64%,Unclear,"DiaSorin,Roche Diagnostics",Not reported,Not reported,,,High,Journal Article (Peer-Reviewed),Cathal Roarty,Queens University Belfast,http://dx.doi.org/10.1136/archdischild-2021-rcpch.65,10/11/2021,16/07/2022,Unverified
211030_UnitedKingdom_QueensUniversityBelfast,30-Sep-21,Regional,United Kingdom of Great Britain and Northern Ireland,GBR,"Northern Ireland, Scotland, Wales, England","Belfast, Glasgow, Cardiff, Manchester,
London",16-Apr-20,03-Jul-20,Household and community samples,Children and Youth (0-17 years),992,6.85%,,,Convenience,"Abbott Laboratories,DiaSorin,Roche Diagnostics",CLIA,"IgG,Total Antibody",,,High,Presentation or Conference,Claire McGinn,Queens University Belfast,http://dx.doi.org/10.1136/archdischild-2021-rcpch.135,10/11/2021,16/07/2022,Verified
211103_Scotland_PublicHealthScotland_1ResidualSera_Overall_PopAdj_TestAdj,03-Nov-21,National,United Kingdom of Great Britain and Northern Ireland,GBR,Scotland,,06-Sep-21,10-Oct-21,Residual sera,Multiple groups,3132,77.60%,75.90%,79.30%,Stratified probability,DiaSorin,CLIA,Not reported,97.30%,99.60%,Moderate,Institutional Report,Public Health Scotland,Public Health Scotland,https://www.publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-3-november-2021/,10/11/2021,16/07/2022,Verified
211103_Scotland_PublicHealthScotland_2BloodDonors_Overall_PopAdj_TestAdj,03-Nov-21,National,United Kingdom of Great Britain and Northern Ireland,GBR,Scotland,,06-Sep-21,10-Oct-21,Blood donors,Multiple groups,2494,99.70%,99.30%,100.00%,Sequential,EUROIMMUN,ELISA,IgG,84.00%,100.00%,Moderate,Institutional Report,Public Health Scotland,Public Health Scotland,https://www.publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-3-november-2021/,10/11/2021,16/07/2022,Verified
211103_Scotland_PublicHealthScotland_3PregnantWomen_Overall_PopAdj_TestAdj,03-Nov-21,National,United Kingdom of Great Britain and Northern Ireland,GBR,Scotland,,06-Sep-21,10-Oct-21,Pregnant or parturient women,Adults (18-64 years),3023,19.70%,18.00%,21.30%,Sequential,Roche Diagnostics,CLIA,Total Antibody,92.30%,100.00%,Moderate,Institutional Report,Public Health Scotland,Public Health Scotland,https://www.publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-3-november-2021/,10/11/2021,16/07/2022,Verified
211201_GreaterLondon_PublicHealthEngland_Staff,01-Dec-21,Local,United Kingdom of Great Britain and Northern Ireland,GBR,England,London,11-May-20,26-Jul-20,Assisted living and long-term care facilities,Adults (18-64 years),712,49.58%,,,Convenience,"Abbott Laboratories,NA",Not reported,"IgG,Not reported",,,High,Journal Article (Peer-Reviewed),Anna Jeffery-Smith,Public Health England,https://dx.doi.org/10.1016/S2666-7568(21)00253-1,14/12/2021,16/07/2022,Unverified
211201_GreaterLondon_PublicHealthEngland_Residents,01-Dec-21,Local,United Kingdom of Great Britain and Northern Ireland,GBR,England,London,11-May-20,26-Jul-20,Assisted living and long-term care facilities,Seniors (65+ years),459,57.73%,,,Convenience,"Abbott Laboratories,NA",Not reported,"IgG,Not reported",,,High,Journal Article (Peer-Reviewed),Anna Jeffery-Smith,Public Health England,https://dx.doi.org/10.1016/S2666-7568(21)00253-1,14/12/2021,16/07/2022,Unverified
211208_Scotland_PublicHealthScotland_1ResidualSera_Overall_PopAdj_TestAdj,08-Dec-21,National,United Kingdom of Great Britain and Northern Ireland,GBR,Scotland,,11-Oct-21,14-Nov-21,Residual sera,Multiple groups,2882,80.50%,78.60%,82.00%,Stratified probability,DiaSorin,CLIA,Not reported,97.30%,99.60%,Moderate,Institutional Report,Public Health Scotland,Public Health Scotland,https://www.publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-8-december-2021/,15/12/2021,16/07/2022,Verified
211208_Scotland_PublicHealthScotland_2BloodDonors_Overall_PopAdj_TestAdj,08-Dec-21,National,United Kingdom of Great Britain and Northern Ireland,GBR,Scotland,,11-Oct-21,14-Nov-21,Blood donors,Multiple groups,2496,99.80%,99.40%,100.00%,Sequential,EUROIMMUN,ELISA,IgG,84.00%,100.00%,Moderate,Institutional Report,Public Health Scotland,Public Health Scotland,https://www.publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-8-december-2021/,15/12/2021,16/07/2022,Verified
211208_Scotland_PublicHealthScotland_3PregnantWomen_Overall_Anti-S_Unadj,08-Dec-21,National,United Kingdom of Great Britain and Northern Ireland,GBR,Scotland,,11-Oct-21,14-Nov-21,Pregnant or parturient women,Adults (18-64 years),2890,86.16%,,,Sequential,Roche Diagnostics,CLIA,Total Antibody,92.30%,100.00%,Moderate,Institutional Report,Public Health Scotland,Public Health Scotland,https://www.publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-8-december-2021/,15/12/2021,16/07/2022,Verified
211130_England_UKHSA_2020SepOct_Overall_AdjustedS,30-Nov-21,National,United Kingdom of Great Britain and Northern Ireland,GBR,England,,01-Sep-20,31-Oct-20,Residual sera,Children and Youth (0-17 years),119,7.60%,3.20%,18.20%,Convenience,Roche Diagnostics,CLIA,Total Antibody,95.50%,100.00%,Moderate,Journal Article (Peer-Reviewed),Clarissa Oeser,"UK Health Security Agency (UKHSA, formerly PHE)",https://dx.doi.org/10.1016/j.jinf.2021.11.019,23/12/2021,16/07/2022,Verified
211130_England_UKHSA_2020NovDec_Overall_AdjustedS,30-Nov-21,National,United Kingdom of Great Britain and Northern Ireland,GBR,England,,01-Nov-20,31-Dec-20,Residual sera,Children and Youth (0-17 years),711,14.80%,11.20%,19.80%,Convenience,Roche Diagnostics,CLIA,Total Antibody,95.50%,100.00%,Moderate,Journal Article (Peer-Reviewed),Clarissa Oeser,"UK Health Security Agency (UKHSA, formerly PHE)",https://dx.doi.org/10.1016/j.jinf.2021.11.019,23/12/2021,16/07/2022,Verified
211130_England_UKHSA_2021JanFeb_Overall_AdjustedS,30-Nov-21,National,United Kingdom of Great Britain and Northern Ireland,GBR,England,,01-Jan-21,28-Feb-21,Residual sera,Children and Youth (0-17 years),970,23.30%,18.40%,29.50%,Convenience,Roche Diagnostics,CLIA,Total Antibody,95.50%,100.00%,Moderate,Journal Article (Peer-Reviewed),Clarissa Oeser,"UK Health Security Agency (UKHSA, formerly PHE)",https://dx.doi.org/10.1016/j.jinf.2021.11.019,23/12/2021,16/07/2022,Verified
211130_England_UKHSA_2021MarApr_Overall_AdjustedS,30-Nov-21,National,United Kingdom of Great Britain and Northern Ireland,GBR,England,,01-Mar-21,30-Apr-21,Residual sera,Children and Youth (0-17 years),925,31.50%,25.30%,39.10%,Convenience,Roche Diagnostics,CLIA,Total Antibody,95.50%,100.00%,Moderate,Journal Article (Peer-Reviewed),Clarissa Oeser,"UK Health Security Agency (UKHSA, formerly PHE)",https://dx.doi.org/10.1016/j.jinf.2021.11.019,23/12/2021,16/07/2022,Verified
211130_England_UKHSA_2021MayJun_Overall_AdjustedS,30-Nov-21,National,United Kingdom of Great Britain and Northern Ireland,GBR,England,,01-May-21,30-Jun-21,Residual sera,Children and Youth (0-17 years),1186,27.50%,20.70%,37.20%,Convenience,Roche Diagnostics,CLIA,Total Antibody,95.50%,100.00%,Moderate,Journal Article (Peer-Reviewed),Clarissa Oeser,"UK Health Security Agency (UKHSA, formerly PHE)",https://dx.doi.org/10.1016/j.jinf.2021.11.019,23/12/2021,16/07/2022,Verified
211130_England_UKHSA_2021JulAug_Overall_AdjustedS,30-Nov-21,National,United Kingdom of Great Britain and Northern Ireland,GBR,England,,01-Jul-21,31-Aug-21,Residual sera,Children and Youth (0-17 years),685,26.40%,20.10%,35.30%,Convenience,Roche Diagnostics,CLIA,Total Antibody,95.50%,100.00%,Moderate,Journal Article (Peer-Reviewed),Clarissa Oeser,"UK Health Security Agency (UKHSA, formerly PHE)",https://dx.doi.org/10.1016/j.jinf.2021.11.019,23/12/2021,16/07/2022,Verified
211130_England_UKHSA_2021SepOct_Overall_AdjustedS,30-Nov-21,National,United Kingdom of Great Britain and Northern Ireland,GBR,England,,01-Sep-21,31-Oct-21,Residual sera,Children and Youth (0-17 years),600,46.10%,38.30%,53.60%,Convenience,Roche Diagnostics,CLIA,Total Antibody,95.50%,100.00%,Moderate,Journal Article (Peer-Reviewed),Clarissa Oeser,"UK Health Security Agency (UKHSA, formerly PHE)",https://dx.doi.org/10.1016/j.jinf.2021.11.019,23/12/2021,16/07/2022,Verified
211211_England_UKHealthSecurityAgency_Round4_Students_S,11-Dec-21,Regional,United Kingdom of Great Britain and Northern Ireland,GBR,England,"Derbyshire, West London, East London, Greater Manchester, Hertfordshire and Birmingham",20-May-21,14-Jul-21,Students and Daycares,Children and Youth (0-17 years),655,41.40%,,,Convenience,Roche Diagnostics,CLIA,IgG,,,High,Preprint,Shamez N. Ladhani,The UK Health Security Agency,https://www.medrxiv.org/content/10.1101/2021.12.10.21267583v1.full-text,25/12/2021,16/07/2022,Verified
211211_England_UKHealthSecurityAgency_Round4_Staff_S,11-Dec-21,Regional,United Kingdom of Great Britain and Northern Ireland,GBR,England,"Derbyshire, West London, East London, Greater Manchester, Hertfordshire and Birmingham",20-May-21,14-Jul-21,Essential non-healthcare workers,Adults (18-64 years),639,97.80%,,,Convenience,Roche Diagnostics,CLIA,IgG,,,High,Preprint,Shamez N. Ladhani,The UK Health Security Agency,https://www.medrxiv.org/content/10.1101/2021.12.10.21267583v1.full-text,25/12/2021,16/07/2022,Verified
220101_England_UCLInstituteOfHealthInformatics_Primary,01-Jan-22,Regional,United Kingdom of Great Britain and Northern Ireland,GBR,England,,01-Jun-20,30-Apr-21,Multiple general populations,Multiple groups,4722,28.80%,,,Self-referral,Abbott Laboratories,Not reported,IgG,,,Moderate,Journal Article (Peer-Reviewed),Maria Krutikov,UCL Institute of Health Informatics,https://dx.doi.org/10.1016/S2666-7568(21)00282-8,08/01/2022,16/07/2022,Unverified
220119_Scotland_PublicHealthScotland_1ResidualSeraOverall_PopAdj_TestAdj,19-Jan-22,National,United Kingdom of Great Britain and Northern Ireland,GBR,Scotland,,15-Nov-21,19-Dec-21,Residual sera,Multiple groups,2815,87.40%,85.70%,88.70%,Stratified probability,DiaSorin,CLIA,Not reported,97.30%,99.60%,Moderate,Institutional Report,Public Health Scotland,Public Health Scotland,https://www.publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-19-january-2022/,25/01/2022,16/07/2022,Verified
220119_Scotland_PublicHealthScotland_2BloodDonors_Overall_PopAdj_TestAdj,19-Jan-22,National,United Kingdom of Great Britain and Northern Ireland,GBR,Scotland,,15-Nov-21,19-Dec-21,Blood donors,Multiple groups,2493,100.00%,99.90%,100.00%,Sequential,EUROIMMUN,ELISA,IgG,84.00%,100.00%,Moderate,Institutional Report,Public Health Scotland,Public Health Scotland,https://www.publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-19-january-2022/,26/01/2022,16/07/2022,Verified
220119_Scotland_PublicHealthScotland_3PregnantWomen_Overall_Unadj,19-Jan-22,National,United Kingdom of Great Britain and Northern Ireland,GBR,Scotland,,15-Nov-21,19-Dec-21,Pregnant or parturient women,Adults (18-64 years),3060,87.25%,,,Sequential,Roche Diagnostics,CLIA,Total Antibody,92.30%,100.00%,Moderate,Institutional Report,Public Health Scotland,Public Health Scotland,https://www.publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-19-january-2022/,26/01/2022,16/07/2022,Verified
220124_SouthWales_PublicHealthWales_Overall,24-Jan-22,Regional,United Kingdom of Great Britain and Northern Ireland,GBR,South Wales,,01-Sep-20,31-Oct-20,Non-essential workers and unemployed persons,Adults (18-64 years),991,7.00%,,,Convenience,Zhejiang Orient Gene Biotech,LFIA,"IgG,IgM",96.00%,95.50%,High,Journal Article (Peer-Reviewed),Alice Puchades,Public Health Wales,https://dx.doi.org/10.1186/s12889-021-12478-x,03/02/2022,16/07/2022,Unverified
211114_UnitedKingdom_UniversityHospitalSouthamptonNHSTrust,14-Nov-21,National,United Kingdom of Great Britain and Northern Ireland,GBR,,,15-Feb-21,15-Mar-21,Residual sera,Multiple groups,478,9.83%,,,Convenience,NA,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Harry Chappell,University Hospital Southampton NHS Trust,https://www.sciencedirect.com/science/article/pii/S016344532100548X,17/02/2022,16/07/2022,Unverified
220216_England_UKHealthSecurityAgency_PrimaryStudents,16-Feb-22,Regional,United Kingdom of Great Britain and Northern Ireland,GBR,England,,17-Nov-20,15-Dec-20,Students and Daycares,Children and Youth (0-17 years),60,8.33%,,,Convenience,NA,ELISA,IgG,75.00%,99.00%,High,Journal Article (Peer-Reviewed),Annabel Powell,UK Health Security Agency,https://dx.doi.org/10.1371/journal.pone.0262515,23/02/2022,16/07/2022,Unverified
220216_England_UKHealthSecurityAgency_SecondaryStudents,16-Feb-22,Regional,United Kingdom of Great Britain and Northern Ireland,GBR,England,,17-Nov-20,15-Dec-20,Students and Daycares,Children and Youth (0-17 years),106,3.80%,,,Convenience,NA,ELISA,IgG,75.00%,99.00%,High,Journal Article (Peer-Reviewed),Annabel Powell,UK Health Security Agency,https://dx.doi.org/10.1371/journal.pone.0262515,23/02/2022,16/07/2022,Unverified
220216_England_UKHealthSecurityAgency_PrimaryStaff,16-Feb-22,Regional,United Kingdom of Great Britain and Northern Ireland,GBR,England,,17-Nov-20,15-Dec-20,Essential non-healthcare workers,Adults (18-64 years),16,0.00%,,,Convenience,NA,ELISA,IgG,75.00%,99.00%,High,Journal Article (Peer-Reviewed),Annabel Powell,UK Health Security Agency,https://dx.doi.org/10.1371/journal.pone.0262515,23/02/2022,16/07/2022,Unverified
220222_UnitedKingdom_QueenMaryUniversityofLondon_Overall,22-Feb-22,National,United Kingdom of Great Britain and Northern Ireland,GBR,"England, Scotland, Wales, and Northern Ireland",,01-May-20,02-Nov-20,Household and community samples,Multiple groups,11130,15.20%,,,Self-referral,The Binding Site,ELISA,"IgG,IgA,IgM",98.60%,98.30%,Moderate,Journal Article (Peer-Reviewed),Mohammad Talaei,Queen Mary University of London,https://dx.doi.org/10.1186/s12916-022-02286-4,08/03/2022,16/07/2022,Unverified
220223_Scotland_PublicHealthScotland_1ResidualSera_Overall_PopAdj_TestAdj,23-Feb-22,National,United Kingdom of Great Britain and Northern Ireland,GBR,Scotland,,20-Dec-21,23-Jan-22,Residual sera,Multiple groups,2863,91.50%,90.50%,93.00%,Stratified probability,DiaSorin,CLIA,Not reported,97.30%,99.60%,Moderate,Institutional Report,Public Health Scotland,Public Health Scotland,https://www.publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-23-february-2022/,08/03/2022,16/07/2022,Verified
220223_Scotland_PublicHealthScotland_2BloodDonors_Overall_PopAdj_TestAdj,23-Feb-22,National,United Kingdom of Great Britain and Northern Ireland,GBR,Scotland,,20-Dec-21,23-Jan-22,Blood donors,Multiple groups,2499,100.00%,99.80%,100.00%,Sequential,EUROIMMUN,ELISA,IgG,84.00%,100.00%,Moderate,Institutional Report,Public Health Scotland,Public Health Scotland,https://www.publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-23-february-2022/,08/03/2022,16/07/2022,Verified
220223_Scotland_PublicHealthScotland_3PregnantWomen_Overall_Unadj,23-Feb-22,National,United Kingdom of Great Britain and Northern Ireland,GBR,Scotland,,20-Dec-21,23-Jan-22,Pregnant or parturient women,Adults (18-64 years),2914,91.01%,,,Sequential,Roche Diagnostics,CLIA,Total Antibody,92.30%,100.00%,Moderate,Institutional Report,Public Health Scotland,Public Health Scotland,https://www.publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-23-february-2022/,08/03/2022,16/07/2022,Verified
220121_Oxford_UniversityOfOxford,21-Jan-22,Local,United Kingdom of Great Britain and Northern Ireland,GBR,,Oxford,26-May-20,24-Sep-21,Patients seeking care for non-COVID-19 reasons,Multiple groups,344,6.69%,,,Convenience,"Roche Diagnostics,Siemens",Not reported,Total Antibody,,,High,Presentation or Conference,S Y Wong,University of Oxford,https://dx.doi.org/10.1093/ecco-jcc/jjab232.469,08/03/2022,16/07/2022,Unverified
210525_Scotland_NHSLothian,25-Jun-21,National,United Kingdom of Great Britain and Northern Ireland,GBR,Scotland,,27-Apr-20,03-Aug-20,Household and community samples,Multiple groups,355,4.50%,,,Sequential,"Abbott Laboratories,Roche Diagnostics,DiaSorin,Siemens,EUROIMMUN",Multiple Types,"IgG,IgM,IgA",,,Unclear,Journal Article (Peer-Reviewed),Lindsay McDonald,NHS Lothian,https://dx.doi.org/10.1016/j.jcvp.2021.100028,18/03/2022,16/07/2022,Unverified
220330_Scotland_PublicHealthScotland_1ResidualSera_1Overall_PopAdj_TestAdj,30-Mar-22,National,United Kingdom of Great Britain and Northern Ireland,GBR,Scotland,,24-Jan-22,27-Feb-22,Residual sera,Multiple groups,2884,93.36%,92.80%,94.70%,Stratified probability,DiaSorin,CLIA,Not reported,97.30%,99.60%,Moderate,Institutional Report,Public Health Scotland,Public Health Scotland,https://www.publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-30-march-2022/,04/04/2022,16/07/2022,Verified
220330_Scotland_PublicHealthScotland_2BloodDonors_Overall_PopAdj_TestAdj,30-Mar-22,National,United Kingdom of Great Britain and Northern Ireland,GBR,Scotland,,24-Jan-22,27-Feb-22,Blood donors,Multiple groups,2499,100.00%,99.60%,100.00%,Sequential,EUROIMMUN,ELISA,IgG,84.00%,100.00%,Moderate,Institutional Report,Public Health Scotland,Public Health Scotland,https://www.publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-30-march-2022/,04/04/2022,16/07/2022,Verified
220330_Scotland_PublicHealthScotland_3PregnantWomen_3Overall_PopAdj_TestAdj,30-Mar-22,National,United Kingdom of Great Britain and Northern Ireland,GBR,Scotland,,24-Jan-22,27-Feb-22,Pregnant or parturient women,Adults (18-64 years),3217,94.30%,93.20%,95.80%,Sequential,Roche Diagnostics,CLIA,Total Antibody,92.30%,100.00%,Moderate,Institutional Report,Public Health Scotland,Public Health Scotland,https://www.publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-30-march-2022/,04/04/2022,16/07/2022,Verified
220303_NorthernIreland_UlsterUniversity,03-Mar-22,Local,United Kingdom of Great Britain and Northern Ireland,GBR,Northern Ireland,Belfast,01-Mar-21,31-Mar-21,Household and community samples,Multiple groups,80,11.25%,,,Convenience, Abingdon Health,LFIA,IgG,97.58%,99.59%,High,Journal Article (Peer-Reviewed),Louise Robertson,Ulster University,https://dx.doi.org/10.1016/j.vaccine.2022.02.087,06/04/2022,16/07/2022,Unverified
220310_Sheffield_SheffieldTeachingHospitalsNHSFoundationTrust_Follow-up2_UnAdj,10-Mar-22,Local,United Kingdom of Great Britain and Northern Ireland,GBR,England,Sheffield,15-Jun-20,10-Jul-20,Health care workers and caregivers,Adults (18-64 years),1166,27.27%,,,Convenience,NA,ELISA,"IgG,IgA",99.47%,99.56%,High,Journal Article (Peer-Reviewed),Hayley Colton,Sheffield Teaching Hospitals NHS Foundation Trust,https://wellcomeopenresearch.org/articles/6-220/v2,07/04/2022,16/07/2022,Unverified
220310_Sheffield_SheffieldTeachingHospitalsNHSFoundationTrust_Baseline1_TestAdj,10-Mar-22,Local,United Kingdom of Great Britain and Northern Ireland,GBR,England,Sheffield,15-May-20,12-Jun-20,Health care workers and caregivers,Adults (18-64 years),1275,23.10%,14.10%,33.30%,Convenience,NA,ELISA,"IgG,IgA",99.47%,99.56%,High,Journal Article (Peer-Reviewed),Hayley Colton,Sheffield Teaching Hospitals NHS Foundation Trust,https://wellcomeopenresearch.org/articles/6-220/v2,07/04/2022,16/07/2022,Unverified
220408_UKHealthSecurityAgency_England_May-June(1)_Euroimmun,08-Apr-22,National,United Kingdom of Great Britain and Northern Ireland,GBR,,,01-May-20,30-Jun-20,Residual sera,Multiple groups,5455,4.10%,3.10%,5.30%,Sequential,EUROIMMUN,ELISA,IgG,72.00%,99.00%,High,Preprint,Heather Whitaker,UK Health Security Agency,https://dx.doi.org/10.1016/j.jinf.2022.04.016,22/04/2022,16/07/2022,Verified
220408_UKHealthSecurityAgency_England_July-August(2)_Euroimmun,08-Apr-22,National,United Kingdom of Great Britain and Northern Ireland,GBR,,,01-Jul-20,31-Aug-20,Residual sera,Multiple groups,5781,5.20%,4.50%,6.10%,Sequential,EUROIMMUN,ELISA,IgG,72.00%,99.00%,High,Preprint,Heather Whitaker,UK Health Security Agency,https://dx.doi.org/10.1016/j.jinf.2022.04.016,22/04/2022,16/07/2022,Verified
220408_UKHealthSecurityAgency_England_Sept-Oct(3)_Euroimmun,08-Apr-22,National,United Kingdom of Great Britain and Northern Ireland,GBR,,,01-Sep-20,01-Oct-20,Residual sera,Multiple groups,5478,5.50%,4.80%,6.40%,Sequential,EUROIMMUN,ELISA,IgG,72.00%,99.00%,High,Preprint,Heather Whitaker,UK Health Security Agency,https://dx.doi.org/10.1016/j.jinf.2022.04.016,22/04/2022,16/07/2022,Verified
220408_UKHealthSecurityAgency_England_Nov-Dec(4)_Euroimmun,08-Apr-22,National,United Kingdom of Great Britain and Northern Ireland,GBR,,,01-Nov-20,31-Dec-20,Residual sera,Multiple groups,4934,6.60%,5.70%,7.60%,Sequential,EUROIMMUN,ELISA,IgG,72.00%,99.00%,High,Preprint,Heather Whitaker,UK Health Security Agency,https://dx.doi.org/10.1016/j.jinf.2022.04.016,22/04/2022,16/07/2022,Verified
220421_GreatBritain_UniversityCollegeLondon_Overall,21-Apr-22,National,United Kingdom of Great Britain and Northern Ireland,GBR,"England, Wales",,01-Feb-21,08-Jun-21,Household and community samples,Multiple groups,3775,12.10%,,,Convenience,Roche Diagnostics,CLIA,Total Antibody,,,High,Journal Article (Peer-Reviewed),Sarah Beale,University College London,https://dx.doi.org/10.1136/oemed-2021-107920,04/05/2022,16/07/2022,Verified
220504_Scotland_PublicHealthScotland_1ResidualSera_Overall_PopAdj_TestAdj,04-May-22,National,United Kingdom of Great Britain and Northern Ireland,GBR,Scotland,,28-Feb-22,03-Apr-22,Residual sera,Multiple groups,2885,94.80%,94.50%,96.10%,Stratified probability,DiaSorin,CLIA,Not reported,97.30%,99.60%,Moderate,Institutional Report,Public Health Scotland,Public Health Scotland,https://www.publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-4-may-2022/,15/05/2022,16/07/2022,Verified
220504_Scotland_PublicHealthScotland_2BloodDonors_Overall_PopAdj_TestAdj,04-May-22,National,United Kingdom of Great Britain and Northern Ireland,GBR,Scotland,,28-Feb-22,03-Apr-22,Blood donors,Multiple groups,2499,100.00%,99.70%,100.00%,Sequential,EUROIMMUN,ELISA,IgG,84.00%,100.00%,Moderate,Institutional Report,Public Health Scotland,Public Health Scotland,https://www.publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-4-may-2022/,15/05/2022,16/07/2022,Verified
220504_Scotland_PublicHealthScotland_3PregnantWomen_Overall_PopAdj_TestAdj,04-May-22,National,United Kingdom of Great Britain and Northern Ireland,GBR,Scotland,,28-Feb-22,03-Apr-22,Pregnant or parturient women,Adults (18-64 years),3181,95.40%,94.40%,96.90%,Sequential,Roche Diagnostics,CLIA,Total Antibody,92.30%,100.00%,Moderate,Institutional Report,Public Health Scotland,Public Health Scotland,https://www.publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-4-may-2022/,15/05/2022,16/07/2022,Verified
220608_Scotland_PublicHealthScotland_2BloodDonors_Overall_PopAdj_TestAdj,08-Jun-22,National,United Kingdom of Great Britain and Northern Ireland,GBR,Scotland,,04-Apr-22,08-May-22,Blood donors,Multiple groups,2499,100.00%,99.75%,100.00%,Sequential,EUROIMMUN,ELISA,IgG,84.00%,100.00%,Moderate,Institutional Report,Public Health Scotland,Public Health Scotland,https://www.publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-8-june-2022/,22/06/2022,16/07/2022,Unverified
220608_Scotland_PublicHealthScotland_1ResidualSera_Overall_PopAdj_TestAdj,08-Jun-22,National,United Kingdom of Great Britain and Northern Ireland,GBR,Scotland,,04-Apr-22,08-May-22,Residual sera,Multiple groups,2886,94.77%,94.47%,96.09%,Stratified probability,DiaSorin,CLIA,Not reported,97.30%,99.60%,Moderate,Institutional Report,Public Health Scotland,Public Health Scotland,https://www.publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-8-june-2022/,22/06/2022,16/07/2022,Unverified
220608_Scotland_PublicHealthScotland_3PregnantWomen_Overall_PopAdj_TestAdj,08-Jun-22,National,United Kingdom of Great Britain and Northern Ireland,GBR,Scotland,,04-Apr-22,08-May-22,Pregnant or parturient women,Adults (18-64 years),3181,95.43%,94.41%,96.86%,Sequential,Roche Diagnostics,CLIA,Total Antibody,92.30%,100.00%,Moderate,Institutional Report,Public Health Scotland,Public Health Scotland,https://www.publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-8-june-2022/,22/06/2022,16/07/2022,Unverified
220609_England_ImperialCollegeLondon_Overall,09-Jun-22,Regional,United Kingdom of Great Britain and Northern Ireland,GBR,England,,01-Jul-21,10-Aug-21,Household and community samples,Multiple groups,3758,96.40%,95.70%,97.00%,Convenience,Roche Diagnostics,ELISA,IgG,98.50%,100.00%,High,Preprint,Christina Atchison,Imperial College London,https://www.medrxiv.org/content/10.1101/2022.06.08.22276154v1.full-text,01/07/2022,16/07/2022,Unverified
220721_England_UKHealthSecurityAgency_PrimaryStudents_TestPopAdj_Overall,21-Jul-22,Regional,United Kingdom of Great Britain and Northern Ireland,GBR,England,,10-Nov-21,10-Dec-21,Students and Daycares,Children and Youth (0-17 years),2706,40.10%,37.30%,43.00%,Stratified probability,NA,Other,IgG,,,Moderate,Preprint,Annabel Powell,UK Health Security Agency,https://doi.org/10.1101/2022.07.20.22277838,24/07/2022,27/07/2022,Unverified
220721_England_UKHealthSecurityAgency_SecondaryStudents_TestPopAdj_Overall,21-Jul-22,Regional,United Kingdom of Great Britain and Northern Ireland,GBR,England,,10-Nov-21,10-Dec-21,Students and Daycares,Children and Youth (0-17 years),2274,82.40%,79.50%,85.10%,Stratified probability,NA,Other,IgG,,,Moderate,Preprint,Annabel Powell,UK Health Security Agency,https://doi.org/10.1101/2022.07.20.22277838,24/07/2022,27/07/2022,Unverified
220623_England_UniversityofOxford_period1,23-Jun-22,National,United Kingdom of Great Britain and Northern Ireland,GBR,,Bradford; Bristol; Imperial; Leeds; Manchester; Newcastle; Nottingham; Oxford; Plymouth; Sheffield; Southhampton; St Georges London; West Suffolk,01-Oct-19,31-Mar-20,Household and community samples,Children and Youth (0-17 years),2540,5.00%,,,Convenience,Roche Diagnostics,CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Helen Ratcliffe,University of Oxford,https://dx.doi.org/10.1136/archdischild-2022-324375,27/07/2022,29/07/2022,Unverified
220623_England_UniversityofOxford_period2,23-Jun-22,National,United Kingdom of Great Britain and Northern Ireland,GBR,,Bradford; Bristol; Imperial; Leeds; Manchester; Newcastle; Nottingham; Oxford; Plymouth; Sheffield; Southhampton; St Georges London; West Suffolk,01-Apr-20,31-May-20,Household and community samples,Children and Youth (0-17 years),2540,13.50%,,,Convenience,Roche Diagnostics,CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Helen Ratcliffe,University of Oxford,https://dx.doi.org/10.1136/archdischild-2022-324375,27/07/2022,29/07/2022,Unverified
220623_England_UniversityofOxford_period3,23-Jun-22,National,United Kingdom of Great Britain and Northern Ireland,GBR,,Bradford; Bristol; Imperial; Leeds; Manchester; Newcastle; Nottingham; Oxford; Plymouth; Sheffield; Southhampton; St Georges London; West Suffolk,01-Jun-20,31-Aug-20,Household and community samples,Children and Youth (0-17 years),2540,20.80%,,,Convenience,Roche Diagnostics,CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Helen Ratcliffe,University of Oxford,https://dx.doi.org/10.1136/archdischild-2022-324375,27/07/2022,29/07/2022,Unverified
220623_England_UniversityofOxford_period4,23-Jun-22,National,United Kingdom of Great Britain and Northern Ireland,GBR,,Bradford; Bristol; Imperial; Leeds; Manchester; Newcastle; Nottingham; Oxford; Plymouth; Sheffield; Southhampton; St Georges London; West Suffolk,01-Sep-20,31-Dec-20,Household and community samples,Children and Youth (0-17 years),2540,18.70%,,,Convenience,Roche Diagnostics,CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Helen Ratcliffe,University of Oxford,https://dx.doi.org/10.1136/archdischild-2022-324375,27/07/2022,29/07/2022,Unverified
220623_England_UniversityofOxford_period5,23-Jun-22,National,United Kingdom of Great Britain and Northern Ireland,GBR,,Bradford; Bristol; Imperial; Leeds; Manchester; Newcastle; Nottingham; Oxford; Plymouth; Sheffield; Southhampton; St Georges London; West Suffolk,01-Jan-21,31-Mar-21,Household and community samples,Children and Youth (0-17 years),2540,31.10%,,,Convenience,Roche Diagnostics,CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Helen Ratcliffe,University of Oxford,https://dx.doi.org/10.1136/archdischild-2022-324375,27/07/2022,29/07/2022,Unverified
220623_England_UniversityofOxford_period6,23-Jun-22,National,United Kingdom of Great Britain and Northern Ireland,GBR,,Bradford; Bristol; Imperial; Leeds; Manchester; Newcastle; Nottingham; Oxford; Plymouth; Sheffield; Southhampton; St Georges London; West Suffolk,01-Apr-21,30-Jun-21,Household and community samples,Children and Youth (0-17 years),2540,10.70%,,,Convenience,Roche Diagnostics,CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Helen Ratcliffe,University of Oxford,https://dx.doi.org/10.1136/archdischild-2022-324375,27/07/2022,29/07/2022,Unverified
220713_Scotland_PublicHealthScotland_1ResidualSera_Overall_PopAdj_TestAdj,13-Jul-22,National,United Kingdom of Great Britain and Northern Ireland,GBR,Scotland,,06-Jun-22,10-Jul-22,Residual sera,Multiple groups,2544,95.50%,95.00%,97.00%,Stratified probability,DiaSorin,CLIA,Not reported,97.30%,99.60%,Moderate,Institutional Report,Public Health Scotland,Public Health Scotland,https://www.publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-13-july-2022/,08/08/2022,11/08/2022,Verified
210424_EmirateofAbuDhabi_AbuDhabiPublicHealthCenter_Households_TestAdj.,24-Apr-21,Regional,United Arab Emirates,ARE,Emirate of Abu Dhabi,"Abu Dhabi, Al Ain, Al Dhafra",19-Jul-20,14-Aug-20,Household and community samples,Multiple groups,8831,10.40%,9.50%,11.40%,Stratified probability,"DiaSorin,Roche Diagnostics",CLIA,IgG,97.40%,98.50%,Low,Journal Article (Peer-Reviewed),Ahmed R Alsuwaidi,Abu Dhabi Public Health Center,https://academic.oup.com/ije/advance-article/doi/10.1093/ije/dyab077/6248207,14/05/2021,16/07/2022,Unverified
210424_EmirateofAbuDhabi_AbuDhabiPublicHealthCenter_LabourCamps_TestAdj.,24-Apr-21,Regional,United Arab Emirates,ARE,Emirate of Abu Dhabi,"Abu Dhabi, Al Ain, Al Dhafra",19-Jul-20,14-Aug-20,Essential non-healthcare workers,Multiple groups,4855,68.60%,61.70%,74.70%,Stratified probability,Roche Diagnostics,Not reported,IgG,97.40%,98.50%,Moderate,Journal Article (Peer-Reviewed),Ahmed R Alsuwaidi,Abu Dhabi Public Health Center,https://academic.oup.com/ije/advance-article/doi/10.1093/ije/dyab077/6248207,14/05/2021,16/07/2022,Unverified
210709_Dubai_DubaiHealthAuthority_Overall,09-Jul-21,Local,United Arab Emirates,ARE,NR,Dubai,15-Aug-20,15-Dec-20,Blood donors,Adults (18-64 years),1418,13.50%,,,Simplified probability,Abbott Laboratories,CLIA,IgG,96.77%,99.63%,Moderate,Journal Article (Peer-Reviewed),May Raouf,Dubai Health Authority,http://dx.doi.org/10.1159/000517456,17/08/2021,16/07/2022,Unverified
210927_AbuDhabi_SEHAAbuDhabiHealthServicesCompany,27-Sep-21,Local,United Arab Emirates,ARE,,Abu Dhabi,25-Jan-21,30-Mar-21,Patients seeking care for non-COVID-19 reasons,Multiple groups,446,17.00%,,,Convenience,DiaSorin,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Stephen Holt,SEHA Abu Dhabi Health Services Company,https://dx.doi.org/10.1111/nep.13980,06/10/2021,16/07/2022,Unverified
210501_Poltava_UkranianMedicalStomatologicalAcademy_IgG2,01-May-21,Local,Ukraine,UKR,Poltava Oblast,Poltava,15-Jul-20,15-Dec-20,Household and community samples,Multiple groups,468,47.70%,,,Self-referral,EKVITESTLAB LLC,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Alla Marchenko,Ukranian Medical Stomatological Academy,https://wiadlek.pl/wp-content/uploads/archive/2021/WLek202105116.pdf,21/06/2021,16/07/2022,Verified
210501_Poltava_UkranianMedicalStomatologicalAcademy_IgM1,01-May-21,Local,Ukraine,UKR,Poltava Oblast,Poltava,15-Jul-20,15-Dec-20,Household and community samples,Multiple groups,2375,5.70%,,,Self-referral,EKVITESTLAB LLC,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Alla Marchenko,Ukranian Medical Stomatological Academy,https://wiadlek.pl/wp-content/uploads/archive/2021/WLek202105116.pdf,21/06/2021,16/07/2022,Verified
220221_RakaiRegion_RakaiHealthSciencesProgram_HCWs_TestAdj,21-Feb-22,Regional,Uganda,UGA,"Kyotera district, Lyantonde district, Masaka district, Rakai district.",,30-Nov-20,08-Jan-21,Health care workers and caregivers,Adults (18-64 years),753,26.70%,23.50%,29.80%,Convenience,"Hangzhou Biotest Biotech Co Ltd,Abbott Laboratories",Multiple Types,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Charles Ssuuna,Rakai Health Sciences Program,https://dx.doi.org/10.1186/s12879-022-07161-4,03/03/2022,16/07/2022,Unverified
220221_RakaiRegion_RakaiHealthSciencesProgram_PreOfficialCOVID_TestAdj,21-Feb-22,Regional,Uganda,UGA,"Kyotera district, Lyantonde district, Masaka district, Rakai district.",,15-Oct-19,18-Mar-20,Residual sera,Multiple groups,636,2.30%,1.20%,3.50%,Unclear,"Hangzhou Biotest Biotech Co Ltd,Abbott Laboratories",Multiple Types,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Charles Ssuuna,Rakai Health Sciences Program,https://dx.doi.org/10.1186/s12879-022-07161-4,03/03/2022,16/07/2022,Unverified
220331_Uganda_MakerereUniversity_Primary,31-Mar-22,Regional,Uganda,UGA,Amuru and Kyotera Districts,,15-Jul-20,15-Dec-20,Household and community samples,Multiple groups,72,31.90%,,,Stratified non-probability,Astel diagnostics® ,CLIA,IgG,93.30%,90.00%,High,Journal Article (Peer-Reviewed),Jesca Lukanga Nakavuma,Makerere University,https://doi.org/10.22541/au.164873468.80238886/v1,05/04/2022,16/07/2022,Unverified
210920_Serdivan_SakaryaUniversity,15-Jan-21,Local,Turkey,TUR,Sakarya,Serdivan,07-Apr-20,30-May-20,Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),198,3.50%,,,Unclear,NA,CLIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Cemil Bilir,Sakarya University ,http://dx.doi.org/10.19193/0393-6384_2021_1_103,27/03/2021,16/07/2022,Verified
210303_Turkey_UniversityofHealthSciences_Overall,03-Mar-21,National,Turkey,TUR,Marmara,Istanbul and Kocaeli,30-May-20,06-Jun-20,Health care workers and caregivers,Adults (18-64 years),813,2.70%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Gizem Alkurt,University of Health Sciences,https://dx.doi.org/10.1371/journal.pone.0247865,17/04/2021,16/07/2022,Verified
210310_Ankara_HacettepeUniversity_Overall,10-Mar-21,Local,Turkey,TUR,Central Anatolia,Ankara,24-Mar-20,10-Sep-20,Health care workers and caregivers,Adults (18-64 years),774,7.40%,,,Unclear,NA,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Adem Ozdemir,Hacettepe University,http://www.mikrobiyolbul.org/linkout.aspx?pmid=33882653,17/05/2021,16/07/2022,Verified
210427_Turkey_SakaryaUniversity_Overall,27-Apr-21,Local,Turkey,TUR,,,01-May-20,31-May-20,Health care workers and caregivers,Adults (18-64 years),2988,3.61%,,,Entire sample,Beijing Hotgen Biotech Co. Ltd China,Other,"IgG,IgM",,,Moderate,Journal Article (Peer-Reviewed),Aziz Ogutlu,Sakarya University,https://dx.doi.org/10.1186/s12941-021-00436-9,25/05/2021,16/07/2022,Verified
210523_Istanbul_KocUniversity,23-May-21,Regional,Turkey,TUR,Marmara,Istanbul,01-May-20,31-Dec-20,Health care workers and caregivers,Adults (18-64 years),1732,15.00%,,,Convenience,Roche Diagnostics,CLIA,"IgG,IgM,IgA",,,High,Preprint,Fatihan Pınarlık,Koc University,10.1101/2021.05.20.21257518,07/06/2021,16/07/2022,Unverified
210706_Ankara_EtlikZübeydeHanımWomen'sHealthCareTrainingandResearchHospital_PROMPatients,06-Jul-21,Local,Turkey,TUR,,Ankara,01-Jun-20,31-Jul-20,Pregnant or parturient women,Adults (18-64 years),205,2.93%,,,Sequential,Assure Tech. (Hangzhou) Co. Ltd,LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Ozge Yucel Celik,"Etlik Zübeyde Hanim Women's Health Care, Training, and Research Hospital",https://dx.doi.org/10.5603/GP.a2021.0134,19/07/2021,16/07/2022,Verified
210706_Ankara_EtlikZübeydeHanımWomen'sHealthCareTrainingandResearchHospital_MiscarriagePatients,06-Jul-21,Local,Turkey,TUR,,Ankara,01-Jun-20,31-Jul-20,Pregnant or parturient women,Adults (18-64 years),230,0.00%,,,Sequential,Assure Tech. (Hangzhou) Co. Ltd,LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Ozge Yucel Celik,"Etlik Zübeyde Hanim Women's Health Care, Training, and Research Hospital",https://dx.doi.org/10.5603/GP.a2021.0134,19/07/2021,16/07/2022,Verified
210707_Istanbul_FlorenceNightingaleHospital_primary,07-Jul-21,Local,Turkey,TUR,Marmara,Istanbul,20-Mar-20,20-Jun-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,83,3.60%,,,Convenience,Zhejiang Orient Gene Biotech,LFIA,"IgM,IgG",,,High,Journal Article (Peer-Reviewed),Savas Comlek,Florence Nightingale Hospital,http://dx.doi.org/10.22514/sv.2021.008,28/07/2021,16/07/2022,Unverified
210522_Adana_AdanaDr.TurgutNoyanTeachingandResearchHospital,22-May-21,Local,Turkey,TUR,Mediterranean Region,Adana,18-May-20,30-Jun-20,Health care workers and caregivers,Adults (18-64 years),572,3.70%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Hatice Hale GUMUS,Adana Dr. Turgut Noyan Teaching and Research Hospital,http://mikrobiyolbul.org/managete/fu_folder/2021-03/357-373%20Hatice%20Hale%20Gumus.pdf,02/08/2021,16/07/2022,Unverified
210930_Konya_NecmettinErbakanUniversityMeramFacultyofMedicine_Primary,30-Sep-21,Local,Turkey,TUR,,Konya,01-Jun-20,30-Nov-20,Health care workers and caregivers,Adults (18-64 years),741,17.00%,,,Convenience,"EUROIMMUN,Vircell S.L.",ELISA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Gokce Kader Arslan,Necmettin Erbakan University Meram Faculty of Medicine,http://dx.doi.org/10.5578/FLORA.20219706,27/10/2021,16/07/2022,Unverified
210927_Turkey_HacettepeUniversity_Primary,27-Sep-21,National,Turkey,TUR,"Middle Anatolia region
Marmara region
Aegean region
East Anatolia region
South-east Anatolian region
Black Sea region
Mediterranean region",,25-May-20,10-Jun-20,Health care workers and caregivers,Adults (18-64 years),4927,6.10%,,,Convenience,Assure Tech. (Hangzhou) Co. Ltd,LFIA,"IgG,IgM",,,Moderate,Journal Article (Peer-Reviewed),Pembe Derin Oygar,Hacettepe University,http://dx.doi.org/10.1016/j.ijid.2021.09.054,04/11/2021,16/07/2022,Unverified
211030_Turkey_BiruniUniversity_Other,30-Oct-21,Local,Turkey,TUR,Marmara,Istanbul,01-Dec-20,13-Jan-21,Residual sera,Adults (18-64 years),4258,35.30%,,,Unclear,NA,IFA,IgG,,,High,Journal Article (Peer-Reviewed),Mehmet Islamoglu,Biruni University,https://dx.doi.org/10.1016/j.tmaid.2021.102190,15/11/2021,16/07/2022,Unverified
211030_Turkey_BiruniUniversity_AirCrew,30-Oct-21,Local,Turkey,TUR,Marmara,Istanbul,01-Dec-20,13-Jan-21,Essential non-healthcare workers,Adults (18-64 years),313,46.00%,,,Unclear,NA,IFA,IgG,,,High,Journal Article (Peer-Reviewed),Mehmet Islamoglu,Biruni University,https://dx.doi.org/10.1016/j.tmaid.2021.102190,15/11/2021,16/07/2022,Unverified
211030_Turkey_BiruniUniversity_HCW,30-Oct-21,Local,Turkey,TUR,Marmara,Istanbul,01-Dec-20,13-Jan-21,Health care workers and caregivers,Adults (18-64 years),451,41.00%,,,Unclear,NA,IFA,IgG,,,High,Journal Article (Peer-Reviewed),Mehmet Islamoglu,Biruni University,https://dx.doi.org/10.1016/j.tmaid.2021.102190,15/11/2021,16/07/2022,Unverified
211108_Istanbul_UmraniyeTrainingandResearchHospital,08-Nov-21,Local,Turkey,TUR,Marmara,Istanbul,01-Apr-20,01-Dec-20,Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),436,0.46%,,,Convenience,NA,Not reported,Not reported,,,Unclear,Presentation or Conference,Ferhat Demir,Umraniye Training and Research Hospital,https://dx.doi.org/10.1186/s12969-021-00632-z,02/01/2022,16/07/2022,Unverified
220119_Istanbul_IstanbulUniversity_Overall,19-Jan-22,Local,Turkey,TUR,Marmara,Istanbul,15-Aug-20,15-Oct-20,Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),149,12.75%,,,Convenience,EUROIMMUN,ELISA,"IgG,IgA",,,High,Journal Article (Peer-Reviewed),Fatih Haslak,Istanbul University,https://dx.doi.org/10.1007/s10067-022-06067-5,26/01/2022,16/07/2022,Unverified
220208_Ankara_HacettepeUniversity_Overall,08-Feb-22,Local,Turkey,TUR,Ankara,Ankara,15-Oct-20,18-Oct-20,Health care workers and caregivers,Adults (18-64 years),1974,19.00%,,,Convenience,EUROIMMUN,ELISA,"IgG,IgA",,,High,Journal Article (Peer-Reviewed),Meliha Sonmezer,Hacettepe University,https://dx.doi.org/10.3390/vaccines10020258,23/02/2022,16/07/2022,Unverified
220315_Ankara_AnkaraCItyHospital_overall,15-Mar-22,Local,Turkey,TUR,,Ankary,15-Sep-20,15-Mar-21,Patients seeking care for non-COVID-19 reasons,Multiple groups,91,30.77%,,,Convenience,Siemens,CLIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Dilara Gokce,Ankara City Hospital,https://dx.doi.org/10.6002/ect.2021.0494,24/03/2022,16/07/2022,Unverified
220712_Turkey_DokuzEylulUniversity_Overall,12-Jul-22,National,Turkey,TUR,,,15-Dec-20,15-Jan-21,Multiple populations,Multiple groups,888,29.20%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Oya Eren‑Kutsoylu,Dokuz Eylul University,https://dx.doi.org/10.1007/s11845-022-03095-7,19/07/2022,29/07/2022,Unverified
220622_Trabzon_KaradenizTechnicalUniversity_Controls,22-Jun-22,Local,Turkey,TUR,,Trabzon,15-Jan-21,15-Feb-21,Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),48,22.92%,,,Simplified probability,Roche Diagnostics,Not reported,Not reported,,,High,Presentation or Conference,G. Kaya,Karadeniz Technical University,https://dx.doi.org/10.1097/MPG.0000000000003446,11/08/2022,11/08/2022,Unverified
220622_Trabzon_KaradenizTechnicalUniversity_Patients,22-Jun-22,Local,Turkey,TUR,,Trabzon,15-Jan-21,15-Feb-21,Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),141,25.53%,,,Sequential,Roche Diagnostics,Not reported,Not reported,,,High,Presentation or Conference,G. Kaya,Karadeniz Technical University,https://dx.doi.org/10.1097/MPG.0000000000003446,11/08/2022,11/08/2022,Unverified
20220204_Tunis_UniversityofTunisElManar_AntiSAdj,04-Feb-22,Local,Tunisia,TUN,,Tunis,15-Mar-21,15-Apr-21,Household and community samples,Multiple groups,1676,25.10%,22.20%,28.40%,Stratified probability,NA,ELISA,IgG,93.00%,95.00%,Low,Preprint,Ines Cherif,University of Tunis El Manar,https://www.researchsquare.com/article/rs-1317280/v2,18/02/2022,16/07/2022,Unverified
200807_Lome_UniversiteDeLome_Overall,07-Aug-20,Local,Togo,TGO,,Lome,23-Apr-20,08-May-20,Non-essential workers and unemployed persons,Adults (18-64 years),955,0.90%,0.40%,1.80%,Convenience,Hangzhou Clongene Biotech Co. Ltd ,LFIA,"IgM,IgG",77.10%,95.40%,High,Journal Article (Peer-Reviewed),Wemboo Halatoko,Universite de Lome,https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0242124,23/09/2020,16/07/2022,Verified
220705_Togo_UniversitedeLome_PopTestAdj,05-Jul-22,National,Togo,TGO,"Maritime, Plateaux, Centrale, Savanes","Grand Lome, Kara",05-May-21,30-Jun-21,Household and community samples,Multiple groups,7593,65.50%,64.30%,66.60%,Stratified probability,Beijing Wantai Biological,ELISA,Total Antibody,94.36%,100.00%,Low,Preprint,Yao Konu,Universite de Lome,https://doi.org/10.21203/rs.3.rs-1769582/v1,12/07/2022,16/07/2022,Unverified
220615_Lome_UniveristyofLome_Overall,15-Jun-22,Local,Togo,TGO,,"Lomé
",01-Sep-20,31-Oct-20,Representative patient population,Multiple groups,243,5.80%,,,Convenience,CLUNGENE,LFIA,"IgG,IgM",77.00%,95.00%,High,Journal Article (Peer-Reviewed),Ameyo Monique Dorkenoo,University of Lomé,https://dx.doi.org/10.1007/s11686-022-00586-6,20/07/2022,29/07/2022,Unverified
220328_Dili_CharlesDarwinUniversity_FollowUp_Overall,28-Mar-22,Local,Timor-Leste,TLS,Dili,Dili,09-Jul-21,08-Sep-21,Health care workers and caregivers,Adults (18-64 years),157,94.30%,,,Convenience,Ortho Clinical Diagnostics Inc.,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Paul Arkell,Charles Darwin University,https://dx.doi.org/10.1016/j.ijid.2022.03.043,12/04/2022,16/07/2022,Unverified
210401_Ranong_ChulalongkornUniversity,01-Apr-21,Local,Thailand,THA,Ranong,,17-Apr-20,17-May-20,Health care workers and caregivers,Adults (18-64 years),844,0.80%,0.40%,1.70%,Convenience,Baiya Phytopharm,LFIA,"IgG,IgM",94.10%,98.00%,Moderate,Journal Article (Peer-Reviewed),Tanawin Nopsopon,Chulalongkorn University,https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0238088,05/04/2021,16/07/2022,Unverified
210714_Thailand_MinistryOfPublicHealthThailand_Overall,14-Jul-21,National,Thailand,THA,"Eastern, Western, Central Thailand",,18-Jan-21,05-Mar-21,Health care workers and caregivers,Adults (18-64 years),600,0.20%,,,Convenience,EUROIMMUN,ELISA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Wanitchaya Kittikraisak,"Ministry of Public Health, Thailand",https://dx.doi.org/10.1371/journal.pone.0254563,19/07/2021,16/07/2022,Unverified
210720_Bangkok_ChulalongkornUniversity,20-Jul-21,Local,Thailand,THA,,Bangkok,15-Aug-20,15-Jan-21,Patients seeking care for non-COVID-19 reasons,Multiple groups,210,0.95%,,,Unclear,Baiya Phytopharm,LFIA,"IgG,IgM",88.66%,90.63%,High,Preprint,Amarin Narkwichean,Chulalongkorn University,https://www.medrxiv.org/content/10.1101/2021.07.16.21259725v1.full-text,04/08/2021,16/07/2022,Unverified
211029_Thailand_ChulalongkornUniversity_overall_popadj,29-Oct-21,National,Thailand,THA,"Northern Region, Northeastern Region, Central Region, Eastern Region, Southern Region",,06-Apr-20,26-Jun-20,Multiple populations,Adults (18-64 years),857,6.30%,,,Convenience,Baiya Phytopharm,LFIA,"IgM,IgG",94.10%,98.00%,High,Journal Article (Peer-Reviewed),Tanawin Nopsopon,Chulalongkorn University,https://dx.doi.org/10.1136/bmjopen-2020-046676,10/11/2021,16/07/2022,Unverified
220121_Thailand_MahidolUniversity_HealthPersonnel_Overall,21-Jan-22,Regional,Thailand,THA,"Chiang Mai, Bangkok",Bangkok,14-May-20,21-May-21,Health care workers and caregivers,Multiple groups,472,0.00%,,,Unclear,"NA,Abbott Laboratories,Author designed",Multiple Types,"Neutralizing ,IgG,IgA,IgM",,,Unclear,Preprint,Hatairat Lerdsamra,Mahidol University,https://www.medrxiv.org/content/10.1101/2022.01.18.22269501v1.full-text,01/02/2022,16/07/2022,Unverified
220202_Thailand_ChiangMaiUniversity_Overall,02-Feb-22,National,Thailand,THA,Chiang Mai and Lamphun,,15-Nov-20,15-Jan-21,Household and community samples,Multiple groups,1651,0.90%,0.50%,1.40%,Unclear,"NA,Innovita Biological Technology Co. Ltd,SD Biosensor,ACRO Biotech Inc",LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Siriluk Takalay,Chiang Mai University,https://dx.doi.org/10.1371/journal.pone.0263127,07/02/2022,16/07/2022,Unverified
220415_MahasarakhamUniversity_Mahasarakham_Patients1,15-Apr-22,Regional,Thailand,THA,Mahasarakham Province,,20-Feb-20,30-Apr-20,Multiple populations,Multiple groups,78,2.60%,0.30%,9.00%,Sequential,Snibe Co. Ltd (Shenzhen New Industries Biomedical Engineering Co. Ltd),CLIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Samadhi Patamatamkul,Mahasarakham University,https://dx.doi.org/10.1097/IPC.0000000000001150,22/04/2022,16/07/2022,Unverified
220415_MahasarakhamUniversity_Mahasarakham_HCW2,15-Apr-22,Regional,Thailand,THA,Mahasarakham Province,,20-Feb-20,30-Apr-20,Health care workers and caregivers,Multiple groups,112,0.90%,0.02%,4.90%,Convenience,Snibe Co. Ltd (Shenzhen New Industries Biomedical Engineering Co. Ltd),CLIA,IgG,91.21%,97.33%,High,Journal Article (Peer-Reviewed),Samadhi Patamatamkul,Mahasarakham University,https://dx.doi.org/10.1097/IPC.0000000000001150,22/04/2022,16/07/2022,Unverified
220427_Thailand_MahidolUniversity_ReturnedWorkers_Primary,27-Apr-22,Local,Thailand,THA,,"Bangkok, Chiang Mai",17-May-20,12-Oct-20,Multiple populations,Adults (18-64 years),553,28.00%,23.79%,32.80%,Unclear,"NA,Abbott Laboratories",Multiple Types,"IgG,IgM,IgA",,,,Journal Article (Peer-Reviewed),Hatairat Lerdsamran,Mahidol University,https://dx.doi.org/10.1371/journal.pone.0263316,03/05/2022,16/07/2022,Unverified
220427_Thailand_MahidolUniversity_AtRiskOccupation_Primary,27-Apr-22,Local,Thailand,THA,,"Bangkok, Chiang Mai",15-May-20,17-May-21,Multiple populations,Multiple groups,2113,0.14%,0.03%,0.42%,Unclear,"NA,Abbott Laboratories",Multiple Types,"IgG,IgM,IgA",,,,Journal Article (Peer-Reviewed),Hatairat Lerdsamran,Mahidol University,https://dx.doi.org/10.1371/journal.pone.0263316,03/05/2022,16/07/2022,Unverified
220427_Thailand_MahidolUniversity_CloseContact_Primary,27-Apr-22,Local,Thailand,THA,,"Bangkok, Chiang Mai",14-May-20,21-May-21,Contacts of COVID patients,Multiple groups,1856,2.04%,1.44%,2.81%,Unclear,"NA,Abbott Laboratories",Multiple Types,"IgG,IgM,IgA",,,,Journal Article (Peer-Reviewed),Hatairat Lerdsamran,Mahidol University,https://dx.doi.org/10.1371/journal.pone.0263316,03/05/2022,16/07/2022,Unverified
220525_Mahasarakham_MahasarakhamUniversity,03-Jun-22,Local,Thailand,THA,Maha Sarakham Province,Mahasarakham,01-Jul-20,31-Mar-21,Household and community samples,Adults (18-64 years),27,0.00%,,,Convenience,"Snibe Co. Ltd (Shenzhen New Industries Biomedical Engineering Co. Ltd),Roche Diagnostics",Multiple Types,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Ploysai Rujkorakarn,Mahasarakham University,https://dx.doi.org/10.2147/OPTH.S366353,24/06/2022,16/07/2022,Unverified
210913_Syria_ArabInternationalUniversity_Overall,13-Sep-21,Local,Syrian Arab Republic,SYR,Daraa Governorate,Ghabaghib,17-Feb-21,31-Mar-21,Household and community samples,Multiple groups,94,63.83%,,,Convenience,Vircell S.L.,ELISA,IgG,,,High,Preprint,Wafika Zarzour,Arab International University,https://www.researchsquare.com/article/rs-885678/v1,21/09/2021,16/07/2022,Verified
200611_Geneva_UniversityofLausanne_genpop,11-Jun-20,Regional,Switzerland,CHE,Geneva,,06-Apr-20,09-May-20,Household and community samples,Multiple groups,2766,7.81%,,,Stratified probability,EUROIMMUN,ELISA,IgG,93.00%,,Moderate,Journal Article (Peer-Reviewed),Silvia Stringhini,Geneva University Hospitals,https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31304-0/fulltext#seccestitle10,16/07/2020,16/07/2022,Verified
200807_Zurich_UniversityofZurich_USZCohort_MarchQDA,07-Aug-20,Local,Switzerland,CHE,Zurich,Zurich,15-Mar-20,31-Mar-20,Residual sera,Adults (18-64 years),3806,0.30%,0.10%,0.50%,Sequential,NA,ELISA,IgG,100.00%,100.00%,Moderate,Preprint,Marc Emmenegger,University of Zurich,https://www.medrxiv.org/content/10.1101/2020.05.31.20118554v4,27/09/2020,16/07/2022,Verified
200807_Zurich_UniversityofZurich_USZCohort_AprilQDA,07-Aug-20,Local,Switzerland,CHE,Zurich,Zurich,01-Apr-20,30-Apr-20,Residual sera,Adults (18-64 years),4275,1.40%,1.00%,1.70%,Sequential,NA,ELISA,IgG,100.00%,100.00%,Moderate,Preprint,Marc Emmenegger,University of Zurich,https://www.medrxiv.org/content/10.1101/2020.05.31.20118554v4,27/09/2020,16/07/2022,Verified
200807_Zurich_UniversityofZurich_USZCohort_May-JulyAveQDA,07-Aug-20,Local,Switzerland,CHE,Zurich,Zurich,15-May-20,15-Jul-20,Residual sera,Adults (18-64 years),12831,0.90%,,,Sequential,NA,ELISA,IgG,100.00%,100.00%,Moderate,Preprint,Marc Emmenegger,University of Zurich,https://www.medrxiv.org/content/10.1101/2020.05.31.20118554v4,27/09/2020,16/07/2022,Verified
200807_Zurich_UniversityofZurich_BDSCohort_AprilQDA,07-Aug-20,Local,Switzerland,CHE,Zurich,Zurich,01-Apr-20,30-Apr-20,Blood donors,Adults (18-64 years),1469,1.20%,0.70%,,Sequential,NA,ELISA,IgG,100.00%,100.00%,Moderate,Preprint,Marc Emmenegger,University of Zurich,https://www.medrxiv.org/content/10.1101/2020.05.31.20118554v4,27/09/2020,16/07/2022,Verified
200807_Zurich_UniversityofZurich_BDSCohort_earlyJulyQDA,07-Aug-20,Local,Switzerland,CHE,Zurich,Zurich,01-Jul-20,15-Jul-20,Blood donors,Adults (18-64 years),1067,0.70%,0.30%,1.20%,Sequential,NA,ELISA,IgG,100.00%,100.00%,Moderate,Preprint,Marc Emmenegger,University of Zurich,https://www.medrxiv.org/content/10.1101/2020.05.31.20118554v4,27/09/2020,16/07/2022,Verified
201008_StGallen_CantonalHospitalStGallen_hcw,08-Oct-20,Regional,Switzerland,CHE,St. Gallen,St. Gallen,19-Mar-20,03-Apr-20,Health care workers and caregivers,Adults (18-64 years),1012,0.99%,,,Convenience,"Abbott Laboratories,Roche Diagnostics,Sugentech, Inc.",Multiple Types,IgG,,,High,Journal Article (Peer-Reviewed),Phillipp Kohler,Cantonal Hospital St. Gallen,https://dx.doi.org/10.1017/ice.2020.1244,17/01/2021,16/07/2022,Verified
201108_Geneva_GenevaUniversityHospital_Overall,08-Nov-20,Local,Switzerland,CHE,,Geneva,01-Apr-20,30-Apr-20,Residual sera,Children and Youth (0-17 years),208,8.70%,,,Sequential,"EUROIMMUN,NA",Multiple Types,IgG,,,High,Journal Article (Peer-Reviewed),Klara Posfay Barbe,Geneva University Hospital,https://dx.doi.org/10.1093/cid/ciaa1702,17/01/2021,16/07/2022,Verified
201103_Vaud_UniversityofLausanne_GenPop1_Roche,03-Nov-20,Regional,Switzerland,CHE,Vaud,,04-May-20,27-Jun-20,Household and community samples,Multiple groups,311,3.90%,,,Simplified probability,Roche Diagnostics,CLIA,Total Antibody,93.00%,100.00%,High,Journal Article (Peer-Reviewed),Craig Fenwick,Lausanne University Hospital and University of Lausanne,http://dx.doi.org/10.1128/JVI.01828-20,23/01/2021,16/07/2022,Verified
201103_Vaud_UniversityofLausanne_CloseContacts2_Roche,03-Nov-20,Regional,Switzerland,CHE,Vaud,,04-May-20,27-Jun-20,Contacts of COVID patients,Multiple groups,177,32.20%,,,Unclear,Roche Diagnostics,CLIA,Total Antibody,93.00%,100.00%,High,Journal Article (Peer-Reviewed),Craig Fenwick,Lausanne University Hospital and University of Lausanne,http://dx.doi.org/10.1128/JVI.01828-20,23/01/2021,16/07/2022,Verified
210201_Geneva_GenevaUniversityHospitals_overall_adj,01-Feb-21,Local,Switzerland,CHE,,Geneva,23-Nov-20,23-Dec-20,Household and community samples,Multiple groups,4000,21.10%,19.20%,23.10%,Stratified probability,Roche Diagnostics,CLIA,Total Antibody,,,Low,Journal Article (Peer-Reviewed),Silvia Stringhini,Geneva University Hospitals,https://dx.doi.org/10.1016/S1473-3099(21)00054-2,28/02/2021,16/07/2022,Verified
201130_Fribourg_UniversitéDeFribourg_overall,30-Nov-20,Regional,Switzerland,CHE,Canton of Fribourg,,08-Jul-20,14-Oct-20,Household and community samples,Multiple groups,418,8.00%,4.00%,12.00%,Simplified probability,NA,Luminex,"IgG,IgA",96.60%,99.70%,Moderate,Institutional Report,Daniela Anker,Université de Fribourg,https://www.unifr.ch/med/imf/fr/assets/public/images/COVID-19/2020-PopHealthLab-Corona-Immunitas-E1.pdf,13/03/2021,16/07/2022,Verified
210419_Fribourg_UniversitédeFribourg_Overall_TestPopAdj,01-Apr-21,Regional,Switzerland,CHE,Canton of Fribourg,,30-Nov-20,05-Feb-21,Household and community samples,Multiple groups,449,19.00%,15.00%,23.00%,Simplified probability,NA,ELISA,IgG,96.60%,99.70%,Moderate,Institutional Report,Emna El May,Université de Fribourg,https://www.unifr.ch/med/imf/fr/assets/public/images/COVID-19/2021-PopHealthLab-Corona-Immunitas-E2.pdf,19/04/2021,16/07/2022,Verified
210319_Geneva_GenevaUniversityHospitals_HospitalEmployees,19-Mar-21,Local,Switzerland,CHE,,Geneva,30-Mar-20,12-Jun-20,Health care workers and caregivers,Adults (18-64 years),3421,7.90%,7.00%,8.80%,Convenience,"EUROIMMUN,Roche Diagnostics",Multiple Types,IgG,,,High,Journal Article (Peer-Reviewed),Romain Martischang,Geneva University Hospitals,https://dx.doi.org/10.1017/ice.2021.117,23/04/2021,16/07/2022,Unverified
200929_Ticino_InstituteofPublicHealth_primary,29-Sep-20,Local,Switzerland,CHE,,,01-Jul-20,31-Jul-20,Household and community samples,Adults (18-64 years),647,11.00%,,,Simplified probability,NA,Not reported,Not reported,,,Unclear,News and Media,Universita della Svizzera Italiana,The Institute of Public Health on the Università della Svizzera italiana,https://www.biomed.usi.ch/en/feeds/8913,23/04/2021,16/07/2022,Verified
210402_Switzerland_UniversitàdellaSvizzeraItaliana_overall,02-Apr-21,Regional,Switzerland,CHE,Southern Switzerland ,,15-Jul-20,15-Dec-20,Household and community samples,Adults (18-64 years),301,3.30%,,,Sequential,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Elena Giuliano,Università della Svizzera Italiana,https://dx.doi.org/10.1136/bmjmilitary-2021-001828,24/04/2021,16/07/2022,Verified
210115_Neuchatel_EcoleSuisseDeSantéPublique_PhaseII_overall,31-Mar-21,Regional,Switzerland,CHE,Canton of Neuchâtel ,,21-Aug-20,29-Oct-20,Household and community samples,Multiple groups,381,4.90%,2.38%,8.14%,Stratified probability,NA,ELISA,"IgG,IgA",96.60%,99.70%,Moderate,News and Media,Republique et Canton de Neuchatel,École suisse de santé publique,https://www.ne.ch/autorites/DFS/SCSP/medecin-cantonal/maladies-vaccinations/coronaimmunitas/Pages/R%c3%a9sultats-de-l'%c3%a9tude.aspx,27/04/2021,16/07/2022,Verified
210115_Neuchatel_EcoleSuisseDeSantéPublique_PhaseIII,31-Mar-21,Regional,Switzerland,CHE,Canton of Neuchâtel ,,23-Dec-20,17-Mar-21,Household and community samples,Multiple groups,559,22.00%,17.90%,26.30%,Stratified probability,NA,ELISA,"IgG,IgA",96.60%,99.70%,Moderate,News and Media,Republique et Canton de Neuchatel,École suisse de santé publique,https://www.ne.ch/autorites/DFS/SCSP/medecin-cantonal/maladies-vaccinations/coronaimmunitas/Pages/R%c3%a9sultats-de-l'%c3%a9tude.aspx,27/04/2021,16/07/2022,Verified
20210226_Zurich_UniversityofZurich_carehomeworkers,26-Feb-21,Regional,Switzerland,CHE,Canton of Zurich,,09-Sep-20,23-Oct-20,Health care workers and caregivers,Adults (18-64 years),296,14.90%,,,Convenience,NA,Not reported,Not reported,,,Unclear,Institutional Report,Canton Zurich,University of Zurich,https://www.zh.ch/de/news-uebersicht/medienmitteilungen/2021/02/zuercher-studien-zu-seropraevalenz-von-spitex--und-heimpersonal-sowie-zu-immunantwort-und-langzeitfolgen-bei-corona-positiv-getesteten.html,10/05/2021,16/07/2022,Unverified
20210226_Zurich_UniversityofZurich_spitexworkers,26-Feb-21,Regional,Switzerland,CHE,Canton of Zurich,,09-Sep-20,23-Oct-20,Health care workers and caregivers,Adults (18-64 years),131,3.80%,,,Convenience,NA,Not reported,Not reported,,,Unclear,Institutional Report,Canton Zurich,University of Zurich,https://www.zh.ch/de/news-uebersicht/medienmitteilungen/2021/02/zuercher-studien-zu-seropraevalenz-von-spitex--und-heimpersonal-sowie-zu-immunantwort-und-langzeitfolgen-bei-corona-positiv-getesteten.html,10/05/2021,16/07/2022,Unverified
210203_Ticino_UniversitàdellaSvizzeraitaliana_primary,03-Feb-21,Regional,Switzerland,CHE,Ticino,,01-Nov-20,13-Jan-21,Household and community samples,Multiple groups,1463,16.00%,,,Simplified probability,NA,Not reported,Not reported,,,Unclear,News and Media,Institute of Public Health of the Universita della Svizzera italiana,Università della Svizzera italiana,https://www.biomed.usi.ch/it/feeds/9035,18/05/2021,16/07/2022,Verified
210412_ValMesolcina_UniversitàdellaSvizzeraItaliana_HCW,12-Apr-21,Local,Switzerland,CHE,Grisons,NR,15-May-20,31-May-20,Health care workers and caregivers,Adults (18-64 years),289,15.90%,,,Convenience,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Gregorio Milani ,Università della Svizzera Italiana,https://dx.doi.org/10.3390/pathogens10040465,19/05/2021,16/07/2022,Verified
210412_ValMesolcina_UniversitàdellaSvizzeraItaliana__Genpop,12-Apr-21,Local,Switzerland,CHE,Grisons,NR,15-May-20,31-May-20,Household and community samples,Multiple groups,423,2.60%,,,Convenience,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Gregorio Milani ,Università della Svizzera Italiana,https://dx.doi.org/10.3390/pathogens10040465,19/05/2021,16/07/2022,Verified
210521_Zurich_UniversityofZurich_Overall,21-May-21,Regional,Switzerland,CHE,Canton of Zurich,,26-Oct-20,19-Nov-20,Students and Daycares,Children and Youth (0-17 years),1355,8.04%,,,Stratified probability,NA,Not reported,"IgG,IgM,IgA",94.30%,99.00%,Moderate,Preprint,Thomas Radtke,University of Zurich,https://www.medrxiv.org/content/10.1101/2021.05.16.21257255v2,06/06/2021,16/07/2022,Unverified
210608_Geneva_UniversityOfGeneva_overall,08-Jun-21,Regional,Switzerland,CHE,Canton of Geneva,,18-May-20,18-Sep-20,Essential non-healthcare workers,Adults (18-64 years),10513,9.80%,,,Convenience,EUROIMMUN,ELISA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Silvia Stringhini,The University of Geneva,http://dx.doi.org/10.1038/s41467-021-23796-4,30/06/2021,16/07/2022,Unverified
210621_Geneva_GenevaUniversityHospitals_overall,21-Jun-21,Local,Switzerland,CHE,,Geneva,01-Jun-20,30-Jun-20,Residual sera,Multiple groups,1167,5.90%,4.70%,7.40%,Convenience,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Stephanie Baggio,Geneva University Hospitals,http://dx.doi.org/10.1016/j.ypmed.2021.106696,07/07/2021,16/07/2022,Verified
201207_Ticino_UniversitaDellaSvizzeraItaliana,17-Dec-20,Regional,Switzerland,CHE,Canton of Ticino,,16-Apr-20,30-Apr-20,Health care workers and caregivers,Multiple groups,4726,9.60%,,,Convenience,NA,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Luca Piccoli,Università della Svizzera italiana,https://dx.doi.org/10.1016/j.lanepe.2020.100013,07/07/2021,16/07/2022,Unverified
210705_Lausanne_UniversityOfLausanne_Overall,05-Jul-21,Local,Switzerland,CHE,,Lausanne,18-May-20,12-Jun-20,Health care workers and caregivers,Multiple groups,1874,10.00%,8.70%,11.50%,Stratified non-probability,NA,ELISA,IgG,97.00%,98.00%,High,Journal Article (Peer-Reviewed),Sylvain Meylan,Lausanne University Hospital and University of Lausanne,https://dx.doi.org/10.1136/bmjopen-2021-049232,13/07/2021,16/07/2022,Unverified
210726_Zurich_UniversityofZurich_Adults_Overall,26-Jul-21,Local,Switzerland,CHE,Zurich,Zurich,16-Jun-20,09-Jul-20,Household and community samples,Adults (18-64 years),857,3.60%,1.70%,5.40%,Simplified probability,NA,ELISA,"IgG,IgA",98.30%,98.40%,Low,Journal Article (Peer-Reviewed),Agne Ulyte,University of Zurich,https://dx.doi.org/10.1136/bmjopen-2020-047483,03/08/2021,16/07/2022,Verified
210326_Vaud_UniversityofLausanne_CloseContactsOutsideHousehold2_Overall_ClusterAdj,26-Mar-21,Regional,Switzerland,CHE,Vaud,,04-May-20,27-Jun-20,Contacts of COVID patients,Multiple groups,69,19.00%,10.00%,33.20%,Simplified probability,NA,Other,IgG,96.70%,99.20%,High,Journal Article (Peer-Reviewed),Julien Dupraz,University of Lausanne,https://dx.doi.org/10.1093/ofid/ofab149,05/08/2021,16/07/2022,Verified
210326_Vaud_UniversityofLausanne_Household1_Overall_ClusterAdj,26-Mar-21,Regional,Switzerland,CHE,Vaud,,04-May-20,27-Jun-20,Contacts of COVID patients,Multiple groups,302,57.20%,49.50%,64.30%,Simplified probability,NA,Other,IgG,96.70%,99.20%,Moderate,Journal Article (Peer-Reviewed),Julien Dupraz,University of Lausanne,https://dx.doi.org/10.1093/ofid/ofab149,05/08/2021,16/07/2022,Verified
210813_Geneva_GenevaUniversityHospital_Primary,13-Aug-21,Local,Switzerland,CHE,,Geneva,01-Jun-21,07-Jul-21,Household and community samples,Multiple groups,3355,29.90%,28.00%,31.90%,Stratified probability,Roche Diagnostics,CLIA,Total Antibody,,,Low,Preprint,Silvia Stringhini,Geneva University Hospital ,https://www.medrxiv.org/content/10.1101/2021.08.12.21261929v1,24/08/2021,16/07/2022,Verified
210820_Solothurn_UniversityofBern_Primary,20-Aug-21,Regional,Switzerland,CHE,Canton of Solothurn,,01-Jun-20,01-Jul-20,Health care workers and caregivers,Adults (18-64 years),357,3.40%,1.70%,5.80%,Convenience,"Abbott Laboratories,DiaSorin",CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Kathrin Zurcher,University of Bern,https://dx.doi.org/10.4414/SMW.2021.w30021,15/09/2021,16/07/2022,Unverified
210706_Geneva_JohnsHopkinsBloombergSchoolofPublicHealth_RocheS1_Baseline_Overall,06-Jul-21,Local,Switzerland,CHE,,Geneva,15-Apr-20,15-Jul-20,Multiple populations,Multiple groups,187,12.30%,,,Simplified probability,Roche Diagnostics,CLIA,"IgG,IgA,IgM",,,High,Journal Article (Peer-Reviewed),Javier Perez Saez,Johns Hopkins Bloomberg School of Public Health,https://doi.org/10.1016/j.cmi.2021.06.040,15/09/2021,16/07/2022,Unverified
210706_Geneva_JohnsHopkinsBloombergSchoolofPublicHealth_RocheS1_FollowUp_Overall,06-Jul-21,Local,Switzerland,CHE,,Geneva,01-Nov-20,30-Nov-20,Multiple populations,Multiple groups,187,27.27%,,,Simplified probability,Roche Diagnostics,CLIA,"IgG,IgA,IgM",,,High,Journal Article (Peer-Reviewed),Javier Perez Saez,Johns Hopkins Bloomberg School of Public Health,https://doi.org/10.1016/j.cmi.2021.06.040,15/09/2021,16/07/2022,Unverified
210903_Grisons_CantonalHospitalGrisons,03-Sep-21,Regional,Switzerland,CHE,Canton of Grisons,,01-Jun-20,31-Jan-21,Health care workers and caregivers,Adults (18-64 years),5109,9.30%,,,Convenience,Roche Diagnostics,CLIA,Not reported,,,High,Presentation or Conference,Katarzyna Szajek,Cantonal Hospital Grisons,https://aricjournal.biomedcentral.com/track/pdf/10.1186/s13756-021-00974-z.pdf,29/09/2021,16/07/2022,Unverified
210901_Switzerland_KantonsspitalStGallen,01-Sep-21,Local,Switzerland,CHE,St. Gallen,St. Gallen,10-Jan-21,15-Mar-21,Patients seeking care for non-COVID-19 reasons,Multiple groups,77,5.19%,,,Unclear,Roche Diagnostics,Not reported,Not reported,,,High,Journal Article (Peer-Reviewed),Andrea Rubbert-Roth,Kantonsspital St. Gallen,https://smw.ch/article/doi/SMW.2021.w30056,29/09/2021,16/07/2022,Unverified
211022_Switzerland_CantonalHospitalStGallen,22-Oct-21,National,Switzerland,CHE,,,15-Jan-21,15-Feb-21,Health care workers and caregivers,Multiple groups,3334,20.34%,,,Convenience,Roche Diagnostics,CLIA,Total Antibody,88.00%,99.00%,Moderate,Preprint,Carol Strahm,Cantonal Hospital St Gallen,https://www.medrxiv.org/content/10.1101/2021.10.19.21265187v1.full-text,04/11/2021,16/07/2022,Unverified
211019_Geneva_GenevaUniversityHospitals_Overall_Adjusted,19-Oct-21,Regional,Switzerland,CHE,Canton of Geneva,,06-Apr-20,30-Jun-20,Household and community samples,Multiple groups,8344,7.80%,6.80%,8.90%,Simplified probability,EUROIMMUN,ELISA,IgG,93.00%,100.00%,Low,Journal Article (Peer-Reviewed),Aude Richard,Geneva University Hospitals,https://www.medrxiv.org/content/10.1101/2020.12.16.20248180v1.full-text,17/11/2021,16/07/2022,Verified
211112_Zurich_UniversityofZurich_T3,12-Nov-21,Regional,Switzerland,CHE,Zurich,,15-Mar-21,16-Apr-21,Students and Daycares,Children and Youth (0-17 years),2450,16.40%,12.10%,19.50%,Stratified probability,NA,IFA,"IgA,IgM,IgG",98.20%,99.40%,Moderate,Journal Article (Peer-Reviewed),Agne Ulyte,University of Zurich,https://dx.doi.org/10.4414/smw.2021.w30092,02/12/2021,16/07/2022,Unverified
220105_Bern_InselspitalUniversityHospital_ELISA_S1,05-Jan-22,Local,Switzerland,CHE,,Bern,15-Apr-20,15-Nov-20,Multiple populations,Multiple groups,3658,6.29%,,,Sequential,EUROIMMUN,ELISA,IgG,86.20%,98.20%,Moderate,Journal Article (Peer-Reviewed),Michael P Horn,Inselspital University Hospital,https://dx.doi.org/10.1111/all.15206,09/01/2022,16/07/2022,Unverified
211228_Ticino_Ufficiodelmedicocantonale_Phase4_OverallAdjusted,28-Dec-21,Regional,Switzerland,CHE,Ticino,,03-May-21,13-Jun-21,Household and community samples,Multiple groups,722,22.30%,19.20%,25.70%,Stratified probability,Technogenetics,LFIA,"IgM,IgG",95.10%,98.90%,Moderate,Journal Article (Peer-Reviewed),Ottavio Beretta,Ufficio del medico cantonale,https://smw.ch/article/doi/smw.2021.w30116,09/01/2022,16/07/2022,Verified
220112_Zurich_UniversityofZurich_OAT,12-Jan-22,Local,Switzerland,CHE,,Zurich,01-Jul-20,16-Oct-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,122,9.80%,5.10%,17.20%,Convenience,Swiss Federal Institute of Technology,Not reported,"IgA,IgG",96.60%,99.70%,High,Journal Article (Peer-Reviewed),Philip Bruggmann,University of Zurich,https://smw.ch/article/doi/smw.2022.w30122,18/01/2022,16/07/2022,Verified
220110_Grisons_ CantonalHospitalGrisons_Followup2_Overall,10-Jan-22,Regional,Switzerland,CHE,Canton of Grisons,,04-Jan-21,19-Feb-21,Health care workers and caregivers,Adults (18-64 years),2315,16.20%,,,Convenience,Roche Diagnostics,CLIA,Not reported,100.00%,99.80%,High,Journal Article (Peer-Reviewed),Katarzyna Szajek, Cantonal Hospital of Grisons,https://dx.doi.org/10.1186/s13756-021-01047-x,18/01/2022,16/07/2022,Unverified
211020_Vaud_UniversityofLausanne_Center1,20-Oct-21,Regional,Switzerland,CHE,Vaud,,15-May-20,15-Jun-20,Household and community samples,Multiple groups,82,13.00%,3.00%,14.00%,Convenience,NA,Not reported,"IgG,IgA",,,High,Presentation or Conference,K Morisod,University of Lausanne,https://academic.oup.com/eurpub/article/31/Supplement_3/ckab164.250/6405568?login=true,19/01/2022,16/07/2022,Unverified
211020_Vaud_UniversityofLausanne_Center2,20-Oct-21,Regional,Switzerland,CHE,Vaud,,15-May-20,15-Jun-20,Household and community samples,Multiple groups,42,50.00%,34.00%,65.00%,Convenience,NA,Not reported,"IgG,IgA",,,High,Presentation or Conference,K Morisod,University of Lausanne,https://academic.oup.com/eurpub/article/31/Supplement_3/ckab164.250/6405568?login=true,19/01/2022,16/07/2022,Unverified
220128_Zurich_UniversityofZurich_T1Children_testadj,28-Jan-22,Regional,Switzerland,CHE,Zurich,,15-Jun-20,15-Jul-20,Students and Daycares,Children and Youth (0-17 years),2473,4.40%,2.10%,6.20%,Convenience,Swiss Federal Institute of Technology,Not reported,Not reported,98.30%,98.40%,Moderate,Preprint,Agne Ulyte,University of Switzerland,https://www.medrxiv.org/content/10.1101/2022.01.25.22269827v1.full-text,08/02/2022,16/07/2022,Unverified
220128_Zurich_UniversityofZurich_T1Personnel_testadj ,28-Jan-22,Regional,Switzerland,CHE,Zurich,,15-Aug-20,15-Sep-20,Essential non-healthcare workers,Multiple groups,1608,4.60%,2.30%,6.70%,Convenience,Swiss Federal Institute of Technology,Not reported,Not reported,98.30%,98.40%,Moderate,Preprint,Agne Ulyte,University of Switzerland,https://www.medrxiv.org/content/10.1101/2022.01.25.22269827v1.full-text,08/02/2022,16/07/2022,Unverified
220128_Zurich_UniversityofZurich_T1Parents_testadj,28-Jan-22,Regional,Switzerland,CHE,Zurich,,15-Aug-20,15-Sep-20,Household and community samples,Multiple groups,2045,5.80%,3.50%,7.80%,Convenience,Swiss Federal Institute of Technology,Not reported,Not reported,98.30%,98.40%,Moderate,Preprint,Agne Ulyte,University of Switzerland,https://www.medrxiv.org/content/10.1101/2022.01.25.22269827v1.full-text,08/02/2022,16/07/2022,Unverified
220128_Zurich_UniversityofZurich_T2Children_testadj,28-Jan-22,Regional,Switzerland,CHE,Zurich,,15-Mar-21,15-Apr-21,Students and Daycares,Children and Youth (0-17 years),2450,18.10%,15.70%,20.70%,Convenience,Swiss Federal Institute of Technology,Not reported,Not reported,98.30%,98.40%,Moderate,Preprint,Agne Ulyte,University of Switzerland,https://www.medrxiv.org/content/10.1101/2022.01.25.22269827v1.full-text,08/02/2022,16/07/2022,Unverified
220128_Zurich_UniversityofZurich_T2Personnel_testadj,28-Jan-22,Regional,Switzerland,CHE,Zurich,,15-Mar-21,15-Apr-21,Essential non-healthcare workers,Multiple groups,1435,16.90%,14.10%,19.80%,Convenience,Swiss Federal Institute of Technology,Not reported,Not reported,98.30%,98.40%,Moderate,Preprint,Agne Ulyte,University of Switzerland,https://www.medrxiv.org/content/10.1101/2022.01.25.22269827v1.full-text,08/02/2022,16/07/2022,Unverified
220128_Zurich_UniversityofZurich_T2Parents_testadj ,28-Jan-22,Regional,Switzerland,CHE,Zurich,,15-Mar-21,15-Apr-21,Household and community samples,Multiple groups,1545,20.90%,18.00%,23.90%,Convenience,Swiss Federal Institute of Technology,Not reported,Not reported,98.30%,98.40%,Moderate,Preprint,Agne Ulyte,University of Switzerland,https://www.medrxiv.org/content/10.1101/2022.01.25.22269827v1.full-text,08/02/2022,16/07/2022,Unverified
220128_Switzerland_CantonalHospitalStGallen_Overall,28-Jan-22,Regional,Switzerland,CHE,"Northern Switzerland, Eastern Switzerland",,15-Jan-21,15-Feb-21,Health care workers and caregivers,Adults (18-64 years),3334,23.52%,,,Unclear,Roche Diagnostics,CLIA,Total Antibody,88.00%,99.00%,Moderate,Journal Article (Peer-Reviewed),Carol Strahm,Cantonal Hospital St Gallen,https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciac054/6516835,10/02/2022,16/07/2022,Unverified
211110_CantonofFribourg_UniversityofFribourg_Overall_Adj,10-Nov-21,Regional,Switzerland,CHE,Fribourg,,20-May-21,13-Aug-21,Household and community samples,Multiple groups,504,74.00%,69.00%,79.00%,Simplified probability,Swiss Federal Institute of Technology,Luminex,IgG,96.60%,99.70%,Moderate,Institutional Report,Emna El May,Swiss School of Public Health,https://zenodo.org/record/5665477,09/03/2022,16/07/2022,Verified
220216_Geneva_CantonalHospitalStGallen_Baseline,16-Feb-22,Local,Switzerland,CHE,,Geneva,02-Sep-20,04-Sep-20,Multiple populations,Multiple groups,168,2.98%,,,Convenience,Roche Diagnostics,CLIA,Total Antibody,,,High,Journal Article (Peer-Reviewed),Johannes Sumer,Cantonal Hospital St. Gallen,https://dx.doi.org/10.3389/ijph.2022.1604147,16/03/2022,16/07/2022,Unverified
220316_Zurich_UniversityOfZurich_NursingHomes_Overall,16-Mar-22,Regional,Switzerland,CHE,Canton of Zurich,,21-Sep-20,23-Oct-20,Assisted living and long-term care facilities,Adults (18-64 years),296,14.90%,11.10%,19.60%,Convenience,Swiss Federal Institute of Technology,Not reported,"IgG,IgA",96.60%,99.70%,High,Journal Article (Peer-Reviewed),Erin West,University of Zurich,https://doi.org/10.1186/s12879-022-07222-8,24/03/2022,16/07/2022,Verified
220316_Zurich_UniversityOfZurich_HomeHealthcare_Overall,16-Mar-22,Regional,Switzerland,CHE,Canton of Zurich,,21-Sep-20,23-Oct-20,Assisted living and long-term care facilities,Adults (18-64 years),131,3.80%,1.40%,9.10%,Simplified probability,Swiss Federal Institute of Technology,Not reported,"IgG,IgA",96.60%,99.70%,High,Journal Article (Peer-Reviewed),Erin West,University of Zurich,https://doi.org/10.1186/s12879-022-07222-8,24/03/2022,16/07/2022,Verified
220316_Zurich_UniversityOfZurich_GeneralPop_Overall_TestPopAdj,16-Mar-22,Regional,Switzerland,CHE,Canton of Zurich,,17-Jun-20,14-Sep-20,Household and community samples,Adults (18-64 years),472,3.50%,1.50%,5.90%,Simplified probability,Swiss Federal Institute of Technology,Luminex,"IgG,IgA",96.60%,99.70%,Moderate,Journal Article (Peer-Reviewed),Erin West,University of Zurich,https://doi.org/10.1186/s12879-022-07222-8,24/03/2022,16/07/2022,Verified
220531_Zurich_UniversityOfZurich,31-May-22,Local,Switzerland,CHE,Canton of Zürich,Zürich,26-Oct-20,19-Nov-20,Students and Daycares,Children and Youth (0-17 years),2500,5.60%,3.50%,7.60%,Stratified probability,Swiss Federal Institute of Technology,CLIA,"IgG,IgA",94.00%,99.20%,Moderate,Preprint,Sarah R Haile,University of Zurich,https://www.medrxiv.org/content/10.1101/2022.05.31.22275814v1,07/06/2022,16/07/2022,Unverified
220620_Switzerland_Children’sHospitalofEasternSwitzerland_Overall,20-Jun-22,National,Switzerland,CHE,"Basle-Country, Grisons, Ticino, Vaud
","Basle-City, Berne, Fribourg, Lucerne, Neuchatel, St. Gallen, Zurich ",18-Oct-20,15-Feb-21,Household and community samples,Adults (18-64 years),2393,17.30%,,,Simplified probability,Swiss Federal Institute of Technology,ELISA,"IgG,IgA",96.60%,99.70%,High,Journal Article (Peer-Reviewed),Jacob Blankenberger,Children’s Hospital of Eastern Switzerland,https://dx.doi.org/10.1186/s12916-022-02431-z,27/06/2022,16/07/2022,Unverified
220524_Switzerland_FribourgHospitalHFR_Primary,24-May-22,Regional,Switzerland,CHE,Fribourg,,11-Jan-21,14-Mar-21,Residual sera,Children and Youth (0-17 years),871,20.70%,,,Convenience,NA,Other,IgG,96.60%,99.20%,Moderate,Journal Article (Peer-Reviewed),Paola A. Rouge Elton,Fribourg Hospital HFR,https://dx.doi.org/10.4414/smw.2022.w30173,06/07/2022,29/07/2022,Unverified
220527_Geneva_GenevaUniversityHospitals_Overall,27-May-22,Local,Switzerland,CHE,,Geneva,01-Dec-21,18-Feb-22,Household and community samples,Children and Youth (0-17 years),1015,54.60%,,,Convenience,NA,Not reported,Not reported,,,High,Presentation or Conference,Roxane Dumont,Geneva University Hospitals,https://doi.org/10.4414/smw.2022.w30203,20/07/2022,20/07/2022,Unverified
220527_CantonTicino_OspedaleSanGiovanni,27-May-22,Regional,Switzerland,CHE,Canton Ticino,,30-Oct-19,15-Sep-21,Household and community samples,Children and Youth (0-17 years),506,10.40%,,,Sequential,NA,Not reported,Not reported,,,Unclear,Journal Article (Peer-Reviewed),Mazzara C,Ospedale San Giovanni,https://doi.org/10.4414/smw.2022.w30203,26/07/2022,27/07/2022,Unverified
220606_Bern_UniversityofBern_Baseline,06-Jun-22,Regional,Switzerland,CHE,Bern,,01-Sep-21,30-Sep-21,Essential non-healthcare workers,Adults (18-64 years),982,15.30%,,,Convenience,Roche Diagnostics,Not reported,Not reported,,,High,Journal Article (Peer-Reviewed),Parham Sendi,University of Bern,https://dx.doi.org/10.1002/iid3.640,29/07/2022,29/07/2022,Unverified
220606_Bern_UniversityofBern_3Month,06-Jun-22,Regional,Switzerland,CHE,Bern,,09-Feb-21,09-Mar-21,Essential non-healthcare workers,Adults (18-64 years),978,12.90%,,,Convenience,Roche Diagnostics,Not reported,Not reported,,,High,Journal Article (Peer-Reviewed),Parham Sendi,University of Bern,https://dx.doi.org/10.1002/iid3.640,29/07/2022,29/07/2022,Unverified
220606_Bern_UniversityofBern_6Month,06-Jun-22,Regional,Switzerland,CHE,Bern,,15-Apr-21,15-May-21,Essential non-healthcare workers,Adults (18-64 years),997,14.40%,,,Convenience,Roche Diagnostics,Not reported,Not reported,,,High,Journal Article (Peer-Reviewed),Parham Sendi,University of Bern,https://dx.doi.org/10.1002/iid3.640,29/07/2022,29/07/2022,Unverified
220729_Geneva_GenevaUniversityHospitals_Any,29-Jul-22,Local,Switzerland,CHE,,Geneva,29-Apr-22,09-Jun-22,Household and community samples,Multiple groups,2521,93.80%,93.10%,94.50%,Simplified probability,Roche Diagnostics,Not reported,"IgG,IgM,IgA",,,Low,Preprint,María-Eugenia Zaballa,Geneva University Hospitals,10.1101/2022.07.27.22278126,10/08/2022,10/08/2022,Unverified
220803_Switzerland_UniversityOfLausanne,03-Aug-22,Regional,Switzerland,CHE,,,15-Feb-21,15-Mar-21,Health care workers and caregivers,Adults (18-64 years),594,45.30%,41.20%,49.30%,Convenience,Luminex Corporation,ELISA,IgG,98.10%,99.20%,High,Journal Article (Peer-Reviewed),Damien Jacot,University of Lausanne,https://dx.doi.org/10.1099/jmm.0.001558,14/08/2022,14/08/2022,Unverified
220804_Ticino_UniversityOfZurich_AntiS_PopTestAdj_Overall,04-Aug-22,Regional,Switzerland,CHE,Canton of Ticino,,01-Mar-22,31-Mar-22,Household and community samples,Multiple groups,850,97.50%,95.80%,99.00%,Stratified probability,Swiss Federal Institute of Technology,Luminex,IgG,99.00%,98.00%,Moderate,Journal Article (Peer-Reviewed),Rebecca Amati,University of Zurich,https://doi.org/10.2807/1560-7917.ES.2022.27.31.2200561,16/08/2022,17/08/2022,Unverified
220804_Zurich_UniversityOfZurich_AntiS_PopTestAdj_Overall,04-Aug-22,Regional,Switzerland,CHE,Canton of Zurich,,01-Mar-22,31-Mar-22,Household and community samples,Multiple groups,1044,98.80%,97.90%,99.50%,Stratified probability,Swiss Federal Institute of Technology,Luminex,IgG,99.00%,98.00%,Moderate,Journal Article (Peer-Reviewed),Rebecca Amati,University of Zurich,https://doi.org/10.2807/1560-7917.ES.2022.27.31.2200561,16/08/2022,17/08/2022,Unverified
200720_Uppsala_UppsalaUniversity_Total,20-Jul-20,Regional,Sweden,SWE,Uppsala,,27-May-20,25-Jun-20,Health care workers and caregivers,Multiple groups,8679,6.60%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Anna-Karin Lidstrom,Uppsala University ,https://dx.doi.org/10.1080/03009734.2020.1793039,01/08/2020,16/07/2022,Verified
200723_Sweden_Werlabs_GenPop,23-Jul-20,Local,Sweden,SWE,"Skåne, Västra Götaland, Uppland","Stockholm, Gothenburg, Malmo",01-Jul-20,22-Jul-20,Household and community samples,Multiple groups,83000,14.40%,,,Unclear,NA,Not reported,Not reported,,,High,News and Media,The Local,Werlabs,https://www.google.com/url?rct=j&sa=t&url=https://www.thelocal.se/20200723/14-of-antibody-tests-positive-in-sweden&ct=ga&cd=CAAYBzIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNHl1If-XI0aCeB5tGakbaJvFktByQ,02/08/2020,16/07/2022,Verified
200805_Stockholm_UppsalaUniversity_CaregiversOverall_IgGORIgM,05-Aug-20,Local,Sweden,SWE,,Stockholm,01-Apr-20,20-Apr-20,Health care workers and caregivers,Adults (18-64 years),1005,22.90%,20.40%,25.70%,Convenience,Zhejiang Orient Gene Biotech,LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Johanna Lindahl,Uppsala University ,https://dx.doi.org/10.1080/20008686.2020.1789036,14/10/2020,16/07/2022,Verified
200811_Stockholm_UppsalaUniversity_Djurgårdsstaden_TotalAbpositive,11-Aug-20,Local,Sweden,SWE,"Södermanland, Uppland",Stockholm,17-Jun-20,18-Jun-20,Household and community samples,Adults (18-64 years),123,4.10%,0.60%,7.60%,Simplified probability,Zhejiang Orient Gene Biotech,LFIA,"IgG,IgM",100.00%,95.50%,High,Journal Article (Peer-Reviewed),Ake Lundkvist,Uppsala University ,https://dx.doi.org/10.1080/20008686.2020.1806505,16/10/2020,16/07/2022,Verified
200811_Stockholm_UppsalaUniversity_Tensta_TotalAbPositive,11-Aug-20,Local,Sweden,SWE,"Södermanland, Uppland",Stockholm,17-Jun-20,18-Jun-20,Household and community samples,Adults (18-64 years),90,30.00%,20.30%,39.70%,Simplified probability,Zhejiang Orient Gene Biotech,LFIA,"IgG,IgM",100.00%,95.50%,High,Journal Article (Peer-Reviewed),Ake Lundkvist,Uppsala University ,https://dx.doi.org/10.1080/20008686.2020.1806505,16/10/2020,16/07/2022,Verified
200618_Sweden_SwedishPublicHealthAgency_Outpatients_Week17_Overall,18-Jun-20,National,Sweden,SWE,"Jämtland-Härjedalen, Jönköping, Kalmar, Skåne, Stockholm, Uppsala, Västerbotten Västra Götaland, Örebro",,20-Apr-20,26-Apr-20,Residual sera,Multiple groups,1200,5.30%,3.80%,7.10%,Stratified non-probability,Sci LifeLab / KTH,ELISA,Not reported,99.40%,,High,Institutional Report,Swedish Public Health Agency,Sweden Public Health Agency,https://www.folkhalsomyndigheten.se/contentassets/9c5893f84bd049e691562b9eeb0ca280/pavisning-antikroppar-genomgangen-covid-19-blodprov-oppenvarden-delrapport-1.pdf,24/10/2020,16/07/2022,Verified
200618_Sweden_SwedishPublicHealthAgency_Outpatients_Week18_Overall,18-Jun-20,National,Sweden,SWE,"Jämtland-Härjedalen, Jönköping, Kalmar, Skåne, Stockholm, Uppsala, Västerbotten Västra Götaland, Örebro",,27-Apr-20,03-May-20,Residual sera,Multiple groups,1200,4.00%,2.71%,5.67%,Stratified non-probability,Sci LifeLab / KTH,ELISA,Not reported,99.40%,,High,Institutional Report,Swedish Public Health Agency,Sweden Public Health Agency,https://www.folkhalsomyndigheten.se/contentassets/9c5893f84bd049e691562b9eeb0ca280/pavisning-antikroppar-genomgangen-covid-19-blodprov-oppenvarden-delrapport-1.pdf,25/10/2020,16/07/2022,Verified
200618_Sweden_SwedishPublicHealthAgency_Outpatients_Week19_Overall,18-Jun-20,National,Sweden,SWE,"Jämtland-Härjedalen, Jönköping, Kalmar, Skåne, Stockholm, Uppsala, Västerbotten Västra Götaland, Örebro",,04-May-20,10-May-20,Residual sera,Multiple groups,1200,3.90%,2.61%,5.42%,Stratified non-probability,Sci LifeLab / KTH,ELISA,Not reported,99.40%,,High,Institutional Report,Swedish Public Health Agency,Sweden Public Health Agency,https://www.folkhalsomyndigheten.se/contentassets/9c5893f84bd049e691562b9eeb0ca280/pavisning-antikroppar-genomgangen-covid-19-blodprov-oppenvarden-delrapport-1.pdf,25/10/2020,16/07/2022,Verified
200618_Sweden_SwedishPublicHealthAgency_Outpatients_Week20_Overall,18-Jun-20,National,Sweden,SWE,"Jämtland-Härjedalen, Jönköping, Kalmar, Skåne, Stockholm, Uppsala, Västerbotten Västra Götaland, Örebro",,11-May-20,17-May-20,Residual sera,Multiple groups,1200,4.50%,3.07%,6.15%,Stratified non-probability,Sci LifeLab / KTH,ELISA,Not reported,99.40%,,High,Institutional Report,Swedish Public Health Agency,Sweden Public Health Agency,https://www.folkhalsomyndigheten.se/contentassets/9c5893f84bd049e691562b9eeb0ca280/pavisning-antikroppar-genomgangen-covid-19-blodprov-oppenvarden-delrapport-1.pdf,25/10/2020,16/07/2022,Verified
200618_Sweden_SwedishPublicHealthAgency_Outpatients_Week21_Overall,18-Jun-20,National,Sweden,SWE,"Jämtland-Härjedalen, Jönköping, Kalmar, Skåne, Stockholm, Uppsala, Västerbotten Västra Götaland, Örebro",,18-May-20,24-May-20,Residual sera,Multiple groups,1200,5.20%,3.67%,7.00%,Stratified non-probability,Sci LifeLab / KTH,ELISA,Not reported,99.40%,,High,Institutional Report,Swedish Public Health Agency,Sweden Public Health Agency,https://www.folkhalsomyndigheten.se/contentassets/9c5893f84bd049e691562b9eeb0ca280/pavisning-antikroppar-genomgangen-covid-19-blodprov-oppenvarden-delrapport-1.pdf,25/10/2020,16/07/2022,Verified
200618_Sweden_SwedishPublicHealthAgency_Outpatients_Week22_Overall,18-Jun-20,National,Sweden,SWE,"Jämtland-Härjedalen, Jönköping, Kalmar, Skåne, Stockholm, Uppsala, Västerbotten Västra Götaland, Örebro",,25-May-20,31-May-20,Residual sera,Multiple groups,1200,5.70%,3.98%,7.72%,Stratified non-probability,Sci LifeLab / KTH,ELISA,Not reported,99.40%,,High,Institutional Report,Swedish Public Health Agency,Sweden Public Health Agency,https://www.folkhalsomyndigheten.se/contentassets/9c5893f84bd049e691562b9eeb0ca280/pavisning-antikroppar-genomgangen-covid-19-blodprov-oppenvarden-delrapport-1.pdf,25/10/2020,16/07/2022,Verified
200618_Sweden_SwedishPublicHealthAgency_Outpatients_Week23_Overall,18-Jun-20,National,Sweden,SWE,"Jämtland-Härjedalen, Jönköping, Kalmar, Skåne, Stockholm, Uppsala, Västerbotten Västra Götaland, Örebro",,01-Jun-20,07-Jun-20,Residual sera,Multiple groups,1200,6.80%,5.07%,8.80%,Stratified non-probability,Sci LifeLab / KTH,ELISA,Not reported,99.40%,,High,Institutional Report,Swedish Public Health Agency,Sweden Public Health Agency,https://www.folkhalsomyndigheten.se/contentassets/9c5893f84bd049e691562b9eeb0ca280/pavisning-antikroppar-genomgangen-covid-19-blodprov-oppenvarden-delrapport-1.pdf,25/10/2020,16/07/2022,Verified
200618_Sweden_SwedishPublicHealthAgency_Outpatients_Week24_Overall,18-Jun-20,National,Sweden,SWE,"Jämtland-Härjedalen, Jönköping, Kalmar, Skåne, Stockholm, Uppsala, Västerbotten Västra Götaland, Örebro",,08-Jun-20,14-Jun-20,Residual sera,Multiple groups,1200,5.20%,3.74%,7.06%,Stratified non-probability,Sci LifeLab / KTH,ELISA,Not reported,99.40%,,High,Institutional Report,Swedish Public Health Agency,Sweden Public Health Agency,https://www.folkhalsomyndigheten.se/contentassets/9c5893f84bd049e691562b9eeb0ca280/pavisning-antikroppar-genomgangen-covid-19-blodprov-oppenvarden-delrapport-1.pdf,25/10/2020,16/07/2022,Verified
200716_Stockholm_RegionStockholm,16-Jul-20,Local,Sweden,SWE,Uppland,Stockholm,15-Jun-20,15-Jul-20,Household and community samples,Multiple groups,149616,17.60%,,,Self-referral,NA,Not reported,Not reported,,,High,Institutional Report,Stockholm Region,Sweden Public Health Authority,https://www.sll.se/verksamhet/halsa-och-vard/nyheter-halsa-och-vard/2020/07/16-juli-lagesrapport-om-arbetet-med-det-nya-coronaviruset/,25/10/2020,16/07/2022,Verified
201008_Stockholm_DanderydHospital,08-Oct-20,Local,Sweden,SWE,Sodermanland,Stockholm,14-Apr-20,08-May-20,Health care workers and caregivers,Adults (18-64 years),2149,19.10%,,,Convenience,NA,Not reported,IgG,99.20%,99.80%,Moderate,Journal Article (Peer-Reviewed),Ann Sofie Rudberg,Danderyd Hospital,http://dx.doi.org/10.1038/s41467-020-18848-0,10/12/2020,16/07/2022,Verified
201222_Stockholm_KarolinskaUniversityHospital_LTCFstaff_primary,22-Dec-20,Local,Sweden,SWE,,Stockholm,11-May-20,17-Jun-20,Assisted living and long-term care facilities,Multiple groups,403,20.10%,,,Convenience,NA,CLIA,IgG,99.20%,99.80%,High,Preprint,Sadaf Sakina Hassan,Karolinska University Hospital,https://www.medrxiv.org/content/10.1101/2020.12.18.20248511v1,02/02/2021,16/07/2022,Verified
210129_Stockholm_KarolinskaInstitutet_HCW,29-Jan-21,Local,Sweden,SWE,Uppland,Stockholm,11-May-20,11-Jun-20,Health care workers and caregivers,Adults (18-64 years),3981,17.70%,,,Convenience,NA,ELISA,IgG,99.20%,99.80%,Moderate,Preprint,Susanna Klevebro,Karolinska Institutet,https://doi.org/10.1101/2021.01.28.21250664,21/02/2021,16/07/2022,Verified
201124_Vasteras_HospitalofVastmanland_HCW,24-Nov-20,Local,Sweden,SWE,,Vasteras,04-May-20,19-Aug-20,Health care workers and caregivers,Adults (18-64 years),131,19.08%,,,Convenience,Abbott Laboratories,CLIA,IgG,100.00%,99.90%,High,Journal Article (Peer-Reviewed),Mulki Rashid Abdi,The Hospital of Vastmanland ,https://dx.doi.org/10.1080/23744235.2020.1849787,23/02/2021,16/07/2022,Verified
210121_Sweden_CopenhagenUniversityHospital_Sweden,21-Jan-21,National,Sweden,SWE,,,22-Jun-20,10-Aug-20,Health care workers and caregivers,Adults (18-64 years),1248,8.30%,,,Convenience,"Zhuhai Livzon Diagnostics Inc,Guangzhou Wondfo Biotech Co. Ltd",LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Jannie Laursen,Copenhagen University Hospital,https://dx.doi.org/10.3390/ijerph18030923,25/02/2021,16/07/2022,Verified
210309_SkåneRegion_LundUniversity_UniversityEmployees,09-Mar-21,Local,Sweden,SWE,Skåne Region,Lund,08-Sep-20,10-Nov-20,Non-essential workers and unemployed persons,Adults (18-64 years),192,6.00%,,,Convenience,ZetaGene Ltd.,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),David Nygren,Lund University,https://dx.doi.org/10.1080/23744235.2021.1892819,01/04/2021,16/07/2022,Verified
210309_SkåneRegion_LundUniversity_HCWs,09-Mar-21,Local,Sweden,SWE,Skåne Region,,08-Sep-20,10-Nov-20,Health care workers and caregivers,Adults (18-64 years),271,5.90%,,,Convenience,ZetaGene Ltd.,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),David Nygren,Lund University,https://dx.doi.org/10.1080/23744235.2021.1892819,01/04/2021,16/07/2022,Verified
210412_Stockholm_KarolinskaInstitutet_hcw,12-Apr-21,Local,Sweden,SWE,Södermanland and Uppland,Stockholm,11-May-20,17-Jun-20,Health care workers and caregivers,Adults (18-64 years),403,20.10%,,,Convenience,NA,ELISA,IgG,99.20%,99.80%,Moderate,Journal Article (Peer-Reviewed),S Hassan,Karolinska Institutet,https://dx.doi.org/10.1111/joim.13274,03/05/2021,16/07/2022,Verified
210317_Sweden_TheSwedishPublicHealthAgency_BloodDonors_overall,17-Mar-21,National,Sweden,SWE,"Regions of: Jämtland-Härjedalen, Jönköping, Kalmar,
Skåne, Stockholm, Uppsala, Västerbotten, Västra Götaland and Örebro",,23-Nov-20,04-Dec-20,Blood donors,Multiple groups,3183,7.00%,5.75%,8.48%,Convenience,Sci LifeLab / KTH,ELISA,Not reported,99.40%,98.90%,Unclear,Institutional Report,Swedish Public Health Agency,The Swedish Public Health Agency (Folkhälsomyndigheten),https://www.folkhalsomyndigheten.se/contentassets/376f9021a4c84da08de18ac597284f0c/pavisning-antikroppar-genomgangen-covid-19-blodgivare-delrapport-2.pdf,03/05/2021,16/07/2022,Verified
210305_Stockholm_Västerås_primary,05-Mar-21,Local,Sweden,SWE,,Stockholm,04-Jun-20,15-Jun-20,Health care workers and caregivers,Adults (18-64 years),70,4.30%,,,Convenience,Abbott Laboratories,CLIA,IgG,100.00%,99.60%,High,Journal Article (Peer-Reviewed),Elisabet Granstam,Västerås,https://bmjophth.bmj.com/content/6/1/e000616,20/05/2021,16/07/2022,Verified
200617_Norbotten_UmeaUniversity_overall,17-Jun-20,Regional,Sweden,SWE,Norbotten,"Piteå, Luleå/Boden, Gällivare, Kalix, Kiruna",25-May-20,05-Jun-20,Household and community samples,Multiple groups,425,1.90%,0.80%,3.70%,Simplified probability,"Abbott Laboratories,EUROIMMUN",Multiple Types,IgG,,,Moderate,Institutional Report,Mats Eliasson,Umea University,https://web.archive.org/web/20200623000020/https://www.norrbotten.se/publika/lg/kom/Corona/Rapport%20-%20förekomst%20av%20antikroppar/Förekomst%20av%20antikroppar%20mot%20covid-19%20i%20Norrbottens%20befolkning%20maj%202020%20-%20Region%20Norrbotten%20rapport%20200618.pdf,21/05/2021,16/07/2022,Verified
210518_Stockholm_KarolinskaInstitutet,18-May-21,Local,Sweden,SWE,Uppland,Stockholm,14-Mar-20,28-Feb-21,Multiple general populations,Adults (18-64 years),5100,19.20%,15.10%,24.40%,Simplified probability,NA,ELISA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Xaquin Castro Dopico,Karolinska Institutet,https://onlinelibrary.wiley.com/doi/full/10.1111/joim.13304,28/05/2021,16/07/2022,Verified
210507_Stockholm_KarolinskaUniversityHospital,07-May-21,Local,Sweden,SWE,Uppland,Stockholm,01-Jun-20,30-Jun-20,Health care workers and caregivers,Adults (18-64 years),839,12.00%,,,Convenience,NA,Not reported,IgG,99.20%,99.80%,Moderate,Preprint,Maria Froberg,Karolinska University Hospital,https://www.researchsquare.com/article/rs-493146/v1,29/05/2021,16/07/2022,Verified
210511_SkåneUniversityHospital_LundUniversity_HCW,11-May-21,Local,Sweden,SWE,,Lund,01-Aug-20,22-Aug-20,Health care workers and caregivers,Adults (18-64 years),107,35.50%,,,Convenience,ZetaGene Ltd.,LFIA,"IgG,IgM",95.00%,97.00%,High,Journal Article (Peer-Reviewed),Rasmus Strand,Lund University,https://dx.doi.org/10.1080/23744235.2021.1925739,31/05/2021,16/07/2022,Verified
210427_Sweden_SwedishPublicHealthAgency_Outpatients_9_Week42-43_Overall,27-Apr-21,National,Sweden,SWE,"Jämtland-Härjedalen, Jönköping, Kalmar, Skåne, Stockholm, Uppsala, Västerbotten Västra Götaland, Örebro",,12-Oct-20,23-Oct-20,Residual sera,Multiple groups,4500,6.70%,5.67%,7.79%,Stratified probability,Sci LifeLab / KTH,ELISA,Not reported,99.40%,,Moderate,Institutional Report,Swedish Public Health Agency,Sweden Public Health Agency,https://www.folkhalsomyndigheten.se/contentassets/9c5893f84bd049e691562b9eeb0ca280/pavisning-antikroppar-genomgangen-covid-19-blodprov-oppenvarden-delrapport-1.pdf,08/06/2021,16/07/2022,Unverified
210427_Sweden_SwedishPublicHealthAgency_Outpatients_11_Week9-10_2021_Overall,27-Apr-21,National,Sweden,SWE,"Jönköping, Kalmar, Skåne,Stockholm, Uppsala, Västerbotten, Västra Götaland, Örebo",,01-Mar-21,12-Mar-21,Residual sera,Multiple groups,4749,20.70%,19.41%,22.08%,Stratified probability,Sci LifeLab / KTH,ELISA,Not reported,99.40%,,Moderate,Institutional Report,Swedish Public Health Agency,Sweden Public Health Agency,https://www.folkhalsomyndigheten.se/contentassets/9c5893f84bd049e691562b9eeb0ca280/pavisning-antikroppar-genomgangen-covid-19-blodprov-oppenvarden-delrapport-1.pdf,08/06/2021,16/07/2022,Unverified
210427_Sweden_SwedishPublicHealthAgency_Outpatients_10_Week48-49_Overall,27-Apr-21,National,Sweden,SWE,"Jämtland-Härjedalen, Jönköping, Kalmar, Skåne, Stockholm, Uppsala, Västerbotten Västra Götaland, Örebro",,23-Nov-20,04-Dec-20,Residual sera,Multiple groups,4500,7.90%,6.79%,9.19%,Stratified probability,Sci LifeLab / KTH,ELISA,Not reported,99.40%,,Moderate,Institutional Report,Swedish Public Health Agency,Sweden Public Health Agency,https://www.folkhalsomyndigheten.se/contentassets/9c5893f84bd049e691562b9eeb0ca280/pavisning-antikroppar-genomgangen-covid-19-blodprov-oppenvarden-delrapport-1.pdf,08/06/2021,16/07/2022,Unverified
210618_Sweden_PublicHealthAgencyOfSweden,18-Jun-21,National,Sweden,SWE,,,30-Oct-20,08-Dec-20,Household and community samples,Multiple groups,324,8.60%,,,Convenience,NA,Not reported,IgG,99.70%,100.00%,High,Preprint,Thomas Akerlund,Public Health Agency of Sweden,https://www.medrxiv.org/content/10.1101/2021.06.16.21258960v1.full-text,30/06/2021,16/07/2022,Unverified
210617_Stockholm_KTHRoyalInstituteofTechnology,17-Jun-21,Local,Sweden,SWE,,Stolkholm,15-Apr-20,15-May-20,Household and community samples,Multiple groups,878,12.50%,10.30%,14.70%,Simplified probability,NA,ELISA,"IgG,IgM",100.00%,96.00%,Moderate,Journal Article (Peer-Reviewed),Niclas Roxhed,KTH Royal Institute of Technology,https://dx.doi.org/10.1038/s41467-021-23893-4,06/07/2021,16/07/2022,Verified
200720_Sweden_TheSwedishPublicHealthAgency_Primary,20-Jul-21,National,Sweden,SWE,,,26-Apr-21,09-May-21,Blood donors,Multiple groups,2860,32.80%,30.60%,35.10%,Self-referral,NA,ELISA,IgG,,,Moderate,Institutional Report,Swedish Public Health Agency,The Swedish Public Health Agency,https://www.folkhalsomyndigheten.se/contentassets/45eafde72689438a8a21efa93a5591a4/forekomsten-antikroppar-mot-sars-cov-2.pdf,28/07/2021,16/07/2022,Unverified
210805_Varmland_CentreforClinicalResearchandEducation_primary,05-Aug-21,Regional,Sweden,SWE,Varmland,,20-Jun-20,12-Oct-20,Health care workers and caregivers,Multiple groups,4955,5.70%,,,Entire sample,Abbott Laboratories,CLIA,IgG,97.00%,99.50%,High,Journal Article (Peer-Reviewed),Lukas Frans Ocias,Centre for Clinical Research and Education of Varmland,https://dx.doi.org/10.1080/23744235.2021.1959949,10/08/2021,16/07/2022,Unverified
210614_Gothenburg_TheSwedishPublicHealthAgency_Primary,14-Jun-21,Local,Sweden,SWE,,Gothenburg,01-Mar-21,16-Mar-21,Blood donors,Seniors (65+ years),724,6.90%,5.30%,9.00%,Self-referral,Abbott Laboratories,CLIA,IgG,,,High,Institutional Report,Swedish Public Health Agency,"The Public Health Agency of Sweden, University of Gothenburg, Sahlgrenska University Hospital and Region Västra Götaland",https://www.folkhalsomyndigheten.se/contentassets/eee8b4f90ef24a18b2a65865341710e1/forekomsten-antikroppar-sars-cov-2-aldre-goteborg.pdf,10/08/2021,16/07/2022,Unverified
210827_Linkoping_LinkopingUniversity_Overall,27-Aug-21,Local,Sweden,SWE,Ostergotland,Linkoping,15-Mar-20,15-Jan-21,Patients seeking care for non-COVID-19 reasons,Multiple groups,100,36.00%,,,Sequential,NA,ELISA,"IgG,IgM,IgA",,,High,Journal Article (Peer-Reviewed),Johanna Sjowall,Linkoping University,https://www.frontiersin.org/articles/10.3389/fimmu.2021.724047/full,07/09/2021,16/07/2022,Unverified
200925_Stockholm_TheStockholmRegion,25-Sep-20,Local,Sweden,SWE,,Stockholm,15-Jun-20,20-Sep-20,Household and community samples,Multiple groups,483345,15.20%,,,Unclear,NA,Not reported,Not reported,,,Unclear,Institutional Report,The Stockholm Region,The Stockholm Region,https://www.sll.se/verksamhet/halsa-och-vard/nyheter-halsa-och-vard/2020/09/25-september-lagesrapport-om-arbetet-med-det-nya-coronaviruset/,11/09/2021,16/07/2022,Verified
200929_Stockholm_TheStockholmRegion,29-Sep-20,Local,Sweden,SWE,,Stockholm,21-Sep-20,27-Sep-20,Household and community samples,Multiple groups,9648,14.30%,,,Unclear,NA,Not reported,Not reported,,,Unclear,Institutional Report,The Stockholm Region,The Stockholm Region,https://www.sll.se/verksamhet/halsa-och-vard/nyheter-halsa-och-vard/2020/09/29-september-lagesrapport-om-covid-19/,11/09/2021,16/07/2022,Verified
210821_Stockholm_KarolinskaUniversityHospital_Overall,21-Aug-21,Local,Sweden,SWE,Sodermanland and Uppland,Stockholm,23-Apr-20,24-Jun-20,Health care workers and caregivers,Adults (18-64 years),12928,11.50%,,,Convenience,NA,ELISA,IgG,99.40%,99.10%,Moderate,Journal Article (Peer-Reviewed),Klara Miriam Elfstrom,Karolinska University Hospital,https://dx.doi.org/10.1016/j.pmedr.2021.101518,13/09/2021,16/07/2022,Verified
201006_Stockholm_TheStockholmRegion,06-Oct-20,Local,Sweden,SWE,,Stockholm,28-Sep-20,04-Oct-20,Household and community samples,Multiple groups,11670,15.40%,,,Unclear,NA,Not reported,Not reported,,,Unclear,Institutional Report,The Stockholm Region,The Stockholm Region,https://www.sll.se/verksamhet/halsa-och-vard/nyheter-halsa-och-vard/2020/10/6-oktober-lagesrapport-om-covid-19/,13/09/2021,16/07/2022,Verified
210719_Sweden_SwedishPublicHealthAgency_Outpatients_Week21-22_Primary,19-Jul-21,National,Sweden,SWE,,"Jönköping, Kalmar, Skåne, Stockholm, Uppsala, Västerbotten, Västra Götalandoch Örebro",24-May-21,04-Jun-21,Residual sera,Multiple groups,3949,52.20%,50.37%,54.05%,Stratified non-probability,Sci LifeLab / KTH,ELISA,Not reported,98.90%,99.40%,Moderate,Institutional Report,Swedish Public Health Agency,Swedish Public Health Agency,https://www.folkhalsomyndigheten.se/contentassets/9c5893f84bd049e691562b9eeb0ca280/pavisning-antikroppar-mot-sars-cov-2-blodprov-oppenvarden.pdf,14/09/2021,16/07/2022,Verified
210728_Stockholm_TheSwedishPublicHealthAgency,28-Jul-21,Local,Sweden,SWE,"Södermanland, Uppland",Stockholm,15-Nov-20,15-Dec-20,Essential non-healthcare workers,Adults (18-64 years),49,36.70%,,,Unclear,Beijing Wantai Biological,ELISA,Not reported,,,High,Institutional Report,Swedish Public Health Agency,The Swedish Public Health Agency,https://www.folkhalsomyndigheten.se/publicerat-material/publikationsarkiv/u/undersokning-av-immunologiskt-svar-mot-sars-cov-2-hos-barn-unga-och-skolpersonal/,15/09/2021,16/07/2022,Unverified
201013_Stockholm_TheStockholmRegion,13-Oct-20,Local,Sweden,SWE,,Stockholm,05-Oct-20,11-Oct-20,Household and community samples,Multiple groups,11065,15.20%,,,Unclear,NA,Not reported,Not reported,,,Unclear,Institutional Report,The Stockholm Region,The Stockholm Region,https://www.sll.se/verksamhet/halsa-och-vard/nyheter-halsa-och-vard/2020/10/13-oktober-lagesrapport-om-covid-19/,27/09/2021,16/07/2022,Verified
201020_Stockholm_TheStockholmRegion,20-Oct-20,Local,Sweden,SWE,,Stockholm,12-Oct-20,18-Oct-20,Household and community samples,Multiple groups,10297,15.40%,,,Unclear,NA,Not reported,Not reported,,,Unclear,Institutional Report,The Stockholm Region,The Stockholm Region,https://www.sll.se/verksamhet/halsa-och-vard/nyheter-halsa-och-vard/2020/10/20-oktober-lagesrapport-om-covid-19/,27/09/2021,16/07/2022,Verified
201027_Stockholm_TheStockholmRegion,27-Oct-20,Local,Sweden,SWE,,Stockholm,19-Oct-20,25-Oct-20,Household and community samples,Multiple groups,8941,20.60%,,,Unclear,NA,Not reported,Not reported,,,Unclear,Institutional Report,The Stockholm Region,The Stockholm Region,https://www.sll.se/verksamhet/halsa-och-vard/nyheter-halsa-och-vard/2020/10/27-oktober-lagesrapport-om-covid-19/,27/09/2021,16/07/2022,Verified
211103_Stockholm_TheStockholmRegion,03-Nov-20,Local,Sweden,SWE,,Stockholm,26-Oct-20,01-Nov-20,Household and community samples,Multiple groups,9580,21.70%,,,Unclear,NA,Not reported,Not reported,,,Unclear,Institutional Report,The Stockholm Region,The Stockholm Region,https://www.sll.se/verksamhet/halsa-och-vard/nyheter-halsa-och-vard/2020/11/3-november-lagesrapport-om-covid-19/,27/09/2021,16/07/2022,Verified
201110_Stockholm_TheStockholmRegion,10-Nov-20,Local,Sweden,SWE,,Stockholm,02-Nov-20,08-Nov-20,Household and community samples,Multiple groups,11500,25.90%,,,Unclear,NA,Not reported,Not reported,,,Unclear,Institutional Report,The Stockholm Region,The Stockholm Region,https://www.sll.se/verksamhet/halsa-och-vard/nyheter-halsa-och-vard/2020/11/10-november-lagesrapport-om-covid-19/,04/10/2021,16/07/2022,Verified
201117_Stockholm_TheStockholmRegion,17-Nov-20,Local,Sweden,SWE,,Stockholm,09-Nov-20,15-Nov-20,Household and community samples,Multiple groups,13273,27.80%,,,Unclear,NA,Not reported,Not reported,,,Unclear,Institutional Report,The Stockholm Region,The Stockholm Region,https://www.sll.se/verksamhet/halsa-och-vard/nyheter-halsa-och-vard/2020/11/17-november-lagesrapport-om-covid-19/,04/10/2021,16/07/2022,Verified
201124_Stockholm_TheStockholmRegion,24-Nov-20,Local,Sweden,SWE,,Stockholm,16-Nov-20,22-Nov-20,Household and community samples,Multiple groups,15474,31.40%,,,Unclear,NA,Not reported,Not reported,,,Unclear,Institutional Report,The Stockholm Region,The Stockholm Region,https://www.sll.se/verksamhet/halsa-och-vard/nyheter-halsa-och-vard/2020/11/24-november-lagesrapport-om-covid-19/,04/10/2021,16/07/2022,Verified
201201_Stockholm_TheStockholmRegion,01-Dec-20,Local,Sweden,SWE,,Stockholm,23-Nov-20,29-Nov-20,Household and community samples,Multiple groups,16389,33.60%,,,Unclear,NA,Not reported,Not reported,,,Unclear,Institutional Report,The Stockholm Region,The Stockholm Region,https://www.sll.se/verksamhet/halsa-och-vard/nyheter-halsa-och-vard/2020/12/1-december-lagesrapport-om-covid-19/,04/10/2021,16/07/2022,Verified
201208_Stockholm_TheStockholmRegion,08-Dec-20,Local,Sweden,SWE,,Stockholm,30-Nov-20,06-Dec-20,Household and community samples,Multiple groups,16943,36.70%,,,Unclear,NA,Not reported,Not reported,,,Unclear,Institutional Report,The Stockholm Region,The Stockholm Region,https://www.sll.se/verksamhet/halsa-och-vard/nyheter-halsa-och-vard/2020/12/8-december-lagesrapport-om-covid-19/,04/10/2021,16/07/2022,Verified
201215_Stockholm_TheStockholmRegion,15-Dec-20,Local,Sweden,SWE,,Stockholm,07-Dec-20,13-Dec-20,Household and community samples,Multiple groups,20466,39.00%,,,Unclear,NA,Not reported,Not reported,,,Unclear,Institutional Report,The Stockholm Region,The Stockholm Region,https://www.sll.se/verksamhet/halsa-och-vard/nyheter-halsa-och-vard/2020/12/15-december-lagesrapport-om-covid-19/,14/10/2021,16/07/2022,Verified
201222_Stockholm_TheStockholmRegion,22-Dec-20,Local,Sweden,SWE,,Stockholm,14-Dec-20,20-Dec-20,Household and community samples,Multiple groups,23466,38.10%,,,Unclear,NA,Not reported,Not reported,,,Unclear,Institutional Report,The Stockholm Region,The Stockholm Region,https://www.sll.se/verksamhet/halsa-och-vard/nyheter-halsa-och-vard/2020/12/22-december-lagesrapport-om-covid-19/,14/10/2021,16/07/2022,Verified
201229_Stockholm_TheStockholmRegion,29-Dec-20,Local,Sweden,SWE,,Stockholm,21-Dec-20,27-Dec-20,Household and community samples,Multiple groups,17624,37.80%,,,Unclear,NA,Not reported,Not reported,,,Unclear,Institutional Report,The Stockholm Region,The Stockholm Region,https://www.sll.se/verksamhet/halsa-och-vard/nyheter-halsa-och-vard/2020/12/29-december-lagesrapport-om-covid-19/,14/10/2021,16/07/2022,Verified
210105_Stockholm_TheStockholmRegion,05-Jan-21,Local,Sweden,SWE,,Stockholm,28-Dec-20,03-Jan-21,Household and community samples,Multiple groups,15061,42.40%,,,Unclear,NA,Not reported,Not reported,,,Unclear,Institutional Report,The Stockholm Region,The Stockholm Region,https://www.sll.se/verksamhet/halsa-och-vard/nyheter-lagesrapporter-covid-19/2021/01/5-januari-lagesrapport-om-covid-19/,18/10/2021,16/07/2022,Verified
210112_Stockholm_TheStockholmRegion,12-Jan-21,Local,Sweden,SWE,,Stockholm,04-Jan-21,10-Jan-21,Household and community samples,Multiple groups,10378,42.80%,,,Unclear,NA,Not reported,Not reported,,,Unclear,Institutional Report,The Stockholm Region,The Stockholm Region,https://www.sll.se/verksamhet/halsa-och-vard/nyheter-lagesrapporter-covid-19/2021/01/12-januari-lagesrapport-om-covid-19/,18/10/2021,16/07/2022,Verified
210119_Stockholm_TheStockholmRegion,19-Jan-21,Local,Sweden,SWE,,Stockholm,11-Jan-21,17-Jan-21,Household and community samples,Multiple groups,18544,45.30%,,,Unclear,NA,Not reported,Not reported,,,Unclear,Institutional Report,The Stockholm Region,The Stockholm Region,https://www.sll.se/verksamhet/halsa-och-vard/nyheter-lagesrapporter-covid-19/2021/01/19-januari-lagesrapport-om-covid-19/,18/10/2021,16/07/2022,Verified
210126_Stockholm_TheStockholmRegion,26-Jan-21,Local,Sweden,SWE,,Stockholm,18-Jan-21,24-Jan-21,Household and community samples,Multiple groups,15498,44.40%,,,Unclear,NA,Not reported,Not reported,,,Unclear,Institutional Report,The Stockholm Region,The Stockholm Region,https://www.sll.se/verksamhet/halsa-och-vard/nyheter-lagesrapporter-covid-19/2021/01/26-januari-lagesrapport-om-covid-19/,18/10/2021,16/07/2022,Verified
210202_Stockholm_TheStockholmRegion,02-Feb-21,Local,Sweden,SWE,,Stockholm,25-Jan-21,31-Jan-21,Household and community samples,Multiple groups,11749,45.70%,,,Unclear,NA,Not reported,Not reported,,,Unclear,Institutional Report,The Stockholm Region,The Stockholm Region,https://www.sll.se/verksamhet/halsa-och-vard/nyheter-lagesrapporter-covid-19/2021/02/2-februari-lagesrapport-om-covid-19/,18/10/2021,16/07/2022,Verified
211023_Sweden_KarolinskaInstitutet_Overall,23-Oct-21,National,Sweden,SWE,,,06-Oct-20,23-Jun-21,Household and community samples,Adults (18-64 years),977,28.40%,,,Convenience,NA,ELISA,"IgA,IgM,IgG",,,High,Journal Article (Peer-Reviewed),Sophia Bjorkander,Karolinska Institutet,https://www.sciencedirect.com/science/article/pii/S0091674921016262,03/11/2021,16/07/2022,Unverified
2101028_Sweden_SwedishPublicHealthAgency_Outpatients_Week38-39_Primary,28-Oct-21,National,Sweden,SWE,,,20-Sep-21,03-Oct-21,Residual sera,Multiple groups,2959,75.60%,73.82%,77.29%,Convenience,Sci LifeLab / KTH,ELISA,Not reported,98.90%,99.40%,Moderate,Institutional Report,Swedish Public Health Agency,Swedish Public Health Agency,https://www.folkhalsomyndigheten.se/publicerat-material/publikationsarkiv/p/pavisning-av-antikroppar-efter-genomgangen-covid-19-i-blodprov-fran-oppenvarden-delrapport-1/,04/11/2021,16/07/2022,Verified
2101028_Sweden_SwedishPublicHealthAgency_BloodDoner_Week9-10,28-Oct-21,National,Sweden,SWE,,,01-Mar-21,12-Mar-21,Blood donors,Multiple groups,3067,22.40%,20.32%,24.49%,Self-referral,Sci LifeLab / KTH,Not reported,Not reported,,,Moderate,Institutional Report,Swedish Public Health Agency,Sweden Public Health Agency,https://www.folkhalsomyndigheten.se/contentassets/376f9021a4c84da08de18ac597284f0c/pavisning-antikroppar-mot-sars-cov-2-blodgivare.pdf,04/11/2021,16/07/2022,Unverified
2101028_Sweden_SwedishPublicHealthAgency_BloodDoner_Week21-22,28-Oct-21,National,Sweden,SWE,,,24-May-21,04-Jun-21,Blood donors,Multiple groups,3009,51.90%,49.53%,54.36%,Self-referral,Sci LifeLab / KTH,Not reported,Not reported,,,Moderate,Institutional Report,Swedish Public Health Agency,Sweden Public Health Agency,https://www.folkhalsomyndigheten.se/contentassets/376f9021a4c84da08de18ac597284f0c/pavisning-antikroppar-mot-sars-cov-2-blodgivare.pdf,04/11/2021,16/07/2022,Unverified
2101028_Sweden_SwedishPublicHealthAgency_BloodDoner_Week38-39,28-Oct-21,National,Sweden,SWE,,,20-Sep-21,03-Oct-21,Blood donors,Multiple groups,402,96.80%,94.46%,98.49%,Self-referral,Sci LifeLab / KTH,Not reported,Not reported,,,Moderate,Institutional Report,Swedish Public Health Agency,Sweden Public Health Agency,https://www.folkhalsomyndigheten.se/contentassets/376f9021a4c84da08de18ac597284f0c/pavisning-antikroppar-mot-sars-cov-2-blodgivare.pdf,04/11/2021,16/07/2022,Unverified
210209_Stockholm_TheStockholmRegion,09-Feb-21,Local,Sweden,SWE,,Stockholm,01-Feb-21,07-Feb-21,Household and community samples,Multiple groups,11175,44.70%,,,Unclear,NA,Not reported,Not reported,,,Unclear,Institutional Report,The Stockholm Region,The Stockholm Region,https://www.regionstockholm.se/verksamhet/halsa-och-vard/nyheter-lagesrapporter-covid-19/2021/02/9-februari-lagesrapport-om-covid-19/,22/11/2021,16/07/2022,Verified
210216_Stockholm_TheStockholmRegion,16-Feb-21,Local,Sweden,SWE,,Stockholm,08-Feb-21,14-Feb-21,Household and community samples,Multiple groups,8108,42.50%,,,Unclear,NA,Not reported,Not reported,,,Unclear,Institutional Report,The Stockholm Region,The Stockholm Region,https://www.regionstockholm.se/verksamhet/halsa-och-vard/nyheter-lagesrapporter-covid-19/2021/02/16-februari-lagesrapport-om-covid-19/,22/11/2021,16/07/2022,Verified
210223_Stockholm_TheStockholmRegion,23-Feb-21,Local,Sweden,SWE,,Stockholm,15-Feb-21,21-Feb-21,Household and community samples,Multiple groups,9024,42.40%,,,Unclear,NA,Not reported,Not reported,,,Unclear,Institutional Report,The Stockholm Region,The Stockholm Region,https://www.regionstockholm.se/verksamhet/halsa-och-vard/nyheter-lagesrapporter-covid-19/2021/02/23-februari-lagesrapport-om-covid-19/,22/11/2021,16/07/2022,Verified
210302_Stockholm_TheStockholmRegion,02-Mar-21,Local,Sweden,SWE,,Stockholm,22-Feb-21,28-Feb-21,Household and community samples,Multiple groups,12605,40.90%,,,Unclear,NA,Not reported,Not reported,,,Unclear,Institutional Report,The Stockholm Region,The Stockholm Region,https://www.regionstockholm.se/verksamhet/halsa-och-vard/nyheter-lagesrapporter-covid-19/2021/03/2-mars-lagesrapport-om-covid-19/,22/11/2021,16/07/2022,Verified
210309_Stockholm_TheStockholmRegion,09-Mar-21,Local,Sweden,SWE,,Stockholm,01-Mar-21,07-Mar-21,Household and community samples,Multiple groups,9237,39.50%,,,Unclear,NA,Not reported,Not reported,,,Unclear,Institutional Report,The Stockholm Region,The Stockholm Region,https://www.regionstockholm.se/verksamhet/halsa-och-vard/nyheter-lagesrapporter-covid-19/2021/03/9-mars-lagesrapport-om-covid-19/,22/11/2021,16/07/2022,Verified
210316_Stockholm_TheStockholmRegion,16-Mar-21,Local,Sweden,SWE,,Stockholm,08-Mar-21,14-Mar-21,Household and community samples,Multiple groups,9769,39.80%,,,Unclear,NA,Not reported,Not reported,,,Unclear,Institutional Report,The Stockholm Region,The Stockholm Region,https://www.regionstockholm.se/verksamhet/halsa-och-vard/nyheter-lagesrapporter-covid-19/2021/03/16-mars-lagesrapport-om-covid-19/,22/11/2021,16/07/2022,Verified
210323_Stockholm_TheStockholmRegion,23-Mar-21,Local,Sweden,SWE,,Stockholm,15-Mar-21,21-Mar-21,Household and community samples,Multiple groups,9040,40.40%,,,Unclear,NA,Not reported,Not reported,,,Unclear,Institutional Report,The Stockholm Region,The Stockholm Region,https://www.regionstockholm.se/verksamhet/halsa-och-vard/nyheter-lagesrapporter-covid-19/2021/03/23-mars-lagesrapport-om-covid-19/,22/11/2021,16/07/2022,Verified
210330_Stockholm_TheStockholmRegion,30-Mar-21,Local,Sweden,SWE,,Stockholm,22-Mar-21,28-Mar-21,Household and community samples,Multiple groups,10146,40.90%,,,Unclear,NA,Not reported,Not reported,,,Unclear,Institutional Report,The Stockholm Region,The Stockholm Region,https://www.regionstockholm.se/verksamhet/halsa-och-vard/nyheter-lagesrapporter-covid-19/2021/03/30-mars-lagesrapport-om-covid-19/,22/11/2021,16/07/2022,Verified
210406_Stockholm_TheStockholmRegion,06-Apr-21,Local,Sweden,SWE,,Stockholm,29-Mar-21,04-Apr-21,Household and community samples,Multiple groups,10419,42.70%,,,Unclear,NA,Not reported,Not reported,,,Unclear,Institutional Report,The Stockholm Region,The Stockholm Region,https://www.regionstockholm.se/verksamhet/halsa-och-vard/nyheter-lagesrapporter-covid-19/2021/04/6-april-lagesrapport-om-covid-19/,22/11/2021,16/07/2022,Verified
210413_Stockholm_TheStockholmRegion,13-Apr-21,Local,Sweden,SWE,,Stockholm,05-Apr-21,11-Apr-21,Household and community samples,Multiple groups,2084,50.90%,,,Unclear,NA,Not reported,Not reported,,,Unclear,Institutional Report,The Stockholm Region,The Stockholm Region,https://www.regionstockholm.se/verksamhet/halsa-och-vard/nyheter-lagesrapporter-covid-19/2021/04/13-april-lagesrapport-om-covid-19/,01/12/2021,16/07/2022,Verified
210420_Stockholm_TheStockholmRegion,20-Apr-21,Local,Sweden,SWE,,Stockholm,12-Apr-21,18-Apr-21,Household and community samples,Multiple groups,868,57.60%,,,Unclear,NA,Not reported,Not reported,,,Unclear,Institutional Report,The Stockholm Region,The Stockholm Region,https://www.regionstockholm.se/verksamhet/halsa-och-vard/nyheter-lagesrapporter-covid-19/2021/04/mall-lagesrapport-med-tabell/,01/12/2021,16/07/2022,Verified
210427_Stockholm_TheStockholmRegion,27-Apr-21,Local,Sweden,SWE,,Stockholm,19-Apr-21,25-Apr-21,Household and community samples,Multiple groups,953,61.50%,,,Unclear,NA,Not reported,Not reported,,,Unclear,Institutional Report,The Stockholm Region,The Stockholm Region,https://www.regionstockholm.se/verksamhet/halsa-och-vard/nyheter-lagesrapporter-covid-19/2021/04/27-april-Lagesrapport-om-ovid-19/,01/12/2021,16/07/2022,Verified
211102_Sweden_UniversityofGothenburg_BloodDonorsTP5_N+S,02-Nov-21,Local,Sweden,SWE,,Gothenburg,12-Jan-21,29-Jan-21,Blood donors,Multiple groups,253,11.86%,,,Unclear,Shenzhen Yhlo Biotech Co. Ltd,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Emelie Marklund,University of Gothenburg,https://dx.doi.org/10.3389/fimmu.2021.750448,02/12/2021,16/07/2022,Verified
211102_Sweden_UniversityofGothenburg_HCWsTP5_N+S,02-Nov-21,Local,Sweden,SWE,,Gothenburg,12-Jan-21,29-Jan-21,Health care workers and caregivers,Multiple groups,280,29.29%,,,Convenience,Shenzhen Yhlo Biotech Co. Ltd,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Emelie Marklund,University of Gothenburg,https://dx.doi.org/10.3389/fimmu.2021.750448,02/12/2021,16/07/2022,Verified
220525_Sweden_UppsalaUniversityHospital_Overall,25-May-22,National,Sweden,SWE,,,15-Jun-20,07-Sep-21,Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),136,33.00%,25.00%,41.00%,Convenience,NA,Not reported,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Emil Sundberg,Uppsala University Hospital,https://dx.doi.org/10.1002/pbc.29773,02/06/2022,16/07/2022,Unverified
220625_Sweden_PublicHealthAgencyofSweden,25-Jun-22,National,Sweden,SWE,,,26-Apr-21,09-May-21,Household and community samples,Multiple groups,2860,32.60%,30.30%,34.90%,Simplified probability,NA,ELISA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Jessica Beser,Public Health Agency of Sweden,https://dx.doi.org/10.1038/s41598-022-15183-w,07/07/2022,16/07/2022,Unverified
220630_Stockholm_FolktandvardenStockholm,30-Jun-22,Local,Sweden,SWE,,Stockholm,01-Jun-20,15-Jun-20,Health care workers and caregivers,Adults (18-64 years),341,10.30%,,,Convenience,Luminex Corporation,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Lars Fredriksson,Folktandvården Stockholm,https://dx.doi.org/10.1080/00016357.2022.2095023,13/07/2022,16/07/2022,Unverified
201023_Khartoum_FederalMinistryofHealthSudan,23-Oct-20,Regional,Sudan,SDN,Khartoum,,22-May-20,05-Jul-20,Household and community samples,Multiple groups,967,18.30%,,,Unclear,NA,LFIA,Not reported,,,Unclear,News and Media,William McCollum,Federal Ministry of Health (MOH) in Sudan,https://www.tephinet.org/sudan-fetp-conducts-targeted-testing-for-covid-19-in-khartoum-state,03/05/2021,16/07/2022,Verified
220501_GreaterOmdurman_MédecinsSansFrontières_TestAdjusted,01-May-22,Local,Sudan,SDN,Khartoum State,Omdurman,01-Mar-21,10-Apr-21,Household and community samples,Multiple groups,2375,54.60%,51.40%,57.80%,Stratified probability,"SD Biosensor,EUROIMMUN",LFIA,"IgG,IgM",,,Moderate,Journal Article (Peer-Reviewed),Wendelin Moser,Médecins Sans Frontières,https://dx.doi.org/10.3201/eid2805.211951,03/05/2022,16/07/2022,Verified
211108_Colombo_UniversityofSriJayewardenepura,08-Nov-21,Local,Sri Lanka,LKA,,Colombo,15-Apr-20,19-May-20,Contacts of COVID patients,Multiple groups,2633,3.38%,,,Convenience,Beijing Wantai Biological,ELISA,Total Antibody,,100.00%,High,Journal Article (Peer-Reviewed),Chandima Jeewandara,University of Sri Jayewardenepura,https://dx.doi.org/10.1371/journal.pone.0257548,17/11/2021,16/07/2022,Unverified
211112_Colombo_UniversityofSriJayewardenepura_Overall,12-Nov-21,Local,Sri Lanka,LKA,Western Province,Colombo,15-Jan-21,31-Jan-21,Household and community samples,Multiple groups,2547,24.46%,,,Convenience,Beijing Wantai Biological,ELISA,Total Antibody,98.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Chandima Jeewandara,University of Sri Jayewardenepura,https://www.frontiersin.org/articles/10.3389/fpubh.2021.724398/full,14/12/2021,16/07/2022,Unverified
200616_Madrid_UniversidadAutónomadeMadrid_TotalPop,16-Jun-20,Local,Spain,ESP,Community of Madrid,Madrid,26-Apr-20,16-May-20,Multiple populations,Multiple groups,674,13.80%,,,Sequential,PCL Inc,LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Vicente Soriano, Universidad Autónoma de Madrid,https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciaa769/5858269,18/06/2020,16/07/2022,Verified
200606_Leon_UniversidadedeLeon_HCWs_TestAdj2,06-Jun-20,Local,Spain,ESP,Léon,Léon,01-Apr-20,15-Apr-20,Health care workers and caregivers,Adults (18-64 years),676,7.40%,5.50%,10.00%,Convenience,Hanghzhou AllTest Biotech Co. Ltd,LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Vicente Martin,"Gerencia de Atención Primaria del Área de Salud de León, Spain",https://dx.doi.org/10.1016/j.semerg.2020.05.014,30/07/2020,16/07/2022,Verified
200806_Valencia_HospitalClínicoUniversitario_HCWs_IgG_and_IgM,06-Aug-20,Local,Spain,ESP,Valencia,Valencia,13-Apr-20,30-Apr-20,Health care workers and caregivers,Adults (18-64 years),1153,3.50%,,,Unclear,Snibe Co. Ltd (Shenzhen New Industries Biomedical Engineering Co. Ltd),CLIA,"IgG,IgM",95.60%,96.00%,High,Journal Article (Peer-Reviewed),Arantxa Valdivia,Hospital Clínico Universitario,https://onlinelibrary.wiley.com/doi/full/10.1002/jmv.26400,27/09/2020,16/07/2022,Verified
200810_Spain_CostadelSolHospital_HCW_IgGANDORIgM,10-Aug-20,Local,Spain,ESP,,Marbella,15-Apr-20,25-Apr-20,Health care workers and caregivers,Adults (18-64 years),498,2.20%,,,Convenience,Zhejiang Orient Gene Biotech,LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Julian Olalla, Hospital Costa del Sol ,http://dx.doi.org/10.1093/qjmed/hcaa238,03/10/2020,16/07/2022,Verified
200617_TorrejonDeArdoz_MunicipalityOfTorrejonDeArdoz_IgGIgM,17-Jun-20,Local,Spain,ESP,,Torrejon de Ardoz,29-May-20,03-Jun-20,Household and community samples,Multiple groups,104299,23.07%,,,Entire sample,NA,Not reported,"IgG,IgM",,,Moderate,Institutional Report,Daniel Flores,Municipality of Torrejon de Ardoz,https://www.rtve.es/noticias/20200617/test-serologicos-torrejon-ardoz-arrojan-2018-habitantes-tiene-anticuerpos-coronavirus/2018787.shtml,08/10/2020,16/07/2022,Verified
200831_Madrid_HospitalGeneralUniversitarioGregorioMaranon_Overall_UnAdj,31-Aug-20,Local,Spain,ESP,Community of Madrid,Torrejon de Ardoz,01-Jun-20,19-Jun-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,229,31.40%,,,Convenience,Hangzhou Testsea Biotechnology Co. Ltd,Not reported,"IgG,IgM",96.00%,100.00%,High,Journal Article (Peer-Reviewed),Luis Cabezon-Gutierrez,Hospital General Universitario Gregorio Maranon,https://dx.doi.org/10.1016/j.ctrv.2020.102102,20/10/2020,16/07/2022,Verified
200918_Madrid_UniversityHospitalGregorioMarañón_Overall,18-Sep-20,Local,Spain,ESP,,Madrid,06-May-20,21-May-20,Pregnant or parturient women,Adults (18-64 years),100,13.00%,,,Sequential,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Maria Vinuela,University Hospital Gregorio Marañón,http://dx.doi.org/10.37201/req/088.2020,12/11/2020,16/07/2022,Verified
200806_Barcelona_UniversitatdeBarcelona_PregnantWomen_Overall,06-Aug-20,Local,Spain,ESP,,Barcelona,14-Apr-20,05-May-20,Pregnant or parturient women,Adults (18-64 years),874,14.00%,,,Convenience,"Vircell S.L.,Ortho Clinical Diagnostics Inc.",Not reported,"IgG,IgM,IgA",,,High,Journal Article (Peer-Reviewed),Francesca Crovetto,Universitat de Barcelona,https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31714-1/fulltext,03/01/2021,16/07/2022,Verified
200911_Santiago_HospitalClinicoUniversitariodeSantiagodeCompostela_Overall,11-Sep-20,Local,Spain,ESP,Galicia,Santiago de Compostela,14-Apr-20,16-Apr-20,Health care workers and caregivers,Adults (18-64 years),175,4.00%,1.10%,6.90%,Convenience,Genobio Pharmaceutical (Shanghai China),Other,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Ana Dacosta Urbieta,Hospital Clinico Universitario de Santiago de Compostela,http://dx.doi.org/10.3389/fped.2020.00547,05/01/2021,16/07/2022,Verified
201021_Spain_IVIRMA_Overall,01-Sep-20,National,Spain,ESP,,,27-Apr-20,26-Jun-20,Residual sera,Adults (18-64 years),6140,0.68%,,,Convenience,"Epitope Diagnostics, Inc.",ELISA,IgM,,,Unclear,Journal Article (Peer-Reviewed),Nicolas Prados,IVIRMA Global Headquarters,http://dx.doi.org/10.1016/j.fertnstert.2020.09.077,08/01/2021,16/07/2022,Verified
200911_Barcelona_SardenyaPrimaryHealthCareCenter_Overall,11-Sep-20,Local,Spain,ESP,Catalonia,Barcelona,21-Apr-20,24-Apr-20,Household and community samples,Multiple groups,311,5.47%,3.44%,8.58%,Stratified probability,"Zhuhai Livzon Diagnostics Inc,SureScreen Diagnostics,NA",LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Patricia Montenegro, Sardenya Primary Health Care Center,http://dx.doi.org/10.1093/fampra/cmaa096,08/01/2021,16/07/2022,Verified
201024_Madrid_HospitalUniversitarioPrincipeDeAsturias_HCW_Overall,29-Oct-20,Local,Spain,ESP,,Madrid,01-May-20,30-May-20,Health care workers and caregivers,Adults (18-64 years),2424,22.40%,,,Convenience,Hanghzhou AllTest Biotech Co. Ltd,LFIA,"IgG,IgM",88.00%,100.00%,High,Journal Article (Peer-Reviewed),Felipe Perez Garcia ,Hospital Universitario Príncipe de Asturias,https://dx.doi.org/10.1017/ice.2020.1303,08/01/2021,16/07/2022,Verified
201112_Barcelona_UniversityHospitalSantJoandeDeu_HHC_primaryest,12-Nov-20,Local,Spain,ESP,Catalonia,Barcelona,28-Apr-20,03-Jun-20,Contacts of COVID patients,Multiple groups,1084,17.99%,,,Convenience,Innovita Biological Technology Co. Ltd,LFIA,"IgM,IgG",83.30%,,Moderate,Journal Article (Peer-Reviewed),Pedro Brotons,University Hospital Sant Joan de Deu,https://dx.doi.org/10.1093/cid/ciaa1721,23/01/2021,16/07/2022,Verified
201125_Valencia_HospitalArnauDeVilanova_Overall,25-Nov-20,Local,Spain,ESP,Valencia,Valencia,02-May-20,30-Jun-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,166,1.80%,,,Sequential,DiaSorin,ELISA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Javier Garde Noguera,"Hospital Arnau de Vilanova de Valencia, Spain",https://dx.doi.org/10.3390/cancers12123513,23/01/2021,16/07/2022,Verified
201130_Spain_UniversityofZaragoza_unadj,30-Nov-20,Local,Spain,ESP,,Madrid,31-Mar-20,31-Aug-20,Pregnant or parturient women,Adults (18-64 years),260,6.92%,,,Sequential,"Biozek,Abbott Laboratories,Vircell S.L.",Multiple Types,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Ricardo Saviron Cornudella,University of Zaragoza,https://dx.doi.org/10.1016/j.ejogrb.2020.11.069,23/01/2021,16/07/2022,Verified
201026_Zaragoza_HospitalSanJuandeDios_HCW_primary,13-Nov-20,Local,Spain,ESP,Aragon,Zaragoza,20-Mar-20,21-Apr-20,Health care workers and caregivers,Adults (18-64 years),289,5.88%,,,Convenience,NA,LFIA,"IgG,IgM",100.00%,98.00%,High,Journal Article (Peer-Reviewed),Luis Antonio Moreno Borraz,Hospital San Juan de Dios,https://dx.doi.org/10.1016/j.regg.2020.10.005,27/01/2021,16/07/2022,Verified
201026_Zaragoza_HospitalSanJuandeDios_patients_primary,13-Nov-20,Local,Spain,ESP,Aragon,Zaragoza,20-Mar-20,21-Apr-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,229,6.99%,,,Convenience,NA,LFIA,"IgG,IgM",100.00%,98.00%,High,Journal Article (Peer-Reviewed),Luis Antonio Moreno Borraz,Hospital San Juan de Dios,https://dx.doi.org/10.1016/j.regg.2020.10.005,27/01/2021,16/07/2022,Verified
201014_Alicante_COVID-19GroupoftheInfectionsCommission,14-Oct-20,Local,Spain,ESP,Alacant,Alicante,24-Apr-20,08-May-20,Health care workers and caregivers,Adults (18-64 years),4179,6.60%,5.80%,7.30%,Unclear,NA,ELISA,IgG,,,Unclear,Journal Article (Peer-Reviewed),Paula Gras-Valenti,COVID-19 Group of the Infections Commission,https://dx.doi.org/10.1016/j.eimc.2020.09.015,29/01/2021,16/07/2022,Verified
201228_Barcelona_InstitutCatalàdelaSalut_HCW_primary,28-Dec-20,Local,Spain,ESP,,Barcelona,04-May-20,22-May-20,Health care workers and caregivers,Multiple groups,7563,10.30%,,,Self-referral,"DiaSorin,Abbott Laboratories",Not reported,IgG,,,High,Journal Article (Peer-Reviewed),Jaume Barallat,Institut Català de la Salut,https://dx.doi.org/10.1371/journal.pone.0244348,30/01/2021,16/07/2022,Verified
201202_Tenerife_ QuironsaludTenerifeHospital_patients_primary,02-Dec-20,Local,Spain,ESP,Canary Islands,Tenerife,27-Apr-20,15-Jun-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,211,1.90%,0.07%,4.80%,Sequential,"NA,Roche Diagnostics",CLIA,Total Antibody,,,High,Journal Article (Peer-Reviewed),Alejandro Hernandez Camba, Quironsalud Tenerife Hospital,https://dx.doi.org/10.17235/reed.2020.7434/2020,31/01/2021,16/07/2022,Verified
201130_Madrid_UniversidadComplutensedeMadrid_primary,30-Nov-20,Local,Spain,ESP,,Madrid,28-Feb-20,10-May-20,Pregnant or parturient women,Adults (18-64 years),769,11.20%,,,Sequential,NA,ELISA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Cecilia Villalaın,The Universidad Complutense de Madrid,https://dx.doi.org/10.1371/journal.pone.0243029,31/01/2021,16/07/2022,Verified
210114_Fuenlabrada_HospitalUniversitariodeFuenlabrada_HCW_IgG,14-Jan-21,Local,Spain,ESP,,Fuenlabrada,14-Apr-20,13-May-20,Health care workers and caregivers,Adults (18-64 years),2439,16.90%,,,Convenience,Snibe Co. Ltd (Shenzhen New Industries Biomedical Engineering Co. Ltd),CLIA,IgG,100.00%,,High,Journal Article (Peer-Reviewed),Javier Fernandez,Hospital Universitario de Fuenlabrada,https://dx.doi.org/10.1371/journal.pone.0245001,04/02/2021,16/07/2022,Verified
210112_Spain_HMHospitales_overall,12-Jan-21,National,Spain,ESP,,,15-Apr-20,30-Jun-20,Health care workers and caregivers,Multiple groups,6038,11.00%,,,Convenience,Snibe Co. Ltd (Shenzhen New Industries Biomedical Engineering Co. Ltd),CLIA,IgG,91.21%,97.66%,Moderate,Journal Article (Peer-Reviewed),Jose Varona,HM Hospidales,https://dx.doi.org/10.1093/ije/dyaa277,06/02/2021,16/07/2022,Unverified
201221_Spain_HospitalClínicoUniversitarioLozanoBlesa,21-Dec-20,Local,Spain,ESP,Zaragoza,Zaragoza,27-Apr-20,29-May-20,Pregnant or parturient women,Adults (18-64 years),169,8.28%,,,Sequential,"Guangzhou Wondfo Biotech Co. Ltd,Abbott Laboratories,Vircell S.L.",LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),M Fabre,Hospital Clínico Universitario Lozano Blesa,https://dx.doi.org/10.1177/0004563220980495,07/02/2021,16/07/2022,Verified
210127_Madrid_UH-FundacionJimenezDiazUAM_primary,27-Jan-21,Local,Spain,ESP,Community of Madrid,Madrid,01-Mar-20,30-Mar-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,28,42.90%,,,Convenience,Vircell S.L.,ELISA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Maria Soledad Pizarro Sanchez,UH-Fundacion Jimenez Diaz UAM,https://dx.doi.org/10.1159/000512535,27/02/2021,16/07/2022,Verified
210209_Madrid_HospitalUniversitarioVirgendelRocio,09-Feb-21,Local,Spain,ESP,Community of Madrid,Madrid,15-Mar-20,15-May-20,Contacts of COVID patients,Children and Youth (0-17 years),113,41.60%,,,Convenience,Vircell S.L.,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Ana Mendez Echevarria,Hospital Universitario Virgen del Rocio,https://dx.doi.org/10.1097/INF.0000000000003088,11/03/2021,16/07/2022,Verified
210119_Madrid_HospitalInfantilUniversitarioNiñoJesús,19-Jan-21,Local,Spain,ESP,Community of Madrid,Madrid,13-Apr-20,30-Apr-20,Health care workers and caregivers,Adults (18-64 years),1292,17.20%,15.16%,19.35%,Convenience,Hanghzhou AllTest Biotech Co. Ltd,LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Eva Escribano Ceruelo,Hospital Infantil Universitario Niño Jesús,https://dx.doi.org/10.1016/j.eimc.2020.12.011,16/03/2021,16/07/2022,Verified
210318_Barcelona_UniversitatDeBarcelona_overall,08-Feb-21,Local,Spain,ESP,,Barcelona,15-Mar-20,31-May-20,Pregnant or parturient women,Adults (18-64 years),2225,14.10%,,,Sequential,"Vircell S.L.,Ortho Clinical Diagnostics Inc.,NA",Multiple Types,"IgG,IgA,IgM",,,High,Journal Article (Peer-Reviewed),Francesca Crovetto,Universitat de Barcelona,https://dx.doi.org/10.1093/cid/ciab104,18/03/2021,16/07/2022,Unverified
201218_Madrid_HospitalUniversitarioFundaciónAlcorcón_HCW_Overall,18-Dec-20,Local,Spain,ESP,,Madrid,14-Apr-20,27-Apr-20,Health care workers and caregivers,Adults (18-64 years),2590,31.60%,,,Convenience,Palex,ELISA,IgG,88.90%,91.80%,High,Journal Article (Peer-Reviewed),Isabel Galan,Hospital Universitario Fundación Alcorcón,https://dx.doi.org/10.1016/j.eimc.2020.11.015,24/03/2021,16/07/2022,Verified
210216_Alicante_UniversityofAlicante_overall_PopAdj_TestAdj,16-Feb-21,Local,Spain,ESP,Alicante,Alicante,06-Jul-20,22-Jul-20,Non-essential workers and unemployed persons,Adults (18-64 years),1479,2.89%,2.06%,3.73%,Stratified probability,Cellex Inc.,LFIA,"IgG,IgM",87.80%,99.90%,Moderate,Journal Article (Peer-Reviewed),Jose Tuells,University of Alicante,http://dx.doi.org/10.3390/ijerph18041908,27/03/2021,16/07/2022,Verified
210223_Barcelona_UniversitatDeBarcelona_primary,23-Feb-21,Local,Spain,ESP,,Barcelona,29-Sep-20,20-Oct-20,Health care workers and caregivers,Adults (18-64 years),507,16.40%,13.30%,19.90%,Simplified probability,NA,ELISA,"IgA,IgG,IgM",95.78%,100.00%,Moderate,Preprint,Natalia Ortega,Universitat de Barcelona ,https://www.medrxiv.org/content/10.1101/2021.02.22.21252150v1.full-text,31/03/2021,16/07/2022,Verified
210226_Mallorca_SonLlatzerUniversityHospital_overall,26-Feb-21,Local,Spain,ESP,,,28-Apr-20,11-Jun-20,Health care workers and caregivers,Adults (18-64 years),2210,2.80%,2.50%,3.10%,Convenience,Abbott Laboratories,CLIA,"IgG,IgM",96.70%,99.60%,Moderate,Journal Article (Peer-Reviewed),Adrian Rodriguez,Son Llatzer University Hospital,https://dx.doi.org/10.1016/j.ijid.2021.02.104,02/04/2021,16/07/2022,Verified
210316_Spain_HospitalUniversitarioPuertadeHierro_LymphomaPatients,16-Mar-21,National,Spain,ESP,,,22-May-20,11-Jun-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,150,6.00%,,,Convenience,NA,ELISA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Fernando Franco,Hospital Universitario Puerta de Hierro,https://dx.doi.org/10.3390/curroncol28020118,23/04/2021,16/07/2022,Unverified
210401_Madrid_HospitalUniversitarioRamonyCajal_HCW,01-Apr-21,Local,Spain,ESP,,Madrid,15-May-20,15-Jun-20,Health care workers and caregivers,Adults (18-64 years),5875,23.10%,22.10%,24.30%,Convenience,"Hanghzhou AllTest Biotech Co. Ltd,Vircell S.L.",ELISA,IgG,,,Unclear,Journal Article (Peer-Reviewed),Mario Rodriguez Dominguez,Hospital Universitario Ramon y Cajal,https://dx.doi.org/10.1016/j.cmi.2021.03.018,25/04/2021,16/07/2022,Unverified
200828_CendeadeCizur_ISGlobal_primary,28-Aug-20,Local,Spain,ESP,Navarra,Cendea de Cizur,01-Jun-20,30-Jun-20,Household and community samples,Multiple groups,728,7.90%,,,Unclear,NA,Not reported,"IgA,IgG,IgM",,,Unclear,News and Media,Barcelona Institute for Global Health,ISGlobla,https://www.isglobal.org/en_GB/-/coronavirus-nuevos-datos-de-seroprevalencia-para-un-municipio-en-navarra,30/04/2021,16/07/2022,Verified
210305_Madrid_UNIRHealthSciencesSchoolandMedicalCentre_firstwave_primary,01-Apr-21,Local,Spain,ESP,,Madrid,15-Mar-20,30-Jun-20,Residual sera,Multiple groups,968,12.60%,,,Sequential,PCL Inc,LFIA,Not reported,,,Moderate,Journal Article (Peer-Reviewed),Vicente Soriano,UNIR Health Sciences School and Medical Centre,https://dx.doi.org/10.1016/j.ijid.2021.02.115,18/05/2021,16/07/2022,Verified
210305_Madrid_UNIRHealthSciencesSchoolandMedicalCentre_secondwave_primary,01-Apr-21,Local,Spain,ESP,,Madrid,15-Sep-20,24-Dec-20,Residual sera,Multiple groups,601,7.70%,,,Sequential,PCL Inc,LFIA,Not reported,,,Moderate,Journal Article (Peer-Reviewed),Vicente Soriano,UNIR Health Sciences School and Medical Centre,https://dx.doi.org/10.1016/j.ijid.2021.02.115,18/05/2021,16/07/2022,Verified
210501_CastillaYLeon_CentroDeHemoterapiaYHemodonación,01-May-21,National,Spain,ESP,Castilla y Leon,,15-Jul-19,15-Oct-20,Blood donors,Multiple groups,9886,6.73%,,,Simplified probability,Roche Diagnostics,ELISA,Total Antibody,,,Moderate,Preprint,Carmen Martin,Centro de Hemoterapia y Hemodonación de Castilla y León,https://www.medrxiv.org/content/10.1101/2021.04.28.21256242v1,21/05/2021,16/07/2022,Verified
210301_Madrid_HospitalUniversitarioLaPaz_primary,01-Mar-21,Local,Spain,ESP,,Madrid,15-Mar-20,15-May-20,Health care workers and caregivers,Adults (18-64 years),105,5.70%,,,Convenience,NA,Not reported,Not reported,,,High,Journal Article (Peer-Reviewed),G Santos Simarro,Hospital Universitario La Paz,http://dx.doi.org/10.1097/01.pcc.0000741352.50491.98,22/05/2021,16/07/2022,Verified
210507_Salamanca_UniversityofSalamanca,07-May-21,Local,Spain,ESP,Province of Salamanca,Salamanca,15-Jul-20,15-Oct-20,Non-essential workers and unemployed persons,Multiple groups,8197,8.25%,,,Convenience,DiaSorin,ELISA,"IgG,IgM",,,High,Preprint,Vicente Santiago Belen,University of Salamanca,https://www.researchsquare.com/article/rs-489321/v1,22/05/2021,16/07/2022,Unverified
210415_MadridZaragoza_GeneralUniversityHospital_pregnant,15-Apr-21,Local,Spain,ESP,NA & Zaragoza,Madrid & Zaragoza,31-Mar-20,30-Sep-20,Pregnant or parturient women,Adults (18-64 years),1211,5.04%,,,Unclear,"Biozek,Abbott Laboratories,Vircell S.L.",Multiple Types,"IgG,IgM",,,Unclear,Journal Article (Peer-Reviewed),Ricardo Saviron Cornudella,University of Zaragoza,http://dx.doi.org/10.1016/j.lfs.2021.119200,23/05/2021,16/07/2022,Verified
210420_Barcelona_CIBERESP,20-Apr-21,Local,Spain,ESP,,Barcelona,29-Jun-20,31-Jul-20,Students and Daycares,Multiple groups,1518,3.22%,,,Convenience,NA,Multiple Types,"IgG,IgM,IgA",,,High,Preprint,Carlota Dobano,Consorcio de Investigación Biomédica en Red de Epidemiología y Salud Públic,10.1101/2021.04.20.440593,23/05/2021,16/07/2022,Unverified
210504_Madrid_HospitalGeneralUniversitarioLaPaz_LongTermCareResidents1,04-May-21,Local,Spain,ESP,,,07-Jul-20,23-Oct-20,Assisted living and long-term care facilities,Seniors (65+ years),9332,55.40%,54.40%,56.40%,Convenience,Abbott Laboratories,CLIA,IgG,100.00%,99.60%,Moderate,Journal Article (Peer-Reviewed),Francisco Candel,Hospital General Universitario La Paz,https://dx.doi.org/10.1093/ageing/afab096,28/05/2021,16/07/2022,Verified
210504_Madrid_HospitalGeneralUniversitarioLaPaz_LongTermCareWorkers2,04-May-21,Local,Spain,ESP,,,07-Jul-20,23-Oct-20,Health care workers and caregivers,Adults (18-64 years),10614,31.50%,30.60%,32.40%,Convenience,Abbott Laboratories,CLIA,IgG,100.00%,99.60%,Moderate,Journal Article (Peer-Reviewed),Francisco Candel,Hospital General Universitario La Paz,https://dx.doi.org/10.1093/ageing/afab096,28/05/2021,16/07/2022,Verified
210514_Madrid_HospitalUniversitarioLaPaz,14-May-21,Local,Spain,ESP,Madrid,Madrid,15-Sep-20,15-Feb-21,Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),105,20.00%,,,Convenience,NA,CLIA,IgG,,,High,Preprint,Clara Udaondo ,Hospital Universitario La Paz,https://www.researchsquare.com/article/rs-505561/v1,28/05/2021,16/07/2022,Verified
210510_Cantabria_UniversityofCantabria_Overall,10-May-21,Regional,Spain,ESP,Cantabria,NR,27-Apr-20,29-May-20,Household and community samples,Multiple groups,1022,3.10%,2.20%,4.40%,Stratified probability,Hangzhou Clongene Biotech Co. Ltd ,LFIA,IgG,97.40%,98.89%,Low,Journal Article (Peer-Reviewed),Paula Iruzubieta,University of Cantabria,https://dx.doi.org/10.1038/s41598-021-89236-x,31/05/2021,16/07/2022,Verified
210428_Europe_SorbonneUniversité_4ComunidaddeMadrid,28-Apr-21,Regional,Spain,ESP,Comunidad de Madrid,,07-Jul-20,08-Dec-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,524,13.40%,,,Convenience,"Abbott Laboratories,Siemens,DiaSorin,Beckman Coulter,Roche Diagnostics",Not reported,"IgG,IgM,IgA",,,High,Journal Article (Peer-Reviewed),David Saadoun,Sorbonne Université,https://dx.doi.org/10.1016/S2665-9913(21)00112-0,31/05/2021,16/07/2022,Verified
210403_Majadahonda_HospitalUniversitarioPuertaDeHierro_overall_Unadj,03-Apr-21,Local,Spain,ESP,,Municipality of Majadahonda,01-May-20,31-May-20,Health care workers and caregivers,Adults (18-64 years),50,12.00%,,,Convenience,Vircell S.L.,ELISA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Jesus Romero,Hospital Universitario Puerta de Hierro,10.5603/RPOR.a2021.0036,02/06/2021,16/07/2022,Unverified
210526_HospitalUniversitarioFundacionJimenezDiaz_Madrid_hcw,26-May-21,Local,Spain,ESP,,Madrid,06-Apr-20,25-Apr-20,Health care workers and caregivers,Multiple groups,5995,16.20%,,,Convenience,Biozek,LFIA,"IgM,IgG",,,Moderate,Journal Article (Peer-Reviewed),Fabian Vazquez Rivas,Fundación Jiménez Díaz University Hospital,https://dx.doi.org/10.1136/oemed-2020-107001,06/06/2021,16/07/2022,Unverified
210614_Barcelona_HospitalUniversitariValld’Hebron,14-Jun-21,Local,Spain,ESP,Province of Barcelona,Barcelona,10-May-20,26-Oct-20,Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),294,3.10%,,,Convenience,"Roche Diagnostics,DiaSorin",CLIA,"IgG,IgM,IgA",,,High,Journal Article (Peer-Reviewed),Isabel Campos-Varela,Hospital Universitari Vall d’Hebron,https://dx.doi.org/10.1111/tri.13946,21/06/2021,16/07/2022,Verified
210531_Madrid_CentroDeTransfusiónDeLaComunidadDeMadrid_overall,31-May-21,Local,Spain,ESP,,Madrid,01-Jan-20,22-Mar-20,Blood donors,Multiple groups,2419,0.08%,,,Sequential,Quotient ,Other,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),R. Alenda,Centro de Transfusión de la Comunidad de Madrid,http://dx.doi.org/10.1111/vox.13117,30/06/2021,16/07/2022,Verified
210617_Barcelona_UniversitatDeBarcelona_Overall_PopAdj,17-Jun-21,Local,Spain,ESP,Catalonia,Barcelona,14-Dec-20,25-Feb-21,Multiple populations,Adults (18-64 years),2775,14.16%,,,Stratified probability,Roche Diagnostics,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Sebastian Videla,Universitat de Barcelona,http://dx.doi.org/10.3390/ijerph18126526,01/07/2021,16/07/2022,Verified
210622_Madrid_HospitalCentralDeLaDefensaGomezUlla,22-Jun-21,Local,Spain,ESP,,Madrid,27-Apr-20,10-Jun-20,Health care workers and caregivers,Adults (18-64 years),2781,16.20%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Maria Simon Sacristan,Hospital Central de la Defensa Gómez Ulla,https://dx.doi.org/10.1007/s00284-021-02541-6,06/07/2021,16/07/2022,Unverified
210626_Spain_HospitalGregorioMaranon_popadj,26-Jun-21,National,Spain,ESP,,,01-Apr-20,30-Sep-20,Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),1076,8.10%,6.50%,10.00%,Convenience,Bio-rad,ELISA,"IgG,IgM,IgA",,,High,Journal Article (Peer-Reviewed),Juan Berenguer,Hospital Gregorio Maranon,https://dx.doi.org/10.1016/j.cmi.2021.06.023,07/07/2021,16/07/2022,Verified
210309_Madrid_FundacionRenalInigoAlvarezDeToledo,09-Mar-21,Local,Spain,ESP,,Madrid,01-Mar-20,15-Apr-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,672,15.02%,,,Convenience,Vircell S.L.,ELISA,"IgM,IgA",88.00%,99.00%,High,Journal Article (Peer-Reviewed),Roberto Alcazar Arroyo,Fundación Renal Íñigo Álvarez de Toledo,https://dx.doi.org/10.1093/ckj/sfab048,14/07/2021,16/07/2022,Unverified
201120_Barcelona_UniversityHospitalSantJoanDeDeuBarcelona_Children1,20-Nov-20,Local,Spain,ESP,,Barcelona,28-Apr-20,03-Jun-20,Household and community samples,Multiple groups,672,17.60%,14.80%,20.70%,Convenience,"Innovita Biological Technology Co. Ltd,Abbott Laboratories",ELISA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Pedro Brotons,University Hospital Sant Joan de Deu Barcelona,http://dx.doi.org/10.1093/cid/ciaa1721,20/07/2021,16/07/2022,Unverified
201120_Barcelona_UniversityHospitalSantJoanDeDeuBarcelona_Adults2,20-Nov-20,Local,Spain,ESP,,Barcelona,28-Apr-20,03-Jun-20,Household and community samples,Multiple groups,412,18.70%,15.00%,22.80%,Convenience,"Innovita Biological Technology Co. Ltd,Abbott Laboratories",ELISA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Pedro Brotons,University Hospital Sant Joan de Deu Barcelona,http://dx.doi.org/10.1093/cid/ciaa1721,20/07/2021,16/07/2022,Unverified
201029_Madrid_HospitalUniversitarioPríncipedeAsturias,29-Oct-20,Local,Spain,ESP,NR,Madrid,01-May-20,30-May-20,Health care workers and caregivers,Adults (18-64 years),2424,22.40%,,,Convenience,Hanghzhou AllTest Biotech Co. Ltd,LFIA,"IgG,IgM",88.00%,100.00%,High,Journal Article (Peer-Reviewed),Felipe Perez Garcia,Hospital Universitario Príncipe de Asturias,http://dx.doi.org/10.1017/ice.2020.1303,02/08/2021,16/07/2022,Verified
210528_Spain_InstitutodeInvestigacionesBiomédicasdeMálaga_Overall,28-May-21,National,Spain,ESP,,,21-Apr-20,03-Jun-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,1500,8.50%,7.20%,10.10%,Unclear,NA,Not reported,IgG,,,Unclear,Journal Article (Peer-Reviewed),Mariano Provencio,Instituto de Investigaciones Biomédicas de Málaga (IBIMA),https://ascopubs.org/doi/abs/10.1200/JCO.2021.39.15_suppl.8531,18/08/2021,16/07/2022,Verified
210817_Seville_HospitalUniversitarioVirgendeValme_HIV,17-Aug-21,Local,Spain,ESP,Andalusia,Seville,09-Feb-20,04-Mar-21,Patients seeking care for non-COVID-19 reasons,Multiple groups,707,7.50%,,,Convenience,Roche Diagnostics,CLIA,Total Antibody,99.50%,99.80%,Moderate,Journal Article (Peer-Reviewed),Marta Fernandez-Fuertes,Hospital Universitario Virgen de Valme,https://dx.doi.org/10.1111/tbed.14293,25/08/2021,16/07/2022,Unverified
210806_Barcelona_InstitutdeRecercaSantJoandeDéu,06-Aug-21,Local,Spain,ESP,Catalonia,Barcelona,01-Jun-20,30-Jun-20,Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),65,10.70%,7.00%,13.00%,Convenience,NA,Not reported,"IgG,IgM,IgA",,,High,Journal Article (Peer-Reviewed),Angela Deya-Martinez,Institut de Recerca Sant Joan de Déu,https://dx.doi.org/10.1016/j.clim.2021.108821,25/08/2021,16/07/2022,Unverified
210823_Madrid_HospitalUniversitarioPuertadeHierroMajadahonda_HCW,23-Aug-21,Local,Spain,ESP,Communidad de Madrid,Madrid,24-Apr-20,08-May-20,Health care workers and caregivers,Adults (18-64 years),4324,16.60%,15.50%,17.70%,Convenience,"Vircell S.L.,Roche Diagnostics",Multiple Types,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Mireia Cantero,Hospital Universitario Puerta de Hierro Majadahonda,https://dx.doi.org/10.1080/23744235.2021.1963468,31/08/2021,16/07/2022,Unverified
210826_Borriana_PublicHealthCenterOfCastellon_PrimaryIgG,26-Aug-21,Local,Spain,ESP,Castellon,Borriana,23-Jun-20,27-Jun-20,Household and community samples,Multiple groups,997,51.00%,,,Stratified probability,"Roche Diagnostics,Healgen",Multiple Types,IgG,,,Moderate,Journal Article (Peer-Reviewed),Salvador Domenech Montoliu,Public Health Center of Castellon,http://dx.doi.org/10.1371/journal.pone.0256747,08/09/2021,16/07/2022,Verified
211022_AlcaladeHenares_HospitalUniversitarioPríncipedeAsturias_primary,22-Oct-21,Local,Spain,ESP,Madrid,Alcala de Henares,01-May-20,31-Jul-20,Health care workers and caregivers,Adults (18-64 years),1339,22.63%,,,Convenience,"Hanghzhou AllTest Biotech Co. Ltd,Siemens,Vircell S.L.",Multiple Types,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Felipe Perez Garcia,Hospital Universitario Príncipede Asturias,https://pubmed.ncbi.nlm.nih.gov/34675168/,02/11/2021,16/07/2022,Unverified
211021_Spain_AlcalaUniversity_Students_Overall,21-Oct-21,Regional,Spain,ESP,"Community of Madrid, Community of Castilla-La Mancha","Madrid, Guadalajara",08-Jun-20,16-Jun-20,Students and Daycares,Adults (18-64 years),507,17.20%,,,Stratified probability,"Siemens,Vircell S.L.",CLIA,"IgG,IgM,IgA",,,High,Journal Article (Peer-Reviewed),Ramon Perez-Tanoira,Alcala University,https://dx.doi.org/10.2147/IJGM.S332803,04/11/2021,16/07/2022,Unverified
211021_Spain_AlcalaUniversity_TeachingStaff_Overall,21-Oct-21,Regional,Spain,ESP,"Community of Madrid, Community of Castilla-La Mancha","Madrid, Guadalajara",08-Jun-20,16-Jun-20,Essential non-healthcare workers,Multiple groups,132,25.80%,,,Stratified probability,"Siemens,Vircell S.L.",CLIA,"IgG,IgM,IgA",,,High,Journal Article (Peer-Reviewed),Ramon Perez-Tanoira,Alcala University,https://dx.doi.org/10.2147/IJGM.S332803,08/11/2021,16/07/2022,Unverified
211021_Spain_AlcalaUniversity_AdminStaff_Overall,21-Oct-21,Regional,Spain,ESP,"Community of Madrid, Community of Castilla-La Mancha","Madrid, Guadalajara",08-Jun-20,16-Jun-20,Essential non-healthcare workers,Multiple groups,66,13.60%,,,Stratified probability,"Siemens,Vircell S.L.",CLIA,"IgG,IgM,IgA",,,High,Journal Article (Peer-Reviewed),Ramon Perez-Tanoira,Alcala University,https://dx.doi.org/10.2147/IJGM.S332803,08/11/2021,16/07/2022,Unverified
211002_Madrid_HospitalLaPaz_Overall,02-Oct-21,Local,Spain,ESP,Community of Madrid,Madrid,26-Feb-21,26-Mar-21,Patients seeking care for non-COVID-19 reasons,Multiple groups,338,18.64%,,,Convenience,NA,ELISA,IgG,,,High,Presentation or Conference,M. Hernandez Perez,Hospital La Paz,http://dx.doi.org/10.1002/ueg2.12144,09/11/2021,16/07/2022,Unverified
211103_Madrid_LaPazUniversityHospitalInstituteforHealthResearch_Overall_Testadj,03-Nov-21,Local,Spain,ESP,Community of Madrid,Madrid,15-Apr-20,15-Jun-20,Multiple populations,Multiple groups,449,33.69%,29.27%,38.21%,Convenience,Durviz S.L.,LFIA,IgG,100.00%,98.00%,High,Journal Article (Peer-Reviewed),Patricia Torres Martinez,La Paz University Hospital Institute for Health Research,https://dx.doi.org/10.1038/s41598-021-00990-4,10/11/2021,16/07/2022,Unverified
211103_Catalonia_BarcelonaInstituteForGlobalHealth_adults_popadj,03-Nov-21,Regional,Spain,ESP,Catalonia,,30-Jun-20,15-Nov-20,Household and community samples,Multiple groups,4740,15.30%,,,Convenience,NA,CLIA,"IgG,IgA,IgM",95.78%,100.00%,High,Journal Article (Peer-Reviewed),Marianna Karachaliou,Barcelona Institute For Global Health,https://dx.doi.org/10.1038/s41598-021-00807-4,10/11/2021,16/07/2022,Verified
211103_Catalonia_BarcelonaInstituteForGlobalHealth_adolescents_unadj,03-Nov-21,Regional,Spain,ESP,Catalonia,,30-Jun-20,15-Nov-20,Household and community samples,Children and Youth (0-17 years),260,11.50%,,,Convenience,NA,CLIA,"IgG,IgA,IgM",95.78%,100.00%,High,Journal Article (Peer-Reviewed),Marianna Karachaliou,Barcelona Institute For Global Health,https://dx.doi.org/10.1038/s41598-021-00807-4,12/11/2021,16/07/2022,Verified
211117_Catalonia_BarcelonaInstituteforGlobalHealth_Overall,17-Nov-21,Regional,Spain,ESP,Catalonia,,17-May-20,15-Nov-20,Household and community samples,Adults (18-64 years),4103,18.11%,,,Convenience,NA,Luminex,"IgM,IgA,IgG",95.78%,100.00%,Moderate,Journal Article (Peer-Reviewed),Manolis Kogevinas,Barcelona Institute for Global Health,https://dx.doi.org/10.1289/EHP9726,24/11/2021,16/07/2022,Verified
220117_GranCanaria_InstitutoUniversitariodeInvestigacionesBiomédicasySanitarias,17-Jan-22,Regional,Spain,ESP,Las Palmas,Gran Canaria,15-Oct-20,15-Aug-21,Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),33,3.03%,,,Entire sample,NA,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),Yeray Novoa-Medina,Instituto Universitario de Investigaciones Biomédicas y Sanitarias (IUIBS),https://pubmed.ncbi.nlm.nih.gov/35026884/,23/01/2022,16/07/2022,Unverified
220209_Madrid_CityofMadrid_Overall,09-Feb-22,Local,Spain,ESP,,Madrid,15-Jun-20,15-Oct-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,473,5.10%,,,Convenience,JOYSBIO,LFIA,"IgG,IgM",94.00%,97.00%,High,Journal Article (Peer-Reviewed),Jose Olalla,City of Madrid,https://www.sanidad.gob.es/biblioPublic/publicaciones/recursos_propios/resp/revista_cdrom/VOL96/ORIGINALES/RS96C_202202014.pdf,14/02/2022,16/07/2022,Unverified
220204_Catalonia_TransfusionSafetyLaboratory_24Feb-9Mar_TestAdj,04-Feb-22,Regional,Spain,ESP,"The 4 provinces inside Catalonia (Barcelona, Tarragona, Girona, and Lleida).",,24-Feb-20,09-Mar-20,Blood donors,Multiple groups,10170,0.00%,,,Sequential,Beijing Wantai Biological,ELISA,Total Antibody,95.00%,99.50%,High,Journal Article (Peer-Reviewed),Maria Piron,Transfusion Safety Laboratory,https://dx.doi.org/10.2450/2022.0232-21,25/02/2022,16/07/2022,Unverified
220204_Catalonia_TransfusionSafetyLaboratory_16May-3Jun_TestAdj,04-Feb-22,Regional,Spain,ESP,"The 4 provinces inside Catalonia (Barcelona, Tarragona, Girona, and Lleida).",,16-May-20,03-Jun-20,Blood donors,Multiple groups,3867,5.42%,4.47%,6.48%,Sequential,"EUROIMMUN,Beijing Wantai Biological",ELISA,"IgG,Total Antibody",,,High,Journal Article (Peer-Reviewed),Maria Piron,Transfusion Safety Laboratory,https://dx.doi.org/10.2450/2022.0232-21,25/02/2022,16/07/2022,Unverified
220204_Catalonia_TransfusionSafetyLaboratory_4Jun-17Jun_TestAdj,04-Feb-22,Regional,Spain,ESP,"The 4 provinces inside Catalonia (Barcelona, Tarragona, Girona, and Lleida).",,04-Jun-20,17-Jun-20,Blood donors,Multiple groups,2962,5.65%,4.81%,6.60%,Sequential,Beijing Wantai Biological,ELISA,Total Antibody,95.00%,99.50%,High,Journal Article (Peer-Reviewed),Maria Piron,Transfusion Safety Laboratory,https://dx.doi.org/10.2450/2022.0232-21,25/02/2022,16/07/2022,Unverified
220309_Barcelona_HospitaldelaSantaCreuiSantPau_Overall,09-Mar-22,Local,Spain,ESP,,Barcelona,01-Mar-20,31-May-20,Pregnant or parturient women,Adults (18-64 years),817,15.20%,,,Sequential,"Vircell S.L.,Ortho Clinical Diagnostics Inc.,Luminex Corporation",Multiple Types,"IgG,IgM,IgA",,,High,Journal Article (Peer-Reviewed),Cristina Trilla,Hospital de la Santa Creu i Sant Pau,https://dx.doi.org/10.1159/000523974,15/03/2022,16/07/2022,Unverified
220311_Spain_InstitutodeSaludCarlosIII_AntiRBD,11-Mar-22,National,Spain,ESP,,,16-Nov-20,29-Nov-20,Household and community samples,Multiple groups,5827,5.40%,4.80%,6.00%,Simplified probability,Beckman Coulter,CLIA,IgG,98.80%,100.00%,Low,Journal Article (Peer-Reviewed),Mayte Perez-Olmeda,Instituto de Salud Carlos III,https://www.sciencedirect.com/science/article/pii/S138665322200066X,30/03/2022,16/07/2022,Verified
220302_Madrid_UniversidadReyJuanCarlos_Residents,02-Mar-22,Local,Spain,ESP,,Madrid,15-Jul-20,15-Oct-20,Assisted living and long-term care facilities,Seniors (65+ years),1218,50.00%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Jesus San Roman,Universidad Rey Juan Carlos,https://dx.doi.org/10.3390/vaccines10030383,04/04/2022,16/07/2022,Unverified
220302_Madrid_UniversidadReyJuanCarlos_Staff,02-Mar-22,Local,Spain,ESP,,Madrid,15-Jul-20,15-Oct-20,Assisted living and long-term care facilities,Adults (18-64 years),755,35.90%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Jesus San Roman,Universidad Rey Juan Carlos,https://dx.doi.org/10.3390/vaccines10030383,04/04/2022,16/07/2022,Unverified
220408_Spain_Osakidetza_Patients,08-Apr-22,Local,Spain,ESP,Biscay,,04-May-20,18-May-20,Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),189,1.10%,,,Convenience,NA,Not reported,"IgG,IgM",,,,Presentation or Conference,Barrenetxea Ziarrusta G,Osakidetza,https://academic.oup.com/humrep/article/35/Supplement_1/i1/5867890?searchresult=1&login=true,11/04/2022,16/07/2022,Unverified
220709_Spain_IVIRMA_IgG,09-Jul-20,National,Spain,ESP,,,27-Apr-20,19-May-20,Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),1549,3.81%,,,Unclear,"Epitope Diagnostics, Inc.",ELISA,IgG,,,Unclear,Presentation or Conference,C Gonzalez-Ravina,IVIRMA Global,https://academic.oup.com/humrep/article/35/Supplement_1/i1/5867890?searchresult=1&login=true,11/04/2022,16/07/2022,Unverified
220411_Madrid_HospitalGeneralUniversitarioGregorioMaranon_Residents_Overall,11-Apr-22,Local,Spain,ESP,,Madrid,18-Apr-20,20-Jun-20,Assisted living and long-term care facilities,Seniors (65+ years),942,70.60%,,,Self-referral,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Pilar Escribano,Hospital General Universitario Gregorio Maranon,https://dx.doi.org/10.37201/req/008.2022,21/04/2022,16/07/2022,Unverified
220411_Madrid_HospitalGeneralUniversitarioGregorioMaranon_Staff_Overall,11-Apr-22,Local,Spain,ESP,,Madrid,18-Apr-20,20-Jun-20,Assisted living and long-term care facilities,Adults (18-64 years),846,47.00%,,,Self-referral,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Pilar Escribano,Hospital General Universitario Gregorio Maranon,https://dx.doi.org/10.37201/req/008.2022,21/04/2022,16/07/2022,Unverified
20220418_Catalonia_InstitutodeSaludGlobalBarcelona_Primary,18-Apr-22,Regional,Spain,ESP,Catalonia,,26-May-21,21-Jul-21,Blood donors,Multiple groups,1076,92.57%,,,Convenience,NA,Other,"IgG,IgM,IgA",95.78%,100.00%,Moderate,Preprint,Marianna Karachaliou,Instituto de Salud Global Barcelona,doi.org/10.21203/rs.3.rs-1536936/v1,26/04/2022,16/07/2022,Unverified
220421_Catalonia_HospitalUniversitarideBellvitge,21-Apr-22,Regional,Spain,ESP,"Catalonia Region (Four provinces: Barcelona, Girona, Lleida, and Tarragona)",,21-May-20,26-Jun-20,Health care workers and caregivers,Adults (18-64 years),1235,8.91%,7.44%,10.63%,Convenience,"DiaSorin,Abbott Laboratories",CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Paula Peremiquel-Trillas,Hospital Universitari de Bellvitge,https://dx.doi.org/10.1136/bmjopen-2021-056637,04/05/2022,16/07/2022,Unverified
210430_Madrid_LaPazUniversityHospital,30-Apr-22,Local,Spain,ESP,Community of Madrid,Madrid,15-Sep-20,15-Feb-21,Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),105,20.00%,,,Convenience,Vircell S.L.,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Clara Udaondo,La Paz University Hospital,https://dx.doi.org/10.1007/s10067-022-06186-z,09/05/2022,16/07/2022,Verified
220429_HospitalUniversitarioArnaudeVilanova_IRBLleida_Overall,29-Apr-22,Local,Spain,ESP,Lleida,Lleida,15-Mar-20,15-Sep-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,259,20.46%,,,Convenience,Diagnostic Bioprobes,ELISA,"IgG,IgM,IgA",,,High,Journal Article (Peer-Reviewed),Agustin Sancho-Saldana,IRB Leida,https://dx.doi.org/10.3390/jcm11092509,10/05/2022,16/07/2022,Unverified
220602_Catalonia_InstitutCataladeLaSalut_Stage1_OverallCrude,02-Jun-22,Local,Spain,ESP,Catalonia,Vilanova del Camí,01-Oct-20,31-Oct-20,Household and community samples,Multiple groups,691,12.16%,,,Convenience,Salofa Oy,Not reported,IgG,93.70%,99.90%,Moderate,Journal Article (Peer-Reviewed),Sandra Moreno,Institut Catala de La Salut,https://doi.org/10.1038/s41598-022-13290-2,08/06/2022,16/07/2022,Unverified
220602_Catalonia_InstitutCataladeLaSalut_Stage2_OverallCrude,02-Jun-22,Local,Spain,ESP,Catalonia,Vilanova del Camí,01-Dec-20,31-Dec-20,Household and community samples,Multiple groups,1479,8.38%,,,Convenience,Salofa Oy,Not reported,IgG,93.70%,99.90%,Moderate,Journal Article (Peer-Reviewed),Sandra Moreno,Institut Catala de La Salut,https://doi.org/10.1038/s41598-022-13290-2,08/06/2022,16/07/2022,Unverified
220610_Madrid_HospitalUniversitarioRamonyCajal_Overall,10-Jun-22,Local,Spain,ESP,,Madrid,15-Apr-20,15-May-20,Health care workers and caregivers,Adults (18-64 years),4943,21.40%,,,Convenience,Vircell S.L.,ELISA,"IgG,IgM,IgA",,,High,Journal Article (Peer-Reviewed),Jose Casado,Hospital Universitario Ramón y Cajal,https://dx.doi.org/10.3390/jcm11123352,21/06/2022,16/07/2022,Unverified
220613_HospitalUniversitarioRamónYCajal_Madrid,13-Jun-22,Local,Spain,ESP,,Madrid,15-Apr-20,22-Dec-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,152,25.70%,,,Sequential,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Antia Garcia-Fernandez,Hospital Universitario Ramón y Cajal,https://dx.doi.org/10.1097/RHU.0000000000001876,24/06/2022,16/07/2022,Unverified
220527_ArgandaDelRey_ComplutenseUniversityofMadrid,27-May-22,Local,Spain,ESP,,Arganda del Rey,18-Jan-21,18-Mar-21,Household and community samples,Multiple groups,13590,24.20%,,,Simplified probability,Zhejiang Orient Gene Biotech,LFIA,IgG,97.20%,100.00%,Moderate,Journal Article (Peer-Reviewed),Kora-Mareen Buhler,Complutense University of Madrid,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9137247/,29/06/2022,16/07/2022,Unverified
220624_Spain_EmiratesSpecialityHospitalDubai,24-Jun-22,National,Spain,ESP,,,01-Jul-20,31-Jul-20,Residual sera,Children and Youth (0-17 years),233,7.30%,,,Convenience,Palex,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Zarife Perez,Emirates Speciality Hospital Dubai,https://dx.doi.org/10.1111/jpc.16068,12/07/2022,16/07/2022,Unverified
220624_Barcelona_GermansTriasiPujolHospital,24-Jun-22,Local,Spain,ESP,Catalonia,Barcelona,01-Jun-21,31-Aug-21,Health care workers and caregivers,Adults (18-64 years),5000,98.04%,,,Convenience,DiaSorin,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Gema Fernandez-Rivas,Germans Trias i Pujol Hospital,https://dx.doi.org/10.3390/v14071385,13/07/2022,16/07/2022,Unverified
220719_Valencia_INCLIVAHealthResearchInstitute_Age_0-9,19-Jul-22,Local,Spain,ESP,,Valencia,01-Apr-22,30-Apr-22,Household and community samples,Multiple groups,40,80.00%,67.00%,93.00%,Convenience,NA,CLIA,Not reported,,,High,Preprint,Jorge Camacho,INCLIVA Health Research Institute,10.1101/2022.07.19.22277747,28/07/2022,28/07/2022,Unverified
220719_Valencia_INCLIVAHealthResearchInstitute_Age_20-34,19-Jul-22,Local,Spain,ESP,,Valencia,01-Apr-22,30-Apr-22,Household and community samples,Multiple groups,150,97.30%,94.70%,99.90%,Convenience,NA,CLIA,Not reported,,,High,Preprint,Jorge Camacho,INCLIVA Health Research Institute,10.1101/2022.07.19.22277747,28/07/2022,28/07/2022,Unverified
220719_Valencia_INCLIVAHealthResearchInstitute_Age_10-19,19-Jul-22,Local,Spain,ESP,,Valencia,01-Apr-22,30-Apr-22,Household and community samples,Multiple groups,87,98.80%,96.60%,100.00%,Convenience,NA,CLIA,Not reported,,,High,Preprint,Jorge Camacho,INCLIVA Health Research Institute,10.1101/2022.07.19.22277747,28/07/2022,28/07/2022,Unverified
220719_Valencia_INCLIVAHealthResearchInstitute_Age_50-64,19-Jul-22,Local,Spain,ESP,,Valencia,01-Apr-22,30-Apr-22,Household and community samples,Multiple groups,173,98.30%,96.30%,100.00%,Convenience,NA,CLIA,Not reported,,,High,Preprint,Jorge Camacho,INCLIVA Health Research Institute,10.1101/2022.07.19.22277747,28/07/2022,28/07/2022,Unverified
220719_Valencia_INCLIVAHealthResearchInstitute_Age_65-79,19-Jul-22,Local,Spain,ESP,,Valencia,01-Apr-22,30-Apr-22,Household and community samples,Multiple groups,159,98.70%,97.00%,100.00%,Convenience,NA,CLIA,Not reported,,,High,Preprint,Jorge Camacho,INCLIVA Health Research Institute,10.1101/2022.07.19.22277747,28/07/2022,28/07/2022,Unverified
220719_Valencia_INCLIVAHealthResearchInstitute_Age_35-49,19-Jul-22,Local,Spain,ESP,,Valencia,01-Apr-22,30-Apr-22,Household and community samples,Multiple groups,181,98.30%,96.50%,100.00%,Convenience,NA,CLIA,Not reported,,,High,Preprint,Jorge Camacho,INCLIVA Health Research Institute,10.1101/2022.07.19.22277747,28/07/2022,28/07/2022,Unverified
220719_Valencia_INCLIVAHealthResearchInstitute_Age_80+,19-Jul-22,Local,Spain,ESP,,Valencia,01-Apr-22,30-Apr-22,Household and community samples,Multiple groups,141,97.20%,94.30%,99.90%,Convenience,NA,CLIA,Not reported,,,High,Preprint,Jorge Camacho,INCLIVA Health Research Institute,10.1101/2022.07.19.22277747,28/07/2022,28/07/2022,Unverified
220719_Valencia_INCLIVAHealthResearchInstitute_Overall_PopAdj,19-Jul-22,Local,Spain,ESP,,Valencia,01-Apr-22,30-Apr-22,Household and community samples,Multiple groups,931,96.70%,95.50%,97.80%,Convenience,NA,CLIA,Not reported,,,High,Preprint,Jorge Camacho,INCLIVA Health Research Institute,10.1101/2022.07.19.22277747,28/07/2022,29/07/2022,Unverified
220726_Spain_DiputaciónDeAlbacete_Employees,26-Jul-22,Local,Spain,ESP,Castilla-la Mancha,Albacete,15-Jun-20,18-Dec-20,Health care workers and caregivers,Multiple groups,255,24.00%,,,Unclear,Abbott Laboratories,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),Sergio Salmerón,"Universidad de Castilla-La Mancha, ",https://dx.doi.org/10.3390/geriatrics7040078,05/08/2022,06/08/2022,Unverified
220726_Spain_DiputaciónDeAlbacete_Residents,26-Jul-22,Local,Spain,ESP,Castilla-la Mancha,Albacete,15-Jun-20,18-Dec-20,Assisted living and long-term care facilities,Multiple groups,107,51.40%,,,Unclear,Abbott Laboratories,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),Sergio Salmerón,"Universidad de Castilla-La Mancha, ",https://dx.doi.org/10.3390/geriatrics7040078,05/08/2022,06/08/2022,Unverified
210427_Juba_WorldHealthOrganization_Overall_PopTestAdj,27-Apr-21,Local,South Sudan,SSD,Central Equatoria,Juba,10-Aug-20,11-Sep-20,Household and community samples,Multiple groups,2214,38.30%,,,Stratified probability,NA,ELISA,IgG,65.50%,100.00%,Moderate,Journal Article (Peer-Reviewed),Kirsten E Wiens,World Health Organization,https://dx.doi.org/10.3201/eid2706.210568,02/06/2021,16/07/2022,Verified
200928_CapeTown_UniversityofCapeTown_overall_testadj,20-Sep-20,Local,South Africa,ZAF,,Cape Town,15-Jun-20,07-Aug-20,Residual sera,Adults (18-64 years),2791,44.60%,42.60%,46.60%,Sequential,Roche Diagnostics,CLIA,"IgG,IgM",91.20%,99.70%,High,Institutional Report,Marvin Hsiao, University of Cape Town,https://www.nicd.ac.za/wp-content/uploads/2020/09/COVID-19-Special-Public-Health-Surveillance-Bulletin_Issue-5.pdf,03/03/2021,16/07/2022,Verified
210107_CapeTown_UniversityCollegeLondon_PaediatricHCW,27-Jan-21,Local,South Africa,ZAF,NR,Capetown,10-Jun-20,17-Aug-20,Health care workers and caregivers,Adults (18-64 years),222,10.36%,7.00%,15.07%,Convenience,"Epitope Diagnostics, Inc.,Meso Scale Discovery",ELISA,IgG,,,High,Journal Article (Peer-Reviewed),D Goldblatt,University College London,http://dx.doi.org/10.1016/j.jhin.2020.12.019,13/03/2021,16/07/2022,Verified
210225_CapeTown_StellenboschUniversity_Overall,25-Feb-21,Local,South Africa,ZAF,,Cape Town,17-Aug-20,04-Sep-20,Essential non-healthcare workers,Adults (18-64 years),405,23.70%,,,Convenience,Abbott Laboratories,CLIA,IgG,,98.54%,High,Journal Article (Peer-Reviewed),Jane Shaw,Stellenbosch University,https://dx.doi.org/10.1371/journal.pone.0247852,27/03/2021,16/07/2022,Verified
210505_Johannesburg_UniversityoftheWitwatersrand,05-May-21,Local,South Africa,ZAF,Gauteng Province,Johannesburg,22-Apr-20,15-Sep-20,Health care workers and caregivers,Adults (18-64 years),395,41.30%,,,Convenience,NA,ELISA,IgG,100.00%,100.00%,High,Journal Article (Peer-Reviewed),Marta Nunes,University of the Witwatersrand,https://dx.doi.org/10.1093/cid/ciab398,29/05/2021,16/07/2022,Verified
210706_SouthAfrica_SouthAfricanNationalBloodService_Overall_PopAdj,06-Jul-21,National,South Africa,ZAF,,,15-Jan-21,15-May-21,Blood donors,Multiple groups,16762,47.40%,46.20%,48.60%,Sequential,Roche Diagnostics,CLIA,Total Antibody,100.00%,99.50%,Low,Preprint,Marion Vermeulen,South African National Blood Service,https://assets.researchsquare.com/files/rs-690372/v2_covered.pdf?c=1627923426,13/07/2021,16/07/2022,Verified
211030_Gauteng_UniversityoftheWitwatersrand_Primary,30-Oct-21,Regional,South Africa,ZAF,Gauteng,,04-Nov-20,22-Jan-21,Household and community samples,Multiple groups,5584,19.10%,18.10%,20.10%,Stratified probability,NA,Not reported,IgG,,,Moderate,Journal Article (Peer-Reviewed),Portia Chipo Mutevedzi,University of the Witwatersrand,https://dx.doi.org/10.1093/ije/dyab217,09/11/2021,16/07/2022,Verified
211105_Gauteng_NationalHealthLaboratoryService_OverallFullAdjust,05-Nov-21,Regional,South Africa,ZAF,Gauteng,,01-Aug-20,31-Oct-20,Residual sera,Multiple groups,6477,27.80%,,,Convenience,Roche Diagnostics,CLIA,IgG,93.00%,99.00%,Moderate,Journal Article (Peer-Reviewed),Jaya George,National Health Laboratory Service,https://doi.org/10.7196/SAMJ.2021.v111i11.15669,07/12/2021,16/07/2022,Unverified
220215_SouthAfrica_StellenboschUniversity,15-Feb-22,National,South Africa,ZAF,"Eastern Cape, Free state, Gauteng, Limpopo, Mpulanga, Northern Cape, North West, KwaZulu Natal",,08-Nov-21,12-Nov-21,Blood donors,Multiple groups,3395,71.10%,68.80%,73.50%,Convenience,Roche Diagnostics,CLIA,Total Antibody,99.50%,100.00%,Moderate,Preprint,Russel Cable,Stellenbosch University,https://www.researchsquare.com/article/rs-1359658/v1,24/02/2022,16/07/2022,Unverified
220223_GautengProvince_UniversityoftheWitwatersrand_Overall,23-Feb-22,Regional,South Africa,ZAF,Gauteng,,22-Oct-21,09-Dec-21,Household and community samples,Multiple groups,7010,73.10%,72.00%,74.10%,Stratified probability,NA,Not reported,IgG,,,Moderate,Journal Article (Peer-Reviewed),Shabir Madhi,University of the Witwatersrand,https://doi.org/10.1056/nejmoa2119658,03/03/2022,16/07/2022,Unverified
220318_EasternCape_WalterSisuluUniversity_Primary,18-Mar-22,Regional,South Africa,ZAF,Eastern Cape,,04-Nov-20,18-Dec-20,Health care workers and caregivers,Adults (18-64 years),1295,37.70%,,,Stratified probability,NA,Not reported,IgG,,,Moderate,Journal Article (Peer-Reviewed),David Stead,Walter Sisulu University,https://dx.doi.org/10.1136/bmjopen-2021-058761,29/03/2022,16/07/2022,Unverified
220323_SouthAfrica_NationalHealthLaboratoryService_Urban_BD9_TestAdj,23-Mar-22,Local,South Africa,ZAF,North West Province,Matlosana Municipality,15-Nov-21,27-Nov-21,Household and community samples,Multiple groups,479,70.00%,66.00%,74.00%,Simplified probability,Roche Diagnostics,CLIA,Not reported,,,Moderate,Journal Article (Peer-Reviewed),Jackie Kleynhans,National Health Laboratory Service,https://dx.doi.org/10.3201/eid2805.220278,31/03/2022,16/07/2022,Verified
220323_SouthAfrica_NationalHealthLaboratoryService_Rural_BD9_TestAdj,23-Mar-22,Local,South Africa,ZAF,Mpumalanga Province,Bushbuckridge Municipality,15-Nov-21,27-Nov-21,Household and community samples,Multiple groups,550,60.00%,56.00%,64.00%,Simplified probability,Roche Diagnostics,CLIA,Not reported,,,Moderate,Journal Article (Peer-Reviewed),Jackie Kleynhans,National Health Laboratory Service,https://dx.doi.org/10.3201/eid2805.220278,31/03/2022,16/07/2022,Verified
220310_SouthAfrica_NationalHealthLaboratoryService_Overall,10-Mar-22,National,South Africa,ZAF,"KwaZulu-Natal, North West Province, Western Cape","Pietermaritzburg, Klerksdorp, Mitchell's Plain",15-Nov-20,15-Apr-21,Multiple general populations,Multiple groups,7577,45.23%,43.70%,46.70%,Stratified probability,"Beijing Wantai Biological,Roche Diagnostics",ELISA,Total Antibody,,,Moderate,Journal Article (Peer-Reviewed),Nicole Wolter,National Health Laboratory Service,https://dx.doi.org/10.1093/cid/ciac198,04/04/2022,16/07/2022,Unverified
220526_SouthAfrica_StellenboschUniversity_Spike,26-May-22,National,South Africa,ZAF,,,08-Mar-22,22-Mar-22,Blood donors,Multiple groups,3395,97.20%,96.50%,98.00%,Convenience,Roche Diagnostics,CLIA,Total Antibody,99.50%,100.00%,Moderate,Preprint,Jeremy Bingham,Stellenbosch University,https://doi.org/10.21203/rs.3.rs-1687679/v2,04/06/2022,16/07/2022,Unverified
220531_Klerksdorp_UniversityofWitwatersrand,31-May-22,Local,South Africa,ZAF,North West Province,Klerksdorp,15-Jul-20,15-Aug-21,Household and community samples,Multiple groups,501,55.70%,,,Convenience,Roche Diagnostics,CLIA,Not reported,,,High,Journal Article (Peer-Reviewed),Kaiyuan Sun,University of Witwatersrand,https://doi.org/10.1126/scitranslmed.abo7081,10/06/2022,16/07/2022,Unverified
220331_SouthAfrica_HumanSciencesResearchCouncil,31-Mar-22,National,South Africa,ZAF,,,15-Nov-20,15-Jun-21,Household and community samples,Multiple groups,13640,19.60%,17.90%,21.30%,Convenience,"EUROIMMUN,Abbott Laboratories",Multiple Types,Not reported,,,High,Presentation or Conference,Leickness Simbayi,Human Sciences Research Council,https://www.iasusa.org/tam/march-2022/,15/06/2022,16/07/2022,Unverified
220301_SouthAfrica_UniversityOfCapeTown,01-Mar-22,National,South Africa,ZAF,,,15-Apr-21,15-Jun-21,Household and community samples,Multiple groups,8146,6.27%,,,Unclear,"Abbott Laboratories,EUROIMMUN,Roche Diagnostics",CLIA,IgG,,,Unclear,Journal Article (Peer-Reviewed),Sizulu Moyo,University of Cape Town,https://www.iasusa.org/tam/march-2022/,17/06/2022,16/07/2022,Unverified
220413_Gugulethu_ICGEB_Primary,13-Apr-22,Local,South Africa,ZAF,Western Cape,Gugulethu,15-Oct-20,15-Jun-21,Representative patient population,Adults (18-64 years),150,70.70%,,,Sequential,NA,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Humaira Lambarey,International Centre for Genetic Engineering and Biotechnology,https://dx.doi.org/10.3390/v14061222,27/06/2022,16/07/2022,Unverified
220621_Drakenstein_UniversityCollegeLondon_Wave1,21-Jun-22,Local,South Africa,ZAF,,Drakenstein,08-Jun-20,30-Aug-20,Residual sera,Adults (18-64 years),339,51.90%,,,Convenience,Meso Scale Discovery,Not reported,IgG,,,High,Preprint,Heather Zar,University College London,https://doi.org/10.1101/2022.06.20.22276647,09/07/2022,16/07/2022,Unverified
220621_Drakenstein_UniversityCollegeLondon_Wave2,21-Jun-22,Local,South Africa,ZAF,,Drakenstein,23-Nov-20,07-Feb-21,Residual sera,Adults (18-64 years),337,74.30%,,,Convenience,Meso Scale Discovery,Not reported,IgG,,,High,Preprint,Heather Zar,University College London,https://doi.org/10.1101/2022.06.20.22276647,09/07/2022,16/07/2022,Unverified
220621_Drakenstein_UniversityCollegeLondon_Wave3,21-Jun-22,Local,South Africa,ZAF,,Drakenstein,10-May-21,19-Sep-21,Residual sera,Adults (18-64 years),244,89.80%,,,Convenience,Meso Scale Discovery,Not reported,IgG,,,High,Preprint,Heather Zar,University College London,https://doi.org/10.1101/2022.06.20.22276647,09/07/2022,16/07/2022,Unverified
220621_Drakenstein_UniversityCollegeLondon_Wave4,21-Jun-22,Local,South Africa,ZAF,,Drakenstein,08-Nov-21,23-Jan-22,Residual sera,Adults (18-64 years),185,97.30%,,,Convenience,Meso Scale Discovery,Not reported,IgG,,,High,Preprint,Heather Zar,University College London,https://doi.org/10.1101/2022.06.20.22276647,09/07/2022,16/07/2022,Unverified
220715_Gauteng_UniversityOfTheWitwatersrand_Primary,15-Jul-22,Regional,South Africa,ZAF,Gauteng,,01-Mar-22,11-Apr-22,Household and community samples,Multiple groups,7510,90.90%,90.20%,91.50%,Stratified probability,NA,Other,IgG,,,Low,Preprint,Shabir A. Madhi,University of the Witwatersrand ,10.1101/2022.07.13.22277575,25/07/2022,25/07/2022,Unverified
220130_Benadir_SIMADUniversity_Overall,30-Jan-22,Regional,Somalia,SOM,Benadir region,,19-May-21,29-Jul-21,Household and community samples,Multiple groups,2400,44.80%,,,Stratified non-probability,Guangzhou Wondfo Biotech Co. Ltd,LFIA,"IgG,IgM",87.12%,99.74%,Moderate,Journal Article (Peer-Reviewed),Mohamed Adam,SIMAD University,https://dx.doi.org/10.3390/vaccines10020220,14/02/2022,16/07/2022,Unverified
220609_Mogadishu_SIMADUniversity,09-Jun-22,Local,Somalia,SOM,Banaadir,Mogadishu,31-Jul-21,31-Aug-21,Pregnant or parturient women,Multiple groups,477,36.70%,,,Convenience,"CTK Biotech, Inc.",LFIA,"IgG,IgM",97.10%,97.80%,High,Journal Article (Peer-Reviewed),Maryan Nur,SIMAD University,https://dx.doi.org/10.1136/bmjopen-2021-059617,21/06/2022,16/07/2022,Unverified
210407_Slovenia_UniversityofLjubljana_FirstRound_GenPop_ElecsysTestAdj,07-Apr-21,National,Slovenia,SVN,,,20-Apr-20,01-May-20,Household and community samples,Multiple groups,1316,0.87%,0.40%,1.38%,Simplified probability,Roche Diagnostics,CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Mario Poljak ,University of Ljubljana,https://dx.doi.org/10.1016/j.cmi.2021.03.009,20/05/2021,16/07/2022,Verified
210407_Slovenia_UniversityofLjubljana_SecondRound_Nov,07-Apr-21,National,Slovenia,SVN,,,17-Oct-20,10-Nov-20,Household and community samples,Multiple groups,1211,4.29%,3.18%,5.47%,Simplified probability,Roche Diagnostics,CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Mario Poljak ,University of Ljubljana,https://dx.doi.org/10.1016/j.cmi.2021.03.009,05/08/2021,16/07/2022,Verified
220715_Slovenia_NationalInstituteofPublicHealth_Overall,15-Jul-22,National,Slovenia,SVN,,,15-Nov-20,15-Dec-20,Health care workers and caregivers,Adults (18-64 years),813,20.40%,,,Convenience,EUROIMMUN,ELISA,IgG,100.00%,97.70%,High,Journal Article (Peer-Reviewed),Maja Socan,National Laboratory for Health,https://dx.doi.org/10.13075/ijomeh.1896.01932,28/07/2022,28/07/2022,Unverified
211116_Bratislava_SlovakAcademyOfSciences,16-Nov-21,Local,Slovakia,SVK,,Bratislava,01-Jul-21,15-Aug-21,Non-essential workers and unemployed persons,Multiple groups,1928,84.13%,,,Convenience,EUROIMMUN,ELISA,IgG,94.40%,99.60%,Moderate,Journal Article (Peer-Reviewed),Ivana Kajanova,Slovak Academy Of Sciences,https://dx.doi.org/10.4149/av_2021_407,02/12/2021,16/07/2022,Unverified
220718_Trencin_SlovakAcademyofSciences_Overall,18-Jul-22,Local,Slovakia,SVK,,Trencin,20-Jan-22,02-Mar-22,Household and community samples,Multiple groups,3013,74.48%,,,Self-referral,EUROIMMUN,ELISA,IgG,94.40%,99.60%,High,Preprint,Ivana Kajanova,Slovak Academy of Sciences,https://dx.doi.org/10.4149/av_2022_301,28/07/2022,28/07/2022,Unverified
200429_Singapore_NCID_GeneralPopulation,29-Apr-20,Local,Singapore,SGP,,Singapore,15-Feb-20,15-Apr-20,Household and community samples,Multiple groups,774,0.00%,,,Unclear,NA,Not reported,Not reported,,,Unclear,News and Media,Rei Kurohi,Singapore National Centre for Infectious Diseases,https://www.straitstimes.com/singapore/health/coronavirus-community-transmission-in-spore-very-low-but-so-is-herd-immunity-says,03/05/2020,16/07/2022,Verified
200429_Singapore_Singapore_NCID_HCW,29-Apr-20,Local,Singapore,SGP,,Singapore,15-Feb-20,15-Apr-20,Health care workers and caregivers,Multiple groups,1096,0.00%,,,Unclear,NA,Not reported,Not reported,,,Unclear,News and Media,Rei Kurohi,Singapore National Centre for Infectious Diseases,https://www.straitstimes.com/singapore/health/coronavirus-community-transmission-in-spore-very-low-but-so-is-herd-immunity-says,03/05/2020,16/07/2022,Verified
210209_Singapore_MinistryOfHealthSingapore,09-Feb-21,Local,Singapore,SGP,Singapore,Singapore,25-Mar-20,25-Jul-20,Multiple populations,Adults (18-64 years),135760,60.10%,,,Convenience,"Siemens,Abbott Laboratories,Roche Diagnostics",Multiple Types,Not reported,,,Moderate,Journal Article (Peer-Reviewed),Iain Tan,Ministry of Health Singapore,https://dx.doi.org/10.1001/jama.2020.24071,06/03/2021,16/07/2022,Verified
201102_Singapore_NationalCentreForInfectiousDiseases_overall,02-Nov-20,National,Singapore,SGP,,,23-Jan-20,03-Apr-20,Contacts of COVID patients,Multiple groups,1150,3.80%,,,Entire sample,NA,Neutralization,Neutralizing ,98.90%,100.00%,Moderate,Journal Article (Peer-Reviewed),Oon Tek Ng,"National Centre for Infectious Diseases, Singapore",https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(20)30833-1/fulltext?dgcid=raven_jbs_etoc_email,12/03/2021,16/07/2022,Verified
210420_Singapore_NationalUniversityOfSingapore_MigrantWorkers_TestAdj,20-Apr-21,Local,Singapore,SGP,,,15-May-20,15-Jun-20,Essential non-healthcare workers,Adults (18-64 years),478,63.80%,57.90%,70.30%,Simplified probability,GenScript,Neutralization,Neutralizing ,80.30%,99.30%,High,Preprint, Hannah E Clapham,National University of Singapore,https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3826194,20/05/2021,16/07/2022,Verified
210420_Singapore_NationalUniversityOfSingapore_Community_TestAdj,20-Apr-21,National,Singapore,SGP,,,15-Nov-20,15-Dec-20,Household and community samples,Multiple groups,937,0.16%,0.01%,0.72%,Convenience,GenScript,Neutralization,Neutralizing ,80.30%,99.30%,High,Preprint, Hannah E Clapham,National University of Singapore,https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3826194,20/05/2021,16/07/2022,Verified
220216_Singapore_NationalUniversityofSingapore,16-Feb-22,Local,Singapore,SGP,Central Region of Singapore,Queenstown,16-Mar-20,19-Jun-20,Residual sera,Multiple groups,51,15.69%,,,Convenience,"GenScript,Roche Diagnostics",Multiple Types,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Gail Cross,National University of Singapore,https://dx.doi.org/10.1002/jmv.27656,25/02/2022,16/07/2022,Unverified
210705_SierraLeone_HarvardMedicalSchool_WeightedOverall,05-Jul-21,National,Sierra Leone,SLE,,,01-Mar-21,31-Mar-21,Household and community samples,Multiple groups,1893,2.60%,1.90%,3.40%,Stratified probability,Hangzhou Biotest Biotech Co. Ltd,LFIA,"IgG,IgM",100.00%,100.00%,Low,Preprint,Mohamed Bailor Barrie,Harvard Medical School,https://dx.doi.org/10.1101/2021.06.27.21259271,13/07/2021,16/07/2022,Unverified
210709_Vojvodina_UniversityOfNoviSad_Unadj_April1_Overall,09-Jul-21,Regional,Serbia,SRB,Vojvodina,,17-Apr-20,30-Apr-20,Household and community samples,Multiple groups,1267,2.60%,1.80%,3.63%,Stratified probability,Innovita Biological Technology Co. Ltd,LFIA,"IgG,IgM",87.30%,100.00%,High,Journal Article (Peer-Reviewed),Mioljub Ristic,University Of Novi Sad,https://dx.doi.org/10.1371/journal.pone.0254516,21/07/2021,16/07/2022,Verified
210709_Vojvodina_UniversityOfNoviSad_Unadj_May2_Overall,09-Jul-21,Regional,Serbia,SRB,Vojvodina,,18-May-20,31-May-20,Household and community samples,Multiple groups,1068,3.93%,2.85%,5.28%,Stratified probability,Innovita Biological Technology Co. Ltd,LFIA,"IgG,IgM",87.30%,100.00%,High,Journal Article (Peer-Reviewed),Mioljub Ristic,University Of Novi Sad,https://dx.doi.org/10.1371/journal.pone.0254516,21/07/2021,16/07/2022,Verified
210709_Vojvodina_UniversityOfNoviSad_Unadj_June3_Overall,09-Jul-21,Regional,Serbia,SRB,Vojvodina,,17-Jun-20,30-Jun-20,Household and community samples,Multiple groups,1014,6.11%,4.72%,7.77%,Stratified probability,Innovita Biological Technology Co. Ltd,LFIA,"IgG,IgM",87.30%,100.00%,High,Journal Article (Peer-Reviewed),Mioljub Ristic,University Of Novi Sad,https://dx.doi.org/10.1371/journal.pone.0254516,21/07/2021,16/07/2022,Verified
210709_Vojvodina_UniversityOfNoviSad_LFIA_September4_Overall,09-Jul-21,Regional,Serbia,SRB,Vojvodina,,17-Sep-20,30-Sep-20,Household and community samples,Multiple groups,1041,14.60%,12.51%,16.81%,Stratified probability,Innovita Biological Technology Co. Ltd,LFIA,"IgG,IgM",87.30%,100.00%,High,Journal Article (Peer-Reviewed),Mioljub Ristic,University Of Novi Sad,https://dx.doi.org/10.1371/journal.pone.0254516,21/07/2021,16/07/2022,Verified
220324_UniversityOfBelgrade_Belgrade,24-Mar-22,Local,Serbia,SRB,,Belgrade,15-Jun-20,30-Jun-20,Health care workers and caregivers,Adults (18-64 years),575,18.30%,,,Convenience,NA,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Marija Zdravkovic,University of Belgrade,https://dx.doi.org/10.3390/vaccines10040500,22/04/2022,16/07/2022,Unverified
220525_Belgrade_UniversityofBelgrade_Overall_TestAdj,25-May-22,Local,Serbia,SRB,Belgrade,Belgrade,15-Jun-20,15-Oct-20,Health care workers and caregivers,Adults (18-64 years),1580,16.80%,,,Convenience,NA,ELISA,IgG,99.00%,98.00%,High,Journal Article (Peer-Reviewed),Ljiljana Markovic-Denic,University of Belgrade,https://dx.doi.org/10.1016/j.jiph.2022.05.009,29/06/2022,16/07/2022,Verified
210817_Senegal_UniversityGastonBerger_Primary,17-Aug-21,National,Senegal,SEN,,,15-Jun-20,15-Sep-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,303,21.20%,16.70%,26.10%,Simplified probability,Healgen,LFIA,"IgM,IgG",,,Moderate,Preprint,Sidy Mohamed Seck,University Gaston Berger,https://www.researchsquare.com/article/rs-660094/v1,24/08/2021,16/07/2022,Unverified
220305_Senegal_InstitutPasteurdeDakar_OverallTestPopAdj,05-Mar-22,National,Senegal,SEN,,,25-Oct-20,26-Nov-20,Household and community samples,Multiple groups,1422,28.40%,26.10%,30.80%,Simplified probability,"Omega diagnostics,Beijing Wantai Biological",ELISA,"IgG,Total Antibody",,,Low,Journal Article (Peer-Reviewed),Cheikh Talla,Institut Pasteur de Dakar,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8897837/,28/06/2022,16/07/2022,Unverified
211224_Senegal_InstitutDeRechercheEnSante_TestAdj_Overall,24-Dec-21,National,Senegal,SEN,,"Dakar , Thiès, Ziguinchor, Saint-Louis, Kaolack, Kolda, Touba, Tambacounda, Louga, Bounkiling",15-Jun-20,15-Oct-20,Household and community samples,Multiple groups,3231,20.40%,,,Convenience,Abbott Laboratories,CLIA,IgG,100.00%,99.63%,High,Journal Article (Peer-Reviewed),Ambroise Ahouidi,Institut de Recherche en Sante,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8702669/,30/06/2022,16/07/2022,Unverified
200906_Madinah_KingFahadGeneralHospital_HCWs_Overall,06-Sep-20,Local,Saudi Arabia,SAU,Hejaz,Madinah,18-Apr-20,17-Jun-20,Health care workers and caregivers,Adults (18-64 years),330,24.24%,,,Unclear,Vircell S.L.,ELISA,"IgM,IgA,IgG",,,High,Journal Article (Peer-Reviewed),Suliman Alharbi,King Fahad General Hospital,https://assets.cureus.com/uploads/original_article/pdf/39817/1599507536-20200907-8365-icotwh.pdf,28/09/2020,16/07/2022,Verified
201120_SaudiArabia_SaudiCDC_Overall,20-Nov-20,National,Saudi Arabia,SAU,"Hail, Najran, Baha, Qassim, Norther Border, Jazan, Riyadh, Emirate of the Eastern Province, Aseer, Madinah, Makkah",,20-May-20,30-May-20,Health care workers and caregivers,Adults (18-64 years),12621,2.36%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Haleema Ali Alserehi,Saudi Center for Disease Prevention and Control,https://dx.doi.org/10.1016/j.diagmicrobio.2020.115273,23/01/2021,16/07/2022,Verified
210112_Dammam_KingFahadSpecialistHospital_Overall,12-Jan-21,Local,Saudi Arabia,SAU,Eastern Province,Dammam,15-Aug-20,12-Oct-20,Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),72,12.50%,,,Sequential,"DiaSorin,Abbott Laboratories",CLIA,IgG,,,High,Preprint,Alanoud Alshami,King Fahad Specialist Hospital,https://assets.researchsquare.com/files/rs-140932/v1/a7cb2461-27b8-4eca-bf34-171b60bb1272.pdf,05/02/2021,16/07/2022,Verified
210116_SaudiArabia_MinistryofHealth_overall,16-Jan-21,National,Saudi Arabia,SAU,,,20-May-20,25-May-20,Blood donors,Adults (18-64 years),837,1.40%,,,Convenience,Roche Diagnostics,CLIA,Total Antibody,99.80%,99.50%,High,Journal Article (Peer-Reviewed),Ayman Banjar,Ministry of Health (Saudi Arabia),https://dx.doi.org/10.1016/j.ijid.2021.01.028,07/02/2021,16/07/2022,Verified
210105_Jeddah_KingAbdulazizUniversity_overall,05-Jan-21,Local,Saudi Arabia,SAU,,Jeddah,01-Jan-20,31-May-20,Blood donors,Adults (18-64 years),956,1.50%,,,Sequential,NA,ELISA,IgG,100.00%,98.40%,High,Journal Article (Peer-Reviewed),Thamir Alandijany,King Abdulaziz University,https://dx.doi.org/10.3390/healthcare9010051,10/02/2021,16/07/2022,Verified
201206_Al-Madinah_TaibahUniversity_Overall,11-Dec-20,Local,Saudi Arabia,SAU,,Al-Madinah,15-May-20,15-Jul-20,Blood donors,Adults (18-64 years),1212,19.31%,17.12%,21.64%,Convenience,NA,Multiple Types,IgG,,,High,Journal Article (Peer-Reviewed),Waleed H Mahallawi,Taibah University,https://dx.doi.org/10.1016/j.sjbs.2020.12.009,17/02/2021,16/07/2022,Verified
210131_SaudiArabia_KingAbdullahInternationalMedicalResearchCenter_genpop_overall,31-Jan-21,National,Saudi Arabia,SAU,"Riyadh, Jazan, Qassim, Hail, Al-Ahsa, Makkah",,15-Jun-20,15-Nov-20,Multiple general populations,Multiple groups,11275,10.90%,10.30%,11.60%,Convenience,"EUROIMMUN,NA",ELISA,IgG,,,Moderate,Preprint,Naif Khalaf Alharbi,King Abdullah International Medical Research Center,https://www.medrxiv.org/content/10.1101/2021.01.28.21250598v1,04/03/2021,16/07/2022,Verified
210131_Riyadh_KingAbdullahInternationalMedicalResearchCenter_HCW_overall,31-Jan-21,Local,Saudi Arabia,SAU,,Riyadh City,15-Jun-20,15-Nov-20,Health care workers and caregivers,Adults (18-64 years),400,7.50%,4.95%,10.16%,Unclear,NA,ELISA,IgG,,,High,Preprint,Naif Khalaf Alharbi,King Abdullah International Medical Research Center,https://www.medrxiv.org/content/10.1101/2021.01.28.21250598v1,04/03/2021,16/07/2022,Verified
210213_Makkah_KingAbdulazizUniversity_HCW,13-Feb-21,Local,Saudi Arabia,SAU,Mecca Province,Makkah (Mecca),01-Jun-20,31-Jul-20,Health care workers and caregivers,Adults (18-64 years),204,6.30%,,,Convenience,NA,Multiple Types,IgG,,,High,Journal Article (Peer-Reviewed),Waleed Ahmed,King Abdulaziz University,https://www.sciencedirect.com/science/article/pii/S1018364721000276?via%3Dihub,29/03/2021,16/07/2022,Verified
210628_Jeddah_KingAbdulazizUniversity,28-Jun-21,Local,Saudi Arabia,SAU,Mecca,Jeddah,09-Aug-20,02-Nov-20,Health care workers and caregivers,Adults (18-64 years),319,12.20%,,,Convenience,NA,Multiple Types,"IgG,Neutralizing ",,,High,Journal Article (Peer-Reviewed),Sara Farsi,King Abdulaziz University,https://dx.doi.org/10.15537/smj.2021.42.7.20210348,07/07/2021,16/07/2022,Verified
210720_Jeddah_KingAbdulazizUniversity_Overall,20-Jul-21,Local,Saudi Arabia,SAU,,Jeddah,29-Jun-20,10-Aug-20,Health care workers and caregivers,Adults (18-64 years),693,32.20%,28.80%,35.80%,Convenience,NA,Multiple Types,"Neutralizing ,IgG,IgM",,,Moderate,Journal Article (Peer-Reviewed),Rowa Alhabbab,King Abdulaziz University,10.3390/v13071413,02/08/2021,16/07/2022,Verified
210801_Riyadh_KingSaudUniversity_Primary,01-Aug-21,Local,Saudi Arabia,SAU,,Riyadh,22-Nov-20,17-Dec-20,Blood donors,Adults (18-64 years),515,12.23%,,,Convenience,Abbott Laboratories,CLIA,IgG,100.00%,99.60%,Moderate,Journal Article (Peer-Reviewed),Mohammed F. Alosaimi,King Saud University,https://dx.doi.org/10.15537/smj.2021.42.8.20210238,10/08/2021,16/07/2022,Verified
210802_Riyadh_KingSaudUniversity_Primary,02-Aug-21,Local,Saudi Arabia,SAU,Riyadh Province,Riyadh,22-Nov-20,17-Dec-20,Blood donors,Multiple groups,515,12.23%,,,Convenience,Abbott Laboratories,CLIA,IgG,100.00%,99.60%,High,Journal Article (Peer-Reviewed),Mohammed Alosaimi,King Saud University,http://dx.doi.org/10.15537/SMJ.2021.42.8.20210238,24/08/2021,16/07/2022,Verified
210901_Riyadh_KingSaudbinAbdulazizUniversity,01-Sep-21,Local,Saudi Arabia,SAU,Riyadh Province,Riyadh City,01-Jul-20,31-Dec-20,Health care workers and caregivers,Adults (18-64 years),420,14.80%,11.50%,18.50%,Convenience,EUROIMMUN,ELISA,IgG,94.40%,99.60%,High,Journal Article (Peer-Reviewed),Fayhan Alroqi,King Saudbin Abdulaziz University for Health Sciences,https://dx.doi.org/10.1016/j.jiph.2021.08.029,13/09/2021,16/07/2022,Unverified
210922_Madinah_TaibahUniversity_children1_primary,22-Sep-21,Local,Saudi Arabia,SAU,, Madinah,15-Jan-21,15-Apr-21,Residual sera,Children and Youth (0-17 years),332,58.73%,,,Convenience,BGI Genomics,ELISA,IgG,98.71%,98.38%,Moderate,Journal Article (Peer-Reviewed),Waleed Mahallawi,Taibah University,http://dx.doi.org/10.3390/ijerph18199971,06/10/2021,16/07/2022,Verified
210922_Madinah_TaibahUniversity_women2,22-Sep-21,Local,Saudi Arabia,SAU,, Madinah,15-Jan-21,15-Apr-21,Residual sera,Adults (18-64 years),247,50.20%,,,Convenience,BGI Genomics,ELISA,IgG,98.71%,98.38%,Moderate,Journal Article (Peer-Reviewed),Waleed Mahallawi,Taibah University,http://dx.doi.org/10.3390/ijerph18199971,06/10/2021,16/07/2022,Verified
211101_Riyadh_PrinceSultanMilitaryMedicalCity_Primary,01-Nov-21,Local,Saudi Arabia,SAU,,,15-Jul-20,15-Aug-20,Health care workers and caregivers,Adults (18-64 years),188,3.20%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Abeer M. Albaadani,Prince Sultan Military Medical City,https://dx.doi.org/10.15537/smj.2021.42.11.20210391,09/11/2021,16/07/2022,Unverified
211126_Jazan_JazanUniversity_Primary,26-Nov-21,Regional,Saudi Arabia,SAU,Jazan province,,25-Aug-20,30-Dec-20,Household and community samples,Multiple groups,594,25.75%,21.20%,30.00%,Self-referral,"Vircell S.L.,NA",ELISA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Abdulaziz Alhazmi,Jazan University,http://dx.doi.org/10.3390/ijerph182312451,06/12/2021,16/07/2022,Unverified
211208_SaudiArabia_JohnsHopkinsAramcoHealthcare_Primary,08-Dec-21,Local,Saudi Arabia,SAU,,,01-Aug-20,31-Aug-20,Household and community samples,Multiple groups,5629,50.20%,48.80%,51.50%,Simplified probability,Roche Diagnostics,CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Sami Almudarra,Saudi Ministry of Health,https://dx.doi.org/10.1007/s15010-021-01726-2,13/12/2021,16/07/2022,Unverified
220131_Riyadh_KingSaudMedicalCity,31-Jan-22,Local,Saudi Arabia,SAU,,Riyadh,15-Dec-20,31-Dec-20,Health care workers and caregivers,Adults (18-64 years),3644,26.50%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Hala Amer,"""Prevention and Control of Infection Administration, King Saud Medical City""",https://dx.doi.org/10.1016/j.jiph.2022.01.018,22/02/2022,16/07/2022,Unverified
220407_Madinah_TaibahUniversity_Overall,07-Apr-22,Local,Saudi Arabia,SAU,,Madinah,15-Dec-20,30-Apr-21,Residual sera,Multiple groups,527,23.53%,,,Convenience,NA,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Waleed Mahallawi,Taibah University,https://dx.doi.org/10.5144/0256-4947.2022.69,13/04/2022,16/07/2022,Unverified
220422_Riyadh_KingAbdullahInternationalMedicalResearchCenter_ResidualSera,22-Apr-22,Local,Saudi Arabia,SAU,Riyadh Province,Riyadh City,01-Jun-20,16-Jun-20,Residual sera,Multiple groups,432,9.25%,,,Sequential,NA,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Mohammed Alenazi,King Abdullah International Medical Research Center,https://dx.doi.org/10.1016/j.sjbs.2022.103282,04/05/2022,16/07/2022,Unverified
220422_Riyadh_KingAbdullahInternationalMedicalResearchCenter_BloodDonors,22-Apr-22,Local,Saudi Arabia,SAU,Riyadh Province,Riyadh City,01-Jun-20,16-Jun-20,Residual sera,Multiple groups,350,6.00%,,,Sequential,NA,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Mohammed Alenazi,King Abdullah International Medical Research Center,https://dx.doi.org/10.1016/j.sjbs.2022.103282,04/05/2022,16/07/2022,Unverified
211123_Riyadh_KingFaisalHospitalAndResearchCentre,23-Nov-21,Local,Saudi Arabia,SAU,Riyadh Province,Riyadh,15-Jun-20,15-Dec-20,Health care workers and caregivers,Adults (18-64 years),1076,24.30%,,,Convenience,Abbott Laboratories,CLIA,IgG,71.90%,96.54%,High,Journal Article (Peer-Reviewed),Reem Almaghrabi,King Faisal Hospital and Research Centre,https://dx.doi.org/10.1016/j.ijregi.2021.11.009,28/06/2022,16/07/2022,Unverified
220711_Madinah_TaibahUniversity,11-Jul-22,Local,Saudi Arabia,SAU,,Madinah,15-Oct-19,15-Jan-20,Blood donors,Multiple groups,478,4.18%,,,Sequential,BGI Genomics,ELISA,"IgG,IgM",98.71%,96.76%,High,Journal Article (Peer-Reviewed),Waleed Mahallawi,Taibah University,https://dx.doi.org/10.3389/fmed.2022.923715,15/08/2022,16/08/2022,Unverified
220602_Abha_KingKhalidUniversity_Overall_ELISA_IgGIgM_Primary,02-Jun-22,Local,Saudi Arabia,SAU,'Asir,Abha,15-Oct-20,15-Feb-21,Health care workers and caregivers,Adults (18-64 years),186,16.12%,,,Simplified probability,Vircell S.L.,ELISA,"IgG,IgM",,,,Journal Article (Peer-Reviewed),Ahmed M. Al-Hakami,King Khalid University,https://www.bahrainmedicalbulletin.com/JUNE_2022/BMB-22-204.pdf,19/08/2022,19/08/2022,Unverified
220810_Dhahran_JohnsHopkinsAramcoHealthcare,10-Aug-22,Local,Saudi Arabia,SAU,Eastern Province,Dhahran,15-Jun-20,30-Apr-21,Health care workers and caregivers,Adults (18-64 years),682,12.76%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Hayat Mushcab,Johns Hopkins Aramco Healthcare,https://dx.doi.org/10.2147/IDR.S369755,22/08/2022,23/08/2022,Unverified
200611_Russia_NationalCouncilCombatingCoronavirus_GenPop,10-Jun-20,National,Russian Federation,RUS,,,,10-Jun-20,Household and community samples,Multiple groups,650000,14.00%,,,Unclear,NA,Not reported,Not reported,95.00%,98.00%,Moderate,News and Media,Sergei Kiselyov,Russian National Council for Combating Coronavirus,https://www.themoscowtimes.com/2020/06/10/1-in-7-russians-have-coronavirus-immunity-official-a70540 ; https://www.interfax.ru/russia/712617,27/06/2020,16/07/2022,Verified
200626_Moscow_CityofMoscow,26-Jun-20,Local,Russian Federation,RUS,Central Russia,Moscow,05-Jun-20,18-Jun-20,Household and community samples,Multiple groups,90000,19.90%,,,Simplified probability,NA,Not reported,Not reported,,,High,News and Media,Jonny Tickle,City of Moscow,https://www.google.com/url?rct=j&sa=t&url=https://www.rt.com/russia/493055-moscow-mass-antibody-testing/&ct=ga&cd=CAEYESoUMTExMTExNDMxMTUyMzY3OTYzMDcyGjkwZGVhOTg5OTRlOTE4NTk6Y29tOmVuOlVT&usg=AFQjCNHh2eLjbkaY212mSAjMBempJCE7bA,31/07/2020,16/07/2022,Verified
201007_MinistryofHealthofRussianFederation_employees,07-Oct-20,Local,Russian Federation,RUS,,Moscow,15-Apr-20,15-Jun-20,Health care workers and caregivers,Adults (18-64 years),1589,8.90%,,,Unclear,NA,ELISA,IgG,,,Unclear,Journal Article (Peer-Reviewed),LV Krechetova,Ministry of Health of Russia,http://dx.doi.org/10.18565/aig.2020.7.122-128,16/01/2021,16/07/2022,Verified
210205_Ekaterinburg_RussianAcademyOfSciences_overall,05-Feb-21,Local,Russian Federation,RUS,,Ekaterinburg,15-May-20,15-Aug-20,Health care workers and caregivers,Adults (18-64 years),157,11.50%,,,Convenience,Vector BEST,ELISA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),M Sarapultseva,Russian Academy of Sciences,https://dx.doi.org/10.1177/2380084421993099,20/02/2021,16/07/2022,Verified
200920_Leningrad_Saint-PetersburgPasteurResearchInstitute_Overall,16-Sep-20,Regional,Russian Federation,RUS,Northwestern Federal District,,23-Jun-20,26-Jun-20,Household and community samples,Multiple groups,3130,20.70%,,,Simplified probability,NA,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Anna Popova,Saint-Petersburg Pasteur Research Institute of Epidemiology and Microbiology,https://journal.microbe.ru/jour/article/view/1371/1150#,11/03/2021,16/07/2022,Verified
201019_Irkutsk_SaintPetersburgPasteurResearchInstitute_Overall,10-Oct-20,Regional,Russian Federation,RUS,Irkutsk Region,,28-Jun-20,19-Jul-20,Household and community samples,Multiple groups,2674,5.80%,5.35%,6.25%,Simplified probability,NA,ELISA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Anna Popova,Saint-Petersburg Pasteur Research Institute,https://journal.microbe.ru/jour/article/view/1370/1149,14/03/2021,16/07/2022,Verified
200923_Saint-Petersburg_Saint-PetersburgPasteurResearchInstituteofEpidemiologyandMicrobiology_Overall,23-Sep-20,Local,Russian Federation,RUS,,Saint-Petersburg,15-Jun-20,20-Jun-20,Household and community samples,Multiple groups,2713,26.00%,24.30%,27.70%,Simplified probability,NA,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Anna Popova,Saint-Petersburg Pasteur Research Institute of Epidemiology and Microbiology,https://journal.microbe.ru/jour/article/view/1372/1151,20/03/2021,16/07/2022,Verified
201001_TyumenRegion_SaintPetersburgPasteurInstitute,01-Oct-20,Regional,Russian Federation,RUS,Tyumen region,,07-Jun-20,20-Jun-20,Household and community samples,Multiple groups,2758,24.50%,22.90%,26.10%,Simplified probability,NA,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Anna Popova,Saint Petersburg Pasteur Institute,https://microbiol.elpub.ru/jour/article/view/890/520,20/03/2021,16/07/2022,Verified
210119_Kaliningrad_RussianAcademyOfSciences_overall,19-Jan-21,Regional,Russian Federation,RUS,Kaliningrad Region,,03-Aug-20,07-Aug-20,Household and community samples,Multiple groups,2939,50.20%,49.03%,51.10%,Stratified probability,FBSI State scientific center for applied microbiology and biotechnology,ELISA,IgG,,,Moderate,Journal Article (Peer-Reviewed),A Yu Popova,The Russian Academy of Sciences ,http://dx.doi.org/10.22625/2072-6732-2020-12-5-62-71,25/03/2021,16/07/2022,Verified
20201231_Moscow_MoscowResearchInstituteofEpidemiologyAndMicrobiology_Overall,14-Oct-20,Regional,Russian Federation,RUS,Central Russia,Moscow Region,22-Jun-20,11-Jul-20,Household and community samples,Multiple groups,2688,21.00%,,,Simplified probability,FBSI State scientific center for applied microbiology and biotechnology,ELISA,IgG,,,Unclear,Journal Article (Peer-Reviewed),A Popova,Moscow Research Insistute of Epidemiology and Microbiology named after V.I G.N Gabrichevsky,http://dx.doi.org/10.20953/1729-9225-2020-4-17-26,26/04/2021,16/07/2022,Verified
210101_MurmanskRegion_StPetersburgPasteurInstitute_Overall,01-Jan-21,Regional,Russian Federation,RUS,Murmansk Region,,03-Aug-20,11-Aug-20,Household and community samples,Multiple groups,3117,31.20%,30.40%,32.00%,Stratified probability,FBSI State scientific center for applied microbiology and biotechnology,ELISA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Anna Popova,St. Petersburg Pasteur Institute,https://hiv.bmoc-spb.ru/jour/article/view/605#,05/05/2021,16/07/2022,Verified
201021_RepublicOfTartarstan_SaintPetersburgPasteurInstitute_overall,21-Oct-20,Regional,Russian Federation,RUS,Republic of Tartarstan,,20-Sep-20,27-Sep-20,Household and community samples,Multiple groups,2946,31.30%,,,Simplified probability,NA,ELISA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Anna Yu Popova,Saint Petersburg Pasteur Institute,https://microbiol.elpub.ru/jour/article/view/940?locale=en_US,18/05/2021,16/07/2022,Verified
201228_Moscow_SaintPetersburgPasteurInstitute_primary,06-Apr-21,Local,Russian Federation,RUS,,Moscow,01-Jul-20,30-Jul-20,Household and community samples,Multiple groups,2688,22.10%,,,Simplified probability,FBSI State scientific center for applied microbiology and biotechnology,ELISA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Popova A Yu,Saint-Petersburg Pasteur Institute,http://dx.doi.org/10.20953/1729-9225-2020-4-8-16,19/05/2021,16/07/2022,Verified
210625_Ekaterinburg_DentalCollegeYamunanagar,25-Jun-21,Local,Russian Federation,RUS,Ural,Ekaterinburg,15-May-20,15-Aug-20,Health care workers and caregivers,Adults (18-64 years),157,12.10%,,,Convenience,Vector BEST,Not reported,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Neeraj Gugnani,Dental College Yamunanagar,https://dx.doi.org/10.1038/s41432-021-0171-5,06/07/2021,16/07/2022,Unverified
210629_StPetersburg_Saint-PetersburgStateUniversityHospital_overall,29-Jun-21,Local,Russian Federation,RUS,,St. Petersburg,27-May-20,19-Mar-21,Non-essential workers and unemployed persons,Adults (18-64 years),180,15.56%,,,Unclear,EUROIMMUN,ELISA,IgA,,,Unclear,Journal Article (Peer-Reviewed),Andrei Ivanov,B.P.Konstantinov St Petersburg Nuclear Physics Institute,https://dx.doi.org/10.1002/jmv.27166,06/07/2021,16/07/2022,Verified
210609_Chelyabinsk_SouthUralStateUniversity_HighRisk_testadj,09-Jun-21,Local,Russian Federation,RUS,,Chelyabinsk,28-Sep-20,30-Dec-20,Health care workers and caregivers,Adults (18-64 years),1091,17.23%,17.17%,17.29%,Unclear,Vector BEST,ELISA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Alexandr Zurochka,South Ural State University,http://dx.doi.org/10.3390/vaccines9060627,07/07/2021,16/07/2022,Unverified
210819_RussianFederation_StPetersburgPasteurInstitute_Overall,19-Aug-21,National,Russian Federation,RUS,,,15-Jun-20,31-Dec-20,Household and community samples,Multiple groups,74158,19.20%,18.90%,19.50%,Unclear,FBSI State scientific center for applied microbiology and biotechnology,ELISA,IgG,,,Unclear,Journal Article (Peer-Reviewed),Anna Popova,Saint Petersburg Pasteur Institute,http://dx.doi.org/10.3390/v13081648,31/08/2021,16/07/2022,Unverified
210831_Novosibirsk_StPetersburgPasteurInstitute_Phase1_Overall,31-Aug-21,Local,Russian Federation,RUS,,"Kochenyevsky, Krasnozyersky, Moshkovsky, Novosibirsk, Elitny Village, Toguchinsky Districts",28-Jun-20,15-Jul-20,Household and community samples,Multiple groups,2728,9.10%,8.00%,10.20%,Stratified probability,FBSI State scientific center for applied microbiology and biotechnology,ELISA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Anna Popova,St Petersburg Pasteur Institute,https://dx.doi.org/10.36233/0507-4088-54,28/09/2021,16/07/2022,Unverified
210831_Novosibirsk_StPetersburgPasteurInstitute_Phase1_1-6,31-Aug-21,Local,Russian Federation,RUS,,"Kochenyevsky, Krasnozyersky, Moshkovsky, Novosibirsk, Elitny Village, Toguchinsky Districts",28-Jun-20,15-Jul-20,Household and community samples,Children and Youth (0-17 years),55,10.90%,4.10%,16.90%,Stratified probability,FBSI State scientific center for applied microbiology and biotechnology,ELISA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Anna Popova,St Petersburg Pasteur Institute,https://dx.doi.org/10.36233/0507-4088-54,28/09/2021,16/07/2022,Unverified
210831_Novosibirsk_StPetersburgPasteurInstitute_Phase1_7-13,31-Aug-21,Local,Russian Federation,RUS,,"Kochenyevsky, Krasnozyersky, Moshkovsky, Novosibirsk, Elitny Village, Toguchinsky Districts",28-Jun-20,15-Jul-20,Household and community samples,Children and Youth (0-17 years),151,8.60%,4.70%,14.30%,Stratified probability,FBSI State scientific center for applied microbiology and biotechnology,ELISA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Anna Popova,St Petersburg Pasteur Institute,https://dx.doi.org/10.36233/0507-4088-54,28/09/2021,16/07/2022,Unverified
210831_Novosibirsk_StPetersburgPasteurInstitute_Phase1_14-17,31-Aug-21,Local,Russian Federation,RUS,,"Kochenyevsky, Krasnozyersky, Moshkovsky, Novosibirsk, Elitny Village, Toguchinsky Districts",28-Jun-20,15-Jul-20,Household and community samples,Children and Youth (0-17 years),182,17.60%,12.30%,23.90%,Stratified probability,FBSI State scientific center for applied microbiology and biotechnology,ELISA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Anna Popova,St Petersburg Pasteur Institute,https://dx.doi.org/10.36233/0507-4088-54,28/09/2021,16/07/2022,Unverified
210831_Novosibirsk_StPetersburgPasteurInstitute_Phase1_18-29,31-Aug-21,Local,Russian Federation,RUS,,"Kochenyevsky, Krasnozyersky, Moshkovsky, Novosibirsk, Elitny Village, Toguchinsky Districts",28-Jun-20,15-Jul-20,Household and community samples,Adults (18-64 years),399,5.50%,3.50%,8.20%,Stratified probability,FBSI State scientific center for applied microbiology and biotechnology,ELISA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Anna Popova,St Petersburg Pasteur Institute,https://dx.doi.org/10.36233/0507-4088-54,28/09/2021,16/07/2022,Unverified
210831_Novosibirsk_StPetersburgPasteurInstitute_Phase1_30-39,31-Aug-21,Local,Russian Federation,RUS,,"Kochenyevsky, Krasnozyersky, Moshkovsky, Novosibirsk, Elitny Village, Toguchinsky Districts",28-Jun-20,15-Jul-20,Household and community samples,Adults (18-64 years),388,4.90%,3.00%,8.00%,Stratified probability,FBSI State scientific center for applied microbiology and biotechnology,ELISA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Anna Popova,St Petersburg Pasteur Institute,https://dx.doi.org/10.36233/0507-4088-54,28/09/2021,16/07/2022,Unverified
210831_Novosibirsk_StPetersburgPasteurInstitute_Phase1_40-49,31-Aug-21,Local,Russian Federation,RUS,,"Kochenyevsky, Krasnozyersky, Moshkovsky, Novosibirsk, Elitny Village, Toguchinsky Districts",28-Jun-20,15-Jul-20,Household and community samples,Adults (18-64 years),391,9.70%,7.00%,13.10%,Stratified probability,FBSI State scientific center for applied microbiology and biotechnology,ELISA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Anna Popova,St Petersburg Pasteur Institute,https://dx.doi.org/10.36233/0507-4088-54,28/09/2021,16/07/2022,Unverified
210831_Novosibirsk_StPetersburgPasteurInstitute_Phase1_50-59,31-Aug-21,Local,Russian Federation,RUS,,"Kochenyevsky, Krasnozyersky, Moshkovsky, Novosibirsk, Elitny Village, Toguchinsky Districts",28-Jun-20,15-Jul-20,Household and community samples,Adults (18-64 years),409,7.60%,5.20%,10.60%,Stratified probability,FBSI State scientific center for applied microbiology and biotechnology,ELISA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Anna Popova,St Petersburg Pasteur Institute,https://dx.doi.org/10.36233/0507-4088-54,28/09/2021,16/07/2022,Unverified
210831_Novosibirsk_StPetersburgPasteurInstitute_Phase1_60-69,31-Aug-21,Local,Russian Federation,RUS,,"Kochenyevsky, Krasnozyersky, Moshkovsky, Novosibirsk, Elitny Village, Toguchinsky Districts",28-Jun-20,15-Jul-20,Household and community samples,Multiple groups,376,8.00%,5.40%,11.20%,Stratified probability,FBSI State scientific center for applied microbiology and biotechnology,ELISA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Anna Popova,St Petersburg Pasteur Institute,https://dx.doi.org/10.36233/0507-4088-54,28/09/2021,16/07/2022,Unverified
210831_Novosibirsk_StPetersburgPasteurInstitute_Phase1_70+,31-Aug-21,Local,Russian Federation,RUS,,"Kochenyevsky, Krasnozyersky, Moshkovsky, Novosibirsk, Elitny Village, Toguchinsky Districts",28-Jun-20,15-Jul-20,Household and community samples,Seniors (65+ years),377,14.80%,11.40%,18.80%,Stratified probability,FBSI State scientific center for applied microbiology and biotechnology,ELISA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Anna Popova,St Petersburg Pasteur Institute,https://dx.doi.org/10.36233/0507-4088-54,28/09/2021,16/07/2022,Unverified
210831_Novosibirsk_StPetersburgPasteurInstitute_Phase2-Stage3_Overall,31-Aug-21,Local,Russian Federation,RUS,,"Kochenyevsky, Krasnozyersky, Moshkovsky, Novosibirsk, Elitny Village, Toguchinsky Districts",28-Jun-20,15-Jul-20,Household and community samples,Multiple groups,1651,31.00%,28.80%,33.30%,Convenience,FBSI State scientific center for applied microbiology and biotechnology,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Anna Popova,St Petersburg Pasteur Institute,https://dx.doi.org/10.36233/0507-4088-54,28/09/2021,16/07/2022,Unverified
211101_Kazan_ScientificResearchInstitutesofRospotrebnadzor_nonHCW,31-Oct-21,Local,Russian Federation,RUS,Tatarstan,Kazan,30-Jun-20,27-Jul-20,Essential non-healthcare workers,Adults (18-64 years),61,21.31%,,,Simplified probability,Vector BEST,ELISA,"IgG,IgM",,,Unclear,Journal Article (Peer-Reviewed),Irina Dmitrievna Reshetnikova,Scientific Research Institutes of Rospotrebnadzor,https://dx.doi.org/10.15789/2220-7619-SOT-1587,06/01/2022,16/07/2022,Unverified
211101_Kazan_ScientificResearchInstitutesofRospotrebnadzor_HCW,31-Oct-21,Local,Russian Federation,RUS,Tatarstan,Kazan,30-Jun-20,27-Jul-20,Health care workers and caregivers,Adults (18-64 years),60,46.67%,,,Simplified probability,Vector BEST,ELISA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Irina Dmitrievna Reshetnikova,Scientific Research Institutes of Rospotrebnadzor,https://dx.doi.org/10.15789/2220-7619-SOT-1587,06/01/2022,16/07/2022,Unverified
210928_Moscow_RussianFederation,28-Sep-21,Regional,Russian Federation,RUS,Central Russia,Moscow,14-Apr-20,31-Dec-20,Health care workers and caregivers,Multiple groups,24373,22.10%,,,Unclear,Vector BEST,ELISA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Anna Popova,Russian Federation,https://dx.doi.org/10.20953/1729-9225-2021-3-5-13,23/01/2022,16/07/2022,Unverified
220122_Arkhangelsk_LondonSchoolofHygieneandTropicalMedicine_TestAdj,22-Jan-22,Local,Russian Federation,RUS,,Arkhangelsk,24-Feb-21,28-May-21,Household and community samples,Multiple groups,1067,72.60%,64.20%,83.10%,Convenience,Vector BEST,ELISA,IgG,89.00%,100.00%,High,Journal Article (Peer-Reviewed),Ekaterina Krieger,London School of Hygiene & Tropical Medicine,https://dx.doi.org/10.3201/eid2802.211640,31/01/2022,16/07/2022,Unverified
220201_Moscow_InstituteofPreventiveMedicine_Overall,01-Feb-22,Local,Russian Federation,RUS,Central,Moscow,01-Aug-19,31-Aug-21,Residual sera,Multiple groups,310,22.58%,,,Unclear,Mediagnost,ELISA,IgG,95.55%,98.36%,Unclear,Preprint,Nadezhda Gumanova,Institute of Preventive Medicine,https://www.researchsquare.com/article/rs-1308920/v1,10/02/2022,16/07/2022,Unverified
211227_Stavropol_StPetersburgResearchInstituteofEpidemiologyandMicrobiology_Round1_Overall,27-Dec-21,Regional,Russian Federation,RUS,Stavropol Region,,06-Jun-20,29-Jun-20,Household and community samples,Multiple groups,2683,9.80%,8.70%,10.90%,Convenience,NA,ELISA,IgG,,,Moderate,Journal Article (Peer-Reviewed),A Papova,Saint-Petersburg Research Institute of Epidemiology and Microbiology,https://dx.doi.org/10.22625/2072-6732-2021-13-4-79-89,10/02/2022,16/07/2022,Unverified
220212_Moscow_RussianMedicalAcademyOfContinuousProfessionalEducation_After1st_Primary,12-Feb-22,Local,Russian Federation,RUS,,Moscow,29-May-20,30-Sep-20,Health care workers and caregivers,Adults (18-64 years),202,27.20%,,,Unclear,Vector BEST,ELISA,IgG,,98.50%,High,Journal Article (Peer-Reviewed),Vera S. Kichatova,Russian Medical Academy of Continuous Professional Education,https://dx.doi.org/10.3390/microorganisms10020429,09/03/2022,16/07/2022,Unverified
220212_Moscow_RussianMedicalAcademyOfContinuousProfessionalEducation_2nd_Primary,12-Feb-22,Local,Russian Federation,RUS,,Moscow,01-Oct-20,31-Jan-21,Health care workers and caregivers,Adults (18-64 years),202,17.80%,,,Unclear,Vector BEST,ELISA,IgG,,98.50%,High,Journal Article (Peer-Reviewed),Vera S. Kichatova,Russian Medical Academy of Continuous Professional Education,https://dx.doi.org/10.3390/microorganisms10020429,09/03/2022,16/07/2022,Unverified
220212_Moscow_RussianMedicalAcademyOfContinuousProfessionalEducation_After2nd_Primary,12-Feb-22,Local,Russian Federation,RUS,,Moscow,01-Feb-21,30-May-21,Health care workers and caregivers,Adults (18-64 years),123,52.80%,,,Unclear,Vector BEST,ELISA,IgG,,98.50%,High,Journal Article (Peer-Reviewed),Vera S. Kichatova,Russian Medical Academy of Continuous Professional Education,https://dx.doi.org/10.3390/microorganisms10020429,09/03/2022,16/07/2022,Unverified
211227_Krasnodar_KubanStateMedicalUniversity_Round2_Overall_NeutAssay,27-Dec-21,Local,Russian Federation,RUS,Krasnodar Kai,Krasnodar,26-Oct-20,30-Dec-20,Household and community samples,Adults (18-64 years),806,35.50%,,,Convenience,Beckman Coulter,Neutralization,IgG,,,High,Journal Article (Peer-Reviewed),Vladimir Gorodin,Kuban State Medical University,https://dx.doi.org/10.20953/1729-9225-2021-4-98-102,21/04/2022,16/07/2022,Unverified
20220412_Moscow_MoscowInstituteofPhysicsandTechnology_Primary,12-Apr-22,Local,Russian Federation,RUS,,"Moscow
",15-Oct-20,15-Dec-20,Blood donors,Multiple groups,5340,50.30%,,,Convenience,Shenzhen Mindray Bio-Medical Electronics Co.,CLIA,"IgG,IgM",,,High,Preprint,Ivan A. Molodtsov,Moscow Institute of Physics and Technology,https://dx.doi.org/10.1093/cid/ciac278,26/04/2022,16/07/2022,Unverified
220418_StPetersburg_SaintPetersburgPasteurInstitute_Stage5_antiRBD,18-Apr-22,Local,Russian Federation,RUS,Saint Petersburg,Saint Petersburg,30-Aug-21,03-Sep-21,Household and community samples,Multiple groups,1000,40.40%,37.30%,43.50%,Simplified probability,NA,ELISA,IgG,,,High,Preprint,Viacheslav Smirnov,Saint Petersburg Pasteur Institute,10.20944/preprints202204.0165.v1,27/04/2022,16/07/2022,Unverified
"221215_Saratov_RossiyskiyNauchno-Issledovatel'skiyProtivochumnyyInstitut""Mikrob""Rospotrebnadzora",28-Feb-22,Local,Russian Federation,RUS,Saratov Region,City of Saratov,23-Jun-20,01-Sep-20,Residual sera,Multiple groups,129,63.60%,,,Convenience,Vector BEST,ELISA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Svetlana Portenko,Saratov City Clinical Hospital No. 10,https://dx.doi.org/10.15789/2220-7619-EPO-1747,04/06/2022,16/07/2022,Unverified
220530_SaintPetersburg_SaintPetersburgStateUniversityHospital,30-May-22,Local,Russian Federation,RUS,Northwestern Federal District,St. Petersburg,15-May-20,15-Nov-20,Household and community samples,Multiple groups,158283,16.70%,,,Sequential,"EUROIMMUN,Abbott Laboratories,Vector BEST,NA",Multiple Types,"IgG,IgM,IgA",,,High,Journal Article (Peer-Reviewed),Ekaterina V Parshina,Saint Petersburg State University Hospital,https://dx.doi.org/10.1007/s44197-022-00041-9,10/06/2022,16/07/2022,Unverified
220615_StPetersburg_SmorodintsevResearchInstituteofInfluenza_Round4_Overall_PopTestAdj,15-Jun-22,Local,Russian Federation,RUS,Northwestern Region,Saint Petersburg,15-Feb-21,04-Apr-21,Household and community samples,Multiple groups,1140,43.90%,39.70%,48.00%,Convenience,Genetico,ELISA,Total Antibody,92.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Anton Barchuk,Smorodinova Research Institute of Influenza,https://dx.doi.org/10.1371/journal.pone.0266945,29/06/2022,16/07/2022,Unverified
220615_StPetersburg_SmorodintsevResearchInstituteofInfluenza_Round2_Overall_PopTestAdj,15-Jun-22,Local,Russian Federation,RUS,Northwestern Region,Saint Petersburg,20-Jul-20,08-Aug-20,Household and community samples,Multiple groups,474,13.30%,9.90%,16.60%,Simplified probability,Genetico,ELISA,Total Antibody,92.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Anton Barchuk,Smorodinova Research Institute of Influenza,https://dx.doi.org/10.1371/journal.pone.0266945,29/06/2022,16/07/2022,Unverified
220615_StPetersburg_SmorodintsevResearchInstituteofInfluenza_Round1_Overall_PopTestAdj,15-Jun-22,Local,Russian Federation,RUS,Northwestern Region,Saint Petersburg,25-May-20,28-Jun-20,Household and community samples,Multiple groups,988,9.70%,7.70%,11.70%,Simplified probability,Genetico,ELISA,Total Antibody,92.00%,100.00%,Low,Journal Article (Peer-Reviewed),Anton Barchuk,Smorodinova Research Institute of Influenza,https://dx.doi.org/10.1371/journal.pone.0266945,29/06/2022,16/07/2022,Unverified
200424_Romania_MedLife_HCW,24-Apr-20,National,Romania,ROU,"Nord-Est, Sud-Est, Sud-Mutenia, Sud-Vest Oltenia, Vest, Nord-Vest, Centru, Bucuresti-Ilfov","Bucharest, Arad, Brasov, Sibiu, Piatra Neamt, Braila, Timisoara, Pitesti, Galati, Targoviste, Ploiesti",24-Mar-20,21-Apr-20,Health care workers and caregivers,Multiple groups,371,2.96%,,,Convenience,"Abbott Laboratories,Snibe Co. Ltd (Shenzhen New Industries Biomedical Engineering Co. Ltd),Shenzhen Yhlo Biotech Co. Ltd",Multiple Types,"IgG,IgM",,,Unclear,Institutional Report,MedLife,MedLife,https://www.medlife.ro/comunicat-de-presa/concluzii-preliminare-studiu-medlife-cel-mai-probabil-populatia-nu-are-imunitate-dobandita-natural-pentru-covid-19-respectarea-masurilor-de-protectie-si-extinderea-testarii-reprezinta-sansa-noastra-de-a-functiona-in-siguranta-si-de-a,27/06/2020,16/07/2022,Verified
210104_Romania_CarolDavilaUniversityofMedicineAndPharmacy_Overall_adj,04-Jan-21,Local,Romania,ROU,,Bucharest,17-May-20,01-Dec-20,Multiple populations,Adults (18-64 years),546,6.00%,,,Convenience,DiaSorin,CLIA,"IgG,IgM",90.70%,98.60%,High,Preprint,Corina Manolea,Carol Davila University of Medicine and Pharmacy,https://www.preprints.org/manuscript/202101.0024/v1,23/01/2021,16/07/2022,Verified
210107_Romania_UniversityCollegeLondon_PaediatricHCW,27-Jan-21,Local,Romania,ROU,NR,NR,14-May-20,27-May-20,Health care workers and caregivers,Adults (18-64 years),124,0.81%,0.14%,4.30%,Convenience,"Epitope Diagnostics, Inc.,Meso Scale Discovery",ELISA,IgG,,,High,Journal Article (Peer-Reviewed),D Goldblatt,University College London,http://dx.doi.org/10.1016/j.jhin.2020.12.019,13/03/2021,16/07/2022,Verified
210106_TimisCounty_VictorBabesUniversityofMedicineandPharmacy_Overall,06-Jan-21,Local,Romania,ROU,,,08-Jul-20,01-Sep-20,Blood donors,Adults (18-64 years),2115,1.51%,1.07%,2.13%,Sequential,Roche Diagnostics,CLIA,"IgA,IgM,IgG",100.00%,99.81%,Moderate,Journal Article (Peer-Reviewed),Tudor Rares Olariu,Victor Babes University of Medicine and Pharmacy,http://dx.doi.org/10.1016/j.cmi.2020.12.027,18/03/2021,16/07/2022,Verified
210727_Bucharest_CarolDavilaUniversityOfMedicineAndPharmacy_Patients_Unadj,27-Jul-21,Local,Romania,ROU,,Bucharest,17-May-20,01-Dec-20,Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),516,6.80%,,,Convenience,DiaSorin,CLIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Corina Manolea,Carol Davila University of Medicine and Pharmacy,https://dx.doi.org/10.1093/hropen/hoab028,03/08/2021,16/07/2022,Unverified
210727_Bucharest_CarolDavilaUniversityOfMedicineAndPharmacy_HCW_Unadj,27-Jul-21,Local,Romania,ROU,,Bucharest,17-May-20,01-Dec-20,Health care workers and caregivers,Adults (18-64 years),30,23.30%,,,Convenience,DiaSorin,CLIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Corina Manolea,Carol Davila University of Medicine and Pharmacy,https://dx.doi.org/10.1093/hropen/hoab028,03/08/2021,16/07/2022,Unverified
211226_Timisoara_VictorBabesUniversityOfMedicineAndPharmacy_Overall,26-Dec-21,Local,Romania,ROU,,,10-Mar-21,10-Jun-21,Residual sera,Multiple groups,2443,45.60%,43.63%,47.58%,Sequential,Roche Diagnostics,Not reported,Total Antibody,99.50%,99.80%,High,Journal Article (Peer-Reviewed),Tudor Rares Olariu,Victor Babes University of Medicine and Pharmacy,https://dx.doi.org/10.3390/medicina58010035,02/02/2022,16/07/2022,Unverified
220211_TimisCounty_VictorBabesUniversityofMedicineandPharmacy_Overall,11-Feb-22,Local,Romania,ROU,,,02-Jul-21,02-Sep-21,Blood donors,Adults (18-64 years),2395,41.04%,,,Sequential,Roche Diagnostics,CLIA,Total Antibody,100.00%,99.81%,Moderate,Journal Article (Peer-Reviewed),Tudor Olariu,Victor Babes University of Medicine and Pharmacy,https://dx.doi.org/10.1080/23744235.2022.2036811,23/02/2022,16/07/2022,Verified
220406_TimisCounty_VictorBabesUniversityOfMedicineAndPharmacyTimisoara_Overall,06-Apr-22,Local,Romania,ROU,,Timisoara,10-Mar-21,10-Jun-21,Residual sera,Children and Youth (0-17 years),379,46.70%,,,Sequential,Roche Diagnostics,CLIA,Total Antibody,99.50%,99.80%,High,Journal Article (Peer-Reviewed),Tudor Olariu,Victor Babes University of Medicine and Pharmacy Timisoara,https://dx.doi.org/10.1089/vbz.2022.0003,14/04/2022,16/07/2022,Verified
200709_Korea_KoreaCentersforDiseaseControlandPrevention_Total,09-Jul-20,National,Republic of Korea,KOR,Korea,,,09-Jul-20,Household and community samples,Multiple groups,3055,0.03%,,,Unclear,NA,Not reported,Not reported,,,Unclear,News and Media,Ock Hyun-ju,Korea Centers for Disease Control and Prevention,https://www.google.com/url?rct=j&sa=t&url=http://www.koreaherald.com/view.php%3Fud%3D20200709000787&ct=ga&cd=CAAYEDIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNG8AlCeBcx2rR4FfgC726ll5TtgUw,31/07/2020,16/07/2022,Verified
200716_Daegu_DaeguCatholicUniversityHospital_Overall,16-Jul-20,Local,Republic of Korea,KOR,North Gyeongsang,Daegu,25-May-20,05-Jun-20,Multiple populations,Multiple groups,198,7.60%,,,Convenience,Shin Jin Medics Inc,LFIA,IgG,100.00%,92.00%,High,Journal Article (Peer-Reviewed),Suk-Kyoon Song,Daegu Catholic University Hospital,https://dx.doi.org/10.3346/jkms.2020.35.e269,26/09/2020,16/07/2022,Verified
200824_Seoul_KoreaUniversity_Overall,24-Aug-20,Local,Republic of Korea,KOR,,Seoul,25-May-20,29-May-20,Residual sera,Multiple groups,1500,0.07%,,,Convenience,Roche Diagnostics,CLIA,Total Antibody,99.50%,99.80%,Moderate,Journal Article (Peer-Reviewed),Ji Noh,Korea University,https://jkms.org/DOIx.php?id=10.3346/jkms.2020.35.e311,04/10/2020,16/07/2022,Verified
201120_SouthKorea_SungkyunkwanUniversitySchoolofMedicine_DesHCW_ELISA1,20-Nov-20,National,Republic of Korea,KOR,,,26-Apr-20,09-May-20,Health care workers and caregivers,Adults (18-64 years),309,0.32%,,,Convenience,PCL Inc,ELISA,Total Antibody,98.20%,100.00%,High,Journal Article (Peer-Reviewed),Jae Hoon Ko,Sungkyunkwan University School of Medicine,https://dx.doi.org/10.3389/fmicb.2020.587613,24/02/2021,16/07/2022,Verified
201120_SouthKorea_SungkyunkwanUniversitySchoolofMedicine_NonDesHCW_ELISA1,20-Nov-20,National,Republic of Korea,KOR,,,26-Apr-20,09-May-20,Health care workers and caregivers,Adults (18-64 years),123,0.00%,,,Convenience,PCL Inc,ELISA,Total Antibody,98.20%,100.00%,High,Journal Article (Peer-Reviewed),Jae Hoon Ko,Sungkyunkwan University School of Medicine,https://dx.doi.org/10.3389/fmicb.2020.587613,24/02/2021,16/07/2022,Verified
201123_Korea_KoreaDiseaseControlAndPreventionAgency_genpop,23-Nov-20,National,Republic of Korea,KOR,,,15-Aug-20,15-Oct-20,Household and community samples,Multiple groups,1379,0.22%,,,Unclear,NA,Not reported,Not reported,,,Unclear,News and Media,KBS World,Korea Disease Control and Prevention Agency,https://world.kbs.co.kr/service/news_view.htm?lang=e&Seq_Code=157801,07/03/2021,16/07/2022,Verified
201123_Korea_KoreaDiseaseControlAndPreventionAgency_military,23-Nov-20,National,Republic of Korea,KOR,,,15-Aug-20,15-Oct-20,Essential non-healthcare workers,Adults (18-64 years),6900,0.36%,,,Unclear,NA,Not reported,Not reported,,,Unclear,News and Media,KBS World,Korea Disease Control and Prevention Agency,https://world.kbs.co.kr/service/news_view.htm?lang=e&Seq_Code=157801,07/03/2021,16/07/2022,Verified
210424_SouthKorea_KoreaAssociationofHealthPromotion_Primary,24-Apr-21,National,Republic of Korea,KOR,N/A,"Seoul (Dongbu), Chuncheon, Chungju, Daegu (Dong-gu), Daegu (Buk-gu), Ulsan, Busan, Changwon, Kwangju, Jeonju, Daejeon, Suwon, Seoul (Kangnam), Incheon, Seoul (Seobu), Jeju ",24-Sep-20,09-Dec-20,Residual sera,Multiple groups,4085,0.39%,0.20%,0.58%,Stratified probability,Roche Diagnostics,CLIA,"IgG,IgM,IgA",99.50%,99.80%,Moderate,Journal Article (Peer-Reviewed),Eun Hee Nah,Korea Association of Health Promotion,https://bmjopen.bmj.com/content/11/4/e049837.abstract,17/05/2021,16/07/2022,Unverified
210428_ChungbukProvince_ChungbukNationalUniversity_NonEpicenter_OverallAdj,28-Apr-21,Local,Republic of Korea,KOR,Chungbuk Province,,01-May-20,17-Jul-20,Residual sera,Multiple groups,3981,0.91%,0.69%,1.13%,Simplified probability,NA,IFA,IgG,99.50%,100.00%,Moderate,Journal Article (Peer-Reviewed),Hye Won Jeong,Chungbuk National University,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8079228/,17/05/2021,16/07/2022,Verified
210428_DaeguCity_ChungbukNationalUniversity_Epicenter_OverallAdj,28-Apr-21,Local,Republic of Korea,KOR,North Gyeongsang Province,Daegu,01-May-20,17-Jul-20,Residual sera,Multiple groups,3268,1.27%,1.01%,1.53%,Simplified probability,NA,IFA,IgG,99.50%,100.00%,Moderate,Journal Article (Peer-Reviewed),Hye Won Jeong,Chungbuk National University,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8079228/,18/05/2021,16/07/2022,Verified
210524_SouthKorea_KoreaDiseaseControlAndPreventionAgency_July1_overall,24-May-21,National,Republic of Korea,KOR,,,21-Apr-20,16-Jun-20,Residual sera,Multiple groups,1500,0.00%,,,Convenience,NA,Neutralization,Neutralizing ,93.30%,97.10%,High,Journal Article (Peer-Reviewed),Kwangmin Lee,Korea Disease Control and Prevention Agency,https://dx.doi.org/10.1007/s42952-021-00131-7,07/06/2021,16/07/2022,Verified
210524_SouthKorea_KoreaDiseaseControlAndPreventionAgency_November3_TestAdj,24-May-21,National,Republic of Korea,KOR,,,14-Aug-20,31-Oct-20,Residual sera,Multiple groups,1379,0.62%,,,Convenience,NA,Neutralization,Neutralizing ,93.30%,97.10%,High,Journal Article (Peer-Reviewed),Kwangmin Lee,Korea Disease Control and Prevention Agency,https://dx.doi.org/10.1007/s42952-021-00131-7,07/06/2021,16/07/2022,Verified
210524_SouthKorea_KoreaDiseaseControlAndPreventionAgency_September2,24-May-21,National,Republic of Korea,KOR,,,10-Jun-20,13-Aug-20,Residual sera,Multiple groups,1440,0.07%,,,Convenience,NA,Neutralization,Neutralizing ,93.30%,97.10%,High,Journal Article (Peer-Reviewed),Kwangmin Lee,Korea Disease Control and Prevention Agency,https://dx.doi.org/10.1007/s42952-021-00131-7,07/06/2021,16/07/2022,Verified
210630_Hwaseong_DongtanSacredHeartHospital,30-Jun-21,Local,Republic of Korea,KOR,Gyeonggi,Hwaseong,04-Mar-21,12-Mar-21,Health care workers and caregivers,Adults (18-64 years),298,0.00%,,,Convenience,GenScript,Neutralization,"IgG,IgM,Neutralizing ",95.40%,90.80%,Moderate,Journal Article (Peer-Reviewed),Seri Jeong,Dongtan Sacred Heart Hospital,https://dx.doi.org/10.1128/JCM.01105-21,07/07/2021,16/07/2022,Unverified
211019_Daegu_KyungpookNationalUniversity_Overall,19-Oct-21,Local,Republic of Korea,KOR,,Daegu,18-Jan-21,26-Feb-21,Health care workers and caregivers,Multiple groups,2935,0.41%,,,Convenience,"Roche Diagnostics,NA,Abbott Laboratories,GenScript",Multiple Types,"IgG,IgM,IgA,Neutralizing ",,,Moderate,Journal Article (Peer-Reviewed),Yu Kim,Kyungpook National University,https://dx.doi.org/10.3346/jkms.2021.36.e294,16/11/2021,16/07/2022,Unverified
221230_Gyeonggi_HallymUniversityCollegeofMedicine_Overall,30-Dec-21,Regional,Republic of Korea,KOR,Gyeonggi,,01-Mar-21,12-Mar-21,Health care workers and caregivers,Adults (18-64 years),228,0.00%,,,Unclear,Roche Diagnostics,CLIA,Total Antibody,,,High,Journal Article (Peer-Reviewed),Seri Jeong,Hallym University College of Medicine,https://dx.doi.org/10.3390/diagnostics12010085,02/02/2022,16/07/2022,Unverified
220221_Korea_NationalInstituteofInfectiousDiseases_Overall,21-Feb-22,National,Republic of Korea,KOR,,,24-Apr-20,12-Dec-20,Residual sera,Multiple groups,5284,0.09%,,,Convenience,"Roche Diagnostics,Abbott Laboratories,Beckman Coulter,SG medical, Inc.,Sugentech, Inc.,NA",Multiple Types,"IgG,IgM,IgA,Neutralizing ",,,High,Journal Article (Peer-Reviewed),Ah-Ra Kim,National Institute of Infectious Diseases,https://dx.doi.org/10.4178/epih.e2022028,07/03/2022,16/07/2022,Verified
220504_KoreanArmyTrainingCenter_InjeUniversity_Overall,04-May-22,National,Republic of Korea,KOR,,,01-Sep-20,30-Nov-20,Essential non-healthcare workers,Adults (18-64 years),9954,0.31%,,,Simplified probability,"Roche Diagnostics,Abbott Laboratories,Beckman Coulter,SG medical, Inc.,Sugentech, Inc.,NA",Multiple Types,"IgG,IgM,Neutralizing ",,,Moderate,Journal Article (Peer-Reviewed),Kwang Mun,Armed Force Medical Science Research Institute,https://dx.doi.org/10.12659/MSM.934926,10/05/2022,16/07/2022,Unverified
201124_Qatar_MinistryofPublicHealth_Overall_popadj,24-Nov-20,National,Qatar,QAT,,,26-Jul-20,09-Sep-20,Non-essential workers and unemployed persons,Multiple groups,2641,55.30%,53.30%,57.30%,Stratified probability,Roche Diagnostics,CLIA,Total Antibody,95.00%,99.80%,Moderate,Preprint,Mohamed H Al Thani,Ministry of Public Health,https://www.medrxiv.org/content/10.1101/2020.11.24.20237719v1,23/01/2021,16/07/2022,Verified
210309_Qatar_HamadMedicalCorporation_MortuaryWorkers,09-Mar-21,Local,Qatar,QAT,NR,NR,17-Sep-20,17-Sep-20,Essential non-healthcare workers,Adults (18-64 years),32,25.00%,,,Convenience,Roche Diagnostics,CLIA,Not reported,,,High,Journal Article (Peer-Reviewed),Moza Alishaq,Hamad Medical Corporation,http://dx.doi.org/10.1016/j.ijid.2021.03.012,16/04/2021,16/07/2022,Verified
210309_Qatar_HamadMedicalCorporation_CemetaryWorkers,09-Mar-21,Local,Qatar,QAT,NR,NR,01-Sep-20,01-Sep-20,Essential non-healthcare workers,Adults (18-64 years),64,34.38%,,,Convenience,Roche Diagnostics,CLIA,Not reported,,,High,Journal Article (Peer-Reviewed),Moza Alishaq,Hamad Medical Corporation,http://dx.doi.org/10.1016/j.ijid.2021.03.012,16/04/2021,16/07/2022,Verified
210501_Qatar_CornellUniversity,01-May-21,National,Qatar,QAT,,,21-Jun-20,09-Sep-20,Essential non-healthcare workers,Adults (18-64 years),4970,64.40%,63.00%,65.70%,Convenience,Roche Diagnostics,CLIA,Total Antibody,99.50%,99.80%,Moderate,Journal Article (Peer-Reviewed),Andrew Jeremijenko,Cornell University ,https://wwwnc.cdc.gov/eid/article/27/5/20-4365_article,23/05/2021,16/07/2022,Unverified
210604_Qatar_CornellUniversity_Overall1,04-Jun-21,National,Qatar,QAT,,,26-Jul-20,09-Sep-20,Non-essential workers and unemployed persons,Adults (18-64 years),394,46.50%,41.60%,51.40%,Convenience,"Shenzhen Mindray Bio-Medical Electronics Co.,Biomerieux,Roche Diagnostics",Multiple Types,IgG,,,High,Journal Article (Peer-Reviewed),Gheyath K Nasrallah,Cornell University,https://dx.doi.org/10.1038/s41598-021-91235-x,16/06/2021,16/07/2022,Verified
210502_Qatar_CornellUniversity_Primary,02-May-21,National,Qatar,QAT,,,26-Jul-20,09-Sep-20,Essential non-healthcare workers,Multiple groups,2641,55.30%,53.30%,57.30%,Stratified probability,Roche Diagnostics,CLIA,Not reported,,,Low,Journal Article (Peer-Reviewed),Mohamed Al-Thani,Cornell University,https://academic.oup.com/ofid/article/8/8/ofab221/6261968,07/09/2021,16/07/2022,Unverified
210930_Qatar_HamadMedicalCorporation_Primary,30-Sep-21,National,Qatar,QAT,,,01-Mar-20,31-Oct-20,Multiple populations,Multiple groups,12126,17.70%,,,Convenience,Roche Diagnostics,CLIA,Not reported,,,High,Journal Article (Peer-Reviewed),Moza Alishaq,Hamad Medical Corporation,http://dx.doi.org/10.1371/journal.pone.0257845,14/10/2021,16/07/2022,Unverified
211019_Qatar_PrimaryHealthCareCorporation_Timepoint1,19-Oct-21,National,Qatar,QAT,,,01-Jul-20,31-Jul-20,Household and community samples,Multiple groups,943,12.00%,,,Stratified probability,Shenzhen Mindray Bio-Medical Electronics Co.,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Mohamed Syed,Primary Health Care Corporation (PHCC),https://journals.sagepub.com/doi/full/10.1177/21501327211050569,09/11/2021,16/07/2022,Verified
211019_Qatar_PrimaryHealthCareCorporation_Timepoint2,19-Oct-21,National,Qatar,QAT,,,01-Oct-20,31-Oct-20,Household and community samples,Multiple groups,943,17.20%,,,Stratified probability,Shenzhen Mindray Bio-Medical Electronics Co.,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Mohamed Syed,Primary Health Care Corporation (PHCC),https://journals.sagepub.com/doi/full/10.1177/21501327211050569,09/11/2021,16/07/2022,Verified
210523_Qatar_CornellUniversity_Overall_PopTestAdj,23-May-21,National,Qatar,QAT,,,12-May-20,09-Sep-20,Residual sera,Multiple groups,112941,14.80%,,,Sequential,Roche Diagnostics,CLIA,Not reported,99.50%,99.80%,Moderate,Journal Article (Peer-Reviewed),Peter Coyle,Cornell University,http://dx.doi.org/10.1016/j.isci.2021.102646,11/11/2021,16/07/2022,Verified
211111_Qatar_HamadMedicalCorporation_SchoolEnd,11-Nov-21,Local,Qatar,QAT,,,16-Dec-20,22-Dec-20,Essential non-healthcare workers,Adults (18-64 years),331,31.72%,,,Convenience,Roche Diagnostics,CLIA,Total Antibody,99.50%,99.80%,High,Journal Article (Peer-Reviewed),Moza Alishaq,Hamad Medical Corporation,https://dx.doi.org/10.1186/s12889-021-12134-4,25/11/2021,16/07/2022,Unverified
220131_Qatar_CornellUniversity_RocheElecsys,31-Jan-22,National,Qatar,QAT,,,10-Oct-20,21-Oct-20,Residual sera,Multiple groups,709,71.93%,68.50%,75.20%,Convenience,Roche Diagnostics,CLIA,Not reported,89.00%,99.80%,Moderate,Journal Article (Peer-Reviewed),Peter Coyle,Cornell University,https://dx.doi.org/10.1371/journal.pone.0262897,10/02/2022,16/07/2022,Verified
220615_Qatar_PrimaryHealthCareCorporation_Primary,15-Jun-22,National,Qatar,QAT,,,01-Jul-20,31-Jul-20,Blood donors,Multiple groups,2044,9.05%,,,Simplified probability,Shenzhen Mindray Bio-Medical Electronics Co.,CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Mohamed Syed,Primary Health Care Corporation,https://dx.doi.org/10.1016/j.ijregi.2022.02.005,28/06/2022,16/07/2022,Unverified
220721_Qatar_HamadMedicalCorporation_Restricted_Overall,21-Jul-22,National,Qatar,QAT,,,17-Mar-20,10-Sep-20,Multiple populations,Adults (18-64 years),1636,5.13%,,,Sequential,Roche Diagnostics,CLIA,Not reported,99.50%,99.80%,High,Journal Article (Peer-Reviewed),Moza Alishaq,Hamad Medical Corporation,https://dx.doi.org/10.2147/IDR.S360241,12/08/2022,12/08/2022,Unverified
201123_PuertoRico_PuertoRicoPublicHealthTrust_Primary,23-Nov-20,National,Puerto Rico,PRI,,"Arecibo, Bayamón, Caguas, Fajardo,Mayagüez, Aguadilla, Metro / San Juan, Ponce",20-Nov-20,23-Nov-20,Household and community samples,Multiple groups,1816,2.80%,,,Stratified probability,NA,Not reported,"IgM,IgG",,,High,Institutional Report,Puerto Rico Public Health Trust,Puerto Rico Public Health Trust,https://sites.google.com/view/casperpr/análisis-y-resultados?authuser=0,21/05/2021,16/07/2022,Verified
200902_Lisbon_UniversityofLisbon_Overall,02-Sep-20,Local,Portugal,PRT,Estremadura,Lisbon,13-May-20,10-Jul-20,Non-essential workers and unemployed persons,Adults (18-64 years),2571,1.50%,,,Convenience,NA,ELISA,"IgG,IgM,IgA",94.74%,98.00%,Moderate,Preprint,Patricia Figueiredo Campos,University of Lisbon,https://www.medrxiv.org/content/10.1101/2020.08.30.20184309v1,19/10/2020,16/07/2022,Verified
201218_Lisbon_NovaUniversityofLisbon,18-Dec-20,Local,Portugal,PRT,Lisboa Region,Lisbon,15-Jun-20,30-Jun-20,Non-essential workers and unemployed persons,Multiple groups,1636,3.05%,,,Convenience,NA,ELISA,IgG,94.74%,99.53%,Moderate,Journal Article (Peer-Reviewed),Juliana Goncalves,NOVA University of Lisbon,https://dx.doi.org/10.3389/fmed.2020.603996,23/01/2021,16/07/2022,Verified
210201_Portugal_InstitutoNacionalDeSaúdeDoutorRicardoJorge_overall_TestAdj_PopAdj,01-Feb-21,National,Portugal,PRT,"Norte Region, Centro Region, Lisboa Region, Alentejo Region, Algarve Region, Madeira, Azores",,21-May-20,08-Jul-20,Residual sera,Multiple groups,2301,1.70%,0.00%,3.30%,Stratified non-probability,"EUROIMMUN,Beijing Wantai Biological",ELISA,"IgG,IgM",,,Moderate,Journal Article (Peer-Reviewed),Irina Kislaya, Instituto Nacional de Saúde Doutor Ricardo Jorge,https://actamedicaportuguesa.com/revista/index.php/amp/article/view/15122,11/03/2021,16/07/2022,Verified
201021_UniversidadeDeLisboa_UniversidadeDeLisboa_overall,21-Oct-20,Local,Portugal,PRT,,Lisbon,13-May-20,10-Jul-20,Non-essential workers and unemployed persons,Adults (18-64 years),2715,2.60%,,,Convenience,NA,ELISA,IgG,99.00%,100.00%,High,Journal Article (Peer-Reviewed),Patricia Figueiredo Campos,Universidade de Lisboa,https://onlinelibrary.wiley.com/doi/10.1002/eji.202048970,22/03/2021,16/07/2022,Verified
210426_Portugal_DepartmentofEpidemiologyandInfectiousDiseasesoftheNationalInstitutesofHealth,26-Apr-21,National,Portugal,PRT,,,02-Feb-21,31-Mar-21,Household and community samples,Multiple groups,8463,15.50%,,,Convenience,NA,Not reported,"IgG,IgM",,,Unclear,News and Media,Pedro Simas,Department of Epidemiology and Infectious Diseases of the National Institutes of Health (INSA),https://newsline.news/the-second-national-serological-survey-showed-that-15-5-of-the-portuguese-population-has-antibodies-against-sars-cov-2/,17/05/2021,16/07/2022,Verified
210428_Europe_SorbonneUniversité_3Centro,28-Apr-21,Regional,Portugal,PRT,Região do Centro,,07-Jul-20,08-Dec-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,526,1.10%,,,Convenience,"Abbott Laboratories,Siemens,DiaSorin,Beckman Coulter,Roche Diagnostics",Not reported,"IgG,IgA,IgM",,,High,Journal Article (Peer-Reviewed),David Saadoun,Sorbonne Université,https://dx.doi.org/10.1016/S2665-9913(21)00112-0,30/05/2021,16/07/2022,Verified
210621_Portugal_LosAlamosNationalLaboratory_overall_PopAdj_TestAdj,21-Jun-21,National,Portugal,PRT,,,01-Mar-21,17-Mar-21,Household and community samples,Multiple groups,2435,17.30%,15.80%,18.80%,Stratified probability,Siemens,CLIA,Total Antibody,98.10%,99.90%,Moderate,Preprint,Luisa Canto e Castro,Los Alamos National Laboratory,https://europepmc.org/article/PPR/PPR359402,02/07/2021,16/07/2022,Verified
210630_Porto_UniversidadeDoPorto_primary,30-Jun-21,Local,Portugal,PRT,Norte,Porto,21-May-20,31-Jul-20,Essential non-healthcare workers,Multiple groups,4592,2.50%,0.10%,5.30%,Convenience,SD Biosensor,Multiple Types,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Paula Meireles, Universidade do Porto,https://dx.doi.org/10.1136/oemed-2021-107519,06/07/2021,16/07/2022,Verified
210616_Lisbon_ UniversidadeNOVAdeLisboa_primary,16-Jun-21,Local,Portugal,PRT,,Lisbon,15-Jun-20,30-Jun-20,Non-essential workers and unemployed persons,Multiple groups,1624,3.10%,,,Convenience,NA,ELISA,IgG,94.74%,99.53%,High,Journal Article (Peer-Reviewed),David G. Lopes, Universidade NOVA de Lisboa,https://dx.doi.org/10.3389/fpubh.2021.689919,15/07/2021,16/07/2022,Unverified
211012_NortheastPortugal_FernandoPessoaUniversity_Overall,12-Oct-21,National,Portugal,PRT,,,15-Apr-20,15-Feb-21,Household and community samples,Multiple groups,358,30.45%,,,Self-referral,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Mary Duro,Fernando Pessoa University,https://dx.doi.org/10.1007/s11845-021-02799-6,19/10/2021,16/07/2022,Verified
211018_UniversityofPorto_UniversityofPorto_Overall_TestAdj,18-Oct-21,Local,Portugal,PRT,Norte,Porto,24-Sep-20,15-Dec-20,Students and Daycares,Multiple groups,6512,7.90%,4.90%,11.10%,Convenience,"SD Biosensor,Qingdao Hightop Biotech Co. Ltd ,NA",Multiple Types,"IgM,IgG",,,Moderate,Preprint,Paula Meireles,University of Porto,https://www.medrxiv.org/content/10.1101/2021.10.14.21264978v1,27/10/2021,16/07/2022,Unverified
211018_Porto_UniversidadedoPorto,18-Oct-21,Local,Portugal,PRT,Porto District,Porto,27-Nov-20,29-Jan-21,Non-essential workers and unemployed persons,Multiple groups,1891,10.68%,,,Self-referral,SD Biosensor,Not reported,"IgG,IgM",94.50%,95.70%,Moderate,Preprint,Joana Costa,Universidade do Porto,10.1101/2021.10.14.21264980,28/10/2021,16/07/2022,Unverified
211130_Porto_CentroHospitalarUniversitáriodeSãoJoão,30-Nov-21,Local,Portugal,PRT,Norte,Porto,01-Mar-20,31-Dec-20,Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),19,0.00%,,,Convenience,NA,Not reported,Not reported,,,High,Presentation or Conference,Laura Leite-Almeida,Centro Hospitalar Universitário de São João,https://dx.doi.org/10.1080/2331205X.2021.2002558,17/01/2022,16/07/2022,Unverified
211130_SantaMariadaFeira_CHEDV,30-Nov-21,Local,Portugal,PRT,Norte,Santa Maria da Feira,01-Apr-20,31-May-21,Perinatal,Children and Youth (0-17 years),32,31.25%,,,Convenience,NA,Not reported,Not reported,,,High,Presentation or Conference,Rosario Cunha,Centro Hospitalar de Entre Douro e Vouga,https://dx.doi.org/10.1080/2331205X.2021.2002558,18/01/2022,16/07/2022,Unverified
211217_Portugal_NationalInstituteofHealth_Primary,17-Dec-21,National,Portugal,PRT,,,28-Sep-21,19-Nov-21,Household and community samples,Multiple groups,4545,86.40%,85.20%,87.60%,Stratified non-probability,Abbott Laboratories,CLIA,IgG,,,Moderate,Institutional Report,ISN COVID-19 Group,National Institute of Health,http://repositorio.insa.pt/handle/10400.18/7828,26/01/2022,16/07/2022,Verified
220207_Porto_UniversidadedoPorto_FirstRound,07-Feb-22,Local,Portugal,PRT,,Porto,21-May-20,31-Jul-20,Non-essential workers and unemployed persons,Multiple groups,3628,4.10%,,,Convenience,SD Biosensor,Multiple Types,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Joana Costa,Universidade do Porto,https://dx.doi.org/10.1080/23744235.2022.2035429,14/02/2022,16/07/2022,Unverified
220207_Porto_UniversidadedoPorto_SecondRound,07-Feb-22,Local,Portugal,PRT,,Porto,27-Nov-20,29-Jan-21,Non-essential workers and unemployed persons,Multiple groups,2661,13.20%,,,Convenience,SD Biosensor,IFA,"IgG,IgM",94.50%,95.70%,Moderate,Journal Article (Peer-Reviewed),Joana Costa,Universidade do Porto,https://dx.doi.org/10.1080/23744235.2022.2035429,14/02/2022,16/07/2022,Unverified
220207_Porto_UniversidadedoPorto_Cohort_Primary,07-Feb-22,Local,Portugal,PRT,,Porto,21-May-20,29-Jan-21,Non-essential workers and unemployed persons,Multiple groups,1891,10.70%,,,Convenience,SD Biosensor,Multiple Types,"IgG,IgM",,,Moderate,Journal Article (Peer-Reviewed),Joana Costa,Universidade do Porto,https://dx.doi.org/10.1080/23744235.2022.2035429,14/02/2022,16/07/2022,Unverified
220207_PortoandMatosinhos_UniversityofPorto_Overall,07-Feb-22,Local,Portugal,PRT,Norte,"Porto, Matosinhos",15-May-20,19-Jun-20,Essential non-healthcare workers,Adults (18-64 years),1696,2.95%,2.10%,3.70%,Convenience,SureScreen Diagnostics,Not reported,"IgG,IgM",96.60%,99.70%,Moderate,Journal Article (Peer-Reviewed),Nuno Ferreira,University of Porto,https://dx.doi.org/10.13075/ijomeh.1896.01878,18/02/2022,16/07/2022,Unverified
220221_Lisboa_HospitalDaLuzLisboa_Visit2_Overall,21-Feb-22,Local,Portugal,PRT,,Lisbon,06-Jun-20,14-Jul-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,72,2.78%,,,Convenience,Snibe Co. Ltd (Shenzhen New Industries Biomedical Engineering Co. Ltd),CLIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Goncalo Fernandes,Hospital da Luz Lisboa,https://www.cureus.com/articles/82283-sars-cov-2-antibody-seroprevalence-in-patients-with-cancer-on-systemic-antineoplastic-treatment-in-the-first-wave-of-the-covid-19-pandemic-in-portugal,08/03/2022,16/07/2022,Unverified
220511_CentroHospitalareUniversitáriodeCoimbra_UniversityofCoimbra,11-May-22,Local,Portugal,PRT,Coimbra,Coimbra,15-Dec-20,04-Mar-21,Health care workers and caregivers,Adults (18-64 years),2968,2.12%,,,Convenience,Abbott Laboratories,CLIA,IgG,99.37%,99.55%,Moderate,Journal Article (Peer-Reviewed),Joana Oliveira-Silva,University of Coimbra,https://dx.doi.org/10.1016/j.ijid.2022.05.026,05/06/2022,16/07/2022,Unverified
220617_Portugal_CentroHospitalareUniversitariodeSaoJoao_Overall,17-Jun-22,National,Portugal,PRT,,,09-Apr-20,30-May-20,Health care workers and caregivers,Adults (18-64 years),1027,2.70%,,,Convenience,"EUROIMMUN,Abbott Laboratories,Roche Diagnostics,Bio-Rad",Multiple Types,"IgG,Total Antibody",,,High,Journal Article (Peer-Reviewed),Angelica Ramos,Centro Hospitalar e Universitario de Sao Joao,https://dx.doi.org/10.1097/j.pbj.0000000000000166,13/07/2022,16/07/2022,Unverified
220601_VilaNovadeGaia_OrdemdosMédicosPortugueses_Overall_PopAdj,01-Jun-22,Local,Portugal,PRT,,,23-Jun-20,17-Jul-20,Household and community samples,Multiple groups,2754,3.03%,2.37%,3.87%,Stratified non-probability,DiaSorin,CLIA,IgG,98.70%,99.50%,Moderate,Journal Article (Peer-Reviewed),Alvaro Carvalho,Ordem dos Médicos Portugueses,https://dx.doi.org/10.20344/amp.17676,26/07/2022,26/07/2022,Unverified
201011_Mazowieckie_MedicalUniversityofWarsaw_IgG_Overall,11-Oct-20,Regional,Poland,POL,Mazowieckie Province,,22-Jun-20,08-Jul-20,Essential non-healthcare workers,Multiple groups,5082,4.30%,3.70%,4.90%,Stratified probability,Vircell S.L.,ELISA,IgG,97.00%,94.00%,Moderate,Journal Article (Peer-Reviewed),Mariusz Gujski,Medical University of Warsaw,http://dx.doi.org/10.3390/jcm9103245,29/01/2021,16/07/2022,Verified
210205_Poland_CentralClinicalHospital_IBDPatients_IgG,05-Feb-21,National,Poland,POL,,,01-May-20,15-Jun-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,432,4.60%,,,Sequential,Vircell S.L.,ELISA,IgG,88.00%,99.00%,High,Journal Article (Peer-Reviewed),Michal Lodyga,Central Clinical Hospital of the Ministry of the Interior and Administration,https://dx.doi.org/10.20452/pamw.15796,23/02/2021,16/07/2022,Verified
210205_Poland_CentralClinicalHospital_HCWs_IgG,05-Feb-21,National,Poland,POL,,,01-May-20,15-Jun-20,Health care workers and caregivers,Multiple groups,432,1.60%,,,Stratified non-probability,Vircell S.L.,ELISA,IgG,85.00%,98.00%,High,Journal Article (Peer-Reviewed),Michal Lodyga,Central Clinical Hospital of the Ministry of the Interior and Administration,https://dx.doi.org/10.20452/pamw.15796,23/02/2021,16/07/2022,Verified
201222_Warsaw_CentralClinicalHospitalMSWiA,22-Dec-20,Local,Poland,POL,,Warsaw,01-Apr-20,31-Oct-20,Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),61,16.39%,,,Sequential,Vircell S.L.,ELISA,"IgA,IgG,IgM",,,High,Journal Article (Peer-Reviewed),Piotr Ciechanowicz,Central ClinicalHospital MSWiA,https://dx.doi.org/10.1080/09546634.2020.1861177,07/03/2021,16/07/2022,Verified
210401_Warsaw_Children’sMemorialHealthInstitute_HCW,01-Apr-21,Local,Poland,POL,,Warsaw,01-Jul-20,09-Aug-20,Health care workers and caregivers,Adults (18-64 years),1879,0.85%,,,Convenience,Abbott Laboratories,CLIA,IgG,99.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Beata Kasztelewicz,Children’s Memorial Health Institute,https://dx.doi.org/10.1371/journal.pone.0249550,02/05/2021,16/07/2022,Unverified
210331_Poznań_PolishAcademyofSciences_Primary,31-Mar-21,Local,Poland,POL,Greater Poland,Poznań,15-Jul-20,15-Sep-20,Household and community samples,Multiple groups,1500,0.93%,0.56%,1.56%,Simplified probability,"EUROIMMUN,Polycheck",Multiple Types,IgG,,,Moderate,Preprint,Dagny Lorent,Polish Academy of Sciences,https://www.medrxiv.org/content/10.1101/2021.03.29.21254544v1.full,15/05/2021,16/07/2022,Verified
210317_SilesianVoivodeship_JanKochanowskiUniversity,17-Mar-21,Regional,Poland,POL,Silesian Voivodeship,,15-May-20,15-Jun-20,Non-essential workers and unemployed persons,Adults (18-64 years),516,1.94%,,,Convenience,Nanjing Vazyme Medical Technology Co. Ltd,LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Rafal Krygier, Jan Kochanowski University,https://dx.doi.org/10.13075/ijomeh.1896.01756,18/05/2021,16/07/2022,Verified
210419_Lublin_MedicalUniversityofLublin_JIA,19-Apr-21,Local,Poland,POL,Lublin Voivodeship,Lublin,01-Jun-20,30-Sep-20,Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),62,4.80%,,,Sequential,EUROIMMUN,ELISA,IgG,,91.90%,High,Journal Article (Peer-Reviewed),Violetta Opoka Winiarska ,Medical University of Lublin,https://dx.doi.org/10.3390/jcm10081771,19/05/2021,16/07/2022,Verified
210419_Lublin_MedicalUniversityofLublin_HealthyControls,19-Apr-21,Local,Poland,POL,Lublin Voivodeship,Lublin,01-Jun-20,30-Sep-20,Household and community samples,Children and Youth (0-17 years),32,6.30%,,,Convenience,EUROIMMUN,ELISA,IgG,,91.90%,High,Journal Article (Peer-Reviewed),Violetta Opoka Winiarska ,Medical University of Lublin,https://dx.doi.org/10.3390/jcm10081771,19/05/2021,16/07/2022,Verified
210420_Bytom1_UniversityofOpole,20-Apr-21,Local,Poland,POL,Silesian,Bytom,15-Jul-20,15-Aug-20,Health care workers and caregivers,Adults (18-64 years),90,10.00%,,,Convenience,EUROIMMUN,ELISA,IgG,,99.00%,High,Journal Article (Peer-Reviewed),Rafal Jakub Buldak,University of Opole,https://dx.doi.org/10.3390/ijerph18084376,21/05/2021,16/07/2022,Unverified
210420_MiasteczkoSlaskie2_UniversityofOpole,20-Apr-21,Local,Poland,POL,Silesian,Miasteczko Slaskie,15-Jul-20,15-Aug-20,Health care workers and caregivers,Adults (18-64 years),25,4.00%,,,Convenience,EUROIMMUN,ELISA,IgG,,99.00%,High,Journal Article (Peer-Reviewed),Rafal Jakub Buldak,University of Opole,https://dx.doi.org/10.3390/ijerph18084376,21/05/2021,16/07/2022,Unverified
210420_Opole3_UniversityofOpole,20-Apr-21,Local,Poland,POL,Opole,Opole,15-Jul-20,15-Aug-20,Health care workers and caregivers,Adults (18-64 years),84,1.19%,,,Convenience,EUROIMMUN,ELISA,IgG,,99.00%,High,Journal Article (Peer-Reviewed),Rafal Jakub Buldak,University of Opole,https://dx.doi.org/10.3390/ijerph18084376,21/05/2021,16/07/2022,Unverified
210415_Poland_MedicalUniversityOfSilesiaInKatowice_Overall,21-Apr-21,Regional,Poland,POL,Silesian Voivodeship,"Katowice, Gliwice, Sosnowiec",15-Oct-20,15-Nov-20,Household and community samples,Multiple groups,5479,22.90%,,,Self-referral,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Małgorzata Kowalska,Medical University of SilesiaIn Katowice,https://dx.doi.org/10.3390/vaccines9050415,28/05/2021,16/07/2022,Verified
210608_Warsaw_CentralClinicalHospitalOfTheMinistryOfInterior,08-Jun-21,Local,Poland,POL,Mazovia,Warsaw,21-Apr-20,20-Jul-20,Health care workers and caregivers,Adults (18-64 years),1572,22.70%,,,Convenience,NA,ELISA,"IgG,IgM,IgA",,,High,Journal Article (Peer-Reviewed),Radosław Rzeplinski,Central Clinical Hospital of the Ministry of Interior and Administration,https://dx.doi.org/10.20452/pamw.16025,19/06/2021,16/07/2022,Unverified
210820_Poland_CentralClinicalHospitaloftheMinistryoftheInteriorandAdministration,20-Aug-21,National,Poland,POL,"Masovian Voivodeship, Greater Poland Voivodeship, Łódź Voivodeship","Warsaw, Poznań, Łódź",01-May-20,30-Sep-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,473,9.30%,,,Unclear,Vircell S.L.,ELISA,IgG,88.00%,99.00%,High,Journal Article (Peer-Reviewed),Michal Lodyga,Central Clinical Hospital of the Ministry of the Interior and Administration,http://dx.doi.org/10.3390/jcm10163689,31/08/2021,16/07/2022,Unverified
211109_Poland_SlaskiUniwersytetMedyczny_Primary,09-Nov-21,Local,Poland,POL,,"Katowice, Gliwice and Sosnowiec",15-Oct-20,15-Nov-20,Household and community samples,Multiple groups,1167,11.40%,9.50%,13.20%,Simplified probability,EUROIMMUN,ELISA,IgG,88.00%,99.00%,Moderate,Journal Article (Peer-Reviewed),Jan Zejda,Slaski Uniwersytet Medyczny,https://dx.doi.org/10.13075/mp.5893.01179,18/11/2021,16/07/2022,Verified
210527_Krakow_JagiellonianUniversityMedicalCollege_Primary,27-May-21,Local,Poland,POL,,Kraskow,04-Mar-20,03-Mar-21,Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),62,30.60%,,,Convenience,Abbott Laboratories,CLIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Ruth Sladek,Jagiellonian University Medical College,https://academic.oup.com/ecco-jcc/article/15/Supplement_1/S372/6286668,24/11/2021,16/07/2022,Unverified
211127_Bydgoszcz_NicolausCopernicusUniversity_OverallIgG,27-Nov-21,Local,Poland,POL,Kuyavian-Pomeranian,Bydgoszcz,15-Jul-20,15-Dec-20,Health care workers and caregivers,Adults (18-64 years),120,0.00%,,,Convenience,NA,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Joanna Kwiecinska-Pirog,Nicolaus Copernicus University,https://dx.doi.org/10.3390/vaccines9121402,04/01/2022,16/07/2022,Unverified
211130_Lublin_MedicalUniversityofLublin_JIA,30-Nov-21,Local,Poland,POL,Lublin,Lublin,10-Jan-21,30-May-21,Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),65,29.20%,,,Convenience,NA,ELISA,IgA,,,High,Presentation or Conference,Izabela Morawska,Medical University of Lublin,https://dx.doi.org/10.1080/2331205X.2021.2002558,18/01/2022,16/07/2022,Unverified
211130_Lublin_MedicalUniversityofLublin_HC,30-Nov-21,Local,Poland,POL,Lublin,Lublin,10-Jan-21,30-May-21,Residual sera,Children and Youth (0-17 years),31,6.50%,,,Convenience,NA,ELISA,IgA,,,High,Presentation or Conference,Izabela Morawska,Medical University of Lublin,https://dx.doi.org/10.1080/2331205X.2021.2002558,18/01/2022,16/07/2022,Unverified
220110_Wrocław_WroclawMedicalUniversity,10-Jan-22,Local,Poland,POL,Silesia,Wrocław,15-Mar-21,15-Apr-21,Patients seeking care for non-COVID-19 reasons,Multiple groups,93,25.00%,,,Convenience,Abbott Laboratories,Other,IgG,,,Moderate,Journal Article (Peer-Reviewed),Maciej Majcherek ,Wroclaw Medical University ,https://dx.doi.org/10.3390/cancers14020325,19/01/2022,16/07/2022,Unverified
220217_Lublin_MedicalUniversityofLublin_May2020_Overall,17-Feb-22,Local,Poland,POL,,Lublin,05-May-20,25-May-20,Health care workers and caregivers,Multiple groups,208,7.20%,,,Convenience,EUROIMMUN,ELISA,"IgG,IgA",,,High,Journal Article (Peer-Reviewed),Izabela Korona-Głowniak,Medical University of Lublin,https://dx.doi.org/10.3390/ijerph19042319,02/03/2022,16/07/2022,Unverified
220217_Lublin_MedicalUniversityofLublin_Dec2020_Overall,17-Feb-22,Local,Poland,POL,,Lublin,04-Dec-20,15-Dec-20,Health care workers and caregivers,Adults (18-64 years),179,48.00%,,,Convenience,EUROIMMUN,ELISA,"IgG,IgA",,,High,Journal Article (Peer-Reviewed),Izabela Korona-Głowniak,Medical University of Lublin,https://dx.doi.org/10.3390/ijerph19042319,02/03/2022,16/07/2022,Unverified
220210_Wroclaw_WroclawMedicalUniversity_Dentists,10-Feb-22,Local,Poland,POL,,Wroclaw,28-Sep-20,19-Nov-20,Health care workers and caregivers,Adults (18-64 years),67,6.00%,,,Convenience,Demeditec,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Irena Dus-Ilnicka,Wroclaw Medical University,https://dx.doi.org/10.1016/j.identj.2022.02.003,15/03/2022,16/07/2022,Unverified
220210_Wroclaw_WroclawMedicalUniversity_ChairsideAssistants,10-Feb-22,Local,Poland,POL,,Wroclaw,28-Sep-20,19-Nov-20,Health care workers and caregivers,Adults (18-64 years),40,7.50%,,,Convenience,Demeditec,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Irena Dus-Ilnicka,Wroclaw Medical University,https://dx.doi.org/10.1016/j.identj.2022.02.003,15/03/2022,16/07/2022,Unverified
220210_Wroclaw_WroclawMedicalUniversity_AdministrativeWorkers,10-Feb-22,Local,Poland,POL,,Wroclaw,28-Sep-20,19-Nov-20,Health care workers and caregivers,Adults (18-64 years),20,5.00%,,,Convenience,Demeditec,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Irena Dus-Ilnicka,Wroclaw Medical University,https://dx.doi.org/10.1016/j.identj.2022.02.003,15/03/2022,16/07/2022,Unverified
220317_Poland_NationalResearchInstitute_Primary,17-Mar-22,National,Poland,POL,"Pomorskie voivodeship, Mazowieckie voivodeship, Wielkopolskie voivodeship","Gdańsk, Wejherowo, Warsaw, Grójec, Krotoszyn",01-Dec-20,23-Dec-20,Health care workers and caregivers,Multiple groups,1040,25.20%,22.60%,27.90%,Self-referral,"Nanjing Vazyme Medical Technology Co. Ltd,NovaTec Immundiagnostics GmbH",Multiple Types,"IgG,IgM",,,Moderate,Journal Article (Peer-Reviewed),Magdalena Rosiska,National Research Institute,https://dx.doi.org/10.13075/mp.5893.01216,29/03/2022,16/07/2022,Unverified
220323_Wroclaw_RegionalSpecializedHospitalinWroclaw_Overall,23-Mar-22,Local,Poland,POL,Lower Silesian Voivodeship,Wroclaw,11-Dec-21,11-Dec-21,Household and community samples,Multiple groups,38,28.95%,,,Convenience,TestLine Clinical Diagnostics,Not reported,IgG,,,High,Preprint,Alina Szewczyk-Dabrowska,Regional Specialized Hospital in Wroclaw,https://www.medrxiv.org/content/10.1101/2022.03.20.22272651v1.full-text,30/03/2022,16/07/2022,Unverified
220329_Krakow_UniversityHospitalinKrakow_Overall,29-Mar-22,Local,Poland,POL,,Krakow,04-Jan-21,19-Jan-21,Health care workers and caregivers,Adults (18-64 years),1221,42.67%,,,Convenience,Roche Diagnostics,CLIA,"IgG,IgM",89.50%,99.06%,High,Journal Article (Peer-Reviewed),Barbara Zoltowska,University Hospital in Krakow,https://dx.doi.org/10.3390/ijerph19074044,05/04/2022,16/07/2022,Unverified
220405_Silesia_MedicalUniversityofSilesia,05-Apr-22,Regional,Poland,POL,Silesia,,15-Oct-20,15-Nov-20,Health care workers and caregivers,Adults (18-64 years),575,19.10%,,,Convenience,EUROIMMUN,ELISA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Marek Wojczyk,Medical University of Silesia,https://dx.doi.org/10.13075/mp.5893.01221,13/04/2022,16/07/2022,Unverified
220316_Zabrze_MedicalUniversityofSilesia_Overall,16-Mar-22,Local,Poland,POL,Silesia,Zabrze,15-Feb-21,15-Sep-21,Patients seeking care for non-COVID-19 reasons,Multiple groups,371,73.60%,,,Sequential,Roche Diagnostics,CLIA,Not reported,84.00%,100.00%,High,Journal Article (Peer-Reviewed),Agnieszka Kuczaj,Medical University of Silesia,https://dx.doi.org/10.1016/j.transproceed.2022.02.044,21/04/2022,16/07/2022,Unverified
220430_Poland_WroclawMedicalUniversity_Primary,30-Apr-22,Local,Poland,POL,,,15-Nov-20,10-Feb-21,Health care workers and caregivers,Multiple groups,344,34.60%,,,Convenience,EUROIMMUN,ELISA,IgG,93.20%,99.80%,High,Journal Article (Peer-Reviewed),Ewa Morgiel,Wroclaw Medical University,https://dx.doi.org/10.3390/vaccines10050710,05/06/2022,16/07/2022,Unverified
220701_Bydgoszcz_VoivodeshipInfectiousObservationHospital,01-Jul-22,Local,Poland,POL,,Bydgoszcz,01-Jun-21,30-Apr-22,Residual sera,Multiple groups,686,57.00%,,,Unclear,DiaSorin,CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Justyna Franczak,Voivodeship Infectious Observation Hospital,https://dx.doi.org/10.3390/jcm11133819,12/07/2022,16/07/2022,Unverified
220101_SanLazaroHospital_NagasakiUniversity_OverallTestAdjusted,01-Jan-22,Local,Philippines,PHL,National Capital Region,Manila,08-Mar-21,24-Apr-21,Health care workers and caregivers,Multiple groups,525,36.00%,30.00%,38.10%,Convenience,Beijing Wantai Biological,ELISA,Total Antibody,,,High,Journal Article (Peer-Reviewed),Nimfa Putong,Nagasaki University,https://dx.doi.org/10.1016/j.lanwpc.2021.100353,18/01/2022,16/07/2022,Unverified
200726_Peru_NationalCenterforEpidemiology_Overall,27-Jul-20,Local,Peru,PER,"Lima, Callao","Lima, Callao",28-Jun-20,09-Jul-20,Household and community samples,Multiple groups,3118,21.60%,18.70%,24.60%,Stratified probability,NA,LFIA,"IgG,IgM",40.00%,,High,News and Media,Peruvian Government,"National Center for Epidemiology, Prevention and Control of Diseases",https://gestion.pe/peru/coronavirus-peru-minsa-divulga-ficha-tecnica-del-estudio-que-revela-que-el-253-de-lima-y-callao-adquirio-el-covid-19-cuarentena-estado-de-emergencia-nndc-noticia/,20/10/2020,16/07/2022,Verified
210120_Iquitos_DIRESA_1monthFollowUp_overall_adj,20-Jan-21,Local,Peru,PER,Loreto,Iquitos,13-Aug-20,18-Aug-20,Household and community samples,Multiple groups,621,66.00%,62.00%,70.10%,Stratified probability,Zhejiang Orient Gene Biotech,LFIA,"IgG,IgM",95.80%,100.00%,Low,Preprint,Carlos Alvarez-Antonio,Universidad de Ingeniería y Tecnología,https://www.medrxiv.org/content/10.1101/2021.01.17.21249913v1,12/02/2021,16/07/2022,Verified
210331_Lima_PeruvianMinistryOfHealth_Overall_PopAdj_TestAdj,31-Mar-21,Local,Peru,PER,Lima and Callao,Lima metropolitan area,28-Jun-20,09-Jul-20,Household and community samples,Multiple groups,3212,20.80%,17.20%,23.50%,Stratified probability,SD Biosensor,LFIA,"IgG,IgM",96.94%,96.23%,Low,Journal Article (Peer-Reviewed),Mary F Reyes Vega,Peruvian Ministry of Health,https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(21)00081-X/fulltext#%20,10/04/2021,16/07/2022,Verified
210312_Lima_InstitutoNacionalDeSalud_Overall,12-Mar-21,Local,Peru,PER,,Lima,23-Apr-20,02-May-20,Contacts of COVID patients,Multiple groups,236,53.00%,,,Stratified non-probability,Core Technology Co. Ltd,LFIA,"IgG,IgM",97.60%,100.00%,High,Journal Article (Peer-Reviewed),Yolanda Angulo Bazan,Instituto Nacional de Salud,https://dx.doi.org/10.1590/0102-311X00238720,12/05/2021,16/07/2022,Verified
200808_Lima_NationalMaternalPerinatalInstitute_overall,08-Aug-20,Local,Peru,PER,Lima Province,Lima,15-Apr-20,15-May-20,Pregnant or parturient women,Adults (18-64 years),2419,7.00%,6.10%,8.10%,Sequential,NA,LFIA,"IgG,IgM",97.60%,98.80%,Moderate,Journal Article (Peer-Reviewed),Enrique Guevara Rios,National Maternal Perinatal Institut,http://www.scielo.org.pe/scielo.php?pid=S2304-51322020000300002&script=sci_abstract&tlng=en,18/05/2021,16/07/2022,Verified
210406_Lambayeque_UniversidadParticulardeChiclayo_PopTestAdj,06-Apr-21,Regional,Peru,PER,Lambayeque Province,,24-Jun-20,10-Jul-20,Household and community samples,Multiple groups,2010,29.50%,27.60%,31.50%,Stratified probability,Core Technology Co. Ltd,LFIA,"IgG,IgM",66.00%,97.00%,Low,Journal Article (Peer-Reviewed),Cristian Diaz Velez,Universidad Particular de Chiclayo,https://dx.doi.org/10.7717/peerj.11210,19/05/2021,16/07/2022,Verified
210421_Lima_HarvardMedicalSchool_Market1,21-Apr-21,Local,Peru,PER,Lima Province,Lima,05-Jun-20,18-Jul-20,Essential non-healthcare workers,Adults (18-64 years),1285,45.00%,,,Convenience,SD Biosensor,Not reported,"IgG,IgM",90.00%,99.00%,High,Journal Article (Peer-Reviewed),Marco Tovar,Harvard Medical School,https://dx.doi.org/10.1093/cid/ciab323,20/05/2021,16/07/2022,Unverified
210421_Lima_HarvardMedicalSchool_BusDepot2,21-Apr-21,Local,Peru,PER,Lima Province,Lima,05-Jun-20,18-Jul-20,Essential non-healthcare workers,Adults (18-64 years),477,36.33%,,,Convenience,SD Biosensor,Not reported,"IgG,IgM",90.00%,99.00%,High,Journal Article (Peer-Reviewed),Marco Tovar,Harvard Medical School,https://dx.doi.org/10.1093/cid/ciab323,20/05/2021,16/07/2022,Unverified
200901_Loreto_HospitalRegionaldeLoreto_primary,01-Sep-20,Local,Peru,PER,,Loreto,19-May-20,06-Jun-20,Health care workers and caregivers,Adults (18-64 years),1147,58.30%,,,Convenience,NA,LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Ricci Alonso Chafloque Vasquez,Hospital Regional de Loreto,https://amp.cmp.org.pe/index.php/AMP/article/view/1050,21/05/2021,16/07/2022,Verified
210901_LimaPeru_HospitalNacionalDocenteMadreNinoSanBartolome_primary,01-Sep-20,Local,Peru,PER,,Lima,15-Apr-20,15-Jul-20,Pregnant or parturient women,Adults (18-64 years),1869,18.50%,,,Sequential,NA,LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Edy Martin Vera Loyola,Hospital Nacional Docente Madre Nino San Bartolome ,http://www.spog.org.pe/web/revista/index.php/RPGO/article/download/2265/pdf,06/06/2021,16/07/2022,Verified
210701_LaRinconada_GrenobleAlpesUniversity_overall,01-Jul-21,Local,Peru,PER,Puno,La Riconanda,11-Oct-20,18-Oct-20,Household and community samples,Multiple groups,159,48.40%,40.50%,56.40%,Sequential,AAZ LMB,LFIA,"IgG,IgM",100.00%,100.00%,High,Journal Article (Peer-Reviewed),Benoit Champigneulle,Grenoble Alpes University,http://dx.doi.org/10.1089/ham.2021.0020,29/07/2021,16/07/2022,Verified
210920_Peru_UniversidadAndinadelCusco_OverallPopAdj,20-Sep-21,Regional,Peru,PER,Cusco Region,,12-Sep-20,27-Sep-20,Household and community samples,Multiple groups,1924,33.10%,30.10%,36.40%,Simplified probability,Roche Diagnostics,CLIA,Total Antibody,96.70%,98.60%,Low,Journal Article (Peer-Reviewed),Charles Huamani,Universidad Andina del Cusco,http://dx.doi.org/10.7717/peerj.12149,05/10/2021,16/07/2022,Verified
211023_Peru_GermanCentreforInfectionResearch_CLIAandNeutralization,23-Oct-21,Regional,Peru,PER,San Martin,,01-Mar-21,31-Mar-21,Household and community samples,Multiple groups,563,58.97%,55.00%,63.00%,Simplified probability,"GenScript,Snibe Co. Ltd (Shenzhen New Industries Biomedical Engineering Co. Ltd)",Multiple Types,"IgG,Neutralizing ",,,Moderate,Preprint,Andres Moreira-Soto,German Centre for Infection Research,https://www.medrxiv.org/content/10.1101/2021.10.19.21265219v1.full-text,04/11/2021,16/07/2022,Verified
211215_Lima_InstitutoNacionalMaternoPerinatal,15-Dec-21,Local,Peru,PER,,Lima,01-Jun-20,30-Sep-20,Pregnant or parturient women,Adults (18-64 years),4733,31.40%,,,Sequential,Celer Technologies Inc.,LFIA,"IgM,IgG",,,High,Journal Article (Peer-Reviewed),Carmen Davila-Aliaga,Instituto Nacional Materno Perinatal,https://dx.doi.org/10.5867/medwave.2021.11.002141,23/12/2021,16/07/2022,Unverified
211223_Lima_UniversidadPeruanaCayetanoHeredia,01-Jan-22,Local,Peru,PER,Lima,Lima,01-Aug-20,30-Sep-20,Pregnant or parturient women,Adults (18-64 years),440,37.50%,,,Convenience,SD Biosensor,Not reported,"IgG,IgM",,,High,Presentation or Conference,Arianna Portmann-Baracco,Universidad Peruana Cayetano Heredia,https://dx.doi.org/10.1016/j.ajog.2021.11.1178,10/01/2022,16/07/2022,Unverified
220119_Cantagallo_MINSA_Round1,19-Jan-22,Local,Peru,PER,Lima,Cantagallo,02-May-20,02-May-20,Household and community samples,Multiple groups,119,33.61%,,,Convenience,NA,LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Luis Zavalaga,MINSA,https://dx.doi.org/10.20453/RMH.V32I4.4120,09/03/2022,16/07/2022,Unverified
220119_Cantagallo_MINSA_Round2,19-Jan-22,Local,Peru,PER,Lima,Cantagallo,12-May-20,12-May-20,Household and community samples,Multiple groups,475,73.26%,,,Convenience,NA,LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Luis Zavalaga,MINSA,https://dx.doi.org/10.20453/RMH.V32I4.4120,09/03/2022,16/07/2022,Unverified
220119_Cantagallo_MINSA_Round3,19-Jan-22,Local,Peru,PER,Lima,Cantagallo,10-Aug-20,10-Aug-20,Household and community samples,Multiple groups,485,68.04%,,,Convenience,NA,LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Luis Zavalaga,MINSA,https://dx.doi.org/10.20453/RMH.V32I4.4120,09/03/2022,16/07/2022,Unverified
211204_Lima_CentersForDiseaseControlAndPrevention,04-Dec-21,Local,Peru,PER,,Lima,15-Aug-20,15-Mar-21,Health care workers and caregivers,Adults (18-64 years),667,32.08%,,,Convenience,NA,ELISA,Not reported,,,High,Presentation or Conference,Matthew Westercamp,Centers for Disease Control and Prevention,https://dx.doi.org/10.1093/ofid/ofab466.576,22/03/2022,16/07/2022,Unverified
220325_Pucallpa_NationalUniversityofJaén_IgGorIgM,25-Mar-22,Local,Peru,PER,Coronel Portillo,Pucallpa,25-Jun-20,24-Jul-20,Persons who are incarcerated,Adults (18-64 years),325,57.85%,,,Simplified probability,NA,CLIA,"IgG,IgM",,,Unclear,Preprint,Arturo Rafael-Heredia,National University of Jaén,https://preprints.scielo.org/index.php/scielo/preprint/view/3828,06/04/2022,16/07/2022,Unverified
220408_Peru_UniversidadPeruanadeCienciasAplicadas_IgM,08-Apr-22,Local,Peru,PER,Jaen,Jaen,15-Apr-20,15-Mar-21,Representative patient population,Multiple groups,464,35.80%,,,Sequential,ImmunoDiagnostics,ELISA,IgM,88.20%,92.00%,High,Journal Article (Peer-Reviewed),Yordi Tarazona-Castro,Universidad Peruana de Ciencias Aplicadas,https://dx.doi.org/10.1371/journal.pone.0265820,21/04/2022,16/07/2022,Unverified
221227_SanJuandeLurigancho_VanderbiltUniversity_FollowUp,27-Dec-21,Local,Peru,PER,Lima,Lima,15-Jan-21,19-Mar-21,Household and community samples,Multiple groups,111,53.15%,43.45%,62.69%,Convenience,SD Biosensor,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),Claudio Lanata,Vanderbilt University,https://dx.doi.org/10.1111/irv.12952,03/05/2022,16/07/2022,Unverified
221227_SanJuandeLurigancho_VanderbiltUniversity_Baseline,27-Dec-21,Local,Peru,PER,Lima,Lima,09-Dec-20,15-Jan-21,Household and community samples,Multiple groups,128,46.09%,37.25%,55.12%,Convenience,SD Biosensor,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),Claudio Lanata,Vanderbilt University,https://dx.doi.org/10.1111/irv.12952,03/05/2022,16/07/2022,Unverified
201215_CiudaddelEste_MinisteriodeSaludPública_primary,15-Dec-20,Local,Paraguay,PRY,,Ciudad del Este,29-Nov-20,15-Dec-20,Household and community samples,Multiple groups,1675,30.00%,,,Unclear,NA,Not reported,Not reported,,,Unclear,News and Media,Not reported,Ministerio de Salud Pública,https://www.ultimahora.com/el-30-testeados-el-este-tuvieron-covid-n2918654.html,22/04/2021,16/07/2022,Verified
210302_Panama_InstitutodeInvestigacionesCientíficasyServiciosdeAltaTecnología_BloodDonors,02-Mar-21,Local,Panama,PAN,,"Panama City,
Colon",30-Apr-20,07-Jul-20,Blood donors,Multiple groups,255,13.33%,,,Convenience,NA,LFIA,"IgG,IgM",87.01%,98.89%,High,Journal Article (Peer-Reviewed),Alcibiades Villarreal,Instituto de Investigaciones Científicas y Servicios de Alta Tecnología,https://www.frontiersin.org/articles/10.3389/fmed.2021.616106/full,07/04/2021,16/07/2022,Verified
210302_Panama_InstitutodeInvestigacionesCientíficasyServiciosdeAltaTecnología_HCWs,02-Mar-21,Local,Panama,PAN,,"Panama City,
Colon",30-Apr-20,07-Jul-20,Health care workers and caregivers,Multiple groups,351,12.82%,,,Unclear,NA,LFIA,"IgG,IgM",87.01%,98.89%,High,Journal Article (Peer-Reviewed),Alcibiades Villarreal,Instituto de Investigaciones Científicas y Servicios de Alta Tecnología,https://www.frontiersin.org/articles/10.3389/fmed.2021.616106/full,07/04/2021,16/07/2022,Verified
200720_Lahore_ChughtaiInstituteofPathology_Overall,19-Aug-20,Local,Pakistan,PAK,,Lahore,20-May-20,30-May-20,Essential non-healthcare workers,Adults (18-64 years),154,15.60%,,,Convenience,Abbott Laboratories,CLIA,IgG,96.77%,99.00%,High,Journal Article (Peer-Reviewed),Omar Chughtai,Chughtai Institute of Pathology,https://jcpsp.pk/article-detail/frequency-of-covid19-igg-antibodies-among-special-police-squad-lahore-pakistan,03/10/2020,16/07/2022,Verified
200824_Karachi_NationalInstituteofBloodDiseases&BoneMarrowTransplantation_Overall,24-Aug-20,Local,Pakistan,PAK,Sindh,Karachi,15-May-20,15-Jul-20,Blood donors,Adults (18-64 years),370,34.60%,,,Sequential,Roche Diagnostics,CLIA,"IgA,IgM,IgG",,,High,Journal Article (Peer-Reviewed),Amber Younas,National Institute of Blood Diseases & Bone Marrow Transplantation,https://dx.doi.org/10.1016/j.transci.2020.102923,20/10/2020,16/07/2022,Verified
201109_ Peshawar_HayatabadMedicalComplex_Overall,09-Nov-20,Local,Pakistan,PAK,Khyber Pakhtunkhwa,Peshawar,13-Jul-20,15-Jul-20,Health care workers and caregivers,Multiple groups,1011,30.76%,,,Stratified probability,Roche Diagnostics,Not reported,"IgG,IgM",87.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Mohammad Noor,Hayatabad Medical Complex,https://dx.doi.org/10.7759/cureus.11389,17/01/2021,16/07/2022,Verified
200930_PeshawarCity_RiphahInternationalUniversity_Overall,30-Sep-20,Local,Pakistan,PAK,Khyber Pakhtunkhwa,Peshawar City,15-Jun-20,29-Jun-20,Health care workers and caregivers,Adults (18-64 years),1011,30.70%,27.80%,33.60%,Stratified non-probability,Roche Diagnostics,Not reported,Total Antibody,98.80%,100.00%,Moderate,Preprint,Mohsina Haq,Riphah International University,https://www.medrxiv.org/content/10.1101/2020.09.29.20203125v1,19/01/2021,16/07/2022,Verified
210103_Pakistan_LiaquatUniversity_primary,03-Jan-21,Local,Pakistan,PAK,NR,NR,15-Jun-20,15-Aug-20,Residual sera,Multiple groups,728,10.80%,,,Convenience,NA,ELISA,Not reported,100.00%,99.80%,High,Journal Article (Peer-Reviewed),Sheeba Ansari,Liaquat University,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7854312/,19/02/2021,16/07/2022,Verified
210101_Pakistan_ColSultan’sLab_Overall,01-Jan-21,Local,Pakistan,PAK,NR,NR,13-Jun-20,08-Jul-20,Residual sera,Multiple groups,453,63.80%,,,Self-referral,Roche Diagnostics,CLIA,Not reported,,,High,Journal Article (Peer-Reviewed),Sidra Ghazanfer,Col Sultan’s Lab,https://dx.doi.org/10.29271/jcpsp.2021.01.S55,11/04/2021,16/07/2022,Verified
200814_Pakistan_GetzPharma_Overall,14-Aug-20,Regional,Pakistan,PAK,NR,"Karachi, Lahore, Multan, Peshawar and Quetta",,06-Jul-20,Household and community samples,Adults (18-64 years),24210,17.50%,,,Simplified probability,Getz Pharma,LFIA,"IgG,IgM",,,Moderate,Preprint,Wajiha Javed,Getz Pharma,https://www.medrxiv.org/content/10.1101/2020.08.13.20173914v1,17/05/2021,16/07/2022,Verified
210321_Karachi_AgaKhanUniversity_Phase1Malir_PopAdj_TestAdj,15-Mar-21,Local,Pakistan,PAK,Karachi,District Malir,15-Apr-20,25-Apr-20,Household and community samples,Multiple groups,500,0.20%,0.00%,0.70%,Simplified probability,Roche Diagnostics,CLIA,"IgG,IgM",100.00%,99.80%,Low,Journal Article (Peer-Reviewed),Muhammed Imran Nisar,Aga Khan University,http://dx.doi.org/10.1016/j.ijid.2021.03.040,17/05/2021,16/07/2022,Verified
210321_Karachi_AgaKhanUniversity_Phase1East_PopAdj_TestAdj,15-Mar-21,Local,Pakistan,PAK,Karachi,District East,15-Apr-20,25-Apr-20,Household and community samples,Multiple groups,500,0.40%,0.00%,1.30%,Simplified probability,Roche Diagnostics,CLIA,"IgG,IgM",100.00%,99.80%,Low,Journal Article (Peer-Reviewed),Muhammed Imran Nisar,Aga Khan University,http://dx.doi.org/10.1016/j.ijid.2021.03.040,17/05/2021,16/07/2022,Verified
210321_Karachi_AgaKhanUniversity_Phase2Malir_PopAdj_TestAdj,15-Mar-21,Local,Pakistan,PAK,Karachi,District Malir,25-Jun-20,11-Jul-20,Household and community samples,Multiple groups,504,8.70%,5.10%,13.10%,Simplified probability,Roche Diagnostics,CLIA,"IgG,IgM",100.00%,99.80%,Low,Journal Article (Peer-Reviewed),Muhammed Imran Nisar,Aga Khan University,http://dx.doi.org/10.1016/j.ijid.2021.03.040,17/05/2021,16/07/2022,Verified
210321_Karachi_AgaKhanUniversity_Phase2East_PopAdj_TestAdj,15-Mar-21,Local,Pakistan,PAK,Karachi,District East ,25-Jun-20,11-Jul-20,Household and community samples,Multiple groups,500,15.10%,9.40%,21.70%,Simplified probability,Roche Diagnostics,CLIA,"IgG,IgM",100.00%,99.80%,Low,Journal Article (Peer-Reviewed),Muhammed Imran Nisar,Aga Khan University,http://dx.doi.org/10.1016/j.ijid.2021.03.040,17/05/2021,16/07/2022,Verified
210321_Karachi_AgaKhanUniversity_Phase3Malir_PopAdj_TestAdj,15-Mar-21,Local,Pakistan,PAK,Karachi,District Malir,17-Aug-20,22-Aug-20,Household and community samples,Multiple groups,501,12.80%,8.30%,17.70%,Simplified probability,Roche Diagnostics,CLIA,"IgG,IgM",100.00%,99.80%,Low,Journal Article (Peer-Reviewed),Muhammed Imran Nisar,Aga Khan University,http://dx.doi.org/10.1016/j.ijid.2021.03.040,17/05/2021,16/07/2022,Verified
210321_Karachi_AgaKhanUniversity_Phase3East_PopAdj_TestAdj,15-Mar-21,Local,Pakistan,PAK,Karachi,District East ,17-Aug-20,22-Aug-20,Household and community samples,Multiple groups,500,21.50%,15.60%,28.00%,Simplified probability,Roche Diagnostics,CLIA,"IgG,IgM",100.00%,99.80%,Low,Journal Article (Peer-Reviewed),Muhammed Imran Nisar,Aga Khan University,http://dx.doi.org/10.1016/j.ijid.2021.03.040,17/05/2021,16/07/2022,Verified
210421_Pakistan_MemorialCancerHospitalandResearchCenter_overall,21-Apr-21,Local,Pakistan,PAK,Punjab,Lahore,29-Jul-20,31-Jul-20,Health care workers and caregivers,Adults (18-64 years),2162,39.60%,,,Convenience,Roche Diagnostics,CLIA,"IgG,IgM,IgA",,,High,Journal Article (Peer-Reviewed),Salma Abbas,Shaukat Khanum Memorial Cancer Hospital and Research Centre,https://dx.doi.org/10.1177/10105395211011010,19/05/2021,16/07/2022,Verified
200930_Karachi_NationalInstituteOfBloodDiseasesAndBoneMarrowTransplantation,30-Sep-20,Local,Pakistan,PAK,Sindh,Kararchi,30-Aug-20,12-Sep-20,Household and community samples,Adults (18-64 years),2404,55.00%,,,Convenience,NA,CLIA,"IgG,IgM,IgA",,,High,Preprint,Faiza Rezwan,National Institute of Blood Diseases and Bone Marrow Transplantation,https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3700931,20/05/2021,16/07/2022,Unverified
210525_Pakistan_RiphahInternationalUniversity,25-May-21,National,Pakistan,PAK,,,15-Jul-20,31-Jul-20,Household and community samples,Multiple groups,15390,42.40%,41.50%,43.14%,Stratified probability,Roche Diagnostics,CLIA,"IgG,IgM,IgA",98.80%,100.00%,Moderate,Journal Article (Peer-Reviewed),Mohsina Haq,Riphah International University ,https://dx.doi.org/10.1007/s15010-021-01629-2,07/06/2021,16/07/2022,Verified
210529_Pakistan_CombinedMilitaryHospitalKharianMedicalCollege,29-May-21,National,Pakistan,PAK,,,01-Sep-20,30-Sep-20,Non-essential workers and unemployed persons,Multiple groups,442,16.96%,,,Convenience,Boditech Med Inc.,LFIA,IgG,95.80%,96.70%,High,Journal Article (Peer-Reviewed),Iffat Naiyar,Combined Military Hospital Kharian Medical College,https://dx.doi.org/10.1016/j.jtumed.2021.04.004,17/06/2021,16/07/2022,Unverified
210816_Pakistan_ChughtaiInstituteofPathology_Primary,16-Aug-21,National,Pakistan,PAK,,,01-Jul-21,20-Jul-21,Health care workers and caregivers,Adults (18-64 years),15000,33.00%,,,Simplified probability,Abbott Laboratories,CLIA,IgG,99.60%,96.70%,Moderate,Journal Article (Peer-Reviewed),Hijab Batool,Chughtai Institute of Pathology,https://dx.doi.org/10.1136/bmjopen-2020-046276,24/08/2021,16/07/2022,Unverified
210929_Islamabad_NationalInstituteofHealth_Overall,29-Sep-21,Local,Pakistan,PAK,Islamabad Capital Territory,Islamabad,01-Jun-20,30-Jun-20,Household and community samples,Multiple groups,6333,16.30%,,,Stratified probability,Abbott Laboratories,CLIA,"IgG,IgM",,,Moderate,Preprint,Mirza Amir Baig,National Institute of Health,https://www.medrxiv.org/content/10.1101/2021.09.27.21264003v1.article-info,05/10/2021,16/07/2022,Verified
210927_Karachi_AgaKhanUniversityandHospital_primary,27-Sep-21,Local,Pakistan,PAK,,Karachi,15-Dec-20,14-Feb-21,Blood donors,Multiple groups,558,53.40%,,,Convenience,NA,ELISA,IgG,,,High,Preprint,Muhammad Hasan,The Aga Khan University and Hospital,https://www.researchsquare.com/article/rs-941908/v1,13/10/2021,16/07/2022,Verified
211213_Sindh_ShaheedMohtarmaBenazirBhuttoMedicalUniversity_Primary,13-Dec-21,Regional,Pakistan,PAK,Sindh,Hyderabad,01-Aug-20,30-Nov-20,Residual sera,Adults (18-64 years),1229,16.76%,,,Convenience,Roche Diagnostics,CLIA,Not reported,,,High,Journal Article (Peer-Reviewed),Shahzad Rasheed Qureshi,Liaquat University of Medical and Health Sciences ,http://libraryaplos.com/xmlui/handle/123456789/8719,10/01/2022,16/07/2022,Unverified
220310_PeshawarCity_RiphahInternationalUniversity_OverallCrude,10-Mar-22,Local,Pakistan,PAK,,Peshawar,15-Jun-20,29-Jun-20,Health care workers and caregivers,Adults (18-64 years),987,31.41%,28.50%,34.40%,Simplified probability,Roche Diagnostics,Not reported,Not reported,10.00%,98.80%,Moderate,Journal Article (Peer-Reviewed),Mohsina Haq,Riphah International University,https://dx.doi.org/10.1177/25151355221080724,21/03/2022,16/07/2022,Unverified
220406_Pakistan_MinistryofNationalHealthServicesRegulationsandCoordination_Overall,06-Apr-22,National,Pakistan,PAK,"Punjab, Sindh, Baluchistan, Khyber Pakhtunkhwa, Azad Jammu & Kashmir, Gilgit Baltistan",,21-Oct-20,08-Nov-20,Household and community samples,Multiple groups,4998,7.02%,,,Stratified probability,Bioperfectus,LFIA,"IgG,IgM",,95.00%,Moderate,Journal Article (Peer-Reviewed),Ahsan Ahmad,Ministry of National Health Services Regulations and Coordination,https://bmjopen.bmj.com/content/12/4/e055381.abstract,12/04/2022,16/07/2022,Verified
220520_Pakistan_GetzPharma_IgGorIgM,20-May-22,National,Pakistan,PAK,Sindh; Punjab; Khyber Pakhtunkhwa; Balochistan.,Karachi; Lahore; Multan; Peshawar; and Quetta.,15-Apr-20,15-Sep-20,Multiple populations,Adults (18-64 years),17764,15.82%,,,Convenience,Getz Pharma,LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Wajiha Javed,Getz Pharma,https://doi.org/10.1186/s12879-022-07461-9,30/05/2022,16/07/2022,Unverified
220524_KhyberPakhtunkhwa_KhyberMedicalUniversity_SecondWave,24-May-22,Local,Pakistan,PAK,Khyber Pakhtunkhw,Peshawar,01-Nov-20,01-Jan-21,Blood donors,Adults (18-64 years),2100,56.00%,,,Convenience,"Abbott Laboratories,Roche Diagnostics",CLIA,Not reported,,,,Journal Article (Peer-Reviewed),M. Khan,Khyber Medical University,https://dx.doi.org/10.1111/vox.13285,06/07/2022,29/07/2022,Unverified
220620_Peshawar_RegionalBloodCentre_Overall,20-Jun-22,Regional,Pakistan,PAK,Khyber Pakhtunkhwa,Peshawar,15-Nov-20,15-Jun-21,Residual sera,Multiple groups,4047,59.00%,,,Sequential,Roche Diagnostics,CLIA,Not reported,100.00%,99.50%,High,Journal Article (Peer-Reviewed),Muhammad Nisar Khan,Regional Blood Centre,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9301020/,03/08/2022,03/08/2022,Unverified
210427_Oman_Directorate-GeneralforDiseasesSurveillanceandControl_Primary,27-Apr-21,Regional,Oman,OMN,"Al Dakhilia, North Batinah, and South Batinah goveronates",,14-Sep-20,28-Sep-20,Health care workers and caregivers,Adults (18-64 years),1078,21.00%,,,Stratified probability,DiaSorin,CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Amal Al Maani,Directorate-General for Diseases Surveillance and Control,https://dx.doi.org/10.1016/j.ijid.2021.04.071,31/05/2021,16/07/2022,Verified
210930_Oman_MinistryOfHealth_Cycle1_PrimaryEstimate,30-Sep-21,National,Oman,OMN,,,12-Jul-20,23-Jul-20,Household and community samples,Multiple groups,4210,5.50%,4.80%,6.20%,Stratified probability,DiaSorin,CLIA,IgG,,,Low,Journal Article (Peer-Reviewed),Seif Al-Abri,Ministry of Health (Oman),https://dx.doi.org/10.1016/j.ijid.2021.09.062,14/10/2021,16/07/2022,Verified
210930_Oman_MinistryOfHealth_Cycle2_PrimaryEstimate,30-Sep-21,National,Oman,OMN,,,16-Aug-20,27-Aug-20,Household and community samples,Multiple groups,4403,9.70%,8.50%,11.00%,Stratified probability,DiaSorin,CLIA,IgG,,,Low,Journal Article (Peer-Reviewed),Seif Al-Abri,Ministry of Health (Oman),https://dx.doi.org/10.1016/j.ijid.2021.09.062,14/10/2021,16/07/2022,Verified
210930_Oman_MinistryOfHealth_Cycle3_PrimaryEstimate,30-Sep-21,National,Oman,OMN,,,13-Sep-20,24-Sep-20,Household and community samples,Multiple groups,4780,16.40%,14.50%,18.40%,Stratified probability,DiaSorin,CLIA,IgG,,,Low,Journal Article (Peer-Reviewed),Seif Al-Abri,Ministry of Health (Oman),https://dx.doi.org/10.1016/j.ijid.2021.09.062,14/10/2021,16/07/2022,Verified
210930_Oman_MinistryOfHealth_Cycle4_PrimaryEstimate,30-Sep-21,National,Oman,OMN,,,08-Nov-20,19-Nov-20,Household and community samples,Multiple groups,4064,22.00%,19.60%,24.60%,Stratified probability,DiaSorin,CLIA,IgG,,,Low,Journal Article (Peer-Reviewed),Seif Al-Abri,Ministry of Health (Oman),https://dx.doi.org/10.1016/j.ijid.2021.09.062,14/10/2021,16/07/2022,Verified
210915_Oman_ArmedForcesHospital_HCW_overall,15-Sep-21,Local,Oman,OMN,,Muscat,09-Dec-20,24-Dec-20,Health care workers and caregivers,Adults (18-64 years),1111,33.60%,,,Convenience,Roche Diagnostics,Not reported,Total Antibody,98.80%,99.98%,High,Journal Article (Peer-Reviewed),Khalid Al-Naamani,Armed Forces Hospital,https://dx.doi.org/10.1016/j.jiph.2021.09.006,02/11/2021,16/07/2022,Unverified
220705_Muscat_RoyalHospital_Baseline,05-Jul-22,Local,Oman,OMN,,"Muscat
",01-May-20,31-May-20,Health care workers and caregivers,Adults (18-64 years),328,1.20%,,,Convenience,NA,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Amal Altai,The Royal Hospital,https://dx.doi.org/10.5001/omj.2022.74,19/08/2022,20/08/2022,Unverified
220705_Muscat_RoyalHospital_Follow-up,05-Jul-22,Local,Oman,OMN,,Muscat,01-Aug-20,31-Aug-20,Health care workers and caregivers,Adults (18-64 years),328,3.70%,,,Convenience,NA,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Amal Altai,The Royal Hospital,https://dx.doi.org/10.5001/omj.2022.74,19/08/2022,20/08/2022,Unverified
210107_WestBank_ArabAmericanUniversity_Households_overall_adj,07-Jan-21,Local,occupied Palestinian territory - including east Jerusalem,PSE,,West Bank,15-Jun-20,30-Jun-20,Household and community samples,Multiple groups,1355,0.00%,0.00%,0.43%,Stratified probability,Roche Diagnostics,CLIA,Total Antibody,83.87%,100.00%,Low,Journal Article (Peer-Reviewed),Nouar Qutob,Arab American University ,https://bmjopen.bmj.com/content/11/2/e044552,18/02/2021,16/07/2022,Verified
210107_WestBank_ArabAmericanUniversity_LabReferrals_overall_adj,07-Jan-21,Local,occupied Palestinian territory - including east Jerusalem,PSE,,West Bank,01-May-20,09-Jul-20,Residual sera,Multiple groups,1136,0.35%,0.13%,1.16%,Convenience,Roche Diagnostics,CLIA,Total Antibody,100.00%,83.87%,High,Journal Article (Peer-Reviewed),Nouar Qutob,Arab American University ,https://bmjopen.bmj.com/content/11/2/e044552,18/02/2021,16/07/2022,Verified
211007_Palestine_PalestinianNationalInstituteofPublicHealth_WestBank_Overall,07-Oct-21,Regional,occupied Palestinian territory - including east Jerusalem,PSE,West Bank,N/A,01-Dec-20,31-Dec-20,Household and community samples,Multiple groups,4356,38.00%,,,Stratified probability,Roche Diagnostics,CLIA,IgG,98.80%,99.98%,Moderate,Preprint,I Rayan,Palestinian National Institute of Public Health,https://www.medrxiv.org/content/10.1101/2021.10.04.21263131v1,13/10/2021,16/07/2022,Verified
211007_Palestine_PalestinianNationalInstituteofPublicHealth_Gaza_Overall,07-Oct-21,Regional,occupied Palestinian territory - including east Jerusalem,PSE,Gaza,N/A,01-Dec-20,31-Dec-20,Household and community samples,Multiple groups,2904,40.00%,,,Stratified probability,Roche Diagnostics,CLIA,IgG,98.80%,99.98%,Moderate,Preprint,I Rayan,Palestinian National Institute of Public Health,https://www.medrxiv.org/content/10.1101/2021.10.04.21263131v1,13/10/2021,16/07/2022,Verified
211008_Palestine_An-NajahNationalUniversity_Overall,08-Oct-21,Regional,occupied Palestinian territory - including east Jerusalem,PSE,West Bank,,01-Nov-20,31-Dec-20,Residual sera,Multiple groups,1269,24.03%,21.70%,26.50%,Simplified probability,Roche Diagnostics,CLIA,Total Antibody,,,Moderate,Journal Article (Peer-Reviewed),Beesan Maraqa,An-Najah National University,https://dx.doi.org/10.1371/journal.pone.0258255,19/10/2021,16/07/2022,Verified
200615_Bergen_UniversityofBergen_HouseholdMembers,15-Jun-20,Local,Norway,NOR,Western Norway,Bergen,28-Feb-20,04-Apr-20,Contacts of COVID patients,Multiple groups,77,31.17%,,,Convenience,NA,ELISA,"IgM,IgG,IgA",,,High,Journal Article (Peer-Reviewed),Rebecca Cox,University of Bergen,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7295487/,19/07/2020,16/07/2022,Verified
201128_Bergen_UniversityofBergen_primaryest_HCW,28-Nov-20,Local,Norway,NOR,Midhordland,Bergen,06-Mar-20,09-Apr-20,Health care workers and caregivers,Multiple groups,607,5.27%,,,Convenience,NA,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Mai Chi Trieu,University of Bergen,https://dx.doi.org/10.1093/infdis/jiaa737,29/01/2021,16/07/2022,Verified
210115_Norway_NorwegianArmedForcesJointMedicalServices_primary,15-Jan-21,National,Norway,NOR,,,19-Apr-20,27-Apr-20,Essential non-healthcare workers,Adults (18-64 years),1170,0.70%,,,Convenience,Roche Diagnostics,CLIA,"IgG,IgM",,,Moderate,Journal Article (Peer-Reviewed),Einar Kristian Borud,Norwegian Armed Forces Joint Medical Services,https://dx.doi.org/10.1002/hsr2.233,27/02/2021,16/07/2022,Verified
210223_Lorenskog_AkershusUniversityHospital_Overall,23-Feb-21,Local,Norway,NOR,,Lorenskog,11-May-20,11-Jun-20,Health care workers and caregivers,Adults (18-64 years),360,3.30%,,,Convenience,"DiaSorin,Roche Diagnostics",CLIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Nina Handal,Akershus University Hospital,https://dx.doi.org/10.1080/23744235.2021.1885734,23/03/2021,16/07/2022,Verified
210331_Bergen_UniversityOfBergen_overall_unadj,31-Mar-21,Local,Norway,NOR,,Bergen,28-Feb-20,04-Apr-20,Contacts of COVID patients,Multiple groups,179,45.00%,38.00%,53.00%,Convenience,NA,ELISA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Kanika Kuwelker,University of Bergen ,https://dx.doi.org/10.1016/j.lanepe.2020.100014,17/05/2021,16/07/2022,Verified
210326_Norway_ArcticUniversityOfNorway_PopAdj_TestAdj,26-Mar-21,National,Norway,NOR,,,25-Nov-20,15-Feb-21,Household and community samples,Multiple groups,27700,0.90%,0.70%,1.00%,Stratified probability,"EUROIMMUN,NA",Multiple Types,IgG,,,Low,Preprint,Erik Anda,Arctic University of Norway,https://www.medrxiv.org/content/10.1101/2021.03.23.21253730v1,18/05/2021,16/07/2022,Verified
211109_Norway_NorwegianInstituteofPublicHealth_Time1_PopTestAdj,09-Nov-21,National,Norway,NOR,,,19-Apr-20,16-May-20,Residual sera,Multiple groups,900,1.00%,0.10%,2.40%,Convenience,NA,Other,IgG,86.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Gro Tunheim,Norwegian Institute of Public Health,https://dx.doi.org/10.1111/irv.12932,18/11/2021,16/07/2022,Verified
211109_Norway_NorwegianInstituteofPublicHealth_Time2_PopTestAdj,09-Nov-21,National,Norway,NOR,,,19-Jul-20,12-Sep-20,Residual sera,Multiple groups,1812,0.60%,0.20%,1.20%,Convenience,NA,Other,IgG,86.00%,99.90%,Moderate,Journal Article (Peer-Reviewed),Gro Tunheim,Norwegian Institute of Public Health,https://dx.doi.org/10.1111/irv.12932,18/11/2021,16/07/2022,Verified
211109_Norway_NorwegianInstituteofPublicHealth_Time3_PopTestAdj,09-Nov-21,National,Norway,NOR,,,27-Dec-20,13-Feb-21,Residual sera,Multiple groups,1912,3.20%,2.30%,4.20%,Convenience,NA,Other,IgG,96.00%,99.80%,Moderate,Journal Article (Peer-Reviewed),Gro Tunheim,Norwegian Institute of Public Health,https://dx.doi.org/10.1111/irv.12932,18/11/2021,16/07/2022,Verified
211109_Norway_NorwegianInstituteofPublicHealth_Time4_Primary,09-Nov-21,National,Norway,NOR,,,01-Aug-19,31-Aug-19,Residual sera,Multiple groups,216,0.00%,,,Convenience,NA,Other,IgG,,,Unclear,Journal Article (Peer-Reviewed),Gro Tunheim,Norwegian Institute of Public Health,https://dx.doi.org/10.1111/irv.12932,18/11/2021,16/07/2022,Verified
211117_Norway_OsloUniversityHospital_KidneyTransplantRecipient,17-Nov-21,National,Norway,NOR,,,15-Jun-20,31-Oct-20,Representative patient population,Multiple groups,815,0.00%,,,Convenience,"Roche Diagnostics,NA",Multiple Types,IgG,,,High,Preprint,Kjersti B. Blom,Oslo University Hospital,https://dx.doi.org/10.1016/j.xkme.2021.09.006,01/12/2021,16/07/2022,Unverified
220113_Lorenskog_UniversityofOslo_Overall_TestAdj,13-Jan-22,Local,Norway,NOR,Akershus,Lorenskog,01-Dec-19,31-Dec-20,Pregnant or parturient women,Adults (18-64 years),6520,1.70%,,,Sequential,"Roche Diagnostics,DiaSorin",CLIA,"IgG,IgM",,,Moderate,Journal Article (Peer-Reviewed),Anne Eskild,University of Oslo,https://dx.doi.org/10.1017/S0950268822000073,18/01/2022,16/07/2022,Verified
220331_Norway_TheArcticUniversityofNorway_Popadj,31-Mar-22,National,Norway,NOR,,,15-Nov-20,15-Feb-21,Household and community samples,Multiple groups,27700,0.90%,0.70%,1.00%,Convenience,"EUROIMMUN,NA",ELISA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Erik Eik Anda,The Arctic University of Norway,https://dx.doi.org/10.2807/1560-7917.ES.2022.27.13.2100376,13/04/2022,16/07/2022,Unverified
220630_Oslo_NationalInstituteofOccupationalHealth_Followup,30-Jun-22,Local,Norway,NOR,,Oslo,07-Jan-21,17-Mar-21,Essential non-healthcare workers,Multiple groups,158,6.96%,,,Convenience,Luminex Corporation,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),Anne-Mari Moe,National Institute of Occupational Health,https://dx.doi.org/10.13075/ijomeh.1896.01942,13/07/2022,29/07/2022,Unverified
220630_Norway_NorwegianInstituteofPublicHealth_Overall_PopTestAdj,30-Jun-22,National,Norway,NOR,,,19-Jul-21,12-Sep-21,Residual sera,Multiple groups,1926,62.60%,60.10%,65.20%,Sequential,NA,Other,IgG,97.00%,99.70%,Moderate,Journal Article (Peer-Reviewed),Gro Tunheim,Norwegian Institute of Public Health,https://dx.doi.org/10.1111/irv.13024,25/07/2022,26/07/2022,Unverified
210531_Skopje_InstituteForTransfusionMedicine,31-May-21,Local,North Macedonia,MKD,Skopje,Skopje,15-Nov-20,15-Mar-21,Blood donors,Multiple groups,9773,25.00%,,,Sequential,Abbott Laboratories,CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Tatjana Makarovska Bojadjieva, Institute for Transfusion Medicine,http://dx.doi.org/10.1111/vox.13117,01/07/2021,16/07/2022,Verified
200724_Nigeria_JosephUkpoHospitalsandResearchInstitutes_HCWPatients_IgG_T1,24-Jul-20,Local,Nigeria,NGA,Cross River State,Calabar,17-Jun-20,24-Jun-20,Multiple populations,Adults (18-64 years),66,26.00%,,,Unclear,Healgen,LFIA,IgG,,,High,Preprint,Marcus Inyama Asuquo,Joseph Ukpo Hospitals and Research Institutes,https://www.medrxiv.org/content/10.1101/2020.07.02.20145441v2,27/09/2020,16/07/2022,Verified
200805_Niger_IbrahimBadamasiBabangidaUniversity_IgG_GenPop_UnAdj,05-Aug-20,Regional,Nigeria,NGA,Niger State,,26-Jun-20,30-Jun-20,Household and community samples,Multiple groups,185,25.41%,,,Stratified probability,Cambridge Network,LFIA,IgG,100.00%,100.00%,Moderate,Preprint,Hussaini Majiya,Ibrahim Badamasi Babangida University,https://www.medrxiv.org/content/10.1101/2020.08.04.20168112v1.full.pdf,14/10/2020,16/07/2022,Verified
210121_Abuja_MolecularPathologyInstituteEnugu,21-Jan-21,Local,Nigeria,NGA,NR,"Abuja, Enugu",01-Aug-20,31-Aug-20,Blood donors,Adults (18-64 years),113,42.00%,34.00%,52.00%,Convenience,NovaTec Immundiagnostics GmbH,ELISA,IgG,100.00%,100.00%,High,Preprint,Ijeoma Ifeorah,Molecular Pathology Institute,https://www.researchsquare.com/article/rs-151037/v1,22/05/2021,16/07/2022,Unverified
210719_AnambraState_StateMinistryOfHealth_testadj,19-Jul-21,Regional,Nigeria,NGA,Anambra State,,08-Dec-20,15-Dec-20,Household and community samples,Multiple groups,3142,16.07%,,,Stratified probability,Hangzhou Realy Tech Co. Ltd,LFIA,"IgG,IgM",98.00%,99.00%,Moderate,Journal Article (Peer-Reviewed),OgoChukwu Vincent Okpala,Anambra State Ministry of Health,https://www.sciencedirect.com/science/article/pii/S1201971221005968,03/08/2021,16/07/2022,Verified
220628_Kaduna_UniversityofGlasgow_Overall,28-Jun-22,Regional,Nigeria,NGA,Kaduna,"Kaduna City, Kofar-Gayan",11-Oct-21,08-Nov-21,Residual sera,Multiple groups,802,43.70%,,,Convenience,NA,LFIA,"IgG,IgM",99.00%,98.60%,High,Journal Article (Peer-Reviewed),Gloria Chechet,University of Glasgow,https://dx.doi.org/10.1093/ije/dyac141,06/07/2022,16/07/2022,Unverified
220715_Lagos_UniversityOfCambridge,15-Jul-22,Local,Nigeria,NGA,,Lagos,01-Jan-21,31-Jan-21,Health care workers and caregivers,Adults (18-64 years),140,59.29%,,,Convenience,NA,Luminex,IgG,,,High,Preprint,Adam Abdullahi,University of Cambridge,http://doi.org/10.21203/rs.3.rs-1834968/v1,28/07/2022,28/07/2022,Unverified
210819_Managua_UniversityOfMichiganAnnArbor_Primary_PopAdj,19-Aug-21,Local,Nicaragua,NIC,,Managua,15-Oct-20,15-Nov-20,Household and community samples,Multiple groups,1995,57.50%,,,Self-referral,NA,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Hannah E. Maier,"University of Michigan, Ann Arbor ",http://dx.doi.org/10.1093/cid/ciab717,21/09/2021,16/07/2022,Verified
211020_Leon_NationalAutonomousUniversityofNicaraguaatLeon_FebMar2021_TestAdj,20-Oct-21,Local,Nicaragua,NIC,, León,15-Feb-21,15-Mar-21,Household and community samples,Multiple groups,1243,34.70%,31.20%,38.20%,Convenience,NA,ELISA,Total Antibody,95.20%,96.70%,Moderate,Journal Article (Peer-Reviewed),Fredman Gonzalez,The National Autonomous University of Nicaragua at León,10.1017/s0950268821002144,01/01/2022,16/07/2022,Unverified
220105_Managua_UniversityofMichigan,05-Jan-22,Local,Nicaragua,NIC,Managua,Managua,01-Mar-20,15-Oct-21,Household and community samples,Children and Youth (0-17 years),1824,49.80%,,,Unclear,NA,ELISA,Not reported,,,Moderate,Preprint,John Kubale,University of Michigan,https://www.medrxiv.org/content/10.1101/2022.01.03.22268684v1.full-text,18/01/2022,16/07/2022,Unverified
220105_Nicaragua_MountAuburnHospital_Overall,05-Jan-22,National,Nicaragua,NIC,,,22-Feb-21,19-Mar-21,Household and community samples,Multiple groups,502,38.00%,,,Convenience,SafeCare Bio-Tech,LFIA,"IgG,IgM",91.00%,96.00%,High,Journal Article (Peer-Reviewed),Jorge Huete-Perez,Mount Auburn Hospital,https://dx.doi.org/10.1016/j.ijregi.2021.12.013,28/06/2022,16/07/2022,Unverified
220105_Nicaragua_MountAuburnHospital_Ages_0-18,05-Jan-22,National,Nicaragua,NIC,,,22-Feb-21,19-Mar-21,Household and community samples,Children and Youth (0-17 years),78,15.38%,,,Convenience,SafeCare Bio-Tech,LFIA,"IgG,IgM",91.00%,96.00%,High,Journal Article (Peer-Reviewed),Jorge Huete-Perez,Mount Auburn Hospital,https://dx.doi.org/10.1016/j.ijregi.2021.12.013,28/06/2022,16/07/2022,Unverified
220105_Nicaragua_MountAuburnHospital_Ages_19-39,05-Jan-22,National,Nicaragua,NIC,,,22-Feb-21,19-Mar-21,Household and community samples,Adults (18-64 years),208,43.75%,,,Convenience,SafeCare Bio-Tech,LFIA,"IgG,IgM",91.00%,96.00%,High,Journal Article (Peer-Reviewed),Jorge Huete-Perez,Mount Auburn Hospital,https://dx.doi.org/10.1016/j.ijregi.2021.12.013,28/06/2022,16/07/2022,Unverified
220105_Nicaragua_MountAuburnHospital_Ages_40-59,05-Jan-22,National,Nicaragua,NIC,,,22-Feb-21,19-Mar-21,Household and community samples,Adults (18-64 years),156,42.31%,,,Convenience,SafeCare Bio-Tech,LFIA,"IgG,IgM",91.00%,96.00%,High,Journal Article (Peer-Reviewed),Jorge Huete-Perez,Mount Auburn Hospital,https://dx.doi.org/10.1016/j.ijregi.2021.12.013,28/06/2022,16/07/2022,Unverified
220105_Nicaragua_MountAuburnHospital_Ages_60+,05-Jan-22,National,Nicaragua,NIC,,,22-Feb-21,19-Mar-21,Household and community samples,Seniors (65+ years),60,36.67%,,,Convenience,SafeCare Bio-Tech,LFIA,"IgG,IgM",91.00%,96.00%,High,Journal Article (Peer-Reviewed),Jorge Huete-Perez,Mount Auburn Hospital,https://dx.doi.org/10.1016/j.ijregi.2021.12.013,28/06/2022,16/07/2022,Unverified
220105_Nicaragua_MountAuburnHospital_Sex_Female,05-Jan-22,National,Nicaragua,NIC,,,22-Feb-21,19-Mar-21,Household and community samples,Multiple groups,274,37.59%,,,Convenience,SafeCare Bio-Tech,LFIA,"IgG,IgM",91.00%,96.00%,High,Journal Article (Peer-Reviewed),Jorge Huete-Perez,Mount Auburn Hospital,https://dx.doi.org/10.1016/j.ijregi.2021.12.013,28/06/2022,16/07/2022,Unverified
220105_Nicaragua_MountAuburnHospital_Sex_Male,05-Jan-22,National,Nicaragua,NIC,,,22-Feb-21,19-Mar-21,Household and community samples,Multiple groups,228,38.60%,,,Convenience,SafeCare Bio-Tech,LFIA,"IgG,IgM",91.00%,96.00%,High,Journal Article (Peer-Reviewed),Jorge Huete-Perez,Mount Auburn Hospital,https://dx.doi.org/10.1016/j.ijregi.2021.12.013,28/06/2022,16/07/2022,Unverified
220105_Nicaragua_MountAuburnHospital_City_Managua,05-Jan-22,National,Nicaragua,NIC,,Managua,22-Feb-21,19-Mar-21,Household and community samples,Multiple groups,451,38.36%,,,Convenience,SafeCare Bio-Tech,LFIA,"IgG,IgM",91.00%,96.00%,High,Journal Article (Peer-Reviewed),Jorge Huete-Perez,Mount Auburn Hospital,https://dx.doi.org/10.1016/j.ijregi.2021.12.013,28/06/2022,16/07/2022,Unverified
220105_Nicaragua_MountAuburnHospital_CIty_Leon_Masaya,05-Jan-22,National,Nicaragua,NIC,,"Leon, Masaya",22-Feb-21,19-Mar-21,Household and community samples,Multiple groups,51,35.29%,,,Convenience,SafeCare Bio-Tech,LFIA,"IgG,IgM",91.00%,96.00%,High,Journal Article (Peer-Reviewed),Jorge Huete-Perez,Mount Auburn Hospital,https://dx.doi.org/10.1016/j.ijregi.2021.12.013,28/06/2022,16/07/2022,Unverified
220525_Managua_UniversityofMichigan_2020,25-May-22,Local,Nicaragua,NIC,,Managua,01-Mar-20,30-Sep-21,Residual sera,Children and Youth (0-17 years),1455,1.60%,,,Sequential,NA,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Aaron Frutos,University of Michigan ,https://dx.doi.org/10.1371/journal.pgph.0000414,13/07/2022,25/07/2022,Unverified
220525_Managua_ UniversityofMichigan_2021,25-May-22,Local,Nicaragua,NIC,,Managua,01-Mar-20,30-Sep-21,Residual sera,Children and Youth (0-17 years),1743,49.00%,,,Sequential,NA,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Aaron Frutos,University of Michigan ,https://dx.doi.org/10.1371/journal.pgph.0000414,13/07/2022,25/07/2022,Unverified
220627_Nicarugua_UniversityOfMichiganSchoolOfPublicHealth,27-Jun-22,National,Nicaragua,NIC,,,01-Mar-20,15-Oct-21,Household and community samples,Children and Youth (0-17 years),1824,49.80%,47.50%,52.10%,Convenience,NA,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),John Kubale,University of Michigan School of Public Health,https://dx.doi.org/10.1001/jamanetworkopen.2022.18794,25/07/2022,25/07/2022,Unverified
210419_NewZealand_UniversityOfAuckland_BloodDonors,19-Apr-21,National,New Zealand,NZL,,,03-Dec-20,06-Jan-21,Blood donors,Adults (18-64 years),9806,0.10%,0.09%,0.12%,Sequential,"EUROIMMUN,GenScript",Multiple Types,IgG,81.70%,100.00%,Moderate,Preprint,Lauren Carlton,University of Auckland,https://www.medrxiv.org/content/10.1101/2021.04.12.21255282v1,20/05/2021,16/07/2022,Verified
210518_NewZealand_SouthernCommunityLaboratories_MostAdj,18-May-21,Regional,New Zealand,NZL,Southern Region,,04-Jun-20,04-Aug-20,Contacts of COVID patients,Multiple groups,1127,0.80%,0.40%,1.50%,Convenience,"Abbott Laboratories,Beijing Wantai Biological,EUROIMMUN,GenScript,NA",Multiple Types,"IgG,Neutralizing ",,,Moderate,Journal Article (Peer-Reviewed),Alyson Craigie,Southern Community Laboratories,https://dx.doi.org/10.1016/j.pathol.2021.04.001,20/06/2021,16/07/2022,Verified
201112_Netherlands_AmsterdamUMC_GenPop_Overall_1Test,12-Nov-20,National,Netherlands,NLD,,,01-Apr-20,15-Apr-20,Blood donors,Multiple groups,7361,3.40%,,,Sequential,Beijing Wantai Biological,ELISA,"IgG,IgA,IgM",100.00%,99.10%,Moderate,Journal Article (Peer-Reviewed),Ed Slot,Amsterdam UMC,https://www.nature.com/articles/s41467-020-19481-7,25/05/2020,16/07/2022,Verified
200824_Rotterdam_ErasmusMedicalCentre_1_March,24-Aug-20,Local,Netherlands,NLD,,Rotterdam,02-Mar-20,06-Mar-20,Residual sera,Multiple groups,879,0.20%,,,Convenience,NA,Not reported,IgG,,100.00%,High,Preprint,Brenda Westerhuis,Erasmus Medical Centre,https://www.medrxiv.org/content/10.1101/2020.08.21.20177857v1,19/10/2020,16/07/2022,Verified
200824_Rotterdam_ErasmusMedicalCentre_2_April,24-Aug-20,Local,Netherlands,NLD,,Rotterdam,03-Apr-20,07-Apr-20,Residual sera,Multiple groups,729,2.50%,,,Convenience,NA,Not reported,IgG,,100.00%,High,Preprint,Brenda Westerhuis,Erasmus Medical Centre,https://www.medrxiv.org/content/10.1101/2020.08.21.20177857v1,19/10/2020,16/07/2022,Verified
201128_Netherlands_CentreforInfectiousDiseaseControl_LowVaccineCoverage_overall,28-Nov-20,National,Netherlands,NLD,,,31-Mar-20,11-May-20,Household and community samples,Multiple groups,570,2.90%,1.40%,6.30%,Stratified probability,NA,ELISA,IgG,84.40%,99.00%,Low,Journal Article (Peer-Reviewed),Eric Vos,Centre for Infectious Disease Control,https://dx.doi.org/10.1136/jech-2020-215678,24/01/2021,16/07/2022,Verified
210316_Netherlands_SanquinResearch_blooddonors,16-Mar-21,National,Netherlands,NLD,,,11-May-20,18-May-20,Blood donors,Multiple groups,3676,6.50%,,,Entire sample,Beijing Wantai Biological,ELISA,Not reported,98.70%,99.60%,Moderate,Journal Article (Peer-Reviewed),Katj van den HUrk,Sanquin Research,https://dx.doi.org/10.1016/j.xcrm.2021.100222,10/05/2021,16/07/2022,Verified
210430_Amsterdam_AmsterdamUniversityMedicalCenter,30-Apr-21,Local,Netherlands,NLD,North Holland,Amsterdam,31-Jul-20,18-Dec-20,Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),546,11.70%,,,Convenience,NA,Not reported,Not reported,98.10%,99.50%,High,Journal Article (Peer-Reviewed),Zoe van Kempen,Amsterdam University Medical Center,https://dx.doi.org/10.1001/jamaneurol.2021.1364,25/05/2021,16/07/2022,Unverified
210323_Budel_MaastrichtUniversity_Overall,23-Mar-21,Local,Netherlands,NLD,North Brabant,Budel,04-Jun-20,16-Jun-20,Health care workers and caregivers,Adults (18-64 years),240,39.17%,,,Convenience,Beijing Wantai Biological,Not reported,"IgA,IgG,IgM",96.10%,98.00%,High,Journal Article (Peer-Reviewed),Joyce Heffels,Maastricht University,https://dx.doi.org/10.36613/tgg.1875-6832/2021.01.01,08/06/2021,16/07/2022,Verified
210728_Amsterdam_AmsterdamUniversityMedicalCenters_COVIDCare3,28-Jul-21,Local,Netherlands,NLD,,Amsterdam,23-Mar-20,25-Jun-20,Health care workers and caregivers,Adults (18-64 years),439,13.20%,9.90%,16.40%,Convenience,Beijing Wantai Biological,ELISA,Total Antibody,85.20%,99.30%,High,Journal Article (Peer-Reviewed),Jonne Sikkens,Amsterdam University Medical Centers ,https://dx.doi.org/10.1001/jamanetworkopen.2021.18554,02/08/2021,16/07/2022,Verified
210728_Amsterdam_AmsterdamUniversityMedicalCenters_NonCOVIDCare2,28-Jul-21,Local,Netherlands,NLD,,Amsterdam,25-Jun-20,25-Jun-20,Health care workers and caregivers,Adults (18-64 years),164,6.70%,2.80%,10.50%,Convenience,Beijing Wantai Biological,ELISA,Total Antibody,85.20%,99.30%,High,Journal Article (Peer-Reviewed),Jonne Sikkens,Amsterdam University Medical Centers ,https://dx.doi.org/10.1001/jamanetworkopen.2021.18554,02/08/2021,16/07/2022,Verified
210728_Amsterdam_AmsterdamUniversityMedicalCenters_NoPatientCare1,28-Jul-21,Local,Netherlands,NLD,,Amsterdam,23-Mar-20,25-Jun-20,Health care workers and caregivers,Adults (18-64 years),198,3.60%,0.90%,6.10%,Convenience,Beijing Wantai Biological,ELISA,Total Antibody,85.20%,99.30%,High,Journal Article (Peer-Reviewed),Jonne Sikkens,Amsterdam University Medical Centers ,https://dx.doi.org/10.1001/jamanetworkopen.2021.18554,02/08/2021,16/07/2022,Verified
210915_Netherlands_UniversityofAmsterdam_Wantai_Overall,15-Sep-21,Local,Netherlands,NLD,North Holland,Amsterdam,12-Apr-20,02-Oct-20,Residual sera,Children and Youth (0-17 years),487,3.29%,1.90%,5.30%,Convenience,Beijing Wantai Biological,ELISA,Total Antibody,96.70%,97.50%,High,Journal Article (Peer-Reviewed),Maya Keuning,University of Amsterdam,https://dx.doi.org/10.1128/Spectrum.00731-21,22/09/2021,16/07/2022,Verified
211008_NorthBrabant_RegionalPublicHealthServiceofWestBrabant_Overall,08-Oct-21,Regional,Netherlands,NLD,North Brabant,,01-Jun-20,14-Jul-20,Non-essential workers and unemployed persons,Multiple groups,497,11.30%,,,Convenience,Beijing Wantai Biological,ELISA,"IgA,IgM,IgG",96.00%,99.00%,Moderate,Journal Article (Peer-Reviewed),Dymphie Mioch,Regional Public Health Service of West-Brabant,https://dx.doi.org/10.1016/j.pmedr.2021.101594,19/10/2021,16/07/2022,Unverified
211018_Venlo_VieCuriMedicalCentre_Overall,18-Oct-21,Local,Netherlands,NLD,Limburg,Venlo,22-Jun-20,03-Jul-20,Health care workers and caregivers,Multiple groups,2507,21.10%,,,Convenience,Beijing Wantai Biological,ELISA,Total Antibody,97.50%,99.60%,Moderate,Journal Article (Peer-Reviewed),Maud Bouwman,VieCuri Medical Centre,http://dx.doi.org/10.1136/bmjopen-2021-051573,04/11/2021,16/07/2022,Unverified
211027_Amsterdam_AmsterdamUniversityMedicalCenters_HIVpos_SepOct2020,27-Oct-21,Local,Netherlands,NLD,,Amsterdam,01-Sep-20,31-Oct-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,236,5.50%,,,Convenience,Eurofins Ingenasa,ELISA,Total Antibody,100.00%,98.20%,High,Presentation or Conference,Myrthe L Verburgh,Amsterdam University Medical Centers,http://dx.doi.org/10.1111/hiv.13183,14/12/2021,16/07/2022,Verified
211027_Amsterdam_AmsterdamUniversityMedicalCenters_HIVneg_SepOct2020,27-Oct-21,Local,Netherlands,NLD,,Amsterdam,01-Sep-20,31-Oct-20,Multiple populations,Multiple groups,312,6.70%,,,Convenience,Eurofins Ingenasa,ELISA,Total Antibody,100.00%,98.20%,High,Presentation or Conference,Myrthe L Verburgh,Amsterdam University Medical Centers,http://dx.doi.org/10.1111/hiv.13183,14/12/2021,16/07/2022,Verified
211027_Amsterdam_AmsterdamUniversityMedicalCenters_HIVpos_MarApr2021,27-Oct-21,Local,Netherlands,NLD,,Amsterdam,01-Mar-21,30-Apr-21,Patients seeking care for non-COVID-19 reasons,Multiple groups,202,12.90%,,,Convenience,Eurofins Ingenasa,ELISA,Total Antibody,100.00%,98.20%,High,Presentation or Conference,Myrthe L Verburgh,Amsterdam University Medical Centers,http://dx.doi.org/10.1111/hiv.13183,14/12/2021,16/07/2022,Verified
211027_Amsterdam_AmsterdamUniversityMedicalCenters_HIVneg_MarApr2021,27-Oct-21,Local,Netherlands,NLD,,Amsterdam,01-Mar-21,30-Apr-21,Multiple populations,Multiple groups,288,12.20%,,,Convenience,Eurofins Ingenasa,ELISA,Total Antibody,100.00%,98.20%,High,Presentation or Conference,Myrthe L Verburgh,Amsterdam University Medical Centers,http://dx.doi.org/10.1111/hiv.13183,14/12/2021,16/07/2022,Verified
211228_Limburg_SouthLimburgPublicHealthService_Primary,28-Dec-21,Regional,Netherlands,NLD,Limburg,,28-Oct-20,23-Dec-20,Household and community samples,Multiple groups,10001,19.50%,18.70%,20.30%,Convenience,Beijing Wantai Biological,ELISA,"IgG,IgM,IgA",95.40%,99.60%,High,Preprint,Demi Pagen,South Limburg Public Health Service,https://assets.researchsquare.com/files/rs-1159143/v1/ad6e3392-8480-4bf2-9e9a-37c27020976e.pdf?c=1640718437,08/01/2022,16/07/2022,Verified
211220_Amsterdam_AmsterdamInfectionandImmunityInstitute_Overall,20-Dec-21,Local,Netherlands,NLD,North Holland,Amsterdam,15-Sep-20,15-Apr-21,Multiple populations,Multiple groups,563,10.83%,,,Convenience,Eurofins Ingenasa,Not reported,Total Antibody,100.00%,98.20%,High,Journal Article (Peer-Reviewed),Myrthe Verburgh,Amsterdam Infection and Immunity Institute,https://dx.doi.org/10.1093/infdis/jiab616,09/01/2022,16/07/2022,Verified
211214_Amsterdam_UniversityofAmsterdam_Visit2,14-Dec-21,Local,Netherlands,NLD,North Holland,Amsterdam,23-Nov-20,04-Jun-21,Household and community samples,Multiple groups,2075,23.61%,,,Convenience,Beijing Wantai Biological,ELISA,"IgA,IgG,IgM",94.00%,,High,Journal Article (Peer-Reviewed),Liza Coyer,University of Amsterdam,https://dx.doi.org/10.1016/j.lanepe.2021.100284,12/01/2022,16/07/2022,Verified
211009_Rotterdam_FranciscusGasthuisandVlietland_Period1_Overall,01-Dec-21,Local,Netherlands,NLD,South Holland,Rotterdam,19-Jul-20,19-Sep-20,Residual sera,Children and Youth (0-17 years),209,4.10%,1.10%,7.10%,Sequential,Beijing Wantai Biological,ELISA,Total Antibody,,,High,Journal Article (Peer-Reviewed),I.L.M. Rotee,Franciscus Gasthuis & Vlietland,https://dx.doi.org/10.1016/j.jcvp.2021.100045,15/03/2022,16/07/2022,Verified
211009_Rotterdam_FranciscusGasthuisandVlietland_Period2_Overall,01-Dec-21,Local,Netherlands,NLD,South Holland,Rotterdam,19-Oct-20,19-Dec-20,Residual sera,Children and Youth (0-17 years),240,13.80%,9.00%,18.70%,Sequential,Beijing Wantai Biological,ELISA,Total Antibody,,,High,Journal Article (Peer-Reviewed),I.L.M. Rotee, Franciscus Gasthuis & Vlietland,https://dx.doi.org/10.1016/j.jcvp.2021.100045,15/03/2022,16/07/2022,Verified
210404_Nepal_GovernmentOfNepal_overall_PopAdj,04-Apr-21,National,Nepal,NPL,,,09-Oct-20,22-Oct-20,Household and community samples,Multiple groups,3040,14.40%,11.80%,17.00%,Stratified probability,Beijing Wantai Biological,ELISA,Total Antibody,96.70%,97.50%,Low,Institutional Report,Government of Nepal,Government of Nepal,https://mohp.gov.np/attachments/article/708/First%20Sero-prevalence_final_report_04-04-2021.pdf,22/05/2021,16/07/2022,Verified
210623_KathmanduValley_NepalHealthResearchCouncil_TestAdj,23-Jun-21,Regional,Nepal,NPL,Bagmati Pradesh Province,Kathmandu Valley,03-Dec-20,25-Dec-20,Health care workers and caregivers,Adults (18-64 years),800,38.99%,29.08%,43.91%,Stratified probability,Ortho Clinical Diagnostics Inc.,CLIA,IgG,89.30%,99.20%,Moderate,Preprint,Kiran Raj Pandey,Nepal Health Research Council,10.21203/rs.3.rs-626260/v1,05/07/2021,16/07/2022,Unverified
210706_Kathmandu_ManmohanMemorialMedicalCollege_primary,06-Jul-21,Local,Nepal,NPL,,Kathmandu,15-Nov-20,15-Jan-21,Health care workers and caregivers,Adults (18-64 years),185,22.20%,,,Convenience,Zybio Inc.,Other,"IgM,IgG",,,High,Preprint,Suraj Aryal,Manmohan Memorial Medical College,https://www.medrxiv.org/content/10.1101/2021.07.01.21259884v1.full-text,13/07/2021,16/07/2022,Verified
210830_Nepal_MinistryofHealthandPopulation_Overall,30-Aug-21,National,Nepal,NPL,,,05-Jul-21,14-Aug-21,Household and community samples,Multiple groups,13161,68.60%,,,Simplified probability,NA,Not reported,Not reported,,,Unclear,News and Media,Shuvam Dhungana,Ministry of Health and Population,https://kathmandupost.com/health/2021/08/30/over-two-thirds-population-has-covid-19-antibodies-seroprevalence-study-shows,07/09/2021,16/07/2022,Verified
220201_Kathmandu_ManmohanMemorialMedicalCollegeAndTeachingHospital_Overall,01-Feb-22,Local,Nepal,NPL,,Kathmandu,15-Nov-20,15-Jan-21,Health care workers and caregivers,Adults (18-64 years),185,22.16%,,,Convenience,Zybio Inc.,LFIA,"IgM,IgG",,,High,Journal Article (Peer-Reviewed),Suraj Aryal,Manmohan Memorial Medical College and Teaching Hospital,https://dx.doi.org/10.1155/2022/8515051,20/02/2022,16/07/2022,Unverified
201127_Chimoio_RepúblicaDeMoçambiqueMinistérioDaSaúde_Genpop_Primary,27-Nov-20,Local,Mozambique,MOZ,Manica Province,Chimoio,02-Nov-20,17-Nov-20,Household and community samples,Multiple groups,9756,1.40%,,,Stratified probability,Qingdao Hightop Biotech Co. Ltd ,LFIA,"IgG,IgM",,,Moderate,Presentation or Conference,Arlete Mahumane,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/11/Inqueirito-SE-SARS-CoV-2-de-Cidade-de-Chimoio-Resultados-preliminares-27-Nov-2020-V_1.1_corrigido-I_JANI_FINAL1.pdf,20/05/2021,16/07/2022,Verified
201216_Mozambique_RepúblicaDeMoçambiqueMinistérioDaSaúde_Massinga2_Genpop_Primary,16-Dec-20,Local,Mozambique,MOZ,Inhambane,Massinga,26-Nov-20,03-Dec-20,Household and community samples,Multiple groups,1577,7.40%,,,Stratified probability,Qingdao Hightop Biotech Co. Ltd ,LFIA,"IgG,IgM",,,Moderate,Presentation or Conference,Mussagy Mahomed,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/12/Inquerito-de-SARS-CoV-2_Maxixe-e-Massinga.pdf,21/05/2021,16/07/2022,Verified
201216_Maxixe&Massinga_RepúblicaDeMoçambiqueMinistérioDaSaúde_Maxixe1_Genpop_Primary,16-Dec-20,Local,Mozambique,MOZ,Inhambane,Maxixe,07-Nov-20,21-Nov-20,Household and community samples,Multiple groups,3974,5.50%,,,Stratified probability,Qingdao Hightop Biotech Co. Ltd ,LFIA,"IgG,IgM",,,Moderate,Presentation or Conference,Mussagy Mahomed,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/12/Inquerito-de-SARS-CoV-2_Maxixe-e-Massinga.pdf,21/05/2021,16/07/2022,Verified
200701_NampulaCity_RepúblicaDeMoçambiqueMinistérioDaSaúde_Genpop_Primary,07-Jul-20,Local,Mozambique,MOZ,Nampula,Nampula,17-Jun-20,30-Jun-20,Household and community samples,Multiple groups,1769,5.00%,4.00%,6.00%,Stratified probability,SD Biosensor,LFIA,"IgG,IgM",,,Moderate,Presentation or Conference,Eduardo Samo Gudo,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/12/Inquerito-SARS-CoV-2-NAMPULA_vfinal.pdf,21/05/2021,16/07/2022,Verified
201015_Beira_RepúblicaDeMoçambiqueMinistérioDaSaúde_Genpop,15-Oct-20,Local,Mozambique,MOZ,Sofala,Beira,21-Sep-20,02-Oct-20,Household and community samples,Multiple groups,4940,5.20%,,,Stratified probability,Abbott Laboratories,LFIA,"IgG,IgM",,,Moderate,Presentation or Conference,Nedio Mabunda,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/10/InCOVID-2020_-BEIRA_-RESULTADOS-PRELIMINARES.pdf,21/05/2021,16/07/2022,Verified
200924_TeteCity_RepúblicaDeMoçambiqueMinistérioDaSaúde_Genpop,24-Sep-20,Local,Mozambique,MOZ,Tete,Tete,31-Aug-20,12-Oct-20,Household and community samples,Multiple groups,1946,0.70%,,,Stratified probability,Qingdao Hightop Biotech Co. Ltd ,LFIA,"IgG,IgM",,,Moderate,Presentation or Conference,Mussagy Mahomed,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/09/Inque%CC%81rito-SE-SARS-CoV-2_Cidade-de-Tete_resultados.pdf,21/05/2021,16/07/2022,Verified
201021_Matola_RepúblicaDeMoçambiqueMinistérioDaSaúde_Genpop,21-Oct-20,Local,Mozambique,MOZ,Maputo,Matolo,14-Sep-20,30-Sep-20,Household and community samples,Multiple groups,5394,3.56%,,,Stratified probability,Abbott Laboratories,LFIA,"IgG,IgM",,,Moderate,Presentation or Conference,Ivalda Macicame,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/10/Inque%CC%81rito-Provincia-de-Maputo_resultados-preliminares_21Out2020-versao-final.pdf,21/05/2021,16/07/2022,Verified
201019_Lichinga_RepúblicaDeMoçambiqueMinistérioDaSaúde_Genpop,19-Oct-20,Local,Mozambique,MOZ,Niassa,Lichinga,28-Sep-20,09-Oct-20,Household and community samples,Multiple groups,1635,0.30%,,,Stratified probability,Qingdao Hightop Biotech Co. Ltd ,LFIA,"IgG,IgM",,,Moderate,Presentation or Conference,Jeronimo Langa,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/10/Inquerito-SE-SARS-CoV-2-Lichinga_19-10-020.pdf,22/05/2021,16/07/2022,Verified
201208_Xai-Xai&Chokwe_RepúblicaDeMoçambiqueMinistérioDaSaúde_Xai-Xai1_Genpop_Primary,08-Dec-20,Local,Mozambique,MOZ,Gaza,Xai-Xai,02-Nov-20,12-Nov-20,Household and community samples,Multiple groups,4932,3.70%,,,Stratified probability,Abbott Laboratories,LFIA,"IgG,IgM",,,Moderate,Presentation or Conference,Paulo Arnaldo,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/12/InCOVID-2020_-XAI-XAI-CHOKWE_-RESULTADOS-PRELIMINARES_08-12-2020.pdf,22/05/2021,16/07/2022,Verified
201208_Xai-Xai&Chokwe_RepúblicaDeMoçambiqueMinistérioDaSaúde_Chokwe2_Genpop_Primary,08-Dec-20,Local,Mozambique,MOZ,Gaza,Chokwe,16-Nov-20,21-Nov-20,Household and community samples,Multiple groups,2451,5.30%,,,Stratified probability,Abbott Laboratories,LFIA,"IgG,IgM",,,Moderate,Presentation or Conference,Paulo Arnaldo,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/12/InCOVID-2020_-XAI-XAI-CHOKWE_-RESULTADOS-PRELIMINARES_08-12-2020.pdf,22/05/2021,16/07/2022,Verified
201727_Pemba_RepúblicaDeMoçambiqueMinistérioDaSaúde_Fishermen,27-Jul-20,Local,Mozambique,MOZ,Cabo Delgado,Pemba,06-Jul-20,13-Jul-20,Non-essential workers and unemployed persons,Adults (18-64 years),80,5.00%,,,Convenience,Qingdao Hightop Biotech Co. Ltd ,LFIA,"IgG,IgM",,,High,Presentation or Conference,Paulo Arnaldo,República de Moçambique Ministério da Saúde,https://covid19.ins.gov.mz/wp-content/uploads/2020/09/Inquerito-SARS-CoV-2-PEMBA_-RESULTADOS-PRELIMINARES_FINAL_3_27.07.2020.pdf,25/06/2021,16/07/2022,Verified
201727_Pemba_RepúblicaDeMoçambiqueMinistérioDaSaúde_DisplacedPeople,27-Jul-20,Local,Mozambique,MOZ,Cabo Delgado,Pemba,06-Jul-20,13-Jul-20,Persons experiencing homelessness,Multiple groups,66,6.10%,,,Convenience,Qingdao Hightop Biotech Co. Ltd ,LFIA,"IgG,IgM",,,High,Presentation or Conference,Paulo Arnaldo,República de Moçambique Ministério da Saúde,https://covid19.ins.gov.mz/wp-content/uploads/2020/09/Inquerito-SARS-CoV-2-PEMBA_-RESULTADOS-PRELIMINARES_FINAL_3_27.07.2020.pdf,25/06/2021,16/07/2022,Verified
201015_Beira_RepúblicaDeMoçambiqueMinistérioDaSaúde_CommercialEstablishments,15-Oct-20,Local,Mozambique,MOZ,Sofala,Beira,21-Sep-20,02-Oct-20,Non-essential workers and unemployed persons,Multiple groups,188,6.90%,,,Convenience,Abbott Laboratories,LFIA,"IgG,IgM",,,High,Presentation or Conference,Nedio Mabunda,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/10/InCOVID-2020_-BEIRA_-RESULTADOS-PRELIMINARES.pdf,09/07/2021,16/07/2022,Verified
201015_Beira_RepúblicaDeMoçambiqueMinistérioDaSaúde_DefenceForces,15-Oct-20,Local,Mozambique,MOZ,Sofala,Beira,21-Sep-20,02-Oct-20,Essential non-healthcare workers,Multiple groups,324,2.80%,,,Convenience,Abbott Laboratories,LFIA,"IgG,IgM",,,High,Presentation or Conference,Nedio Mabunda,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/10/InCOVID-2020_-BEIRA_-RESULTADOS-PRELIMINARES.pdf,09/07/2021,16/07/2022,Verified
201015_Beira_RepúblicaDeMoçambiqueMinistérioDaSaúde_HCW,15-Oct-20,Local,Mozambique,MOZ,Sofala,Beira,21-Sep-20,02-Oct-20,Health care workers and caregivers,Multiple groups,787,3.90%,,,Convenience,Abbott Laboratories,LFIA,"IgG,IgM",,,High,Presentation or Conference,Nedio Mabunda,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/10/InCOVID-2020_-BEIRA_-RESULTADOS-PRELIMINARES.pdf,09/07/2021,16/07/2022,Verified
201015_Beira_RepúblicaDeMoçambiqueMinistérioDaSaúde_TransportationWorkers,15-Oct-20,Local,Mozambique,MOZ,Sofala,Beira,21-Sep-20,02-Oct-20,Essential non-healthcare workers,Multiple groups,473,8.70%,,,Convenience,Abbott Laboratories,LFIA,"IgG,IgM",,,High,Presentation or Conference,Nedio Mabunda,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/10/InCOVID-2020_-BEIRA_-RESULTADOS-PRELIMINARES.pdf,09/07/2021,16/07/2022,Verified
201015_Beira_RepúblicaDeMoçambiqueMinistérioDaSaúde_VendorsMerchants,15-Oct-20,Local,Mozambique,MOZ,Sofala,Beira,21-Sep-20,02-Oct-20,Non-essential workers and unemployed persons,Multiple groups,1585,8.30%,,,Convenience,Abbott Laboratories,LFIA,"IgG,IgM",,,High,Presentation or Conference,Nedio Mabunda,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/10/InCOVID-2020_-BEIRA_-RESULTADOS-PRELIMINARES.pdf,09/07/2021,16/07/2022,Verified
200701_NampulaCity_RepúblicaDeMoçambiqueMinistérioDaSaúde_Refugees,07-Jul-20,Local,Mozambique,MOZ,Nampula,Nampula,17-Jun-20,30-Jun-20,Persons experiencing homelessness,Multiple groups,221,6.00%,2.00%,8.00%,Convenience,SD Biosensor,LFIA,"IgG,IgM",,,High,Presentation or Conference,Eduardo Samo Gudo,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/12/Inquerito-SARS-CoV-2-NAMPULA_vfinal.pdf,12/07/2021,16/07/2022,Verified
200701_NampulaCity_RepúblicaDeMoçambiqueMinistérioDaSaúde_CommercialEstablishments,07-Jul-20,Local,Mozambique,MOZ,Nampula,Nampula,17-Jun-20,30-Jun-20,Non-essential workers and unemployed persons,Adults (18-64 years),250,5.00%,2.00%,7.00%,Convenience,SD Biosensor,LFIA,"IgG,IgM",,,High,Presentation or Conference,Eduardo Samo Gudo,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/12/Inquerito-SARS-CoV-2-NAMPULA_vfinal.pdf,12/07/2021,16/07/2022,Verified
200701_NampulaCity_RepúblicaDeMoçambiqueMinistérioDaSaúde_Police,07-Jul-20,Local,Mozambique,MOZ,Nampula,Nampula,17-Jun-20,30-Jun-20,Essential non-healthcare workers,Adults (18-64 years),564,6.00%,4.00%,8.00%,Convenience,SD Biosensor,LFIA,"IgG,IgM",,,High,Presentation or Conference,Eduardo Samo Gudo,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/12/Inquerito-SARS-CoV-2-NAMPULA_vfinal.pdf,12/07/2021,16/07/2022,Verified
200701_NampulaCity_RepúblicaDeMoçambiqueMinistérioDaSaúde_HCW,07-Jul-20,Local,Mozambique,MOZ,Nampula,Nampula,17-Jun-20,30-Jun-20,Health care workers and caregivers,Adults (18-64 years),1427,7.00%,6.00%,9.00%,Convenience,SD Biosensor,LFIA,"IgG,IgM",,,High,Presentation or Conference,Eduardo Samo Gudo,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/12/Inquerito-SARS-CoV-2-NAMPULA_vfinal.pdf,12/07/2021,16/07/2022,Verified
200701_NampulaCity_RepúblicaDeMoçambiqueMinistérioDaSaúde_TransportationWorkers,07-Jul-20,Local,Mozambique,MOZ,Nampula,Nampula,17-Jun-20,30-Jun-20,Essential non-healthcare workers,Adults (18-64 years),554,3.00%,1.00%,4.00%,Convenience,SD Biosensor,LFIA,"IgG,IgM",,,High,Presentation or Conference,Eduardo Samo Gudo,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/12/Inquerito-SARS-CoV-2-NAMPULA_vfinal.pdf,12/07/2021,16/07/2022,Verified
200701_NampulaCity_RepúblicaDeMoçambiqueMinistérioDaSaúde_MerchantsVendors,07-Jul-20,Local,Mozambique,MOZ,Nampula,Nampula,17-Jun-20,30-Jun-20,Non-essential workers and unemployed persons,Adults (18-64 years),1493,10.00%,8.00%,11.00%,Convenience,SD Biosensor,LFIA,"IgG,IgM",,,High,Presentation or Conference,Eduardo Samo Gudo,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/12/Inquerito-SARS-CoV-2-NAMPULA_vfinal.pdf,12/07/2021,16/07/2022,Verified
201127_Chimoio_RepúblicaDeMoçambiqueMinistérioDaSaúde_TransportationWorkers,27-Nov-20,Local,Mozambique,MOZ,Manica Province,Chimoio,02-Nov-20,17-Nov-20,Essential non-healthcare workers,Adults (18-64 years),287,1.00%,,,Convenience,Qingdao Hightop Biotech Co. Ltd ,LFIA,"IgG,IgM",,,High,Presentation or Conference,Arlete Mahumane,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/11/Inqueirito-SE-SARS-CoV-2-de-Cidade-de-Chimoio-Resultados-preliminares-27-Nov-2020-V_1.1_corrigido-I_JANI_FINAL1.pdf,12/07/2021,16/07/2022,Verified
201127_Chimoio_RepúblicaDeMoçambiqueMinistérioDaSaúde_HCW,27-Nov-20,Local,Mozambique,MOZ,Manica Province,Chimoio,02-Nov-20,17-Nov-20,Health care workers and caregivers,Adults (18-64 years),380,1.30%,,,Convenience,Qingdao Hightop Biotech Co. Ltd ,LFIA,"IgG,IgM",,,High,Presentation or Conference,Arlete Mahumane,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/11/Inqueirito-SE-SARS-CoV-2-de-Cidade-de-Chimoio-Resultados-preliminares-27-Nov-2020-V_1.1_corrigido-I_JANI_FINAL1.pdf,12/07/2021,16/07/2022,Verified
201127_Chimoio_RepúblicaDeMoçambiqueMinistérioDaSaúde_DefenceForces,27-Nov-20,Local,Mozambique,MOZ,Manica Province,Chimoio,02-Nov-20,17-Nov-20,Essential non-healthcare workers,Adults (18-64 years),407,4.90%,,,Convenience,Qingdao Hightop Biotech Co. Ltd ,LFIA,"IgG,IgM",,,High,Presentation or Conference,Arlete Mahumane,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/11/Inqueirito-SE-SARS-CoV-2-de-Cidade-de-Chimoio-Resultados-preliminares-27-Nov-2020-V_1.1_corrigido-I_JANI_FINAL1.pdf,12/07/2021,16/07/2022,Verified
201127_Chimoio_RepúblicaDeMoçambiqueMinistérioDaSaúde_CommercialEstablishments,27-Nov-20,Local,Mozambique,MOZ,Manica Province,Chimoio,02-Nov-20,17-Nov-20,Non-essential workers and unemployed persons,Adults (18-64 years),172,4.70%,,,Convenience,Qingdao Hightop Biotech Co. Ltd ,LFIA,"IgG,IgM",,,High,Presentation or Conference,Arlete Mahumane,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/11/Inqueirito-SE-SARS-CoV-2-de-Cidade-de-Chimoio-Resultados-preliminares-27-Nov-2020-V_1.1_corrigido-I_JANI_FINAL1.pdf,12/07/2021,16/07/2022,Verified
201127_Chimoio_RepúblicaDeMoçambiqueMinistérioDaSaúde_VendorsMerchants,27-Nov-20,Local,Mozambique,MOZ,Manica Province,Chimoio,02-Nov-20,17-Nov-20,Non-essential workers and unemployed persons,Adults (18-64 years),643,1.90%,,,Convenience,Qingdao Hightop Biotech Co. Ltd ,LFIA,"IgG,IgM",,,High,Presentation or Conference,Arlete Mahumane,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/11/Inqueirito-SE-SARS-CoV-2-de-Cidade-de-Chimoio-Resultados-preliminares-27-Nov-2020-V_1.1_corrigido-I_JANI_FINAL1.pdf,12/07/2021,16/07/2022,Verified
201019_Lichinga_RepúblicaDeMoçambiqueMinistérioDaSaúde_VendorsMerchants,19-Oct-20,Local,Mozambique,MOZ,Niassa,Lichinga,28-Sep-20,09-Oct-20,Non-essential workers and unemployed persons,Adults (18-64 years),871,0.20%,,,Convenience,Qingdao Hightop Biotech Co. Ltd ,LFIA,"IgG,IgM",,,High,Presentation or Conference,Jeronimo Langa,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/10/Inquerito-SE-SARS-CoV-2-Lichinga_19-10-020.pdf,17/07/2021,16/07/2022,Verified
201019_Lichinga_RepúblicaDeMoçambiqueMinistérioDaSaúde_TransporationWorkers,19-Oct-20,Local,Mozambique,MOZ,Niassa,Lichinga,28-Sep-20,09-Oct-20,Essential non-healthcare workers,Adults (18-64 years),230,0.40%,,,Convenience,Qingdao Hightop Biotech Co. Ltd ,LFIA,"IgG,IgM",,,High,Presentation or Conference,Jeronimo Langa,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/10/Inquerito-SE-SARS-CoV-2-Lichinga_19-10-020.pdf,17/07/2021,16/07/2022,Verified
201019_Lichinga_RepúblicaDeMoçambiqueMinistérioDaSaúde_HCWs,19-Oct-20,Local,Mozambique,MOZ,Niassa,Lichinga,28-Sep-20,09-Oct-20,Health care workers and caregivers,Adults (18-64 years),454,1.80%,,,Convenience,Qingdao Hightop Biotech Co. Ltd ,LFIA,"IgG,IgM",,,High,Presentation or Conference,Jeronimo Langa,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/10/Inquerito-SE-SARS-CoV-2-Lichinga_19-10-020.pdf,17/07/2021,16/07/2022,Verified
201019_Lichinga_RepúblicaDeMoçambiqueMinistérioDaSaúde_PoliceForces,19-Oct-20,Local,Mozambique,MOZ,Niassa,Lichinga,28-Sep-20,09-Oct-20,Essential non-healthcare workers,Adults (18-64 years),471,1.50%,,,Convenience,Qingdao Hightop Biotech Co. Ltd ,LFIA,"IgG,IgM",,,High,Presentation or Conference,Jeronimo Langa,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/10/Inquerito-SE-SARS-CoV-2-Lichinga_19-10-020.pdf,17/07/2021,16/07/2022,Verified
201019_Lichinga_RepúblicaDeMoçambiqueMinistérioDaSaúde_CommercialEstablishments,19-Oct-20,Local,Mozambique,MOZ,Niassa,Lichinga,28-Sep-20,09-Oct-20,Non-essential workers and unemployed persons,Adults (18-64 years),122,0.00%,,,Convenience,Qingdao Hightop Biotech Co. Ltd ,LFIA,"IgG,IgM",,,High,Presentation or Conference,Jeronimo Langa,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/10/Inquerito-SE-SARS-CoV-2-Lichinga_19-10-020.pdf,17/07/2021,16/07/2022,Verified
200924_TeteCity_RepúblicaDeMoçambiqueMinistérioDaSaúde_Police,24-Sep-20,Local,Mozambique,MOZ,Tete,Tete,31-Aug-20,12-Oct-20,Essential non-healthcare workers,Adults (18-64 years),554,2.90%,,,Convenience,Qingdao Hightop Biotech Co. Ltd ,LFIA,"IgG,IgM",,,High,Presentation or Conference,Mussagy Mahomed,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/09/Inque%CC%81rito-SE-SARS-CoV-2_Cidade-de-Tete_resultados.pdf,17/07/2021,16/07/2022,Verified
200924_TeteCity_RepúblicaDeMoçambiqueMinistérioDaSaúde_TransporationWorkers,24-Sep-20,Local,Mozambique,MOZ,Tete,Tete,31-Aug-20,12-Oct-20,Essential non-healthcare workers,Adults (18-64 years),334,1.50%,,,Convenience,Qingdao Hightop Biotech Co. Ltd ,LFIA,"IgG,IgM",,,High,Presentation or Conference,Mussagy Mahomed,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/09/Inque%CC%81rito-SE-SARS-CoV-2_Cidade-de-Tete_resultados.pdf,17/07/2021,16/07/2022,Verified
200924_TeteCity_RepúblicaDeMoçambiqueMinistérioDaSaúde_VendorsMerchants,24-Sep-20,Local,Mozambique,MOZ,Tete,Tete,31-Aug-20,12-Oct-20,Non-essential workers and unemployed persons,Adults (18-64 years),1556,0.80%,,,Convenience,Qingdao Hightop Biotech Co. Ltd ,LFIA,"IgG,IgM",,,High,Presentation or Conference,Mussagy Mahomed,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/09/Inque%CC%81rito-SE-SARS-CoV-2_Cidade-de-Tete_resultados.pdf,17/07/2021,16/07/2022,Verified
200924_TeteCity_RepúblicaDeMoçambiqueMinistérioDaSaúde_HCW,24-Sep-20,Local,Mozambique,MOZ,Tete,Tete,31-Aug-20,12-Oct-20,Health care workers and caregivers,Adults (18-64 years),569,0.70%,,,Convenience,Qingdao Hightop Biotech Co. Ltd ,LFIA,"IgG,IgM",,,High,Presentation or Conference,Mussagy Mahomed,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/09/Inque%CC%81rito-SE-SARS-CoV-2_Cidade-de-Tete_resultados.pdf,17/07/2021,16/07/2022,Verified
200924_TeteCity_RepúblicaDeMoçambiqueMinistérioDaSaúde_CommercialEstablishments,24-Sep-20,Local,Mozambique,MOZ,Tete,Tete,31-Aug-20,12-Oct-20,Non-essential workers and unemployed persons,Adults (18-64 years),404,0.50%,,,Convenience,Qingdao Hightop Biotech Co. Ltd ,LFIA,"IgG,IgM",,,High,Presentation or Conference,Mussagy Mahomed,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/09/Inque%CC%81rito-SE-SARS-CoV-2_Cidade-de-Tete_resultados.pdf,17/07/2021,16/07/2022,Verified
201021_Matola_RepúblicaDeMoçambiqueMinistérioDaSaúde_CommercialEstablishments,21-Oct-20,Local,Mozambique,MOZ,Maputo,Matolo,14-Sep-20,30-Sep-20,Non-essential workers and unemployed persons,Adults (18-64 years),323,5.88%,,,Convenience,Abbott Laboratories,LFIA,"IgG,IgM",,,High,Presentation or Conference,Ivalda Macicame,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/10/Inque%CC%81rito-Provincia-de-Maputo_resultados-preliminares_21Out2020-versao-final.pdf,18/07/2021,16/07/2022,Verified
201021_Matola_RepúblicaDeMoçambiqueMinistérioDaSaúde_VendorsMerchants,21-Oct-20,Local,Mozambique,MOZ,Maputo,Matolo,14-Sep-20,30-Sep-20,Non-essential workers and unemployed persons,Adults (18-64 years),1288,4.97%,,,Convenience,Abbott Laboratories,LFIA,"IgG,IgM",,,High,Presentation or Conference,Ivalda Macicame,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/10/Inque%CC%81rito-Provincia-de-Maputo_resultados-preliminares_21Out2020-versao-final.pdf,18/07/2021,16/07/2022,Verified
201021_Matola_RepúblicaDeMoçambiqueMinistérioDaSaúde_PoliceForces,21-Oct-20,Local,Mozambique,MOZ,Maputo,Matolo,14-Sep-20,30-Sep-20,Essential non-healthcare workers,Adults (18-64 years),456,4.39%,,,Convenience,Abbott Laboratories,LFIA,"IgG,IgM",,,High,Presentation or Conference,Ivalda Macicame,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/10/Inque%CC%81rito-Provincia-de-Maputo_resultados-preliminares_21Out2020-versao-final.pdf,18/07/2021,16/07/2022,Verified
201021_Matola_RepúblicaDeMoçambiqueMinistérioDaSaúde_HCWs,21-Oct-20,Local,Mozambique,MOZ,Maputo,Matolo,14-Sep-20,30-Sep-20,Health care workers and caregivers,Adults (18-64 years),793,3.90%,,,Convenience,Abbott Laboratories,LFIA,"IgG,IgM",,,High,Presentation or Conference,Ivalda Macicame,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/10/Inque%CC%81rito-Provincia-de-Maputo_resultados-preliminares_21Out2020-versao-final.pdf,18/07/2021,16/07/2022,Verified
201021_Matola_RepúblicaDeMoçambiqueMinistérioDaSaúde_TransportationWorkers,21-Oct-20,Local,Mozambique,MOZ,Maputo,Matolo,14-Sep-20,30-Sep-20,Essential non-healthcare workers,Adults (18-64 years),282,3.19%,,,Convenience,Abbott Laboratories,LFIA,"IgG,IgM",,,High,Presentation or Conference,Ivalda Macicame,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/10/Inque%CC%81rito-Provincia-de-Maputo_resultados-preliminares_21Out2020-versao-final.pdf,18/07/2021,16/07/2022,Verified
200831_MaputoCity_RepúblicaDeMoçambiqueMinistérioDaSaúde_Police,31-Aug-20,Local,Mozambique,MOZ,,Maputo,03-Aug-20,21-Aug-20,Essential non-healthcare workers,Adults (18-64 years),559,3.94%,,,Convenience,Abbott Laboratories,LFIA,"IgG,IgM",,,High,Presentation or Conference,Edna Viegas,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/08/Inqu%C3%A9rito-SE-SARS-CoV-2_Cidade-de-Maputo_resultados_31Ago2020.pdf,18/07/2021,16/07/2022,Verified
200831_MaputoCity_RepúblicaDeMoçambiqueMinistérioDaSaúde_Airport&PortWorkers,31-Aug-20,Local,Mozambique,MOZ,,Maputo,03-Aug-20,21-Aug-20,Essential non-healthcare workers,Adults (18-64 years),362,3.31%,,,Convenience,Abbott Laboratories,LFIA,"IgG,IgM",,,High,Presentation or Conference,Edna Viegas,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/08/Inqu%C3%A9rito-SE-SARS-CoV-2_Cidade-de-Maputo_resultados_31Ago2020.pdf,18/07/2021,16/07/2022,Verified
200831_MaputoCity_RepúblicaDeMoçambiqueMinistérioDaSaúde_NursingHomeWorkers,31-Aug-20,Local,Mozambique,MOZ,,Maputo,03-Aug-20,21-Aug-20,Health care workers and caregivers,Adults (18-64 years),85,1.18%,,,Convenience,Abbott Laboratories,LFIA,"IgG,IgM",,,High,Presentation or Conference,Edna Viegas,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/08/Inqu%C3%A9rito-SE-SARS-CoV-2_Cidade-de-Maputo_resultados_31Ago2020.pdf,18/07/2021,16/07/2022,Verified
201216_Maxixe&Massinga_RepúblicaDeMoçambiqueMinistérioDaSaúde_Maxixe1_DefenceForcesy,16-Dec-20,Local,Mozambique,MOZ,Inhambane,Maxixe,07-Nov-20,21-Nov-20,Essential non-healthcare workers,Multiple groups,174,9.20%,,,Convenience,Qingdao Hightop Biotech Co. Ltd ,LFIA,"IgG,IgM",,,High,Presentation or Conference,Mussagy Mahomed,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/12/Inquerito-de-SARS-CoV-2_Maxixe-e-Massinga.pdf,24/07/2021,16/07/2022,Verified
201216_Maxixe&Massinga_RepúblicaDeMoçambiqueMinistérioDaSaúde_Maxixe1_TransportationWorkers,16-Dec-20,Local,Mozambique,MOZ,Inhambane,Maxixe,07-Nov-20,21-Nov-20,Essential non-healthcare workers,Adults (18-64 years),153,4.60%,,,Convenience,Qingdao Hightop Biotech Co. Ltd ,LFIA,"IgG,IgM",,,High,Presentation or Conference,Mussagy Mahomed,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/12/Inquerito-de-SARS-CoV-2_Maxixe-e-Massinga.pdf,24/07/2021,16/07/2022,Verified
201216_Maxixe&Massinga_RepúblicaDeMoçambiqueMinistérioDaSaúde_Maxixe1_VendorsMerchants,16-Dec-20,Local,Mozambique,MOZ,Inhambane,Maxixe,07-Nov-20,21-Nov-20,Non-essential workers and unemployed persons,Adults (18-64 years),1001,4.50%,,,Convenience,Qingdao Hightop Biotech Co. Ltd ,LFIA,"IgG,IgM",,,High,Presentation or Conference,Mussagy Mahomed,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/12/Inquerito-de-SARS-CoV-2_Maxixe-e-Massinga.pdf,24/07/2021,16/07/2022,Verified
201216_Maxixe&Massinga_RepúblicaDeMoçambiqueMinistérioDaSaúde_Maxixe1_CommercialEstablishments,16-Dec-20,Local,Mozambique,MOZ,Inhambane,Maxixe,07-Nov-20,21-Nov-20,Non-essential workers and unemployed persons,Adults (18-64 years),255,3.50%,,,Convenience,Qingdao Hightop Biotech Co. Ltd ,LFIA,"IgG,IgM",,,High,Presentation or Conference,Mussagy Mahomed,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/12/Inquerito-de-SARS-CoV-2_Maxixe-e-Massinga.pdf,24/07/2021,16/07/2022,Verified
201216_Maxixe&Massinga_RepúblicaDeMoçambiqueMinistérioDaSaúde_Maxixe1_HCW,16-Dec-20,Local,Mozambique,MOZ,Inhambane,Maxixe,07-Nov-20,21-Nov-20,Health care workers and caregivers,Adults (18-64 years),342,2.00%,,,Convenience,Qingdao Hightop Biotech Co. Ltd ,LFIA,"IgG,IgM",,,High,Presentation or Conference,Mussagy Mahomed,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/12/Inquerito-de-SARS-CoV-2_Maxixe-e-Massinga.pdf,24/07/2021,16/07/2022,Verified
201216_Mozambique_RepúblicaDeMoçambiqueMinistérioDaSaúde_Massinga2_DefenceForces,16-Dec-20,Local,Mozambique,MOZ,Inhambane,Massinga,26-Nov-20,03-Dec-20,Essential non-healthcare workers,Adults (18-64 years),116,18.10%,,,Convenience,Qingdao Hightop Biotech Co. Ltd ,LFIA,"IgG,IgM",,,High,Presentation or Conference,Mussagy Mahomed,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/12/Inquerito-de-SARS-CoV-2_Maxixe-e-Massinga.pdf,24/07/2021,16/07/2022,Verified
201216_Mozambique_RepúblicaDeMoçambiqueMinistérioDaSaúde_Massinga2_TransportationWorkers,16-Dec-20,Local,Mozambique,MOZ,Inhambane,Massinga,26-Nov-20,03-Dec-20,Essential non-healthcare workers,Adults (18-64 years),34,5.90%,,,Convenience,Qingdao Hightop Biotech Co. Ltd ,LFIA,"IgG,IgM",,,High,Presentation or Conference,Mussagy Mahomed,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/12/Inquerito-de-SARS-CoV-2_Maxixe-e-Massinga.pdf,24/07/2021,16/07/2022,Verified
201216_Mozambique_RepúblicaDeMoçambiqueMinistérioDaSaúde_Massinga2_Vendors/Merchants,16-Dec-20,Local,Mozambique,MOZ,Inhambane,Massinga,26-Nov-20,03-Dec-20,Non-essential workers and unemployed persons,Adults (18-64 years),517,8.90%,,,Convenience,Qingdao Hightop Biotech Co. Ltd ,LFIA,"IgG,IgM",,,High,Presentation or Conference,Mussagy Mahomed,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/12/Inquerito-de-SARS-CoV-2_Maxixe-e-Massinga.pdf,24/07/2021,16/07/2022,Verified
201216_Mozambique_RepúblicaDeMoçambiqueMinistérioDaSaúde_Massinga2_CommercialEstablishments,16-Dec-20,Local,Mozambique,MOZ,Inhambane,Massinga,26-Nov-20,03-Dec-20,Non-essential workers and unemployed persons,Adults (18-64 years),128,10.90%,,,Convenience,Qingdao Hightop Biotech Co. Ltd ,LFIA,"IgG,IgM",,,High,Presentation or Conference,Mussagy Mahomed,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/12/Inquerito-de-SARS-CoV-2_Maxixe-e-Massinga.pdf,24/07/2021,16/07/2022,Verified
201216_Mozambique_RepúblicaDeMoçambiqueMinistérioDaSaúde_Massinga2_HCW,16-Dec-20,Local,Mozambique,MOZ,Inhambane,Massinga,26-Nov-20,03-Dec-20,Health care workers and caregivers,Adults (18-64 years),131,6.10%,,,Convenience,Qingdao Hightop Biotech Co. Ltd ,LFIA,"IgG,IgM",,,High,Presentation or Conference,Mussagy Mahomed,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/12/Inquerito-de-SARS-CoV-2_Maxixe-e-Massinga.pdf,24/07/2021,16/07/2022,Verified
201208_Xai-Xai&Chokwe_RepúblicaDeMoçambiqueMinistérioDaSaúde_Xai-Xai1_VendorsMerchants,08-Dec-20,Local,Mozambique,MOZ,Gaza,Xai-Xai,02-Nov-20,12-Nov-20,Non-essential workers and unemployed persons,Adults (18-64 years),460,5.90%,,,Convenience,Abbott Laboratories,LFIA,"IgG,IgM",,,High,Presentation or Conference,Paulo Arnaldo,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/12/InCOVID-2020_-XAI-XAI-CHOKWE_-RESULTADOS-PRELIMINARES_08-12-2020.pdf,24/07/2021,16/07/2022,Verified
201208_Xai-Xai&Chokwe_RepúblicaDeMoçambiqueMinistérioDaSaúde_Xai-Xai1_TransporationWorkers,08-Dec-20,Local,Mozambique,MOZ,Gaza,Xai-Xai,02-Nov-20,12-Nov-20,Essential non-healthcare workers,Adults (18-64 years),209,3.80%,,,Convenience,Abbott Laboratories,LFIA,"IgG,IgM",,,High,Presentation or Conference,Paulo Arnaldo,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/12/InCOVID-2020_-XAI-XAI-CHOKWE_-RESULTADOS-PRELIMINARES_08-12-2020.pdf,24/07/2021,16/07/2022,Verified
201208_Xai-Xai&Chokwe_RepúblicaDeMoçambiqueMinistérioDaSaúde_Xai-Xai1_HCWs,08-Dec-20,Local,Mozambique,MOZ,Gaza,Xai-Xai,02-Nov-20,12-Nov-20,Health care workers and caregivers,Adults (18-64 years),281,5.70%,,,Convenience,Abbott Laboratories,LFIA,"IgG,IgM",,,High,Presentation or Conference,Paulo Arnaldo,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/12/InCOVID-2020_-XAI-XAI-CHOKWE_-RESULTADOS-PRELIMINARES_08-12-2020.pdf,24/07/2021,16/07/2022,Verified
201208_Xai-Xai&Chokwe_RepúblicaDeMoçambiqueMinistérioDaSaúde_Xai-Xai1_DefenceForces,08-Dec-20,Local,Mozambique,MOZ,Gaza,Xai-Xai,02-Nov-20,12-Nov-20,Essential non-healthcare workers,Adults (18-64 years),116,1.70%,,,Convenience,Abbott Laboratories,LFIA,"IgG,IgM",,,High,Presentation or Conference,Paulo Arnaldo,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/12/InCOVID-2020_-XAI-XAI-CHOKWE_-RESULTADOS-PRELIMINARES_08-12-2020.pdf,24/07/2021,16/07/2022,Verified
201208_Xai-Xai&Chokwe_RepúblicaDeMoçambiqueMinistérioDaSaúde_Xai-Xai1_CommercialEstablishments,08-Dec-20,Local,Mozambique,MOZ,Gaza,Xai-Xai,02-Nov-20,12-Nov-20,Non-essential workers and unemployed persons,Adults (18-64 years),272,3.30%,,,Convenience,Abbott Laboratories,LFIA,"IgG,IgM",,,High,Presentation or Conference,Paulo Arnaldo,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/12/InCOVID-2020_-XAI-XAI-CHOKWE_-RESULTADOS-PRELIMINARES_08-12-2020.pdf,24/07/2021,16/07/2022,Verified
201208_Xai-Xai&Chokwe_RepúblicaDeMoçambiqueMinistérioDaSaúde_Chokwe2_VendorsMerchants,08-Dec-20,Local,Mozambique,MOZ,Gaza,Chokwe,16-Nov-20,21-Nov-20,Non-essential workers and unemployed persons,Adults (18-64 years),472,6.80%,,,Convenience,Abbott Laboratories,LFIA,"IgG,IgM",,,High,Presentation or Conference,Paulo Arnaldo,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/12/InCOVID-2020_-XAI-XAI-CHOKWE_-RESULTADOS-PRELIMINARES_08-12-2020.pdf,24/07/2021,16/07/2022,Verified
201208_Xai-Xai&Chokwe_RepúblicaDeMoçambiqueMinistérioDaSaúde_Chokwe2_TransporationWorkers,08-Dec-20,Local,Mozambique,MOZ,Gaza,Chokwe,16-Nov-20,21-Nov-20,Essential non-healthcare workers,Adults (18-64 years),112,16.10%,,,Convenience,Abbott Laboratories,LFIA,"IgG,IgM",,,High,Presentation or Conference,Paulo Arnaldo,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/12/InCOVID-2020_-XAI-XAI-CHOKWE_-RESULTADOS-PRELIMINARES_08-12-2020.pdf,24/07/2021,16/07/2022,Verified
201208_Xai-Xai&Chokwe_RepúblicaDeMoçambiqueMinistérioDaSaúde_Chokwe2_HCWs,08-Dec-20,Local,Mozambique,MOZ,Gaza,Chokwe,16-Nov-20,21-Nov-20,Health care workers and caregivers,Adults (18-64 years),165,10.30%,,,Convenience,Abbott Laboratories,LFIA,"IgG,IgM",,,High,Presentation or Conference,Paulo Arnaldo,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/12/InCOVID-2020_-XAI-XAI-CHOKWE_-RESULTADOS-PRELIMINARES_08-12-2020.pdf,24/07/2021,16/07/2022,Verified
201208_Xai-Xai&Chokwe_RepúblicaDeMoçambiqueMinistérioDaSaúde_Chokwe2_CommercialEstablishments,08-Dec-20,Local,Mozambique,MOZ,Gaza,Chokwe,16-Nov-20,21-Nov-20,Non-essential workers and unemployed persons,Adults (18-64 years),145,7.50%,,,Convenience,Abbott Laboratories,LFIA,"IgG,IgM",,,High,Presentation or Conference,Paulo Arnaldo,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/12/InCOVID-2020_-XAI-XAI-CHOKWE_-RESULTADOS-PRELIMINARES_08-12-2020.pdf,24/07/2021,16/07/2022,Verified
201208_Xai-Xai&Chokwe_RepúblicaDeMoçambiqueMinistérioDaSaúde_Chokwe2_DefenceForces,08-Dec-20,Local,Mozambique,MOZ,Gaza,Chokwe,16-Nov-20,21-Nov-20,Essential non-healthcare workers,Adults (18-64 years),67,10.40%,,,Convenience,Abbott Laboratories,LFIA,"IgG,IgM",,,High,Presentation or Conference,Paulo Arnaldo,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/12/InCOVID-2020_-XAI-XAI-CHOKWE_-RESULTADOS-PRELIMINARES_08-12-2020.pdf,24/07/2021,16/07/2022,Verified
220624_MaputoCity_InstitutoNacionaldeSaúde_GenPop_Overall_TestAdj_PopAdj,24-Jun-22,Local,Mozambique,MOZ,Maputo,Maputo City,04-Aug-20,24-Aug-20,Household and community samples,Multiple groups,4719,2.10%,1.20%,3.30%,Stratified probability,Abbott Laboratories,LFIA,"IgG,IgM",83.30%,98.00%,Moderate,Journal Article (Peer-Reviewed),Paulo Arnaldo,Instituto Nacional de Saúde,https://dx.doi.org/10.1093/cid/ciac516,07/07/2022,16/07/2022,Unverified
220624_Pemba_InstitutoNacionaldeSaúde_GenPop_Overall_TestAdjPopAdj,24-Jun-22,Local,Mozambique,MOZ,Cabo Delgado,Pemba,06-Jul-20,13-Jul-20,Household and community samples,Multiple groups,1358,3.00%,1.00%,6.60%,Stratified probability,Qingdao Hightop Biotech Co. Ltd ,LFIA,"IgG,IgM",86.70%,98.70%,Moderate,Journal Article (Peer-Reviewed),Paulo Arnaldo,Instituto Nacional de Saúde,https://dx.doi.org/10.1093/cid/ciac516,12/07/2022,16/07/2022,Unverified
220624_Quelimane_InstitutoNacionaldeSaúde_GenPop_Overall_TestAdj_PopAdj,24-Jun-22,Local,Mozambique,MOZ,Zambezia,Quelimane,10-Aug-20,21-Aug-20,Household and community samples,Multiple groups,5066,0.90%,0.10%,1.90%,Stratified probability,Abbott Laboratories,LFIA,"IgG,IgM",83.30%,98.00%,Moderate,Journal Article (Peer-Reviewed),Paulo Arnaldo,Instituto Nacional de Saúde,https://dx.doi.org/10.1093/cid/ciac516,12/07/2022,16/07/2022,Unverified
211123_Mongolia_MongolianNationalUniversityofMedicalSciences_Primary_Popadjust,23-Nov-21,National,Mongolia,MNG,,,13-Oct-20,04-Dec-20,Household and community samples,Multiple groups,5000,1.36%,1.11%,1.63%,Stratified probability,"Beijing Wantai Biological,Kantaro Biosciences LLC",Multiple Types,"Total Antibody,IgG",,,Low,Journal Article (Peer-Reviewed),Battogtokh Chimeddorj,Mongolian National University of Medical Sciences,https://dx.doi.org/10.1016/j.lanwpc.2021.100317,07/12/2021,16/07/2022,Verified
201021_VeracruzCity_UniversidadVeracruzana_unadj,21-Oct-20,Local,Mexico,MEX,Veracruz,Veracruz City,01-Jun-20,31-Jul-20,Residual sera,Multiple groups,2174,29.50%,27.59%,31.47%,Sequential,Abbott Laboratories,CLIA,IgG,,,High,Preprint,Jose Maria Remes-Troche,Universidad Veracruzana,https://www.medrxiv.org/content/10.1101/2020.10.19.20215558v1,17/01/2021,16/07/2022,Verified
210624_NuevoLeon_AutonomousUniversityofNuevoLeon_primary,24-Jun-21,Regional,Mexico,MEX,Nuevo Leon,,01-Jan-20,15-Dec-20,Blood donors,Adults (18-64 years),2068,5.30%,,,Sequential,Abbott Laboratories,CLIA,IgG,90.00%,100.00%,High,Journal Article (Peer-Reviewed),Natalia Martinez-Acu a,Autonomous University of Nuevo Leon,https://dx.doi.org/10.3390/v13071225,04/02/2021,16/07/2022,Verified
210415_Mexico_InstitutodeSaludparaelBienestar_Overall,15-Apr-21,National,Mexico,MEX,NR,NR,10-Feb-20,31-Dec-20,Residual sera,Multiple groups,24273,15.90%,,,Stratified non-probability,"DiaSorin,GenScript",Multiple Types,"IgG,Neutralizing ",,,Moderate,Journal Article (Peer-Reviewed),Jose Munoz-Medina,Instituto de Salud para el Bienestar,https://dx.doi.org/10.3390/microorganisms9040850,19/05/2021,16/07/2022,Verified
210423_Monterrey_UniversidadAutónomaDeNuevoLeón,23-Apr-21,Local,Mexico,MEX,Nuevo Leon,Monterrey,22-May-20,30-May-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,154,11.70%,,,Sequential,Healgen,LFIA,"IgG,IgM",90.11%,98.46%,High,Journal Article (Peer-Reviewed),Giovanna Yazmin Arteaga Muller,Universidad Autónoma de Nuevo León,https://dx.doi.org/10.1007/s11255-021-02852-4,21/05/2021,16/07/2022,Unverified
201216_Mexico_GovernmentOfMexico_overall,16-Dec-20,National,Mexico,MEX,,,15-Aug-20,15-Nov-20,Household and community samples,Multiple groups,7098,25.00%,,,Unclear,NA,Not reported,Not reported,,,Unclear,News and Media,Secretaria de Salud ,Government of Mexico,https://www.gob.mx/salud/prensa/255-secretaria-de-salud-presenta-resultados-preliminares-de-la-encuesta-nacional-de-salud-y-nutricion-covid-19?idiom=es,06/06/2021,16/07/2022,Verified
210607_NuevoLeon_HealthServicesOfTheStateOfNuevoLeon_Overall,07-Jun-21,Regional,Mexico,MEX,Nuevo Leon,,15-Aug-20,15-Nov-20,Household and community samples,Multiple groups,4495,27.10%,25.80%,28.40%,Convenience,Abbott Laboratories,CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Edgar Rodriguez-Vidales,Health Services of the State of Nuevo Leon,https://dx.doi.org/10.1002/jmv.27131,22/06/2021,16/07/2022,Verified
210812_MexicoCity_InstitutoNacionaldeRehabilitacion_Overall,12-Aug-21,Local,Mexico,MEX,,Mexico City,10-Aug-20,09-Sep-20,Health care workers and caregivers,Multiple groups,299,13.00%,,,Stratified probability,EUROIMMUN,ELISA,IgG,94.60%,99.80%,Moderate,Journal Article (Peer-Reviewed),Esteban Cruz-Arenas,Nacional de Rehabilitacion hospital,http://dx.doi.org/10.1371/journal.pone.0255916,29/08/2021,16/07/2022,Unverified
210819_CityofGuadalupe_UniversidadAutónomadeNuevoLeón_Overall,19-Aug-21,Local,Mexico,MEX,Nuevo Leon,Guadalupe,09-Jul-20,23-Jul-20,Multiple populations,Multiple groups,3268,5.90%,5.10%,6.80%,Convenience,Roche Diagnostics,CLIA,"IgG,IgM",99.50%,99.80%,High,Journal Article (Peer-Reviewed),Cristina Diaz‑Salazar,Universidad Autonoma de Nuevo Leon,https://dx.doi.org/10.1186/s12879-021-06550-5,01/09/2021,16/07/2022,Verified
210916_MexicoCity_UniversidadNacionalAutónomaDeMéxico_Primary,16-Sep-21,Local,Mexico,MEX,,Mexico City,21-Sep-20,31-Dec-20,Health care workers and caregivers,Adults (18-64 years),169,20.70%,,,Convenience,NA,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Fatima Sofía Magana-Guerrero,Universidad Nacional Autónoma De México,https://dx.doi.org/10.1080/09286586.2021.1974493,28/09/2021,16/07/2022,Unverified
211109_Nayarit_AutonomousUniversityofNayarit_overall,09-Nov-21,Local,Mexico,MEX,Nayarit,Ciudad de Tepic,28-Jun-21,28-Jun-21,Household and community samples,Children and Youth (0-17 years),134,17.00%,,,Convenience,NA,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Gladys Alejandra Toledo-Ibarra,Autonomous University of Nayarit,https://saludpublica.mx/index.php/spm/article/view/13128/12175,01/12/2021,16/07/2022,Unverified
211105_Mexico_InstitutoNacionaldeSaludPublica_Children_Primary,05-Nov-21,National,Mexico,MEX,,,15-Aug-20,15-Nov-20,Household and community samples,Children and Youth (0-17 years),858,26.70%,22.10%,31.30%,Stratified probability,Roche Diagnostics,CLIA,IgG,92.00%,99.50%,Low,Journal Article (Peer-Reviewed),Francisco Canto-Osorio,Instituto Nacional de Salud Públic,https://saludpublica.mx/index.php/spm/article/view/12847,01/12/2021,16/07/2022,Verified
211105_Mexico_InstitutoNacionaldeSaludPublica_Adolescent_Primary,05-Nov-21,National,Mexico,MEX,,,15-Aug-20,15-Nov-20,Household and community samples,Children and Youth (0-17 years),944,18.70%,14.90%,22.50%,Stratified probability,Roche Diagnostics,CLIA,IgG,92.00%,99.50%,Low,Journal Article (Peer-Reviewed),Francisco Canto-Osorio,Instituto Nacional de Salud Públic,https://saludpublica.mx/index.php/spm/article/view/12847,01/12/2021,16/07/2022,Verified
211213_MexicoCity_INCMNSZ_FollowUp,13-Dec-21,Local,Mexico,MEX,,Mexico City,15-Aug-20,30-Sep-20,Multiple populations,Multiple groups,97,7.20%,,,Unclear,Abbott Laboratories,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),Monica Meneses-Medina,The National Institute of Medical Sciences and Nutrition Salvador Zubirán,https://dx.doi.org/10.1200/GO.21.00207,04/01/2022,16/07/2022,Unverified
220201_Mexico_NationalInstituteofPublicHealth_Overall,01-Feb-22,National,Mexico,MEX,,,15-Aug-20,15-Nov-20,Household and community samples,Multiple groups,9463,24.90%,22.20%,26.70%,Stratified probability,Roche Diagnostics,CLIA,IgG,92.02%,99.52%,Moderate,Journal Article (Peer-Reviewed),Ana Basto-Abreu,National Institute of Public Health,https://dx.doi.org/10.1038/s41467-022-28232-9,08/02/2022,16/07/2022,Unverified
220127_Campeche_UniversidadAutonomaCampeche_Overall,27-Jan-22,Regional,Mexico,MEX,Campeche,,15-Aug-21,15-Sep-21,Blood donors,Multiple groups,479,69.10%,,,Sequential,NA,ELISA,IgG,94.00%,100.00%,High,Journal Article (Peer-Reviewed),Victor Monteon,Universidad Autonoma Campeche,https://dx.doi.org/10.1016/j.transci.2022.103374,09/02/2022,16/07/2022,Verified
220311_Tijuana_UniversityofCaliforniaSanFrancisco_2020NovDec,11-Mar-22,Local,Mexico,MEX,Baja California,Tijuana,15-Feb-21,15-Apr-21,Persons experiencing homelessness,Adults (18-64 years),84,46.30%,,,Convenience,NA,Not reported,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Ietza Bojorquez-Chapela,University of California San Francisco,https://dx.doi.org/10.1136/bmjgh-2021-007202,22/03/2022,16/07/2022,Unverified
220311_Tijuana_UniversityofCaliforniaSanFrancisco_2021FebApr,11-Mar-22,Local,Mexico,MEX,Baja California,Tijuana,15-Nov-20,15-Dec-20,Persons experiencing homelessness,Adults (18-64 years),397,54.50%,,,Convenience,NA,Not reported,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Ietza Bojorquez-Chapela,University of California San Francisco,https://dx.doi.org/10.1136/bmjgh-2021-007202,22/03/2022,16/07/2022,Unverified
220328_Mexico_SaludDignaAC_PopAdj_Overall,28-Mar-22,National,Mexico,MEX,"Aguascalientes,Baja California,Baja California Sur,Campeche,Chiapas,Chihuahua,Ciudad de México,Coahuila,Colima,Durango,Estado de México,Guanajuato,Guerrero,Hidalgo,Jalisco,Michoacán,Morelos,Nayarit,Nuevo León,Oaxaca,Puebla,Querétaro,Quintana Roo,San Luis Potosí,Sinaloa,Sonora,Tabasco,Tamaulipas,Tlaxcala,Veracruz,Yucatán,Zacatecas",,05-Jul-20,31-Dec-20,Residual sera,Multiple groups,522690,32.80%,32.10%,33.50%,Sequential,Roche Diagnostics,CLIA,"IgG,IgM",99.50%,99.80%,Moderate,Journal Article (Peer-Reviewed),Miguel Fernández-Rojas,Salud Digna A.C.,https://dx.doi.org/10.1038/s41598-022-09395-3,06/04/2022,16/07/2022,Verified
220317_MexicoCity_NationalInstituteofRespiratoryDiseases_Overall_TestAdj,17-Mar-22,Local,Mexico,MEX,Mexico City,Mexico City,15-Oct-20,15-Jun-21,Health care workers and caregivers,Adults (18-64 years),883,33.50%,,,Convenience,Roche Diagnostics,CLIA,Not reported,97.92%,99.95%,Moderate,Journal Article (Peer-Reviewed),Vanessa Davila-Conn,National Institute of Respiratory Diseases,https://dx.doi.org/10.1371/journal.pone.0264964,06/04/2022,16/07/2022,Unverified
220512_MexicoCity_GeneralHospitalofMexico_Overall,12-May-22,Local,Mexico,MEX,,Mexico City,15-Aug-20,15-Jan-21,Health care workers and caregivers,Adults (18-64 years),109,58.72%,,,Convenience,NA,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Nallely Bueno-Hernandez,General Hospital of Mexico,https://dx.doi.org/10.3390/healthcare10050896,09/06/2022,16/07/2022,Unverified
220605_Sinaloa_UniversityofSinaloa_PregnantWomen1,05-Jun-22,Regional,Mexico,MEX,Sinaloa State,,15-Aug-20,15-Dec-20,Pregnant or parturient women,Multiple groups,116,11.20%,,,Unclear,Roche Diagnostics,CLIA,IgG,,,Unclear,Journal Article (Peer-Reviewed),Nidia Leon-Sicairos,University of Sinaloa,https://dx.doi.org/10.1111/aji.13583,21/06/2022,16/07/2022,Unverified
220605_Sinaloa_UniversityofSinaloa_Neonates2,05-Jun-22,Regional,Mexico,MEX,Sinaloa State,,15-Aug-20,15-Dec-20,Perinatal,Children and Youth (0-17 years),84,35.70%,,,Unclear,Roche Diagnostics,CLIA,IgG,,,Unclear,Journal Article (Peer-Reviewed),Nidia Leon-Sicairos,University of Sinaloa,https://dx.doi.org/10.1111/aji.13583,23/06/2022,16/07/2022,Unverified
210118_Nouakchott_CentreHospitalierNationalDeNouakchott_Overall,18-Jan-21,Local,Mauritania,MRT,,Nouakchott,05-May-20,27-May-20,Health care workers and caregivers,Adults (18-64 years),835,1.67%,,,Convenience,Xiamen Biotime Biotechnology Co. Ltd,LFIA,"IgG,IgM",96.40%,98.70%,High,Journal Article (Peer-Reviewed),Mohamed Lemine Ould Salem,Centre Hospitalier National de Nouakchott,http://dx.doi.org/10.11604/pamj.2021.38.55.24259,13/04/2021,16/07/2022,Verified
220107_Bamako_UniversityOfBamako,07-Jan-22,Local,Mali,MLI,,Bamako,15-Nov-20,15-Jun-21,Health care workers and caregivers,Adults (18-64 years),238,61.76%,,,Convenience,Enzo Life Sciences,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Anou M. Somboro,University Of Bamako,https://dx.doi.org/10.3390/v14010102,21/01/2022,16/07/2022,Unverified
220216_Bamako_SorbonneUniversite_Overall,16-Feb-22,Local,Mali,MLI,,Bamako,16-Mar-21,15-Jul-21,Health care workers and caregivers,Adults (18-64 years),195,52.30%,,,Convenience,Abbott Laboratories,LFIA,"IgG,IgM",,94.00%,High,Preprint,Almoustapha Maiga,Sorbonne Universite,https://dx.doi.org/10.1016/j.cmi.2022.02.019,28/02/2022,16/07/2022,Unverified
210629_Mali_NationalInstitutesofHealth_1SotubaVisit2_OverallAdjusted,29-Jun-21,Local,Mali,MLI,Bamako,Bamako,21-Dec-20,26-Jan-21,Household and community samples,Multiple groups,528,70.40%,56.80%,84.10%,Convenience,NA,ELISA,IgG,73.90%,99.40%,Moderate,Journal Article (Peer-Reviewed),Issaka Sagara,National Institutes of Health, https://doi.org/10.1093/cid/ciab589,09/03/2022,16/07/2022,Verified
210629_Mali_NationalInstitutesofHealth_2BancoumanaVisit2_OverallAdjusted,29-Jun-21,Local,Mali,MLI,Koulikoro Region,Bancoumana,28-Dec-20,29-Jan-21,Household and community samples,Multiple groups,904,52.10%,41.90%,62.30%,Convenience,NA,ELISA,IgG,73.90%,99.40%,Moderate,Journal Article (Peer-Reviewed),Issaka Sagara,National Institutes of Health, https://doi.org/10.1093/cid/ciab589,09/03/2022,16/07/2022,Verified
210629_Mali_NationalInstitutesofHealth_3DoneguebougouVisit2_OverallAdjusted,29-Jun-21,Local,Mali,MLI,Koulikoro Region,Doneguebougou,14-Dec-20,15-Jan-21,Household and community samples,Multiple groups,1088,35.00%,27.90%,42.10%,Convenience,NA,ELISA,IgG,73.90%,99.40%,Moderate,Journal Article (Peer-Reviewed),Issaka Sagara,National Institutes of Health, https://doi.org/10.1093/cid/ciab589,09/03/2022,16/07/2022,Verified
220605_Bamako_AixMarseilleUniversity_PopAdj_Overall,05-Jun-22,Local,Mali,MLI,,Bamako,01-Sep-20,30-Sep-20,Household and community samples,Multiple groups,1327,16.40%,,,Stratified probability,BioMérieux,Not reported,"IgG,IgM",,,Moderate,Preprint,Mady Cissoko,Aix-Marseille University,https://doi.org/10.1101/2022.06.03.22275924,13/06/2022,16/07/2022,Unverified
220616_Kita_UniversityCollegeLondon_Community_Overall,16-Jun-22,Local,Mali,MLI,,Kita,01-Dec-20,31-Dec-20,Household and community samples,Multiple groups,875,27.66%,,,Stratified probability,Beijing Wantai Biological,ELISA,"IgM,IgG",93.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Dagmar Alber,Tampere University,https://dx.doi.org/10.1136/bmjopen-2021-060367,29/06/2022,16/07/2022,Unverified
211226_Male_MaldivesNationalUniversity_overall,26-Dec-21,Local,Maldives,MDV,,Male',15-Oct-20,16-Nov-20,Household and community samples,Multiple groups,1940,13.40%,,,Stratified probability,Ortho Clinical Diagnostics Inc.,CLIA,Total Antibody,90.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Raheema Abdul-Raheem,Maldives National University,https://apjai-journal.org/wp-content/uploads/2022/01/AP-040721-1177.pdf,12/01/2022,16/07/2022,Verified
200813_Selangor_UniversityMalaya_OverallPopAdj,13-Aug-20,Regional,Malaysia,MYS,Selangor,Kuala Lumpur,29-Jan-20,06-Jun-20,Residual sera,Multiple groups,588,0.40%,0.00%,0.93%,Convenience,NA,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),I Ching Sam,University Malaya,https://onlinelibrary.wiley.com/doi/full/10.1002/jmv.26426,02/10/2020,16/07/2022,Verified
210321_KlangValley_MalaysianMinistryofHealth_HCW,21-Mar-21,Local,Malaysia,MYS,Klang Valley,,13-Apr-20,12-May-20,Health care workers and caregivers,Adults (18-64 years),400,0.00%,0.00%,0.01%,Self-referral,GenScript,Neutralization,Not reported,91.30%,100.00%,High,Journal Article (Peer-Reviewed),Yuan Liang Woon,Malaysian Ministry of Health,https://dx.doi.org/10.1016/j.lanwpc.2021.100123,18/04/2021,16/07/2022,Verified
211110_Malaysia_UniversityofMalaya_PopAdjusted,10-Nov-21,Regional,Malaysia,MYS,Selangor,Kuala Lumpur,15-Dec-20,15-Apr-21,Residual sera,Multiple groups,653,3.00%,,,Convenience,Beijing Wantai Biological,ELISA,Not reported,96.70%,99.50%,High,Journal Article (Peer-Reviewed),I-Ching Sam,University of Malaya,https://dx.doi.org/10.1002/jmv.27441,18/11/2021,16/07/2022,Verified
220117_KlangValleyAndPerak_HealthyMalaysiaSociety_LocalWorkers_TestAndSeroReversionAdj,17-Jan-22,Regional,Malaysia,MYS,Klang Valley; and Perak,,15-Jul-21,15-Sep-21,Essential non-healthcare workers,Adults (18-64 years),204,12.10%,8.00%,16.20%,Convenience,ECO Diagnostica LTDA,LFIA,Not reported,83.00%,96.00%,High,Preprint,Noorliza Mohamad Noordin,Healthy Malaysia Society,https://doi.org/10.1101/2022.01.16.22269388,25/01/2022,16/07/2022,Unverified
220117_KlangValleyAndPerak_HealthyMalaysiaSociety_MigrantWorkers_TestAndSeroReversionAdj,17-Jan-22,Regional,Malaysia,MYS,Klang Valley; and Perak,,15-Jul-21,15-Sep-21,Essential non-healthcare workers,Adults (18-64 years),874,99.90%,96.70%,100.00%,Convenience,ECO Diagnostica LTDA,LFIA,Not reported,83.00%,96.00%,High,Preprint,Noorliza Mohamad Noordin,Healthy Malaysia Society,https://doi.org/10.1101/2022.01.16.22269388,25/01/2022,16/07/2022,Unverified
220301_KlangValley_UniversitiTeknologiMARA_Spike,01-Mar-22,Regional,Malaysia,MYS,Klang Valley,,15-Feb-21,15-Mar-21,Blood donors,Adults (18-64 years),806,4.59%,,,Sequential,Beijing Wantai Biological,ELISA,Not reported,,,High,Presentation or Conference,A.M.A. Shukri,Universiti Teknologi MARA,https://dx.doi.org/10.1016/j.ijid.2021.12.080,14/03/2022,16/07/2022,Verified
220602_UniversitiMalaysiaSabah_INTIInternationalUniversity_Overall,02-Jun-22,Local,Malaysia,MYS,Sabah,Kota Kinabalu,15-Dec-20,15-Jun-21,Multiple populations,Adults (18-64 years),168,8.33%,,,Convenience,SD Biosensor,Not reported,"IgG,IgM",100.00%,,High,Journal Article (Peer-Reviewed),Mohd Hijazi,INTI International University,https://dx.doi.org/10.3390/ijerph19116840,16/06/2022,16/07/2022,Unverified
200805_Blantyre_Malawi-Liverpool-WellcomeTrust_HCW_TestAdj,05-Aug-20,National,Malawi,MWI,Southern Region Malawi,Blantyre,22-May-20,19-Jun-20,Health care workers and caregivers,Adults (18-64 years),500,12.30%,8.20%,16.50%,Convenience,Omega diagnostics,ELISA,IgG,88.10%,93.20%,High,Preprint,Marah Chibwana,Malawi-Liverpool-Wellcome Trust Clinical Research Programme,https://www.medrxiv.org/content/10.1101/2020.07.30.20164970v3.full.pdf,08/08/2020,16/07/2022,Verified
211119_Malawi_Malawi-Liverpool-WellcomeTrustClinicalResearchProgramme_Primary,19-Nov-21,National,Malawi,MWI,,,15-Jan-20,15-Jul-21,Blood donors,Multiple groups,5085,27.60%,,,Simplified probability,Beijing Wantai Biological,ELISA,Total Antibody,97.00%,98.00%,Moderate,Journal Article (Peer-Reviewed),Jonathan Mandolo,Malawi-Liverpool-Wellcome Trust Clinical Research Programme,https://dx.doi.org/10.1186/s12916-021-02187-y,30/11/2021,16/07/2022,Verified
211217_Lilongwe_UniversitatsmedizinBerlin,17-Dec-21,Local,Malawi,MWI,Central Region,Lilongwe,24-Aug-20,03-Sep-20,Multiple populations,Multiple groups,914,7.99%,,,Convenience,"EUROIMMUN,GenScript",ELISA,"IgG,Neutralizing ",,,High,Journal Article (Peer-Reviewed),C Meinus,University of Malawi ,https://dx.doi.org/10.1016/j.ijid.2021.12.336,12/01/2022,16/07/2022,Unverified
210604_Madagascar_InstitutPasteurDeMadagascar_AntananarivoMarch_Adj,04-Jun-21,Local,Madagascar,MDG,,Antananarivo,01-Mar-20,30-Mar-20,Blood donors,Adults (18-64 years),496,0.00%,0.00%,0.00%,Convenience,ID.Vet,ELISA,IgG,92.60%,99.60%,High,Journal Article (Peer-Reviewed),Matthieu Schoenhals,Institut Pasteur de Madagascar,https://dx.doi.org/10.1016/j.ebiom.2021.103419,16/06/2021,16/07/2022,Verified
210604_Madagascar_InstitutPasteurDeMadagascar_AntananarivoApril_Adj,04-Jun-21,Local,Madagascar,MDG,,Antananarivo,01-Apr-20,30-Apr-20,Blood donors,Adults (18-64 years),157,0.00%,0.00%,0.00%,Convenience,ID.Vet,ELISA,IgG,92.60%,99.60%,High,Journal Article (Peer-Reviewed),Matthieu Schoenhals,Institut Pasteur de Madagascar,https://dx.doi.org/10.1016/j.ebiom.2021.103419,16/06/2021,16/07/2022,Verified
210604_Madagascar_InstitutPasteurDeMadagascar_AntananarivoMay_Adj,04-Jun-21,Local,Madagascar,MDG,,Antananarivo,01-May-20,31-May-20,Blood donors,Adults (18-64 years),598,0.00%,0.00%,0.00%,Convenience,ID.Vet,ELISA,IgG,92.60%,99.60%,High,Journal Article (Peer-Reviewed),Matthieu Schoenhals,Institut Pasteur de Madagascar,https://dx.doi.org/10.1016/j.ebiom.2021.103419,16/06/2021,16/07/2022,Verified
210604_Madagascar_InstitutPasteurDeMadagascar_AntananarivoJune_Adj,04-Jun-21,Local,Madagascar,MDG,,Antananarivo,01-Jun-20,30-Jun-20,Blood donors,Adults (18-64 years),308,2.80%,2.70%,2.90%,Convenience,ID.Vet,ELISA,IgG,92.60%,99.60%,High,Journal Article (Peer-Reviewed),Matthieu Schoenhals,Institut Pasteur de Madagascar,https://dx.doi.org/10.1016/j.ebiom.2021.103419,16/06/2021,16/07/2022,Verified
210604_Madagascar_InstitutPasteurDeMadagascar_AntananarivoJuly_Adj,04-Jun-21,Local,Madagascar,MDG,,Antananarivo,01-Jul-20,31-Jul-20,Blood donors,Adults (18-64 years),428,35.40%,35.20%,35.60%,Convenience,ID.Vet,ELISA,IgG,92.60%,99.60%,High,Journal Article (Peer-Reviewed),Matthieu Schoenhals,Institut Pasteur de Madagascar,https://dx.doi.org/10.1016/j.ebiom.2021.103419,16/06/2021,16/07/2022,Verified
210604_Madagascar_InstitutPasteurDeMadagascar_AntananarivoAugust_Adj,04-Jun-21,Local,Madagascar,MDG,,Antananarivo,01-Aug-20,30-Aug-20,Blood donors,Adults (18-64 years),432,41.30%,41.10%,41.50%,Convenience,ID.Vet,ELISA,IgG,92.60%,99.60%,High,Journal Article (Peer-Reviewed),Matthieu Schoenhals,Institut Pasteur de Madagascar,https://dx.doi.org/10.1016/j.ebiom.2021.103419,16/06/2021,16/07/2022,Verified
210604_Madagascar_InstitutPasteurDeMadagascar_AntananarivoSeptember_Adj,04-Jun-21,Local,Madagascar,MDG,,Antananarivo,01-Sep-20,30-Sep-20,Blood donors,Adults (18-64 years),481,43.50%,43.30%,43.80%,Convenience,ID.Vet,ELISA,IgG,92.60%,99.60%,High,Journal Article (Peer-Reviewed),Matthieu Schoenhals,Institut Pasteur de Madagascar,https://dx.doi.org/10.1016/j.ebiom.2021.103419,16/06/2021,16/07/2022,Verified
210604_Madagascar_InstitutPasteurDeMadagascar_AntananarivoOctober_Adj,04-Jun-21,Local,Madagascar,MDG,,Antananarivo,01-Oct-20,31-Oct-20,Blood donors,Adults (18-64 years),495,43.20%,43.00%,43.40%,Convenience,ID.Vet,ELISA,IgG,92.60%,99.60%,High,Journal Article (Peer-Reviewed),Matthieu Schoenhals,Institut Pasteur de Madagascar,https://dx.doi.org/10.1016/j.ebiom.2021.103419,16/06/2021,16/07/2022,Verified
210604_Madagascar_InstitutPasteurDeMadagascar_AntananarivoNovember_Adj,04-Jun-21,Local,Madagascar,MDG,,Antananarivo,01-Nov-20,30-Nov-20,Blood donors,Adults (18-64 years),502,38.00%,37.90%,38.20%,Convenience,ID.Vet,ELISA,IgG,92.60%,99.60%,High,Journal Article (Peer-Reviewed),Matthieu Schoenhals,Institut Pasteur de Madagascar,https://dx.doi.org/10.1016/j.ebiom.2021.103419,16/06/2021,16/07/2022,Verified
210604_Madagascar_InstitutPasteurDeMadagascar_ToamasinaJune_Adj,04-Jun-21,Local,Madagascar,MDG,,Toamasina,01-Jun-20,30-Jun-20,Blood donors,Adults (18-64 years),82,43.70%,43.10%,44.30%,Convenience,ID.Vet,ELISA,IgG,92.60%,99.60%,High,Journal Article (Peer-Reviewed),Matthieu Schoenhals,Institut Pasteur de Madagascar,https://dx.doi.org/10.1016/j.ebiom.2021.103419,16/06/2021,16/07/2022,Verified
210604_Madagascar_InstitutPasteurDeMadagascar_ToamasinaJuly_Adj,04-Jun-21,Local,Madagascar,MDG,,Toamasina,01-Jul-20,31-Jul-20,Blood donors,Adults (18-64 years),182,51.20%,50.80%,51.60%,Convenience,ID.Vet,ELISA,IgG,92.60%,99.60%,High,Journal Article (Peer-Reviewed),Matthieu Schoenhals,Institut Pasteur de Madagascar,https://dx.doi.org/10.1016/j.ebiom.2021.103419,16/06/2021,16/07/2022,Verified
210604_Madagascar_InstitutPasteurDeMadagascar_ToamasinaAugust_Adj,04-Jun-21,Local,Madagascar,MDG,,Toamasina,01-Aug-20,31-Aug-20,Blood donors,Adults (18-64 years),227,49.20%,48.90%,49.50%,Convenience,ID.Vet,ELISA,IgG,92.60%,99.60%,High,Journal Article (Peer-Reviewed),Matthieu Schoenhals,Institut Pasteur de Madagascar,https://dx.doi.org/10.1016/j.ebiom.2021.103419,16/06/2021,16/07/2022,Verified
210604_Madagascar_InstitutPasteurDeMadagascar_ToamasinaSeptember_Adj,04-Jun-21,Local,Madagascar,MDG,,Toamasina,01-Sep-20,30-Sep-20,Blood donors,Adults (18-64 years),213,36.20%,35.90%,36.50%,Convenience,ID.Vet,ELISA,IgG,92.60%,99.60%,High,Journal Article (Peer-Reviewed),Matthieu Schoenhals,Institut Pasteur de Madagascar,https://dx.doi.org/10.1016/j.ebiom.2021.103419,16/06/2021,16/07/2022,Verified
210604_Madagascar_InstitutPasteurDeMadagascar_ToamasinaOctober_Adj,04-Jun-21,Local,Madagascar,MDG,,Toamasina,01-Oct-20,31-Oct-20,Blood donors,Adults (18-64 years),199,33.00%,32.60%,33.30%,Convenience,ID.Vet,ELISA,IgG,92.60%,99.60%,High,Journal Article (Peer-Reviewed),Matthieu Schoenhals,Institut Pasteur de Madagascar,https://dx.doi.org/10.1016/j.ebiom.2021.103419,16/06/2021,16/07/2022,Verified
210604_Madagascar_InstitutPasteurDeMadagascar_ToamasinaNovember_Adj,04-Jun-21,Local,Madagascar,MDG,,Toamasina,01-Nov-20,30-Nov-20,Blood donors,Adults (18-64 years),282,23.30%,23.10%,23.50%,Convenience,ID.Vet,ELISA,IgG,92.60%,99.60%,High,Journal Article (Peer-Reviewed),Matthieu Schoenhals,Institut Pasteur de Madagascar,https://dx.doi.org/10.1016/j.ebiom.2021.103419,16/06/2021,16/07/2022,Verified
210604_Madagascar_InstitutPasteurDeMadagascar_FianarantsoaJune_Adj,04-Jun-21,Local,Madagascar,MDG,,Fianarantsoa,01-Jun-20,30-Jun-20,Blood donors,Adults (18-64 years),129,0.00%,0.00%,0.00%,Convenience,ID.Vet,ELISA,IgG,92.60%,99.60%,High,Journal Article (Peer-Reviewed),Matthieu Schoenhals,Institut Pasteur de Madagascar,https://dx.doi.org/10.1016/j.ebiom.2021.103419,17/06/2021,16/07/2022,Verified
210604_Madagascar_InstitutPasteurDeMadagascar_FianarantsoaJuly_Adj,04-Jun-21,Local,Madagascar,MDG,,Fianarantsoa,01-Jul-20,30-Jul-20,Blood donors,Adults (18-64 years),142,0.00%,0.00%,0.00%,Convenience,ID.Vet,ELISA,IgG,92.60%,99.60%,High,Journal Article (Peer-Reviewed),Matthieu Schoenhals,Institut Pasteur de Madagascar,https://dx.doi.org/10.1016/j.ebiom.2021.103419,17/06/2021,16/07/2022,Verified
210604_Madagascar_InstitutPasteurDeMadagascar_FianarantsoaAugust_Adj,04-Jun-21,Local,Madagascar,MDG,,Fianarantsoa,01-Aug-20,31-Aug-20,Blood donors,Adults (18-64 years),120,10.40%,10.20%,10.60%,Convenience,ID.Vet,ELISA,IgG,92.60%,99.60%,High,Journal Article (Peer-Reviewed),Matthieu Schoenhals,Institut Pasteur de Madagascar,https://dx.doi.org/10.1016/j.ebiom.2021.103419,17/06/2021,16/07/2022,Verified
210604_Madagascar_InstitutPasteurDeMadagascar_FianarantsoaSeptember_Adj,04-Jun-21,Local,Madagascar,MDG,,Fianarantsoa,01-Sep-20,30-Sep-20,Blood donors,Adults (18-64 years),173,21.90%,21.60%,22.10%,Convenience,ID.Vet,ELISA,IgG,92.60%,99.60%,High,Journal Article (Peer-Reviewed),Matthieu Schoenhals,Institut Pasteur de Madagascar,https://dx.doi.org/10.1016/j.ebiom.2021.103419,17/06/2021,16/07/2022,Verified
210604_Madagascar_InstitutPasteurDeMadagascar_FianarantsoaOctober_Adj,04-Jun-21,Local,Madagascar,MDG,,Fianarantsoa,01-Oct-20,31-Oct-20,Blood donors,Adults (18-64 years),152,18.70%,18.50%,18.90%,Convenience,ID.Vet,ELISA,IgG,92.60%,99.60%,High,Journal Article (Peer-Reviewed),Matthieu Schoenhals,Institut Pasteur de Madagascar,https://dx.doi.org/10.1016/j.ebiom.2021.103419,17/06/2021,16/07/2022,Verified
210604_Madagascar_InstitutPasteurDeMadagascar_FianarantsoaNovember_Adj,04-Jun-21,Local,Madagascar,MDG,,Fianarantsoa,01-Nov-20,30-Nov-20,Blood donors,Adults (18-64 years),172,16.20%,16.00%,16.40%,Convenience,ID.Vet,ELISA,IgG,92.60%,99.60%,High,Journal Article (Peer-Reviewed),Matthieu Schoenhals,Institut Pasteur de Madagascar,https://dx.doi.org/10.1016/j.ebiom.2021.103419,17/06/2021,16/07/2022,Verified
210604_Madagascar_InstitutPasteurDeMadagascar_MahajangaJune_Adj,04-Jun-21,Local,Madagascar,MDG,,Mahajanga,01-Jun-20,30-Jun-20,Blood donors,Adults (18-64 years),50,0.00%,0.00%,0.00%,Convenience,ID.Vet,ELISA,IgG,92.60%,99.60%,High,Journal Article (Peer-Reviewed),Matthieu Schoenhals,Institut Pasteur de Madagascar,https://dx.doi.org/10.1016/j.ebiom.2021.103419,17/06/2021,16/07/2022,Verified
210604_Madagascar_InstitutPasteurDeMadagascar_MahajangaJuly_Adj,04-Jun-21,Local,Madagascar,MDG,,Mahajanga,01-Jul-20,31-Jul-20,Blood donors,Adults (18-64 years),98,0.00%,0.00%,0.10%,Convenience,ID.Vet,ELISA,IgG,92.60%,99.60%,High,Journal Article (Peer-Reviewed),Matthieu Schoenhals,Institut Pasteur de Madagascar,https://dx.doi.org/10.1016/j.ebiom.2021.103419,17/06/2021,16/07/2022,Verified
210604_Madagascar_InstitutPasteurDeMadagascar_MahajangaAugust_Adj,04-Jun-21,Local,Madagascar,MDG,,Mahajanga,01-Aug-20,31-Aug-20,Blood donors,Adults (18-64 years),107,44.50%,44.10%,44.80%,Convenience,ID.Vet,ELISA,IgG,92.60%,99.60%,High,Journal Article (Peer-Reviewed),Matthieu Schoenhals,Institut Pasteur de Madagascar,https://dx.doi.org/10.1016/j.ebiom.2021.103419,17/06/2021,16/07/2022,Verified
210604_Madagascar_InstitutPasteurDeMadagascar_MahajangaSeptember_Adj ,04-Jun-21,Local,Madagascar,MDG,,Mahajanga,01-Sep-20,30-Sep-20,Blood donors,Adults (18-64 years),53,26.00%,25.90%,26.10%,Convenience,ID.Vet,ELISA,IgG,92.60%,99.60%,High,Journal Article (Peer-Reviewed),Matthieu Schoenhals,Institut Pasteur de Madagascar,https://dx.doi.org/10.1016/j.ebiom.2021.103419,17/06/2021,16/07/2022,Verified
210604_Madagascar_InstitutPasteurDeMadagascar_MahajangaOctober_Adj,04-Jun-21,Local,Madagascar,MDG,,Mahajanga,01-Oct-20,31-Oct-20,Blood donors,Adults (18-64 years),26,29.60%,28.90%,30.20%,Convenience,ID.Vet,ELISA,IgG,92.60%,99.60%,High,Journal Article (Peer-Reviewed),Matthieu Schoenhals,Institut Pasteur de Madagascar,https://dx.doi.org/10.1016/j.ebiom.2021.103419,17/06/2021,16/07/2022,Verified
210604_Madagascar_InstitutPasteurDeMadagascar_MahajangaNovember_Adj ,04-Jun-21,Local,Madagascar,MDG,,Mahajanga,01-Nov-20,30-Nov-20,Blood donors,Adults (18-64 years),30,21.50%,20.90%,22.00%,Convenience,ID.Vet,ELISA,IgG,92.60%,99.60%,High,Journal Article (Peer-Reviewed),Matthieu Schoenhals,Institut Pasteur de Madagascar,https://dx.doi.org/10.1016/j.ebiom.2021.103419,17/06/2021,16/07/2022,Verified
210604_Madagascar_InstitutPasteurDeMadagascar_ToliaraJune_Adj,04-Jun-21,Local,Madagascar,MDG,,Toliara,01-Jun-20,30-Jun-20,Blood donors,Adults (18-64 years),87,0.00%,0.00%,0.10%,Convenience,ID.Vet,ELISA,IgG,92.60%,99.60%,High,Journal Article (Peer-Reviewed),Matthieu Schoenhals,Institut Pasteur de Madagascar,https://dx.doi.org/10.1016/j.ebiom.2021.103419,17/06/2021,16/07/2022,Verified
210604_Madagascar_InstitutPasteurDeMadagascar_ToliaraJuly_Adj,04-Jun-21,Local,Madagascar,MDG,,Toliara,01-Jul-20,31-Jul-20,Blood donors,Adults (18-64 years),147,0.00%,0.00%,0.00%,Convenience,ID.Vet,ELISA,IgG,92.60%,99.60%,High,Journal Article (Peer-Reviewed),Matthieu Schoenhals,Institut Pasteur de Madagascar,https://dx.doi.org/10.1016/j.ebiom.2021.103419,17/06/2021,16/07/2022,Verified
210604_Madagascar_InstitutPasteurDeMadagascar_ToliaraAugust_Adj,04-Jun-21,Local,Madagascar,MDG,,Toliara,01-Aug-20,31-Aug-20,Blood donors,Adults (18-64 years),167,7.90%,7.70%,8.10%,Convenience,ID.Vet,ELISA,IgG,92.60%,99.60%,High,Journal Article (Peer-Reviewed),Matthieu Schoenhals,Institut Pasteur de Madagascar,https://dx.doi.org/10.1016/j.ebiom.2021.103419,17/06/2021,16/07/2022,Verified
210604_Madagascar_InstitutPasteurDeMadagascar_ToliaraSeptember_Adj,04-Jun-21,Local,Madagascar,MDG,,Toliara,01-Sep-20,30-Sep-20,Blood donors,Adults (18-64 years),185,24.20%,23.90%,24.40%,Convenience,ID.Vet,ELISA,IgG,92.60%,99.60%,High,Journal Article (Peer-Reviewed),Matthieu Schoenhals,Institut Pasteur de Madagascar,https://dx.doi.org/10.1016/j.ebiom.2021.103419,17/06/2021,16/07/2022,Verified
210604_Madagascar_InstitutPasteurDeMadagascar_ToliaraOctober_Adj,04-Jun-21,Local,Madagascar,MDG,,Toliara,01-Oct-20,31-Oct-20,Blood donors,Adults (18-64 years),139,27.70%,27.30%,28.00%,Convenience,ID.Vet,ELISA,IgG,92.60%,99.60%,High,Journal Article (Peer-Reviewed),Matthieu Schoenhals,Institut Pasteur de Madagascar,https://dx.doi.org/10.1016/j.ebiom.2021.103419,17/06/2021,16/07/2022,Verified
210604_Madagascar_InstitutPasteurDeMadagascar_ToliaraNovember_Adj,04-Jun-21,Local,Madagascar,MDG,,Toliara,01-Nov-20,30-Nov-20,Blood donors,Adults (18-64 years),199,23.50%,23.20%,23.80%,Convenience,ID.Vet,ELISA,IgG,92.60%,99.60%,High,Journal Article (Peer-Reviewed),Matthieu Schoenhals,Institut Pasteur de Madagascar,https://dx.doi.org/10.1016/j.ebiom.2021.103419,17/06/2021,16/07/2022,Verified
211001_Antananarivo_InstitutPasteurdeMadagascar_8May2021_AntiRBD,14-Sep-21,Local,Madagascar,MDG,, Antananarivo,01-May-21,26-May-21,Blood donors,Adults (18-64 years),500,64.80%,56.10%,72.60%,Sequential,Beijing Wantai Biological,ELISA,Total Antibody,100.00%,94.36%,High,Presentation or Conference,Solohery Razafimahatratra,Institut Pasteur de Madagascar,http://dx.doi.org/10.1016/S2214-109X%2821%2900361-2,22/09/2021,16/07/2022,Verified
211001_Antananarivo_InstitutPasteurdeMadagascar_6March2021_AntiRBD,14-Sep-21,Local,Madagascar,MDG,, Antananarivo,01-Mar-21,31-Mar-21,Blood donors,Adults (18-64 years),497,49.90%,45.50%,54.30%,Sequential,Beijing Wantai Biological,ELISA,Total Antibody,100.00%,94.36%,High,Presentation or Conference,Solohery Razafimahatratra,Institut Pasteur de Madagascar,http://dx.doi.org/10.1016/S2214-109X%2821%2900361-2,22/09/2021,16/07/2022,Verified
211001_Antananarivo_InstitutPasteurdeMadagascar_4January2021_AntiRBD,14-Sep-21,Local,Madagascar,MDG,, Antananarivo,01-Jan-21,31-Jan-21,Blood donors,Adults (18-64 years),389,44.70%,39.90%,49.70%,Sequential,Beijing Wantai Biological,ELISA,Total Antibody,100.00%,94.36%,High,Presentation or Conference,Solohery Razafimahatratra,Institut Pasteur de Madagascar,http://dx.doi.org/10.1016/S2214-109X%2821%2900361-2,22/09/2021,16/07/2022,Verified
211001_Antananarivo_InstitutPasteurdeMadagascar_7April2021_AntiRBD,14-Sep-21,Local,Madagascar,MDG,, Antananarivo,01-Apr-21,30-Apr-21,Blood donors,Adults (18-64 years),493,58.40%,54.00%,62.70%,Sequential,Beijing Wantai Biological,ELISA,Total Antibody,100.00%,94.36%,High,Presentation or Conference,Solohery Razafimahatratra,Institut Pasteur de Madagascar,http://dx.doi.org/10.1016/S2214-109X%2821%2900361-2,22/09/2021,16/07/2022,Unverified
211001_Antananarivo_InstitutPasteurdeMadagascar_5February2021_AntiRBD,14-Sep-21,Local,Madagascar,MDG,, Antananarivo,01-Feb-21,28-Feb-21,Blood donors,Adults (18-64 years),319,50.50%,45.00%,55.90%,Sequential,Beijing Wantai Biological,ELISA,Total Antibody,100.00%,94.36%,High,Presentation or Conference,Solohery Razafimahatratra,Institut Pasteur de Madagascar,http://dx.doi.org/10.1016/S2214-109X%2821%2900361-2,22/09/2021,16/07/2022,Unverified
211001_Antananarivo_InstitutPasteurdeMadagascar_3December2020,14-Sep-21,Local,Madagascar,MDG,, Antananarivo,01-Dec-20,31-Dec-20,Blood donors,Adults (18-64 years),177,22.00%,16.60%,28.70%,Sequential,ID.Vet,ELISA,IgG,,,High,Presentation or Conference,Solohery Razafimahatratra,Institut Pasteur de Madagascar,http://dx.doi.org/10.1016/S2214-109X%2821%2900361-2,22/09/2021,16/07/2022,Verified
200518_Luxembourg_LuxembourgInstituteofHealth_GenPop_IgGPopAdj,18-May-20,National,Luxembourg,LUX,,,15-Apr-20,05-May-20,Household and community samples,Multiple groups,1820,2.09%,1.37%,2.82%,Stratified probability,EUROIMMUN,ELISA,IgG,85.70%,97.80%,Moderate,Preprint,Chantal Snoeck,Luxembourg Institute of Health,https://www.medrxiv.org/content/10.1101/2020.05.11.20092916v1,12/07/2020,16/07/2022,Verified
210107_Lithuania_UniversityCollegeLondon_PaediatricHCW,27-Jan-21,Local,Lithuania,LTU,NR,NR,01-Jun-20,12-Jun-20,Health care workers and caregivers,Adults (18-64 years),300,0.66%,0.18%,2.40%,Convenience,"Epitope Diagnostics, Inc.,Meso Scale Discovery",ELISA,IgG,,,High,Journal Article (Peer-Reviewed),D Goldblatt,University College London,http://dx.doi.org/10.1016/j.jhin.2020.12.019,13/03/2021,16/07/2022,Verified
210206_Kaunas_HospitalofLithuanianUniversityofHealthSciencesKaunoKlinikos_LFIA,06-Feb-21,Local,Lithuania,LTU,,Kaunas,15-Jun-20,21-Sep-20,Health care workers and caregivers,Multiple groups,432,1.16%,,,Convenience,AMEDA Labordiagnostik GmbH,LFIA,"IgG,IgM",91.80%,96.40%,High,Journal Article (Peer-Reviewed),Laura Pereckaite,The Hospital of Lithuanian University of Health Sciences Kauno Klinikos,https://dx.doi.org/10.3390/medicina57020148,16/03/2021,16/07/2022,Verified
210118_Lithuania_210118_Lithuania_LithuanianUniversityofHealthSciences_TestAdj,18-Jan-21,National,Lithuania,LTU,"Vilnius County, Kaunas county, Klaipėda County, Tauragė County, Utena county
","Vilnius, Kaunas, Klaipėda
",10-Aug-20,10-Sep-20,Household and community samples,Multiple groups,3089,1.40%,0.92%,1.99%,Simplified probability,AMEDA Labordiagnostik GmbH,LFIA,"IgG,IgM",92.00%,99.40%,Moderate,Journal Article (Peer-Reviewed),Kastytis Smigelskas, Lithuanian University of Health Sciences,https://www.journals.vu.lt/AML/article/view/22344,13/05/2021,16/07/2022,Verified
210212_Kaunas_LithuanianUniversityOfHealthSciences_HidradenitisSuppurativa,12-Feb-21,Local,Lithuania,LTU,,Kaunas,12-Aug-20,30-Dec-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,26,7.70%,2.13%,24.14%,Convenience,EUROIMMUN,ELISA,"IgG,IgM",,,High,Presentation or Conference,Vaiva Jariene,Lithuanian University of Health Sciences,https://www.researchgate.net/publication/349992124_SARS-CoV-2_Seroprevalence_in_Patients_with_Hidradenitis_Suppurativa_in_Lithuania,05/07/2021,16/07/2022,Verified
201209_Liechtenstein_KantonsspitalGraubunden_Overall,09-Dec-20,National,Liechtenstein,LIE,,,02-Jun-20,06-Oct-20,Multiple populations,Multiple groups,1159,7.80%,6.40%,9.50%,Convenience,"Roche Diagnostics,Abbott Laboratories,DiaSorin,EUROIMMUN,Epitope Diagnostics, Inc.,Sugentech, Inc.",Multiple Types,"IgG,IgM",,,Unclear,Journal Article (Peer-Reviewed),Anna Schaffner,Kantonsspital Graunbunden,https://dx.doi.org/10.3390/jcm9123989,28/01/2021,16/07/2022,Verified
200526_AlzintanCity_Al-ZintanUniversity_HealthCareWorkers,26-May-20,Local,Libya,LBY,Libya,Alzintan City,02-Apr-20,18-May-20,Health care workers and caregivers,Multiple groups,77,0.00%,,,Stratified probability,Guangzhou Wondfo Biotech Co. Ltd,LFIA,"IgM,IgG",86.40%,99.60%,High,Preprint,Abdulwahab Kammon,Al-Zintan University,https://www.medrxiv.org/content/10.1101/2020.05.25.20109470v1,30/05/2020,16/07/2022,Verified
200526_AlzintanCity_Al-ZintanUniversity_GenPopulation,26-May-20,Local,Libya,LBY,Libya,Alzintan City,02-Apr-20,18-May-20,Multiple populations,Multiple groups,142,4.23%,,,Simplified probability,Guangzhou Wondfo Biotech Co. Ltd,LFIA,"IgM,IgG",86.40%,99.60%,High,Preprint,Abdulwahab Kammon,Al-Zintan University,https://www.medrxiv.org/content/10.1101/2020.05.25.20109470v1,30/05/2020,16/07/2022,Verified
200929_Benghazi_TheCenterOfInfectiousDiseases-Benghazi_overall,29-Sep-20,Local,Libya,LBY,,Benghazi,02-May-20,07-May-20,Household and community samples,Multiple groups,600,0.00%,,,Stratified probability,NA,LFIA,"IgG,IgM",81.70%,96.70%,Moderate,Journal Article (Peer-Reviewed),Amal A Elfakhri,The Center of Infectious Diseases- Benghazi,https://preventive-medicine.imedpub.com/populationbased-random-survey-for-detection-of-covid19-infection-and-seroprevalence-in-benghazi-libya-may2020.pdf,26/04/2021,16/07/2022,Verified
220727_Tobruk_UniversityOfTobruk,27-Jul-22,Local,Libya,LBY,,,15-Jan-21,15-Feb-21,Blood donors,Multiple groups,200,4.00%,,,Unclear,SD Biosensor,Not reported,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Faisal Ismail,University of Tobruk,https://dx.doi.org/10.1017/dmp.2022.180,03/08/2022,03/08/2022,Unverified
220110_Lebanon_LebaneseUniversity_Overall_TestPopAdj,10-Jan-22,National,Lebanon,LBN,"Beirut, Mount Lebanon, North Lebanon, Akkar, Baalbek El-Hermel, Bekaa, Nabatieh, and South Lebanon",,07-Dec-20,15-Jan-21,Household and community samples,Multiple groups,2058,18.50%,16.80%,20.20%,Stratified probability,Technogenetics,LFIA,IgG,92.30%,100.00%,Low,Journal Article (Peer-Reviewed),Abbas Hoballah,Lebanese University,https://dx.doi.org/10.1186/s12879-022-07031-z,18/01/2022,16/07/2022,Verified
220521_Lebanon_HumanLink_Overall,21-May-22,National,Lebanon,LBN,"Beirut, North, South, Akkar, Nabatiye, Bekaa, Baalbak-Hermel",,15-Oct-20,15-Apr-21,Multiple populations,Multiple groups,2783,58.90%,,,Convenience,NA,Neutralization,Neutralizing ,,,High,Journal Article (Peer-Reviewed),Omar Bahlawan,Human Link,https://dx.doi.org/10.1007/s00705-022-05470-2,05/06/2022,16/07/2022,Unverified
220129_Lebanon_LebaneseAmericanUniversityMedicalCentre_TestAdj_Overall,29-Jan-22,National,Lebanon,LBN,eight Lebanese governorates,138 Lebanese municipalities,21-Sep-20,08-Apr-21,Household and community samples,Multiple groups,13755,24.60%,,,Stratified probability,Roche Diagnostics,CLIA,Not reported,99.50%,99.81%,Moderate,Journal Article (Peer-Reviewed),Ahmad Mahdi,Lebanese American University Medical Centre,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8800496/,29/06/2022,16/07/2022,Unverified
210107_Latvia_UniversityCollegeLondon_PaediatricHCW,27-Jan-21,Local,Latvia,LVA,NR,NR,19-May-20,20-Jun-20,Health care workers and caregivers,Adults (18-64 years),177,0.00%,0.00%,2.14%,Convenience,"Epitope Diagnostics, Inc.,Meso Scale Discovery",ELISA,IgG,,,High,Journal Article (Peer-Reviewed),D Goldblatt,University College London,http://dx.doi.org/10.1016/j.jhin.2020.12.019,13/03/2021,16/07/2022,Verified
210713_LaoPDR_InstitutPasteurDuLaos_GeneralCommunity_Primary_Adjusted,13-Jul-21,National,Lao People's Democratic Republic,LAO,"Vientiane Prefecture, Oudomxay, Luangprabang, Savannakhet, Champassak",,12-Aug-20,25-Sep-20,Household and community samples,Multiple groups,2433,5.20%,4.20%,6.50%,Stratified probability,NA,ELISA,Not reported,,,Moderate,Journal Article (Peer-Reviewed),Siriphone Virachith,Institut Pasteur du Laos,https://dx.doi.org/10.1016/j.lanwpc.2021.100197,28/07/2021,16/07/2022,Verified
210713_LaoPDR_InstitutPasteurDuLaos_HCW_Primary_Adjusted,13-Jul-21,National,Lao People's Democratic Republic,LAO,"Vientiane Prefecture, Oudomxay, Luangprabang, Savannakhet, Champassak",,12-Aug-20,25-Sep-20,Health care workers and caregivers,Adults (18-64 years),666,1.95%,1.10%,3.30%,Convenience,NA,ELISA,Not reported,,,Moderate,Journal Article (Peer-Reviewed),Siriphone Virachith,Institut Pasteur du Laos,https://dx.doi.org/10.1016/j.lanwpc.2021.100197,28/07/2021,16/07/2022,Verified
210713_LaoPDR_InstitutPasteurDuLaos_WildlifeContacts_Primary,13-Jul-21,Regional,Lao People's Democratic Republic,LAO,Vientiane Province,,12-Aug-20,25-Sep-20,Non-essential workers and unemployed persons,Multiple groups,74,20.30%,12.60%,31.00%,Convenience,NA,ELISA,Not reported,,,High,Journal Article (Peer-Reviewed),Siriphone Virachith,Institut Pasteur du Laos,https://dx.doi.org/10.1016/j.lanwpc.2021.100197,28/07/2021,16/07/2022,Verified
211209_Kyrgyzstan_SaintPetersburgPasteurInstitute_Overall,09-Dec-21,National,Kyrgyzstan,KGZ,,,28-Jun-21,03-Jul-21,Household and community samples,Multiple groups,9471,48.70%,47.70%,49.70%,Simplified probability,NA,ELISA,IgG,,,Moderate,Preprint,Anna Popova,Saint Petersburg Pasteur Institute,https://www.researchsquare.com/article/rs-1138128/v1,15/12/2021,16/07/2022,Verified
201205_Kuwait_KuwaitUniversity_Overall_unadj,05-Dec-20,National,Kuwait,KWT,,,23-May-20,26-Jun-20,Essential non-healthcare workers,Adults (18-64 years),525,38.10%,34.00%,42.30%,Stratified probability,Biozek,LFIA,"IgG,IgM",66.00%,97.00%,High,Journal Article (Peer-Reviewed),Walid Q Alali,University of Kuwait,https://dx.doi.org/10.1093/jtm/taaa223,23/01/2021,16/07/2022,Verified
210816_Kuwait_MinistryofHealth_primary,16-Aug-21,National,Kuwait,KWT,,,15-Aug-20,15-Oct-20,Health care workers and caregivers,Multiple groups,847,20.50%,,,Convenience,DiaSorin,CLIA,"IgM,IgG",,,High,Journal Article (Peer-Reviewed),SarahAl Youha,Ministry of Health,http://dx.doi.org/10.1016/j.jiph.2021.08.012,30/08/2021,16/07/2022,Unverified
210513_Kuwait_KuwaitUniversity_Overall,03-May-21,National,Kuwait,KWT,"Ahmadi, Farwaniya, Hawali, Asma, Jahra, Mubarak Alkabeer","Jeleeb Al Shuyoukh, Mahboula",18-Apr-20,10-May-20,Non-essential workers and unemployed persons,Adults (18-64 years),10256,5.90%,5.40%,6.30%,Simplified probability,Biozek,LFIA,"IgG,IgM",,,Moderate,Journal Article (Peer-Reviewed),Haya Altawalah,Institut Pasteur du Maroc,https://dx.doi.org/10.1016/j.jcvp.2021.100017,14/03/2022,16/07/2022,Unverified
211128_Prishtina_MunicipalityofPrishtina_Primary,28-Nov-21,Local,Kosovo,XKX,,Prishtina,01-Oct-20,30-Nov-20,Non-essential workers and unemployed persons,Adults (18-64 years),418,21.05%,,,Convenience,"BioMérieux,NA",Not reported,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Bujar Gashi,Municipality of Prishtina,http://dx.doi.org/10.3390/ijerph182312545,07/12/2021,16/07/2022,Unverified
220116_Prishtina_PrishtinaStarts_IgMorIgG_Overall,16-Jan-22,Local,Kosovo,XKX,,Prishtina,14-Oct-20,17-Dec-20,Health care workers and caregivers,Adults (18-64 years),475,17.47%,,,Entire sample,Biomerieux,Not reported,"IgM,IgG",,,High,Journal Article (Peer-Reviewed),Rrezart Halili,Prishtina Starts,https://dx.doi.org/10.1186/s12879-022-07038-6,27/01/2022,16/07/2022,Unverified
210217_Kenya_KEMRI-WellcomeTrustResearchProgramme_TestAdj,17-Feb-21,National,Kenya,KEN,,,30-Sep-20,23-Oct-20,Essential non-healthcare workers,Adults (18-64 years),830,42.30%,38.40%,46.30%,Convenience,NA,ELISA,IgG,93.00%,99.00%,Moderate,Preprint,E Wangeci Kagucia,KEMRI-Wellcome Trust Research Programme,https://www.medrxiv.org/content/10.1101/2021.02.12.21251294v1,16/03/2021,16/07/2022,Verified
210208_Kenya_KEMRI-WellcomeTrust_Nairobi_Overall_TestAdj,08-Feb-21,Local,Kenya,KEN,Nairobi,Nairobi,30-Jul-20,25-Aug-20,Pregnant or parturient women,Adults (18-64 years),196,49.90%,42.70%,58.00%,Sequential,NA,ELISA,IgG,92.70%,99.00%,Moderate,Preprint,R Lucinde,KEMRI-Wellcome Trust,https://www.medrxiv.org/content/10.1101/2021.02.05.21250735v1.full-text,15/04/2021,16/07/2022,Verified
210421_Kenya_KEMRI-WellcomeTrustResearchProgramme_TestAdj,24-Apr-21,National,Kenya,KEN,"Central, Coastal, Western",,30-Jul-20,04-Dec-20,Health care workers and caregivers,Adults (18-64 years),684,20.80%,17.50%,24.40%,Convenience,NA,ELISA,IgG,92.70%,99.00%,Moderate,Journal Article (Peer-Reviewed),Anthony Etyang,KEMRI-Wellcome Trust Research Programme,https://dx.doi.org/10.1093/cid/ciab346,23/05/2021,16/07/2022,Verified
210208_Kenya_KEMRI-WellcomeTrust_KilifiOct_TestAdj,08-Feb-21,Local,Kenya,KEN,NR,Kilifi,01-Oct-20,31-Oct-20,Pregnant or parturient women,Adults (18-64 years),183,1.50%,0.07%,4.10%,Sequential,NA,ELISA,IgG,92.70%,99.00%,Moderate,Preprint,R Lucinde,KEMRI-Wellcome Trust,https://www.medrxiv.org/content/10.1101/2021.02.05.21250735v1.full-text,23/06/2021,16/07/2022,Verified
210208_Kenya_KEMRI-WellcomeTrust_KilifiSept_TestAdj,08-Feb-21,Local,Kenya,KEN,,Kilifi,18-Sep-20,30-Sep-20,Pregnant or parturient women,Adults (18-64 years),82,1.30%,0.04%,4.70%,Sequential,NA,ELISA,IgG,92.70%,99.00%,Moderate,Preprint,R Lucinde,KEMRI-Wellcome Trust,https://www.medrxiv.org/content/10.1101/2021.02.05.21250735v1.full-text,23/06/2021,16/07/2022,Verified
210625_Kenya_KEMRI-WellcomeTrustResearchProgramme_overall_adj,25-Jun-21,National,Kenya,KEN,,,30-Apr-20,30-Sep-20,Blood donors,Adults (18-64 years),9922,7.90%,6.70%,9.00%,Sequential,NA,ELISA,IgG,92.70%,99.00%,Low,Journal Article (Peer-Reviewed),Ifedayo M. O. Adetifa,KEMRI-Wellcome Trust Research Programme,https://dx.doi.org/10.1038/s41467-021-24062-3,07/07/2021,16/07/2022,Verified
210726_Dagahaley_MédecinsSansFrontières_Patients_Overall,26-Jul-21,Local,Kenya,KEN,NR,"Dagahaley camp, Daadab Refugee Complex",01-Mar-21,14-Apr-21,Multiple populations,Multiple groups,619,6.90%,,,Sequential,Biosynex,LFIA,"IgG,IgM",95.80%,98.10%,Moderate,Preprint,Etienne Gignoux,Médicins Sans Frontières,https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3893538,03/08/2021,16/07/2022,Unverified
210726_Dagahaley_MédecinsSansFrontières_FamilyMembers,26-Jul-21,Local,Kenya,KEN,NR,"Dagahaley camp, Daadab Refugee Complex",01-Mar-21,14-Apr-21,Multiple populations,Multiple groups,587,9.20%,,,Convenience,Biosynex,LFIA,"IgG,IgM",95.80%,98.10%,Moderate,Preprint,Etienne Gignoux,Médicins Sans Frontières,https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3893538,03/08/2021,16/07/2022,Unverified
210612_Kenya_KEMRI-WellcomeTrustResearchProgramme_PrimaryTestAdj,12-Jun-21,Regional,Kenya,KEN,"Western Province, Coast Province ","Magarini, Busia, Malaba",30-Sep-20,23-Oct-20,Essential non-healthcare workers,Adults (18-64 years),830,42.30%,38.40%,46.30%,Convenience,NA,ELISA,IgG,93.00%,99.00%,High,Journal Article (Peer-Reviewed),Eunice Kagucia,KEMRI-Wellcome Trust Research Programme,http://dx.doi.org/10.1093/ofid/ofab314,24/08/2021,16/07/2022,Verified
210902_Kenya_KEMRI-WellcomeTrustResearchProgramme_OverallPopAndTestAdjusted,02-Sep-21,National,Kenya,KEN,,,03-Jan-21,15-Mar-21,Blood donors,Multiple groups,3018,48.50%,45.20%,52.10%,Convenience,NA,ELISA,IgG,92.70%,99.00%,Moderate,Journal Article (Peer-Reviewed),Sophie Uyoga,KEMRI-Wellcome Trust Research Programme,https://dx.doi.org/10.1001/jama.2021.15265,09/09/2021,16/07/2022,Verified
210901_WesternKenya_WalterReedArmyInstituteofResearch_overall,01-Sep-21,Regional,Kenya,KEN,Western Region,"Kisumu, Kericho",01-Jan-20,19-Mar-20,Residual sera,Adults (18-64 years),582,3.30%,,,Convenience,Bio-rad,ELISA,"IgA,IgG,IgM",,,High,Journal Article (Peer-Reviewed),Trevor Crowell,Walter Reed Army Institute of Research,https://dx.doi.org/10.1097/QAD.0000000000003054,13/09/2021,16/07/2022,Verified
210902_Nairobi_WashingtonStateUniversity_TestAdjPopAdj,02-Sep-21,Local,Kenya,KEN,,,02-Nov-20,23-Nov-20,Household and community samples,Multiple groups,1164,34.70%,31.80%,37.60%,Simplified probability,Beijing Wantai Biological,ELISA,"IgM,IgG",94.40%,100.00%,Low,Journal Article (Peer-Reviewed),Isaac Ngere,Washington State University,https://dx.doi.org/10.1016/j.ijid.2021.08.062,12/10/2021,16/07/2022,Verified
210826_Nairobi_KenyaMedicalResearchInstitute_Overall_PopAdjusted,26-Aug-21,Local,Kenya,KEN,Nairobi,,27-Nov-20,05-Dec-20,Household and community samples,Multiple groups,511,43.30%,37.40%,49.50%,Simplified probability,Beijing Wantai Biological,ELISA,"IgM,IgG",94.40%,100.00%,Moderate,Journal Article (Peer-Reviewed),Patrick Munywoki,Kenya Medical Research Institute,https://f1000research.com/articles/10-853,04/11/2021,16/07/2022,Verified
211227_Kenya_KEMRI-WellcomeTrustResearchProgramme_BloodDonors_Aug2021_WANTAI,27-Dec-21,National,Kenya,KEN,,,01-Aug-21,31-Aug-21,Blood donors,Adults (18-64 years),176,83.00%,,,Convenience,Beijing Wantai Biological,ELISA,Total Antibody,95.30%,97.90%,High,Journal Article (Peer-Reviewed),James Nyagwange,KEMRI-Wellcome Trust Research Programme,https://dx.doi.org/10.1016/j.jcv.2021.105061,09/01/2022,16/07/2022,Verified
211227_Kenya_KEMRI-WellcomeTrustResearchProgramme_BloodDonors_May2020_Wantai,27-Dec-21,National,Kenya,KEN,,,01-May-20,31-May-20,Blood donors,Adults (18-64 years),176,2.27%,,,Convenience,Beijing Wantai Biological,ELISA,Total Antibody,95.30%,97.90%,High,Journal Article (Peer-Reviewed),James Nyagwange,KEMRI-Wellcome Trust Research Programme,https://dx.doi.org/10.1016/j.jcv.2021.105061,14/01/2022,16/07/2022,Verified
220209_Kenya_KEMRIWellcomeTrustResearchProgramme_Kisumu_OverallAdjusted,09-Feb-22,Local,Kenya,KEN,,Kisumu,01-Feb-21,31-May-21,Household and community samples,Multiple groups,853,38.10%,34.10%,42.40%,Stratified probability,NA,ELISA,IgG,92.70%,99.00%,Low,Preprint,Anthony Etyang,KEMRI-Wellcome Trust Research Programme,https://www.medrxiv.org/content/10.1101/2022.02.07.22270012v1.full-text,22/02/2022,16/07/2022,Verified
220209_Kenya_KEMRIWellcomeTrustResearchProgramme_Nairobi_OverallAdjusted,09-Feb-22,Local,Kenya,KEN,,Nairobi,01-Jan-21,31-May-21,Household and community samples,Multiple groups,850,40.40%,36.00%,45.00%,Stratified probability,NA,ELISA,IgG,92.70%,99.00%,Low,Preprint,Anthony Etyang,KEMRI-Wellcome Trust Research Programme,https://www.medrxiv.org/content/10.1101/2022.02.07.22270012v1.full-text,22/02/2022,16/07/2022,Verified
220209_Kenya_KEMRIWellcomeTrustResearchProgramme_Kilifi_OverallAdjusted,09-Feb-22,Local,Kenya,KEN,,Kilifi,01-Dec-20,30-Apr-21,Household and community samples,Multiple groups,856,19.80%,16.80%,23.10%,Stratified probability,NA,ELISA,IgG,92.70%,99.00%,Low,Preprint,Anthony Etyang,KEMRI-Wellcome Trust Research Programme,https://www.medrxiv.org/content/10.1101/2022.02.07.22270012v1.full-text,22/02/2022,16/07/2022,Verified
220223_CoastalKenya_KenyaMedicalResearchInstitute_Overall,23-Feb-22,Local,Kenya,KEN,,,17-Mar-20,15-Nov-20,Blood donors,Multiple groups,2437,20.30%,,,Unclear,NA,ELISA,IgG,92.70%,99.00%,High,Journal Article (Peer-Reviewed),James Nyagwange,Kenya Medical Research Institute,https://wellcomeopenresearch.org/articles/7-69,09/03/2022,16/07/2022,Unverified
220306_Kenya_KEMRIWellcomeTrustResearchProgramme_Nairobi_20210907-20211019_OverallAdjusted,06-Mar-22,Local,Kenya,KEN,,Nairobi,07-Sep-21,19-Oct-21,Pregnant or parturient women,Adults (18-64 years),245,84.90%,78.30%,91.50%,Sequential,NA,ELISA,IgG,92.70%,99.00%,High,Preprint,R Lucinde,KEMRI-Wellcome Trust Research Programme,https://www.medrxiv.org/content/10.1101/2022.03.03.22271860v1.full-text,16/03/2022,16/07/2022,Verified
220306_Kenya_KEMRIWellcomeTrustResearchProgramme_Nairobi_20210127-20210311_OverallAdjusted,06-Mar-22,Local,Kenya,KEN,,Nairobi,27-Jan-21,11-Mar-21,Pregnant or parturient women,Adults (18-64 years),265,32.10%,26.20%,38.40%,Sequential,NA,ELISA,IgG,92.70%,99.00%,High,Preprint,R Lucinde,KEMRI-Wellcome Trust Research Programme,https://www.medrxiv.org/content/10.1101/2022.03.03.22271860v1.full-text,16/03/2022,16/07/2022,Verified
220306_Kenya_KEMRIWellcomeTrustResearchProgramme_Busia_20210415-20210521_OverallAdjusted,06-Mar-22,Local,Kenya,KEN,,Busia,15-Apr-21,21-May-21,Pregnant or parturient women,Adults (18-64 years),270,30.60%,24.70%,37.10%,Sequential,NA,ELISA,IgG,92.70%,99.00%,High,Preprint,R Lucinde,KEMRI-Wellcome Trust Research Programme,https://www.medrxiv.org/content/10.1101/2022.03.03.22271860v1.full-text,16/03/2022,16/07/2022,Verified
220306_Kenya_KEMRIWellcomeTrustResearchProgramme_Busia_20210920-20211022_OverallAdjusted,06-Mar-22,Local,Kenya,KEN,,Busia,20-Sep-21,22-Oct-21,Pregnant or parturient women,Adults (18-64 years),297,70.70%,64.10%,77.40%,Sequential,NA,ELISA,IgG,92.70%,99.00%,High,Preprint,R Lucinde,KEMRI-Wellcome Trust Research Programme,https://www.medrxiv.org/content/10.1101/2022.03.03.22271860v1.full-text,16/03/2022,16/07/2022,Verified
220306_Kenya_KEMRIWellcomeTrustResearchProgramme_Kilifi_1NovDec2020_OverallAdjusted,06-Mar-22,Local,Kenya,KEN,,Kilifi,01-Nov-20,31-Dec-20,Pregnant or parturient women,Adults (18-64 years),236,14.00%,9.40%,19.50%,Sequential,NA,ELISA,IgG,92.70%,99.00%,High,Preprint,R Lucinde,KEMRI-Wellcome Trust Research Programme,https://www.medrxiv.org/content/10.1101/2022.03.03.22271860v1.full-text,16/03/2022,16/07/2022,Verified
220306_Kenya_KEMRIWellcomeTrustResearchProgramme_Kilifi_2MarApr2021_OverallAdjusted,06-Mar-22,Local,Kenya,KEN,,Kilifi,01-Mar-21,30-Apr-21,Pregnant or parturient women,Adults (18-64 years),260,22.20%,16.70%,28.10%,Sequential,NA,ELISA,IgG,92.70%,99.00%,High,Preprint,R Lucinde,KEMRI-Wellcome Trust Research Programme,https://www.medrxiv.org/content/10.1101/2022.03.03.22271860v1.full-text,16/03/2022,16/07/2022,Verified
220306_Kenya_KEMRIWellcomeTrustResearchProgramme_Kilifi_3MayJun2021_OverallAdjusted,06-Mar-22,Local,Kenya,KEN,,Kilifi,01-May-21,30-Jun-21,Pregnant or parturient women,Adults (18-64 years),382,28.90%,23.90%,34.40%,Sequential,NA,ELISA,IgG,92.70%,99.00%,High,Preprint,R Lucinde,KEMRI-Wellcome Trust Research Programme,https://www.medrxiv.org/content/10.1101/2022.03.03.22271860v1.full-text,16/03/2022,16/07/2022,Verified
220306_Kenya_KEMRIWellcomeTrustResearchProgramme_Kilifi_4JulAug2021_OverallAdjusted,06-Mar-22,Local,Kenya,KEN,,Kilifi,01-Jul-21,31-Aug-21,Pregnant or parturient women,Adults (18-64 years),260,61.20%,54.40%,68.40%,Sequential,NA,ELISA,IgG,92.70%,99.00%,High,Preprint,R Lucinde,KEMRI-Wellcome Trust Research Programme,https://www.medrxiv.org/content/10.1101/2022.03.03.22271860v1.full-text,16/03/2022,16/07/2022,Verified
220306_Kenya_KEMRIWellcomeTrustResearchProgramme_Kilifi_5SepOct2021_OverallAdjusted,06-Mar-22,Local,Kenya,KEN,,Kilifi,01-Sep-21,31-Oct-21,Pregnant or parturient women,Adults (18-64 years),305,62.70%,56.20%,69.10%,Sequential,NA,ELISA,IgG,92.70%,99.00%,High,Preprint,R Lucinde,KEMRI-Wellcome Trust Research Programme,https://www.medrxiv.org/content/10.1101/2022.03.03.22271860v1.full-text,16/03/2022,16/07/2022,Verified
220416_Nairobi_AgaKhanUniversityHospital_TestAdj,16-Apr-22,Local,Kenya,KEN,Central Province of Kenya,Nairobi,15-Nov-20,15-Feb-21,Health care workers and caregivers,Adults (18-64 years),1631,21.40%,19.20%,23.70%,Convenience,Abbott Laboratories,CLIA,IgG,86.00%,99.60%,High,Preprint,Daniel Maina,Aga Khan University Hospital ,10.1101/2022.04.13.22273817,28/04/2022,16/07/2022,Unverified
220315_Kenya_UniversityofWashington_Primary,15-Mar-22,Local,Kenya,KEN,,,15-Apr-21,15-Jul-21,Blood donors,Multiple groups,1000,30.90%,,,Unclear,Bio-rad,ELISA,Total Antibody,,,High,Presentation or Conference,Shradha J. Doshi,University of Washington,https://www.iasusa.org/tam/march-2022/,15/06/2022,16/07/2022,Unverified
220627_Kenya_UniversityOfWashington_Mothers_Primary,27-Jun-22,Local,Kenya,KEN,,,01-Jan-20,31-Dec-20,Pregnant or parturient women,Adults (18-64 years),101,35.60%,,,Sequential,Bio-rad,ELISA,Total Antibody,97.40%,94.90%,Moderate,Preprint,Emily R. Begnel,University of Washington,10.1101/2022.06.23.22276827,06/07/2022,16/07/2022,Unverified
220627_Kenya_UniversityOfWashington_Infants_Primary,27-Jun-22,Local,Kenya,KEN,,Nairobi,01-Jan-20,31-Dec-20,Representative patient population,Children and Youth (0-17 years),89,16.90%,,,Sequential,Bio-rad,ELISA,Total Antibody,97.40%,94.90%,Moderate,Preprint,Emily R. Begnel,University of Washington,10.1101/2022.06.23.22276827,06/07/2022,29/07/2022,Unverified
220729_Kenya_JaramogiOginga OdingaUniversityofScienceandTechnology,29-Jul-22,Regional,Kenya,KEN,Kisumu County and Siaya County,,15-Dec-21,15-Mar-22,Household and community samples,Multiple groups,98,76.50%,66.90%,84.50%,Self-referral,"InBios International, Inc.",ELISA,"IgG,IgM",,,High,Preprint,Shehu Shagari Awandu,Jaramogi Oginga Odinga University of Science and Technology,10.1101/2022.07.27.22278095,09/08/2022,10/08/2022,Unverified
210910_Kazakhstan_KaragandaMedicalUniversity,10-Sep-21,Local,Kazakhstan,KAZ,Karaganda,Karaganda,01-Apr-21,31-May-21,Non-essential workers and unemployed persons,Adults (18-64 years),98,34.70%,,,Convenience,EUROIMMUN,ELISA,"IgA,IgG",,,High,Preprint,Irina Kadyrova,Karaganda Medical University,https://www.medrxiv.org/content/10.1101/2021.09.03.21262885v1.full-text,21/09/2021,16/07/2022,Unverified
220217_Kazakhstan_NazarbayevUniversitySchoolofMedicine_Overall_IgG,17-Feb-22,National,Kazakhstan,KAZ,,,16-Jul-20,07-Jul-21,Residual sera,Multiple groups,85346,63.00%,62.70%,63.30%,Sequential,Vector BEST,ELISA,IgG,90.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Yuliya Semenova,Nazarbayev University School of Medicine,https://dx.doi.org/10.3390/ijerph19042263,28/02/2022,16/07/2022,Unverified
220315_Kazakhstan_KazakhNationalMedicalUniversity_Almaty_OverallPopAdj,15-Mar-22,Local,Kazakhstan,KAZ,,Almaty,24-Oct-20,11-Jan-21,Household and community samples,Multiple groups,4461,57.00%,56.90%,59.80%,Stratified probability,Beijing Wantai Biological,ELISA,Total Antibody,,,Moderate,Journal Article (Peer-Reviewed),Manar Smagul,Kazakh National Medical University,https://dx.doi.org/10.1002/hsr2.562,28/05/2022,16/07/2022,Verified
220315_Kazakhstan_KazakhNationalMedicalUniversity_Oskemen_OverallPopAdj,15-Mar-22,Local,Kazakhstan,KAZ,,Oskemen,24-Oct-20,11-Jan-21,Household and community samples,Multiple groups,664,60.70%,57.90%,65.50%,Stratified probability,Beijing Wantai Biological,ELISA,Total Antibody,,,Moderate,Journal Article (Peer-Reviewed),Manar Smagul,Kazakh National Medical University,https://dx.doi.org/10.1002/hsr2.562,28/05/2022,16/07/2022,Verified
220315_Kazakhstan_KazakhNationalMedicalUniversity_Kostanay_OverallPopAdj,15-Mar-22,Local,Kazakhstan,KAZ,,Kostanay,24-Oct-20,11-Jan-21,Household and community samples,Multiple groups,614,39.40%,35.80%,43.70%,Stratified probability,Beijing Wantai Biological,ELISA,Total Antibody,,,Moderate,Journal Article (Peer-Reviewed),Manar Smagul,Kazakh National Medical University,https://dx.doi.org/10.1002/hsr2.562,28/05/2022,16/07/2022,Verified
210416_Jordan_KingHusseinCancerCenter_Grp3_January_TestAdj,19-Apr-21,National,Jordan,JOR,"North, Center, South",,28-Jan-21,05-Feb-21,Blood donors,Adults (18-64 years),292,27.30%,22.50%,32.90%,Sequential,Roche Diagnostics,CLIA,Total Antibody,100.00%,99.80%,High,Journal Article (Peer-Reviewed),Maher Sughayer,King Hussein Cancer Center,http://dx.doi.org/10.1016/j.ijid.2021.04.059,08/06/2021,16/07/2022,Verified
210416_Jordan_KingHusseinCancerCenter_Grp2_September,19-Apr-21,National,Jordan,JOR,"North, Center, South",,01-Sep-20,15-Sep-20,Blood donors,Adults (18-64 years),348,0.00%,0.00%,0.51%,Sequential,Roche Diagnostics,CLIA,Total Antibody,100.00%,99.80%,High,Journal Article (Peer-Reviewed),Maher Sughayer,King Hussein Cancer Center,http://dx.doi.org/10.1016/j.ijid.2021.04.059,08/06/2021,16/07/2022,Verified
210416_Jordan_KingHusseinCancerCenter_Grp1_June,19-Apr-21,National,Jordan,JOR,"North, Center, South",,15-Jan-20,15-Jun-20,Blood donors,Adults (18-64 years),736,0.00%,0.00%,0.51%,Sequential,Roche Diagnostics,CLIA,Total Antibody,100.00%,99.80%,High,Journal Article (Peer-Reviewed),Maher Sughayer,King Hussein Cancer Center,http://dx.doi.org/10.1016/j.ijid.2021.04.059,08/06/2021,16/07/2022,Verified
210710_Jordan_WorldHealthOrganization_August2020_,10-Jul-21,National,Jordan,JOR,,,01-Aug-20,31-Aug-20,Household and community samples,Multiple groups,4704,0.30%,0.20%,0.40%,Stratified probability,Beijing Wantai Biological,ELISA,"IgG,IgM",,,Moderate,Journal Article (Peer-Reviewed),Saverio Bellizzi,World Health Organization,http://dx.doi.org/10.1016/j.onehlt.2021.100292,29/07/2021,16/07/2022,Verified
210710_Jordan_WorldHealthOrganization_October2020,10-Jul-21,National,Jordan,JOR,,,01-Oct-20,31-Oct-20,Household and community samples,Multiple groups,5470,7.00%,6.80%,7.20%,Stratified probability,Beijing Wantai Biological,ELISA,"IgG,IgM",,,Moderate,Journal Article (Peer-Reviewed),Saverio Bellizzi,World Health Organization,http://dx.doi.org/10.1016/j.onehlt.2021.100292,29/07/2021,16/07/2022,Verified
210710_Jordan_WorldHealthOrganization_January2021,10-Jul-21,National,Jordan,JOR,,,27-Dec-20,06-Jan-21,Household and community samples,Multiple groups,5044,34.20%,33.80%,34.60%,Stratified probability,Beijing Wantai Biological,ELISA,"IgG,IgM",,,Moderate,Journal Article (Peer-Reviewed),Saverio Bellizzi,World Health Organization,http://dx.doi.org/10.1016/j.onehlt.2021.100292,29/07/2021,16/07/2022,Verified
210818_Jordan_KingHusseinCancerCenter_Primary,18-Aug-21,National,Jordan,JOR,,,01-Jun-21,30-Jun-21,Blood donors,Adults (18-64 years),536,74.40%,,,Sequential,Roche Diagnostics,CLIA,Total Antibody,98.80%,100.00%,High,Preprint,Maher Sughayer,King Hussein Cancer Center,https://www.medrxiv.org/content/10.1101/2021.08.15.21261584v1.full-text,24/08/2021,16/07/2022,Verified
211015_JordanUniversityOfScienceAndTechnology_Primary,15-Oct-21,Local,Jordan,JOR,,,15-Sep-20,15-Jan-21,Blood donors,Adults (18-64 years),1000,14.50%,,,Self-referral,Roche Diagnostics,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),Ziad Elnasser,Jordan University of Science and Technology,https://dx.doi.org/10.1097/MD.0000000000027537,09/11/2021,16/07/2022,Verified
220420_Amman_KingHusseinCancerCenter_Overall,20-Apr-22,Local,Jordan,JOR,,Amman,15-Jul-21,15-Sep-21,Health care workers and caregivers,Multiple groups,485,95.88%,,,Simplified probability,Abbott Laboratories,CLIA,IgG,99.35%,99.60%,High,Journal Article (Peer-Reviewed),Lina Souan,King Hussein Cancer Center,https://dx.doi.org/10.3390/vaccines10050642,18/05/2022,16/07/2022,Unverified
200707_Jersey_StatisticsJersey_Round3_TestAdj_PopAdj,07-Jul-20,National,Jersey,JEY,,,21-Jun-20,27-Jun-20,Household and community samples,Multiple groups,1386,4.00%,2.80%,5.20%,Simplified probability,"CTK Biotech, Inc.",LFIA,"IgG,IgM",90.00%,99.39%,Low,Institutional Report,Statistics Jersey,Statistics Jersey,https://www.gov.je/SiteCollectionDocuments/Government%20and%20administration/R%20Prevalence%20of%20antibodies%2020200707%20SJ.pdf,30/04/2021,16/07/2022,Verified
210419_Kobe_KobeMedicalCenterGeneralHospital_Outpatients_PopAdj,19-Apr-21,Local,Japan,JPN,Hyogo Prefecture,Kobe,31-Mar-20,07-Apr-20,Residual sera,Multiple groups,1000,2.70%,1.80%,3.90%,Simplified probability,Kurabo Industries Ltd,LFIA,IgG,76.38%,100.00%,High,Journal Article (Peer-Reviewed),Asaka Doi,Kobe City Medical Center General Hospital,https://dx.doi.org/10.1016/j.cegh.2021.100747,01/05/2020,16/07/2022,Verified
200621_Japan_SoftBank_HCW,21-Jun-20,Local,Japan,JPN,,,12-May-20,18-May-20,Health care workers and caregivers,Multiple groups,5850,1.79%,,,Convenience,NA,Not reported,Not reported,,,Unclear,News and Media,Simon Denyer,SoftBank,https://www.google.com/url?rct=j&sa=t&url=https://www.lmtonline.com/news/article/Japanese-firm-s-blanket-testing-of-employees-15355433.php&ct=ga&cd=CAEYHCoUMTM4NjAwODY3NjE3NzkyOTU2ODYyGjkwZGVhOTg5OTRlOTE4NTk6Y29tOmVuOlVT&usg=AFQjCNGl9_tc35Q3fUbB67SoWaNsH2ltMw,27/06/2020,16/07/2022,Verified
200721_Tokyo_NavitasClinicTachikawa_Overall,21-Jul-20,Regional,Japan,JPN,"Kantō, Chūbu ","Tokyo, Kangawa, Saitama, Chiba, Yamanashi",20-Apr-20,20-May-20,Household and community samples,Multiple groups,1071,3.83%,2.76%,5.16%,Self-referral,Kurabo Industries Ltd,LFIA,IgG,76.40%,100.00%,High,Journal Article (Peer-Reviewed),Morihito Takita,Navitas Clinic Tachikawa,https://dx.doi.org/10.1177/2150132720942695,17/07/2020,16/07/2022,Verified
210226_Iwate_IwatePrefecturalCentralHospital_HCW_Abbot&Roche,26-Feb-21,Local,Japan,JPN,Honshu,Morioka,18-May-20,29-May-20,Health care workers and caregivers,Adults (18-64 years),1000,0.00%,,,Convenience,"Abbott Laboratories,Roche Diagnostics,Alfa Scientific Designs",CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Akihiro Nakamura,Iwate Prefectural Central Hospital,https://dx.doi.org/10.5387/fms.2020-21,17/07/2020,16/07/2022,Verified
200730_Sapporo_HokkaidoUniversityGraduateSchoolofMedicine_LiverDiseasePatientsMay2020,30-Jul-20,Local,Japan,JPN,Hokkaido,Sapporo,01-May-20,31-May-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,300,0.00%,0.00%,0.00%,Unclear,Roche Diagnostics,CLIA,IgG,100.00%,99.80%,High,Journal Article (Peer-Reviewed),Goki Suda,Hokkaido University Graduate School of Medicine,https://dx.doi.org/10.1111/hepr.13551,01/10/2020,16/07/2022,Verified
200730_Sapporo_HokkaidoUniversityGraduateSchoolofMedicine_LiverDiseasePatientsMarch2020,30-Jul-20,Local,Japan,JPN,Hokkaido,Sapporo,01-Mar-20,31-Mar-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,300,0.30%,0.00%,1.80%,Unclear,Roche Diagnostics,CLIA,IgG,100.00%,99.80%,High,Journal Article (Peer-Reviewed),Goki Suda,Hokkaido University Graduate School of Medicine,https://dx.doi.org/10.1111/hepr.13551,01/10/2020,16/07/2022,Verified
200911_Osaka_ToyonakaMunicipalHospital_Overall,11-Sep-20,Local,Japan,JPN,Kansai,Osaka,12-Jun-20,19-Jun-20,Health care workers and caregivers,Adults (18-64 years),925,0.43%,0.17%,1.10%,Convenience,Abbott Laboratories,CLIA,IgG,100.00%,99.60%,Moderate,Preprint,Tsutomu Nishida,Toyonaka Municipal Hospital,https://www.medrxiv.org/content/10.1101/2020.09.10.20191866v1,22/10/2020,16/07/2022,Verified
201008_Fujisawa_ShonanFujisawaTokushukaiHospital_MedicalStaff,08-Oct-20,Local,Japan,JPN,Kanagawa,Fujisawa,01-Jun-20,30-Jul-20,Health care workers and caregivers,Adults (18-64 years),806,0.74%,0.27%,1.61%,Convenience,Abbott Laboratories,CLIA,IgG,100.00%,,Unclear,Journal Article (Peer-Reviewed),M Hibino,Shonan Fujisawa Tokushukai Hospital,https://dx.doi.org/10.1016/j.jhin.2020.10.001,24/11/2020,16/07/2022,Verified
201207_Kyoto_NationalHospitalOrganizationKyotoMedicalCenter,07-Dec-20,Local,Japan,JPN,Kansai,Kyoto,10-Apr-20,20-Apr-20,Health care workers and caregivers,Adults (18-64 years),92,5.40%,,,Convenience,"CTK Biotech, Inc.",ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Kohei Fujita,National Hospital Organization Kyoto Medical Center,https://dx.doi.org/10.3389/fpubh.2020.595348,01/02/2021,16/07/2022,Verified
201120_Japan_TokyoNationalHospital_overall,20-Nov-20,Local,Japan,JPN,,Tokyo,01-Jun-20,30-Oct-20,Patients seeking care for non-COVID-19 reasons,Seniors (65+ years),93,16.10%,,,Convenience,"GenBody Inc.,Roche Diagnostics",Multiple Types,"IgG,IgM",,,High,Preprint,Shomi Oka,Tokyo National Hospital,https://www.researchsquare.com/article/rs-112294/v1,07/02/2021,16/07/2022,Verified
210113_Wakayama_WakayamaMedicalUniversity_overall,13-Jan-21,Local,Japan,JPN,,Wakayama,07-Jul-20,15-Sep-20,Health care workers and caregivers,Multiple groups,1528,0.79%,0.34%,1.22%,Convenience,Kurabo Industries Ltd,LFIA,IgG,76.40%,100.00%,High,Preprint,Sadahiro Iwabuchi,Wakayama Medical University,https://www.medrxiv.org/content/10.1101/2021.01.10.21249421v1,07/02/2021,16/07/2022,Unverified
201230_Fukushima_ HirataCentralHospital_CLIA_IgG,30-Dec-20,Local,Japan,JPN,Fukushima Prefecture,Hirata,08-May-20,28-May-20,Health care workers and caregivers,Multiple groups,637,0.94%,,,Unclear,Shenzhen Yhlo Biotech Co. Ltd,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Yurie Kobashi, Hirata Central Hospital,https://dx.doi.org/10.1016/j.intimp.2020.107360,16/02/2021,16/07/2022,Verified
210120_Japan_ResearchInstituteOfTuberculosis_GenPop,20-Jan-21,National,Japan,JPN,,"Tokyo, Osaka, Miyagi",01-Jun-20,07-Jun-20,Household and community samples,Multiple groups,7950,0.10%,0.04%,0.20%,Stratified probability,"Roche Diagnostics,Abbott Laboratories",CLIA,"Total Antibody,IgG",,,Low,Journal Article (Peer-Reviewed),Takashi Yoshiyama,Government of Japan,https://dx.doi.org/10.3201/eid2702.204088,28/02/2021,16/07/2022,Verified
210129_Hyogo_KobeUniversityGraduateSchoolOfMedicine_Overall,29-Jan-21,Regional,Japan,JPN,Kansai,,06-Aug-20,01-Oct-20,Residual sera,Multiple groups,10377,0.60%,,,Sequential,"Sysmex,Roche Diagnostics",CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Koichi Furukawa,Kobe University Graduate School of Medicine,https://dx.doi.org/10.31662/jmaj.2020-0094,20/03/2021,16/07/2022,Verified
210206_YokohamaCity_YokohamaCityUniversity,06-Feb-21,Local,Japan,JPN,Kanagawa Prefecture,Yokohama City,01-Jun-20,31-Jul-20,Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),432,3.90%,,,Sequential,NA,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Shigeta Miyake,Yokohama City University,http://dx.doi.org/10.1111/den.13945,05/04/2021,16/07/2022,Verified
200920_Tokyo_NationalCenterForGlobalHealthAndMedicine_Overall,09-Sep-20,Local,Japan,JPN,,Tokyo,14-Feb-20,03-Apr-20,Health care workers and caregivers,Adults (18-64 years),49,0.00%,,,Convenience,NA,Multiple Types,"IgG,Neutralizing ",,,High,Journal Article (Peer-Reviewed),Tetsuya Suzuki,National Center for Global Health and Medicine,http://dx.doi.org/10.1016/j.jiac.2020.09.006,11/04/2021,16/07/2022,Verified
210330_Tokyo_JapanMinistryOfHealth1_overall,30-Mar-21,Regional,Japan,JPN,Tokyo Prefecture,,14-Dec-20,26-Dec-20,Household and community samples,Multiple groups,3399,1.35%,,,Unclear,NA,Not reported,Not reported,,,High,News and Media,The Bharat Express News,Japan Ministry of Health,https://www.thebharatexpressnews.com/1-35-in-tokyo-have-antibodies-against-the-coronavirus/,11/04/2021,16/07/2022,Unverified
210330_Osaka_JapanMinistryOfHealth2_overall,30-Mar-21,Regional,Japan,JPN,Osaka Prefecture,,14-Dec-20,26-Dec-20,Household and community samples,Multiple groups,2746,0.69%,,,Unclear,NA,Not reported,Not reported,,,High,News and Media,The Bharat Express News,Japan Ministry of Health,https://www.thebharatexpressnews.com/1-35-in-tokyo-have-antibodies-against-the-coronavirus/,11/04/2021,16/07/2022,Unverified
210330_ Aichi_JapanMinistryOfHealth3_overall,30-Mar-21,Regional,Japan,JPN,Aichi Prefecture,,14-Dec-20,26-Dec-20,Household and community samples,Multiple groups,2960,0.71%,,,Unclear,NA,Not reported,Not reported,,,High,News and Media,The Bharat Express News,Japan Ministry of Health,https://www.thebharatexpressnews.com/1-35-in-tokyo-have-antibodies-against-the-coronavirus/,11/04/2021,16/07/2022,Unverified
210330_Miyagi_JapanMinistryOfHealth4_overall,30-Mar-21,Regional,Japan,JPN,Miyagi Prefecture,,14-Dec-20,26-Dec-20,Household and community samples,Multiple groups,2860,0.14%,,,Unclear,NA,Not reported,Not reported,,,High,News and Media,The Bharat Express News,Japan Ministry of Health,https://www.thebharatexpressnews.com/1-35-in-tokyo-have-antibodies-against-the-coronavirus/,11/04/2021,16/07/2022,Unverified
210330_ Fukuoka_JapanMinistryOfHealth5_overall,30-Mar-21,Regional,Japan,JPN,Fukuoka Prefecture,,14-Dec-20,26-Dec-20,Household and community samples,Multiple groups,3078,0.42%,,,Unclear,NA,Not reported,Not reported,,,High,News and Media,The Bharat Express News,Japan Ministry of Health,https://www.thebharatexpressnews.com/1-35-in-tokyo-have-antibodies-against-the-coronavirus/,11/04/2021,16/07/2022,Unverified
200727_Japan_HealthandWelfareDepartment_primary,27-Jul-20,Regional,Japan,JPN,prefecture 3,,15-Jun-20,28-Jun-20,Residual sera,Multiple groups,3000,0.00%,,,Convenience,NA,Not reported,IgG,,,Unclear,News and Media,Okuda,Health and Welfare Department,http://wave.pref.wakayama.lg.jp/news/kensei/shiryo.php?sid=31587,22/04/2021,16/07/2022,Verified
210212_Hiroshima_HiroshimaUniversity_overall,12-Feb-21,Regional,Japan,JPN,Hiroshima Prefecture,"Hiroshima, Fukuyama, Miyoshi, and Higashi-Hiroshima",15-Oct-20,15-Nov-20,Household and community samples,Multiple groups,2396,0.25%,,,Simplified probability,Roche Diagnostics,CLIA,Not reported,,,High,Institutional Report,Prefecture of Hiroshima,Hiroshima University ,https://www.chugoku-np.co.jp/local/news/article.php?comment_id=726622&comment_sub_id=0&category_id=256,30/04/2021,16/07/2022,Verified
210320_Japan_NationalCenterForGlobalHealthAndMedicine,20-Mar-21,National,Japan,JPN,,,14-Feb-20,13-Mar-20,Health care workers and caregivers,Adults (18-64 years),10,0.00%,,,Convenience,NA,Multiple Types,Not reported,,,High,Preprint,Tetsuya Suzuki,National Center for Global Health and Medicine,10.1101/https://www.medrxiv.org/content/10.1101/2021.03.17.21251964v1,05/05/2021,16/07/2022,Unverified
210315_FukuokaCity_KanenokumaHospital_Staff,15-Mar-21,Local,Japan,JPN,,Fukuoka City,23-Apr-20,15-Jun-20,Health care workers and caregivers,Adults (18-64 years),40,0.00%,,,Convenience,"NA,Hanghzhou AllTest Biotech Co. Ltd",Multiple Types,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Yong Chong,Kanenokuma Hospital,https://dx.doi.org/10.1186/s12879-021-05972-5,13/05/2021,16/07/2022,Verified
201216_Utsunomiya_TokyoMedicalandDentalUniversity_PopAdj,16-Dec-20,Regional,Japan,JPN,Tochigi Prefecture,Utsunomiya City,14-Jun-20,05-Jul-20,Household and community samples,Multiple groups,742,1.23%,0.17%,2.28%,Simplified probability,Shenzhen Yhlo Biotech Co. Ltd,CLIA,IgG,97.30%,96.30%,Low,Journal Article (Peer-Reviewed),Nobutoshi Nawa,Tokyo Medical and Dental University,https://onlinelibrary.wiley.com/doi/full/10.1002/jgf2.408,13/05/2021,16/07/2022,Verified
210315_FukuokaCity_KanenokumaHospital_Residents,15-Mar-21,Local,Japan,JPN,,Fukuoka City,23-Apr-20,15-Jun-20,Assisted living and long-term care facilities,Seniors (65+ years),76,7.89%,,,Convenience,"NA,Hanghzhou AllTest Biotech Co. Ltd",Multiple Types,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Yong Chong,Kanenokuma Hospital,https://dx.doi.org/10.1186/s12879-021-05972-5,13/05/2021,16/07/2022,Verified
210405_Japan_SOUSEIKAI_Overall,05-Apr-21,Local,Japan,JPN,"Fukuoka, Kumamoto, Tokyo",,15-Aug-20,15-Oct-20,Health care workers and caregivers,Multiple groups,2160,1.70%,,,Convenience,Innovita Biological Technology Co. Ltd,LFIA,"IgG,IgM",87.30%,100.00%,Moderate,Journal Article (Peer-Reviewed),Tatsuya Yoshihara,SOUSEIKAI Medical Group,http://dx.doi.org/10.3390/ijerph18073786,14/05/2021,16/07/2022,Verified
210324_Morioka_IwatePrefecturalCentralHospital_hcw,24-Mar-21,Local,Japan,JPN,Tonoku,Morioka,18-May-20,19-May-20,Health care workers and caregivers,Adults (18-64 years),1404,0.00%,,,Convenience,"Abbott Laboratories,Roche Diagnostics",Multiple Types,IgG,,,High,Journal Article (Peer-Reviewed),Akihiro Nakamura,Iwate Prefectural Central Hospital ,https://onlinelibrary.wiley.com/doi/10.1002/jmv.26962,16/05/2021,16/07/2022,Verified
210416_Tokyo_JuntendoUniversity_HCW_Overall_testadj,16-Apr-21,Local,Japan,JPN,Kantō,Tokyo,06-Jul-20,21-Aug-20,Health care workers and caregivers,Multiple groups,4147,0.38%,0.22%,0.63%,Convenience,Roche Diagnostics,CLIA,"IgA,IgM,IgG",100.00%,99.80%,Moderate,Journal Article (Peer-Reviewed),Hiroshi Fukuda,Juntendo Univesity,https://dx.doi.org/10.1038/s41598-021-87688-9,22/05/2021,16/07/2022,Verified
210223_Osaka_KyotoUniversity_RLA_Overall,23-Feb-21,Local,Japan,JPN,Honshu,Osaka,08-Jul-20,22-Jul-20,Health care workers and caregivers,Adults (18-64 years),1000,0.40%,,,Convenience,NA,Other,IgG,,,High,Journal Article (Peer-Reviewed),Hidenori Matsunaga,Kyoto University,https://www.mdpi.com/1999-4915/13/2/347,23/05/2021,16/07/2022,Verified
210417_Itami_ItamiCityHospital,17-Apr-21,Local,Japan,JPN,Kansai,Itami,15-May-20,20-Nov-20,Residual sera,Multiple groups,592,2.20%,,,Unclear,NA,Not reported,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Tsuyoshi Nakai,Itami City Hospital,https://dx.doi.org/10.1016/j.jos.2021.02.017,25/05/2021,16/07/2022,Unverified
210430_Tokyo_NationalCenterForGlobalHealthAndMedicine_Primary,30-Apr-21,Local,Japan,JPN,Tokyo Prefecture,Tokyo,01-Jul-20,31-Jul-20,Health care workers and caregivers,Adults (18-64 years),1228,0.08%,0.02%,0.45%,Convenience,Abbott Laboratories,CLIA,IgG,100.00%,99.90%,Moderate,Journal Article (Peer-Reviewed),Shohei Yamamoto,National Center for Global Health and Medicine,https://dx.doi.org/10.35772/ghm.2021.01022,30/05/2021,16/07/2022,Verified
200515_Tokyo_UniversityOfTokyo,15-May-20,Regional,Japan,JPN,Tokyo Prefecture,Tokyo,01-May-20,02-May-20,Residual sera,Multiple groups,500,0.60%,,,Convenience,NA,CLIA,"IgG,IgM",,,High,Presentation or Conference,Tatsuhiko Kodama,University of Tokyo,https://www.rcast.u-tokyo.ac.jp/ja/news/release/20200515.html,02/06/2021,16/07/2022,Verified
20210524_NCGM_Japan_hcw,24-May-21,Regional,Japan,JPN,,"Tokyo, Chiba",01-Oct-20,31-Dec-20,Essential non-healthcare workers,Adults (18-64 years),2563,0.70%,0.42%,1.11%,Convenience,"Abbott Laboratories,EUROIMMUN,Roche Diagnostics",Multiple Types,IgG,,,Unclear,Journal Article (Peer-Reviewed),Shohei Yamamoto,The National Center for Global Health and Medicine (NCGM),https://dx.doi.org/10.1016/j.jinf.2021.05.017,06/06/2021,16/07/2022,Unverified
210504_Okinawa_OkinawaInstituteOfScienceAndTechnology,04-May-21,Local,Japan,JPN,Okinawa Prefecture,Okinawa,01-Aug-20,31-Aug-20,Multiple populations,Adults (18-64 years),675,0.00%,,,Convenience,NA,ELISA,Not reported,92.50%,100.00%,Moderate,Journal Article (Peer-Reviewed),Melissa M Matthews,Okinawa Institute of Science and Technology,https://dx.doi.org/10.1038/s41598-021-88850-z,07/06/2021,16/07/2022,Verified
210528_Tokyo_NationalCancerCenterHospital_HCW_primary,28-May-21,Local,Japan,JPN,,Tokyo,01-Sep-20,30-Oct-20,Health care workers and caregivers,Multiple groups,1190,0.67%,0.29%,1.32%,Convenience,Sysmex,CLIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Shu Yazaki,National Cancer Center Hospital,https://dx.doi.org/10.1001/jamaoncol.2021.2159,07/06/2021,16/07/2022,Unverified
210528_Tokyo_NationalCancerCenterHospital_patients_primary,28-May-21,Local,Japan,JPN,,Tokyo,03-Aug-20,31-Aug-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,500,1.00%,0.33%,2.32%,Convenience,Sysmex,CLIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Shu Yazaki,National Cancer Center Hospital,https://dx.doi.org/10.1001/jamaoncol.2021.2159,07/06/2021,16/07/2022,Unverified
210608_Tokyo_BostonChildrensHospital_May26-June9,08-Jun-21,Local,Japan,JPN,Tokyo Prefecture,Tokyo,26-May-20,09-Jun-20,Non-essential workers and unemployed persons,Adults (18-64 years),51,5.88%,,,Convenience,Aurora Biomed Inc,LFIA,"IgG,IgM",,,High,Preprint,Sawako Hibino,Medical Corporation Koshikai ,https://www.researchsquare.com/article/rs-564670/v1,21/06/2021,16/07/2022,Verified
210608_Tokyo_BostonChildrensHospital_June10-June23,08-Jun-21,Local,Japan,JPN,Tokyo Prefecture,Tokyo,10-Jun-20,23-Jun-20,Non-essential workers and unemployed persons,Adults (18-64 years),119,5.00%,,,Convenience,Aurora Biomed Inc,LFIA,"IgG,IgM",,,High,Preprint,Sawako Hibino,Medical Corporation Koshikai ,https://www.researchsquare.com/article/rs-564670/v1,21/06/2021,16/07/2022,Verified
210608_Tokyo_BostonChildrensHospital_June24-July7,08-Jun-21,Local,Japan,JPN,Tokyo Prefecture,Tokyo,24-Jun-20,07-Jul-20,Non-essential workers and unemployed persons,Adults (18-64 years),187,25.67%,,,Convenience,Aurora Biomed Inc,LFIA,"IgG,IgM",,,High,Preprint,Sawako Hibino,Medical Corporation Koshikai ,https://www.researchsquare.com/article/rs-564670/v1,21/06/2021,16/07/2022,Verified
210608_Tokyo_BostonChildrensHospital_July8-July21,08-Jun-21,Local,Japan,JPN,Tokyo Prefecture,Tokyo,08-Jul-20,21-Jul-20,Non-essential workers and unemployed persons,Adults (18-64 years),256,37.10%,,,Convenience,Aurora Biomed Inc,LFIA,"IgG,IgM",,,High,Preprint,Sawako Hibino,Medical Corporation Koshikai ,https://www.researchsquare.com/article/rs-564670/v1,21/06/2021,16/07/2022,Verified
210608_Tokyo_BostonChildrensHospital_July22-August4,08-Jun-21,Local,Japan,JPN,Tokyo Prefecture,Tokyo,22-Jul-20,04-Aug-20,Non-essential workers and unemployed persons,Adults (18-64 years),175,38.86%,,,Convenience,Aurora Biomed Inc,LFIA,"IgG,IgM",,,High,Preprint,Sawako Hibino,Medical Corporation Koshikai ,https://www.researchsquare.com/article/rs-564670/v1,21/06/2021,16/07/2022,Verified
210608_Tokyo_BostonChildrensHospital_August5-August18,08-Jun-21,Local,Japan,JPN,Tokyo Prefecture,Tokyo,05-Aug-20,18-Aug-20,Non-essential workers and unemployed persons,Adults (18-64 years),115,41.74%,,,Convenience,Aurora Biomed Inc,LFIA,"IgG,IgM",,,High,Preprint,Sawako Hibino,Medical Corporation Koshikai ,https://www.researchsquare.com/article/rs-564670/v1,21/06/2021,16/07/2022,Verified
210608_Tokyo_BostonChildrensHospital_August19-September2,08-Jun-21,Local,Japan,JPN,Tokyo Prefecture,Tokyo,19-Aug-20,02-Sep-20,Non-essential workers and unemployed persons,Adults (18-64 years),62,46.77%,,,Convenience,Aurora Biomed Inc,LFIA,"IgG,IgM",,,High,Preprint,Sawako Hibino,Medical Corporation Koshikai ,https://www.researchsquare.com/article/rs-564670/v1,21/06/2021,16/07/2022,Verified
210201_Yamagata_YamagataUniversity_Overall,01-Feb-21,Local,Japan,JPN,Yamagata prefecture,Yamagata,01-Jun-20,04-Jun-20,Residual sera,Multiple groups,1009,0.50%,0.06%,0.93%,Sequential,Roche Diagnostics,CLIA,Total Antibody,,99.80%,High,Institutional Report,Keita Morikane,Yamagata University,https://dx.doi.org/10.5365/wpsar.2020.11.3.012,23/06/2021,16/07/2022,Verified
210625_Osaka_ ToyonakaMunicipalHospital_Overall,25-Jun-21,Local,Japan,JPN,Osaka Prefecture,Osaka,12-Jun-20,19-Jun-20,Health care workers and caregivers,Adults (18-64 years),925,0.43%,0.17%,1.10%,Convenience,Abbott Laboratories,CLIA,IgG,100.00%,99.60%,Moderate,Journal Article (Peer-Reviewed),Tsutomu Nishida, Toyonaka Municipal Hospital,https://dx.doi.org/10.1097/MD.0000000000026433,30/06/2021,16/07/2022,Verified
210612_Tokyo_TheUniversityOfTokyo_overall,12-Jun-21,Regional,Japan,JPN,,Tokyo,11-Jun-20,28-Oct-20,Multiple populations,Multiple groups,6609,0.48%,,,Self-referral,Shenzhen Yhlo Biotech Co. Ltd,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Akihisa Mitani,The University of Tokyo,https://dx.doi.org/10.1016/j.jiac.2021.06.008,30/06/2021,16/07/2022,Verified
210619_Tokyo_KeioUniversityHealthCenter,19-Jun-21,Local,Japan,JPN,,Tokyo,01-Aug-20,31-Aug-20,Health care workers and caregivers,Adults (18-64 years),2320,0.86%,0.53%,1.33%,Convenience,Shenzhen Yhlo Biotech Co. Ltd,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Tomoyasu Nishimura,Keio University Health Center,https://dx.doi.org/10.2169/internalmedicine.7033-21,07/07/2021,16/07/2022,Verified
210614_Fukushima_HirataCentralHospital_May_CLIA_IgG,14-Jun-21,Local,Japan,JPN,Fukushima,Ishikawa District,08-May-20,28-May-20,Health care workers and caregivers,Multiple groups,515,0.97%,0.32%,2.25%,Entire sample,Shenzhen Yhlo Biotech Co. Ltd,CLIA,IgG,97.30%,96.30%,Low,Journal Article (Peer-Reviewed),Yurie Kobashi,Hirata Central Hospital,https://dx.doi.org/10.1016/j.intimp.2021.107884,19/07/2021,16/07/2022,Unverified
210614_Fukushima_HirataCentralHospital_Oct_CLIA_IgG,14-Jun-21,Local,Japan,JPN,Fukushima,Ishikawa District,05-Oct-20,23-Oct-20,Health care workers and caregivers,Multiple groups,515,0.39%,0.05%,1.40%,Entire sample,Shenzhen Yhlo Biotech Co. Ltd,CLIA,IgG,97.30%,96.30%,Low,Journal Article (Peer-Reviewed),Yurie Kobashi,Hirata Central Hospital,https://dx.doi.org/10.1016/j.intimp.2021.107884,19/07/2021,16/07/2022,Unverified
210719_Kanagawa_OsakaCityUniversity,19-Jul-21,Local,Japan,JPN,Kanagawa,Yokohama City,30-Jun-20,02-Jul-20,Health care workers and caregivers,Adults (18-64 years),377,7.16%,,,Convenience,"Abbott Laboratories,GenScript",Multiple Types,"IgG,Neutralizing ,IgM",,,High,Preprint,Yu Nakagama,Osaka City University,https://www.medrxiv.org/content/10.1101/2021.07.15.21260585v1.full-text,28/07/2021,16/07/2022,Unverified
210727_Tokyo_MusashinoRed CrossHospital_Baseline,27-Jul-21,Regional,Japan,JPN,,Tokyo,15-Mar-21,15-May-21,Essential non-healthcare workers,Multiple groups,59,0.00%,,,Convenience,Abbott Laboratories,CLIA,IgG,100.00%,99.60%,High,Journal Article (Peer-Reviewed),Shun Kaneko,Musashino Red Cross Hospital,https://dx.doi.org/10.1002/jmv.27231,04/08/2021,16/07/2022,Unverified
210529_Yokohama_YokohamaDai-ichiHospital,29-May-21,Local,Japan,JPN,,Yokohama,01-Aug-20,14-Dec-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,55,3.64%,,,Sequential,Roche Diagnostics,CLIA,"IgG,IgM,IgA",,,High,Journal Article (Peer-Reviewed),Takayasu Taira,Yokohama Dai-ichi Hospital,http://dx.doi.org/10.1093/ndt/gfab098.0019,13/09/2021,16/07/2022,Unverified
211011_SaitamaCity_JichiMedicalUniversity_crosssectional_HCW,11-Oct-21,Local,Japan,JPN,Saitama Prefecture,Saitama City,05-Jul-20,19-Jul-20,Health care workers and caregivers,Adults (18-64 years),607,0.17%,0.01%,1.06%,Convenience,"Abbott Laboratories,NA",Multiple Types,IgG,,,High,Journal Article (Peer-Reviewed),Hiroshi Hori,Jichi Medical University,https://dx.doi.org/10.1371/journal.pone.0257513,19/10/2021,16/07/2022,Unverified
211011_SaitamaCity_JichiMedicalUniversity_cohort_HCW_primary,11-Oct-21,Local,Japan,JPN,Saitama Prefecture,Saitama City,15-May-20,15-Jul-20,Health care workers and caregivers,Adults (18-64 years),116,0.00%,,,Convenience,Roche Diagnostics,CLIA,IgG,100.00%,99.81%,High,Journal Article (Peer-Reviewed),Hiroshi Hori,Jichi Medical University,https://dx.doi.org/10.1371/journal.pone.0257513,19/10/2021,16/07/2022,Unverified
211030_Aichi_NationalCenterforGeriatricsandGerontology_Primary,30-Oct-21,Regional,Japan,JPN,Aichi Prefecture,,01-Jun-21,30-Jun-21,Health care workers and caregivers,Adults (18-64 years),556,93.70%,,,Convenience,Sysmex,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Akihiko Nishikimi,National Center for Geriatrics and Gerontology,https://dx.doi.org/10.1016/j.jinf.2021.10.021,10/11/2021,16/07/2022,Unverified
211029_OsakaCity_OsakaCityGeneralHospital_Overall,29-Oct-21,Local,Japan,JPN,Osaka Prefecture,Osaka City,01-Nov-20,31-Mar-21,Residual sera,Multiple groups,94,6.40%,,,Convenience,Roche Diagnostics,CLIA,IgG,99.50%,99.80%,High,Journal Article (Peer-Reviewed),Yusuke Hanioka,Osaka City General Hospital,https://dx.doi.org/10.2147/IJGM.S330525,17/11/2021,16/07/2022,Unverified
211113_Tokyo_TokyoMetropolitanInstituteofMedicalScience_Overall,13-Nov-21,Regional,Japan,JPN,,Tokyo,01-Sep-20,31-Mar-21,Residual sera,Multiple groups,23234,1.83%,1.66%,2.01%,Simplified probability,Shenzhen Yhlo Biotech Co. Ltd,CLIA,IgG,,100.00%,Moderate,Journal Article (Peer-Reviewed),Takahiro Sanada,Tokyo Metropolitan Institute of Medical Science,https://dx.doi.org/10.2188/jea.JE20210324,22/11/2021,16/07/2022,Unverified
211205_Tokyo_UniversityofTokyo_iFlashIgG,05-Dec-21,Regional,Japan,JPN,,Tokyo,11-Jun-20,22-Dec-20,Multiple populations,Adults (18-64 years),10039,0.23%,,,Convenience,Shenzhen Yhlo Biotech Co. Ltd,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Akihisa Mitani,University of Tokyo,https://dx.doi.org/10.1016/j.jiac.2021.11.020,04/01/2022,16/07/2022,Unverified
211119_IwateMedicalUniversity_IwateMedicalUniversity,19-Nov-21,Local,Japan,JPN,Tohoku,Morioke,15-Mar-21,31-May-21,Health care workers and caregivers,Adults (18-64 years),10,0.00%,,,Unclear,NA,Not reported,Not reported,,,High,Presentation or Conference,Hiromi Nagashima,Iwate Medical University,https://onlinelibrary.wiley.com/doi/full/10.1111/resp.14150_356,12/01/2022,16/07/2022,Unverified
211228_Kanagawa_ ShonanFujisawaTokushukaiHospital_AbbottIgG-S,28-Dec-21,Local,Japan,JPN,,Kanagawa,15-Apr-21,15-May-21,Health care workers and caregivers,Adults (18-64 years),100,5.00%,,,Convenience,Abbott Laboratories,CLIA,IgG,100.00%,100.00%,High,Journal Article (Peer-Reviewed),Makoto Hibino, Shonan Fujisawa Tokushukai Hospital,https://dx.doi.org/10.2169/internalmedicine.8704-21,13/01/2022,16/07/2022,Unverified
220112_KantohDistrict_EPSHoldingsInc,12-Jan-22,Regional,Japan,JPN,,,26-Apr-21,01-Aug-21,Household and community samples,Multiple groups,139,12.23%,7.29%,18.86%,Convenience,NA,ELISA,IgG,,,High,Preprint,Keiichi Tsukinoki,"EPS Holdings, Inc.",https://www.medrxiv.org/content/10.1101/2022.01.09.22268986v2.full-text,17/01/2022,16/07/2022,Unverified
200906_Kanagawa_KanagawaPhysiciansAssociation_HCWs_PopAdjust,06-Sep-20,Regional,Japan,JPN,Kanagawa Prefecture,,18-May-20,24-Jun-20,Health care workers and caregivers,Adults (18-64 years),504,2.10%,,,Convenience,NA,ELISA,IgG,100.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Ikuro Matsuba,Kanagawa Physicians Association,https://www.sciencedirect.com/science/article/pii/S1341321X20303251,01/02/2022,16/07/2022,Unverified
200906_Kanagawa_KanagawaPhysiciansAssociation_Patients_PopAdjust,06-Sep-20,Regional,Japan,JPN,Kanagawa Prefecture,,18-May-20,24-Jun-20,Residual sera,Multiple groups,988,2.70%,,,Convenience,NA,ELISA,IgG,100.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Ikuro Matsuba,Kanagawa Physicians Association,https://www.sciencedirect.com/science/article/pii/S1341321X20303251,01/02/2022,16/07/2022,Unverified
220121_Hyogo_UniversityOfOxford,21-Jan-22,Local,Japan,JPN,,Hyogo,26-May-20,24-Sep-21,Patients seeking care for non-COVID-19 reasons,Multiple groups,339,2.36%,,,Convenience,"Roche Diagnostics,Siemens",Not reported,Total Antibody,,,High,Presentation or Conference,S Y Wong,University of Oxford,https://dx.doi.org/10.1093/ecco-jcc/jjab232.469,08/03/2022,16/07/2022,Unverified
220121_Japan_HyogoCollegeofMedicine_Patients_Overall,21-Jan-22,National,Japan,JPN,,,15-Mar-21,15-Oct-21,Representative patient population,Multiple groups,679,,,,Convenience,NA,Not reported,IgG,,,Unclear,Journal Article (Peer-Reviewed),K Watanabe,Shiga University of Medical Science,https://dx.doi.org/10.1093/ecco-jcc/jjab232.063,09/03/2022,16/07/2022,Unverified
220121_Japan_HyogoCollegeofMedicine_Controls_Overall,21-Jan-22,National,Japan,JPN,,,15-Mar-21,15-Oct-21,Residual sera,Multiple groups,203,,,,Convenience,NA,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),K Watanabe,Shiga University of Medical Science,https://dx.doi.org/10.1093/ecco-jcc/jjab232.063,09/03/2022,16/07/2022,Unverified
121203_Tochigi_JichiMedicalUniversity_Apr-May2020,03-Dec-21,Local,Japan,JPN,Shimotsuke,Tochigi,15-Apr-20,15-May-20,Health care workers and caregivers,Adults (18-64 years),54,3.70%,,,Entire sample,"Innovita Biological Technology Co. Ltd,Shenzhen Yhlo Biotech Co. Ltd,Roche Diagnostics,Abbott Laboratories",Multiple Types,Not reported,,,High,Journal Article (Peer-Reviewed),Kouichi Miura,Jichi Medical University,https://dx.doi.org/10.1002/deo2.79,28/03/2022,16/07/2022,Unverified
121203_Tochigi_JichiMedicalUniversity_Jun-Nov2020,03-Dec-21,Local,Japan,JPN,Shimotsuke,Tochigi,15-Jun-20,15-Nov-20,Health care workers and caregivers,Adults (18-64 years),349,1.43%,,,Entire sample,"Innovita Biological Technology Co. Ltd,Shenzhen Yhlo Biotech Co. Ltd,Roche Diagnostics,Abbott Laboratories",Multiple Types,Not reported,,,High,Journal Article (Peer-Reviewed),Kouichi Miura,Jichi Medical University,https://dx.doi.org/10.1002/deo2.79,28/03/2022,16/07/2022,Unverified
121203_Tochigi_JichiMedicalUniversity_Dec2020-Mar2021,03-Dec-21,Local,Japan,JPN,Shimotsuke,Tochigi,15-Dec-20,15-Mar-21,Health care workers and caregivers,Adults (18-64 years),86,1.16%,,,Entire sample,"Innovita Biological Technology Co. Ltd,Shenzhen Yhlo Biotech Co. Ltd,Roche Diagnostics,Abbott Laboratories",Multiple Types,Not reported,,,High,Journal Article (Peer-Reviewed),Kouichi Miura,Jichi Medical University,https://dx.doi.org/10.1002/deo2.79,28/03/2022,16/07/2022,Unverified
220327_Yokohama_YokohamaCityUniversity_Popadj,27-Mar-22,Local,Japan,JPN,Kanagawa Prefecture,Yokohama,30-Jan-22,28-Feb-22,Household and community samples,Multiple groups,1277,94.20%,93.00%,95.40%,Simplified probability,TOSOH,CLIA,IgG,,,Moderate,Preprint,Atsushi Goto,Yokohama City University,https://www.medrxiv.org/content/10.1101/2022.03.26.22272766v1.full-text,05/04/2022,16/07/2022,Verified
220331_Maebashi_GunmaUniversityHospital_Overall,31-Mar-22,Local,Japan,JPN,Gunma Prefecture,Maebashi,01-Mar-21,31-Mar-21,Health care workers and caregivers,Multiple groups,771,0.39%,,,Convenience,Roche Diagnostics,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Suguru Hiramoto,Gunma University Hospital,https://dx.doi.org/10.1620/tjem.2022.J017,06/04/2022,16/07/2022,Unverified
220303_Okinawa_OkinawaPrefectureEpidemiologicalStatisticsAndAnalysisCommittee_1stSurveyMain_Overall,03-Mar-22,Local,Japan,JPN,Okinawa Prefecture,,01-Jul-20,31-Jul-20,Household and community samples,Multiple groups,392,0.00%,0.00%,0.90%,Convenience,NA,ELISA,IgG,92.50%,100.00%,Moderate,Journal Article (Peer-Reviewed),Kenji Mizumoto,Okinawa Prefecture Epidemiological Statistics and Analysis Committee,https://www.medrxiv.org/content/10.1101/2022.03.02.22271759v1.full-text,07/04/2022,16/07/2022,Verified
220303_Okinawa_OkinawaPrefectureEpidemiologicalStatisticsAndAnalysisCommittee_2ndSurveyMain_Overall,03-Mar-22,Local,Japan,JPN,Okinawa Prefecture,,01-Oct-20,31-Dec-20,Household and community samples,Multiple groups,1448,0.60%,0.20%,1.10%,Convenience,NA,ELISA,IgG,92.50%,100.00%,High,Journal Article (Peer-Reviewed),Kenji Mizumoto,Okinawa Prefecture Epidemiological Statistics and Analysis Committee,https://www.medrxiv.org/content/10.1101/2022.03.02.22271759v1.full-text,07/04/2022,16/07/2022,Verified
220303_Okinawa_OkinawaPrefectureEpidemiologicalStatisticsAndAnalysisCommittee_3rdSurveyMain_Overall,03-Mar-22,Local,Japan,JPN,Okinawa Prefecture,,01-Feb-21,28-Feb-21,Household and community samples,Multiple groups,582,1.40%,0.20%,5.80%,Convenience,NA,ELISA,IgG,92.50%,100.00%,High,Journal Article (Peer-Reviewed),Kenji Mizumoto,Okinawa Prefecture Epidemiological Statistics and Analysis Committee,https://www.medrxiv.org/content/10.1101/2022.03.02.22271759v1.full-text,07/04/2022,16/07/2022,Verified
220405_Japan_KobeUniversity_Baseline_OverallAntiS,05-Apr-22,Regional,Japan,JPN,Hyogo Prefecture,Kobe,19-Jul-21,06-Aug-21,Residual sera,Adults (18-64 years),1000,38.70%,,,Convenience,NA,ELISA,IgG,,,Unclear,Journal Article (Peer-Reviewed),Zhenxiao Ren,Kobe Univesity,https://dx.doi.org/10.1371/journal.pone.0266270,22/04/2022,16/07/2022,Unverified
220405_Japan_KobeUniversity_FollowUp_OverallAntiS,05-Apr-22,Regional,Japan,JPN,Hyogo Prefecture,Kobe,22-Nov-21,08-Dec-21,Residual sera,Adults (18-64 years),1000,90.80%,,,Convenience,NA,ELISA,IgG,,,Unclear,Journal Article (Peer-Reviewed),Zhenxiao Ren,Kobe Univesity,https://dx.doi.org/10.1371/journal.pone.0266270,22/04/2022,16/07/2022,Unverified
220303_Okinawa_OkinawaPrefectureEpidemiologicalStatisticsAndAnalysisCommittee_2ndSurveyRemote_Overall,03-Mar-22,Local,Japan,JPN,Okinawa Prefecture,,01-Oct-20,31-Dec-20,Household and community samples,Multiple groups,144,0.00%,,,Convenience,NA,ELISA,IgG,92.50%,100.00%,High,Journal Article (Peer-Reviewed),Kenji Mizumoto,Okinawa Prefecture Epidemiological Statistics and Analysis Committee,https://www.medrxiv.org/content/10.1101/2022.03.02.22271759v1.full-text,18/05/2022,16/07/2022,Verified
220303_Okinawa_OkinawaPrefectureEpidemiologicalStatisticsAndAnalysisCommittee_3rdSurveyRemote_Overall,03-Mar-22,Local,Japan,JPN,Okinawa Prefecture,,01-Feb-21,28-Feb-21,Household and community samples,Multiple groups,123,1.60%,0.20%,5.80%,Convenience,NA,ELISA,IgG,92.50%,100.00%,High,Journal Article (Peer-Reviewed),Kenji Mizumoto,Okinawa Prefecture Epidemiological Statistics and Analysis Committee,https://www.medrxiv.org/content/10.1101/2022.03.02.22271759v1.full-text,18/05/2022,16/07/2022,Verified
210820_AichiPrefecture_FujitaHealthUniversity,20-Aug-21,Local,Japan,JPN,Aichi Prefecture,Toyoake,17-Aug-20,30-Sep-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,35,0.00%,,,Convenience,Ortho Clinical Diagnostics Inc.,CLIA,"IgG,IgM,IgA",,,High,Journal Article (Peer-Reviewed),Masataka Yoshinaga,Fujita Health University,https://dx.doi.org/10.20407/fmj.2020-032,24/05/2022,16/07/2022,Verified
220520_Tokyo_TokyoShinagawaHospital_RBD,20-May-22,Local,Japan,JPN,,Tokyo,15-Mar-21,15-Apr-21,Health care workers and caregivers,Adults (18-64 years),685,9.50%,,,Unclear,Abbott Laboratories,CLIA,IgG,96.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Masashi Nishimura,Tokyo Shinagawa Hospital,https://dx.doi.org/10.1371/journal.pone.0267566,02/06/2022,16/07/2022,Unverified
220524_Tokyo_JuntendoUniversity_PreVaccination2020_AntiS,24-May-22,Local,Japan,JPN,,Tokyo,06-Jul-20,21-Aug-20,Health care workers and caregivers,Multiple groups,2203,1.32%,,,Unclear,Roche Diagnostics,Not reported,Total Antibody,,99.98%,High,Journal Article (Peer-Reviewed),Gene Igawa,Juntendo University,https://dx.doi.org/10.1038/s41598-022-12809-x,04/06/2022,16/07/2022,Unverified
220524_Tokyo_JuntendoUniversity_PostVaccination2021_AntiN,24-May-22,Local,Japan,JPN,,Tokyo,01-Jun-21,30-Jun-21,Health care workers and caregivers,Multiple groups,2202,1.59%,,,Sequential,Roche Diagnostics,Not reported,Total Antibody,,,High,Journal Article (Peer-Reviewed),Gene Igawa,Juntendo University,https://dx.doi.org/10.1038/s41598-022-12809-x,05/06/2022,16/07/2022,Unverified
220524_Japan_KanagawaDentalUniversity_Primary,24-May-22,Regional,Japan,JPN,Kantoh region,,08-Apr-21,02-Aug-21,Multiple populations,Multiple groups,180,52.78%,45.21%,60.25%,Unclear,NA,ELISA,IgA,,,High,Journal Article (Peer-Reviewed),Keiichi Tsukinoki,Teikyo University,https://dx.doi.org/10.1111/1348-0421.13011,05/06/2022,16/07/2022,Unverified
220531_Matsuyama_EhimeUniversity_HCW1,31-May-22,Local,Japan,JPN,Ehime Prefecture,Matsuyama,11-Jun-20,17-Jun-20,Health care workers and caregivers,Adults (18-64 years),743,0.00%,,,Sequential,"Roche Diagnostics,Abbott Laboratories",CLIA,"IgG,Total Antibody",,,High,Journal Article (Peer-Reviewed),Koichiro Suemori,Ehime University,https://dx.doi.org/10.7883/yoken.JJID.2022.155,07/06/2022,16/07/2022,Unverified
220531_Matsuyama_EhimeUniversity_Outpatients2,31-May-22,Local,Japan,JPN,Ehime Prefecture,Matsuyama,11-Jun-20,17-Jun-20,Residual sera,Multiple groups,1000,0.10%,0.02%,0.56%,Sequential,"Roche Diagnostics,Abbott Laboratories",CLIA,"IgG,Total Antibody",,,High,Journal Article (Peer-Reviewed),Koichiro Suemori,Ehime University,https://dx.doi.org/10.7883/yoken.JJID.2022.155,07/06/2022,16/07/2022,Unverified
220530_Tokyo_KitasatoUniversitySchoolofMedicine,30-May-22,Local,Japan,JPN,,Tokyo,08-Jun-20,04-Jul-20,Health care workers and caregivers,Adults (18-64 years),3677,0.35%,0.19%,0.60%,Sequential,Roche Diagnostics,CLIA,IgG,100.00%,99.80%,High,Journal Article (Peer-Reviewed),Yoko Takayama,Kitasato University School of Medicine,https://dx.doi.org/10.1272/jnms.JNMS.2022_89-511,09/06/2022,16/07/2022,Unverified
220624_Shiga_ShigaUniversityofMedicalScience,24-Jun-22,Regional,Japan,JPN,Shiga Prefecture,,15-Feb-21,26-Feb-21,Health care workers and caregivers,Adults (18-64 years),1237,1.78%,,,Convenience,"Roche Diagnostics,Abbott Laboratories",Multiple Types,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Tokuchiro Chano,Shiga University of Medical Science,https://dx.doi.org/10.1371/journal.pone.0270334,07/07/2022,16/07/2022,Unverified
220712_Japan_UniversityofTokyo_0to9,12-Jul-22,Local,Japan,JPN,,Tokyo,01-Jan-20,31-Jan-20,Hospital visitors,Children and Youth (0-17 years),148,0.00%,,,Convenience,Zeus,ELISA,IgG,100.00%,99.50%,High,Preprint,Seiya Yamayoshi,University of Tokyo,https://doi.org/10.1101/2022.07.11.22277481,22/07/2022,22/07/2022,Unverified
220712_Japan_UniversityofTokyo_10to19,12-Jul-22,Local,Japan,JPN,,Tokyo,01-Jan-20,31-Jan-20,Hospital visitors,Children and Youth (0-17 years),81,2.50%,,,Convenience,Zeus,ELISA,IgG,100.00%,99.50%,High,Preprint,Seiya Yamayoshi,University of Tokyo,https://doi.org/10.1101/2022.07.11.22277481,22/07/2022,22/07/2022,Unverified
220712_Japan_UniversityofTokyo_20to29,12-Jul-22,Local,Japan,JPN,,Tokyo,01-Jan-20,31-Jan-20,Hospital visitors,Adults (18-64 years),134,8.20%,,,Convenience,Zeus,ELISA,IgG,100.00%,99.50%,High,Preprint,Seiya Yamayoshi,University of Tokyo,https://doi.org/10.1101/2022.07.11.22277481,22/07/2022,22/07/2022,Unverified
220712_Japan_UniversityofTokyo_30to39,12-Jul-22,Local,Japan,JPN,,Tokyo,01-Jan-20,31-Jan-20,Hospital visitors,Adults (18-64 years),244,5.70%,,,Convenience,Zeus,ELISA,IgG,100.00%,99.50%,High,Preprint,Seiya Yamayoshi,University of Tokyo,https://doi.org/10.1101/2022.07.11.22277481,22/07/2022,22/07/2022,Unverified
220712_Japan_UniversityofTokyo_40to49,12-Jul-22,Local,Japan,JPN,,Tokyo,01-Jan-20,31-Jan-20,Hospital visitors,Adults (18-64 years),213,2.80%,,,Convenience,Zeus,ELISA,IgG,100.00%,99.50%,High,Preprint,Seiya Yamayoshi,University of Tokyo,https://doi.org/10.1101/2022.07.11.22277481,22/07/2022,22/07/2022,Unverified
220712_Japan_UniversityofTokyo_50to59,12-Jul-22,Local,Japan,JPN,,Tokyo,01-Jan-20,31-Jan-20,Hospital visitors,Adults (18-64 years),298,2.00%,,,Convenience,Zeus,ELISA,IgG,100.00%,99.50%,High,Preprint,Seiya Yamayoshi,University of Tokyo,https://doi.org/10.1101/2022.07.11.22277481,22/07/2022,22/07/2022,Unverified
220712_Japan_UniversityofTokyo_60to69,12-Jul-22,Local,Japan,JPN,,Tokyo,01-Jan-20,31-Jan-20,Hospital visitors,Multiple groups,358,4.20%,,,Convenience,Zeus,ELISA,IgG,100.00%,99.50%,High,Preprint,Seiya Yamayoshi,University of Tokyo,https://doi.org/10.1101/2022.07.11.22277481,22/07/2022,22/07/2022,Unverified
220712_Japan_UniversityofTokyo_70to79,12-Jul-22,Local,Japan,JPN,,Tokyo,01-Jan-20,31-Jan-20,Hospital visitors,Seniors (65+ years),554,4.00%,,,Convenience,Zeus,ELISA,IgG,100.00%,99.50%,High,Preprint,Seiya Yamayoshi,University of Tokyo,https://doi.org/10.1101/2022.07.11.22277481,22/07/2022,22/07/2022,Unverified
220712_Japan_UniversityofTokyo_80plus,12-Jul-22,Local,Japan,JPN,,Tokyo,01-Jan-20,31-Jan-20,Hospital visitors,Seniors (65+ years),355,3.70%,,,Convenience,Zeus,ELISA,IgG,100.00%,99.50%,High,Preprint,Seiya Yamayoshi,University of Tokyo,https://doi.org/10.1101/2022.07.11.22277481,22/07/2022,22/07/2022,Unverified
20220707_Hiroshima_Hiroshima University_Jan-Feb2021_Overall,07-Jul-22,Local,Japan,JPN,Chūgoku Region,"Hiroshima, Fukuyama, Higashi-Hiroshima, Miyoshi, and Kita-Hiroshima",01-Jan-21,28-Feb-21,Household and community samples,Multiple groups,2351,0.30%,0.08%,0.52%,Stratified probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,GenScript,Roche Diagnostics",Multiple Types,"IgG,Total Antibody",,,Moderate,Journal Article (Peer-Reviewed),Aya Sugiyama,Hiroshima University,https://dx.doi.org/10.1265/ehpm.22-00016,27/07/2022,27/07/2022,Unverified
210211_Kingston_UniversityOfTheWestIndies_Overall,11-Feb-21,Local,Jamaica,JAM,,Kingston,01-Mar-20,30-Nov-20,Pregnant or parturient women,Adults (18-64 years),249,14.86%,,,Sequential,Abbott Laboratories,CLIA,IgG,80.00%,96.15%,High,Preprint,TeAnne Chisolm,University of the West Indies,10.1101/2021.02.08.21251367,18/03/2021,16/07/2022,Verified
200508_Bari_IstitutoTumoriGPaolo_HCW_IgG,08-May-20,Local,Italy,ITA,Puglia,Bari,26-Mar-20,17-Apr-20,Health care workers and caregivers,Adults (18-64 years),606,0.33%,,,Convenience,Snibe Co. Ltd (Shenzhen New Industries Biomedical Engineering Co. Ltd),CLIA,IgG,,,High,Preprint,Angelo Virgilio Paradiso,Istituto Tumori G. Paolo II,https://www.medrxiv.org/content/10.1101/2020.05.05.20086017v1,14/05/2020,16/07/2022,Verified
210203_Milan_FondazioneIRCCSCa'GrandaOspedaleMaggiore_GenPop_UnAdj,03-Feb-21,Local,Italy,ITA,Lombardy,Milan,24-Feb-20,08-Apr-20,Blood donors,Adults (18-64 years),789,5.10%,,,Convenience,PRIMA Lab S.A.,LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Luca Valenti, Fondazione IRCCS Ca' Granda Ospedale Maggiore ,https://dx.doi.org/10.2450/2021.0324-20,21/05/2020,16/07/2022,Verified
200430_Bergamo_ATSBergamo_GeneralPopulation_AnalyzedLab1,30-Apr-20,Local,Italy,ITA,Lombardy,"Alzano, Nembro",23-Apr-20,28-Apr-20,Household and community samples,Multiple groups,750,61.00%,,,Unclear,NA,Not reported,Not reported,,,Unclear,News and Media,Armando Di Landro,ATS Bergamo,https://bergamo.corriere.it/notizie/cronaca/20_aprile_30/coronavirus-bergamo-primi-risultati-test-61percento-positivi-85e8e36c-8a6b-11ea-94d3-9879860c12b6.shtml?refresh_ce-cp,02/06/2020,16/07/2022,Verified
200430_Bergamo_HospitalofBergamo_HCW,30-Apr-20,Local,Italy,ITA,Lombardy,Bergamo,,24-Apr-20,Health care workers and caregivers,Adults (18-64 years),3000,13.00%,,,Unclear,NA,Not reported,Not reported,,,Unclear,News and Media,Armando Di Landro,Hospital of Bergamo,https://bergamo.corriere.it/notizie/cronaca/20_aprile_30/coronavirus-bergamo-primi-risultati-test-61percento-positivi-85e8e36c-8a6b-11ea-94d3-9879860c12b6.shtml?refresh_ce-cp,02/06/2020,16/07/2022,Verified
200609_Milan_UniMilan_OverallAb,09-Jun-20,Local,Italy,ITA,Lombardy,Milan,30-Mar-20,31-Mar-20,Household and community samples,Adults (18-64 years),197,10.15%,,,Self-referral,"Beijing Wantai Biological,EUROIMMUN",ELISA,"IgG,IgM,IgA",,,High,Journal Article (Peer-Reviewed),Gregorio Milani,University of Milan,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7280100/pdf/main.pdf,23/06/2020,16/07/2022,Verified
200609_Bergamo_HealthAgency_GenPop,09-Jun-20,Regional,Italy,ITA,Lombardy,,23-Apr-20,03-Jun-20,Household and community samples,Multiple groups,9965,57.00%,,,Simplified probability,NA,Not reported,Not reported,,,Moderate,News and Media,Angelo Amante,Bergamo Health Agency,https://www.google.com/url?rct=j&sa=t&url=https://www.thejakartapost.com/news/2020/06/09/over-half-of-people-tested-in-italys-bergamo-have-covid-19-antibodies.html&ct=ga&cd=CAAYAjIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNEF-NEDdVnSHZTUUTQEQL5px8dXmw,06/07/2020,16/07/2022,Verified
200617_Italy_D.CotugnoHospital_HCW_IgG,17-Jun-20,Local,Italy,ITA,Campania,Naples,23-Mar-20,02-Apr-20,Health care workers and caregivers,Adults (18-64 years),115,1.74%,,,Convenience,Snibe Co. Ltd (Shenzhen New Industries Biomedical Engineering Co. Ltd),CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Francesco Fusco,D. Cotugno’ Hospital,https://www.journalofhospitalinfection.com/article/S0195-6701(20)30306-6/fulltext,18/07/2020,16/07/2022,Verified
200619_Rome_UniversityofRome_IgG,19-Jun-20,Local,Italy,ITA,Lazio,Rome,07-Apr-20,27-Apr-20,Health care workers and caregivers,Adults (18-64 years),1084,0.70%,,,Convenience,Medical Systems,CLIA,IgG,50.00%,99.10%,High,Journal Article (Peer-Reviewed),Edith Lahner,University of Rome,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7345358/,22/07/2020,16/07/2022,Verified
200707_Turin_University of Turin_PregnantWomen_IgGonly,07-Jul-20,Local,Italy,ITA,Piedmont,Turin,16-Apr-20,04-Jun-20,Pregnant or parturient women,Adults (18-64 years),138,5.80%,,,Sequential,Boditech Med Inc.,LFIA,IgG,,,High,Journal Article (Peer-Reviewed),Stefano Cosma,University of Turin,https://onlinelibrary.wiley.com/doi/epdf/10.1002/jmv.26267,01/08/2020,16/07/2022,Verified
200808_Italy_UniversityofTurin_CLLPatients_Overall,08-Aug-20,Local,Italy,ITA,Piedmont,"Turin, Novara, Alessandria, Verbania",08-Mar-20,30-Apr-20,Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),24,12.50%,,,Convenience,"Medical Systems,DiaSorin,In3diagnostic",Multiple Types,IgG,,,High,Journal Article (Peer-Reviewed),Marco Denina ,University of Turin,http://dx.doi.org/10.1016/j.jaad.2020.08.021,25/09/2020,16/07/2022,Verified
200813_Foggia_UniversityofFoggia_OverallIgG/IgM,13-Aug-20,Local,Italy,ITA, Apulia,Foggia,01-May-20,31-May-20,Blood donors,Adults (18-64 years),904,0.99%,,,Convenience,Snibe Co. Ltd (Shenzhen New Industries Biomedical Engineering Co. Ltd),CLIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Jose Ramon Fiore,University of Foggia,https://onlinelibrary.wiley.com/doi/full/10.1002/jmv.26425,27/09/2020,16/07/2022,Verified
200804_Tuscany_ArezzoHospital_HealthcareWorkers_Overall,04-Aug-20,Regional,Italy,ITA,Tuscany,,01-Apr-20,30-Apr-20,Health care workers and caregivers,Adults (18-64 years),17098,3.10%,,,Convenience,"Screen Italia S.R.L,Zhejiang Orient Gene Biotech",LFIA,"IgG,IgM",,,High,Preprint,Francesca Carozzi,Arezzo Hospital,https://www.medrxiv.org/content/10.1101/2020.07.30.20149567v1,27/09/2020,16/07/2022,Verified
200721_Arezzo_OspedaleSanDonato_Total,21-Jul-20,Local,Italy,ITA,Tuscany,Arezzo,17-Mar-20,21-Mar-20,Residual sera,Adults (18-64 years),516,13.00%,,,Sequential,ACRO Biotech Inc,LFIA,"IgG,IgM",37.00%,94.00%,High,Journal Article (Peer-Reviewed),Alessandro Pancrazzi,Ospedale San Donato,http://dx.doi.org/10.1016/j.clinbiochem.2020.07.002,28/09/2020,16/07/2022,Verified
200728_Prato_SantoStefanoHospital_Overall,28-Jul-20,Local,Italy,ITA,Tuscany,Prato,04-Apr-20,16-May-20,Pregnant or parturient women,Adults (18-64 years),134,4.48%,,,Sequential,ACRO Biotech Inc,LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Anna Cavaliere,Santo Stefano Hospital,http://dx.doi.org/10.1080/14767058.2020.1793317,29/09/2020,16/07/2022,Verified
200729_Milan_UniversitadegliStudidiMilano_Overall_IgG,29-Jul-20,Local,Italy,ITA,Lombardy,Milan,02-Apr-20,16-Apr-20,Health care workers and caregivers,Adults (18-64 years),202,7.40%,3.80%,11.00%,Convenience,"BioMedomics, Inc.",LFIA,IgG,88.70%,90.60%,High,Journal Article (Peer-Reviewed),Giovanni Sotgiu,Università degli Studi di Milano ,https://bmcpulmmed.biomedcentral.com/articles/10.1186/s12890-020-01237-0,29/09/2020,16/07/2022,Verified
200803_Italy_ItalianMinistryOfHealth_Overall,03-Aug-20,National,Italy,ITA,"Abruzzo, Basilicata, Calabria, Campania, Emilia Romagna, Friuli-Venezia Giulia, Lazio, Liguria, Lombardy, Marche, Molise, Piemonte, Trentino-Alto Adige, Puglia, Sardegna, Sicily, Tuscany, Umbria, Valle D'Aosta, Veneto",,25-May-20,15-Jul-20,Household and community samples,Multiple groups,64660,2.50%,,,Stratified non-probability,Abbott Laboratories,CLIA,IgG,,,Unclear,Institutional Report,Instituto Nazionale di Statistica,Italian Ministry of Health,https://www.istat.it/it/files//2020/08/ReportPrimiRisultatiIndagineSiero.pdf,04/10/2020,16/07/2022,Verified
200907_Bari_PoliclinicoHospital_Overall,07-Sep-20,Local,Italy,ITA, Apulia,Bari,23-Mar-20,21-Apr-20,Residual sera,Multiple groups,819,8.55%,,,Sequential,VivaChek Biotech (Hangzhou) Co. Ltd,LFIA,"IgG,IgM",35.10%,97.30%,High,Journal Article (Peer-Reviewed),Daniela Loconsole,Policlinico Hospital,https://dx.doi.org/10.3390/ijerph17186493,14/10/2020,16/07/2022,Verified
200823_Bergamo_HospitalPapaGiovanniXXIII_Overall,26-Aug-20,Local,Italy,ITA,Lombardy,Bergamo,04-Mar-20,10-Jul-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,90,21.10%,,,Convenience,VivaChek Biotech (Hangzhou) Co. Ltd,LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Lorenzo Norsa,Papa Giovani XXII,http://dx.doi.org/10.1053/j.gastro.2020.08.046,15/10/2020,16/07/2022,Verified
200827_LiguriaLombardia_UniversityofGenoa_Overall,27-Aug-20,Regional,Italy,ITA,"Lombardy, Liguria",,01-Mar-20,30-Apr-20,Residual sera,Adults (18-64 years),3609,11.00%,10.00%,12.10%,Convenience,"Snibe Co. Ltd (Shenzhen New Industries Biomedical Engineering Co. Ltd),Hangzhou Realy Tech Co. Ltd,Biosynex",Multiple Types,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Antonio Vena,University of Genoa,https://dx.doi.org/10.3390/jcm9092780,15/10/2020,16/07/2022,Verified
200818_Brescia_UniversityofBrescia_Overall,18-Aug-20,Local,Italy,ITA,Lombardy,Brescia,27-Apr-20,27-Apr-20,Health care workers and caregivers,Adults (18-64 years),76,11.80%,,,Convenience,DiaSorin,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),Alberto Dalla Volta,University of Brescia,http://dx.doi.org/10.3389/fonc.2020.01574,15/10/2020,16/07/2022,Verified
200806_Milan_UniversityofMilan_Overall,06-Aug-20,Local,Italy,ITA,Lombardy,Milan,15-Apr-20,15-Apr-20,Health care workers and caregivers,Adults (18-64 years),663,5.13%,,,Convenience,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Antonella Amendola,University of Milan,http://dx.doi.org/10.1017/ice.2020.401,25/10/2020,16/07/2022,Verified
201006_Turin_UniversityofTorino_TotalHCWs,06-Oct-20,Local,Italy,ITA,Piemonte,Torino (Turin),17-Apr-20,20-May-20,Health care workers and caregivers,Adults (18-64 years),5444,6.90%,,,Convenience,DiaSorin,CLIA,IgG,97.90%,98.50%,Moderate,Journal Article (Peer-Reviewed),Andrea Calcagno,University of Torino,https://dx.doi.org/10.3201/eid2701.203027,10/12/2020,16/07/2022,Verified
200915_Naples_AziendaOspedalieradiRilievoNazionaleSantobonoPausilipon_Patients&Caregivers,15-Sep-20,Local,Italy,ITA,Campania,Naples,03-Apr-20,29-May-20,Multiple populations,Multiple groups,1397,0.43%,,,Convenience,"VivaChek Biotech (Hangzhou) Co. Ltd,NA",LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Pio Stellato,Azienda Ospedaliera di Rilievo Nazionale Santobono Pausilipon,http://dx.doi.org/10.1136/bmjpo-2020-000818,15/12/2020,16/07/2022,Verified
200915_Naples_AziendaOspedalieradiRilievoNazionaleSantobonoPausilipon_HCW,15-Sep-20,Local,Italy,ITA,Campania,Naples,03-Apr-20,29-May-20,Health care workers and caregivers,Adults (18-64 years),249,2.01%,,,Convenience,"VivaChek Biotech (Hangzhou) Co. Ltd,NA",LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Pio Stellato,Azienda Ospedaliera di Rilievo Nazionale Santobono Pausilipon,http://dx.doi.org/10.1136/bmjpo-2020-000818,15/12/2020,16/07/2022,Verified
201103_Cagliari_UniversityofCagliari_SurgicalPatients_IGGorIGM,03-Nov-20,Local,Italy,ITA,Sardinia,Cagliari,31-Mar-20,30-Jun-20,Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),86,5.80%,,,Convenience,Snibe Co. Ltd (Shenzhen New Industries Biomedical Engineering Co. Ltd),CLIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Fabio Medas, University of Cagliari,https://dx.doi.org/10.1016/j.amsu.2020.11.006,09/01/2021,16/07/2022,Verified
201027_Perugia_UniversityofPerugia_HIVPositive1_PLWHIgG,27-Oct-20,Local,Italy,ITA,Umbria,Perugia,04-May-20,31-May-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,270,3.70%,,,Sequential,Screen Italia S.R.L,LFIA,IgG,,,High,Journal Article (Peer-Reviewed),Chiara Papalini,University of Perugia,https://dx.doi.org/10.4084/MJHID.2020.080,10/01/2021,16/07/2022,Verified
201031_Milan_SanRaffaeleScientificInstitute_HCW_IgG,31-Oct-20,Local,Italy,ITA,Lombardy,Milan,15-Mar-20,15-Apr-20,Health care workers and caregivers,Adults (18-64 years),40,5.00%,,,Convenience,"PRIMA Lab S.A.,DiaSorin",Multiple Types,IgG,,,High,Journal Article (Peer-Reviewed),Diana Canetti,San Raffaele Scientific Institute,https://pubmed.ncbi.nlm.nih.gov/33135083/,12/01/2021,16/07/2022,Verified
201021_Italy_IRCCS_Overall_IgG_unadj,21-Oct-20,Regional,Italy,ITA,Lombardy,,30-Mar-20,11-May-20,Multiple populations,Multiple groups,166,41.57%,,,Convenience,PRIMA Lab S.A.,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),Antonio Marra,Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS),https://dx.doi.org/10.1016/j.annonc.2020.10.473,16/01/2021,16/07/2022,Verified
201008_Udine_UniversityofUdine_SCTrecipients,08-Oct-20,Local,Italy,ITA,Udine,Udine,01-Apr-20,30-May-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,70,1.43%,,,Sequential,Cellex Inc.,LFIA,"IgG,IgM",93.75%,96.40%,High,Journal Article (Peer-Reviewed),Alessandra Sperotto,The University of Udine,https://dx.doi.org/10.1002/jmv.26586,18/01/2021,16/07/2022,Verified
201111_Italy_IstitutoNazionaleTumori_primaryest,11-Nov-20,National,Italy,ITA,,,01-Sep-19,10-Mar-20,Residual sera,Multiple groups,959,11.60%,,,Sequential,NA,ELISA,"IgM,IgG",85.70%,98.10%,High,Journal Article (Peer-Reviewed),Giovanni Apolone,Istituto Nazionale Tumori ,https://dx.doi.org/10.1177/0300891620974755,21/01/2021,16/07/2022,Verified
200806_Lombardy_BrunoKesslerFoundation,06-Aug-20,Regional,Italy,ITA,Lombardy,,16-Apr-20,25-May-20,Contacts of COVID patients,Multiple groups,4120,53.10%,,,Stratified non-probability,DiaSorin,Not reported,IgG,94.40%,98.30%,Moderate,Journal Article (Peer-Reviewed),Piero Poletti,Bruno Kessler Foundation,http://dx.doi.org/10.2807/1560-7917.ES.2020.25.31.2001383,21/01/2021,16/07/2022,Verified
201031_VillaCaldari_IstitutoZooprofilatticoSperimentaleDell’AbruzzoEdelMoliseG.Caporale_Overall,31-Oct-20,Local,Italy,ITA,Abruzzo,Villa Caldari,18-Apr-20,19-Apr-20,Household and community samples,Multiple groups,667,10.90%,8.80%,13.50%,Entire sample,Beijing Wantai Biological,ELISA,Total Antibody,93.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Francesa Cito,Istituto Zooprofilattico Sperimentale dell’Abruzzo e del Molise G. Caporale ,https://dx.doi.org/10.3390/microorganisms8111711,22/01/2021,16/07/2022,Verified
201222_Rome_EleemosynariaApostolica_overall,22-Dec-20,Local,Italy,ITA,Lazio,Rome,14-Apr-20,31-Jul-20,Multiple populations,Multiple groups,173,1.80%,,,Convenience,Biozek,LFIA,"IgG,IgM",96.00%,96.00%,High,Journal Article (Peer-Reviewed),Massimo Ralli,Eleemosynaria Apostolica,https://dx.doi.org/10.4081/jphr.2020.1986,23/01/2021,16/07/2022,Verified
201219_Tuscany_UniversityOfFlorence_Overall,19-Dec-20,Regional,Italy,ITA,Prato,,01-May-20,31-May-20,Multiple populations,Multiple groups,4656,3.00%,2.50%,3.50%,Convenience,Hangzhou Laihe Biotech Co. Ltd,LFIA,"IgG,IgM",100.00%,98.80%,Moderate,Journal Article (Peer-Reviewed),Vieri Lastrucci,University of Florence,https://dx.doi.org/10.3390/vaccines8040778,23/01/2021,16/07/2022,Verified
201119_Italy_UniversityofCagliari_Milano1_IBDPatients,19-Nov-20,Local,Italy,ITA,,"Milan, Cagliari, Erlangen",15-Apr-20,15-Jun-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,354,2.30%,0.80%,3.80%,Convenience,NA,ELISA,"IgG,IgA",97.64%,95.20%,High,Journal Article (Peer-Reviewed),Roberto Berte,University of Cagliari,https://dx.doi.org/10.1093/ecco-jcc/jjaa237,23/01/2021,16/07/2022,Verified
201119_Italy_UniversityofCagliari_MilanoGenPop3_GenPop,19-Nov-20,Local,Italy,ITA,Lombardy,Milan,15-Apr-20,15-Jun-20,Household and community samples,Multiple groups,129,7.00%,4.40%,9.60%,Sequential,NA,ELISA,"IgG,IgA",97.64%,95.20%,High,Journal Article (Peer-Reviewed),Roberto Berte,University of Cagliari,https://dx.doi.org/10.1093/ecco-jcc/jjaa237,23/01/2021,16/07/2022,Verified
201127_Trento_AziendaProvincialeperiServiziSanitari_OverallAdj,27-Nov-20,Regional,Italy,ITA,Trento,,05-May-20,15-May-20,Household and community samples,Multiple groups,6075,25.70%,,,Convenience,Abbott Laboratories,CLIA,IgG,90.00%,100.00%,Low,Journal Article (Peer-Reviewed),Paola Stefanelli,Azienda Provinciale per i Servizi Sanitari,https://dx.doi.org/10.1016/j.cmi.2020.11.013,23/01/2021,16/07/2022,Verified
201109_Milan_UniversitadegliStudidiMilano_patients_antiN_S,20-Nov-20,Local,Italy,ITA,Lombardy ,Milan,11-May-20,05-Jul-20,Residual sera,Multiple groups,2753,3.34%,,,Sequential,"Abbott Laboratories,DiaSorin",CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Valeria Cento,Universita degli Studi di Milano,http://dx.doi.org/10.1371/journal.pone.0242765,23/01/2021,16/07/2022,Verified
201201_Verona_InstitutoDiRicoveroECuraACaratterre_Overall,01-Dec-20,Local,Italy,ITA,Veneto,Verona,25-Apr-20,08-May-20,Household and community samples,Multiple groups,1515,2.70%,,,Simplified probability,Abbott Laboratories,CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Massimo Guerriero,Instituto di Ricovero e Cura A Caratterre,https://dx.doi.org/10.3201/eid2701.202740,30/01/2021,16/07/2022,Verified
201126_Naples_UniversityofNaples_MS,26-Nov-20,Local,Italy,ITA,Campania,Naples,11-May-20,15-Jun-20,Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),310,2.90%,,,Sequential,Shanghai Kehua Bio-engineering (KHB) Co. Ltd,LFIA,"IgG,IgM",66.00%,96.60%,Moderate,Journal Article (Peer-Reviewed),Nicola Capasso,University of Naples,https://dx.doi.org/10.3390/jcm9124066,31/01/2021,16/07/2022,Verified
201126_Naples_UniversityofNaples_LowRisk,26-Nov-20,Local,Italy,ITA,Campania, Naples,11-May-20,15-Jun-20,Health care workers and caregivers,Adults (18-64 years),862,1.30%,,,Convenience,Shanghai Kehua Bio-engineering (KHB) Co. Ltd,LFIA,"IgG,IgM",66.00%,96.60%,Moderate,Journal Article (Peer-Reviewed),Nicola Capasso,University of Naples,https://dx.doi.org/10.3390/jcm9124066,31/01/2021,16/07/2022,Verified
201126_Naples_UniversityofNaples_HighRisk,26-Nov-20,Local,Italy,ITA,Campania,Naples,11-May-20,15-Jun-20,Health care workers and caregivers,Adults (18-64 years),235,10.60%,,,Convenience,Shanghai Kehua Bio-engineering (KHB) Co. Ltd,LFIA,"IgG,IgM",66.00%,96.60%,High,Journal Article (Peer-Reviewed),Nicola Capasso,University of Naples,https://dx.doi.org/10.3390/jcm9124066,31/01/2021,16/07/2022,Verified
210109_GiglioIsland_UniversitàdegliStudidiMilano,09-Jan-21,Local,Italy,ITA,Tuscany,Giglio Island,29-Apr-20,03-May-20,Household and community samples,Adults (18-64 years),723,0.41%,,,Self-referral,Zhejiang Orient Gene Biotech,LFIA,"IgG,IgM",87.90%,100.00%,High,Preprint,Antonio Bognanni,Università degli Studi di Milano,https://www.medrxiv.org/content/10.1101/2021.01.08.20248948v1,31/01/2021,16/07/2022,Verified
201217_Naples_UniversityofCampania_ELISA,17-Dec-20,Local,Italy,ITA,Campania,Naples,27-Mar-20,30-Aug-20,Health care workers and caregivers,Adults (18-64 years),65,0.00%,,,Convenience,Beijing Wantai Biological,ELISA,Total Antibody,100.00%,100.00%,High,Journal Article (Peer-Reviewed),Antonio Russo,University of Campania,https://dx.doi.org/10.2147/IDR.S282652,01/02/2021,16/07/2022,Verified
201223_Bergamo_OspedalePapaGiovanniXXIII_overall,23-Dec-20,Local,Italy,ITA,Lombardy,Bergamo,01-Apr-20,30-Apr-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,560,31.00%,,,Sequential,nal von minden GmbH,LFIA,"IgG,IgM",92.10%,99.20%,High,Journal Article (Peer-Reviewed),Alberto Zambelli,Ospedale Papa Giovanni XXIII,https://dx.doi.org/10.1002/onco.13654,03/02/2021,16/07/2022,Verified
210111_Pavia_University of Pavia_overall,13-Jan-21,Local,Italy,ITA,,Pavia,04-May-20,03-Jun-20,Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),104,13.46%,,,Convenience,Roche Diagnostics,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Giulia Mallucci,University of Pavia,https://doi.org/10.1016/j.msard.2021.102754,03/02/2021,16/07/2022,Verified
201213_Foggia_AziendaOspedalieraUniversitariaPoliclinicoRiunitiDiFoggia_HCW,13-Dec-20,Local,Italy,ITA,"Apulia, Province of Foggia",Foggia,17-Mar-20,18-May-20,Health care workers and caregivers,Adults (18-64 years),3242,1.90%,1.40%,2.30%,Convenience,Shenzhen Yhlo Biotech Co. Ltd,CLIA,"IgG,IgM",97.00%,98.80%,Moderate,Journal Article (Peer-Reviewed),Armando De Carlo,Azienda Ospedaliera-Universitaria Policlinico Riuniti di Foggia,https://dx.doi.org/10.3390/ijerph17249324,05/02/2021,16/07/2022,Verified
201101_ Borgosesia_ASLVercelli_overall,01-Nov-20,Local,Italy,ITA,Piedmont,Borgosesia,23-May-20,24-May-20,Household and community samples,Multiple groups,4987,4.90%,4.33%,5.55%,Self-referral,PRIMA Lab S.A.,LFIA,"IgG,IgM",100.00%,98.00%,High,Journal Article (Peer-Reviewed),Daniela Alessi,ASL Vercelli,https://dx.doi.org/10.19191/EP20.5-6.S2.119,08/02/2021,16/07/2022,Verified
210306_Rome_UniversitaCattolicadelSacroCuore_VenousBloodTest_overall,06-Mar-21,Local,Italy,ITA,,Rome,04-Jun-20,03-Jul-20,Health care workers and caregivers,Multiple groups,4694,1.19%,,,Convenience,EUROIMMUN,ELISA,IgG,78.79%,99.36%,High,Journal Article (Peer-Reviewed),Giuseppe Vetrugno,Università Cattolica del Sacro Cuore,http://dx.doi.org/10.3390/ijerph18052650,09/02/2021,16/07/2022,Verified
210204_Milan_ASSTFatebenefratelliSacco_PhaseI_overall,04-Feb-21,Local,Italy,ITA,,Mlilan,04-Mar-20,12-Mar-20,Health care workers and caregivers,Adults (18-64 years),679,0.40%,,,Convenience,Beijing Wantai Biological,ELISA,Total Antibody,78.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Laura Milazzo,ASST Fatebenefratelli Sacco,http://dx.doi.org/10.1136/oemed-2020-107060,12/02/2021,16/07/2022,Unverified
210204_Milan_ASSTFatebenefratelliSacco_PhaseIII,04-Feb-21,Local,Italy,ITA,,Mlilan,20-May-20,27-May-20,Health care workers and caregivers,Adults (18-64 years),629,4.60%,,,Convenience,Beijing Wantai Biological,ELISA,Total Antibody,78.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Laura Milazzo,ASST Fatebenefratelli Sacco,http://dx.doi.org/10.1136/oemed-2020-107060,12/02/2021,16/07/2022,Unverified
210204_Milan_ASSTFatebenefratelliSacco_PhaseII,04-Feb-21,Local,Italy,ITA,,Mlilan,14-Apr-20,22-Apr-20,Health care workers and caregivers,Adults (18-64 years),608,4.20%,,,Convenience,Beijing Wantai Biological,ELISA,Total Antibody,78.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Laura Milazzo,ASST Fatebenefratelli Sacco,http://dx.doi.org/10.1136/oemed-2020-107060,12/02/2021,16/07/2022,Unverified
201231_Modena_OspedaleCivileS.AgostinoEstense_overall,31-Dec-20,Local,Italy,ITA,Emilia-Romagna Region,Modena,30-Mar-20,31-May-20,Health care workers and caregivers,Adults (18-64 years),7711,5.00%,,,Convenience,NA,CLIA,"IgG,IgM",,,Unclear,Journal Article (Peer-Reviewed),Valentina Pecoraro,Ospedale Civile S.Agostino Estense,https://pesquisa.bvsalud.org/global-literature-on-novel-coronavirus-2019-ncov/resource/en/covidwho-984696,12/02/2021,16/07/2022,Verified
210105_SanGiovaniRotondo_FondazioneCasaSollievoDellaSofferenza_overall,05-Jan-21,Local,Italy,ITA,,San Giovanni Rotondo,01-May-20,15-Jun-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,245,0.88%,,,Convenience,"Shanghai Kehua Bio-engineering (KHB) Co. Ltd,Tecan",Multiple Types,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Fabrizio Bossa,Fondazione Casa Sollievo della Sofferenza,http://dx.doi.org/10.1016/j.dld.2020.12.120,13/02/2021,16/07/2022,Verified
210127_Merano_FranzTappeinerHospital_patients_primary,27-Jan-21,Local,Italy,ITA,,Merano,22-Jun-20,17-Jul-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,250,0.80%,,,Sequential,Abbott Laboratories,CLIA,IgG,100.00%,99.60%,High,Journal Article (Peer-Reviewed),Dominic Fong,Franz Tappeiner Hospital,https://dx.doi.org/10.1007/s00508-020-01807-6,23/02/2021,16/07/2022,Verified
210127_Merano_FranzTappeinerHospital_HCW_primary,27-Jan-21,Local,Italy,ITA,,Merano,22-Jun-20,17-Jul-20,Health care workers and caregivers,Adults (18-64 years),36,5.50%,,,Convenience,Abbott Laboratories,CLIA,IgG,100.00%,99.60%,High,Journal Article (Peer-Reviewed),Dominic Fong,Franz Tappeiner Hospital,https://dx.doi.org/10.1007/s00508-020-01807-6,23/02/2021,16/07/2022,Unverified
201027_Perugia_UniversityofPerugia_HIVNegative2_Overall,27-Oct-20,Local,Italy,ITA,Umbria,Perugia,04-May-20,31-May-20,Multiple populations,Multiple groups,2843,5.40%,,,Unclear,Screen Italia S.R.L,LFIA,IgG,,,Unclear,Journal Article (Peer-Reviewed),Chiara Papalini,University of Perugia,https://dx.doi.org/10.4084/MJHID.2020.080,27/02/2021,16/07/2022,Verified
210112_ArianoIrpino_Zoo-ProphylacticInstituteOfSouthernItaly_overall,12-Jan-21,Local,Italy,ITA,Province of Avellino in the Campania region,Ariano Irpino,16-May-20,19-May-20,Household and community samples,Multiple groups,13218,5.60%,5.20%,6.00%,Convenience,Roche Diagnostics,CLIA,Total Antibody,,,Moderate,Journal Article (Peer-Reviewed),Pellegrino Cerino,The Zoo-Prophylactic Institute of Southern Italy,https://www.future-science.com/doi/10.2144/fsoa-2020-0203,04/03/2021,16/07/2022,Verified
210127_UniversityHospitalofBari_UniversityofBari_overall_IgG_unadj,27-Jan-21,Local,Italy,ITA,Puglia,Bari,08-Apr-20,07-Jun-20,Health care workers and caregivers,Adults (18-64 years),2407,2.37%,,,Convenience,Abbott Laboratories,CLIA,IgG,50.00%,97.99%,High,Journal Article (Peer-Reviewed),Luigi Vimercati,University of Bari,https://dx.doi.org/10.1016/j.envres.2021.110793,11/03/2021,16/07/2022,Verified
210209_Catania_UniversityofCatania,09-Feb-21,Local,Italy,ITA,Sicily,Catania,15-Jun-20,15-Jul-20,Health care workers and caregivers,Adults (18-64 years),133,3.00%,,,Convenience,NovaTec Immundiagnostics GmbH,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Caterina Ledda ,University of Catania,https://dx.doi.org/10.3390/tropicalmed6010021,14/03/2021,16/07/2022,Verified
201031_Veneto_NationalAssociationofCompanyandCompetentDoctors,31-Oct-20,Local,Italy,ITA,Veneto,,11-Apr-20,29-Apr-20,Essential non-healthcare workers,Adults (18-64 years),1267,1.58%,,,Convenience,"NA,Snibe Co. Ltd (Shenzhen New Industries Biomedical Engineering Co. Ltd)",Multiple Types,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Danilo Bontadi,National Association of Company and Competent Doctors,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7809981/,16/03/2021,16/07/2022,Verified
210204_Milan_UniversityOfMilan_Overall,04-Feb-21,Local,Italy,ITA,Lombardy,Milan,13-Jun-20,06-Aug-20,Contacts of COVID patients,Children and Youth (0-17 years),49,16.30%,,,Convenience,Zhuhai Livzon Diagnostics Inc,LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Marco Farronato ,University of Milan,https://dx.doi.org/10.3390/ijerph18041488,19/03/2021,16/07/2022,Verified
210302_Milan_FondazioneIRCCSIstitutoNazionaleDeiTumori_HCW_overall,02-Mar-21,Local,Italy,ITA,,Milan,09-Apr-20,09-Sep-20,Health care workers and caregivers,Adults (18-64 years),110,20.00%,,,Simplified probability,Diagnostic Bioprobes,ELISA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Chiara Maura Ciniselli,Fondazione IRCCS Istituto Nazionale dei Tumori (INT),http://dx.doi.org/10.3390/cancers13051035,24/03/2021,16/07/2022,Verified
210224_NortheastItaly_PaduaUniversityHospital_HCW,24-Feb-21,Local,Italy,ITA,Veneto Region,Padua,08-Apr-20,29-May-20,Health care workers and caregivers,Adults (18-64 years),344,7.85%,,,Convenience,Snibe Co. Ltd (Shenzhen New Industries Biomedical Engineering Co. Ltd),CLIA,"IgG,IgM",91.21%,97.30%,High,Preprint,F Barbaro,Padua University Hospital ,https://doi.org/10.1101/2021.02.23.21249481,25/03/2021,16/07/2022,Verified
201020_DipartimentoOncologicoAziendaUslToscanaCentroFirenze_Florence,20-Oct-20,Local,Italy,ITA,Tuscany,Florence,11-May-20,17-May-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,1145,2.30%,,,Sequential,NA,Not reported,"IgG,IgM",,,Unclear,Journal Article (Peer-Reviewed),Francesca Martella ,Azienda Usl Toscana Centro Oncology,http://dx.doi.org/10.1177/0300891620953388,27/03/2021,16/07/2022,Verified
201020_Milan_UniversitàdegliStudidiMilano_Patients1_Overall,20-Oct-20,Local,Italy,ITA,Lombardy,Milan,15-Apr-20,15-May-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,42,9.50%,,,Unclear,NA,CLIA,IgG,,,Unclear,Journal Article (Peer-Reviewed),Andrea Sartore Bianchi,Università degli Studi di Milano,http://dx.doi.org/10.1177/0300891620953388,27/03/2021,16/07/2022,Verified
210220_Lazio_ UniversitàCattolicadelSacroCuore_Overall,20-Feb-21,Local,Italy,ITA,Lazio,Rome,25-May-20,10-Aug-20,Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),202,1.50%,,,Convenience,Siemens,CLIA,Not reported,,,High,Journal Article (Peer-Reviewed),Fabio Del Zompo,Università Cattolica del Sacro Cuore,https://dx.doi.org/10.1016/j.dld.2021.02.015,27/03/2021,16/07/2022,Verified
210303_Lodi_IRCCSPoliclinico_overall_CLIA,03-Mar-21,Local,Italy,ITA,Lombardy region,Lodi,18-Mar-20,24-Jun-20,Blood donors,Multiple groups,1922,19.70%,,,Convenience,DiaSorin,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Irene Cassaniti,IRCCS Policlinico,https://dx.doi.org/10.1016/j.cmi.2021.01.030,31/03/2021,16/07/2022,Verified
210204_Milan_ FoundationIRCCS Ca'GrandaOspedaleMaggiorePoliclinico_overall_adj,22-Feb-21,Local,Italy,ITA,Lombardy,Milan,27-Apr-20,12-Jun-20,Health care workers and caregivers,Multiple groups,4055,6.40%,,,Convenience,DiaSorin,CLIA,IgG,97.40%,98.50%,Moderate,Journal Article (Peer-Reviewed),Andrea Lombardi,Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico,https://dx.doi.org/10.1136/bmjopen-2020-047216,03/04/2021,16/07/2022,Verified
201020_Sondrio_AltoLario-OncologiaMedicaSondrio_Overall,20-Oct-20,Local,Italy,ITA,Lombardy,Sondrio,01-Mar-20,19-Oct-20,Health care workers and caregivers,Adults (18-64 years),220,11.36%,,,Convenience,nal von minden GmbH,LFIA,"IgG,IgM",94.10%,99.20%,Unclear,Journal Article (Peer-Reviewed),G Caponigro ,ASST della Valtellina  Alto Lario-Oncologia Medica Sondrio,http://dx.doi.org/10.1177/0300891620953388,04/04/2021,16/07/2022,Verified
200826_Veneto_UniversityHospitalOfPadova,26-Aug-20,Regional,Italy,ITA,Veneto,,22-Feb-20,29-May-20,Health care workers and caregivers,Adults (18-64 years),8285,4.60%,4.10%,5.00%,Unclear,Snibe Co. Ltd (Shenzhen New Industries Biomedical Engineering Co. Ltd),CLIA,"IgG,IgM",73.00%,98.00%,High,Journal Article (Peer-Reviewed),Mario Plebani,University Hospital Of Padova,https://www.degruyter.com/document/doi/10.1515/cclm-2020-1236/html,08/04/2021,16/07/2022,Verified
210324_NorthernItaly_UniversitàDegliStudiDelPiemonteOrientale_HCW,24-Mar-21,Local,Italy,ITA,Piedmont,Vercelli,08-May-20,03-Jun-20,Health care workers and caregivers,Adults (18-64 years),2250,17.11%,15.55%,18.67%,Convenience,DiaSorin,CLIA,IgG,97.90%,98.50%,Moderate,Journal Article (Peer-Reviewed),Chiara Airoldi,Università degli Studi del Piemonte Orientale,http://dx.doi.org/10.3390/ijerph18073343,09/04/2021,16/07/2022,Verified
210226_Turin_UniversityofTurin_Pharmacists,26-Feb-21,Regional,Italy,ITA,Turin,,01-Jul-20,31-Jul-20,Essential non-healthcare workers,Adults (18-64 years),286,3.50%,,,Self-referral,PRIMA Lab S.A.,LFIA,"IgG,IgM",100.00%,98.00%,High,Journal Article (Peer-Reviewed),Francesca Baratta,University of Turin,https://dx.doi.org/10.3390/ijerph18052302,09/04/2021,16/07/2022,Verified
201105_Italy_UniversityofVerona_overall_unadj,05-Nov-20,National,Italy,ITA,"Veneto, Lazio and Friuli-Venezia Giulia",,18-May-20,29-Jul-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,339,1.47%,,,Sequential,NA,LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Massimiliano Bonifacio,University of Verona,http://dx.doi.org/10.1182/blood-2020-140032,12/04/2021,16/07/2022,Verified
210125_TerreRoveresche_UniversityOfUrbinoCarloBo_Overall,25-Jan-21,Local,Italy,ITA,Le Marche Region,Municipality of Terre Roveresche,15-Mar-20,15-Jun-20,Multiple populations,Multiple groups,341,14.40%,,,Convenience,Diagnostic Bioprobes,ELISA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Mauro De Santi,University of Urbino Carlo Bo,https://dx.doi.org/10.23750/abm.v92i1.10847,13/04/2021,16/07/2022,Verified
210225_Brescia_UniversityofBrescia_HCW,25-Feb-21,Local,Italy,ITA,Lombardy,Brescia,26-Apr-20,31-May-20,Health care workers and caregivers,Adults (18-64 years),1893,22.90%,,,Convenience,DiaSorin,CLIA,IgG,95.70%,98.50%,Moderate,Journal Article (Peer-Reviewed),Agnese Comelli,University of Brescia,https://dx.doi.org/10.3390/microorganisms9030488,15/04/2021,16/07/2022,Verified
210224_Castiglioned'Adda_UniversityofMilan_Overall,24-Feb-21,Local,Italy,ITA,Lombardy,Castiglione D’Adda,18-May-20,07-Jun-20,Household and community samples,Multiple groups,4143,22.20%,,,Entire sample,PRIMA Lab S.A.,LFIA,IgG,100.00%,96.00%,Low,Journal Article (Peer-Reviewed),Gabriele Pagani,University of Milan,https://dx.doi.org/10.1371/journal.pone.0246513,17/04/2021,16/07/2022,Verified
210226_UniversityOfTurin_Turin,26-Feb-21,Local,Italy,ITA,Piedmont,Turin,16-Apr-20,22-Jun-20,Pregnant or parturient women,Adults (18-64 years),164,9.70%,,,Convenience,Boditech Med Inc.,LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Stefano Cosma,University of Turin,https://dx.doi.org/10.3390/diagnostics11030398,17/04/2021,16/07/2022,Verified
201020_Milan_UniversitàdegliStudidiMilano_Physicians2_Overall,20-Oct-20,Local,Italy,ITA,Lombardy,Milan,15-Apr-20,15-May-20,Health care workers and caregivers,Multiple groups,34,5.88%,,,Convenience,NA,CLIA,IgG,,,Unclear,Journal Article (Peer-Reviewed),Andrea Sartore Bianchi,Università degli Studi di Milano,http://dx.doi.org/10.1177/0300891620953388,20/04/2021,16/07/2022,Verified
200721_Lodi_A.S.S.T.Lodi_HCW_overall,21-Jul-20,Local,Italy,ITA,Lombardy Region,,23-Apr-20,05-May-20,Health care workers and caregivers,Adults (18-64 years),2415,16.80%,,,Convenience,DiaSorin,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Alessandro  Baracco,A.S.S.T. Lodi ,https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3650227,21/04/2021,16/07/2022,Verified
200721_Lodi_A.S.S.T.Lodi_genpop,21-Jul-20,Local,Italy,ITA,Lombardy region,Lodi,23-Apr-20,05-May-20,Household and community samples,Multiple groups,1792,29.80%,,,Simplified probability,DiaSorin,CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Alessandro  Baracco,A.S.S.T.Lodi,https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3650227,21/04/2021,16/07/2022,Verified
210309_Benevento_UniversitàdegliStudidelSannio_Overall,09-Mar-21,Local,Italy,ITA,Campania,NR,01-Sep-20,30-Sep-20,Household and community samples,Seniors (65+ years),1383,4.70%,,,Convenience,Beijing Lepu Medical Technology,LFIA,"IgG,IgM",98.60%,97.60%,Moderate,Journal Article (Peer-Reviewed),Immacolata Polvere,Università degli Studi del Sannio,https://dx.doi.org/10.3390/diagnostics11030483,21/04/2021,16/07/2022,Verified
210404_Marche_UniversitàPolitecnicadelleMarche_ConfirmationAssay,04-Apr-21,Local,Italy,ITA,Marche,Ancona,01-Jul-20,26-Oct-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,949,0.70%,,,Sequential,"Zhejiang Orient Gene Biotech,Shenzhen Yhlo Biotech Co. Ltd",Multiple Types,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Luca Cantini,Università Politecnica delle Marche,http://dx.doi.org/10.3390/jcm10071503,21/04/2021,16/07/2022,Verified
210324_Milan_UniversityofMilan_UniversityEmployees,24-Mar-21,Local,Italy,ITA,,Milan,13-May-20,23-Jun-20,Non-essential workers and unemployed persons,Multiple groups,1826,11.30%,,,Convenience,NA,ELISA,IgG,85.70%,98.10%,High,Journal Article (Peer-Reviewed),Gregorio Milani,University of Milan,https://dx.doi.org/10.1136/bmjopen-2020-046800,24/04/2021,16/07/2022,Unverified
210331_Naples_IstitutoNazionaleTumori_CancerPatients,31-Mar-21,Local,Italy,ITA,,"Naples
",30-Mar-20,15-May-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,885,5.42%,,,Convenience,Beijing Lepu Medical Technology,Other,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Maria Isgro,Istituto Nazionale Tumori,https://dx.doi.org/10.1186/s12967-021-02798-2,30/04/2021,16/07/2022,Verified
210331_Naples_IstitutoNazionaleTumori_HCWs,31-Mar-21,Local,Italy,ITA,,Naples,30-Mar-20,15-May-20,Health care workers and caregivers,Multiple groups,1050,4.60%,3.30%,5.90%,Convenience,Beijing Lepu Medical Technology,Other,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Maria Isgro,Istituto Nazionale Tumori,https://dx.doi.org/10.1186/s12967-021-02798-2,30/04/2021,16/07/2022,Verified
210402_Italy_FondazioneIstitutoStomatologicoItaliano_DentalStaff,02-Apr-21,National,Italy,ITA,"Como, Lecco, Monza-Brianza, Sondrio, Varese, Bergamo, Brescia  Cremona, Lodi, Mantova, Pavia, Milan",,28-May-20,30-Sep-20,Health care workers and caregivers,Adults (18-64 years),499,10.80%,,,Convenience,Shanghai Kehua Bio-engineering (KHB) Co. Ltd,LFIA,"IgM,IgG",95.10%,99.30%,Moderate,Journal Article (Peer-Reviewed),Silvano Gallus,Fondazione Istituto Stomatologico Italiano,http://dx.doi.org/10.3390/ijerph18073711,02/05/2021,16/07/2022,Unverified
210320_GardenaValley_HospitalOfBolzano_PopAdj_TestAdj,20-Mar-21,Local,Italy,ITA,,"Gardena Valley ( Ortisei, Santa Cristina, and Selva, the main municipalities)",26-May-20,08-Jun-20,Household and community samples,Multiple groups,2106,26.90%,25.20%,28.60%,Stratified probability,Abbott Laboratories,CLIA,IgG,96.90%,99.90%,Low,Preprint,Roberto Melotti,Hospital of Bolzano,10.1101/2021.03.19.21253883,12/05/2021,16/07/2022,Verified
210320_Cogne_UniversitàDiTorino_genpop_overall,20-Mar-21,Local,Italy,ITA,Valle D'Aosta,Cogne,04-Jun-20,05-Jun-20,Household and community samples,Multiple groups,857,3.38%,,,Entire sample,Shenzhen Yhlo Biotech Co. Ltd,CLIA,"IgG,IgM",,,Low,Preprint,F Truc,Università di Torino,https://www.medrxiv.org/content/10.1101/2021.03.19.21253962v1.full-text,14/05/2021,16/07/2022,Verified
210317_Bolzano_HospitalofBolzano,17-Mar-21,Local,Italy,ITA,Trentino-Alto Adige/Südtirol,Bolzano,29-Oct-20,28-Dec-20,Residual sera,Multiple groups,3033,34.50%,,,Sequential,Roche Diagnostics,CLIA,Total Antibody,,,Moderate,Journal Article (Peer-Reviewed),Thomas Mueller,Hospital of Bolzano,https://dx.doi.org/10.1016/j.cca.2021.03.007,17/05/2021,16/07/2022,Verified
210312_Venice_TheVenetoEyeBankFoundation,27-Mar-21,Local,Italy,ITA,Veneto region,Venice,15-Mar-20,15-May-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,30,3.33%,,,Sequential,Snibe Co. Ltd (Shenzhen New Industries Biomedical Engineering Co. Ltd),CLIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Antonella Franch,The Veneto Eye Bank Foundation,https://dx.doi.org/10.1177/11206721211006565,18/05/2021,16/07/2022,Verified
201007_Turin_UniversityofTurin_primary,01-Apr-21,Local,Italy,ITA,,Turin,22-Feb-20,21-May-20,Pregnant or parturient women,Adults (18-64 years),225,9.30%,,,Convenience,"Boditech Med Inc.,DiaSorin",Multiple Types,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Stefano Cosma,University of Turin,http://dx.doi.org/10.1016/j.ajog.2020.10.005,18/05/2021,16/07/2022,Verified
210419_Turin_AziendaOspedalieraOrdineMauriziano_Primary,19-Apr-21,Local,Italy,ITA,Piedmont,Turin,08-May-20,15-May-20,Health care workers and caregivers,Multiple groups,1562,9.80%,,,Convenience,DiaSorin,CLIA,IgG,84.10%,93.70%,High,Journal Article (Peer-Reviewed),Marco Daperno,Azienda Ospedaliera Ordine Mauriziano,https://onlinelibrary.wiley.com/doi/10.1111/imj.15201,20/05/2021,16/07/2022,Verified
210420_Foggia_UniversityOfFoggia,20-Apr-21,Local,Italy,ITA,Apulia,Foggia,15-Mar-20,15-Jun-20,Blood donors,Adults (18-64 years),1797,1.00%,,,Sequential,"Ortho Clinical Diagnostics Inc.,Snibe Co. Ltd (Shenzhen New Industries Biomedical Engineering Co. Ltd)",CLIA,"Total Antibody,IgG",,,High,Journal Article (Peer-Reviewed),Mariantonietta Di Stefano,University of Foggia,https://www.karger.com/Article/Abstract/515258,20/05/2021,16/07/2022,Verified
210425_Florence_UniversityofFlorence_HP,25-Apr-21,Local,Italy,ITA,Tuscany,Florence,04-Nov-19,09-Mar-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,234,4.30%,,,Sequential,"CHiL,MP Biomedical",LFIA,IgG,,,High,Journal Article (Peer-Reviewed),Laura Gragnani,University of Florence,https://dx.doi.org/10.26355/eurrev_202104_25746,21/05/2021,16/07/2022,Verified
210425_Florence_UniversityofFlorence_BloodDonors,25-Apr-21,Local,Italy,ITA,Tuscany,Florence,22-Jan-20,09-Mar-20,Blood donors,Multiple groups,56,3.60%,,,Sequential,"CHiL,MP Biomedical",LFIA,IgG,,,High,Journal Article (Peer-Reviewed),Laura Gragnani,University of Florence,https://dx.doi.org/10.26355/eurrev_202104_25746,21/05/2021,16/07/2022,Verified
201221_Lombardy_ATSMilan_cohabitants,21-Dec-20,Regional,Italy,ITA,Lombardy,,01-Apr-20,30-Apr-20,Family of essential workers,Adults (18-64 years),755,24.40%,,,Convenience,ACRO Biotech Inc,LFIA,IgG,96.00%,79.20%,High,Journal Article (Peer-Reviewed),Rinaldo Missaglia,University of Milano-Bicocca,https://ijponline.biomedcentral.com/articles/10.1186/s13052-020-00950-0,21/05/2021,16/07/2022,Verified
201221_Lombardy_ATSMilan_staff,21-Dec-20,Regional,Italy,ITA,Lombardy,,01-Apr-20,30-Apr-20,Health care workers and caregivers,Adults (18-64 years),108,15.70%,,,Convenience,ACRO Biotech Inc,LFIA,IgG,96.00%,79.20%,High,Journal Article (Peer-Reviewed),Rinaldo Missaglia,University of Milano-Bicocca,https://ijponline.biomedcentral.com/articles/10.1186/s13052-020-00950-0,21/05/2021,16/07/2022,Verified
201221_Lombardy_ATSMilan_peds,21-Dec-20,Regional,Italy,ITA,Lombardy,,01-Apr-20,30-Apr-20,Health care workers and caregivers,Adults (18-64 years),377,14.90%,,,Convenience,ACRO Biotech Inc,LFIA,IgG,96.00%,79.20%,High,Journal Article (Peer-Reviewed),Rinaldo Missaglia,University of Milano-Bicocca,https://ijponline.biomedcentral.com/articles/10.1186/s13052-020-00950-0,21/05/2021,16/07/2022,Verified
210415_Campania_UniversityofNapoli,15-Apr-21,Regional,Italy,ITA,Campania,,11-May-20,18-May-20,Household and community samples,Multiple groups,388,1.80%,0.69%,2.91%,Simplified probability,NovaTec Immundiagnostics GmbH,ELISA,IgG,94.90%,96.20%,High,Journal Article (Peer-Reviewed),Valeria Caturano ,University of Napoli ,https://dx.doi.org/10.1186/s12879-021-06054-2,22/05/2021,16/07/2022,Verified
210324_UniversiteCatholiquedeLouvain_Piedmont_workers,24-Mar-21,Regional,Italy,ITA,PIedmont,,20-Jun-20,23-Jul-20,Multiple populations,Multiple groups,6033,4.80%,,,Convenience,"ZenTech, Angleur, Belgium",LFIA,"IgM,IgG",,,High,Journal Article (Peer-Reviewed),Omar Nyabi,Université Catholique de Louvain,http://dx.doi.org/10.3390/ijerph18073372,22/05/2021,16/07/2022,Verified
210429_SouthernItaly_UniversityofCampania,29-Apr-21,Regional,Italy,ITA,Southern Italy,"Caserta, Naples",21-Sep-20,31-Dec-20,Multiple populations,Multiple groups,2394,5.85%,,,Convenience,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,DiaSorin",CLIA,Total Antibody,,,High,Journal Article (Peer-Reviewed),Francesco Napolitano,University of Campania,https://www.mdpi.com/1660-4601/18/9/4761,22/05/2021,16/07/2022,Unverified
201202_Rome_UniversitàCattolicaDelSacroCuore_overall,02-Dec-20,Local,Italy,ITA,Lazio,Rome,01-Dec-19,29-Feb-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,451,0.00%,0.00%,0.01%,Convenience,"Eagle Bioscience,Palex",ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Francesca Lombardi,Università Cattolica del Sacro Cuore,http://dx.doi.org/10.1016/j.cmi.2020.11.026,27/05/2021,16/07/2022,Verified
210501_Rome_SapienzaUniversity,01-May-21,Local,Italy,ITA,Lazio,Rome,15-May-20,15-Jun-20,Essential non-healthcare workers,Adults (18-64 years),17377,1.22%,,,Convenience,"DiaSorin,Roche Diagnostics",CLIA,"IgG,IgM,IgA",,,High,Journal Article (Peer-Reviewed),Guido Antonelli,Sapienza University,https://dx.doi.org/10.1016/S2666-5247(21)00083-5,28/05/2021,16/07/2022,Verified
210504_Cagliari_UniversityofCagliari_SurgicalPatients_IGGorIGM,04-May-21,Local,Italy,ITA,Sardinia,Cagliari,01-Sep-20,10-Dec-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,121,10.70%,,,Convenience,Snibe Co. Ltd (Shenzhen New Industries Biomedical Engineering Co. Ltd),CLIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Federico Cappellacci, University of Cagliari,https://dx.doi.org/10.1016/j.amsu.2021.102375,29/05/2021,16/07/2022,Verified
210428_Europe_SorbonneUniversité_5EmiliaRomagna,28-Apr-21,Regional,Italy,ITA,Emilia Romagna,,07-Jun-20,08-Dec-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,522,1.50%,,,Convenience,"Abbott Laboratories,Siemens,DiaSorin,Beckman Coulter,Roche Diagnostics",Not reported,"IgG,IgM,IgA",,,High,Journal Article (Peer-Reviewed),David Saadoun,Sorbonne Université,https://dx.doi.org/10.1016/S2665-9913(21)00112-0,30/05/2021,16/07/2022,Verified
210528_Bari_IRCCSIstitutoTumoriGiovanniPaoloII_Baseline,28-May-21,Local,Italy,ITA,Puglia,Bari,26-Mar-20,31-Mar-20,Health care workers and caregivers,Multiple groups,606,1.10%,,,Convenience,VivaChek Biotech (Hangzhou) Co. Ltd,LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Angelo Virgilio Paradiso,IRCCS Istituto Tumori “Giovanni Paolo II” ,https://dx.doi.org/10.3390/diagnostics11060975,08/06/2021,16/07/2022,Unverified
210614_Verona_UniversityofVerona,14-Jun-21,Local,Italy,ITA,Province of Verona,Verona ,28-Apr-20,20-Jul-20,Health care workers and caregivers,Adults (18-64 years),5299,6.00%,5.30%,6.60%,Convenience,Snibe Co. Ltd (Shenzhen New Industries Biomedical Engineering Co. Ltd),LFIA,"IgG,IgM",,,Moderate,Journal Article (Peer-Reviewed),Stefano Porru,University of Verona,http://dx.doi.org/10.3390/ijerph18126446,21/06/2021,16/07/2022,Unverified
210607_Italy_UniversityofMilan_Patients1,07-Jun-21,National,Italy,ITA,,,15-Jul-20,15-Sep-20,Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),178,1.70%,,,Stratified probability,NA,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),William Morello,University of Milan,https://dx.doi.org/10.2215/CJN.00330121,21/06/2021,16/07/2022,Unverified
210610_Lombardy_HumanitasUniversity_HCW_overall,10-Jun-21,Regional,Italy,ITA,Lombardy ,"Milan, Rozzano, Varese, Castellanza and Bergamo",28-Apr-20,16-May-20,Health care workers and caregivers,Multiple groups,3985,13.00%,,,Convenience,DiaSorin,CLIA,IgG,90.40%,98.50%,Moderate,Journal Article (Peer-Reviewed),Maria Teresa Sandri,Humanitas University,https://dx.doi.org/10.1038/s41598-021-91773-4,21/06/2021,16/07/2022,Verified
210607_Italy_UniversityofMilan_Siblings2,07-Jun-21,National,Italy,ITA,,,15-Jul-20,15-Sep-20,Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),90,7.00%,,,Stratified probability,NA,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),William Morello,University of Milan,https://dx.doi.org/10.2215/CJN.00330121,21/06/2021,16/07/2022,Unverified
210607_Italy_UniversityofMilan_Cohabitants3,07-Jun-21,National,Italy,ITA,,,15-Jul-20,15-Sep-20,Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),271,3.00%,,,Stratified probability,NA,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),William Morello,University of Milan,https://dx.doi.org/10.2215/CJN.00330121,21/06/2021,16/07/2022,Unverified
210505_Trieste_ItalianNationalInstituteOfHealth,05-Jun-21,Regional,Italy,ITA,NR,Trieste,05-Jan-21,31-Jan-21,Blood donors,Children and Youth (0-17 years),169,9.50%,,,Sequential,DiaSorin,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Manola Comar,Italian National Institute of Health,https://dx.doi.org/10.1186/s13052-021-01074-9,21/06/2021,16/07/2022,Unverified
201111_Italy_IstitutoNazionaleTumori_Sept2019,11-Nov-20,National,Italy,ITA,,,01-Sep-19,30-Sep-19,Residual sera,Multiple groups,162,14.20%,,,Sequential,NA,ELISA,"IgM,IgG",85.70%,98.10%,High,Journal Article (Peer-Reviewed),Giovanni Apolone,Istituto Nazionale Tumori ,https://dx.doi.org/10.1177/0300891620974755,30/06/2021,16/07/2022,Verified
201111_Italy_IstitutoNazionaleTumori_Feb2020,11-Nov-20,National,Italy,ITA,,,01-Feb-20,10-Mar-20,Residual sera,Multiple groups,105,20.00%,,,Sequential,NA,ELISA,"IgM,IgG",85.70%,98.10%,High,Journal Article (Peer-Reviewed),Giovanni Apolone,Istituto Nazionale Tumori ,https://dx.doi.org/10.1177/0300891620974755,30/06/2021,16/07/2022,Verified
201111_Italy_IstitutoNazionaleTumori_Oct2019,11-Nov-20,National,Italy,ITA,,,01-Oct-19,31-Oct-19,Residual sera,Multiple groups,166,16.30%,,,Sequential,NA,ELISA,"IgM,IgG",85.70%,98.10%,High,Journal Article (Peer-Reviewed),Giovanni Apolone,Istituto Nazionale Tumori ,https://dx.doi.org/10.1177/0300891620974755,30/06/2021,16/07/2022,Verified
201111_Italy_IstitutoNazionaleTumori_Nov2019,11-Nov-20,National,Italy,ITA,,,01-Nov-19,30-Nov-19,Residual sera,Multiple groups,273,9.50%,,,Sequential,NA,ELISA,"IgM,IgG",85.70%,98.10%,High,Journal Article (Peer-Reviewed),Giovanni Apolone,Istituto Nazionale Tumori ,https://dx.doi.org/10.1177/0300891620974755,30/06/2021,16/07/2022,Verified
201111_Italy_IstitutoNazionaleTumori_Dec2019,11-Nov-20,National,Italy,ITA,,,01-Dec-19,31-Dec-19,Residual sera,Multiple groups,147,7.50%,,,Sequential,NA,ELISA,"IgM,IgG",85.70%,98.10%,High,Journal Article (Peer-Reviewed),Giovanni Apolone,Istituto Nazionale Tumori ,https://dx.doi.org/10.1177/0300891620974755,30/06/2021,16/07/2022,Verified
201111_Italy_IstitutoNazionaleTumori_Jan2020,11-Nov-20,National,Italy,ITA,,,01-Jan-20,31-Jan-20,Residual sera,Multiple groups,106,2.80%,,,Sequential,NA,ELISA,"IgM,IgG",85.70%,98.10%,High,Journal Article (Peer-Reviewed),Giovanni Apolone,Istituto Nazionale Tumori ,https://dx.doi.org/10.1177/0300891620974755,30/06/2021,16/07/2022,Verified
210603_Italy_UniversityHospitalCittaDellaSalute_University,03-Jun-21,Local,Italy,ITA,Piedmont,Turin,29-Jun-20,29-Jul-20,Non-essential workers and unemployed persons,Adults (18-64 years),1185,3.30%,2.40%,4.50%,Convenience,DiaSorin,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Gitana Scozzari,University Hospital Città Della Salute e Della Scienza di Torino,http://dx.doi.org/10.3390/v13061064,05/07/2021,16/07/2022,Unverified
210603_Italy_UniversityHospitalCittaDellaSalute_Healthcare,03-Jun-21,Local,Italy,ITA,Piedmont,Turin,04-May-20,31-Jul-20,Health care workers and caregivers,Adults (18-64 years),8769,7.60%,7.10%,8.20%,Convenience,DiaSorin,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Gitana Scozzari,University Hospital Città Della Salute e Della Scienza di Torino,http://dx.doi.org/10.3390/v13061064,05/07/2021,16/07/2022,Unverified
210611_Padova_UniversityOfPadova_SpAPatients_Overall,11-Jun-21,Local,Italy,ITA,Province of Padova,Padova,01-Jun-20,07-Aug-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,200,12.50%,,,Convenience,Snibe Co. Ltd (Shenzhen New Industries Biomedical Engineering Co. Ltd),CLIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Augusta Ortolan,University of Padova,https://dx.doi.org/10.3389/fimmu.2021.682850,06/07/2021,16/07/2022,Unverified
210611_Padova_UniversityOfPadova_HCW_Overall,11-Jun-21,Local,Italy,ITA,Province of Padova,Padova,01-Jun-20,07-Aug-20,Health care workers and caregivers,Multiple groups,95,8.40%,,,Convenience,Snibe Co. Ltd (Shenzhen New Industries Biomedical Engineering Co. Ltd),CLIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Augusta Ortolan,University of Padova,https://dx.doi.org/10.3389/fimmu.2021.682850,06/07/2021,16/07/2022,Unverified
210628_Lombardy_UniversityofPavia_patients_primary,28-Jun-21,Local,Italy,ITA,,,15-May-20,31-May-20,Assisted living and long-term care facilities,Adults (18-64 years),36,36.10%,,,Convenience,NA,ELISA,"IgA,IgG",97.00%,86.00%,High,Journal Article (Peer-Reviewed),Natascia Brondino ,University of Pavia,https://dx.doi.org/10.3390/brainsci11070860,12/07/2021,16/07/2022,Unverified
210628_Lombardy_UniversityofPavia_staff_primary,28-Jun-21,Local,Italy,ITA,,,15-May-20,31-May-20,Health care workers and caregivers,Adults (18-64 years),35,34.30%,,,Convenience,NA,ELISA,"IgA,IgG",97.00%,86.00%,High,Journal Article (Peer-Reviewed),Natascia Brondino ,University of Pavia,https://dx.doi.org/10.3390/brainsci11070860,12/07/2021,16/07/2022,Unverified
210703_Rome_FondazionePoliclinicoUniversitario_Primary,03-Jul-21,Local,Italy,ITA,,Rome,01-Mar-20,30-Nov-20,Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),1106,0.72%,,,Sequential,"Siemens,EUROIMMUN",Multiple Types,IgG,,,High,Journal Article (Peer-Reviewed),Francesca Lombardi,Fondazione Policlinico Universitario,https://dx.doi.org/10.3390/diagnostics11071154,12/07/2021,16/07/2022,Unverified
210626_Torno_SaccoUniversityHospital_Residents1,26-Jun-21,Local,Italy,ITA,Lombardy,Torno,01-Jun-20,22-Jun-20,Assisted living and long-term care facilities,Seniors (65+ years),74,0.00%,,,Convenience,NA,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),Mario Tagliabue,Sacco University Hospital,https://dx.doi.org/10.1016/j.pmedr.2021.101471,12/07/2021,16/07/2022,Unverified
210626_Torno_SaccoUniversityHospital_Staff2,26-Jun-21,Local,Italy,ITA,Lombardy,Torno,01-Jun-20,22-Jun-20,Health care workers and caregivers,Adults (18-64 years),51,0.00%,,,Convenience,NA,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),Mario Tagliabue,Sacco University Hospital,https://dx.doi.org/10.1016/j.pmedr.2021.101471,12/07/2021,16/07/2022,Unverified
210625_Emilia-Romagna_UniversityofMilan_primary,25-Jun-21,Regional,Italy,ITA,"Calerno, Parma, Spilamberto",,01-Jun-20,30-Jun-20,Essential non-healthcare workers,Adults (18-64 years),815,3.80%,,,Convenience,PRIMA Lab S.A.,LFIA,"IgG,IgM",,,Moderate,Journal Article (Peer-Reviewed),Susanna Esposito,University of Milan,https://dx.doi.org/10.3389/fpubh.2021.628098,19/07/2021,16/07/2022,Unverified
210724_Brescia-Lombardy_UniversityOfBrescia_Residents1,24-Jul-21,Local,Italy,ITA,Province of Brescia,Brescia,19-May-20,30-Jun-20,Assisted living and long-term care facilities,Multiple groups,246,24.00%,,,Convenience,Core Technology Co. Ltd,LFIA,"IgG,IgM",97.60%,100.00%,High,Journal Article (Peer-Reviewed),Antonella Savio,University Of Brescia,https://dx.doi.org/10.3389/fpubh.2021.649524,20/07/2021,16/07/2022,Unverified
210724_Brescia-Lombardy_UniversityOfBrescia_Staff2,24-Jul-21,Local,Italy,ITA,Province of Brescia,Brescia,23-Apr-20,14-May-20,Health care workers and caregivers,Multiple groups,286,16.78%,,,Convenience,Core Technology Co. Ltd,LFIA,"IgG,IgM",97.60%,100.00%,High,Journal Article (Peer-Reviewed),Antonella Savio,University Of Brescia,https://dx.doi.org/10.3389/fpubh.2021.649524,20/07/2021,16/07/2022,Unverified
210706_Lombardy_BrunoKesslerFoundation_HCW,06-Jul-21,Regional,Italy,ITA,Lombardy region,,01-Apr-20,26-Jun-20,Health care workers and caregivers,Multiple groups,82961,12.20%,12.00%,12.40%,Convenience,DiaSorin,CLIA,IgG,94.40%,98.30%,Moderate,Journal Article (Peer-Reviewed),Piero Poletti,Bruno Kessler Foundation,https://dx.doi.org/10.1001/jamanetworkopen.2021.15699,21/07/2021,16/07/2022,Unverified
210720_Italy_UniversityofGenoa,20-Jul-21,National,Italy,ITA,,,04-Mar-21,09-Jul-21,Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),1022,11.20%,,,Convenience,Roche Diagnostics,CLIA,Not reported,,,High,Preprint,Maria Pia Sormani,University of Genoa,10.2139/ssrn.3886420,28/07/2021,16/07/2022,Unverified
210727_Modena_UniversityofModenaandReggioEmilia_Overall,27-Jul-21,Regional,Italy,ITA,Modena,,18-May-20,05-Oct-20,Essential non-healthcare workers,Adults (18-64 years),246608,0.45%,,,Convenience,NA,Not reported,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Alberto Modenese,University of Modena and Reggio Emilia,http://dx.doi.org/10.3390/ijerph18157948,02/08/2021,16/07/2022,Unverified
210706_Italy_FondazioneIRCCSPoliclinicoSanMatteo_Primary,06-Jul-21,Regional,Italy,ITA,"Pavia, Lecco, Piacenza",,29-Apr-20,29-May-20,Health care workers and caregivers,Adults (18-64 years),9610,15.20%,,,Unclear,DiaSorin,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Francesca Rovida ,Fondazione IRCCS Policlinico San Matteo,http://dx.doi.org/10.1016/j.ijid.2021.07.003,10/08/2021,16/07/2022,Verified
210726_Florence_MeyerChildren'sUniversityHospital,26-Jul-21,Local,Italy,ITA,"Tuscany
",Florence,02-Apr-20,06-May-20,Health care workers and caregivers,Adults (18-64 years),1502,2.80%,,,Convenience,Zhejiang Orient Gene Biotech,LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Valentina Guarnieri,Meyer Children's University Hospital,https://dx.doi.org/10.3389/fpubh.2021.644702,17/08/2021,16/07/2022,Unverified
210808_North-WesternItaly_UniversitàDelPiemonteOrientale,08-Aug-21,Regional,Italy,ITA,,"Torino, Biella, Cuneo, Novara",28-Apr-20,07-Aug-20,Essential non-healthcare workers,Multiple groups,23568,4.97%,4.69%,5.25%,Convenience,Zeus,ELISA,IgG,93.30%,100.00%,Moderate,Journal Article (Peer-Reviewed),Chiara Airoldi,Università del Piemonte Orientale,https://dx.doi.org/10.1093/annweh/wxab062,18/08/2021,16/07/2022,Unverified
210519_Lombardy_ASSTGaetanoPini-CTOInstitute,19-May-21,Regional,Italy,ITA,Lombardy,,04-May-20,16-Jun-20,Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),300,18.60%,14.60%,23.40%,Unclear,NA,ELISA,"IgG,IgM,IgA",,,High,Journal Article (Peer-Reviewed),Ennio Giulio Favalli,The ASST Gaetano Pini-CTO Institute,http://dx.doi.org/10.1136/annrheumdis-2021-eular.594,24/08/2021,16/07/2022,Verified
210831_Italy_UniversityofVerona_Overall,31-Aug-21,National,Italy,ITA,"Veneto, Friuli-Venezia Giulia, and Lazio",,18-May-20,03-Nov-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,564,1.95%,1.09%,3.46%,Sequential,Menarini Diagnostics,LFIA,"IgM,IgG",,100.00%,Moderate,Journal Article (Peer-Reviewed),Massimiliano Bonifacio,University of Verona,https://dx.doi.org/10.1002/cam4.4179,07/09/2021,16/07/2022,Unverified
210719_Vo_UniversityOfPadova_Overall_Adj,19-Jul-21,Local,Italy,ITA,Padova,Vo,01-May-20,31-May-20,Household and community samples,Multiple groups,2602,3.50%,2.80%,4.30%,Entire sample,"Abbott Laboratories,Roche Diagnostics,DiaSorin",CLIA,IgG,,,Low,Journal Article (Peer-Reviewed),Ilaria Dorigatti,University of Padova,https://dx.doi.org/10.1038/s41467-021-24622-7,08/09/2021,16/07/2022,Verified
210827_Italy_AOUCittàdellaSaluteedellaScienzadiTorino,27-Aug-21,Local,Italy,ITA,Piedmont,Turin,25-Nov-20,12-Feb-21,Patients seeking care for non-COVID-19 reasons,Multiple groups,98,22.40%,,,Convenience,DiaSorin,Not reported,IgG,,,Moderate,Presentation or Conference,Margherita Saracco,AOU Citta della Salute e della Scienza di Torino,https://onlinelibrary.wiley.com/doi/10.1111/tri.13944,13/09/2021,16/07/2022,Unverified
210902_Milan_UniversityofMilan_September2020_Overall,02-Sep-21,Local,Italy,ITA,Lombardy,Milan,07-Sep-20,14-Sep-20,Students and Daycares,Children and Youth (0-17 years),1109,2.80%,1.90%,3.90%,Convenience,PerkinElmer,Other,IgG,96.00%,100.00%,High,Journal Article (Peer-Reviewed),Lucia Barcellini,University of Milan,http://dx.doi.org/10.1371/journal.pone.0257046,14/09/2021,16/07/2022,Unverified
210902_Milan_UniversityofMilan_January2021_Overall,02-Sep-21,Local,Italy,ITA,Lombardy,Milan,15-Jan-21,29-Jan-21,Students and Daycares,Children and Youth (0-17 years),1109,12.50%,10.60%,14.60%,Convenience,PerkinElmer,Other,IgG,96.00%,100.00%,High,Journal Article (Peer-Reviewed),Lucia Barcellini,University of Milan,http://dx.doi.org/10.1371/journal.pone.0257046,14/09/2021,16/07/2022,Unverified
210827_Modena_UniversityofModenaandReggioEmilia_Overall,27-Aug-21,Local,Italy,ITA,Province of Modena,Modena,01-Jun-20,25-Sep-20,Multiple populations,Multiple groups,7561,4.70%,4.20%,5.20%,Self-referral,"Roche Diagnostics,Shanghai Kehua Bio-engineering (KHB) Co. Ltd,EUROIMMUN",Multiple Types,"IgG,IgM,IgA",,,High,Journal Article (Peer-Reviewed),Nausicaa Berselli,University of Modena and Reggio Emilia,https://dx.doi.org/10.13075/ijomeh.1896.01826,21/09/2021,16/07/2022,Unverified
210413_Verona_UniversityofVerona_IgAorIgG_Overall,13-Apr-21,Local,Italy,ITA,,Verona,01-Mar-20,31-Aug-20,Residual sera,Multiple groups,332,7.83%,,,Convenience,NA,Not reported,"IgG,IgA",,,High,Presentation or Conference,Cecilia Zivelonghi,University of Verona,https://n.neurology.org/content/96/15_Supplement/4295,24/09/2021,16/07/2022,Unverified
210908_Italy_UniversityofFlorence_Players,08-Sep-21,Local,Italy,ITA,,,14-May-20,15-May-20,Non-essential workers and unemployed persons,Adults (18-64 years),27,67.00%,,,Convenience,NA,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),Michele Spinicci,University of Florence,http://dx.doi.org/10.1017/S0950268821002065,27/09/2021,16/07/2022,Unverified
210908_Italy_UniversityofFlorence_Staff,08-Sep-21,Local,Italy,ITA,,,14-May-20,15-May-20,Non-essential workers and unemployed persons,Adults (18-64 years),26,65.00%,,,Convenience,NA,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),Michele Spinicci,University of Florence,http://dx.doi.org/10.1017/S0950268821002065,27/09/2021,16/07/2022,Unverified
210920_Genoa_UniversitàdegliStudidiGenova_overall,20-Sep-21,Local,Italy,ITA,Liguria,Genoa,14-Apr-20,23-Aug-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,446,3.14%,,,Convenience,Shenzhen Yhlo Biotech Co. Ltd,CLIA,"IgG,IgM",,,High,Preprint,Francesco Ravera,Università degli Studi di Genova,https://www.researchsquare.com/article/rs-864803/v1,28/09/2021,16/07/2022,Unverified
210917_Gussago_FondazionePoliambulanzaHospital,17-Sep-21,Local,Italy,ITA,Brescia,Gussago ,01-Jan-21,01-Apr-21,Health care workers and caregivers,Adults (18-64 years),337,37.98%,,,Unclear,NA,Not reported,Total Antibody,,,Moderate,Journal Article (Peer-Reviewed),Marcello Salvaggio,Fondazione Poliambulanza Hospital,http://dx.doi.org/10.3390/jcm10184204,29/09/2021,16/07/2022,Unverified
210909_Milan_FondazioneIRCCSCa’GrandaOspedaleMaggiorePoliclinico,09-Sep-21,Local,Italy,ITA,,Milan,20-Apr-20,30-Jun-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,109,18.35%,,,Convenience,NA,ELISA,"IgG,IgA",,,High,Journal Article (Peer-Reviewed),Luca Elli,Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico,https://dx.doi.org/10.1016/j.dld.2021.08.027,05/10/2021,16/07/2022,Unverified
210929_CasolaDiNapoli_UniversityOfSalerno_Overall,29-Sep-21,Local,Italy,ITA,Naples,City of Napoli,25-Jun-20,12-Jul-20,Household and community samples,Multiple groups,2738,1.40%,,,Self-referral,VivaChek Biotech (Hangzhou) Co. Ltd,LFIA,"IgM,IgG",,,Moderate,Journal Article (Peer-Reviewed),Carmine Coppola,University of Salerno,https://dx.doi.org/10.1111/jvh.13623,06/10/2021,16/07/2022,Verified
211004_Lombardy_UniversityOfPavia,04-Oct-21,Regional,Italy,ITA,Lombardy,,15-Jun-20,15-May-21,Patients seeking care for non-COVID-19 reasons,Multiple groups,93,13.00%,,,Unclear,NA,ELISA,IgG,,,Unclear,Journal Article (Peer-Reviewed),Syed M A Ahmed,University Of Pavia,https://dx.doi.org/10.1111/jdv.17721,12/10/2021,16/07/2022,Unverified
211006_Italy_IRCCSOrthopedicInstituteGaleazzi_IOG-CSS,06-Oct-21,National,Italy,ITA,"Lombardy, Apulia","Milan, San Giovanni Rotondo",04-Jan-21,12-Feb-21,Health care workers and caregivers,Multiple groups,950,18.42%,,,Unclear,Siemens,CLIA,IgG,100.00%,99.90%,Moderate,Journal Article (Peer-Reviewed),Davide Ferrari,IRCCS Orthopedic Institute Galeazzi,https://dx.doi.org/10.1515/cclm-2021-0364,14/10/2021,16/07/2022,Unverified
211006_Italy_IRCCSOrthopedicInstituteGaleazzi_OSR,06-Oct-21,Local,Italy,ITA,Lombardy,Milan,04-Jan-21,12-Feb-21,Health care workers and caregivers,Multiple groups,3340,9.13%,,,Unclear,Roche Diagnostics,CLIA,Total Antibody,,,Moderate,Journal Article (Peer-Reviewed),Davide Ferrari,IRCCS Orthopedic Institute Galeazzi,https://dx.doi.org/10.1515/cclm-2021-0364,14/10/2021,16/07/2022,Unverified
211011_SanSiro_ASSTFatebenefratelliSacco_primary,11-Oct-21,Local,Italy,ITA,Lombardy,Milan,23-Dec-20,19-Feb-21,Household and community samples,Multiple groups,2044,11.20%,,,Self-referral,Technogenetics,Other,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Gabriele Pagani,ASST Fatebenefratelli Sacco,http://dx.doi.org/10.3390/ijerph182010621,20/10/2021,16/07/2022,Unverified
211014_Milan_UniversitàdegliStudidiMilano_Primary,14-Oct-21,Local,Italy,ITA,,Milan,01-Jul-20,23-Feb-21,Blood donors,Multiple groups,10680,5.90%,,,Sequential,"PRIMA Lab S.A.,DiaSorin",Multiple Types,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Luca Valenti,Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico Milano,https://dx.doi.org/10.1111/trf.16693,20/10/2021,16/07/2022,Verified
211001_Italy_UniversityofUrbino,01-Oct-21,Regional,Italy,ITA,Marche,,15-May-20,15-Apr-21,Non-essential workers and unemployed persons,Adults (18-64 years),10000,5.19%,,,Convenience,NA,LFIA,"IgG,IgM",,,Unclear,Journal Article (Peer-Reviewed),Chiara Orlandi,University of Urbino,http://dx.doi.org/10.23750/abm.v92iS6.12238,27/10/2021,16/07/2022,Unverified
211001_Verona_IRCCSSacroCuoreDonCalabriaHospital_IBDpatients,01-Oct-21,Local,Italy,ITA,Verona,Negrar di Valpolicella,07-Dec-20,31-Jan-21,Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),386,10.40%,,,Convenience,DiaSorin,Not reported,"IgM,IgG",,,High,Journal Article (Peer-Reviewed),Mirko Di Ruscio,IRCCS Sacro Cuore Don Calabria Hospital,https://dx.doi.org/10.3390/medicina57101048,02/11/2021,16/07/2022,Unverified
211001_Verona_IRCCSSacroCuoreDonCalabriaHospital_HCW_overall,01-Oct-21,Local,Italy,ITA,Verona,Negrar di Valpolicella,01-Jan-21,31-Jan-21,Health care workers and caregivers,Adults (18-64 years),2209,13.00%,,,Convenience,DiaSorin,Not reported,"IgM,IgG",,,High,Journal Article (Peer-Reviewed),Mirko Di Ruscio,IRCCS Sacro Cuore Don Calabria Hospital,https://dx.doi.org/10.3390/medicina57101048,02/11/2021,16/07/2022,Unverified
210804_Italy_UniversityofCampania_Primary,04-Aug-21,Regional,Italy,ITA,Campania (Southern Italy),,21-Apr-20,10-Jun-20,Blood donors,Multiple groups,1808,0.83%,,,Sequential,Beijing Wantai Biological,ELISA,Total Antibody,94.50%,100.00%,Moderate,Journal Article (Peer-Reviewed),Federica Calo,University of Campania,https://dx.doi.org/10.2450/2021.0196-21,03/11/2021,16/07/2022,Verified
211028_UniversityHospitalofTrieste_University of Trieste,28-Oct-21,Local,Italy,ITA,Northeast Italy,Trieste,15-May-20,15-Sep-20,Health care workers and caregivers,Adults (18-64 years),389,34.70%,,,Convenience,DiaSorin,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Francesca Filon,University of Trieste,https://dx.doi.org/10.23749/mdl.v112i5.11798,09/11/2021,16/07/2022,Unverified
211028_Italy_FondazioneIRCCS_STest,28-Oct-21,Local,Italy,ITA,,Pavia,15-Jun-20,15-Dec-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,201,14.40%,,,Sequential,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Anna Lia Asti,IRCCS San Matteo Hospital ,https://pubmed.ncbi.nlm.nih.gov/34783351/,22/11/2021,16/07/2022,Unverified
210930_Novara_UniversityofPiemonteOrientale_pregnant_overall,30-Sep-21,Local,Italy,ITA,Novara,Novara City,27-Apr-20,01-Jul-20,Pregnant or parturient women,Adults (18-64 years),344,2.60%,,,Convenience,NA,Not reported,Not reported,,,High,Journal Article (Peer-Reviewed),Viviana Piccirllo,University of Piemonte Orientale,http://dx.doi.org/10.1080/14767058.2021.1962370,24/11/2021,16/07/2022,Unverified
210930_Novara_UniversityofPiemonteOrientale_nonpregnant_overall,30-Sep-21,Local,Italy,ITA,"Novara
",Novara City,27-Apr-20,01-Jul-20,Household and community samples,Adults (18-64 years),588,12.80%,,,Unclear,NA,Not reported,Not reported,,,High,Journal Article (Peer-Reviewed),Viviana Piccirllo,University of Piemonte Orientale,http://dx.doi.org/10.1080/14767058.2021.1962370,24/11/2021,16/07/2022,Unverified
211116_Italy_BambinoGesuChildrensHospital,16-Nov-21,Local,Italy,ITA,,Rome,01-May-20,31-Jan-21,Patients seeking care for non-COVID-19 reasons,Multiple groups,85,5.80%,,,Convenience,DiaSorin,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Chiara Casamento Tumeo,Bambino Gesù Children’s Hospital,https://www.researchsquare.com/article/rs-1061389/v1,24/11/2021,16/07/2022,Unverified
211115_Foggia_UniversityHospital“Ospedali Riuniti”Foggia_general_primary,16-Nov-21,Local,Italy,ITA,,Foggia,15-May-20,15-Mar-21,Blood donors,Multiple groups,8183,6.30%,,,Convenience,Ortho Clinical Diagnostics Inc.,CLIA,"Total Antibody,IgG",,,High,Journal Article (Peer-Reviewed),Francescopaolo Antonucci,University Hospital “Ospedali Riuniti” Foggia,https://dx.doi.org/10.1080/23744235.2021.2003856,25/11/2021,16/07/2022,Verified
211120_Italy_UniversitàCattolicadelSacroCuore_Primary,21-Nov-21,National,Italy,ITA,,,15-Apr-20,15-Jul-20,Essential non-healthcare workers,Multiple groups,10535,4.80%,4.40%,5.30%,Self-referral,Zhejiang Orient Gene Biotech,LFIA,"IgG,IgM",,100.00%,Low,Journal Article (Peer-Reviewed),Sergio Garbarino,Università Cattolica del Sacro Cuore,http://dx.doi.org/10.3390/ijerph182212201,29/11/2021,16/07/2022,Unverified
211027_SicilianRegion_UniversityOfCatania_Primary,27-Oct-21,Local,Italy,ITA,Sicilian,,01-Apr-20,30-Jun-20,Non-essential workers and unemployed persons,Multiple groups,328,0.03%,,,Entire sample,NA,Not reported,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Ermanno Vitale,University of Catania ,https://www.mdpi.com/2076-3417/11/21/10051/htm,30/11/2021,16/07/2022,Unverified
211201_Veneto_MonastierDiTrevisoHospital_Primary,01-Dec-21,Local,Italy,ITA,Veneto,,04-May-20,15-Jul-20,Household and community samples,Multiple groups,922,2.10%,,,Stratified probability,NA,Other,IgG,,,Moderate,Journal Article (Peer-Reviewed),Marco Bassanello,Monastier di Treviso Hospital,https://dx.doi.org/10.1038/s41598-021-02654-9,06/12/2021,16/07/2022,Unverified
211110_Modena_UniversityofModenaandReggioEmilia,10-Nov-21,Local,Italy,ITA,,Modena,15-Jan-21,15-Jun-21,Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),85,15.29%,,,Unclear,NA,CLIA,IgG,,,Unclear,Presentation or Conference,B Predieri,University of Modena and Reggio Emilia,http://dx.doi.org/10.1111/pedi.13269,14/12/2021,16/07/2022,Unverified
211111_Verona_UniversityofVerona,11-Nov-21,Local,Italy,ITA,Veneto,Verona,01-Jan-20,31-Dec-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,49,18.40%,,,Convenience,"EUROIMMUN,DiaSorin,Beckman Coulter",Multiple Types,"IgG,IgA",,,High,Presentation or Conference,M Trentinaglia,University of Verona,http://dx.doi.org/10.1111/jns.12472,15/12/2021,16/07/2022,Unverified
211025_Piacenza_1AUSLPiacenza,25-Oct-21,Local,Italy,ITA,Emilia-Romagna,Piacenza,20-Mar-21,29-May-21,Patients seeking care for non-COVID-19 reasons,Multiple groups,293,7.17%,,,Convenience,NA,Not reported,IgG,,,High,Presentation or Conference,Biasini C,Azienda Unita Sanitaria Locale di Piacenza,http://dx.doi.org/10.1177/03008916211041664,15/12/2021,16/07/2022,Unverified
211210_Rome_UniversityofRomeTorVergata,10-Dec-21,Local,Italy,ITA,,Rome,01-Mar-20,31-Dec-20,Health care workers and caregivers,Adults (18-64 years),918,2.10%,,,Convenience,NA,CLIA,IgG,98.60%,99.50%,High,Journal Article (Peer-Reviewed),Luca Coppeta,University of Rome Tor Vergata,https://dx.doi.org/10.3390/ijerph182413053,02/01/2022,16/07/2022,Unverified
211207_Milan_SanGiuseppeHospital_Total1stWave,17-Dec-21,Local,Italy,ITA,,Milan,15-Mar-20,15-May-20,Health care workers and caregivers,Adults (18-64 years),25,4.00%,,,Self-referral,Technogenetics,LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Matteo Sacchi,San Giuseppe Hospital,https://dx.doi.org/10.1097/MD.0000000000028192,09/01/2022,16/07/2022,Unverified
211212_Italy_UniversitàdegliStudidiMilano_Overall,12-Dec-21,Regional,Italy,ITA,Northern Italy,,15-Mar-21,15-Jun-21,Patients seeking care for non-COVID-19 reasons,Multiple groups,434,14.75%,11.50%,18.40%,Convenience,Roche Diagnostics,CLIA,Total Antibody,98.80%,100.00%,High,Journal Article (Peer-Reviewed),Gianfranco Alicandro,Università degli Studi di Milano,https://dx.doi.org/10.1016/j.jcf.2021.12.011,10/01/2022,16/07/2022,Unverified
211218_Italy_SanRaffaeleUniversity_Overall,18-Dec-21,Local,Italy,ITA,Milan,Milan,15-Feb-20,15-Apr-21,Patients seeking care for non-COVID-19 reasons,Multiple groups,291,10.31%,,,Convenience,NA,CLIA,IgG,97.00%,100.00%,High,Journal Article (Peer-Reviewed),Rossana Caldara,Vita-Salute San Raffaele University,https://dx.doi.org/10.3390/biology10121349,14/01/2022,16/07/2022,Unverified
211020_Bari_UniversityofSiena_ELISA_IgG,20-Oct-21,Local,Italy,ITA,Apulia,,22-Sep-19,31-Dec-19,Residual sera,Multiple groups,455,2.42%,,,Convenience,NA,ELISA,IgG,,,High,Presentation or Conference,S Marchi,University of Siena,https://academic.oup.com/eurpub/article/31/Supplement_3/ckab164.096/6405069?login=true,17/01/2022,16/07/2022,Unverified
210730_Abruzzo_GDannunzioUniversity,30-Jul-21,Regional,Italy,ITA,Abruzzo,,01-Aug-20,20-Oct-20,Essential non-healthcare workers,Adults (18-64 years),216,5.09%,,,Unclear,Snibe Co. Ltd (Shenzhen New Industries Biomedical Engineering Co. Ltd),CLIA,IgG,91.21%,97.30%,High,Journal Article (Peer-Reviewed),E Toniato,G. D'Annunzio University,https://www.biolifesas.org/biolife/wp-content/uploads/2021/07/S3-Toniato-15.pdf,18/01/2022,16/07/2022,Unverified
220111_Rome_GemelliUniversityHospital,11-Jan-22,Local,Italy,ITA,Lazio,Rome,01-Mar-20,30-Apr-21,Perinatal,Children and Youth (0-17 years),59,15.25%,,,Convenience,Vircell S.L.,ELISA,IgG,85.00%,98.00%,High,Journal Article (Peer-Reviewed),Danilo Buonsenso,Gemelli University,https://dx.doi.org/10.1007/s00431-021-04319-1,27/01/2022,16/07/2022,Unverified
220202_Friuli-VeneziaGiulia_SantaMariadellaMisericordiaHospital_Overall,02-Feb-22,Regional,Italy,ITA,Friuli-Venezia Giulia,,01-May-20,15-Jun-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,860,1.62%,,,Sequential,Cellex Inc.,LFIA,"IgG,IgM",98.40%,96.40%,High,Journal Article (Peer-Reviewed),Anna Candoni,Santa Maria della Misericordia Hospital,https://dx.doi.org/10.1371/journal.pone.0262784,09/02/2022,16/07/2022,Unverified
220212_Friuli-VeneziaGiulia_UniversityofTrieste_Period1_Overall,12-Feb-22,Regional,Italy,ITA,"Friuli-Venezia Giulia
Region",,01-Jan-21,28-Feb-21,Students and Daycares,Children and Youth (0-17 years),217,11.10%,,,Convenience,DiaSorin,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Marzia Lazzerini,IRCCS “Burlo Garofolo”,https://dx.doi.org/10.3390/children9020246,08/03/2022,16/07/2022,Unverified
220212_Friuli-VeneziaGiulia_UniversityofTrieste_Period2_Overall,12-Feb-22,Regional,Italy,ITA,"Friuli-Venezia Giulia
Region",,01-Apr-21,31-May-21,Students and Daycares,Children and Youth (0-17 years),208,15.40%,,,Convenience,DiaSorin,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Marzia Lazzerini,IRCCS “Burlo Garofolo”,https://dx.doi.org/10.3390/children9020246,08/03/2022,16/07/2022,Unverified
220212_Friuli-VeneziaGiulia_UniversityofTrieste_Period3_Overall,12-Feb-22,Regional,Italy,ITA,"Friuli-Venezia Giulia
Region",,01-Jun-21,31-Jul-21,Students and Daycares,Children and Youth (0-17 years),169,11.80%,,,Convenience,DiaSorin,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Marzia Lazzerini,IRCCS “Burlo Garofolo”,https://dx.doi.org/10.3390/children9020246,08/03/2022,16/07/2022,Unverified
220227_Verona_UniversityofVerona_Patients_Overall,27-Feb-22,Local,Italy,ITA,,Verona,01-Aug-20,31-May-21,Patients seeking care for non-COVID-19 reasons,Multiple groups,30,40.00%,,,Sequential,"EUROIMMUN,DiaSorin,Beckman Coulter,Roche Diagnostics",Multiple Types,"IgG,IgA,Total Antibody",,,High,Journal Article (Peer-Reviewed),Sara Mariotto,University of Verona,https://dx.doi.org/10.1111/ene.15304,08/03/2022,16/07/2022,Unverified
220227_Verona_UniversityofVerona_Controls_Overall,27-Feb-22,Local,Italy,ITA,,Verona,01-Aug-20,31-May-21,Residual sera,Multiple groups,30,20.00%,,,Convenience,"EUROIMMUN,DiaSorin,Beckman Coulter,Roche Diagnostics",Multiple Types,"IgG,IgA,Total Antibody",,,High,Journal Article (Peer-Reviewed),Sara Mariotto,University of Verona,https://dx.doi.org/10.1111/ene.15304,08/03/2022,16/07/2022,Unverified
220121_NorthItaly_UniversityofPiemonteOrientale,21-Jan-22,Regional,Italy,ITA,North Italy,,15-Apr-20,15-Apr-21,Patients seeking care for non-COVID-19 reasons,Multiple groups,238,4.20%,,,Unclear,NA,Not reported,Not reported,,,High,Presentation or Conference,L Pisani,University of Piemonte Orientale,https://dx.doi.org/10.1093/ecco-jcc/jjab232.060,09/03/2022,16/07/2022,Unverified
220224_Piedmont_UniversityOfTurin_HCWs,24-Feb-22,Regional,Italy,ITA,Region of Piedmont,"Alessandria, Cuneo, Turin",01-Jan-21,31-Jan-21,Health care workers and caregivers,Multiple groups,495,53.13%,,,Convenience,EUROIMMUN,ELISA,IgG,93.20%,99.80%,High,Journal Article (Peer-Reviewed),Valerio Bordino,University of Turin,https://dx.doi.org/10.1002/jmv.27670,09/03/2022,16/07/2022,Unverified
211106_Milan_PoliclinicoSMatteoUniversity_Overall,06-Nov-21,Regional,Italy,ITA,Lombardy,,04-May-20,16-Jun-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,300,18.67%,14.60%,23.40%,Sequential,NA,ELISA,"IgG,IgM,IgA",,,High,Presentation or Conference,Gabriella Maioli,Policlinico S. Matteo University,https://acrabstracts.org/abstract/the-true-prevalence-of-sars-cov-2-infection-in-an-italian-cohort-of-patients-with-inflammatory-arthritis-a-seroepidemiological-study/,09/03/2022,16/07/2022,Unverified
220224_Piedmont_UniversityOfTurin_LTCFsResidents,24-Feb-22,Regional,Italy,ITA,Region of Piedmont,"Alessandria, Cuneo, Turin",01-Jan-21,31-Jan-21,Assisted living and long-term care facilities,Multiple groups,163,65.03%,,,Convenience,EUROIMMUN,ELISA,IgG,93.20%,99.80%,High,Journal Article (Peer-Reviewed),Valerio Bordino,University of Turin,https://dx.doi.org/10.1002/jmv.27670,09/03/2022,16/07/2022,Unverified
211011_Italy_AziendaUSLofModena_Overall,11-Oct-21,National,Italy,ITA,,,11-Mar-20,30-Sep-20,Residual sera,Multiple groups,42911,5.50%,,,Convenience,NA,Multiple Types,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Valentina Pecoraro,University-Hospital of Padova,https://doi.org/10.1515/cclm-2021-1071,15/03/2022,16/07/2022,Unverified
220315_Bari_UniversityofSiena,15-Mar-22,Regional,Italy,ITA,Bari,,15-Sep-19,31-Dec-19,Residual sera,Multiple groups,455,3.70%,,,Sequential,"Diesse,AESKU,NA",ELISA,"IgA,IgM,IgG",,,High,Journal Article (Peer-Reviewed),Claudia Maria Trombetta,University of Siena,https://dx.doi.org/10.1080/21645515.2022.2047582,21/03/2022,16/07/2022,Unverified
220228_Italy_FedericoIIUniversityOfNaples_ECLIA,28-Feb-22,Local,Italy,ITA,Naples,,15-May-20,09-Oct-20,Blood donors,Multiple groups,1100,1.00%,,,Self-referral,Roche Diagnostics,CLIA,IgG,,99.00%,Moderate,Journal Article (Peer-Reviewed),Giovanni Dell’Aversana Orabona,Federico II University of Naples,https://dx.doi.org/10.3855/jidc.15144,07/04/2022,16/07/2022,Unverified
220311_Lombardy_UniversitàdegliStudidiMilano_Overall,11-Mar-22,Regional,Italy,ITA,Lombardy,,04-May-20,16-Jun-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,358,18.44%,14.00%,23.20%,Convenience,Diagnostic Bioprobes,ELISA,"IgG,IgM,IgA",,,High,Journal Article (Peer-Reviewed),Ennio Favalli,Università degli Studi di Milano,https://dx.doi.org/10.3389/fmed.2022.850858,12/04/2022,16/07/2022,Unverified
220316_Cremona_ASSTCremona_Overall,16-Mar-22,Local,Italy,ITA,,Cremona,22-Apr-20,31-May-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,103,18.40%,,,Sequential,DiaSorin,CLIA,IgG,97.10%,88.90%,High,Journal Article (Peer-Reviewed),Clara Conti,ASST Cremona,https://dx.doi.org/10.4253/wjge.v14.i3.153,27/04/2022,16/07/2022,Unverified
220512_Milan_UniversityofMilan,12-May-22,Regional,Italy,ITA,Milan,,16-Feb-22,28-Feb-22,Students and Daycares,Children and Youth (0-17 years),665,56.69%,,,Unclear,PerkinElmer,Not reported,IgG,,,Moderate,Journal Article (Peer-Reviewed),Alessandra Mari,University of Milan,https://dx.doi.org/10.1097/INF.0000000000003583,07/06/2022,16/07/2022,Unverified
220501_TorVergataUniversityHospital_UniversityofRome_Overall,01-May-22,Local,Italy,ITA,,Rome,15-Nov-20,15-Mar-21,Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),85,9.41%,,,Convenience,NA,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),M Mossa,Tor Vergata University of Rome,https://dx.doi.org/10.26355/eurrev_202205_28875,08/06/2022,16/07/2022,Unverified
220512_Milan_ MaggiorePoliclinicoHospital,12-May-22,Local,Italy,ITA,Lombardy,Milan,10-Aug-20,15-Feb-21,Patients seeking care for non-COVID-19 reasons,Multiple groups,302,20.53%,,,Convenience,NA,Other,"IgG,IgM",86.10%,98.90%,High,Journal Article (Peer-Reviewed),Mariana Siddi,Maggiore Policlinico Hospital,https://dx.doi.org/10.3390/pathogens11050572,10/06/2022,16/07/2022,Unverified
220602_Milan_UniversityVita-SaluteSanRaffaele,06-Jun-22,Local,Italy,ITA,Lombardy,Milan,15-Jan-21,15-Feb-21,Health care workers and caregivers,Adults (18-64 years),1172,8.12%,,,Unclear,Roche Diagnostics,CLIA,"IgG,IgM,IgA",,,High,Journal Article (Peer-Reviewed),Davide Ferrari,University Vita-Salute San Raffaele,https://dx.doi.org/10.1016/j.jim.2022.113293,20/06/2022,16/07/2022,Unverified
220627_EmiliaRomagnaRegion_UniversityOfModenaAndReggioEmilia_Overall,27-Jun-22,Regional,Italy,ITA,"Emilia-Romagna Region; including provinces of Modena, Reggio Emilia, Parma, Bologna, and other provinces.",,26-Sep-20,26-Mar-21,Multiple populations,Multiple groups,5128,11.31%,,,Self-referral,"Roche Diagnostics,Shanghai Kehua Bio-engineering (KHB) Co. Ltd",Multiple Types,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Stefania Paduano,University of Modena and Reggio Emilia,https://dx.doi.org/10.3390/ijerph19137882,04/07/2022,29/07/2022,Unverified
220630_Udine_UniversityofUdine,30-Jun-22,Local,Italy,ITA,Friuli Venezia Giulia region,Udine,01-Mar-20,31-Oct-20,Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),143,0.70%,,,Sequential,"Siemens,Shenzhen Yhlo Biotech Co. Ltd",CLIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Pierluigi Toniutto,University of Udine,https://dx.doi.org/10.1007/s12664-022-01241-8,07/07/2022,29/07/2022,Unverified
220630_Tuscany_UniversityofSiena,30-Jun-22,Regional,Italy,ITA,Tuscany,,28-Jan-20,31-Dec-20,Residual sera,Multiple groups,2480,3.15%,,,Sequential,"Diesse,NA",ELISA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Serena Marchi,University of Siena,https://dx.doi.org/10.3390/v14071441,21/07/2022,21/07/2022,Unverified
220614_Rome_HospitalPhysiotherapyInstitutes,14-Jun-22,Local,Italy,ITA,Lazio,Rome,15-Mar-20,15-Oct-21,Persons experiencing homelessness,Multiple groups,632,50.31%,,,Convenience,DiaSorin,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Aldo Morrone,Hospital Physiotherapy Institutes,https://dx.doi.org/10.3389/ijph.2022.1604851,25/07/2022,26/07/2022,Unverified
220622_Lombardy_VittoreBuzziChildren'sHospital,22-Jun-22,Regional,Italy,ITA,Lombardy,,15-Jan-21,15-May-21,Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),29,17.20%,,,Convenience,NA,Not reported,Not reported,,,High,Presentation or Conference,L. Gianolio,Vittore Buzzi Children's Hospital,https://dx.doi.org/10.1097/MPG.0000000000003446,03/08/2022,03/08/2022,Unverified
220811_Veneto_UniversityHospitalOfPadova_2020Aug_Overall,11-Aug-22,Regional,Italy,ITA,Veneto,,,15-Aug-20,Residual sera,Multiple groups,84,0.00%,,,Sequential,NA,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),Chiara Sabbadin,University-Hospital of Padova,https://dx.doi.org/10.2174/1871530322666220811103755,22/08/2022,22/08/2022,Unverified
220811_Veneto_UniversityHospitalOfPadova_2021MarApr_Overall,11-Aug-22,Regional,Italy,ITA,Veneto,,15-Mar-21,15-Apr-21,Residual sera,Multiple groups,84,9.52%,,,Sequential,NA,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),Chiara Sabbadin,University-Hospital of Padova,https://dx.doi.org/10.2174/1871530322666220811103755,22/08/2022,22/08/2022,Unverified
200601_Israel_PandemicTaskForce_GenPop,02-Jun-20,National,Israel,ISR,Israel,,,02-Jun-20,Household and community samples,Multiple groups,1700,2.50%,,,Stratified probability,NA,Not reported,IgG,,,Moderate,News and Media,Michael Bachner,Israeli Pandemic Task Force,https://www.google.com/url?rct=j&sa=t&url=https://www.timesofisrael.com/initial-antibody-tests-indicate-200000-israelis-have-had-covid-19-report/&ct=ga&cd=CAAYBjIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNHYeXqD2hIEiNnZoH5qLiVlZKxQjg,03/06/2020,16/07/2022,Verified
201008_BneiBrak_CentralBureauofStatistics_primary,08-Oct-20,Local,Israel,ISR,,Bnei Brak,15-Jun-20,15-Aug-20,Household and community samples,Multiple groups,3500,14.60%,,,Stratified probability,NA,Not reported,Not reported,,,Moderate,News and Media,Aaron Rabinowitz,The Central Bureau of Statistics ,https://www.haaretz.com/israel-news/.premium-antibody-tests-30-percent-of-bnei-brak-residents-have-been-infected-with-covid-1.9217689,23/04/2021,16/07/2022,Verified
210421_Israel_MinistryofHealth_genpop_primary,21-Apr-21,National,Israel,ISR,,,28-Jun-20,14-Sep-20,Household and community samples,Multiple groups,54357,4.60%,4.40%,4.80%,Convenience,"Abbott Laboratories,DiaSorin",ELISA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Shay Reicher,Ministry of Health,https://dx.doi.org/10.1007/s10654-021-00749-1,20/05/2021,16/07/2022,Verified
210412_TelAviv_TelAvivUniversity,12-Apr-21,Local,Israel,ISR,,Tel Aviv,01-May-20,31-May-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,242,2.07%,,,Sequential,EUROIMMUN,ELISA,"IgG,IgA",100.00%,98.50%,High,Journal Article (Peer-Reviewed),Tali Eviatar ,Tel Aviv University,https://dx.doi.org/10.1111/imj.15202,22/05/2021,16/07/2022,Verified
210416_Safed_ZivMedicalCentre_overall_unadj,16-Apr-21,Local,Israel,ISR,,Safed,15-Dec-20,15-Mar-21,Health care workers and caregivers,Adults (18-64 years),725,3.45%,,,Convenience,"Abbott Laboratories,DiaSorin",Not reported,IgG,,,High,Preprint,Kamal Abu Jabal,Ziv Medical Centre,10.1101/2021.04.11.21255273,22/05/2021,16/07/2022,Verified
210624_Modiin_IsraelMinistryOfHealth_Primary,24-Jun-21,Local,Israel,ISR,,Modiin,01-Sep-20,30-Sep-20,Household and community samples,Multiple groups,283,16.61%,,,Convenience,"Abbott Laboratories,DiaSorin,NA",Multiple Types,IgG,,,High,Journal Article (Peer-Reviewed),Yael Gozlan,Israel Ministry of Health,http://dx.doi.org/10.1017/S0950268821001369,14/07/2021,16/07/2022,Verified
210624_Israel_TelAvivUniversity_overall,24-Jun-21,National,Israel,ISR,,,15-Apr-20,15-May-20,Health care workers and caregivers,Adults (18-64 years),874,1.10%,0.60%,2.10%,Convenience,"EUROIMMUN,Roche Diagnostics",Multiple Types,"IgG,Total Antibody",,,Moderate,Journal Article (Peer-Reviewed),Khitam Muhsen,Tel Aviv University,https://dx.doi.org/10.3389/fmed.2021.689994,20/07/2021,16/07/2022,Verified
210715_Israel_ShaareZedekMedicalCenter_Primary,15-Jul-21,Local,Israel,ISR,,Jerusalem,18-Oct-20,12-Jan-21,Residual sera,Children and Youth (0-17 years),1138,10.00%,,,Convenience,"Abbott Laboratories,DiaSorin",CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Adin Breuer,Shaare Zedek Medical Center,http://dx.doi.org/10.1111/apa.16031,03/08/2021,16/07/2022,Verified
210924_BneiBrak_MayaneiHayeshuaMedicalCenter_primary,24-Sep-21,Local,Israel,ISR,Tel Aviv District,Bnei Brak,28-Feb-21,08-Mar-21,Pregnant or parturient women,Adults (18-64 years),21,0.00%,,,Convenience,Roche Diagnostics,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),Lior Kashani-Ligumsky,Mayanei Hayeshua Medical Center,https://dx.doi.org/10.1038/s41372-021-01216-1,06/10/2021,16/07/2022,Unverified
211006_Israel_IsraelInstituteforBiologicalResearch,06-Oct-21,National,Israel,ISR,,,24-Apr-20,24-Apr-20,Household and community samples,Multiple groups,146,0.00%,,,Convenience,NA,Not reported,IgG,98.20%,100.00%,Unclear,Journal Article (Peer-Reviewed),Morly Fisher,Israel Institute for Biological Research,https://dx.doi.org/10.1128/Spectrum.00870-21,12/10/2021,16/07/2022,Verified
211015_Jerusalem_ShaareZedekMedicalCenter,15-Oct-21,Local,Israel,ISR,Jerusalem District,Jerusalem,01-Dec-20,15-Feb-21,Patients seeking care for non-COVID-19 reasons,Multiple groups,249,18.07%,,,Entire sample,"Abbott Laboratories,DiaSorin",CLIA,IgG,,,Low,Journal Article (Peer-Reviewed),Jenny Weinbrand-Goichberg,Shaare Zedek Medical Centre (SZMC),https://dx.doi.org/10.1007/s40620-021-01171-2,25/10/2021,16/07/2022,Unverified
211001_Israel_MaccabiHealthcareServices_Overall_TestAdjusted,01-Oct-21,National,Israel,ISR,,,28-Jun-20,27-Jul-20,Residual sera,Multiple groups,15459,1.91%,,,Convenience,"Abbott Laboratories,DiaSorin",CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Anat Ekka Zohar,Maccabi Healthcare Services,https://www.ima.org.il/MedicineIMAJ/viewarticle.aspx?year=2021&month=10&page=611,30/11/2021,16/07/2022,Verified
211202_Israel_Tel-AvivUniversity,02-Dec-21,Local,Israel,ISR,Tel Aviv District,Ramat Gan,04-Apr-20,13-Jul-20,Health care workers and caregivers,Adults (18-64 years),428,0.70%,0.24%,2.00%,Self-referral,EUROIMMUN,ELISA,IgG,81.80%,98.00%,High,Journal Article (Peer-Reviewed),Yaniv Lustig,Tel-Aviv University,https://dx.doi.org/10.2807/1560-7917.ES.2021.26.48.2001690,14/12/2021,16/07/2022,Unverified
211202_Israel_TelAvivUniversity_Overall,02-Dec-21,National,Israel,ISR,,,01-Jan-20,31-Mar-21,Residual sera,Children and Youth (0-17 years),2765,5.64%,4.80%,6.60%,Convenience,NA,Multiple Types,"IgG,Neutralizing ",,,Moderate,Journal Article (Peer-Reviewed),Victoria Indenbaum,Tel Aviv University,https://dx.doi.org/10.2807/1560-7917.ES.2021.26.48.2101040,15/12/2021,16/07/2022,Verified
220426_NorthernIsrael_RambamHealthCareCampus_Overall,26-Apr-22,Regional,Israel,ISR,Northern Israel,,15-Nov-20,30-Nov-20,Health care workers and caregivers,Adults (18-64 years),4519,4.60%,,,Convenience,"NA,DiaSorin",CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Khetam Hussein,Rambam Health Care Campus,https://dx.doi.org/10.5041/RMMJ.10469,05/05/2022,16/07/2022,Unverified
220524_EmekMedicalCenter_EmekMedicalCenter_Overall,24-May-22,Local,Israel,ISR,Northern District,Afula,01-Apr-20,15-Apr-21,Health care workers and caregivers,Adults (18-64 years),101,9.90%,,,Convenience,"Abbott Laboratories,DiaSorin",Not reported,IgG,,,High,Journal Article (Peer-Reviewed),Carmel Kasher,Emek Medical Center,https://www.ima.org.il/MedicineIMAJ/viewarticle.aspx?year=2022&month=05&page=284,04/06/2022,16/07/2022,Unverified
210907_TelAviv_TelAvivUniversity_Overall,07-Sep-21,Local,Israel,ISR,,Tel Aviv,15-Sep-20,15-Mar-21,Patients seeking care for non-COVID-19 reasons,Multiple groups,572,5.24%,,,Sequential,"Abbott Laboratories,DiaSorin",CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Tali Eviatar,Tel Aviv University,https://dx.doi.org/10.55563/clinexprheumatol/ykin5p,24/07/2022,29/07/2022,Unverified
220716_Israel_ BaruchPadehMedicalCenter_Overall,16-Jul-22,Local,Israel,ISR,North District,"Tiberias, Afula",14-Jul-20,03-Feb-21,Multiple populations,Adults (18-64 years),297,3.40%,,,Convenience,"Abbott Laboratories,DiaSorin",Multiple Types,IgG,,,High,Journal Article (Peer-Reviewed),Enav Yefet,Emek Medical Centre,https://dx.doi.org/10.1002/ijgo.14359,28/07/2022,29/07/2022,Unverified
210212_Dublin_RotundaHospital,12-Feb-21,Local,Ireland,IRL,Leinster,Dublin,12-May-20,31-Jul-20,Health care workers and caregivers,Adults (18-64 years),51,4.00%,,,Convenience,Trinity Biotech,ELISA,IgG,95.92%,100.00%,High,Preprint,Joanna Griffin,Rotunda Hospital,https://www.medrxiv.org/content/10.1101/2021.02.10.20248323v1.full-text,26/03/2021,16/07/2022,Verified
210602_Dublin_UniversityCollegeDublin_overall_Unadj,02-Jun-21,Local,Ireland,IRL,Leinster,Dublin,15-Jun-20,15-Sep-20,Multiple populations,Adults (18-64 years),109,0.92%,,,Unclear,"EUROIMMUN,Fortress Diagnostics,DIAsource,Roche Diagnostics",Multiple Types,"IgG,Total Antibody",,,High,Journal Article (Peer-Reviewed),Emma Heffernan,University College Dublin,https://dx.doi.org/10.1177/00045632211012728,22/05/2021,16/07/2022,Verified
210518_Mid-WestIreland_UniversityofLimerick_Staff1,18-May-21,Regional,Ireland,IRL,Munster,,15-Jun-20,10-Jul-20,Health care workers and caregivers,Multiple groups,172,11.10%,4.00%,19.00%,Convenience,Maccura Biotechnology Ltd,LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Michael Edmund O'Callaghan,University of Limerick,https://dx.doi.org/10.3399/BJGPO.2021.0038,01/06/2021,16/07/2022,Unverified
210518_Mid-WestIreland_UniversityofLimerick_Patients2,18-May-21,Regional,Ireland,IRL,Munster,,15-Jun-20,10-Jul-20,Health care workers and caregivers,Multiple groups,799,12.60%,8.00%,17.00%,Convenience,Maccura Biotechnology Ltd,LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Michael Edmund O'Callaghan,University of Limerick,https://dx.doi.org/10.3399/BJGPO.2021.0038,02/06/2021,16/07/2022,Unverified
210526_Ireland_TrinityCollege,26-May-21,Regional,Ireland,IRL,,,01-Oct-20,31-Oct-20,Health care workers and caregivers,Adults (18-64 years),5787,9.50%,,,Convenience,Roche Diagnostics,CLIA,Total Antibody,100.00%,99.80%,Moderate,Journal Article (Peer-Reviewed),Niamh Allen,"Trinity College, University of Dublin",https://europepmc.org/article/PPR/PPR347943,07/06/2021,16/07/2022,Unverified
210608_SouthWestOfIreland_CorkUniversityHospital,08-Jun-21,Regional,Ireland,IRL,Munster,Cork,27-May-20,07-Jul-20,Health care workers and caregivers,Adults (18-64 years),404,1.49%,,,Convenience,Abbott Laboratories,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Eamonn Faller,Cork University Hospital,http://dx.doi.org/10.1136/bmjopen-2021-051415,30/06/2021,16/07/2022,Unverified
210630_Dublin_TrinityCollegeDublin_Overall,30-Jun-21,Local,Ireland,IRL,,Dublin,15-Jul-20,15-Oct-20,Health care workers and caregivers,Adults (18-64 years),1176,17.90%,,,Convenience,Roche Diagnostics,CLIA,Total Antibody,86.10%,100.00%,High,Journal Article (Peer-Reviewed),Ann Leonard,Trinity College Dublin,https://dx.doi.org/10.1007/s11845-021-02690-4,05/07/2021,16/07/2022,Verified
210707_Dublin_StJames'sHospital,07-Jul-21,Local,Ireland,IRL,Leinster,Dublin,01-Apr-20,30-Apr-20,Health care workers and caregivers,Adults (18-64 years),49,29.00%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Colm Kerr,St. James’s Hospital,https://dx.doi.org/10.1007/s11845-021-02700-5,14/07/2021,16/07/2022,Unverified
210709_Dublin_HSENationalDrugTreatmentCentre_overall,09-Jul-21,Local,Ireland,IRL,,Dublin,15-Jul-20,15-Oct-20,Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),103,1.90%,,,Convenience,"Abbott Laboratories,DiaSorin,Fortress",Multiple Types,"IgG,Total Antibody",,,High,Journal Article (Peer-Reviewed),Fiona Fenton,HSE National Drug Treatment Centre,https://dx.doi.org/10.1007/s11845-021-02660-w,18/07/2021,16/07/2022,Unverified
210826_Dublin_MaterMisericordiaeUniversityHospital,26-Aug-21,Local,Ireland,IRL,,Dublin,24-Jun-20,06-Jul-20,Multiple populations,Multiple groups,157,6.40%,,,Unclear,"Superbio Biomedical Company ,Abbott Laboratories,Roche Diagnostics",Neutralization,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Brendan O'Kelly,Mater Misericordiae University Hospital,https://dx.doi.org/10.3389/fmed.2021.642318,24/09/2021,16/07/2022,Unverified
210824_Ireland_UniversityofLimerick_HCW_TestAdjusted,24-Aug-21,Regional,Ireland,IRL,Midwest Region,,15-Jun-20,10-Jul-20,Health care workers and caregivers,Adults (18-64 years),171,11.10%,4.20%,18.60%,Stratified non-probability,Maccura Biotechnology Ltd,LFIA,IgG,71.00%,98.00%,Moderate,Journal Article (Peer-Reviewed),Michael O'Callaghan,University of Limerick,http://dx.doi.org/10.3399/BJGPO.2021.0038,20/10/2021,16/07/2022,Verified
210824_Ireland_UniversityofLimerick_Patients_TestAdjusted,24-Aug-21,Regional,Ireland,IRL,Midwest Region,,15-Jun-20,10-Jul-20,Residual sera,Multiple groups,796,12.60%,7.50%,16.60%,Stratified non-probability,Maccura Biotechnology Ltd,LFIA,IgG,71.00%,98.00%,Moderate,Journal Article (Peer-Reviewed),Michael O'Callaghan,University of Limerick,http://dx.doi.org/10.3399/BJGPO.2021.0038,20/10/2021,16/07/2022,Verified
211125_Ireland_IrishBloodTransfusionService_Primary,25-Nov-21,National,Ireland,IRL,,,15-Feb-20,15-Sep-20,Blood donors,Multiple groups,8509,2.41%,2.09%,2.76%,Simplified probability,"Abbott Laboratories,NA,Fortress",Multiple Types,"IgG,IgM,Total Antibody",,,Moderate,Journal Article (Peer-Reviewed),Dearbhla Butler,Irish Blood Transfusion Service,https://dx.doi.org/10.1016/j.jcv.2021.105045,13/12/2021,16/07/2022,Unverified
211115_Ireland_RoyalCollegeofSurgeonsinIreland,15-Nov-21,National,Ireland,IRL,,,15-Mar-20,15-May-20,Perinatal,Children and Youth (0-17 years),200,1.50%,,,Unclear,NA,Not reported,Not reported,,,Unclear,Journal Article (Peer-Reviewed),Marguerite Lawler,Royal College of Surgeons in Ireland,http://dx.doi.org/10.1111/all.15095,13/12/2021,16/07/2022,Unverified
211202_Ireland_HealthProtectionSurveillanceCentre_Dublin_OverallWeighted,02-Dec-21,Local,Ireland,IRL,,,22-Jun-20,16-Jul-20,Household and community samples,Multiple groups,913,3.12%,2.05%,4.53%,Simplified probability,"Abbott Laboratories,Beijing Wantai Biological",Multiple Types,"IgG,Total Antibody",,,Moderate,Journal Article (Peer-Reviewed),Laura Heavey,Health Protection Surveillance Centre,https://dx.doi.org/10.2807/1560-7917.ES.2021.26.48.2001741,15/12/2021,16/07/2022,Verified
211202_Ireland_HealthProtectionSurveillanceCentre_Sligo_OverallWeighted,02-Dec-21,Local,Ireland,IRL,,,22-Jun-20,16-Jul-20,Household and community samples,Multiple groups,820,0.58%,0.18%,1.38%,Simplified probability,"Abbott Laboratories,Beijing Wantai Biological",Multiple Types,"IgG,Total Antibody",,,Moderate,Journal Article (Peer-Reviewed),Laura Heavey,Health Protection Surveillance Centre,https://dx.doi.org/10.2807/1560-7917.ES.2021.26.48.2001741,15/12/2021,16/07/2022,Verified
220204_Ireland_UniversityHospitalGalway_Overall_TestAdj,04-Feb-22,Regional,Ireland,IRL,"Leinster, Connacht","Dublin, Galway",19-Apr-21,28-Apr-21,Health care workers and caregivers,Adults (18-64 years),5085,18.00%,17.00%,19.00%,Convenience,Roche Diagnostics,CLIA,Total Antibody,,,Moderate,Journal Article (Peer-Reviewed),Niamh Allen,University Hospital Galway,https://dx.doi.org/10.3389/fmed.2021.758118,07/03/2022,16/07/2022,Unverified
220414_Ireland_HealthProtectionSurveillanceCentre_AntiS_Adj,14-Apr-22,Local,Ireland,IRL,,"Dublin, Cork",17-Oct-21,14-Jan-22,Blood donors,Multiple groups,5226,98.40%,98.00%,99.00%,Sequential,Abbott Laboratories,Not reported,IgG,98.70%,99.60%,Moderate,Institutional Report,Health Protection Surveillance Centre,Health Protection Surveillance Centre,https://www.hpsc.ie/a-z/nationalserosurveillanceprogramme/reports/SEU%20IBTS%2012%20week%20surveillance%20report.pdf,25/07/2022,25/07/2022,Unverified
220603_Ireland_HealthProtectionSurveillanceCentre_Children_antiS_Adj,03-Jun-22,Local,Ireland,IRL,,Dublin,30-Jan-22,18-Feb-22,Residual sera,Children and Youth (0-17 years),170,38.40%,31.30%,46.00%,Convenience,Abbott Laboratories,Not reported,IgG,98.75%,99.55%,Moderate,Institutional Report,Health Protection Surveillance Centre,"emergency department, medical outpatient clinics, general practice phlebotomy, and urgent care centres in Dublin",https://www.hpsc.ie/a-z/nationalserosurveillanceprogramme/reports/NSP%20combined%20adult%20paeds%20cycle%201%20report_final.pdf,25/07/2022,29/07/2022,Unverified
220603_Ireland_HealthProtectionSurveillanceCentre_Adult_antiS_Adj,03-Jun-22,National,Ireland,IRL,,,30-Jan-22,19-Feb-22,Residual sera,Multiple groups,1410,96.50%,95.20%,97.50%,Convenience,Abbott Laboratories,Not reported,IgG,98.75%,99.55%,,Institutional Report,Health Protection Surveillance Centre,seven clinical chemistry laboratories throughout Ireland,https://www.hpsc.ie/a-z/nationalserosurveillanceprogramme/reports/NSP%20combined%20adult%20paeds%20cycle%201%20report_final.pdf,25/07/2022,25/07/2022,Unverified
210326_Duhok_UniversityOfDuhok_Overall,26-Mar-21,Local,Iraq,IRQ,,Duhok,10-Jan-21,30-Jan-21,Household and community samples,Multiple groups,743,62.58%,,,Stratified probability,Roche Diagnostics,CLIA,IgG,,,Moderate,Preprint,Nawfal Hussein,University of Duhok,10.1101/2021.03.23.21254169,09/04/2021,16/07/2022,Verified
220411_Babylon_UniversityofBabylon_IgG,11-Apr-22,Regional,Iraq,IRQ,Babylon Province,,15-Jan-21,22-Mar-21,Residual sera,Multiple groups,553,37.79%,,,Unclear,Biozek,LFIA,IgG,,,High,Journal Article (Peer-Reviewed),Dalia Al-Saray,Department of Clinical Laboratory Sciences,https://dx.doi.org/10.3889/oamjms.2022.9372,14/06/2022,16/07/2022,Unverified
220728_Zakho_GeneralDirectorateofDuhokEducation_Overall,28-Jul-22,Local,Iraq,IRQ,Duhok,Zakho,15-Jul-20,15-Sep-20,Residual sera,Multiple groups,489,26.58%,,,Convenience,BioMérieux,IFA,IgG,,,High,Journal Article (Peer-Reviewed),Ali Saeed,General Directorate of Duhok Education,https://dx.doi.org/10.3855/jidc.15825,09/08/2022,09/08/2022,Unverified
200915_Tehran_IranUniversityOfMedicalSciences_Patients_Overall,01-Sep-20,Local,Iran (Islamic Republic of),IRN,Tehran,Tehran,20-Feb-20,20-Mar-20,Multiple populations,Multiple groups,178,17.98%,,,Convenience,Pishtaz Diagnostics Iran,ELISA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Shahrzad Ossareh,Iran University of Medical Sciences,http://www.ijkd.org/index.php/ijkd/article/view/5832/1205,30/10/2020,16/07/2022,Verified
201221_Guilan_TehranUniversityofMedicalSciences_overall,21-Dec-20,Regional,Iran (Islamic Republic of),IRN,Guilan,,11-Apr-20,19-Apr-20,Household and community samples,Multiple groups,528,22.20%,16.40%,28.50%,Stratified probability,VivaChek Biotech (Hangzhou) Co. Ltd,LFIA,"IgG,IgM",83.30%,99.00%,Moderate,Journal Article (Peer-Reviewed),Maryam Shakiba,Tehran University of Medical Sciences,https://dx.doi.org/10.3201/eid2702.201960,23/01/2021,16/07/2022,Verified
201110_Tehran_TehranUniversityofMedicalSciences_unadj,10-Nov-20,Local,Iran (Islamic Republic of),IRN,Tehran,Tehran,20-Mar-20,20-May-20,Essential non-healthcare workers,Adults (18-64 years),243,41.56%,,,Convenience,Karma Azma Andish Co.,LFIA,"IgM,IgG",71.10%,58.70%,High,Journal Article (Peer-Reviewed),Peyman Saberian,Tehran University of Medical Sciences,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7720855/,23/01/2021,16/07/2022,Verified
201206_Tehran_HighInstituteforResearchandEducationinTransfusionMedicine,06-Dec-20,Local,Iran (Islamic Republic of),IRN,Tehran,Tehran,20-Apr-20,05-May-20,Health care workers and caregivers,Adults (18-64 years),475,29.40%,,,Convenience,Hanghzhou AllTest Biotech Co. Ltd,LFIA,"IgG,IgM",99.90%,98.00%,High,Journal Article (Peer-Reviewed),Shahnaz Armin,High Institute for Research and Education in Transfusion Medicine,https://sites.kowsarpub.com/jjm/articles/108592.html,27/01/2021,16/07/2022,Verified
201223_RafsanjanCounty_UniversityofPecs,23-Dec-20,Local,Iran (Islamic Republic of),IRN,Kerman,,01-Mar-20,30-Apr-20,Contacts of COVID patients,Multiple groups,238,15.55%,,,Sequential,NA,Not reported,"IgG,IgM",,,High,Preprint,Reza Vazirinejad,University of Pecs,https://europepmc.org/article/ppr/ppr257302#fulltext--permissions-,02/02/2021,16/07/2022,Verified
201215_Iran_TehranUniversityofMedicalSciences_GenPop1_overall_PopTestAdj,15-Dec-20,National,Iran (Islamic Republic of),IRN,,"Ahvaz, Ardabil, Babol , Esfahan , Gorgan, Hamedan, Kerman, Kermanshah, Mashhad, Qom, Rasht, Sanandaj, Sari, Shiraz, Tabriz, Tehran, Urmia, Zahedan",17-Apr-20,02-Jun-20,Household and community samples,Multiple groups,3530,17.10%,14.60%,19.50%,Stratified probability,Pishtaz Diagnostics Iran,ELISA,"IgG,IgM",66.90%,98.20%,Low,Journal Article (Peer-Reviewed),Hossein Poustchi,Tehran University of Medical Sciences,http://dx.doi.org/10.1016/S1473-3099%2820%2930858-6,06/02/2021,16/07/2022,Verified
201215_Iran_TehranUniversityofMedicalSciences_HighRisk2_overall_PopTestAdj ,15-Dec-20,National,Iran (Islamic Republic of),IRN,,"Ahvaz, Ardabil, Babol , Esfahan , Gorgan, Hamedan, Kerman, Kermanshah, Mashhad, Qom, Rasht, Sanandaj, Sari, Shiraz, Tabriz, Tehran, Urmia, Zahedan",17-Apr-20,02-Jun-20,Multiple populations,Multiple groups,5372,20.00%,18.50%,21.70%,Stratified probability,Pishtaz Diagnostics Iran,ELISA,"IgG,IgM",66.90%,98.20%,Moderate,Journal Article (Peer-Reviewed),Hossein Poustchi,Tehran University of Medical Sciences,http://dx.doi.org/10.1016/S1473-3099%2820%2930858-6,06/02/2021,16/07/2022,Verified
2101_Zahedan_TehranUniversityofMedicalSciences,01-Jan-21,Local,Iran (Islamic Republic of),IRN,Sistan and Balouchestan,Zahedan,01-Jul-20,31-Jul-20,Persons experiencing homelessness,Adults (18-64 years),167,9.70%,,,Convenience,Pishtaz Diagnostics Iran,ELISA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Zahra Mohammadi,Tehran University of Medical Sciences,http://dx.doi.org/10.34172/mejdd.2021.206a,14/03/2021,16/07/2022,Verified
2101_Zahedan_TehranUniversityofMedicalSciences_NonDrugUsers,01-Jan-21,Local,Iran (Islamic Republic of),IRN,Sistan and Balouchestan,Zahedan,01-Jul-20,31-Jul-20,Household and community samples,Adults (18-64 years),134,4.80%,,,Simplified probability,Pishtaz Diagnostics Iran,ELISA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Zahra Mohammadi,Tehran University of Medical Sciences,http://dx.doi.org/10.34172/mejdd.2021.206a,14/03/2021,16/07/2022,Verified
210105_Mazandaran_MazandaranUniversityofMedicalSciences_OverallPopAdj,05-Jan-21,Regional,Iran (Islamic Republic of),IRN,Mazandaran,,15-Mar-20,15-May-20,Household and community samples,Multiple groups,1588,17.29%,14.84%,17.79%,Stratified probability,Pishtaz Diagnostics Iran,ELISA,"IgG,IgM",59.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Seyed Abbas Mousavi,Mazandaran University of Medical Sciences,https://www.apjtm.org/article.asp?issn=1995-7645;year=2021;volume=14;issue=1;spage=10;epage=16;aulast=Mousavi,17/03/2021,16/07/2022,Verified
210217_Shiraz_ShirazUniversityOfMedicalSciences_Overall,17-Feb-21,Local,Iran (Islamic Republic of),IRN,Fars,Shiraz City,13-Jul-20,05-Aug-20,Health care workers and caregivers,Multiple groups,494,5.90%,,,Convenience,Pishtaz Diagnostics Iran,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Kamran Bagheri Lankarani,Shiraz University of Medical Sciences,http://dx.doi.org/10.5812/semj.112681 ,16/04/2021,16/07/2022,Verified
210301_Tehran_ShahidBeheshtiUniversityOfMedicalSciences_IgG,01-Mar-21,Local,Iran (Islamic Republic of),IRN,Tehran Province,Tehran,04-Apr-20,06-Apr-20,Multiple general populations,Multiple groups,2021,14.40%,,,Unclear,NA,ELISA,IgG,,,Unclear,Journal Article (Peer-Reviewed),Sahar Mortezagholi,Shahid Beheshti University Of Medical Sciences,https://dx.doi.org/10.22034/iji.2021.88168.1851,27/04/2021,16/07/2022,Unverified
210413_Tabriz_TabrizUniversityOfMedicalSciences_overall_unadj_IgG_anti-S,13-Apr-21,Local,Iran (Islamic Republic of),IRN,,Tabriz,15-Apr-20,15-Jun-20,Health care workers and caregivers,Adults (18-64 years),609,6.07%,,,Unclear,NA,ELISA,"IgG,IgM",93.75%,98.00%,Moderate,Journal Article (Peer-Reviewed),Mohammad Sadegh Soltani Zangbar,Tabriz University of Medical Sciences,https://dx.doi.org/10.1016/j.genrep.2021.101140,19/05/2021,16/07/2022,Verified
210323_Tabriz_TabrizUniversityofMedicalSciences,23-Mar-21,Local,Iran (Islamic Republic of),IRN,East Azerbaijan Province,Tabriz,01-Jun-20,30-Jun-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,288,10.10%,,,Sequential,NA,ELISA,"IgG,IgM",93.00%,98.00%,High,Journal Article (Peer-Reviewed),Jalal Etemadi,Tabriz University of Medical Sciences,https://dx.doi.org/10.1080/08820139.2021.1899202,21/05/2021,16/07/2022,Verified
210420_Iran_TehranUniversityOfMedicalSciences,20-Apr-21,National,Iran (Islamic Republic of),IRN,,,15-Sep-20,15-Oct-20,Non-essential workers and unemployed persons,Adults (18-64 years),1243,17.90%,15.80%,20.10%,Entire sample,Pishtaz Diagnostics Iran,ELISA,"IgG,IgM",79.40%,97.30%,Moderate,Journal Article (Peer-Reviewed),Bahar Hassanmirzaei,Tehran University of Medical Sciences,https://dx.doi.org/10.1136/postgradmedj-2021-140176,27/05/2021,16/07/2022,Verified
210605_Tehran_ShahidBeheshtiUniversityOfMedicalSciences_Overall,05-Jun-21,Local,Iran (Islamic Republic of),IRN,Tehran,Tehran,15-Jun-20,15-Jul-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,168,17.26%,,,Convenience,Pishtaz Diagnostics Iran,ELISA,"IgG,IgM",100.00%,,High,Journal Article (Peer-Reviewed),Maliheh Arab,Shahid Beheshti University of Medical Sciences,https://dx.doi.org/10.31557/APJCP.2021.22.6.1667,06/07/2021,16/07/2022,Unverified
210607_Iran_TehranUniversityofMedicalSciences_Primary,07-Jun-21,National,Iran (Islamic Republic of),IRN,,,03-Aug-20,31-Oct-20,Household and community samples,Multiple groups,11256,14.20%,13.30%,15.20%,Stratified probability,Pishtaz Diagnostics Iran,ELISA,IgG,74.00%,98.00%,Low,Journal Article (Peer-Reviewed),Kazem Khalagi ,Tehran University of Medical Sciences,http://dx.doi.org/10.1016/j.cmi.2021.06.002,07/07/2021,16/07/2022,Verified
210714_Iran_TarbiatModaresUniversity_primary,14-Jul-21,National,Iran (Islamic Republic of),IRN,,"Tehran, Mashhad",30-May-20,17-Jun-20,Multiple populations,Multiple groups,716,17.30%,8.80%,25.80%,Unclear,Pishtaz Diagnostics Iran,ELISA,IgG,94.10%,98.30%,High,Preprint,Nazila Hajiahmadi,Tarbiat Modares University,10.1101/2021.07.11.21260336,20/07/2021,16/07/2022,Unverified
210816_Iran_HighInstituteForResearchEducationInTransfusionMedicine_Primary,21-Aug-21,National,Iran (Islamic Republic of),IRN,,,18-May-20,27-May-20,Blood donors,Multiple groups,1339,12.09%,10.34%,13.84%,Stratified non-probability,Hanghzhou AllTest Biotech Co. Ltd,LFIA,"IgM,IgG",85.00%,100.00%,Moderate,Preprint,Ali Arabkhazaeli,High Institute for Research and Education in Transfusion Medicine ,https://dx.doi.org/10.1016/j.tracli.2021.08.008,30/08/2021,16/07/2022,Verified
210827_Birjand_BirjandUniversityOfMedicalSciences,27-Aug-21,Local,Iran (Islamic Republic of),IRN,South Khorasan Province,Birjand,15-Jul-20,15-Aug-20,Health care workers and caregivers,Adults (18-64 years),137,5.10%,,,Convenience,Pishtaz Diagnostics Iran,ELISA,"IgG,IgM",94.10%,98.30%,High,Journal Article (Peer-Reviewed),Malihe Zangoue,Birjand University Of MedicalSciences,https://dx.doi.org/10.3233/WOR-210634,31/08/2021,16/07/2022,Verified
210930_Tehran_TehranUniversityofMedicalSciences_2020-05_to_2020-06_Overall,30-Sep-21,Local,Iran (Islamic Republic of),IRN,Tehran,Tehran,01-May-20,30-Jun-20,Household and community samples,Multiple groups,573,9.77%,,,Unclear,Pishtaz Diagnostics Iran,ELISA,IgG,94.10%,98.30%,High,Journal Article (Peer-Reviewed),Zahra Heydarifard,Tehran University of Medical Sciences,https://dx.doi.org/10.1007/s12250-021-00446-z,05/10/2021,16/07/2022,Verified
210930_Tehran_TehranUniversityofMedicalSciences_2020-07_to_2020-08_Overall,30-Sep-21,Local,Iran (Islamic Republic of),IRN,Tehran,Tehran,01-Jul-20,31-Aug-20,Household and community samples,Multiple groups,1221,20.39%,,,Unclear,Pishtaz Diagnostics Iran,ELISA,IgG,94.10%,98.30%,High,Journal Article (Peer-Reviewed),Zahra Heydarifard,Tehran University of Medical Sciences,https://dx.doi.org/10.1007/s12250-021-00446-z,05/10/2021,16/07/2022,Verified
210930_Tehran_TehranUniversityofMedicalSciences_2020-09_to_2020-10_Overall,30-Sep-21,Local,Iran (Islamic Republic of),IRN,Tehran,Tehran,01-Sep-20,31-Oct-20,Household and community samples,Multiple groups,1387,33.67%,,,Unclear,Pishtaz Diagnostics Iran,ELISA,IgG,94.10%,98.30%,High,Journal Article (Peer-Reviewed),Zahra Heydarifard,Tehran University of Medical Sciences,https://dx.doi.org/10.1007/s12250-021-00446-z,05/10/2021,16/07/2022,Verified
210930_Tehran_TehranUniversityofMedicalSciences_2020-11_to_2020-12_Overall,30-Sep-21,Local,Iran (Islamic Republic of),IRN,Tehran,Tehran,01-Nov-20,31-Dec-20,Household and community samples,Multiple groups,1074,45.81%,,,Unclear,Pishtaz Diagnostics Iran,ELISA,IgG,94.10%,98.30%,High,Journal Article (Peer-Reviewed),Zahra Heydarifard,Tehran University of Medical Sciences,https://dx.doi.org/10.1007/s12250-021-00446-z,05/10/2021,16/07/2022,Verified
210930_Tehran_TehranUniversityofMedicalSciences_2021-01_to_2021-02_Overall,30-Sep-21,Local,Iran (Islamic Republic of),IRN,Tehran,Tehran,01-Jan-21,28-Feb-21,Household and community samples,Multiple groups,294,36.05%,,,Unclear,Pishtaz Diagnostics Iran,ELISA,IgG,94.10%,98.30%,High,Journal Article (Peer-Reviewed),Zahra Heydarifard,Tehran University of Medical Sciences,https://dx.doi.org/10.1007/s12250-021-00446-z,05/10/2021,16/07/2022,Verified
210930_Tehran_TehranUniversityofMedicalSciences_2021-03_to_2021-04_Overall,30-Sep-21,Local,Iran (Islamic Republic of),IRN,Tehran,Tehran,01-Mar-21,30-Apr-21,Household and community samples,Multiple groups,367,25.07%,,,Unclear,Pishtaz Diagnostics Iran,ELISA,IgG,94.10%,98.30%,High,Journal Article (Peer-Reviewed),Zahra Heydarifard,Tehran University of Medical Sciences,https://dx.doi.org/10.1007/s12250-021-00446-z,05/10/2021,16/07/2022,Verified
211026_Iran_NeyshaburUniversityofMedicalSciences_Overall,26-Oct-21,National,Iran (Islamic Republic of),IRN,"Razavi Khorasan Province, Mazandaran Province","Neyshabur, Sabzevar, Babol",01-Apr-21,30-Jun-21,Patients seeking care for non-COVID-19 reasons,Multiple groups,270,29.30%,,,Sequential,Pishtaz Diagnostics Iran,ELISA,IgG,94.10%,98.30%,High,Journal Article (Peer-Reviewed),Seyed Alireza Javadinia,Neyshabur University of Medical Sciences,https://dx.doi.org/10.1080/07357907.2021.1995742,02/11/2021,16/07/2022,Unverified
211022_Guilan_GuilanUniversityofMedical Sciences,22-Oct-21,Local,Iran (Islamic Republic of),IRN,Guilan,Rasht,15-Apr-20,15-May-20,Health care workers and caregivers,Multiple groups,503,39.00%,34.80%,43.30%,Simplified probability,Pishtaz Diagnostics Iran,ELISA,"IgG,IgM",94.10%,,Low,Journal Article (Peer-Reviewed),Heydar Balou,Guilan University of Medical Sciences,https://dx.doi.org/10.1155/2021/9081491,02/11/2021,16/07/2022,Unverified
211202_Tehran_ImamHosseinHospital,02-Dec-21,Local,Iran (Islamic Republic of),IRN,Tehran,Tehran,01-Aug-20,30-Oct-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,107,14.02%,,,Convenience,Pishtaz Diagnostics Iran,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Ali Motlagh,Imam Hossein Hospital,https://dx.doi.org/10.1038/s41598-021-02692-3,14/12/2021,16/07/2022,Unverified
211007_WestOfIran_KurdistanUniversityOfMedicalSciences_Overall,07-Oct-21,Regional,Iran (Islamic Republic of),IRN,"Three provinces of Kurdistan, Kermanshah, and Hamedan.","Three cities of Sanandaj, Kermanshah, and Hamedan.",05-Nov-20,15-Nov-20,Essential non-healthcare workers,Multiple groups,1106,28.70%,,,Convenience,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Ghobad Moradi,Kurdistan University of Medical Sciences,http://jmums.mazums.ac.ir/article-1-16926-en.html,13/01/2022,16/07/2022,Unverified
211007_WestOfIran_KurdistanUniversityOfMedicalSciences_Male,07-Oct-21,Regional,Iran (Islamic Republic of),IRN,"Three provinces of Kurdistan, Kermanshah, and Hamedan.","Three cities of Sanandaj, Kermanshah, and Hamedan.",05-Nov-20,15-Nov-20,Essential non-healthcare workers,Multiple groups,823,27.80%,,,Convenience,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Ghobad Moradi,Kurdistan University of Medical Sciences,http://jmums.mazums.ac.ir/article-1-16926-en.html,13/01/2022,16/07/2022,Unverified
211007_WestOfIran_KurdistanUniversityOfMedicalSciences_Female,07-Oct-21,Regional,Iran (Islamic Republic of),IRN,"Three provinces of Kurdistan, Kermanshah, and Hamedan.","Three cities of Sanandaj, Kermanshah, and Hamedan.",05-Nov-20,15-Nov-20,Essential non-healthcare workers,Multiple groups,278,31.30%,,,Convenience,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Ghobad Moradi,Kurdistan University of Medical Sciences,http://jmums.mazums.ac.ir/article-1-16926-en.html,13/01/2022,16/07/2022,Unverified
211007_WestOfIran_KurdistanUniversityOfMedicalSciences_Married,07-Oct-21,Regional,Iran (Islamic Republic of),IRN,"Three provinces of Kurdistan, Kermanshah, and Hamedan.","Three cities of Sanandaj, Kermanshah, and Hamedan.",05-Nov-20,15-Nov-20,Essential non-healthcare workers,Multiple groups,883,28.20%,,,Convenience,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Ghobad Moradi,Kurdistan University of Medical Sciences,http://jmums.mazums.ac.ir/article-1-16926-en.html,13/01/2022,16/07/2022,Unverified
211007_WestOfIran_KurdistanUniversityOfMedicalSciences_Single,07-Oct-21,Regional,Iran (Islamic Republic of),IRN,"Three provinces of Kurdistan, Kermanshah, and Hamedan.","Three cities of Sanandaj, Kermanshah, and Hamedan.",05-Nov-20,15-Nov-20,Essential non-healthcare workers,Multiple groups,219,30.10%,,,Convenience,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Ghobad Moradi,Kurdistan University of Medical Sciences,http://jmums.mazums.ac.ir/article-1-16926-en.html,13/01/2022,16/07/2022,Unverified
211007_WestOfIran_KurdistanUniversityOfMedicalSciences_ComorbidityYes,07-Oct-21,Regional,Iran (Islamic Republic of),IRN,"Three provinces of Kurdistan, Kermanshah, and Hamedan.","Three cities of Sanandaj, Kermanshah, and Hamedan.",05-Nov-20,15-Nov-20,Essential non-healthcare workers,Multiple groups,159,27.00%,,,Convenience,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Ghobad Moradi,Kurdistan University of Medical Sciences,http://jmums.mazums.ac.ir/article-1-16926-en.html,13/01/2022,16/07/2022,Unverified
211007_WestOfIran_KurdistanUniversityOfMedicalSciences_ComorbidityNo,07-Oct-21,Regional,Iran (Islamic Republic of),IRN,"Three provinces of Kurdistan, Kermanshah, and Hamedan.","Three cities of Sanandaj, Kermanshah, and Hamedan.",05-Nov-20,15-Nov-20,Essential non-healthcare workers,Multiple groups,947,28.90%,,,Convenience,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Ghobad Moradi,Kurdistan University of Medical Sciences,http://jmums.mazums.ac.ir/article-1-16926-en.html,13/01/2022,16/07/2022,Unverified
211007_WestOfIran_KurdistanUniversityOfMedicalSciences_RegionSanandaj,07-Oct-21,Local,Iran (Islamic Republic of),IRN,"Three provinces of Kurdistan, Kermanshah, and Hamedan.",Sanandaj,05-Nov-20,15-Nov-20,Essential non-healthcare workers,Multiple groups,406,32.00%,,,Convenience,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Ghobad Moradi,Kurdistan University of Medical Sciences,http://jmums.mazums.ac.ir/article-1-16926-en.html,13/01/2022,16/07/2022,Unverified
211007_WestOfIran_KurdistanUniversityOfMedicalSciences_RegionKermanshah,07-Oct-21,Local,Iran (Islamic Republic of),IRN,"Three provinces of Kurdistan, Kermanshah, and Hamedan.",Kermanshah,05-Nov-20,15-Nov-20,Essential non-healthcare workers,Multiple groups,362,27.30%,,,Convenience,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Ghobad Moradi,Kurdistan University of Medical Sciences,http://jmums.mazums.ac.ir/article-1-16926-en.html,13/01/2022,16/07/2022,Unverified
211007_WestOfIran_KurdistanUniversityOfMedicalSciences_RegionHamedan,07-Oct-21,Local,Iran (Islamic Republic of),IRN,"Three provinces of Kurdistan, Kermanshah, and Hamedan.",Hamedan,05-Nov-20,15-Nov-20,Essential non-healthcare workers,Multiple groups,338,26.00%,,,Convenience,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Ghobad Moradi,Kurdistan University of Medical Sciences,http://jmums.mazums.ac.ir/article-1-16926-en.html,13/01/2022,16/07/2022,Unverified
211007_WestOfIran_KurdistanUniversityOfMedicalSciences_EducationPrimary,07-Oct-21,Regional,Iran (Islamic Republic of),IRN,"Three provinces of Kurdistan, Kermanshah, and Hamedan.","Three cities of Sanandaj, Kermanshah, and Hamedan.",05-Nov-20,15-Nov-20,Essential non-healthcare workers,Multiple groups,53,26.40%,,,Convenience,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Ghobad Moradi,Kurdistan University of Medical Sciences,http://jmums.mazums.ac.ir/article-1-16926-en.html,13/01/2022,16/07/2022,Unverified
211007_WestOfIran_KurdistanUniversityOfMedicalSciences_EducationSomeSecondary,07-Oct-21,Regional,Iran (Islamic Republic of),IRN,"Three provinces of Kurdistan, Kermanshah, and Hamedan.","Three cities of Sanandaj, Kermanshah, and Hamedan.",05-Nov-20,15-Nov-20,Essential non-healthcare workers,Multiple groups,73,24.70%,,,Convenience,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Ghobad Moradi,Kurdistan University of Medical Sciences,http://jmums.mazums.ac.ir/article-1-16926-en.html,13/01/2022,16/07/2022,Unverified
211007_WestOfIran_KurdistanUniversityOfMedicalSciences_EducationCompletedSecondary,07-Oct-21,Regional,Iran (Islamic Republic of),IRN,"Three provinces of Kurdistan, Kermanshah, and Hamedan.","Three cities of Sanandaj, Kermanshah, and Hamedan.",05-Nov-20,15-Nov-20,Essential non-healthcare workers,Multiple groups,258,29.80%,,,Convenience,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Ghobad Moradi,Kurdistan University of Medical Sciences,http://jmums.mazums.ac.ir/article-1-16926-en.html,13/01/2022,16/07/2022,Unverified
211007_WestOfIran_KurdistanUniversityOfMedicalSciences_EducationBachelor,07-Oct-21,Regional,Iran (Islamic Republic of),IRN,"Three provinces of Kurdistan, Kermanshah, and Hamedan.","Three cities of Sanandaj, Kermanshah, and Hamedan.",05-Nov-20,15-Nov-20,Essential non-healthcare workers,Multiple groups,422,29.90%,,,Convenience,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Ghobad Moradi,Kurdistan University of Medical Sciences,http://jmums.mazums.ac.ir/article-1-16926-en.html,13/01/2022,16/07/2022,Unverified
211007_WestOfIran_KurdistanUniversityOfMedicalSciences_EducationMastersOrHigher,07-Oct-21,Regional,Iran (Islamic Republic of),IRN,"Three provinces of Kurdistan, Kermanshah, and Hamedan.","Three cities of Sanandaj, Kermanshah, and Hamedan.",05-Nov-20,15-Nov-20,Essential non-healthcare workers,Multiple groups,300,27.30%,,,Convenience,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Ghobad Moradi,Kurdistan University of Medical Sciences,http://jmums.mazums.ac.ir/article-1-16926-en.html,13/01/2022,16/07/2022,Unverified
211007_WestOfIran_KurdistanUniversityOfMedicalSciences_OccupationTaxiDriver,07-Oct-21,Regional,Iran (Islamic Republic of),IRN,"Three provinces of Kurdistan, Kermanshah, and Hamedan.","Three cities of Sanandaj, Kermanshah, and Hamedan.",05-Nov-20,15-Nov-20,Essential non-healthcare workers,Multiple groups,72,33.30%,,,Convenience,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Ghobad Moradi,Kurdistan University of Medical Sciences,http://jmums.mazums.ac.ir/article-1-16926-en.html,13/01/2022,16/07/2022,Unverified
211007_WestOfIran_KurdistanUniversityOfMedicalSciences_OccupationShopOwner,07-Oct-21,Regional,Iran (Islamic Republic of),IRN,"Three provinces of Kurdistan, Kermanshah, and Hamedan.","Three cities of Sanandaj, Kermanshah, and Hamedan.",05-Nov-20,15-Nov-20,Essential non-healthcare workers,Multiple groups,168,26.20%,,,Convenience,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Ghobad Moradi,Kurdistan University of Medical Sciences,http://jmums.mazums.ac.ir/article-1-16926-en.html,13/01/2022,16/07/2022,Unverified
211007_WestOfIran_KurdistanUniversityOfMedicalSciences_OccupationGovernmentEmployee,07-Oct-21,Regional,Iran (Islamic Republic of),IRN,"Three provinces of Kurdistan, Kermanshah, and Hamedan.","Three cities of Sanandaj, Kermanshah, and Hamedan.",05-Nov-20,15-Nov-20,Essential non-healthcare workers,Multiple groups,682,28.60%,,,Convenience,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Ghobad Moradi,Kurdistan University of Medical Sciences,http://jmums.mazums.ac.ir/article-1-16926-en.html,13/01/2022,16/07/2022,Unverified
211007_WestOfIran_KurdistanUniversityOfMedicalSciences_OccupationPrivateSectorEmployee,07-Oct-21,Regional,Iran (Islamic Republic of),IRN,"Three provinces of Kurdistan, Kermanshah, and Hamedan.","Three cities of Sanandaj, Kermanshah, and Hamedan.",05-Nov-20,15-Nov-20,Essential non-healthcare workers,Multiple groups,184,29.30%,,,Convenience,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Ghobad Moradi,Kurdistan University of Medical Sciences,http://jmums.mazums.ac.ir/article-1-16926-en.html,13/01/2022,16/07/2022,Unverified
220225_Qom_TehranUniversityOfMedicalSciences,25-Feb-22,Regional,Iran (Islamic Republic of),IRN,Qom Province,,01-Jun-20,01-Aug-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,202,12.87%,,,Convenience,NA,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),Sepideh Paybast,Tehran University of Medical Sciences,https://dx.doi.org/10.1016/j.msard.2022.103712,17/03/2022,16/07/2022,Unverified
220208_Ardabil_ArdabilUniversityOfMedicalSciences_IgGIgM,08-Feb-22,Local,Iran (Islamic Republic of),IRN,Ardabil,Ardabil,20-May-20,07-Jun-20,Household and community samples,Multiple groups,1013,12.11%,,,Stratified probability,Pishtaz Diagnostics Iran,ELISA,"IgG,IgM",94.10%,98.30%,Moderate,Journal Article (Peer-Reviewed),Hamed Zandian,Ardabil University of Medical Sciences,https://dx.doi.org/10.2174/18749445-v15-e2201140,21/04/2022,16/07/2022,Verified
220324_Tehran_TehranUniversityofMedicalSciences_Overall_TestAdjusted,24-Mar-22,Local,Iran (Islamic Republic of),IRN,,Tehran,15-Apr-20,15-Jun-20,Health care workers and caregivers,Multiple groups,2065,22.60%,20.20%,25.10%,Convenience,Pishtaz Diagnostics Iran,ELISA,"IgG,IgM",66.90%,98.20%,Moderate,Journal Article (Peer-Reviewed),Maryam Darvishian,Tehran University of Medical Sciences,https://dx.doi.org/10.3389/fpubh.2022.832003,22/04/2022,16/07/2022,Unverified
220306_Tehran_IranUniversity,06-Mar-22,Local,Iran (Islamic Republic of),IRN,Tehran Province,Tehran,15-Jun-20,15-Oct-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,155,6.50%,,,Sequential,EUROIMMUN,ELISA,IgG,90.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Saba Garshasbi ,Iran University,https://dx.doi.org/10.5812/JJM.121929,02/05/2022,16/07/2022,Unverified
220523_Iran_TehranUniversityofMedicalSciences_OverallPopTestAdjust,23-May-22,National,Iran (Islamic Republic of),IRN,,"Ahvaz,Ardabil,Babol,Gorgan,Hamedan,Kerman,Kermanshah,Mashhad,Qom,Sanandaj,Sari,Shiraz,Tabriz,Tehran,Urmia,Zahedan",15-Jan-21,15-Mar-21,Household and community samples,Multiple groups,7411,34.20%,31.00%,37.30%,Simplified probability,Pishtaz Diagnostics Iran,ELISA,"IgG,IgM",66.90%,98.20%,Low,Journal Article (Peer-Reviewed),Mohammad Zamani,Tehran University of Medical Sciences,https://dx.doi.org/10.1186/s12889-022-13464-7,04/06/2022,16/07/2022,Unverified
220526_Iran_ShahidBeheshtiUniversityOfMedicalSciences_UC1,26-May-22,Local,Iran (Islamic Republic of),IRN,,"Tehran, Mashhad, Qazvin, Karaj, Isfahan, and Bandar Abbas",15-Jun-20,15-Nov-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,381,19.16%,,,Convenience,Pishtaz Diagnostics Iran,ELISA,"IgG,IgM",94.10%,98.30%,High,Journal Article (Peer-Reviewed),Shabnam Shahrokh,Shahid Beheshti University of Medical Sciences,https://dx.doi.org/10.1080/13813455.2022.2080228,08/06/2022,16/07/2022,Unverified
220526_Iran_ShahidBeheshtiUniversityOfMedicalSciences_CD2,26-May-22,Local,Iran (Islamic Republic of),IRN,,"Tehran, Mashhad, Qazvin, Karaj, Isfahan, and Bandar Abbas",15-Jun-20,15-Nov-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,153,23.53%,,,Convenience,Pishtaz Diagnostics Iran,ELISA,"IgG,IgM",94.10%,98.30%,High,Journal Article (Peer-Reviewed),Shabnam Shahrokh,Shahid Beheshti University of Medical Sciences,https://dx.doi.org/10.1080/13813455.2022.2080228,08/06/2022,16/07/2022,Unverified
220526_Iran_ShahidBeheshtiUniversityOfMedicalSciences_NonIBD3,26-May-22,Local,Iran (Islamic Republic of),IRN,,"Tehran, Mashhad, Qazvin, Karaj, Isfahan, and Bandar Abbas",15-Jun-20,15-Nov-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,46,73.91%,,,Convenience,Pishtaz Diagnostics Iran,ELISA,"IgG,IgM",94.10%,98.30%,High,Journal Article (Peer-Reviewed),Shabnam Shahrokh,Shahid Beheshti University of Medical Sciences,https://dx.doi.org/10.1080/13813455.2022.2080228,08/06/2022,16/07/2022,Unverified
210506_EastJava_KobeUniversity,06-May-21,Regional,Indonesia,IDN,East Java,"Surabaya, Jombang",15-Jun-20,15-Dec-20,Household and community samples,Multiple groups,1819,11.40%,,,Convenience,Nanjing Vazyme Medical Technology Co. Ltd,LFIA,IgG,91.54%,97.02%,Moderate,Journal Article (Peer-Reviewed),Ni Luh Ayu Megasari,Kobe University,https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0251234,18/05/2021,16/07/2022,Verified
211223_TanjungPriok_CenterforIndonesia’sStrategicDevelopmentInitiatives_Primary,23-Dec-21,Local,Indonesia,IDN,,Jakarta,23-Nov-20,19-Feb-21,Household and community samples,Adults (18-64 years),3196,28.52%,25.44%,31.81%,Simplified probability,NA,CLIA,Not reported,,99.81%,Moderate,Journal Article (Peer-Reviewed),Olivia Herlinda,"World Health Organization, Geneva, Switzerland",https://dx.doi.org/10.1371/journal.pone.0261931,09/01/2022,16/07/2022,Unverified
220110_Surabaya_AirlanggaUniversity,10-Jan-22,Local,Indonesia,IDN,East Java,Surabaya,15-May-20,15-Feb-21,Health care workers and caregivers,Adults (18-64 years),45,28.90%,,,Unclear,Nanjing Vazyme Medical Technology Co. Ltd,LFIA,"IgG,IgM",91.54%,97.02%,High,Journal Article (Peer-Reviewed),Maria Lusida,Airlangga University,https://dx.doi.org/10.1111/1348-0421.12962,19/01/2022,16/07/2022,Unverified
220609_Indonesia_UniversitasGadjahMada_Primary,09-Jun-22,Local,Indonesia,IDN,Yogyakarta,,15-Mar-21,15-Apr-21,Household and community samples,Multiple groups,425,31.10%,,,Stratified probability,FineTest,ELISA,IgG,70.00%,83.00%,Moderate,Preprint,Riris Andono Ahmad,Universitas Gadjah Mada,10.1101/2022.06.07.22276128,15/06/2022,16/07/2022,Unverified
200606_Bengaluru_SJICSR_Staff,06-Jun-20,Local,India,IND,Karnataka,Bengaluru,23-May-20,06-Jun-20,Health care workers and caregivers,Adults (18-64 years),1000,1.00%,,,Convenience,NA,Not reported,IgG,,,Unclear,News and Media,Sunitha Rao,Sri Jayadeva Institute of Cardiovascular Sciences and Research,https://www.google.com/url?rct=j&sa=t&url=https://timesofindia.indiatimes.com/city/bengaluru/covid-19-jayadeva-says-its-survey-hints-at-herd-immunity/articleshow/76228490.cms&ct=ga&cd=CAAYADIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNHrh7Scfh82driNisE_8HVxMcpd8Q,27/06/2020,16/07/2022,Verified
200614_Thiruvananthapuram_HealthDepartment_GenPop,14-Jun-20,Local,India,IND,Kerala,Thiruvananthapuram,09-Jun-20,12-Jun-20,Household and community samples,Multiple groups,450,2.67%,,,Unclear,NA,Not reported,"IgM,IgG",,,Unclear,News and Media,Aswin Kumar,Thiruvanathapuram Health Department,https://www.google.com/url?rct=j&sa=t&url=https://timesofindia.indiatimes.com/city/thiruvananthapuram/initial-trend-positivity-rate-low-in-antibody-testing/articleshow/76363847.cms&ct=ga&cd=CAAYADIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNHcN3WpGsIDw6iptLnm7KkY9Nl-tg,06/07/2020,16/07/2022,Verified
200721_Haryana_IntegratedDiseaseSurveillanceProgramme_GenPop,21-Jul-20,Regional,India,IND,Haryana,"Gurugram, Faridabad, Ambala, Panchkula, Sonipat",21-Jun-20,15-Jul-20,Household and community samples,Adults (18-64 years),1544,12.00%,,,Stratified probability,NA,ELISA,IgG,,,High,News and Media,Prayag Arora Desai,Haryana Health Department,https://www.hindustantimes.com/gurugram/pvt-lab-says-16-20-sero-prevalence-in-gurugram-health-dept-distances-itself-from-data/story-265qYKX4XhRPeMVc5HrKEO.html,31/07/2020,16/07/2022,Verified
200719_Lucknow_India_KingGeorgeMedicalUniversity_BloodDonors,19-Jul-20,Local,India,IND,Uttar Pradesh,Lucknow,05-Jul-20,19-Jul-20,Blood donors,Multiple groups,1235,3.70%,,,Convenience,NA,Not reported,IgG,,,High,News and Media,Yusra Husain,King George's Medical University,https://www.google.com/url?rct=j&sa=t&url=https://timesofindia.indiatimes.com/city/lucknow/4-healthy-blood-donors-in-city-found-with-covid-antibodies/articleshow/77044828.cms&ct=ga&cd=CAAYBjIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNHrdF6GLOiOPUVeEg19jMKbusa8DA,01/08/2020,16/07/2022,Verified
200723_Delhi_IndianCentreforDiseaseControl_GenPop,21-Jul-20,Regional,India,IND,NCT Delhi,,27-Jun-20,10-Jul-20,Household and community samples,Multiple groups,21387,23.48%,,,Stratified probability,Zydus Diagnostics,ELISA,IgG,98.70%,100.00%,Moderate,Institutional Report,Ministry of Health and Family Welfare,Indian Center for Disease Control,https://pib.gov.in/PressReleaseIframePage.aspx?PRID=1640137,02/08/2020,16/07/2022,Verified
200723_India_Thyrocare_GenPop,23-Jul-20,National,India,IND,,,28-Jun-20,19-Jul-20,Household and community samples,Multiple groups,53000,15.00%,,,Simplified probability,NA,Multiple Types,Not reported,,,High,News and Media,India com News Desk,Thyrocare,https://www.google.com/url?rct=j&sa=t&url=https://www.india.com/news/india/covid-19-people-from-bhiwandi-anand-vihar-have-antibodies-against-corona-check-report-4092355/&ct=ga&cd=CAAYBTIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNGDZBY0JyrN9eer5kq9FJfLncpL8Q,04/08/2020,16/07/2022,Verified
200826_India_AllIndiaInstituteofMedicalSciences_HospitalPatients_UnAdj,26-Aug-20,Local,India,IND,Punjab,New Delhi,08-Jun-20,08-Aug-20,Residual sera,Multiple groups,212,19.80%,14.70%,25.80%,Convenience,NA,ELISA,IgG,88.24%,99.79%,High,Preprint,Animesh Ray,All India Institute of Medical Sciences,https://www.medrxiv.org/content/10.1101/2020.08.22.20179937v2,13/10/2020,16/07/2022,Verified
200914_PaschimMedinipur_MedicalCollegeKolkata_Overall,14-Sep-20,Regional,India,IND,West Bengal,,26-Jul-20,08-Aug-20,Household and community samples,Multiple groups,458,4.15%,2.52%,6.40%,Stratified probability,Calbiotech Inc.,ELISA,IgG,98.30%,98.10%,Moderate,Preprint,Parthasarathi Satpati,Medical College Kolkata,https://www.medrxiv.org/content/10.1101/2020.09.12.20193219v1,05/11/2020,16/07/2022,Verified
200903_NewDelhi_MaxSuperSpecialtyHospital_Overall,03-Sep-20,Local,India,IND,NCT Delhi,New Delhi,15-Apr-20,15-Aug-20,Multiple populations,Multiple groups,780,19.50%,,,Convenience,Roche Diagnostics,CLIA,Total Antibody,94.50%,99.40%,High,Preprint,Samreen Siddiqui,Max Super Specialty Hospital,https://www.medrxiv.org/content/10.1101/2020.09.02.20186486v1,06/11/2020,16/07/2022,Verified
200922_Delhi_NationalCenterforDiseaseControlIndia_Survey1_PopAdj,22-Sep-20,Local,India,IND,NCT Delhi,New Delhi,26-Jun-20,10-Jul-20,Household and community samples,Multiple groups,21387,23.48%,22.96%,24.01%,Unclear,Zydus Diagnostics,ELISA,IgG,92.37%,97.90%,Unclear,Preprint,Smarajit Dey,National Centre for Disease Control,https://www.researchsquare.com/article/rs-80259/v1,18/11/2020,16/07/2022,Verified
200922_Delhi_NationalCenterforDiseaseControlIndia_Survey2_PopAdj,22-Sep-20,Local,India,IND,NCT Delhi,New Delhi,01-Aug-20,07-Aug-20,Household and community samples,Multiple groups,15311,29.10%,28.51%,29.95%,Unclear,Zydus Diagnostics,ELISA,IgG,92.37%,97.90%,Unclear,Preprint,Smarajit Dey,National Centre for Disease Control,https://www.researchsquare.com/article/rs-80259/v1,18/11/2020,16/07/2022,Verified
200917_India_MinistryofHealth&FamilyWelfare_OverallPopTestAdj,17-Sep-20,National,India,IND,,,11-May-20,04-Jun-20,Household and community samples,Multiple groups,28000,0.73%,0.34%,1.13%,Stratified probability,"Zydus Diagnostics,EUROIMMUN",ELISA,IgG,,,Low,Journal Article (Peer-Reviewed),Manoj Murhekar,Indian Council of Medical Research,http://dx.doi.org/10.4103/ijmr.IJMR_3290_20,26/11/2020,16/07/2022,Verified
201207_Mumbai_KokilabenDhirubhaiAmbaniHospital_hcw_primaryest,07-Dec-20,Local,India,IND,Maharashtra,Mumbai,01-Jun-20,30-Jun-20,Health care workers and caregivers,Adults (18-64 years),208,12.50%,,,Convenience,"Abbott Laboratories,Roche Diagnostics",CLIA,Not reported,,,High,Journal Article (Peer-Reviewed),Tanu Singhal,Kokilaben Dhirubhai Ambani Hospital and Medical Research Institute,https://dx.doi.org/10.4103/ijmm.IJMM_20_308,12/01/2021,16/07/2022,Verified
201109_Kokalta_ApolloGleneaglesHospitals_HCW_Overall,09-Nov-20,Local,India,IND,West Bengal,Kolkata,12-Jul-20,23-Aug-20,Health care workers and caregivers,Adults (18-64 years),1122,11.94%,,,Stratified probability,Ortho Clinical Diagnostics Inc.,CLIA,IgG,90.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Mahesh Goenka,Apollo Gleneagles Hospitals,https://www.japi.org/x264a444/seroprevalence-of-covid-19-amongst-health-care-workers-in-a-tertiary-care-hospital-of-a-metropolitan-city-from-india,18/01/2021,16/07/2022,Verified
201104_India_HindujaHospital_GenPop,04-Nov-20,Local,India,IND,Maharashtra,Mumbai,01-Jun-20,30-Jun-20,Health care workers and caregivers,Multiple groups,801,11.10%,9.10%,13.50%,Unclear,Roche Diagnostics,Not reported,Total Antibody,99.80%,100.00%,High,Journal Article (Peer-Reviewed),Nishant Kumar,Postgraduate Institute of Medical Education and Research,https://dx.doi.org/10.1016/j.vaccine.2020.10.094,18/01/2021,16/07/2022,Verified
201109_Kolkata_ApolloGleneaglesHospitalsGastroDept_Overall,09-Nov-20,Local,India,IND,West Bengal,Kolkata,01-Aug-20,31-Aug-20,Health care workers and caregivers,Adults (18-64 years),117,32.48%,,,Convenience,Ortho Clinical Diagnostics Inc.,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Mahesh Goenka,Apollo Gleneagles Hospitals,http://dx.doi.org/10.1002/jgh3.12447,30/01/2021,16/07/2022,Verified
201214_Ahmedabad_ MunicipalMedicalCollege_genpop_primary,14-Dec-20,Local,India,IND,Gujarat,Ahmedabad,16-Jun-20,07-Jul-20,Residual sera,Multiple groups,29891,17.61%,17.18%,18.04%,Convenience,Zydus Diagnostics,ELISA,IgG,92.37%,97.90%,High,Journal Article (Peer-Reviewed),Om Prakash, Municipal Medical College ,https://dx.doi.org/10.1136/bmjopen-2020-044101,02/02/2021,16/07/2022,Verified
210104_Chennai_KanchiKamakotiCHILDSTrustHospital_overall,04-Jan-21,Local,India,IND,Tamil Nadu,Chennai,30-Jul-20,07-Aug-20,Health care workers and caregivers,Adults (18-64 years),95,16.80%,,,Convenience,Shenzhen Yhlo Biotech Co. Ltd,CLIA,IgG,,,High,Preprint,Manoj Madhusudan,"Kanchi Kamakoti CHILDS Trust Hospital,",https://pubmed.ncbi.nlm.nih.gov/33408287/,04/02/2021,16/07/2022,Unverified
200916_Kerala_AmritaInstituteofMedicalSciencesandResearchCentre,16-Sep-20,Local,India,IND,Kerala,,11-Jul-20,24-Jul-20,Health care workers and caregivers,Multiple groups,635,0.00%,,,Convenience,"Abbott Laboratories,Ortho Clinical Diagnostics Inc.,Roche Diagnostics",CLIA,"IgG,Total Antibody",,,High,Journal Article (Peer-Reviewed),Anil Kumar,Amrita Institute of Medical Sciences & Research Centre,http://dx.doi.org/10.1016/j.cmi.2020.09.013,06/02/2021,16/07/2022,Verified
211104_Karnataka_Mapmygenome_primary_adj,04-Feb-21,Regional,India,IND,Karnataka,,15-Jun-20,29-Aug-20,Household and community samples,Multiple groups,1197,46.70%,43.30%,50.00%,Stratified probability,NA,ELISA,IgG,84.70%,100.00%,Moderate,Journal Article (Peer-Reviewed),Manoj Mohanan,Mapmygenome,https://dx.doi.org/10.1001/jama.2021.0332,08/02/2021,16/07/2022,Verified
201130_PuneCity_IndianInstituteOfScienceEducationAndResearch_OverallAdj,30-Nov-20,Local,India,IND,Maharashtra,Pune,20-Jul-20,05-Aug-20,Household and community samples,Multiple groups,1659,51.30%,39.90%,62.40%,Stratified probability,NA,ELISA,IgG,,,Moderate,Preprint,Aurnab Ghose,Indian Institute of Science Education and Research,https://www.medrxiv.org/content/10.1101/2020.11.17.20228155v2.full-text,12/02/2021,16/07/2022,Verified
210114_Puducherry_JawaharlalInstitute_August_primary,14-Jan-21,Regional,India,IND,Puducherry,,11-Aug-20,16-Aug-20,Household and community samples,Multiple groups,869,4.90%,3.50%,6.40%,Stratified probability,Roche Diagnostics,CLIA,Total Antibody,99.50%,99.80%,Moderate,Journal Article (Peer-Reviewed),Sitanshu Sekhar Kar,Jawaharlal Institute,https://dx.doi.org/10.3201/2702.204480,16/02/2021,16/07/2022,Verified
210114_Puducherry_JawaharlalInstitute_Sep_primary,14-Jan-21,Regional,India,IND,Puducherry,,10-Sep-20,16-Sep-20,Household and community samples,Multiple groups,898,20.70%,18.00%,23.30%,Stratified probability,Roche Diagnostics,CLIA,Total Antibody,99.50%,99.80%,Moderate,Journal Article (Peer-Reviewed),Sitanshu Sekhar Kar,Jawaharlal Institute,https://dx.doi.org/10.3201/2702.204480,16/02/2021,16/07/2022,Verified
210114_Puducherry_JawaharlalInstitute_Oct_primary,14-Jan-21,Regional,India,IND,Puducherry,,12-Oct-20,16-Oct-20,Household and community samples,Multiple groups,900,34.50%,31.50%,37.70%,Stratified probability,Roche Diagnostics,CLIA,Total Antibody,99.50%,99.80%,Moderate,Journal Article (Peer-Reviewed),Sitanshu Sekhar Kar,Jawaharlal Institute,https://dx.doi.org/10.3201/2702.204480,16/02/2021,16/07/2022,Verified
210120_Chennai_NationalInstituteOfEpidemiology_primary_adj,20-Jan-21,Local,India,IND,,Chennai,01-Jul-20,31-Jul-20,Household and community samples,Multiple groups,12405,18.40%,14.80%,22.60%,Stratified probability,Abbott Laboratories,CLIA,IgG,100.00%,99.60%,Low,Journal Article (Peer-Reviewed),Sriram Selvaraju,National Institute of Epidemiology,https://dx.doi.org/10.3201/eid2702.203938,21/02/2021,16/07/2022,Verified
201113_Mumbai_TataInstituteforFundamentalResearch_slums_testpopadj,13-Nov-20,Local,India,IND,Maharashtra,Mumbai,29-Jun-20,19-Jul-20,Persons living in slums,Multiple groups,4202,58.30%,56.80%,59.90%,Stratified probability,Abbott Laboratories,CLIA,IgG,90.00%,99.00%,Low,Journal Article (Peer-Reviewed),Anup Malani,Tata Institute for Fundamental Research,http://dx.doi.org/10.1016/S2214-109X%2820%2930467-8,22/02/2021,16/07/2022,Verified
201113_Mumbai_TataInstituteforFundamentalResearch_nonslums_adj,13-Nov-20,Local,India,IND,Maharashtra,Mumbai,29-Jun-20,19-Jul-20,Household and community samples,Multiple groups,2702,17.10%,15.80%,18.40%,Stratified probability,Abbott Laboratories,CLIA,IgG,90.00%,99.00%,Low,Journal Article (Peer-Reviewed),Anup Malani,Tata Institute for Fundamental Research,http://dx.doi.org/10.1016/S2214-109X%2820%2930467-8,22/02/2021,16/07/2022,Verified
210201_Chennai_KanchiKamakotiCHILDSTrustHospital_overall_IgG,01-Feb-21,Local,India,IND,Tamil Nadu,Chennai,01-Jun-20,30-Sep-20,Residual sera,Children and Youth (0-17 years),463,19.60%,15.40%,22.50%,Convenience,Shenzhen Yhlo Biotech Co. Ltd,CLIA,IgG,,,High,Preprint,Aishwarya Venkataraman,Bristol Royal Hospital for Children,https://www.medrxiv.org/content/10.1101/2021.01.29.21250660v1,03/03/2021,16/07/2022,Verified
201031_Bhubaneswar_RegionalMedicalResearchCentre_overall,31-Oct-20,Local,India,IND,,Bhubaneswar,16-Oct-20,18-Oct-20,Household and community samples,Multiple groups,1403,50.00%,,,Simplified probability,NA,Not reported,Not reported,,,Unclear,News and Media,Riyan Ramanath,The Regional Medical Research Centre in Bhubaneswar,https://timesofindia.indiatimes.com/city/bhubaneswar/survey-50-of-bhubaneswar-residents-have-antibodies/articleshow/78966615.cms,07/03/2021,16/07/2022,Verified
201027_DistrictSrinagar_GovernmentMedicalCollege_Overall,27-Oct-20,Local,India,IND,Kashmir,,15-Jun-20,29-Jun-20,Health care workers and caregivers,Adults (18-64 years),2905,2.50%,2.00%,3.10%,Convenience,Abbott Laboratories,CLIA,IgG,100.00%,,Moderate,Preprint,Muhammad Salim Khan,Government Medical College,https://www.medrxiv.org/content/10.1101/2020.10.23.20218164v1.full-text,16/03/2021,16/07/2022,Verified
210127_India_ICRM_overall_adj,27-Jan-21,National,India,IND,,,18-Aug-20,20-Sep-20,Household and community samples,Multiple groups,29082,6.60%,5.80%,7.40%,Stratified probability,Abbott Laboratories,CLIA,IgG,100.00%,99.60%,Low,Journal Article (Peer-Reviewed),Manoj V Murhekar,The Indian Council of Medical Research (ICMR),https://dx.doi.org/10.1016/S2214-109X(20)30544-1,17/03/2021,16/07/2022,Verified
210205_India_ICRM_overall,05-Feb-21,National,India,IND,,,17-Dec-20,08-Jan-21,Household and community samples,Multiple groups,28589,21.50%,,,Stratified probability,NA,Not reported,Not reported,,,Unclear,News and Media,BBC News,The Indian Council of Medical Research (ICMR),https://www.bbc.com/news/world-asia-india-55945382,17/03/2021,16/07/2022,Verified
210301_NewDelhi_AllIndiaInstituteofMedicalSciences_Overall,01-Mar-21,Local,India,IND,NCT Delhi,New Delhi,22-Jun-20,24-Jul-20,Health care workers and caregivers,Adults (18-64 years),3739,13.02%,,,Convenience,Siemens,CLIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Ritu Gupta,All India Institute of Medical Sciences,https://pubmed.ncbi.nlm.nih.gov/33642348/,24/03/2021,16/07/2022,Verified
210311_Vellore_UniversityOfEdinburgh_CommunitySurvey1_overall,11-Mar-21,Local,India,IND,Tamil Nadu,,06-Jul-20,20-Aug-20,Household and community samples,Multiple groups,501,2.20%,0.80%,3.40%,Simplified probability,"Siemens,Roche Diagnostics",CLIA,IgG,,,Moderate,Preprint,Rita Isaac,University of Edinburgh,https://www.researchsquare.com/article/rs-289385/v1,30/03/2021,16/07/2022,Verified
210311_Vellore_UniversityOfEdinburgh_CommunitySurvey2_overall ,11-Mar-21,Local,India,IND,Tamil Nadu,,06-Nov-20,20-Nov-20,Household and community samples,Multiple groups,200,22.00%,16.30%,27.70%,Simplified probability,"Siemens,Roche Diagnostics",CLIA,IgG,,,Moderate,Preprint,Rita Isaac,University of Edinburgh,https://www.researchsquare.com/article/rs-289385/v1,30/03/2021,16/07/2022,Verified
210212_Gurugram_Medanta-TheMedicity,12-Feb-21,Local,India,IND,Haryana,Gurugram,12-Jan-21,13-Feb-21,Health care workers and caregivers,Adults (18-64 years),3258,46.20%,44.40%,47.90%,Convenience,DiaSorin,CLIA,IgG,,,High,Preprint,Sushila Kataria,Madanta- The Medicity,https://www.medrxiv.org/content/10.1101/2021.02.10.21251543v1,30/03/2021,16/07/2022,Verified
201111_Srinagar_GovernmentMedicalCollegeSrinagar,11-Nov-20,Regional,India,IND,Srinagar,District Srinagar,01-Jul-20,15-Jul-20,Residual sera,Multiple groups,2906,3.60%,2.90%,4.30%,Convenience,Abbott Laboratories,CLIA,IgG,100.00%,99.60%,Moderate,Journal Article (Peer-Reviewed),S Muhammad Salim Khan,Government Medical College Srinagar,https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0239303,09/04/2021,16/07/2022,Verified
210326_Bhubaneswar_ICMRRegionalMedicalResearchCentre_September_AnaesthesiaHCW,26-Mar-21,Local,India,IND,,Bhubaneswar,01-Sep-20,30-Sep-20,Health care workers and caregivers,Adults (18-64 years),128,12.50%,7.30%,19.50%,Unclear,Abbott Laboratories,CLIA,IgG,100.00%,99.63%,High,Preprint,Debaprasad Parai,ICMR-Regional Medical Research Centre (Government of India),https://www.medrxiv.org/content/10.1101/2021.03.20.21253819v2,09/04/2021,16/07/2022,Verified
210326_Bhubaneswar_ICMRRegionalMedicalResearchCentre_December_AnaesthesiaHCW,26-Mar-21,Local,India,IND,,Bhubaneswar,01-Dec-20,31-Dec-20,Health care workers and caregivers,Adults (18-64 years),164,38.40%,30.90%,46.30%,Unclear,Abbott Laboratories,CLIA,IgG,100.00%,99.63%,High,Preprint,Debaprasad Parai,ICMR-Regional Medical Research Centre (Government of India),https://www.medrxiv.org/content/10.1101/2021.03.20.21253819v2,09/04/2021,16/07/2022,Verified
210411_India_BanarasHinduUniversity_Overall,11-Apr-21,National,India,IND,,,15-Sep-20,15-Dec-20,Household and community samples,Adults (18-64 years),2301,30.55%,28.70%,32.50%,Simplified probability,"Biosense Technologies, India",Not reported,"IgM,IgA,IgG,Total Antibody",100.00%,99.00%,Moderate,Preprint,Prajjval Singh,Banaras Hindu University,https://www.medrxiv.org/content/10.1101/2021.02.05.21251118v2,15/04/2021,16/07/2022,Unverified
210202_Delhi_DelhiGovernment,02-Feb-21,Local,India,IND,,Delhi,15-Jan-21,23-Jan-21,Household and community samples,Multiple groups,28000,56.13%,,,Unclear,NA,CLIA,Not reported,,,Unclear,News and Media,Mallika Soni,Delhi Government,https://www.hindustantimes.com/india-news/after-5th-serosurvey-health-minister-jain-says-don-t-let-your-guard-down-101612264692531.html,15/04/2021,16/07/2022,Verified
210215_Patna_AllIndiaInstituteOfMedicalSciences_Overall,15-Feb-21,Local,India,IND,Bihar,Patna,01-Sep-20,30-Sep-20,Health care workers and caregivers,Adults (18-64 years),919,13.30%,11.20%,15.60%,Convenience,Siemens,CLIA,IgG,100.00%,99.80%,High,Journal Article (Peer-Reviewed),Mala Mahto,All India Institute of Medical Sciences,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8010601/,15/04/2021,16/07/2022,Verified
210301_Ahmedabad_SmtNHLMunicipalMedicalCollege_Overall,01-Mar-21,Local,India,IND,Gujarat,Ahmedabad,01-Jul-20,31-Jul-20,Health care workers and caregivers,Adults (18-64 years),1333,27.76%,,,Unclear,Siemens,CLIA,Total Antibody,100.00%,99.80%,Moderate,Journal Article (Peer-Reviewed),Jemil Makadia,Smt NHL Municipal Medical College,http://dx.doi.org/10.7860/JCDR/2021/46817.14599,17/04/2021,16/07/2022,Verified
210311_NewDelhi_AllIndiaInstituteOfMedicalSciences_Overall,11-Mar-21,Local,India,IND,,,15-Apr-20,15-Jul-20,Blood donors,Adults (18-64 years),1191,9.50%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Hem Chandra Pandey,All India Institute of Medical Sciences ,https://dx.doi.org/10.1016/j.transci.2021.103118,18/04/2021,16/07/2022,Verified
201103_Haryan_TheHindu_primary,03-Nov-20,Regional,India,IND,Haryan,,18-Oct-20,24-Oct-20,Household and community samples,Multiple groups,16477,14.76%,,,Stratified probability,NA,Not reported,Not reported,,,Unclear,News and Media,Ashok Kumar,Unclear,https://www.thehindu.com/news/cities/Delhi/6-rise-in-seropositivity-among-delhis-neighbours/article33006634.ece,22/04/2021,16/07/2022,Verified
201017_Ujjain_TheTimesOfIndia_primary,17-Sep-20,Regional,India,IND,Madhya Pradesh,,27-Aug-20,30-Aug-20,Household and community samples,Multiple groups,3000,11.90%,,,Unclear,NA,Not reported,Not reported,,,Unclear,News and Media,Amarjeet Singh,The Times of India,https://timesofindia.indiatimes.com/city/bhopal/11-9-seroprevalence-in-ujjain-finds-survey/articleshow/78159395.cms,22/04/2021,16/07/2022,Verified
200820_Punjab_PunjabSeroSurvey_genpop,20-Aug-20,Regional,India,IND,Punjab,,01-Aug-20,17-Aug-20,Household and community samples,Multiple groups,1250,27.70%,,,Simplified probability,NA,LFIA,"IgM,IgG",,,Unclear,News and Media,Express News Service,NR,https://indianexpress.com/article/india/punjab-sero-survey-report-27-7-people-in-containment-zones-have-antibodies-against-covid-6563226/,26/04/2021,16/07/2022,Verified
200901_Aurangabad_GovernmentMedicalSchool_overall,01-Sep-20,Local,India,IND,Maharashtra,,10-Aug-20,19-Aug-20,Household and community samples,Multiple groups,6571,5.80%,,,Stratified probability,NA,ELISA,IgG,,,Moderate,Journal Article (Peer-Reviewed),J V Dixit,"Government Medical School, Aurangabad",https://ijcrt.org/papers/IJCRT2009467.pdf,26/04/2021,16/07/2022,Verified
210303_Jabalpur_NationalCentreForDiseaseControl_TestPopAdj,31-Mar-21,Local,India,IND,Madya Pradesh,Jabalpur,11-Dec-20,21-Dec-20,Household and community samples,Multiple groups,9279,29.42%,28.41%,30.42%,Stratified probability,Zydus Diagnostics,ELISA,IgG,92.37%,97.90%,Low,Journal Article (Peer-Reviewed),Sudarshan Ramaswamy,National Centre for Disease Control,https://web.archive.org/web/20210410213821/http://medical.advancedresearchpublications.com/index.php/Journal-CommunicableDiseases/article/view/536,27/04/2021,16/07/2022,Verified
200831_Mumbai_NITI-Aayog_Slums_overall,31-Aug-20,Local,India,IND,,Mumbai,16-Aug-20,29-Aug-20,Persons living in slums,Multiple groups,3024,44.90%,43.20%,46.70%,Stratified probability,Abbott Laboratories,CLIA,IgG,93.00%,100.00%,Low,Institutional Report,Ullas Kolthur Seetharam,NITI-Aayog,https://www.tifr.res.in/TSN/article/Mumbai-Serosurvey%20Technical%20report-NITI_BMC-Round-2%20for%20TIFR%20website.pdf,06/05/2021,16/07/2022,Verified
200831_Mumbai_NITI-Aayog_Non-Slum_overall,31-Aug-20,Local,India,IND,,Mumbai,16-Aug-20,29-Aug-20,Household and community samples,Multiple groups,2176,17.50%,15.90%,19.10%,Stratified probability,Abbott Laboratories,CLIA,IgG,93.00%,100.00%,Low,Institutional Report,Ullas Kolthur Seetharam,NITI-Aayog,https://www.tifr.res.in/TSN/article/Mumbai-Serosurvey%20Technical%20report-NITI_BMC-Round-2%20for%20TIFR%20website.pdf,06/05/2021,16/07/2022,Verified
200831_Mumbai_NITI-Aayog_HCW,31-Aug-20,Local,India,IND,,Mumbai,16-Aug-20,29-Aug-20,Health care workers and caregivers,Adults (18-64 years),728,27.30%,24.10%,30.60%,Unclear,Abbott Laboratories,CLIA,IgG,93.00%,100.00%,Unclear,Institutional Report,Ullas Kolthur Seetharam,NITI-Aayog,https://www.tifr.res.in/TSN/article/Mumbai-Serosurvey%20Technical%20report-NITI_BMC-Round-2%20for%20TIFR%20website.pdf,06/05/2021,16/07/2022,Verified
210427_Bhubaneswar_IndianCouncilOfMedicalResearch_overall,27-Apr-21,Local,India,IND,Odisha,Bhubaneswar,01-Sep-20,30-Sep-20,Household and community samples,Multiple groups,1403,49.04%,46.39%,51.68%,Stratified probability,Roche Diagnostics,CLIA,Total Antibody,,,Moderate,Journal Article (Peer-Reviewed),Jaya Singh Kshatri,Indian Council of Medical Research,https://www.cambridge.org/core/journals/epidemiology-and-infection/article/seroprevalence-of-sarscov2-in-bhubaneswar-india-findings-from-3-rounds-of-community-surveys/29A7905F297A1EFA68749AC3C6383300,13/05/2021,16/07/2022,Verified
201011_Assam_Srijanasom_overall,11-Oct-20,Regional,India,IND,Assam,,23-Aug-20,26-Sep-20,Household and community samples,Multiple groups,2390,23.70%,,,Unclear,NA,CLIA,IgG,,,Unclear,News and Media,Bikash Singh,Srijanasom,https://economictimes.indiatimes.com/news/politics-and-nation/assams-sero-survey-found-23-7-per-cent-seroprevalence-in-the-state/articleshow/78606153.cms,14/05/2021,16/07/2022,Verified
210320_Ahmedabad_AMCMETMedicalCollege_Overall,20-Mar-21,Local,India,IND,Gujarat,Ahmedabad,17-Aug-20,31-Aug-20,Contacts of COVID patients,Multiple groups,3973,31.92%,30.48%,33.38%,Stratified non-probability,Zydus Diagnostics,ELISA,IgG,92.37%,97.90%,Moderate,Journal Article (Peer-Reviewed),Om Prakash,AMC MET Medical College,https://pubmed.ncbi.nlm.nih.gov/33753682/,19/05/2021,16/07/2022,Verified
210401_Srinagar_GovernmentMedicalCollegeSrinagar_Primary,01-Apr-21,Local,India,IND,Kashmir,Srinagar,17-Oct-20,20-Oct-20,Household and community samples,Multiple groups,2418,40.60%,38.70%,42.60%,Stratified probability,Abbott Laboratories,CLIA,IgG,100.00%,99.60%,Moderate,Journal Article (Peer-Reviewed),Taha Ayub,Government Medical College Srinagar,https://www.ijcmph.com/index.php/ijcmph/article/view/7827,19/05/2021,16/07/2022,Verified
200930_Kerala_GovernmentOfKerala_August,30-Sep-20,Regional,India,IND,Kerala,"Ernakulam, Palakkad, Thrissur",24-Aug-20,26-Aug-20,Household and community samples,Multiple groups,1281,0.80%,,,Unclear,NA,Not reported,Not reported,,,Unclear,Institutional Report,Government of Kerala,Indian Medical Research Council,https://arogyakeralam.gov.in/wp-content/uploads/2020/03/Technical-Paper-COVID-19-ICMR-Sero-Surveillance-Study.docx.pdf,20/05/2021,16/07/2022,Verified
200930_Kerala_GovernmentOfKerala_May,30-Sep-20,Regional,India,IND,Kerala,"Ernakulam, Palakkad, Thrissur",18-May-20,23-May-20,Household and community samples,Multiple groups,1193,0.33%,,,Unclear,NA,Not reported,Not reported,,,Unclear,Institutional Report,Government of Kerala,Indian Medical Research Council,https://arogyakeralam.gov.in/wp-content/uploads/2020/03/Technical-Paper-COVID-19-ICMR-Sero-Surveillance-Study.docx.pdf,20/05/2021,16/07/2022,Verified
210321_Jamshedpur_TataMainHospital_OverallHCW,21-Mar-21,Local,India,IND,Jharkhand,Jamshedpur,07-Oct-20,30-Nov-20,Health care workers and caregivers,Adults (18-64 years),2110,43.80%,,,Convenience,Beckman Coulter,CLIA,IgG,100.00%,98.60%,Moderate,Journal Article (Peer-Reviewed),Minakshi Mishra,Tata Main Hospital,https://pubmed.ncbi.nlm.nih.gov/33898113/,21/05/2021,16/07/2022,Verified
210501_Ahmedabad_MunicipalMedicalCollege_Genpop_primary,01-May-21,Local,India,IND,,Ahmedabad,15-Oct-20,31-Oct-20,Household and community samples,Multiple groups,17009,24.20%,23.57%,24.85%,Convenience,Zydus Diagnostics,ELISA,IgG,92.37%,97.90%,Moderate,Journal Article (Peer-Reviewed),Om Prakash,Municipal Medical College,https://www.nepjol.info/index.php/AJMS/article/view/35099,22/05/2021,16/07/2022,Verified
210324_India_UniversityofToronto_genpop_overall_unadj,24-Mar-21,National,India,IND,"Maharashtra, West Bengal, Tamil Nadu, Karnataka, Gujarat, Rajasthan, Bihar, Andhra Pradesh","Mumbia, Delhi, Kolkata, Chennai, Bangalore, Ahmedabad, Pune, Surat, Jaipur, Nagpur, Coimbatore, Visakhapatnam",12-Jun-20,31-Dec-20,Household and community samples,Multiple groups,448518,31.00%,,,Self-referral,"Abbott Laboratories,Roche Diagnostics",CLIA,"IgG,Total Antibody",,,Moderate,Preprint,Arokiaswamy Velumani,University of Toronto ,10.1101/2021.03.19.21253429,22/05/2021,16/07/2022,Verified
210418_Delhi_CouncilofScientificandIndustrialResearchInstituteofGenomicsandIntegrativeBiology_HCW,18-Apr-21,Regional,India,IND,Delhi,,01-Jan-21,31-Jan-21,Health care workers and caregivers,Adults (18-64 years),307,42.00%,,,Convenience,Roche Diagnostics,Not reported,Not reported,,,High,Preprint,Rajat Ujjainia,Council of Scientific and Industrial Research Institute of Genomics and Integrative Biology,https://www.medrxiv.org/content/10.1101/2021.02.28.21252621v3,23/05/2021,16/07/2022,Unverified
210420_Kashmir_GovernmentMedicalCollege,20-Apr-21,Regional,India,IND,Kashmir,,15-Jun-20,29-Jun-20,Health care workers and caregivers,Multiple groups,2905,2.50%,2.00%,3.10%,Convenience,NA,ELISA,IgG,100.00%,99.00%,High,Journal Article (Peer-Reviewed),Muhammad Salim Khan,Government Medical College,https://dx.doi.org/10.12788/jhm.3609,26/05/2021,16/07/2022,Unverified
210521_Bengaluru_BangaloreMedicalCollege,21-May-21,Local,India,IND,Karnataka,Bangalore,15-Apr-21,22-Apr-21,Persons living in slums,Multiple groups,728,20.30%,,,Convenience,NA,Not reported,Not reported,,,High,News and Media,Ranganath TS,Bangalore Medical College and Research Institute,https://timesofindia.indiatimes.com/city/bengaluru/one-in-five-has-antibodies-against-covid-in-slums-in-bengaluru-study/articleshow/82825325.cms,27/05/2021,16/07/2022,Unverified
210409_NewDelhi_MaulanaAzadMedicalCollege,09-Apr-21,Local,India,IND,National Capital Territory of Delhi,New Delhi,15-Aug-20,15-Sep-20,Health care workers and caregivers,Adults (18-64 years),1401,12.10%,10.40%,13.80%,Convenience,Zydus Diagnostics,ELISA,IgG,92.40%,97.90%,Moderate,Journal Article (Peer-Reviewed),Pragya Sharma,Maulana Azad Medical College,https://dx.doi.org/10.24171/j.phrp.2021.12.2.06,31/05/2021,16/07/2022,Verified
210508_Ahmedabad_GujaratUniversity,08-May-21,Local,India,IND,Gujarat,Ahmedabad,15-Aug-20,31-Aug-20,Health care workers and caregivers,Multiple groups,1710,23.65%,21.70%,25.73%,Convenience,Zydus Diagnostics,ELISA,IgG,92.37%,97.90%,Moderate,Journal Article (Peer-Reviewed),Om Prakash,"Smt. Nathiba Hargovandas Lakhmichand (NHL) Municipal Medical College, Gujarat University",https://dx.doi.org/10.1016/j.cegh.2021.100766,03/06/2021,16/07/2022,Unverified
210408_Malegaon_MunicipalCorporationofMalegaon_genpop_overall,08-Apr-21,Local,India,IND,,Malegaon,25-Jul-20,20-Aug-20,Household and community samples,Multiple groups,336,40.00%,35.00%,45.00%,Stratified non-probability,NA,ELISA,IgG,93.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Pallavi Saple,The Municipality of Malegaon ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8140273/,06/06/2021,16/07/2022,Verified
210602_SouthEastAsia_MaulanaAzadMedicalCollege,02-Jun-21,Local,India,IND,,New Delhi,22-Jun-20,22-Dec-20,Contacts of COVID patients,Multiple groups,166,37.30%,,,Convenience,Erba Manneim,ELISA,IgG,,,High,Preprint,Mradul Kumar Daga,Maulana Azad Medical College,https://www.researchsquare.com/article/rs-540165/v1,07/06/2021,16/07/2022,Unverified
210408_Indore_NationalCentreforDiseaseControl_Primary,08-Apr-21,Local,India,IND,Madhya Pradesh,Indore,11-Aug-20,23-Aug-20,Household and community samples,Multiple groups,7103,7.75%,7.14%,8.36%,Stratified probability,Zydus Diagnostics,ELISA,IgG,92.10%,97.70%,Low,Journal Article (Peer-Reviewed),Salil Sakalle,National Centre for Disease Control,https://dx.doi.org/10.4103/jfmpc.jfmpc_2015_20,07/06/2021,16/07/2022,Unverified
210521_Karnataka_IndianInstituteOfPublicHealth_Primary,21-May-21,Regional,India,IND,Karnataka,,03-Sep-20,16-Sep-20,Household and community samples,Multiple groups,15624,16.80%,15.50%,18.10%,Stratified probability,Zydus Diagnostics,ELISA,IgG,92.10%,97.70%,Low,Journal Article (Peer-Reviewed),Giridhara Babu,Indian Institute of Public Health,http://dx.doi.org/10.1016/j.ijid.2021.05.043,08/06/2021,16/07/2022,Verified
201708_Pune_AshokaUniversity_primary,17-Aug-20,Local,India,IND,Maharashtra,Pune,20-Jul-20,05-Aug-20,Household and community samples,Multiple groups,1664,51.50%,,,Stratified probability,NA,Not reported,IgG,,,Unclear,News and Media,Anuradha Mascarenhas,Ashoka University,https://indianexpress.com/article/cities/pune/first-sero-survey-shows-extensive-spread-of-covid-19-from-36-1-to-65-4-in-selected-areas-sampled-in-pune-6558853/,17/06/2021,16/07/2022,Unverified
210616_India_AllIndiaInstituteOfMedicalSciences_DelhiUrban1,16-Jun-21,Local,India,IND,National Capital Territory of Delhi,New Delhi,15-Mar-21,31-Mar-21,Household and community samples,Multiple groups,1001,74.70%,,,Stratified probability,Beijing Wantai Biological,ELISA,Total Antibody,94.40%,100.00%,Moderate,Preprint,Puneet Misra,All India Institute of Medical Sciences,https://europepmc.org/article/PPR/PPR357490,22/06/2021,16/07/2022,Verified
210616_India_AllIndiaInstituteOfMedicalSciences_DelhiRural2,16-Jun-21,Local,India,IND,"Haryana
","Faridabad
",12-Apr-21,22-May-21,Household and community samples,Multiple groups,1059,59.30%,,,Stratified probability,Beijing Wantai Biological,ELISA,Total Antibody,94.40%,100.00%,Moderate,Preprint,Puneet Misra,All India Institute of Medical Sciences,https://europepmc.org/article/PPR/PPR357490,22/06/2021,16/07/2022,Verified
210616_India_AllIndiaInstituteOfMedicalSciences_Bhubaneswar3,16-Jun-21,Local,India,IND,Odisha,Bhubaneswar,22-Mar-21,07-May-21,Household and community samples,Multiple groups,1000,52.60%,,,Stratified probability,Beijing Wantai Biological,ELISA,Total Antibody,94.40%,100.00%,Moderate,Preprint,Puneet Misra,All India Institute of Medical Sciences,https://europepmc.org/article/PPR/PPR357490,22/06/2021,16/07/2022,Verified
210616_India_AllIndiaInstituteOfMedicalSciences_Gorakhpur4,16-Jun-21,Local,India,IND,Uttar Pradesh,Gorakhpur,22-Apr-21,10-Jun-21,Household and community samples,Multiple groups,448,87.90%,,,Stratified probability,Beijing Wantai Biological,ELISA,Total Antibody,94.40%,100.00%,Moderate,Preprint,Puneet Misra,All India Institute of Medical Sciences,https://europepmc.org/article/PPR/PPR357490,22/06/2021,16/07/2022,Verified
210616_India_AllIndiaInstituteOfMedicalSciences_Agartala5,16-Jun-21,Local,India,IND,Tripura,Agartala,26-Mar-21,01-Jun-21,Household and community samples,Multiple groups,1001,51.90%,,,Stratified probability,Beijing Wantai Biological,ELISA,Total Antibody,94.40%,100.00%,Moderate,Preprint,Puneet Misra,All India Institute of Medical Sciences,https://europepmc.org/article/PPR/PPR357490,22/06/2021,16/07/2022,Verified
200826_Andhra_CollegeOfVeterinarySciences_Krishna1,26-Aug-20,Regional,India,IND,Andhra,,07-Aug-20,12-Aug-20,Household and community samples,Multiple groups,3750,21.70%,,,Unclear,NA,CLIA,IgG,,,High,News and Media,Dr K Rambabu,College of Veterinary Sciences,https://theprint.in/health/andhras-second-sero-survey-begins-today-45000-samples-to-be-collected-from-9-districts/489208/,23/06/2021,16/07/2022,Unverified
200826_Andhra_CollegeOfVeterinary Sciences_Anantapur2,26-Aug-20,Regional,India,IND,Andhra,,07-Aug-20,12-Aug-20,Household and community samples,Multiple groups,3750,16.70%,,,Unclear,NA,CLIA,IgG,,,High,News and Media,Dr K Rambabu,College of Veterinary Sciences,https://theprint.in/health/andhras-second-sero-survey-begins-today-45000-samples-to-be-collected-from-9-districts/489208/,23/06/2021,16/07/2022,Unverified
200826_Andhra_CollegeOfVeterinary Sciences_EastGodavari3,26-Aug-20,Regional,India,IND,Andhra,,07-Aug-20,12-Aug-20,Household and community samples,Multiple groups,3750,14.40%,,,Unclear,NA,CLIA,IgG,,,High,News and Media,Dr K Rambabu,College of Veterinary Sciences,https://theprint.in/health/andhras-second-sero-survey-begins-today-45000-samples-to-be-collected-from-9-districts/489208/,23/06/2021,16/07/2022,Unverified
200826_Andhra_CollegeOfVeterinary Sciences_Nellore4,26-Aug-20,Regional,India,IND,Andhra,,07-Aug-20,12-Aug-20,Household and community samples,Multiple groups,3750,8.20%,,,Unclear,NA,CLIA,IgG,,,High,News and Media,Dr K Rambabu,College of Veterinary Sciences,https://theprint.in/health/andhras-second-sero-survey-begins-today-45000-samples-to-be-collected-from-9-districts/489208/,23/06/2021,16/07/2022,Unverified
200903_Ahmedabad_AhmedabadMunicipalCorporation,03-Sep-20,Local,India,IND,Gujarat,Ahmedabad,15-Aug-20,29-Aug-20,Household and community samples,Multiple groups,10310,23.24%,,,Unclear,NA,Not reported,Not reported,,,High,News and Media,Express News Service ,Ahmedabad Municipal Corporation,https://indianexpress.com/article/cities/ahmedabad/second-survey-in-ahmedabad-sero-positivity-up-by-5-6-per-cent-since-june-no-herd-immunity-yet-6580951/,23/06/2021,16/07/2022,Unverified
210601_Chennai_GovernmentKilpaukMedicalCollege,01-Jun-21,Local,India,IND,Tamil Nadu,Chennai,15-Apr-20,15-Dec-20,Health care workers and caregivers,Adults (18-64 years),45,26.66%,,,Convenience,J. Mitra & Co. Pvt. Ltd,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Therese Dhason,Government Kilpauk Medical College,http://dx.doi.org/10.7860/JCDR/2021/48889.14995,29/06/2021,16/07/2022,Unverified
210620_Delhi_AllIndiaInstituteOfMedicalScience,20-Jun-21,Local,India,IND,,New Delhi,01-Sep-20,30-Nov-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,164,14.00%,9.10%,20.30%,Convenience,Abbott Laboratories,CLIA,IgG,94.00%,100.00%,High,Preprint,Shivdas Rajaram Naik,All India Institute Of Medical Science,https://www.medrxiv.org/content/10.1101/2021.06.17.21259066v1.full-text,30/06/2021,16/07/2022,Verified
210710_SouthIndia_AravindEyeHospital_Primary,10-Jul-21,Regional,India,IND,South India,,19-Aug-20,28-Aug-20,Health care workers and caregivers,Multiple groups,1313,15.80%,,,Convenience,Zydus Diagnostics,ELISA,IgG,92.10%,99.70%,Moderate,Journal Article (Peer-Reviewed),Rajapandian Karthikeyan,Aravind Eye Hospital,https://dx.doi.org/10.1016/j.ijmmb.2021.06.014,19/07/2021,16/07/2022,Unverified
210721_India_IndianCouncilOfMedicalResearch_genpop_overall,21-Jul-21,National,India,IND,,,20-Jun-21,10-Jul-21,Household and community samples,Multiple groups,28975,67.60%,,,Simplified probability,NA,Not reported,IgG,,,Unclear,News and Media,Rhythma Kaul,Indian Council of Medical Research,https://www.hindustantimes.com/india-news/antibodies-in-68-indians-101626804217418.html,26/07/2021,16/07/2022,Verified
210722_Kolkata_IndianStatisticalInstitute_Primary,22-Jul-21,Local,India,IND,West Bengal,Kolkata,15-Nov-20,15-Jan-21,Health care workers and caregivers,Adults (18-64 years),313,40.00%,,,Simplified probability,Ortho Clinical Diagnostics Inc.,CLIA,Total Antibody,,,Moderate,Preprint,Soma Sarkar,Indian Statistical Institute,10.1101/2021.07.20.21260278,28/07/2021,16/07/2022,Verified
210722_Kerala_GovernmentMedicalCollegeThiruvananthapuram_TestAdj,22-Jul-21,Local,India,IND,Kerala,Thiruvananthapuram,08-Jan-21,19-Jan-21,Health care workers and caregivers,Adults (18-64 years),940,21.20%,,,Stratified probability,Ortho Clinical Diagnostics Inc.,CLIA,IgG,90.00%,100.00%,Moderate,Preprint,S J Jessy,Government Medical College Thiruvananthapuram,10.1101/2021.07.19.21260792,29/07/2021,16/07/2022,Unverified
210702_Ahmedabad_AMC-MET-MedicalCollege_Primary,02-Jul-21,Local,India,IND,Gujarat,Ahmedabad,15-Aug-20,31-Aug-20,Household and community samples,Multiple groups,10310,23.24%,22.43%,24.06%,Stratified probability,Zydus Diagnostics,ELISA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Om Prakash,AMC MET Medical College,https://dx.doi.org/10.4103/jfmpc.jfmpc_2062_20,04/08/2021,16/07/2022,Verified
210702_Jodhpur_AllIndiaInstituteOfMedicalSciences_1,02-Jul-21,Local,India,IND,Rajasthan,Jodhpur,28-Jul-20,28-Jul-20,Essential non-healthcare workers,Adults (18-64 years),22,2.44%,,,Unclear,J. Mitra & Co. Pvt. Ltd,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Vidhi Jain,All India Institute Of Medical Sciences,https://dx.doi.org/10.4103/jfmpc.jfmpc_2381_20,04/08/2021,16/07/2022,Unverified
210702_Jaipur_AllIndiaInstituteOfMedicalSciences_2,02-Jul-21,Local,India,IND,Rajasthan,Jaipur,04-Aug-20,04-Aug-20,Essential non-healthcare workers,Adults (18-64 years),41,13.64%,,,Unclear,J. Mitra & Co. Pvt. Ltd,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Vidhi Jain,All India Institute Of Medical Sciences,https://dx.doi.org/10.4103/jfmpc.jfmpc_2381_20,04/08/2021,16/07/2022,Unverified
210721_Pune_ArmedForcesMedicalCollege,27-Jul-21,Local,India,IND,Maharashtra,Pune,16-Jun-20,16-Aug-20,Non-essential workers and unemployed persons,Adults (18-64 years),413,7.50%,5.30%,10.40%,Convenience,Calbiotech Inc.,ELISA,IgG,98.00%,99.00%,Moderate,Journal Article (Peer-Reviewed),Sourav Sen,Armed Forces Medical College,https://dx.doi.org/10.1016/j.mjafi.2021.02.008,11/08/2021,16/07/2022,Unverified
210701_Kerala_ JubileeMissionMedicalCollegeandResearchInstitute_primary,01-Jul-21,Local,India,IND,,Kerala,20-Dec-20,30-Dec-20,Health care workers and caregivers,Adults (18-64 years),423,8.75%,6.23%,11.86%,Stratified non-probability,Ortho Clinical Diagnostics Inc.,CLIA,IgG,90.00%,100.00%,High,Journal Article (Peer-Reviewed),Aboobacker Mohamed Rafi, Jubilee Mission Medical College and Research Institute,https://www.jcdr.net/articles/PDF/15154/48703_CE[Ra1]_F(SL)_PF1(AG_OM)_PFA(KM_AnK)%20PB(AG_AnK)_PN(KM).pdf,12/08/2021,16/07/2022,Unverified
210726_India_ArmedForcesMedicalCollege,26-Jul-21,National,India,IND,,"Jaipur, Pune, Ahmedabad, Kolkata, Delhi, Jammu, Mumbai, Bangalore",21-Aug-20,20-Nov-20,Health care workers and caregivers,Adults (18-64 years),3253,19.70%,18.50%,21.70%,Simplified probability,Zydus Diagnostics,ELISA,IgG,92.40%,97.90%,High,Journal Article (Peer-Reviewed),Subhadeep Ghosh,Armed Forces Medical College,https://dx.doi.org/10.1016/j.mjafi.2021.03.020,12/08/2021,16/07/2022,Unverified
210501_Ahmedabad_MunicipalMedicalCollege_HCW,01-May-21,Local,India,IND,,Ahmedabad,15-Oct-20,31-Oct-20,Health care workers and caregivers,Adults (18-64 years),1737,20.84%,,,Convenience,Zydus Diagnostics,ELISA,IgG,92.37%,97.90%,High,Journal Article (Peer-Reviewed),Om Prakash,Municipal Medical College,https://www.nepjol.info/index.php/AJMS/article/view/35099,13/08/2021,16/07/2022,Verified
210501_Ahmedabad_MunicipalMedicalCollege_ContactCases,01-May-21,Local,India,IND,,Ahmedabad,15-Oct-20,31-Oct-20,Contacts of COVID patients,Multiple groups,2038,26.05%,,,Convenience,Zydus Diagnostics,ELISA,IgG,92.37%,97.90%,High,Journal Article (Peer-Reviewed),Om Prakash,Municipal Medical College,https://www.nepjol.info/index.php/AJMS/article/view/35099,13/08/2021,16/07/2022,Verified
210810_Odisha_IndianCouncilofMedicalResearch_primary,10-Aug-21,Regional,India,IND,Odisha,,15-Jul-20,15-Nov-20,Multiple populations,Multiple groups,5434,34.90%,33.60%,36.20%,Convenience,Roche Diagnostics,CLIA,IgG,,,High,Preprint,Srikanta Kanungo,Indian Council of Medical Research,https://www.researchsquare.com/article/rs-664559/v1,16/08/2021,16/07/2022,Verified
210811_Karnataka_IndianInstituteofPublicHealth_Overall_PopTestAdj,11-Aug-21,Regional,India,IND,Karnataka,,25-Jan-21,18-Feb-21,Multiple populations,Multiple groups,41228,15.60%,14.90%,16.30%,Stratified probability,Zydus Diagnostics,ELISA,IgG,92.37%,97.90%,Moderate,Preprint,Rajagopal Padma,Indian Institute of Public Health,https://www.medrxiv.org/content/10.1101/2021.08.10.21261842v1,18/08/2021,16/07/2022,Unverified
210813_Madurai_UniversityOfCaliforniaBerkeley_Primary,13-Aug-21,Local,India,IND,Tami Nadu,Madurai,19-Oct-20,05-Nov-20,Household and community samples,Multiple groups,1140,40.20%,35.90%,44.70%,Stratified probability,Shenzhen Yhlo Biotech Co. Ltd,CLIA,IgG,93.00%,92.90%,Moderate,Journal Article (Peer-Reviewed),Ramanan Laxminarayan,University of California Berkeley,https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(21)00393-5/fulltext,31/08/2021,16/07/2022,Verified
210518_Odisha_ICMR-RegionalMedicalResearchCentre_BAM_GenderAdj,18-May-21,Local,India,IND,Odisha,Berhampur,01-Aug-20,31-Aug-20,Household and community samples,Multiple groups,1375,31.14%,28.69%,33.66%,Simplified probability,Roche Diagnostics,CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Jaya Singh Kshatri,ICMR-Regional Medical Research Centre,https://dx.doi.org/10.1038/s41598-021-89877-y,04/09/2021,16/07/2022,Verified
210518_Odisha_ICMR-RegionalMedicalResearchCentre_BBS_GenderAdj,18-May-21,Local,India,IND,Odisha,Bhubaneswar,01-Aug-20,31-Aug-20,Household and community samples,Multiple groups,1319,5.24%,4.10%,6.58%,Simplified probability,Roche Diagnostics,CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Jaya Singh Kshatri,ICMR-Regional Medical Research Centre,https://dx.doi.org/10.1038/s41598-021-89877-y,04/09/2021,16/07/2022,Verified
210518_Odisha_ICMR-RegionalMedicalResearchCentre_RKL_GenderADj,18-May-21,Local,India,IND,Odisha,Rourkela,01-Aug-20,31-Aug-20,Household and community samples,Multiple groups,1452,24.59%,22.39%,26.88%,Simplified probability,Roche Diagnostics,CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Jaya Singh Kshatri,ICMR-Regional Medical Research Centre,https://dx.doi.org/10.1038/s41598-021-89877-y,04/09/2021,16/07/2022,Verified
210829_Delhi_CouncilOfScientificAndIndustrialResearch_overall,29-Aug-21,Local,India,IND,,Delhi,15-May-21,15-Jun-21,Multiple populations,Multiple groups,846,87.00%,,,Convenience,NA,Not reported,Not reported,,,Unclear,News and Media,Anonna Dutt,Council Of Scientific And Industrial Research (CSIR),https://www.hindustantimes.com/india-news/covid-crisis-one-in-four-patients-in-delhi-were-reinfected-during-the-second-wave-says-preprint-study-101630175376759-amp.html,06/09/2021,16/07/2022,Unverified
210701_India_IndianCouncilOfMedicalResearch_GenPop_TestPopAdj,01-Jul-21,National,India,IND,,,18-Dec-20,06-Jan-21,Household and community samples,Multiple groups,28598,24.10%,23.00%,25.30%,Stratified probability,"Siemens,Abbott Laboratories",Multiple Types,IgG,,,Low,Journal Article (Peer-Reviewed),Manoj V Murhekar,Indian Council of Medical Research,http://dx.doi.org/10.1016/j.ijid.2021.05.040,13/09/2021,16/07/2022,Verified
210701_India_IndianCouncilOfMedicalResearch_HCWs_TestPopAdj,01-Jul-21,National,India,IND,,,18-Dec-20,06-Jan-21,Health care workers and caregivers,Multiple groups,7385,25.60%,23.50%,27.80%,Stratified probability,Siemens,CLIA,IgG,100.00%,99.90%,Low,Journal Article (Peer-Reviewed),Manoj V Murhekar,Indian Council of Medical Research,http://dx.doi.org/10.1016/j.ijid.2021.05.040,13/09/2021,16/07/2022,Verified
210802_Delhi_ DirectorateGeneralHealthServices_Aug1_PopTestAdj,02-Aug-21,Regional,India,IND,NCT Delhi,,01-Aug-20,07-Aug-20,Household and community samples,Multiple groups,14779,28.39%,27.65%,29.14%,Stratified probability,J. Mitra & Co. Pvt. Ltd,ELISA,IgG,92.10%,97.70%,Low,Journal Article (Peer-Reviewed),Nandini Sharma,Government of National Capital Territory of Delhi,https://dx.doi.org/10.1093/trstmh/trab109,14/09/2021,16/07/2022,Verified
210802_Delhi_ DirectorateGeneralHealthServices_Oct3_PopTestAdj,02-Aug-21,Regional,India,IND,NCT Delhi,,15-Oct-20,21-Oct-20,Household and community samples,Multiple groups,14905,24.71%,24.01%,25.42%,Stratified probability,Calbiotech Inc.,ELISA,IgG,99.12%,99.33%,Low,Journal Article (Peer-Reviewed),Nandini Sharma,Government of National Capital Territory of Delhi,https://dx.doi.org/10.1093/trstmh/trab109,14/09/2021,16/07/2022,Verified
210802_Delhi_ DirectorateGeneralHealthServices_Sept2_PopTestAdj,02-Aug-21,Regional,India,IND,NCT Delhi,,01-Sep-20,07-Sep-20,Household and community samples,Multiple groups,16953,24.08%,23.43%,24.74%,Stratified probability,Calbiotech Inc.,ELISA,IgG,99.12%,99.33%,Low,Journal Article (Peer-Reviewed),Nandini Sharma,Government of National Capital Territory of Delhi,https://dx.doi.org/10.1093/trstmh/trab109,14/09/2021,16/07/2022,Verified
210801_India_SevenHillsDedicatedCovidHospital,01-Aug-21,Local,India,IND,Maharashtra,Mumbai,15-Dec-20,15-Feb-21,Health care workers and caregivers,Adults (18-64 years),1005,12.30%,,,Convenience,Shenzhen Yhlo Biotech Co. Ltd,Multiple Types,IgG,,,Moderate,Journal Article (Peer-Reviewed),Chavhan Santosh,Seven Hills Dedicated Covid Hospital,https://europepmc.org/article/med/34472805,15/09/2021,16/07/2022,Unverified
210913_Delhi_MaulanaAzadMedicalCollege_PopTestAdj,13-Sep-21,Regional,India,IND,Delhi,,11-Jan-21,22-Jan-21,Household and community samples,Multiple groups,27436,56.13%,55.49%,56.77%,Stratified probability,Ortho Clinical Diagnostics Inc.,CLIA,IgG,90.00%,100.00%,Low,Preprint,Nandini Sharma,Maulana Azad Medical College,10.1101/2021.09.09.21263331,21/09/2021,16/07/2022,Verified
210903_Maharashtra_ICMR-NationalInstituteOfImmunohematology,03-Sep-21,Regional,India,IND,Maharashtra,Dombivli,21-Jul-20,03-Aug-20,Health care workers and caregivers,Adults (18-64 years),500,11.00%,,,Convenience,Zydus Diagnostics,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Reetika Malik Yadav,ICMR-National Institute of Immunohematology,https://dx.doi.org/10.2991/jegh.k.210518.001,24/09/2021,16/07/2022,Unverified
210918_Chandigarh_GovernmentMedicalCollegeandHospital_overall,18-Sep-21,Local,India,IND,Punjab,Chandigarh,01-Jul-21,31-Jul-21,Household and community samples,Adults (18-64 years),1200,80.20%,,,Simplified probability,NA,Not reported,Not reported,,,Unclear,News and Media,Hindustan Times Correspondent,Government Medical College and Hospital,https://www.hindustantimes.com/cities/chandigarh-news/sero-survey-80-of-chandigarh-s-adults-have-covid-antibodies-101631914347989.html,24/09/2021,16/07/2022,Verified
210922_PimpriChinchwad_DrDYPatilVidyapeeth_Overall,22-Sep-21,Local,India,IND,Maharashtra,Pimpri-Chinchwad,07-Oct-20,17-Oct-20,Household and community samples,Multiple groups,5000,34.04%,31.30%,36.80%,Stratified probability,Abbott Laboratories,CLIA,IgG,92.70%,99.90%,Low,Journal Article (Peer-Reviewed),Amitav Banerjee,"Dr. D. Y. Patil Medical College, Hospital and Research Centre",https://www.ijph.in/article.asp?issn=0019-557X;year=2021;volume=65;issue=3;spage=256;epage=260;aulast=Banerjee,05/10/2021,16/07/2022,Verified
210923_Kashmir_GovernmentMedicalCollegeSrinagar_PopAndTestAdjusted,23-Sep-21,Regional,India,IND,Kashmir,,17-Oct-20,04-Nov-20,Household and community samples,Multiple groups,6230,36.70%,34.30%,39.20%,Stratified probability,Abbott Laboratories,CLIA,IgG,100.00%,99.63%,Low,Journal Article (Peer-Reviewed),Muhammad Khan,Government Medical College Srinagar,https://dx.doi.org/10.1136/bmjopen-2021-053791,05/10/2021,16/07/2022,Verified
210919_India_TataMainHospital_Jul2021_Primary,19-Sep-21,Local,India,IND,Jharkhand,,01-Jul-21,31-Jul-21,Multiple populations,Multiple groups,4575,75.00%,,,Unclear,Beckman Coulter,CLIA,IgG,100.00%,100.00%,High,Journal Article (Peer-Reviewed),Deb Sanjay Nag,Tata Main Hospital,https://dx.doi.org/10.7759/cureus.18097,05/10/2021,16/07/2022,Verified
211005_NewDelhi_AllIndiaInstituteofMedicalSciences_Overall,05-Oct-21,Local,India,IND,Delhi,New Delhi,01-Jan-20,26-Feb-21,Household and community samples,Adults (18-64 years),352,45.20%,,,Unclear,DiaSorin,CLIA,IgG,97.40%,98.50%,High,Journal Article (Peer-Reviewed),Alpesh Goyal,All India Institute of Medical Sciences,https://dx.doi.org/10.1007/s13300-021-01158-z,12/10/2021,16/07/2022,Unverified
210901_Potheri_SRMInstituteofScienceandTechnology_Group1_Overall,01-Sep-21,Local,India,IND,Tamil Nadu,Potheri,15-Jan-21,15-Feb-21,Health care workers and caregivers,Adults (18-64 years),82,9.76%,,,Convenience,NA,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Bhuvanamha Ramamurthy,SRM Institute of Science and Technology,https://www.jcdr.net/article_fulltext.asp?issn=0973-709x&year=2021&volume=15&issue=9&page=EC29&issn=0973-709x&id=15422,13/10/2021,16/07/2022,Unverified
210901_Potheri_SRMInstituteofScienceandTechnology_Group2_Overall,01-Sep-21,Local,India,IND,Tamil Nadu,Potheri,15-Jan-21,15-Feb-21,Health care workers and caregivers,Adults (18-64 years),46,13.04%,,,Convenience,NA,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Bhuvanamha Ramamurthy,SRM Institute of Science and Technology,https://www.jcdr.net/article_fulltext.asp?issn=0973-709x&year=2021&volume=15&issue=9&page=EC29&issn=0973-709x&id=15422,13/10/2021,16/07/2022,Unverified
211011_Kerala_KeralaGovernment_Primary,11-Oct-21,Regional,India,IND,Kerala,,04-Jul-21,07-Aug-21,Household and community samples,Multiple groups,13000,82.60%,,,Unclear,NA,Not reported,Not reported,,,Unclear,News and Media,Hindustan Times,Kerala Government,https://www.hindustantimes.com/india-news/82-adults-in-state-have-covid-19-antibodies-says-latest-serosurvey-in-kerala-101633964468707.html,19/10/2021,16/07/2022,Verified
210827_Bhubaneswar_AllIndiaInstituteOfMedicalSciences_Primary,27-Aug-21,Local,India,IND,Odisha,Bhubaneswar,01-Aug-20,08-Aug-20,Health care workers and caregivers,Adults (18-64 years),821,3.90%,2.60%,5.10%,Simplified probability,SD Biosensor,LFIA,"IgG,IgM",99.10%,95.09%,Moderate,Journal Article (Peer-Reviewed),Mishra Baijayantimala,All India Institute of Medical Sciences (AIIMS),https://dx.doi.org/10.4103/jfmpc.jfmpc_2486_20,25/10/2021,16/07/2022,Unverified
211013_Odisha_GovernmentofIndia_Primary,13-Oct-21,Regional,India,IND,Odisha,,01-Jan-21,31-Jan-21,Health care workers and caregivers,Adults (18-64 years),134,41.00%,,,Convenience,Roche Diagnostics,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Debaprasad Parai,Government of India,https://dx.doi.org/10.1016/j.tmaid.2021.102170,26/10/2021,16/07/2022,Unverified
211013_Cuttack_SriramChandraBhanjaMedicalCollegeandHospital_Primary,13-Oct-21,Local,India,IND,"Odisha
",Cuttack,01-Nov-20,31-Jan-21,Blood donors,Adults (18-64 years),1032,35.85%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Smita Mahapatra,Sriram Chandra Bhanja Medical College and Hospital,https://dx.doi.org/10.1016/j.tracli.2021.10.004,26/10/2021,16/07/2022,Verified
210906_NashikCity_GovernmentMedicalCollege_NonSlums_Overall,06-Sep-21,Local,India,IND,Maharashtra ,Nashik,09-Jan-21,11-Jan-21,Household and community samples,Multiple groups,1629,38.12%,35.76%,40.53%,Stratified probability,NA,ELISA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Bapusaheb Nagargoje,Government Medical College,https://www.jrmds.in/articles/seroprevalence-of-covid19-in-a-city-in-india-a-communitybased-crosssectional-study-83821.html,02/11/2021,16/07/2022,Verified
210906_NashikCity_GovernmentMedicalCollege_Slums_Overall,06-Sep-21,Local,India,IND,Maharashtra ,Nashik,09-Jan-21,11-Jan-21,Household and community samples,Multiple groups,726,42.70%,39.07%,46.39%,Stratified probability,NA,ELISA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Bapusaheb Nagargoje,Government Medical College,https://www.jrmds.in/articles/seroprevalence-of-covid19-in-a-city-in-india-a-communitybased-crosssectional-study-83821.html,02/11/2021,16/07/2022,Verified
211020_NewDelhi_ SirGangaRamHospital_Overall,20-Oct-21,Local,India,IND,,New Delhi,18-Sep-20,24-Sep-20,Health care workers and caregivers,Multiple groups,1033,25.85%,,,Stratified probability,Ortho Clinical Diagnostics Inc.,CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Chand Wattal, Sir Ganga Ram Hospital,https://dx.doi.org/10.1016/j.ijmmb.2021.09.011,04/11/2021,16/07/2022,Unverified
211014_Delhi_InstituteofLiverandBiliarySciences_Primary,14-Oct-21,Local,India,IND,,"Delhi
",24-Sep-20,31-Oct-20,Blood donors,Adults (18-64 years),1066,27.57%,,,Convenience,Ortho Clinical Diagnostics Inc.,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Pratibha Kale,Institute of Liver and Biliary Sciences,https://dx.doi.org/10.1016/j.transci.2021.103293,05/11/2021,16/07/2022,Verified
211029_Delhi_MaulanaAzadMedicalCollege,29-Oct-21,Local,India,IND,,Delhi,24-Sep-20,09-Oct-21,Household and community samples,Multiple groups,28000,97.00%,,,Stratified probability,NA,CLIA,Not reported,,,Moderate,News and Media,The Times of India,Maulana Azad Medical College,https://timesofindia.indiatimes.com/city/delhi/covid-antibodies-found-in-97-of-delhi-residents/articleshow/87350053.cms,09/11/2021,16/07/2022,Unverified
211029_Jatni_ICMRRegionalMedicalResearchCentre,29-Oct-21,Local,India,IND,Odisha,Jatni,15-Jan-21,15-Feb-21,Household and community samples,Multiple groups,174,42.53%,,,Simplified probability,Diagnostic Bioprobes,ELISA,IgG,98.00%,98.00%,Moderate,Journal Article (Peer-Reviewed),Abhinav Sinha,ICMR-Regional Medical Research Centre,https://dx.doi.org/10.1080/21645515.2021.1989925,10/11/2021,16/07/2022,Unverified
211026_UttarPrasesh_GovernmentofUttarPradesh_primary,26-Oct-21,Regional,India,IND,Uttar Pradesh,,04-Sep-20,10-Sep-20,Household and community samples,Multiple groups,16012,22.20%,21.50%,22.90%,Stratified probability,Zydus Diagnostics,LFIA,IgG,92.37%,97.90%,Low,Journal Article (Peer-Reviewed),Vasanthakumar Namasivayam,Government of Uttar Pradesh,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8546397/,11/11/2021,16/07/2022,Verified
210601_Kerala_GovernmentofKerala,01-Jun-21,National,India,IND,,,01-May-21,31-May-21,Household and community samples,Multiple groups,28975,67.60%,,,Unclear,NA,Not reported,IgG,,,Unclear,Institutional Report,Government of Kerala,Government of Kerala Department of Health & Family Welfare,https://health.kerala.gov.in/pdf/Technical_paper_COVID_19_Sero_Surveillance_Round_4_ICMR.pdf,18/11/2021,16/07/2022,Unverified
210101_Kerala_GovernmentofKerala,01-Jan-21,Regional,India,IND,Kerala,,20-Dec-20,30-Dec-20,Household and community samples,Multiple groups,1246,11.60%,9.91%,13.50%,Unclear,NA,Not reported,IgG,,,Unclear,Institutional Report,Government of Kerala,Government of Kerala Department of Health & Family Welfare,https://health.kerala.gov.in/pdf/Technical-paper-COVID-19-Sero-Surveillance-Round-3-ICMR.pdf,18/11/2021,16/07/2022,Unverified
210930_Kerala_GovernmentOfKerala_GenPop_Primary,30-Sep-21,Regional,India,IND,Kerala,,01-Sep-21,30-Sep-21,Household and community samples,Multiple groups,4429,82.61%,81.50%,83.73%,Stratified probability,"Siemens,Abbott Laboratories",CLIA,IgG,,,Moderate,Institutional Report,Government of Kerala,Government of Kerala Department of Health,https://health.kerala.gov.in/pdf/Sero_Surveillance_Report_aug_sep.pdf,19/11/2021,16/07/2022,Verified
210930_Kerala_GovernmentOfKerala_Antenatal_Primary,30-Sep-21,Regional,India,IND,Kerala,,15-Aug-21,15-Sep-21,Pregnant or parturient women,Adults (18-64 years),2274,65.40%,63.40%,67.40%,Convenience,"Siemens,Abbott Laboratories",CLIA,IgG,,,Moderate,Institutional Report,Government of Kerala,Government of Kerala Department of Health,https://health.kerala.gov.in/pdf/Sero_Surveillance_Report_aug_sep.pdf,19/11/2021,16/07/2022,Verified
210930_Kerala_GovernmentOfKerala_Children_Primary,30-Sep-21,Regional,India,IND,Kerala,,01-Sep-21,30-Sep-21,Household and community samples,Children and Youth (0-17 years),1459,40.20%,,,Stratified probability,"Siemens,Abbott Laboratories",CLIA,IgG,,,Moderate,Institutional Report,Government of Kerala,Government of Kerala Department of Health,https://health.kerala.gov.in/pdf/Sero_Surveillance_Report_aug_sep.pdf,19/11/2021,16/07/2022,Verified
210930_Kerala_GovernmentOfKerala_Tribal_Primary,30-Sep-21,Regional,India,IND,Kerala,,01-Sep-21,30-Sep-21,Household and community samples,Multiple groups,1521,78.20%,,,Stratified probability,"Siemens,Abbott Laboratories",CLIA,IgG,,,Moderate,Institutional Report,Government of Kerala,Government of Kerala Department of Health,https://health.kerala.gov.in/pdf/Sero_Surveillance_Report_aug_sep.pdf,19/11/2021,16/07/2022,Verified
210930_Kerala_GovernmentOfKerala_Coastal_Primary,30-Sep-21,Regional,India,IND,Kerala,,01-Sep-21,30-Sep-21,Household and community samples,Multiple groups,1476,87.70%,86.00%,89.30%,Stratified probability,"Siemens,Abbott Laboratories",CLIA,IgG,,,Moderate,Institutional Report,Government of Kerala,Government of Kerala Department of Health,https://health.kerala.gov.in/pdf/Sero_Surveillance_Report_aug_sep.pdf,19/11/2021,16/07/2022,Verified
210930_Kerala_GovernmentOfKerala_Slum_Primary,30-Sep-21,Regional,India,IND,Kerala,,01-Sep-21,30-Sep-21,Persons living in slums,Multiple groups,1706,85.30%,83.63%,86.97%,Stratified probability,"Siemens,Abbott Laboratories",CLIA,IgG,,,Moderate,Institutional Report,Government of Kerala,Government of Kerala Department of Health,https://health.kerala.gov.in/pdf/Sero_Surveillance_Report_aug_sep.pdf,19/11/2021,16/07/2022,Verified
211115_TamilNadu_GovernmentofTamilNadu_Round1_Primary,15-Nov-21,Regional,India,IND,Tamil Nadu,,19-Oct-20,30-Nov-20,Household and community samples,Multiple groups,26135,31.60%,30.30%,32.70%,Stratified probability,"Ortho Clinical Diagnostics Inc.,Shenzhen Yhlo Biotech Co. Ltd",CLIA,IgG,,,Moderate,Preprint,T S Selvavinayagam,Government of Tamil Nadu,https://www.medrxiv.org/content/10.1101/2021.11.14.21265758v1.full-text,23/11/2021,16/07/2022,Unverified
211115_TamilNadu_GovernmentofTamilNadu_Round2_Primary,15-Nov-21,Regional,India,IND,Tamil Nadu,,07-Apr-21,30-Apr-21,Household and community samples,Multiple groups,21992,22.90%,21.80%,23.90%,Stratified probability,"Ortho Clinical Diagnostics Inc.,Shenzhen Yhlo Biotech Co. Ltd",CLIA,IgG,,,Moderate,Preprint,T S Selvavinayagam,Government of Tamil Nadu,https://www.medrxiv.org/content/10.1101/2021.11.14.21265758v1.full-text,23/11/2021,16/07/2022,Unverified
211115_TamilNadu_GovernmentofTamilNadu_Round3_Primary,15-Nov-21,Regional,India,IND,Tamil Nadu,,28-Jun-21,07-Jul-21,Household and community samples,Multiple groups,26592,67.10%,65.90%,68.30%,Stratified probability,"Ortho Clinical Diagnostics Inc.,Shenzhen Yhlo Biotech Co. Ltd",CLIA,IgG,,,Moderate,Preprint,T S Selvavinayagam,Government of Tamil Nadu,https://www.medrxiv.org/content/10.1101/2021.11.14.21265758v1.full-text,23/11/2021,16/07/2022,Unverified
211110_Bangalore_BangaloreBaptistHospital_Phase1_HCW_overall,10-Nov-21,Local,India,IND,Karnataka,Bangalore,15-May-20,15-Jun-20,Health care workers and caregivers,Adults (18-64 years),211,0.00%,,,Convenience,Roche Diagnostics,CLIA,"IgG,IgM,IgA",97.20%,99.80%,High,Journal Article (Peer-Reviewed),Sindhulina Chandrasingh,Bangalore Baptist Hospital,https://dx.doi.org/10.1016/j.ijmmb.2021.10.006,24/11/2021,16/07/2022,Verified
211110_Bangalore_BangaloreBaptistHospital_Phase2_HCW_overall,10-Nov-21,Local,India,IND,Karnataka,Bangalore,15-Sep-20,15-Nov-20,Health care workers and caregivers,Adults (18-64 years),206,9.20%,8.60%,9.40%,Convenience,Roche Diagnostics,CLIA,"IgG,IgM,IgA",97.20%,99.80%,High,Journal Article (Peer-Reviewed),Sindhulina Chandrasingh,Bangalore Baptist Hospital,https://dx.doi.org/10.1016/j.ijmmb.2021.10.006,24/11/2021,16/07/2022,Verified
211110_Karnataka_BangaloreBaptistHospital_Phase1_BloodDonors_overall,10-Nov-21,Regional,India,IND,Karnataka,,15-May-20,15-Jun-20,Blood donors,Multiple groups,210,0.00%,,,Convenience,Roche Diagnostics,CLIA,"IgG,IgM,IgA",97.20%,99.80%,High,Journal Article (Peer-Reviewed),Sindhulina Chandrasingh,Bangalore Baptist Hospital,https://dx.doi.org/10.1016/j.ijmmb.2021.10.006,24/11/2021,16/07/2022,Verified
211118_Delhi_RajivGandhiSuperSpecialityHospital,18-Nov-21,Local,India,IND,,Delhi,01-Oct-20,31-Oct-20,Health care workers and caregivers,Adults (18-64 years),305,21.96%,,,Unclear,Calbiotech Inc.,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),B.L. Sherwal,Rajiv Gandhi Super Speciality Hospital,https://dx.doi.org/10.1016/j.ijmmb.2021.11.006,30/11/2021,16/07/2022,Unverified
210914_Chennai_NationalInstituteofEpidemiology_Overall_PopandTestAdjusted,14-Sep-21,Local,India,IND,Tamil Nadu,Chennai,08-Oct-20,15-Oct-20,Household and community samples,Multiple groups,6366,30.10%,24.70%,36.10%,Stratified probability,Abbott Laboratories,CLIA,IgG,100.00%,99.60%,Low,Journal Article (Peer-Reviewed),Muthusamy Kumar,National Institute of Epidemiology,https://academic.oup.com/trstmh/article/115/11/1350/6370308?login=true,30/11/2021,16/07/2022,Verified
211119_Kashmir_GovernmentMedicalCollegeSrinagarJammuKashmir_Primary,19-Nov-21,Regional,India,IND,Kashmir,,14-Jan-21,17-Jan-21,Health care workers and caregivers,Adults (18-64 years),2003,26.80%,24.80%,28.80%,Convenience,NA,CLIA,IgG,100.00%,99.00%,Moderate,Journal Article (Peer-Reviewed),Inaamul Haq,"Government Medical College Srinagar, Jammu and Kashmir",https://dx.doi.org/10.1371/journal.pone.0259893,01/12/2021,16/07/2022,Unverified
211029_Maharashtra_ArmedForcesMedicalCollege_Primary,29-Oct-21,Regional,India,IND,Maharashtra,,01-Aug-20,31-Aug-20,Health care workers and caregivers,Adults (18-64 years),117,32.48%,,,Convenience,NA,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Harish Kumur,Armed Forces Medical College,https://www.journaljpri.com/index.php/JPRI/article/view/33074,07/12/2021,16/07/2022,Unverified
211210_India_ICMR_GenPop_OverallTestAdjust,10-Dec-21,National,India,IND,"Andhra Pradesh,Assam,Bihar,Chhattisgarh,Gujarat,Haryana,Himachal Pradesh,Jammu & Kashmir,Jharkhand,Karnataka,Kerala,Madhya Pradesh,Maharashtra,Odisha,Punjab,Rajasthan,Tamil Nadu,Telangana,Uttar Pradesh,Uttarakhand,West Bengal",,14-Jun-21,06-Jul-21,Household and community samples,Multiple groups,28975,66.80%,65.50%,68.00%,Stratified probability,Siemens,CLIA,IgG,80.00%,99.00%,Moderate,Journal Article (Peer-Reviewed),Manoj Murhekar,Indian Council of Medical Research,https://dx.doi.org/10.1371/journal.pmed.1003877,29/12/2021,16/07/2022,Unverified
211210_India_ICMR_HCW_OverallTestAdjust,10-Dec-21,National,India,IND,"Andhra Pradesh,Assam,Bihar,Chhattisgarh,Gujarat,Haryana,Himachal Pradesh,Jammu & Kashmir,Jharkhand,Karnataka,Kerala,Madhya Pradesh,Maharashtra,Odisha,Punjab,Rajasthan,Tamil Nadu,Telangana,Uttar Pradesh,Uttarakhand,West Bengal",,14-Jun-21,06-Jul-21,Health care workers and caregivers,Multiple groups,7252,87.40%,85.60%,89.10%,Convenience,Siemens,CLIA,IgG,80.00%,99.00%,Moderate,Journal Article (Peer-Reviewed),Manoj Murhekar,Indian Council of Medical Research,https://dx.doi.org/10.1371/journal.pmed.1003877,29/12/2021,16/07/2022,Unverified
211107_India_ESICMedicalCollegeAndHospital_OverallCrude,07-Nov-21,Local,India,IND,Telangana,Hyderabad,15-Oct-20,15-Jan-21,Health care workers and caregivers,Multiple groups,190,25.26%,,,Unclear,Ortho Clinical Diagnostics Inc.,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),Lakshmi Tadi,ESIC Medical College & Hospital,https://dx.doi.org/10.7759/cureus.19341,04/01/2022,16/07/2022,Unverified
211205_Jaipur_MahatmaGandhiMedicalCollege&Hospital_Overall,05-Dec-21,Local,India,IND,Rajasthan,Jaipur,15-Dec-20,15-Jan-21,Blood donors,Adults (18-64 years),534,42.88%,,,Sequential,Ortho Clinical Diagnostics Inc.,CLIA,IgG,90.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Ram Jaiswal,Mahatma Gandhi Medical College & Hospital,https://dx.doi.org/10.1016/j.transci.2021.103338,08/01/2022,16/07/2022,Unverified
211227_Vellore_ChristianMedicalCollege_Jan2021_PopAdj,27-Dec-21,Local,India,IND,,Vellore,01-Jan-21,31-Jan-21,Household and community samples,Multiple groups,1228,28.50%,22.30%,33.70%,Stratified probability,"InBios International, Inc.",ELISA,IgG,,97.60%,Moderate,Journal Article (Peer-Reviewed),Divya Dayanand,Christian Medical College,https://dx.doi.org/10.1016/j.ijid.2021.12.356,08/01/2022,16/07/2022,Verified
211227_Vellore_ChristianMedicalCollege_July2021_PopAdj,27-Dec-21,Local,India,IND,,Vellore,01-Jul-21,31-Jul-21,Household and community samples,Multiple groups,1205,71.60%,62.80%,80.50%,Stratified probability,"InBios International, Inc.",ELISA,IgG,,97.60%,Moderate,Journal Article (Peer-Reviewed),Divya Dayanand,Christian Medical College,https://dx.doi.org/10.1016/j.ijid.2021.12.356,08/01/2022,16/07/2022,Verified
210921_Mumbai_UniversityofPittsburghMedicalCenter_Patients_Overall,21-Sep-21,Local,India,IND,Maharashtra,Mumbai,24-Mar-20,17-May-20,Residual sera,Multiple groups,110,37.27%,,,Convenience,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Viswanath Billa,University of Pittsburgh Medical Center,https://dx.doi.org/10.4103/ijn.IJN_361_20,09/01/2022,16/07/2022,Unverified
210921_Mumbai_UniversityofPittsburghMedicalCenter_Staff_Overall,21-Sep-21,Local,India,IND,Maharashtra,Mumbai,24-Mar-20,17-May-20,Health care workers and caregivers,Multiple groups,85,43.53%,,,Convenience,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Viswanath Billa,University of Pittsburgh Medical Center,https://dx.doi.org/10.4103/ijn.IJN_361_20,09/01/2022,16/07/2022,Unverified
211229_UttarPradesh_KingGeorgeMedicalUniversity_blooddonors_Overall,29-Dec-21,Regional,India,IND,Uttar Pradesh,Lucknow,01-Jun-20,30-Jun-20,Blood donors,Adults (18-64 years),2163,1.90%,1.36%,2.52%,Sequential,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Tulika Chandra,King George Medical University,https://dx.doi.org/10.1155/2021/2404170,11/01/2022,16/07/2022,Unverified
211229_Lucknow_KingGeorgeMedicalUniversity_HCWs,29-Dec-21,Local,India,IND,Uttar Pradesh,Lucknow,01-Jun-20,30-Jun-20,Health care workers and caregivers,Adults (18-64 years),560,2.30%,1.07%,3.57%,Simplified probability,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Tulika Chandra,King George Medical University,https://dx.doi.org/10.1155/2021/2404170,11/01/2022,16/07/2022,Unverified
211214_NewDelhi_AllIndiaInstituteofMedicalSciences_overall,14-Dec-21,Local,India,IND,National Capital Territory of Delhi,New Delhi,01-Oct-20,27-Feb-21,Multiple populations,Multiple groups,643,50.40%,,,Convenience,DiaSorin,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Alpesh Goyal,All India Institute of Medical Sciences,https://dx.doi.org/10.1016/j.eprac.2021.12.009,12/01/2022,16/07/2022,Unverified
211229_Delhi_MaulanaAzadMedicalCollege_Overall_PopTestAdj,29-Dec-21,Regional,India,IND,Delhi,Delhi,24-Sep-21,14-Oct-21,Household and community samples,Multiple groups,27811,97.50%,97.00%,98.00%,Stratified probability,Ortho Clinical Diagnostics Inc.,CLIA,IgG,90.00%,100.00%,Low,Preprint,Pragya Sharma,Maulana Azad Medical College,https://www.medrxiv.org/content/10.1101/2021.12.28.21268451v1,12/01/2022,16/07/2022,Verified
211231_Delhi_HamdardInstituteoMedicalSciencesandResearch,31-Dec-21,Local,India,IND,,Delhi,15-Sep-20,15-Feb-21,Contacts of COVID patients,Adults (18-64 years),407,28.90%,24.60%,33.60%,Convenience,Roche Diagnostics,CLIA,"IgM,IgG",,,High,Journal Article (Peer-Reviewed),Ayan Kumar Das,Hamdard Institute of Medical Sciences & Research,https://dx.doi.org/10.1016/j.ijmmb.2021.12.012,19/01/2022,16/07/2022,Unverified
211229_Delhi_MaulanaAzadMedicalCollege_HCW,29-Dec-21,Local,India,IND,,Delhi,02-Dec-20,25-May-21,Health care workers and caregivers,Adults (18-64 years),625,51.36%,,,Convenience,Beijing Wantai Biological,ELISA,IgG,94.70%,100.00%,Moderate,Journal Article (Peer-Reviewed),Pragya Sharma,Maulana Azad Medical College,https://www.cureus.com/articles/80002-seroprevalence-of-sars-cov-2-and-risk-assessment-among-healthcare-workers-at-a-dedicated-tertiary-care-covid-19-hospital-in-delhi-india-a-cohort-study,21/01/2022,16/07/2022,Unverified
211201_Chennai_YRCCARE,01-Dec-21,Local,India,IND,Tamil Nadu,Chennai,15-Dec-20,15-May-21,Patients seeking care for non-COVID-19 reasons,Multiple groups,393,10.40%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Presentation or Conference,RT Khan,YRGCARE,https://journals.sagepub.com/doi/abs/10.1177/13596535211063242?journalCode=avta,02/02/2022,16/07/2022,Unverified
220126_India_CouncilOfScientificAndIndustrialResearch_202106_TestAdjusted,26-Jan-22,Regional,India,IND," Arunachal Pradesh, Assam, Manipur, Meghalaya, Mizoram, Nagaland, Tripura, Sikkim",,01-Jun-21,30-Jun-21,Household and community samples,Multiple groups,436,46.23%,41.55%,50.91%,Unclear,Roche Diagnostics,Not reported,IgG,99.80%,100.00%,Unclear,Preprint,Romi Wahengbam,Council of Scientific and Industrial Research,https://www.medrxiv.org/content/10.1101/2022.01.25.22269702v1.full-text,11/02/2022,16/07/2022,Verified
220126_India_CouncilOfScientificAndIndustrialResearch_202102_TestAdjusted,26-Jan-22,Regional,India,IND," Arunachal Pradesh, Assam, Manipur, Meghalaya, Mizoram, Nagaland, Tripura, Sikkim",,01-Feb-21,28-Feb-21,Household and community samples,Multiple groups,866,40.21%,36.95%,43.48%,Unclear,Roche Diagnostics,Not reported,IgG,99.80%,100.00%,Unclear,Preprint,Romi Wahengbam,Council of Scientific and Industrial Research,https://www.medrxiv.org/content/10.1101/2022.01.25.22269702v1.full-text,11/02/2022,16/07/2022,Verified
220126_India_CouncilOfScientificAndIndustrialResearch_202008_TestAdjusted,26-Jan-22,Regional,India,IND," Arunachal Pradesh, Assam, Manipur, Meghalaya, Mizoram, Nagaland, Tripura, Sikkim",,01-Aug-20,31-Aug-20,Household and community samples,Multiple groups,724,10.61%,8.37%,12.85%,Unclear,Roche Diagnostics,Not reported,IgG,99.80%,100.00%,Unclear,Preprint,Romi Wahengbam,Council of Scientific and Industrial Research,https://www.medrxiv.org/content/10.1101/2022.01.25.22269702v1.full-text,11/02/2022,16/07/2022,Verified
220207_Pune_ICMRNARI,07-Feb-22,Local,India,IND,Maharashtra,Pune,15-Mar-21,15-Jun-21,Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),405,54.60%,,,Convenience,Erba Manneim,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Manisha Ghate,Indian Council of Medical Research-NationalAIDS Research Institute (ICMR-NARI),https://dx.doi.org/10.1177/23259582221077943,17/02/2022,16/07/2022,Unverified
20220130_India_ESICMedicalCollegeHospital_Primary,30-Jan-22,Local,India,IND,South India,,15-Sep-20,15-Mar-21,Blood donors,Adults (18-64 years),1034,54.90%,51.50%,58.30%,Self-referral,Ortho Clinical Diagnostics Inc.,CLIA,IgG,96.30%,99.90%,High,Journal Article (Peer-Reviewed),Srinivasa Rao Chunchu,ESIC Medical College Hospital ,https://dx.doi.org/10.1007/s12288-021-01512-y,20/02/2022,16/07/2022,Unverified
220131_Ahmedabad_AMCMETMedicalCollege,31-Jan-22,Local,India,IND,Gujarat,Ahmedabad,15-Oct-20,31-Oct-20,Health care workers and caregivers,Multiple groups,1737,20.84%,19.00%,22.81%,Stratified non-probability,Zydus Diagnostics,ELISA,IgG,92.37%,97.90%,Low,Journal Article (Peer-Reviewed),Om Prakash,AMC MET Medical College,10.4103/ijabmr.ijabmr_516_21,01/03/2022,16/07/2022,Unverified
220201_NewDelhi_InstituteOfMedicalSciences_Overall,01-Feb-22,Local,India,IND,,New Delhi,15-Jun-20,15-Aug-20,Health care workers and caregivers,Adults (18-64 years),800,16.75%,,,Convenience,Erba Manneim,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Mala Chhabra,Institute of Medical Sciences,https://dx.doi.org/10.4103/jpsic.jpsic_15_21,02/03/2022,16/07/2022,Unverified
211007_NorthIndia_ArmyCollegeOfMedicalSciencesAndBaseHospitalDelhiCantt_HCWs_Overall,07-Oct-21,Regional,India,IND,A Himalayan Region in North India,,01-Feb-21,28-Feb-21,Health care workers and caregivers,Adults (18-64 years),570,39.30%,35.40%,43.30%,Stratified probability,Karwa Enterprises,ELISA,IgG,93.00%,100.00%,High,Journal Article (Peer-Reviewed),Inam Khan,Army College of Medical Sciences and Base Hospital Delhi Cantt,10.4103/jmms.jmms_73_21,02/03/2022,16/07/2022,Unverified
211007_NorthIndia_ArmyCollegeOfMedicalSciencesAndBaseHospitalDelhiCantt_ArmedForces_Overall,07-Oct-21,Regional,India,IND,A Himalayan Region in North India,,01-Feb-21,28-Feb-21,Essential non-healthcare workers,Adults (18-64 years),400,34.50%,30.00%,39.20%,Stratified probability,Karwa Enterprises,ELISA,IgG,93.00%,100.00%,High,Journal Article (Peer-Reviewed),Inam Khan,Army College of Medical Sciences and Base Hospital Delhi Cantt,10.4103/jmms.jmms_73_21,02/03/2022,16/07/2022,Unverified
220121_NewDelhi_AllIndiaInstituteOfMedicalSciences_IBD_Overall,21-Jan-22,Local,India,IND,,New Delhi,15-Jul-20,15-Apr-21,Patients seeking care for non-COVID-19 reasons,Multiple groups,235,31.50%,,,Convenience,Siemens,CLIA,IgG,,,High,Presentation or Conference,B Kante,All India Institute of Medical Sciences,https://dx.doi.org/10.1093/ecco-jcc/jjab232.841,08/03/2022,16/07/2022,Unverified
220121_NewDelhi_AllIndiaInstituteOfMedicalSciences_NoIBD_Overall,21-Jan-22,Local,India,IND,,New Delhi,15-Jul-20,15-Apr-21,Household and community samples,Multiple groups,73,27.40%,,,Unclear,Siemens,CLIA,IgG,,,High,Presentation or Conference,B Kante,All India Institute of Medical Sciences,https://dx.doi.org/10.1093/ecco-jcc/jjab232.841,08/03/2022,16/07/2022,Unverified
220121_NewDelhi_UniversityOfOxford,21-Jan-22,Local,India,IND,,New Delhi,26-May-20,24-Sep-21,Patients seeking care for non-COVID-19 reasons,Multiple groups,171,57.90%,,,Convenience,"Roche Diagnostics,Siemens",Not reported,Total Antibody,,,High,Presentation or Conference,S Y Wong,University of Oxford,https://dx.doi.org/10.1093/ecco-jcc/jjab232.469,08/03/2022,16/07/2022,Unverified
210930_India_48FieldHealthOrganization_Primary,30-Sep-21,Regional,India,IND,"Punjab, UP, Haryana, and Rajasthan",,15-Oct-20,15-Nov-20,Non-essential workers and unemployed persons,Multiple groups,3680,16.57%,,,Stratified non-probability,"Zydus Diagnostics,SD Biosensor",Multiple Types,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Vikram Grewal,48 Field Health Organization,https://www.marinemedicalsociety.in/article.asp?issn=0975-3605;year=2021;volume=23;issue=2;spage=171;epage=177;aulast=Grewal,08/03/2022,16/07/2022,Unverified
220225_Chennai_JohnsHopkinsBloombergSchoolofPublicHealth_Overall_Anti-S,25-Feb-22,Local,India,IND,Tamil Nadu,Chennai,15-Jan-21,15-May-21,Household and community samples,Multiple groups,4629,62.00%,60.60%,63.40%,Stratified probability,Abbott Laboratories,CLIA,IgG,,,Moderate,Preprint,Matt Hitchings,The Johns Hopkins Bloomberg School of Public Health,https://doi.org/10.1101/2022.02.24.22271002,09/03/2022,16/07/2022,Verified
220201_Gurugram_MedantaTheMedicity,01-Feb-22,Local,India,IND,Haryana,Gurugram,15-Jun-20,15-Dec-20,Health care workers and caregivers,Adults (18-64 years),230,25.70%,,,Self-referral,DiaSorin,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Sonam Singla,Mendanta - The Medicity ,https://dx.doi.org/10.7860/JCDR/2022/51855.16011,09/03/2022,16/07/2022,Unverified
220303_Odisha_ICMR_Athagarh1_Overall_PopAdj,03-Mar-22,Local,India,IND,Odisha,Athagar,15-Mar-21,15-Apr-21,Household and community samples,Multiple groups,887,60.29%,56.98%,63.53%,Stratified probability,Roche Diagnostics,CLIA,IgG,100.00%,99.81%,Moderate,Journal Article (Peer-Reviewed),Pujarini Dash,Indian Council of Medical Research–Regional Medical Research Centre,https://dx.doi.org/10.1017/S0950268822000346,11/03/2022,16/07/2022,Verified
220303_Odisha_ICMR_Badamba2_Overall_PopAdj,03-Mar-22,Local,India,IND,Odisha,Badamba,15-Mar-21,15-Apr-21,Household and community samples,Multiple groups,862,55.47%,52.08%,58.83%,Stratified probability,Roche Diagnostics,CLIA,IgG,100.00%,99.81%,Moderate,Journal Article (Peer-Reviewed),Pujarini Dash,Indian Council of Medical Research–Regional Medical Research Centre,https://dx.doi.org/10.1017/S0950268822000346,11/03/2022,16/07/2022,Verified
220303_Odisha_ICMR_Narsinghpur3_Overall_PopAdj,03-Mar-22,Local,India,IND,Odisha,Narsinghpur,15-Mar-21,15-Apr-21,Household and community samples,Multiple groups,988,39.79%,36.71%,42.93%,Stratified probability,Roche Diagnostics,CLIA,IgG,100.00%,99.81%,Moderate,Journal Article (Peer-Reviewed),Pujarini Dash,Indian Council of Medical Research–Regional Medical Research Centre,https://dx.doi.org/10.1017/S0950268822000346,11/03/2022,16/07/2022,Verified
220303_Odisha_ICMR_Tigiria4_Overall_PopAdj,03-Mar-22,Local,India,IND,Odisha,Tigiria,15-Mar-21,15-Apr-21,Household and community samples,Multiple groups,885,63.26%,59.98%,66.45%,Stratified probability,Roche Diagnostics,CLIA,IgG,100.00%,99.81%,Moderate,Journal Article (Peer-Reviewed),Pujarini Dash,Indian Council of Medical Research–Regional Medical Research Centre,https://dx.doi.org/10.1017/S0950268822000346,11/03/2022,16/07/2022,Verified
220301_Ahmedabad_AhmedabadMunicipalCorporationMedicalEducationTrustMedicalCollege_Overall,01-Mar-22,Local,India,IND,Gujarat,Ahmedabad,22-Feb-21,01-Mar-21,Household and community samples,Multiple groups,10136,27.92%,27.06%,28.80%,Stratified non-probability,Zydus Diagnostics,ELISA,IgG,92.37%,97.90%,Moderate,Journal Article (Peer-Reviewed),Om Prakash,Nathiba Hargovandas Lakhmichand (NHL) Municipal Medical College,10.7759/cureus.22759,14/03/2022,16/07/2022,Verified
211116_Mumbai_BreachCandyHospital_Overall,16-Nov-21,Local,India,IND,Maharashtra,Mumbai,18-Jul-20,25-Jul-20,Health care workers and caregivers,Adults (18-64 years),474,31.22%,,,Convenience,Ortho Clinical Diagnostics Inc.,CLIA,"Total Antibody,IgG",,,High,Presentation or Conference,Seema Rohra,Breach Candy Hospital,https://dx.doi.org/10.1016/j.ijmmb.2021.08.251,15/03/2022,16/07/2022,Unverified
220223_Pondicherry_PondicherryInstituteOfMedicalSciences_1stPhase_Overall,23-Feb-22,Local,India,IND,,Pondicherry,15-Jul-20,15-Sep-20,Health care workers and caregivers,Adults (18-64 years),382,3.40%,2.00%,5.70%,Stratified non-probability,Roche Diagnostics,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Aneesh Basheer,Pondicherry Institute of Medical Sciences,https://doi.org/10.7759/cureus.22520,15/03/2022,16/07/2022,Unverified
220223_Pondicherry_PondicherryInstituteOfMedicalSciences_2ndPhase_Overall,23-Feb-22,Local,India,IND,,Pondicherry,15-Feb-21,15-Apr-21,Health care workers and caregivers,Adults (18-64 years),168,42.26%,,,Stratified non-probability,Roche Diagnostics,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Aneesh Basheer,Pondicherry Institute of Medical Sciences,https://doi.org/10.7759/cureus.22520,15/03/2022,16/07/2022,Unverified
211116_NewDelhi_MaulanaAzadMedicalCollege_Overall,16-Nov-21,Local,India,IND,Delhi,New Delhi,15-Aug-20,15-Sep-20,Health care workers and caregivers,Adults (18-64 years),1401,12.10%,,,Unclear,Zydus Diagnostics,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Pradeep Kumar Bharti,Maulana Azad Medical College,https://dx.doi.org/10.1016/j.ijmmb.2021.08.233,17/03/2022,16/07/2022,Unverified
220303_Chandigarh_PostGraduateInstituteofMedicalEducationandResearch_Overall,03-Mar-22,Local,India,IND,Chandigarh,Chandigarh,15-Apr-21,15-Aug-21,Patients seeking care for non-COVID-19 reasons,Multiple groups,46,39.00%,,,Convenience,Roche Diagnostics,CLIA,Not reported,98.80%,99.90%,High,Journal Article (Peer-Reviewed),Madhu Chopra,Post Graduate Institute of Medical Education and Research,https://dx.doi.org/10.1007/s12288-022-01528-y,18/03/2022,16/07/2022,Unverified
220310_Bangalore_BangaloreBaptistHospital_Primary,10-Mar-22,Regional,India,IND,Karnataka,,01-Jul-21,31-Jul-21,Household and community samples,Multiple groups,831,44.90%,42.50%,47.40%,Simplified probability,Roche Diagnostics,CLIA,IgG,84.00%,100.00%,Low,Journal Article (Peer-Reviewed),Carolin George,Bangalore Baptist Hospital,https://dx.doi.org/10.1371/journal.pone.0265236,21/03/2022,16/07/2022,Unverified
220302_NewDelhi_HamdardInstituteofMedicalScienceandResearch_FollowUp,02-Mar-22,Local,India,IND,Delhi,New Delhi,15-Dec-20,15-Jun-21,Health care workers and caregivers,Adults (18-64 years),139,77.70%,,,Convenience,Beijing Wantai Biological,ELISA,Total Antibody,,,High,Preprint,Mridu Dudeja, Hamdard Institute of Medical Science and Research,https://doi.org/10.1101/2022.02.28.22271674,21/03/2022,16/07/2022,Unverified
220301_Dibrugarh_AssamMedicalCollegeandHospital,01-Mar-22,Local,India,IND,Assam,Dibrugarh,15-Oct-20,14-Dec-20,Health care workers and caregivers,Adults (18-64 years),215,25.12%,,,Convenience,BioMérieux,Other,IgG,,,High,Journal Article (Peer-Reviewed),Mithu Medhi,Assam Medical College and Hospital,https://dx.doi.org/10.7860/JCDR/2022/51664.16066,21/03/2022,16/07/2022,Unverified
220308_KingGeorgesMedicalUniversity_KingGeorgesMedicalUniversity_Overall,08-Mar-22,Local,India,IND,Uttar Pradesh,Lucknow,01-Oct-20,31-Oct-20,Health care workers and caregivers,Adults (18-64 years),500,25.60%,,,Unclear,Trivitron Healthcare,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Anuragani Verma,King George's Medical University,https://dx.doi.org/10.1016/j.ijmmb.2022.02.004,25/03/2022,16/07/2022,Unverified
220324_Ballabhgarh_AllIndiaInstituteMedicalSciences_TotalAb,24-Mar-22,Local,India,IND,Haryana,Ballabhgarh,15-Apr-21,15-Aug-21,Pregnant or parturient women,Adults (18-64 years),220,77.30%,,,Convenience,Biomérieux,ELISA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Aparna Sharma,All India Institute of Medical Sciences,https://dx.doi.org/10.1002/ijgo.14189,29/03/2022,16/07/2022,Unverified
220115_Jodhpur_AllIndiaInstituteofMedicalSciences_Primary,15-Jan-22,Local,India,IND,Rajasthan,Jodhpur,02-Sep-20,02-Sep-20,Health care workers and caregivers,Adults (18-64 years),39,10.30%,,,Entire sample,Karwa Enterprises,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Vidhi Jain,All India Institute of Medical Sciences,https://dx.doi.org/10.4103/jfmpc.jfmpc_534_21,05/04/2022,16/07/2022,Unverified
220405_NewDelhi_AllIndiaInstituteofMedicalSciences,05-Apr-22,Local,India,IND,,New Delhi,15-Aug-20,15-Feb-21,Multiple general populations,Adults (18-64 years),240,45.40%,,,Convenience,DiaSorin,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Alpesh Goyal,All India Institue of Medical Sciences,https://dx.doi.org/10.1111/cen.14731,13/04/2022,16/07/2022,Verified
220220_SouthAndaman_AndamanandNicobarIslandsInstituteofMedicalSciences_Overall,20-Feb-22,Local,India,IND,Andaman and Nicobar Islands,South Andaman district,15-Dec-20,14-Feb-21,Household and community samples,Multiple groups,4089,39.74%,,,Stratified probability,Erba Manneim,ELISA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Deepak Kumar,Andaman and Nicobar Islands Institute of Medical Sciences,https://dx.doi.org/10.7759/cureus.22398,13/04/2022,16/07/2022,Verified
220316_Mumbai_SethGSMedicalCollege,16-Mar-22,Local,India,IND,Maharashtra,Mumbai,01-Mar-21,31-Mar-21,Residual sera,Multiple groups,10197,36.30%,,,Convenience,"Abbott Laboratories,Siemens",CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Gajanan Velhal,Seth GS Medical College,https://dx.doi.org/10.4103/ijcm.ijcm_984_21,17/04/2022,16/07/2022,Unverified
220316_Mumbai_SethGSMedicalCollege_Age_<18,16-Mar-22,Local,India,IND,Maharashtra,Mumbai,01-Mar-21,31-Mar-21,Residual sera,Multiple groups,467,39.40%,,,Convenience,"Abbott Laboratories,Siemens",CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Gajanan Velhal,Seth GS Medical College,https://dx.doi.org/10.4103/ijcm.ijcm_984_21,17/04/2022,16/07/2022,Unverified
220316_Mumbai_SethGSMedicalCollege_Age_18-30,16-Mar-22,Local,India,IND,Maharashtra,Mumbai,01-Mar-21,31-Mar-21,Residual sera,Multiple groups,2691,32.96%,,,Convenience,"Abbott Laboratories,Siemens",CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Gajanan Velhal,Seth GS Medical College,https://dx.doi.org/10.4103/ijcm.ijcm_984_21,17/04/2022,16/07/2022,Unverified
220316_Mumbai_SethGSMedicalCollege_Age_31-40,16-Mar-22,Local,India,IND,Maharashtra,Mumbai,01-Mar-21,31-Mar-21,Residual sera,Multiple groups,1905,34.44%,,,Convenience,"Abbott Laboratories,Siemens",CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Gajanan Velhal,Seth GS Medical College,https://dx.doi.org/10.4103/ijcm.ijcm_984_21,17/04/2022,16/07/2022,Unverified
220316_Mumbai_SethGSMedicalCollege_Age_41-50 ,16-Mar-22,Local,India,IND,Maharashtra,Mumbai,01-Mar-21,31-Mar-21,Residual sera,Multiple groups,1758,37.88%,,,Convenience,"Abbott Laboratories,Siemens",CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Gajanan Velhal,Seth GS Medical College,https://dx.doi.org/10.4103/ijcm.ijcm_984_21,17/04/2022,16/07/2022,Unverified
220316_Mumbai_SethGSMedicalCollege_Age_51-60,16-Mar-22,Local,India,IND,Maharashtra,Mumbai,01-Mar-21,31-Mar-21,Residual sera,Multiple groups,1673,45.53%,,,Convenience,"Abbott Laboratories,Siemens",CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Gajanan Velhal,Seth GS Medical College,https://dx.doi.org/10.4103/ijcm.ijcm_984_21,17/04/2022,16/07/2022,Unverified
220316_Mumbai_SethGSMedicalCollege_Age_>61,16-Mar-22,Local,India,IND,Maharashtra,Mumbai,01-Mar-21,31-Mar-21,Residual sera,Multiple groups,1691,37.85%,,,Convenience,"Abbott Laboratories,Siemens",CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Gajanan Velhal,Seth GS Medical College,https://dx.doi.org/10.4103/ijcm.ijcm_984_21,17/04/2022,16/07/2022,Unverified
220316_Mumbai_SethGSMedicalCollege_Sex_Female,16-Mar-22,Local,India,IND,Maharashtra,Mumbai,01-Mar-21,31-Mar-21,Residual sera,Multiple groups,,,,,Convenience,"Abbott Laboratories,Siemens",CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Gajanan Velhal,Seth GS Medical College,https://dx.doi.org/10.4103/ijcm.ijcm_984_21,17/04/2022,16/07/2022,Unverified
220316_Mumbai_SethGSMedicalCollege_Sex_Male,16-Mar-22,Local,India,IND,Maharashtra,Mumbai,01-Mar-21,31-Mar-21,Residual sera,Multiple groups,,,,,Convenience,"Abbott Laboratories,Siemens",CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Gajanan Velhal,Seth GS Medical College,https://dx.doi.org/10.4103/ijcm.ijcm_984_21,17/04/2022,16/07/2022,Unverified
220410_Mumbai_BEST_Primary,10-Apr-22,Local,India,IND,Maharashtra,Mumbai,28-Mar-22,30-Mar-22,Essential non-healthcare workers,Adults (18-64 years),776,100.00%,,,Convenience,NA,Not reported,Not reported,,,High,News and Media,Pratip Acharya,Brihanmumbai Electric Supply and Transport,https://www.hindustantimes.com/cities/mumbai-news/100-best-drivers-conductors-developed-antibodies-101649607686530.html,20/04/2022,16/07/2022,Unverified
220324_NewDelhi_AllIndiaInstituteofMedicalSciences_IgG,24-Mar-22,Local,India,IND,National Capital Territory of Delhi,New Delhi,15-Apr-21,15-Aug-21,Pregnant or parturient women,Adults (18-64 years),220,72.73%,66.80%,78.60%,Unclear,BioMérieux,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Kandala Sharma,All India Institute of Medical Sciences,https://dx.doi.org/10.1002/ijgo.14189,26/04/2022,16/07/2022,Unverified
220310_HimachalPradesh_DrRPGovernmentMedicalCollege_Overall,10-Mar-22,Local,India,IND,Himachal Pradesh,,15-Sep-20,15-Jan-21,Health care workers and caregivers,Adults (18-64 years),1279,12.67%,,,Convenience,Trivitron Healthcare,ELISA,IgG,98.00%,100.00%,High,Journal Article (Peer-Reviewed),Dinesh Kumar,Dr. Rajendra Prasad Government Medical College,https://dx.doi.org/10.4103/jfmpc.jfmpc_288_21,09/05/2022,16/07/2022,Unverified
201203_Mumbai_MGMInstituteOfHealthSciences,30-Dec-20,Local,India,IND,Maharashtra,Mumbai,17-Jul-20,31-Jul-20,Essential non-healthcare workers,Multiple groups,2077,25.37%,,,Convenience,Roche Diagnostics,CLIA,"IgG,IgM,IgA",,,High,Journal Article (Peer-Reviewed),Samant Parineeta,Mahatma Gandhi Mission Institute of Health Sciences,https://dx.doi.org/10.36848/PMR/2020/12100.50430,17/05/2022,16/07/2022,Unverified
220331_Chennai_BloombergSchoolofPublicHealth,31-Mar-22,Local,India,IND,Tamil Nadu,Chennai,15-Jan-21,15-May-21,Household and community samples,Multiple groups,4712,61.90%,60.50%,65.30%,Stratified probability,Abbott Laboratories,CLIA,IgG,,,Moderate,Presentation or Conference,Eshan Patel,Bloomberg School of Public Health ,https://www.iasusa.org/tam/march-2022/,15/06/2022,16/07/2022,Unverified
220531_Gurugram_SGTUniversity,31-May-22,Local,India,IND,Haryana,Gurugram,15-Jan-21,15-Jul-21,Health care workers and caregivers,Multiple groups,150,28.00%,,,Convenience,HiMedia Laboratories,ELISA,IgG,100.00%,100.00%,High,Journal Article (Peer-Reviewed),Leimapokpam Devi,SGT University,https://dx.doi.org/10.1155/2022/4729844,23/06/2022,16/07/2022,Unverified
211119_Hyderabad_CSIR-CentreForCellularAndMolecularBiology_Primary,19-Nov-21,Local,India,IND,Telangana,Hyderabad,08-Jan-21,24-Jan-21,Household and community samples,Multiple groups,9363,54.20%,53.20%,55.20%,Simplified probability,Roche Diagnostics,CLIA,Total Antibody,,,High,Journal Article (Peer-Reviewed),Avula Laxmaiah,CSIR-CentreForCellularAndMolecularBiology,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8603330/,29/06/2022,16/07/2022,Unverified
211030_Karnataka_IndianInstituteofPublicHealth_PopTestAdj_Overall,30-Oct-21,Regional,India,IND,Karnataka,Including eight administrative zones of the Bengaluru metropolitan area,25-Jan-21,18-Feb-21,Multiple populations,Multiple groups,40030,15.60%,14.90%,16.30%,Stratified probability,Zydus Diagnostics,ELISA,IgG,92.20%,97.70%,Low,Journal Article (Peer-Reviewed),Rajagopal Padma,Indian Institute of Public Health,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8620812/,29/06/2022,16/07/2022,Unverified
220607_Mumbai_FortisMemorialResearchInstitute_Overall,07-Jun-22,Local,India,IND,Maharashtra,Mumbai,22-Jan-21,02-Feb-21,Essential non-healthcare workers,Adults (18-64 years),3077,74.10%,72.50%,75.60%,Convenience,Roche Diagnostics,CLIA,Total Antibody,100.00%,99.80%,Moderate,Journal Article (Peer-Reviewed),Shibal Bhartiya,Hindaju Hospital,https://dx.doi.org/10.1007/s13337-022-00766-y,29/06/2022,16/07/2022,Verified
220509_Uttarakhand_AllIndiaInstituteofMedicalSciences_Overall,09-May-22,Regional,India,IND,Uttarakhand,,15-Jul-20,14-Aug-20,Health care workers and caregivers,Adults (18-64 years),704,1.99%,,,Convenience,NA,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),Amit Saini,All India Institute of Medical Sciences,https://dx.doi.org/10.7759/cureus.24840,30/06/2022,16/07/2022,Verified
220615_Hyderabad_ESICMedicalCollegeAndHospitalSanathNagar_Overall,15-Jun-22,Local,India,IND,,Hyderabad,10-Aug-20,25-Aug-20,Health care workers and caregivers,Adults (18-64 years),875,24.91%,,,Convenience,Jmitra,ELISA,IgG,92.10%,97.70%,High,Journal Article (Peer-Reviewed),Pravin Pissude,ESIC Medical College & Hospital Sanath Nagar,https://seronjihou.files.wordpress.com/2022/06/293208.pdf,04/07/2022,16/07/2022,Unverified
20220524_ Thrissur_JubileeMissionMedicalCollegeandResearchInstitute_IgG,24-May-22,Local,India,IND,Thrissur,NR,16-Mar-21,10-Jul-21,Blood donors,Adults (18-64 years),300,15.30%,,,Sequential,Beckman Coulter,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),S. John, Jubilee Mission Medical College and Research Institute,https://dx.doi.org/10.1111/vox.13285,06/07/2022,29/07/2022,Unverified
220705_Jammu_GovernmentMedicalCollege_TestAdj_Overall,05-Jul-22,Local,India,IND,Jammu and Kashmir,,30-Sep-20,01-Oct-20,Household and community samples,Multiple groups,2000,8.80%,8.78%,8.82%,Stratified probability,Meril Diagnostics (Meril Life),ELISA,IgG,93.30%,100.00%,Moderate,Journal Article (Peer-Reviewed),Dinesh Kumar,Government Medical College,https://dx.doi.org/10.4103/ijmr.IJMR_4489_20,12/07/2022,16/07/2022,Unverified
220610_Delhi_MaulanaAzadMedicalCollege_Time2_TestAdj,10-Jun-22,Regional,India,IND,Delhi,,15-Sep-21,15-Oct-21,Household and community samples,Children and Youth (0-17 years),4211,90.80%,89.80%,91.70%,Stratified probability,Ortho Clinical Diagnostics Inc.,CLIA,IgG,90.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Pragya Sharma,Maulana Azad Medical College,https://dx.doi.org/10.24171/j.phrp.2022.0014,19/07/2022,19/07/2022,Unverified
220610_Delhi_MaulanaAzadMedicalCollege_Time1_Overall,10-Jun-22,Regional,India,IND,Delhi,,01-Jan-21,31-Jan-21,Household and community samples,Children and Youth (0-17 years),4338,52.80%,51.30%,54.30%,Stratified probability,Ortho Clinical Diagnostics Inc.,CLIA,IgG,90.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Pragya Sharma,Maulana Azad Medical College,https://dx.doi.org/10.24171/j.phrp.2022.0014,19/07/2022,19/07/2022,Unverified
200901_Iceland_deCODEGenetics_OverallPopAdj,01-Sep-20,National,Iceland,ISL,,,27-Apr-20,12-Jun-20,Household and community samples,Multiple groups,23452,0.30%,,,Convenience,"Roche Diagnostics,Beijing Wantai Biological",CLIA,"IgG,IgM,IgA",91.10%,,Moderate,Journal Article (Peer-Reviewed),Daniel Gudbjartsson,deCODE Genetics,http://dx.doi.org/10.1056/NEJMoa2026116,13/10/2020,16/07/2022,Verified
200717_Hungary_SemmelweisUniversity__GenPop_PopAdj,17-Jul-20,National,Hungary,HUN,,,01-May-20,16-May-20,Household and community samples,Multiple groups,10474,0.68%,0.50%,0.86%,Stratified probability,Abbott Laboratories,CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Bela Merkely,Semmelweis University,https://dx.doi.org/10.1007/s11357-020-00226-9,01/08/2020,16/07/2022,Verified
211215_Budapest_SemmelweisUniversity_Physicians,15-Dec-21,Local,Hungary,HUN,Central Hungary,Budapest,01-Jul-20,01-Aug-20,Health care workers and caregivers,Adults (18-64 years),1552,1.50%,0.90%,2.20%,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Annamaria Kosztin,Semmelweis University,https://dx.doi.org/10.13075/ijomeh.1896.01804,11/01/2022,16/07/2022,Unverified
211215_Budapest_SemmelweisUniversity_OtherHCW,15-Dec-21,Local,Hungary,HUN,Central Hungary,Budapest,01-Jul-20,01-Aug-20,Health care workers and caregivers,Adults (18-64 years),2926,1.80%,1.40%,2.30%,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Annamaria Kosztin,Semmelweis University,https://dx.doi.org/10.13075/ijomeh.1896.01804,11/01/2022,16/07/2022,Unverified
211215_Budapest_SemmelweisUniversity_IntStudents,15-Dec-21,Local,Hungary,HUN,Central Hungary,Budapest,01-Jul-20,01-Aug-20,Students and Daycares,Adults (18-64 years),1832,2.10%,1.40%,2.70%,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Annamaria Kosztin,Semmelweis University,https://dx.doi.org/10.13075/ijomeh.1896.01804,11/01/2022,16/07/2022,Unverified
211215_Budapest_SemmelweisUniversity_HungarianIntProgram,15-Dec-21,Local,Hungary,HUN,Central Hungary,Budapest,01-Jul-20,01-Aug-20,Students and Daycares,Adults (18-64 years),682,1.60%,0.70%,2.60%,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Annamaria Kosztin,Semmelweis University,https://dx.doi.org/10.13075/ijomeh.1896.01804,11/01/2022,16/07/2022,Unverified
211215_Budapest_SemmelweisUniversity_HungarianProgram,15-Dec-21,Local,Hungary,HUN,Central Hungary,Budapest,01-Jul-20,01-Aug-20,Students and Daycares,Adults (18-64 years),956,0.60%,0.00%,1.10%,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Annamaria Kosztin,Semmelweis University,https://dx.doi.org/10.13075/ijomeh.1896.01804,11/01/2022,16/07/2022,Unverified
201217_Honduras_ColegioMédico_OverallGenpop,17-Dec-20,National,Honduras,HND,,,16-Jun-20,23-Jun-20,Household and community samples,Multiple groups,792,6.20%,,,Stratified probability,NA,LFIA,"IgG,IgM",93.40%,97.70%,Moderate,Journal Article (Peer-Reviewed),Mario Rene Mejia Nunez ,Colegio Médico,https://revistas.ucr.ac.cr/index.php/psm/article/view/43261/46175,16/04/2021,16/07/2022,Verified
210203_VaticanCity_UniversitàCattolicadelSacroCuore_Overall,03-Feb-21,National,Holy See,VAT,Vatican City State,Vatican City,08-Jun-20,04-Jan-21,Household and community samples,Multiple groups,1539,4.35%,,,Convenience,Siemens,CLIA,Total Antibody,97.48%,99.80%,Moderate,Journal Article (Peer-Reviewed),Massimo Ralli,Università Cattolica del Sacro Cuore,https://dx.doi.org/10.1016/j.ejim.2021.01.029,24/03/2021,16/07/2022,Verified
220320_Haiti_UniversityOfFlorida_Overall,20-Mar-22,Local,Haiti,HTI,,Port Au Prince,15-Jun-19,15-Mar-21,Residual sera,Children and Youth (0-17 years),257,16.70%,12.70%,21.80%,Convenience,NA,ELISA,IgG,,,High,Preprint,Rigan Louis,University of Florida,https://www.medrxiv.org/content/10.1101/2022.03.17.22272561v1.full-text,31/03/2022,16/07/2022,Unverified
211203_Bissau_UniversityofSouthernDenmark,03-Dec-21,Local,Guinea-Bissau,GNB,,Bissau,09-Nov-20,24-Nov-20,Health care workers and caregivers,Multiple groups,140,18.00%,,,Convenience,"CTK Biotech, Inc.",LFIA,IgG,90.00%,100.00%,High,Journal Article (Peer-Reviewed),Christine Benn,University of Southern Denmark,https://dx.doi.org/10.1016/j.puhe.2021.11.013,18/01/2022,16/07/2022,Unverified
220601_Bissau_IndepthNetwork_Overall,01-Jun-22,Local,Guinea-Bissau,GNB,,Bissau,01-Jun-21,01-Oct-21,Patients seeking care for non-COVID-19 reasons,Multiple groups,293,43.00%,,,Stratified non-probability,Hanghzhou AllTest Biotech Co. Ltd,LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),A. Dutschke,Indepth Network,https://dx.doi.org/10.1016/j.puhe.2022.05.017,12/07/2022,29/07/2022,Unverified
220322_Conakry_UniversiteGamalAbdelNasserdeConakry_Survey1_Overall,23-Mar-22,Local,Guinea,GIN,,Conakry,02-Dec-20,26-Dec-20,Household and community samples,Multiple groups,535,17.30%,12.40%,23.80%,Stratified non-probability,Luminex Corporation,Luminex,IgG,,99.70%,Moderate,Journal Article (Peer-Reviewed),Abou Soumah,Université Gamal Abdel Nasser de Conakry ,https://dx.doi.org/10.1093/ofid/ofac152,12/05/2022,16/07/2022,Verified
220322_Conakry_UniversiteGamalAbdelNasserdeConakry_Survey2_Overall,23-Mar-22,Local,Guinea,GIN,,Conakry,02-Dec-20,26-Dec-20,Household and community samples,Multiple groups,1195,28.90%,25.60%,32.40%,Stratified non-probability,Luminex Corporation,Luminex,IgG,,99.70%,Moderate,Journal Article (Peer-Reviewed),Abou Soumah,Université Gamal Abdel Nasser de Conakry ,https://dx.doi.org/10.1093/ofid/ofac152,12/05/2022,16/07/2022,Verified
220322_Conakry_UniversiteGamalAbdelNasserdeConakry_Survey3_Overall,23-Mar-22,Local,Guinea,GIN,,Conakry,02-Dec-20,26-Dec-20,Household and community samples,Multiple groups,1073,42.40%,39.50%,45.30%,Stratified non-probability,Luminex Corporation,Luminex,IgG,,99.70%,Moderate,Journal Article (Peer-Reviewed),Abou Soumah,Université Gamal Abdel Nasser de Conakry ,https://dx.doi.org/10.1093/ofid/ofac152,12/05/2022,16/07/2022,Verified
211102_Guatemala_UnidadNacionaldeOftalmología_HCW,02-Nov-21,Local,Guatemala,GTM,,Guatemala City,25-Nov-20,25-Nov-20,Health care workers and caregivers,Adults (18-64 years),94,18.00%,,,Convenience,Roche Diagnostics,CLIA,"IgG,IgA,IgM",100.00%,99.81%,High,Journal Article (Peer-Reviewed),Pamela Davila Siliezar,Unidad Nacional de Oftalmología,https://dx.doi.org/10.1080/07853890.2021.1993325,10/11/2021,16/07/2022,Unverified
220224_Guatemala_ColoradoSchoolofPublicHealth_Overall,24-Feb-22,National,Guatemala,GTM,,,15-Aug-21,15-Nov-21,Essential non-healthcare workers,Adults (18-64 years),4343,29.40%,,,Convenience,SD Biosensor,LFIA,"IgG,IgM",,,High,Preprint,Diva Calvimontes,Colorado School of Public Health,10.1101/2022.02.22.22270907,02/03/2022,16/07/2022,Unverified
220721_Guatemala_CentersforDiseaseControlandPrevention_Overall,21-Jul-22,Regional,Guatemala,GTM,"The southwestern
coastal lowlands",,15-Jun-20,15-Dec-20,Essential non-healthcare workers,Adults (18-64 years),1334,46.20%,,,Convenience,Roche Diagnostics,CLIA,IgG,95.00%,99.80%,Moderate,Journal Article (Peer-Reviewed),Chelsea Iwamoto,Colorado School of Public Health,https://dx.doi.org/10.3390/vaccines10071160,03/08/2022,03/08/2022,Unverified
210929_PointAPitre_UniversityHospitalofGuadeloupe,29-Sep-21,Local,Guadeloupe,GLP,Pointe-à-Pitre,Pointe-à-Pitre,01-Jul-20,28-Oct-20,Health care workers and caregivers,Adults (18-64 years),892,5.00%,3.60%,6.50%,Convenience,Abbott Laboratories,CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Vincenzo Palmeri, University Hospital of Guadeloupe,https://pubmed.ncbi.nlm.nih.gov/34625780/,20/10/2021,16/07/2022,Unverified
200806_Greece_UniversityofThessaly_Overall,06-Aug-20,National,Greece,GRC,"Central Macedonia, Attica, Peloponnese, Thessaly, Western Macedonia, Central Greece, Western Greece, Epirus",,01-Mar-20,30-Apr-20,Residual sera,Multiple groups,6586,0.36%,,,Convenience,Abbott Laboratories,CLIA,IgG,84.00%,99.70%,Moderate,Journal Article (Peer-Reviewed),Zacharoula Bogogiannidou,University of Thessaly,https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2020.25.31.2001369,03/10/2020,16/07/2022,Verified
200921_Athens_NationalandKapodistrianUniversityofAthens_OverallAdj,21-Sep-20,Local,Greece,GRC,,Athens,15-Jun-20,15-Jul-20,Non-essential workers and unemployed persons,Multiple groups,2500,0.93%,0.27%,2.09%,Convenience,Roche Diagnostics,CLIA,Total Antibody,100.00%,99.81%,Moderate,Journal Article (Peer-Reviewed),Ourania Tsitsilonis ,National and Kapodistrian University of Athens,https://dx.doi.org/10.3390/life10090214,09/11/2020,16/07/2022,Verified
201027_Athens_NationalandKapodistrianUniversityofAthens_Overall,27-Oct-20,Local,Greece,GRC,Attica,Athens,25-Apr-20,10-May-20,Health care workers and caregivers,Adults (18-64 years),321,2.18%,,,Unclear,EUROIMMUN,ELISA,IgG,93.00%,100.00%,High,Journal Article (Peer-Reviewed),Panayiotis Vlachoyiannopoulosa,National and Kapodistrian University of Athens/Laiko University Hospital,http://dx.doi.org/10.1016/j.clim.2020.108619,12/01/2021,16/07/2022,Verified
201203_Athens_UniversityOfAthens_Overall_BothAdj,03-Dec-20,Local,Greece,GRC,Attica,Athens,13-Apr-20,15-May-20,Health care workers and caregivers,Multiple groups,1495,1.26%,0.43%,3.26%,Convenience,GenBody Inc.,LFIA,"IgG,IgM",74.10%,100.00%,Moderate,Journal Article (Peer-Reviewed),Mina Psichogiou,University of Athens,https://dx.doi.org/10.1371/journal.pone.0243025,07/02/2021,16/07/2022,Verified
210107_Greece_UniversityCollegeLondon_PaediatricHCW,27-Jan-21,Local,Greece,GRC,NR,NR,19-Jun-20,16-Jul-20,Health care workers and caregivers,Adults (18-64 years),77,1.30%,0.23%,7.00%,Convenience,"Epitope Diagnostics, Inc.,Meso Scale Discovery",ELISA,IgG,,,High,Journal Article (Peer-Reviewed),D Goldblatt,University College London,http://dx.doi.org/10.1016/j.jhin.2020.12.019,13/03/2021,16/07/2022,Verified
210302_Athens_NationalandKapodistrianUniversityofAthens_PopTestAdj,02-Mar-21,Local,Greece,GRC,Attica,Athens,15-Jun-20,15-Nov-20,Non-essential workers and unemployed persons,Multiple groups,4996,1.60%,0.92%,2.54%,Simplified probability,Roche Diagnostics,CLIA,"IgG,IgA,IgM",100.00%,99.81%,Low,Journal Article (Peer-Reviewed),Ourania Tsitsilonis,National and Kapodistrian University of Athens,http://dx.doi.org/10.3390/vaccines9030207,14/05/2021,16/07/2022,Verified
210513_Greece_UniversityThessaly_TestPopAdj,13-May-21,National,Greece,GRC,,,01-May-20,31-Aug-20,Household and community samples,Multiple groups,20110,0.19%,0.08%,0.30%,Stratified probability,Abbott Laboratories,CLIA,IgG,84.00%,99.70%,Low,Journal Article (Peer-Reviewed),Zacharoula Bogogiannidou,University of Thessaly,https://dx.doi.org/10.3390/vaccines9050504,07/06/2021,16/07/2022,Unverified
210430_AghiaSophiaChildrensHospital_Athens_HCW,05-Jul-21,Local,Greece,GRC,Atica,Athens,01-Jun-20,30-Jun-20,Health care workers and caregivers,Adults (18-64 years),1216,0.66%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Elizabeth‑Barbara Tatsi,"The ""Aghia Sophia"" Children's Hospital ",https://dx.doi.org/10.1007/s15010-021-01653-2,13/07/2021,16/07/2022,Verified
210731_Greece_NationalandKapodistrianUniversityofAthens_Primary,31-Jul-21,National,Greece,GRC,,,01-Jun-20,09-Jul-20,Health care workers and caregivers,Adults (18-64 years),57418,0.66%,,,Self-referral,Abbott Laboratories,Other,IgG,100.00%,99.60%,Moderate,Journal Article (Peer-Reviewed),Petros Galanis,National and Kapodistrian University of Athens,https://dx.doi.org/10.1016/j.puhe.2021.07.029,12/09/2021,16/07/2022,Unverified
211101_Thrace_UniversityGeneralHospitalOfAlexandroupolis_Primary,01-Nov-21,Regional,Greece,GRC,Thrace,,15-Jun-20,15-Jul-20,Health care workers and caregivers,Adults (18-64 years),1036,0.58%,,,Self-referral,"Epitope Diagnostics, Inc.,Abbott Laboratories",Multiple Types,IgG,,,High,Journal Article (Peer-Reviewed),Theocharis Konstantinidis,University General Hospital of Alexandroupolis,http://dx.doi.org/10.18683/germs.2021.1274,01/11/2021,16/07/2022,Unverified
211123_Athens_UniversityofAthens_March_Overall,23-Nov-21,Local,Greece,GRC,Attica,Athens,01-Mar-21,22-Mar-21,Residual sera,Multiple groups,764,11.60%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Helena Maltezou,University of Athens,https://dx.doi.org/10.1002/jmv.27465,01/12/2021,16/07/2022,Verified
211123_Athens_UniversityofAthens_June_Overall,23-Nov-21,Local,Greece,GRC,Attica,Athens,01-Jun-21,22-Jun-21,Residual sera,Multiple groups,901,55.70%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Helena Maltezou,University of Athens,https://dx.doi.org/10.1002/jmv.27465,01/12/2021,16/07/2022,Verified
211231_Deskati_UniversityofThessaly_Overall,31-Dec-21,Local,Greece,GRC,West Macedonia,Deskati ,06-Jun-21,06-Jun-21,Household and community samples,Multiple groups,69,79.71%,,,Convenience,Abbott Laboratories,ELISA,IgG,99.90%,100.00%,High,Journal Article (Peer-Reviewed),Ourania Kotsiou,University of Thessaly,https://dx.doi.org/10.3390/ijerph19010407,08/01/2022,16/07/2022,Verified
220121_Athens_NationalandKapodistrianUniversityofAthens_Overall,21-Jan-22,Local,Greece,GRC,,Athens,01-May-20,31-Aug-21,Residual sera,Children and Youth (0-17 years),3099,11.10%,,,Sequential,Roche Diagnostics,CLIA,"IgA,IgM,IgG",99.50%,99.80%,Moderate,Journal Article (Peer-Reviewed),Filippos Filippatos,National and Kapodistrian University of Athens,https://dx.doi.org/10.1002/jmv.27608,03/02/2022,16/07/2022,Unverified
220121_Athens_NationalandKapodistrianUniversityofAthens_1st_Overall,21-Jan-22,Local,Greece,GRC,,Athens,01-May-20,31-Aug-20,Residual sera,Children and Youth (0-17 years),793,1.39%,,,Sequential,Roche Diagnostics,CLIA,"IgA,IgM,IgG",99.50%,99.80%,Moderate,Journal Article (Peer-Reviewed),Filippos Filippatos,National and Kapodistrian University of Athens,https://dx.doi.org/10.1002/jmv.27608,18/02/2022,16/07/2022,Unverified
220125_Greece_UniversityofThessaly_Overall,25-Jan-22,National,Greece,GRC,,,01-Mar-20,31-Dec-20,Residual sera,Multiple groups,55947,1.26%,,,Stratified probability,Abbott Laboratories,CLIA,IgG,84.00%,99.70%,Moderate,Journal Article (Peer-Reviewed),Michalis Koureas,University of Thessaly,https://www.mdpi.com/2075-4418/12/2/295,28/05/2022,16/07/2022,Verified
220517_Greece_UniversityofThessaly_Malesina_Overall,17-May-22,Local,Greece,GRC,Phthiotis,Malesina,14-Jun-21,16-Jun-21,Household and community samples,Multiple groups,525,77.50%,,,Convenience,Abbott Laboratories,CLIA,IgG,99.00%,100.00%,High,Journal Article (Peer-Reviewed),Ourania Kotsiou,University of Thessaly,https://dx.doi.org/10.3390/ijerph19106110,02/06/2022,16/07/2022,Unverified
220517_Greece_UniversityofThessaly_Domokos_Overall,17-May-22,Local,Greece,GRC,Phthiotis,Dokomos,09-Jul-21,09-Jul-21,Household and community samples,Multiple groups,151,77.50%,,,Convenience,Abbott Laboratories,CLIA,IgG,99.00%,100.00%,High,Journal Article (Peer-Reviewed),Ourania Kotsiou,University of Thessaly,https://dx.doi.org/10.3390/ijerph19106110,02/06/2022,16/07/2022,Unverified
210706_Ghana_UniversityOfGhana_Phase1_Overall,06-Jul-21,National,Ghana,GHA,"Greater Acra Region, Central Region, Eastern Region, Upper East Region","Accra, Kasoa, Cape Coast, Akropong, Navrongo, Bolgatanga",27-Jul-20,14-Sep-20,Multiple general populations,Multiple groups,1305,19.00%,,,Convenience,Wuhan UNscience Biotechnology Co. Ltd,LFIA,"IgG,IgM",66.00%,94.00%,High,Journal Article (Peer-Reviewed),Peter Kojo Quashie,University of Ghana,https://wellcomeopenresearch.org/articles/6-173,13/07/2021,16/07/2022,Unverified
210706_Ghana_UniversityOfGhana_Phase2_Overall,06-Jul-21,National,Ghana,GHA,"Greater Acra Region, Central Region, Eastern Region","Accra, Kasoa, Cape Coast, Akropong, Navrongo, Bolgatanga",01-Oct-20,31-Oct-20,Multiple general populations,Multiple groups,395,15.20%,,,Convenience,Wuhan UNscience Biotechnology Co. Ltd,LFIA,"IgG,IgM",66.00%,94.00%,High,Journal Article (Peer-Reviewed),Peter Kojo Quashie,University of Ghana,https://wellcomeopenresearch.org/articles/6-173,13/07/2021,16/07/2022,Unverified
210706_Ghana_UniversityOfGhana_Phase3_Overall,06-Jul-21,National,Ghana,GHA,"Greater Acra Region, Central Region, Eastern Region","Accra, Kasoa, Cape Coast, Akropong, Navrongo, Bolgatanga",01-Dec-20,31-Dec-20,Multiple general populations,Multiple groups,393,9.70%,,,Convenience,Wuhan UNscience Biotechnology Co. Ltd,LFIA,"IgG,IgM",66.00%,94.00%,High,Journal Article (Peer-Reviewed),Peter Kojo Quashie,University of Ghana,https://wellcomeopenresearch.org/articles/6-173,13/07/2021,16/07/2022,Unverified
210706_Ghana_UniversityOfGhana_Phase4_Overall,06-Jul-21,National,Ghana,GHA,"Greater Acra Region, Central Region, Eastern Region","Accra, Kasoa, Cape Coast, Akropong, Navrongo, Bolgatanga",01-Feb-21,28-Feb-21,Multiple general populations,Multiple groups,636,22.80%,,,Convenience,Wuhan UNscience Biotechnology Co. Ltd,LFIA,"IgG,IgM",66.00%,94.00%,High,Journal Article (Peer-Reviewed),Peter Kojo Quashie,University of Ghana,https://wellcomeopenresearch.org/articles/6-173,13/07/2021,16/07/2022,Unverified
220715_Kumasi_UniversityOfCambridge,15-Jul-22,Local,Ghana,GHA,,Kumasi,03-Mar-21,11-Mar-21,Multiple populations,Adults (18-64 years),527,42.50%,,,Simplified probability,NA,Luminex,IgG,,,High,Preprint,Adam Abdullahi,University of Cambridge,http://doi.org/10.21203/rs.3.rs-1834968/v1,28/07/2022,29/07/2022,Unverified
200525_Frankfurt_Goethe-UniversityFrankfurt_Employees,25-May-20,Local,Germany,DEU,Hesse,Frankfurt,06-Apr-20,14-Apr-20,Essential non-healthcare workers,Adults (18-64 years),998,0.40%,0.16%,1.02%,Convenience,NA,ELISA,IgG,,99.20%,High,Preprint,Verena Kraehling, Goethe-University Frankfurt,https://www.medrxiv.org/content/10.1101/2020.05.20.20107730v1,27/05/2020,16/07/2022,Verified
200514_Saalfeld_Thuringia_IgG,14-May-20,Local,Germany,DEU,Thuringia,Saalfeld,16-Apr-20,21-Apr-20,Health care workers and caregivers,Adults (18-64 years),18,0.00%,,,Convenience,EUROIMMUN,ELISA,IgG,,98.50%,High,Journal Article (Peer-Reviewed),Igor Harsch,Thuringia Clinic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273321/pdf/HIC-15-09.pdf,19/06/2020,16/07/2022,Verified
200615_Germany_UniversityofHannover_hcw,15-Jun-20,Local,Germany,DEU,Lower Saxony,Hannover,20-Apr-20,30-Apr-20,Health care workers and caregivers,Multiple groups,385,2.86%,,,Convenience,EUROIMMUN,ELISA,IgG,94.60%,99.80%,High,Journal Article (Peer-Reviewed),Simone Schmidt,University of Hannover,https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0235417,26/06/2020,16/07/2022,Verified
200717_Ilm-Kreis_JenaUniversityHospital_Overall,17-Jul-20,Local,Germany,DEU,Thuringia,,12-May-20,22-May-20,Household and community samples,Multiple groups,620,8.39%,,,Convenience,"Epitope Diagnostics, Inc.,Snibe Co. Ltd (Shenzhen New Industries Biomedical Engineering Co. Ltd),DiaSorin,Abbott Laboratories,EUROIMMUN,Roche Diagnostics",Multiple Types,IgG,,,Moderate,Preprint,Sebastian Weis ,Jena University Hospital,https://www.medrxiv.org/content/10.1101/2020.07.15.20154112v1,18/07/2020,16/07/2022,Verified
200622_Rostock_UniversitätsmedizinRostock_Mothers_IgGorIgA,22-Jun-20,Local,Germany,DEU,Mecklenburg-Westpomerania,Rostock,20-Apr-20,22-Apr-20,Household and community samples,Adults (18-64 years),401,0.00%,,,Self-referral,"EUROIMMUN,NA",Multiple Types,"IgG,IgA,IgM",,,High,Journal Article (Peer-Reviewed),Emil Reisinger ,Universitätsmedizin Rostock,https://www.thieme-connect.de/products/ejournals/abstract/10.1055/a-1197-4293,05/08/2020,16/07/2022,Verified
200807_Bavaria_UniversityHospitalMunich,07-Aug-20,Regional,Germany,DEU,Bavaria,Dachau,02-Apr-20,06-Apr-20,Health care workers and caregivers,Adults (18-64 years),151,2.60%,0.80%,7.10%,Convenience,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Korbinian Lackermair,University Hospital Munich,http://dx.doi.org/10.1093/fampra/cmaa078,25/09/2020,16/07/2022,Verified
200904_Hannover_HannoverMedicalSchool_HCWs_S1IgG,04-Sep-20,Local,Germany,DEU,Lower Saxony,Hannover,23-Mar-20,17-Apr-20,Health care workers and caregivers,Adults (18-64 years),217,1.38%,,,Convenience,EUROIMMUN,ELISA,IgG,87.20%,99.30%,High,Journal Article (Peer-Reviewed),Georg Behrens, Hannover Medical School,https://link.springer.com/article/10.1007/s40121-020-00334-1,28/09/2020,16/07/2022,Verified
200824_Jena_UniversitätsklinikumJena_Pregnantwomen_Overall,24-Aug-20,Local,Germany,DEU,Thuringia,Jena,06-Apr-20,13-May-20,Pregnant or parturient women,Multiple groups,180,0.60%,0.00%,1.70%,Sequential,"Epitope Diagnostics, Inc.",ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Janine Zollkau,Universitätsklinikum Jena,https://www.thieme-connect.com/products/ejournals/abstract/10.1055/a-1206-1033,28/09/2020,16/07/2022,Verified
200717_Germany_NorthRhineWestphaliaLowerSaxonyHesse_BloodDonors_PrimaryEstimate,16-Jul-20,Regional,Germany,DEU,"North Rhine-Westphalia, Lower Saxony, Hesse",,09-Mar-20,03-Jun-20,Residual sera,Multiple groups,3186,0.91%,0.58%,1.24%,Sequential,"Abbott Laboratories,EUROIMMUN,DiaSorin",ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Bastian Fischer,Heart and Diabetes Center NRW,https://dx.doi.org/10.2807/1560-7917.ES.2020.25.28.2001285,01/10/2020,16/07/2022,Verified
200723_Germany_ThuringiaClinicSaalfeld_CleaningStaffIgG,23-Jul-20,Local,Germany,DEU,Thuringia,Saalfeld,15-Jun-20,30-Jun-20,Health care workers and caregivers,Adults (18-64 years),45,0.00%,,,Convenience,EUROIMMUN,ELISA,IgG,,98.50%,High,Journal Article (Peer-Reviewed),Jorg Epstude,Thuringia Clinic,https://dx.doi.org/10.3205/dgkh000353,01/10/2020,16/07/2022,Verified
200723_Germany_ThuringiaClinicSaalfeld_OncologyStaffIgG,23-Jul-20,Local,Germany,DEU,Thuringia,Saalfeld,15-Jun-20,30-Jun-20,Health care workers and caregivers,Adults (18-64 years),20,5.00%,,,Convenience,EUROIMMUN,ELISA,IgG,,98.50%,High,Journal Article (Peer-Reviewed),Jorg Epstude,Thuringia Clinic,https://dx.doi.org/10.3205/dgkh000353,01/10/2020,16/07/2022,Verified
200629_Fulda_UniversitätsmedizinMarburg_Entirecohort_IgG,29-Jun-20,Local,Germany,DEU,,Fulda,09-Apr-20,16-Apr-20,Multiple populations,Multiple groups,1780,0.96%,0.56%,1.53%,Unclear,EUROIMMUN,ELISA,IgG,93.80%,99.00%,High,Journal Article (Peer-Reviewed),Peter Kern,Universitätsmedizin Marburg,http://dx.doi.org/10.1055/a-1198-1243,11/10/2020,16/07/2022,Verified
200929_Oberspreewald-Lausitz_BrandenburgUniversityofTechnologyCottbus-Senftenberg_HCW,29-Sep-20,Local,Germany,DEU,Brandenburg,Oberspreewald-Lausitz,01-Jul-20,31-Jul-20,Health care workers and caregivers,Adults (18-64 years),156,1.30%,,,Convenience,NA,CLIA,Total Antibody,99.50%,99.80%,High,Preprint,Stephanie Hoffmann,Brandenburg University of Technology Cottbus-Senftenberg,https://doi.org/10.21203/rs.3.rs-84703/v1,28/11/2020,16/07/2022,Verified
200806_Regensburg_UniversityofRegensburg_12Wks,06-Aug-20,Local,Germany,DEU,Bavaria,Regensburg,15-Mar-20,07-Jun-20,Health care workers and caregivers,Adults (18-64 years),139,0.00%,,,Convenience,"EUROIMMUN,Roche Diagnostics",ELISA,"IgG,IgA",,,High,Journal Article (Peer-Reviewed),Sara Malfertheiner,University of Regensburg,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7406471/pdf/main.pdf,02/12/2020,16/07/2022,Verified
200813_Northrhine-Westfalia_SpecialistPracticeAndLaboratory_IgGandOverall,13-Aug-20,Regional,Germany,DEU,North Rhine-Westphalia,,26-Mar-20,04-Jun-20,Residual sera,Multiple groups,415,1.20%,,,Convenience,EUROIMMUN,ELISA,IgG,94.40%,99.60%,High,Journal Article (Peer-Reviewed),Burkhard Herrmann,Internal medicine and laboratory medicine specialist practice and laboratory,http://dx.doi.org/10.1007/s15006-020-0750-y,05/01/2021,16/07/2022,Verified
201103_Germany_UniversityofWitten,03-Nov-20,National,Germany,DEU,,,15-Jun-20,01-Sep-20,Residual sera,Children and Youth (0-17 years),731,11.20%,,,Convenience,"EUROIMMUN,Roche Diagnostics",Multiple Types,"IgG,IgA,IgM",,,High,Journal Article (Peer-Reviewed),Silke Schwarz,University of Witten,https://dx.doi.org/10.1007/s00112-020-01050-3,07/01/2021,16/07/2022,Verified
201023_Berlin_CharitéUniversity_primary,23-Oct-20,Local,Germany,DEU,Berlin,Berlin,19-Mar-20,19-May-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,223,7.10%,,,Unclear,EUROIMMUN,Multiple Types,"IgA,IgG",,,High,Journal Article (Peer-Reviewed),Mira Choi,Charité University,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7690804/,13/01/2021,16/07/2022,Verified
201126_Germany_RobertKochInstitute_BloodDonors_TestAdj,26-Nov-20,National,Germany,DEU,,,15-Apr-20,05-Nov-20,Blood donors,Multiple groups,48976,1.35%,,,Simplified probability,NA,ELISA,IgG,,,Moderate,Institutional Report,Robert Koch Institute,Robert Koch Institute,https://www.rki.de/DE/Content/InfAZ/N/Neuartiges_Coronavirus/Projekte_RKI/SeBluCo_Zwischenbericht.html;jsessionid=0C30892A66A0F7CDD897F3809AA3F10F.internet102,14/01/2021,16/07/2022,Verified
201130_Hamburg_UniversityMedicalCenterHamburg-Eppendorf_S3,30-Nov-20,Local,Germany,DEU,Hamburg,Hamburg,22-Jun-20,17-Jul-20,Health care workers and caregivers,Adults (18-64 years),1253,1.80%,1.00%,2.50%,Convenience,EUROIMMUN,ELISA,IgG,94.40%,99.60%,Moderate,Journal Article (Peer-Reviewed),Thomas Brehm,University Medical Center Hamburg-Eppendorf,https://dx.doi.org/10.1016/j.ijheh.2020.113671,21/01/2021,16/07/2022,Verified
210103_Munich_LudwigMaximillianUniversityofMunich_Overall,03-Jan-21,Local,Germany,DEU,,Munich,24-Mar-20,07-Jul-20,Health care workers and caregivers,Adults (18-64 years),300,4.67%,,,Convenience,"EUROIMMUN,DiaSorin,Abbott Laboratories,Roche Diagnostics",Multiple Types,"IgG,Total Antibody",,,High,Journal Article (Peer-Reviewed),Tobias Weinberger,Ludwig Maximillian University of Munich,https://dx.doi.org/10.1093/cid/ciaa1935,23/01/2021,16/07/2022,Verified
201111_NeustadtAmRennsteig_FriedrichSchillerUniversity_Overall,19-Nov-20,Local,Germany,DEU,Thuringia,,13-May-20,16-May-20,Household and community samples,Multiple groups,620,8.40%,,,Self-referral,"Epitope Diagnostics, Inc.,Snibe Co. Ltd (Shenzhen New Industries Biomedical Engineering Co. Ltd),DiaSorin,Abbott Laboratories,EUROIMMUN,Roche Diagnostics",Multiple Types,IgG,,,Moderate,Journal Article (Peer-Reviewed),Sebastian Weis,Friedrich Schiller University,https://dx.doi.org/10.1016/j.cmi.2020.11.009,27/01/2021,16/07/2022,Verified
201203_Tirschenreuth_MunichClinic_HCW_Overall,03-Dec-20,Local,Germany,DEU,Bavaria,"Tirschenreuth, Wieden",29-Jun-20,29-Jul-20,Health care workers and caregivers,Adults (18-64 years),1838,15.10%,,,Convenience,Roche Diagnostics,Not reported,"IgM,IgG",99.50%,99.80%,Moderate,Journal Article (Peer-Reviewed),T Finkenzeller,Munich Clinic,https://dx.doi.org/10.1007/s00063-020-00761-5,27/01/2021,16/07/2022,Verified
201203_Tirschenreuth_MunichClinic_NMU_Overall,03-Dec-20,Local,Germany,DEU,Bavaria,"Tirschenreuth, Wieden",29-Jun-20,29-Jul-20,Essential non-healthcare workers,Adults (18-64 years),986,3.70%,,,Convenience,Roche Diagnostics,Not reported,"IgM,IgG",99.50%,99.80%,High,Journal Article (Peer-Reviewed),T Finkenzeller,Munich Clinic,https://dx.doi.org/10.1007/s00063-020-00761-5,27/01/2021,16/07/2022,Verified
200101_Hamburg_UniversityHospitalsoftheRuhr-UniversityofBochum_Overall,16-Oct-20,Local,Germany,DEU,Schleswig-Holstein,Hamburg,14-Apr-20,16-Jun-20,Health care workers and caregivers,Multiple groups,871,2.64%,,,Convenience,"Mikrogen GmbH,EUROIMMUN",ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Jonas Herzberg,University Hospitals of the Ruhr‑University of Bochum,http://dx.doi.org/10.1016/j.ijid.2020.10.026,30/01/2021,16/07/2022,Verified
201204_Germany_SaarlandUniversity_overall,04-Dec-20,National,Germany,DEU,,,16-Jun-20,30-Jun-20,Non-essential workers and unemployed persons,Multiple groups,1007,2.09%,1.37%,3.17%,Self-referral,"EUROIMMUN,NA,Roche Diagnostics",Multiple Types,"IgG,Not reported",,,High,Journal Article (Peer-Reviewed),Dietrich Mack,Saarland University,https://dx.doi.org/10.1016/j.cmi.2020.11.033,31/01/2021,16/07/2022,Verified
201126_Kupferzell_RobertKochInstitute_OverallAdj,26-Nov-20,Local,Germany,DEU,Baden-Württemberg,Kupferzell,20-May-20,09-Jun-20,Household and community samples,Multiple groups,2203,12.00%,10.40%,14.00%,Simplified probability,EUROIMMUN,ELISA,IgG,88.30%,99.20%,Low,Journal Article (Peer-Reviewed),Claudia Santos Hovener,Robert Koch Institute,https://dx.doi.org/10.2807/1560-7917.ES.2020.25.47.2001752,04/02/2021,16/07/2022,Verified
210102_Munich_MUCResearch,02-Jan-21,Local,Germany,DEU,,Munich,29-May-20,15-Jul-20,Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),500,1.50%,0.70%,3.13%,Sequential,Mikrogen GmbH,ELISA,IgG,,,Moderate,Journal Article (Peer-Reviewed),S Noe,MUC Research,https://dx.doi.org/10.1007/s15010-020-01564-8,05/02/2021,16/07/2022,Unverified
201216_Germany_Ruhr-UniversityBochum_overall,16-Dec-20,Local,Germany,DEU,,Bochum,01-Apr-20,31-May-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,99,3.03%,,,Sequential,EUROIMMUN,ELISA,"IgG,IgA",,,High,Journal Article (Peer-Reviewed),Constantin J Thieme,Ruhr-University Bochum,https://dx.doi.org/10.1016/j.transproceed.2020.12.001,06/02/2021,16/07/2022,Verified
210129_Eschweiler_St.AntoniusHospitalEschweiler_IgG,29-Jan-21,Local,Germany,DEU,North Rhine-Westphalia,Eschweiler,27-Apr-20,20-May-20,Health care workers and caregivers,Multiple groups,1212,3.30%,,,Convenience,EUROIMMUN,ELISA,IgG,94.40%,99.60%,Moderate,Journal Article (Peer-Reviewed),Martin Platten,St. Antonius Hospital Eschweiler,https://dx.doi.org/10.1055/a-1322-5355,14/02/2021,16/07/2022,Verified
210122_Germany_HeidelbergUniversity_Parents_Overall_unadj,22-Jan-21,Regional,Germany,DEU,Baden-Württemberg,"Freiburg, Heidelberg, Tübingen, Ulm",22-Apr-20,15-May-20,Household and community samples,Adults (18-64 years),2482,1.90%,,,Self-referral,"EUROIMMUN,Roche Diagnostics,NA",Multiple Types,IgG,,99.60%,High,Journal Article (Peer-Reviewed),Burkhard Tonshoff,Heidelberg University,https://dx.doi.org/10.1001/jamapediatrics.2021.0001,19/02/2021,16/07/2022,Verified
210122_Germany_HeidelbergUniversity_Children_Overall_unadj,22-Jan-21,Regional,Germany,DEU,Baden-Württemberg,"Freiburg, Heidelberg, Tübingen, Ulm",22-Apr-20,15-May-20,Students and Daycares,Children and Youth (0-17 years),2482,0.90%,,,Self-referral,"EUROIMMUN,Roche Diagnostics,NA",Multiple Types,IgG,,99.60%,High,Journal Article (Peer-Reviewed),Burkhard Tonshoff,Heidelberg University,https://dx.doi.org/10.1001/jamapediatrics.2021.0001,19/02/2021,16/07/2022,Verified
210129_Berlin_UniversitätsmedizinBerlin_Students_Overall,29-Jan-21,Local,Germany,DEU,,Berlin,02-Nov-20,16-Nov-20,Students and Daycares,Children and Youth (0-17 years),347,2.00%,0.80%,4.10%,Stratified probability,NA,ELISA,IgG,,,Moderate,Preprint,Stefanie Theuring,Universitätsmedizin Berlin,https://www.medrxiv.org/content/10.1101/2021.01.27.21250517v1,22/02/2021,16/07/2022,Verified
210129_Berlin_UniversitätsmedizinBerlin_Staff_Overall ,29-Jan-21,Local,Germany,DEU,,Berlin,02-Nov-20,16-Nov-20,Essential non-healthcare workers,Adults (18-64 years),141,1.40%,0.20%,5.00%,Stratified probability,NA,ELISA,IgG,,,Moderate,Preprint,Stefanie Theuring,Universitätsmedizin Berlin,https://www.medrxiv.org/content/10.1101/2021.01.27.21250517v1,22/02/2021,16/07/2022,Verified
210129_Berlin_UniversitätsmedizinBerlin_HouseholdMembers_Overall,29-Jan-21,Local,Germany,DEU,,Berlin,02-Nov-20,16-Nov-20,Household and community samples,Multiple groups,576,1.40%,0.60%,2.70%,Stratified probability,NA,ELISA,IgG,,,Moderate,Preprint,Stefanie Theuring,Universitätsmedizin Berlin,https://www.medrxiv.org/content/10.1101/2021.01.27.21250517v1,22/02/2021,16/07/2022,Verified
210203_Dusseldorf_InstituteOfMedicalSociology_overall_TestAdj,03-Feb-21,Local,Germany,DEU,,Düsseldorf,02-Nov-20,23-Nov-20,Household and community samples,Adults (18-64 years),2186,3.10%,2.40%,4.00%,Simplified probability,Roche Diagnostics,CLIA,"IgG,IgA,IgM",90.00%,99.80%,Low,Institutional Report,Insa Backhaus,Institute Of Medical Sociology,https://www.uniklinik-duesseldorf.de/patienten-besucher/klinikeninstitutezentren/institut-fuer-medizinische-soziologie/das-institut/forschung/serodus,09/03/2021,16/07/2022,Verified
210203_Dusseldorf_InstituteOfMedicalSociology_SERODUSII_overall_TestAdj,03-Feb-21,Local,Germany,DEU,,Düsseldorf,23-Nov-20,27-Nov-20,Essential non-healthcare workers,Adults (18-64 years),745,4.40%,3.10%,6.20%,Convenience,Roche Diagnostics,CLIA,"IgG,IgM,IgA",90.00%,99.80%,High,Institutional Report,Insa Backhaus,Institute Of Medical Sociology,https://www.uniklinik-duesseldorf.de/patienten-besucher/klinikeninstitutezentren/institut-fuer-medizinische-soziologie/das-institut/forschung/serodus,09/03/2021,16/07/2022,Verified
200731_Bremen_UniversityOfBremen_IgG/IgA,31-Jul-20,Local,Germany,DEU,,Bremen,31-Mar-20,16-May-20,Multiple populations,Adults (18-64 years),281,2.13%,,,Unclear,EUROIMMUN,ELISA,"IgG,IgA",,,High,Journal Article (Peer-Reviewed),Jan Neumann,University of Bremen,https://www.asu-arbeitsmedizin.com/node/153868/print,11/03/2021,16/07/2022,Verified
210219_Jena_JenaUniversityHospital_Overall,19-Feb-21,Local,Germany,DEU,Thuringia,Jena,19-May-20,19-Jun-20,Health care workers and caregivers,Adults (18-64 years),660,2.70%,1.60%,4.30%,Convenience,"Epitope Diagnostics, Inc.,Roche Diagnostics",Multiple Types,IgG,,,Moderate,Journal Article (Peer-Reviewed),Christina Bahrs,Jena University Hospital,https://dx.doi.org/10.1111/tbed.14041,13/03/2021,16/07/2022,Verified
201001_SouthwesternGermany_UniversityMedicalCenterofTheJohannesGutenbergUniversityMainz_BloodDonors_Overall,01-Oct-20,Regional,Germany,DEU,Southwest,,15-Mar-20,15-Jun-20,Blood donors,Multiple groups,3880,0.90%,,,Convenience,Abbott Laboratories,CLIA,IgG,,99.60%,High,Journal Article (Peer-Reviewed),Stefan Runkel,University Medical Center of The Johannes Gutenberg-University Mainz,https://pubmed.ncbi.nlm.nih.gov/33073955/,14/03/2021,16/07/2022,Verified
210212_Bavaria_ GermanResearchCenterForEnvironmentalHealth_Newborns_overall,12-Feb-21,Regional,Germany,DEU,Bavaria,,01-Apr-20,30-Jun-20,Pregnant or parturient women,Adults (18-64 years),1916,0.47%,,,Convenience,NA,Other,Total Antibody,97.30%,100.00%,High,Journal Article (Peer-Reviewed),Markus Hippich, German Research Center for Environmental Health,https://www.cell.com/med/fulltext/S2666-6340(20)30020-9?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS2666634020300209%3Fshowall%3Dtrue,18/03/2021,16/07/2022,Verified
201127_Germany_IfoInstitue_overall_PopAdj,27-Nov-20,National,Germany,DEU,,,26-Oct-20,18-Nov-20,Household and community samples,Multiple groups,9929,1.10%,0.92%,1.33%,Convenience,Roche Diagnostics,CLIA,Total Antibody,,99.80%,Unclear,Institutional Report,Clemens Fuest,ifo Institute,https://www.ifo.de/en/publikationen/2020/monograph-authorship/die-deutschen-und-corona,21/03/2021,16/07/2022,Verified
201216_Heidelberg_UniversityHospitalHeidelberg_Overall,16-Dec-20,Local,Germany,DEU,Baden-Württemberg,Heidelberg,05-May-20,06-Aug-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,219,3.20%,,,Sequential,EUROIMMUN,ELISA,IgG,94.60%,99.80%,High,Journal Article (Peer-Reviewed),Conrad Rauber,University Hospital Heidelberg,https://www.sciencedirect.com/science/article/abs/pii/S0041134520329043?via%3Dihub,08/04/2021,16/07/2022,Verified
210203_HeinsbergDistrict_UniversityHospitalDusseldorf_NeutralizationAssay,03-Feb-21,Local,Germany,DEU,,,09-Apr-20,09-Apr-20,Contacts of COVID patients,Multiple groups,42,61.90%,,,Convenience,NA,Neutralization,"IgG,IgA",,,High,Journal Article (Peer-Reviewed),Lisa Muller,University Hospital Dusseldorf,https://dx.doi.org/10.1007/s10096-021-04169-7,09/04/2021,16/07/2022,Verified
210310_Bavaria_BrandenburgMedicalSchoolTheodorFontane,10-Mar-21,Local,Germany,DEU,Bavaria,Wieden,17-Jul-20,31-Jul-20,Health care workers and caregivers,Adults (18-64 years),1838,15.10%,13.40%,16.70%,Convenience,Roche Diagnostics,CLIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Thomas Finkenzeller,Brandenburg Medical School Theodor Fontane,https://dx.doi.org/10.1055/a-1393-6668,16/04/2021,16/07/2022,Verified
210310_Brandenburg_BrandenburgMedicalSchoolTheodorFontane,10-Mar-21,Local,Germany,DEU,Brandenburg,NR,17-Jul-20,31-Jul-20,Health care workers and caregivers,Adults (18-64 years),585,2.10%,1.20%,3.80%,Convenience,EUROIMMUN,ELISA,"IgG,IgA",,,High,Journal Article (Peer-Reviewed),Thomas Finkenzeller,Brandenburg Medical School Theodor Fontane,https://dx.doi.org/10.1055/a-1393-6668,16/04/2021,16/07/2022,Verified
210223_Regensberg_HospitalStHedwigOfTheOrderOfStJohn_IgG+,23-Feb-21,Local,Germany,DEU,Bavaria,Regensberg,09-Apr-20,30-Apr-20,Pregnant or parturient women,Adults (18-64 years),151,2.00%,,,Sequential,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Sebastian Hausler,Hospital St Hedwig of the Order of St John,https://dx.doi.org/10.1515/jpm-2021-0001,18/04/2021,16/07/2022,Verified
210408_Germany_HeinrichHeineUniversityDuesseldorf_Physicians,08-Apr-21,National,Germany,DEU,,,16-Jun-20,02-Jul-20,Health care workers and caregivers,Adults (18-64 years),516,3.10%,,,Convenience,Roche Diagnostics,CLIA,Total Antibody,,,High,Journal Article (Peer-Reviewed),Detlef Kindgen Milles,Heinrich-Heine University Duesseldorf,https://dx.doi.org/10.1371/journal.pone.0248813,24/04/2021,16/07/2022,Unverified
201211_BadFeilnbach_RobertKochInstitute_primary,11-Dec-20,Local,Germany,DEU,,Bad Feilnbach,23-Jun-20,04-Jul-20,Household and community samples,Multiple groups,2152,9.10%,,,Simplified probability,NA,Not reported,IgG,88.30%,99.40%,Moderate,News and Media,Robert Koch Institute,Robert Koch Institute,https://www.rki.de/DE/Content/Gesundheitsmonitoring/Studien/cml-studie/Factsheet_Bad_Feilnbach.html,30/04/2021,16/07/2022,Verified
210331_SchleswigHolstein_RuhrUniversityBochum_HCW,31-Mar-21,Local,Germany,DEU,Schleswig-Holstein,,14-Apr-20,20-Oct-20,Health care workers and caregivers,Adults (18-64 years),268,0.75%,,,Convenience,"EUROIMMUN,DiaSorin,Abbott Laboratories",ELISA,IgG,,,High,Preprint,Jonas Herzberg,Ruhr University Bochum,https://www.medrxiv.org/content/10.1101/2021.03.29.21254538v1,02/05/2021,16/07/2022,Unverified
210302_Dresden_TechnischeUniversitätDresden,02-Mar-21,Local,Germany,DEU,Saxony,Dresden,15-Jun-20,15-Jan-21,Contacts of COVID patients,Multiple groups,248,34.27%,,,Sequential,"DiaSorin,Abbott Laboratories,EUROIMMUN",Multiple Types,IgG,,,High,Preprint,Lukas Galow,Technische Universität Dresden,10.2139/ssrn.3790443,03/05/2021,16/07/2022,Unverified
210408_Germany_BundeswehrInstituteofMicrobiology_overall,08-Apr-21,Local,Germany,DEU,,Offenburg,02-Apr-20,08-Apr-20,Health care workers and caregivers,Adults (18-64 years),198,3.50%,,,Convenience,EUROIMMUN,ELISA,"IgG,IgA",,,High,Journal Article (Peer-Reviewed),Katharina Muller,Bundeswehr Institute of Microbiology,http://dx.doi.org/10.3390/ijerph18083910,07/05/2021,16/07/2022,Verified
210427_Germany_HelmholtzCentreForInfectionResearch,27-Apr-21,National,Germany,DEU,,,15-Jul-20,15-Dec-20,Household and community samples,Multiple groups,13405,2.00%,,,Stratified probability,EUROIMMUN,ELISA,IgG,,,Moderate,Preprint,Daniela Gornyk,Helmholtz Centre for Infection Research,https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3834300,10/05/2021,16/07/2022,Verified
210308_Berlin_UniversitatmedizinBerlin,08-Mar-21,Local,Germany,DEU,,Berlin,11-Jun-20,19-Jun-20,Multiple populations,Multiple groups,527,1.30%,,,Stratified non-probability,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Franziska Hommes,Universitatmedizin Berlin,http://dx.doi.org/10.3390/ijerph18052739,11/05/2021,16/07/2022,Unverified
210429_Munich_GermanResearchCenterForEnvironmentalHealth_overall_popadj_testadj,29-Apr-21,Local,Germany,DEU,,Munich,02-Nov-20,31-Jan-21,Household and community samples,Multiple groups,4433,3.60%,2.90%,4.30%,Simplified probability,Roche Diagnostics,CLIA,Not reported,99.20%,98.70%,Low,Preprint,Katja Radon,German Research Center for Environmental Health,https://www.medrxiv.org/content/10.1101/2021.04.27.21256133v1,14/05/2021,16/07/2022,Verified
210315_Thuringia_ThuringiaClinic_ICU_Overall,15-Mar-21,Local,Germany,DEU,Thuringia,Saalfeld/Saale,01-Oct-20,31-Oct-20,Health care workers and caregivers,Adults (18-64 years),50,0.00%,,,Convenience,EUROIMMUN,ELISA,"IgG,IgA",,,High,Journal Article (Peer-Reviewed),Jorg Epstude,Thuringia Clinic,https://dx.doi.org/10.3205/dgkh000382,14/05/2021,16/07/2022,Verified
210315_Thuringia_ThuringiaClinic_COVIDStaff_overall,15-Mar-21,Local,Germany,DEU,Thuringia,Saalfeld/Saale,01-Oct-20,31-Oct-20,Health care workers and caregivers,Adults (18-64 years),18,5.60%,,,Convenience,EUROIMMUN,ELISA,IgG,,98.50%,High,Journal Article (Peer-Reviewed),Jorg Epstude,Thuringia Clinic,https://dx.doi.org/10.3205/dgkh000382,14/05/2021,16/07/2022,Verified
201215_Straubing_RobertKochInstitut_ELISA_poptestadj,15-Dec-20,Local,Germany,DEU,Bavaria,Straubing,08-Sep-20,26-Sep-20,Household and community samples,Multiple groups,2361,1.70%,,,Simplified probability,EUROIMMUN,ELISA,IgG,88.30%,99.40%,Moderate,News and Media,Robert Koch Institute,Robert Koch Institute,https://www.rki.de/DE/Content/Gesundheitsmonitoring/Studien/cml-studie/Factsheet_Straubing.html,16/05/2021,16/07/2022,Verified
210220_Dresden_DresdenUniversityOfTechnology_December,24-Mar-21,Local,Germany,DEU,Saxony,Dresden,10-Dec-20,11-Dec-20,Students and Daycares,Multiple groups,237,6.80%,3.80%,10.10%,Convenience,"DiaSorin,Abbott Laboratories,EUROIMMUN",Multiple Types,IgG,,,High,Journal Article (Peer-Reviewed),Jakob Armann,Dresden University of Technology ,http://dx.doi.org/10.1136/bmjpo-2021-001036,17/05/2021,16/07/2022,Unverified
210317_Bavaria_LudwigMaximiliansUniversityMunich_Overall,17-Mar-21,Local,Germany,DEU,Bavaria,Wasserburg,15-May-20,15-Jun-20,Health care workers and caregivers,Adults (18-64 years),1342,8.80%,,,Convenience,NA,CLIA,Total Antibody,100.00%,99.80%,Moderate,Journal Article (Peer-Reviewed),M Rentrop,Ludwig Maximilians University Munich,https://dx.doi.org/10.1007/s00115-021-01101-4,17/05/2021,16/07/2022,Verified
210217_Berlin-Mitte_RobertKochInstit_ELISA_testadj_popadj,17-Feb-21,Local,Germany,DEU,Berlin,Berlin-Mitte,17-Nov-20,05-Dec-20,Household and community samples,Multiple groups,2287,4.40%,,,Simplified probability,EUROIMMUN,ELISA,IgG,,,Moderate,News and Media,Robert Koch Institut,Robert Koch Institut,https://www.rki.de/DE/Content/Gesundheitsmonitoring/Studien/cml-studie/Factsheet_Berlin-Mitte.html,18/05/2021,16/07/2022,Verified
210402_Bavaria_GermanResearchCenterforEnvironmentalHealth_firstwave_primary,02-Apr-21,Regional,Germany,DEU,Bavaria,,15-Jan-20,15-Aug-20,Household and community samples,Children and Youth (0-17 years),15523,0.68%,0.56%,0.82%,Unclear,NA,Not reported,Not reported,,,High,Journal Article (Peer-Reviewed),Markus Hippich,German Research Center for Environmental Health,https://dx.doi.org/10.1016/j.medj.2021.03.019,19/05/2021,16/07/2022,Verified
210402_Bavaria_GermanResearchCenterforEnvironmentalHealth_secondwave_primary,02-Apr-21,Regional,Germany,DEU,Bavaria,,15-Sep-20,15-Feb-21,Household and community samples,Children and Youth (0-17 years),11380,3.92%,3.57%,4.29%,Unclear,NA,Not reported,Not reported,,,High,Journal Article (Peer-Reviewed),Markus Hippich,German Research Center for Environmental Health,https://dx.doi.org/10.1016/j.medj.2021.03.019,19/05/2021,16/07/2022,Verified
210403_Mainz_JohannesGutenbergUniversity_overall_unadj,03-Apr-21,Local,Germany,DEU,Rhineland-Palatinate,Mainz,01-Jan-20,28-Feb-21,Patients seeking care for non-COVID-19 reasons,Multiple groups,248,5.24%,,,Convenience,Abbott Laboratories,CLIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed), Simone C Boedecker,Johannes Gutenberg University,http://dx.doi.org/10.3390/pathogens10040429,19/05/2021,16/07/2022,Verified
210404_Tirschenreuth_ FriedrichAlexanderUniversity_primary,04-Apr-21,Local,Germany,DEU,Bavaria,,28-Jun-20,10-Jul-20,Household and community samples,Multiple groups,4201,8.64%,,,Simplified probability,"Shenzhen Yhlo Biotech Co. Ltd,Roche Diagnostics,NA",Multiple Types,IgG,,,Moderate,Preprint,Ralf Wagner,Friedrich-Alexander University,https://www.medrxiv.org/content/10.1101/2021.03.29.21254343v1,19/05/2021,16/07/2022,Verified
200515_Regensburg_UniversityOfRegensburg,15-May-20,Local,Germany,DEU,Bavaria,Regensburg,01-Mar-20,31-Mar-20,Health care workers and caregivers,Adults (18-64 years),201,20.40%,,,Convenience,EUROIMMUN,ELISA,"IgG,IgA",,,High,Journal Article (Peer-Reviewed),Susanne Brandstetter,University of Regensburg,https://onlinelibrary.wiley.com/doi/abs/10.1111/pai.13278?af=R,20/05/2021,16/07/2022,Unverified
210422_Brandenburg_MedicalSchoolTheodorFontane_followup_primary,22-Apr-21,Regional,Germany,DEU,Brandenburg,"Brandenburg/Havel, Neuruppin",31-May-20,06-Jun-20,Health care workers and caregivers,Adults (18-64 years),811,2.20%,,,Convenience,EUROIMMUN,ELISA,IgG,95.00%,96.20%,High,Journal Article (Peer-Reviewed),Mark Reinwald ,Brandenburg Medical School Theodor Fontane,https://dx.doi.org/10.3390/healthcare9050498,20/05/2021,16/07/2022,Verified
210425_Essen_UniversityHospitalEssen,25-Apr-21,Local,Germany,DEU,North Rhine-Westphalia,Essen,01-Oct-20,15-Dec-20,Health care workers and caregivers,Adults (18-64 years),315,5.10%,,,Convenience,EUROIMMUN,ELISA,IgG,94.40%,99.60%,High,Journal Article (Peer-Reviewed),Johannes Korth,University Hospital Essen,https://dx.doi.org/10.3390/ijerph18094540,21/05/2021,16/07/2022,Verified
210429_Germany_BoehringerIngelheim_primary,29-Apr-21,National,Germany,DEU,,,15-Apr-20,15-Jun-20,Essential non-healthcare workers,Adults (18-64 years),121,1.65%,,,Convenience,EUROIMMUN,ELISA,IgG,55.00%,100.00%,High,Journal Article (Peer-Reviewed),Petra C Moroni Zentgraf,Boehringer Ingelheim,https://dx.doi.org/10.1080/03007995.2021.1914943,22/05/2021,16/07/2022,Verified
210409_Bonn_UniversityOfBonn_RhinelandStudy1_overall_Unadj_ELISA,09-Apr-21,Local,Germany,DEU,North Rhine-Westphalia,Bonn,24-Apr-20,30-Jun-20,Household and community samples,Multiple groups,4755,0.97%,0.72%,1.30%,Convenience,EUROIMMUN,ELISA,IgG,94.40%,99.60%,High,Journal Article (Peer-Reviewed),N Ahmad Aziz,University of Bonn,https://dx.doi.org/10.1038/s41467-021-22351-5,22/05/2021,16/07/2022,Verified
210409_Bonn_UniversityOfBonn_Voluntary2_overall_Unadj_ELISA,09-Apr-21,Local,Germany,DEU,North Rhine-Westphalia,Bonn,24-Apr-20,30-Jun-20,Household and community samples,Multiple groups,360,1.94%,0.84%,4.42%,Self-referral,EUROIMMUN,ELISA,IgG,94.40%,99.60%,High,Journal Article (Peer-Reviewed),N Ahmad Aziz,University of Bonn,https://dx.doi.org/10.1038/s41467-021-22351-5,22/05/2021,16/07/2022,Verified
210331_SchleswigHolstein_RuhrUniversityBochum_NonHCW,31-Mar-21,Local,Germany,DEU,Schleswig-Holstein,,14-Apr-20,20-Oct-20,Health care workers and caregivers,Adults (18-64 years),138,0.72%,,,Convenience,"EUROIMMUN,DiaSorin,Abbott Laboratories",ELISA,IgG,,,High,Preprint,Jonas Herzberg,Ruhr University Bochum,https://www.medrxiv.org/content/10.1101/2021.03.29.21254538v1,24/05/2021,16/07/2022,Unverified
210506_Berlin_FreieUniversitätBerlin,06-May-21,Local,Germany,DEU,Berlin,Berlin,28-Sep-20,02-Oct-20,Students and Daycares,Multiple groups,720,0.14%,,,Convenience,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Marlene Thielecke,Freie Universität Berlin,https://dx.doi.org/10.1093/eurpub/ckab079,28/05/2021,16/07/2022,Unverified
210513_Ulm_UlmUniversity_Overall,13-May-21,Local,Germany,DEU,Baden-Württemberg,Ulm,15-Nov-20,07-Mar-21,Multiple populations,Adults (18-64 years),818,14.50%,,,Convenience,Roche Diagnostics,CLIA,"IgG,IgM,IgA",98.80%,99.98%,Moderate,Preprint,Michael Schon,Ulm University,https://www.medrxiv.org/content/10.1101/2021.05.04.21256382v2.full-text,28/05/2021,16/07/2022,Unverified
210428_Europe_SorbonneUniversité_1Nordrhein-Westfalen,28-Apr-21,Regional,Germany,DEU,Nordrhein-Westfalen,,07-Jun-20,08-Dec-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,624,0.80%,,,Convenience,"Abbott Laboratories,Siemens,DiaSorin,Beckman Coulter,Roche Diagnostics",Not reported,"IgG,IgM,IgA",,,High,Journal Article (Peer-Reviewed),David Saadoun,Sorbonne Université,https://dx.doi.org/10.1016/S2665-9913(21)00112-0,30/05/2021,16/07/2022,Verified
210413_Tubingen_EberhardKarlsUniversitatTubingen,13-Apr-21,Local,Germany,DEU,Baden-Württemberg,Tubingen,01-May-20,01-May-20,Essential non-healthcare workers,Adults (18-64 years),318,2.80%,1.50%,5.30%,Convenience,"Siemens,EUROIMMUN,Roche Diagnostics",Multiple Types,Not reported,,,High,Journal Article (Peer-Reviewed),Focke Ziemssen,Eberhard Karls Universitat Tubingen,https://bmjophth.bmj.com/content/bmjophth/6/1/e000688.full.pdf,01/06/2021,16/07/2022,Unverified
210512_Lübeck_UniversityofLübeck_TotalStudy,12-May-21,Local,Germany,DEU,,Lubeck,06-May-20,01-Feb-21,Household and community samples,Multiple groups,3051,3.44%,,,Self-referral,EUROIMMUN,ELISA,IgG,,,High,Preprint,Christine Klein,University of Lübeck,https://www.medrxiv.org/content/10.1101/2021.05.10.21256966v1.full-text,02/06/2021,16/07/2022,Verified
201212_Europe_UniversityOfGlasgow_Germany2,12-Dec-20,National,Germany,DEU,,"Berlin, Düsseldorf and Wiesbaden",15-Apr-20,30-Jun-20,Health care workers and caregivers,Adults (18-64 years),137,2.92%,1.14%,7.27%,Convenience,Abbott Laboratories,CLIA,IgG,100.00%,99.60%,High,Journal Article (Peer-Reviewed),Scott M Nelson,University of Glasgow,https://dx.doi.org/10.1093/hropen/hoaa056,07/06/2021,16/07/2022,Verified
210618_Bonn_BonnUniversityHospital_primary,18-Jun-21,Local,Germany,DEU,,Bonn,15-Dec-20,15-Jan-21,Health care workers and caregivers,Multiple groups,118,14.00%,,,Convenience,Roche Diagnostics,ELISA,IgG,99.50%,99.50%,High,Journal Article (Peer-Reviewed),Kathrin van Bremen,Bonn University Hospital,https://dx.doi.org/10.1007/s15010-021-01641-6,06/07/2021,16/07/2022,Unverified
210625_Germany_RobertKochInstitute_overall,25-Jun-21,National,Germany,DEU,,,15-Oct-20,15-Feb-21,Household and community samples,Multiple groups,15122,1.30%,,,Simplified probability,EUROIMMUN,ELISA,IgG,,,Moderate,Preprint,Jens Hoebel,German Institute for Economic Research,https://www.medrxiv.org/content/10.1101/2021.06.21.21259001v1.full-text,07/07/2021,16/07/2022,Verified
210701_Heilbronn_SLKClinicsHeilbronn_Primary,01-Jul-21,Local,Germany,DEU,Baden-Württemberg,Heilbronn,01-Jul-20,21-Jul-20,Health care workers and caregivers,Multiple groups,3066,3.10%,,,Convenience,"Siemens,Abbott Laboratories,DiaSorin,EUROIMMUN",Multiple Types,"IgG,IgM",100.00%,,Moderate,Journal Article (Peer-Reviewed),Lionel Larribere,SLK Clinics Heilbronn ,http://dx.doi.org/10.3390/ijerph18137057,14/07/2021,16/07/2022,Verified
210714_Baden-Württemberg_UlmUniversityHospital_Residents1_overall,14-Jul-21,Local,Germany,DEU,Baden-Württemberg,Alb-Danube district and Ulm ,27-Jul-20,25-Aug-20,Assisted living and long-term care facilities,Multiple groups,100,1.00%,,,Convenience,NA,CLIA,Not reported,,,High,Journal Article (Peer-Reviewed),Lukas Perkhofer,Ulm University Hospital ,https://dx.doi.org/10.1007/s00391-021-01931-6,18/07/2021,16/07/2022,Unverified
210714_Baden-Württemberg_UlmUniversityHospital_Employees2_overall,14-Jul-21,Local,Germany,DEU,Baden-Württemberg,Alb-Danube district and Ulm ,27-Jul-20,25-Aug-20,Health care workers and caregivers,Adults (18-64 years),394,0.25%,,,Convenience,NA,CLIA,Not reported,,,High,Journal Article (Peer-Reviewed),Lukas Perkhofer,Ulm University Hospital ,https://dx.doi.org/10.1007/s00391-021-01931-6,18/07/2021,16/07/2022,Unverified
210520_NorthRhine-Westphalia_RuhrUniversityBochum,20-May-21,Local,Germany,DEU,North Rhine-Westphalia,,01-Jul-20,30-Sep-20,Health care workers and caregivers,Adults (18-64 years),907,1.43%,,,Convenience,Roche Diagnostics,CLIA,IgG,99.00%,99.00%,High,Journal Article (Peer-Reviewed),Anke Hildebrandt ,Ruhr University Bochum,10.1016/j.ijheh.2021.113771,29/07/2021,16/07/2022,Unverified
210803_Mainz_UniversityMedicalCentreOfMainz_Adj,03-Aug-21,Local,Germany,DEU,Rhineland-Palatinate,Mainz,15-Aug-20,15-Oct-20,Health care workers and caregivers,Adults (18-64 years),3664,1.89%,1.39%,2.47%,Convenience,NA,Not reported,"IgG,IgM",,,High,Preprint,Stephan Gehring,University Medical Centre of Mainz,https://www.researchsquare.com/article/rs-688656/v1,11/08/2021,16/07/2022,Unverified
210811_Munich_LudwigMaximiliansUniversitatMunich_overall,11-Aug-21,Local,Germany,DEU,,Munich,27-May-20,12-Aug-20,Health care workers and caregivers,Adults (18-64 years),7554,2.20%,1.89%,2.55%,Convenience,"Abbott Laboratories,EUROIMMUN,Roche Diagnostics,Mikrogen GmbH,NA",Multiple Types,"IgG,Total Antibody",,,Moderate,Journal Article (Peer-Reviewed),Paul Wratil,Ludwig Maximilians UNiversitat Munich (LMU Munich),https://dx.doi.org/10.1007/s15010-021-01672-z,16/08/2021,16/07/2022,Unverified
210820_Hamburg_UniversitätHamburg_primary,20-Aug-21,Local,Germany,DEU,,Hamburg,19-Aug-20,18-Sep-20,Health care workers and caregivers,Multiple groups,619,0.33%,0.04%,1.17%,Stratified non-probability,EUROIMMUN,ELISA,IgG,94.60%,99.80%,Moderate,Journal Article (Peer-Reviewed),Marietta Neumann,Universität Hamburg,https://dx.doi.org/10.1007/s12519-021-00447-8,31/08/2021,16/07/2022,Verified
210901_Dusseldorf_HeinrichHeineUniversityDusseldorf,01-Sep-21,Local,Germany,DEU,North Rhine-Westphalia,Dusseldorf,17-Dec-20,19-Feb-21,Patients seeking care for non-COVID-19 reasons,Multiple groups,39,25.60%,,,Convenience,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Benedikt Botticher,Heinrich Heine University ,https://dx.doi.org/10.1007/s00431-021-04242-5,07/09/2021,16/07/2022,Verified
210826_Berlin_UniversitätsmedizinBerlin_PrimaryStudent_Primary,26-Aug-21,Local,Germany,DEU,,Berlin,02-Nov-20,16-Nov-20,Students and Daycares,Children and Youth (0-17 years),174,1.10%,,,Stratified probability,EUROIMMUN,ELISA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Stefanie Theuring,Universitätsmedizin Berlin,https://dx.doi.org/10.2807/1560-7917.ES.2021.26.34.2100184,07/09/2021,16/07/2022,Verified
210826_Berlin_UniversitätsmedizinBerlin_SecondaryStudent_Primary,26-Aug-21,Local,Germany,DEU,,Berlin,02-Nov-20,16-Nov-20,Students and Daycares,Children and Youth (0-17 years),173,2.90%,,,Stratified probability,EUROIMMUN,ELISA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Stefanie Theuring,Universitätsmedizin Berlin,https://dx.doi.org/10.2807/1560-7917.ES.2021.26.34.2100184,07/09/2021,16/07/2022,Verified
210826_Berlin_UniversitätsmedizinBerlin_Staff_Primary,26-Aug-21,Local,Germany,DEU,,Berlin,02-Nov-20,16-Nov-20,Essential non-healthcare workers,Adults (18-64 years),141,1.40%,0.20%,5.00%,Stratified probability,EUROIMMUN,ELISA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Stefanie Theuring,Universitätsmedizin Berlin,https://dx.doi.org/10.2807/1560-7917.ES.2021.26.34.2100184,07/09/2021,16/07/2022,Verified
210826_Berlin_UniversitätsmedizinBerlin_HouseholdMembers_Primary,26-Aug-21,Local,Germany,DEU,,Berlin,02-Nov-20,16-Nov-20,Household and community samples,Multiple groups,576,1.40%,0.60%,2.70%,Stratified probability,EUROIMMUN,ELISA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Stefanie Theuring,Universitätsmedizin Berlin,https://dx.doi.org/10.2807/1560-7917.ES.2021.26.34.2100184,07/09/2021,16/07/2022,Verified
210726_Dresden_TechnischeUniversitatDresden_200715-201115_Adults,26-Jul-21,Local,Germany,DEU,Saxony,Dresden,15-Jul-20,15-Nov-20,Multiple populations,Multiple groups,350,0.60%,,,Convenience,"DiaSorin,Abbott Laboratories,EUROIMMUN",Multiple Types,IgG,,,High,Journal Article (Peer-Reviewed),Luise Haag,Technische Universitat Dresden,http://dx.doi.org/10.1016/j.jpeds.2021.07.054,14/09/2021,16/07/2022,Unverified
210726_Dresden_TechnischeUniversitatDresden_201116-210131_Adults,26-Jul-21,Local,Germany,DEU,Saxony,Dresden,16-Jul-20,31-Jan-21,Multiple populations,Multiple groups,424,11.30%,,,Convenience,"DiaSorin,EUROIMMUN,Abbott Laboratories",Multiple Types,IgG,,,High,Journal Article (Peer-Reviewed),Luise Haag,Technische Universitat Dresden\,http://dx.doi.org/10.1016/j.jpeds.2021.07.054,14/09/2021,16/07/2022,Unverified
210916_Augsburg_UniversityHospitalofAugsburg_HCW,16-Sep-21,Local,Germany,DEU,Bavaria,Augsburg,24-Dec-20,31-Dec-20,Health care workers and caregivers,Adults (18-64 years),43,2.30%,,,Convenience,nal von minden GmbH,LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Stephan Zellmer,University Hospital of Augsburg,https://dx.doi.org/10.1055/a-1526-1169,29/09/2021,16/07/2022,Unverified
211005_Munich_LMUMunich_TestAdjusted,05-Oct-21,Local,Germany,DEU,Bavaria,Munich,14-May-20,30-Sep-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,509,1.27%,0.46%,2.44%,Convenience,"Roche Diagnostics,EUROIMMUN",Multiple Types,"IgG,Total Antibody",,,Moderate,Journal Article (Peer-Reviewed),Katharina Eisenhut,LMU Munich,https://dx.doi.org/10.1007/s00415-021-10818-w,14/10/2021,16/07/2022,Unverified
211011_NorthRhineWestphalia_UniversityofDuisburgEssen_Overall,11-Oct-21,Regional,Germany,DEU,North Rhine-Westphalia,,01-Jun-20,31-Jul-20,Health care workers and caregivers,Multiple groups,861,0.81%,,,Unclear,"Abbott Laboratories,DiaSorin,EUROIMMUN,NA",Multiple Types,IgG,,,Moderate,Journal Article (Peer-Reviewed),Dorothea Dehnen,University of Duisburg-Essen,https://dx.doi.org/10.1002/jmv.27385,19/10/2021,16/07/2022,Unverified
211012_Germany_UniversitätWürzburg_Overall,12-Oct-21,Local,Germany,DEU,Bavaria,Würzburg,01-Jun-20,31-Oct-20,Household and community samples,Multiple groups,3034,1.10%,0.70%,1.50%,Stratified non-probability,Roche Diagnostics,CLIA,"IgA,IgG,IgM",,,Moderate,Journal Article (Peer-Reviewed),Felizitas Eichner,Universität Würzburg,https://dx.doi.org/10.1055/a-1630-7601,20/10/2021,16/07/2022,Verified
211012_Essen_EssenUniversityHospital_overall,12-Oct-21,Local,Germany,DEU,,Essen,28-May-20,29-May-20,Essential non-healthcare workers,Adults (18-64 years),729,0.82%,,,Convenience,EUROIMMUN,ELISA,IgG,,95.80%,High,Journal Article (Peer-Reviewed),Bastian Brune,Essen University Hospital,https://dx.doi.org/10.1007/s10049-021-00948-z,27/10/2021,16/07/2022,Unverified
211004_Bavaria_UniversityofRegensburg_ELISA-ELECSYS-Neutralization,04-Oct-21,Regional,Germany,DEU,Bavaria,"Tirschenreuth, Regensburg city and county, and Oberbayern/ alpine region",22-May-20,22-Jul-20,Multiple general populations,Children and Youth (0-17 years),2832,4.77%,,,Simplified probability,"NA,Roche Diagnostics",Multiple Types,"IgG,IgM,IgA,Neutralizing ",,,Moderate,Journal Article (Peer-Reviewed),Otto Laub,University of Regensburg,http://dx.doi.org/10.3389/fped.2021.678937,02/11/2021,16/07/2022,Verified
211025_Baden-Württemberg_HeidelbergUniversityHospital_overall,25-Oct-21,Regional,Germany,DEU,Baden-Württemberg,"Alb-Donau, Breisgau-Hochschwarzwald, Heidelberg/Rhein-Neckar, Karlsruhe, Mannheim, Neckar-Odenwald, Reutlingen, and Tübingen",11-May-20,01-Aug-20,Contacts of COVID patients,Multiple groups,1220,32.79%,,,Convenience,"Roche Diagnostics,Mikrogen GmbH,Siemens",Multiple Types,"IgG,IgM,Total Antibody",,,Moderate,Journal Article (Peer-Reviewed),Maximilian Stich,Heidelberg University Hospital,https://wwwnc.cdc.gov/eid/article/27/12/21-0978_article,02/11/2021,16/07/2022,Unverified
211101_Germany_RuhrUniversityBochum,01-Nov-21,Local,Germany,DEU,,Bochum,15-Aug-20,15-Feb-21,Patients seeking care for non-COVID-19 reasons,Multiple groups,110,9.09%,,,Convenience,Roche Diagnostics,Not reported,"IgG,IgM",99.50%,,High,Journal Article (Peer-Reviewed),Oliver Overheu,Ruhr-University Bochum,https://dx.doi.org/10.1159/000520572,11/11/2021,16/07/2022,Unverified
211124_Germany_RobertKochInstitute_Primary,24-Nov-21,National,Germany,DEU,,,15-Oct-20,15-Nov-20,Household and community samples,Multiple groups,14781,1.30%,0.90%,1.70%,Stratified probability,EUROIMMUN,ELISA,IgG,81.10%,99.70%,Low,Preprint,Hannelore Neuhauser,Robert Koch Institute,10.1101/2021.11.22.21266711,30/11/2021,16/07/2022,Unverified
211122_Germany_SaarlandUniversity_PLWH_Primary,22-Nov-21,Regional,Germany,DEU,South-west Germany,,01-Apr-20,30-Jun-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,594,1.85%,,,Convenience,"EUROIMMUN,Roche Diagnostics",Multiple Types,IgG,,,High,Journal Article (Peer-Reviewed),Dominic Kaddu-Mulindwa,Saarland University,https://dx.doi.org/10.1111/hiv.13207,01/12/2021,16/07/2022,Unverified
211122_Germany_SaarlandUniversity_PEP/PrEP_Primary,22-Nov-21,Regional,Germany,DEU,South-west Germany,,01-Apr-20,30-Jun-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,50,6.00%,,,Convenience,"EUROIMMUN,Roche Diagnostics",Multiple Types,IgG,,,High,Journal Article (Peer-Reviewed),Dominic Kaddu-Mulindwa,Saarland University,https://dx.doi.org/10.1111/hiv.13207,01/12/2021,16/07/2022,Unverified
211112_Ruhr_RuhrUniversityBochum_Primary,12-Nov-21,Regional,Germany,DEU,Ruhr,"Bochum, Gütersloh, Herne",15-Jun-20,15-Feb-21,Residual sera,Children and Youth (0-17 years),2145,2.56%,,,Convenience,Roche Diagnostics,CLIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Folke Brinkmann,Ruhr University Bochum,https://dx.doi.org/10.3390/idr13040088,07/12/2021,16/07/2022,Verified
220104_Wuerzburg_UniversityHospitalWuerzburg_Children_BeforeStudy,04-Jan-22,Local,Germany,DEU,Bavaria,Wuerzburg,01-Oct-20,15-Oct-20,Students and Daycares,Children and Youth (0-17 years),381,0.30%,,,Convenience,"Abbott Laboratories,Institut Virion/Serion,Roche Diagnostics",Multiple Types,IgG,,,High,Journal Article (Peer-Reviewed),Johannes Forster,University Hospital Wuerzburg,https://dx.doi.org/10.1001/jamanetworkopen.2021.42057,10/01/2022,16/07/2022,Unverified
220104_Wuerzburg_UniversityHospitalWuerzburg_Children_AfterStudy,04-Jan-22,Local,Germany,DEU,Bavaria,Wuerzburg,01-Mar-21,15-Mar-21,Students and Daycares,Children and Youth (0-17 years),338,2.37%,,,Convenience,"Abbott Laboratories,Institut Virion/Serion,Roche Diagnostics",Multiple Types,IgG,,,High,Journal Article (Peer-Reviewed),Johannes Forster,University Hospital Wuerzburg,https://dx.doi.org/10.1001/jamanetworkopen.2021.42057,10/01/2022,16/07/2022,Unverified
220104_Wuerzburg_UniversityHospitalWuerzburg_ChildcareWorkers_BeforeStudy,04-Jan-22,Local,Germany,DEU,Bavaria,Wuerzburg,01-Oct-20,15-Oct-20,Essential non-healthcare workers,Multiple groups,139,0.70%,,,Convenience,"Abbott Laboratories,Institut Virion/Serion,Roche Diagnostics",Multiple Types,IgG,,,High,Journal Article (Peer-Reviewed),Johannes Forster,University Hospital Wuerzburg,https://dx.doi.org/10.1001/jamanetworkopen.2021.42057,10/01/2022,16/07/2022,Unverified
220104_Wuerzburg_UniversityHospitalWuerzburg_ChildcareWorkers_AfterStudy,04-Jan-22,Local,Germany,DEU,Bavaria,Wuerzburg,01-Mar-21,15-Mar-21,Essential non-healthcare workers,Multiple groups,109,4.59%,,,Convenience,"Abbott Laboratories,Institut Virion/Serion,Roche Diagnostics",Multiple Types,IgG,,,High,Journal Article (Peer-Reviewed),Johannes Forster,University Hospital Wuerzburg,https://dx.doi.org/10.1001/jamanetworkopen.2021.42057,10/01/2022,16/07/2022,Unverified
211223_Friedrich-AlexanderUniversityErlangen-Nuremberg_Erlangen_Patients1_Overall,23-Dec-21,Local,Germany,DEU,Bavaria,Erlangen,15-Dec-20,15-Mar-21,Patients seeking care for non-COVID-19 reasons,Multiple groups,2869,4.20%,,,Unclear,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),David Simon,Friedrich-Alexander University (FAU) Erlangen-Nuremberg,https://dx.doi.org/10.1002/art.42035,12/01/2022,16/07/2022,Unverified
211223_Friedrich-AlexanderUniversityErlangen-Nuremberg_Erlangen_GenPop3_Overall,23-Dec-21,Local,Germany,DEU,Bavaria,Erlangen,15-Dec-20,15-Mar-21,Household and community samples,Multiple groups,1184,7.09%,5.70%,8.71%,Unclear,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),David Simon,Friedrich-Alexander University (FAU) Erlangen-Nuremberg,https://dx.doi.org/10.1002/art.42035,12/01/2022,16/07/2022,Unverified
211223_Friedrich-AlexanderUniversityErlangen-Nuremberg_Erlangen_HCW2_Overall,23-Dec-21,Local,Germany,DEU,Bavaria,Erlangen,15-Dec-20,15-Mar-21,Health care workers and caregivers,Multiple groups,455,11.21%,8.46%,14.47%,Unclear,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),David Simon,Friedrich-Alexander University (FAU) Erlangen-Nuremberg,https://dx.doi.org/10.1002/art.42035,12/01/2022,16/07/2022,Unverified
220103_Regensburg_UniversityHospitalRegensburg,03-Jan-22,Local,Germany,DEU,Bavaria,Regensburg,15-Mar-20,15-Feb-21,Health care workers and caregivers,Adults (18-64 years),205,5.10%,,,Convenience,"Roche Diagnostics,EUROIMMUN",ELISA,"IgG,IgM,IgA",,,High,Journal Article (Peer-Reviewed),Julian Hupf,University Hospital Regensburg,https://dx.doi.org/10.1007/s00063-021-00890-5,12/01/2022,16/07/2022,Unverified
211113_Hannover_HannoverMedicalSchool_Overall_Roche+Neut,23-Nov-21,Local,Germany,DEU,Lower Saxony,Hannover,15-Jun-20,15-Jun-21,Students and Daycares,Children and Youth (0-17 years),667,1.65%,,,Convenience,"Roche Diagnostics,NA",Multiple Types,"Total Antibody,Neutralizing ",,,Moderate,Journal Article (Peer-Reviewed),Mira Paulsen,Hannover Medical School,https://dx.doi.org/10.1016/j.jadohealth.2021.11.021,13/01/2022,16/07/2022,Unverified
211209_Dusseldorf_HeinrichHeineUniversityDusseldorf_TestAdj,09-Dec-21,Local,Germany,DEU,,Düsseldorf,27-Nov-20,04-Dec-20,Essential non-healthcare workers,Adults (18-64 years),745,4.00%,3.10%,6.20%,Convenience,Roche Diagnostics,CLIA,"IgG,IgA,IgM",99.50%,99.80%,Moderate,Journal Article (Peer-Reviewed),Insa Backhaus,Heinrich Heine University Düsseldorf,https://dx.doi.org/10.1093/occmed/kqab164,17/01/2022,16/07/2022,Unverified
220111_Germany_UniversityMedicineGreifswald_Overall,11-Jan-22,National,Germany,DEU,"Berlin, Hamburg, Saxony, Baden-Württemberg, North Rhine-Westphalia","Berlin, Hamburg, Dresden, Stuttgart, Cologne",15-Jan-21,21-Apr-21,Health care workers and caregivers,Adults (18-64 years),2784,5.20%,,,Convenience,EUROIMMUN,ELISA,IgG,94.40%,99.60%,Moderate,Journal Article (Peer-Reviewed),Maria Mksoud,University Medicine Greifswald,https://dx.doi.org/10.1007/s00784-021-04363-z,18/01/2022,16/07/2022,Unverified
220121_Bavaria_LudwigMaximiliansUniversitat_Children_Overall,21-Jan-22,Regional,Germany,DEU,Bavaria,,15-Jun-21,15-Jul-21,Students and Daycares,Children and Youth (0-17 years),509,7.70%,,,Convenience,Roche Diagnostics,CLIA,Total Antibody,,,High,Preprint,Anna Kern,Ludwig-Maximilians-Universitat,10.1101/2022.01.18.22269445,01/02/2022,16/07/2022,Unverified
220121_Bavaria_LudwigMaximiliansUniversitat_Teachers_Overall,21-Jan-22,Regional,Germany,DEU,Bavaria,,15-Jun-21,15-Jul-21,Essential non-healthcare workers,Adults (18-64 years),202,4.50%,,,Convenience,Roche Diagnostics,CLIA,Total Antibody,,,High,Preprint,Anna Kern,Ludwig-Maximilians-Universitat,10.1101/2022.01.18.22269445,01/02/2022,16/07/2022,Unverified
220124_Berlin_RobertKochInstitute_MayJune2020_Overall,24-Jan-22,Local,Germany,DEU,,Berlin,18-May-20,10-Jun-20,Health care workers and caregivers,Adults (18-64 years),1477,1.20%,,,Convenience,"EUROIMMUN,Beijing Wantai Biological,NA",Multiple Types,"IgG,Total Antibody,Neutralizing ",,,High,Journal Article (Peer-Reviewed),Sara Tomczyk,BG Klinikum Unfallkrankenhaus Berlin gGmbH,https://dx.doi.org/10.1186/s12879-022-07057-3,01/02/2022,16/07/2022,Unverified
220124_Berlin_RobertKochInstitute_Dec2020_TestAdj,24-Jan-22,Local,Germany,DEU,,"Berlin
",08-Dec-20,20-Dec-20,Health care workers and caregivers,Adults (18-64 years),1223,4.60%,3.34%,6.11%,Convenience,"EUROIMMUN,Beijing Wantai Biological,NA",Multiple Types,"IgG,Total Antibody,Neutralizing ",,,High,Journal Article (Peer-Reviewed),Sara Tomczyk,BG Klinikum Unfallkrankenhaus Berlin gGmbH,https://dx.doi.org/10.1186/s12879-022-07057-3,01/02/2022,16/07/2022,Unverified
220128_Gangelt_GermanCenterforInfectionResearch_Visit3,28-Jan-22,Local,Germany,DEU,North Rhine-Westphalia,Gangelt,01-Apr-21,30-Apr-21,Household and community samples,Multiple groups,406,35.90%,30.00%,42.00%,Simplified probability,EUROIMMUN,ELISA,IgG,90.90%,99.10%,Moderate,Preprint,Enrico Richter,German Center for Infection Research,https://www.medrxiv.org/content/10.1101/2022.01.26.22269805v1.full-text,09/02/2022,16/07/2022,Verified
211215_Marburg_PhilippsUniversityMarburg_Overall,15-Dec-21,Local,Germany,DEU,Hesse,Marburg,28-May-20,19-Jun-20,Health care workers and caregivers,Adults (18-64 years),3623,0.36%,,,Convenience,"EUROIMMUN,Roche Diagnostics,Beijing Wantai Biological,NA",Other,"IgG,Total Antibody,Neutralizing ",,,High,Journal Article (Peer-Reviewed),Christian Keller,Philipps University Marburg,https://doi.org/10.1515/labmed-2021-0107,10/02/2022,16/07/2022,Unverified
211124_Cologne_UniversityHospitalOfCologne,21-Dec-21,Local,Germany,DEU,North Rhine-Westphalia,Cologne,15-Apr-20,15-Apr-21,Residual sera,Multiple groups,203,2.96%,,,Convenience,Roche Diagnostics,CLIA,Total Antibody,,,High,Journal Article (Peer-Reviewed),Patrick Affeldt,University Hospital of Cologne,https://dx.doi.org/10.3390/microorganisms10010004,10/02/2022,16/07/2022,Unverified
220211_Hamburg_UniversityMedicalCenterHamburg-Eppendorf_Primary,11-Feb-22,Local,Germany,DEU,,Hamburg,11-May-20,30-Jun-20,Household and community samples,Children and Youth (0-17 years),4657,1.44%,,,Convenience,"Roche Diagnostics,DiaSorin",CLIA,"Total Antibody,IgG",,,Moderate,Preprint,Gabor Dunay,University Medical Center Hamburg-Eppendorf,https://www.medrxiv.org/content/10.1101/2022.02.11.22270611v1.full-text,22/02/2022,16/07/2022,Unverified
210901_Saxony-Anhalt_OttoVonGuerickeUniversityMagdeburg,01-Sep-21,Local,Germany,DEU,Saxony-Anhalt,Magdeburg,21-Jan-21,21-Apr-21,Blood donors,Adults (18-64 years),2236,12.90%,,,Convenience,NA,Not reported,Not reported,,,Unclear,Presentation or Conference,Stephan Werner Kramer,Otto Von Guericke University Magdeburg,https://dx.doi.org/10.1159/000518751,22/02/2022,16/07/2022,Unverified
220216_LowerSaxony_LeibnizUniversityHannover_Overall,16-Feb-22,Local,Germany,DEU,Lower Saxony,"Hannover, Goettingen",15-Sep-20,15-Jun-21,Multiple populations,Multiple groups,1883,6.16%,,,Convenience,"Roche Diagnostics,Viramed Biotech AG",Multiple Types,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Rebecca Jonczyk,Leibniz University Hannover,https://dx.doi.org/10.1128/spectrum.01512-21,24/02/2022,16/07/2022,Unverified
220215_Germany_InstitutfurLaboratoriumsundTransfusionsmedizin_Overall_1test,15-Feb-22,National,Germany,DEU,"North Rhine-Westphalia, Lower Saxony, Hesse",,01-Jul-20,30-Jun-21,Blood donors,Adults (18-64 years),3759,26.10%,,,Convenience,EUROIMMUN,ELISA,IgG,,,High,Preprint,Bastian Fischer,Institut fur Laboratoriums- und Transfusionsmedizin,https://www.medrxiv.org/content/10.1101/2022.02.11.22270833v1.full-text,24/02/2022,16/07/2022,Verified
220131_Munich_TechnicalUniversityofMunich_Overall,31-Jan-22,Local,Germany,DEU,Bavaria,Munich,14-Apr-20,29-May-20,Health care workers and caregivers,Adults (18-64 years),4554,2.40%,1.90%,2.90%,Convenience,"Shenzhen Yhlo Biotech Co. Ltd,EUROIMMUN,NA,Roche Diagnostics",Multiple Types,"IgG,Total Antibody",,,High,Journal Article (Peer-Reviewed),Johanna Erber,Technical University Munich,https://dx.doi.org/10.3201/eid2803.204436,03/03/2022,16/07/2022,Unverified
211125_NorthRhine-Westphalia_UniversitiyClinicsHamburgEppendorf_Apr2020_Overall,25-Nov-21,Regional,Germany,DEU,North Rhine-Westphalia,,01-Apr-20,30-Apr-20,Health care workers and caregivers,Adults (18-64 years),1212,2.20%,,,Convenience,NA,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),Albert Nienhaus,St. Antonius Hospital,10.1183/13993003.congress-2021.PA3187,03/03/2022,16/07/2022,Unverified
220225_Erlangen_FriedrichAlexanderUniversity_Period1_Overall,25-Feb-22,Local,Germany,DEU,"Bavaria
","Erlangen
",15-Oct-20,15-Nov-20,Residual sera,Children and Youth (0-17 years),872,1.40%,,,Sequential,Roche Diagnostics,CLIA,"IgG,IgM,IgA",,,High,Journal Article (Peer-Reviewed),Felix Wachter,Friedrich Alexander University,https://dx.doi.org/10.1515/cclm-2022-0037,07/03/2022,16/07/2022,Unverified
220225_Erlangen_FriedrichAlexanderUniversity_Period2_Overall,25-Feb-22,Local,Germany,DEU,"Bavaria
","Erlangen
",01-Apr-21,30-Apr-21,Residual sera,Children and Youth (0-17 years),808,9.20%,,,Sequential,Roche Diagnostics,CLIA,"IgG,IgM,IgA",,,High,Journal Article (Peer-Reviewed),Felix Wachter,Friedrich Alexander University,https://dx.doi.org/10.1515/cclm-2022-0037,07/03/2022,16/07/2022,Unverified
220225_Erlangen_FriedrichAlexanderUniversity_Period3_Overall,25-Feb-22,Local,Germany,DEU,"Bavaria
","Erlangen
",15-Jun-21,15-Jul-21,Residual sera,Children and Youth (0-17 years),946,14.60%,,,Sequential,Roche Diagnostics,CLIA,"IgG,IgM,IgA",,,High,Journal Article (Peer-Reviewed),Felix Wachter,Friedrich Alexander University,https://dx.doi.org/10.1515/cclm-2022-0037,07/03/2022,16/07/2022,Unverified
220219_Eschweiler_StAntoniusHospitalEschweiler_Round1,19-Feb-22,Local,Germany,DEU,North Rhine-Westphalia,Eschweiler,15-Apr-20,15-May-20,Health care workers and caregivers,Multiple groups,1211,3.30%,,,Convenience,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Martin Platten,St. Antonius Hospital Eschweiler ,https://dx.doi.org/10.3390/ijerph19042429,08/03/2022,16/07/2022,Unverified
220219_Eschweiler_StAntoniusHospitalEschweiler_Round2,19-Feb-22,Local,Germany,DEU,North Rhine-Westphalia,Eschweiler,01-Sep-20,30-Sep-20,Health care workers and caregivers,Multiple groups,1023,3.00%,,,Convenience,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Martin Platten,St. Antonius Hospital Eschweiler ,https://dx.doi.org/10.3390/ijerph19042429,09/03/2022,16/07/2022,Unverified
220219_Eschweiler_StAntoniusHospitalEschweiler_Round3,19-Feb-22,Local,Germany,DEU,North Rhine-Westphalia,Eschweiler,15-Nov-20,15-Dec-20,Health care workers and caregivers,Multiple groups,1074,5.20%,,,Convenience,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Martin Platten,St. Antonius Hospital Eschweiler ,https://dx.doi.org/10.3390/ijerph19042429,09/03/2022,16/07/2022,Unverified
220219_Eschweiler_StAntoniusHospitalEschweiler_Round4,19-Feb-22,Local,Germany,DEU,North Rhine-Westphalia,Eschweiler,01-Apr-21,30-Apr-21,Health care workers and caregivers,Multiple groups,1040,9.90%,,,Convenience,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Martin Platten,St. Antonius Hospital Eschweiler ,https://dx.doi.org/10.3390/ijerph19042429,09/03/2022,16/07/2022,Unverified
211203_Germany_HelmholtzCenterforInfectionResearch_Reutlingen1_Overall_PopTestAdj,03-Dec-21,Local,Germany,DEU,Baden-Württemberg,Reutlingen,01-Jul-20,28-Jul-20,Household and community samples,Multiple groups,2407,2.00%,1.00%,3.00%,Simplified probability,EUROIMMUN,ELISA,IgG,88.30%,99.20%,Low,Journal Article (Peer-Reviewed),Daniela Gornyk,Helmholtz Center for Infection Research,https://dx.doi.org/10.3238/arztebl.m2021.0364,09/03/2022,16/07/2022,Unverified
211203_Germany_HelmholtzCenterforInfectionResearch_Reutlingen2_Overall_PopTestAdj,03-Dec-21,Local,Germany,DEU,Baden-Württemberg,Reutlingen,14-Oct-20,10-Nov-20,Household and community samples,Multiple groups,2360,2.10%,1.20%,3.20%,Simplified probability,EUROIMMUN,ELISA,IgG,88.30%,99.20%,Low,Journal Article (Peer-Reviewed),Daniela Gornyk,Helmholtz Center for Infection Research,https://dx.doi.org/10.3238/arztebl.m2021.0364,09/03/2022,16/07/2022,Unverified
211203_Germany_HelmholtzCenterforInfectionResearch_Freiburg1_Overall_PopTestAdj,03-Dec-21,Local,Germany,DEU,Baden-Württemberg,Freiburg,05-Aug-20,01-Sep-20,Household and community samples,Multiple groups,2867,1.20%,0.50%,1.90%,Simplified probability,EUROIMMUN,ELISA,IgG,88.30%,99.20%,Low,Journal Article (Peer-Reviewed),Daniela Gornyk,Helmholtz Center for Infection Research,https://dx.doi.org/10.3238/arztebl.m2021.0364,09/03/2022,16/07/2022,Unverified
211203_Germany_HelmholtzCenterforInfectionResearch_Freiburg2_Overall_PopTestAdj,03-Dec-21,Local,Germany,DEU,Baden-Württemberg,Freiburg,18-Nov-20,15-Dec-20,Household and community samples,Multiple groups,2867,2.00%,1.00%,3.10%,Simplified probability,EUROIMMUN,ELISA,IgG,88.30%,99.20%,Low,Journal Article (Peer-Reviewed),Daniela Gornyk,Helmholtz Center for Infection Research,https://dx.doi.org/10.3238/arztebl.m2021.0364,09/03/2022,16/07/2022,Unverified
211203_Germany_HelmholtzCenterforInfectionResearch_Aachen1_Overall_PopTestAdj,03-Dec-21,Local,Germany,DEU,North Rhine-Westphalia,Aachen,09-Sep-20,09-Oct-20,Household and community samples,Multiple groups,2023,2.00%,1.00%,2.90%,Simplified probability,EUROIMMUN,ELISA,IgG,88.30%,99.20%,Low,Journal Article (Peer-Reviewed),Daniela Gornyk,Helmholtz Center for Infection Research,https://dx.doi.org/10.3238/arztebl.m2021.0364,09/03/2022,16/07/2022,Unverified
211203_Germany_HelmholtzCenterforInfectionResearch_Aachen2_Overall_PopTestAdj,03-Dec-21,Local,Germany,DEU,North Rhine-Westphalia,Aachen,27-Jan-21,23-Feb-21,Household and community samples,Multiple groups,1888,5.20%,3.60%,6.90%,Simplified probability,EUROIMMUN,ELISA,IgG,88.30%,99.20%,Low,Journal Article (Peer-Reviewed),Daniela Gornyk,Helmholtz Center for Infection Research,https://dx.doi.org/10.3238/arztebl.m2021.0364,09/03/2022,16/07/2022,Unverified
211203_Germany_HelmholtzCenterforInfectionResearch_Osnabruck1_Overall_PopTestAdj,03-Dec-21,Local,Germany,DEU,Lower Saxony,Osnabruck,15-Oct-20,15-Nov-20,Household and community samples,Multiple groups,2923,1.10%,0.40%,1.70%,Simplified probability,EUROIMMUN,ELISA,IgG,88.30%,99.20%,Low,Journal Article (Peer-Reviewed),Daniela Gornyk,Helmholtz Center for Infection Research,https://dx.doi.org/10.3238/arztebl.m2021.0364,09/03/2022,16/07/2022,Unverified
211203_Germany_HelmholtzCenterforInfectionResearch_Osnabruck2_Overall_PopTestAdj,03-Dec-21,Local,Germany,DEU,Lower Saxony,Osnabruck,01-Mar-21,31-Mar-21,Household and community samples,Multiple groups,1611,3.70%,2.10%,5.20%,Simplified probability,EUROIMMUN,ELISA,IgG,88.30%,99.20%,Low,Journal Article (Peer-Reviewed),Daniela Gornyk,Helmholtz Center for Infection Research,https://dx.doi.org/10.3238/arztebl.m2021.0364,09/03/2022,16/07/2022,Unverified
211203_Germany_HelmholtzCenterforInfectionResearch_Magdeburg1_Overall_PopTestAdj,03-Dec-21,Local,Germany,DEU,Saxony-Anhalt,Magdeburg,18-Nov-20,15-Dec-20,Household and community samples,Multiple groups,2713,2.00%,1.10%,2.90%,Simplified probability,EUROIMMUN,ELISA,IgG,88.30%,99.20%,Low,Journal Article (Peer-Reviewed),Daniela Gornyk,Helmholtz Center for Infection Research,https://dx.doi.org/10.3238/arztebl.m2021.0364,09/03/2022,16/07/2022,Unverified
211203_Germany_HelmholtzCenterforInfectionResearch_Magdeburg2_Overall_PopTestAdj,03-Dec-21,Local,Germany,DEU,Saxony-Anhalt,Magdeburg,07-Apr-21,05-May-21,Household and community samples,Multiple groups,1118,9.20%,6.90%,11.60%,Simplified probability,EUROIMMUN,ELISA,IgG,88.30%,99.20%,Low,Journal Article (Peer-Reviewed),Daniela Gornyk,Helmholtz Center for Infection Research,https://dx.doi.org/10.3238/arztebl.m2021.0364,09/03/2022,16/07/2022,Unverified
211203_Germany_HelmholtzCenterforInfectionResearch_Chemnitz1_Overall_PopTestAdj,03-Dec-21,Local,Germany,DEU,Saxony,Chemnitz,03-Mar-21,01-Apr-21,Household and community samples,Multiple groups,2702,14.30%,12.00%,16.50%,Simplified probability,EUROIMMUN,ELISA,IgG,88.30%,99.20%,Low,Journal Article (Peer-Reviewed),Daniela Gornyk,Helmholtz Center for Infection Research,https://dx.doi.org/10.3238/arztebl.m2021.0364,09/03/2022,16/07/2022,Unverified
211203_Germany_HelmholtzCenterforInfectionResearch_Chemnitz2_Overall_PopTestAdj,03-Dec-21,Local,Germany,DEU,Saxony,Chemnitz,21-Jul-21,17-Aug-21,Household and community samples,Multiple groups,358,37.40%,31.50%,43.40%,Simplified probability,EUROIMMUN,ELISA,IgG,88.30%,99.20%,Low,Journal Article (Peer-Reviewed),Daniela Gornyk,Helmholtz Center for Infection Research,https://dx.doi.org/10.3238/arztebl.m2021.0364,09/03/2022,16/07/2022,Unverified
211203_Germany_HelmholtzCenterforInfectionResearch_Greifswald_Overall_PopTestAdj,03-Dec-21,Local,Germany,DEU,Mecklenburg-Vorpommern,Greifswald,08-Jun-21,08-Jun-21,Household and community samples,Multiple groups,954,13.60%,10.20%,17.10%,Simplified probability,EUROIMMUN,ELISA,IgG,88.30%,99.20%,Low,Journal Article (Peer-Reviewed),Daniela Gornyk,Helmholtz Center for Infection Research,https://dx.doi.org/10.3238/arztebl.m2021.0364,09/03/2022,16/07/2022,Unverified
220219_Germany_StVincenzHospital,19-Feb-22,National,Germany,DEU,,,15-Jun-20,15-Jun-21,Health care workers and caregivers,Multiple groups,1842,13.20%,,,Convenience,Roche Diagnostics,CLIA,IgG,99.00%,99.00%,Low,Journal Article (Peer-Reviewed),Anke Hildebradnt,St. Vincenz Hospital,https://dx.doi.org/10.3390/ijerph19042402,09/03/2022,16/07/2022,Unverified
220308_UniversityMedicalCenterHamburgEppendorf_UniversityofHamburg,08-Mar-22,Local,Germany,DEU,Hamburg,Hamburg,17-Jan-22,31-Jan-22,Health care workers and caregivers,Adults (18-64 years),697,9.76%,,,Convenience,Roche Diagnostics,CLIA,"IgA,IgG,IgM",99.50%,99.80%,High,Preprint,Thomas Brehm,University of Hamburg,https://www.medrxiv.org/content/10.1101/2022.03.06.22271718v1.full-text,17/03/2022,16/07/2022,Unverified
220301_Wurselen_UniversityHospitalHamburgEppendorf_Overall,01-Mar-22,Local,Germany,DEU,North Rhine-Westphalia,Würselen,19-Jun-20,17-Jul-20,Health care workers and caregivers,Multiple groups,903,5.43%,,,Convenience,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Philipp Stuven,University Hospital Hamburg Eppendorf,https://dx.doi.org/10.3205/dgkh000407,24/03/2022,16/07/2022,Unverified
220220_Hamburg_UniversityHeartAndVascularCenter_overall,20-Feb-22,Local,Germany,DEU,,Hamburg,09-May-20,30-Jun-20,Household and community samples,Children and Youth (0-17 years),4657,1.30%,,,Unclear,NA,Not reported,Not reported,,,Unclear,Journal Article (Peer-Reviewed),J Olfe,University Heart and Vascular Center,https://dx.doi.org/10.1055/s-0042-1742988,24/03/2022,16/07/2022,Unverified
20220324_German_FriedrichSchillerUniversity_Primary,24-Mar-22,Local,Germany,DEU,,Jena,15-Feb-20,15-Mar-21,Patients seeking care for non-COVID-19 reasons,Multiple groups,156,4.20%,1.70%,9.80%,Self-referral,"DiaSorin,Roche Diagnostics",Multiple Types,IgG,,,Moderate,Journal Article (Peer-Reviewed),Anke Jaudszus,Friedrich Schiller University,https://dx.doi.org/10.1186/s12890-022-01900-8,05/04/2022,16/07/2022,Unverified
220423_EasternSaxony_TechnischeUniversitatDresden_Students_JuneJuly21,23-Apr-22,Regional,Germany,DEU,Eastern Saxony,,15-Jun-21,15-Jul-21,Students and Daycares,Children and Youth (0-17 years),841,21.50%,18.80%,24.40%,Convenience,"DiaSorin,Abbott Laboratories,EUROIMMUN",Multiple Types,IgG,,,Moderate,Journal Article (Peer-Reviewed),Carolin Kirsten,Technische Universität Dresden,https://dx.doi.org/10.1007/s15010-022-01824-9,04/05/2022,16/07/2022,Unverified
220423_EasternSaxony_TechnischeUniversitatDresden_Teachers_JuneJuly21,23-Apr-22,Regional,Germany,DEU,Eastern Saxony,,15-Jun-21,15-Jul-21,Non-essential workers and unemployed persons,Adults (18-64 years),46,30.40%,17.40%,43.50%,Convenience,"DiaSorin,Abbott Laboratories,EUROIMMUN",Multiple Types,IgG,,,High,Journal Article (Peer-Reviewed),Carolin Kirsten,Technische Universität Dresden,https://dx.doi.org/10.1007/s15010-022-01824-9,04/05/2022,16/07/2022,Unverified
220415_GreaterLubeckArea_UniversityofLubeck_Overall,15-Apr-22,Local,Germany,DEU,Schleswig-Holstein,Lubeck,06-May-20,01-Feb-21,Household and community samples,Multiple groups,3051,2.80%,,,Self-referral,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Christine Klein,University of Lubeck ,https://dx.doi.org/10.1126/sciadv.abm5016,17/05/2022,16/07/2022,Verified
220402_Germany_CharitéResearchOrganisationGmbH_June2020-July2020,20-Apr-22,National,Germany,DEU,,,29-Jun-20,03-Jul-20,Essential non-healthcare workers,Adults (18-64 years),1064,1.90%,,,Convenience,EUROIMMUN,ELISA,IgG,94.40%,99.60%,Moderate,Journal Article (Peer-Reviewed),HyoungJin Kim,Deutsche Bahn AG,https://dx.doi.org/10.1017/S095026882200070X,24/05/2022,16/07/2022,Unverified
220402_Germany_CharitéResearchOrganisationGmbH_Oct2020-Oct2020,20-Apr-22,National,Germany,DEU,,,26-Oct-20,30-Oct-20,Essential non-healthcare workers,Adults (18-64 years),1076,2.40%,,,Convenience,EUROIMMUN,ELISA,IgG,94.40%,99.60%,Moderate,Journal Article (Peer-Reviewed),HyoungJin Kim,Deutsche Bahn AG,https://dx.doi.org/10.1017/S095026882200070X,24/05/2022,16/07/2022,Unverified
220402_Germany_CharitéResearchOrganisationGmbH_Feb2021-Mar2021,20-Apr-22,National,Germany,DEU,,,24-Feb-21,02-Mar-21,Essential non-healthcare workers,Adults (18-64 years),1014,6.50%,,,Convenience,EUROIMMUN,ELISA,IgG,94.40%,99.60%,Moderate,Journal Article (Peer-Reviewed),HyoungJin Kim,Deutsche Bahn AG,https://dx.doi.org/10.1017/S095026882200070X,24/05/2022,16/07/2022,Unverified
220323_Dusseldorf_HeinrichHeineUniversity_TestAdjusted,23-Mar-22,Regional,Germany,DEU,North Rhine-Westphalia,Dusseldorf,02-Nov-20,27-Nov-20,Household and community samples,Adults (18-64 years),2186,3.10%,2.40%,4.00%,Simplified probability,Roche Diagnostics,CLIA,"IgG,IgM,IgA",99.50%,99.80%,Low,Journal Article (Peer-Reviewed),Insa Backhaus,Heinrich Heine University,https://dx.doi.org/10.1016/j.puhe.2022.03.009,27/05/2022,16/07/2022,Verified
220526_Germany_UniversitätsmedizinBerlin,26-May-22,National,Germany,DEU,,,01-Jan-21,31-Jan-22,Patients seeking care for non-COVID-19 reasons,Multiple groups,119,7.56%,,,Sequential,NA,Neutralization,Not reported,,,High,Journal Article (Peer-Reviewed),Elisabeth Bluthner,Universitätsmedizin Berlin,https://dx.doi.org/10.1002/jpen.2410,31/05/2022,16/07/2022,Unverified
220518_Saarland_SaarlandUniversityMedicalCenter_PopTestAdj,18-May-22,Regional,Germany,DEU,Saarland,,22-Jul-20,15-Oct-20,Household and community samples,Multiple groups,2940,0.32%,,,Simplified probability,EUROIMMUN,ELISA,IgG,84.90%,99.30%,Moderate,Journal Article (Peer-Reviewed),Stefan Lohse,Saarland University Medical Center,https://dx.doi.org/10.1038/s43856-022-00100-z,02/06/2022,16/07/2022,Unverified
220601_Stuttgart_UniversityofCologne_Primary(S-IgG),01-Jun-22,Local,Germany,DEU,Baden-Württemberg,Stuttgart,15-Jun-21,14-Jul-21,Household and community samples,Multiple groups,454,71.60%,,,Stratified probability,EUROIMMUN,ELISA,IgG,98.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Gregor Paul,University of Cologne,https://dx.doi.org/10.1007/s15010-022-01830-x,11/06/2022,16/07/2022,Unverified
220606_Germany_Ludwig-MaximiliansUniversityofMunich_Overall,06-Jun-22,National,Germany,DEU,,"Hamburg, Hannover, Berlin, Krefeld, Dusseldorf, Aachen, Gießen, Dresden, Wurzburg, Mannheim, Homburg (town), Freiburg, Munich",01-Jun-20,31-May-21,Residual sera,Children and Youth (0-17 years),10358,4.50%,,,Convenience,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Anna-Lisa Sorg,Heidelberg University,https://doi.org/10.1038/s41467-022-30482-6,14/06/2022,16/07/2022,Unverified
220527_Tirschenreuth_UniversityofRegensburg_FollowUp2,27-May-22,Regional,Germany,DEU,Tirschenreuth District,,01-Apr-21,30-Apr-21,Household and community samples,Multiple groups,3177,15.68%,,,Convenience,Roche Diagnostics,CLIA,Total Antibody,,,Moderate,Journal Article (Peer-Reviewed),Sebastian Einhauser,University of Regensburg,https://dx.doi.org/10.3390/v14061168,24/06/2022,16/07/2022,Unverified
220706_Bavaria_Ludwig-Maximilians-Universität_Children1,06-Jul-22,Regional,Germany,DEU,Bavaria,,01-Jun-21,31-Jul-22,Students and Daycares,Children and Youth (0-17 years),315,8.57%,,,Convenience,NA,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),Anna Kern,Ludwig-Maximilians-Universität,https://dx.doi.org/10.3389/fped.2022.888498,17/08/2022,18/08/2022,Unverified
220706_Bavaria_Ludwig-Maximilians-Universität_Staff2,06-Jul-22,Regional,Germany,DEU,Bavaria,,01-Jun-21,31-Jul-22,Essential non-healthcare workers,Adults (18-64 years),123,4.88%,,,Convenience,NA,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),Anna Kern,Ludwig-Maximilians-Universität,https://dx.doi.org/10.3389/fped.2022.888498,17/08/2022,18/08/2022,Unverified
200918_Tbilisi_InfectiousDiseaseResearchCenter_Total_PopTestAdj,18-Sep-20,Local,Georgia,GEO,Tbilisi,Tbilisi,18-May-20,27-May-20,Household and community samples,Multiple groups,1086,1.02%,0.38%,2.18%,Convenience,Zhejiang Orient Gene Biotech,LFIA,IgG,93.10%,99.20%,Moderate,Preprint,Tengiz Tsertsvadze,"Infectious Diseases, AIDS and Clinical Immunology Research Center",https://www.medrxiv.org/content/10.1101/2020.09.18.20195024v1,22/11/2020,16/07/2022,Verified
210420_Libreville_CentreHospitalierUniversitaire(CHU)‐Mère‐Enfant_overall_unadj,20-Apr-21,Local,Gabon,GAB,,Libreville,15-Jul-20,15-Oct-20,Residual sera,Multiple groups,1495,36.20%,,,Convenience,"Biomerieux,Roche Diagnostics",Multiple Types,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Amandine Mveang Nzoghe,Centre Hospitalier Universitaire (CHU) ‐ Mère‐ Enfant,https://dx.doi.org/10.1186/s13104-021-05570-3,19/05/2021,16/07/2022,Verified
210506_Gabon_CHUMèreEnfantFondationJeanneEbori,06-May-21,National,Gabon,GAB,,,15-Mar-20,15-Aug-20,Contacts of COVID patients,Multiple groups,319,55.00%,,,Convenience,NA,LFIA,Not reported,,,Unclear,Journal Article (Peer-Reviewed),Amandine Mveang Nzoghe,CHU Mère Enfant Fondation Jeanne Ebori,https://dx.doi.org/10.1038/s41598-021-87043-y,28/05/2021,16/07/2022,Verified
211112_FrenchGuiana_InstitutPasteurinFrenchGuiana_Overall_PopAdjusted,12-Nov-21,National,French Guiana,GUF,"Cayenne, Saint-Laurent-du-Maroni","Cayenne, Matoury, Mana, Apatou, Saint-Laurent-du-Maroni, Awala-Yalimapo, Iracoubo, Sinnamary, Kourou, Macouria, Cayenne, Rémire-Montjoly, Saint-Georges, Maripasoula, Papaïchton, Grand-Santi",15-Jul-20,23-Jul-20,Residual sera,Multiple groups,480,15.40%,9.30%,24.40%,Convenience,EUROIMMUN,ELISA,IgG,93.80%,99.60%,Moderate,Journal Article (Peer-Reviewed),Claude Flamand,Institut Pasteur in French Guiana,https://dx.doi.org/10.1371/journal.pntd.0009945,23/11/2021,16/07/2022,Verified
200902_Lille_InstitutPasteur_BloodDonors_ELISA-N,02-Sep-20,Local,France,FRA,Hauts-de-France,"Clermont, Noyon, Lille",20-Mar-20,24-Mar-20,Blood donors,Multiple groups,200,0.00%,,,Sequential,NA,ELISA,"IgA,IgE,IgD,IgM,IgG,Total Antibody",,95.00%,High,Journal Article (Peer-Reviewed),Ludivine Grzelak,Institut Pasteur,https://stm.sciencemag.org/content/12/559/eabc3103,28/04/2020,16/07/2022,Verified
200501_France_ CentreLeonBerard_HCW,01-May-20,Local,France,FRA,Auvergne-Rhône-Alpes,Lyon,01-Mar-20,16-Apr-20,Health care workers and caregivers,Adults (18-64 years),85,5.88%,,,Convenience,TODA Pharma,LFIA,"IgG,IgM",100.00%,100.00%,High,Journal Article (Peer-Reviewed),M Solodky,Centre Leon Berard,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7252166/,19/07/2020,16/07/2022,Verified
200501_France_ CentreLeonBerard_CancerPatient,01-May-20,Local,France,FRA,Auvergne-Rhône-Alpes,Lyon,01-Mar-20,16-Apr-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,244,5.33%,,,Sequential,TODA Pharma,LFIA,"IgG,IgM",100.00%,100.00%,High,Journal Article (Peer-Reviewed),M Solodky,Centre Leon Berard,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7252166/,19/07/2020,16/07/2022,Verified
200715_France_UnitedesVirusEmergents_BloodDonors,15-Jul-20,National,France,FRA,"Provence-Alpes-Côte d'Azur, Grand-Est, Hauts-de-France, Île-de-France",,25-Mar-20,07-Apr-20,Blood donors,Adults (18-64 years),998,2.71%,,,Sequential,NA,Neutralization,Not reported,,100.00%,High,Journal Article (Peer-Reviewed),Pierre Gallian,Unite des Virus Emergents,https://reader.elsevier.com/reader/sd/pii/S0166354220302941?token=72010A825B9F560E0F15AF8D56563D596F45421D41A05764732590DB465F0C2C839E77D689CCDEDEFB85BA331FE13C72,01/08/2020,16/07/2022,Verified
200722_France_PicardieUniversity_IBDPatients_Overall,22-Jul-20,Local,France,FRA,Somme,Amiens,25-Mar-20,11-May-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,146,4.80%,,,Convenience,DiaSorin,CLIA,IgG,97.40%,98.50%,High,Journal Article (Peer-Reviewed),Mathurin Fumery,Picardie University,https://dx.doi.org/10.1093/ecco-jcc/jjaa154,02/08/2020,16/07/2022,Verified
200827_Paris_RothschildFoundationHospital_HealthcareProfessionals,27-Aug-20,Local,France,FRA,Paris,Paris,08-Jun-20,22-Jun-20,Health care workers and caregivers,Adults (18-64 years),646,12.00%,,,Convenience,Roche Diagnostics,ELISA,IgG,99.50%,99.80%,High,Journal Article (Peer-Reviewed),Malcie Mesnil,Rothschild Foundation Hospital,http://dx.doi.org/10.1016/j.accpm.2020.08.003,21/10/2020,16/07/2022,Verified
200903_Paris_HopitalEuropeenGeorgesPompidou_Overall,03-Sep-20,Local,France,FRA, Île-de-France,Paris,02-May-20,26-Jun-20,Health care workers and caregivers,Adults (18-64 years),3569,11.90%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Helene Pere,Hopital Europeen Georges Pompidou,https://dx.doi.org/10.1016/j.jcv.2020.104617,10/11/2020,16/07/2022,Verified
201015_Paris_ParisSaclayUniversity_unadj,15-Oct-20,Local,France,FRA,Paris,Paris,04-May-20,31-May-20,Pregnant or parturient women,Adults (18-64 years),249,8.00%,,,Sequential,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Jeremie Mattern,Paris Saclay University,http://dx.doi.org/10.1371/journal.pone.0240782,16/01/2021,16/07/2022,Verified
201106_Lyon_UniversitéClaudeBernardLyon_Overall,06-Nov-20,Local,France,FRA,Auvergne-Rhône-Alpes,Lyon,10-Apr-20,28-May-20,Health care workers and caregivers,Adults (18-64 years),190,3.68%,,,Unclear,"Biomerieux,Beijing Wantai Biological",Multiple Types,"Total Antibody,IgG",,,High,Preprint,Antonin Bal,Université Claude Bernard Lyon,https://www.medrxiv.org/content/10.1101/2020.11.04.20225862v1,17/01/2021,16/07/2022,Verified
201105_Corsica_UniversitédeCorse_Totaladj,05-Nov-20,Regional,France,FRA,Corsica,"Ajaccio
Corte",16-Apr-20,15-Jun-20,Residual sera,Multiple groups,1973,5.46%,4.51%,6.57%,Sequential,EUROIMMUN,ELISA,IgG,86.40%,96.20%,Moderate,Journal Article (Peer-Reviewed),Lisandru Capai,Université de Corse,https://www.mdpi.com/2077-0383/9/11/3569,18/01/2021,16/07/2022,Verified
210205_IledeFrance_Epicentre_Shelters,05-Feb-21,Local,France,FRA,Ile de France,Paris,23-Jun-20,02-Jul-20,Persons experiencing homelessness,Multiple groups,818,52.00%,,,Convenience,NA,Multiple Types,"IgG,Neutralizing ",,,High,Journal Article (Peer-Reviewed),Thomas Roederer,Médecins sans Frontières (Epicentre) ,https://www.thelancet.com/action/showPdf?pii=S2468-2667%2821%2900001-3,23/01/2021,16/07/2022,Verified
201104_Paris_CochinAPHP_HCW,04-Nov-20,Local,France,FRA,Île-de-France,Paris,14-May-20,17-Jun-20,Health care workers and caregivers,Adults (18-64 years),4607,11.50%,10.60%,12.40%,Convenience,Abbott Laboratories,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),Chantal Delmas,Cochin APHP,https://dx.doi.org/10.1017/ice.2020.1309,23/01/2021,16/07/2022,Verified
201130_Strasbourg_StrasbourgUniversityHospital_Abbott,30-Nov-20,Local,France,FRA,Grand-Est ,Strasbourg,07-May-20,26-Jun-20,Contacts of COVID patients,Adults (18-64 years),11,0.00%,,,Unclear,Abbott Laboratories,CLIA,IgG,100.00%,100.00%,High,Journal Article (Peer-Reviewed),Floriane Gallais,Strasbourg University Hospital,https://dx.doi.org/10.3201/eid2701.203611,23/01/2021,16/07/2022,Verified
201210_ Paris_UniversitéParis-Saclay,10-Dec-20,Local,France,FRA,Île-de-France,Paris ,29-Apr-20,26-Jun-20,Pregnant or parturient women,Adults (18-64 years),529,4.70%,3.00%,6.70%,Sequential,Abbott Laboratories,CLIA,IgG,92.70%,99.00%,High,Journal Article (Peer-Reviewed),Vassilis Tsatsarisa,Université Paris-Saclay,https://dx.doi.org/10.1016/j.jogoh.2020.102041,23/01/2021,16/07/2022,Verified
210208_Paris_JeanVerdierHospital_DaycareChildren1_Overall_TestAdj,08-Feb-21,National,France,FRA,"Île-de-France, Auvergne-Rhône-Alpes, Normandy","Paris, Annecy, Rouen",04-Jun-20,03-Jul-20,Students and Daycares,Children and Youth (0-17 years),327,3.70%,1.30%,6.80%,Convenience,Biosynex,LFIA,"IgM,IgG",91.80%,99.20%,High,Journal Article (Peer-Reviewed),Eric Lachassinne,Jean Verdier Hospital,https://www.thelancet.com/journals/lanchi/article/PIIS2352-4642(21)00024-9/fulltext,19/02/2021,16/07/2022,Verified
210118_France_SorbonneUniversité_primary,18-Jan-21,National,France,FRA,Île-de-France and Grand Est ,,15-May-20,15-Jun-20,Household and community samples,Multiple groups,9782,3.46%,,,Simplified probability,"EUROIMMUN,NA",Multiple Types,IgG,,,Moderate,Journal Article (Peer-Reviewed),Nathanael Lapidus,Sorbonne Université,https://dx.doi.org/10.1016/j.idnow.2020.12.007,26/02/2021,16/07/2022,Verified
201119_Paris_CentreHospitalierIntercommunalDeCréteil_Children,19-Nov-20,Local,France,FRA,Île-de-France,Paris,14-Apr-20,12-May-20,Residual sera,Children and Youth (0-17 years),605,10.70%,8.40%,13.50%,Sequential,Biosynex,LFIA,"IgG,IgM",91.80%,99.20%,High,Journal Article (Peer-Reviewed),Robert Cohen,Centre Hospitalier Intercommunal de Créteil,http://dx.doi.org/10.1136/bmjpo-2020-000887,28/02/2021,16/07/2022,Verified
210201_France_TissueBankofLille_overall_unadj,01-Feb-21,Local,France,FRA,,Lille,01-Nov-19,16-Mar-20,Tissue donor,Multiple groups,235,1.70%,,,Sequential,"Abbott Laboratories,Beijing Wantai Biological",Multiple Types,"IgG,Total Antibody",,,High,Journal Article (Peer-Reviewed),Nicolas Germain,CHU Lille,https://dx.doi.org/10.1007/s10561-021-09901-3,13/03/2021,16/07/2022,Verified
201223_Paris_InstitutCurie_overall,23-Dec-20,Local,France,FRA, Île-de-France,Paris,28-Apr-20,31-Jul-20,Health care workers and caregivers,Multiple groups,1847,11.60%,10.20%,13.20%,Convenience,NA,Multiple Types,"IgG,Total Antibody,Neutralizing ",,99.00%,Moderate,Journal Article (Peer-Reviewed),Francois Anna, Institut Curie,https://onlinelibrary.wiley.com/doi/epdf/10.1002/eji.202049058,19/03/2021,16/07/2022,Verified
210127_Nice_UniversitéCôted'Azur,27-Jan-21,Local,France,FRA,Provence-Alpes-Côte d'Azur,Nice,15-Apr-20,26-May-20,Health care workers and caregivers,Adults (18-64 years),196,15.00%,,,Convenience,EUROIMMUN,ELISA,"IgA,IgG",100.00%,,High,Journal Article (Peer-Reviewed),Marion Cremoni,Université Côte d'Azur,https://dx.doi.org/10.3389/fmed.2020.608804,27/03/2021,16/07/2022,Verified
210312_Strasbourg_UniversityHospitalStrasbourg_overall,12-Mar-21,Local,France,FRA,,Strasbourg,18-Feb-21,25-Feb-21,Patients seeking care for non-COVID-19 reasons,Multiple groups,241,10.80%,,,Unclear,Abbott Laboratories,CLIA,IgG,,,High,Preprint,Ilies Benotmane,"University Hospital, Strasbourg",https://www.medrxiv.org/content/10.1101/2021.03.08.21252741v1.full-text,31/03/2021,16/07/2022,Verified
210312_Paris_SorbonneUniversite_M3,12-Mar-21,Local,France,FRA,,Paris,16-Jun-20,24-Jul-20,Health care workers and caregivers,Adults (18-64 years),938,13.00%,11.10%,15.20%,Convenience,Abbott Laboratories,CLIA,IgG,,,Moderate,Preprint,Pierre Hausfater,Sorbonne Universite ,10.1101/2021.03.09.21253200,01/04/2021,16/07/2022,Verified
210206_France_ParisUniversity_ELISA,06-Feb-21,National,France,FRA,,,04-Nov-19,16-Mar-20,Residual sera,Multiple groups,9144,3.90%,,,Simplified probability,EUROIMMUN,ELISA,IgG,,100.00%,Moderate,Journal Article (Peer-Reviewed),Fabrice Carrat,Paris University,http://dx.doi.org/10.1007/s10654-020-00716-2,05/04/2021,16/07/2022,Unverified
210206_France_ParisUniversity_ELISA+NT,06-Feb-21,National,France,FRA,,,04-Nov-19,16-Mar-20,Residual sera,Multiple groups,9144,0.48%,,,Simplified probability,"EUROIMMUN,NA",Multiple Types,"Neutralizing ,IgG",,100.00%,Moderate,Journal Article (Peer-Reviewed),Fabrice Carrat,Paris University,http://dx.doi.org/10.1007/s10654-020-00716-2,05/04/2021,16/07/2022,Verified
210223_France_MontpellierUniversity_NursingHomeResidents,23-Feb-21,Regional,France,FRA,Occitanie,,21-Apr-20,29-Jul-20,Assisted living and long-term care facilities,Seniors (65+ years),456,30.70%,,,Convenience,NA,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Hubert Blain, Montpellier University,https://dx.doi.org/10.1093/ageing/afab050,09/04/2021,16/07/2022,Verified
210227_GeorgesFrancoisLeclercCancerCentre_CentreGeorgesFrancoisLeclerc_Staff_Overall,27-Feb-21,Local,France,FRA,,Dijon,11-May-20,25-May-20,Health care workers and caregivers,Adults (18-64 years),663,1.80%,,,Convenience,Roche Diagnostics,CLIA,"IgG,IgM,IgA,Total Antibody",100.00%,99.80%,Moderate,Journal Article (Peer-Reviewed),Sylvain Ladoire,Centre Georges Francois Leclerc,https://dx.doi.org/10.1016/j.ejca.2021.02.027,18/04/2021,16/07/2022,Verified
210227_GeorgesFrancoisLeclercCancerCentre_CentreGeorgesFrancoisLeclerc_Patients_Overall,27-Feb-21,Local,France,FRA,,Dijon,25-May-20,30-Jun-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,1011,1.70%,,,Convenience,Roche Diagnostics,CLIA,"IgG,IgM,IgA,Total Antibody",100.00%,99.80%,Moderate,Journal Article (Peer-Reviewed),Sylvain Ladoire,Centre Georges Francois Leclerc,https://dx.doi.org/10.1016/j.ejca.2021.02.027,18/04/2021,16/07/2022,Verified
210322_GrandEst_StrasbourgUniversityHospital_KidneyTransplantPatients,22-Mar-21,Local,France,FRA,Grand Est,,,15-Sep-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,780,6.20%,,,Convenience,"NA,Abbott Laboratories,EUROIMMUN,Biosynex,Snibe Co. Ltd (Shenzhen New Industries Biomedical Engineering Co. Ltd)",Multiple Types,"IgG,IgM,IgA",,,High,Journal Article (Peer-Reviewed),Sophie Caillard,Strasbourg University Hospital,https://dx.doi.org/10.1097/TP.0000000000003766,18/04/2021,16/07/2022,Verified
210415_France_InstitutPasteur_HighSchool1_overall,15-Apr-21,Local,France,FRA,Hauts-de-France,,30-Mar-20,04-Apr-20,Students and Daycares,Multiple groups,664,25.10%,,,Convenience,NA,ELISA,IgG,99.40%,99.00%,High,Journal Article (Peer-Reviewed),Arnaud Fontanet,Institut Pasteur,https://dx.doi.org/10.2807/1560-7917.ES.2021.26.15.2001695,06/05/2021,16/07/2022,Unverified
210415_France_InstitutPasteur_PrimarySchool2_overall,15-Apr-21,Local,France,FRA,Hauts-de-France,,28-Apr-20,30-Apr-20,Students and Daycares,Multiple groups,1340,10.40%,,,Convenience,NA,ELISA,IgG,99.40%,99.00%,High,Journal Article (Peer-Reviewed),Arnaud Fontanet,Institut Pasteur,https://dx.doi.org/10.2807/1560-7917.ES.2021.26.15.2001695,06/05/2021,16/07/2022,Unverified
210208_Paris_JeanVerdierHospital_DaycareStaff2_Overall_TestAdj,08-Feb-21,National,France,FRA,"Île-de-France, Auvergne-Rhône-Alpes, Normandy","Paris, Annecy, Rouen",04-Jun-20,03-Jul-20,Essential non-healthcare workers,Adults (18-64 years),197,6.80%,3.20%,11.50%,Convenience,Biosynex,LFIA,"IgM,IgG",91.80%,99.20%,High,Journal Article (Peer-Reviewed),Eric Lachassinne,Jean Verdier Hospital,https://www.thelancet.com/journals/lanchi/article/PIIS2352-4642(21)00024-9/fulltext,10/05/2021,16/07/2022,Verified
210208_Paris_JeanVerdierHospital_HCW3_Overall_TestAdj,08-Feb-21,National,France,FRA,"Île-de-France, Auvergne-Rhône-Alpes, Normandy","Paris, Annecy, Rouen",04-Jun-20,03-Jul-20,Health care workers and caregivers,Adults (18-64 years),164,5.00%,1.60%,9.80%,Unclear,Biosynex,LFIA,"IgM,IgG",91.80%,99.20%,High,Journal Article (Peer-Reviewed),Eric Lachassinne,Jean Verdier Hospital,https://www.thelancet.com/journals/lanchi/article/PIIS2352-4642(21)00024-9/fulltext,10/05/2021,16/07/2022,Verified
210101_Montpellier_UniversityHospitalMontpellier_HCW,30-Oct-20,Local,France,FRA,,Montpellier,21-Apr-20,03-Jun-20,Health care workers and caregivers,Adults (18-64 years),647,2.01%,0.93%,3.09%,Unclear,NA,ELISA,IgG,,,Unclear,Journal Article (Peer-Reviewed),Marie Bistoquet,University Hospital Montpellier,https://www.journalofhospitalinfection.com/article/S0195-6701(20)30505-3/fulltext,20/05/2021,16/07/2022,Verified
210428_Europe_SorbonneUniversité_2Île-de-France,28-Apr-21,Regional,France,FRA,Île-de-France,,07-Jun-20,08-Dec-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,593,7.10%,,,Convenience,"Abbott Laboratories,Siemens,DiaSorin,Beckman Coulter,Roche Diagnostics",Not reported,"IgG,IgM,IgA",,,High,Journal Article (Peer-Reviewed),David Saadoun,Sorbonne Université,https://dx.doi.org/10.1016/S2665-9913(21)00112-0,28/05/2021,16/07/2022,Verified
210513_Lyon_CentreHospitalierSaintJosephSaintLuc,13-May-21,Local,France,FRA,Auvergne-Rhône-Alpes,Lyon,08-Jun-20,30-Jun-20,Health care workers and caregivers,Adults (18-64 years),971,9.00%,8.80%,9.20%,Convenience,Roche Diagnostics,CLIA,"IgG,IgM,IgA",99.00%,99.00%,High,Journal Article (Peer-Reviewed),Emmanuel Vivier,Centre Hospitalier Saint Joseph Saint Luc,https://dx.doi.org/10.1186/s13613-021-00868-8,29/05/2021,16/07/2022,Verified
210510_Paris_GroupeHospitalierNordEssonneLongjumeau,10-May-21,Local,France,FRA,Île-de-France,Paris,08-May-20,27-Jul-20,Contacts of COVID patients,Multiple groups,120,39.00%,,,Convenience,NA,LFIA,"IgG,IgM",100.00%,100.00%,High,Journal Article (Peer-Reviewed),Lorelei Charbonnier,Groupe Hospitalier Nord Essonne Longjumeau,https://dx.doi.org/10.3389/fped.2021.638502,05/06/2021,16/07/2022,Unverified
210531_Marseille_HôpitauxdeMarseille,31-May-21,Local,France,FRA,Provence-Alpes-Côte d'Azur,Marseille,01-Jun-20,05-Aug-20,Persons experiencing homelessness,Adults (18-64 years),1156,5.62%,2.90%,7.21%,Convenience,Biosynex,Not reported,"IgG,IgM",100.00%,99.50%,Moderate,Preprint,Sandrine Loubiere,Hôpitaux de Marseille,https://europepmc.org/article/PPR/PPR350578,07/06/2021,16/07/2022,Unverified
210521_France_SantePubliqueFrance_March1_Overall_PopAdj_TestAdj,21-May-21,National,France,FRA,"Guadeloupe, Martinique, French Guiana, La Reunion, Île-de-France, Centre-Val-de-Loire,  Bourgogne-Franche Comté, Normandie, Hauts-de-France, Grand-Est, Pays de la Loire, Bretagne, Nouvelle-Aquitaine, Occitanie, Auvergne-Rhône-Alpes, Corse, Provence-Alpes-Côte d'Azur",,09-Mar-20,15-Mar-20,Residual sera,Multiple groups,3834,0.41%,0.05%,0.88%,Stratified probability,NA,Multiple Types,"IgG,Neutralizing ",100.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Stephane Le Vu,Santé publique France,https://dx.doi.org/10.1038/s41467-021-23233-6,07/06/2021,16/07/2022,Verified
210521_France_SantePubliqueFrance_April2_Overall_PopAdj_TestAdj,21-May-21,National,France,FRA,"Guadeloupe, Martinique, French Guiana, La Reunion, Île-de-France, Centre-Val-de-Loire,  Bourgogne-Franche Comté, Normandie, Hauts-de-France, Grand-Est, Pays de la Loire, Bretagne, Nouvelle-Aquitaine, Occitanie, Auvergne-Rhône-Alpes, Corse, Provence-Alpes-Côte d'Azur",,06-Apr-20,12-Apr-20,Residual sera,Multiple groups,3595,4.14%,3.31%,4.99%,Stratified probability,NA,Multiple Types,"IgG,Neutralizing ",100.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Stephane Le Vu,Santé publique France,https://dx.doi.org/10.1038/s41467-021-23233-6,07/06/2021,16/07/2022,Verified
210521_France_SantePubliqueFrance_May3_Overall_PopAdj_TestAdj,21-May-21,National,France,FRA,"Guadeloupe, Martinique, French Guiana, La Reunion, Île-de-France, Centre-Val-de-Loire,  Bourgogne-Franche Comté, Normandie, Hauts-de-France, Grand-Est, Pays de la Loire, Bretagne, Nouvelle-Aquitaine, Occitanie, Auvergne-Rhône-Alpes, Corse, Provence-Alpes-Côte d'Azur",,11-May-20,17-May-20,Residual sera,Multiple groups,3592,4.93%,4.02%,5.89%,Stratified probability,NA,Multiple Types,"IgG,Neutralizing ",100.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Stephane Le Vu,Santé publique France,https://dx.doi.org/10.1038/s41467-021-23233-6,07/06/2021,16/07/2022,Verified
210525_Paris_SamusocialDeParis_Residents_Overall,25-May-21,Local,France,FRA,Ile de France,Paris,01-Mar-20,31-May-20,Persons experiencing homelessness,Multiple groups,96,69.80%,,,Convenience,Abbott Laboratories,CLIA,IgG,96.00%,99.30%,Moderate,Journal Article (Peer-Reviewed),Maya Husain,Samusocial de Paris,http://dx.doi.org/10.1016/j.cmi.2021.05.039,29/06/2021,16/07/2022,Unverified
210525_Paris_SamusocialDeParis_Staff_Overall,25-May-21,Local,France,FRA,Ile de France,Paris,01-Mar-20,31-May-20,Essential non-healthcare workers,Multiple groups,81,18.50%,,,Convenience,Abbott Laboratories,CLIA,IgG,96.00%,99.30%,Moderate,Journal Article (Peer-Reviewed),Maya Husain,Samusocial de Paris,http://dx.doi.org/10.1016/j.cmi.2021.05.039,29/06/2021,16/07/2022,Unverified
210604_Nancy_UniversiteDeLorraine_Overall_PopAdj,04-Jun-21,Local,France,FRA,Grand Est,Nancy,26-Jun-20,24-Jul-20,Household and community samples,Multiple groups,2006,2.50%,1.80%,3.30%,Convenience,"Bio-rad,Biosynex,EUROIMMUN",ELISA,"IgG,IgM,IgA,Total Antibody",,,Moderate,Journal Article (Peer-Reviewed),Anne Petit,Université de Lorraine,http://dx.doi.org/10.3390/v13061076,30/06/2021,16/07/2022,Verified
210623_Marseille_Aix-MarseilleUniversity,23-Jun-21,Local,France,FRA,Provence,Marseille,01-Jun-20,31-Jul-20,Health care workers and caregivers,Multiple groups,99,6.10%,,,Convenience,Biosynex,LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Emilie Mosnier,Aix-Marseille University,https://dx.doi.org/10.1016/j.puhip.2021.100154,06/07/2021,16/07/2022,Verified
210706_France_InstitutdeCancérologiedel’Ouest_patients_primary,06-Jul-21,Regional,France,FRA,"Western France, Eastern France, Central France",,17-Jul-20,30-Nov-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,878,6.70%,,,Convenience,NG Biotech Laboratoires,LFIA,"IgG,IgM",100.00%,95.30%,High,Journal Article (Peer-Reviewed),Ke Zhou ,Institut de Cancérologie de l’Ouest,http://dx.doi.org/10.3390/cancers13143389,13/07/2021,16/07/2022,Unverified
210706_France_InstitutdeCancérologiedel’Ouest_HCW_primary,06-Jul-21,Regional,France,FRA,"Western France, Eastern France, Central France",,17-Jul-20,30-Nov-20,Health care workers and caregivers,Adults (18-64 years),940,7.80%,,,Self-referral,NG Biotech Laboratoires,LFIA,"IgG,IgM",100.00%,95.30%,High,Journal Article (Peer-Reviewed),Ke Zhou ,Institut de Cancérologie de l’Ouest,http://dx.doi.org/10.3390/cancers13143389,13/07/2021,16/07/2022,Unverified
210518_Paris_HopitalBichat-ClaudeBernard,18-May-21,Local,France,FRA,,Paris,12-May-20,02-Jun-20,Health care workers and caregivers,Adults (18-64 years),72,15.30%,6.90%,23.70%,Convenience,"AAZ LMB,NG Biotech Laboratoires,Abbott Laboratories",Multiple Types,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Charlotte Charpentier,Hopital Bichat-Claude Bernard,https://dx.doi.org/10.1016/j.diagmicrobio.2021.115430,14/07/2021,16/07/2022,Unverified
210713_Strasbourg_HôpitauxUniversitairesdeStrasbourg_primary,13-Jul-21,Local,France,FRA,,Strasbourg,18-May-20,02-Jul-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,469,6.60%,,,Convenience,NA,Not reported,Not reported,,,High,Journal Article (Peer-Reviewed),Renaud Felten,Hôpitaux Universitaires de Strasbourg studied patienst with rare autoimmune diseases (n=469) and found a seroprevalence of 6.6%,https://dx.doi.org/10.1186/s13075-021-02565-0,20/07/2021,16/07/2022,Unverified
210721_Nancy_CHRUNancy_Primary,21-Jul-21,Local,France,FRA,,Nancy,01-Apr-20,30-Apr-20,Health care workers and caregivers,Multiple groups,396,2.30%,,,Entire sample,Biosynex,LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),C Hartard,Nancy University Hospital,https://dx.doi.org/10.1017/ice.2021.334,27/07/2021,16/07/2022,Unverified
210723_France_InstitutPasteur_overall_Luminex+Neut,23-Jul-21,National,France,FRA,,,15-Feb-20,15-Aug-20,Residual sera,Multiple groups,2399,5.29%,,,Convenience,NA,Multiple Types,"IgG,Neutralizing ",,,High,Journal Article (Peer-Reviewed),Tom Woudenberg,Institut Pasteur,https://dx.doi.org/10.1016/j.ebiom.2021.103495,02/08/2021,16/07/2022,Verified
210722_Lyon_UniversitéClaudeBernardLyon1_overall,22-Jul-21,Local,France,FRA,,Lyon,10-May-20,28-Jun-20,Health care workers and caregivers,Adults (18-64 years),190,3.68%,,,Convenience,"Beijing Wantai Biological,BioMérieux",Multiple Types,"IgG,Total Antibody",,,High,Journal Article (Peer-Reviewed),Antonin Bal,Université Claude Bernard Lyon 1,https://dx.doi.org/10.1038/s41598-021-93828-y,03/08/2021,16/07/2022,Verified
210726_Corsica_UniversitédeCorse_Overall_PopTestAdj,26-Jul-21,Regional,France,FRA,Corsica,,06-Nov-20,12-Feb-21,Residual sera,Multiple groups,4505,8.70%,,,Convenience,EUROIMMUN,ELISA,IgG,90.30%,99.80%,Moderate,Journal Article (Peer-Reviewed),Lisandru Capai,Université de Corse,https://dx.doi.org/10.3389/fpubh.2021.715192,17/08/2021,16/07/2022,Verified
210727_FrenchAlps_AnnecyGenevoisHospital,27-Jul-21,Regional,France,FRA,French Alps Region,NR,27-Jun-20,30-Sep-20,Health care workers and caregivers,Adults (18-64 years),3454,5.00%,4.30%,5.80%,Convenience,"Abbott Laboratories,Roche Diagnostics",CLIA,"IgG,Total Antibody",,,Moderate,Journal Article (Peer-Reviewed),Virginie Vitrat,Annecy Genevois Hospital,http://dx.doi.org/10.3390/vaccines9080824,17/08/2021,16/07/2022,Verified
210801_Europe_UniversityHospitalsPitiéSalpêtrière_Primary,01-Aug-21,National,France,FRA,,,07-Jun-20,08-Dec-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,3028,5.50%,,,Unclear,NA,Not reported,Not reported,,,High,Presentation or Conference,D Saadoun,University Hospitals Pitié Salpêtrière,http://dx.doi.org/10.1136/annrheumdis-2021-eular.3368,24/08/2021,16/07/2022,Unverified
210812_Amiens_UniversitéPicardieJules-Verne_NH,12-Aug-21,Local,France,FRA,Hauts-de-France  ,Amiens,15-Jun-20,16-Jun-20,Assisted living and long-term care facilities,Seniors (65+ years),107,88.70%,,,Convenience,Abbott Laboratories,ELISA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Julien Moyet,Université Picardie Jules-Verne,https://www.jle.com/10.1684/pnv.2021.0952,31/08/2021,16/07/2022,Unverified
210812_Amiens_UniversitéPicardieJules-Verne_LTC,12-Aug-21,Local,France,FRA,Hauts-de-France  ,Amiens,15-Jun-20,16-Jun-20,Assisted living and long-term care facilities,Seniors (65+ years),114,45.60%,,,Convenience,Abbott Laboratories,ELISA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Julien Moyet,Université Picardie Jules-Verne,https://www.jle.com/10.1684/pnv.2021.0952,31/08/2021,16/07/2022,Unverified
210906_Strasbourg_CHUdeStrasbourg_Overall,06-Sep-21,Local,France,FRA,Grand Est,Strasbourg,22-Jun-20,01-Nov-20,Health care workers and caregivers,Adults (18-64 years),5694,8.47%,,,Convenience,Biosynex,LFIA,"IgG,IgM",93.00%,99.00%,High,Journal Article (Peer-Reviewed),Baptiste Panaget,Centres Hospitaliers et Universitaires de Strasbourg ,https://dx.doi.org/10.1017/ice.2021.402,14/09/2021,16/07/2022,Unverified
210920_France_ToulouseUniversityHospital,21-Sep-21,National,France,FRA,,,10-Jun-20,10-Jul-20,Health care workers and caregivers,Adults (18-64 years),8758,3.20%,,,Unclear,Beijing Wantai Biological,ELISA,Total Antibody,,,Unclear,Journal Article (Peer-Reviewed),Chloe Dimeglio,Tolouse University Hospital,https://dx.doi.org/10.1016/j.jinf.2021.09.013,06/10/2021,16/07/2022,Verified
211014_Marseille_AixMarseilleUniversity,14-Oct-21,Local,France,FRA,,Marseille,02-Apr-20,06-Apr-20,Essential non-healthcare workers,Adults (18-64 years),85,25.88%,,,Entire sample,NA,Not reported,Neutralizing ,,,High,Journal Article (Peer-Reviewed),Guillaume Durand,Aix Marseille University,https://dx.doi.org/10.2807/1560-7917.ES.2021.26.41.2001676,24/10/2021,16/07/2022,Unverified
211019_Paris_HopitalEuropeenGeorgesPompidou_Primary,19-Oct-21,Local,France,FRA,,Paris,05-Mar-20,04-Dec-20,Health care workers and caregivers,Adults (18-64 years),3186,12.10%,11.00%,13.30%,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Maxime Wack,Hopital Europeen Georges Pompidou,https://dx.doi.org/10.1016/j.jcv.2021.104999,03/11/2021,16/07/2022,Unverified
211026_France_UniversitéParisSaclay_November(Round2)_Primary,26-Oct-21,National,France,FRA,,,01-Nov-20,30-Nov-20,Household and community samples,Multiple groups,63524,6.20%,5.90%,6.60%,Simplified probability,EUROIMMUN,ELISA,IgG,94.40%,,Low,Preprint,Josiane Warszawski,Université Paris-Saclay,https://www.medrxiv.org/content/10.1101/2021.10.25.21265456v1.full-text,03/11/2021,16/07/2022,Verified
211021_France_UNIVIsanté,21-Oct-21,National,France,FRA,,,31-Aug-20,16-Oct-20,Assisted living and long-term care facilities,Seniors (65+ years),1141,14.40%,12.40%,16.40%,Unclear,NA,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Marc Harboun,UNIVI santé,https://dx.doi.org/10.1016/j.revmed.2021.10.330,10/11/2021,16/07/2022,Unverified
211108_France_UniversitedeParis_Overall,"8 November 2021, 8 November 2021",National,France,FRA,,,15-May-20,15-Nov-20,Household and community samples,Adults (18-64 years),26823,4.07%,,,Convenience,EUROIMMUN,ELISA,IgG,87.00%,97.50%,Moderate,"Journal Article (Peer-Reviewed), Journal Article (Peer-Reviewed)","Joane Matta, Joane Matta",Universite de Paris,"https://dx.doi.org/10.1001/jamainternmed.2021.6454, https://jamanetwork.com/journals/jamainternalmedicine/article-abstract/2785832",17/11/2021,16/07/2022,Verified
211109_Strasbourg_StrasbourgUniversityHospitals_V0,09-Nov-21,Local,France,FRA,,Strasbourg,06-Apr-20,07-May-20,Health care workers and caregivers,Multiple groups,1497,34.40%,,,Stratified probability,"Biosynex,Epitope Diagnostics, Inc.",Multiple Types,"IgG,IgM",,,High,Preprint,A Velay,Strasbourg University Hospitals,https://dx.doi.org/10.1016/j.idnow.2021.11.002,22/11/2021,16/07/2022,Unverified
211111_Rennes_RennesUniversityHospital_Primary,11-Nov-21,Local,France,FRA,,Rennes,29-May-20,10-Jul-20,Health care workers and caregivers,Adults (18-64 years),3234,3.80%,,,Convenience,"NG Biotech Laboratoires,Beijing Wantai Biological",Multiple Types,IgG,,,Moderate,Journal Article (Peer-Reviewed),Christophe Paris,Rennes University Hospital,https://dx.doi.org/10.1016/j.ajic.2021.11.001,24/11/2021,16/07/2022,Unverified
210528_Lille_OscarLambretComprehensiveCancerCenter,28-May-21,Local,France,FRA,Hauts-de-France,Lille,04-May-20,26-Jun-20,Health care workers and caregivers,Adults (18-64 years),392,1.80%,0.70%,3.60%,Convenience,,LFIA,Not reported,,,High,Presentation or Conference,Philippe Doutrelant,Oscar Lambret Comprehensive Cancer Center,https://ascopubs.org/doi/abs/10.1200/JCO.2021.39.15_suppl.e13604,30/11/2021,16/07/2022,Unverified
211123_Perpignan_PerpignanHospitalCenter_Overall,23-Nov-21,Local,France,FRA,Occitanie,Perpignan,29-Jun-20,17-Jul-20,Household and community samples,Multiple groups,700,35.40%,30.20%,41.00%,Stratified probability,Roche Diagnostics,CLIA,"IgM,IgG",99.50%,99.80%,Moderate,Journal Article (Peer-Reviewed),Adeline Beaumont,Perpignan Hospital Center,https://dx.doi.org/10.1136/bmjopen-2021-053201,01/12/2021,16/07/2022,Unverified
211125_France_UnitédesVirusÉmergents_Overall_PopAdjusted,25-Nov-21,National,France,FRA,"Haut de France, Normandi, Ile de France, Bretagne, Grand Est, Bourgogne France Comte, Centre val de Loire, Auvergne Rhome Alpes, Pays de Loire, Occitanie, Nouvelle Aquitaine, Provence-Alpes-Côte d'Azur",,04-May-20,30-Sep-20,Household and community samples,Multiple groups,82126,5.10%,4.90%,5.40%,Convenience,EUROIMMUN,ELISA,IgG,87.00%,97.50%,Moderate,Journal Article (Peer-Reviewed),Fabrice Carrat,Unité des Virus Émergents,https://dx.doi.org/10.1007/s15010-021-01731-5,03/12/2021,16/07/2022,Verified
211130_France_SorbonneParisNordUniversity_Primary,30-Nov-21,National,France,FRA,,,15-May-20,15-Oct-20,Blood donors,Multiple groups,7766,4.00%,,,Self-referral,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Melanie Deschasaux-Tanguy,Sorbonne Paris Nord University,https://dx.doi.org/10.1186/s12916-021-02168-1,06/12/2021,16/07/2022,Unverified
211201_Ermont_CliniqueClaudeBernard_Overall,01-Dec-21,Local,France,FRA,Île-de-France,Ermont,15-Sep-20,15-Oct-20,Residual sera,Multiple groups,299,19.70%,,,Convenience,Roche Diagnostics,CLIA,Total Antibody,,,High,Journal Article (Peer-Reviewed),Henri Boulanger,Clinique Claude Bernard,https://dx.doi.org/10.1155/2021/4747221,16/12/2021,16/07/2022,Unverified
211201_NorthernFrance_CentreHospitalierdeTourcoing,01-Dec-21,Local,France,FRA,Northern France,Tourcoing,01-Apr-20,01-Aug-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,600,2.70%,,,Convenience,NA,CLIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Agnes Meybeck,Centre Hospitalier de Tourcoing,https://dx.doi.org/10.3390/microorganisms9122491,10/01/2022,16/07/2022,Unverified
211206_CochinHospital_ParisDescartesUniversity_Overall_Nonly,06-Dec-21,Local,France,FRA,Île-de-France,Paris,01-Jun-20,31-Aug-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,283,2.83%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Clothilde Gros,Paris Descartes Université,https://dx.doi.org/10.1016/j.jbspin.2021.105312,12/01/2022,16/07/2022,Unverified
220109_France_UniversityofParisSaclay_Overall_PopAdj,09-Jan-22,National,France,FRA,,,02-May-20,02-Jun-20,Household and community samples,Multiple groups,12114,4.50%,3.90%,5.00%,Stratified non-probability,EUROIMMUN,ELISA,IgG,94.40%,100.00%,Low,Journal Article (Peer-Reviewed),Josiane Warszawski,University of Paris-Saclay,https://dx.doi.org/10.1186/s12879-021-06973-0,18/01/2022,16/07/2022,Verified
210415_France_InstitutPasteur_HighSchool1_Under12,15-Apr-21,Local,France,FRA,Hauts-de-France,,30-Mar-20,04-Apr-20,Students and Daycares,Children and Youth (0-17 years),8,0.00%,,,Convenience,NA,ELISA,IgG,99.40%,99.00%,High,Journal Article (Peer-Reviewed),Arnaud Fontanet,Institut Pasteur,https://dx.doi.org/10.2807/1560-7917.ES.2021.26.15.2001695,07/02/2022,16/07/2022,Unverified
210415_France_InstitutPasteur_HighSchool1_12-17,15-Apr-21,Local,France,FRA,Hauts-de-France,,30-Mar-20,04-Apr-20,Students and Daycares,Children and Youth (0-17 years),235,34.90%,,,Convenience,NA,ELISA,IgG,99.40%,99.00%,High,Journal Article (Peer-Reviewed),Arnaud Fontanet,Institut Pasteur,https://dx.doi.org/10.2807/1560-7917.ES.2021.26.15.2001695,07/02/2022,16/07/2022,Unverified
210415_France_InstitutPasteur_PrimarySchool2_Under12,15-Apr-21,Local,France,FRA,Hauts-de-France,,28-Apr-20,30-Apr-20,Students and Daycares,Children and Youth (0-17 years),538,8.60%,,,Convenience,NA,ELISA,IgG,99.40%,99.00%,High,Journal Article (Peer-Reviewed),Arnaud Fontanet,Institut Pasteur,https://dx.doi.org/10.2807/1560-7917.ES.2021.26.15.2001695,07/02/2022,16/07/2022,Unverified
210415_France_InstitutPasteur_PrimarySchool2_12-17,15-Apr-21,Local,France,FRA,Hauts-de-France,,28-Apr-20,30-Apr-20,Students and Daycares,Children and Youth (0-17 years),78,15.40%,,,Convenience,NA,ELISA,IgG,99.40%,99.00%,High,Journal Article (Peer-Reviewed),Arnaud Fontanet,Institut Pasteur,https://dx.doi.org/10.2807/1560-7917.ES.2021.26.15.2001695,07/02/2022,16/07/2022,Unverified
220210_Corte_UniversitéDeCorsePascalPaoli_TestAdjusted,10-Feb-22,Local,France,FRA,Corsica,Corte,23-Nov-20,31-Jan-21,Students and Daycares,Adults (18-64 years),418,12.80%,9.80%,16.60%,Convenience,EUROIMMUN,ELISA,IgG,99.80%,90.30%,High,Journal Article (Peer-Reviewed),Dorine Decarreaux,Université De Corse Pascal Paoli,https://dx.doi.org/10.3390/ijerph19041953,25/02/2022,16/07/2022,Unverified
220131_Dijon_CentreGeorgesFrancoisLeclerc_HCWs_Primary,31-Jan-22,Local,France,FRA,,,12-Jan-21,22-Jan-21,Health care workers and caregivers,Multiple groups,502,15.10%,,,Self-referral,Roche Diagnostics,CLIA,Total Antibody,,,High,Journal Article (Peer-Reviewed),Sylvain Ladoire,Centre Georges Franc ois Leclerc,https://dx.doi.org/10.1016/j.ejca.2022.01.005,08/03/2022,16/07/2022,Unverified
220131_Dijon_CentreGeorgesFrancoisLeclerc_Patients_Primary,31-Jan-22,Local,France,FRA,,,25-Jan-21,26-Feb-21,Patients seeking care for non-COVID-19 reasons,Multiple groups,507,4.10%,,,Self-referral,Roche Diagnostics,CLIA,Total Antibody,,,High,Journal Article (Peer-Reviewed),Sylvain Ladoire,Centre Georges Franc ois Leclerc,https://dx.doi.org/10.1016/j.ejca.2022.01.005,08/03/2022,16/07/2022,Unverified
220219_Italy_UniversityofVerona_Primary,19-Feb-22,Local,France,FRA,,,01-Jan-21,31-Jan-21,Health care workers and caregivers,Adults (18-64 years),1957,19.10%,,,Unclear,Abbott Laboratories,CLIA,"IgM,IgG",,,High,Journal Article (Peer-Reviewed),Alessandra Ruggiero,University of Verona,https://dx.doi.org/10.1016/j.ebiom.2022.103888,08/03/2022,16/07/2022,Unverified
220308_RobertDebréHospital_ParisUniversity_Psychiatric,08-Mar-22,Local,France,FRA,Île-de-France,Paris,15-Dec-20,15-Apr-21,Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),52,9.61%,3.59%,21.80%,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Anael Ayrolles,Paris University,https://dx.doi.org/10.1002/npr2.12236,14/03/2022,16/07/2022,Verified
220308_RobertDebréHospital_ParisUniversity_Emergency,08-Mar-22,Local,France,FRA,Île-de-France,Paris,15-Dec-20,15-Apr-21,Residual sera,Children and Youth (0-17 years),52,34.61%,22.33%,49.16%,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Anael Ayrolles,Paris University,https://dx.doi.org/10.1002/npr2.12236,14/03/2022,16/07/2022,Verified
220307_Marseille_HopitauxdeMarseille_Campaign2,07-Mar-22,Local,France,FRA,Provence-Alpes-Côte d'Azur,Marseille,11-Sep-20,18-Dec-20,Persons experiencing homelessness,Multiple groups,721,18.86%,,,Convenience,Biosynex,Not reported,"IgM,IgG",,,High,Journal Article (Peer-Reviewed),Agathe Allibert,Hôpitaux de Marseille,https://dx.doi.org/10.3390/ijerph19053129,22/03/2022,16/07/2022,Unverified
220420_France_HopitalLaPorteVerte_HCWs_Primary,20-Apr-22,National,France,FRA,,,24-Jul-20,16-Oct-20,Health care workers and caregivers,Adults (18-64 years),1334,12.80%,11.00%,14.70%,Unclear,NA,ELISA,Not reported,,,High,Journal Article (Peer-Reviewed),A. de Malherbe,UNIVI Group,https://dx.doi.org/10.1007/s12603-022-1780-1,03/05/2022,16/07/2022,Unverified
220420_France_HopitalLaPorteVerte_Residents_Primary,20-Apr-22,National,France,FRA,,,24-Jul-20,16-Oct-20,Assisted living and long-term care facilities,Seniors (65+ years),1145,14.40%,12.40%,16.60%,Unclear,NA,ELISA,Not reported,,,,Journal Article (Peer-Reviewed),A. de Malherbe,UNIVI Group,https://dx.doi.org/10.1007/s12603-022-1780-1,03/05/2022,16/07/2022,Unverified
220504_Paris_SorbonneUniversité,04-May-22,Local,France,FRA,Île-de-France,Paris,16-Mar-20,24-Apr-20,Health care workers and caregivers,Adults (18-64 years),1060,5.90%,4.70%,7.50%,Convenience,Abbott Laboratories,CLIA,IgG,99.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Pierre Hausfater,Sorbonne Université,https://dx.doi.org/10.1038/s41598-022-10945-y,10/05/2022,16/07/2022,Unverified
220511_Amiens_CHUAmiensPicardie_Overall,11-May-22,Local,France,FRA,,Amiens,18-May-20,26-Jul-20,Health care workers and caregivers,Adults (18-64 years),4840,9.70%,7.00%,12.40%,Convenience,Beijing Wantai Biological,ELISA,"Total Antibody,IgG",94.50%,100.00%,Moderate,Journal Article (Peer-Reviewed),Marion Pierson-Marchandise,CHU Amiens-Picardie,https://dx.doi.org/10.1136/bmjopen-2020-047010,24/05/2022,16/07/2022,Unverified
220503_France_UniversitédeCorsePascalPaoli_Neutralizing_Overall,03-May-22,National,France,FRA,,,10-May-21,31-Aug-21,Health care workers and caregivers,Multiple groups,1612,81.30%,79.40%,83.20%,Convenience,NA,Neutralization,Neutralizing ,,100.00%,Moderate,Journal Article (Peer-Reviewed),Dorine Decarreaux,Université de Corse Pascal Paoli,https://dx.doi.org/10.3390/v14050957,04/06/2022,16/07/2022,Unverified
220516_Nancy_CHRU-Nancy_Overall,16-May-22,Local,France,FRA,,Nancy,25-May-20,29-Jun-20,Health care workers and caregivers,Multiple groups,4696,5.10%,,,Convenience,"NA,Snibe Co. Ltd (Shenzhen New Industries Biomedical Engineering Co. Ltd),EUROIMMUN",Multiple Types,"IgG,IgM,IgA",,,High,Journal Article (Peer-Reviewed),Stephanie Weber ,CHRU-Nancy,https://dx.doi.org/10.1016/j.idh.2022.05.002,09/06/2022,16/07/2022,Unverified
220601_Ile-de-France_HopitalPitie-Salpetriere_Overall,01-Jun-22,Regional,France,FRA,Ile-de-France,,15-Apr-20,15-Sep-21,Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),1901,13.40%,11.90%,15.00%,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Basma Abdi,Hopital Pitie Salpetriere,https://dx.doi.org/10.1016/j.jinf.2022.05.036,15/06/2022,16/07/2022,Unverified
220601_Paris_HopitaldeFresnes,01-Jun-22,Local,France,FRA,,Paris,14-Jan-21,08-Jul-21,Persons who are incarcerated,Multiple groups,1014,18.20%,16.90%,19.40%,Unclear,Roche Diagnostics,CLIA,Not reported,,,High,Journal Article (Peer-Reviewed),Guillaume Mellon,Hopital Paul Brousse,https://dx.doi.org/10.1016/j.jinf.2022.05.032,24/06/2022,16/07/2022,Unverified
220412_Paris_AssistancePublique–HopitauxdeParis_SAPRIS-Sero_Overall,12-Apr-22,Local,France,FRA,,Paris,01-May-20,31-Oct-20,Household and community samples,Adults (18-64 years),844,9.20%,,,Convenience,EUROIMMUN,ELISA,IgG,98.00%,99.00%,Moderate,Journal Article (Peer-Reviewed),Constance Delaugerre,Universit de Paris,https://dx.doi.org/10.1093/ofid/ofac188,13/07/2022,16/07/2022,Unverified
220412_Paris_AssistancePublique–HopitauxdeParis_PREVENIR_Overall,12-Apr-22,Local,France,FRA,,Paris,01-May-20,31-Oct-20,Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),844,10.80%,,,Convenience,Abbott Laboratories,CLIA,IgG,98.00%,99.00%,High,Journal Article (Peer-Reviewed),Constance Delaugerre,Universit de Paris,https://dx.doi.org/10.1093/ofid/ofac188,13/07/2022,29/07/2022,Unverified
220713_AixMarseilleProvence_CentredeNéphrologieetTransplantationRénale_Caregiver_FU2,13-Jul-22,Local,France,FRA,,Aix-en-Provence,01-Dec-20,31-Dec-20,Health care workers and caregivers,Adults (18-64 years),191,12.60%,8.20%,18.10%,Convenience,Biosynex,LFIA,"IgG,IgM",82.90%,97.70%,High,Journal Article (Peer-Reviewed),Thomas Robert,Centre de Néphrologie et Transplantation Rénale,https://dx.doi.org/10.1038/s41598-022-15913-0,20/07/2022,29/07/2022,Unverified
220713_AixMarseilleProvence_CentredeNéphrologieetTransplantationRénale_Patients_FU2,13-Jul-22,Local,France,FRA,,Aix-en-Provence,01-Dec-20,31-Dec-20,Patients seeking care for non-COVID-19 reasons,Seniors (65+ years),382,13.80%,10.50%,17.70%,Convenience,Biosynex,LFIA,"IgG,IgM",82.90%,97.70%,High,Journal Article (Peer-Reviewed),Thomas Robert,Centre de Néphrologie et Transplantation Rénale,https://dx.doi.org/10.1038/s41598-022-15913-0,20/07/2022,29/07/2022,Unverified
220616_France_CHUNantes_Overall,16-Jun-22,National,France,FRA,,,15-Mar-20,15-Jun-20,Residual sera,Multiple groups,886,2.30%,,,Convenience,NA,Not reported,Not reported,,,Unclear,Journal Article (Peer-Reviewed),Margaux Lelong,CHU Nantes,https://dx.doi.org/10.1016/S0016-5085%2822%2961412-4,04/08/2022,04/08/2022,Unverified
220731_France_EtablissementFrancaisduSang_T1,31-Jul-22,National,France,FRA,,,27-Mar-20,04-Apr-20,Blood donors,Multiple groups,2232,7.53%,,,Sequential,EUROIMMUN,ELISA,IgG,,,Moderate,Preprint,Pierre Gallian,Etablissement Francais du Sang,10.1101/2022.07.29.22278190,12/08/2022,13/08/2022,Unverified
220731_France_EtablissementFrancaisduSang_T2,31-Jul-22,National,France,FRA,,,11-May-20,29-May-20,Blood donors,Multiple groups,3241,7.22%,,,Sequential,EUROIMMUN,ELISA,IgG,,,Moderate,Preprint,Pierre Gallian,Etablissement Francais du Sang,10.1101/2022.07.29.22278190,12/08/2022,13/08/2022,Unverified
220731_France_EtablissementFrancaisduSang_T3,31-Jul-22,National,France,FRA,,,01-Jul-20,23-Jul-20,Blood donors,Multiple groups,2951,6.12%,,,Sequential,EUROIMMUN,ELISA,IgG,,,Moderate,Preprint,Pierre Gallian,Etablissement Francais du Sang,10.1101/2022.07.29.22278190,12/08/2022,13/08/2022,Unverified
220731_France_EtablissementFrancaisduSang_T4,31-Jul-22,National,France,FRA,,,28-Sep-20,29-Oct-20,Blood donors,Multiple groups,6009,5.34%,,,Sequential,EUROIMMUN,ELISA,IgG,,,Moderate,Preprint,Pierre Gallian,Etablissement Francais du Sang,10.1101/2022.07.29.22278190,12/08/2022,13/08/2022,Unverified
220731_France_EtablissementFrancaisduSang_T5,31-Jul-22,National,France,FRA,,,03-Nov-20,18-Nov-20,Blood donors,Multiple groups,6156,7.81%,,,Sequential,EUROIMMUN,ELISA,IgG,,,Moderate,Preprint,Pierre Gallian,Etablissement Francais du Sang,10.1101/2022.07.29.22278190,12/08/2022,13/08/2022,Unverified
220731_France_EtablissementFrancaisduSang_T6,31-Jul-22,National,France,FRA,,,14-Jan-21,09-Feb-21,Blood donors,Multiple groups,12016,8.20%,,,Sequential,EUROIMMUN,ELISA,IgG,,,Moderate,Preprint,Pierre Gallian,Etablissement Francais du Sang,10.1101/2022.07.29.22278190,12/08/2022,13/08/2022,Unverified
220805_Ile-de-France_EtablissementFrancaisduSang_July2021_Euroimmun,05-Aug-22,Regional,France,FRA,Ile-de-France ,,01-Jul-21,17-Jul-21,Blood donors,Multiple groups,1001,83.00%,,,Sequential,EUROIMMUN,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),Pierre Gallian,Unité des Virus Émergents,https://dx.doi.org/10.1016/j.tracli.2022.08.002,19/08/2022,19/08/2022,Unverified
220805_Ile-de-France_EtablissementFrancaisduSang_Jan2021_Euroimmun,05-Aug-22,Regional,France,FRA,Ile-de-France ,,01-Jan-21,31-Jan-21,Blood donors,Multiple groups,875,8.57%,,,Sequential,EUROIMMUN,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),Pierre Gallian,Unité des Virus Émergents,https://dx.doi.org/10.1016/j.tracli.2022.08.002,19/08/2022,19/08/2022,Unverified
201213_Helsinki_UniversityofHelsinki_HCW_unadj,13-Dec-20,Local,Finland,FIN,Uusimaa,Helsinki,22-Apr-20,15-May-20,Health care workers and caregivers,Adults (18-64 years),1095,3.00%,,,Convenience,"EUROIMMUN,Abbott Laboratories,NA",Multiple Types,IgG,,,High,Journal Article (Peer-Reviewed),Anu Kantele,University of Helsinki,https://dx.doi.org/10.1016/j.tmaid.2020.101949,01/02/2021,16/07/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2020-W42,07-Oct-21,National,Finland,FIN,,,11-Oct-20,17-Oct-20,Household and community samples,Adults (18-64 years),59,1.69%,0.30%,9.00%,Simplified probability,NA,IFA,IgG,100.00%,100.00%,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,20/09/2021,16/07/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2020-W36,07-Oct-21,National,Finland,FIN,,,30-Aug-20,05-Sep-20,Household and community samples,Adults (18-64 years),63,0.00%,0.00%,5.75%,Simplified probability,NA,Multiple Types,"IgG,Neutralizing ",,,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,20/09/2021,16/07/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2021-W06,07-Oct-21,National,Finland,FIN,,,07-Feb-21,13-Feb-21,Household and community samples,Adults (18-64 years),111,5.41%,2.50%,11.29%,Simplified probability,NA,IFA,IgG,100.00%,100.00%,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,20/09/2021,16/07/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2020-W53,07-Oct-21,National,Finland,FIN,,,27-Dec-20,02-Jan-21,Household and community samples,Adults (18-64 years),26,0.00%,0.00%,12.87%,Simplified probability,NA,IFA,IgG,100.00%,100.00%,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,20/09/2021,16/07/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2021-W11,07-Oct-21,National,Finland,FIN,,,14-Mar-21,20-Mar-21,Household and community samples,Adults (18-64 years),104,6.73%,3.30%,13.25%,Simplified probability,NA,IFA,IgG,100.00%,100.00%,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,20/09/2021,16/07/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2021-W23,07-Oct-21,National,Finland,FIN,,,06-Jun-21,12-Jun-21,Household and community samples,Adults (18-64 years),68,60.29%,48.42%,71.07%,Simplified probability,NA,IFA,IgG,100.00%,100.00%,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,20/09/2021,16/07/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2021-W21,07-Oct-21,National,Finland,FIN,,,23-May-21,29-May-21,Household and community samples,Adults (18-64 years),93,49.46%,39.53%,59.44%,Simplified probability,NA,IFA,IgG,100.00%,100.00%,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,20/09/2021,16/07/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2021-W27,07-Oct-21,National,Finland,FIN,,,04-Jul-21,10-Jul-21,Household and community samples,Adults (18-64 years),12,58.33%,31.95%,80.67%,Simplified probability,NA,IFA,IgG,100.00%,100.00%,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,20/09/2021,16/07/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2021-W28,07-Oct-21,National,Finland,FIN,,,11-Jul-21,17-Jul-21,Household and community samples,Adults (18-64 years),2,100.00%,34.24%,100.00%,Simplified probability,NA,IFA,IgG,100.00%,100.00%,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,20/09/2021,16/07/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2020-W18,07-Oct-21,National,Finland,FIN,,,26-Apr-20,02-May-20,Household and community samples,Adults (18-64 years),426,0.47%,0.13%,1.70%,Simplified probability,NA,Multiple Types,"IgG,Neutralizing ",,,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,20/09/2021,16/07/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2020-W21,07-Oct-21,National,Finland,FIN,,,17-May-20,23-May-20,Household and community samples,Adults (18-64 years),210,0.48%,0.08%,2.65%,Simplified probability,NA,Multiple Types,"IgG,Neutralizing ",,,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,20/09/2021,16/07/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2021-W26,07-Oct-21,National,Finland,FIN,,,27-Jun-21,03-Jul-21,Household and community samples,Adults (18-64 years),48,68.75%,54.67%,80.05%,Simplified probability,NA,IFA,IgG,100.00%,100.00%,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,20/09/2021,16/07/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2020-W23,07-Oct-21,National,Finland,FIN,,,31-May-20,06-Jun-20,Household and community samples,Adults (18-64 years),214,0.47%,0.08%,2.60%,Simplified probability,NA,Multiple Types,"IgG,Neutralizing ",,,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,20/09/2021,16/07/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2020-W32,07-Oct-21,National,Finland,FIN,,,02-Aug-20,08-Aug-20,Household and community samples,Adults (18-64 years),49,2.04%,0.36%,10.69%,Simplified probability,NA,Multiple Types,"IgG,Neutralizing ",,,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,20/09/2021,16/07/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2021-W05,07-Oct-21,National,Finland,FIN,,,31-Jan-21,06-Feb-21,Household and community samples,Adults (18-64 years),110,2.73%,0.93%,7.71%,Simplified probability,NA,IFA,IgG,100.00%,100.00%,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,20/09/2021,16/07/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2020-W34,07-Oct-21,National,Finland,FIN,,,16-Aug-20,22-Aug-20,Household and community samples,Adults (18-64 years),63,0.00%,0.00%,5.75%,Simplified probability,NA,Multiple Types,"IgG,Neutralizing ",,,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,20/09/2021,16/07/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2021-W16,07-Oct-21,National,Finland,FIN,,,18-Apr-21,24-Apr-21,Household and community samples,Adults (18-64 years),102,18.63%,12.26%,27.27%,Simplified probability,NA,IFA,IgG,100.00%,100.00%,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,20/09/2021,16/07/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2020-W33,07-Oct-21,National,Finland,FIN,,,09-Aug-20,15-Aug-20,Household and community samples,Adults (18-64 years),64,0.00%,0.00%,5.66%,Simplified probability,NA,Multiple Types,"IgG,Neutralizing ",,,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,20/09/2021,16/07/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2021-W02,07-Oct-21,National,Finland,FIN,,,10-Jan-21,16-Jan-21,Household and community samples,Adults (18-64 years),6,0.00%,0.00%,39.03%,Simplified probability,NA,IFA,IgG,100.00%,100.00%,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,20/09/2021,16/07/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2020-W25,07-Oct-21,National,Finland,FIN,,,14-Jun-20,20-Jun-20,Household and community samples,Adults (18-64 years),78,0.00%,0.00%,4.69%,Simplified probability,NA,Multiple Types,"IgG,Neutralizing ",,,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,20/09/2021,16/07/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2020-W51,07-Oct-21,National,Finland,FIN,,,13-Dec-20,19-Dec-20,Household and community samples,Adults (18-64 years),115,0.87%,0.15%,4.76%,Simplified probability,NA,IFA,IgG,100.00%,100.00%,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,20/09/2021,16/07/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2020-W24,07-Oct-21,National,Finland,FIN,,,07-Jun-20,13-Jun-20,Household and community samples,Adults (18-64 years),174,0.00%,0.00%,2.16%,Simplified probability,NA,Multiple Types,"IgG,Neutralizing ",,,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,20/09/2021,16/07/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2020-W49,07-Oct-21,National,Finland,FIN,,,29-Nov-20,05-Dec-20,Household and community samples,Adults (18-64 years),80,2.50%,0.69%,8.66%,Simplified probability,NA,IFA,IgG,100.00%,100.00%,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,20/09/2021,16/07/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2020-W52,07-Oct-21,National,Finland,FIN,,,20-Dec-20,26-Dec-20,Household and community samples,Adults (18-64 years),65,0.00%,0.00%,5.58%,Simplified probability,NA,IFA,IgG,100.00%,100.00%,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,20/09/2021,16/07/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2020-W47,07-Oct-21,National,Finland,FIN,,,15-Nov-20,21-Nov-20,Household and community samples,Adults (18-64 years),64,3.12%,0.86%,10.70%,Simplified probability,NA,IFA,IgG,100.00%,100.00%,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,20/09/2021,16/07/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2021-W04,07-Oct-21,National,Finland,FIN,,,24-Jan-21,30-Jan-21,Household and community samples,Adults (18-64 years),30,0.00%,0.00%,11.35%,Simplified probability,NA,IFA,IgG,100.00%,100.00%,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,20/09/2021,16/07/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2021-W10,07-Oct-21,National,Finland,FIN,,,07-Mar-21,13-Mar-21,Household and community samples,Adults (18-64 years),64,3.12%,0.86%,10.70%,Simplified probability,NA,IFA,IgG,100.00%,100.00%,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,20/09/2021,16/07/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2020-W28,07-Oct-21,National,Finland,FIN,,,05-Jul-20,11-Jul-20,Household and community samples,Adults (18-64 years),51,0.00%,0.00%,7.00%,Simplified probability,NA,Multiple Types,"IgG,Neutralizing ",,,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,20/09/2021,16/07/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2020-W48,07-Oct-21,National,Finland,FIN,,,22-Nov-20,28-Nov-20,Household and community samples,Adults (18-64 years),85,3.53%,1.21%,9.87%,Simplified probability,NA,IFA,IgG,100.00%,100.00%,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,20/09/2021,16/07/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2021-W01,07-Oct-21,National,Finland,FIN,,,03-Jan-21,09-Jan-21,Household and community samples,Adults (18-64 years),12,0.00%,0.00%,24.25%,Simplified probability,NA,IFA,IgG,100.00%,100.00%,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,20/09/2021,16/07/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2020-W19,07-Oct-21,National,Finland,FIN,,,03-May-20,09-May-20,Household and community samples,Adults (18-64 years),514,0.00%,0.00%,0.74%,Simplified probability,NA,Multiple Types,"IgG,Neutralizing ",,,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,20/09/2021,16/07/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2020-W50,07-Oct-21,National,Finland,FIN,,,06-Dec-20,12-Dec-20,Household and community samples,Adults (18-64 years),106,0.94%,0.17%,5.15%,Simplified probability,NA,IFA,IgG,100.00%,100.00%,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,20/09/2021,16/07/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2020-W20,07-Oct-21,National,Finland,FIN,,,10-May-20,16-May-20,Household and community samples,Adults (18-64 years),401,0.25%,0.04%,1.40%,Simplified probability,NA,Multiple Types,"IgG,Neutralizing ",,,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,20/09/2021,16/07/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2020-W31,07-Oct-21,National,Finland,FIN,,,26-Jul-20,01-Aug-20,Household and community samples,Adults (18-64 years),75,1.33%,0.24%,7.17%,Simplified probability,NA,Multiple Types,"IgG,Neutralizing ",,,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,20/09/2021,16/07/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2020-W38,07-Oct-21,National,Finland,FIN,,,13-Sep-20,19-Sep-20,Household and community samples,Adults (18-64 years),48,2.08%,0.37%,10.90%,Simplified probability,NA,Multiple Types,"IgG,Neutralizing ",,,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,20/09/2021,16/07/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2021-W09,07-Oct-21,National,Finland,FIN,,,28-Feb-21,06-Mar-21,Household and community samples,Adults (18-64 years),132,2.27%,0.78%,6.47%,Simplified probability,NA,IFA,IgG,100.00%,100.00%,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,20/09/2021,16/07/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2020-W45,07-Oct-21,National,Finland,FIN,,,01-Nov-20,07-Nov-20,Household and community samples,Adults (18-64 years),55,5.45%,1.87%,14.85%,Simplified probability,NA,IFA,IgG,100.00%,100.00%,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,20/09/2021,16/07/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2020-W26,07-Oct-21,National,Finland,FIN,,,21-Jun-20,27-Jun-20,Household and community samples,Adults (18-64 years),32,0.00%,0.00%,10.72%,Simplified probability,NA,Multiple Types,"IgG,Neutralizing ",,,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,20/09/2021,16/07/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2021-W08,07-Oct-21,National,Finland,FIN,,,21-Feb-21,27-Feb-21,Household and community samples,Adults (18-64 years),123,6.50%,3.33%,12.31%,Simplified probability,NA,IFA,IgG,100.00%,100.00%,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,20/09/2021,16/07/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2020-W17,07-Oct-21,National,Finland,FIN,,,19-Apr-20,25-Apr-20,Household and community samples,Adults (18-64 years),674,0.30%,0.08%,1.08%,Simplified probability,NA,Multiple Types,"IgG,Neutralizing ",,,Moderate,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,20/09/2021,16/07/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2021-W17,07-Oct-21,National,Finland,FIN,,,25-Apr-21,01-May-21,Household and community samples,Adults (18-64 years),109,22.94%,16.05%,31.67%,Simplified probability,NA,IFA,IgG,100.00%,100.00%,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,20/09/2021,16/07/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2020-W44,07-Oct-21,National,Finland,FIN,,,25-Oct-20,31-Oct-20,Household and community samples,Adults (18-64 years),56,1.79%,0.32%,9.45%,Simplified probability,NA,IFA,IgG,100.00%,100.00%,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,20/09/2021,16/07/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2021-W12,07-Oct-21,National,Finland,FIN,,,21-Mar-21,27-Mar-21,Household and community samples,Adults (18-64 years),73,10.56%,6.66%,20.16%,Simplified probability,NA,IFA,IgG,100.00%,100.00%,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,20/09/2021,16/07/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2021-W03,07-Oct-21,National,Finland,FIN,,,17-Jan-21,23-Jan-21,Household and community samples,Adults (18-64 years),5,0.00%,0.00%,43.45%,Simplified probability,NA,IFA,IgG,100.00%,100.00%,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,20/09/2021,16/07/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2021-W19,07-Oct-21,National,Finland,FIN,,,09-May-21,15-May-21,Household and community samples,Adults (18-64 years),52,26.92%,16.77%,40.35%,Simplified probability,NA,IFA,IgG,100.00%,100.00%,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,20/09/2021,16/07/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2021-W13,07-Oct-21,National,Finland,FIN,,,28-Mar-21,03-Apr-21,Household and community samples,Adults (18-64 years),60,8.33%,3.61%,18.07%,Simplified probability,NA,IFA,IgG,100.00%,100.00%,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,20/09/2021,16/07/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2020-W30,07-Oct-21,National,Finland,FIN,,,19-Jul-20,25-Jul-20,Household and community samples,Adults (18-64 years),9,11.11%,1.99%,43.50%,Simplified probability,NA,Multiple Types,"IgG,Neutralizing ",,,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,20/09/2021,16/07/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2020-W27,07-Oct-21,National,Finland,FIN,,,28-Jun-20,04-Jul-20,Household and community samples,Adults (18-64 years),85,0.00%,0.00%,4.32%,Simplified probability,NA,Multiple Types,"IgG,Neutralizing ",,,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,20/09/2021,16/07/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2020-W37,07-Oct-21,National,Finland,FIN,,,06-Sep-20,12-Sep-20,Household and community samples,Adults (18-64 years),54,0.00%,0.00%,6.64%,Simplified probability,NA,Multiple Types,"IgG,Neutralizing ",,,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,20/09/2021,16/07/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2021-W24,07-Oct-21,National,Finland,FIN,,,13-Jun-21,19-Jun-21,Household and community samples,Adults (18-64 years),47,57.45%,43.28%,70.49%,Simplified probability,NA,IFA,IgG,100.00%,100.00%,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,20/09/2021,16/07/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2021-W25,07-Oct-21,National,Finland,FIN,,,20-Jun-21,26-Jun-21,Household and community samples,Adults (18-64 years),44,72.73%,58.15%,80.67%,Simplified probability,NA,IFA,IgG,100.00%,100.00%,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,20/09/2021,16/07/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2020-W35,07-Oct-21,National,Finland,FIN,,,23-Aug-20,29-Aug-20,Household and community samples,Adults (18-64 years),48,2.08%,0.37%,10.90%,Simplified probability,NA,Multiple Types,"IgG,Neutralizing ",,,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,20/09/2021,16/07/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2021-W22,07-Oct-21,National,Finland,FIN,,,30-May-21,05-Jun-21,Household and community samples,Adults (18-64 years),39,48.72%,33.87%,63.80%,Simplified probability,NA,IFA,IgG,100.00%,100.00%,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,20/09/2021,16/07/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2020-W39,07-Oct-21,National,Finland,FIN,,,20-Sep-20,26-Sep-20,Household and community samples,Adults (18-64 years),56,1.79%,0.32%,9.45%,Simplified probability,NA,Multiple Types,"IgG,Neutralizing ",,,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,20/09/2021,16/07/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2021-W18,07-Oct-21,National,Finland,FIN,,,02-May-21,08-May-21,Household and community samples,Adults (18-64 years),74,28.38%,19.37%,39.52%,Simplified probability,NA,IFA,IgG,100.00%,100.00%,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,20/09/2021,16/07/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2021-W14,07-Oct-21,National,Finland,FIN,,,04-Apr-21,10-Apr-21,Household and community samples,Adults (18-64 years),59,6.78%,2.67%,16.18%,Simplified probability,NA,IFA,IgG,100.00%,100.00%,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,20/09/2021,16/07/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2020-W22,07-Oct-21,National,Finland,FIN,,,24-May-20,30-May-20,Household and community samples,Adults (18-64 years),178,0.00%,0.00%,2.11%,Simplified probability,NA,Multiple Types,"IgG,Neutralizing ",,,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,20/09/2021,16/07/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2020-W46,07-Oct-21,National,Finland,FIN,,,08-Nov-20,14-Nov-20,Household and community samples,Adults (18-64 years),52,1.92%,0.34%,10.12%,Simplified probability,NA,IFA,IgG,100.00%,100.00%,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,20/09/2021,16/07/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2021-W20,07-Oct-21,National,Finland,FIN,,,16-May-21,22-May-21,Household and community samples,Adults (18-64 years),86,44.19%,34.16%,54.71%,Simplified probability,NA,IFA,IgG,100.00%,100.00%,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,20/09/2021,16/07/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2020-W40,07-Oct-21,National,Finland,FIN,,,27-Sep-20,03-Oct-20,Household and community samples,Adults (18-64 years),60,1.67%,0.29%,8.86%,Simplified probability,NA,IFA,IgG,100.00%,100.00%,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,20/09/2021,16/07/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2021-W07,07-Oct-21,National,Finland,FIN,,,14-Feb-21,20-Feb-21,Household and community samples,Adults (18-64 years),69,7.25%,3.13%,15.87%,Simplified probability,NA,IFA,IgG,100.00%,100.00%,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,20/09/2021,16/07/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2020-W16,07-Oct-21,National,Finland,FIN,,,12-Apr-20,18-Apr-20,Household and community samples,Adults (18-64 years),362,0.28%,0.05%,1.55%,Simplified probability,NA,Multiple Types,"IgG,Neutralizing ",,,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,20/09/2021,16/07/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2020-W41,07-Oct-21,National,Finland,FIN,,,04-Oct-20,10-Oct-20,Household and community samples,Adults (18-64 years),51,0.00%,0.00%,7.00%,Simplified probability,NA,IFA,IgG,100.00%,100.00%,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,20/09/2021,16/07/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2021-W15,07-Oct-21,National,Finland,FIN,,,11-Apr-21,17-Apr-21,Household and community samples,Adults (18-64 years),29,13.79%,5.50%,30.56%,Simplified probability,NA,IFA,IgG,100.00%,100.00%,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,20/09/2021,16/07/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2020-W43,07-Oct-21,National,Finland,FIN,,,18-Oct-20,24-Oct-20,Household and community samples,Adults (18-64 years),55,0.00%,0.00%,6.53%,Simplified probability,NA,IFA,IgG,100.00%,100.00%,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,20/09/2021,16/07/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2020-W29,07-Oct-21,National,Finland,FIN,,,12-Jul-20,18-Jul-20,Household and community samples,Adults (18-64 years),7,0.00%,0.00%,35.43%,Simplified probability,NA,Multiple Types,"IgG,Neutralizing ",,,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,20/09/2021,16/07/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2021-W31,07-Oct-21,National,Finland,FIN,,,01-Aug-21,07-Aug-21,Household and community samples,Adults (18-64 years),42,92.86%,80.99%,97.54%,Simplified probability,NA,IFA,IgG,100.00%,100.00%,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,14/10/2021,16/07/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2021-W30,07-Oct-21,National,Finland,FIN,,,25-Jul-21,31-Jul-21,Household and community samples,Adults (18-64 years),11,81.82%,52.30%,94.86%,Simplified probability,NA,IFA,IgG,100.00%,100.00%,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,14/10/2021,16/07/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2021-W33,07-Oct-21,National,Finland,FIN,,,15-Aug-21,21-Aug-21,Household and community samples,Adults (18-64 years),7,85.71%,48.69%,97.43%,Simplified probability,NA,IFA,IgG,100.00%,100.00%,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,14/10/2021,16/07/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2021-W34,07-Oct-21,National,Finland,FIN,,,22-Aug-21,28-Aug-21,Household and community samples,Adults (18-64 years),8,75.00%,40.93%,92.85%,Simplified probability,NA,IFA,IgG,100.00%,100.00%,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,14/10/2021,16/07/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2021-W29,07-Oct-21,National,Finland,FIN,,,18-Jul-21,24-Jul-21,Household and community samples,Adults (18-64 years),2,100.00%,34.24%,100.00%,Simplified probability,NA,IFA,IgG,100.00%,100.00%,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,14/10/2021,16/07/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2021-W32,07-Oct-21,National,Finland,FIN,,,08-Aug-21,14-Aug-21,Household and community samples,Adults (18-64 years),25,84.00%,65.35%,93.60%,Simplified probability,NA,IFA,IgG,100.00%,100.00%,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,14/10/2021,16/07/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2021-W35,07-Oct-21,National,Finland,FIN,,,29-Aug-21,04-Sep-21,Household and community samples,Adults (18-64 years),1,0.00%,0.00%,79.35%,Simplified probability,NA,IFA,IgG,100.00%,100.00%,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,14/10/2021,16/07/2022,Verified
210912_Turku_UniversityofTurku_Overall,19-Jan-22,Local,Finland,FIN,Southwest Finland,Turku,13-May-20,17-Dec-20,Health care workers and caregivers,Multiple groups,222,8.11%,,,Convenience,NA,ELISA,IgG,96.30%,99.00%,High,Journal Article (Peer-Reviewed),Paula Tahtinen,University of Turku,https://dx.doi.org/10.1080/23744235.2022.2027008,26/01/2022,16/07/2022,Unverified
211007_Finland_FinnishInstituteforHealthandWelfare_2021-W44,07-Oct-21,National,Finland,FIN,,,31-Oct-21,06-Nov-21,Household and community samples,Adults (18-64 years),79,91.14%,82.82%,95.64%,Simplified probability,NA,IFA,IgG,100.00%,100.00%,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,01/03/2022,16/07/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2021-W42,07-Oct-21,National,Finland,FIN,,,17-Oct-21,23-Oct-21,Household and community samples,Adults (18-64 years),1,0.00%,0.00%,79.35%,Simplified probability,NA,IFA,IgG,100.00%,100.00%,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,01/03/2022,16/07/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2021-W50,07-Oct-21,National,Finland,FIN,,,12-Dec-21,18-Dec-21,Household and community samples,Adults (18-64 years),1,100.00%,20.65%,100.00%,Simplified probability,NA,IFA,IgG,100.00%,100.00%,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,01/03/2022,16/07/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2021-W39,07-Oct-21,National,Finland,FIN,,,26-Sep-21,02-Oct-21,Household and community samples,Adults (18-64 years),2,50.00%,9.45%,90.55%,Simplified probability,NA,IFA,IgG,100.00%,100.00%,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,01/03/2022,16/07/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2021-W37,07-Oct-21,National,Finland,FIN,,,12-Sep-21,18-Sep-21,Household and community samples,Adults (18-64 years),1,100.00%,20.65%,100.00%,Simplified probability,NA,IFA,IgG,100.00%,100.00%,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,01/03/2022,16/07/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2021-W46,07-Oct-21,National,Finland,FIN,,,14-Nov-21,20-Nov-21,Household and community samples,Adults (18-64 years),13,92.31%,66.69%,98.63%,Simplified probability,NA,IFA,IgG,100.00%,100.00%,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,01/03/2022,16/07/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2021-W45,07-Oct-21,National,Finland,FIN,,,07-Nov-21,13-Nov-21,Household and community samples,Adults (18-64 years),30,93.33%,78.68%,98.15%,Simplified probability,NA,IFA,IgG,100.00%,100.00%,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,01/03/2022,16/07/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2021-W47,07-Oct-21,National,Finland,FIN,,,21-Nov-21,27-Nov-21,Household and community samples,Adults (18-64 years),8,87.50%,52.91%,97.76%,Simplified probability,NA,IFA,IgG,100.00%,100.00%,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,01/03/2022,16/07/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2021-W48,07-Oct-21,National,Finland,FIN,,,28-Nov-21,04-Dec-21,Household and community samples,Adults (18-64 years),4,75.00%,30.06%,95.44%,Simplified probability,NA,IFA,IgG,100.00%,100.00%,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,01/03/2022,16/07/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2021-W49,07-Oct-21,National,Finland,FIN,,,05-Dec-21,11-Dec-21,Household and community samples,Adults (18-64 years),4,100.00%,51.01%,100.00%,Simplified probability,NA,IFA,IgG,100.00%,100.00%,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,01/03/2022,16/07/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2021-W36,07-Oct-21,National,Finland,FIN,,,05-Sep-21,11-Sep-21,Household and community samples,Adults (18-64 years),1,100.00%,20.65%,100.00%,Simplified probability,NA,IFA,IgG,100.00%,100.00%,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,01/03/2022,16/07/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2021-W51,07-Oct-21,National,Finland,FIN,,,19-Dec-21,25-Dec-21,Household and community samples,Adults (18-64 years),2,50.00%,9.45%,90.55%,Simplified probability,NA,IFA,IgG,100.00%,100.00%,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,01/03/2022,16/07/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2021-W43,07-Oct-21,National,Finland,FIN,,,24-Oct-21,30-Oct-21,Household and community samples,Adults (18-64 years),11,90.91%,62.26%,98.38%,Simplified probability,NA,IFA,IgG,100.00%,100.00%,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,01/03/2022,16/07/2022,Verified
220428_Finland_UniversityofHelsinkiTime2,28-Apr-22,Local,Finland,FIN,,Helsinki,31-Jan-21,06-Mar-21,Residual sera,Multiple groups,500,28.20%,,,Simplified probability,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Maarit Ahava,University of Helsinki,https://link.springer.com/article/10.1007/s10096-022-04448-x,01/06/2022,16/07/2022,Unverified
220428_Finland_UniversityofHelsinkiTime1,28-Apr-22,Local,Finland,FIN,,Helsinki,15-Nov-21,19-Dec-21,Residual sera,Multiple groups,500,5.20%,,,Simplified probability,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Maarit Ahava,University of Helsinki,https://link.springer.com/article/10.1007/s10096-022-04448-x,01/06/2022,16/07/2022,Unverified
200727_ FaroeIslands_TheFaroeseHospitalSystem_GenPop_TestAdj,27-Jul-20,Regional,Faroe Islands,FRO,Faroe Islands,,27-Apr-20,01-May-20,Household and community samples,Adults (18-64 years),1075,0.70%,,,Simplified probability,Beijing Wantai Biological,ELISA,"IgG,IgM",94.40%,100.00%,Low,Journal Article (Peer-Reviewed),Maria Skaalum Petersen,University of the Faroe Islands,http://dx.doi.org/10.3201/eid2611.202736,27/09/2020,16/07/2022,Verified
210826_FaroeIslands_UniversityoftheFaroeIslands_TestAdjusted,26-Aug-21,National,Faroe Islands,FRO,,,01-May-20,15-Sep-20,Contacts of COVID patients,Multiple groups,584,5.30%,3.50%,7.50%,Entire sample,Beijing Wantai Biological,ELISA,Total Antibody,96.70%,99.50%,Moderate,Journal Article (Peer-Reviewed),Maria Petersen,University of the Faroe Islands,https://wwwnc.cdc.gov/eid/article/27/11/20-4948_article,28/09/2021,16/07/2022,Unverified
211110_FaroeIslands_TheFaroeseHospitalSystem_TestAdj,10-Nov-21,National,Faroe Islands,FRO,,,21-Nov-20,30-Nov-20,Household and community samples,Multiple groups,960,0.40%,0.10%,1.00%,Simplified probability,Beijing Wantai Biological,ELISA,Total Antibody,94.40%,100.00%,Low,Journal Article (Peer-Reviewed),Maria Skaalum Petersen,The Faroese Hospital System,https://dx.doi.org/10.3201/eid2801.210917,18/11/2021,16/07/2022,Verified
200922_AddisAbaba_KuwaitUniversity_GenPop,22-Sep-20,Local,Ethiopia,ETH,Oromia,Addis Ababa,18-May-20,21-May-20,Residual sera,Multiple groups,99,3.00%,0.60%,8.60%,Convenience,Abbott Laboratories,CLIA,IgG,100.00%,99.90%,High,Journal Article (Peer-Reviewed),John Kempen,Kuwait University,https://dx.doi.org/10.4269/ajtmh.20-0816,06/12/2020,16/07/2022,Verified
201013_AddisAbaba_MinistryOfHealthEthiopia_TestAdj_PopUnAdj,13-Oct-20,Local,Ethiopia,ETH,,Addis Ababa,23-Apr-20,28-Apr-20,Household and community samples,Adults (18-64 years),301,8.80%,5.50%,11.60%,Simplified probability,Zhejiang Orient Gene Biotech,LFIA,"IgG,IgM",87.90%,100.00%,Moderate,Preprint,Berhanu Alemu,"Ministry of Health, Ethiopia",https://www.biorxiv.org/content/10.1101/2020.10.13.337287v1,11/12/2020,16/07/2022,Verified
210507_Ethiopia_EthiopianPublicHealthInstitute_AddisAbaba,07-May-21,Local,Ethiopia,ETH,Oromia Region,Addis Ababa,22-Jul-20,02-Sep-20,Household and community samples,Multiple groups,956,3.50%,1.70%,5.40%,Stratified probability,Core Technology Co. Ltd,LFIA,"IgG,IgM",69.00%,97.00%,Moderate,Journal Article (Peer-Reviewed),Saro Abdella,Ethiopian Public Health Institute,http://dx.doi.org/10.1016/j.eclinm.2021.100880,29/05/2021,16/07/2022,Verified
210507_Ethiopia_EthiopianPublicHealthInstitute_JimmaRegion,07-May-21,Local,Ethiopia,ETH,Oromia Region,Jimma,22-Jul-20,02-Sep-20,Household and community samples,Multiple groups,900,0.60%,0.10%,1.80%,Stratified probability,Core Technology Co. Ltd,LFIA,"IgG,IgM",69.00%,97.00%,Moderate,Journal Article (Peer-Reviewed),Saro Abdella,Ethiopian Public Health Institute,http://dx.doi.org/10.1016/j.eclinm.2021.100880,29/05/2021,16/07/2022,Verified
210710_EthiopiaDireDawa_JimmaUniversityInstituteofHealth_Primary,10-Jul-21,Local,Ethiopia,ETH,,Dire Dawa city,15-Jun-20,30-Jul-20,Household and community samples,Multiple groups,684,3.20%,2.00%,4.80%,Simplified probability,Abbott Laboratories,CLIA,IgG,100.00%,99.60%,Low,Journal Article (Peer-Reviewed),Tamrat Shaweno,Jimma University Institute of Health,https://dx.doi.org/10.1186/s41182-021-00347-7,19/07/2021,16/07/2022,Verified
210815_Ethiopia_FederalMinistryofHealth_Overall_Adjusted,15-Aug-21,National,Ethiopia,ETH,,,24-Jun-20,08-Jul-20,Household and community samples,Multiple groups,16932,3.50%,3.20%,3.80%,Simplified probability,Abbott Laboratories,CLIA,IgG,54.50%,100.00%,Low,Journal Article (Peer-Reviewed),Enyew Birru Tadesse,Federal Ministry of Health,http://dx.doi.org/10.1016/j.ijid.2021.08.028,21/09/2021,16/07/2022,Verified
211101_Ethiopia_UniversityofMunich_JimmaUrban_Round3,01-Nov-21,Local,Ethiopia,ETH,,Jimma,02-Feb-21,15-Mar-21,Household and community samples,Multiple groups,166,45.20%,37.70%,52.70%,Convenience,Roche Diagnostics,CLIA,Not reported,100.00%,99.80%,Moderate,Journal Article (Peer-Reviewed),Esayas Gudina,University of Munich,https://dx.doi.org/10.1016/S2214-109X(21)00386-7,04/11/2021,16/07/2022,Verified
211101_Ethiopia_UniversityofMunich_AddisAbaba_AddisKetema_Round3,01-Nov-21,Local,Ethiopia,ETH,,Addis Ababa,08-Apr-21,10-Apr-21,Household and community samples,Multiple groups,176,72.70%,65.90%,79.10%,Convenience,Roche Diagnostics,CLIA,Not reported,100.00%,99.80%,Moderate,Journal Article (Peer-Reviewed),Esayas Gudina,University of Munich,https://dx.doi.org/10.1016/S2214-109X(21)00386-7,04/11/2021,16/07/2022,Verified
211101_Ethiopia_UniversityofMunich_HCW_Jimma_Round3,01-Nov-21,Local,Ethiopia,ETH,,Jimma,05-Jan-21,15-Feb-21,Health care workers and caregivers,Adults (18-64 years),372,56.10%,51.10%,61.10%,Unclear,Roche Diagnostics,Not reported,Not reported,100.00%,99.80%,Moderate,Journal Article (Peer-Reviewed),Esayas Gudina,University of Munich,https://dx.doi.org/10.1016/S2214-109X(21)00386-7,04/11/2021,16/07/2022,Verified
211101_Ethiopia_UniversityofMunich_JimmaRural_Round3,01-Nov-21,Local,Ethiopia,ETH,,Jimma,04-Feb-21,16-Mar-21,Household and community samples,Multiple groups,100,31.00%,22.30%,40.30%,Convenience,Roche Diagnostics,CLIA,Not reported,100.00%,99.80%,Moderate,Journal Article (Peer-Reviewed),Esayas Gudina,University of Munich,https://dx.doi.org/10.1016/S2214-109X(21)00386-7,04/11/2021,16/07/2022,Verified
211101_Ethiopia_UniversityofMunich_HCW_AddisAbaba_Round3,01-Nov-21,Local,Ethiopia,ETH,,Addis Ababa,19-Jan-21,12-Mar-21,Health care workers and caregivers,Adults (18-64 years),121,53.70%,44.80%,62.50%,Unclear,Roche Diagnostics,Not reported,Not reported,100.00%,99.80%,Moderate,Journal Article (Peer-Reviewed),Esayas Gudina,University of Munich,https://dx.doi.org/10.1016/S2214-109X(21)00386-7,04/11/2021,16/07/2022,Verified
211101_Ethiopia_UniversityofMunich_AddisAbaba_Yeka_Round3,01-Nov-21,Local,Ethiopia,ETH,,Addis Ababa,01-Apr-21,03-Apr-21,Household and community samples,Multiple groups,188,54.80%,47.70%,61.90%,Convenience,Roche Diagnostics,CLIA,Not reported,100.00%,99.80%,Moderate,Journal Article (Peer-Reviewed),Esayas Gudina,University of Munich,https://dx.doi.org/10.1016/S2214-109X(21)00386-7,04/11/2021,16/07/2022,Verified
211124_EastHararghe_UniversityofLondon_Overall,24-Nov-21,Regional,Ethiopia,ETH,"Oromia, Harari","Haramaya, Harar",01-Apr-20,31-Mar-21,Pregnant or parturient women,Adults (18-64 years),1447,5.70%,4.60%,7.00%,Simplified probability,Beijing Wantai Biological,LFIA,Total Antibody,100.00%,98.80%,Moderate,Journal Article (Peer-Reviewed),Nega Assefa,The London School of Hygiene & Tropical Medicine,https://dx.doi.org/10.1136/bmjopen-2021-055834,02/12/2021,16/07/2022,Verified
20220207_Ethiopia_WoldiaUniversity,07-Feb-22,Regional,Ethiopia,ETH,North West Ethiopia,Asosa and Pawe COVID-19 treatment centres. ,30-Apr-20,30-May-20,Multiple populations,Multiple groups,446,4.69%,3.10%,7.20%,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Fassikaw Kebede,Woldia University,https://dx.doi.org/10.1177/20503121221076931,25/02/2022,16/07/2022,Unverified
220316_Ethiopia_ArmauerHansenResearchInstitute,16-Mar-22,National,Ethiopia,ETH,,,15-Dec-20,15-Feb-21,Health care workers and caregivers,Adults (18-64 years),1997,39.80%,37.40%,41.70%,Entire sample,NA,ELISA,IgG,67.30%,97.70%,Moderate,Journal Article (Peer-Reviewed),Tesfaye Gelanew,Armauer Hansen Research Institute,https://doi.org/10.1186/s12879-022-07247-z,23/03/2022,16/07/2022,Unverified
210226_Estonia_UniversityOfTartu_Stage14_Overall,13-Jun-22,National,Estonia,EST,,,11-Feb-21,22-Feb-21,Household and community samples,Multiple groups,2626,11.49%,10.29%,12.77%,Stratified probability,Synlab,CLIA,IgG,,,Moderate,Institutional Report,University of Tartu,University of Tartu,https://ut.ee/et/sisu/koroonaviiruse-levimuse-seireuuringu-antikehade-analuusi-tulemused,26/02/2021,16/07/2022,Verified
210107_Estonia_UniversityCollegeLondon_PaediatricHCW,27-Jan-21,Local,Estonia,EST,NR,NR,10-Jun-20,12-Jun-20,Health care workers and caregivers,Adults (18-64 years),130,0.00%,0.00%,2.87%,Convenience,"Epitope Diagnostics, Inc.,Meso Scale Discovery",ELISA,IgG,,,High,Journal Article (Peer-Reviewed),D Goldblatt,University College London,http://dx.doi.org/10.1016/j.jhin.2020.12.019,13/03/2021,16/07/2022,Verified
200924_Estonia_UniversityofTartu_overall,24-Sep-20,National,Estonia,EST,,,04-May-20,10-Jun-20,Pregnant or parturient women,Adults (18-64 years),433,0.46%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Piret Veerus,University of Tartu,https://obgyn.onlinelibrary.wiley.com/doi/full/10.1111/aogs.13995,20/03/2021,16/07/2022,Verified
210323_Estonia_UniversityOfTartu_Stage15_Overall,13-Jun-22,National,Estonia,EST,,,11-Mar-21,22-Mar-21,Household and community samples,Multiple groups,2382,21.41%,19.78%,23.11%,Stratified probability,Synlab,CLIA,IgG,,,Moderate,Institutional Report,University of Tartu,Univeristy of Tartu,https://ut.ee/et/sisu/koroonaviiruse-levimuse-seireuuringu-antikehade-analuusi-tulemused,25/03/2021,16/07/2022,Verified
210420_Estonia_UniversityOfTartu_Stage16_Overall,13-Jun-22,National,Estonia,EST,,,08-Apr-21,19-Apr-21,Household and community samples,Multiple groups,2491,35.87%,33.97%,37.79%,Stratified probability,Synlab,CLIA,IgG,,,Moderate,Institutional Report,University of Tartu,Univeristy of Tartu,https://ut.ee/et/sisu/koroonaviiruse-levimuse-seireuuringu-antikehade-analuusi-tulemused,21/04/2021,16/07/2022,Verified
210527_Estonia_UniversityOfTartu_Stage17_Overall,13-Jun-22,National,Estonia,EST,,,13-May-21,24-May-21,Household and community samples,Multiple groups,2290,49.52%,47.45%,51.59%,Stratified probability,Synlab,CLIA,IgG,,,Moderate,Institutional Report,University of Tartu,Univeristy of Tartu,https://ut.ee/et/sisu/koroonaviiruse-levimuse-seireuuringu-antikehade-analuusi-tulemused,29/05/2021,16/07/2022,Verified
210622_Estonia_UniversityOfTartu_Stage18_Overall,13-Jun-22,National,Estonia,EST,,,10-Jun-21,21-Jun-21,Household and community samples,Multiple groups,2330,67.90%,65.96%,69.79%,Stratified probability,Synlab,CLIA,IgG,,,Moderate,Institutional Report,University of Tartu,Univeristy of Tartu,https://ut.ee/et/sisu/koroonaviiruse-levimuse-seireuuringu-antikehade-analuusi-tulemused,28/06/2021,16/07/2022,Verified
210805_Estonia_TartuUniversityHospital_Tallinn_overall_testadj,07-Sep-21,Local,Estonia,EST,,Tallinn,08-May-20,31-Jul-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,1006,1.50%,0.60%,2.40%,Stratified probability,"Abbott Laboratories,DiaSorin,SD Biosensor,NA",Multiple Types,"IgG,IgM",,,Moderate,Journal Article (Peer-Reviewed),Piia Jogi,University of Tartu,https://dx.doi.org/10.1016/j.vaccine.2021.07.093,25/08/2021,16/07/2022,Verified
210805_Estonia_TartuUniversityHospital_Saaremaa_overall_testadj,07-Sep-21,Local,Estonia,EST,,Saaremaa,08-May-20,31-Jul-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,954,6.70%,5.00%,8.40%,Stratified probability,"Abbott Laboratories,DiaSorin,SD Biosensor,NA",Multiple Types,"IgG,IgM",,,Moderate,Journal Article (Peer-Reviewed),Piia Jogi,University of Tartu,https://dx.doi.org/10.1016/j.vaccine.2021.07.093,25/08/2021,16/07/2022,Verified
210914_Estonia_UniversityofTartu_overall,14-Sep-21,National,Estonia,EST,,,08-Feb-21,25-Mar-21,Residual sera,Multiple groups,2517,20.10%,18.50%,21.70%,Stratified non-probability,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Hiie Soeorg,University of Tartu,https://dx.doi.org/10.1080/23744235.2021.1974540,21/09/2021,16/07/2022,Verified
211001_Estonia_UniversityOfTartu_Stage20_Overall,13-Jun-22,National,Estonia,EST,,,15-Sep-21,27-Sep-21,Household and community samples,Multiple groups,2302,76.70%,74.91%,78.40%,Stratified probability,Synlab,CLIA,IgG,,,Moderate,Institutional Report,University of Tartu,Univeristy of Tartu,https://ut.ee/et/sisu/koroonaviiruse-levimuse-seireuuringu-antikehade-analuusi-tulemused,13/10/2021,16/07/2022,Verified
211025_Estonia_UniversityOfTartu_Stage21_Overall,13-Jun-22,National,Estonia,EST,,,13-Oct-21,25-Oct-21,Household and community samples,Multiple groups,2312,76.40%,74.30%,78.40%,Stratified probability,Synlab,CLIA,IgG,,,Moderate,Institutional Report,University of Tartu,Univeristy of Tartu,https://ut.ee/et/sisu/koroonaviiruse-levimuse-seireuuringu-antikehade-analuusi-tulemused,03/11/2021,16/07/2022,Verified
211213_Estonia_UniversityOfTartu_Stage22_Overall,13-Jun-22,National,Estonia,EST,,,01-Dec-21,13-Dec-21,Household and community samples,Multiple groups,2290,81.50%,78.10%,84.80%,Stratified probability,Synlab,CLIA,IgG,,,Moderate,Institutional Report,University of Tartu,Univeristy of Tartu,https://ut.ee/et/sisu/koroonaviiruse-levimuse-seireuuringu-antikehade-analuusi-tulemused,10/01/2022,16/07/2022,Verified
220124_Estonia_UniversityOfTartu_Stage23_Overall,13-Jun-22,National,Estonia,EST,,,11-Jan-22,24-Jan-22,Household and community samples,Multiple groups,2301,82.80%,80.00%,85.40%,Stratified probability,Synlab,CLIA,IgG,,,Moderate,Institutional Report,University of Tartu,Univeristy of Tartu,https://ut.ee/et/sisu/koroonaviiruse-levimuse-seireuuringu-antikehade-analuusi-tulemused,03/02/2022,16/07/2022,Verified
220321_Estonia_UniversityOfTartu_Stage24_Overall,13-Jun-22,National,Estonia,EST,,,09-Mar-22,21-Mar-22,Household and community samples,Multiple groups,2308,89.10%,87.40%,90.80%,Stratified probability,Synlab,CLIA,IgG,,,Moderate,Institutional Report,University of Tartu,Univeristy of Tartu,https://ut.ee/et/sisu/koroonaviiruse-levimuse-seireuuringu-antikehade-analuusi-tulemused,31/03/2022,16/07/2022,Unverified
220411_Estonia_UniversityOfTartu_Stage25,13-Jun-22,National,Estonia,EST,,,30-Mar-22,11-Apr-22,Household and community samples,Multiple groups,2304,87.10%,84.70%,89.40%,Stratified probability,Synlab,CLIA,IgG,,,Moderate,Institutional Report,University of Tartu,Univeristy of Tartu,https://ut.ee/et/sisu/koroonaviiruse-levimuse-seireuuringu-antikehade-analuusi-tulemused,25/04/2022,16/07/2022,Unverified
220509_Estonia_UniversityOfTartu_Stage26,13-Jun-22,National,Estonia,EST,,,27-Apr-22,09-May-22,Household and community samples,Multiple groups,2228,86.50%,83.20%,89.60%,Stratified probability,Synlab,CLIA,IgG,,,Moderate,Institutional Report,University of Tartu,Univeristy of Tartu,https://ut.ee/et/sisu/koroonaviiruse-levimuse-seireuuringu-antikehade-analuusi-tulemused,18/05/2022,16/07/2022,Unverified
220613_Estonia_UniversityOfTartu_Stage27,13-Jun-22,National,Estonia,EST,,,01-Jun-22,13-Jun-22,Household and community samples,Multiple groups,2439,87.50%,84.90%,89.90%,Stratified probability,Synlab,CLIA,IgG,,,Moderate,Institutional Report,University of Tartu,Univeristy of Tartu,https://ut.ee/et/sisu/koroonaviiruse-levimuse-seireuuringu-antikehade-analuusi-tulemused,29/06/2022,16/07/2022,Unverified
220207_SanSalvador_OsakaCityUniversity_HCW_Overall,07-Feb-22,Local,El Salvador,SLV,,San Salvador,18-Jan-21,14-Feb-21,Health care workers and caregivers,Adults (18-64 years),973,52.60%,,,Convenience,"Roche Diagnostics,Abbott Laboratories",CLIA,"Total Antibody,IgG",,,Moderate,Preprint,Yu Nakagama,Osaka City University,10.1101/2022.02.06.22270565,17/02/2022,16/07/2022,Unverified
200721_Egypt_CairoUniversity_TotalHCW_Overall,21-Jul-20,Local,Egypt,EGY,,Cairo,01-Jun-20,14-Jun-20,Health care workers and caregivers,Adults (18-64 years),74,12.20%,,,Convenience,Artron Laboratories Inc.,LFIA,"IgG,IgM",93.40%,97.70%,High,Journal Article (Peer-Reviewed),Abdel Meguid Kassem,Cairo University,https://dx.doi.org/10.1016/j.ajg.2020.07.005,29/09/2020,16/07/2022,Verified
210115_Cairo_CairoUniversity,15-Jan-21,Local,Egypt,EGY,,Cairo,01-Jun-20,14-Jun-20,Health care workers and caregivers,Adults (18-64 years),203,18.20%,,,Convenience,Artron Laboratories Inc.,LFIA,"IgG,IgM",93.40%,97.70%,High,Journal Article (Peer-Reviewed),Reham Abdelmoniem,Cairo University ,https://dx.doi.org/10.1016/j.jcv.2020.104710,23/01/2021,16/07/2022,Verified
201023_Egypt_AinShamsUniversity_Overall,23-Oct-20,Local,Egypt,EGY,Cairo Governorate,Cairo,22-Apr-20,14-May-20,Health care workers and caregivers,Multiple groups,4040,1.31%,,,Convenience,Artron Laboratories Inc.,LFIA,"IgG,IgM",83.30%,100.00%,High,Journal Article (Peer-Reviewed),Aya Mostafa,Ain Shams University,https://academic.oup.com/ije/advance-article/doi/10.1093/ije/dyaa173/5936053,23/01/2021,16/07/2022,Verified
210402_Cairo_CairoUniversity_HCW,02-Apr-21,Local,Egypt,EGY,,,05-May-20,11-Jun-20,Health care workers and caregivers,Adults (18-64 years),455,7.90%,5.80%,10.80%,Convenience,"SD Biosensor,Shenzhen Yhlo Biotech Co. Ltd",Multiple Types,IgG,,,High,Journal Article (Peer-Reviewed),Ahmed Mukhtar,Cairo University,https://dx.doi.org/10.4081/jphr.2021.2102,18/04/2021,16/07/2022,Verified
210311_Egypt_CenterofScientificExcellenceforInfluenzaViruses_October3,11-Mar-21,National,Egypt,EGY,"Sharkiyah Governorate, Gharbiyah Governorate, Kafr El Sheikh Governorate, Qalyubiyah Governorate, Fayyoum Governorate",,01-Oct-20,31-Oct-20,Household and community samples,Multiple groups,1260,34.80%,,,Simplified probability,NA,Neutralization,Neutralizing ,,,Unclear,Journal Article (Peer-Reviewed),Mokhtar R Gomaa,Center of Scientific Excellence for Influenza Viruses ,https://dx.doi.org/10.1371/journal.ppat.1009413,10/05/2021,16/07/2022,Verified
210610_Cairo_CairoUniversity_HCW1_overall,10-Jun-21,Local,Egypt,EGY,,Cairo,01-Jun-20,14-Jun-20,Health care workers and caregivers,Adults (18-64 years),386,15.80%,,,Convenience,Ortho Clinical Diagnostics Inc.,CLIA,Total Antibody,90.00%,100.00%,High,Journal Article (Peer-Reviewed),Sherief Musa,Cairo University,https://dx.doi.org/10.1016/j.jiph.2021.06.001,06/07/2021,16/07/2022,Verified
210610_Cairo_CairoUniversity_GenPop2_overall_TotalAbCLIA,10-Jun-21,Local,Egypt,EGY,,Cairo,01-Jun-20,14-Jun-20,Household and community samples,Adults (18-64 years),725,29.40%,,,Simplified probability,Ortho Clinical Diagnostics Inc.,CLIA,Total Antibody,90.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Sherief Musa,Cairo University,https://dx.doi.org/10.1016/j.jiph.2021.06.001,06/07/2021,16/07/2022,Verified
210715_Egypt_NationalResearchCentre_Primary,15-Jul-21,Local,Egypt,EGY,,Cairo,15-Aug-20,15-Oct-20,Multiple general populations,Multiple groups,888,30.00%,,,Convenience,NA,Neutralization,Not reported,,,Moderate,Journal Article (Peer-Reviewed),Amira S. El Rifay,National Research Centre,https://dx.doi.org/10.1111/irv.12889,19/07/2021,16/07/2022,Unverified
210715_Cairo_Ain-ShamsUniversity_TestAdj,15-Jul-21,Local,Egypt,EGY,Cairo Governate,Cairo,05-May-20,31-Oct-20,Residual sera,Multiple groups,2927,29.82%,28.16%,31.51%,Sequential,Roche Diagnostics,CLIA,Total Antibody,100.00%,99.81%,Moderate,Journal Article (Peer-Reviewed),Samia Girgis,Ain-Shams University,http://dx.doi.org/10.1371/journal.pone.0254581,03/08/2021,16/07/2022,Unverified
210920_Egypt_AssiutUniversity_Overall,20-Sep-21,National,Egypt,EGY,"Ash Sharqiyah, Asyut","Zagazig, Assiut",15-Oct-20,15-Dec-20,Health care workers and caregivers,Adults (18-64 years),82,46.30%,,,Unclear,NA,ELISA,"IgG,IgM",,,Unclear,Journal Article (Peer-Reviewed),Rehab El-Sokkary,Assiut University,https://dx.doi.org/10.1016/j.jiph.2021.09.011,05/10/2021,16/07/2022,Unverified
211029_Cairo_AinShamsUniversity,29-Oct-21,Local,Egypt,EGY,,Cairo,06-Sep-20,31-Oct-20,Blood donors,Adults (18-64 years),100,38.00%,,,Simplified probability,AMEDA Labordiagnostik GmbH,LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Sahar Abdelmaksoud,Ain-Shams University,https://www.ehj.eg.net/article.asp?issn=1110-1067;year=2021;volume=46;issue=2;spage=65;epage=69;aulast=Abdelmaksoud,14/12/2021,16/07/2022,Verified
220429_Egypt_AssiutUniversity_Mother_TotalAb,29-Apr-22,Local,Egypt,EGY,,Assiut,01-Jul-20,30-Sep-20,Pregnant or parturient women,Adults (18-64 years),171,32.20%,,,Sequential,"Artron Laboratories Inc.,Roche Diagnostics,Abbott Laboratories",Multiple Types,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Tarek Al-Hussaini,Assiut University,https://dx.doi.org/10.1080/01443615.2022.2049720,10/05/2022,16/07/2022,Unverified
220429_Egypt_AssiutUniversity_Baby_TotalAb,29-Apr-22,Local,Egypt,EGY,,Assiut,01-Jul-20,30-Sep-20,Perinatal,Children and Youth (0-17 years),171,28.10%,,,Sequential,"Artron Laboratories Inc.,Roche Diagnostics,Abbott Laboratories",Multiple Types,IgG,,,High,Journal Article (Peer-Reviewed),Tarek Al-Hussaini,Assiut University,https://dx.doi.org/10.1080/01443615.2022.2049720,10/05/2022,16/07/2022,Unverified
220512_Egypt_CairoUniversity_Group2,12-May-22,Local,Egypt,EGY,,Cairo,03-Jun-21,10-Jun-21,Blood donors,Adults (18-64 years),990,19.19%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Nermeen Eldesoukey,Cairo University,https://dx.doi.org/10.1002/hsr2.634,03/06/2022,16/07/2022,Unverified
220512_Egypt_CairoUniversity_Group3,12-May-22,Local,Egypt,EGY,,Cairo,20-Jul-21,30-Jul-21,Blood donors,Adults (18-64 years),1114,66.16%,,,Convenience,Abbott Laboratories,Not reported,"IgG,Neutralizing ",,,High,Journal Article (Peer-Reviewed),Nermeen Eldesoukey,Cairo University,https://dx.doi.org/10.1002/hsr2.634,03/06/2022,16/07/2022,Unverified
220512_Egypt_CairoUniversity_Group1,12-May-22,Local,Egypt,EGY,,Cairo,20-Mar-21,30-Mar-21,Blood donors,Adults (18-64 years),954,13.21%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Nermeen Eldesoukey,Cairo University,https://dx.doi.org/10.1002/hsr2.634,03/06/2022,16/07/2022,Unverified
220506_Asyut_AssiutUniversityHospitals,06-May-22,Local,Egypt,EGY,,Asyut,15-Apr-20,15-Jun-20,Health care workers and caregivers,Adults (18-64 years),199,24.60%,,,Convenience,"Artron Laboratories Inc.,Roche Diagnostics,Abbott Laboratories",Multiple Types,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Azza Eldin,Assiut University Hospitals,https://dx.doi.org/10.1155/2022/7833623,05/06/2022,16/07/2022,Unverified
220604_Egypt_AlexandriaUniversity_Primary,04-Jun-22,National,Egypt,EGY,"Giza, Alexandria, Menoufeya, Cairo, Kafr El-Sheikh",,15-Jan-21,15-Jun-21,Health care workers and caregivers,Multiple groups,559,59.00%,,,Stratified non-probability,EUROIMMUN,ELISA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Engy Mohamed El-Ghitany,Alexandria University,https://dx.doi.org/10.1186/s42506-022-00106-4,15/06/2022,16/07/2022,Unverified
200727_Atahualpa_UniversidadPeruanaCayetanoHeredia_RuralOver40_Overall,27-Jul-20,Local,Ecuador,ECU,El Oro,,01-May-20,25-May-20,Household and community samples,Multiple groups,673,45.00%,,,Convenience,Biohit Health Care Ltd,LFIA,"IgG,IgM",,,Moderate,Journal Article (Peer-Reviewed),Oscar Del Brutto,Universidad Peruana Cayetano Heredia,http://dx.doi.org/10.1093/cid/ciaa1055,02/10/2020,16/07/2022,Verified
200929_Atahualpa_UniversidadPeruanaCayetanoHeredia_overall,29-Sep-20,Local,Ecuador,ECU,,Atahualpa,25-Jun-20,30-Jun-20,Household and community samples,Adults (18-64 years),362,7.70%,,,Simplified probability,Biohit Health Care Ltd,LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Oscar H Del Brutto,Universidad Peruana Cayetano Heredia,https://www.tandfonline.com/doi/full/10.1080/20477724.2020.1826152,26/04/2021,16/07/2022,Verified
200923_Ecuador_UniversidadCatólicaDelEcuador_Patients,23-Sep-20,National,Ecuador,ECU,,Quito,12-May-20,20-Jul-20,Household and community samples,Multiple groups,11540,19.00%,,,Self-referral,NovaTec Immundiagnostics GmbH,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Camilo Zurita Salinas,Universidad Católica Del Ecuador,https://www.researchgate.net/publication/344477310_SEROPREVALENCE_OF_ANTI-SARS-COV-2_IGG_ANTIBODIES_IN_ECUADORIAN_POPULATION,02/05/2021,16/07/2022,Verified
210427_Cuenca_UniversityOfAntwerp_overall_UnAdj,27-Apr-21,Local,Ecuador,ECU,Azuay,,11-Aug-20,01-Nov-20,Household and community samples,Multiple groups,2457,13.20%,,,Stratified probability,SD Biosensor,LFIA,"IgG,IgM",87.90%,94.30%,Moderate,Journal Article (Peer-Reviewed),David Acurio Paez,University of Antwerp,https://www.mdpi.com/1660-4601/18/9/4657,21/05/2021,16/07/2022,Verified
210319_Ecuador_ InstitutoEcuatorianodeEnfermedadesDigestivas,19-Mar-21,Local,Ecuador,ECU,Guayas,Guayaquil,15-Apr-20,22-May-20,Residual sera,Adults (18-64 years),127,7.09%,,,Convenience,NA,Not reported,IgM,,,High,Journal Article (Peer-Reviewed),C Robles Medranda,Instituto Ecuatoriano de Enfermedades Digestivas,http://dx.doi.org/10.1055/s-0041-1724977,06/06/2021,16/07/2022,Verified
210929_Atahualpa_StonyBrookUniversity_April2021_primary,29-Sep-21,Local,Ecuador,ECU,,Atahualpa,01-Apr-21,30-Apr-21,Household and community samples,Multiple groups,277,63.20%,,,Unclear,Biohit Health Care Ltd,LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Oscar Del Brutto,Stony Brook University,https://dx.doi.org/10.1177/21501327211047781,06/10/2021,16/07/2022,Verified
211006_Babahoyo_WayneStateUniversity,06-Oct-21,Local,Ecuador,ECU,Los Ríos,Babahoyo,03-Sep-20,31-Jan-21,Pregnant or parturient women,Multiple groups,100,32.00%,,,Unclear,NA,ELISA,"IgG,IgM",,,Unclear,Journal Article (Peer-Reviewed),Hector Zambrano,Wayne State University,https://dx.doi.org/10.1016/j.placenta.2021.10.001,19/10/2021,16/07/2022,Unverified
211029_Ecuador_UniversidadEspirituSanto,29-Oct-21,Local,Ecuador,ECU,Santa Elena Province,Atahualpa,01-May-20,30-Apr-21,Household and community samples,Adults (18-64 years),673,63.70%,,,Convenience,Biohit Health Care Ltd,LFIA,"IgG,IgM",97.50%,100.00%,High,Journal Article (Peer-Reviewed),Oscar Del Brutto,Universidad Espíritu Santo,https://dx.doi.org/10.1177/21501327211054989,11/11/2021,16/07/2022,Verified
220122_Atahualpa_UniversidadEspirituSanto_Overall,22-Jan-22,Local,Ecuador,ECU,,,15-May-20,15-Apr-21,Household and community samples,Adults (18-64 years),519,63.00%,,,Convenience,Biohit Health Care Ltd,Not reported,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Oscar Del Brutto,Stony Brook University,https://dx.doi.org/10.1177/21501319211070685,31/01/2022,16/07/2022,Unverified
201202_DominicanRepublic_UniversidadIberoamericana_genpop_IgG,02-Dec-20,National,Dominican Republic,DOM,,,15-Apr-20,15-Jun-20,Household and community samples,Multiple groups,12897,5.50%,,,Simplified probability,GenBody Inc.,LFIA,IgG,56.70%,100.00%,High,Journal Article (Peer-Reviewed),Robert Paulino Ramirez,Universidad Iberoamericana,https://dx.doi.org/10.4269/ajtmh.20-0907,12/01/2021,16/07/2022,Verified
200625_Denmark_GeneralPopTestAdj,25-Jun-20,National,Denmark,DNK,,,06-Apr-20,03-May-20,Blood donors,Adults (18-64 years),20640,1.90%,0.80%,2.30%,Entire sample,Zhuhai Livzon Diagnostics Inc,LFIA,"IgG,IgM",82.58%,99.54%,Moderate,Journal Article (Peer-Reviewed),Christian Erikstrup,Copenhagen University Hospital,https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciaa849/5862661,26/06/2020,16/07/2022,Verified
200803_CapitalRegionDenmark_UniversityofCopenhagen_blooddonors_IgG_ANDOR_IgM,03-Aug-20,Regional,Denmark,DNK,Capital Region of Denmark,,15-Apr-20,22-Apr-20,Blood donors,Adults (18-64 years),4672,3.04%,2.58%,3.57%,Sequential,Zhuhai Livzon Diagnostics Inc,LFIA,"IgM,IgG",73.40%,99.90%,High,Journal Article (Peer-Reviewed),Kasper Iversen,University of Copenhagen,https://dx.doi.org/10.1016/S1473-3099(20)30589-2,01/10/2020,16/07/2022,Verified
201003_Denmark_AarhusUniversity_HCW_testadj,03-Oct-20,Regional,Denmark,DNK,Central Denmark Region,,18-May-20,19-Jun-20,Health care workers and caregivers,Adults (18-64 years),17948,3.36%,2.38%,3.82%,Convenience,Beijing Wantai Biological,ELISA,"IgG,IgM,IgA",96.70%,99.50%,Moderate,Journal Article (Peer-Reviewed),Senne Jespersen,Aarhus University Hospital,https://dx.doi.org/10.1093/cid/ciaa1471,19/12/2020,16/07/2022,Verified
201027_Copenhagen_CopenhagenUniversityHospitalHvidovre_ParturientWomen_TestAdj,27-Oct-20,Local,Denmark,DNK,Capital Region of Denmark,Copenhagen,04-Apr-20,03-Jul-20,Pregnant or parturient women,Adults (18-64 years),1313,2.60%,1.70%,4.00%,Sequential,Shenzhen Yhlo Biotech Co. Ltd,CLIA,"IgG,IgM",94.00%,99.30%,Moderate,Journal Article (Peer-Reviewed),Pia Egerup,Copenhagen University Hospital Hvidovre,https://dx.doi.org/10.1097/AOG.0000000000004199,09/01/2021,16/07/2022,Verified
201027_Copenhagen_CopenhagenUniversityHospitalHvidovre_PartnersofParturientWomen_TestAdj,27-Oct-20,Local,Denmark,DNK,Capital Region of Denmark,Copenhagen ,04-Apr-20,03-Jul-20,Hospital visitors,Adults (18-64 years),1188,3.50%,2.30%,5.10%,Sequential,Shenzhen Yhlo Biotech Co. Ltd,CLIA,"IgG,IgM",94.00%,99.30%,Moderate,Journal Article (Peer-Reviewed),Pia Egerup,Copenhagen University Hospital Hvidovre,https://dx.doi.org/10.1097/AOG.0000000000004199,09/01/2021,16/07/2022,Verified
201027_Copenhagen_CopenhagenUniversityHospitalHvidovre_Newborns,27-Oct-20,Local,Denmark,DNK,Capital Region of Denmark,Copenhagen ,04-Apr-20,03-Jul-20,Perinatal,Children and Youth (0-17 years),1206,1.40%,,,Sequential,Shenzhen Yhlo Biotech Co. Ltd,CLIA,"IgG,IgM",94.00%,99.30%,High,Journal Article (Peer-Reviewed),Pia Egerup,Copenhagen University Hospital Hvidovre,https://dx.doi.org/10.1097/AOG.0000000000004199,10/01/2021,16/07/2022,Verified
201026_Denmark_CopenhagenUniversityHospitalRigshospitalet_retired_adj,26-Oct-20,National,Denmark,DNK,,,02-Jun-20,19-Jun-20,Blood donors,Seniors (65+ years),1200,1.40%,0.30%,2.50%,Simplified probability,Beijing Wantai Biological,ELISA,Total Antibody,96.70%,99.50%,Moderate,Journal Article (Peer-Reviewed),Ole Birger Pedersen,Copenhagen University Hospital Rigshospitalet,https://dx.doi.org/10.1093/cid/ciaa1627,10/01/2021,16/07/2022,Verified
201026_Denmark_CopenhagenUniversityHospitalRigshospitalet_Active_adj,26-Oct-20,National,Denmark,DNK,,,01-Jun-20,26-Jun-20,Blood donors,Adults (18-64 years),1110,2.50%,1.30%,3.80%,Sequential,Beijing Wantai Biological,ELISA,Total Antibody,96.70%,99.50%,Moderate,Journal Article (Peer-Reviewed),Ole Birger Pedersen,Copenhagen University Hospital Rigshospitalet,https://dx.doi.org/10.1093/cid/ciaa1627,12/01/2021,16/07/2022,Verified
201227_Denmark_CopenhagenUniversityHospital_PregnancyLoss2_Overall,27-Dec-20,Local,Denmark,DNK,Copenhagen,Copenhagen,14-Apr-20,21-May-20,Pregnant or parturient women,Adults (18-64 years),36,0.00%,,,Self-referral,Shenzhen Yhlo Biotech Co. Ltd,CLIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed), ‪Nina Freiesleben,Copenhagen University Hospital,https://dx.doi.org/10.1093/humrep/deaa311,15/01/2021,16/07/2022,Verified
201027_Aarhus_AarhusDepartmentofPublicHealth_IgGorIgM,20-Nov-20,Local,Denmark,DNK,Central Denmark Region,Aarhus,01-Jun-20,04-Jun-20,Persons experiencing homelessness,Adults (18-64 years),129,4.70%,2.10%,9.80%,Convenience,NA,LFIA,"IgG,IgM",98.90%,97.60%,High,Journal Article (Peer-Reviewed),Signe Storgaard,Aarhus Department of Public Health ,"https://pubmed.ncbi.nlm.nih.gov/33269697/#:~:text=Conclusions%3A%20Despite%20their%20vulnerable%20profile,funded%20by%20Aarhus%20University%20Hospital.",23/01/2021,16/07/2022,Verified
201227_Denmark_CopenhagenUniversityHospital_Pregnant1_Overall,27-Dec-20,Local,Denmark,DNK,Copenhagen,Copenhagen,17-Feb-20,17-Apr-20,Pregnant or parturient women,Adults (18-64 years),1019,1.80%,,,Convenience,Shenzhen Yhlo Biotech Co. Ltd,CLIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed), ‪Nina Freiesleben,Copenhagen University Hospital,https://dx.doi.org/10.1093/humrep/deaa311,13/02/2021,16/07/2022,Verified
210121_Denmark_CopenhagenUniversityHospital_Denmark,21-Jan-21,National,Denmark,DNK,,,22-Jun-20,10-Aug-20,Health care workers and caregivers,Adults (18-64 years),2024,2.80%,,,Convenience,"Zhuhai Livzon Diagnostics Inc,Guangzhou Wondfo Biotech Co. Ltd",LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Jannie Laursen,Copenhagen University Hospital,https://dx.doi.org/10.3390/ijerph18030923,25/02/2021,16/07/2022,Verified
210212_Copenhagen_Herlev-GentofteHospital_Overall,12-Feb-21,Local,Denmark,DNK,Capital Region,Copenhagen,19-Oct-20,26-Oct-20,Health care workers and caregivers,Adults (18-64 years),1096,34.58%,31.82%,37.45%,Convenience,Beijing Wantai Biological,ELISA,"IgG,IgA,IgM",97.00%,99.50%,Moderate,Preprint,Johannes R Madsen,Herlev-Gentofte Hospital,https://www.medrxiv.org/content/10.1101/2021.02.09.21251421v1,18/03/2021,16/07/2022,Verified
210401_Denmark_SlagelseSygehus_blooddonors_primary,01-Apr-21,Regional,Denmark,DNK,Capital Region and Region Zealand,,22-Jun-20,03-Jul-20,Blood donors,Adults (18-64 years),750,2.00%,1.10%,3.30%,Simplified probability,Zhuhai Livzon Diagnostics Inc,LFIA,"IgG,IgM",93.00%,98.00%,Moderate,Journal Article (Peer-Reviewed),Maren J H Rytter,Slagelse Sygehus,http://dx.doi.org/10.1097/INF.0000000000003048,19/05/2021,16/07/2022,Verified
210401_Denmark_SlagelseSygehus_children_primary,01-Apr-21,Regional,Denmark,DNK,Capital Region and Region Zealand,,22-Jun-20,03-Jul-20,Residual sera,Children and Youth (0-17 years),1033,1.60%,1.00%,2.60%,Convenience,Zhuhai Livzon Diagnostics Inc,LFIA,"IgG,IgM",93.00%,98.00%,Moderate,Journal Article (Peer-Reviewed),Maren J H Rytter,Slagelse Sygehus,http://dx.doi.org/10.1097/INF.0000000000003048,19/05/2021,16/07/2022,Verified
210512_Denmark_CopenhagenUniversityHospital_ShelterWorkers2_Overall,12-May-21,National,Denmark,DNK,"Central, North, Capital, South"," Copenhagen, Aarhus, Aalborg and Odense",02-Nov-20,20-Nov-20,Essential non-healthcare workers,Adults (18-64 years),191,6.30%,,,Convenience,"CTK Biotech, Inc.",LFIA,"IgG,IgM",96.86%,99.39%,High,Preprint,Alexandra R Rothlin Eriksen,Copenhagen University Hospital,https://www.medrxiv.org/content/10.1101/2021.05.07.21256388v2,25/05/2021,16/07/2022,Verified
210512_Denmark_CopenhagenUniversityHospital_PEH1_Overall,12-May-21,National,Denmark,DNK,"Central, North, Capital, South"," Copenhagen, Aarhus, Aalborg and Odense",02-Nov-20,20-Nov-20,Persons experiencing homelessness,Adults (18-64 years),628,6.80%,,,Convenience,"CTK Biotech, Inc.",LFIA,"IgG,IgM",96.86%,99.39%,Moderate,Preprint,Alexandra R Rothlin Eriksen,Copenhagen University Hospital,https://www.medrxiv.org/content/10.1101/2021.05.07.21256388v2,25/05/2021,16/07/2022,Verified
210510_Denmark_CopenhagenUniversityHospital_SHOverall,10-May-21,National,Denmark,DNK,,"Copenhagen, Aarhus, Odense, Hoeje Taastrup, Helsingoer and Slagelse ",08-Jan-21,31-Jan-21,Household and community samples,Multiple groups,13279,17.30%,,,Stratified non-probability,"CTK Biotech, Inc.",LFIA,"IgG,IgM",90.00%,100.00%,Moderate,Preprint,Kamille Fogh,Copenhagen University Hospital,https://doi.org/10.1101/2021.05.07.21256725,30/05/2021,16/07/2022,Verified
210510_Denmark_CopenhagenUniversityHospital_BloodDonorsOverall,10-May-21,National,Denmark,DNK,,,08-Jan-21,31-Jan-21,Blood donors,Multiple groups,22677,5.80%,,,Entire sample,Beijing Wantai Biological,ELISA,Not reported,,,Moderate,Preprint,Kamille Fogh,Copenhagen University Hospital,https://doi.org/10.1101/2021.05.07.21256725,31/05/2021,16/07/2022,Verified
201212_Europe_UniversityOfGlasgow_Denmark4,12-Dec-20,National,Denmark,DNK,,Aarhus and Copenhagen,15-Apr-20,30-Jun-20,Health care workers and caregivers,Adults (18-64 years),34,2.94%,0.52%,14.91%,Convenience,Abbott Laboratories,CLIA,IgG,100.00%,99.60%,High,Journal Article (Peer-Reviewed),Scott M Nelson,University of Glasgow,https://dx.doi.org/10.1093/hropen/hoaa056,07/06/2021,16/07/2022,Verified
210531_Denmark_AarhusUniversity_CRDPatients1,31-May-21,National,Denmark,DNK,,,08-Jun-20,19-Jun-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,365,0.30%,,,Convenience,Beijing Wantai Biological,ELISA,Total Antibody,96.70%,99.50%,High,Journal Article (Peer-Reviewed),Christian Ammitzboll,Aarhus University,https://dx.doi.org/10.1002/acr.24716,07/06/2021,16/07/2022,Unverified
210531_Denmark_AarhusUniversity_BloodDonors2,31-May-21,National,Denmark,DNK,,,08-Jun-20,19-Jun-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,513,1.90%,,,Convenience,Beijing Wantai Biological,ELISA,Total Antibody,96.70%,99.50%,Moderate,Journal Article (Peer-Reviewed),Christian Ammitzboll,Aarhus University,https://dx.doi.org/10.1002/acr.24716,07/06/2021,16/07/2022,Unverified
210609_CentralDenmarkRegion_AarhusUniversity,09-Jun-21,Regional,Denmark,DNK,Central Denmark Region,,18-May-20,19-Jun-20,Health care workers and caregivers,Adults (18-64 years),11138,4.00%,,,Convenience,Beijing Wantai Biological,ELISA,"IgG,IgM,IgA",96.70%,99.50%,Moderate,Journal Article (Peer-Reviewed),Kathrine Agergard Kaspersen,Aarhus University,https://dx.doi.org/10.1016/j.ijid.2021.06.017,21/06/2021,16/07/2022,Unverified
210813_Denmark_CopenhagenUniversityHospital_Primary,13-Aug-21,National,Denmark,DNK,,,02-Oct-20,11-Oct-20,Household and community samples,Multiple groups,318552,0.79%,,,Simplified probability,Zhuhai Livzon Diagnostics Inc,LFIA,"IgG,IgM",93.30%,98.20%,Moderate,Preprint,Kamille Fogh,Copenhagen University Hospital,https://www.medrxiv.org/content/10.1101/2021.08.10.21261777v1,23/08/2021,16/07/2022,Verified
210822_Denmark_StatensSerumInstitut_May_testadj,22-Aug-21,National,Denmark,DNK,,,05-May-20,15-May-20,Household and community samples,Multiple groups,2512,1.50%,0.90%,2.10%,Simplified probability,Beijing Wantai Biological,ELISA,Total Antibody,96.70%,99.50%,Low,Journal Article (Peer-Reviewed),Laura Espenhain,Statens Serum Institut,https://dx.doi.org/10.1007/s10654-021-00796-8,31/08/2021,16/07/2022,Verified
210822_Denmark_StatensSerumInstitut_August_testadj,22-Aug-21,National,Denmark,DNK,,,15-Aug-20,30-Sep-20,Household and community samples,Multiple groups,11478,2.00%,1.70%,2.40%,Simplified probability,Beijing Wantai Biological,ELISA,Total Antibody,96.70%,99.50%,Moderate,Journal Article (Peer-Reviewed),Laura Espenhain,Statens Serum Institut,https://dx.doi.org/10.1007/s10654-021-00796-8,31/08/2021,16/07/2022,Verified
210822_Denmark_StatensSerumInstitut_October_testadj,22-Aug-21,National,Denmark,DNK,,,01-Oct-20,30-Nov-20,Household and community samples,Multiple groups,9654,2.40%,1.90%,2.80%,Simplified probability,Beijing Wantai Biological,ELISA,Total Antibody,96.70%,99.50%,Moderate,Journal Article (Peer-Reviewed),Laura Espenhain,Statens Serum Institut,https://dx.doi.org/10.1007/s10654-021-00796-8,31/08/2021,16/07/2022,Verified
210822_Denmark_StatensSerumInstitut_December_testadj,22-Aug-21,National,Denmark,DNK,,,01-Dec-20,31-Dec-20,Household and community samples,Multiple groups,4044,4.30%,3.40%,5.10%,Simplified probability,Beijing Wantai Biological,ELISA,Total Antibody,96.70%,99.50%,Moderate,Journal Article (Peer-Reviewed),Laura Espenhain,Statens Serum Institut,https://dx.doi.org/10.1007/s10654-021-00796-8,31/08/2021,16/07/2022,Verified
210914_Denmark_OdenseUniversityTestAdj,14-Sep-21,Regional,Denmark,DNK,Region of Southern Denmark,,01-May-20,30-Jun-20,Health care workers and caregivers,Adults (18-64 years),7950,1.40%,1.00%,1.80%,Convenience,Zhuhai Livzon Diagnostics Inc,LFIA,"IgG,IgM",78.00%,99.30%,High,Journal Article (Peer-Reviewed),Sebastian von Huth,Odense University,https://dx.doi.org/10.1016/j.ijid.2021.09.023,28/09/2021,16/07/2022,Unverified
210917_DenmarkCapitalRegion_UniversityofCopenhagen_Round3_Overall,17-Sep-21,Regional,Denmark,DNK,Capital Region of Denmark,,30-Sep-20,07-Oct-20,Health care workers and caregivers,Adults (18-64 years),27457,7.36%,,,Convenience,Beijing Wantai Biological,ELISA,Total Antibody,96.70%,99.50%,Moderate,Journal Article (Peer-Reviewed),Kasper Iversen,University of Copenhagen,http://dx.doi.org/10.1016/j.cmi.2021.09.005,20/10/2021,16/07/2022,Unverified
211112_Denmark_AarhusUniversity_2020Weeks41to44_TestAdjusted,12-Nov-21,National,Denmark,DNK,,,05-Oct-20,01-Nov-20,Blood donors,Adults (18-64 years),22690,2.08%,1.17%,2.47%,Entire sample,Beijing Wantai Biological,ELISA,Total Antibody,96.70%,99.50%,Moderate,Journal Article (Peer-Reviewed),Kathrine Kaspersen,Aarhus University,https://dx.doi.org/10.1093/infdis/jiab566,21/11/2021,16/07/2022,Verified
211112_Denmark_AarhusUniversity_2021Weeks5to8_Unadjusted,12-Nov-21,National,Denmark,DNK,,,01-Feb-21,28-Feb-21,Blood donors,Adults (18-64 years),20398,7.40%,,,Entire sample,Beijing Wantai Biological,ELISA,Total Antibody,96.70%,99.50%,Moderate,Journal Article (Peer-Reviewed),Kathrine Kaspersen,Aarhus University,https://dx.doi.org/10.1093/infdis/jiab566,21/11/2021,16/07/2022,Verified
220301_CapitalRegionofDenmark_UniversityofCopenhagen_SMIPatients_Overall_TestAdj,01-Mar-22,Regional,Denmark,DNK,Capital Region of Denmark,,18-Jan-21,19-Feb-21,Patients seeking care for non-COVID-19 reasons,Multiple groups,1258,4.96%,3.87%,,Sequential,Beijing Wantai Biological,ELISA,Total Antibody,94.50%,100.00%,Moderate,Journal Article (Peer-Reviewed),Marie Reeberg Sass,University of Copenhagen,https://dx.doi.org/10.1371/journal.pone.0264325,07/03/2022,16/07/2022,Unverified
220301_CapitalRegionofDenmark_UniversityofCopenhagen_BloodDonors_Overall_TestAdj,01-Mar-22,Regional,Denmark,DNK,Capital Region of Denmark,,18-Jan-21,19-Feb-21,Blood donors,Adults (18-64 years),6088,12.24%,11.41%,13.11%,Sequential,Beijing Wantai Biological,ELISA,Total Antibody,94.50%,100.00%,Moderate,Journal Article (Peer-Reviewed),Marie Reeberg Sass,University of Copenhagen,https://dx.doi.org/10.1371/journal.pone.0264325,07/03/2022,16/07/2022,Unverified
220407_Denmark_UniversityOfCopenhagen,07-Apr-22,National,Denmark,DNK,,,30-Mar-20,29-Jun-20,Health care workers and caregivers,Adults (18-64 years),379,5.30%,,,Sequential,NA,Multiple Types,"IgG,IgM,IgA",,,High,Journal Article (Peer-Reviewed),Caroline Klint Johannesen,University of Copenhagen,https://pubmed.ncbi.nlm.nih.gov/35485785/,10/05/2022,16/07/2022,Unverified
220627_Denmark_CopenhagenUniversityHospital_BloodDonors_Adj,27-Jun-22,National,Denmark,DNK,,,01-Nov-20,22-Nov-20,Blood donors,Multiple groups,18505,2.50%,2.26%,2.76%,Entire sample,Beijing Wantai Biological,ELISA,"IgG,IgM",96.70%,99.50%,Low,Journal Article (Peer-Reviewed),Alexandra Eriksen,Copenhagen University Hospital,https://dx.doi.org/10.1186/s12889-022-13642-7,12/07/2022,29/07/2022,Unverified
220627_Denmark_CopenhagenUniversityHospital_Overall,27-Jun-22,National,Denmark,DNK,,,02-Nov-20,20-Nov-20,Multiple populations,Multiple groups,819,6.70%,,,Convenience,"CTK Biotech, Inc.",LFIA,"IgG,IgM",96.86%,99.39%,Moderate,Journal Article (Peer-Reviewed),Alexandra Eriksen,Copenhagen University Hospital,https://dx.doi.org/10.1186/s12889-022-13642-7,12/07/2022,29/07/2022,Unverified
210216_Bukavu_UniversitéLibredeBruxelles_OverallELISA,16-Feb-21,Local,Democratic Republic of the Congo,COD,South-Kivu,Bukavu,02-Jul-20,19-Aug-20,Health care workers and caregivers,Adults (18-64 years),359,41.20%,,,Convenience,EUROIMMUN,ELISA,IgG,61.70%,98.60%,High,Journal Article (Peer-Reviewed),Denis Mukwege ,Université Libre de Bruxelles (ULB),https://dx.doi.org/10.4269/ajtmh.20-1526,14/03/2021,16/07/2022,Verified
210217_Kinhasa_InstitutNationaldeRechercheBiomedicale_EUROIMMUN,17-Feb-21,Local,Democratic Republic of the Congo,COD,Kinhasa,Kinhasa,17-Jul-20,13-Aug-20,Health care workers and caregivers,Adults (18-64 years),562,36.00%,,,Stratified probability,EUROIMMUN,ELISA,IgG,94.60%,99.80%,Moderate,Journal Article (Peer-Reviewed),Antoine Nkuba Ndaye,Institut National de Recherche Biomedicale,https://www.thelancet.com/journals/langlo/article/PIIS2214-109X(21)00060-7/fulltext,21/03/2021,16/07/2022,Verified
210127_Bukavu_CliniqueSaint-LucDeBukavu_Overall,27-Jan-21,Local,Democratic Republic of the Congo,COD,,Bukavu,15-May-20,30-Aug-20,Multiple populations,Multiple groups,684,40.79%,,,Self-referral,Cellex Inc.,LFIA,"IgG,IgM",93.80%,96.00%,High,Journal Article (Peer-Reviewed),Philippe Bianga Katchunga,Clinique Saint-Luc de Bukavu,https://www.panafrican-med-journal.com/content/article/38/93/full/,15/04/2021,16/07/2022,Verified
210605_Kinshasa_InstitutNationaldeRechercheBiomédicale_primary,05-Jun-21,Local,Democratic Republic of the Congo,COD,,Kinshasa,22-Oct-20,08-Nov-20,Household and community samples,Multiple groups,1080,16.60%,14.00%,19.50%,Stratified probability,NA,CLIA,IgG,100.00%,99.70%,Low,Journal Article (Peer-Reviewed),Antoine Nkuba,Institut National de Recherche Biomédicale,https://dx.doi.org/10.1093/cid/ciab515,17/06/2021,16/07/2022,Verified
200714_CzechRepublic_ResearchCenterIBD_HCW,14-Jul-20,Local,Czechia,CZE,Central Bohemian,Prague,,15-Apr-20,Health care workers and caregivers,Adults (18-64 years),92,2.17%,,,Convenience,EUROIMMUN,ELISA,IgG,,,Unclear,Journal Article (Peer-Reviewed), Karin Malickova,Clinical and Research Center for Inflammatory Bowel Disease,https://dx.doi.org/10.1080/00365521.2020.1791244,02/08/2020,16/07/2022,Verified
201112_Prague_CharlesUniversityandThomayer'sHospital_Roche,12-Nov-20,Local,Czechia,CZE,Prague,Prague,03-Jul-20,19-Aug-20,Residual sera,Children and Youth (0-17 years),200,0.00%,0.00%,0.50%,Sequential,Roche Diagnostics,CLIA,Total Antibody,99.50%,99.80%,High,Journal Article (Peer-Reviewed),Marketa Bloomfield,Charles University and Thomayer’s Hospital,http://dx.doi.org/10.3389/fped.2020.597736,23/01/2021,16/07/2022,Verified
200506_CzechRepublic_MinistryofHealthoftheCzechRepublic_Brno/South Moravian Region,06-May-20,Regional,Czechia,CZE,Brno / South Moravian,,23-Apr-20,01-May-20,Household and community samples,Multiple groups,5049,0.08%,0.01%,0.15%,Stratified non-probability,Fortress Diagnostics,LFIA,Not reported,95.00%,100.00%,Moderate,Presentation or Conference,Ladislav Dušek,Ministry o fHealth of the Czech Republic,https://covid-imunita.uzis.cz/res/file/prezentace/20200506-dusek.pdf,08/06/2021,16/07/2022,Unverified
200506_CzechRepublic_MinistryofHealthoftheCzechRepublic_Prague,06-May-20,Local,Czechia,CZE,,Prague,23-Apr-20,01-May-20,Household and community samples,Multiple groups,5021,0.17%,0.05%,0.28%,Stratified non-probability,Fortress Diagnostics,LFIA,Not reported,95.00%,100.00%,Moderate,Presentation or Conference,Ladislav Dušek,Ministry o fHealth of the Czech Republic,https://covid-imunita.uzis.cz/res/file/prezentace/20200506-dusek.pdf,08/06/2021,16/07/2022,Unverified
200506_CzechRepublic_MinistryofHealthoftheCzechRepublic_Litomerice,06-May-20,Local,Czechia,CZE,,Litomerice,23-Apr-20,01-May-20,Household and community samples,Multiple groups,3106,0.24%,0.07%,0.42%,Stratified non-probability,Fortress Diagnostics,LFIA,Not reported,95.00%,100.00%,Moderate,Presentation or Conference,Ladislav Dušek,Ministry o fHealth of the Czech Republic,https://covid-imunita.uzis.cz/res/file/prezentace/20200506-dusek.pdf,08/06/2021,16/07/2022,Unverified
200506_CzechRepublic_MinistryofHealthoftheCzechRepublic_Litovel_Unicov,06-May-20,Local,Czechia,CZE,,"Litovel, Unicov",23-Apr-20,01-May-20,Household and community samples,Multiple groups,2409,1.79%,1.24%,2.34%,Stratified non-probability,Fortress Diagnostics,LFIA,Not reported,95.00%,100.00%,Moderate,Presentation or Conference,Ladislav Dušek,Ministry o fHealth of the Czech Republic,https://covid-imunita.uzis.cz/res/file/prezentace/20200506-dusek.pdf,08/06/2021,16/07/2022,Unverified
200506_CzechRepublic_MinistryofHealthoftheCzechRepublic_Olomouc/Olomouckykraj,06-May-20,Regional,Czechia,CZE,Olomouc / Olomouc ,,23-Apr-20,01-May-20,Household and community samples,Multiple groups,6686,0.69%,0.48%,0.91%,Stratified non-probability,Fortress Diagnostics,LFIA,Not reported,95.00%,100.00%,Moderate,Presentation or Conference,Ladislav Dušek,Ministry o fHealth of the Czech Republic,https://covid-imunita.uzis.cz/res/file/prezentace/20200506-dusek.pdf,08/06/2021,16/07/2022,Unverified
210701_Prague_InstituteForClinicalAndExperimentalMedicine_Patients,01-Jul-21,Local,Czechia,CZE,,Prague,01-Oct-20,30-Nov-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,1002,6.80%,,,Convenience,DiaSorin,CLIA,IgG,91.20%,90.20%,High,Journal Article (Peer-Reviewed),Maria Magicova,Institute for Clinical and Experimental Medicine,https://dx.doi.org/10.1111/ajt.16746,12/07/2021,16/07/2022,Unverified
210701_Prague_InstituteForClinicalAndExperimentalMedicine_HCWs,01-Jul-21,Local,Czechia,CZE,,Prague,01-Oct-20,30-Nov-20,Health care workers and caregivers,Adults (18-64 years),512,11.90%,,,Convenience,DiaSorin,CLIA,IgG,91.20%,90.20%,High,Journal Article (Peer-Reviewed),Maria Magicova,Institute for Clinical and Experimental Medicine,https://dx.doi.org/10.1111/ajt.16746,12/07/2021,16/07/2022,Unverified
210815_ Czechia_GENNETImmunologyLaboratory_Primary,15-Aug-21,Local,Czechia,CZE,,Prague,28-Mar-20,28-Mar-21,Health care workers and caregivers,Adults (18-64 years),182,35.70%,,,Convenience,"EUROIMMUN,Abbott Laboratories",Multiple Types,IgG,,,High,Journal Article (Peer-Reviewed),Zuzana Kratka,GENNET Immunology Laboratory,https://www.prolekare.cz/casopisy/casopis-lekaru-ceskych/2021-4-5/download?hl=cs,30/08/2021,16/07/2022,Unverified
210728_HavlickuvBrod_CharlesUniversity_Overall,28-Jul-21,Local,Czechia,CZE,Vysočina,Havlíčkův Brod,08-Jun-21,21-Jun-21,Students and Daycares,Children and Youth (0-17 years),196,45.90%,38.80%,53.20%,Convenience,Abbott Laboratories,CLIA,IgG,98.10%,99.60%,High,Journal Article (Peer-Reviewed),Vaclav Fejt,Charles University (Univerzity Karlovy),https://www.prolekare.cz/en/journals/journal-of-czech-physicians/2021-4-5/what-is-the-immunity-of-high-school-students-to-coronavirus-127893,31/08/2021,16/07/2022,Unverified
220301_CzechRepublic_MasarykUniversity_1Oct2020Nov2020_OverallAdjusted,01-Mar-22,National,Czechia,CZE,,,01-Oct-20,30-Nov-20,Household and community samples,Multiple groups,3626,27.90%,26.10%,29.70%,Convenience,"DiaSorin,Abbott Laboratories",CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Pavel Piler,Masaryk University,https://doi.org/10.1038/s43856-022-00080-0,16/03/2022,16/07/2022,Verified
220301_CzechRepublic_MasarykUniversity_2Dec2020Jan2021_OverallAdjusted,01-Mar-22,National,Czechia,CZE,,,01-Dec-20,31-Jan-21,Household and community samples,Multiple groups,6880,42.20%,40.80%,43.50%,Convenience,"DiaSorin,Abbott Laboratories",CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Pavel Piler,Masaryk University,https://doi.org/10.1038/s43856-022-00080-0,16/03/2022,16/07/2022,Verified
220105_Prague_ThomayerUniversityHospital_IgG,05-Jan-22,Local,Czechia,CZE,,Prague,30-Jun-20,07-Sep-20,Health care workers and caregivers,Multiple groups,808,1.86%,,,Convenience,"Roche Diagnostics,EUROIMMUN",Multiple Types,"Total Antibody,IgG",,,High,Journal Article (Peer-Reviewed),Marketa Ibrahimova,Thomayer University Hospital,https://www.prolekare.cz/en/journals/epidemiology-microbiology-immunology/2022-1-21/prevalence-of-sars-cov-2-antibodies-in-the-thomayer-university-hospital-staff-after-the-first-wave-of-covid-19-130625,04/05/2022,16/07/2022,Unverified
220722_CzechRepublic_MasarykUniversity_Overall,22-Jul-22,National,Czechia,CZE,,,15-Apr-21,15-Sep-21,Household and community samples,Multiple groups,22130,87.40%,,,Convenience,"DiaSorin,Abbott Laboratories",Multiple Types,IgG,,,Moderate,Preprint,Vojtěch Thon,Masaryk University,10.1101/2022.07.21.22277881,03/08/2022,03/08/2022,Unverified
211231_Cyprus_CyprusSchoolofMolecularMedicine_AntiS1RBD_TestAdjusted,31-Dec-21,National,Cyprus,CYP,,,15-Oct-20,15-May-21,Household and community samples,Multiple groups,194,6.61%,,,Convenience,ImmunoDiagnostics,ELISA,IgG,92.50%,93.30%,High,Journal Article (Peer-Reviewed),George Krashias,Cyprus School of Molecular Medicine,https://www.mdpi.com/2076-2607/10/1/85,07/02/2022,16/07/2022,Unverified
220101_NorthernCyprus_NearEastUniversity,01-Jan-22,Local,Cyprus,CYP,Northern Cyprus,North Nicosia,15-Sep-20,15-Jan-21,Residual sera,Children and Youth (0-17 years),80,1.25%,,,Convenience,Diagnostic Bioprobes,ELISA,IgG,92.20%,84.00%,High,Journal Article (Peer-Reviewed),Umut Gazi,Near East University,https://dx.doi.org/10.24953/turkjped.2021.1330,25/03/2022,16/07/2022,Unverified
200802_AguadadePasajeros_UniversityofMedicalSciencesofCienfuegos,23-Aug-20,Local,Cuba,CUB,Cienfuegos,Aguada de Pasajeros,23-Mar-20,06-Apr-20,Contacts of COVID patients,Multiple groups,200,0.00%,,,Convenience,NA,Not reported,"IgM,IgG",,,Unclear,Journal Article (Peer-Reviewed),Alain Morejon Giraldoni,University of Medical Sciences of Cienfuegos,http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1727-897X2020000400721,07/01/2021,16/07/2022,Verified
200515_Croatia_UniversityofSplit_IndustryWorkers_Overall,15-May-20,Local,Croatia,HRV,,,23-Apr-20,28-Apr-20,Essential non-healthcare workers,Multiple groups,1494,1.27%,0.77%,1.98%,Convenience,AMEDA Labordiagnostik GmbH,LFIA,"IgM,IgG",91.80%,96.40%,High,Journal Article (Peer-Reviewed),Ivan Jerkovic,University of Split,https://journals.lww.com/joem/Abstract/9000/SARS_CoV_2_Antibody_Seroprevalence_in_Industry.98091.aspx,17/07/2020,16/07/2022,Verified
200826_Croatia_UniversityofZagreb_HCWsIgG,26-Aug-20,National,Croatia,HRV,,,25-Apr-20,24-May-20,Health care workers and caregivers,Adults (18-64 years),592,2.70%,,,Convenience,Vircell S.L.,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Tatjana Vilibic Cavlek,University of Zagreb,https://dx.doi.org/10.1590/0037-8682-0458-2020,17/10/2020,16/07/2022,Verified
201231_Zagreb_ZagrebUniversity_overall,31-Dec-20,Local,Croatia,HRV,,Zagreb,01-May-20,31-May-20,Health care workers and caregivers,Adults (18-64 years),1678,0.60%,,,Convenience,Abbott Laboratories,CLIA,IgG,100.00%,99.60%,Moderate,Journal Article (Peer-Reviewed),Ivana Lapic,Zagreb University,https://pubmed.ncbi.nlm.nih.gov/33410294/,01/02/2021,16/07/2022,Verified
201104_Croatia_CroatianFootballFederation_FootballPlayers&ClubStaff,04-Nov-20,Local,Croatia,HRV,,,29-May-20,31-Jul-20,Non-essential workers and unemployed persons,Adults (18-64 years),305,20.00%,,,Convenience,EUROIMMUN,ELISA,"IgA,IgG",,,Moderate,Preprint,Adriana Vince,Croatian Football Federation,https://www.medrxiv.org/content/10.1101/2020.10.30.20223230v1,06/02/2021,16/07/2022,Verified
210415_Croatia_ChildrensHospitalZagreb_timepoint1_primary,15-Apr-21,Local,Croatia,HRV,,Zagreb,13-May-20,29-May-20,Residual sera,Children and Youth (0-17 years),240,2.90%,,,Convenience,"Vircell S.L.,NA",Multiple Types,"IgA,IgM,IgG,Neutralizing ",,,High,Journal Article (Peer-Reviewed),Jasna Lenicek Krleza,Children's Hospital Zagreb,https://dx.doi.org/10.11613/BM.2021.020706,20/05/2021,16/07/2022,Verified
210415_Croatia_ChildrensHospitalZagreb_timepoint2_primary,15-Apr-21,Local,Croatia,HRV,,Zagreb,24-Oct-20,23-Nov-20,Residual sera,Children and Youth (0-17 years),308,8.40%,,,Convenience,"NA,Roche Diagnostics",Multiple Types,"IgG,IgM,Neutralizing ",,,High,Journal Article (Peer-Reviewed),Jasna Lenicek Krleza,Children's Hospital Zagreb,https://dx.doi.org/10.11613/BM.2021.020706,20/05/2021,16/07/2022,Verified
210620_Croatia_CroatianInstituteOfPublicHealth_FirstWave_Overall,20-Jun-21,National,Croatia,HRV,,,15-May-20,15-Jul-20,Multiple general populations,Multiple groups,1088,2.20%,1.40%,3.30%,Convenience,"Vircell S.L.,NA",Multiple Types,"IgG,Neutralizing ",,,High,Journal Article (Peer-Reviewed),Tatjana Vilibic-Cavlek,Croatian Institute of Public Health,https://dx.doi.org/10.3390/pathogens10060774,13/07/2021,16/07/2022,Verified
210620_Croatia_CroatianInstituteOfPublicHealth_SecondWave_Overall,20-Jun-21,National,Croatia,HRV,,,15-Dec-20,15-Feb-21,Multiple general populations,Multiple groups,1436,25.10%,22.80%,27.40%,Convenience,"Vircell S.L.,NA",Multiple Types,"IgG,Neutralizing ",,,High,Journal Article (Peer-Reviewed),Tatjana Vilibic-Cavlek,Croatian Institute of Public Health,https://dx.doi.org/10.3390/pathogens10060774,13/07/2021,16/07/2022,Verified
210602_Croatia_UniversityofZagreb,02-Jun-21,Local,Croatia,HRV,,,07-Sep-20,27-Nov-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,512,20.10%,16.40%,26.30%,Entire sample,Vircell S.L.,ELISA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Anna Mrzljak,University of Zagreb,https://dx.doi.org/10.11613/BM.2021.030901,24/10/2021,16/07/2022,Unverified
210318_IvoryCoast_CentreHospitalierRegionald’Orleans_Overall,18-Mar-21,National,Côte d'Ivoire,CIV,,,15-Jul-20,13-Oct-20,Essential non-healthcare workers,Adults (18-64 years),1687,25.10%,,,Convenience,AAZ LMB,LFIA,"IgG,IgM",100.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Jean Milleliri,Centre Hospitalier Regional d’Orleans,https://dx.doi.org/10.4269/ajtmh.21-0081,15/04/2021,16/07/2022,Unverified
201222_Brazzaville_FondationCongolaisePourLaRechercheMédicale_GenPop_Overall,22-Dec-20,Local,Congo,COG,,Brazzaville,01-Apr-20,31-Jul-20,Household and community samples,Adults (18-64 years),754,19.70%,,,Self-referral,"Wuhan UNscience Biotechnology Co. Ltd,Salofa Oy manufacturer, Finland",LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed), Armel Batchi Bouyou,Fondation Congolaise pour la Recherche Médicale,https://dx.doi.org/10.1016/j.ijid.2020.12.065,30/01/2021,16/07/2022,Verified
220218_Congo_LaboratoireNationaldeSantéPublique_Overall,18-Feb-22,National,Congo,COG,,"Brazzaville, Pointe-Noire",15-Sep-19,15-Feb-20,Representative patient population,Multiple groups,937,2.99%,,,Convenience,NA,IFA,IgG,100.00%,97.50%,High,Journal Article (Peer-Reviewed),Novy Bonguili,Laboratoire National de Santé Publique,https://wwwnc.cdc.gov/eid/article/28/4/21-2476_article,03/03/2022,16/07/2022,Verified
220315_Bomassa_FCRM_IgGIgM,15-Mar-22,Local,Congo,COG,,"Bomassa
",20-May-21,02-Jun-21,Household and community samples,Adults (18-64 years),304,36.00%,,,Simplified probability,VIROTECH,ELISA,"IgG,IgM",,,Moderate,Journal Article (Peer-Reviewed),LineLobaloba Ingoba,Fondation Congolaise pour la Recherche Médicale,https://www.sciencedirect.com/science/article/pii/S2772707622000066?via%3Dihub,27/04/2022,16/07/2022,Unverified
200918_Bogota_PontificiaUniversidadJaveriana_HCW_FinalEndpoint_UnAdj,03-Jan-21,Local,Colombia,COL,Capital District Cundinamarca,Bogotá,25-Jun-20,10-Aug-20,Health care workers and caregivers,Adults (18-64 years),351,8.26%,5.81%,11.61%,Self-referral,Abbott Laboratories,CLIA,IgG,100.00%,100.00%,High,Journal Article (Peer-Reviewed),Beatriz Ariza,Pontificia Universidad Javeriana,http://www.revistainfectio.org/index.php/infectio/article/view/938,06/10/2020,16/07/2022,Verified
201030_Colombia_UniversidadIndustrialdeSantander_primary,30-Oct-20,National,Colombia,COL,,,17-Apr-20,14-Jul-20,Essential non-healthcare workers,Multiple groups,4234,4.00%,,,Unclear,NA,LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Alvaro J Idrovo,Universidad Industrial de Santander,https://dx.doi.org/10.7705/biomedica.5829,23/01/2021,16/07/2022,Verified
201112_Monteria_UniversidaddeCórdoba_GenPopAdj,12-Nov-20,Local,Colombia,COL,Caribbean Region,Monteria,04-Aug-20,01-Sep-20,Household and community samples,Multiple groups,1368,55.30%,52.50%,57.80%,Stratified probability,Eurofins Ingenasa,ELISA,"IgG,IgM,IgA",92.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Salim Mattar,Universidad de Córdoba,https://dx.doi.org/10.1093/ofid/ofaa550,05/02/2021,16/07/2022,Verified
210122_Bogota_InstitutoNacionaldeSalud_OverallTestAdj,22-Jan-21,Local,Colombia,COL,Capital District Cundinamarca,Bogota,01-Jun-20,30-Sep-20,Essential non-healthcare workers,Adults (18-64 years),212,16.03%,10.43%,21.62%,Convenience,Abbott Laboratories,CLIA,Total Antibody,85.50%,97.30%,High,Journal Article (Peer-Reviewed),Jeadran Malagon Rojas,Instituto Nacional de Salud,https://academic.oup.com/jtm/advance-article/doi/10.1093/jtm/taab006/6106252?searchresult=1,13/03/2021,16/07/2022,Verified
210317_UniversidadDeLosAndes_UniversidadDeLosAndes_overall,17-Mar-21,Local,Colombia,COL,Capital District Cundinamarca,Bogotá,23-Nov-20,06-Dec-20,Essential non-healthcare workers,Adults (18-64 years),237,13.50%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Preprint,John M Gonzalez,Universidad de Los Andes,https://www.medrxiv.org/content/10.1101/2021.03.15.21253609v1,29/03/2021,16/07/2022,Verified
210425_Bucaramanga_FundaciónCardiovascularDeColombia_overall_popadj_testadj,15-Apr-21,Local,Colombia,COL,,Bucaramanga,28-Sep-20,24-Dec-20,Essential non-healthcare workers,Adults (18-64 years),7045,19.50%,18.60%,20.40%,Stratified probability,Abbott Laboratories,Multiple Types,"IgG,IgM",85.20%,97.30%,Moderate,Journal Article (Peer-Reviewed),Claudia Colmenares-Mejia ,Fundación Cardiovascular de Colombia,http://dx.doi.org/10.3390/ijerph18084172,22/05/2021,16/07/2022,Verified
210611_Cordoba_UniversidadNacionaldeColombia_Primary,11-Jun-21,Regional,Colombia,COL,Cordoba,,15-Mar-20,02-Oct-20,Household and community samples,Multiple groups,2447,40.80%,,,Stratified probability,Eurofins Ingenasa,ELISA,"IgG,IgM,IgA",93.00%,95.00%,Moderate,Journal Article (Peer-Reviewed),Nelson Alvis Guzma,Universidad de Cordoba,https://dx.doi.org/10.1016/j.ijid.2021.06.018,21/06/2021,16/07/2022,Verified
210629_Cordoba_ColombiaUniversidadDeCordoba_Overall,29-Jun-21,Regional,Colombia,COL,Cordoba Department,,15-Jul-20,15-Nov-20,Household and community samples,Multiple groups,2564,40.80%,,,Stratified non-probability,Eurofins Ingenasa,ELISA,"IgA,IgG,IgM",,,Moderate,Journal Article (Peer-Reviewed),Evelin Garay,Colombia-Universidad de Cordoba,https://dx.doi.org/10.1093/trstmh/trab094,07/07/2021,16/07/2022,Verified
211001_Colombia_MedicalMissionInstitute_Overall,01-Oct-21,Regional,Colombia,COL,"Department of Cesar, Department of La Guajira","San Juan, Sabana de Higuieron, Piñoncito, Ahuyamal, Surimena, Tezhumake, Valledupar, La Junta, Atanquez, Los Corazones, Patillal, Siminke and Vereda Platanal.",28-Mar-21,26-Apr-21,Household and community samples,Multiple groups,452,27.70%,,,Convenience,PharmACT,LFIA,IgG,,100.00%,High,Journal Article (Peer-Reviewed),Gustavo Concha,Medical Mission Institute,http://dx.doi.org/10.3390/vaccines9101120,13/10/2021,16/07/2022,Verified
211027_Amazon_UniversidaddeCórdoba_Primary,27-Oct-21,Local,Colombia,COL,Columbian Amazon,Mitú,01-Dec-20,31-Dec-20,Household and community samples,Multiple groups,589,57.60%,,,Convenience,Eurofins Ingenasa,ELISA,Total Antibody,90.10%,99.20%,Moderate,Journal Article (Peer-Reviewed),Hector Serrano-Coll,Universidad de Córdoba,http://dx.doi.org/10.3390/tropicalmed6040191,09/11/2021,16/07/2022,Verified
211105_Colombia_InstitutoNacionaldeSalud_TestAdj,05-Nov-21,National,Colombia,COL,,"Bogotá, Barranquilla, Bucaramanga, Cali, Cúcuta, Medellín, Villavicencio, Leticia, Ipiales, Guapi",15-Sep-20,15-Nov-20,Health care workers and caregivers,Adults (18-64 years),3296,35.00%,33.00%,37.00%,Convenience,Siemens,CLIA,Total Antibody,86.00%,99.00%,Moderate,Journal Article (Peer-Reviewed),Jeadran Nevardo Malagon-Rojas,Instituto Nacional de Salud,https://dx.doi.org/10.1136/oemed-2021-107487,17/11/2021,16/07/2022,Unverified
20220223_Colombia_InstitutoNacionaldeSalud_Analysis,22-Feb-22,National,Colombia,COL,,"Bogota, Medellin, Cali, Barranquilla, Cucuta,
Bucaramanga and Villavicencio Leticia, Ipiales and Guapi",21-Sep-20,11-Dec-20,Household and community samples,Multiple groups,17863,32.53%,32.00%,33.00%,Stratified probability,Siemens,CLIA,"IgG,IgM",86.00%,99.00%,Moderate,Journal Article (Peer-Reviewed),Marcela Mercado-Reye,Instituto Nacional de Salud,https://dx.doi.org/10.1016/j.lana.2022.100195,23/02/2022,16/07/2022,Verified
220323_Colombia_FundacionSantaFedeBogota_Overall,23-Mar-22,Local,Colombia,COL,Bogotá,Bogotá,25-Jun-20,30-Oct-20,Health care workers and caregivers,Adults (18-64 years),420,23.10%,,,Convenience,"Qingdao Hightop Biotech Co. Ltd ,Dynamiker Biotechnology (Tianjin) Co. Ltd",Not reported,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Nohemí Caballero,Fundación Santa Fe de Bogotá,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8942465/,29/06/2022,16/07/2022,Unverified
200602_Wuhan_HuazhongUniversityofScienceandTechnology_HealthCareWorkers,02-Jun-20,Local,China,CHN,Hubei,Wuhan,12-Feb-20,17-Mar-20,Health care workers and caregivers,Adults (18-64 years),797,4.39%,,,Convenience,NA,ELISA,IgG,,,Unclear,Preprint,Shue Xiong,Huazhong University of Science and Technology,https://www.medrxiv.org/content/10.1101/2020.05.28.20110767v1.full.pdf,04/06/2020,16/07/2022,Verified
200605_China_NationalClinicalResearchCentre_CommunitySetting,05-Jun-20,National,China,CHN,"Hubei, Sichuan, Guangdong","Wuhan, Guangzhou, Chengdu",09-Mar-20,10-Apr-20,Multiple populations,Adults (18-64 years),10449,0.80%,,,Self-referral,Bioscience Diagnostics,CLIA,"IgG,IgM",,99.30%,High,Journal Article (Peer-Reviewed),Xin Xu,National Clinical Research Centre for Kidney Disease,https://www.nature.com/articles/s41591-020-0949-6,06/06/2020,16/07/2022,Verified
200602_Wuhan_SunYat-senUniversity_HCW_IgG,10-Jun-20,Local,China,CHN,Hubei,Wuhan,07-Feb-20,21-Apr-20,Health care workers and caregivers,Adults (18-64 years),420,0.00%,,,Convenience,Shenzhen Yhlo Biotech Co. Ltd,CLIA,IgG,97.80%,97.90%,High,Journal Article (Peer-Reviewed),Min Liu,Sun Yat-sen University,https://www.bmj.com/content/369/bmj.m2195,12/06/2020,16/07/2022,Verified
200616_Wuhan_ZhongnanHospitalofWuhanUniversity_HealthCareWorkers_IgG,02-Nov-20,Local,China,CHN,Hubei,Wuhan,29-Feb-20,29-Apr-20,Health care workers and caregivers,Multiple groups,3832,4.00%,3.40%,4.70%,Convenience,Shenzhen Yhlo Biotech Co. Ltd,CLIA,IgG,97.80%,97.90%,Moderate,Preprint,Tao Liu,Zhongnan Hospital of Wuhan University,https://www.researchsquare.com/article/rs-99748/v1,18/06/2020,16/07/2022,Verified
200616_Wuhan_ZhongnanHospitalofWuhanUniversity_GenPopWorkers_IgG,02-Nov-20,Local,China,CHN,Hubei,Wuhan,29-Feb-20,29-Apr-20,Household and community samples,Multiple groups,19555,4.60%,4.30%,4.90%,Convenience,Shenzhen Yhlo Biotech Co. Ltd,CLIA,IgG,97.80%,97.90%,Moderate,Preprint,Tao Liu,Zhongnan Hospital of Wuhan University,https://www.researchsquare.com/article/rs-99748/v1,18/06/2020,16/07/2022,Verified
200616_Wuhan_ZhongnanHospitalofWuhanUniversity_NonCOVIDPatients_IgG,02-Nov-20,Local,China,CHN,Hubei,Wuhan,29-Feb-20,29-Apr-20,Residual sera,Multiple groups,1616,1.00%,0.50%,1.50%,Sequential,Shenzhen Yhlo Biotech Co. Ltd,CLIA,IgG,97.80%,97.90%,Moderate,Preprint,Tao Liu,Zhongnan Hospital of Wuhan University,https://www.researchsquare.com/article/rs-99748/v1,18/06/2020,16/07/2022,Verified
200603_WuhantoUSAtravel_CDC_PassengersGenPop,03-Jul-20,Local,China,CHN,Hubei,Wuhan,28-Jan-20,28-Jan-20,Household and community samples,Multiple groups,186,0.54%,,,Convenience,SeraCare Life Sciences,ELISA,"IgG,IgA,IgM",,,High,Journal Article (Peer-Reviewed),Benjamin Hallowell,US Centers for Disease Control and Prevention,https://wwwnc.cdc.gov/eid/article/26/9/20-1590_article,07/07/2020,16/07/2022,Verified
200604_Nanjing_NanjingUniversityMedicalSchool_HCWs/ContactsofCOVID-19patients,04-Jun-20,Local,China,CHN,Jiangsu,Nanjing,19-Feb-20,19-Feb-20,Health care workers and caregivers,Adults (18-64 years),105,17.14%,,,Convenience,NA,ELISA,"IgG,IgM",93.30%,100.00%,High,Journal Article (Peer-Reviewed),Yuxin Chen,Nanjing University Medical School,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7270786/pdf/main.pdf,17/07/2020,16/07/2022,Verified
200420_Wuhan_CR&WISCOGeneralHospital_HospitalizedPatients,20-Apr-20,Local,China,CHN,Hubei,Wuhan,03-Apr-20,15-Apr-20,Residual sera,Multiple groups,381,10.49%,,,Unclear,Innovita Biological Technology Co. Ltd,LFIA,"IgG,IgM",87.30%,100.00%,High,Journal Article (Peer-Reviewed),Xiaodong Wu,Wuhan University,https://onlinelibrary.wiley.com/doi/full/10.1002/jmv.25904,19/07/2020,16/07/2022,Verified
200420_Wuhan_CR&WISCOGeneralHospital_PeopleSeekingReturntoWork,20-Apr-20,Local,China,CHN,Hubei,Wuhan,03-Apr-20,15-Apr-20,Essential non-healthcare workers,Adults (18-64 years),1021,9.60%,,,Unclear,Innovita Biological Technology Co. Ltd,LFIA,"IgG,IgM",87.30%,100.00%,High,Journal Article (Peer-Reviewed),Xiaodong Wu,Wuhan University,https://onlinelibrary.wiley.com/doi/full/10.1002/jmv.25904,19/07/2020,16/07/2022,Verified
200605_China_NationalClinicalResearchCentre_HospitalSetting,05-Jun-20,National,China,CHN,"Hubei, Sichuan, Guangdong","Wuhan, Guangzhou, Jinzhou, Honghu, Chongqing, Chengdu, Foshan",09-Mar-20,10-Apr-20,Multiple populations,Adults (18-64 years),6919,2.46%,,,Self-referral,Bioscience Diagnostics,CLIA,"IgG,IgM",,99.30%,High,Journal Article (Peer-Reviewed),Xin Xu,National Clinical Research Centre for Kidney Disease,https://www.nature.com/articles/s41591-020-0949-6,25/07/2020,16/07/2022,Verified
200720_Guangzhou_GuangzhouMedicalUniversity_OverallIgG/IgM,20-Jul-20,Local,China,CHN,Guangdong,Guangzhou,20-Jan-20,30-Apr-20,Multiple populations,Multiple groups,8782,0.59%,,,Convenience,Shenzhen Yhlo Biotech Co. Ltd,CLIA,"IgG,IgM",,100.00%,High,Journal Article (Peer-Reviewed),Wenhua Liang,The First Affiliated Hospital of Guangzhou Medical University,https://dx.doi.org/10.1038/s41422-020-0371-0,01/08/2020,16/07/2022,Verified
200720_Wuhan_GuangzhouMedicalUniversity_OverallIgG/IgM,20-Jul-20,Local,China,CHN,Hubei,Wuhan,19-Jan-20,30-Apr-20,Multiple populations,Multiple groups,8272,2.14%,,,Convenience,Innovita Biological Technology Co. Ltd,LFIA,"IgG,IgM",87.30%,100.00%,High,Journal Article (Peer-Reviewed),Wenhua Liang,The First Affiliated Hospital of Guangzhou Medical University,https://dx.doi.org/10.1038/s41422-020-0371-0,01/08/2020,16/07/2022,Verified
200703_WuhanHemodialysis_TongjiMedicalCollege_HemodialysisPatients_IgGandorIgM,03-Jul-20,Local,China,CHN,Hubei,Wuhan,08-Mar-20,21-Mar-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,1027,4.58%,,,Convenience,Innovita Biological Technology Co. Ltd,LFIA,"IgG,IgM",87.30%,100.00%,Moderate,Journal Article (Peer-Reviewed),Hui Tang, Tongji Medical College,https://dx.doi.org/10.1053/j.ajkd.2020.06.008,02/08/2020,16/07/2022,Verified
200725_Wuhan_WuhanInstituteofVirology_IgG,25-Jul-20,Local,China,CHN,Hubei,Wuhan,19-Mar-20,20-Mar-20,Health care workers and caregivers,Adults (18-64 years),325,43.08%,,,Stratified probability,"Nanjing Vazyme Medical Technology Co. Ltd,NZK Biotech Co. Wuhan China,Zhuhai Livzon Diagnostics Inc",Multiple Types,IgG,,,High,Journal Article (Peer-Reviewed),Danna Tu,Wuhan Institute of Virology ,http://dx.doi.org/10.1016/j.jinf.2020.07.023,29/09/2020,16/07/2022,Verified
200729_Wuhan_WuhanUniversity_Overall,03-Aug-20,Local,China,CHN,Hubei,Wuhan,14-Jan-20,21-Feb-20,Health care workers and caregivers,Multiple groups,1060,8.30%,,,Convenience,Shenzhen Yhlo Biotech Co. Ltd,CLIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Dong Zhao,Renmin Hospital of Wuhan University,https://dx.doi.org/10.1016/j.ijid.2020.07.082,01/10/2020,16/07/2022,Verified
200725_Shenzhen_ ShenzhenSecondPeoplesHospital_Builders,25-Jul-20,Local,China,CHN,Guangdong,Shenzhen,29-Feb-20,18-Mar-20,Non-essential workers and unemployed persons,Multiple groups,1589,0.38%,,,Convenience,Shenzhen Sciarray Biotech Ltd,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Cantong Zhang,Shenzhen Second People's Hospital,http://dx.doi.org/10.1002/jmv.26355,04/10/2020,16/07/2022,Verified
200829_Hubei_HuazhongUniversity_HospitalizedChildren,29-Aug-20,Local,China,CHN,Hubei,"Wuhan, Xiangyang",23-Jan-20,24-Apr-20,Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),299,0.00%,,,Unclear,NA,CLIA,"IgG,IgM",,,Unclear,Journal Article (Peer-Reviewed),Song mi Want,Huazhong University of Science and Technology,https://link.springer.com/article/10.1007/s11596-020-2228-7,04/10/2020,16/07/2022,Verified
200701_HongKong_QueenMaryHospital_Evacuees_EnzymeImmunoAssay,03-Jun-20,Regional,China,CHN,Hubei,,04-Mar-20,17-Mar-20,Household and community samples,Multiple groups,452,2.88%,,,Convenience,NA,ELISA,IgG,73.30%,100.00%,Moderate,Journal Article (Peer-Reviewed),Kelvin To,Queen Mary Hospital,https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(20)30053-7/fulltext,09/10/2020,16/07/2022,Verified
200701_HongKong_QueenMaryHospital_Jan2020_EnzymeImmunoAssay,03-Jun-20,Local,China,CHN,Hong Kong,Hong Kong,01-Jan-20,31-Jan-20,Residual sera,Multiple groups,580,2.59%,1.46%,4.23%,Sequential,NA,ELISA,IgG,73.30%,100.00%,High,Journal Article (Peer-Reviewed),Kelvin To,Queen Mary Hospital,https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(20)30053-7/fulltext,09/10/2020,16/07/2022,Verified
200701_HongKong_QueenMaryHospital_Feb2020_EnzymeImmunoAssay,03-Jun-20,Local,China,CHN,Hong Kong,Hong Kong,01-Feb-20,13-Feb-20,Residual sera,Multiple groups,233,0.43%,0.01%,2.37%,Sequential,NA,ELISA,IgG,73.30%,100.00%,High,Journal Article (Peer-Reviewed),Kelvin To,Queen Mary Hospital,https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(20)30053-7/fulltext,09/10/2020,16/07/2022,Verified
200811_Wuhan_HuazhongUniversityofScienceandTechnologyIgG,11-Aug-20,Local,China,CHN,Hubei,Wuhan,23-Jan-20,27-Mar-20,Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),44,0.00%,,,Sequential,NA,CLIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Ai Zhang,Huazhong University of Science and Technology,https://onlinelibrary.wiley.com/doi/full/10.1002/pbc.28424,09/10/2020,16/07/2022,Verified
200820_Hubei_NanjingUniversity_hcw_IgG,20-Aug-20,Local,China,CHN,Hubei,Wuhan,12-May-20,15-May-20,Health care workers and caregivers,Adults (18-64 years),191,0.00%,,,Convenience,Shenzhen Yhlo Biotech Co. Ltd,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Xin Tong,Nanjing University Medical School,https://dx.doi.org/10.1002/iid3.340,13/10/2020,16/07/2022,Verified
200819_Guangzhou_InstituteofBloodTransfusion_BloodDonors_TotalAnti,19-Aug-20,Local,China,CHN,Guangdong,Guangzhou,23-Mar-20,02-Apr-20,Blood donors,Adults (18-64 years),2199,0.32%,,,Simplified probability,Beijing Wantai Biological,ELISA,"IgA,IgG",,,High,Journal Article (Peer-Reviewed),Ru Xu,Institute of Blood Transfusion,http://dx.doi.org/10.1002/jmv.26445,18/10/2020,16/07/2022,Verified
200824_Wuhan_WuhanUniversity_IgG_T2,24-Aug-20,Local,China,CHN,Hubei,Wuhan,13-May-20,10-Jun-20,Health care workers and caregivers,Adults (18-64 years),1059,9.30%,,,Convenience,Zhuhai Livzon Diagnostics Inc,LFIA,IgG,,,High,Journal Article (Peer-Reviewed),Lu He,Wuhan University,http://dx.doi.org/10.1016/j.jinf.2020.08.027,19/10/2020,16/07/2022,Verified
200901_Wuhan_ZhongnanHospitalofWuhanUniversity_IgGTotal,14-Sep-20,Local,China,CHN,Hubei,Wuhan,16-Mar-20,25-Mar-20,Health care workers and caregivers,Adults (18-64 years),3674,1.70%,,,Convenience,Shenzhen Yhlo Biotech Co. Ltd,CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Fuling Zhou,Zhongnan Hospital of Wuhan University,http://dx.doi.org/10.1016/j.eclinm.2020.100510,29/10/2020,16/07/2022,Verified
200923_Wuhan_NationalCenterforMedicalServiceAdministration_Overall,23-Sep-20,Local,China,CHN,Hubei,Wuhan,10-Feb-20,22-Mar-20,Contacts of COVID patients,Multiple groups,300,47.67%,,,Convenience,Innovita Biological Technology Co. Ltd,LFIA,"IgG,IgM",97.10%,95.30%,High,Journal Article (Peer-Reviewed),Yaqing Li,National Center for Medical Service Administration,https://dx.doi.org/10.5858/arpa.2020-0310-SA,19/11/2020,16/07/2022,Verified
200923_Beijing_PekingUniversity_Overall,23-Sep-20,Local,China,CHN,Hebei,Beijing,15-Apr-20,18-Apr-20,Household and community samples,Multiple groups,2184,0.17%,,,Stratified probability,"Innovita Biological Technology Co. Ltd,Guangzhou Wondfo Biotech Co. Ltd",Multiple Types,"IgG,IgM",,,Moderate,Preprint,Xiaoli Wang,Peking University,https://www.medrxiv.org/content/10.1101/2020.09.23.20197756v1,22/11/2020,16/07/2022,Verified
200921_Wuhan_TongjiMedicalCollege_Overall,21-Sep-20,Local,China,CHN,Hubei,Wuhan,17-Feb-20,28-Apr-20,Multiple populations,Multiple groups,11766,0.50%,,,Sequential,Shenzhen Yhlo Biotech Co. Ltd,CLIA,"IgM,IgG",66.70%,99.50%,High,Journal Article (Peer-Reviewed),Qing Lei, Tongji Medical College,https://dx.doi.org/10.1111/all.14622,25/11/2020,16/07/2022,Verified
201119_Shanghai_FudanUniversity_Overall,19-Nov-20,Local,China,CHN,Shanghai Municipality,Shanghai,15-May-20,15-Oct-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,6414,0.31%,,,Convenience,Bioscience Diagnostics,CLIA,"IgG,IgM",,,High,Preprint,Shengjie Li,Fudan University,https://www.medrxiv.org/content/10.1101/2020.09.22.20198465v2,30/11/2020,16/07/2022,Verified
200922_Wuhan_WuhanUniversity_IgM/IgG,06-Oct-20,Local,China,CHN,Hubei,Wuhan,15-May-20,26-May-20,Household and community samples,Multiple groups,61437,2.39%,2.27%,2.52%,Stratified probability,Nanjing Vazyme Medical Technology Co. Ltd,LFIA,"IgG,IgM",91.54%,97.02%,Moderate,Journal Article (Peer-Reviewed),Yunbao Pan,Wuhan University,https://dx.doi.org/10.1016/j.cmi.2020.09.044,08/12/2020,16/07/2022,Verified
201023_Wuhan_HuazhongUniversityofScienceandTechnology_Overall_unadj,23-Oct-20,Local,China,CHN,Hubei,Wuhan,27-Mar-20,26-May-20,Household and community samples,Multiple groups,35040,3.90%,3.70%,4.10%,Unclear,Bioscience Diagnostics,CLIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Anding Liu,Huazhong University of Science and Technology,https://dx.doi.org/10.1001/jamanetworkopen.2020.25717,23/01/2021,16/07/2022,Verified
201225_Wuhan_RenminHospitalofWuhanUniversity_Community,25-Dec-20,Local,China,CHN,Hubei,Wuhan,15-May-20,29-May-20,Household and community samples,Multiple groups,4454,2.90%,,,Convenience,Zhuhai Livzon Diagnostics Inc,LFIA,IgG,,,Unclear,Journal Article (Peer-Reviewed),Lu He,Renmin Hospital of Wuhan University,https://dx.doi.org/10.7883/yoken.JJID.2020.691,28/01/2021,16/07/2022,Verified
201225_Wuhan_RenminHopsitalofWuhanUniversity_HCW,25-Dec-20,Local,China,CHN,Hubei,Wuhan,15-May-20,29-May-20,Health care workers and caregivers,Adults (18-64 years),4614,3.30%,,,Convenience,Zhuhai Livzon Diagnostics Inc,LFIA,IgG,,,Unclear,Journal Article (Peer-Reviewed),Lu He,Renmin Hospital of Wuhan University,https://dx.doi.org/10.7883/yoken.JJID.2020.691,28/01/2021,16/07/2022,Verified
201228_Beijing_CapitalMedicalUniversity_IgG,28-Dec-20,Local,China,CHN,,Beijing,01-Jan-20,31-Aug-20,Residual sera,Children and Youth (0-17 years),19797,0.06%,,,Sequential,Innovita Biological Technology Co. Ltd,LFIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Ran Wang,Capital Medical University ,https://dx.doi.org/10.1002/ped4.12231,31/01/2021,16/07/2022,Verified
210107_China_WuhanUniversity,07-Jan-21,Regional,China,CHN,Hubei,,06-Mar-20,03-May-20,Essential non-healthcare workers,Multiple groups,63107,0.74%,,,Unclear,Innovita Biological Technology Co. Ltd,LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Shuhui Duan,Wuhan University,https://dx.doi.org/10.1371/journal.pntd.0008975,07/02/2021,16/07/2022,Unverified
210119_Shenzen_ShenzhenCenterforDiseaseControlandPrevention_contacts_TotalAb_TestAdj,19-Jan-21,Local,China,CHN,,Shenzen,12-Apr-20,04-May-20,Contacts of COVID patients,Multiple groups,880,4.10%,2.90%,5.70%,Convenience,Beijing Wantai Biological,ELISA,Total Antibody,98.00%,99.00%,Moderate,Journal Article (Peer-Reviewed),Zhen Zhang,Shenzhen Center for Disease Control and Prevention,https://dx.doi.org/10.1016/S2666-5247(20)30200-7,24/02/2021,16/07/2022,Verified
210119_Shenzen_ShenzhenCenterforDiseaseControlandPrevention_NeighbourhoodNoCases_TotalAb_TestAdj,19-Jan-21,Local,China,CHN,,Shenzen,17-Apr-20,23-Apr-20,Household and community samples,Multiple groups,350,0.00%,0.00%,1.10%,Convenience,Beijing Wantai Biological,ELISA,Total Antibody,98.00%,99.00%,High,Journal Article (Peer-Reviewed),Zhen Zhang,Shenzhen Center for Disease Control and Prevention,https://dx.doi.org/10.1016/S2666-5247(20)30200-7,24/02/2021,16/07/2022,Verified
210119_Shenzen_ShenzhenCenterforDiseaseControlandPrevention_NeighbourhoodReportedCases_TotalAb_TestAdj,19-Jan-21,Local,China,CHN,,Shenzen,17-Apr-20,23-Apr-20,Household and community samples,Multiple groups,50,0.00%,0.00%,6.80%,Convenience,Beijing Wantai Biological,ELISA,Total Antibody,98.00%,99.00%,High,Journal Article (Peer-Reviewed),Zhen Zhang,Shenzhen Center for Disease Control and Prevention,https://dx.doi.org/10.1016/S2666-5247(20)30200-7,24/02/2021,16/07/2022,Verified
210109_Taiwan_NationalTaiwanUniversityHospital_HCW_Overall,09-Jan-21,Local,China,CHN,Taiwan,Taipei,01-Jul-20,31-Aug-20,Health care workers and caregivers,Adults (18-64 years),194,0.00%,,,Convenience,"Abbott Laboratories,Mikrogen GmbH,Roche Diagnostics",Multiple Types,IgG,,,High,Journal Article (Peer-Reviewed),Sung Ching Pan,National Taiwan University Hospital,https://dx.doi.org/10.1016/j.jfma.2021.01.002,14/03/2021,16/07/2022,Unverified
210206_China_ChineseCenterforDiseaseControlandPrevention_Overall,06-Feb-21,National,China,CHN,,,10-Apr-20,18-Apr-20,Household and community samples,Multiple groups,34857,1.23%,,,Stratified probability,"Guangzhou Wondfo Biotech Co. Ltd,Innovita Biological Technology Co. Ltd,Bioscience Diagnostics,NA",Multiple Types,"IgM,IgG,Neutralizing ,Total Antibody",,,Low,Journal Article (Peer-Reviewed),Zhongjie Li ,Chinese Center for Disease Control and Prevention,https://dx.doi.org/10.1016/j.lanwpc.2021.100094,24/03/2021,16/07/2022,Verified
210320_Wuhan_ChineseAcademyOfMedicalSciences_overall_Roche,20-Mar-21,Regional,China,CHN,Wuhan,,14-Apr-20,15-Apr-20,Household and community samples,Multiple groups,9542,6.92%,6.41%,7.43%,Stratified probability,Roche Diagnostics,CLIA,Total Antibody,100.00%,100.00%,Low,Journal Article (Peer-Reviewed),Zhenyu He,Chinese Academy of Medical Sciences & Peking Union Medical College,https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00238-5/fulltext?dgcid=raven_jbs_etoc_email,24/03/2021,16/07/2022,Verified
200825_Wuhan_ChineseCenterforDiseaseControlandPrevention_primary,25-Aug-20,Local,China,CHN,Hubei,Wuhan,25-Mar-20,28-Apr-20,Household and community samples,Multiple groups,18712,3.27%,3.02%,3.52%,Self-referral,Innovita Biological Technology Co. Ltd,LFIA,"IgG,IgM",89.50%,99.00%,Moderate,Preprint,Ruijie Ling,Chinese Center for Disease Control and Prevention,https://www.medrxiv.org/content/10.1101/2020.06.16.20132423v3,08/04/2021,16/07/2022,Verified
210302_Wuhan_ChineseAcademyofMedicalSciences1_overall_adj,02-Mar-21,Local,China,CHN,Hubei Province,Wuhan,15-Jan-20,15-Apr-20,Blood donors,Adults (18-64 years),17794,2.66%,2.24%,3.07%,Convenience,NA,Neutralization,"IgG,Total Antibody,IgM",,,Moderate,Journal Article (Peer-Reviewed),Le Chang,Chinese Academy of Medical Sciences,https://dx.doi.org/10.1038/s41467-021-21503-x,12/04/2021,16/07/2022,Verified
210302_Shenzhen_ChineseAcademyofMedicalSciences2_overall_adj,02-Mar-21,Local,China,CHN,,Shenzhen,15-Jan-20,15-Apr-20,Blood donors,Multiple groups,6810,0.03%,0.00%,0.27%,Convenience,NA,Neutralization,"IgG,Total Antibody,IgM",,,Moderate,Journal Article (Peer-Reviewed),Le Chang,Chinese Academy of Medical Sciences,https://dx.doi.org/10.1038/s41467-021-21503-x,12/04/2021,16/07/2022,Unverified
210302_Shijiazhuang_ChineseAcademyofMedicalSciences3_overall_adj,02-Mar-21,Local,China,CHN,Hebei Province,Shijiazhuang,15-Jan-20,15-Apr-20,Blood donors,Adults (18-64 years),13540,0.00%,0.00%,0.16%,Convenience,NA,Neutralization,"IgG,Total Antibody,IgM",,,Moderate,Journal Article (Peer-Reviewed),Le Chang,Chinese Academy of Medical Sciences,https://dx.doi.org/10.1038/s41467-021-21503-x,12/04/2021,16/07/2022,Verified
210308_ZhongnanHospital_Wuhan,08-Mar-21,Local,China,CHN,Hubei,Wuhan,01-Jan-20,08-Apr-20,Health care workers and caregivers,Adults (18-64 years),112,0.00%,,,Entire sample,NA,Not reported,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Yin-xian Wen,Zhongnan Hospital of Wuhan University,https://dx.doi.org/10.1111/os.12898,19/04/2021,16/07/2022,Verified
210408_Taiwan_NationalChengKungUniversityHospital_overall,08-Apr-21,National,China,CHN,Taiwan,,15-Aug-20,13-Sep-20,Residual sera,Adults (18-64 years),969,0.00%,,,Convenience,"TONYAR Biotech Inc., Taiwan,Guangzhou Wondfo Biotech Co. Ltd,Roche Diagnostics",CLIA,Total Antibody,,,High,Journal Article (Peer-Reviewed),Ming Chi Li,National Cheng Kung University Hospital,https://dx.doi.org/10.1016/j.jmii.2021.03.018,19/05/2021,16/07/2022,Unverified
210419_Wuhan_ChineseAcademyofSciences,19-Apr-21,Local,China,CHN,Hubei,Wuhan,30-May-20,12-Jun-20,Essential non-healthcare workers,Adults (18-64 years),508,5.91%,,,Unclear,NA,ELISA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Yong Yang,Chinese Academy of Sciences,https://dx.doi.org/10.1080/22221751.2021.1919032,19/05/2021,16/07/2022,Verified
210421_Wuhan_WuhanUniversity_overall,21-Apr-21,Local,China,CHN,Hubei,"Wuhan
",23-Apr-20,24-May-20,Household and community samples,Multiple groups,35326,3.77%,3.58%,3.97%,Convenience,"Nanjing Vazyme Medical Technology Co. Ltd,Shenzhen Yhlo Biotech Co. Ltd",CLIA,"IgG,IgM",,,Moderate,Journal Article (Peer-Reviewed),Huan Han,Wuhan University,https://pubmed.ncbi.nlm.nih.gov/33883260/,22/05/2021,16/07/2022,Verified
210118_Hangzhou_ZhejiangUniversitySchoolofMedicine_Overall,18-Jan-21,Local,China,CHN,Zhejiang,Hangzhou,24-Apr-20,08-May-20,Multiple populations,Multiple groups,16043,0.46%,,,Convenience,"Zhuhai Livzon Diagnostics Inc,Nanjing Vazyme Medical Technology Co. Ltd",LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Jun Huang,Zhejiang University School of Medicine,https://dx.doi.org/10.21037/atm-20-7163,28/05/2021,16/07/2022,Verified
210518_Taiwan_NationalTaiwanUniversity_GroupH1,18-May-21,National,China,CHN,Taiwan,"Taipei, Zhubei",25-Jun-20,29-Jul-20,Health care workers and caregivers,Adults (18-64 years),464,0.00%,0.00%,0.79%,Convenience,"Abbott Laboratories,Roche Diagnostics,Mikrogen GmbH",Multiple Types,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Wen Pin Tseng,National Taiwan University,https://dx.doi.org/10.3389/fimmu.2021.626609,15/06/2021,16/07/2022,Unverified
210518_Taiwan_NationalTaiwanUniversity_GroupC2,18-May-21,National,China,CHN,Taiwan,"Taipei, Zhubei",25-Jun-20,29-Jul-20,Health care workers and caregivers,Adults (18-64 years),1142,0.09%,0.00%,0.49%,Convenience,NA,Multiple Types,IgG,,,High,Journal Article (Peer-Reviewed),Wen Pin Tseng,Researchers at the National Taiwan University studied symptomatic patients with frontline healthcare workers (n=464) and found a stringently judged seroprevalence of 0%.,https://dx.doi.org/10.3389/fimmu.2021.626609,16/06/2021,16/07/2022,Unverified
201010_Taipei_TaipeiVeteransGeneralHospital_popadj,10-Oct-20,Local,China,CHN,,Taipei,25-May-20,08-Jul-20,Residual sera,Multiple groups,14765,0.05%,0.02%,0.10%,Sequential,"Academia Sinica,Roche Diagnostics",Multiple Types,"IgG,IgM,IgA",,,Moderate,Journal Article (Peer-Reviewed),Hsiang-Ling Ho,Taipei Veterans General Hospital,https://dx.doi.org/10.1016/j.lanwpc.2020.100041,07/07/2021,16/07/2022,Verified
210722_Wuhan_HospitalofHubeiProvince_pregnant_primary,22-Jul-21,Local,China,CHN,Hubei,Wuhan,01-Apr-20,30-Dec-20,Pregnant or parturient women,Adults (18-64 years),15953,0.66%,,,Entire sample,NA,LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Hongwen Ma,Hospital of Hubei Province,https://dx.doi.org/10.1007/s12026-021-09213-4,27/07/2021,16/07/2022,Verified
210722_Wuhan_HospitalofHubeiProvince_partners_primary,22-Jul-21,Local,China,CHN,Hubei,Wuhan,01-Apr-20,30-Dec-20,Multiple general populations,Adults (18-64 years),15671,0.73%,,,Entire sample,NA,LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Hongwen Ma,Hospital of Hubei Province,https://dx.doi.org/10.1007/s12026-021-09213-4,27/07/2021,16/07/2022,Verified
210722_Wuhan_HospitalofHubeiProvince_HCW_primary,22-Jul-21,Local,China,CHN,Hubei,Wuhan,01-Apr-20,30-Apr-20,Health care workers and caregivers,Adults (18-64 years),385,1.80%,,,Entire sample,NA,LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Hongwen Ma,Hospital of Hubei Province,https://dx.doi.org/10.1007/s12026-021-09213-4,27/07/2021,16/07/2022,Verified
210806_China_FudanUniversity_OcularSurfaceDisease_Overall,06-Aug-21,National,China,CHN,,,15-May-20,15-Mar-21,Representative patient population,Multiple groups,1755,2.28%,,,Convenience,Bioscience Diagnostics,CLIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Shengjie Li,Shanghai Engineering Research Center of Laser and Autostereoscopic 3D for Vision Care,https://dx.doi.org/10.3389/fimmu.2021.695428,31/08/2021,16/07/2022,Unverified
210806_China_FudanUniversity_NoOcularSurfaceDisease_Overall,06-Aug-21,National,China,CHN,,,15-May-20,15-Mar-21,Representative patient population,Multiple groups,12550,0.70%,,,Convenience,Bioscience Diagnostics,CLIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Shengjie Li,Shanghai Engineering Research Center of Laser and Autostereoscopic 3D for Vision Care,https://dx.doi.org/10.3389/fimmu.2021.695428,01/09/2021,16/07/2022,Unverified
210806_China_FudanUniversity_NoOcularDisease_Overall,06-Aug-21,National,China,CHN,,,15-May-20,15-Mar-21,Residual sera,Multiple groups,5852,0.92%,,,Convenience,Bioscience Diagnostics,CLIA,"IgG,IgM",,,Moderate,Journal Article (Peer-Reviewed),Shengjie Li,Shanghai Engineering Research Center of Laser and Autostereoscopic 3D for Vision Care,https://dx.doi.org/10.3389/fimmu.2021.695428,01/09/2021,16/07/2022,Unverified
210915_Wuhan_HubeiProvincialHospital_AgeSexAdj,15-Sep-21,Local,China,CHN,Hubei,Wuhan,25-Mar-20,28-Apr-20,Multiple populations,Multiple groups,18712,3.15%,2.90%,3.40%,Convenience,Innovita Biological Technology Co. Ltd,LFIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),LING Rui Jie,Hubei Provincial Hospital,https://dx.doi.org/10.3967/bes2021.103,28/09/2021,16/07/2022,Verified
210901_China_SouthernMedicalUniversity_GuangdongHCW4,01-Sep-21,Regional,China,CHN,Guangdong,"Guangzhou, Foshan",01-Mar-20,15-Mar-20,Health care workers and caregivers,Adults (18-64 years),260,1.20%,,,Convenience,Bioscience Diagnostics,CLIA,"IgG,IgM",83.00%,100.00%,High,Journal Article (Peer-Reviewed),Xin Xu,Southern Medical University,http://dx.doi.org/10.1016/j.ekir.2021.07.022,08/10/2021,16/07/2022,Unverified
210901_China_SouthernMedicalUniversity_HubeiHCW3,01-Sep-21,Regional,China,CHN,Hubei province,Honghu and Jingzhou,01-Mar-20,15-Mar-20,Health care workers and caregivers,Adults (18-64 years),2945,1.20%,,,Convenience,Bioscience Diagnostics,CLIA,"IgG,IgM",83.00%,100.00%,High,Journal Article (Peer-Reviewed),Xin Xu,Southern Medical University,http://dx.doi.org/10.1016/j.ekir.2021.07.022,08/10/2021,16/07/2022,Unverified
210901_China_SouthernMedicalUniversity_GuangdongPatients2,01-Sep-21,Regional,China,CHN,Guangdong,Guangzhou and Foshan,01-Mar-20,15-Mar-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,563,2.80%,,,Convenience,Bioscience Diagnostics,CLIA,"IgG,IgM",83.00%,100.00%,High,Journal Article (Peer-Reviewed),Xin Xu,Southern Medical University,http://dx.doi.org/10.1016/j.ekir.2021.07.022,08/10/2021,16/07/2022,Unverified
210901_China_SouthernMedicalUniversity_HubeiPatients1,01-Sep-21,Regional,China,CHN,Hubei province,Honghu and Jingzhou,01-Mar-20,15-Mar-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,978,3.60%,,,Convenience,Bioscience Diagnostics,CLIA,"IgG,IgM",83.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Xin Xu,Southern Medical University,http://dx.doi.org/10.1016/j.ekir.2021.07.022,08/10/2021,16/07/2022,Unverified
211115_HongKong_TheChineseUniversityofHongKong_Overall_PopAdjusted,15-Nov-21,National,China,CHN,NR,NR,21-Apr-20,18-Apr-21,Household and community samples,Multiple groups,4198,0.15%,0.06%,0.32%,Convenience,"Roche Diagnostics,NA",Multiple Types,"IgG,Not reported",,,Moderate,Journal Article (Peer-Reviewed),Siaw Boon,The Chinese University of Hong Kong,https://dx.doi.org/10.1001/jamanetworkopen.2021.32923,22/11/2021,16/07/2022,Unverified
211118_Guangdong_GuangzhouMedicalUniversity_OverallPopAdjust,18-Nov-21,Regional,China,CHN,Guangdong,"Chaozhou,Heyuan,Jiangmen,Jieyang,Maoming,Meizhou,Qingyuan,Shantou,Shanwei,Shaoguan,Yangjiang,Yunfu,Zhanjiang,Zhaoqing,Dongguan,Foshan,Guangzhou,Huizhou,Shenzhen,Zhongshan,Zhuhai",11-Mar-20,24-Jun-20,Residual sera,Multiple groups,14629,0.15%,0.06%,0.24%,Convenience,Bioscience Diagnostics,CLIA,IgG,89.60%,99.20%,Moderate,Journal Article (Peer-Reviewed),Cheng Xiao,Guangzhou Medical University,https://www.mdpi.com/2076-0817/10/11/1505/htm,08/12/2021,16/07/2022,Unverified
211201_Wuhan_ZhongnanHospitalUniversityOfWuhan_IgG,01-Dec-21,Local,China,CHN,Hubei,Wuhan,01-Mar-20,30-Jun-20,Multiple populations,Multiple groups,21398,4.57%,4.30%,4.86%,Convenience,"Shenzhen Yhlo Biotech Co. Ltd,NA",Multiple Types,IgG,,,High,Journal Article (Peer-Reviewed),Yufeng Shang,University of Wuhan Zhongnan Hospital,https://dx.doi.org/10.1002/jmv.27483,09/12/2021,16/07/2022,Unverified
200720_Guangzhou_NanfangHospital_Primary,20-Jul-20,Local,China,CHN,Hubei,Wuhan,20-Mar-20,15-Apr-20,Health care workers and caregivers,Adults (18-64 years),943,0.00%,,,Entire sample,NA,Not reported,"IgG,IgM",87.30%,99.50%,High,Journal Article (Peer-Reviewed),Fan Fan Hou,Nanfang Hospital,https://dx.doi.org/10.1093/PCMEDI/PBAA024,08/01/2022,16/07/2022,Unverified
200720_Wuhan_NanfangHospital_Primary,20-Jul-20,Local,China,CHN,Hubei,Wuhan,20-Mar-20,15-Apr-20,Health care workers and caregivers,Adults (18-64 years),7586,3.20%,,,Entire sample,NA,Not reported,"IgG,IgM",87.30%,99.50%,,Journal Article (Peer-Reviewed),Fan Fan Hou,Nanfang Hospital,https://dx.doi.org/10.1093/PCMEDI/PBAA024,08/01/2022,16/07/2022,Unverified
220104_Wuhan_ZhongnanHospitalOfWuhanUniversity_IgG,04-Jan-22,Local,China,CHN,Hubei,Wuhan,21-Mar-20,21-May-20,Residual sera,Multiple groups,3062,7.51%,,,Convenience,Innovita Biological Technology Co. Ltd,Other,IgG,89.00%,98.00%,Moderate,Journal Article (Peer-Reviewed),Yueting Tang,Zhongnan Hospital of Wuhan University,https://dx.doi.org/10.1186/s12879-021-07010-w,09/01/2022,16/07/2022,Unverified
210331_Wuhan_TongjiMedicalCollege,31-Mar-21,Local,China,CHN,Hubei Province,Wuhan,23-Jan-20,10-Mar-20,Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),113,0.00%,,,Convenience,Beijing Abase Biotechnology Enterprise Co.,LFIA,"IgG,IgM",84.00%,,High,Journal Article (Peer-Reviewed),Zhujun Wang,Tongji Medical College,https://journals.lww.com/jpho-online/Abstract/2022/01000/The_Status_of_Pediatric_Patients_With_Hematologic.27.aspx,19/01/2022,16/07/2022,Unverified
220110_Chongqing_ArmyMedicalUniversity_GenPop,10-Jan-22,Local,China,CHN,,Chongqing,01-Jan-20,31-Mar-20,Blood donors,Adults (18-64 years),250,0.00%,,,Unclear,NA,Not reported,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Shichun Wang,Army Medical University,https://dx.doi.org/10.1016/j.jfma.2022.01.004,25/01/2022,16/07/2022,Unverified
220110_Chongqing_ArmyMedicalUniversity_HCW,10-Jan-22,Local,China,CHN,,Chongqing,01-Jan-20,31-Mar-20,Household and community samples,Adults (18-64 years),248,0.00%,,,Unclear,NA,Not reported,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Shichun Wang,Army Medical University,https://dx.doi.org/10.1016/j.jfma.2022.01.004,25/01/2022,16/07/2022,Unverified
220128_HongKong_TheChineseUniversityofHongKong,28-Jan-22,Local,China,CHN,Hong Kong,Hong Kong,15-Nov-19,15-Oct-20,Pregnant or parturient women,Adults (18-64 years),1830,0.34%,,,Convenience,"Roche Diagnostics,ImmunoDiagnostics",Multiple Types,"IgG,IgM",,,Moderate,Journal Article (Peer-Reviewed),Hillary Leung,The Chinese University of Hong Kong,https://dx.doi.org/10.12809/hkmj219653,09/02/2022,16/07/2022,Unverified
220128_HongKong_TheChineseUniversityofHongKong_AND,28-Jan-22,Local,China,CHN,Hong Kong,Hong Kong,15-Nov-19,15-Oct-20,Pregnant or parturient women,Adults (18-64 years),1830,0.05%,,,Convenience,"Roche Diagnostics,ImmunoDiagnostics",Multiple Types,"IgG,IgM",,,Moderate,Journal Article (Peer-Reviewed),Hillary Leung,The Chinese University of Hong Kong,https://dx.doi.org/10.12809/hkmj219653,09/02/2022,16/07/2022,Unverified
220121_HongKong_UniversityOfOxford,21-Jan-22,Local,China,CHN,,Hong Kong,26-May-20,24-Sep-21,Patients seeking care for non-COVID-19 reasons,Multiple groups,72,0.00%,,,Convenience,"Roche Diagnostics,Siemens",Not reported,Total Antibody,,,High,Presentation or Conference,S Y Wong,University of Oxford,https://dx.doi.org/10.1093/ecco-jcc/jjab232.469,08/03/2022,16/07/2022,Unverified
220407_HongKong_UniversityofHongKong_Overall,07-Apr-22,Regional,China,CHN,Hong Kong,,15-Jan-21,15-Dec-21,Residual sera,Multiple groups,1800,14.70%,,,Convenience,Shenzhen Yhlo Biotech Co. Ltd,CLIA,Neutralizing ,,,Moderate,Preprint,Lin-Lei Chen,The University of Hong Kong,https://www.researchsquare.com/article/rs-1512533/v1,14/04/2022,16/07/2022,Verified
220429_Wuhan_ZhongnanHospitalofWuhanUniversity_HIVpositive_Overall,29-Apr-22,Local,China,CHN,Hubei,Wuhan,01-May-20,30-May-20,Household and community samples,Multiple groups,857,0.47%,,,Simplified probability,NA,LFIA,"IgG,IgM",,,Unclear,Journal Article (Peer-Reviewed),Mengmeng Wu,Zhongnan Hospital of Wuhan University,https://dx.doi.org/10.3389/fpubh.2022.833783,24/05/2022,16/07/2022,Unverified
220429_Wuhan_ZhongnanHospitalofWuhanUniversity_HIVnegative_Overall,29-Apr-22,Local,China,CHN,Hubei,Wuhan,01-May-20,30-May-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,1048,6.01%,,,Simplified probability,NA,LFIA,"IgG,IgM",,,Moderate,Journal Article (Peer-Reviewed),Mengmeng Wu,Zhongnan Hospital of Wuhan University,https://dx.doi.org/10.3389/fpubh.2022.833783,24/05/2022,16/07/2022,Unverified
220715_Wuhan_UnionMedicalCollege_overall,15-Jul-22,Local,China,CHN,,Wuhan,09-Apr-20,13-Apr-20,Household and community samples,Multiple groups,5067,6.18%,,,Stratified probability,Roche Diagnostics,CLIA,"IgG,IgM,IgA",100.00%,99.50%,Low,Journal Article (Peer-Reviewed),Jin Yang,Union Medical College,https://dx.doi.org/10.1186/s12931-022-02096-5,27/07/2022,29/07/2022,Unverified
20220726_HongKong_QueenMaryHospital_Dec2021_RBD,26-Jul-22,Local,China,CHN,,Hong Kong,01-Dec-21,31-Dec-21,Residual sera,Multiple groups,423,52.20%,,,Convenience,Abbott Laboratories,Not reported,IgG,,,High,Preprint,Rosana Wing-Shan Poon,Queen Mary Hospital,https://dx.doi.org/10.1080/22221751.2022.2106899,03/08/2022,03/08/2022,Unverified
20220726_HongKong_QueenMaryHospital_May2022_RBD,26-Jul-22,Local,China,CHN,,Hong Kong,01-May-22,31-May-22,Residual sera,Multiple groups,450,89.30%,,,Convenience,Abbott Laboratories,Not reported,IgG,,,High,Preprint,Rosana Wing-Shan Poon,Queen Mary Hospital,https://dx.doi.org/10.1080/22221751.2022.2106899,03/08/2022,03/08/2022,Unverified
200710_Santiago_UniversidadDeChile_AllStudents,10-Jul-20,Local,Chile,CHL,Santiago,Vitacura,04-May-20,19-May-20,Students and Daycares,Children and Youth (0-17 years),1009,9.90%,8.60%,11.50%,Stratified probability,Genrui Biotech,LFIA,"IgG,IgM",91.01%,95.37%,High,Journal Article (Peer-Reviewed),Juan Pablo Torres,Universidade de Chile,https://academic.oup.com/cid/article/doi/10.1093/cid/ciaa955/5869860,27/07/2020,16/07/2022,Verified
200710_Santiago_UniversidadDeChile_AllStaff,10-Jul-20,Local,Chile,CHL,Santiago,Vitacura,04-May-20,19-May-20,Essential non-healthcare workers,Adults (18-64 years),235,16.60%,12.10%,21.90%,Stratified probability,Genrui Biotech,LFIA,"IgG,IgM",91.01%,95.37%,High,Journal Article (Peer-Reviewed),Juan Pablo Torres,Universidade de Chile,https://academic.oup.com/cid/article/doi/10.1093/cid/ciaa955/5869860,27/07/2020,16/07/2022,Verified
210215_Chile_UniversityOfChile_HCW,15-Feb-21,National,Chile,CHL,,,11-Sep-20,24-Oct-20,Health care workers and caregivers,Multiple groups,85528,7.20%,,,Entire sample,Zhuhai Livzon Diagnostics Inc,LFIA,"IgG,IgM",95.80%,100.00%,Low,Preprint,Marcela Zuniga,Universidad de Chile,https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3785998,22/05/2021,16/07/2022,Verified
210526_Chile_UniversidadDelDesarrollo_Overall2_Overall,26-May-21,Local,Chile,CHL,Santiago,Santiago,27-Apr-20,31-Jul-20,Health care workers and caregivers,Multiple groups,446,24.00%,20.20%,28.30%,Convenience,"Vircell S.L.,EUROIMMUN",ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Mirentxu Iruretagoyena,Universidad del Desarrollo,https://dx.doi.org/10.1186/s12879-021-06208-2,06/06/2021,16/07/2022,Verified
210909_Chile_UniversidaddeChile,09-Sep-21,National,Chile,CHL,,,12-Mar-21,02-Jul-21,Household and community samples,Multiple groups,54261,52.84%,,,Convenience,"CTK Biotech, Inc.",LFIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Denis Saure,Universidad de Chile,https://dx.doi.org/10.1016/S1473-3099(21)00479-5,23/09/2021,16/07/2022,Unverified
211226_Chile_UniversidaddeChile_Overall,26-Dec-21,National,Chile,CHL,,,11-Sep-20,24-Oct-20,Health care workers and caregivers,Multiple groups,85529,7.18%,,,Convenience,Zhuhai Livzon Diagnostics Inc,LFIA,"IgG,IgM",95.80%,100.00%,Moderate,Journal Article (Peer-Reviewed),Marcela Zuniga,Universidad de Chile,https://dx.doi.org/10.1016/j.jclinepi.2021.12.026,12/01/2022,16/07/2022,Unverified
220128_Chile_UniversidaddelDesarrollo_Overall_PopAdj,28-Jan-22,National,Chile,CHL,"Coquimbo, Talca, Santiago",,25-Sep-20,25-Nov-20,Household and community samples,Multiple groups,2493,10.40%,7.80%,13.70%,Stratified probability,"Roche Diagnostics,Zhuhai Livzon Diagnostics Inc",Multiple Types,"IgG,IgM",,,Low,Journal Article (Peer-Reviewed),Pablo Vial,Universidad del Desarrollo,https://dx.doi.org/10.1186/s12879-022-07045-7,08/02/2022,16/07/2022,Verified
220413_Chile_UniversidadDelDesarrollo_Overall,13-Apr-22,Regional,Chile,CHL,Center zone,Santiago; Coquimbo/La Serena; Talca.,05-Oct-21,25-Nov-21,Household and community samples,Multiple groups,2198,97.32%,,,Stratified probability,"Beijing Wantai Biological,Cellex Inc.",Multiple Types,"Total Antibody,IgG,IgM",,,High,Preprint,Ximena Aguilera,Universidad del Desarrollo,https://doi.org/10.21203/rs.3.rs-1548211/v1,23/04/2022,16/07/2022,Unverified
220407_Chile_ClinicaAlemanaUniversidaddelDesarrollo_TestAdj,07-Apr-22,National,Chile,CHL,Valparaiso; Metropolitan; O'Higgins,,15-Sep-20,15-Nov-20,Assisted living and long-term care facilities,Seniors (65+ years),2088,16.20%,14.60%,17.90%,Convenience,Innovita Biological Technology Co. Ltd,LFIA,"IgG,IgM",90.30%,100.00%,Moderate,Journal Article (Peer-Reviewed),Paola Rubilar,Fundacion Chile,https://dx.doi.org/10.5867/medwave.2022.03.002553,28/04/2022,16/07/2022,Unverified
220423_Chile_UniversidadDeChile_Primary,23-Apr-22,National,Chile,CHL,,,,24-Dec-21,Students and Daycares,Children and Youth (0-17 years),2302,85.70%,84.30%,87.10%,Convenience,"CTK Biotech, Inc.",LFIA,IgG,96.70%,98.10%,High,Journal Article (Peer-Reviewed),Juan Torres,Universidad de Chile,https://dx.doi.org/10.1016/j.ijid.2022.04.039,05/05/2022,16/07/2022,Unverified
220713_Santiago_ UniversidadDelDesarrollo_Overall,13-Jul-22,Local,Chile,CHL,Santiago Province,Santiago,24-Apr-20,21-Jun-20,Household and community samples,Multiple groups,1368,6.79%,5.58%,8.26%,Simplified probability,"ACRO Biotech Inc,Cellex Inc.,Dynamiker Biotechnology (Tianjin) Co. Ltd,Zhuhai Livzon Diagnostics Inc",Multiple Types,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Pablo A. Vial,Universidad del Desarrollo,https://dx.doi.org/10.1016/j.epidem.2022.100606,10/08/2022,11/08/2022,Unverified
220713_Santiago_ UniversidadDelDesarrollo_Sex_Male,13-Jul-22,Local,Chile,CHL,Santiago Province,Santiago,24-Apr-20,21-Jun-20,Household and community samples,Multiple groups,590,7.30%,5.40%,9.70%,Simplified probability,"ACRO Biotech Inc,Cellex Inc.,Dynamiker Biotechnology (Tianjin) Co. Ltd,Zhuhai Livzon Diagnostics Inc",Multiple Types,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Pablo A. Vial,Universidad del Desarrollo,https://dx.doi.org/10.1016/j.epidem.2022.100606,11/08/2022,11/08/2022,Unverified
220713_Santiago_ UniversidadDelDesarrollo_Sex_Female,13-Jul-22,Local,Chile,CHL,Santiago Province,Santiago,24-Apr-20,21-Jun-20,Household and community samples,Multiple groups,778,6.40%,4.90%,8.40%,Simplified probability,"ACRO Biotech Inc,Cellex Inc.,Dynamiker Biotechnology (Tianjin) Co. Ltd,Zhuhai Livzon Diagnostics Inc",Multiple Types,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Pablo A. Vial,Universidad del Desarrollo,https://dx.doi.org/10.1016/j.epidem.2022.100606,11/08/2022,11/08/2022,Unverified
220713_Santiago_ UniversidadDelDesarrollo_Age_7-14,13-Jul-22,Local,Chile,CHL,Santiago Province,Santiago,24-Apr-20,21-Jun-20,Household and community samples,Children and Youth (0-17 years),67,10.40%,5.10%,20.30%,Simplified probability,"ACRO Biotech Inc,Cellex Inc.,Dynamiker Biotechnology (Tianjin) Co. Ltd,Zhuhai Livzon Diagnostics Inc",Multiple Types,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Pablo A. Vial,Universidad del Desarrollo,https://dx.doi.org/10.1016/j.epidem.2022.100606,11/08/2022,11/08/2022,Unverified
220713_Santiago_ UniversidadDelDesarrollo_Age_15-24,13-Jul-22,Local,Chile,CHL,Santiago Province,Santiago,24-Apr-20,21-Jun-20,Household and community samples,Multiple groups,167,4.80%,2.40%,9.30%,Simplified probability,"ACRO Biotech Inc,Cellex Inc.,Dynamiker Biotechnology (Tianjin) Co. Ltd,Zhuhai Livzon Diagnostics Inc",Multiple Types,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Pablo A. Vial,Universidad del Desarrollo,https://dx.doi.org/10.1016/j.epidem.2022.100606,11/08/2022,11/08/2022,Unverified
220713_Santiago_ UniversidadDelDesarrollo_Age_25-39,13-Jul-22,Local,Chile,CHL,Santiago Province,Santiago,24-Apr-20,21-Jun-20,Household and community samples,Adults (18-64 years),455,5.70%,3.90%,8.30%,Simplified probability,"ACRO Biotech Inc,Cellex Inc.,Dynamiker Biotechnology (Tianjin) Co. Ltd,Zhuhai Livzon Diagnostics Inc",Multiple Types,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Pablo A. Vial,Universidad del Desarrollo,https://dx.doi.org/10.1016/j.epidem.2022.100606,11/08/2022,11/08/2022,Unverified
220713_Santiago_ UniversidadDelDesarrollo_Age_40-59,13-Jul-22,Local,Chile,CHL,Santiago Province,Santiago,24-Apr-20,21-Jun-20,Household and community samples,Adults (18-64 years),470,7.40%,5.40%,10.20%,Simplified probability,"ACRO Biotech Inc,Cellex Inc.,Dynamiker Biotechnology (Tianjin) Co. Ltd,Zhuhai Livzon Diagnostics Inc",Multiple Types,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Pablo A. Vial,Universidad del Desarrollo,https://dx.doi.org/10.1016/j.epidem.2022.100606,11/08/2022,11/08/2022,Unverified
220713_Santiago_ UniversidadDelDesarrollo_Age_60+,13-Jul-22,Local,Chile,CHL,Santiago Province,Santiago,24-Apr-20,21-Jun-20,Household and community samples,Seniors (65+ years),209,8.10%,5.10%,12.70%,Simplified probability,"ACRO Biotech Inc,Cellex Inc.,Dynamiker Biotechnology (Tianjin) Co. Ltd,Zhuhai Livzon Diagnostics Inc",Multiple Types,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Pablo A. Vial,Universidad del Desarrollo,https://dx.doi.org/10.1016/j.epidem.2022.100606,11/08/2022,11/08/2022,Unverified
220803_Santiago_UniversidadDelDesarrollo_Overall,03-Aug-22,Local,Chile,CHL,,Santiago,01-Nov-20,30-Nov-20,Health care workers and caregivers,Multiple groups,463,22.25%,,,Convenience,Vircell S.L.,ELISA,IgG,85.70%,98.50%,High,Preprint,Andrea Olea,Universidad del Desarrollo,http://doi.org/10.1101/2022.08.03.22278369,18/08/2022,18/08/2022,Unverified
211121_Bengui_UniversityofBangui,21-Nov-21,Local,Central African Republic,CAF,,Bangui,12-Jul-21,20-Aug-21,Household and community samples,Multiple groups,799,74.10%,,,Simplified probability,Beijing Wantai Biological,ELISA,Total Antibody,,99.40%,Moderate,Preprint,Alexandre Manirakiza,University of Bangui,https://www.medrxiv.org/content/10.1101/2021.11.18.21266496v1.full-text,30/11/2021,16/07/2022,Unverified
200715_GreaterVancouverArea_BC-Centre-For-Disease-Control_MarchSnapshot_OverallPopAdj,15-Jul-20,Regional,Canada,CAN,British Columbia,,05-Mar-20,13-Mar-20,Residual sera,Multiple groups,869,0.28%,0.03%,0.95%,Stratified probability,"Abbott Laboratories,Ortho Clinical Diagnostics Inc.,NA,Siemens",CLIA,"IgA,IgM,IgG",,,Moderate,Preprint,Danuta Skowronski,British Columbia Centre for Disease Control,https://www.medrxiv.org/content/10.1101/2020.07.13.20153148v1,16/07/2020,16/07/2022,Verified
200715_GreaterVancouverArea_BC-Centre-for-Disease-Control_MaySnapshot_OverallPopAdj,15-Jul-20,Regional,Canada,CAN,British Columbia,,15-May-20,27-May-20,Residual sera,Multiple groups,885,0.55%,0.15%,1.37%,Stratified probability,"Abbott Laboratories,Ortho Clinical Diagnostics Inc.",CLIA,"IgA,IgM,IgG",,,Moderate,Preprint,Danuta Skowronski,British Columbia Centre for Disease Control,https://www.medrxiv.org/content/10.1101/2020.07.13.20153148v1,16/07/2020,16/07/2022,Verified
210205_Ontario_PublicHealthOntario_July_Abbott,02-Feb-21,Regional,Canada,CAN,Ontario,,04-Jul-20,31-Jul-20,Residual sera,Multiple groups,7001,1.39%,,,Stratified non-probability,Abbott Laboratories,CLIA,IgG,84.20%,100.00%,High,Journal Article (Peer-Reviewed),Shelly Bolotin,Public Health Ontario,https://dx.doi.org/10.1093/infdis/jiaa796,07/12/2020,16/07/2022,Verified
210205_Ontario_PublicHealthOntario_August_Abbott,02-Feb-21,Regional,Canada,CAN,Ontario,,01-Aug-20,21-Aug-20,Residual sera,Multiple groups,5764,1.56%,,,Stratified non-probability,Abbott Laboratories,CLIA,IgG,84.20%,100.00%,High,Journal Article (Peer-Reviewed),Shelly Bolotin,Public Health Ontario,https://dx.doi.org/10.1093/infdis/jiaa796,07/12/2020,16/07/2022,Verified
201017_Vancouver_UniversityofBritishColumbia_LTCF_overall,17-Oct-20,Local,Canada,CAN,British Columbia,Vancouver,04-May-20,14-May-20,Assisted living and long-term care facilities,Multiple groups,291,39.00%,,,Convenience,"DiaSorin,Abbott Laboratories,Ortho Clinical Diagnostics Inc.,Siemens",Not reported,"IgG,Total Antibody",,,High,Journal Article (Peer-Reviewed),Rohit Vijh,University of British Columbia,https://dx.doi.org/10.1016/j.ajic.2020.10.009,18/12/2020,16/07/2022,Verified
201027_Montreal_ShrinersHospital_children_unadj,27-Oct-20,Local,Canada,CAN,Québec,Montreal,10-Jun-20,27-Jul-20,Residual sera,Children and Youth (0-17 years),39,8.00%,,,Convenience,Omega diagnostics,ELISA,IgG,,97.00%,High,Journal Article (Peer-Reviewed),Ghalib Bardai,Shriners Hospital for Children,https://doi.org/10.1111/pan.14047,18/12/2020,16/07/2022,Verified
201027_Montreal_ShrinersHospital_accompanying_unadj,27-Oct-20,Local,Canada,CAN,Québec,Montreal,10-Jun-20,27-Jul-20,Hospital visitors,Adults (18-64 years),61,11.48%,,,Convenience,Omega diagnostics,ELISA,IgG,,97.00%,High,Journal Article (Peer-Reviewed),Ghalib Bardai,Shriners Hospital for Children,https://doi.org/10.1111/pan.14047,18/12/2020,16/07/2022,Verified
201027_Montreal_ShrinersHospital_employees_unadj,27-Oct-20,Local,Canada,CAN,Québec,Montreal,10-Jun-20,27-Jul-20,Health care workers and caregivers,Adults (18-64 years),99,12.00%,,,Convenience,Omega diagnostics,ELISA,IgG,,97.00%,High,Journal Article (Peer-Reviewed),Ghalib Bardai,Shriners Hospital for Children,https://doi.org/10.1111/pan.14047,18/12/2020,16/07/2022,Verified
210112_Canada_CBS_BloodDonors_Overall_PopAdjTestAdj,12-Jan-21,National,Canada,CAN,,,07-Nov-20,25-Nov-20,Blood donors,Multiple groups,17049,1.51%,1.31%,1.71%,Sequential,Abbott Laboratories,CLIA,IgG,92.70%,99.90%,Moderate,Institutional Report,Canadian Blood Services,Canadian Blood Services,https://slack-files.com/files-pri-safe/T011KSPAYPR-F01K401T9J9/covid-19_report_november_2020_final_12jan2021-1.pdf?c=1611144789-a5afc223a057856a,20/01/2021,16/07/2022,Verified
201218_Canada_CBS_BloodDonors_Overall_PopTestAdj,18-Dec-20,National,Canada,CAN,,,12-Oct-20,31-Oct-20,Blood donors,Multiple groups,16811,0.88%,0.73%,1.04%,Sequential,Abbott Laboratories,CLIA,IgG,92.70%,99.90%,Moderate,Institutional Report,Canadian Blood Services,Canadian Blood Services,N/A,21/01/2021,16/07/2022,Verified
201203_Edmonton_UniversityofAlberta_Children,03-Dec-20,Local,Canada,CAN,Alberta,Edmonton,14-Aug-20,23-Oct-20,Household and community samples,Children and Youth (0-17 years),565,1.60%,,,Convenience,Abbott Laboratories,CLIA,IgG,84.20%,100.00%,High,Preprint,Emilie Manny,University of Alberta,https://poseidon01.ssrn.com/delivery.php?ID=579098091025087124113094013092119126025046084059055038121105001063029013061117127066089088099029120125126127122027092067006090071077064116068026070083111035094021057114045098065076072116064007032059100097072054064094007027094015098095104082088098074069111094090004070124099079094007105068078&EXT=pdf&INDEX=TRUE,31/01/2021,16/07/2022,Verified
210208_Canada_CBS_BloodDonors_Overall_PopTestAdj,08-Feb-21,National,Canada,CAN,,,10-Dec-20,23-Dec-20,Blood donors,Multiple groups,16961,1.37%,1.18%,1.56%,Sequential,Abbott Laboratories,CLIA,IgG,92.70%,99.90%,Moderate,Institutional Report,Canadian Blood Services,Canadian Blood Services,N/A,19/02/2021,16/07/2022,Verified
210201_Canada_CanadianBloodServices_Overall_adj,01-Feb-21,National,Canada,CAN,"Yukon, Northwest Territories, Nunavut, British Columbia, Alberta, Saskatchewan, Manitoba, Ontario, New Brunswick, Nove Scotia, Prince Edward Island, Newfoundland and Labrador",,09-May-20,21-Jul-20,Blood donors,Multiple groups,74642,0.70%,0.63%,0.76%,Sequential,Abbott Laboratories,CLIA,IgG,92.70%,99.90%,Moderate,Journal Article (Peer-Reviewed),Sahar Saeed,Canadian Blood Services,http://dx.doi.org/10.1111/trf.16296,21/03/2021,16/07/2022,Verified
210216_Toronto_UniversityHealthNetwork_Euroimmun+Microarray,16-Feb-21,Local,Canada,CAN,Ontario,Toronto,17-Apr-20,29-May-20,Health care workers and caregivers,Adults (18-64 years),996,0.50%,,,Convenience,"EUROIMMUN,NA",Multiple Types,IgG,,,Moderate,Journal Article (Peer-Reviewed),Victor Ferreira,University Health Network,https://dx.doi.org/10.1371/journal.pone.0247258,22/03/2021,16/07/2022,Verified
210315_Vancouver_BCChildren’sHospitalResearchInstitute_OverallPrimary,15-Mar-21,Local,Canada,CAN,British Columbia,Vancouver,17-May-20,19-Jun-20,Household and community samples,Adults (18-64 years),276,0.60%,0.00%,2.71%,Convenience,"Meso Scale Discovery,Ortho Clinical Diagnostics Inc.",Multiple Types,Total Antibody,,,High,Journal Article (Peer-Reviewed),Abdelilah Majdoubi,BC Children’s Hospital Research Institute,https://dx.doi.org/10.1172/jci.insight.146316,11/04/2021,16/07/2022,Verified
210517_Quebec_Héma-Québec_PopAdj,17-May-21,Regional,Canada,CAN,Québec,,25-May-20,09-Jul-20,Blood donors,Adults (18-64 years),7691,2.23%,1.90%,2.56%,Convenience,NA,ELISA,"IgA,IgM,IgG",98.90%,98.50%,Moderate,Journal Article (Peer-Reviewed),Hema-Quebec,Héma-Québec,https://dx.doi.org/10.17269/s41997-021-00531-6,03/06/2021,16/07/2022,Verified
210512_Canada_UniversityofAlberta_April1,12-May-21,National,Canada,CAN,,,01-Apr-20,30-Apr-20,Blood donors,Adults (18-64 years),8999,3.07%,,,Convenience,NA,ELISA,IgG,89.10%,,High,Preprint,Sahar Saeed,University of Alberta,https://www.medrxiv.org/content/10.1101/2021.05.11.21256992v1.full-text#T1,04/06/2021,16/07/2022,Unverified
210512_Canada_UniversityofAlberta_September2,12-May-21,National,Canada,CAN,,,01-Sep-20,30-Sep-20,Blood donors,Adults (18-64 years),8999,2.67%,,,Simplified probability,NA,ELISA,IgG,89.10%,98.20%,Moderate,Preprint,Sahar Saeed,University of Alberta,https://www.medrxiv.org/content/10.1101/2021.05.11.21256992v1.full-text#T1,04/06/2021,16/07/2022,Unverified
210510_Canada_CBS_BloodDonors_RocheS_Overall_PopTestAdj,10-May-21,National,Canada,CAN,,,01-Jan-21,27-Jan-21,Blood donors,Multiple groups,33400,2.78%,2.58%,2.97%,Sequential,Roche Diagnostics,CLIA,Total Antibody,98.80%,99.60%,Moderate,Institutional Report,Canadian Blood Services,Canadian Blood Services,N/A,08/06/2021,16/07/2022,Verified
210618_Vancouver_UniversityOfBritishColumbia_TestAdj,18-Jun-21,Local,Canada,CAN,British Columbia,Vancouver,10-Feb-21,15-May-21,Essential non-healthcare workers,Adults (18-64 years),1556,2.30%,1.60%,3.20%,Self-referral,"Ortho Clinical Diagnostics Inc.,Roche Diagnostics",Multiple Types,"IgG,IgM,IgA",,,Moderate,Preprint,David Goldfarb,University of British Columbia,10.1101/2021.06.16.21258861,30/06/2021,16/07/2022,Unverified
210618_Vancouver_UniversityOfBritishColumbia_BloodDonors_TestAdj,18-Jun-21,Local,Canada,CAN,British Columbia,Vancouver,01-Jan-21,31-Jan-21,Blood donors,Adults (18-64 years),2502,2.30%,1.70%,3.00%,Convenience,Roche Diagnostics,CLIA,"IgG,IgM,IgA",,,High,Preprint,David Goldfarb,University of British Columbia,10.1101/2021.06.16.21258861,30/06/2021,16/07/2022,Unverified
210706_Canada_StatisticsCanada_Overall,06-Jul-21,National,Canada,CAN,,,15-Nov-20,15-Apr-21,Household and community samples,Multiple groups,11124,3.60%,2.60%,4.20%,Stratified probability,NA,Not reported,Not reported,,,Moderate,News and Media,Statistics Canada,Statistics Canada,https://www150.statcan.gc.ca/t1/tbl1/en/tv.action?pid=1310081801,31/07/2021,16/07/2022,Verified
210802_Calgary_UniversityofCalgary,02-Aug-21,Local,Canada,CAN,Alberta,Calgary,15-Oct-20,15-Apr-21,Patients seeking care for non-COVID-19 reasons,Multiple groups,279,1.08%,0.22%,3.11%,Sequential,Abbott Laboratories,CLIA,IgG,95.00%,99.00%,High,Journal Article (Peer-Reviewed),Gilaad Kaplan,University of Calgary,https://dx.doi.org/10.1136/gutjnl-2021-325238,11/08/2021,16/07/2022,Verified
210630_Canada_CBS_BloodDonors_RocheS_Overall_PopTestAdj,30-Jun-21,National,Canada,CAN,,,13-Apr-21,30-Apr-21,Blood donors,Multiple groups,16931,26.92%,26.24%,27.60%,Sequential,Roche Diagnostics,CLIA,Total Antibody,98.80%,99.60%,Moderate,Institutional Report,Canadian Blood Services,Canadian Blood Services,N/A,19/08/2021,16/07/2022,Verified
210609_Canada_CBS_BloodDonors_RocheS_Overall_PopTestAdj,09-Jun-21,National,Canada,CAN,,,27-Feb-21,13-Mar-21,Blood donors,Multiple groups,16873,9.85%,9.39%,10.31%,Sequential,Roche Diagnostics,CLIA,Total Antibody,98.80%,99.60%,Moderate,Institutional Report,Canadian Blood Services,Canadian Blood Services,N/A,19/08/2021,16/07/2022,Verified
210727_Canada_CBS_BloodDonors_RocheS_Overall_PopTestAdj,27-Jul-21,National,Canada,CAN,,,08-May-21,04-Jun-21,Blood donors,Multiple groups,17001,63.90%,63.17%,64.64%,Sequential,Roche Diagnostics,CLIA,Total Antibody,98.80%,99.60%,Moderate,Institutional Report,Canadian Blood Services,Canadian Blood Services,N/A,19/08/2021,16/07/2022,Verified
210818_Alberta_AlbertaPrecisionLaboratories_1_June_Overall_PopAdj,18-Aug-21,Regional,Canada,CAN,Alberta,,01-Jun-20,05-Jun-20,Residual sera,Multiple groups,8442,0.92%,0.91%,0.93%,Sequential,"Abbott Laboratories,DiaSorin",CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Carmen Charlton,Alberta Precision Laboratories,https://dx.doi.org/10.1128/Spectrum.00291-21,03/09/2021,16/07/2022,Verified
210818_Alberta_AlbertaPrecisionLaboratories_2_July_Overall_PopAdj,18-Aug-21,Regional,Canada,CAN,Alberta,,06-Jul-20,10-Jul-20,Residual sera,Multiple groups,13175,0.86%,0.85%,0.87%,Sequential,"Abbott Laboratories,DiaSorin",CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Carmen Charlton,Alberta Precision Laboratories,https://dx.doi.org/10.1128/Spectrum.00291-21,03/09/2021,16/07/2022,Verified
210818_Alberta_AlbertaPrecisionLaboratories_3_August_Overall_PopAdj,18-Aug-21,Regional,Canada,CAN,Alberta,,04-Aug-20,11-Aug-20,Residual sera,Multiple groups,12284,1.24%,1.23%,1.25%,Sequential,"Abbott Laboratories,DiaSorin",CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Carmen Charlton,Alberta Precision Laboratories,https://dx.doi.org/10.1128/Spectrum.00291-21,03/09/2021,16/07/2022,Verified
210818_Alberta_AlbertaPrecisionLaboratories_4_September_Overall_PopAdj,18-Aug-21,Regional,Canada,CAN,Alberta,,07-Sep-20,11-Sep-20,Residual sera,Multiple groups,12006,1.02%,1.00%,1.02%,Sequential,"Abbott Laboratories,DiaSorin",CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Carmen Charlton,Alberta Precision Laboratories,https://dx.doi.org/10.1128/Spectrum.00291-21,03/09/2021,16/07/2022,Verified
210818_Alberta_AlbertaPrecisionLaboratories_5_October_Overall_PopAdj,18-Aug-21,Regional,Canada,CAN,Alberta,,05-Oct-20,09-Oct-20,Residual sera,Multiple groups,13490,1.16%,1.15%,1.17%,Sequential,"Abbott Laboratories,DiaSorin",CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Carmen Charlton,Alberta Precision Laboratories,https://dx.doi.org/10.1128/Spectrum.00291-21,03/09/2021,16/07/2022,Verified
210818_Alberta_AlbertaPrecisionLaboratories_6_November_Overall_PopAdj,18-Aug-21,Regional,Canada,CAN,Alberta,,09-Nov-20,13-Nov-20,Residual sera,Multiple groups,11471,1.61%,1.60%,1.62%,Sequential,"Abbott Laboratories,DiaSorin",CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Carmen Charlton,Alberta Precision Laboratories,https://dx.doi.org/10.1128/Spectrum.00291-21,03/09/2021,16/07/2022,Verified
210818_Alberta_AlbertaPrecisionLaboratories_7_December_Overall_PopAdj,18-Aug-21,Regional,Canada,CAN,Alberta,,07-Dec-20,10-Dec-20,Residual sera,Multiple groups,12076,2.47%,2.46%,2.49%,Sequential,"Abbott Laboratories,DiaSorin",CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Carmen Charlton,Alberta Precision Laboratories,https://dx.doi.org/10.1128/Spectrum.00291-21,03/09/2021,16/07/2022,Verified
210818_Alberta_AlbertaPrecisionLaboratories_8_January_Overall_PopAdj,18-Aug-21,Regional,Canada,CAN,Alberta,,11-Jan-21,14-Jan-21,Residual sera,Multiple groups,11094,4.62%,4.60%,4.64%,Sequential,"Abbott Laboratories,DiaSorin",CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Carmen Charlton,Alberta Precision Laboratories,https://dx.doi.org/10.1128/Spectrum.00291-21,03/09/2021,16/07/2022,Verified
210830_Canada_CBS_BloodDonors_RocheS_Overall_PopTestAdj,30-Aug-21,National,Canada,CAN,,,14-Jun-21,29-Jun-21,Blood donors,Multiple groups,16884,90.78%,90.32%,91.25%,Sequential,Roche Diagnostics,CLIA,Total Antibody,98.80%,99.60%,Moderate,Institutional Report,Canadian Blood Services,Canadian Blood Services,N/A,16/09/2021,16/07/2022,Verified
211012_Ontario_TheHospitalforSickChildren_Primary,12-Oct-21,Regional,Canada,CAN,Ontario,,01-Apr-20,13-Nov-20,Health care workers and caregivers,Adults (18-64 years),1062,5.37%,,,Convenience,EUROIMMUN,ELISA,IgG,90.00%,98.00%,Moderate,Journal Article (Peer-Reviewed),Michelle Science,The Hospital for Sick Children ,https://dx.doi.org/10.9778/cmajo.20210044,19/10/2021,16/07/2022,Unverified
211013_Canada_CBS_BloodDonors_RocheS_Overall_PopTestAdj,13-Oct-21,National,Canada,CAN,,,14-Jul-21,23-Jul-21,Blood donors,Multiple groups,8457,94.69%,94.16%,95.22%,Stratified probability,Roche Diagnostics,CLIA,Total Antibody,98.80%,99.60%,Moderate,Institutional Report,Canadian Blood Services,Canadian Blood Services ,N/A,20/10/2021,16/07/2022,Verified
211122_Montreal_UniversityOfMontreal,23-Nov-21,Local,Canada,CAN,Québec,Montreal,22-Oct-20,22-Mar-21,Students and Daycares,Children and Youth (0-17 years),1632,5.80%,4.90%,7.00%,Convenience,NA,ELISA,IgG,95.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Kate Zinszer,University of Montreal,https://dx.doi.org/10.1001/jamanetworkopen.2021.35975,01/12/2021,16/07/2022,Unverified
211207_Calgary_CummingSchoolofMedicine,07-Dec-21,Local,Canada,CAN,Alberta,Calgary,01-Jan-20,31-Jan-21,Patients seeking care for non-COVID-19 reasons,Multiple groups,173,3.50%,,,Convenience,"EUROIMMUN,Luminex Corporation",Multiple Types,"IgG,IgA",,,High,Journal Article (Peer-Reviewed),Hanna Mathew,"Cumming School of Medicine, University of Calgary",https://dx.doi.org/10.1177/09612033211063793,14/12/2021,16/07/2022,Unverified
211022_Canada_UniversityofAlberta,22-Oct-21,National,Canada,CAN,"British Columbia, Alberta, Ontario, Québec",,19-Mar-20,22-Sep-20,Health care workers and caregivers,Adults (18-64 years),5135,0.19%,,,Unclear,NA,Not reported,Not reported,,,Unclear,Presentation or Conference,Nicola Cherry,University of Alberta,http://dx.doi.org/10.1136/OEM-2021-EPI.34,14/12/2021,16/07/2022,Unverified
211130_Canada_CBS_BloodDonors_RocheS_Overall_PopTestAdj,30-Nov-21,National,Canada,CAN,,,14-Sep-21,24-Sep-21,Blood donors,Multiple groups,9363,97.03%,96.62%,97.44%,Stratified probability,Roche Diagnostics,CLIA,Total Antibody,98.80%,99.60%,Moderate,Institutional Report,Canadian Blood Services,Canadian Blood Services ,https://www.covid19immunitytaskforce.ca/antibody-wane-being-observed-yet-breakthrough-infections-rare-latest-canadian-blood-services-report/,23/12/2021,16/07/2022,Verified
211027_Canada_CBS_BloodDonors_RocheS_Overall_PopTestAdj,27-Oct-21,National,Canada,CAN,,,15-Aug-21,26-Aug-21,Blood donors,Multiple groups,9109,96.09%,95.63%,96.54%,Stratified probability,Roche Diagnostics,CLIA,Total Antibody,98.80%,99.60%,Moderate,Institutional Report,Canadian Blood Services,Canadian Blood Services ,N/A,23/12/2021,16/07/2022,Verified
220103_Canada_CBS_BloodDonors_RocheS_Overall_PopTestAdj,03-Jan-22,National,Canada,CAN,,,14-Oct-21,23-Oct-21,Blood donors,Multiple groups,9627,98.01%,97.65%,98.36%,Stratified probability,Roche Diagnostics,CLIA,Total Antibody,98.80%,99.60%,Low,Institutional Report,Canadian Blood Services,Canadian Blood Services ,https://www.covid19immunitytaskforce.ca/canadian-blood-services-data-reveal-evidence-of-antibody-wane-among-adult-population/,14/01/2022,16/07/2022,Verified
220117_Quebec_McGillUniversity_EDM,17-Jan-22,Local,Canada,CAN,Québec,Montreal,19-Jan-21,20-Jul-21,Persons who are incarcerated,Adults (18-64 years),600,27.33%,,,Convenience,Roche Diagnostics,Not reported,IgG,99.50%,99.80%,Moderate,Journal Article (Peer-Reviewed),Nadine Kronfli,McGill University,https://dx.doi.org/10.1093/cid/ciac031,26/01/2022,16/07/2022,Verified
220117_Quebec_McGillUniversity_EDRDP,17-Jan-22,Local,Canada,CAN,Québec,Montreal,03-Feb-21,24-Mar-21,Persons who are incarcerated,Adults (18-64 years),300,14.67%,,,Convenience,Roche Diagnostics,Not reported,IgG,99.50%,99.80%,High,Journal Article (Peer-Reviewed),Nadine Kronfli,McGill University,https://dx.doi.org/10.1093/cid/ciac031,26/01/2022,16/07/2022,Verified
220117_Quebec_McGillUniversity_EDSJ,17-Jan-22,Local,Canada,CAN,Québec,Saint-Jérôme,30-Mar-21,15-Sep-21,Persons who are incarcerated,Adults (18-64 years),200,19.00%,,,Convenience,Roche Diagnostics,Not reported,IgG,99.50%,99.80%,High,Journal Article (Peer-Reviewed),Nadine Kronfli,McGill University,https://dx.doi.org/10.1093/cid/ciac031,26/01/2022,16/07/2022,Verified
220103_BritishColumbia_UniversityofBritishColumbia_May2020_Overall,03-Jan-22,Local,Canada,CAN,British Columbia,,04-May-20,14-May-20,Assisted living and long-term care facilities,Seniors (65+ years),87,40.20%,,,Convenience,"DiaSorin,Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Siemens",CLIA,Total Antibody,,,High,Journal Article (Peer-Reviewed),Guadalein Tanunliong,University of British Columbia,https://dx.doi.org/10.3389/fimmu.2021.775420,27/01/2022,16/07/2022,Unverified
220103_BritishColumbia_UniversityofBritishColumbia_Dec2020_Overall,03-Jan-22,Local,Canada,CAN,British Columbia,,,22-Dec-20,Assisted living and long-term care facilities,Seniors (65+ years),45,44.40%,,,Convenience,"Siemens,Abbott Laboratories,Ortho Clinical Diagnostics Inc.",CLIA,Total Antibody,,,High,Journal Article (Peer-Reviewed),Guadalein Tanunliong,University of British Columbia,https://dx.doi.org/10.3389/fimmu.2021.775420,27/01/2022,16/07/2022,Unverified
211122_Montreal_UniversityOfMontreal_2-4,23-Nov-21,Local,Canada,CAN,Québec,Montreal,22-Oct-20,22-Mar-21,Students and Daycares,Children and Youth (0-17 years),332,4.80%,2.90%,6.70%,Convenience,NA,ELISA,IgG,95.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Kate Zinszer,University of Montreal,https://dx.doi.org/10.1001/jamanetworkopen.2021.35975,06/02/2022,16/07/2022,Unverified
211122_Montreal_UniversityOfMontreal_5-9,23-Nov-21,Local,Canada,CAN,Québec,Montreal,22-Oct-20,22-Mar-21,Students and Daycares,Children and Youth (0-17 years),542,5.00%,3.40%,6.60%,Convenience,NA,ELISA,IgG,95.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Kate Zinszer,University of Montreal,https://dx.doi.org/10.1001/jamanetworkopen.2021.35975,06/02/2022,16/07/2022,Unverified
211122_Montreal_UniversityOfMontreal_10-14,23-Nov-21,Local,Canada,CAN,Québec,Montreal,22-Oct-20,22-Mar-21,Students and Daycares,Children and Youth (0-17 years),529,6.80%,4.20%,9.40%,Convenience,NA,ELISA,IgG,95.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Kate Zinszer,University of Montreal,https://dx.doi.org/10.1001/jamanetworkopen.2021.35975,06/02/2022,16/07/2022,Unverified
211122_Montreal_UniversityOfMontreal_15-17,23-Nov-21,Local,Canada,CAN,Québec,Montreal,22-Oct-20,22-Mar-21,Students and Daycares,Children and Youth (0-17 years),221,7.20%,3.40%,11.00%,Convenience,NA,ELISA,IgG,95.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Kate Zinszer,University of Montreal,https://dx.doi.org/10.1001/jamanetworkopen.2021.35975,06/02/2022,16/07/2022,Unverified
211130_Calgary_UniversityofCalgary_Visit3_Spike,30-Nov-21,Local,Canada,CAN,Alberta,Calgary,11-Aug-21,22-Oct-21,Household and community samples,Children and Youth (0-17 years),783,48.28%,,,Self-referral,Abbott Laboratories,Not reported,Not reported,,,High,Institutional Report,James Kellner,University of Calgary,,16/02/2022,16/07/2022,Unverified
220217_Ontario_SinaiHealthSystem_Overall,17-Feb-22,Regional,Canada,CAN,Ontario,,18-Feb-21,17-Jul-21,Essential non-healthcare workers,Multiple groups,1252,1.84%,,,Convenience,Bio-Rad,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),Brenda Coleman,Sinai Health System,https://dx.doi.org/10.17269/s41997-022-00613-z,23/02/2022,16/07/2022,Unverified
220125_Canada_CBS_BloodDonors_RocheS_Overall_PopTestAdj,25-Jan-22,National,Canada,CAN,,,13-Nov-21,24-Nov-21,Blood donors,Multiple groups,9018,98.52%,98.18%,98.86%,Stratified probability,Roche Diagnostics,CLIA,Total Antibody,98.80%,99.60%,Moderate,Institutional Report,Canadian Blood Services,Canadian Blood Services ,https://www.covid19immunitytaskforce.ca/latest-canadian-blood-services-data-reflect-uptick-in-infections-prior-to-omicron-surge/,08/03/2022,16/07/2022,Verified
220209_Canada_CBS_BloodDonors_RocheS_Overall_PopTestAdj,09-Feb-22,National,Canada,CAN,,,14-Dec-21,30-Dec-21,Blood donors,Multiple groups,16816,98.58%,98.34%,98.82%,Sequential,Roche Diagnostics,CLIA,Total Antibody,98.80%,99.60%,Low,Institutional Report,Canadian Blood Services,Canadian Blood Services ,https://www.covid19immunitytaskforce.ca/canadian-blood-services-december-report-the-advance-of-omicron/,08/03/2022,16/07/2022,Verified
220121_Toronto_UniversityOfOxford,21-Jan-22,Local,Canada,CAN,,Toronto,26-May-20,24-Sep-21,Patients seeking care for non-COVID-19 reasons,Multiple groups,28,3.57%,,,Convenience,"Roche Diagnostics,Siemens",Not reported,Total Antibody,,,High,Presentation or Conference,S Y Wong,University of Oxford,https://dx.doi.org/10.1093/ecco-jcc/jjab232.469,08/03/2022,16/07/2022,Unverified
220223_Canada_CanadianBloodServices_OverallAND,23-Feb-22,National,Canada,CAN,,,15-Apr-20,15-Mar-21,Blood donors,Multiple groups,17999,2.10%,1.90%,2.30%,Convenience,"Abbott Laboratories,NA",Multiple Types,IgG,,,High,Journal Article (Peer-Reviewed),Ashleigh Tuite,Canadian Blood Services,https://dx.doi.org/10.1128/spectrum.02563-21,09/03/2022,16/07/2022,Verified
211106_Calgary_UniversityofCalgary_Ambulatory_Overall,06-Nov-21,Local,Canada,CAN,Alberta,,15-Mar-20,31-Jan-21,Residual sera,Multiple groups,148,3.38%,,,Sequential,"EUROIMMUN,Luminex Corporation",ELISA,"IgG,IgA",,,High,Presentation or Conference,Hannah Mathew,University of Calgary,https://acrabstracts.org/abstract/sars-cov-2-seroprevalence-and-seroconversion-in-a-systemic-lupus-erythematosus-cohort-and-comparison-to-general-population-controls/,09/03/2022,16/07/2022,Unverified
211106_Calgary_UniversityofCalgary_SLE_Overall,06-Nov-21,Local,Canada,CAN,Alberta,,15-Mar-20,31-Jan-21,Patients seeking care for non-COVID-19 reasons,Multiple groups,173,3.47%,,,Sequential,"EUROIMMUN,Luminex Corporation",ELISA,"IgG,IgA",,,High,Presentation or Conference,Hannah Mathew,University of Calgary,https://acrabstracts.org/abstract/sars-cov-2-seroprevalence-and-seroconversion-in-a-systemic-lupus-erythematosus-cohort-and-comparison-to-general-population-controls/,09/03/2022,16/07/2022,Unverified
220311_Canada_CBS_BloodDonors_RocheS_Overall_PopTestAdj,11-Mar-22,National,Canada,CAN,,,01-Jan-22,31-Jan-22,Blood donors,Multiple groups,32505,98.89%,98.73%,99.06%,Sequential,Roche Diagnostics,CLIA,Total Antibody,98.80%,99.60%,Moderate,Institutional Report,Canadian Blood Services,Canadian Blood Services ,N/A,21/03/2022,16/07/2022,Verified
220307_Quebec_InstitutnationaldesantépubliqueduQuébec_Overall,07-Mar-22,Regional,Canada,CAN,Quebec,,06-Jul-20,24-Sep-20,Health care workers and caregivers,Adults (18-64 years),2056,11.72%,,,Convenience,DiaSorin,CLIA,IgG,82.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Nicholas Brousseau,Institut national de santé publique du Québec,https://dx.doi.org/10.1503/cmaj.202783-f,12/04/2022,16/07/2022,Unverified
220323_BC_UniversityOfBritishColumbia_Spike,23-Mar-22,Regional,Canada,CAN,British Columbia,,15-Mar-20,31-May-20,Residual sera,Multiple groups,488,1.84%,,,Stratified probability,Meso Scale Discovery,CLIA,IgG,100.00%,100.00%,High,Journal Article (Peer-Reviewed),Guadalein Tanunliong,University of British Columbia,https://dx.doi.org/10.3389/fimmu.2022.836449,22/04/2022,16/07/2022,Verified
220401_Ontario_McMasterUniversity_Overall_Pop_Adj,01-Apr-22,Regional,Canada,CAN,Ontario,,14-Apr-21,28-Jul-21,Household and community samples,Multiple groups,916,23.10%,22.90%,23.40%,Convenience,,ELISA,IgG,,,High,Preprint,Sonia Anand,McMaster University,https://www.medrxiv.org/content/10.1101/2022.04.01.22273252v1.full-text,25/04/2022,16/07/2022,Unverified
20220420_Canada_StatisticsCanada_OverallUnadj,20-Apr-22,National,Canada,CAN,10 provinces and 3 territories,,15-Nov-20,15-Apr-21,Household and community samples,Multiple groups,10820,1.90%,,,Stratified probability,NA,ELISA,IgG,,,Low,Institutional Report,Tracey Bushnik,Statistics Canada,https://dx.doi.org/10.25318/82-003-x202200400003-eng,26/04/2022,16/07/2022,Unverified
220504_Vancouver_UniversityOfBritishColumbia_SchoolStaff1_PopAdj,05-Apr-22,Local,Canada,CAN,British Columbia,Vancouver,10-Feb-21,15-May-21,Essential non-healthcare workers,Adults (18-64 years),1556,2.60%,1.90%,3.60%,Convenience,"Ortho Clinical Diagnostics Inc.,Roche Diagnostics",CLIA,Total Antibody,,,Moderate,Journal Article (Peer-Reviewed),David Goldfarb,University of British Colombia,https://dx.doi.org/10.1136/bmjopen-2021-057846,01/05/2022,16/07/2022,Verified
220504_Vancouver_UniversityOfBritishColumbia_BloodDonors2,05-Apr-22,Local,Canada,CAN,British Columbia,Vancouver,01-Jan-21,31-May-21,Blood donors,Adults (18-64 years),5417,2.60%,2.20%,3.10%,Convenience,Roche Diagnostics,CLIA,Total Antibody,98.80%,99.60%,Moderate,Journal Article (Peer-Reviewed),David Goldfarb,University of British Colombia,https://dx.doi.org/10.1136/bmjopen-2021-057846,01/05/2022,16/07/2022,Verified
211216_Ontario_PublicHealthOntario_March_Overall_PopTestAdj,16-Dec-21,Regional,Canada,CAN,Ontario,,27-Mar-20,30-Apr-20,Residual sera,Multiple groups,827,0.50%,0.10%,1.50%,Stratified probability,"Abbott Laboratories,Ortho Clinical Diagnostics Inc.",CLIA,IgG,92.30%,100.00%,Moderate,Journal Article (Peer-Reviewed),Shelly Bolotin,Public Health Ontario,https://dx.doi.org/10.2807/1560-7917.ES.2021.26.50.2001559,06/05/2022,16/07/2022,Verified
211216_Ontario_PublicHealthOntario_May_Overall_PopTestAdj,16-Dec-21,Regional,Canada,CAN,Ontario,,26-May-20,31-May-20,Residual sera,Multiple groups,1061,1.50%,0.70%,2.20%,Stratified probability,"Abbott Laboratories,Ortho Clinical Diagnostics Inc.",CLIA,IgG,92.30%,100.00%,Moderate,Journal Article (Peer-Reviewed),Shelly Bolotin,Public Health Ontario,https://dx.doi.org/10.2807/1560-7917.ES.2021.26.50.2001559,06/05/2022,16/07/2022,Verified
211216_Ontario_PublicHealthOntario_June_Overall_PopTestAdj,16-Dec-21,Regional,Canada,CAN,Ontario,,05-Jun-20,30-Jun-20,Residual sera,Multiple groups,7014,1.10%,0.80%,1.30%,Stratified probability,"Abbott Laboratories,Ortho Clinical Diagnostics Inc.",CLIA,IgG,92.30%,100.00%,Moderate,Journal Article (Peer-Reviewed),Shelly Bolotin,Public Health Ontario,https://dx.doi.org/10.2807/1560-7917.ES.2021.26.50.2001559,06/05/2022,16/07/2022,Verified
220410_Canada_CBS_BloodDonors_RocheS_Overall_PopTestAdj,10-Apr-22,National,Canada,CAN,,,01-Feb-22,28-Feb-22,Blood donors,Multiple groups,28616,99.60%,99.45%,99.75%,Sequential,Roche Diagnostics,CLIA,Total Antibody,98.80%,99.60%,Moderate,Institutional Report,Canadian Blood Services,Canadian Blood Services ,N/A,24/05/2022,16/07/2022,Verified
220506_Canada_CBS_BloodDonors_RocheS_Overall_PopTestAdj,06-May-22,National,Canada,CAN,,,01-Mar-22,31-Mar-22,Blood donors,Multiple groups,26026,99.57%,99.42%,99.73%,Sequential,Roche Diagnostics,CLIA,Total Antibody,98.80%,99.60%,Moderate,Institutional Report,Canadian Blood Services,Canadian Blood Services ,N/A,24/05/2022,16/07/2022,Verified
220517_Canada_CBS_BloodDonors_RocheS_Overall_Unadj,17-May-22,National,Canada,CAN,,,01-Apr-22,15-Apr-22,Blood donors,Multiple groups,14341,99.80%,99.60%,99.99%,Sequential,Roche Diagnostics,CLIA,Total Antibody,98.80%,99.60%,Moderate,Institutional Report,Canadian Blood Service,Canadian Blood Services ,N/A,24/05/2022,16/07/2022,Verified
220518_Canada_UnityHealthToronto_Phase4_Overall_UnAdj,18-May-22,National,Canada,CAN,,,24-Jan-22,15-Mar-22,Household and community samples,Multiple groups,5031,37.15%,,,Convenience,NA,ELISA,IgG,90.00%,90.00%,High,Journal Article (Peer-Reviewed),Patrick Brown,Unity Health Toronto,https://doi.org/10.1056/NEJMc2202879,06/06/2022,16/07/2022,Unverified
220531_Alberta_AlbertaPrecisionLaboratories_March_OverallAdj,31-May-22,Regional,Canada,CAN,Alberta,,26-Feb-21,04-Mar-21,Residual sera,Multiple groups,12490,11.90%,11.90%,12.00%,Convenience,Abbott Laboratories,CLIA,IgG,98.10%,99.60%,Low,Journal Article (Peer-Reviewed),Jamil N. Kanji,Alberta Precision Laboratories,https://dx.doi.org/10.1080/23744235.2022.2080250,07/06/2022,16/07/2022,Unverified
220531_Alberta_AlbertaPrecisionLaboratories_April_Overall_Adj,31-May-22,Regional,Canada,CAN,Alberta,,09-Apr-21,16-Apr-21,Residual sera,Multiple groups,12123,11.90%,11.90%,12.00%,Convenience,Abbott Laboratories,CLIA,IgG,98.10%,99.60%,Low,Journal Article (Peer-Reviewed),Jamil N. Kanji,Alberta Precision Laboratories,https://dx.doi.org/10.1080/23744235.2022.2080250,07/06/2022,16/07/2022,Unverified
220531_Alberta_AlbertaPrecisionLaboratories_May_OverallAdj,31-May-22,Regional,Canada,CAN,Alberta,,30-Apr-21,07-May-21,Residual sera,Multiple groups,11586,34.60%,34.50%,34.60%,Convenience,Abbott Laboratories,CLIA,IgG,98.10%,99.60%,Low,Journal Article (Peer-Reviewed),Jamil N. Kanji,Alberta Precision Laboratories,https://dx.doi.org/10.1080/23744235.2022.2080250,07/06/2022,16/07/2022,Unverified
220531_Alberta_AlbertaPrecisionLaboratories_June_OverallAdj,31-May-22,Regional,Canada,CAN,Alberta,,03-Jun-21,11-Jun-21,Residual sera,Multiple groups,11894,62.40%,62.40%,62.50%,Convenience,Abbott Laboratories,CLIA,IgG,98.10%,99.60%,Low,Journal Article (Peer-Reviewed),Jamil N. Kanji,Alberta Precision Laboratories,https://dx.doi.org/10.1080/23744235.2022.2080250,07/06/2022,16/07/2022,Unverified
220531_Alberta_AlbertaPrecisionLaboratories_July_OverallAdj,31-May-22,Regional,Canada,CAN,Alberta,,02-Jul-21,09-Jul-21,Residual sera,Multiple groups,12539,70.20%,70.20%,70.30%,Convenience,Abbott Laboratories,CLIA,IgG,98.10%,99.60%,Low,Journal Article (Peer-Reviewed),Jamil N. Kanji,Alberta Precision Laboratories,https://dx.doi.org/10.1080/23744235.2022.2080250,07/06/2022,16/07/2022,Unverified
220301_Quebec_McGillUniversity,01-Mar-22,Regional,Canada,CAN,Quebec,,19-Jan-21,15-Sep-21,Persons who are incarcerated,Adults (18-64 years),1100,22.36%,,,Unclear,NA,Not reported,Not reported,,,Unclear,Journal Article (Peer-Reviewed),Nadine Kronfli,McGill University,https://www.iasusa.org/tam/march-2022/,17/06/2022,16/07/2022,Unverified
220612_Canada_CBS_BloodDonors_RocheS_Overall_Unadj,12-Jun-22,National,Canada,CAN,,,01-May-22,15-May-22,Blood donors,Multiple groups,15958,100.00%,99.79%,100.00%,Sequential,Roche Diagnostics,CLIA,Total Antibody,98.80%,99.60%,Moderate,Institutional Report,Canadian Blood Services,Canadian Blood Services ,N/A,22/06/2022,16/07/2022,Unverified
220705_Ontario_McMasterUniversity_Overall_Pop_Adj,05-Jul-22,Regional,Canada,CAN,Ontario,,14-Apr-21,28-Jul-21,Household and community samples,Multiple groups,916,22.90%,20.10%,26.10%,Convenience,,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Sonia Anand,McMaster University,https://doi.org/10.9778/cmajo.20220031,15/07/2022,16/07/2022,Unverified
220712_Ottawa_OMNIResearchGroup_Primary,12-Jul-22,Local,Canada,CAN,Ontario,"Ottawa
",19-Oct-20,27-Nov-20,Pregnant or parturient women,Adults (18-64 years),352,18.50%,,,Convenience,NA,ELISA,Total Antibody,,,High,Journal Article (Peer-Reviewed),Romina Fakhraei,OMNI Research Group,https://dx.doi.org/10.9778/cmajo.20210228,18/07/2022,18/07/2022,Unverified
210530_Cameroon_UniversityofYaoundé_primary,30-May-21,Regional,Cameroon,CMR,,,15-Jun-20,15-Aug-20,Multiple populations,Multiple groups,999,32.00%,27.00%,35.00%,Convenience,Innovita Biological Technology Co. Ltd,LFIA,"IgM,IgG",,,High,Journal Article (Peer-Reviewed),Karl Njuwa Fai,University of Yaoundé,https://dx.doi.org/10.1016/j.sciaf.2021.e00802,16/06/2021,16/07/2022,Unverified
211006_Yaoundé_HopitalCentraldeYaounde_PopTestAdj_Overall,06-Oct-21,Local,Cameroon,CMR,Centre,Yaoundé,14-Oct-20,26-Nov-20,Household and community samples,Multiple groups,971,29.20%,23.80%,34.90%,Simplified probability,Abbott Laboratories,LFIA,IgG,91.50%,93.50%,Low,Journal Article (Peer-Reviewed),Kene Nwosu,Hopital Central de Yaounde,https://dx.doi.org/10.1038/s41467-021-25946-0,13/10/2021,16/07/2022,Verified
210108_CapeVerde_MestreEmSaúdeEDesenvolvimento_overall,08-Jan-21,National,Cabo Verde,CPV,,,26-Jun-20,04-Jul-20,Household and community samples,Multiple groups,5348,0.40%,,,Stratified probability,Guangzhou Wondfo Biotech Co. Ltd,LFIA,"IgG,IgM",86.43%,99.57%,Moderate,Preprint,Lara Ferrero Gomez,Mestre em Saúde e Desenvolvimento,https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3762489,29/04/2021,16/07/2022,Verified
220525_BurkinaFaso_CentredeRechercheBiomoleculairePietroAnnigoni_Overall_TestAdj,25-May-22,Local,Burkina Faso,BFA,,,02-Nov-20,30-Nov-20,Representative patient population,Multiple groups,200,18.27%,,,Convenience,SD Biosensor,LFIA,"IgG,IgM",81.80%,96.70%,High,Journal Article (Peer-Reviewed),Tani Sagna,Centre de Recherche Biomoléculaire Pietro Annigoni,https://dx.doi.org/10.4081/jphia.2022.1778,30/06/2022,16/07/2022,Unverified
200527_Varna_MedicalDiagnosticLaboratory_IgG/IgM,27-May-20,Local,Bulgaria,BGR,Varna, Varna,26-Mar-20,20-Apr-20,Residual sera,Multiple groups,586,4.80%,3.20%,6.80%,Convenience,Zhejiang Orient Gene Biotech,LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Denitsa Tsaneva-Damyanova,"Medical Diagnostic Laboratory ""STATUS"" ",https://www.tandfonline.com/doi/pdf/10.1080/13102818.2020.1772105?needAccess=true,20/07/2020,16/07/2022,Verified
200517_SaoPaolo_GrupoFleury_GenPop,17-May-20,Local,Brazil,BRA,São Paulo,São Paulo,04-May-20,12-May-20,Household and community samples,Multiple groups,520,5.19%,,,Stratified probability,NA,Not reported,Not reported,90.00%,,Unclear,News and Media,Phillippe Watanabe,Grupo Fleury,https://www1.folha.uol.com.br/equilibrioesaude/2020/05/nos-bairros-de-sp-mais-afetados-pela-covid-19-so-5-tiveram-contato-com-o-virus.shtml,02/06/2020,16/07/2022,Verified
200616_Brazil_SecretariadeEstadodaSaúdedoEspíritoSanto_GenPopUrban,16-Jun-20,Regional,Brazil,BRA,Espírito Santo,,13-May-20,15-May-20,Household and community samples,Multiple groups,4612,2.10%,1.67%,2.52%,Stratified probability,Celer Technologies Inc.,LFIA,"IgG,IgM",86.40%,97.63%,High,Preprint,Cristiana Gomes,Secretaria de Estado da Saúde do Espírito Santo,https://www.medrxiv.org/content/10.1101/2020.06.13.20130559v1.full.pdf,18/06/2020,16/07/2022,Verified
200616_Brazil_SecretariadeEstadodaSaúdedoEspíritoSanto_GenPop2Sub-urban,16-Jun-20,Regional,Brazil,BRA,Espírito Santo,,13-May-20,15-May-20,Household and community samples,Multiple groups,1163,0.26%,0.05%,0.75%,Stratified probability,Celer Technologies Inc.,LFIA,"IgG,IgM",86.40%,97.63%,High,Preprint,Cristiana Gomes,Secretaria de Estado da Saúde do Espírito Santo,https://www.medrxiv.org/content/10.1101/2020.06.13.20130559v1.full.pdf,18/06/2020,16/07/2022,Verified
200706_RiodeJaneiro_UniversidadedoEstadodoRiodeJaneiro_BloodDonors_OverallAdj,06-Jul-20,Local,Brazil,BRA,Rio de Janeiro,Rio de Janeiro,14-Apr-20,27-Apr-20,Blood donors,Adults (18-64 years),2857,3.30%,2.60%,4.10%,Sequential,MedLevensohn,LFIA,"IgG,IgM",85.00%,99.00%,Moderate,Journal Article (Peer-Reviewed),Amorim Filho,Universidade do Estado do Rio de Janeiro,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7334006/,10/07/2020,16/07/2022,Verified
200703_Teresina_CentrodeOperaçõesdeEmergênciasemSaúdePública_Apr19,03-Jul-20,Local,Brazil,BRA,Piaui,Teresina,19-Apr-20,19-Apr-20,Household and community samples,Multiple groups,900,0.56%,0.18%,1.30%,Stratified probability,Guangzhou Wondfo Biotech Co. Ltd,LFIA,"IgG,IgM",86.00%,99.00%,Moderate,Journal Article (Peer-Reviewed),Marcelo Vieira, Centro de Operações de Emergências em Saúde Pública,https://dx.doi.org/10.1590/0037-8682-0351-2020,30/07/2020,16/07/2022,Verified
200703_Teresina_CentrodeOperaçõesdeEmergênciasemSaúdePública_Apr26,03-Jul-20,Local,Brazil,BRA,Piaui,Teresina,26-Apr-20,26-Apr-20,Household and community samples,Multiple groups,900,0.89%,0.39%,1.75%,Stratified probability,Guangzhou Wondfo Biotech Co. Ltd,LFIA,"IgG,IgM",86.00%,99.00%,Moderate,Journal Article (Peer-Reviewed),Marcelo Vieira, Centro de Operações de Emergências em Saúde Pública,https://dx.doi.org/10.1590/0037-8682-0351-2020,30/07/2020,16/07/2022,Verified
200703_Teresina_CentrodeOperaçõesdeEmergênciasemSaúdePública_May3,03-Jul-20,Local,Brazil,BRA,Piaui,Teresina,03-May-20,03-May-20,Household and community samples,Multiple groups,900,1.44%,0.77%,2.45%,Stratified probability,Guangzhou Wondfo Biotech Co. Ltd,LFIA,"IgG,IgM",86.00%,99.00%,Moderate,Journal Article (Peer-Reviewed),Marcelo Vieira, Centro de Operações de Emergências em Saúde Pública,https://dx.doi.org/10.1590/0037-8682-0351-2020,30/07/2020,16/07/2022,Verified
200703_Teresina_CentrodeOperaçõesdeEmergênciasemSaúdePública_May10,03-Jul-20,Local,Brazil,BRA,Piaui,Teresina,10-May-20,10-May-20,Household and community samples,Multiple groups,900,2.00%,1.19%,3.14%,Stratified probability,Guangzhou Wondfo Biotech Co. Ltd,LFIA,"IgG,IgM",86.00%,99.00%,Moderate,Journal Article (Peer-Reviewed),Marcelo Vieira, Centro de Operações de Emergências em Saúde Pública,https://dx.doi.org/10.1590/0037-8682-0351-2020,30/07/2020,16/07/2022,Verified
200703_Teresina_CentrodeOperaçõesdeEmergênciasemSaúdePública_May17,03-Jul-20,Local,Brazil,BRA,Piaui,Teresina,17-May-20,17-May-20,Household and community samples,Multiple groups,900,3.78%,2.63%,5.24%,Stratified probability,Guangzhou Wondfo Biotech Co. Ltd,LFIA,"IgG,IgM",86.00%,99.00%,Moderate,Journal Article (Peer-Reviewed),Marcelo Vieira, Centro de Operações de Emergências em Saúde Pública,https://dx.doi.org/10.1590/0037-8682-0351-2020,30/07/2020,16/07/2022,Verified
200703_Teresina_CentrodeOperaçõesdeEmergênciasemSaúdePública_May24,03-Jul-20,Local,Brazil,BRA,Piaui,Teresina,24-May-20,24-May-20,Household and community samples,Multiple groups,900,5.78%,4.30%,7.30%,Stratified probability,Guangzhou Wondfo Biotech Co. Ltd,LFIA,"IgG,IgM",86.00%,99.00%,Moderate,Journal Article (Peer-Reviewed),Marcelo Vieira, Centro de Operações de Emergências em Saúde Pública,https://dx.doi.org/10.1590/0037-8682-0351-2020,30/07/2020,16/07/2022,Verified
200703_Teresina_CentrodeOperaçõesdeEmergênciasemSaúdePública_May31,03-Jul-20,Local,Brazil,BRA,Piaui,Teresina,31-May-20,31-May-20,Household and community samples,Multiple groups,900,8.33%,6.61%,10.33%,Stratified probability,Guangzhou Wondfo Biotech Co. Ltd,LFIA,"IgG,IgM",86.00%,99.00%,Moderate,Journal Article (Peer-Reviewed),Marcelo Vieira, Centro de Operações de Emergências em Saúde Pública,https://dx.doi.org/10.1590/0037-8682-0351-2020,30/07/2020,16/07/2022,Verified
200916_Lajeado_UniversidadedoValedodoTaquari_Survey1,16-Sep-20,Local,Brazil,BRA,Rio Grande do Sul,Lajeado,30-May-20,04-Jun-20,Household and community samples,Multiple groups,1450,4.03%,3.08%,5.18%,Stratified probability,Guangzhou Wondfo Biotech Co. Ltd,LFIA,"IgM,IgG",76.24%,99.57%,Moderate,Journal Article (Peer-Reviewed),Rafael Picon,Universidade do Vale do Taquari,http://dx.doi.org/10.1016/j.ijid.2020.09.028,12/11/2020,16/07/2022,Verified
200916_Lajeado_UniversidadedoValedodoTaquari_Survey2,16-Sep-20,Local,Brazil,BRA,Rio Grande do Sul,Lajeado,13-Jun-20,17-Jun-20,Household and community samples,Multiple groups,1127,2.59%,1.75%,3.70%,Stratified probability,Guangzhou Wondfo Biotech Co. Ltd,LFIA,"IgM,IgG",76.24%,99.57%,Moderate,Journal Article (Peer-Reviewed),Rafael Picon,Universidade do Vale do Taquari,http://dx.doi.org/10.1016/j.ijid.2020.09.028,12/11/2020,16/07/2022,Verified
200930_Sergipe_FederalUniversityofSergipe_OverallIgG,30-Sep-20,Regional,Brazil,BRA,Sergipe,,01-Jun-20,30-Jun-20,Health care workers and caregivers,Multiple groups,471,13.59%,,,Convenience,Boditech Med Inc.,Other,IgG,95.80%,97.00%,High,Preprint,Monica de Melo,Federal University of Sergipe,https://www.medrxiv.org/content/medrxiv/early/2020/09/30/2020.09.24.20200873.full.pdf,23/11/2020,16/07/2022,Verified
201006_Brazil_FederalUniversityofSergipe_genpop_IgG,06-Oct-20,Regional,Brazil,BRA,Sergipe,"Aracaju, Simão Dias, Itabaiana, Itabaianinha, Nossa Senhora do, São Cristóvão, Estância, Lagarto, Tobias Barreto, Nossa Senhora da Glória",02-May-20,09-May-20,Household and community samples,Multiple groups,2635,8.30%,7.20%,9.40%,Convenience,Boditech Med Inc.,LFIA,IgG,,,High,Journal Article (Peer-Reviewed),Lysandro Pinto Borges,Federal University of Sergipe ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7541966/,20/12/2020,16/07/2022,Verified
200901_Petrópolis_CentrodeTerapiaOncológica_HCW_IGGorIGM,01-Sep-20,Local,Brazil,BRA,Rio de Janeiro,Petrópolis,09-Apr-20,29-Apr-20,Health care workers and caregivers,Adults (18-64 years),61,4.91%,,,Convenience,NA,LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),P Ismael Amaral Silva,Centro de Terapia Oncológica,http://dx.doi.org/10.1016/j.annonc.2020.08.1825,04/01/2021,16/07/2022,Verified
201021_SaoPaulo_AdolfoLutzCentralInstitute,21-Oct-20,Local,Brazil,BRA,State of Sao Paulo,Sao Paulo,05-Jun-20,31-Jul-20,Multiple populations,Multiple groups,406,8.60%,,,Convenience,"Guangzhou Wondfo Biotech Co. Ltd,Roche Diagnostics",Multiple Types,"IgG,IgM",,,High,Preprint,Valeria Oliveira Silva,Adolfo Lutz Central Institute,https://www.medrxiv.org/content/10.1101/2020.10.19.20213421v1,17/01/2021,16/07/2022,Verified
201213_SaoPaulo_ FaculdadeDeMedicinaDaUniversidade_Overall,13-Dec-20,Local,Brazil,BRA,São Paulo State,São Paulo ,14-May-20,28-May-20,Health care workers and caregivers,Adults (18-64 years),4987,14.10%,13.10%,15.00%,Convenience,Guangzhou Wondfo Biotech Co. Ltd,LFIA,"IgG,IgM",,,Moderate,Journal Article (Peer-Reviewed),Silvia Costa,Faculdade De Medicina da Universidade,https://dx.doi.org/10.1093/cid/ciaa1845,23/01/2021,16/07/2022,Verified
201119_SaoPaulo_ClinicaDeReumatologia_RheumaticPatients,19-Nov-20,Local,Brazil,BRA,State of Sao Paulo,Sao Paulo,15-Mar-20,15-Aug-20,Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),100,21.00%,,,Convenience,Snibe Co. Ltd (Shenzhen New Industries Biomedical Engineering Co. Ltd),CLIA,"IgG,IgM",,,High,Preprint,Felipe Santana,Clínica de Reumatologia,https://www.researchsquare.com/article/rs-97191/v1,23/01/2021,16/07/2022,Verified
201113_SaoPaulo_UniversidadeSaoPaulo_primary,13-Nov-20,Local,Brazil,BRA,State of Sao Paulo,Sao Paulo,30-Jun-20,04-Aug-20,Residual sera,Multiple groups,439,13.90%,,,Convenience,"DiaSorin,Roche Diagnostics",CLIA,"IgG,Total Antibody",,,High,Journal Article (Peer-Reviewed),Luanda Mara da Silva Oliveira,Universidade de São Paulo,https://dx.doi.org/10.1590/S1678-9946202062091,23/01/2021,16/07/2022,Verified
201130_Sergipe_FederalUniversityofSergipe_residualsera_primary,30-Nov-20,Local,Brazil,BRA,Sergipe,Aracaju,15-Jan-20,15-Apr-20,Residual sera,Multiple groups,987,1.60%,,,Sequential,"NA,Boditech Med Inc.",LFIA,"IgM,IgG",,,Moderate,Journal Article (Peer-Reviewed),Ricardo Queiroz Gurgel,Federal University of Sergipe,http://dx.doi.org/10.1016/j.jinf.2020.11.037,29/01/2021,16/07/2022,Verified
210106_EspiritoSanto_SecretariadeEstadodaSaúdedoEspíritoSanto_primary,06-Jan-21,Regional,Brazil,BRA,Espírito Santo,,01-Dec-19,30-Jun-20,Representative patient population,Multiple groups,7370,2.85%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Lorenzzo Lyrio Stringari,Secretaria de Estado da Saúde do Espírito Santo,https://dx.doi.org/10.1371/journal.pone.0244937,30/01/2021,16/07/2022,Verified
210128_XikrinofBacaja_InstitutodeCiênciasBiológicasdaUniversidadeFederaldoPará_overall,28-Jan-21,Local,Brazil,BRA,Pará,Xikrin of Bacaja Villages,01-Sep-20,30-Sep-20,Household and community samples,Multiple groups,100,73.00%,,,Unclear,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Eliene Putira Sacuema Rodrigues,Instituto de Ciências Biológicas da Universidade Federal do Pará,https://dx.doi.org/10.1186/s12939-021-01392-8,09/03/2021,16/07/2022,Verified
210129_Botuacato_InstitutoButantan_Primary,29-Jan-21,Local,Brazil,BRA,Sao Paolo,Botucato,22-Jun-20,08-Jul-20,Assisted living and long-term care facilities,Multiple groups,209,11.50%,7.10%,16.60%,Convenience,Guangzhou Wondfo Biotech Co. Ltd,LFIA,"IgG,IgM",86.40%,99.60%,Moderate,Journal Article (Peer-Reviewed),Eliana Nogueira Castro de Barros,Instituto Butantan,https://dx.doi.org/10.1590/S1678-9946202163010,18/03/2021,16/07/2022,Verified
210116_SaoPaulo_UniversityOfSãoPaulo_overall_IgG,16-Jan-21,Local,Brazil,BRA,Sao Paulo,Sao Paulo,20-May-20,22-May-20,Multiple populations,Multiple groups,938,5.80%,,,Convenience,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Bruno Caramelli,University of São Paulo,https://dx.doi.org/10.7189/jogh.11.05001,27/03/2021,16/07/2022,Verified
210209_Sergipe_FederalUniversityofSergipe,09-Feb-21,Regional,Brazil,BRA,Sergipe,"Aracaji, Itabaiana, Lagarto, Larangeiras, Nossa Senhora da Gloria, Sao Cristovao",15-Sep-20,06-Oct-20,Students and Daycares,Adults (18-64 years),276,22.50%,17.90%,27.70%,Convenience,"Boditech Med Inc.,Kovalent",LFIA,"IgG,IgM",95.80%,97.00%,High,Journal Article (Peer-Reviewed),Adriano Antunes de Souza Araujo,Federal University of Sergipe,https://dx.doi.org/10.17179/excli2021-3459,27/03/2021,16/07/2022,Verified
210115_Manaus_UniversidadedeSãoPaulo_Feb_PopTestAdj,16-Jan-21,Local,Brazil,BRA,Amazonas,Manaus,07-Feb-20,13-Feb-20,Blood donors,Multiple groups,821,0.40%,0.00%,3.30%,Sequential,Abbott Laboratories,CLIA,IgG,92.20%,96.10%,Moderate,Journal Article (Peer-Reviewed),Lewis Buss,Universidade de Sao Paulo,https://science.sciencemag.org/content/371/6526/288,07/04/2021,16/07/2022,Verified
210115_SaoPaulo_UniversidadedeSãoPaulo_Feb_PopTestAdj,16-Jan-21,Local,Brazil,BRA,Sao Paulo State,Sao Paulo,08-Feb-20,29-Feb-20,Blood donors,Multiple groups,799,1.00%,0.00%,2.90%,Sequential,Abbott Laboratories,CLIA,IgG,92.20%,96.10%,Moderate,Journal Article (Peer-Reviewed),Lewis Buss,Universidade de Sao Paulo,https://science.sciencemag.org/content/371/6526/288,07/04/2021,16/07/2022,Verified
210115_Manaus_UniversidadedeSãoPaulo_Mar_PopTestAdj,16-Jan-21,Local,Brazil,BRA,Amazonas,Manaus,06-Mar-20,12-Mar-20,Blood donors,Multiple groups,832,0.00%,0.00%,0.80%,Sequential,Abbott Laboratories,CLIA,IgG,92.20%,96.10%,Moderate,Journal Article (Peer-Reviewed),Lewis Buss,Universidade de Sao Paulo,https://science.sciencemag.org/content/371/6526/288,07/04/2021,16/07/2022,Verified
210115_SaoPaulo_UniversidadedeSãoPaulo_Mar_PopTestAdj,16-Jan-21,Local,Brazil,BRA,Sao Paulo State,Sao Paulo,09-Mar-20,21-Mar-20,Blood donors,Multiple groups,2454,2.80%,1.80%,3.90%,Sequential,Abbott Laboratories,CLIA,IgG,92.20%,96.10%,Moderate,Journal Article (Peer-Reviewed),Lewis Buss,Universidade de Sao Paulo,https://science.sciencemag.org/content/371/6526/288,07/04/2021,16/07/2022,Verified
210115_Manaus_UniversidadedeSãoPaulo_Apr_PopTestAdj,16-Jan-21,Local,Brazil,BRA,Amazonas,Manaus,06-Apr-20,17-Apr-20,Blood donors,Multiple groups,829,5.00%,2.90%,7.40%,Sequential,Abbott Laboratories,CLIA,IgG,92.20%,96.10%,Moderate,Journal Article (Peer-Reviewed),Lewis Buss,Universidade de Sao Paulo,https://science.sciencemag.org/content/371/6526/288,07/04/2021,16/07/2022,Verified
210115_SaoPaulo_UniversidadedeSãoPaulo_Apr_PopTestAdj,16-Jan-21,Local,Brazil,BRA,Sao Paulo State,Sao Paulo,08-Apr-20,30-Apr-20,Blood donors,Multiple groups,900,4.00%,1.80%,6.60%,Sequential,Abbott Laboratories,CLIA,IgG,92.20%,96.10%,Moderate,Journal Article (Peer-Reviewed),Lewis Buss,Universidade de Sao Paulo,https://science.sciencemag.org/content/371/6526/288,07/04/2021,16/07/2022,Verified
210115_Manaus_UniversidadedeSãoPaulo_May_PopTestAdj,16-Jan-21,Local,Brazil,BRA,Amazonas,Manaus,05-May-20,14-May-20,Blood donors,Multiple groups,901,43.40%,38.40%,48.60%,Sequential,Abbott Laboratories,CLIA,IgG,92.20%,96.10%,Moderate,Journal Article (Peer-Reviewed),Lewis Buss,Universidade de Sao Paulo,https://science.sciencemag.org/content/371/6526/288,07/04/2021,16/07/2022,Verified
210115_SaoPaulo_UniversidadedeSãoPaulo_May_PopTestAdj,16-Jan-21,Local,Brazil,BRA,Sao Paulo State,Sao Paulo,08-May-20,21-May-20,Blood donors,Multiple groups,826,4.70%,2.60%,7.30%,Sequential,Abbott Laboratories,CLIA,IgG,92.20%,96.10%,Moderate,Journal Article (Peer-Reviewed),Lewis Buss,Universidade de Sao Paulo,https://science.sciencemag.org/content/371/6526/288,07/04/2021,16/07/2022,Verified
210115_Manaus_UniversidadedeSãoPaulo_Jun_PopTestAdj,16-Jan-21,Local,Brazil,BRA,Amazonas,Manaus,05-Jun-20,15-Jun-20,Blood donors,Multiple groups,911,55.40%,50.70%,60.10%,Sequential,Abbott Laboratories,CLIA,IgG,92.20%,96.10%,Moderate,Journal Article (Peer-Reviewed),Lewis Buss,Universidade de Sao Paulo,https://science.sciencemag.org/content/371/6526/288,07/04/2021,16/07/2022,Verified
210115_SaoPaulo_UniversidadedeSãoPaulo_Jun_PopTestAdj,16-Jan-21,Local,Brazil,BRA,Sao Paulo State,Sao Paulo,08-Jun-20,20-Jun-20,Blood donors,Multiple groups,880,13.10%,10.30%,16.30%,Sequential,Abbott Laboratories,CLIA,IgG,92.20%,96.10%,Moderate,Journal Article (Peer-Reviewed),Lewis Buss,Universidade de Sao Paulo,https://science.sciencemag.org/content/371/6526/288,07/04/2021,16/07/2022,Verified
210115_Manaus_UniversidadedeSãoPaulo_Jul_PopTestAdj,16-Jan-21,Local,Brazil,BRA,Amazonas,Manaus,06-Jul-20,15-Jul-20,Blood donors,Multiple groups,1147,49.00%,44.20%,53.60%,Sequential,Abbott Laboratories,CLIA,IgG,92.20%,96.10%,Moderate,Journal Article (Peer-Reviewed),Lewis Buss,Universidade de Sao Paulo,https://science.sciencemag.org/content/371/6526/288,07/04/2021,16/07/2022,Verified
210115_SaoPaulo_UniversidadedeSãoPaulo_Jul_PopTestAdj,16-Jan-21,Local,Brazil,BRA,Sao Paulo State,Sao Paulo,13-Jul-20,25-Jul-20,Blood donors,Multiple groups,879,10.60%,8.10%,13.50%,Sequential,Abbott Laboratories,CLIA,IgG,92.20%,96.10%,Moderate,Journal Article (Peer-Reviewed),Lewis Buss,Universidade de Sao Paulo,https://science.sciencemag.org/content/371/6526/288,07/04/2021,16/07/2022,Verified
210115_SaoPaulo_UniversidadedeSãoPaulo_DonorsTestOverall,16-Jan-21,Local,Brazil,BRA,Sao Paulo State,Sao Paulo,01-Jul-20,31-Jul-20,Blood donors,Multiple groups,1000,13.30%,,,Unclear,"Abbott Laboratories,Roche Diagnostics",CLIA,IgG,,,Unclear,Journal Article (Peer-Reviewed),Lewis Buss,Universidade de Sao Paulo,https://science.sciencemag.org/content/371/6526/288,07/04/2021,16/07/2022,Verified
210115_Manaus_UniversidadedeSãoPaulo_Aug_PopTestAdj,16-Jan-21,Local,Brazil,BRA,Amazonas,Manaus,08-Aug-20,19-Aug-20,Blood donors,Multiple groups,881,45.60%,41.10%,50.10%,Sequential,Abbott Laboratories,CLIA,IgG,92.20%,96.10%,Moderate,Journal Article (Peer-Reviewed),Lewis Buss,Universidade de Sao Paulo,https://science.sciencemag.org/content/371/6526/288,07/04/2021,16/07/2022,Verified
210115_SaoPaulo_UniversidadedeSãoPaulo_Aug_PopTestAdj,16-Jan-21,Local,Brazil,BRA,Sao Paulo State,Sao Paulo,10-Aug-20,29-Aug-20,Blood donors,Multiple groups,906,15.50%,12.30%,18.20%,Sequential,Abbott Laboratories,CLIA,IgG,92.20%,96.10%,Moderate,Journal Article (Peer-Reviewed),Lewis Buss,Universidade de Sao Paulo,https://science.sciencemag.org/content/371/6526/288,07/04/2021,16/07/2022,Verified
210115_Manaus_UniversidadedeSãoPaulo_Sept_PopTestAdj,16-Jan-21,Local,Brazil,BRA,Amazonas,Manaus,05-Sep-20,14-Sep-20,Blood donors,Multiple groups,868,47.30%,42.10%,52.50%,Sequential,Abbott Laboratories,CLIA,IgG,92.20%,96.10%,Moderate,Journal Article (Peer-Reviewed),Lewis Buss,Universidade de Sao Paulo,https://science.sciencemag.org/content/371/6526/288,07/04/2021,16/07/2022,Verified
210115_SaoPaulo_UniversidadedeSãoPaulo_Sept_PopTestAdj,16-Jan-21,Local,Brazil,BRA,Sao Paulo State,Sao Paulo,07-Sep-20,29-Sep-20,Blood donors,Multiple groups,933,15.10%,12.30%,18.20%,Sequential,Abbott Laboratories,CLIA,IgG,92.20%,96.10%,Moderate,Journal Article (Peer-Reviewed),Lewis Buss,Universidade de Sao Paulo,https://science.sciencemag.org/content/371/6526/288,07/04/2021,16/07/2022,Verified
210115_Manaus_UniversidadedeSãoPaulo_Oct_PopTestAdj,16-Jan-21,Local,Brazil,BRA,Amazonas,Manaus,10-Oct-20,17-Oct-20,Blood donors,Multiple groups,882,44.60%,39.30%,50.00%,Sequential,Abbott Laboratories,CLIA,IgG,92.20%,96.10%,Moderate,Journal Article (Peer-Reviewed),Lewis Buss,Universidade de Sao Paulo,https://science.sciencemag.org/content/371/6526/288,07/04/2021,16/07/2022,Verified
210115_SaoPaulo_UniversidadedeSãoPaulo_Oct_PopTestAdj,16-Jan-21,Local,Brazil,BRA,Sao Paulo State,Sao Paulo,12-Oct-20,24-Oct-20,Blood donors,Multiple groups,877,18.20%,15.00%,21.70%,Sequential,Abbott Laboratories,CLIA,IgG,92.20%,96.10%,Moderate,Journal Article (Peer-Reviewed),Lewis Buss,Universidade de Sao Paulo,https://science.sciencemag.org/content/371/6526/288,07/04/2021,16/07/2022,Verified
210324_SaoPaulo_UniversityofSaoPaulo_overall,24-Mar-21,Local,Brazil,BRA,Sao Paulo,Sao Paulo,17-Jun-20,08-Jul-20,Health care workers and caregivers,Adults (18-64 years),1996,5.51%,,,Convenience,NA,ELISA,IgG,95.00%,100.00%,High,Journal Article (Peer-Reviewed),Maura Salaroli de Oliveira,University of São Paulo,https://dx.doi.org/10.1016/j.ajic.2021.03.010,19/04/2021,16/07/2022,Verified
210326_RiodeJaneiro_InstitutoD’OrdePesquisaeEnsino,26-Mar-21,Local,Brazil,BRA,Rio de Janeiro,Rio de Janeiro,30-Jun-20,28-Aug-20,Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),114,30.70%,,,Sequential,Beijing Lepu Medical Technology,Other,"IgG,IgM",66.00%,97.00%,High,Journal Article (Peer-Reviewed),Thais Cleto Yamane,Instituto D’Or de Pesquisa e Ensino,https://dx.doi.org/10.1007/s00431-021-04044-9,23/04/2021,16/07/2022,Unverified
200602_Biguacu_SecretariaMunicipaldeSaude_primary,02-Jun-20,Local,Brazil,BRA,,Biguacu,30-May-20,30-May-20,Household and community samples,Multiple groups,217,0.40%,,,Stratified probability,NA,Not reported,Not reported,,,Unclear,News and Media,Ozias Alves Jr,Secretaria Municipal de Saude,http://jbfoco.com.br/2020/06/confira-um-estudo-sobre-a-pandemia-de-covid-19-em-biguacu-em-graficos/,23/04/2021,16/07/2022,Verified
200928_BaixadaSantistaMetropolitanRegion_UniversidadeSantaCecília_overall_Phase 1,28-Sep-20,Local,Brazil,BRA,São Paulo state,Baixada Santista,29-Apr-20,01-May-20,Household and community samples,Multiple groups,2314,1.40%,,,Stratified probability,Guangzhou Wondfo Biotech Co. Ltd,LFIA,Total Antibody,,,High,Preprint,Arthur Chioro,Baixada Santista Metropolitan Region ,https://preprints.scielo.org/index.php/scielo/preprint/view/1270,26/04/2021,16/07/2022,Verified
201027_FernandoNoronha_UniversidadeFederaldoCeará,27-Oct-20,Local,Brazil,BRA,State of Pernambuco,Fernando de Noronha,22-May-20,31-May-20,Household and community samples,Multiple groups,904,4.30%,3.20%,5.90%,Simplified probability,Guangzhou Wondfo Biotech Co. Ltd,Not reported,"IgG,IgM",,,Moderate,Preprint,Mozart Julio Tabosa Sales,Universidade Federal do Ceará,https://www.medrxiv.org/content/10.1101/2020.10.22.20216010v1.full-text,27/04/2021,16/07/2022,Verified
200928_BaixadaSantistaMetropolitanRegion_UniversidadeSantaCecília_overall_Phase 2,28-Sep-20,Local,Brazil,BRA,São Paulo state,Baixada Santista,13-May-20,15-May-20,Household and community samples,Multiple groups,2415,2.20%,,,Stratified probability,Guangzhou Wondfo Biotech Co. Ltd,LFIA,Total Antibody,,,High,Preprint,Arthur Chioro,Baixada Santista Metropolitan Region ,https://preprints.scielo.org/index.php/scielo/preprint/view/1270,28/04/2021,16/07/2022,Verified
200604_Goiania_CityOfGoiania_overall,04-Jun-20,Local,Brazil,BRA,Goiás,Goiania,30-May-20,30-May-20,Household and community samples,Multiple groups,2400,0.75%,,,Simplified probability,NA,Not reported,Not reported,,,Unclear,News and Media,Mauro Junio,City of Goiania,https://www.goiania.go.gov.br/inquerito-aponta-que-1-das-pessoas-ja-tiveram-covid-19-em-goiania/,29/04/2021,16/07/2022,Verified
200527_RioGrandeDoSul_FederalUniversityOfPelotas_overall,27-May-20,Regional,Brazil,BRA,Rio Grande do Sul,,23-May-20,25-May-20,Household and community samples,Multiple groups,4500,0.18%,0.08%,0.35%,Unclear,NA,LFIA,Not reported,,,Unclear,News and Media,Governo do Estato do Rio Grande do Sul,Governo do Estato do Rio Grande do Sul,https://estado.rs.gov.br/quarta-etapa-de-pesquisa-aponta-estabilidade-no-total-de-infectados-por-coronavirus-no-rs,03/05/2021,16/07/2022,Verified
200629_Goiania_CityOfGoiania_overall,29-Jun-20,Local,Brazil,BRA,Goiás,Goiania,10-Jun-20,10-Jun-20,Household and community samples,Multiple groups,2628,2.10%,,,Simplified probability,NA,Not reported,Not reported,,,Unclear,News and Media,City of Goiania,Municipal Health Department of the City of Goiania,https://www.goiania.go.gov.br/pesquisa-aponta-que-31-838-mil-pessoas-ja-foram-infectadas-por-covid-19-em-goiania/,03/05/2021,16/07/2022,Verified
200626_BomJesus_InstitutoPiaunienseDeOpiniaoPubilca_overall,26-Jun-20,Local,Brazil,BRA,Piauí,Bom Jesus,24-Jun-20,26-Jun-20,Household and community samples,Multiple groups,200,8.00%,,,Simplified probability,NA,Not reported,"IgG,IgM",,,High,Institutional Report,Instituto Piauniense de Opiniao Publica,Instituto Piauniense de Opinião Pública,https://portalpontox.com/wp-content/uploads/2020/06/PESQUISA-BOM-JESUS-COVID-24a26-06.2020.pdf,05/05/2021,16/07/2022,Verified
200812_Cajamar_MunicipalSecretariatOfCajamar_overall,12-Aug-20,Local,Brazil,BRA,São Paulo,Municipality of Cajamar,21-Jul-20,27-Jul-20,Household and community samples,Multiple groups,1015,4.00%,,,Convenience,NA,LFIA,Not reported,,,High,News and Media,Municipal Secretariat of Cajamar,Municipal Secretariat of Cajamar,https://cajamar.sp.gov.br/noticias/2020/08/12/secretaria-de-saude-divulga-balanco-da-pesquisa-de-busca-ativa-de-anticorpos-para-sars-cov-2/,06/05/2021,16/07/2022,Verified
200831_Limeira_LimeriaCityHall_overall,31-Aug-20,Local,Brazil,BRA,São Paulo,Limeira,24-Aug-20,29-Aug-20,Household and community samples,Multiple groups,1291,14.60%,11.90%,17.30%,Simplified probability,NA,Not reported,"IgG,IgM",,,High,News and Media,Redacao Educadora,Limeira City Hall,https://elimeira.com.br/noticias/limeira/estudo-sugere-que-quase-36-mil-moradores-de-limeira-tiveram-covid-19/,11/05/2021,16/07/2022,Verified
211006_Goiânia_MunicipalityofGoiâniaHealthDepartment,06-Oct-20,Local,Brazil,BRA,Goiás,,19-Sep-20,19-Sep-20,Household and community samples,Multiple groups,2436,13.96%,,,Unclear,NA,CLIA,IgG,,,High,News and Media,Prefeitura De Goiania,Health Department of the Municipality of Goiânia ,https://www.goiania.go.gov.br/inquerito-populacional-ajuda-identificar-areas-de-maior-concentracao-da-covid-19/,13/05/2021,16/07/2022,Verified
210210_Joinville_CityHallofJoinville_PopAdj,10-Feb-21,Local,Brazil,BRA,Santa Catarina,Joinville,15-Jun-20,07-Aug-20,Household and community samples,Multiple groups,4403,4.84%,,,Stratified probability,Celer Technologies Inc.,LFIA,"IgG,IgM",86.43%,99.57%,Moderate,Preprint,Henrique Diegoli,City Hall of Joinville,https://www.medrxiv.org/content/10.1101/2021.02.08.21251009v1.full,13/05/2021,16/07/2022,Verified
201210_MatoGrosso_StateUniversityOfMatoGrosso,20-Dec-20,Regional,Brazil,BRA,Mato Grosso,"Água Boa, Alta Floresta, Barra do Garças, Cáceres, Cuiabá, Juína, Rondonópolis, Sinop, Tangará da Serra and Várzea Grande",16-Sep-20,15-Oct-20,Household and community samples,Multiple groups,4206,12.50%,,,Simplified probability,NA,CLIA,IgG,,,High,News and Media,Lygia Lima,State University of Mato Gross,http://www.mt.gov.br/-/16042707-unemat-coordena-estudo-sobre-condicoes-de-saude-da-populacao-de-mt-durante-pandemia,17/05/2021,16/07/2022,Unverified
210422_RioGrandeDoSul_SantaCasaDeMisericordiaDePortoAlegre_police,22-Apr-21,Regional,Brazil,BRA,Rio Grande do Sul State,"Porto Alegre, Caxias do Sul, Canoas, Pelotas, Santa Maria, Passo Fundo, Uruguaiana, Santa Cruz do Sul, Ijui, and Lajeado ",23-Jul-20,25-Jul-20,Essential non-healthcare workers,Adults (18-64 years),1592,3.30%,,,Stratified probability,EUROIMMUN,ELISA,"IgG,IgA",,,Moderate,Journal Article (Peer-Reviewed),Alessandro Pasqualotto,Molecular Biology Laboratory at Santa Casa de Misericordia de Porto Alegre,https://dx.doi.org/10.1371/journal.pone.0249672,17/05/2021,16/07/2022,Verified
210419_Sergipe_UniversidadeFederalDeSergipe_Stage3_overall_unadj copy,19-Apr-21,Regional,Brazil,BRA,Sergipe,,18-Feb-21,30-Mar-21,Household and community samples,Multiple groups,5527,15.40%,14.50%,16.40%,Stratified probability,"Kovalent,Boditech Med Inc.",Multiple Types,"IgG,IgM",,,Moderate,Institutional Report,Adriano Araujo,The Federal Univeristy of Sergipe,https://www.researchgate.net/publication/350976274_Evolucao_da_Prevalencia_de_Infeccao_por_SARS-CoV-2_em_Sergipe_Resultados_da_Terceira_Fase_18_de_fevereiro_a_30_de_marco_de_2021,19/05/2021,16/07/2022,Unverified
210419_Sergipe_UniversidadeFederalDeSergipe_Stage2_overall_unadj copy,19-Apr-21,Regional,Brazil,BRA,Sergipe,,11-Aug-20,17-Nov-20,Household and community samples,Multiple groups,5405,7.90%,6.80%,9.10%,Stratified probability,"Kovalent,Boditech Med Inc.",Multiple Types,"IgG,IgM",,,Moderate,Institutional Report,Adriano Araujo,The Federal Univeristy of Sergipe,https://www.researchgate.net/publication/350976274_Evolucao_da_Prevalencia_de_Infeccao_por_SARS-CoV-2_em_Sergipe_Resultados_da_Terceira_Fase_18_de_fevereiro_a_30_de_marco_de_2021,19/05/2021,16/07/2022,Unverified
201110_Maranhao_UniversidadeFederaldoMaranhao_Phase2_OverallPopAdj,10-Nov-20,Regional,Brazil,BRA,Maranhão,,19-Oct-20,30-Oct-20,Household and community samples,Multiple groups,4563,38.10%,34.80%,41.40%,Stratified probability,Roche Diagnostics,CLIA,Total Antibody,,,Moderate,Institutional Report,Antonio da Silva,Universidade Federal do Maranhao,https://www.saude.ma.gov.br/wp-content/uploads/2020/11/Inquerito-Sorologico-Maranhao-Fase-2.pdf,20/05/2021,16/07/2022,Verified
200821_Campinas_CampinasMunicipalHealthDepartment,21-Aug-20,Local,Brazil,BRA,Sao Paulo,Campinas,03-Aug-20,15-Aug-20,Household and community samples,Multiple groups,1876,3.68%,,,Simplified probability,NA,Not reported,Not reported,,,High,News and Media,Campinas City Hall,Campinas Municipal Health Department,https://covid-19.campinas.sp.gov.br/prefeitura-de-campinas-apresenta-segundo-inqu-rito-sorol-gico-da-covid-19,20/05/2021,16/07/2022,Verified
210113_SaoPaulo_CidadeDeSaoPaolo_2021_Phase1_overall,13-Jan-21,Local,Brazil,BRA,Sao Paulo,Sao Paulo,05-Jan-21,07-Jan-21,Household and community samples,Multiple groups,1960,14.10%,11.70%,16.80%,Simplified probability,Guangzhou Wondfo Biotech Co. Ltd,LFIA,"IgG,IgM",97.87%,,Moderate,Institutional Report,City of Sao Paulo,Cidade de São Paulo,http://www.capital.sp.gov.br/arquivos/pdf/2021/coletiva_saude_14-01.pdf,21/05/2021,16/07/2022,Verified
210204_SaoPaulo_CityOfSaoPaulo_2021_Phase2,04-Feb-21,Local,Brazil,BRA,Sao Paulo,Sao Paulo,07-Jan-21,21-Jan-21,Household and community samples,Multiple groups,1841,13.90%,11.70%,16.40%,Simplified probability,Guangzhou Wondfo Biotech Co. Ltd,LFIA,"IgG,IgM",97.87%,,High,Institutional Report,City of Sao Paulo,City of Sao Paulo,http://www.capital.sp.gov.br/arquivos/pdf/2021/inquerito_fase-02_2021.pdf/view,21/05/2021,16/07/2022,Verified
210501_SãoPaulo_Ipec_overall_Unadj,01-May-21,Local,Brazil,BRA,São Paulo,São Paulo,22-Apr-21,01-May-21,Household and community samples,Multiple groups,1187,41.60%,,,Stratified probability,"Abbott Laboratories,Roche Diagnostics",CLIA,"IgG,IgM",,,Moderate,Institutional Report,Beatriz Tess,Inteligência em Pesquisa e Consultoria,https://www.monitoramentocovid19.org/resultados,22/05/2021,16/07/2022,Verified
201211_Pitangueiras_PrefeituraMunicipaldePitangueiras_firstfase_primary,11-Dec-20,Local,Brazil,BRA,,Pitangueiras,24-Aug-20,29-Aug-20,Household and community samples,Multiple groups,150,1.72%,0.51%,2.93%,Stratified probability,NA,Not reported,"IgG,IgM",,,Moderate,Institutional Report,Ana Celeste Crotti Peixoto,Prefeitura Municipal de Pitangueiras  ,https://pitangueiras.sp.gov.br/wp-content/uploads/2020/12/Relatorio-Inquerito-COVID-19-Final.pdf,22/05/2021,16/07/2022,Unverified
201211_Pitangueiras_PrefeituraMunicipaldePitangueiras_secondfase_primary,11-Dec-20,Local,Brazil,BRA,,Pitangueiras,24-Sep-20,29-Sep-20,Household and community samples,Multiple groups,125,8.00%,,,Stratified probability,NA,Not reported,"IgG,IgM",,,Moderate,Institutional Report,Ana Celeste Crotti Peixoto,Prefeitura Municipal de Pitangueiras  ,https://pitangueiras.sp.gov.br/wp-content/uploads/2020/12/Relatorio-Inquerito-COVID-19-Final.pdf,22/05/2021,16/07/2022,Unverified
210416_Itabaianinha_FederalUniversityofSergipe_IGHDCohort1,16-Apr-21,Local,Brazil,BRA,Sergipe,Itabaianinha,01-Oct-20,03-Oct-20,Household and community samples,Multiple groups,27,22.20%,,,Convenience,Boditech Med Inc.,ELISA,"IgG,IgM",95.80%,97.00%,High,Journal Article (Peer-Reviewed),Manuela A Melo,"Federal University of Sergipe, Aracaju",https://dx.doi.org/10.1007/s12020-021-02728-8,22/05/2021,19/08/2022,Unverified
210416_Itabaianinha_FederalUniversityofSergipe_ControlCohort2,16-Apr-21,Local,Brazil,BRA,Sergipe,Itabaianinha,01-Oct-20,03-Oct-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,27,18.50%,,,Convenience,Boditech Med Inc.,ELISA,"IgG,IgM",95.80%,97.00%,High,Journal Article (Peer-Reviewed),Manuela A Melo,"Federal University of Sergipe, Aracaju",https://dx.doi.org/10.1007/s12020-021-02728-8,23/05/2021,19/08/2022,Unverified
210429_Fortaleza_StateUniversityofCearáCampusdoItaperi_Overall,01-May-21,Local,Brazil,BRA,Ceará,Fortaleza,09-Nov-20,09-Dec-20,Multiple populations,Multiple groups,1559,26.70%,,,Simplified probability,Beijing Lepu Medical Technology,Other,"IgG,IgM",98.90%,97.60%,Moderate,Journal Article (Peer-Reviewed),Valdester Cavalcante Pinto Junior,"State University of Ceará, Campus do Itaperi",https://dx.doi.org/10.1016/j.ijid.2021.04.086,27/05/2021,16/07/2022,Verified
210518_Sergipe_FederalUniversityofSergipe_overall,18-May-21,Regional,Brazil,BRA,Sergipe,,01-Jul-20,31-Jul-20,Household and community samples,Multiple groups,5615,9.26%,8.50%,10.10%,Stratified probability,"Guangzhou Wondfo Biotech Co. Ltd,Boditech Med Inc.",Multiple Types,"IgM,IgG",,,Moderate,Journal Article (Peer-Reviewed),Adriano Antunes de Souza Araújo,Federal University of Sergipe,https://dx.doi.org/10.1017/S0950268821001163,31/05/2021,16/07/2022,Verified
210609_SouthBrazil_UniversidadeFederaldoParaná,09-Jun-21,Regional,Brazil,BRA,Mato Grosso do Sul,Curitiba,15-Sep-20,15-Oct-20,Pregnant or parturient women,Adults (18-64 years),195,8.70%,,,Convenience,NA,LFIA,"IgG,IgM",,,High,Preprint,Jullie Anne Chiste,Complexo Hospital de Clínicas da Universidade Federal do Paraná ,https://dx.doi.org/10.1515/jpm-2021-0173,17/06/2021,16/07/2022,Unverified
210624_Brazil_UniversidadeFederalDePelotas_overall,24-Jun-21,National,Brazil,BRA,,,21-Jun-20,24-Jun-20,Household and community samples,Multiple groups,31869,2.70%,,,Stratified probability,Guangzhou Wondfo Biotech Co. Ltd,LFIA,"IgG,IgM",84.80%,99.95%,Moderate,Journal Article (Peer-Reviewed),Ana M. B. Menezes,Universidade Federal de Pelotas,https://dx.doi.org/10.1038/s41598-021-92775-y,06/07/2021,16/07/2022,Verified
210630_RioDeJaneiro_HospitalFederaldosServidoresdoEstado,30-Jun-21,Local,Brazil,BRA,,Rio de Janeiro,13-Apr-20,17-Jun-20,Pregnant or parturient women,Adults (18-64 years),115,23.50%,,,Convenience,NA,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Maria de Lourdes Benamor Teixeira,Hospital Federaldo dos Servidores do Estado,https://dx.doi.org/10.3390/v13071277,12/07/2021,16/07/2022,Verified
210701_RioDeJaneiro_OswaldoCruzFoundation_Primarysam,01-Jul-21,Local,Brazil,BRA,Rio de Janeiro,"Rio de Janeiro
",18-May-20,24-Sep-20,Multiple general populations,Multiple groups,515,29.30%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Pamella Lugon,Oswaldo Cruz Foundation,https://europepmc.org/article/MED/33863845,14/07/2021,16/07/2022,Verified
210702_RibeiraoPreto_UniversidadedeSãoPaulo_Followup,02-Jul-21,Local,Brazil,BRA,São Paulo,Ribeirão Preto (RP),11-Jun-20,14-Jun-20,Household and community samples,Multiple groups,646,2.79%,,,Stratified probability,Guangzhou Wondfo Biotech Co. Ltd,LFIA,Not reported,86.40%,99.60%,Moderate,Journal Article (Peer-Reviewed),Edson Zangiacomi Martinez,Universidade de São Paulo,https://dx.doi.org/10.1590/0037-8682-0210-2021,14/07/2021,16/07/2022,Verified
210312_SaoPaulo_CityOfSaoPaulo_2021_Phase4_overall,12-Mar-21,Local,Brazil,BRA,São Paulo,São Paulo,16-Feb-21,18-Feb-21,Household and community samples,Multiple groups,1793,25.00%,21.70%,28.70%,Simplified probability,"Guangzhou Wondfo Biotech Co. Ltd,EUROIMMUN",Multiple Types,"IgG,IgM",,,High,Institutional Report,City of Sao Paulo,City of São Paulo,http://www.capital.sp.gov.br/arquivos/pdf/2021/inquerito_fase-04_2021.pdf/,20/07/2021,16/07/2022,Verified
210618_Brazil_UniversidadeFederaldePelotas_primary,18-Jun-21,National,Brazil,BRA,,,14-May-20,23-Jun-20,Household and community samples,Multiple groups,89362,2.30%,,,Stratified probability,Guangzhou Wondfo Biotech Co. Ltd,LFIA,Not reported,84.80%,99.00%,Moderate,Journal Article (Peer-Reviewed),Fernando C Barros,Universidade Federal de Pelotas,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8225319/,21/07/2021,16/07/2022,Verified
210629_SaoPaulo_UniversidadeFederaldeSãoPaulo_Overall,29-Jul-21,Local,Brazil,BRA,,Sao Paulo,01-Sep-20,25-Sep-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,416,8.20%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Preprint,Marina P Cristelli,Universidade Federal de São Paulo,https://dx.doi.org/10.1111/tid.13706,02/08/2021,16/07/2022,Unverified
210726_Chapecó_CommunityUniversityOfChapecóRegion_Primary,26-Jul-21,Local,Brazil,BRA,Santa Catarina,Chapecó,15-Jun-20,15-Aug-20,Household and community samples,Multiple groups,2179,0.64%,,,Stratified probability,Celer Technologies Inc.,LFIA,"IgG,IgM",86.00%,99.00%,Moderate,Journal Article (Peer-Reviewed),Maria Silva,Community University of Chapecó Region,https://rsdjournal.org/index.php/rsd/article/view/17996/16175,03/08/2021,16/07/2022,Verified
210729_Mariana+OuroPreto_FederalUniversityOfOuro,29-Jul-21,Local,Brazil,BRA,Minas Gerais,"Mariana, OuroPreto",15-Oct-20,15-Dec-20,Household and community samples,Multiple groups,1762,5.50%,,,Convenience,Guangzhou Wondfo Biotech Co. Ltd,LFIA,"IgG,IgM",86.43%,99.57%,High,Preprint,Adriana Lucia Meireles,Federal University of Ouro,https://preprints.scielo.org/index.php/scielo/preprint/view/2720,10/08/2021,16/07/2022,Unverified
210801_Aracuja_FederalUniversityofSergipe_Overall_IgG,01-Aug-21,Local,Brazil,BRA,Sergipe,Aracuja,01-Jan-21,31-Jan-21,Essential non-healthcare workers,Adults (18-64 years),123,26.00%,,,Convenience,Boditech Med Inc.,LFIA,IgG,95.80%,97.00%,High,Journal Article (Peer-Reviewed),Lysandro Borges,Federal University of Sergipe ,http://dx.doi.org/10.3390/ijerph18158148,13/08/2021,16/07/2022,Verified
210729_SãoPaulo_HospitalIsraelitaAlbertEinstein_Adj,29-Jul-21,Local,Brazil,BRA,"São Paulo State
",São Paulo,15-Sep-20,15-Dec-20,Household and community samples,Multiple groups,272,45.20%,39.40%,51.00%,Simplified probability,Roche Diagnostics,CLIA,Not reported,,,Moderate,Journal Article (Peer-Reviewed),Joao Luiz Miraglia ,Hospital Israelita Albert Einstein,https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0255412,17/08/2021,16/07/2022,Verified
210813_Brazil_FederalUniversityofOuroPreto_Town1,13-Aug-21,Local,Brazil,BRA,Minas Gerais,Nepomuceno,30-May-20,31-May-20,Household and community samples,Multiple groups,400,0.50%,0.13%,1.80%,Stratified probability,Qingdao Hightop Biotech Co. Ltd ,LFIA,"IgG,IgM",95.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Breno Bernardes-Souza,Federal University of Ouro Preto,https://dx.doi.org/10.2196/30406,25/08/2021,16/07/2022,Verified
210813_Brazil_FederalUniversityofOuroPreto_Town2,13-Aug-21,Local,Brazil,BRA,Minas Gerais,Carmópolis,27-Jun-20,28-Jun-20,Household and community samples,Multiple groups,400,1.75%,0.85%,3.57%,Stratified probability,Qingdao Hightop Biotech Co. Ltd ,LFIA,"IgG,IgM",95.00%,100.00%,Low,Journal Article (Peer-Reviewed),Breno Bernardes-Souza,Federal University of Ouro Preto,https://dx.doi.org/10.2196/30406,25/08/2021,16/07/2022,Verified
210810_SaoPaulo_UniversidadedeSaoPaulo_Primary,10-Aug-21,Regional,Brazil,BRA,,Sao Paulo,04-May-20,12-May-20,Multiple general populations,Multiple groups,463,6.00%,3.90%,8.30%,Stratified non-probability,"Snibe Co. Ltd (Shenzhen New Industries Biomedical Engineering Co. Ltd),Roche Diagnostics",Multiple Types,"IgG,IgM,Total Antibody",,,Moderate,Journal Article (Peer-Reviewed),Beatriz Tess,Universidade de Sao Paulo,https://dx.doi.org/10.1016/j.bjid.2021.101604,29/08/2021,16/07/2022,Verified
210617_Campinas_UniversityOfCampinas,17-Jun-21,Regional,Brazil,BRA,Sao Paulo,Campinas,15-Aug-20,15-Jan-21,Representative patient population,Multiple groups,135,11.00%,,,Convenience,Abbott Laboratories,CLIA,"IgG,IgM",,,Moderate,Journal Article (Peer-Reviewed),Luiza Francisco Trafane,University of Campinas,https://onlinelibrary.wiley.com/doi/10.1002/jha2.254,08/09/2021,16/07/2022,Verified
210629_RioGrandedoSul_UniversidadeFederaldePelotas_Primary,29-Jun-21,Regional,Brazil,BRA,Rio Grande do Sul,,11-Apr-20,06-Sep-20,Household and community samples,Multiple groups,35611,0.58%,,,Stratified probability,Guangzhou Wondfo Biotech Co. Ltd,LFIA,Not reported,84.80%,99.95%,Moderate,Journal Article (Peer-Reviewed),Pedro C. Hallal ,Universidade Federal de Pelotas ,https://dx.doi.org/10.2105/AJPH.2021.306351,09/09/2021,16/07/2022,Verified
210902_Manaus_InstitutoNacionaldePesquisasdaAmazônia_overall,02-Sep-21,Local,Brazil,BRA,Amazonas,Manaus,10-Oct-20,14-Nov-20,Household and community samples,Multiple groups,280,64.64%,59.01%,70.28%,Sequential,EUROIMMUN,ELISA,"IgA,IgG",,,Moderate,Journal Article (Peer-Reviewed),Gemilson Soares Pontes,Instituto Nacional de Pesquisas da Amazônia,https://www.nature.com/articles/s41598-021-96843-1,14/09/2021,16/07/2022,Verified
210913_Belém_UniversidadeFederaldoPará,13-Sep-21,Local,Brazil,BRA,Pará State,Belém,15-Sep-20,15-Jan-21,Household and community samples,Multiple groups,101,83.20%,,,Entire sample,EUROIMMUN,ELISA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Hilton Pereira da Silva,Universidade Federal do Pará,https://dx.doi.org/10.1186/s12889-021-11696-7,21/09/2021,16/07/2022,Unverified
210901_Petropolis_SociedadeFrancoBrasileiradeOncologia_followup,01-Sep-21,Local,Brazil,BRA,,Petropolis,05-Nov-20,28-Dec-20,Health care workers and caregivers,Adults (18-64 years),60,10.00%,,,Convenience,DiaSorin,CLIA,IgG,,,High,Presentation or Conference,Carla Ismael,Sociedade Franco Brasileira de Oncologia (SFBO),http://dx.doi.org/10.1016/j.annonc.2021.08.1596,28/09/2021,16/07/2022,Unverified
210926_RiodeJaneiro_OswaldoCruzFoundation_Primary,26-Sep-21,Local,Brazil,BRA,Rio de Janeiro,Rio de Janeiro,07-Jan-20,11-Jan-21,Pregnant or parturient women,Adults (18-64 years),31,19.35%,,,Convenience,Roche Diagnostics,CLIA,Total Antibody,,,High,Journal Article (Peer-Reviewed),Alanna Calheiros Santos,Oswaldo Cruz Foundation,http://dx.doi.org/10.1016/j.aohep.2021.100450,04/10/2021,16/07/2022,Verified
210922_EspiritoSanto_LaboratoriodeEpidemiologia_Overall,22-Sep-21,Regional,Brazil,BRA,Espirito Santo,"Colatina, Linhares, São Mateus, Afonso Cláudio, Nova Venécia, Cachoeiro de Itapemirim, Alegre, Vila Velha, Cariacica, Serra, Vitória",10-May-20,21-Jun-20,Household and community samples,Children and Youth (0-17 years),1693,6.10%,,,Stratified probability,Celer Technologies Inc.,LFIA,"IgM,IgG",86.40%,99.60%,High,Journal Article (Peer-Reviewed),Ethel Leonor Noia Maciel,Laboratorio de Epidemiologia,https://dx.doi.org/10.1590/S1679-49742021000400001,05/10/2021,16/07/2022,Verified
211022_SaoPaulo_SecretariaMunicipalDeSaudeDeSaoPaulo_Phase9,22-Oct-21,Regional,Brazil,BRA,Greater São Paulo,,19-Jan-21,21-Jan-21,Household and community samples,Multiple groups,1795,13.90%,11.70%,16.40%,Stratified probability,Celer Technologies Inc.,LFIA,"IgM,IgG",84.80%,99.00%,Moderate,Journal Article (Peer-Reviewed),José Olimpio Moura de Albuquerque,Secretaria Municipal de Saude de Sao Paulo,https://dx.doi.org/10.11606/s1518-8787.2021055003970,03/11/2021,16/07/2022,Verified
211022_SaoPaulo_SecretariaMunicipalDeSaudeDeSaoPaulo_Phase2,22-Oct-21,Regional,Brazil,BRA,Greater São Paulo,,13-Jul-20,16-Jul-20,Household and community samples,Multiple groups,2323,11.10%,9.60%,12.90%,Stratified probability,Celer Technologies Inc.,LFIA,"IgM,IgG",84.80%,99.00%,Moderate,Journal Article (Peer-Reviewed),José Olimpio Moura de Albuquerque,Secretaria Municipal de Saude de Sao Paulo,https://dx.doi.org/10.11606/s1518-8787.2021055003970,03/11/2021,16/07/2022,Verified
211022_SaoPaulo_SecretariaMunicipalDeSaudeDeSaoPaulo_Phase5,22-Oct-21,Regional,Brazil,BRA,Greater São Paulo,,25-Aug-20,27-Aug-20,Household and community samples,Multiple groups,2225,13.90%,11.80%,16.20%,Stratified probability,Celer Technologies Inc.,LFIA,"IgM,IgG",84.80%,99.00%,Moderate,Journal Article (Peer-Reviewed),José Olimpio Moura de Albuquerque,Secretaria Municipal de Saude de Sao Paulo,https://dx.doi.org/10.11606/s1518-8787.2021055003970,03/11/2021,16/07/2022,Verified
211022_SaoPaulo_SecretariaMunicipalDeSaudeDeSaoPaulo_Phase8,22-Oct-21,Regional,Brazil,BRA,Greater São Paulo,,05-Jan-21,07-Jan-21,Household and community samples,Multiple groups,1908,14.10%,11.70%,16.80%,Stratified probability,Celer Technologies Inc.,LFIA,"IgM,IgG",84.80%,99.00%,Moderate,Journal Article (Peer-Reviewed),José Olimpio Moura de Albuquerque,Secretaria Municipal de Saude de Sao Paulo,https://dx.doi.org/10.11606/s1518-8787.2021055003970,03/11/2021,16/07/2022,Verified
211022_SaoPaulo_SecretariaMunicipalDeSaudeDeSaoPaulo_Phase10,22-Oct-21,Regional,Brazil,BRA,Greater São Paulo,,02-Feb-21,04-Feb-21,Household and community samples,Multiple groups,1742,16.00%,13.10%,19.30%,Stratified probability,Celer Technologies Inc.,LFIA,"IgM,IgG",84.80%,99.00%,Moderate,Journal Article (Peer-Reviewed),José Olimpio Moura de Albuquerque,Secretaria Municipal de Saude de Sao Paulo,https://dx.doi.org/10.11606/s1518-8787.2021055003970,03/11/2021,16/07/2022,Verified
211022_SaoPaulo_SecretariaMunicipalDeSaudeDeSaoPaulo_Phase4,22-Oct-21,Regional,Brazil,BRA,Greater São Paulo,,11-Aug-20,13-Aug-20,Household and community samples,Multiple groups,2447,11.00%,9.00%,13.30%,Stratified probability,Celer Technologies Inc.,LFIA,"IgM,IgG",84.80%,99.00%,Moderate,Journal Article (Peer-Reviewed),José Olimpio Moura de Albuquerque,Secretaria Municipal de Saude de Sao Paulo,https://dx.doi.org/10.11606/s1518-8787.2021055003970,03/11/2021,16/07/2022,Verified
211022_SaoPaulo_SecretariaMunicipalDeSaudeDeSaoPaulo_Phase11,22-Oct-21,Regional,Brazil,BRA,Greater São Paulo,,16-Feb-21,18-Feb-21,Household and community samples,Multiple groups,1780,25.00%,21.70%,28.70%,Stratified probability,"Celer Technologies Inc.,EUROIMMUN",Multiple Types,"IgM,IgG",,,Moderate,Journal Article (Peer-Reviewed),José Olimpio Moura de Albuquerque,Secretaria Municipal de Saude de Sao Paulo,https://dx.doi.org/10.11606/s1518-8787.2021055003970,03/11/2021,16/07/2022,Verified
211022_SaoPaulo_SecretariaMunicipalDeSaudeDeSaoPaulo_Phase6,22-Oct-21,Regional,Brazil,BRA,Greater São Paulo,,08-Sep-20,10-Sep-20,Household and community samples,Multiple groups,2125,11.90%,10.00%,14.10%,Stratified probability,Celer Technologies Inc.,LFIA,"IgM,IgG",84.80%,99.00%,Moderate,Journal Article (Peer-Reviewed),José Olimpio Moura de Albuquerque,Secretaria Municipal de Saude de Sao Paulo,https://dx.doi.org/10.11606/s1518-8787.2021055003970,03/11/2021,16/07/2022,Verified
211022_SaoPaulo_SecretariaMunicipalDeSaudeDeSaoPaulo_Phase3,22-Oct-21,Regional,Brazil,BRA,Greater São Paulo,,28-Jul-20,30-Jul-20,Household and community samples,Multiple groups,2529,10.90%,9.20%,12.90%,Stratified probability,Celer Technologies Inc.,LFIA,"IgM,IgG",84.80%,99.00%,Moderate,Journal Article (Peer-Reviewed),José Olimpio Moura de Albuquerque,Secretaria Municipal de Saude de Sao Paulo,https://dx.doi.org/10.11606/s1518-8787.2021055003970,03/11/2021,16/07/2022,Verified
211022_SaoPaulo_SecretariaMunicipalDeSaudeDeSaoPaulo_Phase1,22-Oct-21,Regional,Brazil,BRA,Greater São Paulo,,29-Jun-20,02-Jul-20,Household and community samples,Multiple groups,2481,9.70%,7.90%,11.80%,Stratified probability,Celer Technologies Inc.,LFIA,"IgM,IgG",84.80%,99.00%,Moderate,Journal Article (Peer-Reviewed),José Olimpio Moura de Albuquerque,Secretaria Municipal de Saude de Sao Paulo,https://dx.doi.org/10.11606/s1518-8787.2021055003970,03/11/2021,16/07/2022,Verified
211022_SaoPaulo_SecretariaMunicipalDeSaudeDeSaoPaulo_Phase7,22-Oct-21,Regional,Brazil,BRA,Greater São Paulo,,22-Sep-20,24-Sep-20,Household and community samples,Multiple groups,2012,13.60%,11.60%,15.80%,Stratified probability,Celer Technologies Inc.,LFIA,"IgM,IgG",84.80%,99.00%,Moderate,Journal Article (Peer-Reviewed),José Olimpio Moura de Albuquerque,Secretaria Municipal de Saude de Sao Paulo,https://dx.doi.org/10.11606/s1518-8787.2021055003970,03/11/2021,16/07/2022,Verified
211022_SaoPaulo_SecretariaMunicipalDeSaudeDeSaoPaulo_Pilot,22-Oct-21,Regional,Brazil,BRA,Greater São Paulo,,10-Jun-20,17-Jun-20,Household and community samples,Multiple groups,2645,9.50%,7.90%,11.40%,Stratified probability,Celer Technologies Inc.,LFIA,"IgM,IgG",84.80%,99.00%,Moderate,Journal Article (Peer-Reviewed),José Olimpio Moura de Albuquerque,Secretaria Municipal de Saude de Sao Paulo,https://dx.doi.org/10.11606/s1518-8787.2021055003970,03/11/2021,16/07/2022,Verified
211101_Manaus_UniversidadeFederaldoAmazona_Primary,01-Nov-21,Local,Brazil,BRA,Amazonas,Manaus,20-Aug-20,20-Nov-20,Household and community samples,Multiple groups,1631,13.06%,11.52%,14.79%,Convenience,NA,ELISA,IgG,94.28%,97.03%,Moderate,Journal Article (Peer-Reviewed),Pritesh Lalwani,Universidade Federal do Amazonas,https://dx.doi.org/10.1016/S2214-109X(21)00355-7,05/11/2021,16/07/2022,Verified
211029_Vitória_UniversidadeFederalDoEspíritoSanto_AGSN,29-Oct-21,Regional,Brazil,BRA,Espírito Santo,Vitória,22-Jun-20,26-Jun-20,Household and community samples,Multiple groups,714,12.05%,9.59%,14.50%,Stratified probability,Celer Technologies Inc.,LFIA,"IgG,IgM",86.40%,97.63%,High,Journal Article (Peer-Reviewed),Ethel Leonor Noia Maciel,Universidade Federal do Espírito Santo,https://dx.doi.org/10.1590/1980-549720210048,11/11/2021,16/07/2022,Unverified
211029_Vitória_UniversidadeFederalDoEspíritoSanto_AGNSN,29-Oct-21,Regional,Brazil,BRA,Espírito Santo,Vitória,22-Jun-20,26-Jun-20,Persons living in slums,Multiple groups,733,10.23%,7.97%,12.50%,Stratified probability,Celer Technologies Inc.,LFIA,"IgG,IgM",86.40%,97.63%,Moderate,Journal Article (Peer-Reviewed),Ethel Leonor Noia Maciel,Universidade Federal do Espírito Santo,https://dx.doi.org/10.1590/1980-549720210048,11/11/2021,16/07/2022,Unverified
211019_SãoPaulo_FederalUniversityofParaná_homeless_overall,19-Oct-21,Local,Brazil,BRA,São Paulo State,São Paulo,25-Aug-20,27-Aug-20,Persons experiencing homelessness,Multiple groups,203,54.70%,47.80%,61.50%,Convenience,NA,ELISA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Anahi Chechia do Couto,Federal University of Paraná,https://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0009754,17/11/2021,16/07/2022,Unverified
211019_SãoPaulo_FederalUniversityofParaná_workers_overall,19-Oct-21,Local,Brazil,BRA,São Paulo State,São Paulo,25-Aug-20,27-Aug-20,Essential non-healthcare workers,Multiple groups,87,49.43%,,,Convenience,NA,ELISA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Anahi Chechia do Couto,Federal University of Paraná,https://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0009754,17/11/2021,16/07/2022,Unverified
211116_RioGrandedoSul_UniversidadeFederaldoRioGrandedoSul_July_Overall,16-Nov-21,Regional,Brazil,BRA,Rio Grande do Sul,,01-Jul-20,31-Jul-20,Essential non-healthcare workers,Multiple groups,48,6.10%,1.90%,17.70%,Stratified non-probability,ACRO Biotech Inc,LFIA,Not reported,,,High,Preprint,Sergio Renato da Rosa Decker,Universidade Federal do Rio Grande do Sul,https://dx.doi.org/10.1080/23744235.2021.1995039,23/11/2021,16/07/2022,Unverified
211116_RioGrandedoSul_UniversidadeFederaldoRioGrandedoSul_August_Overall,16-Nov-21,Regional,Brazil,BRA,Rio Grande do Sul,,01-Aug-20,31-Aug-20,Essential non-healthcare workers,Multiple groups,46,2.30%,0.30%,14.70%,Stratified non-probability,ACRO Biotech Inc,LFIA,Not reported,,,High,Preprint,Sergio Renato da Rosa Decker,Universidade Federal do Rio Grande do Sul,https://dx.doi.org/10.1080/23744235.2021.1995039,23/11/2021,16/07/2022,Unverified
211119_RiodeJaneiro_FundaçãoOswaldoCruz_Primary,19-Nov-21,Local,Brazil,BRA,,Rio de Janeiro,01-Sep-20,28-Feb-21,Patients seeking care for non-COVID-19 reasons,Multiple groups,83,26.50%,17.00%,36.00%,Convenience,NA,LFIA,"IgG,IgM",,,High,Preprint,Karen Gomes,Fundação Oswaldo Cruz,10.1101/2021.11.17.21266274,30/11/2021,16/07/2022,Unverified
211122_RioGrandedoSul_UniversidadeFederaldePelotas_Round9_Overall,22-Nov-21,Regional,Brazil,BRA,Rio Grande do Sul,,05-Feb-21,07-Feb-21,Household and community samples,Multiple groups,4501,9.97%,9.06%,10.95%,Stratified probability,NA,ELISA,IgG,95.00%,98.60%,Low,Journal Article (Peer-Reviewed),Aluisio Barros,Universidade Federal de Pelotas,https://www.scielosp.org/article/rsp/2021.v55/78/,02/12/2021,16/07/2022,Verified
211122_RioGrandedoSul_UniversidadeFederaldePelotas_Round10_Overall,22-Nov-21,Regional,Brazil,BRA,Rio Grande do Sul,,09-Apr-21,11-Apr-21,Household and community samples,Multiple groups,4499,18.16%,16.90%,19.49%,Stratified probability,NA,ELISA,IgG,95.00%,98.60%,Low,Journal Article (Peer-Reviewed),Aluisio Barros,Universidade Federal de Pelotas,https://www.scielosp.org/article/rsp/2021.v55/78/,02/12/2021,16/07/2022,Verified
211111_Brazil_UniversidadedeSantaCruzdoSul_Primary,11-Nov-21,Regional,Brazil,BRA,Vale do Rio Pardo,,01-Aug-20,17-Oct-20,Household and community samples,Multiple groups,4252,2.90%,,,Stratified probability,Beijing Lepu Medical Technology,LFIA,"IgG,IgM",96.80%,97.60%,Low,Journal Article (Peer-Reviewed),Ana Schneider,Universidade de Santa Cruz do Sul,https://dx.doi.org/10.26633/RPSP.2021.145,08/12/2021,16/07/2022,Verified
211105_Sergipe_FederalUniversityofSergipe_Phase1_Overall,05-Nov-21,Regional,Brazil,BRA,Sergipe,,31-Aug-20,09-Sep-20,Persons who are incarcerated,Multiple groups,778,32.00%,,,Simplified probability,Nantong Egens Biotechnology,LFIA,"IgG,IgM",97.00%,99.00%,Moderate,Journal Article (Peer-Reviewed),Lysandro Pinto Borges,Federal University of Sergipe,https://dx.doi.org/10.3390/life11111184,09/12/2021,16/07/2022,Unverified
211105_Sergipe_FederalUniversityofSergipe_Phase2,05-Nov-21,Regional,Brazil,BRA,Sergipe,,05-Oct-20,09-Oct-20,Persons who are incarcerated,Multiple groups,453,19.60%,,,Simplified probability,Nantong Egens Biotechnology,LFIA,"IgG,IgM",97.00%,99.00%,Moderate,Journal Article (Peer-Reviewed),Lysandro Pinto Borges,Federal University of Sergipe,https://dx.doi.org/10.3390/life11111184,09/12/2021,16/07/2022,Unverified
211210_EspíritoSanto_UniversidadeFederaldoEspíritoSanto_HCW_Primary,10-Dec-21,Regional,Brazil,BRA,Espírito Santo,,31-Aug-20,04-Sep-20,Health care workers and caregivers,Adults (18-64 years),311,11.89%,8.14%,15.66%,Stratified probability,MedLevensohn,LFIA,"IgG,IgM",97.40%,99.30%,Moderate,Journal Article (Peer-Reviewed),Adriana Ilha da Silva,Universidade Federal do Espírito Santo,https://dx.doi.org/10.1590/1980-549720210053,15/12/2021,16/07/2022,Unverified
211210_EspíritoSanto_UniversidadeFederaldoEspíritoSanto_PrisonOfficer_Primary,10-Dec-21,Regional,Brazil,BRA,Espírito Santo,,31-Aug-20,04-Sep-20,Essential non-healthcare workers,Adults (18-64 years),675,22.07%,18.87%,25.28%,Stratified probability,MedLevensohn,LFIA,"IgG,IgM",97.40%,99.30%,Moderate,Journal Article (Peer-Reviewed),Adriana Ilha da Silva,Universidade Federal do Espírito Santo,https://dx.doi.org/10.1590/1980-549720210053,15/12/2021,16/07/2022,Unverified
211210_EspíritoSanto_UniversidadeFederaldoEspíritoSanto_PDL_Primary,10-Dec-21,Regional,Brazil,BRA,Espírito Santo,,31-Aug-20,04-Sep-20,Persons who are incarcerated,Adults (18-64 years),884,31.64%,28.44%,34.83%,Stratified probability,MedLevensohn,LFIA,"IgG,IgM",97.40%,99.30%,Moderate,Journal Article (Peer-Reviewed),Adriana Ilha da Silva,Universidade Federal do Espírito Santo,https://dx.doi.org/10.1590/1980-549720210053,15/12/2021,16/07/2022,Unverified
211228_MâncioLima_UniversityofSãoPaulo_OcttoNov2020,28-Dec-21,Regional,Brazil,BRA,Acre,Mâncio Lima,15-Oct-20,15-Nov-20,Household and community samples,Multiple groups,1215,33.50%,33.20%,44.80%,Unclear,EUROIMMUN,ELISA,IgG,90.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Vanessa Nicolete,University of São Paulo,https://dx.doi.org/10.3201/eid2803.211993,08/01/2022,16/07/2022,Unverified
211228_MâncioLima_UniversityofSãoPaulo_AprtoMay2021,28-Dec-21,Regional,Brazil,BRA,Acre,Mâncio Lima,15-Apr-21,15-May-21,Household and community samples,Multiple groups,1215,54.20%,51.30%,57.10%,Unclear,EUROIMMUN,ELISA,IgG,90.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Vanessa Nicolete,University of São Paulo,https://dx.doi.org/10.3201/eid2803.211993,08/01/2022,16/07/2022,Unverified
211231_RibeiraoPreto_ButantanInstitute_Primary,31-Dec-21,Local,Brazil,BRA,Sao Paulo,Ribeirao Preto,01-Oct-19,31-Dec-19,Blood donors,Multiple groups,546,0.00%,,,Unclear,"EUROIMMUN,Abbott Laboratories,NA",Multiple Types,"IgG,Neutralizing ",,,High,Journal Article (Peer-Reviewed),Victoria Simionatto Zucherato,Butantan Institute,https://dx.doi.org/10.1016/j.jinf.2021.12.041,13/01/2022,16/07/2022,Verified
211231_RiodeJaneiro_NationalInstituteofHealthforWomenChildrenandAdolescentsFernandesFigueira,31-Dec-21,Local,Brazil,BRA,,Rio de Janeiro,01-Jun-20,31-Jul-20,Health care workers and caregivers,Adults (18-64 years),1141,30.00%,,,Convenience,EUROIMMUN,ELISA,IgG,99.40%,99.60%,High,Journal Article (Peer-Reviewed),Roberta Correia,"National Institute of Health for Women, Children and Adolescents Fernandes Figueira",https://dx.doi.org/10.1016/j.lana.2021.100170,18/01/2022,16/07/2022,Unverified
220210_Cameta_UniversidadeFederaldoPara_Overall,10-Feb-22,Local,Brazil,BRA,Para,,01-Apr-21,30-Apr-21,Household and community samples,Multiple groups,140,52.10%,,,Convenience,EUROIMMUN,ELISA,IgG,,,Unclear,Journal Article (Peer-Reviewed),Keise Pereira,Universidade Federal do Para,https://dx.doi.org/10.1016/j.bjid.2021.102060,21/02/2022,16/07/2022,Verified
220101_DivonopolisUniversidade FederaldeSaoJoaoDelRei_Wave1,01-Jan-22,Local,Brazil,BRA,Minas Gerais,"Divinopolis
",15-Nov-20,15-Dec-20,Multiple general populations,Multiple groups,616,6.50%,,,Unclear,NA,Not reported,Not reported,,,High,Journal Article (Peer-Reviewed),Gustavo Rocha,Universidade Federal de Sao Joao Del-Rei,https://dx.doi.org/10.1016/j.bjid.2021.102059,22/02/2022,16/07/2022,Unverified
220101_DivonopolisUniversidade FederaldeSaoJoaoDelRei_Wave2,01-Jan-22,Local,Brazil,BRA,Minas Gerais,"Divinopolis
",15-Jan-21,15-Feb-21,Multiple general populations,Multiple groups,671,7.20%,,,Unclear,NA,Not reported,Not reported,,,High,Journal Article (Peer-Reviewed),Gustavo Rocha,Universidade Federal de Sao Joao Del-Rei,https://dx.doi.org/10.1016/j.bjid.2021.102059,22/02/2022,16/07/2022,Unverified
220101_DivonopolisUniversidade FederaldeSaoJoaoDelRei_Wave3,01-Jan-22,Local,Brazil,BRA,Minas Gerais,"Divinopolis
",15-May-21,15-Jul-21,Multiple general populations,Multiple groups,619,13.30%,,,Unclear,NA,Not reported,Not reported,,,High,Journal Article (Peer-Reviewed),Gustavo Rocha,Universidade Federal de Sao Joao Del-Rei,https://dx.doi.org/10.1016/j.bjid.2021.102059,22/02/2022,16/07/2022,Unverified
20220215_Salvadora_YaleSchoolofPublicHealth_Primary,15-Feb-22,Local,Brazil,BRA,Bahia,Salvador,18-Nov-20,26-Feb-21,Persons living in slums,Multiple groups,2035,46.40%,44.30%,48.60%,Entire sample,EUROIMMUN,ELISA,IgG,,,Moderate,Preprint,Mariam Fofana,Yale School of Public Health,https://www.medrxiv.org/content/10.1101/2022.02.13.22270856v1.full-text,23/02/2022,16/07/2022,Verified
220101_Maracana_UniversidadeFederaldoPará,01-Jan-22,Local,Brazil,BRA,Rio de Janeiro,Rio de Janeiro,01-May-21,31-May-21,Household and community samples,Multiple groups,117,42.30%,,,Unclear,NA,ELISA,IgG,,,High,Presentation or Conference,Aline Lima,Universidade Federal do Pará,https://dx.doi.org/10.1016/j.bjid.2021.102011,25/02/2022,16/07/2022,Unverified
220218_MinasGerais_FundacaoHemominas_Overall_TestAdj,18-Feb-22,Regional,Brazil,BRA,Minas Gerais,"Belo Horizonte, Governador Valadares, Juiz de Fora, Montes Claros, Pouso Alegre, Uberaba, and Uberlândia",01-Mar-20,31-Dec-20,Blood donors,Multiple groups,7837,5.20%,4.70%,5.80%,Simplified probability,Abbott Laboratories,CLIA,IgG,90.00%,99.00%,Moderate,Journal Article (Peer-Reviewed),Daniel Chaves,Fundacao Hemominas,https://dx.doi.org/10.3201/eid2804.211961,28/02/2022,16/07/2022,Verified
220112_Sergipe_FederalUniversityofSergipe_Overall,12-Jan-22,Regional,Brazil,BRA,Sergipe,,01-Dec-20,20-Dec-20,Non-essential workers and unemployed persons,Adults (18-64 years),113,24.80%,17.70%,33.50%,Convenience,Boditech Med Inc.,IFA,"IgM,IgG",95.80%,97.00%,High,Journal Article (Peer-Reviewed),Paulo Ricardo Martins-Filho,Federal University of Sergipe,https://dx.doi.org/10.17179/excli2021-4545,07/03/2022,16/07/2022,Unverified
220207_Betim_UniversidadeFederaldeMinasGerais,07-Feb-22,Local,Brazil,BRA,Minas Gerais,Betim,03-Jun-20,15-Jul-20,Household and community samples,Multiple groups,3239,1.20%,,,Stratified probability,Guangzhou Wondfo Biotech Co. Ltd,LFIA,"IgG,IgM",86.43%,99.57%,Moderate,Journal Article (Peer-Reviewed),Ana Silva,Universidade Federal de Minas Gerais,https://dx.doi.org/10.3389/fmicb.2022.799713,07/03/2022,16/07/2022,Verified
220222_Brasilia_MinisteriodaSaudeBrazil_Overall,22-Feb-22,Local,Brazil,BRA,Federal District,Brasilia,17-Jun-20,22-Jul-20,Persons who are incarcerated,Adults (18-64 years),455,81.10%,74.40%,87.80%,Stratified probability,Abbott Laboratories,CLIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Fernando Gouvea-Reis,Universidade de Brasilia,10.1108/IJPH-08-2021-0083,15/03/2022,16/07/2022,Unverified
220228_EspíritoSanto_DiretoriaDeSaúdeDoSistemaPenal_HealthcareProfessional,28-Feb-22,Regional,Brazil,BRA,Espírito Santo,,31-Aug-20,04-Sep-20,Health care workers and caregivers,Adults (18-64 years),311,11.90%,8.10%,15.70%,Simplified probability,MedLevensohn,LFIA,"IgG,IgM",,,Moderate,Journal Article (Peer-Reviewed),Camila Leal Cravo Duque,Diretoria de Saúde do Sistema Penal,https://dx.doi.org/10.1590/S1679-49742022000100008,17/03/2022,16/07/2022,Unverified
220228_EspíritoSanto_DiretoriaDeSaúdeDoSistemaPenal_PrisonOfficers,28-Feb-22,Regional,Brazil,BRA,Espírito Santo,,31-Aug-20,04-Sep-20,Health care workers and caregivers,Adults (18-64 years),675,22.10%,18.80%,25.30%,Simplified probability,MedLevensohn,LFIA,"IgG,IgM",,,Moderate,Journal Article (Peer-Reviewed),Camila Leal Cravo Duque,Diretoria de Saúde do Sistema Penal,https://dx.doi.org/10.1590/S1679-49742022000100008,17/03/2022,16/07/2022,Unverified
211122_Ipojuca_UniversidadedePernambuco,22-Nov-21,Local,Brazil,BRA,Pernambuco,,15-Mar-20,15-Jul-20,Residual sera,Children and Youth (0-17 years),54,16.70%,,,Convenience,NA,Not reported,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Thaysa Santos,Universidade de Pernambuco,https://dx.doi.org/10.1590/1807-3107bor-2022.vol36.0029,18/03/2022,16/07/2022,Unverified
210118_SaoPaulo_ProvinciaFranciscanadaImaculadaConceicaodoBrasil_Overall,18-Jan-21,Local,Brazil,BRA,,Sao Paulo,20-May-20,02-Jun-20,Non-essential workers and unemployed persons,Adults (18-64 years),173,26.60%,,,Convenience,NA,LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Nidia Horie,Província Franciscana da Imaculada Conceição do Brasil,https://dx.doi.org/10.31744/einstein_journal/2022AO6237,21/03/2022,16/07/2022,Unverified
220312_Brazil_FederalUniversityofParaná,12-Mar-22,Regional,Brazil,BRA,Paraná,Matinhos ,15-Jan-21,15-Dec-21,Household and community samples,Multiple groups,1384,11.10%,9.60%,12.60%,Self-referral,NA,IFA,IgG,95.00%,99.50%,High,Preprint,Luciano Huergo,Federal University of Paraná,https://www.medrxiv.org/content/10.1101/2022.03.10.22271805v1.full-text,22/03/2022,16/07/2022,Unverified
220311_Vitoria_FederalUniversityofEspiritoSanto,11-Mar-22,Local,Brazil,BRA,Espírito Santo,Victória,15-Jul-20,15-Oct-20,Pregnant or parturient women,Adults (18-64 years),261,27.20%,,,Sequential,ECO Diagnostica LTDA,CLIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Carolina Ferrugini,Federal University of Espírito Santo,https://dx.doi.org/10.1371/journal.pone.0264901,23/03/2022,16/07/2022,Verified
220314_FederalDistrict_UniversidadedeBrasilia,14-Mar-22,Regional,Brazil,BRA,Federal District,,15-Oct-20,15-Nov-20,Health care workers and caregivers,Multiple groups,324,19.10%,,,Stratified non-probability,"CTK Biotech, Inc.",LFIA,"IgG,IgM",97.10%,97.80%,High,Journal Article (Peer-Reviewed),Jaiane Ribeiro,Universidade de Brasília,https://dx.doi.org/10.1590/1807-3107bor-2022.vol36.0035,23/03/2022,16/07/2022,Unverified
220218_SaoPaulo_UniversidadeFederaldeSaoPaulo_2021February_Overall,18-Feb-22,Regional,Brazil,BRA,São Paulo,Sao Paulo city (Campo Limpo in the south and Tatuape in the east regions of the city); Sao Bernardo do Campo; Sorocaba.,01-Feb-21,28-Feb-21,Blood donors,Adults (18-64 years),940,30.90%,,,Simplified probability,Roche Diagnostics,CLIA,"IgG,IgM",95.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Nayara Vale,Universidade Federal de São Paulo,https://dx.doi.org/10.1016/j.clinsp.2022.100016,29/03/2022,16/07/2022,Verified
220218_SaoPaulo_UniversidadeFederaldeSaoPaulo_2020October_Overall,18-Feb-22,Regional,Brazil,BRA,São Paulo,Sao Paulo city (Campo Limpo in the south and Tatuape in the east regions of the city); Sao Bernardo do Campo; Sorocaba.,01-Oct-20,31-Oct-20,Blood donors,Adults (18-64 years),940,22.00%,,,Simplified probability,Roche Diagnostics,CLIA,"IgG,IgM",95.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Nayara Vale,Universidade Federal de São Paulo,https://dx.doi.org/10.1016/j.clinsp.2022.100016,29/03/2022,16/07/2022,Verified
220218_SaoPaulo_UniversidadeFederaldeSaoPaulo_2020June_Overall,18-Feb-22,Regional,Brazil,BRA,São Paulo,Sao Paulo city (Campo Limpo in the south and Tatuape in the east regions of the city); Sao Bernardo do Campo; Sorocaba.,01-Jun-20,30-Jun-20,Blood donors,Adults (18-64 years),926,11.40%,,,Simplified probability,Roche Diagnostics,CLIA,"IgG,IgM",95.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Nayara Vale,Universidade Federal de São Paulo,https://dx.doi.org/10.1016/j.clinsp.2022.100016,29/03/2022,16/07/2022,Verified
220414_DantePazzaneseInstituteofCardiology_DantePazzaneseInstituteofCardiology_Coronavac,14-Apr-22,Local,Brazil,BRA,,São Paulo,15-Jan-21,15-Feb-21,Health care workers and caregivers,Adults (18-64 years),750,33.47%,,,Unclear,NA,ELISA,IgG,94.00%,,High,Journal Article (Peer-Reviewed),Hui Lin-Wang,Dante Pazzanese Institute of Cardiology,https://dx.doi.org/10.1002/jmv.27782,22/04/2022,16/07/2022,Unverified
220415_Cuiaba_UniversidadeFederaldeMatoGrosso_2020-04_Overall,15-Apr-22,Local,Brazil,BRA,Mato Grosso,Cuiabá,01-Apr-20,30-Apr-20,Residual sera,Multiple groups,202,5.94%,,,Convenience,NA,Not reported,Not reported,,,Unclear,Journal Article (Peer-Reviewed),Cristiane Paula,Universidade Federal de Mato Grosso,https://dx.doi.org/10.1590/1806-9282.20210769,27/04/2022,16/07/2022,Unverified
220415_Cuiaba_UniversidadeFederaldeMatoGrosso_2020-05_Overall,15-Apr-22,Local,Brazil,BRA,Mato Grosso,Cuiabá,01-May-20,31-May-20,Residual sera,Multiple groups,496,4.84%,,,Convenience,NA,Not reported,Not reported,,,Unclear,Journal Article (Peer-Reviewed),Cristiane Paula,Universidade Federal de Mato Grosso,https://dx.doi.org/10.1590/1806-9282.20210769,27/04/2022,16/07/2022,Unverified
220415_Cuiaba_UniversidadeFederaldeMatoGrosso_2020-06_Overall,15-Apr-22,Local,Brazil,BRA,Mato Grosso,Cuiabá,01-Jun-20,30-Jun-20,Residual sera,Multiple groups,1446,14.87%,,,Convenience,NA,Not reported,Not reported,,,Unclear,Journal Article (Peer-Reviewed),Cristiane Paula,Universidade Federal de Mato Grosso,https://dx.doi.org/10.1590/1806-9282.20210769,27/04/2022,16/07/2022,Unverified
220415_Cuiaba_UniversidadeFederaldeMatoGrosso_2020-07_Overall,15-Apr-22,Local,Brazil,BRA,Mato Grosso,Cuiabá,01-Jul-20,31-Jul-20,Residual sera,Multiple groups,4221,27.03%,,,Convenience,NA,Not reported,Not reported,,,Unclear,Journal Article (Peer-Reviewed),Cristiane Paula,Universidade Federal de Mato Grosso,https://dx.doi.org/10.1590/1806-9282.20210769,27/04/2022,16/07/2022,Unverified
220415_Cuiaba_UniversidadeFederaldeMatoGrosso_2020-08_Overall,15-Apr-22,Local,Brazil,BRA,Mato Grosso,Cuiabá,01-Aug-20,31-Aug-20,Residual sera,Multiple groups,1224,31.05%,,,Convenience,NA,Not reported,Not reported,,,Unclear,Journal Article (Peer-Reviewed),Cristiane Paula,Universidade Federal de Mato Grosso,https://dx.doi.org/10.1590/1806-9282.20210769,27/04/2022,16/07/2022,Unverified
220415_Cuiaba_UniversidadeFederaldeMatoGrosso_2020-09_Overall,15-Apr-22,Local,Brazil,BRA,Mato Grosso,Cuiabá,01-Sep-20,30-Sep-20,Residual sera,Multiple groups,402,21.64%,,,Convenience,NA,Not reported,Not reported,,,Unclear,Journal Article (Peer-Reviewed),Cristiane Paula,Universidade Federal de Mato Grosso,https://dx.doi.org/10.1590/1806-9282.20210769,27/04/2022,16/07/2022,Unverified
220415_Cuiaba_UniversidadeFederaldeMatoGrosso_2020-10_Overall,15-Apr-22,Local,Brazil,BRA,Mato Grosso,Cuiabá,01-Oct-20,31-Oct-20,Residual sera,Multiple groups,330,15.76%,,,Convenience,NA,Not reported,Not reported,,,Unclear,Journal Article (Peer-Reviewed),Cristiane Paula,Universidade Federal de Mato Grosso,https://dx.doi.org/10.1590/1806-9282.20210769,27/04/2022,16/07/2022,Unverified
220415_Cuiaba_UniversidadeFederaldeMatoGrosso_2020-11_Overall,15-Apr-22,Local,Brazil,BRA,Mato Grosso,Cuiabá,01-Nov-20,30-Nov-20,Residual sera,Multiple groups,184,13.59%,,,Convenience,NA,Not reported,Not reported,,,Unclear,Journal Article (Peer-Reviewed),Cristiane Paula,Universidade Federal de Mato Grosso,https://dx.doi.org/10.1590/1806-9282.20210769,27/04/2022,16/07/2022,Unverified
220415_Cuiaba_UniversidadeFederaldeMatoGrosso_2020-12_Overall,15-Apr-22,Local,Brazil,BRA,Mato Grosso,Cuiabá,01-Dec-20,31-Dec-20,Residual sera,Multiple groups,379,15.04%,,,Convenience,NA,Not reported,Not reported,,,Unclear,Journal Article (Peer-Reviewed),Cristiane Paula,Universidade Federal de Mato Grosso,https://dx.doi.org/10.1590/1806-9282.20210769,27/04/2022,16/07/2022,Unverified
220429_Brazil_UniversidadeFederaldoCeará_Overall,29-Apr-22,Local,Brazil,BRA,Ceará,Fortaleza,15-Oct-20,15-Nov-20,Essential non-healthcare workers,Multiple groups,1901,8.00%,,,Convenience,Abbott Laboratories,Not reported,IgG,94.40%,100.00%,Moderate,Journal Article (Peer-Reviewed),Pamela Franca,Universidade Federal do Ceará,https://dx.doi.org/10.1590/0037-8682-0606-2021,16/05/2022,16/07/2022,Unverified
220520_Belem_FederalUniversityofPara_Overall,20-May-22,Local,Brazil,BRA,"Para
",Belem,15-Oct-20,15-Feb-21,Household and community samples,Multiple groups,704,39.10%,,,Unclear,EUROIMMUN,ELISA,IgG,,99.60%,High,Journal Article (Peer-Reviewed),Maria Torres,Federal University of Pará ,https://dx.doi.org/10.1038/s41598-022-12629-z,02/06/2022,16/07/2022,Unverified
211022_MinasGerais_FundacaoHemominas_Overall,22-Oct-21,Regional,Brazil,BRA,Minas Gerais,,15-Mar-20,15-Dec-20,Blood donors,Multiple groups,7837,5.60%,,,Convenience,NA,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),IR Oliveira,Fundacao Hemominas,https://dx.doi.org/10.1016/j.htct.2021.10.912,03/06/2022,16/07/2022,Unverified
220510_BeloHorizonte_UniversidadeFederalDeMinasGerais,10-May-22,Local,Brazil,BRA,Minas Gerais,Belo Horizonte,11-Jan-21,12-Mar-21,Health care workers and caregivers,Adults (18-64 years),99,16.20%,,,Convenience,NA,Multiple Types,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Lucyene Miguita,Universidade Federal de Minas Gerais,https://dx.doi.org/10.3389/froh.2022.871107,07/06/2022,16/07/2022,Unverified
220526_RioDeJaneiro_OswaldoCruzFoundation,26-May-22,Local,Brazil,BRA,Rio de Janeiro,Rio de Janeiro,15-May-20,14-Nov-21,Household and community samples,Multiple groups,2501,59.13%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Marilia Sa Carvalho,Oswaldo Cruz Foundation,https://dx.doi.org/10.1016/j.lana.2022.100283,16/06/2022,16/07/2022,Unverified
220606_Brazil_FederalUniversityOfParana_HCWs_Primary,06-Jun-22,Local,Brazil,BRA,Parana,Curitiba,15-Jun-20,15-Oct-20,Health care workers and caregivers,Adults (18-64 years),50,8.00%,,,Convenience,NA,Other,IgG,,,High,Journal Article (Peer-Reviewed),Rafael Mobile,Federal University of Parana,https://dx.doi.org/10.1590/S1678-9946202264039,20/06/2022,16/07/2022,Unverified
220606_Brazil_FederalUniversityOfParana_Patients_Primary,06-Jun-22,Local,Brazil,BRA,Parana,Curitiba,15-Jun-20,15-Dec-20,Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),29,6.90%,,,Convenience,NA,Other,IgG,,,High,Journal Article (Peer-Reviewed),Rafael Mobile,Federal University of Parana,https://dx.doi.org/10.1590/S1678-9946202264039,20/06/2022,16/07/2022,Unverified
220608_MatoGrosso_FederalUniversityOfMatoGrosso_Overall,08-Jun-22,Regional,Brazil,BRA,Mato Grosso,,16-Sep-20,15-Oct-20,Household and community samples,Multiple groups,4306,12.50%,10.50%,14.70%,Stratified probability,DiaSorin,CLIA,IgG,97.40%,98.50%,Moderate,Journal Article (Peer-Reviewed),Elaine Oliveira,Federal University of Mato Grosso,https://dx.doi.org/10.1590/0102-311XPT093021,27/06/2022,16/07/2022,Unverified
220602_SaoPaulo_UniversityOfSaoPaulo,02-Jun-22,Local,Brazil,BRA,Sao Paulo,Sao Paulo,15-Mar-20,15-Jul-20,Multiple populations,Multiple groups,1119,11.53%,,,Unclear,Roche Diagnostics,CLIA,Not reported,96.92%,98.78%,High,Journal Article (Peer-Reviewed),Robert Andreata-Santos,University of São Paulo,https://dx.doi.org/10.3389/fcimb.2022.787411,29/06/2022,16/07/2022,Unverified
220706_ SaoPaulo_UniversityofSaoPaulo,06-Jul-22,Local,Brazil,BRA,,Sao Paulo,26-May-20,30-Sep-20,Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),233,11.20%,,,Convenience,Siemens,CLIA,Total Antibody,99.80%,100.00%,High,Journal Article (Peer-Reviewed),Sandro da Costa Ferreira,University of Sao Paulo,https://dx.doi.org/10.1590/S0004-2803.202202000-32,21/07/2022,29/07/2022,Unverified
220718_CruzeirodoSul_UniversityofSaoPaulo_Overall,18-Jul-22,Local,Brazil,BRA,Acre State,Cruzeiro do Sul,15-Jan-21,04-Jul-21,Perinatal,Children and Youth (0-17 years),660,45.00%,41.20%,48.90%,Convenience,Roche Diagnostics,CLIA,Total Antibody,97.20%,99.80%,High,Journal Article (Peer-Reviewed),Marcelo Ferreira,University of Sao Paulo,https://dx.doi.org/10.1371/journal.pntd.0010580,26/07/2022,26/07/2022,Unverified
220722_MatoGrosso_UniversidadedeSaoPaulo_Overall,22-Jul-22,Regional,Brazil,BRA,Mato Grosso,"Cuiabá, Várzea
Grande, Cáceres, Rondonópolis, Barra do Garças,
Tangará da Serra, Alta Floresta, Água Boa, Juína and Sinop",15-Sep-20,15-Oct-20,Household and community samples,Multiple groups,4203,13.80%,,,Stratified probability,DiaSorin,CLIA,IgG,97.40%,98.50%,Moderate,Journal Article (Peer-Reviewed),Ana Trettel,Universidade de Sao Paulo,https://dx.doi.org/10.1590/1413-81232022278.04972022,03/08/2022,04/08/2022,Unverified
220721_Salvador_UniversidadeFederaldaBahia_Overall,21-Jul-22,Local,Brazil,BRA,,Salvador,15-May-20,15-Sep-20,Health care workers and caregivers,Adults (18-64 years),2083,13.00%,,,Convenience,"ECO Diagnostica LTDA,NA",Multiple Types,IgG,,,High,Journal Article (Peer-Reviewed),Iris Montano-Castellon,Universidade Federal da Bahia,https://dx.doi.org/10.1016/j.bjid.2022.102387,08/08/2022,08/08/2022,Unverified
220729_RiodeJaneiro_FIOCRUZ_AntiS,29-Jul-22,Local,Brazil,BRA,,Rio de Janeiro,15-Sep-20,10-Feb-21,Household and community samples,Multiple groups,4033,48.97%,,,Stratified probability,Abbott Laboratories,CLIA,IgG,99.37%,99.55%,Low,Journal Article (Peer-Reviewed),Lara E. Coelho,FIOCRUZ,https://doi.org/10.1016/j.lana.2022.100338,09/08/2022,10/08/2022,Unverified
220805_RibeiraoPreto_FundacaoOswaldoCruz_Phase2,05-Aug-22,Local,Brazil,BRA,Sao Paulo,Ribeirao Preto,02-Oct-20,03-Nov-20,Health care workers and caregivers,Adults (18-64 years),2129,12.10%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Patricia Evora,Fundacao Oswaldo Cruz,https://dx.doi.org/10.1590/0037-8682-0088-2022,18/08/2022,18/08/2022,Unverified
220805_RibeiraoPreto_FundacaoOswaldoCruz_Phase1,05-Aug-22,Local,Brazil,BRA,Sao Paulo,Ribeirao Preto,29-Jun-20,26-Aug-20,Health care workers and caregivers,Adults (18-64 years),10172,12.70%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Patricia Evora,Fundacao Oswaldo Cruz,https://dx.doi.org/10.1590/0037-8682-0088-2022,18/08/2022,18/08/2022,Unverified
220808_MatoGrosso_UniversidadedoEstadodeMatoGrosso,08-Aug-22,Regional,Brazil,BRA,Mato Grosso,,16-Sep-20,15-Oct-20,,,,,,,,,,,,,,Journal Article (Peer-Reviewed),Ana Cláudia Pereira Terças-Trettel,Universidade do Estado de Mato Grosso,https://dx.doi.org/10.1590/1806-9282.20220078,22/08/2022,22/08/2022,Unverified
210318_Sarajevo_InternationalBurchUniversity_DrAbdulahNakasGeneralHospital1_overall,18-Mar-21,Local,Bosnia and Herzegovina,BIH,,Sarajevo,15-Apr-20,15-May-20,Residual sera,Multiple groups,1720,3.41%,,,Convenience,Artron Laboratories Inc.,LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Adna Asic,International Burch University,https://dx.doi.org/10.5114/aoms/134143,29/05/2021,16/07/2022,Verified
210318_Sarajevo_InternationalBurchUniversity_EurofarmCentreLaboratory2_overall,18-Mar-21,Local,Bosnia and Herzegovina,BIH,,Sarajevo,21-Apr-20,17-Jul-20,Residual sera,Multiple groups,1121,4.28%,,,Convenience,Dynamiker Biotechnology (Tianjin) Co. Ltd,LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Adna Asic,International Burch University,https://dx.doi.org/10.5114/aoms/134143,29/05/2021,16/07/2022,Verified
210604_RepublicOfSrpska_InstituteforTransfusionMedicine_Primary,04-Jun-21,National,Bosnia and Herzegovina,BIH,Republic of Srpska,,17-Jun-20,16-Jul-20,Blood donors,Adults (18-64 years),807,2.70%,,,Unclear,Biomerieux,Other,IgG,,,Unclear,Journal Article (Peer-Reviewed),Gordana Guzijan,Institute for Transfusion Medicine of the Republic of Srpska,http://dx.doi.org/10.2298/VSP200122059G,18/07/2021,16/07/2022,Verified
211013_SarajevoCanton_PublicHealthInstitute_Overall,13-Oct-21,Local,Bosnia and Herzegovina,BIH,,Sarajevo Canton,05-Jan-21,20-Mar-21,Multiple populations,Multiple groups,3650,27.26%,,,Convenience,Snibe Co. Ltd (Shenzhen New Industries Biomedical Engineering Co. Ltd),CLIA,IgG,,,Moderate,Institutional Report,Anes Joguncic,Public Health Institute,,31/10/2021,16/07/2022,Unverified
220128_RepublicOfSrpska_UniversityOfBanjaLuka_Overall,28-Jan-22,Regional,Bosnia and Herzegovina,BIH,Republic of Srpska,"""a total of 64 municipalities""",01-Dec-20,15-Jan-21,Household and community samples,Multiple groups,1855,40.27%,,,Simplified probability,Beijing Wantai Biological,ELISA,Total Antibody,94.36%,100.00%,Moderate,Journal Article (Peer-Reviewed),Biljana Mijovic,University of Banja Luka,https://dx.doi.org/10.1371/journal.pone.0262738,08/02/2022,16/07/2022,Verified
220214_RepublicofSrpska_UniversityofBanjaLuka_Overall,14-Feb-22,Regional,Bosnia and Herzegovina,BIH,Republic of Srpska,,19-Mar-21,30-Apr-21,Health care workers and caregivers,Adults (18-64 years),1023,69.50%,,,Convenience,NA,ELISA,Not reported,,,Unclear,Journal Article (Peer-Reviewed),Darija Knezevic,University of Banja Luka,https://akjournals.com/view/journals/030/aop/article-10.1556-030.2022.01706/article-10.1556-030.2022.01706.xml,09/03/2022,16/07/2022,Unverified
220331_CantonSarajevo_InternationalBurchUniversity_Overall,31-Mar-22,Local,Bosnia and Herzegovina,BIH,,,15-Sep-20,15-May-21,Household and community samples,Multiple groups,18066,29.92%,,,Self-referral,Roche Diagnostics,CLIA,Total Antibody,,99.80%,High,Journal Article (Peer-Reviewed),Jasminka Prguda-Mujic,International Burch University,https://dx.doi.org/10.1371/journal.pone.0265431,14/04/2022,16/07/2022,Unverified
220125_Cochabamba_Aix-MarseilleUniversity_Overall,25-Jan-22,Local,Bolivia (Plurinational State of),BOL,,Cochabamba,01-Jan-21,31-Jan-21,Health care workers and caregivers,Adults (18-64 years),783,43.40%,38.80%,48.00%,Convenience,"Beckman Coulter,EUROIMMUN,NA",Multiple Types,IgG,,,Moderate,Journal Article (Peer-Reviewed),Paola Villarroel,Aix-Marseille University,https://dx.doi.org/10.3390/v14020232,09/02/2022,16/07/2022,Unverified
200615_Belgium_ZiekenhuisOost-Limburg_HealthCareWorkers,15-Jun-20,Local,Belgium,BEL,Limburg,Genk,22-Apr-20,30-Apr-20,Health care workers and caregivers,Adults (18-64 years),3056,6.40%,5.50%,7.30%,Convenience,Multi-G B.V.,LFIA,IgG,92.20%,97.00%,High,Journal Article (Peer-Reviewed),Deborah Steensels,ZiekenhuisOost-Limburg,https://jamanetwork.com/journals/jama/fullarticle/2767382,18/06/2020,16/07/2022,Verified
200625_Brussels_UniversitéLibredeBruxelles_OverallHCW,25-Jun-20,Local,Belgium,BEL,Brussels,City of Brussels,15-Apr-20,18-May-20,Health care workers and caregivers,Adults (18-64 years),326,11.00%,,,Convenience,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Charlotte Martin,Université Libre de Bruxelles,https://www.journalofhospitalinfection.com/article/S0195-6701(20)30313-3/fulltext,21/07/2020,16/07/2022,Verified
200730_Belgium_IrisHospitalsSouth_HCW_UnAdj,30-Jul-20,Local,Belgium,BEL,Brussels,City of Brussels,25-May-20,19-Jun-20,Health care workers and caregivers,Multiple groups,1485,14.61%,,,Convenience,DiaSorin,CLIA,IgG,100.00%,,High,Journal Article (Peer-Reviewed),Laurent Blairon,Iris Hospitals South,https://dx.doi.org/10.1016/j.jinf.2020.07.033,05/10/2020,16/07/2022,Verified
200811_Belgium_universitairesSaint-Luc_Overall,10-Aug-20,Local,Belgium,BEL,,City of Brussels,16-Apr-20,19-May-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,149,2.70%,,,Convenience,Snibe Co. Ltd (Shenzhen New Industries Biomedical Engineering Co. Ltd),CLIA,"IgG,IgM",95.60%,96.00%,High,Journal Article (Peer-Reviewed),Silvia Berardis,Cliniques universitaires Saint-Luc,https://www.sciencedirect.com/science/article/pii/S1569199320308213,24/10/2020,16/07/2022,Verified
201018_Belgium_UniversityHospitalsLeuven_Overall_unadj,18-Oct-20,Local,Belgium,BEL,Limburg,Lanaken,14-Apr-20,16-Apr-20,Multiple populations,Multiple groups,188,18.60%,,,Convenience,SureScreen Diagnostics,LFIA,"IgG,IgM",74.70%,95.10%,High,Journal Article (Peer-Reviewed),Frank Buntinx,University of Leuven,http://dx.doi.org/10.1080/17843286.2020.1834285,16/01/2021,16/07/2022,Verified
210120_Antwerp_UniversityofAntwerp_primary,20-Jan-21,Local,Belgium,BEL,,Antwerp,03-Jun-20,17-Jun-20,Health care workers and caregivers,Adults (18-64 years),431,3.20%,1.90%,5.40%,Convenience,NA,ELISA,IgG,80.00%,98.50%,High,Journal Article (Peer-Reviewed),Kawtar El Abdellati,University of Antwerp,https://dx.doi.org/10.1192/bjo.2020.172,06/02/2021,16/07/2022,Verified
210227_Belgium_AntwerpUniversityHospital_PediatricCancer_DiaSorin,27-Feb-21,Local,Belgium,BEL,,,24-Mar-20,31-May-20,Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),11,9.10%,,,Sequential,DiaSorin,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Peter van Dam,Antwerp University Hospital,https://dx.doi.org/10.1016/j.ejca.2021.02.024,21/04/2021,16/07/2022,Verified
210227_Belgium_AntwerpUniversityHospital_HCW_DiaSorin,27-Feb-21,Local,Belgium,BEL,,,24-Mar-20,31-May-20,Health care workers and caregivers,Adults (18-64 years),92,12.00%,,,Convenience,DiaSorin,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Peter van Dam,Antwerp University Hospital,https://dx.doi.org/10.1016/j.ejca.2021.02.024,21/04/2021,16/07/2022,Verified
210415_Belgium_UniversiteCatholiquedeLouvain_T4_overall,15-Apr-21,Local,Belgium,BEL,Brussels,Brussels,07-Jul-20,08-Jul-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,96,8.33%,,,Convenience,Roche Diagnostics,CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Laura Labriola,University Catholique de Louvain,http://dx.doi.org/10.2215/CJN.12490720,18/05/2021,16/07/2022,Verified
210828_Belgium_KatholiekeUniversiteitLeuven_Overall,28-Aug-21,Local,Belgium,BEL,Limburg Province,"Pelt Municipality, Alken Municipality",21-Sep-20,06-Oct-20,Students and Daycares,Children and Youth (0-17 years),362,9.40%,5.70%,13.10%,Stratified probability,Beijing Wantai Biological,ELISA,"IgG,IgA,IgM",100.00%,99.60%,High,Journal Article (Peer-Reviewed),Lisa Boey,Katholieke Universiteit Leuven,https://dx.doi.org/10.1007/s00431-021-04222-9,23/05/2021,16/07/2022,Verified
210227_Belgium_AntwerpUniversityHospital_Adult_nonCancer_DiaSorin,27-Feb-21,Local,Belgium,BEL,,,24-Mar-20,31-May-20,Residual sera,Multiple groups,90,5.60%,,,Sequential,DiaSorin,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Peter van Dam,Antwerp University Hospital,https://dx.doi.org/10.1016/j.ejca.2021.02.024,24/05/2021,16/07/2022,Verified
210227_Belgium_AntwerpUniversityHospital_AdultCancer_DiaSorin,27-Feb-21,Local,Belgium,BEL,,,24-Mar-20,31-May-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,827,6.20%,,,Sequential,DiaSorin,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Peter van Dam,Antwerp University Hospital,https://dx.doi.org/10.1016/j.ejca.2021.02.024,24/05/2021,16/07/2022,Verified
210505_Brussels_CliniquesUniversitairesSaint-Luc,05-May-21,Local,Belgium,BEL,Brussels-Capital,City of Brussels,19-Jun-20,30-Jun-20,Health care workers and caregivers,Adults (18-64 years),3255,7.80%,,,Convenience,Roche Diagnostics,CLIA,Total Antibody,100.00%,95.00%,Moderate,Journal Article (Peer-Reviewed),Anais Scohy,Cliniques universitaires Saint-Luc,http://dx.doi.org/10.1016/j.diagmicrobio.2021.115414,16/06/2021,16/07/2022,Unverified
210719_Brussels_UniversitéLibredeBruxelles,19-Jul-21,Local,Belgium,BEL,NR,Brussels,15-Mar-20,15-Feb-21,Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),75,20.00%,,,Sequential,NA,Not reported,Not reported,,,High,Journal Article (Peer-Reviewed),Anissa Messaaoui,Université Libre de Bruxelles,https://dx.doi.org/10.1515/jpem-2021-0289,29/07/2021,16/07/2022,Unverified
210722_Belgium_UniversityOfNamur_overall,22-Jul-21,National,Belgium,BEL,,,16-Jan-21,15-Feb-21,Health care workers and caregivers,Multiple groups,200,29.00%,,,Unclear,Roche Diagnostics,CLIA,Total Antibody,,,High,Journal Article (Peer-Reviewed),Julien Favresse,University of Namur,http://dx.doi.org/10.1080/22221751.2021.1953403,01/08/2021,16/07/2022,Verified
210810_Antwerp_UniversityOfAntwerp,10-Aug-21,Local,Belgium,BEL,Antwerp Province,Antwerp,09-Jun-20,29-Jun-20,Health care workers and caregivers,Multiple groups,5233,7.60%,6.90%,8.30%,Convenience,Roche Diagnostics,ELISA,"IgG,IgM",95.00%,99.00%,Moderate,Journal Article (Peer-Reviewed),Reinout Naesens,University Of Antwerp,https://dx.doi.org/10.1017/S0950268821001497,17/08/2021,16/07/2022,Unverified
200529_Belgium_BelgianInstituteofHealth_blooddonors_march_primary,29-May-20,National,Belgium,BEL,,,30-Mar-20,30-Mar-20,Blood donors,Multiple groups,584,1.30%,,,Convenience,NA,Not reported,Not reported,,,High,Institutional Report,Belgian Institute of Health,Belgian Institute of Health ,https://covid-19.sciensano.be/sites/default/files/Covid19/COVID-19_Weekly%20report_20200529%20-%20NL_0.pdf,14/09/2021,16/07/2022,Unverified
210827_Flanders_UniversityofAntwerp_December,27-Aug-21,Regional,Belgium,BEL,Flanders,,01-Dec-20,31-Dec-20,Health care workers and caregivers,Adults (18-64 years),698,13.40%,10.80%,16.40%,Convenience,NA,ELISA,IgG,,99.00%,High,Journal Article (Peer-Reviewed),Joachim Marien,University of Antwerp,https://dx.doi.org/10.1093/fampra/cmab094,15/09/2021,16/07/2022,Unverified
210827_Belgium_UniversityofLiegeHospital_Overall,27-Aug-21,National,Belgium,BEL,,,01-Mar-20,30-Sep-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,525,2.67%,,,Unclear,DiaSorin,CLIA,IgG,,,Unclear,Presentation or Conference,Louis Firket,University of Liege Hospital,http://dx.doi.org/10.1111/tri.13944,21/09/2021,16/07/2022,Unverified
210922_Flanders_GhentUniversity_residents,22-Sep-21,Regional,Belgium,BEL,Flanders,"Wingene, Liedekerke, Assenede, Wetteren",01-Aug-20,31-Aug-20,Assisted living and long-term care facilities,Seniors (65+ years),199,30.15%,,,Convenience,Abbott Laboratories,Other,IgG,,,High,Journal Article (Peer-Reviewed),Eline Meyers,Ghent University,https://dx.doi.org/10.1128/Spectrum.00178-21,28/09/2021,16/07/2022,Unverified
210922_Flanders_GhentUniversity_staff,22-Sep-21,Regional,Belgium,BEL,Flanders,"Wingene, Liedekerke, Assenede, Wetteren",01-Aug-20,31-Aug-20,Assisted living and long-term care facilities,Adults (18-64 years),241,28.63%,,,Convenience,Abbott Laboratories,Other,IgG,,,High,Journal Article (Peer-Reviewed),Eline Meyers,Ghent University,https://dx.doi.org/10.1128/Spectrum.00178-21,28/09/2021,16/07/2022,Unverified
211022_Belgium_UniversitéLibreDeBruxelles,22-Oct-21,National,Belgium,BEL,,,01-Jul-20,31-Oct-20,Students and Daycares,Children and Youth (0-17 years),112,12.50%,,,Convenience,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Lorraine Dethioux,Université Libre de Bruxelles,https://dx.doi.org/10.1007/s00431-021-04284-9,05/11/2021,16/07/2022,Unverified
211118_Belgium_CliniqueNotreDamedeGrace,18-Nov-21,Local,Belgium,BEL,,Gosselies,18-Jan-21,08-Feb-21,Health care workers and caregivers,Adults (18-64 years),189,41.80%,,,Convenience,"DiaSorin,EUROIMMUN,Siemens",CLIA,"IgG,Total Antibody",,,High,Journal Article (Peer-Reviewed),Loris Wauthier,Clinique Notre-Dame de Grâce,https://dx.doi.org/10.1080/17843286.2021.2004349,24/11/2021,16/07/2022,Unverified
211111_UZBrussel_UZBrussel_Phase2,11-Nov-21,Local,Belgium,BEL,,Brussels,01-Oct-20,31-Oct-20,Health care workers and caregivers,Adults (18-64 years),2336,7.92%,,,Convenience,NA,CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Marco Moretti,University Hospital Brussels,https://dx.doi.org/10.1016/j.ajic.2021.10.042,25/11/2021,16/07/2022,Unverified
211227_Ghent_GhentUniversityHospital_Overall,27-Dec-21,Local,Belgium,BEL,East Flanders,Ghent,15-Jan-20,15-Nov-20,Pregnant or parturient women,Adults (18-64 years),265,1.50%,,,Convenience,"EUROIMMUN,Epitope Diagnostics, Inc.",ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Laura Heireman,Ghent University Hospital,https://dx.doi.org/10.1080/01443615.2021.1997960,13/01/2022,16/07/2022,Verified
220127_Flanders_Sciensano_30Mar2020,27-Jan-22,Regional,Belgium,BEL,Flanders (Flemish region),,30-Mar-20,30-Mar-20,Blood donors,Multiple groups,584,2.00%,0.60%,3.50%,Convenience,,Not reported,Total Antibody,,,High,Institutional Report,Sciensano,Sciensano,https://datastudio.google.com/embed/u/0/reporting/7e11980c-3350-4ee3-8291-3065cc4e90c2/page/ZwmOB,16/02/2022,16/02/2022,Unverified
220127_Belgium_Sciensano_4-6Jan2021,27-Jan-22,National,Belgium,BEL,,,04-Jan-21,06-Jan-21,Blood donors,Multiple groups,1011,18.70%,15.60%,21.70%,Convenience,,Not reported,Total Antibody,,,High,Institutional Report,Sciensano,Sciensano,https://datastudio.google.com/embed/u/0/reporting/7e11980c-3350-4ee3-8291-3065cc4e90c2/page/ZwmOB,16/02/2022,16/02/2022,Unverified
220127_Belgium_Sciensano_29-30Mar2021,27-Jan-22,National,Belgium,BEL,,,29-Mar-21,30-Mar-21,Blood donors,Multiple groups,1200,31.50%,27.30%,35.60%,Convenience,,Not reported,Total Antibody,,,High,Institutional Report,Sciensano,Sciensano,https://datastudio.google.com/embed/u/0/reporting/7e11980c-3350-4ee3-8291-3065cc4e90c2/page/ZwmOB,16/02/2022,16/02/2022,Unverified
220127_Belgium_Sciensano_12-14Oct2020,27-Jan-22,National,Belgium,BEL,,,12-Oct-20,14-Oct-20,Blood donors,Multiple groups,900,5.70%,3.80%,7.70%,Convenience,,Not reported,Total Antibody,,,High,Institutional Report,Sciensano,Sciensano,https://datastudio.google.com/embed/u/0/reporting/7e11980c-3350-4ee3-8291-3065cc4e90c2/page/ZwmOB,16/02/2022,16/02/2022,Unverified
220127_Belgium_Sciensano_21-22Jun2021,27-Jan-22,National,Belgium,BEL,,,21-Jun-21,22-Jun-21,Blood donors,Multiple groups,1199,78.70%,75.90%,81.50%,Convenience,,Not reported,Total Antibody,,,High,Institutional Report,Sciensano,Sciensano,https://datastudio.google.com/embed/u/0/reporting/7e11980c-3350-4ee3-8291-3065cc4e90c2/page/ZwmOB,16/02/2022,16/02/2022,Unverified
220127_Belgium_Sciensano_1-2Mar2021,27-Jan-22,National,Belgium,BEL,,,01-Mar-21,02-Mar-21,Blood donors,Multiple groups,1175,25.60%,21.40%,29.90%,Convenience,,Not reported,Total Antibody,,,High,Institutional Report,Sciensano,Sciensano,https://datastudio.google.com/embed/u/0/reporting/7e11980c-3350-4ee3-8291-3065cc4e90c2/page/ZwmOB,16/02/2022,16/02/2022,Unverified
220127_Belgium_Sciensano_19-20Jul2021,27-Jan-22,National,Belgium,BEL,,,19-Jul-21,20-Jul-21,Blood donors,Multiple groups,1185,98.00%,,,Convenience,,Not reported,Total Antibody,,,High,Institutional Report,Sciensano,Sciensano,https://datastudio.google.com/embed/u/0/reporting/7e11980c-3350-4ee3-8291-3065cc4e90c2/page/ZwmOB,16/02/2022,16/02/2022,Unverified
220127_Belgium_Sciensano_9-11Nov2020,27-Jan-22,National,Belgium,BEL,,,09-Nov-20,11-Nov-20,Blood donors,Multiple groups,900,13.60%,10.60%,16.70%,Convenience,,Not reported,Total Antibody,,,High,Institutional Report,Sciensano,Sciensano,https://datastudio.google.com/embed/u/0/reporting/7e11980c-3350-4ee3-8291-3065cc4e90c2/page/ZwmOB,16/02/2022,16/02/2022,Unverified
220127_Belgium_Sciensano_20-23Jul2020,27-Jan-22,National,Belgium,BEL,,,20-Jul-20,23-Jul-20,Blood donors,Multiple groups,900,5.20%,3.50%,6.90%,Convenience,,Not reported,Total Antibody,,,High,Institutional Report,Sciensano,Sciensano,https://datastudio.google.com/embed/u/0/reporting/7e11980c-3350-4ee3-8291-3065cc4e90c2/page/ZwmOB,16/02/2022,16/02/2022,Unverified
220127_Belgium_Sciensano_8-10Jun2020,27-Jan-22,National,Belgium,BEL,,,08-Jun-20,10-Jun-20,Blood donors,Multiple groups,900,4.50%,3.00%,6.10%,Convenience,,Not reported,Total Antibody,,,High,Institutional Report,Sciensano,Sciensano,https://datastudio.google.com/embed/u/0/reporting/7e11980c-3350-4ee3-8291-3065cc4e90c2/page/ZwmOB,16/02/2022,16/02/2022,Unverified
220127_Belgium_Sciensano_18-20Jan2021,27-Jan-22,National,Belgium,BEL,,,18-Jan-21,20-Jan-21,Blood donors,Multiple groups,900,19.40%,16.00%,22.80%,Convenience,,Not reported,Total Antibody,,,High,Institutional Report,Sciensano,Sciensano,https://datastudio.google.com/embed/u/0/reporting/7e11980c-3350-4ee3-8291-3065cc4e90c2/page/ZwmOB,16/02/2022,16/02/2022,Unverified
220127_Belgium_Sciensano_6-7Jul2020,27-Jan-22,National,Belgium,BEL,,,06-Jul-20,07-Jul-20,Blood donors,Multiple groups,900,5.80%,4.00%,7.80%,Convenience,,Not reported,Total Antibody,,,High,Institutional Report,Sciensano,Sciensano,https://datastudio.google.com/embed/u/0/reporting/7e11980c-3350-4ee3-8291-3065cc4e90c2/page/ZwmOB,16/02/2022,16/02/2022,Unverified
220127_Belgium_Sciensano_24-25May2021,27-Jan-22,National,Belgium,BEL,,,24-May-21,25-May-21,Blood donors,Multiple groups,1186,61.10%,57.50%,65.10%,Convenience,,Not reported,Total Antibody,,,High,Institutional Report,Sciensano,Sciensano,https://datastudio.google.com/embed/u/0/reporting/7e11980c-3350-4ee3-8291-3065cc4e90c2/page/ZwmOB,16/02/2022,16/02/2022,Unverified
220127_Belgium_Sciensano_7-9Dec2020,27-Jan-22,National,Belgium,BEL,,,07-Dec-20,09-Dec-20,Blood donors,Multiple groups,900,18.70%,14.90%,22.80%,Convenience,,Not reported,Total Antibody,,,High,Institutional Report,Sciensano,Sciensano,https://datastudio.google.com/embed/u/0/reporting/7e11980c-3350-4ee3-8291-3065cc4e90c2/page/ZwmOB,16/02/2022,16/02/2022,Unverified
220127_Belgium_Sciensano_31Aug-2Sep2020,27-Jan-22,National,Belgium,BEL,,,31-Aug-20,02-Sep-20,Blood donors,Multiple groups,900,4.90%,3.00%,6.90%,Convenience,,Not reported,Total Antibody,,,High,Institutional Report,Sciensano,Sciensano,https://datastudio.google.com/embed/u/0/reporting/7e11980c-3350-4ee3-8291-3065cc4e90c2/page/ZwmOB,16/02/2022,16/02/2022,Unverified
220127_Belgium_Sciensano_26-27Apr2021,27-Jan-22,National,Belgium,BEL,,,26-Apr-21,27-Apr-21,Blood donors,Multiple groups,1200,45.60%,41.20%,50.30%,Convenience,,Not reported,Total Antibody,,,High,Institutional Report,Sciensano,Sciensano,https://datastudio.google.com/embed/u/0/reporting/7e11980c-3350-4ee3-8291-3065cc4e90c2/page/ZwmOB,16/02/2022,16/02/2022,Unverified
220127_Belgium_Sciensano_25-27May2020,27-Jan-22,National,Belgium,BEL,,,25-May-20,27-May-20,Blood donors,Multiple groups,900,5.50%,3.80%,7.40%,Convenience,,Not reported,Total Antibody,,,High,Institutional Report,Sciensano,Sciensano,https://datastudio.google.com/embed/u/0/reporting/7e11980c-3350-4ee3-8291-3065cc4e90c2/page/ZwmOB,16/02/2022,16/02/2022,Unverified
220127_Belgium_Sciensano_1-2Feb2021,27-Jan-22,National,Belgium,BEL,,,01-Feb-21,02-Feb-21,Blood donors,Multiple groups,1135,20.30%,17.50%,23.30%,Convenience,,Not reported,Total Antibody,,,High,Institutional Report,Sciensano,Sciensano,https://datastudio.google.com/embed/u/0/reporting/7e11980c-3350-4ee3-8291-3065cc4e90c2/page/ZwmOB,16/02/2022,16/02/2022,Unverified
220127_Belgium_Sciensano_11-13May2020,27-Jan-22,National,Belgium,BEL,,,11-May-20,13-May-20,Blood donors,Multiple groups,900,5.30%,3.60%,7.20%,Convenience,,Not reported,Total Antibody,,,High,Institutional Report,Sciensano,Sciensano,https://datastudio.google.com/embed/u/0/reporting/7e11980c-3350-4ee3-8291-3065cc4e90c2/page/ZwmOB,16/02/2022,16/02/2022,Unverified
220127_Belgium_Sciensano_28-30Sep2020,27-Jan-22,National,Belgium,BEL,,,28-Sep-20,30-Sep-20,Blood donors,Multiple groups,900,4.80%,3.00%,6.90%,Convenience,,Not reported,Total Antibody,,,High,Institutional Report,Sciensano,Sciensano,https://datastudio.google.com/embed/u/0/reporting/7e11980c-3350-4ee3-8291-3065cc4e90c2/page/ZwmOB,16/02/2022,16/02/2022,Unverified
220127_Belgium_Sciensano_22-24Jun2020,27-Jan-22,National,Belgium,BEL,,,22-Jun-20,24-Jun-20,Blood donors,Multiple groups,900,5.90%,4.30%,7.80%,Convenience,,Not reported,Total Antibody,,,High,Institutional Report,Sciensano,Sciensano,https://datastudio.google.com/embed/u/0/reporting/7e11980c-3350-4ee3-8291-3065cc4e90c2/page/ZwmOB,16/02/2022,16/02/2022,Unverified
220127_Belgium_Sciensano_23-25Nov2020,27-Jan-22,National,Belgium,BEL,,,23-Nov-20,25-Nov-20,Blood donors,Multiple groups,900,16.40%,13.10%,20.30%,Convenience,,Not reported,Total Antibody,,,High,Institutional Report,Sciensano,Sciensano,https://datastudio.google.com/embed/u/0/reporting/7e11980c-3350-4ee3-8291-3065cc4e90c2/page/ZwmOB,16/02/2022,16/02/2022,Unverified
220127_Belgium_Sciensano_27-29Apr2020,27-Jan-22,National,Belgium,BEL,,,27-Apr-20,29-Apr-20,Blood donors,Multiple groups,900,5.00%,3.40%,6.70%,Convenience,,Not reported,Total Antibody,,,High,Institutional Report,Sciensano,Sciensano,https://datastudio.google.com/embed/u/0/reporting/7e11980c-3350-4ee3-8291-3065cc4e90c2/page/ZwmOB,16/02/2022,16/02/2022,Unverified
220127_Belgium_Sciensano_3-5Aug2020,27-Jan-22,National,Belgium,BEL,,,03-Aug-20,05-Aug-20,Blood donors,Multiple groups,869,4.80%,3.10%,6.60%,Convenience,,Not reported,Total Antibody,,,High,Institutional Report,Sciensano,Sciensano,https://datastudio.google.com/embed/u/0/reporting/7e11980c-3350-4ee3-8291-3065cc4e90c2/page/ZwmOB,16/02/2022,16/02/2022,Unverified
220127_Belgium_Sciensano_17-19Aug2020,27-Jan-22,National,Belgium,BEL,,,17-Aug-20,19-Aug-20,Blood donors,Multiple groups,900,6.00%,4.20%,7.90%,Convenience,,Not reported,Total Antibody,,,High,Institutional Report,Sciensano,Sciensano,https://datastudio.google.com/embed/u/0/reporting/7e11980c-3350-4ee3-8291-3065cc4e90c2/page/ZwmOB,16/02/2022,16/02/2022,Unverified
220127_Belgium_Sciensano_26-28Oct2020,27-Jan-22,National,Belgium,BEL,,,26-Oct-20,28-Oct-20,Blood donors,Multiple groups,900,9.20%,6.80%,12.00%,Convenience,,Not reported,Total Antibody,,,High,Institutional Report,Sciensano,Sciensano,https://datastudio.google.com/embed/u/0/reporting/7e11980c-3350-4ee3-8291-3065cc4e90c2/page/ZwmOB,16/02/2022,16/02/2022,Unverified
220127_Belgium_Sciensano_21Dec2020,27-Jan-22,National,Belgium,BEL,,,21-Dec-20,21-Dec-20,Blood donors,Multiple groups,900,19.60%,15.50%,24.50%,Convenience,,Not reported,Total Antibody,,,High,Institutional Report,Sciensano,Sciensano,https://datastudio.google.com/embed/u/0/reporting/7e11980c-3350-4ee3-8291-3065cc4e90c2/page/ZwmOB,16/02/2022,16/02/2022,Unverified
220127_Belgium_Sciensano_14-16Apr2020,27-Jan-22,National,Belgium,BEL,,,14-Apr-20,16-Apr-20,Blood donors,Multiple groups,900,5.30%,3.50%,6.60%,Convenience,,Not reported,Total Antibody,,,High,Institutional Report,Sciensano,Sciensano,https://datastudio.google.com/embed/u/0/reporting/7e11980c-3350-4ee3-8291-3065cc4e90c2/page/ZwmOB,16/02/2022,16/02/2022,Unverified
220127_Belgium_Sciensano_14-16Sep2020,27-Jan-22,National,Belgium,BEL,,,14-Sep-20,16-Sep-20,Blood donors,Multiple groups,900,4.40%,2.80%,6.20%,Convenience,,Not reported,Total Antibody,,,High,Institutional Report,Sciensano,Sciensano,https://datastudio.google.com/embed/u/0/reporting/7e11980c-3350-4ee3-8291-3065cc4e90c2/page/ZwmOB,16/02/2022,16/02/2022,Unverified
220127_Belgium_Sciensano_Primary_3Dec2020-28Jan2021_Overall,27-Jan-22,National,Belgium,BEL,,,03-Dec-20,28-Jan-21,Students and Daycares,Children and Youth (0-17 years),479,11.00%,7.60%,15.90%,Stratified probability,EUROIMMUN,ELISA,IgG,95.90%,98.60%,Moderate,Institutional Report,Sciensano,Sciensano,https://datastudio.google.com/embed/u/0/reporting/7e11980c-3350-4ee3-8291-3065cc4e90c2/page/ZwmOB,16/02/2022,16/07/2022,Unverified
220127_Belgium_Sciensano_Secondary_3Dec2020-28Jan2021,27-Jan-22,National,Belgium,BEL,,,03-Dec-20,28-Jan-21,Students and Daycares,Children and Youth (0-17 years),451,13.60%,9.90%,18.50%,Stratified probability,EUROIMMUN,ELISA,IgG,95.90%,98.60%,Moderate,Institutional Report,Sciensano,Sciensano,https://datastudio.google.com/embed/u/0/reporting/7e11980c-3350-4ee3-8291-3065cc4e90c2/page/ZwmOB,16/02/2022,16/07/2022,Unverified
220127_Belgium_Sciensano_Primary_20Sep-8Oct2021,27-Jan-22,National,Belgium,BEL,,,20-Sep-21,08-Oct-21,Students and Daycares,Children and Youth (0-17 years),478,26.60%,21.50%,32.80%,Stratified probability,EUROIMMUN,ELISA,IgG,95.90%,98.60%,Moderate,Institutional Report,Sciensano,Sciensano,https://datastudio.google.com/embed/u/0/reporting/7e11980c-3350-4ee3-8291-3065cc4e90c2/page/ZwmOB,16/02/2022,16/07/2022,Unverified
220127_Belgium_Sciensano_Primary_6-17Dec2021_Overall,27-Jan-22,National,Belgium,BEL,,,06-Dec-21,17-Dec-21,Students and Daycares,Children and Youth (0-17 years),432,50.90%,,,Stratified probability,EUROIMMUN,ELISA,IgG,95.90%,98.60%,Moderate,Institutional Report,Sciensano,Sciensano,https://datastudio.google.com/embed/u/0/reporting/7e11980c-3350-4ee3-8291-3065cc4e90c2/page/ZwmOB,16/02/2022,16/07/2022,Unverified
220127_Belgium_Sciensano_Primary_1-26Mar2021_Overall,27-Jan-22,National,Belgium,BEL,,,01-Mar-21,26-Mar-21,Students and Daycares,Children and Youth (0-17 years),648,17.10%,13.30%,21.90%,Stratified probability,EUROIMMUN,ELISA,IgG,95.90%,98.60%,Moderate,Institutional Report,Sciensano,Sciensano,https://datastudio.google.com/embed/u/0/reporting/7e11980c-3350-4ee3-8291-3065cc4e90c2/page/ZwmOB,16/02/2022,16/07/2022,Unverified
220127_Belgium_Sciensano_Secondary_17May-11Jun2021,27-Jan-22,National,Belgium,BEL,,,17-May-21,11-Jun-21,Students and Daycares,Children and Youth (0-17 years),525,17.20%,13.10%,22.70%,Stratified probability,EUROIMMUN,ELISA,IgG,95.90%,98.60%,Moderate,Institutional Report,Sciensano,Sciensano,https://datastudio.google.com/embed/u/0/reporting/7e11980c-3350-4ee3-8291-3065cc4e90c2/page/ZwmOB,16/02/2022,16/07/2022,Unverified
220127_Belgium_Sciensano_SchoolStaff_3Dec2020-28Jan2021,27-Jan-22,National,Belgium,BEL,,,03-Dec-20,28-Jan-21,Essential non-healthcare workers,Adults (18-64 years),629,14.80%,12.20%,18.00%,Stratified probability,EUROIMMUN,ELISA,IgG,95.90%,98.60%,Moderate,Institutional Report,Sciensano,Sciensano,https://datastudio.google.com/embed/u/0/reporting/7e11980c-3350-4ee3-8291-3065cc4e90c2/page/ZwmOB,16/02/2022,16/07/2022,Unverified
220127_Belgium_Sciensano_SchoolStaff_17May-11Jun2021,27-Jan-22,National,Belgium,BEL,,,17-May-21,11-Jun-21,Essential non-healthcare workers,Adults (18-64 years),643,38.00%,33.40%,43.30%,Stratified probability,EUROIMMUN,ELISA,IgG,95.90%,98.60%,Moderate,Institutional Report,Sciensano,Sciensano,https://datastudio.google.com/embed/u/0/reporting/7e11980c-3350-4ee3-8291-3065cc4e90c2/page/ZwmOB,16/02/2022,16/07/2022,Unverified
220127_Belgium_Sciensano_SchoolStaff_1-26Mar2021,27-Jan-22,National,Belgium,BEL,,,01-Mar-21,26-Mar-21,Essential non-healthcare workers,Adults (18-64 years),691,19.00%,16.10%,22.30%,Stratified probability,EUROIMMUN,ELISA,IgG,95.90%,98.60%,Moderate,Institutional Report,Sciensano,Sciensano,https://datastudio.google.com/embed/u/0/reporting/7e11980c-3350-4ee3-8291-3065cc4e90c2/page/ZwmOB,16/02/2022,16/07/2022,Unverified
220127_Belgium_Sciensano_Secondary_1-26Mar2021,27-Jan-22,National,Belgium,BEL,,,01-Mar-21,26-Mar-21,Students and Daycares,Children and Youth (0-17 years),515,18.00%,13.60%,23.80%,Stratified probability,EUROIMMUN,ELISA,IgG,95.90%,98.60%,Moderate,Institutional Report,Sciensano,Sciensano,https://datastudio.google.com/embed/u/0/reporting/7e11980c-3350-4ee3-8291-3065cc4e90c2/page/ZwmOB,16/02/2022,16/07/2022,Unverified
220127_Belgium_Sciensano_Primary_17May-11Jun2021,27-Jan-22,National,Belgium,BEL,,,17-May-21,11-Jun-21,Students and Daycares,Children and Youth (0-17 years),664,15.40%,12.20%,19.60%,Stratified probability,EUROIMMUN,ELISA,IgG,95.90%,98.60%,Moderate,Institutional Report,Sciensano,Sciensano,https://datastudio.google.com/embed/u/0/reporting/7e11980c-3350-4ee3-8291-3065cc4e90c2/page/ZwmOB,16/02/2022,16/07/2022,Unverified
220127_Belgium_Sciensano_PHCPs_13-26Dec2021,27-Jan-22,National,Belgium,BEL,,,13-Dec-21,26-Dec-21,Health care workers and caregivers,Adults (18-64 years),2498,93.90%,,,Convenience,"Zhejiang Orient Gene Biotech,Roche Diagnostics,Siemens,DiaSorin",Multiple Types,"IgG,IgM,IgA",,,Moderate,Institutional Report,Sciensano,Sciensano,https://datastudio.google.com/embed/u/0/reporting/7e11980c-3350-4ee3-8291-3065cc4e90c2/page/ZwmOB,17/02/2022,16/07/2022,Unverified
220127_Belgium_Sciensano_HCWs_21-25Apr2021,27-Jan-22,National,Belgium,BEL,,,21-Apr-21,25-Apr-21,Health care workers and caregivers,Adults (18-64 years),304,96.70%,93.40%,98.40%,Stratified probability,EUROIMMUN,ELISA,IgG,93.00%,99.00%,Moderate,Institutional Report,Sciensano,Sciensano,https://datastudio.google.com/embed/u/0/reporting/7e11980c-3350-4ee3-8291-3065cc4e90c2/page/ZwmOB,17/02/2022,16/07/2022,Unverified
220127_Belgium_Sciensano_NursingHomeResidents_29Jul-31Aug2021,27-Jan-22,National,Belgium,BEL,,,29-Jul-21,31-Aug-21,Assisted living and long-term care facilities,Seniors (65+ years),1385,68.00%,64.00%,72.00%,Stratified probability,Zhejiang Orient Gene Biotech,LFIA,"IgG,IgM",92.90%,96.30%,Moderate,Institutional Report,Sciensano,Sciensano,https://datastudio.google.com/embed/u/0/reporting/7e11980c-3350-4ee3-8291-3065cc4e90c2/page/ZwmOB,17/02/2022,16/07/2022,Unverified
220127_Belgium_Sciensano_NursingHomeResidents_1Feb-24Mar2021,27-Jan-22,National,Belgium,BEL,,,01-Feb-21,24-Mar-21,Assisted living and long-term care facilities,Seniors (65+ years),1624,69.00%,63.00%,74.00%,Stratified probability,Zhejiang Orient Gene Biotech,LFIA,"IgG,IgM",92.90%,96.30%,Moderate,Institutional Report,Sciensano,Sciensano,https://datastudio.google.com/embed/u/0/reporting/7e11980c-3350-4ee3-8291-3065cc4e90c2/page/ZwmOB,17/02/2022,16/07/2022,Unverified
220127_Belgium_Sciensano_NursingHomeResidents_31Mar-1May2021,27-Jan-22,National,Belgium,BEL,,,31-Mar-21,01-May-21,Assisted living and long-term care facilities,Seniors (65+ years),1553,90.00%,87.00%,92.00%,Stratified probability,Zhejiang Orient Gene Biotech,LFIA,"IgG,IgM",92.90%,96.30%,Moderate,Institutional Report,Sciensano,Sciensano,https://datastudio.google.com/embed/u/0/reporting/7e11980c-3350-4ee3-8291-3065cc4e90c2/page/ZwmOB,17/02/2022,16/07/2022,Unverified
220127_Belgium_Sciensano_NursingHomeResidents_27Sep-28Oct2021,27-Jan-22,National,Belgium,BEL,,,27-Sep-21,28-Oct-21,Assisted living and long-term care facilities,Seniors (65+ years),1347,69.00%,,,Stratified probability,Zhejiang Orient Gene Biotech,LFIA,"IgG,IgM",92.90%,96.30%,Moderate,Institutional Report,Sciensano,Sciensano,https://datastudio.google.com/embed/u/0/reporting/7e11980c-3350-4ee3-8291-3065cc4e90c2/page/ZwmOB,17/02/2022,16/07/2022,Unverified
220127_Belgium_Sciensano_NursingHomeStaff_1Feb-24Mar2021,27-Jan-22,National,Belgium,BEL,,,01-Feb-21,24-Mar-21,Assisted living and long-term care facilities,Adults (18-64 years),1337,80.00%,76.00%,83.00%,Stratified probability,Zhejiang Orient Gene Biotech,LFIA,"IgG,IgM",92.90%,96.30%,Moderate,Institutional Report,Sciensano,Sciensano,https://datastudio.google.com/embed/u/0/reporting/7e11980c-3350-4ee3-8291-3065cc4e90c2/page/ZwmOB,17/02/2022,16/07/2022,Unverified
220127_Belgium_Sciensano_NursingHomeStaff_27Sep-28Oct2021,27-Jan-22,National,Belgium,BEL,,,27-Sep-21,28-Oct-21,Assisted living and long-term care facilities,Adults (18-64 years),1012,80.00%,,,Stratified probability,Zhejiang Orient Gene Biotech,LFIA,"IgG,IgM",92.90%,96.30%,Moderate,Institutional Report,Sciensano,Sciensano,https://datastudio.google.com/embed/u/0/reporting/7e11980c-3350-4ee3-8291-3065cc4e90c2/page/ZwmOB,17/02/2022,16/07/2022,Unverified
220127_Belgium_Sciensano_NursingHomeResidents_30May-30Jun2021,27-Jan-22,National,Belgium,BEL,,,30-May-21,30-Jun-21,Assisted living and long-term care facilities,Seniors (65+ years),1480,86.00%,83.00%,88.00%,Stratified probability,Zhejiang Orient Gene Biotech,LFIA,"IgG,IgM",92.90%,96.30%,Moderate,Institutional Report,Sciensano,Sciensano,https://datastudio.google.com/embed/u/0/reporting/7e11980c-3350-4ee3-8291-3065cc4e90c2/page/ZwmOB,17/02/2022,16/07/2022,Unverified
220127_Belgium_Sciensano_NursingHomeStaff_29Jul-31Aug2021,27-Jan-22,National,Belgium,BEL,,,29-Jul-21,31-Aug-21,Assisted living and long-term care facilities,Adults (18-64 years),1012,86.00%,83.00%,89.00%,Stratified probability,Zhejiang Orient Gene Biotech,LFIA,"IgG,IgM",92.90%,96.30%,Moderate,Institutional Report,Sciensano,Sciensano,https://datastudio.google.com/embed/u/0/reporting/7e11980c-3350-4ee3-8291-3065cc4e90c2/page/ZwmOB,17/02/2022,16/07/2022,Unverified
220127_Belgium_Sciensano_NursingHomeStaff_31Mar-1May2021,27-Jan-22,National,Belgium,BEL,,,31-Mar-21,01-May-21,Assisted living and long-term care facilities,Adults (18-64 years),1290,92.00%,90.00%,94.00%,Stratified probability,Zhejiang Orient Gene Biotech,LFIA,"IgG,IgM",92.90%,96.30%,Moderate,Institutional Report,Sciensano,Sciensano,https://datastudio.google.com/embed/u/0/reporting/7e11980c-3350-4ee3-8291-3065cc4e90c2/page/ZwmOB,17/02/2022,16/07/2022,Unverified
220127_Belgium_Sciensano_NursingHomeStaff_30May-30Jun2021,27-Jan-22,National,Belgium,BEL,,,30-May-21,30-Jun-21,Assisted living and long-term care facilities,Adults (18-64 years),1184,94.00%,92.00%,95.00%,Stratified probability,Zhejiang Orient Gene Biotech,LFIA,"IgG,IgM",92.90%,96.30%,Moderate,Institutional Report,Sciensano,Sciensano,https://datastudio.google.com/embed/u/0/reporting/7e11980c-3350-4ee3-8291-3065cc4e90c2/page/ZwmOB,17/02/2022,16/07/2022,Unverified
220121_Leuven_UniversityOfOxford,21-Jan-22,Local,Belgium,BEL,,Leuven,26-May-20,24-Sep-21,Patients seeking care for non-COVID-19 reasons,Multiple groups,862,5.68%,,,Convenience,"Roche Diagnostics,Siemens",Not reported,Total Antibody,,,High,Presentation or Conference,S Y Wong,University of Oxford,https://dx.doi.org/10.1093/ecco-jcc/jjab232.469,08/03/2022,16/07/2022,Unverified
220302_Flanders_GhentUniversity_Residents,02-Mar-22,Regional,Belgium,BEL,Region of Flanders,,19-Oct-20,13-Nov-20,Assisted living and long-term care facilities,Seniors (65+ years),615,18.90%,15.90%,22.20%,Convenience,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Heidi Janssens,Ghent University,https://dx.doi.org/10.1017/S095026882200036X,09/03/2022,16/07/2022,Unverified
220302_Flanders_GhentUniversity_Staff,02-Mar-22,Regional,Belgium,BEL,Region of Flanders,,19-Oct-20,13-Nov-20,Health care workers and caregivers,Adults (18-64 years),478,14.90%,11.90%,18.40%,Convenience,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Heidi Janssens,Ghent University,https://dx.doi.org/10.1017/S095026882200036X,09/03/2022,16/07/2022,Unverified
220306_Belgium_UniversityofAntwerp_c1_OverallPopAdj,03-Mar-22,National,Belgium,BEL,,,30-Mar-20,05-Apr-20,Residual sera,Multiple groups,3910,1.83%,1.00%,2.61%,Stratified probability,EUROIMMUN,ELISA,IgG,84.90%,98.70%,Moderate,Journal Article (Peer-Reviewed),Sereina Herzog,University of Antwerp,https://dx.doi.org/10.2807/1560-7917.ES.2022.27.9.2100419,22/03/2022,16/07/2022,Unverified
220306_Belgium_UniversityofAntwerp_c2_OverallPopAdj,03-Mar-22,National,Belgium,BEL,,,20-Apr-20,26-Apr-20,Residual sera,Multiple groups,3397,5.25%,4.22%,6.35%,Stratified probability,EUROIMMUN,ELISA,IgG,84.90%,98.70%,Moderate,Journal Article (Peer-Reviewed),Sereina Herzog,University of Antwerp,https://dx.doi.org/10.2807/1560-7917.ES.2022.27.9.2100419,22/03/2022,16/07/2022,Unverified
220306_Belgium_UniversityofAntwerp_c3_OverallPopAdj,03-Mar-22,National,Belgium,BEL,,,18-May-20,25-May-20,Residual sera,Multiple groups,3242,6.20%,5.05%,7.31%,Stratified probability,EUROIMMUN,ELISA,IgG,84.90%,98.70%,Moderate,Journal Article (Peer-Reviewed),Sereina Herzog,University of Antwerp,https://dx.doi.org/10.2807/1560-7917.ES.2022.27.9.2100419,22/03/2022,16/07/2022,Unverified
220306_Belgium_UniversityofAntwerp_c4_OverallPopAdj,03-Mar-22,National,Belgium,BEL,,,08-Jun-20,13-Jun-20,Residual sera,Multiple groups,2960,4.74%,3.65%,5.85%,Stratified probability,EUROIMMUN,ELISA,IgG,84.90%,98.70%,Moderate,Journal Article (Peer-Reviewed),Sereina Herzog,University of Antwerp,https://dx.doi.org/10.2807/1560-7917.ES.2022.27.9.2100419,22/03/2022,16/07/2022,Unverified
220306_Belgium_UniversityofAntwerp_c5_OverallPopAdj,03-Mar-22,National,Belgium,BEL,,,29-Jun-20,04-Jul-20,Residual sera,Multiple groups,3023,3.66%,2.64%,4.70%,Stratified probability,EUROIMMUN,ELISA,IgG,84.90%,98.70%,Moderate,Journal Article (Peer-Reviewed),Sereina Herzog,University of Antwerp,https://dx.doi.org/10.2807/1560-7917.ES.2022.27.9.2100419,22/03/2022,16/07/2022,Unverified
220306_Belgium_UniversityofAntwerp_c6_OverallPopAdj,03-Mar-22,National,Belgium,BEL,,,07-Sep-20,12-Sep-20,Residual sera,Multiple groups,3047,3.28%,2.29%,4.32%,Stratified probability,EUROIMMUN,ELISA,IgG,84.90%,98.70%,Moderate,Journal Article (Peer-Reviewed),Sereina Herzog,University of Antwerp,https://dx.doi.org/10.2807/1560-7917.ES.2022.27.9.2100419,22/03/2022,16/07/2022,Unverified
220306_Belgium_UniversityofAntwerp_c7_OverallPopAdj,03-Mar-22,National,Belgium,BEL,,,12-Oct-20,17-Oct-20,Residual sera,Multiple groups,2966,4.18%,3.12%,5.20%,Stratified probability,EUROIMMUN,ELISA,IgG,84.90%,98.70%,Moderate,Journal Article (Peer-Reviewed),Sereina Herzog,University of Antwerp,https://dx.doi.org/10.2807/1560-7917.ES.2022.27.9.2100419,22/03/2022,16/07/2022,Unverified
220325_Liege_CHUofLiege_Phase3,25-Mar-22,Local,Belgium,BEL,,Liege,05-Jul-20,05-Aug-20,Health care workers and caregivers,Multiple groups,2498,11.50%,,,Convenience,DiaSorin,CLIA,IgG,,99.30%,High,Journal Article (Peer-Reviewed),Pascale Huynen,CHU of Liege,https://dx.doi.org/10.1038/s41598-022-09215-8,04/04/2022,16/07/2022,Unverified
220401_Belgium_UniversityHospitalsLeuven_antiN/S,01-Apr-22,Local,Belgium,BEL,Flemish Brabant,Leuven,01-May-20,18-Mar-21,Patients seeking care for non-COVID-19 reasons,Multiple groups,168,5.40%,,,Entire sample,Abbott Laboratories,CLIA,IgG,,,,Journal Article (Peer-Reviewed),Jef Verbeek,University Hospitals Leuven,https://journals.lww.com/transplantjournal/Fulltext/2022/04000/Liver_or_Kidney_Transplantation_After_SARS_CoV_2.29.aspx,11/04/2022,16/07/2022,Unverified
220127_Belgium_Sciensano_10-11Oct2021,27-Jan-22,National,Belgium,BEL,,,10-Oct-21,11-Oct-21,Blood donors,Multiple groups,1192,99.00%,,,Convenience,NA,Not reported,Total Antibody,,,High,Institutional Report,Sciensano,Sciensano,https://datastudio.google.com/embed/u/0/reporting/7e11980c-3350-4ee3-8291-3065cc4e90c2/page/ZwmOB,16/05/2022,16/07/2022,Unverified
220127_Belgium_Sciensano_06-08Dec2021,27-Jan-22,National,Belgium,BEL,,,06-Dec-21,08-Dec-21,Blood donors,Multiple groups,1122,100.00%,,,Convenience,NA,Not reported,Total Antibody,,,High,Institutional Report,Sciensano,Sciensano,https://datastudio.google.com/embed/u/0/reporting/7e11980c-3350-4ee3-8291-3065cc4e90c2/page/ZwmOB,16/05/2022,16/07/2022,Unverified
220428_Belgium_Sciensano,28-Apr-22,National,Belgium,BEL,,,25-Mar-21,31-Aug-21,Household and community samples,Multiple groups,2767,25.20%,18.80%,31.60%,Stratified probability,NA,ELISA,IgG,91.80%,98.91%,Moderate,Journal Article (Peer-Reviewed),Victoria Leclercq,Sciensano,https://dx.doi.org/10.3390/v14050920,25/05/2022,16/07/2022,Unverified
220613_Liege_CHUofLiege_Phase1_Overall,13-Jun-22,Local,Belgium,BEL,,Liege,06-Apr-20,05-May-20,Multiple populations,Multiple groups,3776,8.90%,,,Convenience,DiaSorin,CLIA,IgG,100.00%,97.90%,High,Journal Article (Peer-Reviewed),Celine Gregoire,CHU of Liege,https://doi.org/10.1038/s41598-022-13450-4,20/06/2022,16/07/2022,Unverified
220127_Belgium_Sciensano_NursingHomeStaff_26Nov-27Dec2021,27-Jan-22,National,Belgium,BEL,,,26-Nov-21,27-Dec-21,Assisted living and long-term care facilities,Adults (18-64 years),876,88.10%,,,Stratified probability,Zhejiang Orient Gene Biotech,LFIA,"IgG,IgM",92.90%,96.30%,Moderate,Institutional Report,Sciensano,Sciensano,https://datastudio.google.com/embed/u/0/reporting/7e11980c-3350-4ee3-8291-3065cc4e90c2/page/ZwmOB,22/06/2022,16/07/2022,Unverified
220127_Belgium_Sciensano_NursingHomeResidents_26Nov-27Dec2021,27-Jan-22,National,Belgium,BEL,,,26-Nov-21,27-Dec-21,Assisted living and long-term care facilities,Seniors (65+ years),1199,97.70%,,,Stratified probability,Zhejiang Orient Gene Biotech,LFIA,"IgG,IgM",92.90%,96.30%,Moderate,Institutional Report,Sciensano,Sciensano,https://datastudio.google.com/embed/u/0/reporting/7e11980c-3350-4ee3-8291-3065cc4e90c2/page/ZwmOB,22/06/2022,16/07/2022,Unverified
220127_Belgium_Sciensano_NursingHomeResidents_28Feb-22Mar2022,27-Jan-22,National,Belgium,BEL,,,28-Feb-22,24-Mar-22,Assisted living and long-term care facilities,Seniors (65+ years),472,99.60%,,,Stratified probability,Zhejiang Orient Gene Biotech,LFIA,"IgG,IgM",92.90%,96.30%,Moderate,Institutional Report,Sciensano,Sciensano,https://datastudio.google.com/embed/u/0/reporting/7e11980c-3350-4ee3-8291-3065cc4e90c2/page/ZwmOB,22/06/2022,10/08/2022,Unverified
220713_Belgium_UCLouvain_Children,13-Jul-22,Regional,Belgium,BEL,Wallonia and Brussels-Capital Regions,Angleur; Berchem-Ste Agathe; Jette; Koekelberg; Herve; Seraing; Beauraing; Châtelineau; La Hulpe; Farciennes,14-Jan-21,18-May-21,Students and Daycares,Children and Youth (0-17 years),922,21.26%,,,Stratified non-probability,"Avioq Bio-Tech, Shandong, China",LFIA,"IgG,IgM",68.80%,95.80%,High,Preprint,Kelly Cremer,Université catholique de Louvain (UCLouvain),https://doi.org/10.21203/rs.3.rs-1781857/v1,18/07/2022,19/07/2022,Unverified
220713_Belgium_UCLouvain_SchoolStaff,13-Jul-22,Regional,Belgium,BEL,Wallonia and Brussels-Capital Regions,Angleur; Berchem-Ste Agathe; Jette; Koekelberg; Herve; Seraing; Beauraing; Châtelineau; La Hulpe; Farciennes,14-Jan-21,18-May-21,Essential non-healthcare workers,Adults (18-64 years),240,28.33%,,,Stratified non-probability,"Avioq Bio-Tech, Shandong, China",LFIA,"IgG,IgM",68.80%,95.80%,High,Preprint,Kelly Cremer,Université catholique de Louvain (UCLouvain),https://doi.org/10.21203/rs.3.rs-1781857/v1,18/07/2022,19/07/2022,Unverified
220714_Charleroi_GrandHopitalDeCharleroi_Summer2020_Overall,14-Jul-22,Local,Belgium,BEL,Walloon Region,Charleroi,20-Jun-20,11-Aug-20,Health care workers and caregivers,Multiple groups,2817,10.72%,9.63%,11.92%,Convenience,DiaSorin,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),Nathalie de Visscher,Grand Hôpital de Charleroi,https://dx.doi.org/10.3390/v14071535,03/08/2022,04/08/2022,Unverified
220714_Charleroi_GrandHopitalDeCharleroi_Winter2021_Overall,14-Jul-22,Local,Belgium,BEL,Walloon Region,Charleroi,06-Feb-21,31-Mar-21,Health care workers and caregivers,Multiple groups,1191,33.92%,31.29%,36.66%,Convenience,DiaSorin,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),Nathalie de Visscher,Grand Hôpital de Charleroi,https://dx.doi.org/10.3390/v14071535,03/08/2022,04/08/2022,Unverified
220127_Belgium_Sciensano_NursingHomeResidents_25May-22Jun2022,27-Jan-22,National,Belgium,BEL,,,25-May-22,22-Jun-22,Assisted living and long-term care facilities,Seniors (65+ years),428,99.60%,,,Stratified probability,Zhejiang Orient Gene Biotech,LFIA,"IgG,IgM",92.90%,96.30%,Moderate,Institutional Report,Sciensano,Sciensano,https://datastudio.google.com/embed/u/0/reporting/7e11980c-3350-4ee3-8291-3065cc4e90c2/page/ZwmOB,10/08/2022,10/08/2022,Unverified
220808_Liege_UniversityOfLiegeHospital_Period1_Primary,08-Aug-22,Local,Belgium,BEL,Wallonia,Liege,01-Mar-20,30-Sep-20,Representative patient population,Multiple groups,525,2.86%,,,Sequential,DiaSorin,CLIA,IgG,89.00%,97.80%,High,Journal Article (Peer-Reviewed),Louis Firket,University of Liege Hospital,https://dx.doi.org/10.1080/17843286.2022.2108978,17/08/2022,17/08/2022,Unverified
220808_Liege_UniversityOfLiegeHospital_Period2_Primary,08-Aug-22,Local,Belgium,BEL,Wallonia,Liege,01-Oct-20,15-May-21,Representative patient population,Multiple groups,471,4.67%,,,Sequential,DiaSorin,CLIA,IgG,89.00%,97.80%,High,Journal Article (Peer-Reviewed),Louis Firket,University of Liege Hospital,https://dx.doi.org/10.1080/17843286.2022.2108978,17/08/2022,17/08/2022,Unverified
211031_Belarus_StPetersburgPasteurInstitute_Overall,31-Oct-21,National,Belarus,BLR,,,14-May-21,19-May-21,Household and community samples,Multiple groups,12926,38.40%,37.60%,45.50%,Simplified probability,NA,ELISA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Anna Popova,St. Petersburg Pasteur Institute,https://dx.doi.org/10.15789/2220-7619-HIT-1798,13/01/2022,16/07/2022,Unverified
210905_Razarbag_BRACUniversity_GroupII_Overall,05-Sep-21,Local,Bangladesh,BGD,Dhaka District,Dhaka,15-May-20,15-Jun-20,Residual sera,Multiple groups,100,20.00%,,,Stratified non-probability,NA,LFIA,IgG,,96.00%,High,Journal Article (Peer-Reviewed),Md Ahsanul Haq,BRAC University,http://dx.doi.org/10.3329/BJMS.V20I5.55407,12/10/2021,16/07/2022,Verified
220110_SitakundaSubdistrict_icddrb_Overall_PopTestClusterAdj,10-Jan-22,Local,Bangladesh,BGD,,Sitakunda subdistrict,27-Mar-21,13-Jun-21,Household and community samples,Multiple groups,2307,64.10%,60.00%,68.10%,Stratified probability,Beijing Wantai Biological,ELISA,"IgA,IgM,IgG",87.70%,99.10%,Low,Journal Article (Peer-Reviewed),Taufiqur Bhuiyan,"icddr,b [International Centre for Diarrhoeal Disease Research, Bangladesh]",https://dx.doi.org/10.3201/eid2802.211689,02/02/2022,16/07/2022,Verified
220127_Dhaka_BRiCM,27-Jan-22,Local,Bangladesh,BGD,,Dhaka,15-Oct-20,15-Feb-21,Household and community samples,Adults (18-64 years),239,42.20%,,,Convenience,Erba Manneim,ELISA,IgG,98.30%,98.10%,High,Journal Article (Peer-Reviewed),Zabed Ahmed,Bangladesh Reference Institute for Chemical Measurements ,https://dx.doi.org/10.1155/2022/4451144,08/02/2022,16/07/2022,Verified
220209_Chattogram_ChattogramVeterinaryandAnimalSciencesUniversity_Overall_TestAdjusted,09-Feb-22,Local,Bangladesh,BGD,Chittagong Division,Chattogram,15-Feb-21,15-Sep-21,Multiple populations,Multiple groups,748,66.99%,63.40%,70.40%,Stratified probability,Kewei Diagnostic,ELISA,IgG,93.80%,97.30%,High,Preprint,Jahan Ara,Chattogram Veterinary and Animal Sciences University,https://www.medrxiv.org/content/10.1101/2022.02.09.22270717v1.full-text,18/02/2022,16/07/2022,Unverified
220325_Dhaka_icddrb_Day28_HighDensity_IgG,25-Mar-22,Local,Bangladesh,BGD,,Dhaka,27-Jun-20,26-Sep-20,Contacts of COVID patients,Multiple groups,442,63.35%,,,Convenience,NA,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Syed Moinuddin Satter,"International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b)",https://dx.doi.org/10.3390/tropicalmed7040053,02/05/2022,16/07/2022,Unverified
220325_Dhaka_icddrb_Day28_LowDensity_IgG,25-Mar-22,Local,Bangladesh,BGD,,Dhaka,27-Jun-20,26-Sep-20,Contacts of COVID patients,Multiple groups,118,65.25%,,,Convenience,NA,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Syed Moinuddin Satter,"International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b)",https://dx.doi.org/10.3390/tropicalmed7040053,02/05/2022,16/07/2022,Unverified
220523_Bangladesh_icddrb_Overall,23-May-22,National,Bangladesh,BGD,,"Dhaka, Chattogram",15-Oct-20,15-Feb-21,Household and community samples,Multiple groups,3220,67.30%,65.20%,69.30%,Stratified probability,Roche Diagnostics,Not reported,"IgG,IgM",93.80%,100.00%,Moderate,Journal Article (Peer-Reviewed),Rubhana Raqib,icddrb,https://dx.doi.org/10.1371/journal.pone.0268093,01/06/2022,16/07/2022,Unverified
220202_Bangladesh_InternationalCentreforDiarrhoealDiseaseResearch,02-Feb-22,National,Bangladesh,BGD,,,15-Apr-20,15-Oct-20,Household and community samples,Multiple groups,2582,30.40%,24.00%,37.00%,Simplified probability,NA,ELISA,"IgG,IgM",100.00%,98.00%,Low,Journal Article (Peer-Reviewed),Taufiqur Bhuiyan,International Centre for Diarrhoeal Disease Research,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8809641/,30/06/2022,16/07/2022,Unverified
220723_Bangladesh_JohnsHopkins_Mothers,23-Jul-22,Local,Bangladesh,BGD,Sylhet Division,Zakiganj Upazila,01-Mar-21,31-Jul-21,Perinatal,Adults (18-64 years),2041,35.80%,33.70%,37.90%,Unclear,ROCHE,Not reported,Not reported,99.50%,99.80%,"Unclear, Unclear",Journal Article (Peer-Reviewed),Rasheda Khanam,Johns Hopkins,https://dx.doi.org/10.7189/jogh.12.05030,09/08/2022,09/08/2022,Unverified
200720_Tyrol_InnsbruckClinicalMicrobiologyLaboratory_Physicians_IgG,20-Jul-20,Regional,Austria,AUT,Tyrol,,20-Mar-20,27-Mar-20,Health care workers and caregivers,Adults (18-64 years),377,0.30%,0.01%,1.50%,Convenience,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Dorothea Orth-Holler,Innsbruck Clinical Microbiology Laboratory,https://www.tandfonline.com/doi/pdf/10.1080/22221751.2020.1793690,01/08/2020,16/07/2022,Verified
200819_Autria_UniversityHospitalKrems_hcw_ELISA_IgGIgM,19-Aug-20,Local,Austria,AUT,,,01-Apr-20,30-Apr-20,Health care workers and caregivers,Adults (18-64 years),130,2.30%,,,Convenience,"Epitope Diagnostics, Inc.",ELISA,"IgG,IgM",,,High,Preprint,Klaus Hackner,Karl Landsteiner University of Health Sciences,https://www.researchsquare.com/article/rs-50887/v1,18/10/2020,16/07/2022,Verified
200808_Vienna_MedicalUniversityOfVienna_HCP,02-Sep-20,Local,Austria,AUT,Vienna,Vienna,01-Apr-20,04-Jun-20,Health care workers and caregivers,Adults (18-64 years),62,3.20%,0.40%,11.20%,Convenience,"Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,High,Journal Article (Peer-Reviewed),Thorsten Fuereder,Medical University of Vienna,https://dx.doi.org/10.1136/esmoopen-2020-000889,05/11/2020,16/07/2022,Verified
200808_Vienna_MedicalUniversityOfVienna_Patients,02-Sep-20,Local,Austria,AUT,Vienna,Vienna,21-Mar-20,04-Jun-20,Patients seeking care for non-COVID-19 reasons,Multiple groups,84,2.40%,0.30%,8.30%,Convenience,"Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,High,Journal Article (Peer-Reviewed),Thorsten Fuereder,Medical University of Vienna,https://dx.doi.org/10.1136/esmoopen-2020-000889,05/11/2020,16/07/2022,Verified
201222_Vienna_MedicalUniversityofVienna_Overall,22-Dec-20,Local,Austria,AUT,Vienna,Vienna,02-Apr-20,17-Apr-20,Non-essential workers and unemployed persons,Adults (18-64 years),1655,10.15%,,,Convenience,EUROIMMUN,ELISA,"IgA,IgG",,,High,Preprint,Angelika Wagner,Medical University of Vienna,https://www.medrxiv.org/content/10.1101/2020.12.22.20248604v1,23/01/2021,16/07/2022,Verified
210129_Vienna_MedicalUniversityOfVienna_Overall,29-Jan-21,Local,Austria,AUT,Vienna,Vienna,18-May-20,02-Jul-20,Students and Daycares,Children and Youth (0-17 years),2042,1.27%,,,Convenience,"Beijing Wantai Biological,NA,EUROIMMUN",Multiple Types,"Total Antibody,IgG,Neutralizing ",,,Moderate,Journal Article (Peer-Reviewed),Zsolt Szepfalusi,Medical University of Vienna,https://dx.doi.org/10.1111/pai.13459,16/02/2021,16/07/2022,Unverified
210203_Austria_MedicalUniversityOfVienna_Overall,03-Feb-21,National,Austria,AUT,,,11-May-20,21-Dec-20,Health care workers and caregivers,Adults (18-64 years),3301,0.51%,,,Convenience,"DiaSorin,Roche Diagnostics",Multiple Types,"IgA,IgM,IgG",,,High,Preprint,Iris Leister,Medical University of Vienna,10.1101/2021.02.01.21250898,17/02/2021,16/07/2022,Verified
210107_Austria_UniversityCollegeLondon_PaediatricHCW,27-Jan-21,Local,Austria,AUT,,Vienna,17-Jul-20,24-Jul-20,Health care workers and caregivers,Adults (18-64 years),196,0.00%,0.00%,1.92%,Convenience,"Epitope Diagnostics, Inc.,Meso Scale Discovery",ELISA,IgG,,,High,Journal Article (Peer-Reviewed),D Goldblatt,University College London,http://dx.doi.org/10.1016/j.jhin.2020.12.019,13/03/2021,16/07/2022,Unverified
210108_Linz_OrdensklinikumLinzBarmherzigeSchwestern_OverallHCW,08-Jan-21,Local,Austria,AUT,Upper Austria,Linz,15-Jun-20,15-Jul-20,Health care workers and caregivers,Adults (18-64 years),1757,2.00%,,,Convenience,"Abbott Laboratories,Roche Diagnostics",CLIA,IgG,100.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Margot Egger,Ordensklinikum Linz Barmherzige Schwestern and Konventhospital Barmherzige Brueder Linz  ,https://dx.doi.org/10.1515/cclm-2020-1681,19/03/2021,16/07/2022,Verified
210212_Ischgl_MedicalUniversityofInnsbruck_overall,12-Feb-21,Local,Austria,AUT,Tyrol,Ischgl,21-Apr-20,27-Apr-20,Household and community samples,Multiple groups,451,43.70%,,,Entire sample,"Abbott Laboratories,EUROIMMUN,NA",Multiple Types,"IgG,IgA",,,High,Journal Article (Peer-Reviewed),Jens Lehmann, Medical University of Innsbruck,https://dx.doi.org/10.1017/S0950268821000418,27/03/2021,16/07/2022,Verified
210409_Vienna_MedicalUniversityofVienna,09-Apr-21,Local,Austria,AUT,Vienna,Vienna,22-Mar-20,31-Mar-20,Health care workers and caregivers,Adults (18-64 years),235,25.50%,20.40%,31.50%,Convenience,NA,ELISA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Thomas Reiter,Medical University of Vienna,https://dx.doi.org/10.1007/s00508-021-01848-5,23/04/2021,16/07/2022,Unverified
210404_Vienna_MedicalUniversityofVienna_Overall_2months,15-Apr-21,Local,Austria,AUT,Vienna,Vienna,01-Apr-20,01-Jun-20,Health care workers and caregivers,Adults (18-64 years),553,1.50%,,,Convenience,Abbott Laboratories,Other,IgG,,,High,Journal Article (Peer-Reviewed),Lorenz Schubert,Medical University of Vienna,http://dx.doi.org/10.3390/ijerph18084201,17/05/2021,16/07/2022,Verified
201211_Austria_StatistikAustria_overall_PopAdj,11-Dec-20,National,Austria,AUT,,,12-Nov-20,14-Nov-20,Household and community samples,Multiple groups,2229,4.70%,3.80%,5.60%,Simplified probability,NA,Multiple Types,Not reported,,,Moderate,Institutional Report,Statistik Austria,StatistikAustria,http://www.statistik.at/wcm/idc/idcplg?IdcService=GET_PDF_FILE&dDocName=124957,21/05/2021,16/07/2022,Unverified
210428_Austria_HanuschHospital,28-Apr-21,National,Austria,AUT,,,01-Jul-20,31-Jul-20,Non-essential workers and unemployed persons,Adults (18-64 years),7858,1.12%,0.90%,1.38%,Convenience,"Abbott Laboratories,NA",Multiple Types,"IgG,Neutralizing ",,,Moderate,Journal Article (Peer-Reviewed),Johann Bartko,Hanusch Hospital,https://dx.doi.org/10.3390/jcm10091909,21/05/2021,16/07/2022,Verified
210512_Vienna_LudwigBoltzmannInstituteForLungHealth_overall,12-May-21,Local,Austria,AUT,,Vienna,20-Apr-20,20-May-20,Household and community samples,Multiple groups,12419,1.31%,,,Stratified probability,"Roche Diagnostics,EUROIMMUN,NA",Multiple Types,"IgG,Neutralizing ",,,Moderate,Journal Article (Peer-Reviewed),Marie Kathrin Breyer,Ludwig Boltzmann Institute for Lung Health,https://dx.doi.org/10.1038/s41598-021-89711-5,28/05/2021,16/07/2022,Verified
201212_Europe_UniversityOfGlasgow_Austria3,12-Dec-20,National,Austria,AUT,,"Klagenfurt, Vienna and Wels",15-Apr-20,30-Jun-20,Health care workers and caregivers,Adults (18-64 years),72,2.78%,0.77%,9.58%,Convenience,Abbott Laboratories,CLIA,IgG,100.00%,99.60%,High,Journal Article (Peer-Reviewed),Scott M Nelson,University of Glasgow,https://dx.doi.org/10.1093/hropen/hoaa056,07/06/2021,16/07/2022,Verified
210527_Austria_UniversitätsklinikfürInnereMedizinII_HCWs_PeriodB,27-May-21,Local,Austria,AUT,NR,Vienna,08-Sep-20,22-Feb-21,Health care workers and caregivers,Adults (18-64 years),498,7.20%,5.30%,9.80%,Convenience,Roche Diagnostics,CLIA,Total Antibody,,,Unclear,Presentation or Conference,M. Riesenhuber,Universitätsklinik für Innere Medizin II,https://link.springer.com/content/pdf/10.1007/s00508-021-01884-1.pdf,20/06/2021,16/07/2022,Verified
210527_Austria_UniversitätsklinikfürInnereMedizinII_Patients,27-May-21,Local,Austria,AUT,NR,Vienna,24-Aug-20,22-Feb-21,Residual sera,Multiple groups,6092,5.71%,,,Sequential,Roche Diagnostics,CLIA,Total Antibody,,,Unclear,Presentation or Conference,M. Riesenhuber,Universitätsklinik für Innere Medizin II ,https://link.springer.com/content/pdf/10.1007/s00508-021-01884-1.pdf,20/06/2021,16/07/2022,Verified
210811_Ischgl_MedicalUniversityOfInnsbruck,01-Aug-21,Local,Austria,AUT,Tyrol,Ischgl,02-Nov-20,08-Nov-20,Household and community samples,Adults (18-64 years),801,45.40%,42.00%,49.00%,Convenience,"EUROIMMUN,Abbott Laboratories,Roche Diagnostics,NA",Multiple Types,"IgG,IgA",,,Moderate,Journal Article (Peer-Reviewed),Wegene Borena,Medical University Of Innsbruck,https://dx.doi.org/10.1016/j.ebiom.2021.103534,29/08/2021,16/07/2022,Verified
210616_Austria_UniversityHospitalOfSalzburg_Overall,16-Jun-21,National,Austria,AUT,,,05-Jun-20,04-Dec-20,Blood donors,Multiple groups,20228,2.50%,,,Convenience,Roche Diagnostics,CLIA,Total Antibody,100.00%,99.81%,Low,Journal Article (Peer-Reviewed),Lisa Weidner, University Hospital of Salzburg,https://dx.doi.org/10.1007/s15010-021-01639-0,08/09/2021,16/07/2022,Verified
211026_Tyrol_TirolKlinikenGmbH_Abbott_Primary,26-Oct-21,Regional,Austria,AUT,"Tyrol
",,08-Jun-20,04-Sep-20,Blood donors,Multiple groups,5345,3.10%,2.60%,3.60%,Convenience,Abbott Laboratories,CLIA,IgG,100.00%,99.63%,Moderate,Journal Article (Peer-Reviewed),Anita Siller,Tirol Kliniken GmbH,https://dx.doi.org/10.1007/s00508-021-01963-3,03/11/2021,16/07/2022,Unverified
220309_Tyrol_MedicalUniversityofInnsbruck_Overall_UnAdj,09-Mar-22,Regional,Austria,AUT,Tyrol,,19-Mar-21,30-Sep-21,Blood donors,Multiple groups,19792,63.24%,,,Sequential,Abbott Laboratories,CLIA,IgG,99.35%,99.60%,Moderate,Journal Article (Peer-Reviewed),Anita Siller,Medical University of Innsbruck ,https://dx.doi.org/10.3390/v14030568,07/04/2022,16/07/2022,Verified
220411_Austria_LKHHochsteiermarkLeobenVordernbergerstr_Primary,21-Apr-22,Local,Austria,AUT,,Vienna,30-Nov-21,13-Jan-22,Multiple populations,Multiple groups,1217,21.70%,17.60%,25.40%,Unclear,Viramed Biotech AG,IFA,IgG,,,High,Presentation or Conference,Reinhold Kerbl,LKH Hochsteiermark Leoben Vordernbergerstr,https://dx.doi.org/10.1007/s00112-022-01491-y,02/05/2022,16/07/2022,Verified
210714_Vienna_MedicalUniversityofVienna_Overall,14-Jul-21,Local,Austria,AUT,Vienna,Vienna,02-Apr-20,17-Apr-20,Non-essential workers and unemployed persons,Adults (18-64 years),1655,10.15%,,,Convenience,EUROIMMUN,ELISA,"IgA,IgG",,,High,Journal Article (Peer-Reviewed),Angelika Wagner,Medical University of Vienna,https://dx.doi.org/10.1038/s43856-021-00012-4,02/06/2022,16/07/2022,Unverified
220524_Vorarlberg_VIVIT_t1,24-May-22,Regional,Austria,AUT,Vorarlberg,,26-Jun-20,19-Aug-20,Health care workers and caregivers,Adults (18-64 years),395,6.10%,,,Self-referral,Technoclone,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Michele Atzl,Vorarlberg Institute for Vascular Investigation and Treatment,https://dx.doi.org/10.1136/bmjopen-2021-052130,05/06/2022,16/07/2022,Unverified
220727_Weißenkirchen_DanubePrivateUniversity_Overall,27-Jul-22,Local,Austria,AUT,,Weißenkirchen,13-Feb-21,13-Feb-21,Household and community samples,Multiple groups,552,25.00%,,,Convenience,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Heike Rebholz,Danube Private University,https://dx.doi.org/10.1371/journal.pone.0271382,03/08/2022,03/08/2022,Unverified
200803_NewSouthWales_UniversityOfSydney_IndividualsInEducationalSetting,03-Aug-20,Regional,Australia,AUS,New South Wales,,25-Jan-20,10-Apr-20,Contacts of COVID patients,Multiple groups,173,2.31%,,,Convenience,NA,Other,"IgG,IgA,IgM",91.30%,98.90%,Moderate,Journal Article (Peer-Reviewed),Kristine Macartney,University of Sydney,https://dx.doi.org/10.1016/S2352-4642(20)30251-0,16/10/2020,16/07/2022,Verified
210203_Sydney_Children'sHospitalAtWestmead_GeneralPathology_overall_TestAdj,03-Feb-21,Local,Australia,AUS,New South Wales,Sydney,20-Apr-20,22-May-20,Residual sera,Multiple groups,3231,0.15%,0.04%,0.41%,Stratified probability,NA,IFA,IgG,90.70%,99.30%,Moderate,Journal Article (Peer-Reviewed),Heather F Gidding,Children's Hospital at Westmead,https://onlinelibrary.wiley.com/doi/10.5694/mja2.50940,18/03/2021,16/07/2022,Unverified
210203_Sydney_Children'sHospitalAtWestmead_PlasmapheresisDonors_overall_TestAdj,03-Feb-21,Local,Australia,AUS,New South Wales,Sydney,05-May-20,02-Jun-20,Blood donors,Adults (18-64 years),1548,0.29%,0.04%,0.75%,Stratified probability,NA,Other,IgG,90.70%,99.30%,Moderate,Journal Article (Peer-Reviewed),Heather F Gidding,Children's Hospital at Westmead,https://onlinelibrary.wiley.com/doi/10.5694/mja2.50940,19/03/2021,16/07/2022,Unverified
210203_Sydney_Children'sHospitalAtWestmead_AntenatalScreening_overall_TestAdj,03-Feb-21,Local,Australia,AUS,New South Wales,Sydney,04-May-20,23-May-20,Pregnant or parturient women,Adults (18-64 years),560,0.79%,0.04%,1.88%,Stratified probability,NA,IFA,IgG,90.70%,99.30%,Moderate,Journal Article (Peer-Reviewed),Heather F Gidding,Children's Hospital at Westmead,https://onlinelibrary.wiley.com/doi/10.5694/mja2.50940,19/03/2021,16/07/2022,Unverified
210109_Australia_AustralianNationalUniversity_overall_adj,09-Jan-21,National,Australia,AUS,"New South Wales, South Australia, Victoria and Western Australia",,02-Jun-20,17-Jul-20,Residual sera,Multiple groups,2991,0.16%,0.00%,0.47%,Sequential,NA,ELISA,IgG,100.00%,98.90%,Low,Journal Article (Peer-Reviewed),Nicholas Coatsworth ,Australian National University,https://onlinelibrary.wiley.com/doi/full/10.1111/ans.16564,19/03/2021,16/07/2022,Verified
210413_Melbourne_EasternHealth_OverallHCW,01-Aug-21,Local,Australia,AUS,Victoria,Melbourne,09-Nov-20,04-Dec-20,Health care workers and caregivers,Multiple groups,736,2.17%,,,Convenience,"Roche Diagnostics,NA",Multiple Types,IgG,,,Moderate,Journal Article (Peer-Reviewed),Jillian SY Lau,Eastern Health,https://dx.doi.org/10.1016/j.idh.2021.03.004,19/05/2021,16/07/2022,Verified
210703_Melbourne_RoyalChildrensHospital_Primary,03-Jul-21,Local,Australia,AUS,,Melbourne,21-Oct-20,30-Oct-20,Health care workers and caregivers,Adults (18-64 years),318,0.00%,,,Convenience,"DiaSorin,EUROIMMUN,GenScript,Beijing Wantai Biological",Multiple Types,"IgA,IgG,IgM",,,High,Journal Article (Peer-Reviewed),Jane Tuckerman,Royal Children's Hospital,https://dx.doi.org/10.1111/jpc.15585,12/07/2021,16/07/2022,Verified
211111_Australia_NSWWestmeadHospital_Primary,11-Nov-21,National,Australia,AUS,"Australia (Western Australia, South Australia, Tasmania, Victoria
and the Australian Capital Territory) and countries (New Zealand)",,24-Jan-20,31-Jul-20,Multiple populations,Multiple groups,10595,9.80%,,,Sequential,NA,IFA,"IgA,IgG,IgM",91.30%,98.90%,High,Journal Article (Peer-Reviewed),Tasnim Hasan,New South Wales Westmead Hospital,https://dx.doi.org/10.1111/1753-6405.13155,18/11/2021,16/07/2022,Verified
220131_Australia_UniversityOfSydney_Antenatal_Overall_TestAdjustment,31-Jan-22,National,Australia,AUS,,,19-Jun-20,06-Aug-20,Pregnant or parturient women,Adults (18-64 years),2972,0.23%,0.04%,0.54%,Convenience,Beijing Wantai Biological,ELISA,Total Antibody,95.10%,99.60%,Moderate,Journal Article (Peer-Reviewed),Kaitlyn Vette,University of Sydney,https://dx.doi.org/10.1093/ofid/ofac002,22/02/2022,16/07/2022,Verified
220131_Australia_UniversityOfSydney_GeneralPathology_Overall_TestAdjustment,31-Jan-22,National,Australia,AUS,,,19-Jun-20,06-Aug-20,Residual sera,Multiple groups,5132,0.25%,0.03%,0.54%,Convenience,Beijing Wantai Biological,ELISA,Total Antibody,95.10%,99.60%,Moderate,Journal Article (Peer-Reviewed),Kaitlyn Vette,University of Sydney,https://dx.doi.org/10.1093/ofid/ofac002,22/02/2022,16/07/2022,Verified
220131_Australia_UniversityOfSydney_BloodDonors_Overall_TestAdjustment,31-Jan-22,National,Australia,AUS,,,19-Jun-20,06-Aug-20,Blood donors,Multiple groups,3213,0.47%,0.04%,0.89%,Convenience,Beijing Wantai Biological,ELISA,Total Antibody,95.10%,99.60%,Moderate,Journal Article (Peer-Reviewed),Kaitlyn Vette,University of Sydney,https://dx.doi.org/10.1093/ofid/ofac002,22/02/2022,16/07/2022,Verified
220313_Melbourne_UniversityofNewSouthWales_OverallPopTestAdjust,13-Mar-22,Local,Australia,AUS,Victoria,Metropolitan Melbourne,23-Nov-20,17-Dec-20,Blood donors,Adults (18-64 years),4799,0.90%,,,Stratified probability,Beijing Wantai Biological,ELISA,Total Antibody,95.10%,99.60%,Moderate,Preprint,Dorothy Machalek,University of New South Wales,https://www.medrxiv.org/content/10.1101/2022.03.11.22272185v1.full-text,21/03/2022,16/07/2022,Verified
220416_NewSouthWales_DouglassHanlyMoirPathology,16-Apr-22,Local,Australia,AUS,New South Wales and the Australian Capital Territory,,09-Jul-20,19-Sep-21,Residual sera,Multiple groups,545,8.40%,,,Sequential,"Roche Diagnostics,Abbott Laboratories",CLIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Michael Wehrhahn,Douglass Hanly Moir Pathology,https://dx.doi.org/10.1016/j.pathol.2022.03.001,29/04/2022,16/07/2022,Unverified
220521_Australia_UniversityOfSydney_ELISA_TestAdj_Overall,21-May-22,National,Australia,AUS,Queensland; New South Wales; Victoria; South Australia; Western Australia.,Brisbane; Sydney; Melbourne; Adelaide; Perth.,03-Nov-20,12-Mar-21,Residual sera,Children and Youth (0-17 years),1685,0.23%,0.06%,0.57%,Convenience,Beijing Wantai Biological,ELISA,Total Antibody,95.10%,99.60%,High,Journal Article (Peer-Reviewed),Archana Koirala,University of Sydney,https://dx.doi.org/10.5694/mja2.51542,04/06/2022,16/07/2022,Unverified
220603_Australia_KirbyInstitute_antiS,03-Jun-22,National,Australia,AUS,,,23-Feb-22,03-Mar-22,Blood donors,Multiple groups,5185,98.10%,97.70%,98.50%,Convenience,Roche Diagnostics,Not reported,Not reported,,,Moderate,Institutional Report,The Australian COVID-19 Serosurveillance Network,The Kirby Institute,https://kirby.unsw.edu.au/report/seroprevalence-sars-cov-2-specific-antibodies-among-australian-blood-donors-february-march,04/08/2022,04/08/2022,Unverified
220726_Australia_KirbyInstitute_antiS,26-Jul-22,National,Australia,AUS,,,09-Jun-22,18-Jun-22,Blood donors,Multiple groups,5138,99.00%,98.70%,99.20%,Convenience,Roche Diagnostics,Not reported,Not reported,,,Moderate,Institutional Report,The Australian COVID-19 Serosurveillance Network,The Kirby Institute,https://kirby.unsw.edu.au/report/seroprevalence-sars-cov-2-specific-antibodies-among-australian-blood-donors-may-june-2022,04/08/2022,05/08/2022,Unverified
220603_Australia_KirbyInstitute_antiN,03-Jun-22,National,Australia,AUS,,,23-Feb-22,03-Mar-22,Blood donors,Multiple groups,5185,17.00%,16.00%,18.00%,Convenience,Roche Diagnostics,Not reported,Not reported,,,Moderate,Institutional Report,The Australian COVID-19 Serosurveillance Network,The Kirby Institute,https://kirby.unsw.edu.au/report/seroprevalence-sars-cov-2-specific-antibodies-among-australian-blood-donors-february-march,04/08/2022,04/08/2022,Unverified
220726_Australia_KirbyInstitute_antiN_Age18to29,26-Jul-22,National,Australia,AUS,,,09-Jun-22,18-Jun-22,Blood donors,Adults (18-64 years),1127,61.70%,58.80%,64.50%,Convenience,Roche Diagnostics,Not reported,Not reported,,,Moderate,Institutional Report,The Australian COVID-19 Serosurveillance Network,The Kirby Institute,https://kirby.unsw.edu.au/report/seroprevalence-sars-cov-2-specific-antibodies-among-australian-blood-donors-may-june-2022,04/08/2022,05/08/2022,Unverified
200630_Yerevan_ArmeniaMinistryofHealth_HCWs,30-Jun-20,Local,Armenia,ARM,Yerevan,Yerevan,,29-Jun-20,Health care workers and caregivers,Adults (18-64 years),380,16.05%,,,Convenience,NA,Not reported,Not reported,100.00%,99.80%,High,News and Media,Anna Grigoryan,Ministry of Health of the Republic of Armenia,https://www.google.com/url?rct=j&sa=t&url=https://armenpress.am/eng/news/1020040/&ct=ga&cd=CAEYFioTMTc0ODAyMDA0NzI0ODEyNTQxODIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNHN-cSj3u7JgQAyBjN07fSTGAdlgA,01/08/2020,16/07/2022,Verified
211021_Armenia_EcoSenseDiagnosticCenter,21-Oct-21,National,Armenia,ARM,,,15-Mar-20,15-Dec-20,Household and community samples,Multiple groups,837,25.33%,,,Self-referral,NovaTec Immundiagnostics GmbH,ELISA,IgG,,,High,Presentation or Conference,I Nazaryan,EcoSense Diagnostic Center,http://dx.doi.org/10.1515/cclm-2021-5027,14/12/2021,16/07/2022,Unverified
"200718_BuenosAires_MinisterofHealth,BuenosAiresCity_Homeless",18-Jul-20,Local,Argentina,ARG,Buenos Aires,Buenos Aires,10-Jun-20,01-Jul-20,Persons experiencing homelessness,Multiple groups,60,36.00%,,,Convenience,CONICET,ELISA,IgG,95.00%,100.00%,High,Preprint,Silvana Figar,"Minister of Health, Buenos Aires City",https://www.medrxiv.org/content/10.1101/2020.07.14.20153858v1,17/07/2020,16/07/2022,Verified
200909_BuenosAires_InstitutoNacionalDeEpidemiologia_Overall,09-Sep-20,Local,Argentina,ARG,Buenos Aires,Buenos Aires,03-Jun-20,06-Jul-20,Health care workers and caregivers,Multiple groups,738,0.75%,0.00%,8.13%,Stratified probability,CONICET,ELISA,"IgG,IgM",,,Moderate,Preprint,Andrea Silva,Instituto Nacional de Epidemiologia,https://www.medrxiv.org/content/10.1101/2020.09.07.20189050v1,10/11/2020,16/07/2022,Verified
201201_BuenosAires_HospitalGeneraldeNiñosPedrodeElizalde_overall,01-Dec-20,Local,Argentina,ARG,Province of Buenos Aires,Autonomous City of Buenos Aires,08-Jun-20,09-Jun-20,Health care workers and caregivers,Adults (18-64 years),116,0.90%,0.10%,5.50%,Simplified probability,Snibe Co. Ltd (Shenzhen New Industries Biomedical Engineering Co. Ltd),CLIA,"IgG,IgM",95.60%,96.00%,High,Journal Article (Peer-Reviewed),Claudia Insua,Hospital General de Niños Pedro de Elizalde,https://dx.doi.org/10.5546/aap.2020.eng.381,25/01/2021,16/07/2022,Verified
210107_BuenosAires_UniversityOfBuenosAires_Primary,07-Jan-21,Local,Argentina,ARG,,Buenos Aires,01-Mar-20,31-Oct-20,Health care workers and caregivers,Adults (18-64 years),317,3.00%,2.00%,5.00%,Stratified non-probability,NA,ELISA,Not reported,85.00%,95.00%,High,Journal Article (Peer-Reviewed),Puia Sebastian ,University of Buenos Aires,https://dx.doi.org/10.1016/j.jobcr.2021.01.006,18/02/2021,16/07/2022,Verified
200828_VillaAzul_MinisterioDeSaludDeLaProvinciaDeBuenosAires_overall,28-Aug-20,Local,Argentina,ARG,Buenos Aires,Quilmes,15-Jul-20,16-Jul-20,Household and community samples,Multiple groups,284,14.80%,11.10%,19.50%,Stratified non-probability,COVIDAR,ELISA,IgG,95.00%,100.00%,Moderate,Preprint,Laura Munoz,Ministerio de Salud de la Provincia de Buenos Aires,https://preprints.scielo.org/index.php/scielo/preprint/view/1147,21/04/2021,16/07/2022,Verified
210121_BarrioMugica_MinistryOfHealthOfTheCityOfBuenosAires,21-Jan-21,Local,Argentina,ARG,Buenos Aires,Buenos Aires,10-Jun-20,26-Jun-20,Persons living in slums,Multiple groups,873,53.40%,52.80%,54.10%,Simplified probability,CONICET,ELISA,IgG,90.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Silvana Figar,Ministry of Health of the City of Buenos Aires,https://www.medicinabuenosaires.com/revistas/vol81-21/destacado/original_7453.pdf,21/04/2021,16/07/2022,Verified
210122_BuenosAires_GovernmentOfTheProvinceOfBuenosAires,22-Jan-21,Local,Argentina,ARG,Buenos Aires,Metropolitan Area of Buenos Aires,15-Jul-20,15-Dec-20,Household and community samples,Multiple groups,9000,13.00%,,,Unclear,NA,ELISA,Not reported,,,High,News and Media,Government of the Province of Buenos Aires,Government of the Province of Buenos Aires,https://www.gba.gob.ar/saludprovincia/noticias/s%C3%B3lo_el_13_por_ciento_de_los_vecinos_y_vecinas_de_30_barrios_populares_del,17/05/2021,16/07/2022,Unverified
201230_ArgentinaHurlingham_UniversidadNacionalHurlingham,30-Dec-20,Local,Argentina,ARG,Buenos Aires,Buenos Aires,01-Dec-20,30-Dec-20,Household and community samples,Multiple groups,1182,12.10%,10.00%,14.20%,Stratified probability,COVIDAR,ELISA,IgG,,,High,Institutional Report,Universidad Nacional De Hurlingham,Universidad Nacional De Hurlingham,http://www.unahur.edu.ar/es/se-presentaron-los-resultados-del-estudio-de-seroprevalencia-de-covid-19-que-realizo-la-universidad,21/05/2021,16/07/2022,Verified
210615_SantaFe_UniversidadNacionalDelLitoral_genpop_overall,15-Jun-21,Local,Argentina,ARG,,Santa Fe,01-Jul-20,30-Nov-20,Multiple general populations,Multiple groups,3000,8.83%,,,Convenience,COVIDAR,ELISA,IgG,96.70%,100.00%,Moderate,Journal Article (Peer-Reviewed),Luz Maria Rodeles,Universidad Nacional del Litoral,https://dx.doi.org/10.26633/RPSP.2021.66,05/07/2021,16/07/2022,Unverified
220314_PuertoMadryn_UniversidadAustral_Overall,14-Mar-22,Local,Argentina,ARG,Chubut,Puerto Madryn,03-Mar-21,17-Apr-21,Household and community samples,Multiple groups,987,39.21%,36.20%,42.30%,Stratified probability,COVIDAR,Not reported,IgG,100.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Daniel Schonfeld,Universidad Austra,https://dx.doi.org/10.1371/journal.pone.0263679,22/03/2022,16/07/2022,Unverified
220520_Córdoba_MinistryOfHealth_Overall,20-May-22,Local,Argentina,ARG,Córdoba,Córdoba,15-Dec-20,15-Jan-21,Household and community samples,Multiple groups,3225,16.68%,15.41%,18.01%,Stratified probability,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Laura Aballay,Ministry of Health of the Province of Córdoba,https://dx.doi.org/10.1590/0102-311XES219821,01/06/2022,16/07/2022,Unverified
210506_Luanda_InstitutoNacionaldeInvestigaçãoemSaúde_IgG,06-May-21,Local,Angola,AGO,Luanda Province,NR,15-Jul-20,15-Sep-20,Residual sera,Multiple groups,660,1.10%,,,Convenience,Biomerieux,Other,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Cruz Sebastiao,Instituto Nacional de Investigação em Saúde,https://dx.doi.org/10.1002/hsr2.280,30/05/2021,16/07/2022,Verified
211102_Luanda_UniversidadeAgostinhoNeto_Primary,02-Nov-21,Local,Angola,AGO,NR,Luanda,15-Dec-19,15-Sep-20,Blood donors,Adults (18-64 years),343,4.70%,,,Convenience,Biomerieux,ELISA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Cruz Sebastiao,Instituto Nacional de Investigação em Saúde,https://dx.doi.org/10.1186/s12879-021-06814-0,10/11/2021,16/07/2022,Verified
220219_Angola_NationalInstituteforHealthResearch_Overall,19-Feb-22,National,Angola,AGO,,,23-Sep-19,28-Feb-20,Residual sera,Multiple groups,442,9.05%,,,Sequential,Biomérieux,ELISA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Joana Paixao,National Institute for Health Research,https://dx.doi.org/10.2147/IDR.S344437,09/03/2022,16/07/2022,Unverified
210521_Andorra_ISGlobal_Overall,21-May-21,National,Andorra,AND,,,04-May-20,28-May-20,Household and community samples,Multiple groups,72964,11.00%,,,Entire sample,Zhuhai Livzon Diagnostics Inc,LFIA,"IgM,IgG",92.00%,100.00%,Low,Journal Article (Peer-Reviewed),Cristina Royo Cebrecos,ISGlobal,https://www.sciencedirect.com/science/article/pii/S266677622100096X,29/07/2021,16/07/2022,Verified
210921_Andorra_HospitalNostraSenyoradeMeritxell_November,21-Sep-21,Local,Andorra,AND,,,01-Nov-20,30-Nov-20,Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),156,6.41%,,,Convenience,NA,Not reported,Not reported,,,High,Presentation or Conference,C Royo-Cebrecos,Hospital Nostra Senyora de Meritxell,http://dx.doi.org/10.1016/j.annonc.2021.08.1594,28/09/2021,16/07/2022,Unverified
220412_Andorra_HospitalNostraSenyoradeMeritxell_Primary,12-Apr-22,National,Andorra,AND,,,15-May-20,15-Jun-21,Representative patient population,Multiple groups,373,18.20%,,,Convenience,"Zhuhai Livzon Diagnostics Inc,Roche Diagnostics",Multiple Types,"IgG,IgM,IgA",,,High,Preprint,Cristina Royo-Cebrecos,Hospital Nostra Senyora de Meritxell,10.21203/rs.3.rs-1538781/v1,21/04/2022,16/07/2022,Unverified
210220_Tirana_UniversityofMedicineandUniversityHospitalCenterofTirana_July_Adults,20-Feb-21,Local,Albania,ALB,,Tirana,27-Jun-20,03-Jul-20,Household and community samples,Adults (18-64 years),266,7.50%,4.30%,10.70%,Stratified probability,EUROIMMUN,ELISA,IgG,,,High,Preprint,Genc Sulcebe,University of Medicine and University Hospital Center of Tirana,https://doi.org/10.1101/2021.02.18.21251776,21/03/2021,16/07/2022,Verified
210220_Tirana_UniversityofMedicineandUniversityHospitalCenterofTirana_December_Adults,20-Feb-21,Local,Albania,ALB,,Tirana,21-Dec-20,28-Dec-20,Household and community samples,Adults (18-64 years),815,48.20%,44.80%,51.70%,Stratified probability,EUROIMMUN,ELISA,IgG,,,High,Preprint,Genc Sulcebe,University of Medicine and University Hospital Center of Tirana,https://doi.org/10.1101/2021.02.18.21251776,21/03/2021,16/07/2022,Verified
220725_TiranaAndBerat_AcademyOfSciencesOfAlbania_Overall,25-Jul-22,Local,Albania,ALB,,"Tirana, Berat",15-Jun-21,15-Jul-21,Household and community samples,Multiple groups,1527,73.35%,,,Simplified probability,EUROIMMUN,ELISA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Fabian Cenko,Academy of Sciences of Albania,https://dx.doi.org/10.7189/jogh.12.03054,11/08/2022,12/08/2022,Unverified
201220_Afghanistan_UnitedStatesAirForce,31-Dec-20,Local,Afghanistan,AFG,NR,NR,17-Apr-20,01-Jun-20,Essential non-healthcare workers,Adults (18-64 years),1957,1.90%,,,Unclear,NA,Not reported,"IgG,IgM",,,Unclear,Journal Article (Peer-Reviewed),Brian White,United States Air Force,http://dx.doi.org/10.1093/ofid/ofaa439.666,02/05/2021,16/07/2022,Verified
200801_Afghanistan_AfghanistanMinistryofPublicHealth,01-Aug-20,National,Afghanistan,AFG,NR,NR,01-Jun-20,15-Jun-20,Household and community samples,Multiple groups,9514,31.50%,,,Stratified probability,NA,LFIA,"IgG,IgM",,,Moderate,Journal Article (Peer-Reviewed),Sayed Ataullah Saeedzai,Afghanistan Ministry of Public Health ,https://moph.gov.af/sites/default/files/2020-08/Final%20COVID-19%20Survey%20English%20Report.pdf,19/05/2021,16/07/2022,Verified
